# Base de connaissance OpenHealth > Bienvenue dans "SUCCESS", la base de connaissance de votre Plateforme ## العربية ### Les OPTIONS PERSONNALISÉES - [سعر الصرف](https://success.openhealth.fr/ar/articles/8329594-سعر-الصرف.md): تعرف على كيفية حساب سعر الصرف على المنصة ## Dansk ### Votre PLATEFORME - présentation générale - [HUB, en omfattende og kontinuerlig støtteplatform](https://success.openhealth.fr/da/articles/4799621-hub-en-omfattende-og-kontinuerlig-stotteplatform.md) - [Dit erfaringsniveau The HUB](https://success.openhealth.fr/da/articles/5712270-dit-erfaringsniveau-the-hub.md) - [Languages](https://success.openhealth.fr/da/articles/4649389-languages.md): Here is the description of all languages available on Success - [Spørgsmål om vores priser](https://success.openhealth.fr/da/articles/3292143-sporgsmal-om-vores-priser.md): Vores priser ### Køreplanen - [Åben innovation til gavn for vores kunder](https://success.openhealth.fr/da/articles/5200970-aben-innovation-til-gavn-for-vores-kunder.md) - [Apps + Administrationsområde version 240515](https://success.openhealth.fr/da/articles/9310541-apps-administrationsomrade-version-240515.md) - [Apps + Administrationsområde version 240415](https://success.openhealth.fr/da/articles/9310710-apps-administrationsomrade-version-240415.md) - [Apps + Administrationsområde version 240315](https://success.openhealth.fr/da/articles/9310790-apps-administrationsomrade-version-240315.md) - [Apps + Administrationsområde version 240215](https://success.openhealth.fr/da/articles/9311007-apps-administrationsomrade-version-240215.md) - [Platform - opdatering 231215](https://success.openhealth.fr/da/articles/8718485-platform-opdatering-231215.md) - [Platform - opdatering 231015](https://success.openhealth.fr/da/articles/8479932-platform-opdatering-231015.md) - [Apps + Portal version 230915](https://success.openhealth.fr/da/articles/8373640-apps-portal-version-230915.md) - [Apps + Portal version 230815](https://success.openhealth.fr/da/articles/8267860-apps-portal-version-230815.md) - [Nye produkter 230715](https://success.openhealth.fr/da/articles/8115796-nye-produkter-230715.md) - [Apps + Portal version 230615](https://success.openhealth.fr/da/articles/8115791-apps-portal-version-230615.md) - [Apps + Portal version 230515](https://success.openhealth.fr/da/articles/7895393-apps-portal-version-230515.md) - [Apps + Portal version 230415](https://success.openhealth.fr/da/articles/7439447-apps-portal-version-230415.md) - [Apps + Portal version 230315](https://success.openhealth.fr/da/articles/7439646-apps-portal-version-230315.md) - [Apps + Portal version 230215](https://success.openhealth.fr/da/articles/7439744-apps-portal-version-230215.md) - [Ny fra 15/01/2023](https://success.openhealth.fr/da/articles/6895740-ny-fra-15-01-2023.md) - [HUB + GATE version 221215](https://success.openhealth.fr/da/articles/6827027-hub-gate-version-221215.md) - [HUB + GATE version 221115](https://success.openhealth.fr/da/articles/6742628-hub-gate-version-221115.md) - [HUB + GATE version 220915](https://success.openhealth.fr/da/articles/6558070-hub-gate-version-220915.md) - [HUB + GATE version 220815](https://success.openhealth.fr/da/articles/6475311-hub-gate-version-220815.md) - [HUB + GATE version 220615](https://success.openhealth.fr/da/articles/6306090-hub-gate-version-220615.md) - [HUB + GATE version 220515](https://success.openhealth.fr/da/articles/6201877-hub-gate-version-220515.md) - [HUB + GATE version 220415](https://success.openhealth.fr/da/articles/6087747-hub-gate-version-220415.md) - [HUB SMA version 220315](https://success.openhealth.fr/da/articles/6043772-hub-sma-version-220315.md) - [HUB TMA version 220315](https://success.openhealth.fr/da/articles/6043802-hub-tma-version-220315.md) - [HUB UAN version 220315](https://success.openhealth.fr/da/articles/6043852-hub-uan-version-220315.md) - [GATE version 220215](https://success.openhealth.fr/da/articles/5940805-gate-version-220215.md) - [HUB SMA version 220215](https://success.openhealth.fr/da/articles/5940753-hub-sma-version-220215.md) - [HUB TMA version 220215](https://success.openhealth.fr/da/articles/5947859-hub-tma-version-220215.md) - [GATE version 211215](https://success.openhealth.fr/da/articles/5819397-gate-version-211215.md) - [HUB SMA version 211215](https://success.openhealth.fr/da/articles/5784709-hub-sma-version-211215.md) - [HUB TMA version 211215](https://success.openhealth.fr/da/articles/5784888-hub-tma-version-211215.md) - [HUB UAN version 211215](https://success.openhealth.fr/da/articles/5784904-hub-uan-version-211215.md) - [Ansøgning HUB: "Apotekets tilstand".](https://success.openhealth.fr/da/articles/5704485-ansogning-hub-apotekets-tilstand.md) - [GATE version 211115](https://success.openhealth.fr/da/articles/5697844-gate-version-211115.md) - [HUB SMA version 211115](https://success.openhealth.fr/da/articles/5671893-hub-sma-version-211115.md) - [HUB TMA version 211115](https://success.openhealth.fr/da/articles/5671917-hub-tma-version-211115.md) - [HUB UAN version 211115](https://success.openhealth.fr/da/articles/5671927-hub-uan-version-211115.md) - [GATE version 211015](https://success.openhealth.fr/da/articles/5652210-gate-version-211015.md) - [HUB SMA version 211015](https://success.openhealth.fr/da/articles/5649822-hub-sma-version-211015.md) - [HUB TMA version 211015](https://success.openhealth.fr/da/articles/5650073-hub-tma-version-211015.md) - [HUB UAN version 211015](https://success.openhealth.fr/da/articles/5652242-hub-uan-version-211015.md) - [HUB SMA version 210915](https://success.openhealth.fr/da/articles/5370516-hub-sma-version-210915.md) - [HUB TMA version 210915](https://success.openhealth.fr/da/articles/5390983-hub-tma-version-210915.md) - [HUB UAN version 210915](https://success.openhealth.fr/da/articles/5543213-hub-uan-version-210915.md) ### Votre ESPACE D'ADMINISTRATION - fonctionnalités - [Nulstil / skift din adgangskode HUB](https://success.openhealth.fr/da/articles/4425325-nulstil-skift-din-adgangskode-hub.md): Sådan ændres HUB-adgangskoden - [Forbindelsesassistance: Jeg får en fejlmeddelelse](https://success.openhealth.fr/da/articles/5369783-forbindelsesassistance-jeg-far-en-fejlmeddelelse.md) - [Opret og følg en billet](https://success.openhealth.fr/da/articles/3586214-opret-og-folg-en-billet.md): Tutorial til at oprette og følge udviklingen af dine billetter på dit personlige rum The HUB - [Oprette og ændre en SUCCESS-artikel](https://success.openhealth.fr/da/articles/6738705-oprette-og-aendre-en-success-artikel.md) - [Mine kontrakter](https://success.openhealth.fr/da/articles/5712273-mine-kontrakter.md) - [Service Sundhed](https://success.openhealth.fr/da/articles/4990600-service-sundhed.md) - [Mine adgangsrettigheder](https://success.openhealth.fr/da/articles/5783418-mine-adgangsrettigheder.md) - [Opsætning af min hjemmeside](https://success.openhealth.fr/da/articles/5712229-opsaetning-af-min-hjemmeside.md) - [Hvordan ændrer du dit marked fra dit personlige OpenHealth-rum?](https://success.openhealth.fr/da/articles/3585971-hvordan-aendrer-du-dit-marked-fra-dit-personlige-openhealth-rum.md): Integrer, rediger og deaktiver produkter fra dit personlige OpenHealth-rum - [Automatisk modalitetsmodifikationsændring \(Auto MAM\)](https://success.openhealth.fr/da/articles/4164818-automatisk-modalitetsmodifikationsaendring-auto-mam.md): Ret tildelingen af dine produkter direkte - [TIDLIG MAM: Hvordan følger man et brand, der skifter laboratorium / brand / label?](https://success.openhealth.fr/da/articles/4131072-tidlig-mam-hvordan-folger-man-et-brand-der-skifter-laboratorium-brand-label.md): Fordele og risici ved din type sporing - [Automatisk produktintegration \(Auto IPR\)](https://success.openhealth.fr/da/articles/4164932-automatisk-produktintegration-auto-ipr.md): Anmod om integration af et produkt i dit marked - [Automatisk produktdeaktivering \(Auto DPR\)](https://success.openhealth.fr/da/articles/4164866-automatisk-produktdeaktivering-auto-dpr.md): Deaktiver et produkt fra dit marked - [Automatisk genaktivering af produkter \(RPR auto\)](https://success.openhealth.fr/da/articles/4818161-automatisk-genaktivering-af-produkter-rpr-auto.md) - [Etablering af nye produkter](https://success.openhealth.fr/da/articles/5811248-etablering-af-nye-produkter.md) - [Tilføj et marked](https://success.openhealth.fr/da/articles/5712283-tilfoj-et-marked.md) - [Import/eksport af bulkvarer](https://success.openhealth.fr/da/articles/5712257-import-eksport-af-bulkvarer.md) - [Ændring af typologisk modalitet \(CMT\)](https://success.openhealth.fr/da/articles/4670174-aendring-af-typologisk-modalitet-cmt.md) - [De forskellige brugerstatusser](https://success.openhealth.fr/da/articles/3436418-de-forskellige-brugerstatusser.md): Hvad er funktionerne? - [Opret en konto for en bruger fra en tredjepartsorganisation \(TPAA\)](https://success.openhealth.fr/da/articles/6466550-opret-en-konto-for-en-bruger-fra-en-tredjepartsorganisation-tpaa.md) - [Hvordan oprettes, ændres eller slettes en brugerkonto på HUB?](https://success.openhealth.fr/da/articles/3785138-hvordan-oprettes-aendres-eller-slettes-en-brugerkonto-pa-hub.md): Kun en POWER USER kan gøre dette - [Kan jeg oprette differentierede visningsrettigheder på HUB inden for mine teams?](https://success.openhealth.fr/da/articles/3321731-kan-jeg-oprette-differentierede-visningsrettigheder-pa-hub-inden-for-mine-teams.md): Rettigheder i navet - [Aktivitetslogbog](https://success.openhealth.fr/da/articles/4687438-aktivitetslogbog.md) ### Vos APPLICATIONS - présentation - [HUB-uddannelsesvejledning](https://success.openhealth.fr/da/articles/5634967-hub-uddannelsesvejledning.md) - [Sortering drop-down selector](https://success.openhealth.fr/da/articles/5792113-sortering-drop-down-selector.md) - [Opdateringsdato for GSA-apoteksdata \(SMKT\) i HuB](https://success.openhealth.fr/da/articles/3175557-opdateringsdato-for-gsa-apoteksdata-smkt-i-hub.md): Denne artikel beskriver datoen, hvor dataene fra GSA-apoteker \(SMKT\) opdateres. - [Forudsætninger Matchende Apoteker Fil](https://success.openhealth.fr/da/articles/3678146-forudsaetninger-matchende-apoteker-fil.md): Forudsætninger Matchende Apoteker Fil - ["On og Off Recept" vælger](https://success.openhealth.fr/da/articles/3729668-on-og-off-recept-vaelger.md): Specifikationer for objektet 'Prescription Type Selector' - [Hvordan kvalificerer jeg nye produkter i HUB?](https://success.openhealth.fr/da/articles/3376100-hvordan-kvalificerer-jeg-nye-produkter-i-hub.md): Kvalificering af dine nye produkter i HUB - [Hvordan oprettes, ændres og deles en favorit i HUB?](https://success.openhealth.fr/da/articles/3175689-hvordan-oprettes-aendres-og-deles-en-favorit-i-hub.md): Oprettelse og deling af favoritter i Hub - [Hvordan vælger jeg produkter i HUB efter lanceringsdato?](https://success.openhealth.fr/da/articles/3158428-hvordan-vaelger-jeg-produkter-i-hub-efter-lanceringsdato.md): Denne artikel forklarer, hvordan man kun vælger produkter, der er lanceret i en bestemt periode. - [Kan jeg udtrække dataene fra HUB i ".csv"-format?](https://success.openhealth.fr/da/articles/5671278-kan-jeg-udtraekke-dataene-fra-hub-i-csv-format.md) - [ODT-reaktionstid](https://success.openhealth.fr/da/articles/6632310-odt-reaktionstid.md) - [Hvad er den bedste skærmpraksis i HUB](https://success.openhealth.fr/da/articles/3124454-hvad-er-den-bedste-skaermpraksis-i-hub.md): Denne artikel beskriver de bedste fremgangsmåder til at optimere visningen af HUB - [Tekniske krav](https://success.openhealth.fr/da/articles/5369918-tekniske-krav.md) - [Ryd din browsers cache](https://success.openhealth.fr/da/articles/4219722-ryd-din-browsers-cache.md): Sådan ryddes din Google Chrome-browsercache - [Hvordan indstiller jeg Google Chrome som min standardbrowser?](https://success.openhealth.fr/da/articles/3738717-hvordan-indstiller-jeg-google-chrome-som-min-standardbrowser.md): Sådan indstilles Google Chrome som standard - [Navigationselevatoren er ikke synlig i tabellerne](https://success.openhealth.fr/da/articles/3195250-navigationselevatoren-er-ikke-synlig-i-tabellerne.md): Navigationsliften - [Visningen af knapper eller genstande på et ark er delvist afskåret eller ikke synlig](https://success.openhealth.fr/da/articles/3195245-visningen-af-knapper-eller-genstande-pa-et-ark-er-delvist-afskaret-eller-ikke-synlig.md): Vis problem med knapper, objekter - [Mit territoriumadministrationskort indlæses ikke, og meddelelsen "indlæses" vises](https://success.openhealth.fr/da/articles/3195239-mit-territoriumadministrationskort-indlaeses-ikke-og-meddelelsen-indlaeses-vises.md): Territory Management / TMA-kortvisningsproblem - [Hvor kommer fejlmeddelelsen "Du har ikke tilladelse til at få adgang til på denne side" fra?](https://success.openhealth.fr/da/articles/3195338-hvor-kommer-fejlmeddelelsen-du-har-ikke-tilladelse-til-at-fa-adgang-til-pa-denne-side-fra.md): Fejlmeddelelser - [Jeg har en fejlmeddelelse "Forbindelse mistet"](https://success.openhealth.fr/da/articles/4445141-jeg-har-en-fejlmeddelelse-forbindelse-mistet.md): Der opstod en fejl - [Bad Gateway](https://success.openhealth.fr/da/articles/4514555-bad-gateway.md): Fejlmeddelelsen "Bad Gateway" - [Dimensions- og målvælgerne vises ikke længere i forespørgerne "Flere periodeanalyse" og "Mit dataarkiv", ekstraktionen af tabellen i "Markedsanalyse" er delvis](https://success.openhealth.fr/da/articles/3195377-dimensions-og-malvaelgerne-vises-ikke-laengere-i-foresporgerne-flere-periodeanalyse-og-mit-dataarkiv-ekstraktionen-af-tabellen-i-markedsanalyse-er-delvis.md): Dimensioner og mål vises ikke længere - [Hvordan ser man et udtryk i HUB?](https://success.openhealth.fr/da/articles/3194377-hvordan-ser-man-et-udtryk-i-hub.md): HUB giver dig mulighed for let at se quadrimestere i 'Sales Evolution' -arket - [Excel specifikationer og begrænsninger](https://success.openhealth.fr/da/articles/3753088-excel-specifikationer-og-begraensninger.md): Denne artikel forklarer specifikationerne og begrænsningerne for Excel. - [Hvordan opretter, redigerer og deler du en favorit i dine programmer?](https://success.openhealth.fr/da/articles/10502803-hvordan-opretter-redigerer-og-deler-du-en-favorit-i-dine-programmer.md) - [Forbrugerpanel ramme](https://success.openhealth.fr/da/articles/3455845-forbrugerpanel-ramme.md): Artikel vedrørende forbrugerpanelets ramme - [Ramme for markedsanalyse af apoteker](https://success.openhealth.fr/da/articles/3455857-ramme-for-markedsanalyse-af-apoteker.md): Artikel om OpenHealth-rammen til analyse af markedspræstationer på apotekskanalen ### Data kilder - [Hvad er OpenHealth-apotekspanelet?](https://success.openhealth.fr/da/articles/3304106-hvad-er-openhealth-apotekspanelet.md): Denne artikel har til formål at beskrive vores apotekspanel. - [Apoteknetværket, et afgørende aktiv i styringen af nuværende og fremtidige sundhedskriser](https://success.openhealth.fr/da/articles/3825648-apoteknetvaerket-et-afgorende-aktiv-i-styringen-af-nuvaerende-og-fremtidige-sundhedskriser.md): OpenHealth Company, forpligtet til at overvåge en hidtil uset sundhedskrise, mobiliserer sin teknologi og data - [Hvad er de franske oversøiske departements og territoriers synlige områder i HUB?](https://success.openhealth.fr/da/articles/3194382-hvad-er-de-franske-oversoiske-departements-og-territoriers-synlige-omrader-i-hub.md): DROM-COM-områder tilgængelige i hubben - [Forudsat sektoriseringsfil](https://success.openhealth.fr/da/articles/3702701-forudsat-sektoriseringsfil.md): Denne artikel giver dig mulighed for at downloade, udfylde og indsende din sektoriseringsfil. - [SMKT-datakilde](https://success.openhealth.fr/da/articles/4485357-smkt-datakilde.md): IRI, leverandør af GSA-apoteksdata - [GSA Parapharmacy Products Coding Rules \(SMKT\) på IRI](https://success.openhealth.fr/da/articles/3524492-gsa-parapharmacy-products-coding-rules-smkt-pa-iri.md): Påmindelse om kodificeringsreglerne for SMKT-produkter på IRI - [Data fra økologiske butikker - Kilde BIOANALYTICS](https://success.openhealth.fr/da/articles/5631260-data-fra-okologiske-butikker-kilde-bioanalytics.md) - [E-parafarmacier: overvågningsplatforme](https://success.openhealth.fr/da/articles/9167006-e-parafarmacier-overvagningsplatforme.md) - [E-apoteker Produktgevinster og -tab](https://success.openhealth.fr/da/articles/3568773-e-apoteker-produktgevinster-og-tab.md): Artikel vedrørende modulet 'E-apoteker produktgevinster og tab' - [Forbrugerprofil](https://success.openhealth.fr/da/articles/3711085-forbrugerprofil.md): Artikel vedrørende modulet 'Forbrugerprofil' - [AMAZON-data - Kilde SELLINGZ](https://success.openhealth.fr/da/articles/5669013-amazon-data-kilde-sellingz.md) - [Data om e-handel - Kilde WISER](https://success.openhealth.fr/da/articles/7983010-data-om-e-handel-kilde-wiser.md) - [Oversættelse af geografiske områder](https://success.openhealth.fr/da/articles/4661582-oversaettelse-af-geografiske-omrader.md): Hos Open Health Company kan du analysere dine markeder i henhold til de geografiske områder, vi tilbyder dig. - [Hvad er apotekspanelet i Tyskland? INSIGHTHEALTH](https://success.openhealth.fr/da/articles/5391412-hvad-er-apotekspanelet-i-tyskland-insighthealth.md) - [Hvad er apotekspanelet i Grækenland? ALIRAHEALTH](https://success.openhealth.fr/da/articles/6863963-hvad-er-apotekspanelet-i-graekenland-alirahealth.md) - [Hvad er apotekspanelet i Østrig? INSIGHTHEALTH](https://success.openhealth.fr/da/articles/6863949-hvad-er-apotekspanelet-i-ostrig-insighthealth.md) - [Hvad er apotekerpanelet i Afrika? PIEX - Afrika](https://success.openhealth.fr/da/articles/6686633-hvad-er-apotekerpanelet-i-afrika-piex-afrika.md) - [Hvad er online-apotekspanelet i Tyskland? DATAMEDIQ](https://success.openhealth.fr/da/articles/5689640-hvad-er-online-apotekspanelet-i-tyskland-datamediq.md) - [Hvad er apotekerpanelet i Belgien? REDPHARMA](https://success.openhealth.fr/da/articles/4689894-hvad-er-apotekerpanelet-i-belgien-redpharma.md) - [Hvad er apotekspanelet i Spanien? - HMR](https://success.openhealth.fr/da/articles/5391363-hvad-er-apotekspanelet-i-spanien-hmr.md) - [Hvad er apotekerpanelet i Spanien? - INFONIS](https://success.openhealth.fr/da/articles/5428915-hvad-er-apotekerpanelet-i-spanien-infonis.md) - [Hvad er apotekspanelet i Portugal? - HMR](https://success.openhealth.fr/da/articles/5391477-hvad-er-apotekspanelet-i-portugal-hmr.md) - [Hvad er apotekspanelet i Rusland? - ALPHARM](https://success.openhealth.fr/da/articles/5701531-hvad-er-apotekspanelet-i-rusland-alpharm.md) - [Hvad er apotekspanelet i Polen? Pex Pharma](https://success.openhealth.fr/da/articles/5969485-hvad-er-apotekspanelet-i-polen-pex-pharma.md) - [CONVERT GROUP](https://success.openhealth.fr/da/articles/6961966-convert-group.md) - [Hvad er apotekspanelet i Jordan?](https://success.openhealth.fr/da/articles/8176750-hvad-er-apotekspanelet-i-jordan.md) - [Befolkning - kartografi](https://success.openhealth.fr/da/articles/3807695-befolkning-kartografi.md): Analyser den geografiske fordeling af befolkningen - [AMELI - LPP](https://success.openhealth.fr/da/articles/6962021-ameli-lpp.md) - [Befolkning - Evolution efter ALDER & KØN](https://success.openhealth.fr/da/articles/3810789-befolkning-evolution-efter-alder-kon.md): Analyser udviklingen i befolkningsstrukturen - [Befolkning - sammenligning efter ALDER & KØN](https://success.openhealth.fr/da/articles/3836795-befolkning-sammenligning-efter-alder-kon.md): Sammenlign den demografiske profil for to populationer - [EGYPT - Kartografi](https://success.openhealth.fr/da/articles/3714611-egypt-kartografi.md): Analyser befolkningen i Egypten - [EGYPT - Analyse efter AGE & GENDER](https://success.openhealth.fr/da/articles/3714673-egypt-analyse-efter-age-gender.md): Analyser befolkningens struktur - [UGANDA - Analyse af AGE & GENDER](https://success.openhealth.fr/da/articles/3713884-uganda-analyse-af-age-gender.md): Analyser befolkningens struktur - [Befolkning - analyse efter AGE & KØN](https://success.openhealth.fr/da/articles/3807673-befolkning-analyse-efter-age-kon.md): Analyser befolkningens struktur - [Medicabase - lægemiddeldatabase](https://success.openhealth.fr/da/articles/6518920-medicabase-laegemiddeldatabase.md) - [Fødsel](https://success.openhealth.fr/da/articles/6340025-fodsel.md) - [OpenEudra](https://success.openhealth.fr/da/articles/6518977-openeudra.md) - [Opdeling i IRIS](https://success.openhealth.fr/da/articles/6383829-opdeling-i-iris.md) - [ADICAP](https://success.openhealth.fr/da/articles/6959465-adicap.md) - [NEC](https://success.openhealth.fr/da/articles/6519012-nec.md) - [Data om verdens befolkning](https://success.openhealth.fr/da/articles/8217421-data-om-verdens-befolkning.md) - [INSEE: Filer af afdøde personer](https://success.openhealth.fr/da/articles/4498126-insee-filer-af-afdode-personer.md): INSEE \(National Institute for Statistics and Economic Studies\): Fil af afdøde personer - [Data VAERS- VAERSDATA- Kilde CDC](https://success.openhealth.fr/da/articles/6226665-data-vaers-vaersdata-kilde-cdc.md) - [VAERS-data - VAERSVAX - Kilde CDC](https://success.openhealth.fr/da/articles/6226440-vaers-data-vaersvax-kilde-cdc.md) - [VAERS-data - VAERSSYMPTOMS - Kilde CDC](https://success.openhealth.fr/da/articles/6219415-vaers-data-vaerssymptoms-kilde-cdc.md) - [Integrer dine data i Hub'en på mindre end 2 uger](https://success.openhealth.fr/da/articles/5259828-integrer-dine-data-i-hub-en-pa-mindre-end-2-uger.md) - [International dataskabelon](https://success.openhealth.fr/da/articles/4684696-international-dataskabelon.md) - [Hvordan sender vi dine data via FTPS?](https://success.openhealth.fr/da/articles/4143451-hvordan-sender-vi-dine-data-via-ftps.md): Send data via FTPS - [Hvilke oplysninger har OpenHealth brug for for at integrere en ny datakilde?](https://success.openhealth.fr/da/articles/3459148-hvilke-oplysninger-har-openhealth-brug-for-for-at-integrere-en-ny-datakilde.md): Artikel om integration af nye datakilder - [Det lange perspektiv](https://success.openhealth.fr/da/articles/6959482-det-lange-perspektiv.md) - [Hvordan integreres en ny datakilde i HUB?](https://success.openhealth.fr/da/articles/3467598-hvordan-integreres-en-ny-datakilde-i-hub.md): Artikel relateret til dataintegrationsprocessen i HUB - [Integrer dine salgsdata i HUB](https://success.openhealth.fr/da/articles/3471145-integrer-dine-salgsdata-i-hub.md): Artikel om integration af salgsdata - [Specifikationer for modtagelse af salgsdata](https://success.openhealth.fr/da/articles/3660043-specifikationer-for-modtagelse-af-salgsdata.md): Sådan sender du dit sell-in som en del af en sell-in / sell-out analyse eller abonnement på Sell-in Vizualization-modulet - [Hvor kommer analysedataene fra markedet for hjemmesundhedsudbydere \(PSAD\) fra?](https://success.openhealth.fr/da/articles/3376155-hvor-kommer-analysedataene-fra-markedet-for-hjemmesundhedsudbydere-psad-fra.md): PSAD - [Hvordan tilmeldes SantéDom Stat observatoriet?](https://success.openhealth.fr/da/articles/3798795-hvordan-tilmeldes-santedom-stat-observatoriet.md): Vejledning i tilslutning til det nationale observatorium for aktiviteten hos hjemmesundhedsudbydere \(PSAD\) - [Panel ekstrapoleret fra observatoriet SanteDomStat](https://success.openhealth.fr/da/articles/6701602-panel-ekstrapoleret-fra-observatoriet-santedomstat.md) - [Antal patienter](https://success.openhealth.fr/da/articles/3376499-antal-patienter.md): Definition af antallet af patienter i henhold til PSAD-forbundene - [Antal behandlinger](https://success.openhealth.fr/da/articles/3376682-antal-behandlinger.md): Definition af antallet af behandlinger i henhold til PSAD-forbundene - [Antal nye patienter](https://success.openhealth.fr/da/articles/3376672-antal-nye-patienter.md): Definition af antallet af nye patienter ifølge PSAD-forbundene - [Omsætning inklusive skat](https://success.openhealth.fr/da/articles/3376725-omsaetning-inklusive-skat.md): Definition af omsætning inklusive skat i henhold til PSAD-forbundene - [Antal patienter i slutningen af behandlingen](https://success.openhealth.fr/da/articles/3376675-antal-patienter-i-slutningen-af-behandlingen.md): Definition af antallet af patienter i slutningen af behandlingen ifølge PSAD-forbundene - [Obligatorisk sundhedsforsikringsbeløb \(AMO\)](https://success.openhealth.fr/da/articles/3376740-obligatorisk-sundhedsforsikringsbelob-amo.md): Definition af AMO-beløbet i henhold til PSAD-forbundene - [Supplerende sundhedsforsikringsbeløb \(AMC\)](https://success.openhealth.fr/da/articles/3376749-supplerende-sundhedsforsikringsbelob-amc.md): Definition af AMC-beløbet i henhold til PSAD-forbundene - [Udestående afgift \(RAC\)](https://success.openhealth.fr/da/articles/3376751-udestaende-afgift-rac.md): Definition af RAC ifølge PSAD-forbundene - [Kilde: AFSNIT](https://success.openhealth.fr/da/articles/3560018-kilde-afsnit.md): Lægemiddeldatabase \(BdM\) - [Internationale ikke-proprietære navne \(INN\)](https://success.openhealth.fr/da/articles/3954239-internationale-ikke-proprietaere-navne-inn.md): Internationale fællesnavne \(INN\) - [Fakta om åben mad](https://success.openhealth.fr/da/articles/6961970-fakta-om-aben-mad.md) - [LOINC - Logical Observation Identifiers Navne og koder](https://success.openhealth.fr/da/articles/6959323-loinc-logical-observation-identifiers-navne-og-koder.md) - [AMELI - CCAM](https://success.openhealth.fr/da/articles/6959080-ameli-ccam.md) - [WHO ATC VET](https://success.openhealth.fr/da/articles/6959078-who-atc-vet.md) - [CEPS](https://success.openhealth.fr/da/articles/6959068-ceps.md) - [Institution](https://success.openhealth.fr/da/articles/3935678-institution.md): Liste over sundheds-, sociale, medicinsk-sociale virksomheder - [Sundhedstjenester](https://success.openhealth.fr/da/articles/7969680-sundhedstjenester.md) - [Uddrag FINESS](https://success.openhealth.fr/da/articles/3946922-uddrag-finess.md): Udfør en ekstraktion efter dine forventninger - [Evolution FINESS](https://success.openhealth.fr/da/articles/3947009-evolution-finess.md): Følg udviklingen i antallet af strukturer - [Autorisationsplejeaktivitet](https://success.openhealth.fr/da/articles/3947067-autorisationsplejeaktivitet.md): Angiv strukturer i henhold til deres sundhedsaktivitetsgodkendelser - [Større medicinsk udstyr](https://success.openhealth.fr/da/articles/3947269-storre-medicinsk-udstyr.md): Liste strukturer i henhold til deres udstyr i tungt materiale - [Geografisk](https://success.openhealth.fr/da/articles/3947363-geografisk.md): Visualiser fordelingen af strukturer på territoriet - [RPPS](https://success.openhealth.fr/da/articles/3947568-rpps.md): Liste over sundhedspersonale - [FINESS & RPPS](https://success.openhealth.fr/da/articles/3947713-finess-rpps.md): Angiv træningssteder for sundhedspersonale - [Uddrag RPPS](https://success.openhealth.fr/da/articles/3947829-uddrag-rpps.md): RPPS \(Shared Directory of Healthcare Professionals\) ### Modellerne - [Data på UGA](https://success.openhealth.fr/da/articles/4852310-data-pa-uga.md) - [Beregning af salg til sektoren: hvad du har brug for at vide](https://success.openhealth.fr/da/articles/3545561-beregning-af-salg-til-sektoren-hvad-du-har-brug-for-at-vide.md): Hvad er de forskellige trin til beregning af sektor salg hos OpenHealth? - [Sektoromfordeling, statisk eller dynamisk metode?](https://success.openhealth.fr/da/articles/3690615-sektoromfordeling-statisk-eller-dynamisk-metode.md): Sektoromfordeling, statisk eller dynamisk metode? - [Apoteker lag](https://success.openhealth.fr/da/articles/4291490-apoteker-lag.md): Detaljer om de "teoretiske" lag og de "rigtige" eller "effektive" lag. - [Hub-produktionslinjen](https://success.openhealth.fr/da/articles/4816146-hub-produktionslinjen.md) - [Hvordan gennemføres en komparativ analyse?](https://success.openhealth.fr/da/articles/3440093-hvordan-gennemfores-en-komparativ-analyse.md): Du vil sammenligne data fra to forskellige udbydere. - [NIVEAU 1 UNDERSØGELSE - Datakvalitet til tjeneste for OpenHealth Company](https://success.openhealth.fr/da/articles/3595822-niveau-1-undersogelse-datakvalitet-til-tjeneste-for-openhealth-company.md): Ser du et fænomen, som du ikke forstår? Vi kan give dig oprindelsen til denne observation og forklare det for dig. - [Datakvalitetsproces hos OpenHealth](https://success.openhealth.fr/da/articles/3415271-datakvalitetsproces-hos-openhealth.md): Denne artikel beskriver trinene i datakvalitetsprocesser på OpenHealth - [Interval og tillidsniveau](https://success.openhealth.fr/da/articles/3633173-interval-og-tillidsniveau.md): Definitioner, formler og begrænsninger: hvad du har brug for at vide - [Datakvalitet: Batchstyring](https://success.openhealth.fr/da/articles/3433509-datakvalitet-batchstyring.md): Beskrivelse af batchstyringsprocessen - [Datakvalitet: Salgsnedbrydningsproces](https://success.openhealth.fr/da/articles/3415317-datakvalitet-salgsnedbrydningsproces.md): Beskrivelse af salgsopdelingsprocessen - [Sælge- og aktiekompensationer](https://success.openhealth.fr/da/articles/4131084-saelge-og-aktiekompensationer.md): Lager-ind-salg - [Hvorfor analysere salg i volumen?](https://success.openhealth.fr/da/articles/3846167-hvorfor-analysere-salg-i-volumen.md): Hvorfor analysere salg i volumen? - [Der er et datakløft mellem sell-in og sell-out](https://success.openhealth.fr/da/articles/3195358-der-er-et-datakloft-mellem-sell-in-og-sell-out.md): I hvilke tilfælde kan vi have et datakløft mellem sell-in og sell-out? - [Hvad er et atypisk salg?](https://success.openhealth.fr/da/articles/3195366-hvad-er-et-atypisk-salg.md): Atypisk salg og ATYPISK FILTER-proces. - [Hvor kommer oplysningerne om priser, mængder, omsætning fra?](https://success.openhealth.fr/da/articles/3195348-hvor-kommer-oplysningerne-om-priser-maengder-omsaetning-fra.md): Oplysninger om pris / volumen / omsætning - [Anslået salgsmængde efter ordinerende læge](https://success.openhealth.fr/da/articles/4171530-anslaet-salgsmaengde-efter-ordinerende-laege.md): Sådan vurderes dine salgsmængder på apoteker efter ordinerende læge og kategori af ordinerende - [Forstå forskellen mellem 2 ekstraktioner](https://success.openhealth.fr/da/articles/13399689-forsta-forskellen-mellem-2-ekstraktioner.md) ### Trinene - [GTIN](https://success.openhealth.fr/da/articles/3608176-gtin.md): GTIN-kode \(Global Trade Item Number\) - [Kundespecifikation feltspecifikation \(CQCP\)](https://success.openhealth.fr/da/articles/3704913-kundespecifikation-feltspecifikation-cqcp.md): CQCP \(produktkundekvalificeringsfelt\) - [Hvad er en LPPR-kode?](https://success.openhealth.fr/da/articles/3195365-hvad-er-en-lppr-kode.md): LPPR-koden \(Liste over refunderbare produkter og tjenester\) - [Produktudlejningssporing](https://success.openhealth.fr/da/articles/4206554-produktudlejningssporing.md): Produktudlejning - [Jeg vil udvide mit marked](https://success.openhealth.fr/da/articles/4420843-jeg-vil-udvide-mit-marked.md): Abonnementsmarkedet fulgte - [OHC-klassificering](https://success.openhealth.fr/da/articles/3194589-ohc-klassificering.md): Visualiser tildelingen af dine produkter i henhold til den proprietære OpenHealth Company-klassifikation - [EphMRA AC-klasser historie](https://success.openhealth.fr/da/articles/3557908-ephmra-ac-klasser-historie.md): Visualiser udviklingen af EphMRA AC-klasser siden 2014 - [Detaljer om veterinærmedicin](https://success.openhealth.fr/da/articles/3194587-detaljer-om-veterinaermedicin.md): Visualiser egenskaberne ved veterinærlægemidler - [Klassificering af veterinærmedicin](https://success.openhealth.fr/da/articles/3194579-klassificering-af-veterinaermedicin.md): Se klassificeringen af veterinærlægemidler \(ANSES\) - [Humanmedicinske detaljer](https://success.openhealth.fr/da/articles/3421225-humanmedicinske-detaljer.md): Se egenskaberne ved et eller flere produkter gennem detaljerede felter i THESORIMED - [Styring af nye produkter](https://success.openhealth.fr/da/articles/4470813-styring-af-nye-produkter.md): Ny produktstyring - [Klassificering af humanmedicin](https://success.openhealth.fr/da/articles/3417281-klassificering-af-humanmedicin.md): Se EphMRA AC- og OMS ATC-klassifikationerne for dit produktomfang - [Indikationer - Diagnose](https://success.openhealth.fr/da/articles/3568554-indikationer-diagnose.md): Se de medikamenter, der er angivet for en given patologi, og de patologier, der er forbundet med et udvalg af lægemidler - [MP4U](https://success.openhealth.fr/da/articles/3574188-mp4u.md): Se alle klassifikationer stillet til rådighed af OpenHealth Company - [Hvad er TVASI \(tabel over salg, indkøb og ukendte lagre\)](https://success.openhealth.fr/da/articles/5992494-hvad-er-tvasi-tabel-over-salg-indkob-og-ukendte-lagre.md) - [IRI-produktklassificering](https://success.openhealth.fr/da/articles/3194597-iri-produktklassificering.md): Visualiser tildelingen af dine produkter i henhold til klassificeringen ejer IRI - [Fjernelse af usolgte produkter](https://success.openhealth.fr/da/articles/6135938-fjernelse-af-usolgte-produkter.md) - [STANDARDMARKED - Abonnement](https://success.openhealth.fr/da/articles/3798203-standardmarked-abonnement.md): Denne artikel beskriver interessen og begrænsningerne i et såkaldt "standard" marked - [Jeg kan ikke finde mit produkt](https://success.openhealth.fr/da/articles/5686002-jeg-kan-ikke-finde-mit-produkt.md) - [Forvaltning af produktkoder](https://success.openhealth.fr/da/articles/5652478-forvaltning-af-produktkoder.md) - [Produktkvalifikation: mærker](https://success.openhealth.fr/da/articles/5016985-produktkvalifikation-maerker.md) ### Abonnementer og moduler - [De 3 typer af ansøgninger](https://success.openhealth.fr/da/articles/9489652-de-3-typer-af-ansogninger.md) - [Din 2.0-platform](https://success.openhealth.fr/da/articles/8374416-din-2-0-platform.md) - [RESUMÉ](https://success.openhealth.fr/da/articles/3344127-resume.md): Alle egenskaber ved din applikation er tilgængelige i dette modul - [Markeder og udvalg](https://success.openhealth.fr/da/articles/8337016-markeder-og-udvalg.md) - [Oversigt over dashboard](https://success.openhealth.fr/da/articles/9246867-oversigt-over-dashboard.md) - [Analyse](https://success.openhealth.fr/da/articles/9352287-analyse.md) - [Udsugning](https://success.openhealth.fr/da/articles/9246875-udsugning.md) - [Vækstanalyse](https://success.openhealth.fr/da/articles/3158856-vaekstanalyse.md): Bestem nøglefaktorerne i udviklingen af dine markeder og dine konkurrenters - [Sortimentanalyse](https://success.openhealth.fr/da/articles/3473736-sortimentanalyse.md): Undersøg dynamikken i produkter på et marked - [Gennemsnitligt antal produkter](https://success.openhealth.fr/da/articles/3161474-gennemsnitligt-antal-produkter.md): Se det gennemsnitlige antal produkter pr. GSA-salgssted på apoteker eller apoteker - [Start sporing](https://success.openhealth.fr/da/articles/3158488-start-sporing.md): Overvåg produktlanceringer og deres bidrag til vækst - [Avancerede indikatorer krydset](https://success.openhealth.fr/da/articles/6007740-avancerede-indikatorer-krydset.md) - [Salgskoncentration](https://success.openhealth.fr/da/articles/3095338-salgskoncentration.md): Visualiser koncentrationen af et marked gennem salgskoncentrationskurven og GINI-indekset - [Prisdispersion](https://success.openhealth.fr/da/articles/3159289-prisdispersion.md): Visualiser prisspredningen på et produkt. Opret dine egne apoteksegmenter ud fra salgsprisen - [Udsalgsmargenanalyse](https://success.openhealth.fr/da/articles/3358322-udsalgsmargenanalyse.md): Benchmark dine produkters tiltrækningskraft for apoteker - [Udvikling af udsalgsmargenen](https://success.openhealth.fr/da/articles/3815561-udvikling-af-udsalgsmargenen.md) - [Apoteksovervågning \(1/2\)](https://success.openhealth.fr/da/articles/3358248-apoteksovervagning-1-2.md): Følg udviklingen i apotekstrafik - [Apoteksovervågning \(2/2\)](https://success.openhealth.fr/da/articles/3810527-apoteksovervagning-2-2.md): Følg udviklingen i apotekstrafik - [Salesforce Performance](https://success.openhealth.fr/da/articles/3159230-salesforce-performance.md): Sammenlign salgsresultaterne for regioner og sektorer i en salgsstyrke - [ASSISTENT for forvaltning af kunderelationer \(CRM\)](https://success.openhealth.fr/da/articles/5953935-assistent-for-forvaltning-af-kunderelationer-crm.md) - [Point of Sales Tracking](https://success.openhealth.fr/da/articles/3778944-point-of-sales-tracking.md): Point of Sales Tracking - [Udvikling af On Demand](https://success.openhealth.fr/da/articles/6560184-udvikling-af-on-demand.md) - [Analyse efter behov](https://success.openhealth.fr/da/articles/6127483-analyse-efter-behov.md) - [On Demand-tabel](https://success.openhealth.fr/da/articles/3158751-on-demand-tabel.md): Visualiser de vigtigste HUB-indikatorer og deres udvikling over forskellige typer perioder - [Analyse af tidsserier](https://success.openhealth.fr/da/articles/3635940-analyse-af-tidsserier.md): Opdel dit marked i sæson, trend og støj - [Prognose Analyse](https://success.openhealth.fr/da/articles/3636015-prognose-analyse.md): Skøn fremtiden for dit marked - [Sektoriel prognose](https://success.openhealth.fr/da/articles/3689811-sektoriel-prognose.md): Anslå dit fremtidige sektor salg - [Sell-in visualisering](https://success.openhealth.fr/da/articles/3559882-sell-in-visualisering.md): Sammenlign udviklingen i dit salg- og udsalgssalg - [Salgsanalyse](https://success.openhealth.fr/da/articles/6188132-salgsanalyse.md) - [Sell-in-matching](https://success.openhealth.fr/da/articles/6188090-sell-in-matching.md) - [Udvikling af salget](https://success.openhealth.fr/da/articles/6191929-udvikling-af-salget.md) - [Sell-in vs. Sell-out analyse](https://success.openhealth.fr/da/articles/6191947-sell-in-vs-sell-out-analyse.md) - [Udvikling af salg til salg og salg fra salg](https://success.openhealth.fr/da/articles/6191955-udvikling-af-salg-til-salg-og-salg-fra-salg.md) - [Prisudvikling](https://success.openhealth.fr/da/articles/5056489-prisudvikling.md) - [Tilpas farver](https://success.openhealth.fr/da/articles/8407897-tilpas-farver.md) - [Produkteksport](https://success.openhealth.fr/da/articles/3583206-produkteksport.md): Eksporter ark specifikt til alle produkter og MP4U-apps - [Markedsanalyse](https://success.openhealth.fr/da/articles/3121933-markedsanalyse.md): Analyser ydeevnen på dit marked: efter segment, brand, produkt og virksomhed - [Prisanalyse](https://success.openhealth.fr/da/articles/3215190-prisanalyse.md): Se priserne på dit marked og analyser din positionering - [Salgsudvikling](https://success.openhealth.fr/da/articles/3178323-salgsudvikling.md): Se dit voksende salg i hele din tilgængelige historie - [Sammenfatning af dashboardet](https://success.openhealth.fr/da/articles/4533213-sammenfatning-af-dashboardet.md) - [Udvikling af markedsandele](https://success.openhealth.fr/da/articles/3193078-udvikling-af-markedsandele.md): Visualiser udviklingen i salg og markedsandel over lange perioder - [Salg på tværs af bordet](https://success.openhealth.fr/da/articles/3193060-salg-pa-tvaers-af-bordet.md): Opret en simpel drejetabel - [OMSÆTNING / VOLUME \(CU\) Syntese](https://success.openhealth.fr/da/articles/3193048-omsaetning-volume-cu-syntese.md): Visualiser samtidig salgsmængder og værdi på et marked - [Sell Out Value Synthesis \(PHARMACIES / SUPERMARKETS\)](https://success.openhealth.fr/da/articles/3193020-sell-out-value-synthesis-pharmacies-supermarkets.md): Sammenlign GSA apotek og apotek salg - [Analyse af markedsandele](https://success.openhealth.fr/da/articles/3193069-analyse-af-markedsandele.md): Analyser markedsandele i løbet af de sidste 12 måneder - [Mit dataarkiv](https://success.openhealth.fr/da/articles/3193099-mit-dataarkiv.md): Eksporter en flad database til Excel - [Analyse af flere perioder](https://success.openhealth.fr/da/articles/3192953-analyse-af-flere-perioder.md): Opret en helt tilpasset tabel - [Min forespørgsel Alle produkter](https://success.openhealth.fr/da/articles/4280353-min-foresporgsel-alle-produkter.md): Se dine segmenter og kvalificerende felter \(Eks: galenisk, solindeks, forfremmelser ...\) samt din begrænsning - [Lagerudvikling \(NY\)](https://success.openhealth.fr/da/articles/3719256-lagerudvikling-ny.md): Visualiser og analyser lagerudviklingen og deres distribution - [Markedsdefinition](https://success.openhealth.fr/da/articles/3158829-markedsdefinition.md): Baser dit marked på den 100 base, du vælger - [RAW DATA Avancerede indikatorer](https://success.openhealth.fr/da/articles/3711095-raw-data-avancerede-indikatorer.md): Gendan dine førende indikatordata - [Avancerede indikatorer Evolution SMKT](https://success.openhealth.fr/da/articles/3193000-avancerede-indikatorer-evolution-smkt.md): Overvåg ydeevnen på dit laboratorium gennem en analyse af den tidsmæssige udvikling af dine avancerede statistiske indikatorer. - [Avanceret indikatoranalyse SMKT](https://success.openhealth.fr/da/articles/3192366-avanceret-indikatoranalyse-smkt.md): Opdel udviklingen af et GSA-parafarmatmarked til førende indikatorer - [Avancerede indikatorer Evolution](https://success.openhealth.fr/da/articles/3177853-avancerede-indikatorer-evolution.md): Overvåg laboratoriets ydeevne gennem en analyse af den tidsmæssige udvikling af dine avancerede statistiske indikatorer. - [Avancerede indikatorer Evolution Bio](https://success.openhealth.fr/da/articles/7051823-avancerede-indikatorer-evolution-bio.md) - [Nationale avancerede indikatorer](https://success.openhealth.fr/da/articles/3364513-nationale-avancerede-indikatorer.md): Opdel udviklingen af et marked til førende indikatorer - [Aktieanalyse](https://success.openhealth.fr/da/articles/3178015-aktieanalyse.md): Fortolke et lagerniveau og dets udvikling - [Avanceret analyse af indikatorer Bio](https://success.openhealth.fr/da/articles/7051801-avanceret-analyse-af-indikatorer-bio.md) - [Avanceret indikatoranalyse](https://success.openhealth.fr/da/articles/3124439-avanceret-indikatoranalyse.md): Opdel udviklingen af et marked til førende indikatorer - [Kartografi](https://success.openhealth.fr/da/articles/3192450-kartografi.md): Analyser den kommercielle ydeevne i regioner og sektorer i din salgsstyrke - [Geografisk krydstabel](https://success.openhealth.fr/da/articles/3192466-geografisk-krydstabel.md): Opret en pivottabel, der integrerer din sektorisering - [Geografisk salgsudvikling](https://success.openhealth.fr/da/articles/3192482-geografisk-salgsudvikling.md): Visualiser salg efter sektor over 36 måneder i en pivottabel - [Effektivitet af salgsstyrken](https://success.openhealth.fr/da/articles/5624011-effektivitet-af-salgsstyrken.md) - [Analyse af brugerdefinerede vægtningsmetoder](https://success.openhealth.fr/da/articles/5169317-analyse-af-brugerdefinerede-vaegtningsmetoder.md) - [Netværksanalyse](https://success.openhealth.fr/da/articles/3894767-netvaerksanalyse.md): Netværksanalyse - [Udvikling af brugerdefineret vægtningsmetode](https://success.openhealth.fr/da/articles/5169320-udvikling-af-brugerdefineret-vaegtningsmetode.md) - [RESUMÉ KPI'er](https://success.openhealth.fr/da/articles/3478199-resume-kpi-er.md): Visualiser i en dynamisk tabel dine nøgleindikatorer Volumen faldt til regioner og sektorer. - [Salg i konverterede enheder](https://success.openhealth.fr/da/articles/3192412-salg-i-konverterede-enheder.md): Brug konverterede enheder til at visualisere dit salg - [RAW DATA lagerindikatorer](https://success.openhealth.fr/da/articles/3711142-raw-data-lagerindikatorer.md): Eksporter dine beholdningsdata - [RÅ DATA SMKT AIA](https://success.openhealth.fr/da/articles/3720960-ra-data-smkt-aia.md): Find dine SMKT førende indikatordata - [Lagerudvikling](https://success.openhealth.fr/da/articles/3178277-lagerudvikling.md): Visualiser og analyser lagerudviklingen og deres distribution - [Geografiske avancerede indikatorer](https://success.openhealth.fr/da/articles/3192508-geografiske-avancerede-indikatorer.md): Se førende indikatorer efter region eller sektor - [Produkter ydeevne](https://success.openhealth.fr/da/articles/3850331-produkter-ydeevne.md): Sammenlign forretningsresultaterne for regioner og produktsektorer - [Territoriale avancerede indikatorer](https://success.openhealth.fr/da/articles/3370879-territoriale-avancerede-indikatorer.md): Opdel udviklingen af et marked til førende indikatorer - [Tidssektor sektoranalyse](https://success.openhealth.fr/da/articles/3814974-tidssektor-sektoranalyse.md): Opdel dit marked i trend, sæson, støj - [Salgsanalyse efter alder og køn](https://success.openhealth.fr/da/articles/3192701-salgsanalyse-efter-alder-og-kon.md): Analyser salget efter alder og køn - [Salgsudvikling efter graviditetsstatus](https://success.openhealth.fr/da/articles/3192910-salgsudvikling-efter-graviditetsstatus.md): Følg apotekssalg på befolkningen af gravide kvinder - [Salgsudvikling efter alder og køn](https://success.openhealth.fr/da/articles/3192732-salgsudvikling-efter-alder-og-kon.md): Visualiser udviklingen i salg efter alder og køn ved hjælp af HUB's dybde i historien - [Udvikling af krav til ordre](https://success.openhealth.fr/da/articles/5790020-udvikling-af-krav-til-ordre.md) - [Evolution co-dispensationer](https://success.openhealth.fr/da/articles/3192529-evolution-co-dispensationer.md): Visualiser og nedbryd udviklingen af co-dispensationer på apoteker - [Co-dispensationsanalyse](https://success.openhealth.fr/da/articles/3192633-co-dispensationsanalyse.md): Se co-dispensationer på apoteker forbundet med et udvalg af produkter fra mit marked - [Salg pr. Kanal og ordinerer](https://success.openhealth.fr/da/articles/3192751-salg-pr-kanal-og-ordinerer.md): Visualiser influencerne på dit marked - [AMO, AMC & RAC](https://success.openhealth.fr/da/articles/3192929-amo-amc-rac.md): Se de tre beløb for obligatorisk sundhedsforsikring, supplerende sundhedsforsikring og udgifter til lommen - [Co-dispensations spredning](https://success.openhealth.fr/da/articles/3876946-co-dispensations-spredning.md): Visualiser fordelingen af antallet af produkter, der sælges ved dispensation - [Dispensation Dispersion Evolution](https://success.openhealth.fr/da/articles/3920070-dispensation-dispersion-evolution.md): Visualiser fordelingen af antallet af solgte produkter pr. Dispensation over tid - [Praktiserende lægers recepter efter alder og køn](https://success.openhealth.fr/da/articles/5789899-praktiserende-laegers-recepter-efter-alder-og-kon.md) - [Analyse af recepter og ordrer](https://success.openhealth.fr/da/articles/5322866-analyse-af-recepter-og-ordrer.md) - [Udvikling af lægeordinationer](https://success.openhealth.fr/da/articles/5790016-udvikling-af-laegeordinationer.md) - [Kurv analyse](https://success.openhealth.fr/da/articles/3711049-kurv-analyse.md): Beskrivelse af modulet 'Kurvanalyse' - [Samdispensering](https://success.openhealth.fr/da/articles/4738243-samdispensering.md) - [Kohortekvalifikationsmodul](https://success.openhealth.fr/da/articles/3928090-kohortekvalifikationsmodul.md): Kvalifikation af patientkohorte - [Modul til behandlingsstatus](https://success.openhealth.fr/da/articles/3928067-modul-til-behandlingsstatus.md): Analyser dynamikken i behandlingsovervågning - [Behandlingsoverholdelsesmodul](https://success.openhealth.fr/da/articles/3928044-behandlingsoverholdelsesmodul.md): Analyser overholdelse af behandlinger - [Kohortdefinition](https://success.openhealth.fr/da/articles/3894703-kohortdefinition.md): Definer omfanget af din analyse - [Co-behandlinger](https://success.openhealth.fr/da/articles/4163623-co-behandlinger.md): Definer co-behandling inden for dit analyseomfang - [Visualiseringskohorte](https://success.openhealth.fr/da/articles/3894721-visualiseringskohorte.md): Se patientprofilen for den definerede kohorte - [Definition af analysekriterier](https://success.openhealth.fr/da/articles/3894728-definition-af-analysekriterier.md): Definer parametrene til analysen af din kohorte - [Global kohorteudvikling](https://success.openhealth.fr/da/articles/3894747-global-kohorteudvikling.md): Visualiser den månedlige udvikling af kohorten - [Geografisk fordeling](https://success.openhealth.fr/da/articles/3894751-geografisk-fordeling.md): Se den geografiske fordeling af patienter i den definerede kohorte - [Kohortprofil](https://success.openhealth.fr/da/articles/3894755-kohortprofil.md): Analyser den demografiske profil af patienter, der er inkluderet i kohorten - [Behandlingsstatus nedbrydes](https://success.openhealth.fr/da/articles/3894764-behandlingsstatus-nedbrydes.md): Få et overblik over de forskellige typer behandlingsopfølgning - [Behandlingsinitieringer](https://success.openhealth.fr/da/articles/3894778-behandlingsinitieringer.md): Analyser udviklingen af antallet af behandlingsinitieringer - [Behandlingen starter igen](https://success.openhealth.fr/da/articles/3894788-behandlingen-starter-igen.md): Analyser udviklingen af antallet af genoptagelser af behandlingen - [Nye behandlinger](https://success.openhealth.fr/da/articles/3894804-nye-behandlinger.md): Analyser udviklingen af antallet af indledninger og genoptagelser af behandlingen - [Behandling gentages](https://success.openhealth.fr/da/articles/3894812-behandling-gentages.md): Analyser patienter under behandling - [Behandling skifte balance](https://success.openhealth.fr/da/articles/3894821-behandling-skifte-balance.md): Analyser balancen i behandlingsændringer efter behandling - [Behandlingsomskifter gevinster](https://success.openhealth.fr/da/articles/3894830-behandlingsomskifter-gevinster.md): Analyser modtagerne af behandlingsomskiftere - [Tab af behandlingskontakt](https://success.openhealth.fr/da/articles/3894843-tab-af-behandlingskontakt.md): Analyser ved behandling taberne af behandlingsomskifterne - [Skift gevinstoprindelse](https://success.openhealth.fr/da/articles/3894857-skift-gevinstoprindelse.md): Analyser oprindelsen af kontakten til en given behandling - [Skift destination for tab](https://success.openhealth.fr/da/articles/3894864-skift-destination-for-tab.md): Analyser destinationen for kontakten til en given behandling - [Frafald](https://success.openhealth.fr/da/articles/3894874-frafald.md): Analyser behandlingsstop - [KPI-oversigt](https://success.openhealth.fr/da/articles/4229969-kpi-oversigt.md): Resumé af de forskellige typer behandlingsovervågning - [Behandlingens vedholdenhed](https://success.openhealth.fr/da/articles/3894883-behandlingens-vedholdenhed.md): Analyser varigheden af behandlingerne - [Overholdelse](https://success.openhealth.fr/da/articles/3894884-overholdelse.md): Analyser de leverede mængder - [Hvad er regelmæssighedskriteriet?](https://success.openhealth.fr/da/articles/3325816-hvad-er-regelmaessighedskriteriet.md): Definition af begrebet regelmæssighedskriterium - [Død - kartografi](https://success.openhealth.fr/da/articles/3863677-dod-kartografi.md): Analyser den geografiske fordeling af dødsfald - [Forskydning af antallet af dødsfald](https://success.openhealth.fr/da/articles/3863573-forskydning-af-antallet-af-dodsfald.md): Evaluer relevansen af dine data - [Death - Analyse af AGE & GENDER](https://success.openhealth.fr/da/articles/3863808-death-analyse-af-age-gender.md): Analyser strukturen af dødsfald - [Death - Evolution by AGE & KENDER](https://success.openhealth.fr/da/articles/3863939-death-evolution-by-age-kender.md): Analyser udviklingen af dødsstrukturen - [Død - Evolution](https://success.openhealth.fr/da/articles/3864065-dod-evolution.md): Visualiser udviklingen af dødsfald - [Død - Evolution Sammenligning](https://success.openhealth.fr/da/articles/3864073-dod-evolution-sammenligning.md): Sammenlign udviklingen af dødsfald sammenlignet med tidligere år - [Apoteksovervågning CA](https://success.openhealth.fr/da/articles/4634768-apoteksovervagning-ca.md): Beskriv trafikken i henhold til apotekernes størrelse - [Trafikanalyse \(betatest\)](https://success.openhealth.fr/da/articles/6848401-trafikanalyse-betatest.md) - [Oplysninger om apoteksovervågning](https://success.openhealth.fr/da/articles/4527868-oplysninger-om-apoteksovervagning.md): Analyser apotekstrafik efter type apotek - [Trafikudvikling \(betatest\)](https://success.openhealth.fr/da/articles/6848016-trafikudvikling-betatest.md) - [Kartografi til apotekskontrol](https://success.openhealth.fr/da/articles/4527811-kartografi-til-apotekskontrol.md): Analyser apotekstrafikken på det franske fastland - [Oplysninger om apoteksovervågning](https://success.openhealth.fr/da/articles/4262306-oplysninger-om-apoteksovervagning.md): Diskriminer detaljen ved salg efter apotekstype - [Analyse af apoteksovervågning](https://success.openhealth.fr/da/articles/3839223-analyse-af-apoteksovervagning.md): Følg udviklingen i apotekstrafik - [Pharmacy Monitoring Evolution](https://success.openhealth.fr/da/articles/3827973-pharmacy-monitoring-evolution.md): Undersøg udviklingen af apotekstrafik - [Trafiknedbrydning](https://success.openhealth.fr/da/articles/3826074-trafiknedbrydning.md): Overhold komponenterne i sæson, trend og restkoncentrationer - [Trafikundersøgelse](https://success.openhealth.fr/da/articles/3809042-trafikundersogelse.md): Analyser apotekstrafik - [Resumé - PIEX](https://success.openhealth.fr/da/articles/5203335-resume-piex.md) - [Indkøb](https://success.openhealth.fr/da/articles/4605110-indkob.md): Spor dine køb og deres kvitteringer - [Min forespørgsel - PIEX](https://success.openhealth.fr/da/articles/4210627-min-foresporgsel-piex.md): Foretag valg på dine data - [Salgsudvikling - PIEX](https://success.openhealth.fr/da/articles/4210655-salgsudvikling-piex.md): Se udviklingen af din aktivitet i den tilgængelige historie - [Salgsanalyse - PIEX](https://success.openhealth.fr/da/articles/4210650-salgsanalyse-piex.md): Salgsanalyse - PIEX - [Bestillingsoplysninger - PIEX](https://success.openhealth.fr/da/articles/4210659-bestillingsoplysninger-piex.md): Se og spor en salgsordre - [Lageroversigt - PIEX](https://success.openhealth.fr/da/articles/4210672-lageroversigt-piex.md): Visualiser variationerne i dine aktier - [Mit dataarkiv - PIEX](https://success.openhealth.fr/da/articles/4210694-mit-dataarkiv-piex.md): Eksporter en flad database til Excel - [EURAPHARMA- PIEX](https://success.openhealth.fr/da/articles/4366306-eurapharma-piex.md): Visualiser udviklingen af EURAPHARMAs aktivitet - [Matchende produkt](https://success.openhealth.fr/da/articles/4366320-matchende-produkt.md): Korrespondance mellem betegnelserne på PIEX- og EURAPHARMA-produkterne - [CLI Min fil \(1/5\)](https://success.openhealth.fr/da/articles/4626422-cli-min-fil-1-5.md): CLI Min fil \(1/5\) - [CLI\_File Counts \(2/5\)](https://success.openhealth.fr/da/articles/4626421-cli_file-counts-2-5.md): CLI\_File Counts \(2/5\) - [CLI\_File Code Matching med OHC repository](https://success.openhealth.fr/da/articles/4626419-cli_file-code-matching-med-ohc-repository.md): CLI\_FIL Code Matching med OHC Repository - [Udsalg af eksport \(4/5\)](https://success.openhealth.fr/da/articles/4626414-udsalg-af-eksport-4-5.md): Udsalg af eksport \(4/5\) ### PERSONLIGE MULIGHEDER - [Ikke-hierarkiske produktkvalificerende felter](https://success.openhealth.fr/da/articles/4036045-ikke-hierarkiske-produktkvalificerende-felter.md): Tilføj oplysninger om kvalificeringen af dine produkter - [Hvad er den maksimale alder for HUB-dataene?](https://success.openhealth.fr/da/articles/3195251-hvad-er-den-maksimale-alder-for-hub-dataene.md): Sidste tilgængelige data - [Kundetype](https://success.openhealth.fr/da/articles/4197147-kundetype.md): Brugerdefineret mulighed Kundetype - [Sessionsadgang](https://success.openhealth.fr/da/articles/4036458-sessionsadgang.md): Begræns visningen af dine medarbejdere - [Brugerdefineret cyklus](https://success.openhealth.fr/da/articles/4036444-brugerdefineret-cyklus.md): Analyser dine data over personlige tidsperioder - [Regnskabsår](https://success.openhealth.fr/da/articles/4036169-regnskabsar.md): Definer dit regnskabsår - [Dag-knap](https://success.openhealth.fr/da/articles/4036159-dag-knap.md): Visualiser dine data med en mere detaljeret granularitet - [Uge-knap](https://success.openhealth.fr/da/articles/4036111-uge-knap.md): Visualiser dine data med en mere detaljeret granularitet - [Valutakurser](https://success.openhealth.fr/da/articles/8329594-valutakurser.md) - [SMKT-periodekalender](https://success.openhealth.fr/da/articles/4036549-smkt-periodekalender.md): Brug en GSA-kalender - [Begræns omkreds](https://success.openhealth.fr/da/articles/4560699-begraens-omkreds.md): Valg af en GTIN-liste i Min forespørgsel fra en .xlsx-fil - [Begræns omkreds \(kode 7\)](https://success.openhealth.fr/da/articles/4560791-begraens-omkreds-kode-7.md): Valg af en liste med \[TEKNISK KODE 2\] i Min forespørgsel fra en .xlsx-fil - [Markedsflagg](https://success.openhealth.fr/da/articles/4560797-markedsflagg.md): Valg af en GTIN-liste i Min forespørgsel fra en markedsdefinition indeholdt i en .xlsx-fil - [Målretning / definition af en kundetype](https://success.openhealth.fr/da/articles/3777788-malretning-definition-af-en-kundetype.md): Målretning \(kundetype\) ### HUB-INDIKATORERNE - [Ordliste over HUB-indikatorer](https://success.openhealth.fr/da/articles/5194247-ordliste-over-hub-indikatorer.md) - [Salgsmængder](https://success.openhealth.fr/da/articles/3194314-salgsmaengder.md): Salgsmængder - [Salgsværdier](https://success.openhealth.fr/da/articles/3074854-salgsvaerdier.md): Angivelse af salgsværdi-indikatoren - [N MS](https://success.openhealth.fr/da/articles/3194475-n-ms.md): Definition af 'N MS' foranstaltningen - [N MS Evol](https://success.openhealth.fr/da/articles/5634266-n-ms-evol.md) - [N MS Delta](https://success.openhealth.fr/da/articles/3194469-n-ms-delta.md): Definition af 'N MS Delta' foranstaltningen - [Poids Vol \(CA\) par modalité / Custom Weight Vol \(To\)](https://success.openhealth.fr/da/articles/9292839-poids-vol-ca-par-modalite-custom-weight-vol-to.md) - [Salgsværdi baseret på producentens pris ekskl. moms \(Omsætning PF ekskl. moms\) - Marokko](https://success.openhealth.fr/da/articles/7508513-salgsvaerdi-baseret-pa-producentens-pris-ekskl-moms-omsaetning-pf-ekskl-moms-marokko.md) - [N Vækst CTR](https://success.openhealth.fr/da/articles/3194466-n-vaekst-ctr.md): Definition og beregningsformel for målingen 'N Growth CTR' - [I aftale](https://success.openhealth.fr/da/articles/6201859-i-aftale.md) - [Krydset vægtvolumen](https://success.openhealth.fr/da/articles/6066324-krydset-vaegtvolumen.md) - [Vægtomsætning ved krydsning](https://success.openhealth.fr/da/articles/6066273-vaegtomsaetning-ved-krydsning.md) - [N Vækst CTR justeret](https://success.openhealth.fr/da/articles/3205376-n-vaekst-ctr-justeret.md): Definition og beregningsformel for 'N Growth CTR A' måling - [Kildevægt](https://success.openhealth.fr/da/articles/5151525-kildevaegt.md) - [Gennemsnitlig pris observeret](https://success.openhealth.fr/da/articles/3194302-gennemsnitlig-pris-observeret.md): AASP: Gennemsnitlig pris observeret - [Vejet gennemsnitspris](https://success.openhealth.fr/da/articles/3194292-vejet-gennemsnitspris.md): WASP: Vægtet gennemsnitspris - [Pris-effekt](https://success.openhealth.fr/da/articles/8426443-pris-effekt.md) - [Antal apoteker, der sælger](https://success.openhealth.fr/da/articles/3719566-antal-apoteker-der-saelger.md) - [Sælger digital distribution](https://success.openhealth.fr/da/articles/3194321-saelger-digital-distribution.md): Numerisk fordeling - [Global salg af digital distribution](https://success.openhealth.fr/da/articles/3194320-global-salg-af-digital-distribution.md): Global numerisk distribution - [Rebased Selling Digital Distribution](https://success.openhealth.fr/da/articles/4045636-rebased-selling-digital-distribution.md): Numerisk distribution omdefineret - [Global rebased Selling Digital Distribution](https://success.openhealth.fr/da/articles/4045725-global-rebased-selling-digital-distribution.md): Global numerisk distribution omdefineret - [Skræddersyet distribution af digitalt salg på ny](https://success.openhealth.fr/da/articles/6830813-skraeddersyet-distribution-af-digitalt-salg-pa-ny.md) - [Distribution af salgsværdi](https://success.openhealth.fr/da/articles/3194323-distribution-af-salgsvaerdi.md): Vægtet fordeling - [Global salgsværdifordeling](https://success.openhealth.fr/da/articles/3194316-global-salgsvaerdifordeling.md): Global salgsværdifordeling - [Omfordeling af salgsværdifordeling](https://success.openhealth.fr/da/articles/3194501-omfordeling-af-salgsvaerdifordeling.md): Rebaseret DVV - [Global rebaseret salgsværdifordeling](https://success.openhealth.fr/da/articles/4200619-global-rebaseret-salgsvaerdifordeling.md): Global genbaseret DVV - [Skræddersyet, ombaseret fordeling af salgsværdien](https://success.openhealth.fr/da/articles/6834423-skraeddersyet-ombaseret-fordeling-af-salgsvaerdien.md) - [Distribution af digital salg SMKT](https://success.openhealth.fr/da/articles/3365043-distribution-af-digital-salg-smkt.md): Digital salgsdistribution SMKT \(SMK Numerisk distribution\) - [Global SMKT sælger digital distribution](https://success.openhealth.fr/da/articles/4298341-global-smkt-saelger-digital-distribution.md): SMKT global numerisk distribution \(SMKT global numerisk distribution\) - [Rebased SMKT Selling Digital Distribution](https://success.openhealth.fr/da/articles/4298197-rebased-smkt-selling-digital-distribution.md): SMKT Digital distribution rebased \(SMKT numerisk distribution rebased\) - [Global ombaseret SMKT-salg af digital distribution](https://success.openhealth.fr/da/articles/4319783-global-ombaseret-smkt-salg-af-digital-distribution.md): Salg af digital distribution SMKT Rebasée Globale \(SMKT Global Numeric Distribution Rebased\) - [Distribution af SMKT-salgsværdi](https://success.openhealth.fr/da/articles/3365478-distribution-af-smkt-salgsvaerdi.md): Distribution af SMKT-salgsværdi \(SMKT-vægtet distribution\) - [Genberegnet global SMKT-salg af digital distribution](https://success.openhealth.fr/da/articles/4298373-genberegnet-global-smkt-salg-af-digital-distribution.md): SMKT Global Numerisk distribution genberegnet - [Digital distribution sælger SMKT genbaseret genberegnet](https://success.openhealth.fr/da/articles/4298303-digital-distribution-saelger-smkt-genbaseret-genberegnet.md): SMKT Numerisk fordeling genberegnet genbaseret - [Justeret SMKT-salg af digital distribution](https://success.openhealth.fr/da/articles/3369386-justeret-smkt-salg-af-digital-distribution.md): Justeret numerisk distribution SMKT - [Digital distribution sælger SMKT genberegnet](https://success.openhealth.fr/da/articles/4298209-digital-distribution-saelger-smkt-genberegnet.md): SMKT Numerisk distribution genberegnet \(SMKT Numerisk distribution genberegnet\) - [Justeret distribution af SMKT salgsværdi](https://success.openhealth.fr/da/articles/3369397-justeret-distribution-af-smkt-salgsvaerdi.md): Justeret vægtet distribution SMKT - [Organisk digital salgsdistribution](https://success.openhealth.fr/da/articles/7052424-organisk-digital-salgsdistribution.md) - [Omsætning for sælgende apoteker \(TSP\)](https://success.openhealth.fr/da/articles/6096534-omsaetning-for-saelgende-apoteker-tsp.md) - [Skøn over din holder PDM](https://success.openhealth.fr/da/articles/4214883-skon-over-din-holder-pdm.md): Anslå din markedsandel med dine kunder - [Flere apoteker](https://success.openhealth.fr/da/articles/8426451-flere-apoteker.md) - [Tab af apoteker](https://success.openhealth.fr/da/articles/8426460-tab-af-apoteker.md) - [Multichannel digitalt salg og distribution](https://success.openhealth.fr/da/articles/9293487-multichannel-digitalt-salg-og-distribution.md) - [Kumulativ salg af digital distribution \(PHARMA\)](https://success.openhealth.fr/da/articles/9330571-kumulativ-salg-af-digital-distribution-pharma.md) - [Månedligt gennemsnitligt salg](https://success.openhealth.fr/da/articles/3194303-manedligt-gennemsnitligt-salg.md): Gennemsnitligt månedligt salg - [Justeret månedligt gennemsnitssalg](https://success.openhealth.fr/da/articles/3194290-justeret-manedligt-gennemsnitssalg.md): Justeret gennemsnitligt månedligt salg - [Månedlig gennemsnitlig salgsværdi](https://success.openhealth.fr/da/articles/4535404-manedlig-gennemsnitlig-salgsvaerdi.md): VMM CA - [AMS To A: Gennemsnitlig månedlig salgsværdi justeret](https://success.openhealth.fr/da/articles/6028256-ams-to-a-gennemsnitlig-manedlig-salgsvaerdi-justeret.md) - [Gennemsnitligt salg](https://success.openhealth.fr/da/articles/3563716-gennemsnitligt-salg.md): Gennemsnitligt salg - [SMKT gennemsnitligt salg](https://success.openhealth.fr/da/articles/3365496-smkt-gennemsnitligt-salg.md): SMKT gennemsnitligt salg - [Justeret SMKT-gennemsnitssalg](https://success.openhealth.fr/da/articles/3369340-justeret-smkt-gennemsnitssalg.md): Justeret SMKT-gennemsnitssalg - [Gennemsnitligt månedligt organisk salg](https://success.openhealth.fr/da/articles/7052551-gennemsnitligt-manedligt-organisk-salg.md) - [Gennemsnitligt månedligt salg Økologisk værdi](https://success.openhealth.fr/da/articles/7052573-gennemsnitligt-manedligt-salg-okologisk-vaerdi.md) - [Lager](https://success.openhealth.fr/da/articles/3194332-lager.md): Definition og tilgængelighed af lagerdata i HUB via SMAa-applikationer: Sales & Marketing Advanced abonnement - [Gennemsnitlig bestand](https://success.openhealth.fr/da/articles/3194336-gennemsnitlig-bestand.md): Gennemsnitlig bestand - [Andel af lager](https://success.openhealth.fr/da/articles/3194334-andel-af-lager.md): Andel af aktier - [Kommercielt trykindeks](https://success.openhealth.fr/da/articles/3194335-kommercielt-trykindeks.md): Kommercielt trykindeks - [Lagertransformationshastighed](https://success.openhealth.fr/da/articles/3194344-lagertransformationshastighed.md): Aktietransformationshastighed - [Leveringens varighed](https://success.openhealth.fr/da/articles/3194337-leveringens-varighed.md): Leveringsvarighed - [Antal forhandlerapoteker](https://success.openhealth.fr/da/articles/3194338-antal-forhandlerapoteker.md): Antal forhandlerapoteker - [Stockist Digital distribution](https://success.openhealth.fr/da/articles/3194339-stockist-digital-distribution.md): Stockist Distribution \(ND Stock\) - [Digital distributionslager rebaseret](https://success.openhealth.fr/da/articles/4045743-digital-distributionslager-rebaseret.md): Lager numerisk fordeling genbaseret - [Global rebaseret digital stockist distribution](https://success.openhealth.fr/da/articles/4045753-global-rebaseret-digital-stockist-distribution.md): Global rebaseret stockist distribution - [Distributør af værdistandard](https://success.openhealth.fr/da/articles/3194342-distributor-af-vaerdistandard.md): Distributør af lagerværdi \(vægtet lagerfordeling: WD-aktie\) - [Omfordeling af lagerværdifordeling](https://success.openhealth.fr/da/articles/3194505-omfordeling-af-lagervaerdifordeling.md): Genstart DVS - [Digital distribution Glattet lagerfører](https://success.openhealth.fr/da/articles/5141830-digital-distribution-glattet-lagerforer.md) - [Digital Distribution Lagerhandler udjævnet omregnet](https://success.openhealth.fr/da/articles/5142162-digital-distribution-lagerhandler-udjaevnet-omregnet.md) - [Fordeling Udjævnet værdi af aktier](https://success.openhealth.fr/da/articles/5203640-fordeling-udjaevnet-vaerdi-af-aktier.md) - [Udlodning Udjævnet, omreguleret værdi af aktier](https://success.openhealth.fr/da/articles/5203701-udlodning-udjaevnet-omreguleret-vaerdi-af-aktier.md) - [Margen](https://success.openhealth.fr/da/articles/3507716-margen.md): Margen - [Margin sats](https://success.openhealth.fr/da/articles/3507767-margin-sats.md): Margin sats - [Producentpris ekskl. Moms \(PFHT\)](https://success.openhealth.fr/da/articles/4557500-producentpris-ekskl-moms-pfht.md): PFHT - [Sell-in - Analyser af din kundebase](https://success.openhealth.fr/da/articles/3846225-sell-in-analyser-af-din-kundebase.md): Loyalitetsindikatorer: egenskaber ved din kundebase og dens udvikling - [Sell-in - Atypiske apoteker](https://success.openhealth.fr/da/articles/3848791-sell-in-atypiske-apoteker.md): Foranstaltninger til at detektere atypisme - [Udviklingsforhold](https://success.openhealth.fr/da/articles/3194287-udviklingsforhold.md): Udviklingsforhold - [Gennemtrængningsforhold](https://success.openhealth.fr/da/articles/3194286-gennemtraengningsforhold.md): Gennemtrængningsforhold - [Produktsortiment bredde](https://success.openhealth.fr/da/articles/3369425-produktsortiment-bredde.md): Produktsortiment bredde - [Fornyelse af sortimentet](https://success.openhealth.fr/da/articles/3369545-fornyelse-af-sortimentet.md): Fornyelse af sortimentet - [Innovation i sortimentet](https://success.openhealth.fr/da/articles/3369468-innovation-i-sortimentet.md): Innovation i sortimentet - [Slid på sortimentet](https://success.openhealth.fr/da/articles/3369457-slid-pa-sortimentet.md): Slid på sortimentet - [Sortéringsgrad på sortiment](https://success.openhealth.fr/da/articles/3369485-sorteringsgrad-pa-sortiment.md): Sortimentets nedslidningshastighed - [Range innovation rate](https://success.openhealth.fr/da/articles/3369541-range-innovation-rate.md): Range innovation rate - [Andel af salgstilbud](https://success.openhealth.fr/da/articles/3369040-andel-af-salgstilbud.md): Andel af salgstilbud - [Antal valgte produkter](https://success.openhealth.fr/da/articles/3511502-antal-valgte-produkter.md): Dette er antallet af produkter, der er valgt med deres GTIN-13 cifret kode. - [Gennemsnitligt antal produkter](https://success.openhealth.fr/da/articles/3194284-gennemsnitligt-antal-produkter.md): Gennemsnitligt antal produkter - [Områdefornyelsesrate](https://success.openhealth.fr/da/articles/3369561-omradefornyelsesrate.md): Områdefornyelsesrate - [Antal produkter](https://success.openhealth.fr/da/articles/6312686-antal-produkter.md) - [Beløb brugt pr. Handling](https://success.openhealth.fr/da/articles/3447792-belob-brugt-pr-handling.md): Artikel om indikatoren 'Brugte beløb pr. Handling' - [Fordeling af beløb brugt efter købertype](https://success.openhealth.fr/da/articles/3447801-fordeling-af-belob-brugt-efter-kobertype.md): Artikel vedrørende indikatoren 'Fordeling af beløb brugt efter købertype' - [Forbrugsindeks](https://success.openhealth.fr/da/articles/3432701-forbrugsindeks.md): Definition af indikatoren 'Forbrugsindeks' - [Salgsandel](https://success.openhealth.fr/da/articles/3432664-salgsandel.md): Definition af indikatoren 'Salgsandel' - [Værdi loyalitetsrate](https://success.openhealth.fr/da/articles/3432695-vaerdi-loyalitetsrate.md): Definition af indikatoren 'Værdi loyalitetsrate' - [Absolut penetration](https://success.openhealth.fr/da/articles/3432556-absolut-penetration.md): Artikel om indikatoren 'Absolut penetration' - [Andel af omsætningen](https://success.openhealth.fr/da/articles/3432655-andel-af-omsaetningen.md): Definition af indikatoren 'Omsætningsandel' - [p-værdi](https://success.openhealth.fr/da/articles/5781702-p-vaerdi.md) - [Hovedkomponentanalyse](https://success.openhealth.fr/da/articles/4231028-hovedkomponentanalyse.md): AVS - [Negativ forudsigelsesværdi](https://success.openhealth.fr/da/articles/4134220-negativ-forudsigelsesvaerdi.md): Negativ forudsigelsesværdi - [Positiv forudsigelsesværdi](https://success.openhealth.fr/da/articles/4134166-positiv-forudsigelsesvaerdi.md): Positiv forudsigelsesværdi - [Uafhængighedstest](https://success.openhealth.fr/da/articles/4128369-uafhaengighedstest.md): Kontroller, om to variabler er relateret til hinanden - [Undersøgelse af tidsserier](https://success.openhealth.fr/da/articles/3633991-undersogelse-af-tidsserier.md): Sæsonbestemthed, tendens og forudsigelse: hvad du har brug for at vide - [Sæsonbestemt variansrate](https://success.openhealth.fr/da/articles/3653790-saesonbestemt-variansrate.md): Måler variansandelen i en tidsserie - [Følsomhed og specificitet af en test](https://success.openhealth.fr/da/articles/3928135-folsomhed-og-specificitet-af-en-test.md): Forstå begreberne til at analysere effektiviteten af en test - [Trendvariansrate](https://success.openhealth.fr/da/articles/3653847-trendvariansrate.md): Måler andelen af trendkomponenten i en tidsserie - [Restvarians](https://success.openhealth.fr/da/articles/3653851-restvarians.md): Måler andelen af restkomponenten i en tidsserie - [Bestemmelseskoefficient](https://success.openhealth.fr/da/articles/3654093-bestemmelseskoefficient.md): Evaluer kvaliteten af den valgte model - [Variationskoefficient](https://success.openhealth.fr/da/articles/3653915-variationskoefficient.md): Indikator for at vælge din nedbrydningsmodel - [Variation af en tidsserie](https://success.openhealth.fr/da/articles/3653855-variation-af-en-tidsserie.md): Mål spredningen af en serie - [Salgskoncentration](https://success.openhealth.fr/da/articles/3395856-salgskoncentration.md): Salgskoncentration - [Gini-indeks](https://success.openhealth.fr/da/articles/3395323-gini-indeks.md): Gini-indeks - [Befolkning](https://success.openhealth.fr/da/articles/4396779-befolkning.md): Befolkning - [Udvikling af antallet af dødsfald](https://success.openhealth.fr/da/articles/4396765-udvikling-af-antallet-af-dodsfald.md): Udvikling af antallet af dødsfald - [Sexforhold](https://success.openhealth.fr/da/articles/3812167-sexforhold.md): Sexforhold - [Befolkning - gennemsnitsalder](https://success.openhealth.fr/da/articles/3812180-befolkning-gennemsnitsalder.md): Befolkning - gennemsnitsalder - [Befolkning - medianalder](https://success.openhealth.fr/da/articles/3812198-befolkning-medianalder.md): Befolkning - medianalder - [Befolkning - Alder 1. kvartil](https://success.openhealth.fr/da/articles/3812218-befolkning-alder-1-kvartil.md): Befolkning - Alder 1. kvartil - [Befolkning - Alder 3. kvartil](https://success.openhealth.fr/da/articles/3812227-befolkning-alder-3-kvartil.md): Befolkning - Alder 3. kvartil - [Andel af udvælgelsen i den samlede befolkning i territoriet](https://success.openhealth.fr/da/articles/3812233-andel-af-udvaelgelsen-i-den-samlede-befolkning-i-territoriet.md): Andel af udvælgelsen i den samlede befolkning i territoriet - [Dødeligheden](https://success.openhealth.fr/da/articles/3947946-dodeligheden.md): Dødeligheden - [Sags dødelighed](https://success.openhealth.fr/da/articles/3948084-sags-dodelighed.md): Sags dødelighed - [Kvinder i den fødedygtige alder](https://success.openhealth.fr/da/articles/4172859-kvinder-i-den-fodedygtige-alder.md): Kvinder i den fødedygtige alder - [Andel af udvælgelsen i det samlede antal dødsfald på territoriet](https://success.openhealth.fr/da/articles/3863734-andel-af-udvaelgelsen-i-det-samlede-antal-dodsfald-pa-territoriet.md): Andel af udvælgelsen i det samlede antal dødsfald på territoriet - [Modellering af antallet af manglende dødsfald](https://success.openhealth.fr/da/articles/3895572-modellering-af-antallet-af-manglende-dodsfald.md): Forvent antallet af dødsfald på tidspunktet t - [Anslået salg i forbindelse med indledning af receptpligtig medicin](https://success.openhealth.fr/da/articles/5323282-anslaet-salg-i-forbindelse-med-indledning-af-receptpligtig-medicin.md) - [Udvikling efter alder og graviditetsstatus](https://success.openhealth.fr/da/articles/6820051-udvikling-efter-alder-og-graviditetsstatus.md) - [Co-dispensationsprodukter Ratio](https://success.openhealth.fr/da/articles/7892010-co-dispensationsprodukter-ratio.md) - [Anslået salg af receptfornyede recepter](https://success.openhealth.fr/da/articles/5323209-anslaet-salg-af-receptfornyede-recepter.md) - [Vægt af salget af receptopfyldninger](https://success.openhealth.fr/da/articles/5323198-vaegt-af-salget-af-receptopfyldninger.md) - [Vægt af salget i forbindelse med indledning af receptudstedelse](https://success.openhealth.fr/da/articles/5323086-vaegt-af-salget-i-forbindelse-med-indledning-af-receptudstedelse.md) - [Antal co-dispensationer](https://success.openhealth.fr/da/articles/3194351-antal-co-dispensationer.md): Antal co-dispensationer - [Antal dispensationer](https://success.openhealth.fr/da/articles/3194348-antal-dispensationer.md): Antal dispensationer - [Gennemsnitligt antal dispensationer pr. Forsikret person](https://success.openhealth.fr/da/articles/3369626-gennemsnitligt-antal-dispensationer-pr-forsikret-person.md): Gennemsnitligt antal dispensationer pr. Forsikret person - [Overholdelse](https://success.openhealth.fr/da/articles/3411996-overholdelse.md): Medicinbesiddelsesrate \(MPR\) - [Persistensrate](https://success.openhealth.fr/da/articles/3369684-persistensrate.md): Persistensrate - [Terapeutisk overholdelse](https://success.openhealth.fr/da/articles/3412091-terapeutisk-overholdelse.md): Terapeutisk overholdelse - [Gennemsnitlig daglig dosis pr. Forsikret person](https://success.openhealth.fr/da/articles/4153587-gennemsnitlig-daglig-dosis-pr-forsikret-person.md): Gennemsnitlig daglig dosis pr. Forsikret person - [Antal dispensationer præsenteret for refusion](https://success.openhealth.fr/da/articles/3370942-antal-dispensationer-praesenteret-for-refusion.md): Antal dispensationer præsenteret til refusion - [Antal dispensationer, der ikke præsenteres for refusion](https://success.openhealth.fr/da/articles/3370920-antal-dispensationer-der-ikke-praesenteres-for-refusion.md): Antal dispensationer præsenteret til refusion - [Salg af refusionsværdi dækket af obligatorisk sundhedsforsikring](https://success.openhealth.fr/da/articles/3371699-salg-af-refusionsvaerdi-daekket-af-obligatorisk-sundhedsforsikring.md): Salg af indløste værdier - [Salg af refunderede værdier dækket af supplerende sundhedsforsikring](https://success.openhealth.fr/da/articles/3371830-salg-af-refunderede-vaerdier-daekket-af-supplerende-sundhedsforsikring.md): Salg af indløste værdier - [Salg af udestående værdier](https://success.openhealth.fr/da/articles/3371842-salg-af-udestaende-vaerdier.md): Salg af udestående værdier - [Udbredelse](https://success.openhealth.fr/da/articles/3947955-udbredelse.md): Prevalensrate - [Gennemsnitligt antal GTIN'er pr. Dispensation](https://success.openhealth.fr/da/articles/3396154-gennemsnitligt-antal-gtin-er-pr-dispensation.md): Gennemsnitligt antal GTIN'er pr. Dispensation - [Gennemsnitlig volumen pr. Udlevering](https://success.openhealth.fr/da/articles/3396196-gennemsnitlig-volumen-pr-udlevering.md): Gennemsnitlig volumen pr. Dispensering - [Gennemsnitlig omsætning pr. Dispensation](https://success.openhealth.fr/da/articles/3396208-gennemsnitlig-omsaetning-pr-dispensation.md): Gennemsnitlig omsætning pr. Dispensation - [Aktiv principdosering pr. Kasse](https://success.openhealth.fr/da/articles/3675409-aktiv-principdosering-pr-kasse.md): Aktiv principdosering pr. Kasse - [DDD pr. Kasse](https://success.openhealth.fr/da/articles/3675446-ddd-pr-kasse.md): Definer daglig dosis pr. Boks - [Volumen i basisenheder](https://success.openhealth.fr/da/articles/3675520-volumen-i-basisenheder.md): Volumen i basisenheder - [Volumen i aktivt princip](https://success.openhealth.fr/da/articles/3675539-volumen-i-aktivt-princip.md): Volumen i aktivt princip - [DDJ pr. 1.000 indbyggere](https://success.openhealth.fr/da/articles/3675667-ddj-pr-1-000-indbyggere.md): Dagligt defineret dosis pr. 1.000 indbyggere - [Volumen i gennemsnit UA pr. Forsikret person](https://success.openhealth.fr/da/articles/3675761-volumen-i-gennemsnit-ua-pr-forsikret-person.md): Volumen i gennemsnitlige forbrugsenheder pr. Forsikret person - [Volumen i gennemsnit UB pr. Forsikret person](https://success.openhealth.fr/da/articles/3675814-volumen-i-gennemsnit-ub-pr-forsikret-person.md): Volumen i gennemsnitlige basisenheder pr. Forsikret person - [Volumen i gennemsnit aktivt princip pr. Forsikret person](https://success.openhealth.fr/da/articles/3675824-volumen-i-gennemsnit-aktivt-princip-pr-forsikret-person.md): Volumen i gennemsnit aktivt princip pr. Forsikret person - [Observeret gennemsnitlig behandlingsvarighed](https://success.openhealth.fr/da/articles/3675841-observeret-gennemsnitlig-behandlingsvarighed.md): Observeret gennemsnitlig behandlingsvarighed - [Immuniseringsdækning](https://success.openhealth.fr/da/articles/3822264-immuniseringsdaekning.md): Immuniseringsdækning - [Patienter inkluderet](https://success.openhealth.fr/da/articles/3886665-patienter-inkluderet.md): Antal patienter inkluderet i kohorten - [Forskelle mellem MPR og PDC](https://success.openhealth.fr/da/articles/3722666-forskelle-mellem-mpr-og-pdc.md): MPR \(medicinbesiddelsesrate\) vs. PDC \(Andel af dækkede dage\) - [Gennemsnitlig behandlingsvarighed](https://success.openhealth.fr/da/articles/3920967-gennemsnitlig-behandlingsvarighed.md): Mål den gennemsnitlige behandlingstid i slutningen af analyseperioden - [Gennemsnitlig fornyelsestid](https://success.openhealth.fr/da/articles/3921067-gennemsnitlig-fornyelsestid.md): Mål den gennemsnitlige tid mellem fornyelse af behandlingen - [Indledning af behandling](https://success.openhealth.fr/da/articles/3848844-indledning-af-behandling.md): Indledning af behandling - [Behandling fornyelser](https://success.openhealth.fr/da/articles/3885469-behandling-fornyelser.md): Behandling fornyelse - [Behandlingen genoptages](https://success.openhealth.fr/da/articles/3885608-behandlingen-genoptages.md): Behandlingen genoptages - [Nye behandlinger](https://success.openhealth.fr/da/articles/3885297-nye-behandlinger.md): Indledning og genoptagelse af behandlingen - [Behandlingskontakt](https://success.openhealth.fr/da/articles/3848886-behandlingskontakt.md): Behandlingsomskifter - [Behandlingen stopper](https://success.openhealth.fr/da/articles/3885426-behandlingen-stopper.md): Behandlingen stopper - [Sætte af](https://success.openhealth.fr/da/articles/3885387-saette-af.md): Sætte af - [Sporbarhedsindsats](https://success.openhealth.fr/da/articles/4355163-sporbarhedsindsats.md): Sporbarhed - [Stoppet og derefter genstartet](https://success.openhealth.fr/da/articles/8429189-stoppet-og-derefter-genstartet.md) - [Udleveringsandel](https://success.openhealth.fr/da/articles/3624820-udleveringsandel.md): Udleveringsandel - [Overvågning af relevante dispensationer](https://success.openhealth.fr/da/articles/3804193-overvagning-af-relevante-dispensationer.md): Følg udviklingen i trafik på apoteker i relevante dispensationer - [Nedbrydningshastighed](https://success.openhealth.fr/da/articles/4850138-nedbrydningshastighed.md) - [Kinetik af en reaktion](https://success.openhealth.fr/da/articles/4850629-kinetik-af-en-reaktion.md) - [Halveringstid](https://success.openhealth.fr/da/articles/4849710-halveringstid.md) - [Aktiedækningsgrad](https://success.openhealth.fr/da/articles/4210714-aktiedaekningsgrad.md): Aktiedækningsgrad - [Tidsperioder](https://success.openhealth.fr/da/articles/3194479-tidsperioder.md): Tidsperioder - [Ændre definitionen af et regnskabsår](https://success.openhealth.fr/da/articles/3321750-aendre-definitionen-af-et-regnskabsar.md): HUB giver dig mulighed for at indstille dine regnskabsår - [Styring af ugentlige sammenligninger](https://success.openhealth.fr/da/articles/3835180-styring-af-ugentlige-sammenligninger.md): Analytiske virkninger af de undersøgte dage - [GSA's Parapharmacy Calendar \(SMKT\)](https://success.openhealth.fr/da/articles/3175583-gsa-s-parapharmacy-calendar-smkt.md): SMKT-kalenderen \(IRI\) kaldes også GSA-apotekskalenderen - [IKKE](https://success.openhealth.fr/da/articles/3194484-ikke.md): Definition af foranstaltning 'N' - [N Evol](https://success.openhealth.fr/da/articles/3194461-n-evol.md): Definition og beregningsformel for målingen 'N Evol' - [N Trend](https://success.openhealth.fr/da/articles/3194485-n-trend.md): Definition af 'N Trend' foranstaltningen ### IAS - Indicateurs Avancés Sanitaires - [IAS\(r\) Allergi](https://success.openhealth.fr/da/articles/7339151-ias-r-allergi.md) - [IAS\(r\) Poux](https://success.openhealth.fr/da/articles/7339168-ias-r-poux.md) - [IAS\(r\) gastroenteritis](https://success.openhealth.fr/da/articles/7339181-ias-r-gastroenteritis.md) - [IAS\(r\) Influenzalignende sygdom](https://success.openhealth.fr/da/articles/7266711-ias-r-influenzalignende-sygdom.md) ### Marketing Direct - [OpenHealth e-mailing-løsning](https://success.openhealth.fr/da/articles/7055261-openhealth-e-mailing-losning.md) - [Krav til udarbejdelsen af en e-mail-kampagne](https://success.openhealth.fr/da/articles/6282113-krav-til-udarbejdelsen-af-en-e-mail-kampagne.md) - [Rapport om sporing og benchmarks](https://success.openhealth.fr/da/articles/6302721-rapport-om-sporing-og-benchmarks.md) - [Ordliste til e-mail-kampagner](https://success.openhealth.fr/da/articles/6282099-ordliste-til-e-mail-kampagner.md) ### PSAD - [Analyse - NATIONAL](https://success.openhealth.fr/da/articles/3376262-analyse-national.md): Analyser præstationen på markedet for hjemmesundhedsudbydere \(PSAD\): efter område, aktivitet, underaktivitet, segment, LPP-handling - [Volumen / omsætning - NATIONAL](https://success.openhealth.fr/da/articles/3376287-volumen-omsaetning-national.md): Se samtidig aktiviteten i volumen og værdi: efter område, aktivitet, underaktivitet, segment, handling ... - [Evolution - NATIONAL](https://success.openhealth.fr/da/articles/3376370-evolution-national.md): Visualiser udviklingen på markedet i den tilgængelige historie: efter område, aktivitet, underaktivitet, segment, LPP-handling - [Ekstraktion - NATIONAL](https://success.openhealth.fr/da/articles/3376420-ekstraktion-national.md): Eksporter data til Excel - [Definition](https://success.openhealth.fr/da/articles/3376439-definition.md): Find alle funktionerne i SantéDomStat Observatoire National - Essential applikation ### AUTRES THEMATIQUES - [INTERCOM](https://success.openhealth.fr/da/articles/6959415-intercom.md) - [Salesforce](https://success.openhealth.fr/da/articles/6959337-salesforce.md) - [GIHSN: Indsend Excel-fil](https://success.openhealth.fr/da/articles/3977478-gihsn-indsend-excel-fil.md): GIHSN Excel-fil - [Blockchain](https://success.openhealth.fr/da/articles/5385413-blockchain.md) - [DocuSign, CRM-værktøj i vores forretningsproces](https://success.openhealth.fr/da/articles/4514472-docusign-crm-vaerktoj-i-vores-forretningsproces.md): Docusign: CRM-værktøj i vores forretningsproces - [National vaccinationssporing](https://success.openhealth.fr/da/articles/4754333-national-vaccinationssporing.md) - [Vaccinationsdækning](https://success.openhealth.fr/da/articles/4754311-vaccinationsdaekning.md) - [KPI-overvågning](https://success.openhealth.fr/da/articles/4091042-kpi-overvagning.md): POC ProPharma Systems: tendenser på det schweiziske marked - [Apotek Cockpit](https://success.openhealth.fr/da/articles/4091025-apotek-cockpit.md): POC ProPharma Systems: Mit apotek vs Schweiz - [Befolkningsækvivalent \(p.e.\)](https://success.openhealth.fr/da/articles/5431894-befolkningsaekvivalent-p-e.md) - [Iltbehov](https://success.openhealth.fr/da/articles/5137158-iltbehov.md) - [IHU](https://success.openhealth.fr/da/articles/4851687-ihu.md) - [Suspenderet stof](https://success.openhealth.fr/da/articles/5137147-suspenderet-stof.md) - [Kemi af spildevand](https://success.openhealth.fr/da/articles/5137101-kemi-af-spildevand.md) - [NRBCE](https://success.openhealth.fr/da/articles/4851683-nrbce.md) - [Arrhenius' lov](https://success.openhealth.fr/da/articles/4849672-arrhenius-lov.md) - [Resultaternes ydeevne](https://success.openhealth.fr/da/articles/5137034-resultaternes-ydeevne.md) - [Typer af spildevand](https://success.openhealth.fr/da/articles/5137183-typer-af-spildevand.md) - [Koncentration af SARS-CoV-2-virus](https://success.openhealth.fr/da/articles/4867968-koncentration-af-sars-cov-2-virus.md) - [MAPOM / BMPM](https://success.openhealth.fr/da/articles/4851685-mapom-bmpm.md) - [Kontekstualiseret koncentration af SARS-CoV-2](https://success.openhealth.fr/da/articles/4934604-kontekstualiseret-koncentration-af-sars-cov-2.md) - [Type af kloakeringssystem](https://success.openhealth.fr/da/articles/4867954-type-af-kloakeringssystem.md) - [Nedbrydning af virus](https://success.openhealth.fr/da/articles/4865742-nedbrydning-af-virus.md) - [WBE](https://success.openhealth.fr/da/articles/4865735-wbe.md) - [RNA](https://success.openhealth.fr/da/articles/4865733-rna.md) - [Coronavirus](https://success.openhealth.fr/da/articles/4865728-coronavirus.md) - [COVID-19](https://success.openhealth.fr/da/articles/4865726-covid-19.md) - [Seroprevalens: prøveudtagningsmetode](https://success.openhealth.fr/da/articles/3924493-seroprevalens-proveudtagningsmetode.md): Seroprevalens: Prøvetagningsmetode - [SANDRE opbevaring](https://success.openhealth.fr/da/articles/5415040-sandre-opbevaring.md) - [National base ROSEAU](https://success.openhealth.fr/da/articles/5414523-national-base-roseau.md) - [Koncentration af SARS-CoV-2-virus](https://success.openhealth.fr/da/articles/4852404-koncentration-af-sars-cov-2-virus.md) - [Koncentration af SARS-CoV-2-virus - Varianter](https://success.openhealth.fr/da/articles/4909854-koncentration-af-sars-cov-2-virus-varianter.md) - [Marseille - Global overvågning](https://success.openhealth.fr/da/articles/4859311-marseille-global-overvagning.md) - [Koncentration af SARS-CoV-2-virus - Nice](https://success.openhealth.fr/da/articles/4879292-koncentration-af-sars-cov-2-virus-nice.md) - [Befolkning - struktur](https://success.openhealth.fr/da/articles/4842408-befolkning-struktur.md) - [Koncentration af SARS-CoV-2-virus - Toulon \(FRANKRIG\)](https://success.openhealth.fr/da/articles/4886417-koncentration-af-sars-cov-2-virus-toulon-frankrig.md) - [Dubai - Overvågning af spildevand i lufthavne](https://success.openhealth.fr/da/articles/5276423-dubai-overvagning-af-spildevand-i-lufthavne.md): Dubai - Overvågning af spildevand i lufthavne - [Overvågning af SARS-CoV-2 - OBEPINE](https://success.openhealth.fr/da/articles/5210661-overvagning-af-sars-cov-2-obepine.md) - [Kontekstualiseret koncentration af SARS-CoV-2](https://success.openhealth.fr/da/articles/4934608-kontekstualiseret-koncentration-af-sars-cov-2.md) - [SUEZ - Analytisk balance](https://success.openhealth.fr/da/articles/5140509-suez-analytisk-balance.md) - [Palais des festivals - Se T0](https://success.openhealth.fr/da/articles/5373515-palais-des-festivals-se-t0.md) - [Palais des festivals - Daglig vagt](https://success.openhealth.fr/da/articles/5373231-palais-des-festivals-daglig-vagt.md) - [Palais des festivals - Visning](https://success.openhealth.fr/da/articles/5404778-palais-des-festivals-visning.md) - [Mustelider - Se](https://success.openhealth.fr/da/articles/5169577-mustelider-se.md) - [Befolkning - IRIS](https://success.openhealth.fr/da/articles/4842191-befolkning-iris.md) - [SARS-CoV-2](https://success.openhealth.fr/da/articles/4865699-sars-cov-2.md) - [IAS - Analyse](https://success.openhealth.fr/da/articles/4842430-ias-analyse.md) - [SARS-CoV-2-viruskoncentration - SEM](https://success.openhealth.fr/da/articles/5415600-sars-cov-2-viruskoncentration-sem.md) - [Kortvisualisering](https://success.openhealth.fr/da/articles/3864657-kortvisualisering.md): Geografisk fordeling af patienter - [Bidrag websted](https://success.openhealth.fr/da/articles/3864668-bidrag-websted.md): Bidrag pr. Sted og hospital - [Kohortprofil efter sted](https://success.openhealth.fr/da/articles/3864672-kohortprofil-efter-sted.md): Kohortprofil efter sted og hospital - [Kohortprofil efter sæson](https://success.openhealth.fr/da/articles/3864673-kohortprofil-efter-saeson.md): Kohortprofil efter sæson - [Alder og kønsfordeling](https://success.openhealth.fr/da/articles/3864675-alder-og-konsfordeling.md): Demografi - [Virusdistribution efter sted](https://success.openhealth.fr/da/articles/3864678-virusdistribution-efter-sted.md): Virusdistribution efter sted - [Virusfordeling efter alder](https://success.openhealth.fr/da/articles/3864677-virusfordeling-efter-alder.md): Virusfordeling efter alder - [Virusdistributionsudvikling](https://success.openhealth.fr/da/articles/3864681-virusdistributionsudvikling.md): Virusdistributionsudvikling - [Influenza vaccination](https://success.openhealth.fr/da/articles/3864697-influenza-vaccination.md): Influenza vaccination - [Influenza vaccination evolution](https://success.openhealth.fr/da/articles/3864701-influenza-vaccination-evolution.md): Udvikling af influenzavaccination - [Patientfordeling efter kronisk tilstand](https://success.openhealth.fr/da/articles/3864676-patientfordeling-efter-kronisk-tilstand.md): Patientfordeling efter kronisk tilstand - [Patientfordeling efter hospitalsophold](https://success.openhealth.fr/da/articles/3864794-patientfordeling-efter-hospitalsophold.md): Patientfordeling efter længde oh hospitalsophold - [Svaghed](https://success.openhealth.fr/da/articles/3864704-svaghed.md): Skrøbelighed hos patienter - [Alvorlighedsstatus](https://success.openhealth.fr/da/articles/3864705-alvorlighedsstatus.md): Alvorlighedsstatus - [Dødelighed](https://success.openhealth.fr/da/articles/3864710-dodelighed.md): Dødelighed - [GIHSN](https://success.openhealth.fr/da/articles/3864712-gihsn.md): Global Influenza Hospital Surveillance Network - [CARéDIAB - Patientprofil](https://success.openhealth.fr/da/articles/3789234-carediab-patientprofil.md): Analyser patientprofilen for CARéDIAB-populationen - [CARéDIAB - Komplikationer](https://success.openhealth.fr/da/articles/3789515-carediab-komplikationer.md): Analyser forekomsten af komplikationer i vores befolkning CAREDIAB - [CARéDIAB - Global patientovervågning](https://success.openhealth.fr/da/articles/3792041-carediab-global-patientovervagning.md): Analyser hyppigheden af opfølgning for patienter i CARéDIAB-populationen - [CARéDIAB-netværk](https://success.openhealth.fr/da/articles/3789106-carediab-netvaerk.md): CARéDIAB-netværket - [CARéDIAB - Behandlinger](https://success.openhealth.fr/da/articles/3792143-carediab-behandlinger.md): Analyser behandlingen af behandlinger i forbindelse med diabetes ## Nederlands ### Votre PLATEFORME - présentation générale - [De HUB, een uitgebreid, doorlopend ondersteuningsplatform](https://success.openhealth.fr/nl/articles/4799621-de-hub-een-uitgebreid-doorlopend-ondersteuningsplatform.md) - [Jouw ervaringsniveau De HUB](https://success.openhealth.fr/nl/articles/5712270-jouw-ervaringsniveau-de-hub.md) - [Talen](https://success.openhealth.fr/nl/articles/4649389-talen.md) - [Vragen over onze tarieven](https://success.openhealth.fr/nl/articles/3292143-vragen-over-onze-tarieven.md) ### ROADMAP - Innovations & Optimisations de votre Plateforme - ["Open innovatie voor onze klanten](https://success.openhealth.fr/nl/articles/5200970-open-innovatie-voor-onze-klanten.md) - [Apps + beheergebied versie 240515](https://success.openhealth.fr/nl/articles/9310541-apps-beheergebied-versie-240515.md) - [Apps + beheergebied versie 240415](https://success.openhealth.fr/nl/articles/9310710-apps-beheergebied-versie-240415.md) - [Apps + beheergebied versie 240315](https://success.openhealth.fr/nl/articles/9310790-apps-beheergebied-versie-240315.md) - [Apps + beheergebied versie 240215](https://success.openhealth.fr/nl/articles/9311007-apps-beheergebied-versie-240215.md) - [Platform - update 231215](https://success.openhealth.fr/nl/articles/8718485-platform-update-231215.md) - [Platform - update 231015](https://success.openhealth.fr/nl/articles/8479932-platform-update-231015.md) - [Apps + portaal versie 230915](https://success.openhealth.fr/nl/articles/8373640-apps-portaal-versie-230915.md) - [Apps + portaal versie 230815](https://success.openhealth.fr/nl/articles/8267860-apps-portaal-versie-230815.md) - [Nieuwe producten 230715](https://success.openhealth.fr/nl/articles/8115796-nieuwe-producten-230715.md) - [Apps + portaal versie 230615](https://success.openhealth.fr/nl/articles/8115791-apps-portaal-versie-230615.md) - [Apps + portaal versie 230515](https://success.openhealth.fr/nl/articles/7895393-apps-portaal-versie-230515.md) - [Apps + portaal versie 230415](https://success.openhealth.fr/nl/articles/7439447-apps-portaal-versie-230415.md) - [Apps + portaal versie 230315](https://success.openhealth.fr/nl/articles/7439646-apps-portaal-versie-230315.md) - [Apps + portaal versie 230215](https://success.openhealth.fr/nl/articles/7439744-apps-portaal-versie-230215.md) - [Nieuws van 15/01/2023](https://success.openhealth.fr/nl/articles/6895740-nieuws-van-15-01-2023.md) - [HUB + DEUR versie 221215](https://success.openhealth.fr/nl/articles/6827027-hub-deur-versie-221215.md) - [HUB + DEUR versie 221115](https://success.openhealth.fr/nl/articles/6742628-hub-deur-versie-221115.md) - [HUB + DEUR versie 220915](https://success.openhealth.fr/nl/articles/6558070-hub-deur-versie-220915.md) - [HUB + DEUR versie 220815](https://success.openhealth.fr/nl/articles/6475311-hub-deur-versie-220815.md) - [HUB + DEUR versie 220615](https://success.openhealth.fr/nl/articles/6306090-hub-deur-versie-220615.md) - [HUB + DEUR versie 220515](https://success.openhealth.fr/nl/articles/6201877-hub-deur-versie-220515.md) - [HUB + DEUR versie 220415](https://success.openhealth.fr/nl/articles/6087747-hub-deur-versie-220415.md) - [HUB SMA versie 220315](https://success.openhealth.fr/nl/articles/6043772-hub-sma-versie-220315.md) - [HUB TMA versie 220315](https://success.openhealth.fr/nl/articles/6043802-hub-tma-versie-220315.md) - [HUB UAN versie 220315](https://success.openhealth.fr/nl/articles/6043852-hub-uan-versie-220315.md) - [GATE versie 220215](https://success.openhealth.fr/nl/articles/5940805-gate-versie-220215.md) - [HUB SMA versie 220215](https://success.openhealth.fr/nl/articles/5940753-hub-sma-versie-220215.md) - [HUB TMA versie 220215](https://success.openhealth.fr/nl/articles/5947859-hub-tma-versie-220215.md) - [GATE versie 211215](https://success.openhealth.fr/nl/articles/5819397-gate-versie-211215.md) - [HUB SMA versie 211215](https://success.openhealth.fr/nl/articles/5784709-hub-sma-versie-211215.md) - [HUB TMA versie 211215](https://success.openhealth.fr/nl/articles/5784888-hub-tma-versie-211215.md) - [HUB UAN versie 211215](https://success.openhealth.fr/nl/articles/5784904-hub-uan-versie-211215.md) - [De HUB-toepassing: "Huidige situatie van apotheken](https://success.openhealth.fr/nl/articles/5704485-de-hub-toepassing-huidige-situatie-van-apotheken.md) - [GATE versie 211115](https://success.openhealth.fr/nl/articles/5697844-gate-versie-211115.md) - [HUB SMA versie 211115](https://success.openhealth.fr/nl/articles/5671893-hub-sma-versie-211115.md) - [HUB TMA versie 211115](https://success.openhealth.fr/nl/articles/5671917-hub-tma-versie-211115.md) - [HUB UAN versie 211115](https://success.openhealth.fr/nl/articles/5671927-hub-uan-versie-211115.md) - [GATE versie 211015](https://success.openhealth.fr/nl/articles/5652210-gate-versie-211015.md) - [HUB SMA versie 211015](https://success.openhealth.fr/nl/articles/5649822-hub-sma-versie-211015.md) - [HUB TMA versie 211015](https://success.openhealth.fr/nl/articles/5650073-hub-tma-versie-211015.md) - [HUB UAN versie 211015](https://success.openhealth.fr/nl/articles/5652242-hub-uan-versie-211015.md) - [HUB SMA versie 210915](https://success.openhealth.fr/nl/articles/5370516-hub-sma-versie-210915.md) - [HUB TMA versie 210915](https://success.openhealth.fr/nl/articles/5390983-hub-tma-versie-210915.md) - [HUB UAN versie 210915](https://success.openhealth.fr/nl/articles/5543213-hub-uan-versie-210915.md) ### Votre ESPACE D'ADMINISTRATION - fonctionnalités - [Uw The HUB-wachtwoord opnieuw instellen/wijzigen](https://success.openhealth.fr/nl/articles/4425325-uw-the-hub-wachtwoord-opnieuw-instellen-wijzigen.md) - [Assistentie bij verbinding: ik krijg een foutmelding](https://success.openhealth.fr/nl/articles/5369783-assistentie-bij-verbinding-ik-krijg-een-foutmelding.md) - [Een ticket aanmaken en volgen](https://success.openhealth.fr/nl/articles/3586214-een-ticket-aanmaken-en-volgen.md) - [Een SUCCES-item maken en wijzigen](https://success.openhealth.fr/nl/articles/6738705-een-succes-item-maken-en-wijzigen.md) - [Mijn contracten](https://success.openhealth.fr/nl/articles/5712273-mijn-contracten.md) - [Service Gezondheid](https://success.openhealth.fr/nl/articles/4990600-service-gezondheid.md) - [Mijn toegang](https://success.openhealth.fr/nl/articles/5783418-mijn-toegang.md) - [Mijn startpagina instellen](https://success.openhealth.fr/nl/articles/5712229-mijn-startpagina-instellen.md) - [Hoe kan ik mijn markt veranderen vanuit mijn OpenHealth persoonlijke ruimte?](https://success.openhealth.fr/nl/articles/3585971-hoe-kan-ik-mijn-markt-veranderen-vanuit-mijn-openhealth-persoonlijke-ruimte.md) - [Automatische modaliteitstoewijzing wijzigen \(MAM auto\)](https://success.openhealth.fr/nl/articles/4164818-automatische-modaliteitstoewijzing-wijzigen-mam-auto.md) - [MAM TEMPORELLE: Hoe houd je een merk bij dat van laboratorium/merk/label verandert?](https://success.openhealth.fr/nl/articles/4131072-mam-temporelle-hoe-houd-je-een-merk-bij-dat-van-laboratorium-merk-label-verandert.md) - [Productintegratie \(IPR\)](https://success.openhealth.fr/nl/articles/4164932-productintegratie-ipr.md) - [Productverwijdering \(SPR\)](https://success.openhealth.fr/nl/articles/4164866-productverwijdering-spr.md) - [Automatische productreactivering \(RPR auto\)](https://success.openhealth.fr/nl/articles/4818161-automatische-productreactivering-rpr-auto.md) - [Nieuwe producten opzetten](https://success.openhealth.fr/nl/articles/5811248-nieuwe-producten-opzetten.md) - [Een markt toevoegen](https://success.openhealth.fr/nl/articles/5712283-een-markt-toevoegen.md) - [Import/export van bulkproducten](https://success.openhealth.fr/nl/articles/5712257-import-export-van-bulkproducten.md) - [Verandering van typologische modus \(CMT\)](https://success.openhealth.fr/nl/articles/4670174-verandering-van-typologische-modus-cmt.md) - [Verschillende gebruikersstatussen](https://success.openhealth.fr/nl/articles/3436418-verschillende-gebruikersstatussen.md) - [Een account aanmaken voor een gebruiker van een externe organisatie \(TPAA\)](https://success.openhealth.fr/nl/articles/6466550-een-account-aanmaken-voor-een-gebruiker-van-een-externe-organisatie-tpaa.md) - [Hoe maak, wijzig of verwijder ik een gebruikersaccount op The HUB?](https://success.openhealth.fr/nl/articles/3785138-hoe-maak-wijzig-of-verwijder-ik-een-gebruikersaccount-op-the-hub.md) - [Kan ik gedifferentieerde HUB-kijkrechten maken voor mijn teams?](https://success.openhealth.fr/nl/articles/3321731-kan-ik-gedifferentieerde-hub-kijkrechten-maken-voor-mijn-teams.md) - [Activiteitenlogboek](https://success.openhealth.fr/nl/articles/4687438-activiteitenlogboek.md) ### Vos APPLICATIONS - présentation - [De HUB-opleidingsgids](https://success.openhealth.fr/nl/articles/5634967-de-hub-opleidingsgids.md) - [Drop-down sorteerder](https://success.openhealth.fr/nl/articles/5792113-drop-down-sorteerder.md) - [Datum bijwerking gegevens GSA-apotheken en parafarmaceuten \(SMKT\)](https://success.openhealth.fr/nl/articles/3175557-datum-bijwerking-gegevens-gsa-apotheken-en-parafarmaceuten-smkt.md) - [Eisen Matching Apotheekdatabase](https://success.openhealth.fr/nl/articles/3678146-eisen-matching-apotheekdatabase.md) - [Keuzeschakelaar "Aan en uit voorschrift](https://success.openhealth.fr/nl/articles/3729668-keuzeschakelaar-aan-en-uit-voorschrift.md) - [Vraag over gegevens: procedure](https://success.openhealth.fr/nl/articles/4374497-vraag-over-gegevens-procedure.md) - [Hoe kwalificeer je nieuwe producten in de HUB?](https://success.openhealth.fr/nl/articles/3376100-hoe-kwalificeer-je-nieuwe-producten-in-de-hub.md) - [Hoe maak, wijzig en deel ik een favoriet in de HUB?](https://success.openhealth.fr/nl/articles/3175689-hoe-maak-wijzig-en-deel-ik-een-favoriet-in-de-hub.md) - [Hoe selecteer ik producten in de HUB op lanceringsdatum?](https://success.openhealth.fr/nl/articles/3158428-hoe-selecteer-ik-producten-in-de-hub-op-lanceringsdatum.md) - [Kan ik gegevens uit de HUB halen in ".csv" formaat?](https://success.openhealth.fr/nl/articles/5671278-kan-ik-gegevens-uit-de-hub-halen-in-csv-formaat.md) - [Reactietijd ODT](https://success.openhealth.fr/nl/articles/6632310-reactietijd-odt.md) - [Beste werkwijze voor weergave in de HUB](https://success.openhealth.fr/nl/articles/3124454-beste-werkwijze-voor-weergave-in-de-hub.md) - [Technische vereisten](https://success.openhealth.fr/nl/articles/5369918-technische-vereisten.md) - [Leeg de cache van je browser](https://success.openhealth.fr/nl/articles/4219722-leeg-de-cache-van-je-browser.md) - [Hoe stel ik Google Chrome in als standaardbrowser?](https://success.openhealth.fr/nl/articles/3738717-hoe-stel-ik-google-chrome-in-als-standaardbrowser.md) - [De navigatiebalk is niet zichtbaar in tabellen](https://success.openhealth.fr/nl/articles/3195250-de-navigatiebalk-is-niet-zichtbaar-in-tabellen.md) - [De weergave van knoppen of objecten op een blad is gedeeltelijk afgesneden of niet zichtbaar](https://success.openhealth.fr/nl/articles/3195245-de-weergave-van-knoppen-of-objecten-op-een-blad-is-gedeeltelijk-afgesneden-of-niet-zichtbaar.md) - [Mijn Territory Management-kaart wordt niet geladen en het bericht "loading" verschijnt](https://success.openhealth.fr/nl/articles/3195239-mijn-territory-management-kaart-wordt-niet-geladen-en-het-bericht-loading-verschijnt.md) - [Waar komt de foutmelding "U bent niet bevoegd om deze pagina te openen" vandaan?](https://success.openhealth.fr/nl/articles/3195338-waar-komt-de-foutmelding-u-bent-niet-bevoegd-om-deze-pagina-te-openen-vandaan.md) - [Ik krijg een foutmelding "Verbinding verbroken](https://success.openhealth.fr/nl/articles/4445141-ik-krijg-een-foutmelding-verbinding-verbroken.md) - ["Slechte gateway](https://success.openhealth.fr/nl/articles/4514555-slechte-gateway.md) - [Foutbericht: "Er is een fout opgetreden.](https://success.openhealth.fr/nl/articles/3195286-foutbericht-er-is-een-fout-opgetreden.md) - [De dimensie- en maatselectors worden niet langer weergegeven in de query's "Analyse van meerdere perioden" en "Mijn gegevensarchief" en de tabel die wordt geëxtraheerd in "Marktanalyse" is gedeeltelijk.](https://success.openhealth.fr/nl/articles/3195377-de-dimensie-en-maatselectors-worden-niet-langer-weergegeven-in-de-query-s-analyse-van-meerdere-perioden-en-mijn-gegevensarchief-en-de-tabel-die-wordt-geextraheerd-in-marktanalyse-is-gedeeltelijk.md) - [Hoe bekijk ik een term in de HUB?](https://success.openhealth.fr/nl/articles/3194377-hoe-bekijk-ik-een-term-in-de-hub.md) - [Excel-specificaties en -beperkingen](https://success.openhealth.fr/nl/articles/3753088-excel-specificaties-en-beperkingen.md) - [Hoe maak, bewerk en deel je een Favoriet in je applicaties?](https://success.openhealth.fr/nl/articles/10502803-hoe-maak-bewerk-en-deel-je-een-favoriet-in-je-applicaties.md) - [Kader consumentenpanel](https://success.openhealth.fr/nl/articles/3455845-kader-consumentenpanel.md) - [Raamwerk analyse apotheekmarkt](https://success.openhealth.fr/nl/articles/3455857-raamwerk-analyse-apotheekmarkt.md) ### SOURCES / CANAUX DE DISTRIBUTION / TERRITOIRES GEOGRAPHIQUES disponibles - [Wat is het OpenHealth apotheek panel?](https://success.openhealth.fr/nl/articles/3304106-wat-is-het-openhealth-apotheek-panel.md) - [Het apotheeknetwerk, een beslissende troef in het beheer van huidige en toekomstige gezondheidscrisissen](https://success.openhealth.fr/nl/articles/3825648-het-apotheeknetwerk-een-beslissende-troef-in-het-beheer-van-huidige-en-toekomstige-gezondheidscrisissen.md) - [Welke DROM COM-gebieden kunnen worden bekeken in de HUB?](https://success.openhealth.fr/nl/articles/3194382-welke-drom-com-gebieden-kunnen-worden-bekeken-in-de-hub.md) - [Vereisten voor sectorisatiedossier](https://success.openhealth.fr/nl/articles/3702701-vereisten-voor-sectorisatiedossier.md) - [Bron: IRI Frankrijk Parafarmacies \(SMKT\) / Retailers](https://success.openhealth.fr/nl/articles/4485357-bron-iri-frankrijk-parafarmacies-smkt-retailers.md) - [Regels voor het coderen van GSA \(SMKT\) parafarmaceutische producten bij IRI](https://success.openhealth.fr/nl/articles/3524492-regels-voor-het-coderen-van-gsa-smkt-parafarmaceutische-producten-bij-iri.md) - [Gegevens ORGANIC STORE - Bron BIOANALYTICS](https://success.openhealth.fr/nl/articles/5631260-gegevens-organic-store-bron-bioanalytics.md) - [E-parafarmacies: controleplatforms](https://success.openhealth.fr/nl/articles/9167006-e-parafarmacies-controleplatforms.md) - [E-apotheken Product Winsten & Verliezen](https://success.openhealth.fr/nl/articles/3568773-e-apotheken-product-winsten-verliezen.md) - [Consumentenprofiel](https://success.openhealth.fr/nl/articles/3711085-consumentenprofiel.md) - [AMAZON gegevens - Bron SELLINGZ](https://success.openhealth.fr/nl/articles/5669013-amazon-gegevens-bron-sellingz.md) - [Gegevens over e-commerce - Bron WISER](https://success.openhealth.fr/nl/articles/7983010-gegevens-over-e-commerce-bron-wiser.md) - [Geografische gebieden](https://success.openhealth.fr/nl/articles/4661582-geografische-gebieden.md) - [Wat is het apothekerspanel in Duitsland? INSIGHTHEALTH](https://success.openhealth.fr/nl/articles/5391412-wat-is-het-apothekerspanel-in-duitsland-insighthealth.md) - [Internationale gegevens - Paneldekking](https://success.openhealth.fr/nl/articles/7047053-internationale-gegevens-paneldekking.md) - [Wat is het apothekerspanel in Griekenland? ALIRAHEALTH](https://success.openhealth.fr/nl/articles/6863963-wat-is-het-apothekerspanel-in-griekenland-alirahealth.md) - [Wat is het apothekerspanel in Oostenrijk? INSIGHTHEALTH](https://success.openhealth.fr/nl/articles/6863949-wat-is-het-apothekerspanel-in-oostenrijk-insighthealth.md) - [Wat is het apothekenpanel in Afrika? PIEX - Afrika](https://success.openhealth.fr/nl/articles/6686633-wat-is-het-apothekenpanel-in-afrika-piex-afrika.md) - [Wat is het online apothekenpanel in Duitsland? DATAMEDIQ](https://success.openhealth.fr/nl/articles/5689640-wat-is-het-online-apothekenpanel-in-duitsland-datamediq.md) - [Wat is het apothekerspanel in België? REDPHARMA](https://success.openhealth.fr/nl/articles/4689894-wat-is-het-apothekerspanel-in-belgie-redpharma.md) - [Wat is het apothekenpanel in Spanje? - HMR](https://success.openhealth.fr/nl/articles/5391363-wat-is-het-apothekenpanel-in-spanje-hmr.md) - [Wat is het apothekenpanel in Spanje? - INFONIS](https://success.openhealth.fr/nl/articles/5428915-wat-is-het-apothekenpanel-in-spanje-infonis.md) - [Wat is het apothekenpanel in Portugal? - HMR](https://success.openhealth.fr/nl/articles/5391477-wat-is-het-apothekenpanel-in-portugal-hmr.md) - [Wat is het apothekerspanel in Rusland? - ALPHARM](https://success.openhealth.fr/nl/articles/5701531-wat-is-het-apothekerspanel-in-rusland-alpharm.md) - [Wat is het apothekerspanel in Polen? Pex Pharma](https://success.openhealth.fr/nl/articles/5969485-wat-is-het-apothekerspanel-in-polen-pex-pharma.md) - [Wat is het apothekerspanel in Benin? AS PHARM - ASPHARM BENIN](https://success.openhealth.fr/nl/articles/4238167-wat-is-het-apothekerspanel-in-benin-as-pharm-aspharm-benin.md) - [CONVERT GROEP](https://success.openhealth.fr/nl/articles/6961966-convert-groep.md) - [Wat is het apothekenpanel in Jordanië?](https://success.openhealth.fr/nl/articles/8176750-wat-is-het-apothekenpanel-in-jordanie.md) - [Bevolking - Cartografie](https://success.openhealth.fr/nl/articles/3807695-bevolking-cartografie.md) - [AMELI - LPP](https://success.openhealth.fr/nl/articles/6962021-ameli-lpp.md) - [Populatie - Evolutie per LEEFTIJD & GENDER](https://success.openhealth.fr/nl/articles/3810789-populatie-evolutie-per-leeftijd-gender.md) - [Bevolking - Vergelijking per LEEFTIJD & STERKTE](https://success.openhealth.fr/nl/articles/3836795-bevolking-vergelijking-per-leeftijd-sterkte.md) - [EGYPTE - Cartografie](https://success.openhealth.fr/nl/articles/3714611-egypte-cartografie.md) - [EGYPTE - Analyse per LEEFTIJD & GESLACHT](https://success.openhealth.fr/nl/articles/3714673-egypte-analyse-per-leeftijd-geslacht.md) - [OEGANDA - Analyse per LEEFTIJD & SENDER](https://success.openhealth.fr/nl/articles/3713884-oeganda-analyse-per-leeftijd-sender.md) - [Bevolking - Analyse per LEEFTIJD & GENDER](https://success.openhealth.fr/nl/articles/3807673-bevolking-analyse-per-leeftijd-gender.md) - [Medicabase - geneesmiddelendatabase](https://success.openhealth.fr/nl/articles/6518920-medicabase-geneesmiddelendatabase.md) - [Geboorte](https://success.openhealth.fr/nl/articles/6340025-geboorte.md) - [OpenEudra](https://success.openhealth.fr/nl/articles/6518977-openeudra.md) - [Uitsplitsing IRIS](https://success.openhealth.fr/nl/articles/6383829-uitsplitsing-iris.md) - [ADICAP](https://success.openhealth.fr/nl/articles/6959465-adicap.md) - [CND](https://success.openhealth.fr/nl/articles/6519012-cnd.md) - [Wereldbevolkingsgegevens](https://success.openhealth.fr/nl/articles/8217421-wereldbevolkingsgegevens.md) - [INSEE: Dossiers van overleden personen](https://success.openhealth.fr/nl/articles/4498126-insee-dossiers-van-overleden-personen.md) - [Gegevens VAERS- VAERSDATA- Bron CDC](https://success.openhealth.fr/nl/articles/6226665-gegevens-vaers-vaersdata-bron-cdc.md) - [Gegevens VAERS - VAERSVAX - Bron CDC](https://success.openhealth.fr/nl/articles/6226440-gegevens-vaers-vaersvax-bron-cdc.md) - [VAERS-gegevens - VAERSSYMPTOMS - Bron CDC](https://success.openhealth.fr/nl/articles/6219415-vaers-gegevens-vaerssymptoms-bron-cdc.md) - [Integreer uw gegevens in de Hub in minder dan 2 weken](https://success.openhealth.fr/nl/articles/5259828-integreer-uw-gegevens-in-de-hub-in-minder-dan-2-weken.md) - [Internationale gegevenssjabloon](https://success.openhealth.fr/nl/articles/4684696-internationale-gegevenssjabloon.md) - [Hoe stuur je ons je gegevens via FTPS of SFTP?](https://success.openhealth.fr/nl/articles/4143451-hoe-stuur-je-ons-je-gegevens-via-ftps-of-sftp.md) - [Welke informatie heeft OpenHealth nodig om een nieuwe gegevensbron te integreren?](https://success.openhealth.fr/nl/articles/3459148-welke-informatie-heeft-openhealth-nodig-om-een-nieuwe-gegevensbron-te-integreren.md) - [La Longue Vue](https://success.openhealth.fr/nl/articles/6959482-la-longue-vue.md) - [Hoe integreer ik een nieuwe gegevensbron in de HUB?](https://success.openhealth.fr/nl/articles/3467598-hoe-integreer-ik-een-nieuwe-gegevensbron-in-de-hub.md) - [Uw verkoopgegevens integreren in de HUB](https://success.openhealth.fr/nl/articles/3471145-uw-verkoopgegevens-integreren-in-de-hub.md) - [Specificaties voor het ontvangen van verkoopgegevens](https://success.openhealth.fr/nl/articles/3660043-specificaties-voor-het-ontvangen-van-verkoopgegevens.md) - [Waar komen de gegevens voor het analyseren van de thuiszorgmarkt vandaan?](https://success.openhealth.fr/nl/articles/3376155-waar-komen-de-gegevens-voor-het-analyseren-van-de-thuiszorgmarkt-vandaan.md) - [Hoe kan ik deelnemen aan het SantéDom Stat observatorium?](https://success.openhealth.fr/nl/articles/3798795-hoe-kan-ik-deelnemen-aan-het-santedom-stat-observatorium.md) - [Paneel geëxtrapoleerd van het SanteDomStat observatorium](https://success.openhealth.fr/nl/articles/6701602-paneel-geextrapoleerd-van-het-santedomstat-observatorium.md) - [Aantal patiënten](https://success.openhealth.fr/nl/articles/3376499-aantal-patienten.md) - [Aantal behandelingen](https://success.openhealth.fr/nl/articles/3376682-aantal-behandelingen.md) - [Aantal nieuwe patiënten](https://success.openhealth.fr/nl/articles/3376672-aantal-nieuwe-patienten.md) - [Verkoop inclusief btw](https://success.openhealth.fr/nl/articles/3376725-verkoop-inclusief-btw.md) - [Aantal patiënten aan het einde van de behandeling](https://success.openhealth.fr/nl/articles/3376675-aantal-patienten-aan-het-einde-van-de-behandeling.md) - [Bedrag verplichte ziektekostenverzekering \(AMO\)](https://success.openhealth.fr/nl/articles/3376740-bedrag-verplichte-ziektekostenverzekering-amo.md) - [Bedrag aanvullende ziektekostenverzekering \(AMC\)](https://success.openhealth.fr/nl/articles/3376749-bedrag-aanvullende-ziektekostenverzekering-amc.md) - [Out-of-pocket uitgaven \(RAC\)](https://success.openhealth.fr/nl/articles/3376751-out-of-pocket-uitgaven-rac.md) - [Bron : THESORIMED](https://success.openhealth.fr/nl/articles/3560018-bron-thesorimed.md) - [Internationale generieke namen \(INN\)](https://success.openhealth.fr/nl/articles/3954239-internationale-generieke-namen-inn.md) - [Feiten over open voedsel](https://success.openhealth.fr/nl/articles/6961970-feiten-over-open-voedsel.md) - [LOINC - Logical Observation Identifiers Names & Codes](https://success.openhealth.fr/nl/articles/6959323-loinc-logical-observation-identifiers-names-codes.md) - [AMELI - CCAM](https://success.openhealth.fr/nl/articles/6959080-ameli-ccam.md) - [WHO ATC VET](https://success.openhealth.fr/nl/articles/6959078-who-atc-vet.md) - [CEPS](https://success.openhealth.fr/nl/articles/6959068-ceps.md) - [Instelling](https://success.openhealth.fr/nl/articles/3935678-instelling.md) - [Gezondheidsdiensten](https://success.openhealth.fr/nl/articles/7969680-gezondheidsdiensten.md) - [Uittreksel FINESS](https://success.openhealth.fr/nl/articles/3946922-uittreksel-finess.md) - [Verander FINESS](https://success.openhealth.fr/nl/articles/3947009-verander-finess.md) - [Machtiging zorgactiviteit](https://success.openhealth.fr/nl/articles/3947067-machtiging-zorgactiviteit.md) - [Grote medische apparatuur](https://success.openhealth.fr/nl/articles/3947269-grote-medische-apparatuur.md) - [Geografisch](https://success.openhealth.fr/nl/articles/3947363-geografisch.md) - [RPPS](https://success.openhealth.fr/nl/articles/3947568-rpps.md) - [AFWERKING & RPPS](https://success.openhealth.fr/nl/articles/3947713-afwerking-rpps.md) - [RPPS-extract](https://success.openhealth.fr/nl/articles/3947829-rpps-extract.md) ### MODELES ET DATA QUALITY - [Gegevens UGA](https://success.openhealth.fr/nl/articles/4852310-gegevens-uga.md) - [Omzet berekenen per sector/klanttype: wat je moet weten](https://success.openhealth.fr/nl/articles/3545561-omzet-berekenen-per-sector-klanttype-wat-je-moet-weten.md) - [Sectorale herverdeling, statische of dynamische methodologie?](https://success.openhealth.fr/nl/articles/3690615-sectorale-herverdeling-statische-of-dynamische-methodologie.md) - [Strata van apotheken](https://success.openhealth.fr/nl/articles/4291490-strata-van-apotheken.md) - [De Hub-productieketen](https://success.openhealth.fr/nl/articles/4816146-de-hub-productieketen.md) - [Hoe voer je een vergelijkende analyse uit?](https://success.openhealth.fr/nl/articles/3440093-hoe-voer-je-een-vergelijkende-analyse-uit.md) - [Datakwaliteit in dienst van OpenHealth Company](https://success.openhealth.fr/nl/articles/3595822-datakwaliteit-in-dienst-van-openhealth-company.md) - [Gegevenskwaliteitsproces bij OpenHealth](https://success.openhealth.fr/nl/articles/3415271-gegevenskwaliteitsproces-bij-openhealth.md) - [Interval en betrouwbaarheidsniveau](https://success.openhealth.fr/nl/articles/3633173-interval-en-betrouwbaarheidsniveau.md) - [Gegevenskwaliteit: Batchbeheer](https://success.openhealth.fr/nl/articles/3433509-gegevenskwaliteit-batchbeheer.md) - [Gegevenskwaliteit: Verkooponderbrekingsproces](https://success.openhealth.fr/nl/articles/3415317-gegevenskwaliteit-verkooponderbrekingsproces.md) - [Verkopen en voorraadverschuivingen](https://success.openhealth.fr/nl/articles/4131084-verkopen-en-voorraadverschuivingen.md) - [Waarom verkopen analyseren op basis van volume?](https://success.openhealth.fr/nl/articles/3846167-waarom-verkopen-analyseren-op-basis-van-volume.md) - [Er is een gegevenskloof tussen sell-in en sell-out](https://success.openhealth.fr/nl/articles/3195358-er-is-een-gegevenskloof-tussen-sell-in-en-sell-out.md) - [Wat is een atypische verkoop?](https://success.openhealth.fr/nl/articles/3195366-wat-is-een-atypische-verkoop.md) - [Waar komt de informatie over prijzen, volumes en verkoop vandaan?](https://success.openhealth.fr/nl/articles/3195348-waar-komt-de-informatie-over-prijzen-volumes-en-verkoop-vandaan.md) - [Geschat verkoopvolume per voorschrijver](https://success.openhealth.fr/nl/articles/4171530-geschat-verkoopvolume-per-voorschrijver.md) - [Het verschil tussen 2 extracties begrijpen](https://success.openhealth.fr/nl/articles/13399689-het-verschil-tussen-2-extracties-begrijpen.md) ### REFERENTIELS PRODUITS, MARCHÉS et CLASSIFICATIONS - [GTIN](https://success.openhealth.fr/nl/articles/3608176-gtin.md) - [Specificatie productklantkwalificatieveld \(PCQF\)](https://success.openhealth.fr/nl/articles/3704913-specificatie-productklantkwalificatieveld-pcqf.md) - [Wat is een LPPR-code?](https://success.openhealth.fr/nl/articles/3195365-wat-is-een-lppr-code.md) - [Product verhuur bijhouden](https://success.openhealth.fr/nl/articles/4206554-product-verhuur-bijhouden.md) - [Ik wil mijn markt uitbreiden](https://success.openhealth.fr/nl/articles/4420843-ik-wil-mijn-markt-uitbreiden.md) - [OHC-classificatie](https://success.openhealth.fr/nl/articles/3194589-ohc-classificatie.md) - [Geschiedenis EphMRA AC-klassen](https://success.openhealth.fr/nl/articles/3557908-geschiedenis-ephmra-ac-klassen.md) - [Diergeneeskunde Details](https://success.openhealth.fr/nl/articles/3194587-diergeneeskunde-details.md) - [Diergeneeskunde Classificatie](https://success.openhealth.fr/nl/articles/3194579-diergeneeskunde-classificatie.md) - [Menselijke geneeskunde Details](https://success.openhealth.fr/nl/articles/3421225-menselijke-geneeskunde-details.md) - [Nieuwe producten beheren](https://success.openhealth.fr/nl/articles/4470813-nieuwe-producten-beheren.md) - [Menselijke geneeskunde Classificatie](https://success.openhealth.fr/nl/articles/3417281-menselijke-geneeskunde-classificatie.md) - [Indicaties - Diagnose](https://success.openhealth.fr/nl/articles/3568554-indicaties-diagnose.md) - [MP4U: Productnormen](https://success.openhealth.fr/nl/articles/3574188-mp4u-productnormen.md) - [Wat is de TVASI \(tabel met onbekende verkopen, aankopen en voorraden\)?](https://success.openhealth.fr/nl/articles/5992494-wat-is-de-tvasi-tabel-met-onbekende-verkopen-aankopen-en-voorraden.md) - [IRI-classificatie](https://success.openhealth.fr/nl/articles/3194597-iri-classificatie.md) - [Verwijdering van onverkochte producten](https://success.openhealth.fr/nl/articles/6135938-verwijdering-van-onverkochte-producten.md) - [STANDAARDMARKT - Abonnement](https://success.openhealth.fr/nl/articles/3798203-standaardmarkt-abonnement.md) - [Ik kan mijn product niet vinden](https://success.openhealth.fr/nl/articles/5686002-ik-kan-mijn-product-niet-vinden.md) - [Beheer van productcodes](https://success.openhealth.fr/nl/articles/5652478-beheer-van-productcodes.md) - [Productkwalificatie: Merken](https://success.openhealth.fr/nl/articles/5016985-productkwalificatie-merken.md) ### Les ABONNEMENTS et MODULES \(Consumer Health\) - [De 3 soorten toepassingen](https://success.openhealth.fr/nl/articles/9489652-de-3-soorten-toepassingen.md) - [Uw 2.0 platform](https://success.openhealth.fr/nl/articles/8374416-uw-2-0-platform.md) - [SAMENVATTING](https://success.openhealth.fr/nl/articles/3344127-samenvatting.md) - [Markten & selecties](https://success.openhealth.fr/nl/articles/8337016-markten-selecties.md) - [Overzichtsdashboard](https://success.openhealth.fr/nl/articles/9246867-overzichtsdashboard.md) - [Analyse](https://success.openhealth.fr/nl/articles/9352287-analyse.md) - [Afzuigkap](https://success.openhealth.fr/nl/articles/9246875-afzuigkap.md) - [Groeianalyse](https://success.openhealth.fr/nl/articles/3158856-groeianalyse.md) - [Assortimentsanalyse](https://success.openhealth.fr/nl/articles/3473736-assortimentsanalyse.md) - [Gemiddeld aantal producten](https://success.openhealth.fr/nl/articles/3161474-gemiddeld-aantal-producten.md) - [Lancering Volgen](https://success.openhealth.fr/nl/articles/3158488-lancering-volgen.md) - [Geavanceerde indicatoren gekruist](https://success.openhealth.fr/nl/articles/6007740-geavanceerde-indicatoren-gekruist.md) - [Verkoopconcentratie](https://success.openhealth.fr/nl/articles/3095338-verkoopconcentratie.md) - [Prijsspreiding](https://success.openhealth.fr/nl/articles/3159289-prijsspreiding.md) - [Analyse van de uitverkoopmarge](https://success.openhealth.fr/nl/articles/3358322-analyse-van-de-uitverkoopmarge.md) - [Evolutie verkoopmarges](https://success.openhealth.fr/nl/articles/3815561-evolutie-verkoopmarges.md) - [Apotheekcontrole \(1/2\)](https://success.openhealth.fr/nl/articles/3358248-apotheekcontrole-1-2.md) - [Apotheekcontrole \(2/2\)](https://success.openhealth.fr/nl/articles/3810527-apotheekcontrole-2-2.md) - [Salesforce-prestaties](https://success.openhealth.fr/nl/articles/3159230-salesforce-prestaties.md) - [Customer Relationship Management \(CRM\) ASSISTANT](https://success.openhealth.fr/nl/articles/5953935-customer-relationship-management-crm-assistant.md) - [Verkooppunt volgen](https://success.openhealth.fr/nl/articles/3778944-verkooppunt-volgen.md) - [Evolutie op aanvraag](https://success.openhealth.fr/nl/articles/6560184-evolutie-op-aanvraag.md) - [Analyse op aanvraag](https://success.openhealth.fr/nl/articles/6127483-analyse-op-aanvraag.md) - [Tafel op aanvraag](https://success.openhealth.fr/nl/articles/3158751-tafel-op-aanvraag.md) - [Analyse van tijdreeksen](https://success.openhealth.fr/nl/articles/3635940-analyse-van-tijdreeksen.md) - [Prognose-analyse](https://success.openhealth.fr/nl/articles/3636015-prognose-analyse.md) - [Sectorale prognose](https://success.openhealth.fr/nl/articles/3689811-sectorale-prognose.md) - [Verkoop visualisatie](https://success.openhealth.fr/nl/articles/3559882-verkoop-visualisatie.md) - [Verkoopanalyse](https://success.openhealth.fr/nl/articles/6188132-verkoopanalyse.md) - [Wedstrijd verkopen](https://success.openhealth.fr/nl/articles/6188090-wedstrijd-verkopen.md) - [Verkopen Evolutie](https://success.openhealth.fr/nl/articles/6191929-verkopen-evolutie.md) - [Sell-in vs. Sell-out-analyse](https://success.openhealth.fr/nl/articles/6191947-sell-in-vs-sell-out-analyse.md) - [Sell-in vs. Sell-out evolutie](https://success.openhealth.fr/nl/articles/6191955-sell-in-vs-sell-out-evolutie.md) - [Prijsevolutie](https://success.openhealth.fr/nl/articles/5056489-prijsevolutie.md) - [Kleuren aanpassen](https://success.openhealth.fr/nl/articles/8407897-kleuren-aanpassen.md) - [Product Uitvoer](https://success.openhealth.fr/nl/articles/3583206-product-uitvoer.md) - [Marktanalyse](https://success.openhealth.fr/nl/articles/3121933-marktanalyse.md) - [Prijsanalyse](https://success.openhealth.fr/nl/articles/3215190-prijsanalyse.md) - [Verkoopevolutie](https://success.openhealth.fr/nl/articles/3178323-verkoopevolutie.md) - [Dashboard samenvatten](https://success.openhealth.fr/nl/articles/4533213-dashboard-samenvatten.md) - [Evolutie marktaandeel](https://success.openhealth.fr/nl/articles/3193078-evolutie-marktaandeel.md) - [Kruistabel verkoop](https://success.openhealth.fr/nl/articles/3193060-kruistabel-verkoop.md) - [TURNOVER / VOLUME \(CU\) Synthese](https://success.openhealth.fr/nl/articles/3193048-turnover-volume-cu-synthese.md) - [Sell Out Waarde Synthese \(FARMACIJEN / Supermarkten\)](https://success.openhealth.fr/nl/articles/3193020-sell-out-waarde-synthese-farmacijen-supermarkten.md) - [Analyse van het marktaandeel](https://success.openhealth.fr/nl/articles/3193069-analyse-van-het-marktaandeel.md) - [Mijn gegevensarchief](https://success.openhealth.fr/nl/articles/3193099-mijn-gegevensarchief.md) - [Analyse van meerdere perioden](https://success.openhealth.fr/nl/articles/3192953-analyse-van-meerdere-perioden.md) - [Mijn zoekopdracht Alle producten](https://success.openhealth.fr/nl/articles/4280353-mijn-zoekopdracht-alle-producten.md) - [Voorraad Evolutie \(NIEUW\)](https://success.openhealth.fr/nl/articles/3719256-voorraad-evolutie-nieuw.md) - [Marktdefinitie](https://success.openhealth.fr/nl/articles/3158829-marktdefinitie.md) - [RAW DATA Geavanceerde Indicatoren](https://success.openhealth.fr/nl/articles/3711095-raw-data-geavanceerde-indicatoren.md) - [Geavanceerde indicatoren Evolutie SMKT](https://success.openhealth.fr/nl/articles/3193000-geavanceerde-indicatoren-evolutie-smkt.md) - [Geavanceerde Indicatoren Analyse SMKT](https://success.openhealth.fr/nl/articles/3192366-geavanceerde-indicatoren-analyse-smkt.md) - [Evolutie geavanceerde indicatoren](https://success.openhealth.fr/nl/articles/3177853-evolutie-geavanceerde-indicatoren.md) - [Geavanceerde Indicatoren Evolutie Bio](https://success.openhealth.fr/nl/articles/7051823-geavanceerde-indicatoren-evolutie-bio.md) - [Nationale geavanceerde indicatoren](https://success.openhealth.fr/nl/articles/3364513-nationale-geavanceerde-indicatoren.md) - [Analyse van aandelen](https://success.openhealth.fr/nl/articles/3178015-analyse-van-aandelen.md) - [Geavanceerde indicatoren analyse Bio](https://success.openhealth.fr/nl/articles/7051801-geavanceerde-indicatoren-analyse-bio.md) - [Analyse van geavanceerde indicatoren](https://success.openhealth.fr/nl/articles/3124439-analyse-van-geavanceerde-indicatoren.md) - [Cartografie](https://success.openhealth.fr/nl/articles/3192450-cartografie.md) - [Geografische kruistabel](https://success.openhealth.fr/nl/articles/3192466-geografische-kruistabel.md) - [Geografische verkoopevolutie](https://success.openhealth.fr/nl/articles/3192482-geografische-verkoopevolutie.md) - [Effectiviteit verkoopteam](https://success.openhealth.fr/nl/articles/5624011-effectiviteit-verkoopteam.md) - [Aangepaste wegingsmethode analyse](https://success.openhealth.fr/nl/articles/5169317-aangepaste-wegingsmethode-analyse.md) - [Netwerkanalyse](https://success.openhealth.fr/nl/articles/3894767-netwerkanalyse.md) - [Evolutie aangepaste wegingsmethode](https://success.openhealth.fr/nl/articles/5169320-evolutie-aangepaste-wegingsmethode.md) - [KPI's SAMENVATTING](https://success.openhealth.fr/nl/articles/3478199-kpi-s-samenvatting.md) - [Verkoop in geconverteerde eenheden](https://success.openhealth.fr/nl/articles/3192412-verkoop-in-geconverteerde-eenheden.md) - [RAUW GEGEVENS Aandelenindicatoren](https://success.openhealth.fr/nl/articles/3711142-rauw-gegevens-aandelenindicatoren.md) - [RUWE GEGEVENS SMKT AIA](https://success.openhealth.fr/nl/articles/3720960-ruwe-gegevens-smkt-aia.md) - [Voorraad Evolutie](https://success.openhealth.fr/nl/articles/3178277-voorraad-evolutie.md) - [Geografische geavanceerde indicatoren](https://success.openhealth.fr/nl/articles/3192508-geografische-geavanceerde-indicatoren.md) - [Sectoriële analyse van tijdreeksen](https://success.openhealth.fr/nl/articles/3814974-sectoriele-analyse-van-tijdreeksen.md) - [Verkoopanalyse per leeftijd en geslacht](https://success.openhealth.fr/nl/articles/3192701-verkoopanalyse-per-leeftijd-en-geslacht.md) - [Evolutie van de verkoop per zwangerschapsstatus](https://success.openhealth.fr/nl/articles/3192910-evolutie-van-de-verkoop-per-zwangerschapsstatus.md) - [Evolutie van de verkoop naar leeftijd en geslacht](https://success.openhealth.fr/nl/articles/3192732-evolutie-van-de-verkoop-naar-leeftijd-en-geslacht.md) - [Evolutie bestellen](https://success.openhealth.fr/nl/articles/5790020-evolutie-bestellen.md) - [Co-dispensing Evolutie](https://success.openhealth.fr/nl/articles/3192529-co-dispensing-evolutie.md) - [Co-dispensatie analyse](https://success.openhealth.fr/nl/articles/3192633-co-dispensatie-analyse.md) - [Verkoop per kanaal en voorschrijver](https://success.openhealth.fr/nl/articles/3192751-verkoop-per-kanaal-en-voorschrijver.md) - [AMO, AMC & RAC](https://success.openhealth.fr/nl/articles/3192929-amo-amc-rac.md) - [Co-dosering Dispersie](https://success.openhealth.fr/nl/articles/3876946-co-dosering-dispersie.md) - [Dispensatie Verspreiding Evolutie](https://success.openhealth.fr/nl/articles/3920070-dispensatie-verspreiding-evolutie.md) - [Huisartsvoorschriften naar leeftijd en geslacht](https://success.openhealth.fr/nl/articles/5789899-huisartsvoorschriften-naar-leeftijd-en-geslacht.md) - [Analyse van voorschriften](https://success.openhealth.fr/nl/articles/5322866-analyse-van-voorschriften.md) - [Huisartsvoorschriften Evolutie](https://success.openhealth.fr/nl/articles/5790016-huisartsvoorschriften-evolutie.md) - [Mandanalyse](https://success.openhealth.fr/nl/articles/3711049-mandanalyse.md) - [Meedoseren](https://success.openhealth.fr/nl/articles/4738243-meedoseren.md) - [Cohort kwalificatiemodule](https://success.openhealth.fr/nl/articles/3928090-cohort-kwalificatiemodule.md) - [Module behandelingsstatus](https://success.openhealth.fr/nl/articles/3928067-module-behandelingsstatus.md) - [Module Therapietrouw](https://success.openhealth.fr/nl/articles/3928044-module-therapietrouw.md) - [Cohort definitie](https://success.openhealth.fr/nl/articles/3894703-cohort-definitie.md) - [Medebehandelingen](https://success.openhealth.fr/nl/articles/4163623-medebehandelingen.md) - [Cohort visualisatie](https://success.openhealth.fr/nl/articles/3894721-cohort-visualisatie.md) - [Definitie van analysecriteria](https://success.openhealth.fr/nl/articles/3894728-definitie-van-analysecriteria.md) - [Evolutie wereldwijde cohort](https://success.openhealth.fr/nl/articles/3894747-evolutie-wereldwijde-cohort.md) - [Geografische spreiding](https://success.openhealth.fr/nl/articles/3894751-geografische-spreiding.md) - [Cohort profiel](https://success.openhealth.fr/nl/articles/3894755-cohort-profiel.md) - [Uitsplitsing behandelingsstatus](https://success.openhealth.fr/nl/articles/3894764-uitsplitsing-behandelingsstatus.md) - [Initiëren van behandelingen](https://success.openhealth.fr/nl/articles/3894778-initieren-van-behandelingen.md) - [Behandeling wordt hervat](https://success.openhealth.fr/nl/articles/3894788-behandeling-wordt-hervat.md) - [Nieuwe behandelingen](https://success.openhealth.fr/nl/articles/3894804-nieuwe-behandelingen.md) - [Herhalingen van behandelingen](https://success.openhealth.fr/nl/articles/3894812-herhalingen-van-behandelingen.md) - [Behandelingsschakelaar balans](https://success.openhealth.fr/nl/articles/3894821-behandelingsschakelaar-balans.md) - [Winst door omschakeling behandeling](https://success.openhealth.fr/nl/articles/3894830-winst-door-omschakeling-behandeling.md) - [Behandeling schakelverliezen](https://success.openhealth.fr/nl/articles/3894843-behandeling-schakelverliezen.md) - [Schakelaarversterking oorsprong](https://success.openhealth.fr/nl/articles/3894857-schakelaarversterking-oorsprong.md) - [Schakelverlies bestemming](https://success.openhealth.fr/nl/articles/3894864-schakelverlies-bestemming.md) - [Drop-outs](https://success.openhealth.fr/nl/articles/3894874-drop-outs.md) - [KPI samenvatting](https://success.openhealth.fr/nl/articles/4229969-kpi-samenvatting.md) - [Volharding van de behandeling](https://success.openhealth.fr/nl/articles/3894883-volharding-van-de-behandeling.md) - [Naleving](https://success.openhealth.fr/nl/articles/3894884-naleving.md) - [Wat is het regelmatigheidscriterium?](https://success.openhealth.fr/nl/articles/3325816-wat-is-het-regelmatigheidscriterium.md) - [Dood - Cartografie](https://success.openhealth.fr/nl/articles/3863677-dood-cartografie.md) - [Verrekening aantal doden](https://success.openhealth.fr/nl/articles/3863573-verrekening-aantal-doden.md) - [Overlijden - Analyse per LEEFTIJD & GENDER](https://success.openhealth.fr/nl/articles/3863808-overlijden-analyse-per-leeftijd-gender.md) - [Dood - Evolutie per LEEFTIJD & GENDER](https://success.openhealth.fr/nl/articles/3863939-dood-evolutie-per-leeftijd-gender.md) - [Dood - Evolutie](https://success.openhealth.fr/nl/articles/3864065-dood-evolutie.md) - [Dood - Evolutie Vergelijking](https://success.openhealth.fr/nl/articles/3864073-dood-evolutie-vergelijking.md) - [Apotheekcontrole CA](https://success.openhealth.fr/nl/articles/4634768-apotheekcontrole-ca.md) - [Verkeersanalyse \(bètatest\)](https://success.openhealth.fr/nl/articles/6848401-verkeersanalyse-betatest.md) - [Details apotheekcontrole](https://success.openhealth.fr/nl/articles/4527868-details-apotheekcontrole.md) - [Trafic Evolution \(bètatest\)](https://success.openhealth.fr/nl/articles/6848016-trafic-evolution-betatest.md) - [Apotheek Monitoring Cartografie](https://success.openhealth.fr/nl/articles/4527811-apotheek-monitoring-cartografie.md) - [Details apotheekcontrole](https://success.openhealth.fr/nl/articles/4262306-details-apotheekcontrole.md) - [Analyse van apotheekmonitoring](https://success.openhealth.fr/nl/articles/3839223-analyse-van-apotheekmonitoring.md) - [Evolutie apotheekbewaking](https://success.openhealth.fr/nl/articles/3827973-evolutie-apotheekbewaking.md) - [Verdeling van verkeer](https://success.openhealth.fr/nl/articles/3826074-verdeling-van-verkeer.md) - [Verkeersstudie](https://success.openhealth.fr/nl/articles/3809042-verkeersstudie.md) - [Samenvatting - PIEX](https://success.openhealth.fr/nl/articles/5203335-samenvatting-piex.md) - [Inkoop](https://success.openhealth.fr/nl/articles/4605110-inkoop.md) - [Mijn zoekopdracht - PIEX](https://success.openhealth.fr/nl/articles/4210627-mijn-zoekopdracht-piex.md) - [Evolutie van de verkoop - PIEX](https://success.openhealth.fr/nl/articles/4210655-evolutie-van-de-verkoop-piex.md) - [Verkoopanalyse - PIEX](https://success.openhealth.fr/nl/articles/4210650-verkoopanalyse-piex.md) - [Bestelgegevens - PIEX](https://success.openhealth.fr/nl/articles/4210659-bestelgegevens-piex.md) - [Overzicht aandelen - PIEX](https://success.openhealth.fr/nl/articles/4210672-overzicht-aandelen-piex.md) - [Mijn gegevensarchief - PIEX](https://success.openhealth.fr/nl/articles/4210694-mijn-gegevensarchief-piex.md) - [EURAPHARMA- PIEX](https://success.openhealth.fr/nl/articles/4366306-eurapharma-piex.md) - [Bijpassend product](https://success.openhealth.fr/nl/articles/4366320-bijpassend-product.md) - [CLI Mijn bestand \(1/5\)](https://success.openhealth.fr/nl/articles/4626422-cli-mijn-bestand-1-5.md) - [CLI\_File Tellingen \(2/5\)](https://success.openhealth.fr/nl/articles/4626421-cli_file-tellingen-2-5.md) - [CLI\_File Code Overeenstemming met OHC archief](https://success.openhealth.fr/nl/articles/4626419-cli_file-code-overeenstemming-met-ohc-archief.md) - [Sell-Out Export \(4/5\)](https://success.openhealth.fr/nl/articles/4626414-sell-out-export-4-5.md) ### Les OPTIONS PERSONNALISÉES - [Niet-hiërarchische productkwalificaties](https://success.openhealth.fr/nl/articles/4036045-niet-hierarchische-productkwalificaties.md) - [Wat is de maximale backdate voor HUB-gegevens?](https://success.openhealth.fr/nl/articles/3195251-wat-is-de-maximale-backdate-voor-hub-gegevens.md) - [Type klant](https://success.openhealth.fr/nl/articles/4197147-type-klant.md) - [Sessie Toegang](https://success.openhealth.fr/nl/articles/4036458-sessie-toegang.md) - [Aangepaste cyclus](https://success.openhealth.fr/nl/articles/4036444-aangepaste-cyclus.md) - [Boekjaar](https://success.openhealth.fr/nl/articles/4036169-boekjaar.md) - [Dag knop](https://success.openhealth.fr/nl/articles/4036159-dag-knop.md) - [Knop "Week" \(wekelijkse gegevens\)](https://success.openhealth.fr/nl/articles/4036111-knop-week-wekelijkse-gegevens.md) - [Wisselkoersen](https://success.openhealth.fr/nl/articles/8329594-wisselkoersen.md) - [SMKT-periodekalender](https://success.openhealth.fr/nl/articles/4036549-smkt-periodekalender.md) - [Omtrek beperken](https://success.openhealth.fr/nl/articles/4560699-omtrek-beperken.md) - [Perimeter beperken \(code 7\)](https://success.openhealth.fr/nl/articles/4560791-perimeter-beperken-code-7.md) - [Marktvlagg](https://success.openhealth.fr/nl/articles/4560797-marktvlagg.md) - [Scoren / targeten \("Klanttype"\)](https://success.openhealth.fr/nl/articles/3777788-scoren-targeten-klanttype.md) ### Les INDICATEURS et PÉRIODES - [Woordenlijst van HUB-indicatoren](https://success.openhealth.fr/nl/articles/5194247-woordenlijst-van-hub-indicatoren.md) - [Verkoopvolume](https://success.openhealth.fr/nl/articles/3194314-verkoopvolume.md) - [Verkoopwaarde](https://success.openhealth.fr/nl/articles/3074854-verkoopwaarde.md) - [N MS, Marktaandeel](https://success.openhealth.fr/nl/articles/3194475-n-ms-marktaandeel.md) - [N MS Verandering](https://success.openhealth.fr/nl/articles/5634266-n-ms-verandering.md) - [N MS Delta, verandering in marktaandeel](https://success.openhealth.fr/nl/articles/3194469-n-ms-delta-verandering-in-marktaandeel.md) - [Gewicht Vol \(CA\) per modaliteit / Aangepast gewicht Vol \(To\)](https://success.openhealth.fr/nl/articles/9292839-gewicht-vol-ca-per-modaliteit-aangepast-gewicht-vol-to.md) - [Waarde verkoop gebaseerd op prijs fabrikant exclusief BTW \(Omzet PF exclusief BTW\) - Marokko](https://success.openhealth.fr/nl/articles/7508513-waarde-verkoop-gebaseerd-op-prijs-fabrikant-exclusief-btw-omzet-pf-exclusief-btw-marokko.md) - [N Groei CTR](https://success.openhealth.fr/nl/articles/3194466-n-groei-ctr.md) - [In deal](https://success.openhealth.fr/nl/articles/6201859-in-deal.md) - [Gekruist Gewicht Volume](https://success.openhealth.fr/nl/articles/6066324-gekruist-gewicht-volume.md) - [Gekruiste gewichtomzet](https://success.openhealth.fr/nl/articles/6066273-gekruiste-gewichtomzet.md) - [N Groei CTR aangepast](https://success.openhealth.fr/nl/articles/3205376-n-groei-ctr-aangepast.md) - [Bron gewicht](https://success.openhealth.fr/nl/articles/5151525-bron-gewicht.md) - [Gemiddelde prijs](https://success.openhealth.fr/nl/articles/3194302-gemiddelde-prijs.md) - [Gewogen gemiddelde prijs](https://success.openhealth.fr/nl/articles/3194292-gewogen-gemiddelde-prijs.md) - [Prijseffect](https://success.openhealth.fr/nl/articles/8426443-prijseffect.md) - [Aantal verkochte apotheken](https://success.openhealth.fr/nl/articles/3719566-aantal-verkochte-apotheken.md) - [Verkoper Digitale Distributie](https://success.openhealth.fr/nl/articles/3194321-verkoper-digitale-distributie.md) - [Wereldwijde digitale distributie](https://success.openhealth.fr/nl/articles/3194320-wereldwijde-digitale-distributie.md) - [Rebashed verkoopt digitale distributie](https://success.openhealth.fr/nl/articles/4045636-rebashed-verkoopt-digitale-distributie.md) - [Verkoop Digitale Distributie Wereldwijd](https://success.openhealth.fr/nl/articles/4045725-verkoop-digitale-distributie-wereldwijd.md) - [Op maat gemaakte rebased digitale verkoopdistributie](https://success.openhealth.fr/nl/articles/6830813-op-maat-gemaakte-rebased-digitale-verkoopdistributie.md) - [Distributie Verkoopwaarde](https://success.openhealth.fr/nl/articles/3194323-distributie-verkoopwaarde.md) - [Distributie Totale verkoopwaarde](https://success.openhealth.fr/nl/articles/3194316-distributie-totale-verkoopwaarde.md) - [Herberekende verdeling van verkoopwaarde](https://success.openhealth.fr/nl/articles/3194501-herberekende-verdeling-van-verkoopwaarde.md) - [Wereldwijde hergebaseerde verkoopwaardeverdeling](https://success.openhealth.fr/nl/articles/4200619-wereldwijde-hergebaseerde-verkoopwaardeverdeling.md) - [Op maat gemaakte hergebaseerde verdeling van verkoopwaarde](https://success.openhealth.fr/nl/articles/6834423-op-maat-gemaakte-hergebaseerde-verdeling-van-verkoopwaarde.md) - [SMKT Verkoper Digitale Distributie](https://success.openhealth.fr/nl/articles/3365043-smkt-verkoper-digitale-distributie.md) - [SMKT wereldwijde leverancier digitale distributie](https://success.openhealth.fr/nl/articles/4298341-smkt-wereldwijde-leverancier-digitale-distributie.md) - [SMKT Verkoop Digitale Distributie Rebased](https://success.openhealth.fr/nl/articles/4298197-smkt-verkoop-digitale-distributie-rebased.md) - [Verkoop Digitale Distributie SMKT Wereldwijd Rebased](https://success.openhealth.fr/nl/articles/4319783-verkoop-digitale-distributie-smkt-wereldwijd-rebased.md) - [Verdeling verkoopwaarde SMKT](https://success.openhealth.fr/nl/articles/3365478-verdeling-verkoopwaarde-smkt.md) - [SMKT Global herberekend verkoop digitale distributie](https://success.openhealth.fr/nl/articles/4298373-smkt-global-herberekend-verkoop-digitale-distributie.md) - [Verkoop Digitale Distributie SMKT Herberekend](https://success.openhealth.fr/nl/articles/4298303-verkoop-digitale-distributie-smkt-herberekend.md) - [SMKT Aangepaste verkoop digitale distributie](https://success.openhealth.fr/nl/articles/3369386-smkt-aangepaste-verkoop-digitale-distributie.md) - [Herberekende SMKT Verkoop Digitale Distributie](https://success.openhealth.fr/nl/articles/4298209-herberekende-smkt-verkoop-digitale-distributie.md) - [Aangepaste SMKT-verkoopwaardeverdeling](https://success.openhealth.fr/nl/articles/3369397-aangepaste-smkt-verkoopwaardeverdeling.md) - [Organische verkoop Digitale distributie](https://success.openhealth.fr/nl/articles/7052424-organische-verkoop-digitale-distributie.md) - [Omzet van verkopende apotheken \(TSP\)](https://success.openhealth.fr/nl/articles/6096534-omzet-van-verkopende-apotheken-tsp.md) - [Schatting van uw houder PDM](https://success.openhealth.fr/nl/articles/4214883-schatting-van-uw-houder-pdm.md) - [Meer apotheken](https://success.openhealth.fr/nl/articles/8426451-meer-apotheken.md) - [Verlies van apotheken](https://success.openhealth.fr/nl/articles/8426460-verlies-van-apotheken.md) - [Multichannel digitale verkoop en distributie](https://success.openhealth.fr/nl/articles/9293487-multichannel-digitale-verkoop-en-distributie.md) - [Cumulatieve verkoop digitale distributie \(PHARMA\)](https://success.openhealth.fr/nl/articles/9330571-cumulatieve-verkoop-digitale-distributie-pharma.md) - [AMS: Gemiddelde maandelijkse verkoop](https://success.openhealth.fr/nl/articles/3194303-ams-gemiddelde-maandelijkse-verkoop.md) - [AMS A: Aangepaste gemiddelde maandelijkse verkoop](https://success.openhealth.fr/nl/articles/3194290-ams-a-aangepaste-gemiddelde-maandelijkse-verkoop.md) - [AMS Naar: Gemiddelde maandelijkse verkoopwaarde](https://success.openhealth.fr/nl/articles/4535404-ams-naar-gemiddelde-maandelijkse-verkoopwaarde.md) - [AMS Naar A: Aangepaste gemiddelde maandelijkse verkoopwaarde](https://success.openhealth.fr/nl/articles/6028256-ams-naar-a-aangepaste-gemiddelde-maandelijkse-verkoopwaarde.md) - [Gemiddelde verkoop](https://success.openhealth.fr/nl/articles/3563716-gemiddelde-verkoop.md) - [Gemiddelde verkoop SMKT](https://success.openhealth.fr/nl/articles/3365496-gemiddelde-verkoop-smkt.md) - [Aangepaste gemiddelde omzet SMKT](https://success.openhealth.fr/nl/articles/3369340-aangepaste-gemiddelde-omzet-smkt.md) - [Gemiddelde maandelijkse organische omzet](https://success.openhealth.fr/nl/articles/7052551-gemiddelde-maandelijkse-organische-omzet.md) - [Gemiddelde maandelijkse verkoop Organische waarde](https://success.openhealth.fr/nl/articles/7052573-gemiddelde-maandelijkse-verkoop-organische-waarde.md) - [Voorraad](https://success.openhealth.fr/nl/articles/3194332-voorraad.md) - [Gemiddelde voorraad](https://success.openhealth.fr/nl/articles/3194336-gemiddelde-voorraad.md) - [Aandeel in aandelen](https://success.openhealth.fr/nl/articles/3194334-aandeel-in-aandelen.md) - [Commerciële drukindex](https://success.openhealth.fr/nl/articles/3194335-commerciele-drukindex.md) - [Voorraadomzetting](https://success.openhealth.fr/nl/articles/3194344-voorraadomzetting.md) - [Leveringsduur - N Voorraaddekking](https://success.openhealth.fr/nl/articles/3194337-leveringsduur-n-voorraaddekking.md) - [Aantal apotheken in voorraad](https://success.openhealth.fr/nl/articles/3194338-aantal-apotheken-in-voorraad.md) - [Digitale Distributie Stockist](https://success.openhealth.fr/nl/articles/3194339-digitale-distributie-stockist.md) - [Digitale distributie Voorraadhouder](https://success.openhealth.fr/nl/articles/4045743-digitale-distributie-voorraadhouder.md) - [Wereldwijde digitale distributie](https://success.openhealth.fr/nl/articles/4045753-wereldwijde-digitale-distributie.md) - [Uitkering Voorraadwaarde](https://success.openhealth.fr/nl/articles/3194342-uitkering-voorraadwaarde.md) - [Verdeling van aangepaste inventariswaarde](https://success.openhealth.fr/nl/articles/3194505-verdeling-van-aangepaste-inventariswaarde.md) - [Smoothed Stockist Digitale Distributie](https://success.openhealth.fr/nl/articles/5141830-smoothed-stockist-digitale-distributie.md) - [Digitale distributie Stockist afgevlakt rebased](https://success.openhealth.fr/nl/articles/5142162-digitale-distributie-stockist-afgevlakt-rebased.md) - [Distributie Afgevlakte voorraadwaarde](https://success.openhealth.fr/nl/articles/5203640-distributie-afgevlakte-voorraadwaarde.md) - [Uitkering Afgevlakte aangepaste waarde van het aandeel](https://success.openhealth.fr/nl/articles/5203701-uitkering-afgevlakte-aangepaste-waarde-van-het-aandeel.md) - [Marge](https://success.openhealth.fr/nl/articles/3507716-marge.md) - [Marge](https://success.openhealth.fr/nl/articles/3507767-marge.md) - [Aankoopprijs exclusief belasting](https://success.openhealth.fr/nl/articles/4557500-aankoopprijs-exclusief-belasting.md) - [Sell-in - Je klantenbestand analyseren](https://success.openhealth.fr/nl/articles/3846225-sell-in-je-klantenbestand-analyseren.md) - [Sell-in - Atypische apotheken](https://success.openhealth.fr/nl/articles/3848791-sell-in-atypische-apotheken.md) - [Evolutie ratio](https://success.openhealth.fr/nl/articles/3194287-evolutie-ratio.md) - [Penetratiegraad](https://success.openhealth.fr/nl/articles/3194286-penetratiegraad.md) - [Breed assortiment](https://success.openhealth.fr/nl/articles/3369425-breed-assortiment.md) - [Waaiervernieuwing](https://success.openhealth.fr/nl/articles/3369545-waaiervernieuwing.md) - [Innovatie in het assortiment](https://success.openhealth.fr/nl/articles/3369468-innovatie-in-het-assortiment.md) - [Assortiment verloop](https://success.openhealth.fr/nl/articles/3369457-assortiment-verloop.md) - [Assortiment verloop](https://success.openhealth.fr/nl/articles/3369485-assortiment-verloop.md) - [Bereik innovatiesnelheid](https://success.openhealth.fr/nl/articles/3369541-bereik-innovatiesnelheid.md) - [Aandeel in verkoopaanbieding](https://success.openhealth.fr/nl/articles/3369040-aandeel-in-verkoopaanbieding.md) - [Aantal geselecteerde producten](https://success.openhealth.fr/nl/articles/3511502-aantal-geselecteerde-producten.md) - [Gemiddeld aantal producten](https://success.openhealth.fr/nl/articles/3194284-gemiddeld-aantal-producten.md) - [Bereik vernieuwingspercentage](https://success.openhealth.fr/nl/articles/3369561-bereik-vernieuwingspercentage.md) - [Aantal producten](https://success.openhealth.fr/nl/articles/6312686-aantal-producten.md) - [Uitgegeven bedragen per handeling](https://success.openhealth.fr/nl/articles/3447792-uitgegeven-bedragen-per-handeling.md) - [Uitgesplitst naar type koper](https://success.openhealth.fr/nl/articles/3447801-uitgesplitst-naar-type-koper.md) - [Consumptie-index](https://success.openhealth.fr/nl/articles/3432701-consumptie-index.md) - [Aandeel in verkoop](https://success.openhealth.fr/nl/articles/3432664-aandeel-in-verkoop.md) - [Waarde loyaliteit](https://success.openhealth.fr/nl/articles/3432695-waarde-loyaliteit.md) - [Absolute penetratie](https://success.openhealth.fr/nl/articles/3432556-absolute-penetratie.md) - [Aandeel in verkoop](https://success.openhealth.fr/nl/articles/3432655-aandeel-in-verkoop.md) - [p-waarde](https://success.openhealth.fr/nl/articles/5781702-p-waarde.md) - [Principale componentenanalyse](https://success.openhealth.fr/nl/articles/4231028-principale-componentenanalyse.md) - [Negatieve voorspellende waarde](https://success.openhealth.fr/nl/articles/4134220-negatieve-voorspellende-waarde.md) - [Positieve voorspellende waarde](https://success.openhealth.fr/nl/articles/4134166-positieve-voorspellende-waarde.md) - [Onafhankelijkheidstest](https://success.openhealth.fr/nl/articles/4128369-onafhankelijkheidstest.md) - [Studie van tijdreeksen](https://success.openhealth.fr/nl/articles/3633991-studie-van-tijdreeksen.md) - [Seizoensgebonden variantie](https://success.openhealth.fr/nl/articles/3653790-seizoensgebonden-variantie.md) - [Gevoeligheid en specificiteit van een test](https://success.openhealth.fr/nl/articles/3928135-gevoeligheid-en-specificiteit-van-een-test.md) - [Trendvariantie](https://success.openhealth.fr/nl/articles/3653847-trendvariantie.md) - [Restvariantie](https://success.openhealth.fr/nl/articles/3653851-restvariantie.md) - [Bepalingscoëfficiënt](https://success.openhealth.fr/nl/articles/3654093-bepalingscoefficient.md) - [Variatiecoëfficiënt](https://success.openhealth.fr/nl/articles/3653915-variatiecoefficient.md) - [Variantie van een tijdreeks](https://success.openhealth.fr/nl/articles/3653855-variantie-van-een-tijdreeks.md) - [Concentratie van verkoop](https://success.openhealth.fr/nl/articles/3395856-concentratie-van-verkoop.md) - [Gini-index](https://success.openhealth.fr/nl/articles/3395323-gini-index.md) - [Bevolking](https://success.openhealth.fr/nl/articles/4396779-bevolking.md) - [Verandering in het aantal sterfgevallen](https://success.openhealth.fr/nl/articles/4396765-verandering-in-het-aantal-sterfgevallen.md) - [Geslachtsverhouding](https://success.openhealth.fr/nl/articles/3812167-geslachtsverhouding.md) - [Bevolking - Gemiddelde leeftijd](https://success.openhealth.fr/nl/articles/3812180-bevolking-gemiddelde-leeftijd.md) - [Bevolking - Mediane leeftijd](https://success.openhealth.fr/nl/articles/3812198-bevolking-mediane-leeftijd.md) - [Bevolking - Leeftijd 1e kwartiel](https://success.openhealth.fr/nl/articles/3812218-bevolking-leeftijd-1e-kwartiel.md) - [Bevolking - Leeftijd 3e kwartiel](https://success.openhealth.fr/nl/articles/3812227-bevolking-leeftijd-3e-kwartiel.md) - [Percentage van de totale bevolking van het gebied waarop het selectieproces betrekking heeft](https://success.openhealth.fr/nl/articles/3812233-percentage-van-de-totale-bevolking-van-het-gebied-waarop-het-selectieproces-betrekking-heeft.md) - [Sterftecijfer](https://success.openhealth.fr/nl/articles/3947946-sterftecijfer.md) - [Dodelijk slachtoffer](https://success.openhealth.fr/nl/articles/3948084-dodelijk-slachtoffer.md) - [Vrouwen in de vruchtbare leeftijd](https://success.openhealth.fr/nl/articles/4172859-vrouwen-in-de-vruchtbare-leeftijd.md) - [Selectie als percentage van het totale aantal sterfgevallen in de regio](https://success.openhealth.fr/nl/articles/3863734-selectie-als-percentage-van-het-totale-aantal-sterfgevallen-in-de-regio.md) - [Modellering van het aantal ontbrekende sterfgevallen](https://success.openhealth.fr/nl/articles/3895572-modellering-van-het-aantal-ontbrekende-sterfgevallen.md) - [Geschatte initiële verkoop op recept](https://success.openhealth.fr/nl/articles/5323282-geschatte-initiele-verkoop-op-recept.md) - [Trends naar leeftijd en zwangerschapsstatus](https://success.openhealth.fr/nl/articles/6820051-trends-naar-leeftijd-en-zwangerschapsstatus.md) - [Verhouding Medeverdelende Producten](https://success.openhealth.fr/nl/articles/7892010-verhouding-medeverdelende-producten.md) - [Geschatte verkoop van navulrecepten](https://success.openhealth.fr/nl/articles/5323209-geschatte-verkoop-van-navulrecepten.md) - [Gewicht van de verkoop van navulrecepten](https://success.openhealth.fr/nl/articles/5323198-gewicht-van-de-verkoop-van-navulrecepten.md) - [Gewicht van initiatieverkoop op recept](https://success.openhealth.fr/nl/articles/5323086-gewicht-van-initiatieverkoop-op-recept.md) - [Aantal gezamenlijke dispensaties](https://success.openhealth.fr/nl/articles/3194351-aantal-gezamenlijke-dispensaties.md) - [Aantal ontheffingen](https://success.openhealth.fr/nl/articles/3194348-aantal-ontheffingen.md) - [Gemiddeld aantal verstrekkingen per klant-ID](https://success.openhealth.fr/nl/articles/3369626-gemiddeld-aantal-verstrekkingen-per-klant-id.md) - [Naleving](https://success.openhealth.fr/nl/articles/3411996-naleving.md) - [Persistentiegraad](https://success.openhealth.fr/nl/articles/3369684-persistentiegraad.md) - [Therapeutische therapietrouw](https://success.openhealth.fr/nl/articles/3412091-therapeutische-therapietrouw.md) - [Gemiddelde dagelijkse dosis per klant-ID](https://success.openhealth.fr/nl/articles/4153587-gemiddelde-dagelijkse-dosis-per-klant-id.md) - [Aantal verstrekkingen ingediend voor vergoeding](https://success.openhealth.fr/nl/articles/3370942-aantal-verstrekkingen-ingediend-voor-vergoeding.md) - [Aantal verstrekkingen dat niet is ingediend voor vergoeding](https://success.openhealth.fr/nl/articles/3370920-aantal-verstrekkingen-dat-niet-is-ingediend-voor-vergoeding.md) - [Verkoopwaarde vergoed door verplichte ziektekostenverzekering](https://success.openhealth.fr/nl/articles/3371699-verkoopwaarde-vergoed-door-verplichte-ziektekostenverzekering.md) - [Verkoop van terugbetaalde waarden gedekt door aanvullende ziektekostenverzekering](https://success.openhealth.fr/nl/articles/3371830-verkoop-van-terugbetaalde-waarden-gedekt-door-aanvullende-ziektekostenverzekering.md) - [Verkoop van restwaarden](https://success.openhealth.fr/nl/articles/3371842-verkoop-van-restwaarden.md) - [Prevalentie](https://success.openhealth.fr/nl/articles/3947955-prevalentie.md) - [Gemiddeld aantal GTIN's per dispensatie](https://success.openhealth.fr/nl/articles/3396154-gemiddeld-aantal-gtin-s-per-dispensatie.md) - [Gemiddeld volume per dispensatie](https://success.openhealth.fr/nl/articles/3396196-gemiddeld-volume-per-dispensatie.md) - [Gemiddelde omzet per verstrekking](https://success.openhealth.fr/nl/articles/3396208-gemiddelde-omzet-per-verstrekking.md) - [Dosering actief ingrediënt per doos](https://success.openhealth.fr/nl/articles/3675409-dosering-actief-ingredient-per-doos.md) - [DDD per doos](https://success.openhealth.fr/nl/articles/3675446-ddd-per-doos.md) - [Volume in basiseenheden](https://success.openhealth.fr/nl/articles/3675520-volume-in-basiseenheden.md) - [Volume actief ingrediënt](https://success.openhealth.fr/nl/articles/3675539-volume-actief-ingredient.md) - [DDD per 1.000 inwoners](https://success.openhealth.fr/nl/articles/3675667-ddd-per-1-000-inwoners.md) - [Gemiddeld volume CU Klant-ID](https://success.openhealth.fr/nl/articles/3675761-gemiddeld-volume-cu-klant-id.md) - [Gemiddeld BU-volume per klant-ID](https://success.openhealth.fr/nl/articles/3675814-gemiddeld-bu-volume-per-klant-id.md) - [Gemiddeld volume actief ingrediënt per klant-ID](https://success.openhealth.fr/nl/articles/3675824-gemiddeld-volume-actief-ingredient-per-klant-id.md) - [Gemiddelde duur van de behandeling](https://success.openhealth.fr/nl/articles/3675841-gemiddelde-duur-van-de-behandeling.md) - [Vaccinatiegraad](https://success.openhealth.fr/nl/articles/3822264-vaccinatiegraad.md) - [Inclusief klant-ID's](https://success.openhealth.fr/nl/articles/3886665-inclusief-klant-id-s.md) - [Verschillen tussen MPR en PDC](https://success.openhealth.fr/nl/articles/3722666-verschillen-tussen-mpr-en-pdc.md) - [Gemiddelde duur van de behandeling](https://success.openhealth.fr/nl/articles/3920967-gemiddelde-duur-van-de-behandeling.md) - [Gemiddelde verlengingsperiode](https://success.openhealth.fr/nl/articles/3921067-gemiddelde-verlengingsperiode.md) - [Start behandeling](https://success.openhealth.fr/nl/articles/3848844-start-behandeling.md) - [Behandeling vernieuwingen](https://success.openhealth.fr/nl/articles/3885469-behandeling-vernieuwingen.md) - [Behandeling hervat](https://success.openhealth.fr/nl/articles/3885608-behandeling-hervat.md) - [Nieuwe behandelingen](https://success.openhealth.fr/nl/articles/3885297-nieuwe-behandelingen.md) - [Behandelingsschakelaar](https://success.openhealth.fr/nl/articles/3848886-behandelingsschakelaar.md) - [Behandeling stoppen](https://success.openhealth.fr/nl/articles/3885426-behandeling-stoppen.md) - [Drop-off](https://success.openhealth.fr/nl/articles/3885387-drop-off.md) - [Traceerbaarheidsinzetstuk](https://success.openhealth.fr/nl/articles/4355163-traceerbaarheidsinzetstuk.md) - [Gestopt en opnieuw gestart](https://success.openhealth.fr/nl/articles/8429189-gestopt-en-opnieuw-gestart.md) - [Uitgifteaandeel](https://success.openhealth.fr/nl/articles/3624820-uitgifteaandeel.md) - [Relevante ontheffingen bijhouden](https://success.openhealth.fr/nl/articles/3804193-relevante-ontheffingen-bijhouden.md) - [Desintegratiesnelheid](https://success.openhealth.fr/nl/articles/4850138-desintegratiesnelheid.md) - [Reactiekinetiek](https://success.openhealth.fr/nl/articles/4850629-reactiekinetiek.md) - [Halfwaardetijd](https://success.openhealth.fr/nl/articles/4849710-halfwaardetijd.md) - [Voorraaddekkingsgraad - PIEX](https://success.openhealth.fr/nl/articles/4210714-voorraaddekkingsgraad-piex.md) - [HUB-tijdsperioden](https://success.openhealth.fr/nl/articles/3194479-hub-tijdsperioden.md) - [De definitie van een belastingjaar wijzigen](https://success.openhealth.fr/nl/articles/3321750-de-definitie-van-een-belastingjaar-wijzigen.md) - [Beheer van wekelijkse vergelijkingen](https://success.openhealth.fr/nl/articles/3835180-beheer-van-wekelijkse-vergelijkingen.md) - [De parafarmacieagenda van de GSA \(SMKT\)](https://success.openhealth.fr/nl/articles/3175583-de-parafarmacieagenda-van-de-gsa-smkt.md) - [N](https://success.openhealth.fr/nl/articles/3194484-n.md) - [N Verandering](https://success.openhealth.fr/nl/articles/3194461-n-verandering.md) - [N Trend](https://success.openhealth.fr/nl/articles/3194485-n-trend.md) ### IAS - Indicateurs Avancés Sanitaires - [IAS\(r\) Allergie](https://success.openhealth.fr/nl/articles/7339151-ias-r-allergie.md) - [IAS\(r\) Poux](https://success.openhealth.fr/nl/articles/7339168-ias-r-poux.md) - [IAS\(r\) gastro-enteritis](https://success.openhealth.fr/nl/articles/7339181-ias-r-gastro-enteritis.md) - [IAS\(r\) Ademhalingssyndromen](https://success.openhealth.fr/nl/articles/3815345-ias-r-ademhalingssyndromen.md) - [IAS\(r\) Griepachtige ziekte](https://success.openhealth.fr/nl/articles/7266711-ias-r-griepachtige-ziekte.md) ### SOLUTION EMAILING - Professionnels de santé - [OpenHealth e-mailing oplossing](https://success.openhealth.fr/nl/articles/7055261-openhealth-e-mailing-oplossing.md) - [Vereisten voor het produceren van een e-mailcampagne](https://success.openhealth.fr/nl/articles/6282113-vereisten-voor-het-produceren-van-een-e-mailcampagne.md) - [Rapporten en benchmarks bijhouden](https://success.openhealth.fr/nl/articles/6302721-rapporten-en-benchmarks-bijhouden.md) - [Woordenlijst voor e-mailcampagnes](https://success.openhealth.fr/nl/articles/6282099-woordenlijst-voor-e-mailcampagnes.md) ### PSAD - OBSERVATOIRE - [Analyse - NATIONAAL](https://success.openhealth.fr/nl/articles/3376262-analyse-nationaal.md) - [Volume / Verkoop - NATIONAAL](https://success.openhealth.fr/nl/articles/3376287-volume-verkoop-nationaal.md) - [Evolutie - NATIONAAL](https://success.openhealth.fr/nl/articles/3376370-evolutie-nationaal.md) - [Extractie - NATIONAAL](https://success.openhealth.fr/nl/articles/3376420-extractie-nationaal.md) - [Definitie](https://success.openhealth.fr/nl/articles/3376439-definitie.md) ### AUTRES THEMATIQUES - [INTERCOM](https://success.openhealth.fr/nl/articles/6959415-intercom.md) - [Salesforce](https://success.openhealth.fr/nl/articles/6959337-salesforce.md) - [GIHSN: Excel-bestand indienen](https://success.openhealth.fr/nl/articles/3977478-gihsn-excel-bestand-indienen.md) - [Blockchain](https://success.openhealth.fr/nl/articles/5385413-blockchain.md) - [DocuSign, een CRM-tool in ons verkoopproces](https://success.openhealth.fr/nl/articles/4514472-docusign-een-crm-tool-in-ons-verkoopproces.md) - [Nationaal bijhouden van vaccinaties](https://success.openhealth.fr/nl/articles/4754333-nationaal-bijhouden-van-vaccinaties.md) - [Vaccinatiegraad](https://success.openhealth.fr/nl/articles/4754311-vaccinatiegraad.md) - [KPI-monitoring](https://success.openhealth.fr/nl/articles/4091042-kpi-monitoring.md) - [Cockpit apotheek](https://success.openhealth.fr/nl/articles/4091025-cockpit-apotheek.md) - [Bevolkingsequivalent \(i.e.\)](https://success.openhealth.fr/nl/articles/5431894-bevolkingsequivalent-i-e.md) - [Zuurstofbehoefte](https://success.openhealth.fr/nl/articles/5137158-zuurstofbehoefte.md) - [IHU](https://success.openhealth.fr/nl/articles/4851687-ihu.md) - [Zwevende stoffen](https://success.openhealth.fr/nl/articles/5137147-zwevende-stoffen.md) - [Chemie van afvalwater](https://success.openhealth.fr/nl/articles/5137101-chemie-van-afvalwater.md) - [NRBCE](https://success.openhealth.fr/nl/articles/4851683-nrbce.md) - [Wet van Arrhenius](https://success.openhealth.fr/nl/articles/4849672-wet-van-arrhenius.md) - [Resultaat](https://success.openhealth.fr/nl/articles/5137034-resultaat.md) - [Soorten afvalwater](https://success.openhealth.fr/nl/articles/5137183-soorten-afvalwater.md) - [SARS-CoV-2 virusconcentratie](https://success.openhealth.fr/nl/articles/4867968-sars-cov-2-virusconcentratie.md) - [MAPOM / BMPM](https://success.openhealth.fr/nl/articles/4851685-mapom-bmpm.md) - [Gecontextualiseerde concentratie van het SARS-CoV-2 virus](https://success.openhealth.fr/nl/articles/4934604-gecontextualiseerde-concentratie-van-het-sars-cov-2-virus.md) - [Type rioolnetwerk](https://success.openhealth.fr/nl/articles/4867954-type-rioolnetwerk.md) - [Afbraak van het virus](https://success.openhealth.fr/nl/articles/4865742-afbraak-van-het-virus.md) - [WBE](https://success.openhealth.fr/nl/articles/4865735-wbe.md) - [RNA](https://success.openhealth.fr/nl/articles/4865733-rna.md) - [Coronavirus](https://success.openhealth.fr/nl/articles/4865728-coronavirus.md) - [COVID-19](https://success.openhealth.fr/nl/articles/4865726-covid-19.md) - [Seroprevalentie: bemonsteringsmethode](https://success.openhealth.fr/nl/articles/3924493-seroprevalentie-bemonsteringsmethode.md) - [SANDRE referentiesysteem](https://success.openhealth.fr/nl/articles/5415040-sandre-referentiesysteem.md) - [Nationale basis ROSEAU](https://success.openhealth.fr/nl/articles/5414523-nationale-basis-roseau.md) - [SARS-CoV-2 virusconcentratie](https://success.openhealth.fr/nl/articles/4852404-sars-cov-2-virusconcentratie.md) - [SARS-CoV-2 virusconcentratie - Varianten](https://success.openhealth.fr/nl/articles/4909854-sars-cov-2-virusconcentratie-varianten.md) - [Marseille - Wereldwijde bewaking](https://success.openhealth.fr/nl/articles/4859311-marseille-wereldwijde-bewaking.md) - [SARS-CoV-2 virusconcentratie - Nice](https://success.openhealth.fr/nl/articles/4879292-sars-cov-2-virusconcentratie-nice.md) - [Bevolking - Structuur](https://success.openhealth.fr/nl/articles/4842408-bevolking-structuur.md) - [SARS-CoV-2 virusconcentratie - Toulon \(FRANKRIJK\)](https://success.openhealth.fr/nl/articles/4886417-sars-cov-2-virusconcentratie-toulon-frankrijk.md) - [Dubai - Monitoring van afvalwater op luchthavens](https://success.openhealth.fr/nl/articles/5276423-dubai-monitoring-van-afvalwater-op-luchthavens.md) - [SARS-CoV-2 surveillance - OBEPINE](https://success.openhealth.fr/nl/articles/5210661-sars-cov-2-surveillance-obepine.md) - [Gecontextualiseerde concentratie van SARS-CoV-2 virus](https://success.openhealth.fr/nl/articles/4934608-gecontextualiseerde-concentratie-van-sars-cov-2-virus.md) - [SUEZ - Analytische balans](https://success.openhealth.fr/nl/articles/5140509-suez-analytische-balans.md) - [Palais des festivals - Bekijk T0](https://success.openhealth.fr/nl/articles/5373515-palais-des-festivals-bekijk-t0.md) - [Palais des festivals - Dagelijkse monitoring](https://success.openhealth.fr/nl/articles/5373231-palais-des-festivals-dagelijkse-monitoring.md) - [Palais des festivals - Vertoning](https://success.openhealth.fr/nl/articles/5404778-palais-des-festivals-vertoning.md) - [Mustelids - Kijken](https://success.openhealth.fr/nl/articles/5169577-mustelids-kijken.md) - [Bevolking - IRIS](https://success.openhealth.fr/nl/articles/4842191-bevolking-iris.md) - [SARS-CoV-2](https://success.openhealth.fr/nl/articles/4865699-sars-cov-2.md) - [IAS - Analyse](https://success.openhealth.fr/nl/articles/4842430-ias-analyse.md) - [SARS-CoV-2 virusconcentratie - SEM](https://success.openhealth.fr/nl/articles/5415600-sars-cov-2-virusconcentratie-sem.md) - [Kaart visualisatie](https://success.openhealth.fr/nl/articles/3864657-kaart-visualisatie.md) - [Site bijdrage](https://success.openhealth.fr/nl/articles/3864668-site-bijdrage.md) - [Cohortprofiel per locatie](https://success.openhealth.fr/nl/articles/3864672-cohortprofiel-per-locatie.md) - [Cohortprofiel per seizoen](https://success.openhealth.fr/nl/articles/3864673-cohortprofiel-per-seizoen.md) - [Leeftijds- en geslachtsverdeling](https://success.openhealth.fr/nl/articles/3864675-leeftijds-en-geslachtsverdeling.md) - [Virusverspreiding per locatie](https://success.openhealth.fr/nl/articles/3864678-virusverspreiding-per-locatie.md) - [Virusverdeling naar leeftijd](https://success.openhealth.fr/nl/articles/3864677-virusverdeling-naar-leeftijd.md) - [Virusverspreidingsevolutie](https://success.openhealth.fr/nl/articles/3864681-virusverspreidingsevolutie.md) - [Griepvaccinatie](https://success.openhealth.fr/nl/articles/3864697-griepvaccinatie.md) - [Evolutie griepvaccinatie](https://success.openhealth.fr/nl/articles/3864701-evolutie-griepvaccinatie.md) - [Verdeling van patiënten naar chronische aandoening](https://success.openhealth.fr/nl/articles/3864676-verdeling-van-patienten-naar-chronische-aandoening.md) - [Verdeling van patiënten naar verblijfsduur in het ziekenhuis](https://success.openhealth.fr/nl/articles/3864794-verdeling-van-patienten-naar-verblijfsduur-in-het-ziekenhuis.md) - [Fragiliteit](https://success.openhealth.fr/nl/articles/3864704-fragiliteit.md) - [Ernststatus](https://success.openhealth.fr/nl/articles/3864705-ernststatus.md) - [Sterfte](https://success.openhealth.fr/nl/articles/3864710-sterfte.md) - [GIHSN](https://success.openhealth.fr/nl/articles/3864712-gihsn.md) - [CARéDIAB - Patiëntprofielen](https://success.openhealth.fr/nl/articles/3789234-carediab-patientprofielen.md) - [CARéDIAB - Complicaties](https://success.openhealth.fr/nl/articles/3789515-carediab-complicaties.md) - [CARéDIAB - Uitgebreide patiëntbewaking](https://success.openhealth.fr/nl/articles/3792041-carediab-uitgebreide-patientbewaking.md) - [CARéDIAB netwerk](https://success.openhealth.fr/nl/articles/3789106-carediab-netwerk.md) - [CARéDIAB - Behandelingen](https://success.openhealth.fr/nl/articles/3792143-carediab-behandelingen.md) ## English ### Votre PLATEFORME - présentation générale - [The HUB, a complete and continuous support plateform](https://success.openhealth.fr/en/articles/4799621-the-hub-a-complete-and-continuous-support-plateform.md) - [Your level of experience The HUB](https://success.openhealth.fr/en/articles/5712270-your-level-of-experience-the-hub.md) - [Languages](https://success.openhealth.fr/en/articles/4649389-languages.md): Here is the description of all languages available on Success - [Questions about our tariffs](https://success.openhealth.fr/en/articles/3292143-questions-about-our-tariffs.md): Our prices ### Roadmap - [Open-Innovation at the service of our clients](https://success.openhealth.fr/en/articles/5200970-open-innovation-at-the-service-of-our-clients.md) - [Apps + Administration area version 240515](https://success.openhealth.fr/en/articles/9310541-apps-administration-area-version-240515.md) - [Apps + Administration area version 240415](https://success.openhealth.fr/en/articles/9310710-apps-administration-area-version-240415.md) - [Apps + Administration Area version 240315](https://success.openhealth.fr/en/articles/9310790-apps-administration-area-version-240315.md) - [Apps + Administration Area version 240215](https://success.openhealth.fr/en/articles/9311007-apps-administration-area-version-240215.md) - [Platform - update 231215](https://success.openhealth.fr/en/articles/8718485-platform-update-231215.md) - [Platform - update 231015](https://success.openhealth.fr/en/articles/8479932-platform-update-231015.md) - [Apps + Portal version 230915](https://success.openhealth.fr/en/articles/8373640-apps-portal-version-230915.md) - [Apps + Portal version 230815](https://success.openhealth.fr/en/articles/8267860-apps-portal-version-230815.md) - [New products 230715](https://success.openhealth.fr/en/articles/8115796-new-products-230715.md) - [Apps + Portal version 230615](https://success.openhealth.fr/en/articles/8115791-apps-portal-version-230615.md) - [Apps + Portal version 230515](https://success.openhealth.fr/en/articles/7895393-apps-portal-version-230515.md) - [Apps + Portal version 230415](https://success.openhealth.fr/en/articles/7439447-apps-portal-version-230415.md) - [Apps + Portal version 230315](https://success.openhealth.fr/en/articles/7439646-apps-portal-version-230315.md) - [Apps + Portal version 230215](https://success.openhealth.fr/en/articles/7439744-apps-portal-version-230215.md) - [New from 15/01/2023](https://success.openhealth.fr/en/articles/6895740-new-from-15-01-2023.md) - [HUB + GATE version 221215](https://success.openhealth.fr/en/articles/6827027-hub-gate-version-221215.md) - [HUB + GATE version 221115](https://success.openhealth.fr/en/articles/6742628-hub-gate-version-221115.md) - [HUB + GATE version 220915](https://success.openhealth.fr/en/articles/6558070-hub-gate-version-220915.md) - [HUB + GATE version 220815](https://success.openhealth.fr/en/articles/6475311-hub-gate-version-220815.md) - [HUB + GATE version 220615](https://success.openhealth.fr/en/articles/6306090-hub-gate-version-220615.md) - [HUB + GATE version 220515](https://success.openhealth.fr/en/articles/6201877-hub-gate-version-220515.md) - [HUB + GATE version 220415](https://success.openhealth.fr/en/articles/6087747-hub-gate-version-220415.md) - [New version HUB SMA 220315](https://success.openhealth.fr/en/articles/6043772-new-version-hub-sma-220315.md): New version HUB SMA 220315 / Flux vF220315 - [HUB TMA version 220315](https://success.openhealth.fr/en/articles/6043802-hub-tma-version-220315.md) - [HUB UAN version 220315](https://success.openhealth.fr/en/articles/6043852-hub-uan-version-220315.md) - [GATE version 220215](https://success.openhealth.fr/en/articles/5940805-gate-version-220215.md) - [HUB SMA version 220215](https://success.openhealth.fr/en/articles/5940753-hub-sma-version-220215.md) - [HUB TMA version 220215](https://success.openhealth.fr/en/articles/5947859-hub-tma-version-220215.md) - [GATE version 211215](https://success.openhealth.fr/en/articles/5819397-gate-version-211215.md) - [Application The HUB: "The state of the pharmacy".](https://success.openhealth.fr/en/articles/5704485-application-the-hub-the-state-of-the-pharmacy.md) - [GATE version 211115](https://success.openhealth.fr/en/articles/5697844-gate-version-211115.md) - [HUB SMA version 211115](https://success.openhealth.fr/en/articles/5671893-hub-sma-version-211115.md) - [GATE version 211015](https://success.openhealth.fr/en/articles/5652210-gate-version-211015.md) - [HUB SMA version 211015](https://success.openhealth.fr/en/articles/5649822-hub-sma-version-211015.md) - [HUB TMA version 211015](https://success.openhealth.fr/en/articles/5650073-hub-tma-version-211015.md) - [HUB UAN version 211015](https://success.openhealth.fr/en/articles/5652242-hub-uan-version-211015.md) - [HUB SMA version 210915](https://success.openhealth.fr/en/articles/5370516-hub-sma-version-210915.md) - [HUB TMA version 210915](https://success.openhealth.fr/en/articles/5390983-hub-tma-version-210915.md) - [HUB UAN version 210915](https://success.openhealth.fr/en/articles/5543213-hub-uan-version-210915.md) ### Votre ESPACE D'ADMINISTRATION - fonctionnalités - [Reset / change your password The HUB](https://success.openhealth.fr/en/articles/4425325-reset-change-your-password-the-hub.md): How to change the HUB password - [Connection assistance: I am getting an error message](https://success.openhealth.fr/en/articles/5369783-connection-assistance-i-am-getting-an-error-message.md) - [Create and track a ticket](https://success.openhealth.fr/en/articles/3586214-create-and-track-a-ticket.md): Tutorial to create and follow the evolution of your tickets on your personal space The HUB - [Create and modify a SUCCESS article](https://success.openhealth.fr/en/articles/6738705-create-and-modify-a-success-article.md) - [My contracts](https://success.openhealth.fr/en/articles/5712273-my-contracts.md) - [Service Health](https://success.openhealth.fr/en/articles/4990600-service-health.md): Transparency and traceability at your service: The Service Health dashboard. - [My accesses](https://success.openhealth.fr/en/articles/5783418-my-accesses.md) - [Setting up my homepage](https://success.openhealth.fr/en/articles/5712229-setting-up-my-homepage.md) - [How to modify your market from your personal OpenHealth space?](https://success.openhealth.fr/en/articles/3585971-how-to-modify-your-market-from-your-personal-openhealth-space.md): Integrate, modify and deactivate products from your personal OpenHealth space - [Automatic Modifying Modality Assignment \(MAM Auto\)](https://success.openhealth.fr/en/articles/4164818-automatic-modifying-modality-assignment-mam-auto.md): Directly modify the assignments of your products - [TEMPORARY MAM: How to follow a brand that changes laboratory/brand/label?](https://success.openhealth.fr/en/articles/4131072-temporary-mam-how-to-follow-a-brand-that-changes-laboratory-brand-label.md): Advantages and risks of your type of tracking - [Product Integration \(IPR auto\)](https://success.openhealth.fr/en/articles/4164932-product-integration-ipr-auto.md): Request the integration of a product in your market - [Automatic Product Deactivation \(Auto DPR\)](https://success.openhealth.fr/en/articles/4164866-automatic-product-deactivation-auto-dpr.md): Deactivate a product from your market - [Automatic product reactivation \(RPR auto\)](https://success.openhealth.fr/en/articles/4818161-automatic-product-reactivation-rpr-auto.md): Reactivate a product in your market - [Setting up new products](https://success.openhealth.fr/en/articles/5811248-setting-up-new-products.md) - [Add a market](https://success.openhealth.fr/en/articles/5712283-add-a-market.md) - [Import / Export of bulk products](https://success.openhealth.fr/en/articles/5712257-import-export-of-bulk-products.md) - [Change of Typological Modality \(CMT auto\)](https://success.openhealth.fr/en/articles/4670174-change-of-typological-modality-cmt-auto.md): Modify directly your geographical labels \(sectors or regions\) - [The different user statuses](https://success.openhealth.fr/en/articles/3436418-the-different-user-statuses.md): What are the functionalities? - [Create an account for a user from a third party organisation \(TPAA\)](https://success.openhealth.fr/en/articles/6466550-create-an-account-for-a-user-from-a-third-party-organisation-tpaa.md) - [How do I create, modify or delete a user?](https://success.openhealth.fr/en/articles/3785138-how-do-i-create-modify-or-delete-a-user.md): Only a POWER USER can do it - [Can I create differentiated viewing rights at the HUB within my teams?](https://success.openhealth.fr/en/articles/3321731-can-i-create-differentiated-viewing-rights-at-the-hub-within-my-teams.md): Rights in the Hub - [Activity journal](https://success.openhealth.fr/en/articles/4687438-activity-journal.md): Find the trace of the events in the background ### Vos APPLICATIONS - présentation - [The HUB training guide](https://success.openhealth.fr/en/articles/5634967-the-hub-training-guide.md) - [Sorting drop-down selector](https://success.openhealth.fr/en/articles/5792113-sorting-drop-down-selector.md): Operating schematic sorting pull-down selector - [Date of update of data from GSA parapharmacies \(SMKT\) in HuB](https://success.openhealth.fr/en/articles/3175557-date-of-update-of-data-from-gsa-parapharmacies-smkt-in-hub.md): This article describes when data from GSA parapharmacies \(SMKT\) are updated. - [Prerequisites Matching Pharmacies File](https://success.openhealth.fr/en/articles/3678146-prerequisites-matching-pharmacies-file.md): Pre-requisites Matching Pharmacies File - [Sales With / Without prescription selector](https://success.openhealth.fr/en/articles/3729668-sales-with-without-prescription-selector.md): Specification of the object 'Selector Prescription Type'. : Sales With / Without prescription selector - [How to qualify new products in the HUB?](https://success.openhealth.fr/en/articles/3376100-how-to-qualify-new-products-in-the-hub.md): Qualification of your new products in the HUB - [How to create, modify and share a bookmark in your Platform ?](https://success.openhealth.fr/en/articles/3175689-how-to-create-modify-and-share-a-bookmark-in-your-platform.md): Creating and sharing favorites in the Hub - [How do I select products in the HUB by launch date?](https://success.openhealth.fr/en/articles/3158428-how-do-i-select-products-in-the-hub-by-launch-date.md): This article explains how to select only products launched in a certain period. - [Can I extract the data from the HUB in ".csv" format?](https://success.openhealth.fr/en/articles/5671278-can-i-extract-the-data-from-the-hub-in-csv-format.md) - [ODT response time](https://success.openhealth.fr/en/articles/6632310-odt-response-time.md) - [What are the best display practices in the HUB](https://success.openhealth.fr/en/articles/3124454-what-are-the-best-display-practices-in-the-hub.md): This article details the best practices to optimize the display of the HUB - [Technical requirements](https://success.openhealth.fr/en/articles/5369918-technical-requirements.md) - [Empty your browser's cache](https://success.openhealth.fr/en/articles/4219722-empty-your-browser-s-cache.md): How to clear your Google Chrome browser cache - [How do I set Google Chrome as my default browser?](https://success.openhealth.fr/en/articles/3738717-how-do-i-set-google-chrome-as-my-default-browser.md): How to set Google Chrome as default - [The navigation elevator is not visible in the tables](https://success.openhealth.fr/en/articles/3195250-the-navigation-elevator-is-not-visible-in-the-tables.md): The navigation lift - [The display of buttons or objects on a sheet is partially cut off or not visible](https://success.openhealth.fr/en/articles/3195245-the-display-of-buttons-or-objects-on-a-sheet-is-partially-cut-off-or-not-visible.md): Display problem of buttons, objects - [My Territory Management card is not loading and the message "loading" appears](https://success.openhealth.fr/en/articles/3195239-my-territory-management-card-is-not-loading-and-the-message-loading-appears.md): Territory Management / TMA map display problem - [Where does the "You're not authorized to access on this page" error message come from?](https://success.openhealth.fr/en/articles/3195338-where-does-the-you-re-not-authorized-to-access-on-this-page-error-message-come-from.md): Error messages - [I have a "Connection lost" error message](https://success.openhealth.fr/en/articles/4445141-i-have-a-connection-lost-error-message.md): An error has occurred - [Bad gateway](https://success.openhealth.fr/en/articles/4514555-bad-gateway.md): "Bad Gateway" error message - [The dimension and measure selectors are no longer displayed in the "Multiple Period Analysis" and "My Data Archive" queryers, the extraction of the table in "Market Analysis" is partial](https://success.openhealth.fr/en/articles/3195377-the-dimension-and-measure-selectors-are-no-longer-displayed-in-the-multiple-period-analysis-and-my-data-archive-queryers-the-extraction-of-the-table-in-market-analysis-is-partial.md): Dimensions and Measures are no longer displayed - [How to view a term in the HUB?](https://success.openhealth.fr/en/articles/3194377-how-to-view-a-term-in-the-hub.md): The HUB allows you to easily view quadrimesters in the 'Sales Evolution' sheet - [Excel specifications and limitations](https://success.openhealth.fr/en/articles/3753088-excel-specifications-and-limitations.md): This article explains the specifications and limitations for Excel. - [How do you create, edit and share a Favourite in your applications?](https://success.openhealth.fr/en/articles/10502803-how-do-you-create-edit-and-share-a-favourite-in-your-applications.md): Gestion des favoris Mise à jour : 260130\_CC - [Framework consumer panel](https://success.openhealth.fr/en/articles/3455845-framework-consumer-panel.md): Article relating to the consumer panel framework - [Framework pharmacy market analysis](https://success.openhealth.fr/en/articles/3455857-framework-pharmacy-market-analysis.md): Article relating to the OpenHealth framework for analyzing market performance on the pharmacy channel ### Data SOURCES - [What is the OpenHealth Pharmacy Panel?](https://success.openhealth.fr/en/articles/3304106-what-is-the-openhealth-pharmacy-panel.md): The purpose of this article is to describe our panel of pharmacies. - [The pharmacy network, a decisive asset in the management of current and future health crises](https://success.openhealth.fr/en/articles/3825648-the-pharmacy-network-a-decisive-asset-in-the-management-of-current-and-future-health-crises.md): OpenHealth Company, committed to monitoring an unprecedented health crisis, mobilizes its technology and data - [What are the territories of the French overseas departments and territories that can be viewed in the HUB?](https://success.openhealth.fr/en/articles/3194382-what-are-the-territories-of-the-french-overseas-departments-and-territories-that-can-be-viewed-in-the-hub.md): DROM-COM territories available in the Hub - [Requirement sectorisation file](https://success.openhealth.fr/en/articles/3702701-requirement-sectorisation-file.md): This article allows you to download, fill in and transmit your sectorisation file. - [SMKT data source / Stores](https://success.openhealth.fr/en/articles/4485357-smkt-data-source-stores.md): IRI, supplier of GSA drugstore data / Stores sales - [Coding rules for GSA parapharmacy products \(SMKT\) at IRI](https://success.openhealth.fr/en/articles/3524492-coding-rules-for-gsa-parapharmacy-products-smkt-at-iri.md): Reminder of the codification rules for SMKT products at IRI - [E-parapharmacies: monitoring platforms](https://success.openhealth.fr/en/articles/9167006-e-parapharmacies-monitoring-platforms.md) - [Ecommerce data - Source WISER](https://success.openhealth.fr/en/articles/7983010-ecommerce-data-source-wiser.md) - [Geographic Territories](https://success.openhealth.fr/en/articles/4661582-geographic-territories.md): At Open Health Company, you can analyze your markets according to the geographic territories that we offer you. - [What is the pharmacy panel in Germany?](https://success.openhealth.fr/en/articles/5391412-what-is-the-pharmacy-panel-in-germany.md): This article aims to describe the pharmacy panel in Germany View the German data in the Openhealth HUB - [What is the pharmacy panel in Greece? ALIRAHEALTH](https://success.openhealth.fr/en/articles/6863963-what-is-the-pharmacy-panel-in-greece-alirahealth.md) - [What is the pharmacy panel in Austria? INSIGHTHEALTH](https://success.openhealth.fr/en/articles/6863949-what-is-the-pharmacy-panel-in-austria-insighthealth.md) - [What is the Pharmacy Panel in Africa? PIEX - Africa](https://success.openhealth.fr/en/articles/6686633-what-is-the-pharmacy-panel-in-africa-piex-africa.md) - [What is the pharmacy panel in Belgium? REDPHARMA](https://success.openhealth.fr/en/articles/4689894-what-is-the-pharmacy-panel-in-belgium-redpharma.md) - [What is the pharmacy panel in Spain? - HMR](https://success.openhealth.fr/en/articles/5391363-what-is-the-pharmacy-panel-in-spain-hmr.md) - [What is the pharmacy panel in Spain? - INFONIS](https://success.openhealth.fr/en/articles/5428915-what-is-the-pharmacy-panel-in-spain-infonis.md): This article aims to describe the panel of pharmacies in Spain - INFONIS. View the SPANISH data in the Openhealth HUB - [ALPHARM](https://success.openhealth.fr/en/articles/5701531-alpharm.md): ALPHARM - [What is the pharmacy panel in Poland? Pex Pharma](https://success.openhealth.fr/en/articles/5969485-what-is-the-pharmacy-panel-in-poland-pex-pharma.md) - [CONVERT GROUP](https://success.openhealth.fr/en/articles/6961966-convert-group.md) - [What is the pharmacy panel in Jordan?](https://success.openhealth.fr/en/articles/8176750-what-is-the-pharmacy-panel-in-jordan.md): This article describes the pharmacy panel in JORDAN. View Jordan data in your HUB - [Population - Cartography](https://success.openhealth.fr/en/articles/3807695-population-cartography.md): Analyze the geographic distribution of the population - [AMELI - LPP](https://success.openhealth.fr/en/articles/6962021-ameli-lpp.md) - [Population - Evolution by AGE & GENDER](https://success.openhealth.fr/en/articles/3810789-population-evolution-by-age-gender.md): Analyze the evolution of the population structure - [Population - Comparison by AGE & GENDER](https://success.openhealth.fr/en/articles/3836795-population-comparison-by-age-gender.md): Compare the demographic profile of two populations - [EGYPT - Cartography](https://success.openhealth.fr/en/articles/3714611-egypt-cartography.md): Analyze the population of the governorates of Egypt - [EGYPT - Analysis by AGE & GENDER](https://success.openhealth.fr/en/articles/3714673-egypt-analysis-by-age-gender.md): Analyze the structure of the population - [UGANDA - Analysis by AGE & GENDER](https://success.openhealth.fr/en/articles/3713884-uganda-analysis-by-age-gender.md): Analyze the structure of the population - [Population - Analysis by AGE & GENDER](https://success.openhealth.fr/en/articles/3807673-population-analysis-by-age-gender.md): Analyze the structure of the population - [Medicabase - drug database](https://success.openhealth.fr/en/articles/6518920-medicabase-drug-database.md) - [Birth](https://success.openhealth.fr/en/articles/6340025-birth.md) - [OpenEudra](https://success.openhealth.fr/en/articles/6518977-openeudra.md) - [IRIS breakdown](https://success.openhealth.fr/en/articles/6383829-iris-breakdown.md) - [ADICAP](https://success.openhealth.fr/en/articles/6959465-adicap.md) - [NEC](https://success.openhealth.fr/en/articles/6519012-nec.md) - [World population data](https://success.openhealth.fr/en/articles/8217421-world-population-data.md): World population data - [INSEE: Files of deceased persons](https://success.openhealth.fr/en/articles/4498126-insee-files-of-deceased-persons.md): INSEE \(National Institute for Statistics and Economic Studies\): File of deceased persons - [Data VAERS- VAERSDATA- Source CDC](https://success.openhealth.fr/en/articles/6226665-data-vaers-vaersdata-source-cdc.md) - [VAERS data - VAERSVAX - Source CDC](https://success.openhealth.fr/en/articles/6226440-vaers-data-vaersvax-source-cdc.md) - [VAERS data - VAERSSYMPTOMS - Source CDC](https://success.openhealth.fr/en/articles/6219415-vaers-data-vaerssymptoms-source-cdc.md) - [Integrate your data into the Hub in less than 2 weeks](https://success.openhealth.fr/en/articles/5259828-integrate-your-data-into-the-hub-in-less-than-2-weeks.md) - [International Data Template](https://success.openhealth.fr/en/articles/4684696-international-data-template.md): International Data Template \(IDT201204\) - [How to send us your data by FTPS?](https://success.openhealth.fr/en/articles/4143451-how-to-send-us-your-data-by-ftps.md): Send data via FTPS - [What information does OpenHealth need to integrate a new data source?](https://success.openhealth.fr/en/articles/3459148-what-information-does-openhealth-need-to-integrate-a-new-data-source.md): Article on the integration of new data sources - [The Long View](https://success.openhealth.fr/en/articles/6959482-the-long-view.md) - [How to integrate a new data source into the HUB?](https://success.openhealth.fr/en/articles/3467598-how-to-integrate-a-new-data-source-into-the-hub.md): Article related to the data integration process in the HUB - [Integrate your sell-in data into the HUB](https://success.openhealth.fr/en/articles/3471145-integrate-your-sell-in-data-into-the-hub.md): Article on the integration of sell-in data - [Specifications for receiving sell-in data](https://success.openhealth.fr/en/articles/3660043-specifications-for-receiving-sell-in-data.md): How to send us your sell-in as part of a sell-in / sell-out analysis or subscription to the Sell-in Vizualization module - [Where does the analysis data for the Home Health Providers \(PSAD\) market come from?](https://success.openhealth.fr/en/articles/3376155-where-does-the-analysis-data-for-the-home-health-providers-psad-market-come-from.md): PSAD - [How to join the SantéDom Stat observatory?](https://success.openhealth.fr/en/articles/3798795-how-to-join-the-santedom-stat-observatory.md): Tutorial for joining the national observatory of the activity of Home Health Providers \(PSAD\) - [Panel extrapolated from the SanteDomStat observatory](https://success.openhealth.fr/en/articles/6701602-panel-extrapolated-from-the-santedomstat-observatory.md) - [Number of patients](https://success.openhealth.fr/en/articles/3376499-number-of-patients.md): Definition of the number of patients according to the PSAD federations - [Number of treatments](https://success.openhealth.fr/en/articles/3376682-number-of-treatments.md): Definition of the number of treatments according to the PSAD federations - [Number of new patients](https://success.openhealth.fr/en/articles/3376672-number-of-new-patients.md): Definition of the number of new patients according to the PSAD federations - [Turnover including tax](https://success.openhealth.fr/en/articles/3376725-turnover-including-tax.md): Definition of turnover including tax according to the PSAD federations - [Number of patients at the end of treatment](https://success.openhealth.fr/en/articles/3376675-number-of-patients-at-the-end-of-treatment.md): Definition of the number of patients at the end of treatment according to the PSAD federations - [Compulsory health insurance amount \(AMO\)](https://success.openhealth.fr/en/articles/3376740-compulsory-health-insurance-amount-amo.md): Definition of the AMO amount according to the PSAD federations - [Supplementary health insurance amount \(AMC\)](https://success.openhealth.fr/en/articles/3376749-supplementary-health-insurance-amount-amc.md): Definition of the AMC amount according to the PSAD federations - [Outstanding charge \(RAC\)](https://success.openhealth.fr/en/articles/3376751-outstanding-charge-rac.md): Definition of the RAC according to the PSAD federations - [Source: THESORIMED](https://success.openhealth.fr/en/articles/3560018-source-thesorimed.md): Drug database \(BdM\) - [International Nonproprietary Names \(INN\)](https://success.openhealth.fr/en/articles/3954239-international-nonproprietary-names-inn.md): International Common Names \(INN\) - [Open Food Facts](https://success.openhealth.fr/en/articles/6961970-open-food-facts.md) - [LOINC - Logical Observation Identifiers Names & Codes](https://success.openhealth.fr/en/articles/6959323-loinc-logical-observation-identifiers-names-codes.md) - [AMELI - CCAM](https://success.openhealth.fr/en/articles/6959080-ameli-ccam.md) - [WHO ATC VET](https://success.openhealth.fr/en/articles/6959078-who-atc-vet.md) - [CEPS](https://success.openhealth.fr/en/articles/6959068-ceps.md) - [Institution](https://success.openhealth.fr/en/articles/3935678-institution.md): List of health, social, medico-social establishments - [Health services](https://success.openhealth.fr/en/articles/7969680-health-services.md) - [Extract FINESS](https://success.openhealth.fr/en/articles/3946922-extract-finess.md): Perform an extraction according to your expectations - [Evolution FINESS](https://success.openhealth.fr/en/articles/3947009-evolution-finess.md): Follow the evolution of the number of structures - [Authorization care activity](https://success.openhealth.fr/en/articles/3947067-authorization-care-activity.md): List the structures according to their healthcare activity authorizations - [Major medical equipment](https://success.openhealth.fr/en/articles/3947269-major-medical-equipment.md): List the structures according to their equipment in heavy material - [Geographical](https://success.openhealth.fr/en/articles/3947363-geographical.md): Visualize the distribution of structures on the territory - [RPPS](https://success.openhealth.fr/en/articles/3947568-rpps.md): List of healthcare professionals - [FINESS & RPPS](https://success.openhealth.fr/en/articles/3947713-finess-rpps.md): List the places of exercise of health professionals - [Extract RPPS](https://success.openhealth.fr/en/articles/3947829-extract-rpps.md): RPPS \(Shared Directory of Healthcare Professionals\) ### The MODELS - [Data at UGA](https://success.openhealth.fr/en/articles/4852310-data-at-uga.md): What you need to know about sales data calculations at UGA - [Calculation of sales to the sector: what you need to know](https://success.openhealth.fr/en/articles/3545561-calculation-of-sales-to-the-sector-what-you-need-to-know.md): What are the different steps to calculate sector sales at OpenHealth? - [Sector reallocation, static or dynamic methodology?](https://success.openhealth.fr/en/articles/3690615-sector-reallocation-static-or-dynamic-methodology.md): Sector reallocation, static or dynamic methodology? - [Pharmacy strata](https://success.openhealth.fr/en/articles/4291490-pharmacy-strata.md): Details of the “theoretical” strata and the “real” or “effective” strata. - [The Hub production chain](https://success.openhealth.fr/en/articles/4816146-the-hub-production-chain.md): You will find all the steps of our production chain in this article. - [How to conduct a comparative analysis?](https://success.openhealth.fr/en/articles/3440093-how-to-conduct-a-comparative-analysis.md): You want to compare data from two different providers. - [LEVEL 1 INVESTIGATION - Data Quality at the service of OpenHealth Company](https://success.openhealth.fr/en/articles/3595822-level-1-investigation-data-quality-at-the-service-of-openhealth-company.md): Do you observe a phenomenon that you do not understand? We can provide you with the origin of this sighting and explain it to you. - [Data quality process at OpenHealth](https://success.openhealth.fr/en/articles/3415271-data-quality-process-at-openhealth.md): This article details the stages of data quality processes at OpenHealth - [Interval and confidence level](https://success.openhealth.fr/en/articles/3633173-interval-and-confidence-level.md): Definitions, formulas and limitations: what you need to know - [Data quality: Batch management](https://success.openhealth.fr/en/articles/3433509-data-quality-batch-management.md): Description of the batch management process - [Data quality: Sales breakdown process](https://success.openhealth.fr/en/articles/3415317-data-quality-sales-breakdown-process.md): Description of the sales breakdown process - [Sell-in and stock shifts](https://success.openhealth.fr/en/articles/4131084-sell-in-and-stock-shifts.md): Stock sell-in - [Why analyze sell-in in volume?](https://success.openhealth.fr/en/articles/3846167-why-analyze-sell-in-in-volume.md): Why analyze sell-in in volume? - [There is a data gap between sell-in and sell-out](https://success.openhealth.fr/en/articles/3195358-there-is-a-data-gap-between-sell-in-and-sell-out.md): In which cases can we have a data gap between sell-in and sell-out? - [What is an atypical sale?](https://success.openhealth.fr/en/articles/3195366-what-is-an-atypical-sale.md): Atypical sales and the ATYPICAL FILTERING process. - [Where does the information on prices, volumes, turnover come from?](https://success.openhealth.fr/en/articles/3195348-where-does-the-information-on-prices-volumes-turnover-come-from.md): Price / volume / turnover information - [Estimated sales volume by prescriber](https://success.openhealth.fr/en/articles/4171530-estimated-sales-volume-by-prescriber.md): How to evaluate your sales volumes in pharmacies by prescriber and category of prescriber - [Understanding the difference between 2 extractions](https://success.openhealth.fr/en/articles/13399689-understanding-the-difference-between-2-extractions.md) ### MARKETS - [GTIN](https://success.openhealth.fr/en/articles/3608176-gtin.md): GTIN code \(Global Trade Item Number\) - [Product Customer Qualifying Field Specification \(PCQFS\)](https://success.openhealth.fr/en/articles/3704913-product-customer-qualifying-field-specification-pcqfs.md): CQCP \(Product Customer Qualifier Field\) - [What is an LPPR code?](https://success.openhealth.fr/en/articles/3195365-what-is-an-lppr-code.md): The LPPR code \(List of Reimbursable Products and Services\) - [Product rental tracking](https://success.openhealth.fr/en/articles/4206554-product-rental-tracking.md): Product rental - [I want to expand my market](https://success.openhealth.fr/en/articles/4420843-i-want-to-expand-my-market.md): Subscription market followed - [OHC Classification](https://success.openhealth.fr/en/articles/3194589-ohc-classification.md): Visualize the assignment of your products according to the proprietary OpenHealth Company classification - [EphMRA AC Classes History](https://success.openhealth.fr/en/articles/3557908-ephmra-ac-classes-history.md): Visualize the evolution of EphMRA AC classes since 2014 - [Veterinary Medicine Details](https://success.openhealth.fr/en/articles/3194587-veterinary-medicine-details.md): Visualize the characteristics of veterinary drugs - [Veterinary Medicine Classification](https://success.openhealth.fr/en/articles/3194579-veterinary-medicine-classification.md): View the classification of veterinary drugs \(ANSES\) - [Human Medicine Details](https://success.openhealth.fr/en/articles/3421225-human-medicine-details.md): View the characteristics of one or more products through the detail fields of THESORIMED - [Management of new products](https://success.openhealth.fr/en/articles/4470813-management-of-new-products.md): New product management - [Human Medicine Classification](https://success.openhealth.fr/en/articles/3417281-human-medicine-classification.md): View the EphMRA AC and OMS ATC classifications for your product scope - [Indications - Diagnosis](https://success.openhealth.fr/en/articles/3568554-indications-diagnosis.md): View the drugs indicated for a given pathology and the pathologies associated with a selection of drugs - [MP4U](https://success.openhealth.fr/en/articles/3574188-mp4u.md): View all the classifications made available by OpenHealth Company - [What is the TVASI \(Sales, Purchases and Unknown Stocks Table\)](https://success.openhealth.fr/en/articles/5992494-what-is-the-tvasi-sales-purchases-and-unknown-stocks-table.md) - [IRI Products Classification](https://success.openhealth.fr/en/articles/3194597-iri-products-classification.md): Visualize the assignment of your products according to the classification owner IRI - [Removal of unsold products](https://success.openhealth.fr/en/articles/6135938-removal-of-unsold-products.md) - [STANDARD MARKET - Subscription](https://success.openhealth.fr/en/articles/3798203-standard-market-subscription.md): This article describes the interest and the limitations of a so-called "standard" Market - [I can't find my product](https://success.openhealth.fr/en/articles/5686002-i-can-t-find-my-product.md) - [Product code management](https://success.openhealth.fr/en/articles/5652478-product-code-management.md) - [Product Qualification: Brands](https://success.openhealth.fr/en/articles/5016985-product-qualification-brands.md) ### SUBSCRIPTIONS and MODULES - [Types of applications](https://success.openhealth.fr/en/articles/9489652-types-of-applications.md): Description of the three types of Consumer Health applications Mise à jour : 260105 - [Advanced analytical modules](https://success.openhealth.fr/en/articles/8374416-advanced-analytical-modules.md): Mise à jour : 250109\_CC - [Module "Subscription Traceability"](https://success.openhealth.fr/en/articles/3344127-module-subscription-traceability.md): All update dates and features for your application are available within this module. Mise à jour : 250109\_CC - [Markets & Selections](https://success.openhealth.fr/en/articles/8337016-markets-selections.md) - [Summary dashboard](https://success.openhealth.fr/en/articles/9246867-summary-dashboard.md) - [Analysis](https://success.openhealth.fr/en/articles/9352287-analysis.md) - [Extractor](https://success.openhealth.fr/en/articles/9246875-extractor.md) - [Growth Analysis](https://success.openhealth.fr/en/articles/3158856-growth-analysis.md): Determine the key factors in the evolution of your markets and those of your competitors - [Assortment Analysis](https://success.openhealth.fr/en/articles/3473736-assortment-analysis.md): Study the dynamism of products in a market - [Average Number of Products](https://success.openhealth.fr/en/articles/3161474-average-number-of-products.md): View the average number of products per point of sale, in pharmacies or in GSA drugstores - [Launch Tracking](https://success.openhealth.fr/en/articles/3158488-launch-tracking.md): Monitor product launches and their contribution to growth - [Can I extract the data from the HUB in ".csv" format?](https://success.openhealth.fr/en/articles/6007740-can-i-extract-the-data-from-the-hub-in-csv-format.md): Provide a dedicated sheet for the analysis of the crossing of two user selection universes - [Sales Concentration](https://success.openhealth.fr/en/articles/3095338-sales-concentration.md): Visualize the concentration of a market through the sales concentration curve and the GINI index - [Price Dispersion](https://success.openhealth.fr/en/articles/3159289-price-dispersion.md): Visualize the price dispersion of a product. Create your own pharmacy segments from the sale price - [Sell-out Margin Analysis](https://success.openhealth.fr/en/articles/3358322-sell-out-margin-analysis.md): Benchmark the attractiveness of your products for pharmacies - [Evolution of the sales margin](https://success.openhealth.fr/en/articles/3815561-evolution-of-the-sales-margin.md): Benchmark the attractiveness of your products for pharmacies - [Pharmacy Monitoring \(1/2\)](https://success.openhealth.fr/en/articles/3358248-pharmacy-monitoring-1-2.md): Follow the evolution of pharmacy traffic - [Pharmacy Monitoring \(2/2\)](https://success.openhealth.fr/en/articles/3810527-pharmacy-monitoring-2-2.md): Follow the evolution of pharmacy traffic - [Salesforce Performance](https://success.openhealth.fr/en/articles/3159230-salesforce-performance.md): Compare the sales performance of regions and sectors of a sales force - [Customer Relationship Management \(CRM\) ASSISTANT](https://success.openhealth.fr/en/articles/5953935-customer-relationship-management-crm-assistant.md) - [Point of Sales Tracking](https://success.openhealth.fr/en/articles/3778944-point-of-sales-tracking.md): Point of Sales Tracking - [On Demand Evolution](https://success.openhealth.fr/en/articles/6560184-on-demand-evolution.md) - [On Demand Analysis](https://success.openhealth.fr/en/articles/6127483-on-demand-analysis.md) - [On Demand Table](https://success.openhealth.fr/en/articles/3158751-on-demand-table.md): Visualize the main HUB indicators and their evolution over different types of periods - [Time-Series Analysis](https://success.openhealth.fr/en/articles/3635940-time-series-analysis.md): Break down your market into Season, Trend and Noise - [Forecast Analysis](https://success.openhealth.fr/en/articles/3636015-forecast-analysis.md): Estimate the future of your market - [Sectorial Forecast](https://success.openhealth.fr/en/articles/3689811-sectorial-forecast.md): Estimate your future sector sales - [Sell-in Visualization](https://success.openhealth.fr/en/articles/3559882-sell-in-visualization.md): Compare the evolution of your sell-in and sell-out sales - [Sell-in Analysis](https://success.openhealth.fr/en/articles/6188132-sell-in-analysis.md) - [Sell-in Matching](https://success.openhealth.fr/en/articles/6188090-sell-in-matching.md) - [Sell-in Evolution](https://success.openhealth.fr/en/articles/6191929-sell-in-evolution.md) - [Sell-in vs Sell-out Analysis](https://success.openhealth.fr/en/articles/6191947-sell-in-vs-sell-out-analysis.md) - [Sell-in vs Sell-out Evolution](https://success.openhealth.fr/en/articles/6191955-sell-in-vs-sell-out-evolution.md) - [Price evolution](https://success.openhealth.fr/en/articles/5056489-price-evolution.md): View your prices in evolution on all your available history - [Customize colors](https://success.openhealth.fr/en/articles/8407897-customize-colors.md) - [Product Export](https://success.openhealth.fr/en/articles/3583206-product-export.md): Export sheet specific to All Products and MP4U type Apps - [Market Analysis](https://success.openhealth.fr/en/articles/3121933-market-analysis.md): Analyze the performance of your market: by segment, brand, product and company - [Price Analysis](https://success.openhealth.fr/en/articles/3215190-price-analysis.md): View the prices on your market and analyze your positioning - [Sales Evolution](https://success.openhealth.fr/en/articles/3178323-sales-evolution.md): View your evolving sales over all your available history - [Summary of the dashboard](https://success.openhealth.fr/en/articles/4533213-summary-of-the-dashboard.md): View key indicators - [Market Share Evolution](https://success.openhealth.fr/en/articles/3193078-market-share-evolution.md): Visualize the evolution of sales and market share over long periods - [Sales Cross Table](https://success.openhealth.fr/en/articles/3193060-sales-cross-table.md): Create a simple pivot table - [TURNOVER / VOLUME \(CU\) Synthesis](https://success.openhealth.fr/en/articles/3193048-turnover-volume-cu-synthesis.md): Simultaneously view sales volumes and market value - [Sell Out Value Synthesis \(PHARMACIES / SUPERMARKETS\)](https://success.openhealth.fr/en/articles/3193020-sell-out-value-synthesis-pharmacies-supermarkets.md): Compare GSA drugstore and drugstore sales - [Market Share Analysis](https://success.openhealth.fr/en/articles/3193069-market-share-analysis.md): Analyze market shares over the last 12 months - [My Data Archive](https://success.openhealth.fr/en/articles/3193099-my-data-archive.md): Export a flat database to Excel - [Multiple Period Analysis](https://success.openhealth.fr/en/articles/3192953-multiple-period-analysis.md): Create a completely customized table - [My Query All Products](https://success.openhealth.fr/en/articles/4280353-my-query-all-products.md): View your segments and qualifying fields \(Ex: galenic, solar index, promotions ...\) as well as your Restriction - [Stock Evolution \(NEW\)](https://success.openhealth.fr/en/articles/3719256-stock-evolution-new.md): Visualize and analyze the evolution of stocks and their distribution - [Market Definition](https://success.openhealth.fr/en/articles/3158829-market-definition.md): Re-base your market on the 100 base of your choice - [RAW DATA Advanced Indicators](https://success.openhealth.fr/en/articles/3711095-raw-data-advanced-indicators.md): Recover your leading indicator data - [Advanced Indicators Evolution SMKT](https://success.openhealth.fr/en/articles/3193000-advanced-indicators-evolution-smkt.md): Monitor the performance of your laboratory through an analysis of the temporal evolution of your advanced statistical indicators. - [Advanced Indicators Analysis SMKT](https://success.openhealth.fr/en/articles/3192366-advanced-indicators-analysis-smkt.md): Break down the evolution of a GSA parapharmacy market into leading indicators - [Advanced Indicators Evolution](https://success.openhealth.fr/en/articles/3177853-advanced-indicators-evolution.md): Monitor the performance of your laboratory through an analysis of the temporal evolution of your advanced statistical indicators. - [Advanced Indicators Evolution Bio](https://success.openhealth.fr/en/articles/7051823-advanced-indicators-evolution-bio.md) - [National Advanced Indicators](https://success.openhealth.fr/en/articles/3364513-national-advanced-indicators.md): Break down the evolution of a market into leading indicators - [Stock Analysis](https://success.openhealth.fr/en/articles/3178015-stock-analysis.md): Interpret a stock level and its evolution - [Advanced Indicators Analysis Bio](https://success.openhealth.fr/en/articles/7051801-advanced-indicators-analysis-bio.md) - [Advanced Indicators Analysis](https://success.openhealth.fr/en/articles/3124439-advanced-indicators-analysis.md): Decompose the evolution of a market into leading indicators - [Cartography](https://success.openhealth.fr/en/articles/3192450-cartography.md): Analyze the commercial performance of the regions and sectors of your sales force - [Geographical Cross Table](https://success.openhealth.fr/en/articles/3192466-geographical-cross-table.md): Create a pivot table integrating your sectorization - [Geographical Sales Evolution](https://success.openhealth.fr/en/articles/3192482-geographical-sales-evolution.md): Visualize sales by sector over 36 months in a pivot table - [Sales Force Effectiveness](https://success.openhealth.fr/en/articles/5624011-sales-force-effectiveness.md) - [Custom weighting analysis](https://success.openhealth.fr/en/articles/5169317-custom-weighting-analysis.md): Custom Weight" where a selection is calculated on a Market totalizer - but where the "100% rebasing" dimensions are at choice. - [Network Analysis](https://success.openhealth.fr/en/articles/3894767-network-analysis.md): Network Analysis - [Custom Weighthting method evolution](https://success.openhealth.fr/en/articles/5169320-custom-weighthting-method-evolution.md): "Custom Weight" where a selection is calculated on a Market totalizer - but where the "100% rebasing" dimensions are at choice. - [SUMMARY KPIs](https://success.openhealth.fr/en/articles/3478199-summary-kpis.md): Visualize in a dynamic table your key indicators Volume declined to regions and sectors. - [Sales in Converted Units](https://success.openhealth.fr/en/articles/3192412-sales-in-converted-units.md): Use converted units to visualize your sales - [RAW DATA Stock Indicators](https://success.openhealth.fr/en/articles/3711142-raw-data-stock-indicators.md): Export your inventory data - [RAW DATA SMKT AIA](https://success.openhealth.fr/en/articles/3720960-raw-data-smkt-aia.md): Find your SMKT leading indicator data - [Stock Evolution](https://success.openhealth.fr/en/articles/3178277-stock-evolution.md): Visualize and analyze the evolution of stocks and their distribution - [Geographical Advanced Indicators](https://success.openhealth.fr/en/articles/3192508-geographical-advanced-indicators.md): View leading indicators by region or sector - [Products Performance](https://success.openhealth.fr/en/articles/3850331-products-performance.md): Compare the business performance of regions and product sectors - [Territorial Advanced Indicators](https://success.openhealth.fr/en/articles/3370879-territorial-advanced-indicators.md): Break down the evolution of a market into leading indicators - [Time-Series Sectorial Analysis](https://success.openhealth.fr/en/articles/3814974-time-series-sectorial-analysis.md): Break down your market into trend, season, noise - [Sales Analysis by Age & Gender](https://success.openhealth.fr/en/articles/3192701-sales-analysis-by-age-gender.md): Analyze sales by age & gender - [Sales Evolution by Pregnancy Status](https://success.openhealth.fr/en/articles/3192910-sales-evolution-by-pregnancy-status.md): Follow pharmacy sales on the population of pregnant women - [Sales Evolution by Age & Gender](https://success.openhealth.fr/en/articles/3192732-sales-evolution-by-age-gender.md): Visualize the evolution of sales by age & gender using the HUB's depth of history - [Requirements Order Evolution](https://success.openhealth.fr/en/articles/5790020-requirements-order-evolution.md) - [Evolution co-dispensations](https://success.openhealth.fr/en/articles/3192529-evolution-co-dispensations.md): Visualize and break down the evolution of co-dispensations in pharmacies - [Co-dispensations Analysis](https://success.openhealth.fr/en/articles/3192633-co-dispensations-analysis.md): View the Co-Dispensations in pharmacies associated with a selection of products from my market - [Sales per Channel & Prescriber](https://success.openhealth.fr/en/articles/3192751-sales-per-channel-prescriber.md): Visualize the influencers in your market - [AMO, AMC & RAC](https://success.openhealth.fr/en/articles/3192929-amo-amc-rac.md): View the three amounts of compulsory health insurance, complementary health insurance and out-of-pocket expenses - [Co-dispensations Dispersion](https://success.openhealth.fr/en/articles/3876946-co-dispensations-dispersion.md): Visualize the distribution of the number of products sold by dispensation - [Dispensation Dispersion Evolution](https://success.openhealth.fr/en/articles/3920070-dispensation-dispersion-evolution.md): Visualize the distribution of the number of products sold per dispensation over time - [GP Prescriptions by AGE & GENDER](https://success.openhealth.fr/en/articles/5789899-gp-prescriptions-by-age-gender.md) - [Prescriptions Order Analysis](https://success.openhealth.fr/en/articles/5322866-prescriptions-order-analysis.md) - [Basket Analysis](https://success.openhealth.fr/en/articles/3711049-basket-analysis.md): Description of the 'Basket Analysis' module - [Co-dispensing](https://success.openhealth.fr/en/articles/4738243-co-dispensing.md): Analyze the co-dispositions associated with a cohort - [Cohort qualification module](https://success.openhealth.fr/en/articles/3928090-cohort-qualification-module.md): Qualification of the patient cohort - [Treatment Status Module](https://success.openhealth.fr/en/articles/3928067-treatment-status-module.md): Analyze the dynamics of treatment monitoring - [Treatment Adherence module](https://success.openhealth.fr/en/articles/3928044-treatment-adherence-module.md): Analyze adherence to treatments - [Cohort definition](https://success.openhealth.fr/en/articles/3894703-cohort-definition.md): Define the scope of your analysis - [Co-treatments](https://success.openhealth.fr/en/articles/4163623-co-treatments.md): Define co-processing within your scope of analysis - [Visualization cohort](https://success.openhealth.fr/en/articles/3894721-visualization-cohort.md): View the patient profile of the defined cohort - [Definition of analysis criteria](https://success.openhealth.fr/en/articles/3894728-definition-of-analysis-criteria.md): Define the parameters for the analysis of your cohort - [Global cohort evolution](https://success.openhealth.fr/en/articles/3894747-global-cohort-evolution.md): Visualize the monthly evolution of the cohort - [Geographic distribution](https://success.openhealth.fr/en/articles/3894751-geographic-distribution.md): View the geographic distribution of patients in the defined cohort - [Cohort profile](https://success.openhealth.fr/en/articles/3894755-cohort-profile.md): Analyze the demographic profile of patients included in the cohort - [Treatment status break down](https://success.openhealth.fr/en/articles/3894764-treatment-status-break-down.md): Get an overview of the different types of treatment follow-up - [Treatment initiations](https://success.openhealth.fr/en/articles/3894778-treatment-initiations.md): Analyze the evolution of the number of treatment initiations - [Treatment re-starts](https://success.openhealth.fr/en/articles/3894788-treatment-re-starts.md): Analyze the evolution of the number of re-treatments - [New treatments](https://success.openhealth.fr/en/articles/3894804-new-treatments.md): Analyze the evolution of the number of initiations and resumes of treatment - [Treatment recurrencies](https://success.openhealth.fr/en/articles/3894812-treatment-recurrencies.md): Analyze patients on treatment - [Treatment switch balance](https://success.openhealth.fr/en/articles/3894821-treatment-switch-balance.md): Analyze the balance of treatment changes by treatment - [Treatment switch gains](https://success.openhealth.fr/en/articles/3894830-treatment-switch-gains.md): Analyze the beneficiaries of treatment switches - [Treatment switch losses](https://success.openhealth.fr/en/articles/3894843-treatment-switch-losses.md): Analyze by treatment the losers of the treatment switches - [Switch gain origins](https://success.openhealth.fr/en/articles/3894857-switch-gain-origins.md): Analyze the origin of the switch for a given treatment - [Switch loss destination](https://success.openhealth.fr/en/articles/3894864-switch-loss-destination.md): Analyze the destination of the switch for a given treatment - [Drop-outs](https://success.openhealth.fr/en/articles/3894874-drop-outs.md): Analyze treatment stops - [KPI Summary](https://success.openhealth.fr/en/articles/4229969-kpi-summary.md): Summary of the different types of treatment monitoring - [Treatment persistence](https://success.openhealth.fr/en/articles/3894883-treatment-persistence.md): Analyze the duration of treatments - [Compliance](https://success.openhealth.fr/en/articles/3894884-compliance.md): Analyze the quantities delivered - [What is the regularity criterion?](https://success.openhealth.fr/en/articles/3325816-what-is-the-regularity-criterion.md): Definition of the concept of regularity criterion - [Death - Cartography](https://success.openhealth.fr/en/articles/3863677-death-cartography.md): Analyze the geographic distribution of deaths - [Death count shift](https://success.openhealth.fr/en/articles/3863573-death-count-shift.md): Evaluate the relevance of your data - [Death - Analysis by AGE & GENDER](https://success.openhealth.fr/en/articles/3863808-death-analysis-by-age-gender.md): Analyze the structure of deaths - [Death - Evolution by AGE & GENDER](https://success.openhealth.fr/en/articles/3863939-death-evolution-by-age-gender.md): Analyze the evolution of the structure of deaths - [Death - Evolution](https://success.openhealth.fr/en/articles/3864065-death-evolution.md): Visualize the evolution of deaths - [Death - Evolution Comparison](https://success.openhealth.fr/en/articles/3864073-death-evolution-comparison.md): Compare the evolution of deaths compared to previous years - [Pharmacy Monitoring CA](https://success.openhealth.fr/en/articles/4634768-pharmacy-monitoring-ca.md): Describe the traffic according to the size of the pharmacies - [Traffic Analysis \(Beta test\)](https://success.openhealth.fr/en/articles/6848401-traffic-analysis-beta-test.md) - [Pharmacy Monitoring Details](https://success.openhealth.fr/en/articles/4527868-pharmacy-monitoring-details.md): Analyze dispensary traffic by type of pharmacy - [Traffic Evolution \(Beta test\)](https://success.openhealth.fr/en/articles/6848016-traffic-evolution-beta-test.md) - [Pharmacy Monitoring Cartography](https://success.openhealth.fr/en/articles/4527811-pharmacy-monitoring-cartography.md): Analyze the dispensary traffic in mainland France - [Pharmacy Monitoring Details](https://success.openhealth.fr/en/articles/4262306-pharmacy-monitoring-details.md): Discriminate the detail of sales by type of dispensary - [Pharmacy Monitoring Analysis](https://success.openhealth.fr/en/articles/3839223-pharmacy-monitoring-analysis.md): Follow the evolution of pharmacy traffic - [Pharmacy Monitoring Evolution](https://success.openhealth.fr/en/articles/3827973-pharmacy-monitoring-evolution.md): Study the evolution of dispensary traffic - [Decomposition Traffic](https://success.openhealth.fr/en/articles/3826074-decomposition-traffic.md): Observe the components of season, trend and residue - [Traffic study](https://success.openhealth.fr/en/articles/3809042-traffic-study.md): Analyze pharmacy traffic - [Executive Summary - PIEX](https://success.openhealth.fr/en/articles/5203335-executive-summary-piex.md) - [Purchasing](https://success.openhealth.fr/en/articles/4605110-purchasing.md): Track your purchases and their receipts - [My Query - PIEX](https://success.openhealth.fr/en/articles/4210627-my-query-piex.md): Make selections on your data - [Sales Evolution - PIEX](https://success.openhealth.fr/en/articles/4210655-sales-evolution-piex.md): View the evolution of your activity on the available history - [Sales Analysis - PIEX](https://success.openhealth.fr/en/articles/4210650-sales-analysis-piex.md): Sales Analysis - PIEX - [Order details - PIEX](https://success.openhealth.fr/en/articles/4210659-order-details-piex.md): View and track a sales order - [Stock overview - PIEX](https://success.openhealth.fr/en/articles/4210672-stock-overview-piex.md): Visualize the variations of your stocks - [My Data Archive - PIEX](https://success.openhealth.fr/en/articles/4210694-my-data-archive-piex.md): Export a flat database to Excel - [EURAPHARMA- PIEX](https://success.openhealth.fr/en/articles/4366306-eurapharma-piex.md): Visualize the evolution of EURAPHARMA's activity - [Matching product](https://success.openhealth.fr/en/articles/4366320-matching-product.md): Correspondence between the designations of the PIEX and EURAPHARMA products - [CLI My File \(1/5\)](https://success.openhealth.fr/en/articles/4626422-cli-my-file-1-5.md): CLI My File \(1/5\) - [CLI\_File Counts \(2/5\)](https://success.openhealth.fr/en/articles/4626421-cli_file-counts-2-5.md): CLI\_File Counts \(2/5\) - [CLI\_File Code Matching with OHC repository](https://success.openhealth.fr/en/articles/4626419-cli_file-code-matching-with-ohc-repository.md): CLI\_FIL Code Matching with OHC Repository - [Sell-Out Export \(4/5\)](https://success.openhealth.fr/en/articles/4626414-sell-out-export-4-5.md): Sell-out Export \(4/5\) ### PERSONALIZED OPTIONS - [Non-hierarchical product qualifiers](https://success.openhealth.fr/en/articles/4036045-non-hierarchical-product-qualifiers.md): Add details on the qualification of your products - [What is the maximum age of the HUB data?](https://success.openhealth.fr/en/articles/3195251-what-is-the-maximum-age-of-the-hub-data.md): Last data available - [Customer Type](https://success.openhealth.fr/en/articles/4197147-customer-type.md): Custom option Customer Type - [Session Access](https://success.openhealth.fr/en/articles/4036458-session-access.md): Limit the viewing of your employees - [Customised cycle](https://success.openhealth.fr/en/articles/4036444-customised-cycle.md): Analyze your data over personalized time periods - [Fiscal Year](https://success.openhealth.fr/en/articles/4036169-fiscal-year.md): Define your fiscal year - [Day button](https://success.openhealth.fr/en/articles/4036159-day-button.md): Visualize your data with finer granularity - [Week button](https://success.openhealth.fr/en/articles/4036111-week-button.md): Visualize your data with finer granularity - [Exchange rate](https://success.openhealth.fr/en/articles/8329594-exchange-rate.md): Find out how the exchange rate is calculated on your platform - [SMKT period calendar](https://success.openhealth.fr/en/articles/4036549-smkt-period-calendar.md): Use a GSA calendar - [Restrict perimeter](https://success.openhealth.fr/en/articles/4560699-restrict-perimeter.md): Selecting one GTIN list in My Query from an .xlsx file - [Restrict perimeter \(code 7\)](https://success.openhealth.fr/en/articles/4560791-restrict-perimeter-code-7.md): Selection of one list of \[TECHNICAL CODE 2\] in My Query from an .xlsx file - [Market flagg](https://success.openhealth.fr/en/articles/4560797-market-flagg.md): Selecting one GTIN list in My Query from a market definition contained in an .xlsx file - [Targeting / Definition of a Customer Type](https://success.openhealth.fr/en/articles/3777788-targeting-definition-of-a-customer-type.md): Targeting \(Customer Type\) ### HUB INDICATORS - [Glossary of HUB indicators](https://success.openhealth.fr/en/articles/5194247-glossary-of-hub-indicators.md): List of HUB indicator abbreviations and their definitions Mise à jour : 260105\_CC - [Volume \(Sales in quantity for Consumer Unit\)](https://success.openhealth.fr/en/articles/3194314-volume-sales-in-quantity-for-consumer-unit.md): Sales Quantities - [Sales Values](https://success.openhealth.fr/en/articles/3074854-sales-values.md): Indicator specification Sales Values - [N MS](https://success.openhealth.fr/en/articles/3194475-n-ms.md): Definition of the 'N MS' measure - [N MS Evol](https://success.openhealth.fr/en/articles/5634266-n-ms-evol.md) - [N MS Delta](https://success.openhealth.fr/en/articles/3194469-n-ms-delta.md): Definition of the 'N MS Delta' measure - [Poids Vol \(CA\) par modalité / Custom Weight Vol \(To\)](https://success.openhealth.fr/en/articles/9292839-poids-vol-ca-par-modalite-custom-weight-vol-to.md) - [Value sales based on manufacturer's price excluding VAT \(Turnover PF excluding VAT\) - Morocco](https://success.openhealth.fr/en/articles/7508513-value-sales-based-on-manufacturer-s-price-excluding-vat-turnover-pf-excluding-vat-morocco.md) - [N Growth CTR](https://success.openhealth.fr/en/articles/3194466-n-growth-ctr.md): Definition and calculation formula of the 'N Growth CTR' measure - [In deal](https://success.openhealth.fr/en/articles/6201859-in-deal.md) - [Weight Crossed Volume](https://success.openhealth.fr/en/articles/6066324-weight-crossed-volume.md) - [Crossed Weight Turnover](https://success.openhealth.fr/en/articles/6066273-crossed-weight-turnover.md) - [N Growth CTR adjusted](https://success.openhealth.fr/en/articles/3205376-n-growth-ctr-adjusted.md): Definition and calculation formula of the 'N Growth CTR A' measure - [Weight of the source](https://success.openhealth.fr/en/articles/5151525-weight-of-the-source.md): Estimate the share of each of your sources - [Actual Average Sales Price \(AASP\)](https://success.openhealth.fr/en/articles/3194302-actual-average-sales-price-aasp.md): AASP : Actual Average Sales Price - [Weighted Average Sales Price](https://success.openhealth.fr/en/articles/3194292-weighted-average-sales-price.md): WASP : Weighted Average Sales Price - [Price effect](https://success.openhealth.fr/en/articles/8426443-price-effect.md) - [Number of Pharmacies Selling](https://success.openhealth.fr/en/articles/3719566-number-of-pharmacies-selling.md) - [Selling Digital Distribution](https://success.openhealth.fr/en/articles/3194321-selling-digital-distribution.md): Numeric Distribution - [Global Selling Digital Distribution](https://success.openhealth.fr/en/articles/3194320-global-selling-digital-distribution.md): Global Numeric Distribution - [Rebased Selling Digital Distribution](https://success.openhealth.fr/en/articles/4045636-rebased-selling-digital-distribution.md): Numeric Distribution Rebased - [Global Rebased Selling Digital Distribution](https://success.openhealth.fr/en/articles/4045725-global-rebased-selling-digital-distribution.md): Global Numeric Distribution Rebased - [Customised rebased digital sales distribution](https://success.openhealth.fr/en/articles/6830813-customised-rebased-digital-sales-distribution.md) - [Weighted Distribution](https://success.openhealth.fr/en/articles/3194323-weighted-distribution.md): Weighted Distribution - [Global Selling Value Distribution](https://success.openhealth.fr/en/articles/3194316-global-selling-value-distribution.md): Global selling value distribution - [Rebase selling value distribution](https://success.openhealth.fr/en/articles/3194501-rebase-selling-value-distribution.md): Rebased DVV - [Global rebased selling value distribution](https://success.openhealth.fr/en/articles/4200619-global-rebased-selling-value-distribution.md): Global rebased DVV - [Customised rebased sales value distribution](https://success.openhealth.fr/en/articles/6834423-customised-rebased-sales-value-distribution.md) - [Digital Selling Distribution SMKT](https://success.openhealth.fr/en/articles/3365043-digital-selling-distribution-smkt.md): Digital Selling Distribution SMKT \(SMK Numeric Distribution\) - [Global SMKT Selling Digital Distribution](https://success.openhealth.fr/en/articles/4298341-global-smkt-selling-digital-distribution.md): SMKT Global Numeric Distribution \(SMKT Global Numeric Distribution\) - [Digital Selling Distribution SMKT Rebased](https://success.openhealth.fr/en/articles/4298197-digital-selling-distribution-smkt-rebased.md): SMKT Digital Distribution Rebased \(SMKT Numeric Distribution Rebased\) - [Global Rebased SMKT Selling Digital Distribution](https://success.openhealth.fr/en/articles/4319783-global-rebased-smkt-selling-digital-distribution.md): Selling Digital Distribution SMKT Rebasée Globale \(SMKT Global Numeric Distribution Rebased\) - [SMKT Selling Value Distribution](https://success.openhealth.fr/en/articles/3365478-smkt-selling-value-distribution.md): SMKT Selling Value Distribution \(SMKT Weighted Distribution\) - [Recalculated Global SMKT Selling Digital Distribution](https://success.openhealth.fr/en/articles/4298373-recalculated-global-smkt-selling-digital-distribution.md): Selling Digital Distribution SMKT Global Numeric Recalculated \(SMKT Global Numeric Distribution Recalculated\) - [Digital Distribution Selling SMKT Rebased Recalculated](https://success.openhealth.fr/en/articles/4298303-digital-distribution-selling-smkt-rebased-recalculated.md): SMKT Numeric Distribution Recalculated Rebased - [Adjusted SMKT Selling Digital Distribution](https://success.openhealth.fr/en/articles/3369386-adjusted-smkt-selling-digital-distribution.md): Adjusted Numeric Distribution SMKT - [Recalculated SMKT Digital Sales Distribution](https://success.openhealth.fr/en/articles/4298209-recalculated-smkt-digital-sales-distribution.md): SMKT Numeric Distribution Recalculated \(SMKT Numeric Distribution Recalculated\) - [Adjusted SMKT selling value distribution](https://success.openhealth.fr/en/articles/3369397-adjusted-smkt-selling-value-distribution.md): Adjusted Weighted Distribution SMKT - [Organic Digital Sales Distribution](https://success.openhealth.fr/en/articles/7052424-organic-digital-sales-distribution.md) - [Turnover of Selling Pharmacies \(TSP\)](https://success.openhealth.fr/en/articles/6096534-turnover-of-selling-pharmacies-tsp.md) - [Estimating your holder's PDM](https://success.openhealth.fr/en/articles/4214883-estimating-your-holder-s-pdm.md): Estimate your market share with your customers - [More pharmacies](https://success.openhealth.fr/en/articles/8426451-more-pharmacies.md) - [Loss of pharmacies](https://success.openhealth.fr/en/articles/8426460-loss-of-pharmacies.md) - [Multichannel Digital Sales and Distribution](https://success.openhealth.fr/en/articles/9293487-multichannel-digital-sales-and-distribution.md) - [Cumulative Selling Digital Distribution \(PHARMA\)](https://success.openhealth.fr/en/articles/9330571-cumulative-selling-digital-distribution-pharma.md) - [Average Monthly Sales](https://success.openhealth.fr/en/articles/3194303-average-monthly-sales.md): Average Monthly Sales Mise à jour : 260130\_CC - [Adjusted Monthly Average Sales](https://success.openhealth.fr/en/articles/3194290-adjusted-monthly-average-sales.md): Adjusted Average Monthly Sales Mise à jour : 260130\_CC - [Monthly Average Sales Value](https://success.openhealth.fr/en/articles/4535404-monthly-average-sales-value.md): VMM CA - [AMS To A: Average Monthly Sales Value Adjusted](https://success.openhealth.fr/en/articles/6028256-ams-to-a-average-monthly-sales-value-adjusted.md) - [Average sales](https://success.openhealth.fr/en/articles/3563716-average-sales.md): Average Sales - [SMKT Average Sales](https://success.openhealth.fr/en/articles/3365496-smkt-average-sales.md): SMKT Average Sales - [Adjusted SMKT Average Sales](https://success.openhealth.fr/en/articles/3369340-adjusted-smkt-average-sales.md): Adjusted SMKT Average Sales - [Average monthly organic sales](https://success.openhealth.fr/en/articles/7052551-average-monthly-organic-sales.md) - [Average monthly sales Organic value](https://success.openhealth.fr/en/articles/7052573-average-monthly-sales-organic-value.md) - [Stock](https://success.openhealth.fr/en/articles/3194332-stock.md): Definition and availability of stock data in the HUB, via SMA ADVANCED applications: Subscription Sales & Marketing Advanced - [Average stock](https://success.openhealth.fr/en/articles/3194336-average-stock.md): Average stock - [Share of Stock](https://success.openhealth.fr/en/articles/3194334-share-of-stock.md): Share of Stock - [Commercial Pressure Index](https://success.openhealth.fr/en/articles/3194335-commercial-pressure-index.md): Commercial Pressure Index - [Stock Transformation Rate](https://success.openhealth.fr/en/articles/3194344-stock-transformation-rate.md): Stock transformation rate - [Duration of Supply](https://success.openhealth.fr/en/articles/3194337-duration-of-supply.md): Supply Duration - [Number of Stockist Pharmacies](https://success.openhealth.fr/en/articles/3194338-number-of-stockist-pharmacies.md): Number of Stockist Pharmacies - [Stockist Digital Distribution](https://success.openhealth.fr/en/articles/3194339-stockist-digital-distribution.md): Stockist Distribution \(ND Stock\) - [Digital distribution stockist rebased](https://success.openhealth.fr/en/articles/4045743-digital-distribution-stockist-rebased.md): Stock Numeric Distribution Rebased - [Global rebased digital stockist distribution](https://success.openhealth.fr/en/articles/4045753-global-rebased-digital-stockist-distribution.md): Global rebased stock numeric distribution - [Weighted distribution Stock \(WD Stock or DVS\)](https://success.openhealth.fr/en/articles/3194342-weighted-distribution-stock-wd-stock-or-dvs.md): Stockist Value Distribution \(Weighted Stock Distribution: WD Stock\) - [Distribution of Rebased Stock Value](https://success.openhealth.fr/en/articles/3194505-distribution-of-rebased-stock-value.md): Rebase DVS - [Smoothed Digital Stockist Distribution](https://success.openhealth.fr/en/articles/5141830-smoothed-digital-stockist-distribution.md) - [Numerical distribution Smoothed rebased stockist](https://success.openhealth.fr/en/articles/5142162-numerical-distribution-smoothed-rebased-stockist.md): Smoothed Stock Numeric Distribution Rebased - [Distribution Smoothed stock value](https://success.openhealth.fr/en/articles/5203640-distribution-smoothed-stock-value.md) - [Distribution Smoothed rebased stock value](https://success.openhealth.fr/en/articles/5203701-distribution-smoothed-rebased-stock-value.md) - [Margin](https://success.openhealth.fr/en/articles/3507716-margin.md): Margin - [Margin rate](https://success.openhealth.fr/en/articles/3507767-margin-rate.md): Margin rate - [Manufacturer price excluding tax \(PFHT\)](https://success.openhealth.fr/en/articles/4557500-manufacturer-price-excluding-tax-pfht.md): PFHT - [Sell-in - Analyzes of your customer base](https://success.openhealth.fr/en/articles/3846225-sell-in-analyzes-of-your-customer-base.md): Loyalty indicators: characteristics of your customer base and its evolution - [Sell-in - Atypical pharmacies](https://success.openhealth.fr/en/articles/3848791-sell-in-atypical-pharmacies.md): Measures to detect atypisms - [Evolution ratio](https://success.openhealth.fr/en/articles/3194287-evolution-ratio.md): Evolution ratio - [Penetration ratio](https://success.openhealth.fr/en/articles/3194286-penetration-ratio.md): Penetration ratio - [Breadth of product range](https://success.openhealth.fr/en/articles/3369425-breadth-of-product-range.md): Product assortment width - [Renewal of the assortment](https://success.openhealth.fr/en/articles/3369545-renewal-of-the-assortment.md): Renewal of the assortment - [Innovation in the range](https://success.openhealth.fr/en/articles/3369468-innovation-in-the-range.md): Innovation in the assortment - [Attrition from the range](https://success.openhealth.fr/en/articles/3369457-attrition-from-the-range.md): Attrition of the assortment - [Assortment attrition rate](https://success.openhealth.fr/en/articles/3369485-assortment-attrition-rate.md): Assortment attrition rate - [Rate of innovation of the assortment](https://success.openhealth.fr/en/articles/3369541-rate-of-innovation-of-the-assortment.md): Range innovation rate - [Share of selling offer](https://success.openhealth.fr/en/articles/3369040-share-of-selling-offer.md): Share of selling offer - [Number of Selected Products](https://success.openhealth.fr/en/articles/3511502-number-of-selected-products.md): This is the number of products selected by their GTIN-13 digits code. - [Average number of products](https://success.openhealth.fr/en/articles/3194284-average-number-of-products.md): Average number of products - [Renewal rate of the assortment](https://success.openhealth.fr/en/articles/3369561-renewal-rate-of-the-assortment.md): Range renewal rate - [Number of products](https://success.openhealth.fr/en/articles/6312686-number-of-products.md) - [Amounts spent per act](https://success.openhealth.fr/en/articles/3447792-amounts-spent-per-act.md): Article relating to the indicator 'Amounts spent per act' - [Breakdown of amounts spent by type of buyer](https://success.openhealth.fr/en/articles/3447801-breakdown-of-amounts-spent-by-type-of-buyer.md): Article relating to the indicator 'Breakdown of sums spent by type of buyer' - [Consumption index](https://success.openhealth.fr/en/articles/3432701-consumption-index.md): Definition of the 'Consumption index' indicator - [Sales share](https://success.openhealth.fr/en/articles/3432664-sales-share.md): Definition of the 'Sales share' indicator - [Value loyalty rate](https://success.openhealth.fr/en/articles/3432695-value-loyalty-rate.md): Definition of the indicator 'Value loyalty rate' - [Absolute penetration](https://success.openhealth.fr/en/articles/3432556-absolute-penetration.md): Article relating to the indicator 'Absolute penetration' - [Share of turnover](https://success.openhealth.fr/en/articles/3432655-share-of-turnover.md): Definition of the indicator 'Share of turnover' - [p-value](https://success.openhealth.fr/en/articles/5781702-p-value.md) - [Principal Component Analysis](https://success.openhealth.fr/en/articles/4231028-principal-component-analysis.md): ACP - [Negative Predictive Value](https://success.openhealth.fr/en/articles/4134220-negative-predictive-value.md): Negative predictive value - [Positive predictive value](https://success.openhealth.fr/en/articles/4134166-positive-predictive-value.md): Positive predictive value - [Independence test](https://success.openhealth.fr/en/articles/4128369-independence-test.md): Check if two variables are related to each other - [Study of time series](https://success.openhealth.fr/en/articles/3633991-study-of-time-series.md): Seasonality, trend and prediction: what you need to know - [Seasonal variance rate](https://success.openhealth.fr/en/articles/3653790-seasonal-variance-rate.md): Measures the share of variance in a time series - [Sensitivity and specificity of a test](https://success.openhealth.fr/en/articles/3928135-sensitivity-and-specificity-of-a-test.md): Understand the concepts to analyze the effectiveness of a test - [Trend variance rate](https://success.openhealth.fr/en/articles/3653847-trend-variance-rate.md): Measures the share of the trend component in a time series - [Residual variance rate](https://success.openhealth.fr/en/articles/3653851-residual-variance-rate.md): Measures the share of the residual component of a time series - [Coefficient of determination](https://success.openhealth.fr/en/articles/3654093-coefficient-of-determination.md): Evaluate the quality of the chosen model - [Coefficient of variation](https://success.openhealth.fr/en/articles/3653915-coefficient-of-variation.md): Indicator to choose your decomposition model - [Variance of a time series](https://success.openhealth.fr/en/articles/3653855-variance-of-a-time-series.md): Measure the dispersion of a series - [Sales concentration](https://success.openhealth.fr/en/articles/3395856-sales-concentration.md): Sales concentration - [Gini index](https://success.openhealth.fr/en/articles/3395323-gini-index.md): Gini index - [Population](https://success.openhealth.fr/en/articles/4396779-population.md): Population - [Evolution of the number of deaths](https://success.openhealth.fr/en/articles/4396765-evolution-of-the-number-of-deaths.md): Evolution of the number of deaths - [Sex ratio](https://success.openhealth.fr/en/articles/3812167-sex-ratio.md): Sex ratio - [Population - Average age](https://success.openhealth.fr/en/articles/3812180-population-average-age.md): Population - Average age - [Population - Median age](https://success.openhealth.fr/en/articles/3812198-population-median-age.md): Population - Median age - [Population - Age 1st quartile](https://success.openhealth.fr/en/articles/3812218-population-age-1st-quartile.md): Population - Age 1st quartile - [Population - Age 3rd quartile](https://success.openhealth.fr/en/articles/3812227-population-age-3rd-quartile.md): Population - Age 3rd quartile - [Share of selection in the total population of the territory](https://success.openhealth.fr/en/articles/3812233-share-of-selection-in-the-total-population-of-the-territory.md): Share of selection in the total population of the territory - [Mortality rate](https://success.openhealth.fr/en/articles/3947946-mortality-rate.md): Mortality rate - [Case fatality rate](https://success.openhealth.fr/en/articles/3948084-case-fatality-rate.md): Case fatality rate - [Women of childbearing age](https://success.openhealth.fr/en/articles/4172859-women-of-childbearing-age.md): Women of childbearing age - [Share of selection in total deaths in the territory](https://success.openhealth.fr/en/articles/3863734-share-of-selection-in-total-deaths-in-the-territory.md): Share of selection in total deaths in the territory - [Modelling the number of missing deaths](https://success.openhealth.fr/en/articles/3895572-modelling-the-number-of-missing-deaths.md): Anticipate the number of deaths at time t - [Estimated sales in prescription initiation](https://success.openhealth.fr/en/articles/5323282-estimated-sales-in-prescription-initiation.md) - [Evolution by age and pregnancy status](https://success.openhealth.fr/en/articles/6820051-evolution-by-age-and-pregnancy-status.md) - [Co-Dispensation Products Ratio](https://success.openhealth.fr/en/articles/7892010-co-dispensation-products-ratio.md) - [Estimated prescription refill sales](https://success.openhealth.fr/en/articles/5323209-estimated-prescription-refill-sales.md) - [Weight of prescription refill sales](https://success.openhealth.fr/en/articles/5323198-weight-of-prescription-refill-sales.md) - [Weight of sales in prescription initiation](https://success.openhealth.fr/en/articles/5323086-weight-of-sales-in-prescription-initiation.md) - [Number of Co-dispensations](https://success.openhealth.fr/en/articles/3194351-number-of-co-dispensations.md): Number of Co-dispensations - [Number of dispensations](https://success.openhealth.fr/en/articles/3194348-number-of-dispensations.md): Number of dispensations - [Average number of dispensations per insured person](https://success.openhealth.fr/en/articles/3369626-average-number-of-dispensations-per-insured-person.md): Average number of dispensations per insured person - [Observance](https://success.openhealth.fr/en/articles/3411996-observance.md): Medication Possession Rate \(MPR\) - [Persistence rate](https://success.openhealth.fr/en/articles/3369684-persistence-rate.md): Persistence rate - [Therapeutic adherence](https://success.openhealth.fr/en/articles/3412091-therapeutic-adherence.md): Therapeutic adherence - [Average daily dosage per insured person](https://success.openhealth.fr/en/articles/4153587-average-daily-dosage-per-insured-person.md): Average daily dosage per insured person - [Number of dispensations submitted for reimbursement](https://success.openhealth.fr/en/articles/3370942-number-of-dispensations-submitted-for-reimbursement.md): Number of dispensations presented for reimbursement - [Number of dispensations not presented for reimbursement](https://success.openhealth.fr/en/articles/3370920-number-of-dispensations-not-presented-for-reimbursement.md): Number of dispensations presented for reimbursement - [Reimbursed value sales covered by compulsory health insurance](https://success.openhealth.fr/en/articles/3371699-reimbursed-value-sales-covered-by-compulsory-health-insurance.md): Sales of redeemed values - [Sales values reimbursed by supplementary health insurance](https://success.openhealth.fr/en/articles/3371830-sales-values-reimbursed-by-supplementary-health-insurance.md): Sales of redeemed values - [Sales of outstanding values](https://success.openhealth.fr/en/articles/3371842-sales-of-outstanding-values.md): Sales of outstanding values - [Prevalence](https://success.openhealth.fr/en/articles/3947955-prevalence.md): Prevalence rate - [Average number of GTINs per dispensation](https://success.openhealth.fr/en/articles/3396154-average-number-of-gtins-per-dispensation.md): Average number of GTINs per dispensation - [Average volume per dispensation](https://success.openhealth.fr/en/articles/3396196-average-volume-per-dispensation.md): Average volume per dispensing - [Average turnover per dispensation](https://success.openhealth.fr/en/articles/3396208-average-turnover-per-dispensation.md): Average turnover per dispensation - [Active ingredient dosage per box](https://success.openhealth.fr/en/articles/3675409-active-ingredient-dosage-per-box.md): Active principle dosage per box - [DDD per box](https://success.openhealth.fr/en/articles/3675446-ddd-per-box.md): Define Daily Dose per box - [Volume in basic units](https://success.openhealth.fr/en/articles/3675520-volume-in-basic-units.md): Volume in base units - [Volume in active principle](https://success.openhealth.fr/en/articles/3675539-volume-in-active-principle.md): Volume in active principle - [DDJ per 1,000 inhabitants](https://success.openhealth.fr/en/articles/3675667-ddj-per-1-000-inhabitants.md): Daily Defined Dose per 1,000 inhabitants - [Volume in average UA per insured person](https://success.openhealth.fr/en/articles/3675761-volume-in-average-ua-per-insured-person.md): Volume in average consumer units per insured person - [Volume in average UB per insured person](https://success.openhealth.fr/en/articles/3675814-volume-in-average-ub-per-insured-person.md): Volume in average base units per insured person - [Volume in average active principle per insured person](https://success.openhealth.fr/en/articles/3675824-volume-in-average-active-principle-per-insured-person.md): Volume in average active principle per insured person - [Observed mean duration of treatment](https://success.openhealth.fr/en/articles/3675841-observed-mean-duration-of-treatment.md): Observed mean duration of treatment - [Immunization coverage](https://success.openhealth.fr/en/articles/3822264-immunization-coverage.md): Immunization coverage - [Patients included](https://success.openhealth.fr/en/articles/3886665-patients-included.md): Number of patients included in the cohort - [Differences between MPR and PDC](https://success.openhealth.fr/en/articles/3722666-differences-between-mpr-and-pdc.md): MPR \(Medication Possession Rate\) vs. PDC \(Proportion of Days Covered\) - [Average duration of treatment](https://success.openhealth.fr/en/articles/3920967-average-duration-of-treatment.md): Measure the average treatment time at the end of the analysis period - [Average renewal time](https://success.openhealth.fr/en/articles/3921067-average-renewal-time.md): Measure the average time between treatment renewals - [Treatment initiation](https://success.openhealth.fr/en/articles/3848844-treatment-initiation.md): Treatment initiation - [Treatment renewals](https://success.openhealth.fr/en/articles/3885469-treatment-renewals.md): Renewal of treatment - [Treatment resumes](https://success.openhealth.fr/en/articles/3885608-treatment-resumes.md): Resumption of treatment - [New treatments](https://success.openhealth.fr/en/articles/3885297-new-treatments.md): Initiation and resumption of treatment - [Treatment switch](https://success.openhealth.fr/en/articles/3848886-treatment-switch.md): Treatment switch - [Treatment stops](https://success.openhealth.fr/en/articles/3885426-treatment-stops.md): Treatment stops - [Drop-off](https://success.openhealth.fr/en/articles/3885387-drop-off.md): Drop-off - [Traceability insert](https://success.openhealth.fr/en/articles/4355163-traceability-insert.md): Traceability - [Stopped and then restarted](https://success.openhealth.fr/en/articles/8429189-stopped-and-then-restarted.md) - [Dispensing share](https://success.openhealth.fr/en/articles/3624820-dispensing-share.md): Dispensing share - [Monitoring of relevant dispensations](https://success.openhealth.fr/en/articles/3804193-monitoring-of-relevant-dispensations.md): Follow the evolution of traffic in pharmacies of relevant dispensations - [Disintegration rate](https://success.openhealth.fr/en/articles/4850138-disintegration-rate.md): Estimate the remaining quantity of an element - [Kinetics of a reaction](https://success.openhealth.fr/en/articles/4850629-kinetics-of-a-reaction.md): Measuring the speed of a chemical reaction - [Half-life time](https://success.openhealth.fr/en/articles/4849710-half-life-time.md): Metric of the lifetime of an element - [Stock coverage rate](https://success.openhealth.fr/en/articles/4210714-stock-coverage-rate.md): Stock coverage rate - [Time periods](https://success.openhealth.fr/en/articles/3194479-time-periods.md): Time periods Mise à jour : 260107 - [Change the definition of a fiscal year](https://success.openhealth.fr/en/articles/3321750-change-the-definition-of-a-fiscal-year.md): The HUB allows you to set your fiscal years - [Management of weekly comparisons](https://success.openhealth.fr/en/articles/3835180-management-of-weekly-comparisons.md): Analytical impacts of the days studied - [SMKT Calendar](https://success.openhealth.fr/en/articles/3175583-smkt-calendar.md): The SMKT calendar is also called the GSA Parapharmacy Calendar. - [N](https://success.openhealth.fr/en/articles/3194484-n.md): Definition of measure 'N' - [N Evol](https://success.openhealth.fr/en/articles/3194461-n-evol.md): Definition and calculation formula of the 'N Evol' measure - [N Trend](https://success.openhealth.fr/en/articles/3194485-n-trend.md): Definition of the 'N Trend' measure ### IAS - Indicateurs Avancés Sanitaires - [IAS\(r\) Allergy](https://success.openhealth.fr/en/articles/7339151-ias-r-allergy.md) - [IAS\(r\) Poux](https://success.openhealth.fr/en/articles/7339168-ias-r-poux.md) - [IAS\(r\) gastroenteritis](https://success.openhealth.fr/en/articles/7339181-ias-r-gastroenteritis.md) - [IAS \(r\) Respiratory Syndromes](https://success.openhealth.fr/en/articles/3815345-ias-r-respiratory-syndromes.md): Introduction related to IAS \(r\) Respiratory Syndromes - [IAS\(r\) Influenza-like illness](https://success.openhealth.fr/en/articles/7266711-ias-r-influenza-like-illness.md) ### Marketing Direct - [OpenHealth Emailing Solution](https://success.openhealth.fr/en/articles/7055261-openhealth-emailing-solution.md) - [Requirements for creating an email campaign](https://success.openhealth.fr/en/articles/6282113-requirements-for-creating-an-email-campaign.md) - [Tracking Report and Benchmarks](https://success.openhealth.fr/en/articles/6302721-tracking-report-and-benchmarks.md) - [Glossary for email campaigns](https://success.openhealth.fr/en/articles/6282099-glossary-for-email-campaigns.md) ### PSAD - [Analysis - NATIONAL](https://success.openhealth.fr/en/articles/3376262-analysis-national.md): Analyze the performance of the Home Health Providers \(PSAD\) market: by area, activity, sub-activity, segment, LPP act - [Volume / Turnover - NATIONAL](https://success.openhealth.fr/en/articles/3376287-volume-turnover-national.md): Simultaneously view the activity in volume and value: by area, activity, sub-activity, segment, LPP act \(List of products and services\) - [Evolution - NATIONAL](https://success.openhealth.fr/en/articles/3376370-evolution-national.md): Visualize the evolution of the market on the available history: by domain, activity, sub-activity, segment, LPP act - [Extraction - NATIONAL](https://success.openhealth.fr/en/articles/3376420-extraction-national.md): Export data to Excel - [Definition](https://success.openhealth.fr/en/articles/3376439-definition.md): Find all the features of the SantéDomStat Observatoire National - Essential application ### AUTRES THEMATIQUES - [INTERCOM](https://success.openhealth.fr/en/articles/6959415-intercom.md) - [Salesforce](https://success.openhealth.fr/en/articles/6959337-salesforce.md) - [Untitled article](https://success.openhealth.fr/en/articles/3977478-untitled-article.md): GIHSN Excel file - [Blockchain](https://success.openhealth.fr/en/articles/5385413-blockchain.md): The implementation of blockchain - [DocuSign, CRM tool in our business process](https://success.openhealth.fr/en/articles/4514472-docusign-crm-tool-in-our-business-process.md): Docusign: CRM tool in our business process - [National monitoring of vaccinations](https://success.openhealth.fr/en/articles/4754333-national-monitoring-of-vaccinations.md): Tracking the progress of vaccination - [Vaccination coverage](https://success.openhealth.fr/en/articles/4754311-vaccination-coverage.md): Track vaccine coverage by region, gender and age - [KPI Monitoring](https://success.openhealth.fr/en/articles/4091042-kpi-monitoring.md): ProPharma Systems Proof Of Concept : Switzerland Market Trends - [Pharmacy Cockpit](https://success.openhealth.fr/en/articles/4091025-pharmacy-cockpit.md): ProPharma Systems Proof Of Concept : MyPharmacy vs Switzerland - [Population equivalent \(p.e.\)](https://success.openhealth.fr/en/articles/5431894-population-equivalent-p-e.md) - [Oxygen demand](https://success.openhealth.fr/en/articles/5137158-oxygen-demand.md): Amount of material required to treat wastewater - [IHU](https://success.openhealth.fr/en/articles/4851687-ihu.md) - [Suspended matter](https://success.openhealth.fr/en/articles/5137147-suspended-matter.md) - [Wastewater chemistry](https://success.openhealth.fr/en/articles/5137101-wastewater-chemistry.md): Chemical substances monitored in wastewater - [NRBCE](https://success.openhealth.fr/en/articles/4851683-nrbce.md) - [Arrhenius Law](https://success.openhealth.fr/en/articles/4849672-arrhenius-law.md) - [Resulting yield](https://success.openhealth.fr/en/articles/5137034-resulting-yield.md): Calculation of the quality of wastewater treatment - [Types of wastewater](https://success.openhealth.fr/en/articles/5137183-types-of-wastewater.md): Wastewater classification - [Concentration and virus SARS-CoV 2](https://success.openhealth.fr/en/articles/4867968-concentration-and-virus-sars-cov-2.md) - [MAPOM / BMPM](https://success.openhealth.fr/en/articles/4851685-mapom-bmpm.md) - [The contextualized concentration of SARS-CoV 2](https://success.openhealth.fr/en/articles/4934604-the-contextualized-concentration-of-sars-cov-2.md) - [Type of sewerage system](https://success.openhealth.fr/en/articles/4867954-type-of-sewerage-system.md) - [Degradation of the virus](https://success.openhealth.fr/en/articles/4865742-degradation-of-the-virus.md) - [WBE](https://success.openhealth.fr/en/articles/4865735-wbe.md) - [ARN](https://success.openhealth.fr/en/articles/4865733-arn.md) - [Coronavirus](https://success.openhealth.fr/en/articles/4865728-coronavirus.md) - [COVID-19](https://success.openhealth.fr/en/articles/4865726-covid-19.md) - [Seroprevalence: sampling method](https://success.openhealth.fr/en/articles/3924493-seroprevalence-sampling-method.md): Seroprevalence: Sampling method - [SANDRE repository](https://success.openhealth.fr/en/articles/5415040-sandre-repository.md) - [National base ROSEAU](https://success.openhealth.fr/en/articles/5414523-national-base-roseau.md): Information on municipal sanitation - [SARS-CoV2 virus concentration](https://success.openhealth.fr/en/articles/4852404-sars-cov2-virus-concentration.md): Follow the evolution of the SARS-CoV 2 virus concentration by sector - [Concentration and virus SARS-CoV2 - Variants](https://success.openhealth.fr/en/articles/4909854-concentration-and-virus-sars-cov2-variants.md): Track SARS-CoV 2 variants by sector - [Marseille - Global surveillance](https://success.openhealth.fr/en/articles/4859311-marseille-global-surveillance.md): Follow the evolution of the SARS-CoV 2 virus concentration by network - [SARS-CoV2 virus concentration - Nice \(FRANCE\)](https://success.openhealth.fr/en/articles/4879292-sars-cov2-virus-concentration-nice-france.md): Follow the evolution of the SARS-CoV 2 virus concentration by sector - [Population - Structure](https://success.openhealth.fr/en/articles/4842408-population-structure.md): Analyze the population structure - [SARS-CoV2 virus concentration - Toulon \(FRANCE\)](https://success.openhealth.fr/en/articles/4886417-sars-cov2-virus-concentration-toulon-france.md): Follow the evolution of the SARS-CoV 2 virus concentration by sector - [Dubai - Airport wastewater monitoring](https://success.openhealth.fr/en/articles/5276423-dubai-airport-wastewater-monitoring.md): Dubai - Airport wastewater monitoring - [SARS-CoV-2 surveillance - OBEPINE](https://success.openhealth.fr/en/articles/5210661-sars-cov-2-surveillance-obepine.md) - [Contextualized concentration of SARS-CoV2](https://success.openhealth.fr/en/articles/4934608-contextualized-concentration-of-sars-cov2.md) - [SUEZ - Analytical balance sheet](https://success.openhealth.fr/en/articles/5140509-suez-analytical-balance-sheet.md) - [Palais des festivals - Watch T0](https://success.openhealth.fr/en/articles/5373515-palais-des-festivals-watch-t0.md) - [Palais des festivals - Daily vigil](https://success.openhealth.fr/en/articles/5373231-palais-des-festivals-daily-vigil.md) - [Palais des festivals - Screening](https://success.openhealth.fr/en/articles/5404778-palais-des-festivals-screening.md) - [Mustelids - Watch](https://success.openhealth.fr/en/articles/5169577-mustelids-watch.md) - [Population - IRIS](https://success.openhealth.fr/en/articles/4842191-population-iris.md): Analysing the geographical distribution of the population at IRIS - [SARS-CoV 2](https://success.openhealth.fr/en/articles/4865699-sars-cov-2.md): Severe Acute Respiratory Syndrome-related CoronaVirus-2 - [IAS - Analysis](https://success.openhealth.fr/en/articles/4842430-ias-analysis.md): Monitoring the health indicator for respiratory syndromes - [SARS-CoV-2 virus concentration - SEM](https://success.openhealth.fr/en/articles/5415600-sars-cov-2-virus-concentration-sem.md) - [Map visualization](https://success.openhealth.fr/en/articles/3864657-map-visualization.md): Geographical repartition of patients - [Contribution site](https://success.openhealth.fr/en/articles/3864668-contribution-site.md): Contribution by site and hospital - [Cohort profile by site](https://success.openhealth.fr/en/articles/3864672-cohort-profile-by-site.md): Cohort profile by site and hospital - [Cohort profile by season](https://success.openhealth.fr/en/articles/3864673-cohort-profile-by-season.md): Cohort profile by season - [Age & gender distribution](https://success.openhealth.fr/en/articles/3864675-age-gender-distribution.md): Demography - [Virus distribution by site](https://success.openhealth.fr/en/articles/3864678-virus-distribution-by-site.md): Virus distribution by site - [Virus distribution by age](https://success.openhealth.fr/en/articles/3864677-virus-distribution-by-age.md): Virus distribution by age - [Virus distribution evolution](https://success.openhealth.fr/en/articles/3864681-virus-distribution-evolution.md): Virus distribution evolution - [Influenza vaccination](https://success.openhealth.fr/en/articles/3864697-influenza-vaccination.md): Influenza vaccination - [Influenza vaccination evolution](https://success.openhealth.fr/en/articles/3864701-influenza-vaccination-evolution.md): Evolution of influenza vaccination - [Patient distribution by chronic condition](https://success.openhealth.fr/en/articles/3864676-patient-distribution-by-chronic-condition.md): Patient distribution by chronic condition - [Patient distribution by length of hospital stay](https://success.openhealth.fr/en/articles/3864794-patient-distribution-by-length-of-hospital-stay.md): Patient distribution by length oh hospital stay - [Frailty](https://success.openhealth.fr/en/articles/3864704-frailty.md): Fragility of patients - [Severity status](https://success.openhealth.fr/en/articles/3864705-severity-status.md): Severity status - [Mortality](https://success.openhealth.fr/en/articles/3864710-mortality.md): Mortality - [GIHSN](https://success.openhealth.fr/en/articles/3864712-gihsn.md): Global Influenza Hospital Surveillance Network - [CARéDIAB - Patient profile](https://success.openhealth.fr/en/articles/3789234-carediab-patient-profile.md): Analyze the patient profile of the CARéDIAB population - [CARéDIAB - Complications](https://success.openhealth.fr/en/articles/3789515-carediab-complications.md): Analyze the prevalence of complications in our population CAREDIAB - [CARéDIAB - Global patient monitoring](https://success.openhealth.fr/en/articles/3792041-carediab-global-patient-monitoring.md): Analyze the frequency of follow-ups of patients in the CARéDIAB population - [CARéDIAB Network](https://success.openhealth.fr/en/articles/3789106-carediab-network.md): The CARéDIAB network - [CARéDIAB - Treatments](https://success.openhealth.fr/en/articles/3792143-carediab-treatments.md): Analyze the taking of treatments in the context of diabetes ## Suomi ### Votre PLATEFORME - présentation générale - [HUB, kattava ja jatkuva tukifoorumi.](https://success.openhealth.fr/fi/articles/4799621-hub-kattava-ja-jatkuva-tukifoorumi.md) - [Kokemuksesi taso The HUB](https://success.openhealth.fr/fi/articles/5712270-kokemuksesi-taso-the-hub.md) - [Languages](https://success.openhealth.fr/fi/articles/4649389-languages.md): Here is the description of all languages available on Success - [Kysymyksiä hinnoistamme](https://success.openhealth.fr/fi/articles/3292143-kysymyksia-hinnoistamme.md): Hintamme ### Tiekartta - [Avoin innovaatio asiakkaidemme palveluksessa](https://success.openhealth.fr/fi/articles/5200970-avoin-innovaatio-asiakkaidemme-palveluksessa.md) - [Sovellukset + Hallinta-alueen versio 240515](https://success.openhealth.fr/fi/articles/9310541-sovellukset-hallinta-alueen-versio-240515.md) - [Sovellukset + Hallinta-alueen versio 240415](https://success.openhealth.fr/fi/articles/9310710-sovellukset-hallinta-alueen-versio-240415.md) - [Sovellukset + Hallinta-alueen versio 240315](https://success.openhealth.fr/fi/articles/9310790-sovellukset-hallinta-alueen-versio-240315.md) - [Sovellukset + Hallinta-alueen versio 240215](https://success.openhealth.fr/fi/articles/9311007-sovellukset-hallinta-alueen-versio-240215.md) - [Alusta - päivitys 231215](https://success.openhealth.fr/fi/articles/8718485-alusta-paivitys-231215.md) - [Alusta - päivitys 231015](https://success.openhealth.fr/fi/articles/8479932-alusta-paivitys-231015.md) - [Sovellukset + portaali versio 230915](https://success.openhealth.fr/fi/articles/8373640-sovellukset-portaali-versio-230915.md) - [Sovellukset + portaali versio 230815](https://success.openhealth.fr/fi/articles/8267860-sovellukset-portaali-versio-230815.md) - [Uudet tuotteet 230715](https://success.openhealth.fr/fi/articles/8115796-uudet-tuotteet-230715.md) - [Sovellukset + portaali versio 230615](https://success.openhealth.fr/fi/articles/8115791-sovellukset-portaali-versio-230615.md) - [Sovellukset + portaali versio 230515](https://success.openhealth.fr/fi/articles/7895393-sovellukset-portaali-versio-230515.md) - [Sovellukset + portaali versio 230415](https://success.openhealth.fr/fi/articles/7439447-sovellukset-portaali-versio-230415.md) - [Sovellukset + portaali versio 230315](https://success.openhealth.fr/fi/articles/7439646-sovellukset-portaali-versio-230315.md) - [Sovellukset + portaali versio 230215](https://success.openhealth.fr/fi/articles/7439744-sovellukset-portaali-versio-230215.md) - [Uusi 15/01/2023 alkaen](https://success.openhealth.fr/fi/articles/6895740-uusi-15-01-2023-alkaen.md) - [HUB + GATE versio 221215](https://success.openhealth.fr/fi/articles/6827027-hub-gate-versio-221215.md) - [HUB + GATE versio 221115](https://success.openhealth.fr/fi/articles/6742628-hub-gate-versio-221115.md) - [HUB + GATE versio 220915](https://success.openhealth.fr/fi/articles/6558070-hub-gate-versio-220915.md) - [HUB + GATE versio 220815](https://success.openhealth.fr/fi/articles/6475311-hub-gate-versio-220815.md) - [HUB + GATE versio 220615](https://success.openhealth.fr/fi/articles/6306090-hub-gate-versio-220615.md) - [HUB + GATE versio 220515](https://success.openhealth.fr/fi/articles/6201877-hub-gate-versio-220515.md) - [HUB + GATE versio 220415](https://success.openhealth.fr/fi/articles/6087747-hub-gate-versio-220415.md) - [HUB SMA versio 220315](https://success.openhealth.fr/fi/articles/6043772-hub-sma-versio-220315.md) - [HUB TMA versio 220315](https://success.openhealth.fr/fi/articles/6043802-hub-tma-versio-220315.md) - [HUB UAN versio 220315](https://success.openhealth.fr/fi/articles/6043852-hub-uan-versio-220315.md) - [GATE-versio 220215](https://success.openhealth.fr/fi/articles/5940805-gate-versio-220215.md) - [HUB SMA versio 220215](https://success.openhealth.fr/fi/articles/5940753-hub-sma-versio-220215.md) - [HUB TMA versio 220215](https://success.openhealth.fr/fi/articles/5947859-hub-tma-versio-220215.md) - [GATE-versio 211215](https://success.openhealth.fr/fi/articles/5819397-gate-versio-211215.md) - [HUB SMA versio 211215](https://success.openhealth.fr/fi/articles/5784709-hub-sma-versio-211215.md) - [HUB TMA versio 211215](https://success.openhealth.fr/fi/articles/5784888-hub-tma-versio-211215.md) - [HUB UAN versio 211215](https://success.openhealth.fr/fi/articles/5784904-hub-uan-versio-211215.md) - [Sovellus The HUB: "Apteekin tila".](https://success.openhealth.fr/fi/articles/5704485-sovellus-the-hub-apteekin-tila.md) - [GATE-versio 211115](https://success.openhealth.fr/fi/articles/5697844-gate-versio-211115.md) - [HUB SMA versio 211115](https://success.openhealth.fr/fi/articles/5671893-hub-sma-versio-211115.md) - [HUB TMA versio 211115](https://success.openhealth.fr/fi/articles/5671917-hub-tma-versio-211115.md) - [HUB UAN versio 211115](https://success.openhealth.fr/fi/articles/5671927-hub-uan-versio-211115.md) - [GATE-versio 211015](https://success.openhealth.fr/fi/articles/5652210-gate-versio-211015.md) - [HUB SMA versio 211015](https://success.openhealth.fr/fi/articles/5649822-hub-sma-versio-211015.md) - [HUB TMA versio 211015](https://success.openhealth.fr/fi/articles/5650073-hub-tma-versio-211015.md) - [HUB UAN versio 211015](https://success.openhealth.fr/fi/articles/5652242-hub-uan-versio-211015.md) - [HUB SMA versio 210915](https://success.openhealth.fr/fi/articles/5370516-hub-sma-versio-210915.md) - [HUB TMA versio 210915](https://success.openhealth.fr/fi/articles/5390983-hub-tma-versio-210915.md) - [HUB UAN versio 210915](https://success.openhealth.fr/fi/articles/5543213-hub-uan-versio-210915.md) ### Votre ESPACE D'ADMINISTRATION - fonctionnalités - [Palauta / vaihda salasanasi HUB](https://success.openhealth.fr/fi/articles/4425325-palauta-vaihda-salasanasi-hub.md): HUB-salasanan vaihtaminen - [Yhteysapu: Saan virheilmoituksen](https://success.openhealth.fr/fi/articles/5369783-yhteysapu-saan-virheilmoituksen.md) - [Luo lippu ja seuraa sitä](https://success.openhealth.fr/fi/articles/3586214-luo-lippu-ja-seuraa-sita.md): Opetusohjelma lippujen luomiseen ja seuraamiseen henkilökohtaisessa tilassa HUB - [Luo ja muokkaa SUCCESS-artikkelia.](https://success.openhealth.fr/fi/articles/6738705-luo-ja-muokkaa-success-artikkelia.md) - [Minun sopimukseni](https://success.openhealth.fr/fi/articles/5712273-minun-sopimukseni.md) - [Palvelu Terveys](https://success.openhealth.fr/fi/articles/4990600-palvelu-terveys.md) - [Käyttöni](https://success.openhealth.fr/fi/articles/5783418-kayttoni.md) - [Kotisivun perustaminen](https://success.openhealth.fr/fi/articles/5712229-kotisivun-perustaminen.md) - [Kuinka muokata markkinoita henkilökohtaisesta OpenHealth-tilastasi?](https://success.openhealth.fr/fi/articles/3585971-kuinka-muokata-markkinoita-henkilokohtaisesta-openhealth-tilastasi.md): Integroi, muokkaa ja poista tuotteita käytöstä henkilökohtaisesta OpenHealth-tilastasi - [Automaattinen tilauksen määrityksen muutos \(Auto MAM\)](https://success.openhealth.fr/fi/articles/4164818-automaattinen-tilauksen-maarityksen-muutos-auto-mam.md): Muokkaa tuotteiden määrityksiä suoraan - [TEMPORAL MAM: Kuinka seurata brändiä, joka muuttaa laboratoriota / brändiä / etikettiä?](https://success.openhealth.fr/fi/articles/4131072-temporal-mam-kuinka-seurata-brandia-joka-muuttaa-laboratoriota-brandia-etikettia.md): Edut ja riskit seurantatyypistäsi - [Automaattinen tuotteen integrointi \(Auto IPR\)](https://success.openhealth.fr/fi/articles/4164932-automaattinen-tuotteen-integrointi-auto-ipr.md): Pyydä tuotteen integrointia markkinoillesi - [Tuotteen automaattinen deaktivointi \(Auto DPR\)](https://success.openhealth.fr/fi/articles/4164866-tuotteen-automaattinen-deaktivointi-auto-dpr.md): Poista tuote käytöstä markkinoiltasi - [Automaattinen tuotteen uudelleenaktivointi \(RPR auto\)](https://success.openhealth.fr/fi/articles/4818161-automaattinen-tuotteen-uudelleenaktivointi-rpr-auto.md) - [Uusien tuotteiden perustaminen](https://success.openhealth.fr/fi/articles/5811248-uusien-tuotteiden-perustaminen.md) - [Lisää markkinat](https://success.openhealth.fr/fi/articles/5712283-lisaa-markkinat.md) - [Irtotavaroiden tuonti / vienti](https://success.openhealth.fr/fi/articles/5712257-irtotavaroiden-tuonti-vienti.md) - [Typologisen modaliteetin muutos \(CMT\)](https://success.openhealth.fr/fi/articles/4670174-typologisen-modaliteetin-muutos-cmt.md) - [Eri käyttäjän tilat](https://success.openhealth.fr/fi/articles/3436418-eri-kayttajan-tilat.md): Mitkä ovat ominaisuudet? - [Luo tili kolmannen osapuolen organisaation käyttäjälle \(TPAA\).](https://success.openhealth.fr/fi/articles/6466550-luo-tili-kolmannen-osapuolen-organisaation-kayttajalle-tpaa.md) - [Kuinka luoda, muokata tai poistaa käyttäjätili HUB: lta?](https://success.openhealth.fr/fi/articles/3785138-kuinka-luoda-muokata-tai-poistaa-kayttajatili-hub-lta.md): Vain VOIMAKÄYTTÄJÄ voi tehdä tämän - [Voinko luoda eriytettyjä katseluoikeuksia HUB: ssä tiimeihini?](https://success.openhealth.fr/fi/articles/3321731-voinko-luoda-eriytettyja-katseluoikeuksia-hub-ssa-tiimeihini.md): Keskuksen oikeudet - [Toimintaloki](https://success.openhealth.fr/fi/articles/4687438-toimintaloki.md) ### Vos APPLICATIONS - présentation - [HUB-koulutusopas](https://success.openhealth.fr/fi/articles/5634967-hub-koulutusopas.md) - [Lajittelu pudotusvalitsin](https://success.openhealth.fr/fi/articles/5792113-lajittelu-pudotusvalitsin.md) - [Päivitä GSA: n apteekkitietojen \(SMKT\) päivämäärä HuB: ssä](https://success.openhealth.fr/fi/articles/3175557-paivita-gsa-n-apteekkitietojen-smkt-paivamaara-hub-ssa.md): Tässä artikkelissa kuvataan päivämäärä, jolloin GSA-apteekkien \(SMKT\) tiedot päivitetään. - [Vaatimukset, jotka vastaavat apteekkitiedostoa](https://success.openhealth.fr/fi/articles/3678146-vaatimukset-jotka-vastaavat-apteekkitiedostoa.md): Vaatimukset, jotka vastaavat apteekkitiedostoa - ["On and Off Prescription" -valitsin](https://success.openhealth.fr/fi/articles/3729668-on-and-off-prescription-valitsin.md): Prescription Type Selector -objektin määritykset - [Kuinka uudet tuotteet hyväksytään HUB: ssä?](https://success.openhealth.fr/fi/articles/3376100-kuinka-uudet-tuotteet-hyvaksytaan-hub-ssa.md): Uusien tuotteidesi pätevyys HUB: ssä - [Kuinka luoda, muokata ja jakaa suosikki HUB: ssä?](https://success.openhealth.fr/fi/articles/3175689-kuinka-luoda-muokata-ja-jakaa-suosikki-hub-ssa.md): Suosikkien luominen ja jakaminen keskittimessä - [Kuinka voin valita tuotteet HUB: sta julkaisupäivän mukaan?](https://success.openhealth.fr/fi/articles/3158428-kuinka-voin-valita-tuotteet-hub-sta-julkaisupaivan-mukaan.md): Tässä artikkelissa kerrotaan, kuinka valita vain tietyllä ajanjaksolla lanseeratut tuotteet. - [Voinko poimia tiedot HUBista ".csv"-muodossa?](https://success.openhealth.fr/fi/articles/5671278-voinko-poimia-tiedot-hubista-csv-muodossa.md) - [ODT:n vasteaika](https://success.openhealth.fr/fi/articles/6632310-odt-n-vasteaika.md) - [Mitkä ovat parhaat näyttökäytännöt HUB: ssa](https://success.openhealth.fr/fi/articles/3124454-mitka-ovat-parhaat-nayttokaytannot-hub-ssa.md): Tässä artikkelissa kerrotaan parhaista käytännöistä HUB-näytön optimoimiseksi - [Tekniset vaatimukset](https://success.openhealth.fr/fi/articles/5369918-tekniset-vaatimukset.md) - [Tyhjennä selaimen välimuisti](https://success.openhealth.fr/fi/articles/4219722-tyhjenna-selaimen-valimuisti.md): Kuinka tyhjentää Google Chrome -selaimen välimuisti - [Kuinka asetan Google Chromen oletusselaimeksi?](https://success.openhealth.fr/fi/articles/3738717-kuinka-asetan-google-chromen-oletusselaimeksi.md): Kuinka asettaa Google Chrome oletukseksi - [Navigointihissi ei näy taulukoissa](https://success.openhealth.fr/fi/articles/3195250-navigointihissi-ei-nay-taulukoissa.md): Navigointihissi - [Painikkeiden tai esineiden näyttö arkilla on osittain leikattu tai ei näy](https://success.openhealth.fr/fi/articles/3195245-painikkeiden-tai-esineiden-naytto-arkilla-on-osittain-leikattu-tai-ei-nay.md): Painikkeiden, esineiden näyttöongelma - [Oma aluehallintakortti ei lataudu ja näyttöön tulee viesti "ladataan"](https://success.openhealth.fr/fi/articles/3195239-oma-aluehallintakortti-ei-lataudu-ja-nayttoon-tulee-viesti-ladataan.md): Alueen hallinta / TMA-kartan näyttöongelma - [Mistä "Sinulla ei ole oikeutta käyttää tätä sivua" -virhesanoma tulee?](https://success.openhealth.fr/fi/articles/3195338-mista-sinulla-ei-ole-oikeutta-kayttaa-tata-sivua-virhesanoma-tulee.md): Virheilmoitukset - [Minulla on "Yhteys menetetty" -virhesanoma](https://success.openhealth.fr/fi/articles/4445141-minulla-on-yhteys-menetetty-virhesanoma.md): Tapahtui virhe - [Huono yhdyskäytävä](https://success.openhealth.fr/fi/articles/4514555-huono-yhdyskaytava.md): "Virheellinen yhdyskäytävä" -virhesanoma - [Dimensio- ja mittavalitsimia ei enää näytetä kyselyissä "Usean jakson analyysi" ja "Oma data-arkisto", "Markkina-analyysi" -taulukon purku on osittainen](https://success.openhealth.fr/fi/articles/3195377-dimensio-ja-mittavalitsimia-ei-enaa-nayteta-kyselyissa-usean-jakson-analyysi-ja-oma-data-arkisto-markkina-analyysi-taulukon-purku-on-osittainen.md): Mitat ja mitat eivät enää näy - [Kuinka tarkastella termiä HUB: ssä?](https://success.openhealth.fr/fi/articles/3194377-kuinka-tarkastella-termia-hub-ssa.md): HUB: n avulla voit helposti tarkastella quadrimestereitä Sales Evolution -sivulla - [Excel-määritykset ja rajoitukset](https://success.openhealth.fr/fi/articles/3753088-excel-maaritykset-ja-rajoitukset.md): Tässä artikkelissa selitetään Excelin tekniset tiedot ja rajoitukset. - [Miten luot, muokkaat ja jaat suosikkeja sovelluksissasi?](https://success.openhealth.fr/fi/articles/10502803-miten-luot-muokkaat-ja-jaat-suosikkeja-sovelluksissasi.md) - [Kuluttajapaneelin kehys](https://success.openhealth.fr/fi/articles/3455845-kuluttajapaneelin-kehys.md): Artikkeli kuluttajapaneelin kehyksestä - [Apteekkimarkkinoiden analyysikehys](https://success.openhealth.fr/fi/articles/3455857-apteekkimarkkinoiden-analyysikehys.md): Artikkeli, joka koskee OpenHealth-kehystä markkinoiden suorituskyvyn analysoimiseksi apteekikanavalla ### Tietolähteet - [Mikä on OpenHealth-apteekkipaneeli?](https://success.openhealth.fr/fi/articles/3304106-mika-on-openhealth-apteekkipaneeli.md): Tämän artikkelin tarkoituksena on kuvata apteekkipaneeliamme. - [Apteekkiverkosto on ratkaiseva voimavara nykyisten ja tulevien terveyskriisien hallinnassa](https://success.openhealth.fr/fi/articles/3825648-apteekkiverkosto-on-ratkaiseva-voimavara-nykyisten-ja-tulevien-terveyskriisien-hallinnassa.md): OpenHealth Company, joka on sitoutunut seuraamaan ennennäkemättömän terveyskriisin, mobilisoi teknologiansa ja datansa - [Mitkä ovat Ranskan merentakaisten departementtien alueet ja alueet, joita voidaan tarkastella HUB: ssä?](https://success.openhealth.fr/fi/articles/3194382-mitka-ovat-ranskan-merentakaisten-departementtien-alueet-ja-alueet-joita-voidaan-tarkastella-hub-ssa.md): DROM-COM-alueet käytettävissä Hubissa - [Edellytys sektorisointitiedosto](https://success.openhealth.fr/fi/articles/3702701-edellytys-sektorisointitiedosto.md): Tämän artikkelin avulla voit ladata, täydentää ja lähettää sektorisointitiedostosi. - [SMKT-tietolähde](https://success.openhealth.fr/fi/articles/4485357-smkt-tietolahde.md): IRI, GSA-apteekkitietojen toimittaja - [GSA Parapharmacy Products Coding Rules \(SMKT\) IRI: llä](https://success.openhealth.fr/fi/articles/3524492-gsa-parapharmacy-products-coding-rules-smkt-iri-lla.md): Muistutus SMKT-tuotteiden koodaussäännöistä IRI: ssä - [ORGANIC STORE tiedot - Lähde BIOANALYTICS](https://success.openhealth.fr/fi/articles/5631260-organic-store-tiedot-lahde-bioanalytics.md) - [Sähköiset apteekit: seurantafoorumit](https://success.openhealth.fr/fi/articles/9167006-sahkoiset-apteekit-seurantafoorumit.md) - [E-apteekkien tuotevoitot ja -tappiot](https://success.openhealth.fr/fi/articles/3568773-e-apteekkien-tuotevoitot-ja-tappiot.md): Artikkeli '' E-apteekkien tuotevoitot ja -tappiot '' -moduulista - [Kuluttajaprofiili](https://success.openhealth.fr/fi/articles/3711085-kuluttajaprofiili.md): Artikkeli Kuluttajaprofiili-moduulista - [AMAZON-tiedot - Lähde SELLINGZ](https://success.openhealth.fr/fi/articles/5669013-amazon-tiedot-lahde-sellingz.md) - [Sähköistä kaupankäyntiä koskevat tiedot - Lähde WISER](https://success.openhealth.fr/fi/articles/7983010-sahkoista-kaupankayntia-koskevat-tiedot-lahde-wiser.md) - [Maantieteelliset alueet](https://success.openhealth.fr/fi/articles/4661582-maantieteelliset-alueet.md): Open Health Company -yrityksessä voit analysoida markkinoitasi tarjoamiemme maantieteellisten alueiden mukaan. - [Mikä on apteekkipaneeli Saksassa? INSIGHTHEALTH](https://success.openhealth.fr/fi/articles/5391412-mika-on-apteekkipaneeli-saksassa-insighthealth.md) - [Mikä on Kreikan apteekkipaneeli? ALIRAHEALTH](https://success.openhealth.fr/fi/articles/6863963-mika-on-kreikan-apteekkipaneeli-alirahealth.md) - [Mikä on Itävallan apteekkipaneeli? INSIGHTHEALTH](https://success.openhealth.fr/fi/articles/6863949-mika-on-itavallan-apteekkipaneeli-insighthealth.md) - [Mikä on Afrikan apteekkipaneeli? PIEX - Afrikka](https://success.openhealth.fr/fi/articles/6686633-mika-on-afrikan-apteekkipaneeli-piex-afrikka.md) - [Mikä on verkkoapteekkipaneeli Saksassa? DATAMEDIQ](https://success.openhealth.fr/fi/articles/5689640-mika-on-verkkoapteekkipaneeli-saksassa-datamediq.md) - [Mikä on Belgian apteekkipaneeli? REDPHARMA](https://success.openhealth.fr/fi/articles/4689894-mika-on-belgian-apteekkipaneeli-redpharma.md) - [Mikä on Espanjan apteekkipaneeli? - HMR](https://success.openhealth.fr/fi/articles/5391363-mika-on-espanjan-apteekkipaneeli-hmr.md) - [Qu'est-ce que le panel de pharmacies en Espagne ? - INFONIS](https://success.openhealth.fr/fi/articles/5428915-qu-est-ce-que-le-panel-de-pharmacies-en-espagne-infonis.md) - [Mikä on Portugalin apteekkipaneeli? - HMR](https://success.openhealth.fr/fi/articles/5391477-mika-on-portugalin-apteekkipaneeli-hmr.md) - [Mikä on apteekkipaneeli Venäjällä? - ALPHARM](https://success.openhealth.fr/fi/articles/5701531-mika-on-apteekkipaneeli-venajalla-alpharm.md) - [Mikä on Puolan apteekkipaneeli? Pex Pharma](https://success.openhealth.fr/fi/articles/5969485-mika-on-puolan-apteekkipaneeli-pex-pharma.md) - [CONVERT GROUP](https://success.openhealth.fr/fi/articles/6961966-convert-group.md) - [Mikä on Jordanian apteekkipaneeli?](https://success.openhealth.fr/fi/articles/8176750-mika-on-jordanian-apteekkipaneeli.md) - [Väestö - Kartografia](https://success.openhealth.fr/fi/articles/3807695-vaesto-kartografia.md): Analysoi väestön maantieteellinen jakauma - [AMELI - LPP](https://success.openhealth.fr/fi/articles/6962021-ameli-lpp.md) - [Väestö - kehitys ikän ja sukupuolen mukaan](https://success.openhealth.fr/fi/articles/3810789-vaesto-kehitys-ikan-ja-sukupuolen-mukaan.md): Analysoi väestörakenteen kehitys - [Väestö - vertailu iän ja sukupuolen mukaan](https://success.openhealth.fr/fi/articles/3836795-vaesto-vertailu-ian-ja-sukupuolen-mukaan.md): Vertaa kahden väestön demografista profiilia - [Egypti - Kartografia](https://success.openhealth.fr/fi/articles/3714611-egypti-kartografia.md): Analysoi Egyptin kuvernöörien väestö - [Egypti - analyysi iästä ja sukupuolesta](https://success.openhealth.fr/fi/articles/3714673-egypti-analyysi-iasta-ja-sukupuolesta.md): Analysoi väestörakenne - [UGANDA - analyysi iästä ja sukupuolesta](https://success.openhealth.fr/fi/articles/3713884-uganda-analyysi-iasta-ja-sukupuolesta.md): Analysoi väestörakenne - [Väestö - analyysi iästä ja sukupuolesta](https://success.openhealth.fr/fi/articles/3807673-vaesto-analyysi-iasta-ja-sukupuolesta.md): Analysoi väestörakenne - [Medicabase - lääketietokanta](https://success.openhealth.fr/fi/articles/6518920-medicabase-laaketietokanta.md) - [Syntymä](https://success.openhealth.fr/fi/articles/6340025-syntyma.md) - [OpenEudra](https://success.openhealth.fr/fi/articles/6518977-openeudra.md) - [IRIS-erittely](https://success.openhealth.fr/fi/articles/6383829-iris-erittely.md) - [ADICAP](https://success.openhealth.fr/fi/articles/6959465-adicap.md) - [NEC](https://success.openhealth.fr/fi/articles/6519012-nec.md) - [Maailman väestötiedot](https://success.openhealth.fr/fi/articles/8217421-maailman-vaestotiedot.md) - [INSEE: Kuolleiden henkilöiden tiedostot](https://success.openhealth.fr/fi/articles/4498126-insee-kuolleiden-henkiloiden-tiedostot.md): INSEE \(kansallinen tilasto- ja taloustutkimuslaitos\): Kuolleiden henkilöiden arkisto - [Tiedot VAERS- VAERSDATA- Lähde CDC](https://success.openhealth.fr/fi/articles/6226665-tiedot-vaers-vaersdata-lahde-cdc.md) - [VAERS-tiedot - VAERSVAX - Lähde CDC](https://success.openhealth.fr/fi/articles/6226440-vaers-tiedot-vaersvax-lahde-cdc.md) - [VAERS-tiedot - VAERSSYMPTOMS - Lähde CDC](https://success.openhealth.fr/fi/articles/6219415-vaers-tiedot-vaerssymptoms-lahde-cdc.md) - [Integroi tietosi Hubiin alle 2 viikossa.](https://success.openhealth.fr/fi/articles/5259828-integroi-tietosi-hubiin-alle-2-viikossa.md) - [Kansainvälinen tietomalli](https://success.openhealth.fr/fi/articles/4684696-kansainvalinen-tietomalli.md) - [Kuinka lähettää meille tietoja FTPS: llä?](https://success.openhealth.fr/fi/articles/4143451-kuinka-lahettaa-meille-tietoja-ftps-lla.md): Lähetä tietoja FTPS: n kautta - [Mitä tietoja OpenHealth tarvitsee uuden tietolähteen integroimiseksi?](https://success.openhealth.fr/fi/articles/3459148-mita-tietoja-openhealth-tarvitsee-uuden-tietolahteen-integroimiseksi.md): Artikkeli uusien tietolähteiden integroinnista - [Pitkä näkökulma](https://success.openhealth.fr/fi/articles/6959482-pitka-nakokulma.md) - [Kuinka integroida uusi tietolähde HUB: iin?](https://success.openhealth.fr/fi/articles/3467598-kuinka-integroida-uusi-tietolahde-hub-iin.md): Artikkeli tietojen integrointiprosessista HUB: ssa - [Integroi myyntitietosi HUB: iin](https://success.openhealth.fr/fi/articles/3471145-integroi-myyntitietosi-hub-iin.md): Artikkeli myyntitietojen integroinnista - [Myyntitietojen vastaanottamista koskevat eritelmät](https://success.openhealth.fr/fi/articles/3660043-myyntitietojen-vastaanottamista-koskevat-eritelmat.md): Kuinka lähettää meille myyntiosuutesi osana myynti- / myynti-analyysiä tai tilausta myyntivizualisaatio-moduuliin - [Mistä kotiterveydenhuollon tarjoajien \(PSAD\) markkinoiden analyysitiedot ovat peräisin?](https://success.openhealth.fr/fi/articles/3376155-mista-kotiterveydenhuollon-tarjoajien-psad-markkinoiden-analyysitiedot-ovat-peraisin.md): PSAD - [Kuinka liittyä SantéDom Stat-observatorioon?](https://success.openhealth.fr/fi/articles/3798795-kuinka-liittya-santedom-stat-observatorioon.md): Opetusohjelma kotiterveydenhuollon tarjoajien kansalliseen seurantakeskukseen \(PSAD\) liittymiseen - [SanteDomStat-seurantakeskuksen ekstrapoloima paneeli.](https://success.openhealth.fr/fi/articles/6701602-santedomstat-seurantakeskuksen-ekstrapoloima-paneeli.md) - [Potilaiden lukumäärä](https://success.openhealth.fr/fi/articles/3376499-potilaiden-lukumaara.md): Potilaiden lukumäärän määritys PSAD-liittojen mukaan - [Hoitojen lukumäärä](https://success.openhealth.fr/fi/articles/3376682-hoitojen-lukumaara.md): Hoitojen määrän määrittely PSAD-liittojen mukaan - [Uusien potilaiden määrä](https://success.openhealth.fr/fi/articles/3376672-uusien-potilaiden-maara.md): Uusien potilaiden määrän määrittely PSAD-liittojen mukaan - [Liikevaihto verot mukaan lukien](https://success.openhealth.fr/fi/articles/3376725-liikevaihto-verot-mukaan-lukien.md): Liikevaihdon määrittely verojen mukaan PSAD-liittojen mukaan - [Potilaiden lukumäärä hoidon lopussa](https://success.openhealth.fr/fi/articles/3376675-potilaiden-lukumaara-hoidon-lopussa.md): Potilaiden lukumäärän määritys hoidon lopussa PSAD-liittojen mukaan - [Pakollisen sairausvakuutuksen määrä \(AMO\)](https://success.openhealth.fr/fi/articles/3376740-pakollisen-sairausvakuutuksen-maara-amo.md): AMO-määrän määrittely PSAD-federaatioiden mukaan - [Täydentävä sairausvakuutusmäärä \(AMC\)](https://success.openhealth.fr/fi/articles/3376749-taydentava-sairausvakuutusmaara-amc.md): AMC-määrän määrittely PSAD-liittojen mukaan - [Maksamaton varaus \(RAC\)](https://success.openhealth.fr/fi/articles/3376751-maksamaton-varaus-rac.md): RAC: n määrittely PSAD-liittojen mukaan - [Lähde: THESORIMED](https://success.openhealth.fr/fi/articles/3560018-lahde-thesorimed.md): Huumetietokanta \(BdM\) - [Kansainväliset patentoimattomat nimet \(INN\)](https://success.openhealth.fr/fi/articles/3954239-kansainvaliset-patentoimattomat-nimet-inn.md): Kansainväliset yleisnimet \(INN\) - [Open Food Facts](https://success.openhealth.fr/fi/articles/6961970-open-food-facts.md) - [LOINC - Loogiset havainnointitunnisteet Nimet ja koodit](https://success.openhealth.fr/fi/articles/6959323-loinc-loogiset-havainnointitunnisteet-nimet-ja-koodit.md) - [AMELI - CCAM](https://success.openhealth.fr/fi/articles/6959080-ameli-ccam.md) - [WHO ATC VET](https://success.openhealth.fr/fi/articles/6959078-who-atc-vet.md) - [CEPS](https://success.openhealth.fr/fi/articles/6959068-ceps.md) - [Instituutio](https://success.openhealth.fr/fi/articles/3935678-instituutio.md): Luettelo terveys-, sosiaali- ja lääketieteellisistä laitoksista - [Terveyspalvelut](https://success.openhealth.fr/fi/articles/7969680-terveyspalvelut.md) - [Pura FINESS](https://success.openhealth.fr/fi/articles/3946922-pura-finess.md): Suorita uuttaminen odotusten mukaan - [Evolution FINESS](https://success.openhealth.fr/fi/articles/3947009-evolution-finess.md): Seuraa rakenteiden määrän kehitystä - [Lupahoitotoiminta](https://success.openhealth.fr/fi/articles/3947067-lupahoitotoiminta.md): Luettele rakenteet terveydenhuoltotoimilupiensa mukaisesti - [Tärkeimmät lääkinnälliset laitteet](https://success.openhealth.fr/fi/articles/3947269-tarkeimmat-laakinnalliset-laitteet.md): Luettele rakenteet raskaan kaluston mukaan - [Maantieteellinen](https://success.openhealth.fr/fi/articles/3947363-maantieteellinen.md): Visualisoi rakenteiden jakautuminen alueella - [RPPS](https://success.openhealth.fr/fi/articles/3947568-rpps.md): Luettelo terveydenhuollon ammattilaisista - [FINESS & RPPS](https://success.openhealth.fr/fi/articles/3947713-finess-rpps.md): Luettele terveydenhuollon ammattilaisten liikuntapaikat - [Pura RPPS](https://success.openhealth.fr/fi/articles/3947829-pura-rpps.md): RPPS \(Jaettu hakemisto terveydenhuollon ammattilaisille\) ### Mallit - [UGA:n tiedot](https://success.openhealth.fr/fi/articles/4852310-uga-n-tiedot.md) - [Alalle tapahtuvan myynnin laskeminen: mitä sinun tarvitsee tietää](https://success.openhealth.fr/fi/articles/3545561-alalle-tapahtuvan-myynnin-laskeminen-mita-sinun-tarvitsee-tietaa.md): Mitkä ovat eri vaiheet sektorimyynnin laskemiseksi OpenHealthissa? - [Sektorin uudelleenjako, staattinen tai dynaaminen menetelmä?](https://success.openhealth.fr/fi/articles/3690615-sektorin-uudelleenjako-staattinen-tai-dynaaminen-menetelma.md): Sektorin uudelleenjako, staattinen tai dynaaminen menetelmä? - [Apteekkien kerrokset](https://success.openhealth.fr/fi/articles/4291490-apteekkien-kerrokset.md): Yksityiskohdat "teoreettisista" kerroksista ja "todellisista" tai "tehokkaista" kerroksista. - [Hub-tuotantolinja](https://success.openhealth.fr/fi/articles/4816146-hub-tuotantolinja.md) - [Kuinka tehdä vertaileva analyysi?](https://success.openhealth.fr/fi/articles/3440093-kuinka-tehda-vertaileva-analyysi.md): Haluat verrata kahden eri palveluntarjoajan tietoja. - [TASO 1 TUTKIMUS - Tietojen laatu OpenHealth Companyn palveluksessa](https://success.openhealth.fr/fi/articles/3595822-taso-1-tutkimus-tietojen-laatu-openhealth-companyn-palveluksessa.md): Havaitsetko ilmiötä, jota et ymmärrä? Voimme antaa sinulle tämän havainnon alkuperän ja selittää sen sinulle. - [Tietojen laatuprosessi OpenHealthissa](https://success.openhealth.fr/fi/articles/3415271-tietojen-laatuprosessi-openhealthissa.md): Tässä artikkelissa kerrotaan tietojen laatuprosessien vaiheista OpenHealthissa - [Intervalli- ja luottamustaso](https://success.openhealth.fr/fi/articles/3633173-intervalli-ja-luottamustaso.md): Määritelmät, kaavat ja rajoitukset: mitä sinun on tiedettävä - [Tietojen laatu: Erän hallinta](https://success.openhealth.fr/fi/articles/3433509-tietojen-laatu-eran-hallinta.md): Eränhallintaprosessin kuvaus - [Tietojen laatu: Myynnin hajoamisprosessi](https://success.openhealth.fr/fi/articles/3415317-tietojen-laatu-myynnin-hajoamisprosessi.md): Kuvaus myynnin erittelyprosessista - [Sell-in ja Stock Offset](https://success.openhealth.fr/fi/articles/4131084-sell-in-ja-stock-offset.md): Osakkeiden myynti - [Miksi analysoida sisäänmyynnin määrää?](https://success.openhealth.fr/fi/articles/3846167-miksi-analysoida-sisaanmyynnin-maaraa.md): Miksi analysoida sisäänmyynnin määrää? - [Myynnin ja loppuunmyynnin välillä on tietovaje](https://success.openhealth.fr/fi/articles/3195358-myynnin-ja-loppuunmyynnin-valilla-on-tietovaje.md): Missä tapauksissa meillä voi olla tietokuilu sisään- ja ulosmyynnin välillä? - [Mikä on epätyypillinen myynti?](https://success.openhealth.fr/fi/articles/3195366-mika-on-epatyypillinen-myynti.md): Epätyypillinen myynti ja epätyypillinen suodatinprosessi. - [Mistä hinnat, määrät, liikevaihto tulevat?](https://success.openhealth.fr/fi/articles/3195348-mista-hinnat-maarat-liikevaihto-tulevat.md): Hinta / määrä / liikevaihto - [Arvioitu myyntivolyymi lääkemääräyksittäin](https://success.openhealth.fr/fi/articles/4171530-arvioitu-myyntivolyymi-laakemaarayksittain.md): Kuinka arvioida myyntimäärät apteekeissa lääkäreiden ja reseptiluokkien mukaan - [2 uuton eron ymmärtäminen](https://success.openhealth.fr/fi/articles/13399689-2-uuton-eron-ymmartaminen.md) ### Askeleet - [GTIN](https://success.openhealth.fr/fi/articles/3608176-gtin.md): GTIN-koodi \(maailmanlaajuinen kauppanumero\) - [Asiakkaan tuotteen karsintakentän määrittely \(CQCP\)](https://success.openhealth.fr/fi/articles/3704913-asiakkaan-tuotteen-karsintakentan-maarittely-cqcp.md): CQCP \(Product Customer Qualifier -kenttä\) - [Mikä on LPPR-koodi?](https://success.openhealth.fr/fi/articles/3195365-mika-on-lppr-koodi.md): LPPR-koodi \(Luettelo korvattavista tuotteista ja palveluista\) - [Tuotevuokrauksen seuranta](https://success.openhealth.fr/fi/articles/4206554-tuotevuokrauksen-seuranta.md): Tuotevuokraus - [Haluan laajentaa markkinoitani](https://success.openhealth.fr/fi/articles/4420843-haluan-laajentaa-markkinoitani.md): Tilausmarkkinat seurasivat - [OHC-luokitus](https://success.openhealth.fr/fi/articles/3194589-ohc-luokitus.md): Tarkastele tuotteidesi määritystä oman OpenHealth Company -luokituksen mukaan - [EphMRA AC -luokkien historia](https://success.openhealth.fr/fi/articles/3557908-ephmra-ac-luokkien-historia.md): Visualisoi EphMRA AC -luokkien kehitys vuodesta 2014 lähtien - [Eläinlääketieteen tiedot](https://success.openhealth.fr/fi/articles/3194587-elainlaaketieteen-tiedot.md): Visualisoi eläinlääkkeiden ominaisuudet - [Eläinlääketieteen luokitus](https://success.openhealth.fr/fi/articles/3194579-elainlaaketieteen-luokitus.md): Tarkastele eläinlääkkeiden luokitusta \(ANSES\) - [Ihmislääketieteen yksityiskohdat](https://success.openhealth.fr/fi/articles/3421225-ihmislaaketieteen-yksityiskohdat.md): Tarkastele yhden tai useamman tuotteen ominaisuuksia THESORIMED-tietokentissä - [Uusien tuotteiden hallinta](https://success.openhealth.fr/fi/articles/4470813-uusien-tuotteiden-hallinta.md): Uusi tuotehallinta - [Ihmislääketieteen luokitus](https://success.openhealth.fr/fi/articles/3417281-ihmislaaketieteen-luokitus.md): Tarkastele tuotevalikoimaasi kuuluvia EphMRA AC- ja OMS ATC-luokituksia - [Käyttöaiheet - diagnoosi](https://success.openhealth.fr/fi/articles/3568554-kayttoaiheet-diagnoosi.md): Katso tietylle patologialle osoitetut lääkkeet ja lääkevalikoimaan liittyvät patologiat - [MP4U](https://success.openhealth.fr/fi/articles/3574188-mp4u.md): Näytä kaikki luokitukset, jotka OpenHealth Company tarjoaa - [Mikä on TVASI \(Myyntiä, ostoja ja tuntemattomia varastoja koskeva taulukko\)?](https://success.openhealth.fr/fi/articles/5992494-mika-on-tvasi-myyntia-ostoja-ja-tuntemattomia-varastoja-koskeva-taulukko.md) - [IRI-tuotteiden luokitus](https://success.openhealth.fr/fi/articles/3194597-iri-tuotteiden-luokitus.md): Visualisoi tuotteidesi luokitus luokituksen mukaan omistaja IRI - [Myymättömien tuotteiden poistaminen](https://success.openhealth.fr/fi/articles/6135938-myymattomien-tuotteiden-poistaminen.md) - [VAKIMARKKINAT - Tilaus](https://success.openhealth.fr/fi/articles/3798203-vakimarkkinat-tilaus.md): Tässä artikkelissa kuvataan niin sanottujen "vakiomarkkinoiden" kiinnostus ja rajoitukset - [En löydä tuotetta](https://success.openhealth.fr/fi/articles/5686002-en-loyda-tuotetta.md) - [Tuotekoodien hallinta](https://success.openhealth.fr/fi/articles/5652478-tuotekoodien-hallinta.md) - [Tuotteen pätevyys: tuotemerkit](https://success.openhealth.fr/fi/articles/5016985-tuotteen-patevyys-tuotemerkit.md) ### TILAUKSET JA MODUULIT - [3 sovellustyyppiä](https://success.openhealth.fr/fi/articles/9489652-3-sovellustyyppia.md) - [Sinun 2.0-alustasi](https://success.openhealth.fr/fi/articles/8374416-sinun-2-0-alustasi.md) - [YHTEENVETO](https://success.openhealth.fr/fi/articles/3344127-yhteenveto.md): Kaikki sovelluksesi ominaisuudet ovat käytettävissä tässä moduulissa - [Markkinat ja valikoimat](https://success.openhealth.fr/fi/articles/8337016-markkinat-ja-valikoimat.md) - [Yhteenveto kojelauta](https://success.openhealth.fr/fi/articles/9246867-yhteenveto-kojelauta.md) - [Analyysi](https://success.openhealth.fr/fi/articles/9352287-analyysi.md) - [Uutto](https://success.openhealth.fr/fi/articles/9246875-uutto.md) - [Kasvuanalyysi](https://success.openhealth.fr/fi/articles/3158856-kasvuanalyysi.md): Määritä avaintekijät markkinoidesi ja kilpailijoiden kehityksessä - [Lajitelma-analyysi](https://success.openhealth.fr/fi/articles/3473736-lajitelma-analyysi.md): Tutki tuotteiden dynaamisuutta markkinoilla - [Tuotteiden keskimääräinen lukumäärä](https://success.openhealth.fr/fi/articles/3161474-tuotteiden-keskimaarainen-lukumaara.md): Tarkastele tuotteiden keskimääräistä myyntipistettä apteekeissa tai GSA-apteekeissa - [Käynnistä seuranta](https://success.openhealth.fr/fi/articles/3158488-kaynnista-seuranta.md): Seuraa tuotteiden lanseerauksia ja niiden vaikutusta kasvuun - [Edistyneet indikaattorit Rajat ylittyivät](https://success.openhealth.fr/fi/articles/6007740-edistyneet-indikaattorit-rajat-ylittyivat.md) - [Myynnin keskittyminen](https://success.openhealth.fr/fi/articles/3095338-myynnin-keskittyminen.md): Visualisoi markkinoiden keskittyminen myynnin keskittymiskäyrän ja GINI-indeksin avulla - [Hintahajonta](https://success.openhealth.fr/fi/articles/3159289-hintahajonta.md): Visualisoi tuotteen hintahajonta. Luo omat apteekkisegmentit myyntihinnasta - [Loppuunmyytyjen marginaalien analyysi](https://success.openhealth.fr/fi/articles/3358322-loppuunmyytyjen-marginaalien-analyysi.md): Vertaa tuotteiden houkuttelevuutta apteekeihin - [Sell-Out-marginaalin kehitys](https://success.openhealth.fr/fi/articles/3815561-sell-out-marginaalin-kehitys.md) - [Apteekkien seuranta \(1/2\)](https://success.openhealth.fr/fi/articles/3358248-apteekkien-seuranta-1-2.md): Seuraa apteekkiliikenteen kehitystä - [Apteekkien seuranta \(2/2\)](https://success.openhealth.fr/fi/articles/3810527-apteekkien-seuranta-2-2.md): Seuraa apteekkiliikenteen kehitystä - [Salesforce-suorituskyky](https://success.openhealth.fr/fi/articles/3159230-salesforce-suorituskyky.md): Vertaa myyntivoiman alueiden ja sektoreiden myyntituloksia - [Asiakassuhteiden hallinta \(CRM\) ASSISTENTTI](https://success.openhealth.fr/fi/articles/5953935-asiakassuhteiden-hallinta-crm-assistentti.md) - [Myyntipisteen seuranta](https://success.openhealth.fr/fi/articles/3778944-myyntipisteen-seuranta.md): Myyntipisteen seuranta - [On Demand Evolution](https://success.openhealth.fr/fi/articles/6560184-on-demand-evolution.md) - [Tilausanalyysi](https://success.openhealth.fr/fi/articles/6127483-tilausanalyysi.md) - [On Demand -taulukko](https://success.openhealth.fr/fi/articles/3158751-on-demand-taulukko.md): Visualisoi tärkeimmät HUB-indikaattorit ja niiden kehitys erilaisten ajanjaksojen aikana - [Aikasarjan analyysi](https://success.openhealth.fr/fi/articles/3635940-aikasarjan-analyysi.md): Jaa markkinoiden mukaan kausi, trendi ja melu - [Ennuste-analyysi](https://success.openhealth.fr/fi/articles/3636015-ennuste-analyysi.md): Arvioi markkinoidesi tulevaisuus - [Alakohtainen ennuste](https://success.openhealth.fr/fi/articles/3689811-alakohtainen-ennuste.md): Arvioi tulevaisuuden toimialasi myynti - [Sell-in-visualisointi](https://success.openhealth.fr/fi/articles/3559882-sell-in-visualisointi.md): Vertaa myynti- ja myyntimyynnin kehitystä - [Sell-in-analyysi](https://success.openhealth.fr/fi/articles/6188132-sell-in-analyysi.md) - [Sell-in Matching](https://success.openhealth.fr/fi/articles/6188090-sell-in-matching.md) - [Sell-in Evolution](https://success.openhealth.fr/fi/articles/6191929-sell-in-evolution.md) - [Sell-in vs. Sell-out analyysi](https://success.openhealth.fr/fi/articles/6191947-sell-in-vs-sell-out-analyysi.md) - [Sell-in vs Sell-out Evolution](https://success.openhealth.fr/fi/articles/6191955-sell-in-vs-sell-out-evolution.md) - [Hinnan kehitys](https://success.openhealth.fr/fi/articles/5056489-hinnan-kehitys.md) - [Mukauta värejä](https://success.openhealth.fr/fi/articles/8407897-mukauta-vareja.md) - [Tuotteiden vienti](https://success.openhealth.fr/fi/articles/3583206-tuotteiden-vienti.md): Vie taulukko, joka koskee kaikkia tuotteita ja MP4U-tyyppisiä sovelluksia - [Markkina-analyysi](https://success.openhealth.fr/fi/articles/3121933-markkina-analyysi.md): Analysoi markkinoidesi suorituskyky: segmenttien, tuotemerkkien, tuotteiden ja yritysten mukaan - [Hinta-analyysi](https://success.openhealth.fr/fi/articles/3215190-hinta-analyysi.md): Tarkastele markkinoidesi hintoja ja analysoi sijaintisi - [Myynnin kehitys](https://success.openhealth.fr/fi/articles/3178323-myynnin-kehitys.md): Tarkastele muuttuvaa myyntiäsi koko käytettävissä olevan historian aikana - [Yhteenveto Dashboard](https://success.openhealth.fr/fi/articles/4533213-yhteenveto-dashboard.md) - [Markkinaosuuden kehitys](https://success.openhealth.fr/fi/articles/3193078-markkinaosuuden-kehitys.md): Visualisoi myynnin ja markkinaosuuden kehitys pitkällä aikavälillä - [Myynnin ristipöytä](https://success.openhealth.fr/fi/articles/3193060-myynnin-ristipoyta.md): Luo yksinkertainen pivot-taulukko - [PALAUTE / TILAVUUS \(CU\) -synteesi](https://success.openhealth.fr/fi/articles/3193048-palaute-tilavuus-cu-synteesi.md): Visualisoi samanaikaisesti markkinoiden myyntimäärät ja arvo - [Loppuunmyytyjen arvojen synteesi \(APTEEKIT / SUPERMARKETIT\)](https://success.openhealth.fr/fi/articles/3193020-loppuunmyytyjen-arvojen-synteesi-apteekit-supermarketit.md): Vertaa GSA-apteekkien ja apteekkien myyntiä - [Markkinaosuusanalyysi](https://success.openhealth.fr/fi/articles/3193069-markkinaosuusanalyysi.md): Analysoi markkinaosuudet viimeisten 12 kuukauden ajalta - [Oma data-arkisto](https://success.openhealth.fr/fi/articles/3193099-oma-data-arkisto.md): Vie tasainen tietokanta Exceliin - [Usean jakson analyysi](https://success.openhealth.fr/fi/articles/3192953-usean-jakson-analyysi.md): Luo täysin räätälöity taulukko - [Oma kysely Kaikki tuotteet](https://success.openhealth.fr/fi/articles/4280353-oma-kysely-kaikki-tuotteet.md): Tarkastele segmenttejäsi ja karsintakenttiäsi \(esim. Galeeninen, aurinkoindeksi, tarjoukset ...\) sekä rajoitustasi - [Stock Evolution \(UUSI\)](https://success.openhealth.fr/fi/articles/3719256-stock-evolution-uusi.md): Visualisoi ja analysoi varastojen kehitys ja niiden jakautuminen - [Markkinoiden määritelmä](https://success.openhealth.fr/fi/articles/3158829-markkinoiden-maaritelma.md): Pohjaa markkinat uudelleen valitsemallesi 100 tukikohdalle - [RAW DATA Advanced Indikaattorit](https://success.openhealth.fr/fi/articles/3711095-raw-data-advanced-indikaattorit.md): Palauta johtavat indikaattoritiedot - [Edistyneet indikaattorit Evolution SMKT](https://success.openhealth.fr/fi/articles/3193000-edistyneet-indikaattorit-evolution-smkt.md): Seuraa laboratorion suorituskykyä analysoimalla edistyneiden tilastollisten indikaattoreidesi ajallinen kehitys. - [Edistyneiden indikaattoreiden analyysi SMKT](https://success.openhealth.fr/fi/articles/3192366-edistyneiden-indikaattoreiden-analyysi-smkt.md): Jaa GSA-lääkkeiden markkinoiden kehitys johtaviksi indikaattoreiksi - [Kehittyneet indikaattorit](https://success.openhealth.fr/fi/articles/3177853-kehittyneet-indikaattorit.md): Seuraa laboratorion suorituskykyä analysoimalla edistyneiden tilastollisten indikaattoreidesi ajallinen kehitys. - [Edistyneet indikaattorit Evolution Bio](https://success.openhealth.fr/fi/articles/7051823-edistyneet-indikaattorit-evolution-bio.md) - [Kansalliset edistyneet indikaattorit](https://success.openhealth.fr/fi/articles/3364513-kansalliset-edistyneet-indikaattorit.md): Jaa markkinoiden kehitys johtaviksi indikaattoreiksi - [Kanta-analyysi](https://success.openhealth.fr/fi/articles/3178015-kanta-analyysi.md): Tulkitse varastotaso ja sen kehitys - [Kehittyneiden indikaattoreiden analyysi Bio](https://success.openhealth.fr/fi/articles/7051801-kehittyneiden-indikaattoreiden-analyysi-bio.md) - [Kehittyneiden indikaattorien analyysi](https://success.openhealth.fr/fi/articles/3124439-kehittyneiden-indikaattorien-analyysi.md): Jaa markkinoiden kehitys johtaviksi indikaattoreiksi - [Kartografia](https://success.openhealth.fr/fi/articles/3192450-kartografia.md): Analysoi myyntivoimasi alueiden ja alojen kaupallinen suorituskyky - [Maantieteellinen ristipöytä](https://success.openhealth.fr/fi/articles/3192466-maantieteellinen-ristipoyta.md): Luo alakohtainen taulukko integroimalla sektorisointisi - [Maantieteellinen myynnin kehitys](https://success.openhealth.fr/fi/articles/3192482-maantieteellinen-myynnin-kehitys.md): Visualisoi myynti sektorikohtaisesti yli 36 kuukauden ajan pivot-taulukossa - [Myyntihenkilöstön tehokkuus](https://success.openhealth.fr/fi/articles/5624011-myyntihenkiloston-tehokkuus.md) - [Mukautetun painotusmenetelmän analyysi](https://success.openhealth.fr/fi/articles/5169317-mukautetun-painotusmenetelman-analyysi.md) - [Verkkoanalyysi](https://success.openhealth.fr/fi/articles/3894767-verkkoanalyysi.md): Verkkoanalyysi - [Mukautetun painotusmenetelmän kehitys](https://success.openhealth.fr/fi/articles/5169320-mukautetun-painotusmenetelman-kehitys.md) - [YHTEENVETO KPI: t](https://success.openhealth.fr/fi/articles/3478199-yhteenveto-kpi-t.md): Visualisoi dynaamisessa taulukossa tärkeimmät indikaattorit Määrä laski alueille ja sektoreille. - [Myynti muunnetuissa yksiköissä](https://success.openhealth.fr/fi/articles/3192412-myynti-muunnetuissa-yksikoissa.md): Käytä muunnettuja yksiköitä visualisoidaksesi myyntiäsi - [RAW DATA -osakkeen indikaattorit](https://success.openhealth.fr/fi/articles/3711142-raw-data-osakkeen-indikaattorit.md): Vie varastotiedot - [RAAKATIEDOT SMKT AIA](https://success.openhealth.fr/fi/articles/3720960-raakatiedot-smkt-aia.md): Etsi SMKT: n johtavat indikaattoritiedot - [Osakekehitys](https://success.openhealth.fr/fi/articles/3178277-osakekehitys.md): Visualisoi ja analysoi varastojen kehitys ja niiden jakautuminen - [Maantieteelliset edistyneet indikaattorit](https://success.openhealth.fr/fi/articles/3192508-maantieteelliset-edistyneet-indikaattorit.md): Tarkastele johtavia indikaattoreita alueen tai sektorin mukaan - [Tuotteiden suorituskyky](https://success.openhealth.fr/fi/articles/3850331-tuotteiden-suorituskyky.md): Vertaa alueiden ja tuotesektorien liiketoiminnan suorituskykyä - [Alueelliset edistyneet indikaattorit](https://success.openhealth.fr/fi/articles/3370879-alueelliset-edistyneet-indikaattorit.md): Jaa markkinoiden kehitys johtaviksi indikaattoreiksi - [Aikasarjan alakohtainen analyysi](https://success.openhealth.fr/fi/articles/3814974-aikasarjan-alakohtainen-analyysi.md): Jaa markkinat trendiksi, kaudeksi, meluksi - [Myynnin analyysi iän ja sukupuolen mukaan](https://success.openhealth.fr/fi/articles/3192701-myynnin-analyysi-ian-ja-sukupuolen-mukaan.md): Analysoi myyntiä iän ja sukupuolen mukaan - [Myynnin kehitys raskauden tilan mukaan](https://success.openhealth.fr/fi/articles/3192910-myynnin-kehitys-raskauden-tilan-mukaan.md): Seuraa apteekkien myyntiä raskaana olevien naisten joukossa - [Myynnin kehitys ikän ja sukupuolen mukaan](https://success.openhealth.fr/fi/articles/3192732-myynnin-kehitys-ikan-ja-sukupuolen-mukaan.md): Visualisoi myynnin kehitys iän ja sukupuolen mukaan HUB: n historian syvyyden avulla - [Vaatimukset Tilausjärjestyksen kehitys](https://success.openhealth.fr/fi/articles/5790020-vaatimukset-tilausjarjestyksen-kehitys.md) - [Evoluution rinnakkaisannostelut](https://success.openhealth.fr/fi/articles/3192529-evoluution-rinnakkaisannostelut.md): Visualisoi ja hajota apteekkien rinnakkaisjakelun kehitys - [Yhteispakkausanalyysi](https://success.openhealth.fr/fi/articles/3192633-yhteispakkausanalyysi.md): Tarkastele apteekkien yhteishoitoja, jotka liittyvät valikoimaan tuotteita markkinoilleni - [Myynti kanavaa ja lääkäriä kohden](https://success.openhealth.fr/fi/articles/3192751-myynti-kanavaa-ja-laakaria-kohden.md): Visualisoi vaikuttajat markkinoillasi - [AMO, AMC ja RAC](https://success.openhealth.fr/fi/articles/3192929-amo-amc-ja-rac.md): Tarkastele pakollisen sairausvakuutuksen, täydentävän sairausvakuutuksen ja omien kulujen kolmea summaa - [Samanaikainen annostelu](https://success.openhealth.fr/fi/articles/3876946-samanaikainen-annostelu.md): Visualisoi jakelulla myytyjen tuotteiden lukumäärä jakelulla - [Dispensation Dispersion Evolution](https://success.openhealth.fr/fi/articles/3920070-dispensation-dispersion-evolution.md): Visualisoi jaettujen tuotteiden määrä jakelua kohden ajan myötä - [Yleislääkärin määräykset iän ja sukupuolen mukaan](https://success.openhealth.fr/fi/articles/5789899-yleislaakarin-maaraykset-ian-ja-sukupuolen-mukaan.md) - [Reseptit Tilausten analyysi](https://success.openhealth.fr/fi/articles/5322866-reseptit-tilausten-analyysi.md) - [Yleislääkärin lääkemääräykset Evoluutio](https://success.openhealth.fr/fi/articles/5790016-yleislaakarin-laakemaaraykset-evoluutio.md) - [Kori-analyysi](https://success.openhealth.fr/fi/articles/3711049-kori-analyysi.md): Kuvaus 'Basket Analysis' -moduulista - [Yhteisannostelu](https://success.openhealth.fr/fi/articles/4738243-yhteisannostelu.md) - [Kohortin pätevyysmoduuli](https://success.openhealth.fr/fi/articles/3928090-kohortin-patevyysmoduuli.md): Potilasryhmän pätevyys - [Hoitotilan moduuli](https://success.openhealth.fr/fi/articles/3928067-hoitotilan-moduuli.md): Analysoi hoidon seurannan dynamiikkaa - [Hoidon noudattamisen moduuli](https://success.openhealth.fr/fi/articles/3928044-hoidon-noudattamisen-moduuli.md): Analysoi hoitojen noudattamista - [Kohortin määritelmä](https://success.openhealth.fr/fi/articles/3894703-kohortin-maaritelma.md): Määritä analyysisi laajuus - [Yhteishoidot](https://success.openhealth.fr/fi/articles/4163623-yhteishoidot.md): Määritä yhteisprosessointi analyysin puitteissa - [Visualisoinnin kohortti](https://success.openhealth.fr/fi/articles/3894721-visualisoinnin-kohortti.md): Tarkastele määritetyn kohortin potilasprofiilia - [Analyysikriteerien määrittely](https://success.openhealth.fr/fi/articles/3894728-analyysikriteerien-maarittely.md): Määritä kohortin analyysin parametrit - [Globaalin kohortin kehitys](https://success.openhealth.fr/fi/articles/3894747-globaalin-kohortin-kehitys.md): Visualisoi kohortin kuukausittainen kehitys - [Maantieteellinen jakauma](https://success.openhealth.fr/fi/articles/3894751-maantieteellinen-jakauma.md): Tarkastele potilaiden maantieteellistä jakaumaa määritetyssä kohortissa - [Kohortin profiili](https://success.openhealth.fr/fi/articles/3894755-kohortin-profiili.md): Analysoi kohorttiin kuuluvien potilaiden demografinen profiili - [Hoitotila hajoaa](https://success.openhealth.fr/fi/articles/3894764-hoitotila-hajoaa.md): Hanki yleiskuva erityyppisistä hoidon seurannoista - [Hoidon aloittaminen](https://success.openhealth.fr/fi/articles/3894778-hoidon-aloittaminen.md): Analysoi hoidon aloitusten määrän kehitys - [Hoito alkaa uudelleen](https://success.openhealth.fr/fi/articles/3894788-hoito-alkaa-uudelleen.md): Analysoi hoidon uusintamäärien kehitys - [Uudet hoidot](https://success.openhealth.fr/fi/articles/3894804-uudet-hoidot.md): Analysoi hoidon aloittamisen ja jatkamisen määrän kehitys - [Hoidon toistumiset](https://success.openhealth.fr/fi/articles/3894812-hoidon-toistumiset.md): Analysoi potilaita hoidon aikana - [Hoitokytkimen tasapaino](https://success.openhealth.fr/fi/articles/3894821-hoitokytkimen-tasapaino.md): Analysoi hoitomuutosten tasapaino hoidolla - [Hoitokytkimen voitot](https://success.openhealth.fr/fi/articles/3894830-hoitokytkimen-voitot.md): Analysoi hoitokytkimien edunsaajia - [Hoitokytkimen tappiot](https://success.openhealth.fr/fi/articles/3894843-hoitokytkimen-tappiot.md): Analysoi hoitokytkimien häviäjät hoidolla - [Vaihda vahvistuksen alkuperää](https://success.openhealth.fr/fi/articles/3894857-vaihda-vahvistuksen-alkuperaa.md): Analysoi kytkimen alkuperä tietylle hoidolle - [Vaihda häviökohde](https://success.openhealth.fr/fi/articles/3894864-vaihda-haviokohde.md): Analysoi kytkimen kohde tietylle hoidolle - [Pudotukset](https://success.openhealth.fr/fi/articles/3894874-pudotukset.md): Analysoi hoidon loppuminen - [KPI-yhteenveto](https://success.openhealth.fr/fi/articles/4229969-kpi-yhteenveto.md): Yhteenveto erityyppisistä hoidonseurannoista - [Hoidon pysyvyys](https://success.openhealth.fr/fi/articles/3894883-hoidon-pysyvyys.md): Analysoi hoitojen kesto - [Vaatimustenmukaisuus](https://success.openhealth.fr/fi/articles/3894884-vaatimustenmukaisuus.md): Analysoi toimitetut määrät - [Mikä on säännöllisyyskriteeri?](https://success.openhealth.fr/fi/articles/3325816-mika-on-saannollisyyskriteeri.md): Säännöllisyyskriteerin käsitteen määrittely - [Kuolema - kartografia](https://success.openhealth.fr/fi/articles/3863677-kuolema-kartografia.md): Analysoi kuolemien maantieteellinen jakauma - [Kuolemien määrän laskenta](https://success.openhealth.fr/fi/articles/3863573-kuolemien-maaran-laskenta.md): Arvioi tietojesi relevanssi - [Kuolema - analyysi iästä ja sukupuolesta](https://success.openhealth.fr/fi/articles/3863808-kuolema-analyysi-iasta-ja-sukupuolesta.md): Analysoi kuolemien rakenne - [Kuolema - Evolution by AGE & GENDER](https://success.openhealth.fr/fi/articles/3863939-kuolema-evolution-by-age-gender.md): Analysoi kuolemarakenteen kehitys - [Kuolema - evoluutio](https://success.openhealth.fr/fi/articles/3864065-kuolema-evoluutio.md): Visualisoi kuolemien kehitys - [Kuolema - evoluutio-vertailu](https://success.openhealth.fr/fi/articles/3864073-kuolema-evoluutio-vertailu.md): Vertaa kuolemien kehitystä edellisiin vuosiin verrattuna - [Apteekkien seuranta CA](https://success.openhealth.fr/fi/articles/4634768-apteekkien-seuranta-ca.md): Kuvaile liikennettä apteekkien koon mukaan - [Liikenneanalyysi \(beta-testi\)](https://success.openhealth.fr/fi/articles/6848401-liikenneanalyysi-beta-testi.md) - [Apteekkien seurantatiedot](https://success.openhealth.fr/fi/articles/4527868-apteekkien-seurantatiedot.md): Analysoi apteekkiliikenne apteekkityypin mukaan - [Traffic Evolution \(beta-testi\)](https://success.openhealth.fr/fi/articles/6848016-traffic-evolution-beta-testi.md) - [Apteekkien kartografia](https://success.openhealth.fr/fi/articles/4527811-apteekkien-kartografia.md): Analysoi Manner-Ranskan apteekkiliikenne - [Apteekkien seurantatiedot](https://success.openhealth.fr/fi/articles/4262306-apteekkien-seurantatiedot.md): Erota myynnin yksityiskohdat apteekkityypeittäin - [Apteekkien seuranta-analyysi](https://success.openhealth.fr/fi/articles/3839223-apteekkien-seuranta-analyysi.md): Seuraa apteekkiliikenteen kehitystä - [Apteekit seuraavat kehitystä](https://success.openhealth.fr/fi/articles/3827973-apteekit-seuraavat-kehitysta.md): Tutki annosteluliikenteen kehitystä - [Liikenteen hajoaminen](https://success.openhealth.fr/fi/articles/3826074-liikenteen-hajoaminen.md): Tarkkaile vuodenajan, trendin ja jäämien komponentteja - [Liikennetutkimus](https://success.openhealth.fr/fi/articles/3809042-liikennetutkimus.md): Analysoi apteekkiliikenne - [Tiivistelmä - PIEX](https://success.openhealth.fr/fi/articles/5203335-tiivistelma-piex.md) - [Ostaminen](https://success.openhealth.fr/fi/articles/4605110-ostaminen.md): Seuraa ostoksiasi ja niiden kuitteja - [Oma kyselyni - PIEX](https://success.openhealth.fr/fi/articles/4210627-oma-kyselyni-piex.md): Tee valintoja tiedoihisi - [Myynnin kehitys - PIEX](https://success.openhealth.fr/fi/articles/4210655-myynnin-kehitys-piex.md): Tarkastele aktiviteettisi kehitystä käytettävissä olevan historian perusteella - [Myynti-analyysi - PIEX](https://success.openhealth.fr/fi/articles/4210650-myynti-analyysi-piex.md): Myynti-analyysi - PIEX - [Tilaustiedot - PIEX](https://success.openhealth.fr/fi/articles/4210659-tilaustiedot-piex.md): Tarkastele ja seuraa myyntitilausta - [Varastokatsaus - PIEX](https://success.openhealth.fr/fi/articles/4210672-varastokatsaus-piex.md): Visualisoi varastojesi vaihtelut - [Oma tietoarkisto - PIEX](https://success.openhealth.fr/fi/articles/4210694-oma-tietoarkisto-piex.md): Vie tasainen tietokanta Exceliin - [EURAPHARMA-PIEX](https://success.openhealth.fr/fi/articles/4366306-eurapharma-piex.md): Visualisoi EURAPHARMAn toiminnan kehitys - [Vastaava tuote](https://success.openhealth.fr/fi/articles/4366320-vastaava-tuote.md): PIEX- ja EURAPHARMA-tuotteiden nimitysten välinen vastaavuus - [CLI Oma tiedosto \(1/5\)](https://success.openhealth.fr/fi/articles/4626422-cli-oma-tiedosto-1-5.md): CLI Oma tiedosto \(1/5\) - [CLI\_tiedostojen lukumäärä \(2/5\)](https://success.openhealth.fr/fi/articles/4626421-cli_tiedostojen-lukumaara-2-5.md): CLI\_tiedostojen lukumäärä \(2/5\) - [CLI\_File Code Matching OHC-arkiston kanssa](https://success.openhealth.fr/fi/articles/4626419-cli_file-code-matching-ohc-arkiston-kanssa.md): CLI\_FIL-koodin täsmäys OHC-arkiston kanssa - [Loppuunmyyty vienti \(4/5\)](https://success.openhealth.fr/fi/articles/4626414-loppuunmyyty-vienti-4-5.md): Loppuunmyyty vienti \(4/5\) ### HENKILÖKOHTAISET VAIHTOEHDOT - [Ei-hierarkkiset tuotekelpoiset kentät](https://success.openhealth.fr/fi/articles/4036045-ei-hierarkkiset-tuotekelpoiset-kentat.md): Lisää tietoja tuotteidesi pätevyydestä - [Mikä on HUB-tietojen enimmäisikä?](https://success.openhealth.fr/fi/articles/3195251-mika-on-hub-tietojen-enimmaisika.md): Viimeiset tiedot saatavilla - [asiakastyyppi](https://success.openhealth.fr/fi/articles/4197147-asiakastyyppi.md): Mukautettu vaihtoehto Asiakastyyppi - [Istunnon käyttöoikeus](https://success.openhealth.fr/fi/articles/4036458-istunnon-kayttooikeus.md): Rajoita työntekijöiden katselukertaa - [Mukautettu sykli](https://success.openhealth.fr/fi/articles/4036444-mukautettu-sykli.md): Analysoi tietosi henkilökohtaisina ajanjaksoina - [Tilikausi](https://success.openhealth.fr/fi/articles/4036169-tilikausi.md): Määritä tilikausi - [Päivä-painike](https://success.openhealth.fr/fi/articles/4036159-paiva-painike.md): Visualisoi tietosi tarkemmin - [Viikko-painike](https://success.openhealth.fr/fi/articles/4036111-viikko-painike.md): Visualisoi tietosi tarkemmin - [Valuuttakurssit](https://success.openhealth.fr/fi/articles/8329594-valuuttakurssit.md) - [SMKT-ajanjakso](https://success.openhealth.fr/fi/articles/4036549-smkt-ajanjakso.md): Käytä GSA-kalenteria - [Rajoita kehää](https://success.openhealth.fr/fi/articles/4560699-rajoita-kehaa.md): Yhden GTIN-luettelon valitseminen Omassa kyselyssä .xlsx-tiedostosta - [Rajoita kehää \(koodi 7\)](https://success.openhealth.fr/fi/articles/4560791-rajoita-kehaa-koodi-7.md): Yhden \[TEKNINEN KOODI 2\] -luettelon valinta Omassa kyselyssä .xlsx-tiedostosta - [Markkinoiden lippu](https://success.openhealth.fr/fi/articles/4560797-markkinoiden-lippu.md): Yhden GTIN-luettelon valitseminen Omassa kyselyssä .xlsx-tiedoston sisältämästä markkinoiden määritelmästä - [Kohdistus / asiakastyypin määrittely](https://success.openhealth.fr/fi/articles/3777788-kohdistus-asiakastyypin-maarittely.md): Kohdistus \(asiakastyyppi\) ### KESKITTIMEN ILMAISIN - [HUB-indikaattoreita koskeva sanasto](https://success.openhealth.fr/fi/articles/5194247-hub-indikaattoreita-koskeva-sanasto.md) - [Myyntimäärät](https://success.openhealth.fr/fi/articles/3194314-myyntimaarat.md): Myyntimäärät - [Myyntiarvot](https://success.openhealth.fr/fi/articles/3074854-myyntiarvot.md): Myyntiarvojen osoittimen määrittäminen - [N MS](https://success.openhealth.fr/fi/articles/3194475-n-ms.md): 'N MS' -toimenpiteen määritelmä - [N MS Evol](https://success.openhealth.fr/fi/articles/5634266-n-ms-evol.md) - [N MS Delta](https://success.openhealth.fr/fi/articles/3194469-n-ms-delta.md): Määritelmä 'N MS Delta' - [Poids Vol \(CA\) par modalité / Mukautettu paino Vol \(To\)](https://success.openhealth.fr/fi/articles/9292839-poids-vol-ca-par-modalite-mukautettu-paino-vol-to.md) - [Myynnin arvo valmistajan arvonlisäverottomaan hintaan perustuen \(liikevaihto PF ilman arvonlisäveroa\) - Marokko](https://success.openhealth.fr/fi/articles/7508513-myynnin-arvo-valmistajan-arvonlisaverottomaan-hintaan-perustuen-liikevaihto-pf-ilman-arvonlisaveroa-marokko.md) - [N kasvun napsautussuhde](https://success.openhealth.fr/fi/articles/3194466-n-kasvun-napsautussuhde.md): N kasvun napsautussuhteen mittauksen määritelmä ja laskentakaava - [Kaupassa](https://success.openhealth.fr/fi/articles/6201859-kaupassa.md) - [Ristiintaulukoitu paino Tilavuus](https://success.openhealth.fr/fi/articles/6066324-ristiintaulukoitu-paino-tilavuus.md) - [Ristiintaulukoitu painon kierto](https://success.openhealth.fr/fi/articles/6066273-ristiintaulukoitu-painon-kierto.md) - [N kasvun napsautussuhde oikaistu](https://success.openhealth.fr/fi/articles/3205376-n-kasvun-napsautussuhde-oikaistu.md): Määritelmä ja laskentakaava N-kasvun CTR A -mittaukselle - [Lähteen paino](https://success.openhealth.fr/fi/articles/5151525-lahteen-paino.md) - [Keskimääräinen hinta havaittu](https://success.openhealth.fr/fi/articles/3194302-keskimaarainen-hinta-havaittu.md): AASP: Keskimääräinen hinta havaittu - [Painotettu keskihinta](https://success.openhealth.fr/fi/articles/3194292-painotettu-keskihinta.md): WASP: Painotettu keskihinta - [Hintavaikutus](https://success.openhealth.fr/fi/articles/8426443-hintavaikutus.md) - [Myyvien apteekkien lukumäärä](https://success.openhealth.fr/fi/articles/3719566-myyvien-apteekkien-lukumaara.md) - [Digitaalisen jakelun myynti](https://success.openhealth.fr/fi/articles/3194321-digitaalisen-jakelun-myynti.md): Numeerinen jakelu - [Digitaalinen maailmanlaajuinen myynti](https://success.openhealth.fr/fi/articles/3194320-digitaalinen-maailmanlaajuinen-myynti.md): Maailmanlaajuinen numeerinen jakelu - [Digitaalisen jakelun myyntipohja uudelleen](https://success.openhealth.fr/fi/articles/4045636-digitaalisen-jakelun-myyntipohja-uudelleen.md): Numeerinen jakelu uudelleen - [Digitaalisen jakelun maailmanlaajuinen uudelleenperusta](https://success.openhealth.fr/fi/articles/4045725-digitaalisen-jakelun-maailmanlaajuinen-uudelleenperusta.md): Maailmanlaajuinen numeerinen jakelu uudelleen - [Räätälöity digitaalisen myynnin jakelu](https://success.openhealth.fr/fi/articles/6830813-raataloity-digitaalisen-myynnin-jakelu.md) - [Myynti-arvon jakelu](https://success.openhealth.fr/fi/articles/3194323-myynti-arvon-jakelu.md): Painotettu jakelu - [Globaali myynti-arvon jakauma](https://success.openhealth.fr/fi/articles/3194316-globaali-myynti-arvon-jakauma.md): Globaali myynti-arvon jakauma - [Määritä myynti-arvon jakelu uudelleen](https://success.openhealth.fr/fi/articles/3194501-maarita-myynti-arvon-jakelu-uudelleen.md): DVV: n uudelleenasennus - [Myynnin arvonjako maailmanlaajuisesti uudelleen](https://success.openhealth.fr/fi/articles/4200619-myynnin-arvonjako-maailmanlaajuisesti-uudelleen.md): Globaali DVV: n uudelleenkäynnistys - [Räätälöity uudelleenperusteinen myynnin arvonjako](https://success.openhealth.fr/fi/articles/6834423-raataloity-uudelleenperusteinen-myynnin-arvonjako.md) - [Digitaalinen myyntijakelu SMKT](https://success.openhealth.fr/fi/articles/3365043-digitaalinen-myyntijakelu-smkt.md): Digitaalinen myyntijakelu SMKT \(SMK Numeric Distribution\) - [Maailmanlaajuinen SMKT-digitaalimyynnin myynti](https://success.openhealth.fr/fi/articles/4298341-maailmanlaajuinen-smkt-digitaalimyynnin-myynti.md): SMKT: n maailmanlaajuinen numeerinen jakelu \(SMKT: n maailmanlaajuinen numeerinen jakelu\) - [SMKT: n digitaalisen jakelun myyntipohja uudelleen](https://success.openhealth.fr/fi/articles/4298197-smkt-n-digitaalisen-jakelun-myyntipohja-uudelleen.md): SMKT: n digitaalinen jakelu uudelleen \(SMKT: n numeerinen jakelu uudelleen\) - [Digitaalisen jakelun maailmanlaajuinen uudelleenperusta](https://success.openhealth.fr/fi/articles/4319783-digitaalisen-jakelun-maailmanlaajuinen-uudelleenperusta.md): Digitaalisen jakelun myynti SMKT Rebasée Globale \(SMKT Global Numeric Distribution Refased\) - [SMKT: n myynti-arvon jakelu](https://success.openhealth.fr/fi/articles/3365478-smkt-n-myynti-arvon-jakelu.md): SMKT: n myynti-arvon jakelu \(SMKT: n painotettu jakelu\) - [Laskettu uudelleen maailmanlaajuinen SMKT-digitaalisen jakelun myynti](https://success.openhealth.fr/fi/articles/4298373-laskettu-uudelleen-maailmanlaajuinen-smkt-digitaalisen-jakelun-myynti.md): Digitaalisen jakelun myynti SMKT Global laskettu uudelleen \(SMKT Global Numeric Distribution laskettu uudelleen\) - [Digitaalinen jakelu, joka myy SMKT: tä uudelleen laskettu uudelleen](https://success.openhealth.fr/fi/articles/4298303-digitaalinen-jakelu-joka-myy-smkt-ta-uudelleen-laskettu-uudelleen.md): SMKT: n numeerinen jakelu laskettu uudelleen - [Oikaistu SMKT-digitaalisen jakelun myynti](https://success.openhealth.fr/fi/articles/3369386-oikaistu-smkt-digitaalisen-jakelun-myynti.md): Oikaistu numeerinen jakelu SMKT - [Digitaalinen jakelu, joka myy SMKT: tä uudelleen](https://success.openhealth.fr/fi/articles/4298209-digitaalinen-jakelu-joka-myy-smkt-ta-uudelleen.md): SMKT: n numeerinen jakelu laskettu uudelleen \(SMKT: n numeerinen jakelu laskettu uudelleen\) - [Oikaistu SMKT: n myynti-arvojakauma](https://success.openhealth.fr/fi/articles/3369397-oikaistu-smkt-n-myynti-arvojakauma.md): Oikaistu painotettu jakelu SMKT - [Orgaanisen digitaalisen myynnin jakelu](https://success.openhealth.fr/fi/articles/7052424-orgaanisen-digitaalisen-myynnin-jakelu.md) - [Myyvien apteekkien liikevaihto \(TSP\)](https://success.openhealth.fr/fi/articles/6096534-myyvien-apteekkien-liikevaihto-tsp.md) - [Arvio haltijan PDM: stä](https://success.openhealth.fr/fi/articles/4214883-arvio-haltijan-pdm-sta.md): Arvioi markkinaosuutesi asiakkaiden kanssa - [Lisää apteekkeja](https://success.openhealth.fr/fi/articles/8426451-lisaa-apteekkeja.md) - [Apteekkien häviäminen](https://success.openhealth.fr/fi/articles/8426460-apteekkien-haviaminen.md) - [Monikanavainen digitaalinen myynti ja jakelu](https://success.openhealth.fr/fi/articles/9293487-monikanavainen-digitaalinen-myynti-ja-jakelu.md) - [Kumulatiivinen myynti digitaalinen jakelu \(PHARMA\)](https://success.openhealth.fr/fi/articles/9330571-kumulatiivinen-myynti-digitaalinen-jakelu-pharma.md) - [Kuukauden keskimääräinen myynti](https://success.openhealth.fr/fi/articles/3194303-kuukauden-keskimaarainen-myynti.md): Keskimääräinen kuukausimyynti - [Oikaistu kuukausittainen keskimääräinen myynti](https://success.openhealth.fr/fi/articles/3194290-oikaistu-kuukausittainen-keskimaarainen-myynti.md): Oikaistu keskimääräinen kuukausimyynti - [Kuukauden keskimääräinen myyntiarvo](https://success.openhealth.fr/fi/articles/4535404-kuukauden-keskimaarainen-myyntiarvo.md): VMM CA - [AMS A:han: Kuukausittainen keskimääräinen myyntiarvo oikaistuna](https://success.openhealth.fr/fi/articles/6028256-ams-a-han-kuukausittainen-keskimaarainen-myyntiarvo-oikaistuna.md) - [Keskimääräinen myynti](https://success.openhealth.fr/fi/articles/3563716-keskimaarainen-myynti.md): Keskimääräinen myynti - [SMKT: n keskimääräinen myynti](https://success.openhealth.fr/fi/articles/3365496-smkt-n-keskimaarainen-myynti.md): SMKT: n keskimääräinen myynti - [Oikaistu SMKT: n keskimääräinen myynti](https://success.openhealth.fr/fi/articles/3369340-oikaistu-smkt-n-keskimaarainen-myynti.md): Oikaistu SMKT: n keskimääräinen myynti - [Keskimääräinen kuukausittainen orgaaninen myynti](https://success.openhealth.fr/fi/articles/7052551-keskimaarainen-kuukausittainen-orgaaninen-myynti.md) - [Keskimääräinen kuukausittainen myynti Orgaaninen arvo](https://success.openhealth.fr/fi/articles/7052573-keskimaarainen-kuukausittainen-myynti-orgaaninen-arvo.md) - [Varasto](https://success.openhealth.fr/fi/articles/3194332-varasto.md): Varastotietojen määrittely ja saatavuus HUB: ssä, SMAa-sovellusten kautta: Sales & Marketing Advanced -tilaus - [Keskimääräinen varasto](https://success.openhealth.fr/fi/articles/3194336-keskimaarainen-varasto.md): Keskimääräinen varasto - [Osakkeen osuus](https://success.openhealth.fr/fi/articles/3194334-osakkeen-osuus.md): Osakkeen osuus - [Kaupallinen paineindeksi](https://success.openhealth.fr/fi/articles/3194335-kaupallinen-paineindeksi.md): Kaupallinen paineindeksi - [Osakkeen muunnosnopeus](https://success.openhealth.fr/fi/articles/3194344-osakkeen-muunnosnopeus.md): Osakkeiden muuntokurssi - [Toimituksen kesto](https://success.openhealth.fr/fi/articles/3194337-toimituksen-kesto.md): Toimituksen kesto - [Varastoapteekkien lukumäärä](https://success.openhealth.fr/fi/articles/3194338-varastoapteekkien-lukumaara.md): Varastoapteekkien lukumäärä - [Stockist Digitaalinen jakelu](https://success.openhealth.fr/fi/articles/3194339-stockist-digitaalinen-jakelu.md): Stockistin jakelu \(ND Stock\) - [Digitaalisen jakelun kauppias perusti uudelleen](https://success.openhealth.fr/fi/articles/4045743-digitaalisen-jakelun-kauppias-perusti-uudelleen.md): Varastonumeron jakelu uudelleen - [Digitaalisen osakemyyjän jakelu maailmanlaajuisesti uudelleen](https://success.openhealth.fr/fi/articles/4045753-digitaalisen-osakemyyjan-jakelu-maailmanlaajuisesti-uudelleen.md): Digitaalisen osakemyyjän jakelu maailmanlaajuisesti uudelleen - [Pörssiyhtiön arvonjako](https://success.openhealth.fr/fi/articles/3194342-porssiyhtion-arvonjako.md): Pörssiyhtiön arvonjako \(painotettu varastojakauma: WD-varastossa\) - [Laske varaston arvon jakelu uudelleen](https://success.openhealth.fr/fi/articles/3194505-laske-varaston-arvon-jakelu-uudelleen.md): Käynnistä DVS uudelleen - [Digitaalinen jakelu Tasoitettu varastonhoitaja](https://success.openhealth.fr/fi/articles/5141830-digitaalinen-jakelu-tasoitettu-varastonhoitaja.md) - [Digitaalinen jakelu Stockist tasoitettu uudelleenperusteistettu](https://success.openhealth.fr/fi/articles/5142162-digitaalinen-jakelu-stockist-tasoitettu-uudelleenperusteistettu.md) - [Jakelu Tasoitettu osakkeen arvo](https://success.openhealth.fr/fi/articles/5203640-jakelu-tasoitettu-osakkeen-arvo.md) - [Jakautuminen Tasoitettu osakkeen uudelleenlaskettu arvo](https://success.openhealth.fr/fi/articles/5203701-jakautuminen-tasoitettu-osakkeen-uudelleenlaskettu-arvo.md) - [Marginaali](https://success.openhealth.fr/fi/articles/3507716-marginaali.md): Marginaali - [Marginaali](https://success.openhealth.fr/fi/articles/3507767-marginaali.md): Marginaali - [Valmistajan hinta ilman veroja \(PFHT\)](https://success.openhealth.fr/fi/articles/4557500-valmistajan-hinta-ilman-veroja-pfht.md): PFHT - [Sell-in - analyysi asiakaskunnastasi](https://success.openhealth.fr/fi/articles/3846225-sell-in-analyysi-asiakaskunnastasi.md): Kanta-asiakasindikaattorit: asiakaskunnan ominaisuudet ja kehitys - [Myynti - epätyypilliset apteekit](https://success.openhealth.fr/fi/articles/3848791-myynti-epatyypilliset-apteekit.md): Toimenpiteet epätyypillisyyksien havaitsemiseksi - [Kehityssuhde](https://success.openhealth.fr/fi/articles/3194287-kehityssuhde.md): Kehityssuhde - [Tunkeutumissuhde](https://success.openhealth.fr/fi/articles/3194286-tunkeutumissuhde.md): Tunkeutumissuhde - [Tuotevalikoiman leveys](https://success.openhealth.fr/fi/articles/3369425-tuotevalikoiman-leveys.md): Tuotevalikoiman leveys - [Valikoiman uusiminen](https://success.openhealth.fr/fi/articles/3369545-valikoiman-uusiminen.md): Valikoiman uusiminen - [Innovaatio valikoimassa](https://success.openhealth.fr/fi/articles/3369468-innovaatio-valikoimassa.md): Innovaatio valikoimassa - [Valikoiman hankautuminen](https://success.openhealth.fr/fi/articles/3369457-valikoiman-hankautuminen.md): Valikoiman hankautuminen - [Valikoiman kulumisaste](https://success.openhealth.fr/fi/articles/3369485-valikoiman-kulumisaste.md): Valikoiman kulumisaste - [Alueen innovaatioaste](https://success.openhealth.fr/fi/articles/3369541-alueen-innovaatioaste.md): Alueen innovaatioaste - [Myyntitarjouksen osuus](https://success.openhealth.fr/fi/articles/3369040-myyntitarjouksen-osuus.md): Myyntitarjouksen osuus - [Valittujen tuotteiden määrä](https://success.openhealth.fr/fi/articles/3511502-valittujen-tuotteiden-maara.md): Tämä on niiden tuotteiden määrä, jotka on valittu niiden GTIN-13-numerokoodilla. - [Tuotteiden keskimääräinen lukumäärä](https://success.openhealth.fr/fi/articles/3194284-tuotteiden-keskimaarainen-lukumaara.md): Tuotteiden keskimääräinen lukumäärä - [Alueen uusimisnopeus](https://success.openhealth.fr/fi/articles/3369561-alueen-uusimisnopeus.md): Alueen uusimisnopeus - [Tuotteiden lukumäärä](https://success.openhealth.fr/fi/articles/6312686-tuotteiden-lukumaara.md) - [Kulutukset näytöstä kohden](https://success.openhealth.fr/fi/articles/3447792-kulutukset-naytosta-kohden.md): Artikkeli indikaattorista '' Käytetyt määrät asiakirjaa kohti '' - [Kulutettujen summien erittely ostajatyypin mukaan](https://success.openhealth.fr/fi/articles/3447801-kulutettujen-summien-erittely-ostajatyypin-mukaan.md): Artikkeli indikaattorista '' Kulutettujen summien jakautuminen ostajatyypin mukaan '' - [Kulutusindeksi](https://success.openhealth.fr/fi/articles/3432701-kulutusindeksi.md): Kulutusindeksi-indikaattorin määritelmä - [Myynnin osuus](https://success.openhealth.fr/fi/articles/3432664-myynnin-osuus.md): 'Myyntiosuus' -indikaattorin määritelmä - [Arvo-uskollisuusaste](https://success.openhealth.fr/fi/articles/3432695-arvo-uskollisuusaste.md): Indikaattorin 'Value loyalty rate' määritelmä - [Absoluuttinen tunkeutuminen](https://success.openhealth.fr/fi/articles/3432556-absoluuttinen-tunkeutuminen.md): Artikkeli indikaattorista 'Absolute penetration' - [Osuus liikevaihdosta](https://success.openhealth.fr/fi/articles/3432655-osuus-liikevaihdosta.md): Indikaattorin 'osuus liikevaihdosta' määritelmä - [p-arvo](https://success.openhealth.fr/fi/articles/5781702-p-arvo.md) - [Pääkomponenttianalyysi](https://success.openhealth.fr/fi/articles/4231028-paakomponenttianalyysi.md): AKT - [Negatiivinen ennakoiva arvo](https://success.openhealth.fr/fi/articles/4134220-negatiivinen-ennakoiva-arvo.md): Negatiivinen ennustearvo - [Positiivinen ennustearvo](https://success.openhealth.fr/fi/articles/4134166-positiivinen-ennustearvo.md): Positiivinen ennustearvo - [Itsenäisyystesti](https://success.openhealth.fr/fi/articles/4128369-itsenaisyystesti.md): Tarkista, liittyvätkö kaksi muuttujaa toisiinsa - [Aikasarjojen tutkimus](https://success.openhealth.fr/fi/articles/3633991-aikasarjojen-tutkimus.md): Kausiluontoisuus, trendi ja ennuste: mitä sinun tarvitsee tietää - [Kausivaihteluprosentti](https://success.openhealth.fr/fi/articles/3653790-kausivaihteluprosentti.md): Mittaa varianssin osuutta aikasarjassa - [Testin herkkyys ja spesifisyys](https://success.openhealth.fr/fi/articles/3928135-testin-herkkyys-ja-spesifisyys.md): Ymmärtää käsitteet analysoida testin tehokkuutta - [Trendivarianssi](https://success.openhealth.fr/fi/articles/3653847-trendivarianssi.md): Mittaa trendikomponentin osuutta aikasarjassa - [Jäännösvarianssi](https://success.openhealth.fr/fi/articles/3653851-jaannosvarianssi.md): Mittaa aikasarjan jäännöskomponentin osuuden - [Määrityskerroin](https://success.openhealth.fr/fi/articles/3654093-maarityskerroin.md): Arvioi valitun mallin laatu - [Variaatiokerroin](https://success.openhealth.fr/fi/articles/3653915-variaatiokerroin.md): Indikaattori hajoamismallin valitsemiseksi - [Aikasarjan vaihtelu](https://success.openhealth.fr/fi/articles/3653855-aikasarjan-vaihtelu.md): Mittaa sarjan hajonta - [Myynnin keskittyminen](https://success.openhealth.fr/fi/articles/3395856-myynnin-keskittyminen.md): Myynnin keskittyminen - [Gini-indeksi](https://success.openhealth.fr/fi/articles/3395323-gini-indeksi.md): Gini-indeksi - [Väestö](https://success.openhealth.fr/fi/articles/4396779-vaesto.md): Väestö - [Kuolemien määrän kehitys](https://success.openhealth.fr/fi/articles/4396765-kuolemien-maaran-kehitys.md): Kuolemien määrän kehitys - [Sukupuolten välinen suhde](https://success.openhealth.fr/fi/articles/3812167-sukupuolten-valinen-suhde.md): Sukupuolten välinen suhde - [Väestö - Keski-ikä](https://success.openhealth.fr/fi/articles/3812180-vaesto-keski-ika.md): Väestö - Keski-ikä - [Väestö - mediaani-ikä](https://success.openhealth.fr/fi/articles/3812198-vaesto-mediaani-ika.md): Väestö - mediaani-ikä - [Väestö - Ikä 1. kvartiili](https://success.openhealth.fr/fi/articles/3812218-vaesto-ika-1-kvartiili.md): Väestö - Ikä 1. kvartiili - [Väestö - Ikä 3. kvartiili](https://success.openhealth.fr/fi/articles/3812227-vaesto-ika-3-kvartiili.md): Väestö - Ikä 3. kvartiili - [Valinnan osuus alueen koko väestöstä](https://success.openhealth.fr/fi/articles/3812233-valinnan-osuus-alueen-koko-vaestosta.md): Valinnan osuus alueen koko väestöstä - [Kuolleisuus](https://success.openhealth.fr/fi/articles/3947946-kuolleisuus.md): Kuolleisuus - [Tapauskuolleisuus](https://success.openhealth.fr/fi/articles/3948084-tapauskuolleisuus.md): Tapauskuolleisuus - [Hedelmällisessä iässä olevat naiset](https://success.openhealth.fr/fi/articles/4172859-hedelmallisessa-iassa-olevat-naiset.md): Hedelmällisessä iässä olevat naiset - [Valinnan osuus alueen kaikista kuolemista](https://success.openhealth.fr/fi/articles/3863734-valinnan-osuus-alueen-kaikista-kuolemista.md): Valinnan osuus alueen kaikista kuolemista - [Kadonneiden kuolemien määrän mallintaminen](https://success.openhealth.fr/fi/articles/3895572-kadonneiden-kuolemien-maaran-mallintaminen.md): Ennakoi kuolemien lukumäärä hetkellä t - [Arvioitu myynti lääkemääräyksen aloitusajankohtana](https://success.openhealth.fr/fi/articles/5323282-arvioitu-myynti-laakemaarayksen-aloitusajankohtana.md) - [Kehitys iän ja raskaustilanteen mukaan](https://success.openhealth.fr/fi/articles/6820051-kehitys-ian-ja-raskaustilanteen-mukaan.md) - [Yhteisvastikkeelliset tuotteet Suhdeluku](https://success.openhealth.fr/fi/articles/7892010-yhteisvastikkeelliset-tuotteet-suhdeluku.md) - [Arvioitu reseptilääkkeiden myynti](https://success.openhealth.fr/fi/articles/5323209-arvioitu-reseptilaakkeiden-myynti.md) - [Reseptilääkkeiden täydennysmyynnin paino](https://success.openhealth.fr/fi/articles/5323198-reseptilaakkeiden-taydennysmyynnin-paino.md) - [Myynnin painoarvo reseptilääkkeiden määräämisen aloittamisessa](https://success.openhealth.fr/fi/articles/5323086-myynnin-painoarvo-reseptilaakkeiden-maaraamisen-aloittamisessa.md) - [Lisäannosten lukumäärä](https://success.openhealth.fr/fi/articles/3194351-lisaannosten-lukumaara.md): Lisäannosten lukumäärä - [Annostelujen lukumäärä](https://success.openhealth.fr/fi/articles/3194348-annostelujen-lukumaara.md): Annostelujen lukumäärä - [Keskimääräinen vapauttamismäärä vakuutettua kohden](https://success.openhealth.fr/fi/articles/3369626-keskimaarainen-vapauttamismaara-vakuutettua-kohden.md): Keskimääräinen vapauttamismäärä vakuutettua kohden - [Noudattaminen](https://success.openhealth.fr/fi/articles/3411996-noudattaminen.md): Lääkkeiden hallussuhde \(MPR\) - [Pysyvyysaste](https://success.openhealth.fr/fi/articles/3369684-pysyvyysaste.md): Pysyvyysaste - [Terapeuttinen noudattaminen](https://success.openhealth.fr/fi/articles/3412091-terapeuttinen-noudattaminen.md): Terapeuttinen noudattaminen - [Keskimääräinen päivittäinen annos vakuutettua kohden](https://success.openhealth.fr/fi/articles/4153587-keskimaarainen-paivittainen-annos-vakuutettua-kohden.md): Keskimääräinen päivittäinen annos vakuutettua kohden - [Korvausta varten esitettyjen maksujen määrä](https://success.openhealth.fr/fi/articles/3370942-korvausta-varten-esitettyjen-maksujen-maara.md): Korvausta varten esitettyjen maksujen määrä - [Niiden maksujen määrä, joita ei ole esitetty korvausta varten](https://success.openhealth.fr/fi/articles/3370920-niiden-maksujen-maara-joita-ei-ole-esitetty-korvausta-varten.md): Korvausta varten esitettyjen maksujen määrä - [Pakollisen sairausvakuutuksen kattama korvausmaksu](https://success.openhealth.fr/fi/articles/3371699-pakollisen-sairausvakuutuksen-kattama-korvausmaksu.md): Lunastettujen arvojen myynti - [Täydentävän sairausvakuutuksen kattamien korvattujen arvojen myynti](https://success.openhealth.fr/fi/articles/3371830-taydentavan-sairausvakuutuksen-kattamien-korvattujen-arvojen-myynti.md): Lunastettujen arvojen myynti - [Erinomaisen arvon myynti](https://success.openhealth.fr/fi/articles/3371842-erinomaisen-arvon-myynti.md): Erinomaisen arvon myynti - [Levinneisyys](https://success.openhealth.fr/fi/articles/3947955-levinneisyys.md): Levinneisyysaste - [Keskimääräinen GTIN-numero per annos](https://success.openhealth.fr/fi/articles/3396154-keskimaarainen-gtin-numero-per-annos.md): Keskimääräinen GTIN-numero per annos - [Keskimääräinen tilavuus annostelua kohti](https://success.openhealth.fr/fi/articles/3396196-keskimaarainen-tilavuus-annostelua-kohti.md): Keskimääräinen tilavuus annostelua kohti - [Keskimääräinen liikevaihto per annos](https://success.openhealth.fr/fi/articles/3396208-keskimaarainen-liikevaihto-per-annos.md): Keskimääräinen liikevaihto per annos - [Vaikuttava annos per laatikko](https://success.openhealth.fr/fi/articles/3675409-vaikuttava-annos-per-laatikko.md): Vaikuttava annos per laatikko - [DDD / laatikko](https://success.openhealth.fr/fi/articles/3675446-ddd-laatikko.md): Määritä päivittäinen annos laatikkoa kohti - [Tilavuus perusyksiköinä](https://success.openhealth.fr/fi/articles/3675520-tilavuus-perusyksikoina.md): Tilavuus perusyksiköinä - [Äänenvoimakkuus aktiivisena](https://success.openhealth.fr/fi/articles/3675539-aanenvoimakkuus-aktiivisena.md): Äänenvoimakkuus aktiivisena - [DDJ / 1000 asukasta](https://success.openhealth.fr/fi/articles/3675667-ddj-1000-asukasta.md): Päivittäinen määritetty annos / 1000 asukasta - [Keskimääräinen UA-määrä vakuutettua kohti](https://success.openhealth.fr/fi/articles/3675761-keskimaarainen-ua-maara-vakuutettua-kohti.md): Määrä keskimääräisissä kuluttajayksiköissä vakuutettua kohden - [Määrä keskimääräisenä UB: nä vakuutettua kohti](https://success.openhealth.fr/fi/articles/3675814-maara-keskimaaraisena-ub-na-vakuutettua-kohti.md): Määrä keskimääräisinä perusyksiköinä vakuutettua kohden - [Keskimääräinen aktiivisen aineen määrä vakuutettua kohti](https://success.openhealth.fr/fi/articles/3675824-keskimaarainen-aktiivisen-aineen-maara-vakuutettua-kohti.md): Keskimääräinen aktiivisen aineen määrä vakuutettua kohti - [Havaittu keskimääräinen hoidon kesto](https://success.openhealth.fr/fi/articles/3675841-havaittu-keskimaarainen-hoidon-kesto.md): Havaittu keskimääräinen hoidon kesto - [Rokotuksen kattavuus](https://success.openhealth.fr/fi/articles/3822264-rokotuksen-kattavuus.md): Rokotuksen kattavuus - [Potilaat mukaan lukien](https://success.openhealth.fr/fi/articles/3886665-potilaat-mukaan-lukien.md): Kohorttiin kuuluvien potilaiden määrä - [Erot MPR: n ja PDC: n välillä](https://success.openhealth.fr/fi/articles/3722666-erot-mpr-n-ja-pdc-n-valilla.md): MPR \(lääkkeiden hallussapitoaste\) vs. PDC \(katettujen päivien osuus\) - [Keskimääräinen hoidon kesto](https://success.openhealth.fr/fi/articles/3920967-keskimaarainen-hoidon-kesto.md): Mittaa keskimääräinen käsittelyaika analyysijakson lopussa - [Keskimääräinen uusimisaika](https://success.openhealth.fr/fi/articles/3921067-keskimaarainen-uusimisaika.md): Mittaa keskimääräinen aika hoidon uusimisen välillä - [Hoidon aloittaminen](https://success.openhealth.fr/fi/articles/3848844-hoidon-aloittaminen.md): Hoidon aloittaminen - [Hoidon uusiminen](https://success.openhealth.fr/fi/articles/3885469-hoidon-uusiminen.md): Hoidon uusiminen - [Hoito jatkuu](https://success.openhealth.fr/fi/articles/3885608-hoito-jatkuu.md): Hoito jatkuu - [Uudet hoidot](https://success.openhealth.fr/fi/articles/3885297-uudet-hoidot.md): Hoidon aloittaminen ja jatkaminen - [Hoitokytkin](https://success.openhealth.fr/fi/articles/3848886-hoitokytkin.md): Hoitokytkin - [Hoito loppuu](https://success.openhealth.fr/fi/articles/3885426-hoito-loppuu.md): Hoito loppuu - [Pudota pois](https://success.openhealth.fr/fi/articles/3885387-pudota-pois.md): Pudota pois - [Jäljitettävyysosa](https://success.openhealth.fr/fi/articles/4355163-jaljitettavyysosa.md): Jäljitettävyys - [Pysäytettiin ja käynnistettiin uudelleen](https://success.openhealth.fr/fi/articles/8429189-pysaytettiin-ja-kaynnistettiin-uudelleen.md) - [Jakeluosuus](https://success.openhealth.fr/fi/articles/3624820-jakeluosuus.md): Jakeluosuus - [Merkityksellisten taloudenhoitokertojen seuranta](https://success.openhealth.fr/fi/articles/3804193-merkityksellisten-taloudenhoitokertojen-seuranta.md): Seuraa apteekkien liikenteen kehitystä tärkeiden taloudenhoitokausien ajan - [Hajoamisnopeus](https://success.openhealth.fr/fi/articles/4850138-hajoamisnopeus.md) - [Reaktion kinetiikka](https://success.openhealth.fr/fi/articles/4850629-reaktion-kinetiikka.md) - [Puoliintumisaika](https://success.openhealth.fr/fi/articles/4849710-puoliintumisaika.md) - [Osakkeiden kattavuusaste](https://success.openhealth.fr/fi/articles/4210714-osakkeiden-kattavuusaste.md): Osakkeiden kattavuusaste - [Ajanjaksot](https://success.openhealth.fr/fi/articles/3194479-ajanjaksot.md): Ajanjaksot - [Muuta tilikauden määritelmää](https://success.openhealth.fr/fi/articles/3321750-muuta-tilikauden-maaritelmaa.md): HUB: n avulla voit asettaa tilikausi - [Viikoittaisten vertailujen hallinta](https://success.openhealth.fr/fi/articles/3835180-viikoittaisten-vertailujen-hallinta.md): Tutkittujen päivien analyyttiset vaikutukset - [GSA: n lääkkeiden kalenteri \(SMKT\)](https://success.openhealth.fr/fi/articles/3175583-gsa-n-laakkeiden-kalenteri-smkt.md): SMKT-kalenteria \(IRI\) kutsutaan myös GSA-apteekikalenteriksi - [EI](https://success.openhealth.fr/fi/articles/3194484-ei.md): Määritelmä 'N' - [N Evol](https://success.openhealth.fr/fi/articles/3194461-n-evol.md): 'N Evol' -mittauksen määritelmä ja laskentakaava - [N trendi](https://success.openhealth.fr/fi/articles/3194485-n-trendi.md): 'N Trend' -mittauksen määritelmä ### IAS - Indicateurs Avancés Sanitaires - [IAS\(r\) Allergia](https://success.openhealth.fr/fi/articles/7339151-ias-r-allergia.md) - [IAS\(r\) Poux](https://success.openhealth.fr/fi/articles/7339168-ias-r-poux.md) - [IAS\(r\)-gastroenteriitti](https://success.openhealth.fr/fi/articles/7339181-ias-r-gastroenteriitti.md) - [IAS\(r\) Influenssan kaltainen sairaus](https://success.openhealth.fr/fi/articles/7266711-ias-r-influenssan-kaltainen-sairaus.md) ### Marketing Direct - [OpenHealth-sähköpostiratkaisu](https://success.openhealth.fr/fi/articles/7055261-openhealth-sahkopostiratkaisu.md) - [Sähköpostikampanjan tuottamista koskevat vaatimukset](https://success.openhealth.fr/fi/articles/6282113-sahkopostikampanjan-tuottamista-koskevat-vaatimukset.md) - [Seurantaraportti ja vertailuarvot](https://success.openhealth.fr/fi/articles/6302721-seurantaraportti-ja-vertailuarvot.md) - [Sähköpostikampanjoiden sanasto](https://success.openhealth.fr/fi/articles/6282099-sahkopostikampanjoiden-sanasto.md) ### PSAD - [Analyysi - KANSALLINEN](https://success.openhealth.fr/fi/articles/3376262-analyysi-kansallinen.md): Analysoi PSAD-markkinoiden suorituskykyä kotona - [Määrä / liikevaihto - KANSALLINEN](https://success.openhealth.fr/fi/articles/3376287-maara-liikevaihto-kansallinen.md): Visualisoi samanaikaisesti toimintaa määrältään ja arvoltaan: alueen, toiminnan, alatoiminnan, segmentin, toiminnan mukaan ... - [Evoluutio - KANSALLINEN](https://success.openhealth.fr/fi/articles/3376370-evoluutio-kansallinen.md): Visualisoi markkinoiden kehitys käytettävissä olevan historian mukaan: toimialueen, toiminnan, alatoiminnan, segmentin, LPP-säädöksen mukaan - [Uuttaminen - kansallinen](https://success.openhealth.fr/fi/articles/3376420-uuttaminen-kansallinen.md): Vie tiedot Exceliin - [Määritelmä](https://success.openhealth.fr/fi/articles/3376439-maaritelma.md): Löydä kaikki SantéDomStat Observatoire National - Essential -sovelluksen ominaisuudet ### AUTRES THEMATIQUES - [INTERCOM](https://success.openhealth.fr/fi/articles/6959415-intercom.md) - [Salesforce](https://success.openhealth.fr/fi/articles/6959337-salesforce.md) - [GIHSN: Lähetä Excel-tiedosto](https://success.openhealth.fr/fi/articles/3977478-gihsn-laheta-excel-tiedosto.md): GIHSN Excel-tiedosto - [Lohkoketju](https://success.openhealth.fr/fi/articles/5385413-lohkoketju.md) - [DocuSign, CRM-työkalu liiketoimintaprosessissamme](https://success.openhealth.fr/fi/articles/4514472-docusign-crm-tyokalu-liiketoimintaprosessissamme.md): Docusign: CRM-työkalu liiketoimintaprosessissamme - [Kansallinen rokotusten seuranta](https://success.openhealth.fr/fi/articles/4754333-kansallinen-rokotusten-seuranta.md) - [Rokotusten kattavuus](https://success.openhealth.fr/fi/articles/4754311-rokotusten-kattavuus.md) - [KPI-seuranta](https://success.openhealth.fr/fi/articles/4091042-kpi-seuranta.md): POC ProPharma Systems: Sveitsin markkinatrendit - [Apteekkiohjaamo](https://success.openhealth.fr/fi/articles/4091025-apteekkiohjaamo.md): POC ProPharma Systems: Apteekki vs. Sveitsi - [Väestöekvivalentti \(p.e.\)](https://success.openhealth.fr/fi/articles/5431894-vaestoekvivalentti-p-e.md) - [Hapen tarve](https://success.openhealth.fr/fi/articles/5137158-hapen-tarve.md) - [IHU](https://success.openhealth.fr/fi/articles/4851687-ihu.md) - [Suspendoitunut aine](https://success.openhealth.fr/fi/articles/5137147-suspendoitunut-aine.md) - [Jäteveden kemia](https://success.openhealth.fr/fi/articles/5137101-jateveden-kemia.md) - [NRBCE](https://success.openhealth.fr/fi/articles/4851683-nrbce.md) - [Arrheniuksen laki](https://success.openhealth.fr/fi/articles/4849672-arrheniuksen-laki.md) - [Tuloksena oleva suorituskyky](https://success.openhealth.fr/fi/articles/5137034-tuloksena-oleva-suorituskyky.md) - [Jätevesityypit](https://success.openhealth.fr/fi/articles/5137183-jatevesityypit.md) - [SARS-CoV-2 -viruksen pitoisuus](https://success.openhealth.fr/fi/articles/4867968-sars-cov-2-viruksen-pitoisuus.md) - [MAPOM / BMPM](https://success.openhealth.fr/fi/articles/4851685-mapom-bmpm.md) - [SARS-CoV-2:n kontekstisidonnainen pitoisuus](https://success.openhealth.fr/fi/articles/4934604-sars-cov-2-n-kontekstisidonnainen-pitoisuus.md) - [Viemäriverkoston tyyppi](https://success.openhealth.fr/fi/articles/4867954-viemariverkoston-tyyppi.md) - [Viruksen hajoaminen](https://success.openhealth.fr/fi/articles/4865742-viruksen-hajoaminen.md) - [WBE](https://success.openhealth.fr/fi/articles/4865735-wbe.md) - [RNA](https://success.openhealth.fr/fi/articles/4865733-rna.md) - [Coronavirus](https://success.openhealth.fr/fi/articles/4865728-coronavirus.md) - [COVID-19](https://success.openhealth.fr/fi/articles/4865726-covid-19.md) - [Serologinen levinneisyys: näytteenottomenetelmä](https://success.openhealth.fr/fi/articles/3924493-serologinen-levinneisyys-naytteenottomenetelma.md): Serologinen levinneisyys: Näytteenottomenetelmä - [SANDRE-varasto](https://success.openhealth.fr/fi/articles/5415040-sandre-varasto.md) - [Kansallinen tukikohta ROSEAU](https://success.openhealth.fr/fi/articles/5414523-kansallinen-tukikohta-roseau.md) - [SARS-CoV-2 -viruksen pitoisuus](https://success.openhealth.fr/fi/articles/4852404-sars-cov-2-viruksen-pitoisuus.md) - [SARS-CoV-2 -viruksen pitoisuus - Vaihtoehdot](https://success.openhealth.fr/fi/articles/4909854-sars-cov-2-viruksen-pitoisuus-vaihtoehdot.md) - [Marseille - Maailmanlaajuinen seuranta](https://success.openhealth.fr/fi/articles/4859311-marseille-maailmanlaajuinen-seuranta.md) - [SARS-CoV-2 -viruksen pitoisuus - Nizza](https://success.openhealth.fr/fi/articles/4879292-sars-cov-2-viruksen-pitoisuus-nizza.md) - [Väestö - rakenne](https://success.openhealth.fr/fi/articles/4842408-vaesto-rakenne.md) - [SARS-CoV-2 -viruksen pitoisuus - Toulon \(RANSKA\)](https://success.openhealth.fr/fi/articles/4886417-sars-cov-2-viruksen-pitoisuus-toulon-ranska.md) - [Dubai - Lentoaseman jätevesien seuranta](https://success.openhealth.fr/fi/articles/5276423-dubai-lentoaseman-jatevesien-seuranta.md): Dubai - Lentoaseman jätevesien seuranta - [SARS-CoV-2:n valvonta - OBEPINE](https://success.openhealth.fr/fi/articles/5210661-sars-cov-2-n-valvonta-obepine.md) - [SARS-CoV-2:n kontekstisidonnainen pitoisuus](https://success.openhealth.fr/fi/articles/4934608-sars-cov-2-n-kontekstisidonnainen-pitoisuus.md) - [SUEZ - Analyyttinen tase](https://success.openhealth.fr/fi/articles/5140509-suez-analyyttinen-tase.md) - [Palais des festivals - Katso T0](https://success.openhealth.fr/fi/articles/5373515-palais-des-festivals-katso-t0.md) - [Palais des festivals - Päivittäinen valvominen](https://success.openhealth.fr/fi/articles/5373231-palais-des-festivals-paivittainen-valvominen.md) - [Palais des festivals - Näytös](https://success.openhealth.fr/fi/articles/5404778-palais-des-festivals-naytos.md) - [Mustelidit - Katso](https://success.openhealth.fr/fi/articles/5169577-mustelidit-katso.md) - [Väestö - IRIS](https://success.openhealth.fr/fi/articles/4842191-vaesto-iris.md) - [SARS-CoV-2](https://success.openhealth.fr/fi/articles/4865699-sars-cov-2.md) - [IAS - Analyysi](https://success.openhealth.fr/fi/articles/4842430-ias-analyysi.md) - [SARS-CoV-2 -viruksen pitoisuus - SEM](https://success.openhealth.fr/fi/articles/5415600-sars-cov-2-viruksen-pitoisuus-sem.md) - [Kartan visualisointi](https://success.openhealth.fr/fi/articles/3864657-kartan-visualisointi.md): Potilaiden maantieteellinen jakautuminen - [Avustussivusto](https://success.openhealth.fr/fi/articles/3864668-avustussivusto.md): Toiminta paikan ja sairaalan mukaan - [Kohortiprofiili sivustokohtaisesti](https://success.openhealth.fr/fi/articles/3864672-kohortiprofiili-sivustokohtaisesti.md): Kohortin profiili paikkakunnan ja sairaalan mukaan - [Kohortin profiili kauden mukaan](https://success.openhealth.fr/fi/articles/3864673-kohortin-profiili-kauden-mukaan.md): Kohortin profiili kauden mukaan - [Ikä ja sukupuoli jakauma](https://success.openhealth.fr/fi/articles/3864675-ika-ja-sukupuoli-jakauma.md): Väestötiede - [Virusten jakelu sivustoittain](https://success.openhealth.fr/fi/articles/3864678-virusten-jakelu-sivustoittain.md): Virusten jakelu sivustoittain - [Virusten jakautuminen iän mukaan](https://success.openhealth.fr/fi/articles/3864677-virusten-jakautuminen-ian-mukaan.md): Viruksen jakautuminen iän mukaan - [Virusjakelun kehitys](https://success.openhealth.fr/fi/articles/3864681-virusjakelun-kehitys.md): Virusjakelun kehitys - [Influenssarokotus](https://success.openhealth.fr/fi/articles/3864697-influenssarokotus.md): Influenssarokotus - [Influenssarokotusten kehitys](https://success.openhealth.fr/fi/articles/3864701-influenssarokotusten-kehitys.md): Influenssarokotusten kehitys - [Potilaiden jakautuminen kroonisen tilan mukaan](https://success.openhealth.fr/fi/articles/3864676-potilaiden-jakautuminen-kroonisen-tilan-mukaan.md): Potilaiden jakautuminen kroonisen tilan mukaan - [Potilaiden jakauma sairaalahoidon pituuden mukaan](https://success.openhealth.fr/fi/articles/3864794-potilaiden-jakauma-sairaalahoidon-pituuden-mukaan.md): Potilaiden jakauma pituuden mukaan o sairaalahoito - [Hauraus](https://success.openhealth.fr/fi/articles/3864704-hauraus.md): Potilaan hauraus - [Vakavuusaste](https://success.openhealth.fr/fi/articles/3864705-vakavuusaste.md): Vakavuusaste - [Kuolleisuus](https://success.openhealth.fr/fi/articles/3864710-kuolleisuus.md): Kuolleisuus - [GIHSN](https://success.openhealth.fr/fi/articles/3864712-gihsn.md): Globaalin influenssasairaalan seurantaverkosto - [CARéDIAB - Potilasprofiili](https://success.openhealth.fr/fi/articles/3789234-carediab-potilasprofiili.md): Analysoi CARéDIAB-populaation potilasprofiili - [CARéDIAB - Komplikaatiot](https://success.openhealth.fr/fi/articles/3789515-carediab-komplikaatiot.md): Analysoi komplikaatioiden esiintyvyys populaatiossamme CAREDIAB - [CARéDIAB - Potilaan globaali seuranta](https://success.openhealth.fr/fi/articles/3792041-carediab-potilaan-globaali-seuranta.md): Analysoi potilaiden seurantatiheys CARéDIAB-populaatiossa - [CARéDIAB-verkko](https://success.openhealth.fr/fi/articles/3789106-carediab-verkko.md): CARéDIAB-verkko - [CARéDIAB - Hoidot](https://success.openhealth.fr/fi/articles/3792143-carediab-hoidot.md): Analysoi hoitojen ottamista diabeteksen yhteydessä ## Français ### Votre PLATEFORME - présentation générale - [Votre plateforme d’accompagnement complète et continue](https://success.openhealth.fr/fr/articles/4799621-votre-plateforme-d-accompagnement-complete-et-continue.md) - [Base de connaissance "Success" : 18 langues disponibles](https://success.openhealth.fr/fr/articles/4649389-base-de-connaissance-success-18-langues-disponibles.md): Langues disponibles ### ROADMAP - Innovations & Optimisations de votre Plateforme - ["L'Open-Innovation" au service de nos clients](https://success.openhealth.fr/fr/articles/5200970-l-open-innovation-au-service-de-nos-clients.md) - [Apps + Espace Administration version 240515](https://success.openhealth.fr/fr/articles/9310541-apps-espace-administration-version-240515.md): Innovations et optimisations de votre plateforme au 15/05/2024 - [Apps + Espace Administration version 240415](https://success.openhealth.fr/fr/articles/9310710-apps-espace-administration-version-240415.md): Innovations et optimisations de votre plateforme au 15/04/2024 - [Apps + Espace Administration version 240315](https://success.openhealth.fr/fr/articles/9310790-apps-espace-administration-version-240315.md): Innovations et optimisations de votre plateforme au 15/04/2024 - [Apps + Espace Administration version 240215](https://success.openhealth.fr/fr/articles/9311007-apps-espace-administration-version-240215.md): Innovations et optimisations de votre plateforme au 15/04/2024 - [Apps + Espace Administration version 231215](https://success.openhealth.fr/fr/articles/8718485-apps-espace-administration-version-231215.md) - [Apps + Espace Administration version 231015](https://success.openhealth.fr/fr/articles/8479932-apps-espace-administration-version-231015.md): Optimisations et améliorations mensuelles de votre Plateforme - [Apps + Espace Administration version 230915](https://success.openhealth.fr/fr/articles/8373640-apps-espace-administration-version-230915.md): Innovations et optimisations de votre plateforme au 15/09/2023 - [Apps + Espace Administration version 230815](https://success.openhealth.fr/fr/articles/8267860-apps-espace-administration-version-230815.md) - [Apps + Espace Administration version 230715](https://success.openhealth.fr/fr/articles/8115796-apps-espace-administration-version-230715.md) - [Apps + Espace Administration version 230615](https://success.openhealth.fr/fr/articles/8115791-apps-espace-administration-version-230615.md) - [Apps + Espace Administration version 230515](https://success.openhealth.fr/fr/articles/7895393-apps-espace-administration-version-230515.md) - [Apps + Espace Administration version 230415](https://success.openhealth.fr/fr/articles/7439447-apps-espace-administration-version-230415.md): Découvrez les nouveautés du 15 avril 2023 - [Apps + Espace Administration version 230315](https://success.openhealth.fr/fr/articles/7439646-apps-espace-administration-version-230315.md): Découvrez les nouveautés du 15 mars 2023 - [Apps + Espace Administration version 230215](https://success.openhealth.fr/fr/articles/7439744-apps-espace-administration-version-230215.md): Découvrez les nouveautés du 15 février 2023 - [Apps + Espace Administration version 230115](https://success.openhealth.fr/fr/articles/6895740-apps-espace-administration-version-230115.md): Découvrez les nouveautés du 15 janvier 2023 - [Apps + Espace Administration : version 221215](https://success.openhealth.fr/fr/articles/6827027-apps-espace-administration-version-221215.md): Découvrez les nouveautés du 15 décembre 2022 - [Apps + Espace Administration : 221115](https://success.openhealth.fr/fr/articles/6742628-apps-espace-administration-221115.md): Découvrez les nouveautés du 15 novembre 2022 - [Apps + Espace Administration : 220915](https://success.openhealth.fr/fr/articles/6558070-apps-espace-administration-220915.md): Découvrez les nouveautés du 15 septembre 2022 - [Apps + Espace Administration : 220815](https://success.openhealth.fr/fr/articles/6475311-apps-espace-administration-220815.md): Découvrez les nouveautés du 15 août 2022 - [Apps + Espace Administration : 220615](https://success.openhealth.fr/fr/articles/6306090-apps-espace-administration-220615.md): Découvrez les nouveautés du 15 juin 2022 - [Apps + Espace Administration : 220515](https://success.openhealth.fr/fr/articles/6201877-apps-espace-administration-220515.md) - [Apps + Espace Administration : 220415](https://success.openhealth.fr/fr/articles/6087747-apps-espace-administration-220415.md) - [APP SMA version 220315](https://success.openhealth.fr/fr/articles/6043772-app-sma-version-220315.md): Standard : vSMA220315 / Flux : vF220315 - [APP TMA version 220315](https://success.openhealth.fr/fr/articles/6043802-app-tma-version-220315.md): Standard : vTMA220315 / Flux : vF220315 - [APP UAN version 220315](https://success.openhealth.fr/fr/articles/6043852-app-uan-version-220315.md): Standard : vUAN220315 / Flux : vF220315 - [Espace d'administration version 220215](https://success.openhealth.fr/fr/articles/5940805-espace-d-administration-version-220215.md) - [APP SMA version 220215](https://success.openhealth.fr/fr/articles/5940753-app-sma-version-220215.md): Standard : vSMA220215 / Flux : vF220215 - [APP TMA version 220215](https://success.openhealth.fr/fr/articles/5947859-app-tma-version-220215.md): Standard : vTMA220215 / Flux : vF220215 - [Espace d'administration version 211215](https://success.openhealth.fr/fr/articles/5819397-espace-d-administration-version-211215.md) - [APP SMA version 211215](https://success.openhealth.fr/fr/articles/5784709-app-sma-version-211215.md): Standard : vSMA211215 / Flux : vF211123 - [APP TMA version 211215](https://success.openhealth.fr/fr/articles/5784888-app-tma-version-211215.md): Standard : vTMA211215 / Flux : vF211202 - [APP UAN version 211215](https://success.openhealth.fr/fr/articles/5784904-app-uan-version-211215.md): Standard : vUAN211215 / Flux : vF211202 - [Application "Conjoncture officinale"](https://success.openhealth.fr/fr/articles/5704485-application-conjoncture-officinale.md): v211115 - [Espace d'administration version 211115](https://success.openhealth.fr/fr/articles/5697844-espace-d-administration-version-211115.md) - [APP SMA version 211115](https://success.openhealth.fr/fr/articles/5671893-app-sma-version-211115.md): Standard vSMA211115 / Flux vF211022 - [APP TMA version 211115](https://success.openhealth.fr/fr/articles/5671917-app-tma-version-211115.md): Standard vTMA211115 / Flux vF211022 - [APP UAN version 211115](https://success.openhealth.fr/fr/articles/5671927-app-uan-version-211115.md): Standard vUAN211115 / Flux vF211022 - [Espace d'administration version 211015](https://success.openhealth.fr/fr/articles/5652210-espace-d-administration-version-211015.md) - [APP SMA version 211015](https://success.openhealth.fr/fr/articles/5649822-app-sma-version-211015.md): Standard : vSMA211015 / Flux : vF211015 - [APP TMA version 211015](https://success.openhealth.fr/fr/articles/5650073-app-tma-version-211015.md): Standard : vTMA211015 / Flux : vF211015 - [APP UAN version 211015](https://success.openhealth.fr/fr/articles/5652242-app-uan-version-211015.md): Standard : vUAN211015 / Flux : vF211015 - [APP SMA version 210915](https://success.openhealth.fr/fr/articles/5370516-app-sma-version-210915.md): Standard : vSMA2109021234 / Flux : vF210825 - [APP TMA version 210915](https://success.openhealth.fr/fr/articles/5390983-app-tma-version-210915.md): Standard : vTMA2107130928 / Flux : vF210825 - [APP UAN version 210915](https://success.openhealth.fr/fr/articles/5543213-app-uan-version-210915.md): Standard : vUAN2107071058 / Flux : vF210825 ### Votre ESPACE D'ADMINISTRATION - fonctionnalités - [Réinitialiser/modifier son mot de passe sur la plateforme](https://success.openhealth.fr/fr/articles/4425325-reinitialiser-modifier-son-mot-de-passe-sur-la-plateforme.md): Procédure de réinitialisation / modification du mot de passe de votre Plateforme - [Assistance de connexion : les potentiels messages d'erreur](https://success.openhealth.fr/fr/articles/5369783-assistance-de-connexion-les-potentiels-messages-d-erreur.md): Liste et résolution des différents messages d'erreur - [Mes tickets : Créer et suivre un ticket](https://success.openhealth.fr/fr/articles/3586214-mes-tickets-creer-et-suivre-un-ticket.md): Créer et suivre l'évolution de ses tickets sur son espace d'administration - [Mes contrats](https://success.openhealth.fr/fr/articles/5712273-mes-contrats.md): Visualisez le contenu de votre application - [Service Health : suivi de la chaîne de production en transparence](https://success.openhealth.fr/fr/articles/4990600-service-health-suivi-de-la-chaine-de-production-en-transparence.md): La transparence et la traçabilité à votre service : Le dashboard Service Health. - [Mes accès : paramétrage et accès à vos applications](https://success.openhealth.fr/fr/articles/5783418-mes-acces-parametrage-et-acces-a-vos-applications.md): Accédez à vos application et modifier leur paramétrage - [Paramétrage de ma page d'accueil](https://success.openhealth.fr/fr/articles/5712229-parametrage-de-ma-page-d-accueil.md): Définissez vos préférences d'affichage pour votre page d'accueil lors de votre connexion de l'application - [Comment modifier son marché depuis son espace personnel OpenHealth ?](https://success.openhealth.fr/fr/articles/3585971-comment-modifier-son-marche-depuis-son-espace-personnel-openhealth.md): Réaliser l'intégration, la modification et la désactivation de produits depuis votre espace personnel OpenHealth - [Modification d'Affectation de Modalité automatique \(MAM auto\)](https://success.openhealth.fr/fr/articles/4164818-modification-d-affectation-de-modalite-automatique-mam-auto.md): Modifier directement les affectations de vos produits - [MAM TEMPORELLE : Comment suivre une marque rachetée par un autre laboratoire](https://success.openhealth.fr/fr/articles/4131072-mam-temporelle-comment-suivre-une-marque-rachetee-par-un-autre-laboratoire.md): Avantages et risques de votre type de suivi - [Intégration de Produit \(IPR\)](https://success.openhealth.fr/fr/articles/4164932-integration-de-produit-ipr.md): Demander l'intégration d'un produit dans votre marché - [Suppression de Produit \(SPR\)](https://success.openhealth.fr/fr/articles/4164866-suppression-de-produit-spr.md): Désactiver un produit de votre marché - [Réactivation de Produit automatique \(RPR auto\)](https://success.openhealth.fr/fr/articles/4818161-reactivation-de-produit-automatique-rpr-auto.md): Réactiver un produit de votre marché - [Paramétrage des nouveautés produits](https://success.openhealth.fr/fr/articles/5811248-parametrage-des-nouveautes-produits.md): Paramétrez l'intégration de vos nouveautés produits - [Ajouter un marché](https://success.openhealth.fr/fr/articles/5712283-ajouter-un-marche.md): Élargissez votre spectre d'analyse - [Import / Export de produits en masse](https://success.openhealth.fr/fr/articles/5712257-import-export-de-produits-en-masse.md): Exporter / importer au format Excel \(xlsx\) une liste de produits à partir de votre espace d'administration afin de réaliser des modifications d'affectation - [Modification de Libellé de Secteur \(MLS\)](https://success.openhealth.fr/fr/articles/4670174-modification-de-libelle-de-secteur-mls.md): Modifier directement vos libellés géographiques \(secteurs ou régions\) - [Les différents rôles d'utilisateurs](https://success.openhealth.fr/fr/articles/3436418-les-differents-roles-d-utilisateurs.md): Quelles sont les fonctionnalités ? - [Créer un compte pour un utilisateur d'une organisation tiers \(TPAA\)](https://success.openhealth.fr/fr/articles/6466550-creer-un-compte-pour-un-utilisateur-d-une-organisation-tiers-tpaa.md): TPAA : Third Party Access Agreement - [Comment créer, modifier ou supprimer un compte utilisateur sur l'application ?](https://success.openhealth.fr/fr/articles/3785138-comment-creer-modifier-ou-supprimer-un-compte-utilisateur-sur-l-application.md): Seul un POWER USER peut le faire - [Section Access : créer des droits de visualisation différenciés au sein de mes équipes](https://success.openhealth.fr/fr/articles/3321731-section-access-creer-des-droits-de-visualisation-differencies-au-sein-de-mes-equipes.md): Droits de visualisations / Section Access - [Journal d'activité](https://success.openhealth.fr/fr/articles/4687438-journal-d-activite.md): Retrouvez la trace des évènements en arrière plan ### Vos APPLICATIONS - présentation - [Sélecteur déroulant de tri](https://success.openhealth.fr/fr/articles/5792113-selecteur-deroulant-de-tri.md): Tri des colonnes dans On Demand Table - [Date d'actualisation des données](https://success.openhealth.fr/fr/articles/3175557-date-d-actualisation-des-donnees.md): Cet article décrit à quelle date sont actualisées les données de pharmacies et parapharmacies de GMS dans notre plateforme - [Pré-requis Matching Fichier Pharmacies](https://success.openhealth.fr/fr/articles/3678146-pre-requis-matching-fichier-pharmacies.md): Pré-requis Matching Fichier Pharmacies - [Sélecteur split "Sur et Hors Prescription"](https://success.openhealth.fr/fr/articles/3729668-selecteur-split-sur-et-hors-prescription.md): Spécifications de l'objet 'Sélecteur Prescription Type' - [Question sur les données : marche à suivre](https://success.openhealth.fr/fr/articles/4374497-question-sur-les-donnees-marche-a-suivre.md): Quelles vérifications réaliser avant une investigation sur des données ? - [Comment qualifier des nouveautés produit dans votre Plateforme ?](https://success.openhealth.fr/fr/articles/3376100-comment-qualifier-des-nouveautes-produit-dans-votre-plateforme.md): Qualification de vos nouveaux produits dans l'application - [Comment sélectionner des produits dans votre Plateforme par date de lancement ?](https://success.openhealth.fr/fr/articles/3158428-comment-selectionner-des-produits-dans-votre-plateforme-par-date-de-lancement.md): Cet article vous explique comment sélectionner uniquement des produits lancés à une période donnée - [Puis-je extraire les données de ma Plateforme au format ".csv" ?](https://success.openhealth.fr/fr/articles/5671278-puis-je-extraire-les-donnees-de-ma-plateforme-au-format-csv.md): Souhait d'extraire les données au format ".csv" - [Temps de réponse module "On Demand Table"](https://success.openhealth.fr/fr/articles/6632310-temps-de-reponse-module-on-demand-table.md): Mesure des temps de réponses des indicateurs dans le module On Demand Table \(ODT\) - [Les bonnes pratiques d'affichage sur votre Plateforme](https://success.openhealth.fr/fr/articles/3124454-les-bonnes-pratiques-d-affichage-sur-votre-plateforme.md): Cet article détaille les bonnes pratiques d'affichage - [Prérequis techniques](https://success.openhealth.fr/fr/articles/5369918-prerequis-techniques.md): Configuration minimale et prérequis de connexion à la plateforme - [Vider le cache de son navigateur](https://success.openhealth.fr/fr/articles/4219722-vider-le-cache-de-son-navigateur.md): Comment vider le cache de son navigateur Google Chrome - [Comment définir Google Chrome comme navigateur par défaut ?](https://success.openhealth.fr/fr/articles/3738717-comment-definir-google-chrome-comme-navigateur-par-defaut.md): Procédure à suivre pour définir Google Chrome par défaut - [L’ascenseur de navigation n’est pas visible dans les tableaux](https://success.openhealth.fr/fr/articles/3195250-l-ascenseur-de-navigation-n-est-pas-visible-dans-les-tableaux.md): L'ascenseur de navigation - [L’affichage de certains objets est partiel](https://success.openhealth.fr/fr/articles/3195245-l-affichage-de-certains-objets-est-partiel.md): Problème d'affichage des boutons, des objets - [Ma carte ne se charge pas et le message « loading » apparait](https://success.openhealth.fr/fr/articles/3195239-ma-carte-ne-se-charge-pas-et-le-message-loading-apparait.md): Problème d'affichage de la carte Territory Management / TMA - [Message d'erreur : « You’re not authorized to access on this page »](https://success.openhealth.fr/fr/articles/3195338-message-d-erreur-you-re-not-authorized-to-access-on-this-page.md): Le message d'erreur : " You are not authorized " - [Message d'erreur : "Une erreur s'est produite"](https://success.openhealth.fr/fr/articles/4445141-message-d-erreur-une-erreur-s-est-produite.md) - [Message d'erreur : "Bad Gateway"](https://success.openhealth.fr/fr/articles/4514555-message-d-erreur-bad-gateway.md): Messages d'erreur lors de votre connexion de l'application - [Message d'erreur : "Une erreur s’est produite"](https://success.openhealth.fr/fr/articles/3195286-message-d-erreur-une-erreur-s-est-produite.md): Je rencontre le message « Une erreur s’est produite » - [Comment créer, modifier et partager un favori dans vos applications ?](https://success.openhealth.fr/fr/articles/10502803-comment-creer-modifier-et-partager-un-favori-dans-vos-applications.md): Gestion des favoris Mise à jour : 250918\_CC - [Panel consommateur : grille analytique](https://success.openhealth.fr/fr/articles/3455845-panel-consommateur-grille-analytique.md): Framework panel consommateur ### SOURCES / CANAUX DE DISTRIBUTION / TERRITOIRES GEOGRAPHIQUES disponibles - [Qu'est-ce que le panel de pharmacies d'OpenHealth ?](https://success.openhealth.fr/fr/articles/3304106-qu-est-ce-que-le-panel-de-pharmacies-d-openhealth.md): Cet article a pour but de décrire notre panel de pharmacies, la façon dont il est constitué, son évolution et la méthode d’extrapolation. - [Quels sont les territoires des DROM COM visualisables dans la Plateforme ?](https://success.openhealth.fr/fr/articles/3194382-quels-sont-les-territoires-des-drom-com-visualisables-dans-la-plateforme.md): Les territoires DROM-COM disponibles dans la plateforme - [Prérequis fichier de sectorisation](https://success.openhealth.fr/fr/articles/3702701-prerequis-fichier-de-sectorisation.md): Cet article vous permet de télécharger, remplir et transmettre votre fichier de sectorisation. - [Source de données CIRCANA France Parapharmacies de GMS / Enseignes](https://success.openhealth.fr/fr/articles/4485357-source-de-donnees-circana-france-parapharmacies-de-gms-enseignes.md): Circana, fournisseur des données de parapharmacies de GMS / données enseignes - [Règles de codification des produits de parapharmacies de GMS chez CIRCANA](https://success.openhealth.fr/fr/articles/3524492-regles-de-codification-des-produits-de-parapharmacies-de-gms-chez-circana.md): Rappel des règles de codification des produits de parapharmacies de GMS chez CIRCANA - [Données MAGASINS BIO - Source BIOANALYTICS](https://success.openhealth.fr/fr/articles/5631260-donnees-magasins-bio-source-bioanalytics.md): Données MAGASINS BIO - Source BIOANALYTICS - [E-commerce : l'offre "Open E-para"](https://success.openhealth.fr/fr/articles/9167006-e-commerce-l-offre-open-e-para.md): e-commerce / online - [Qu'est-ce que le panel de pharmacies en Allemagne ? INSIGHTHEALTH](https://success.openhealth.fr/fr/articles/5391412-qu-est-ce-que-le-panel-de-pharmacies-en-allemagne-insighthealth.md): Cet article a pour but de décrire le panel de pharmacies en Allemagne Données disponible dans votre Plateforme - [Qu'est-ce que le panel de pharmacies en Grèce ? ALIRAHEALTH](https://success.openhealth.fr/fr/articles/6863963-qu-est-ce-que-le-panel-de-pharmacies-en-grece-alirahealth.md): Qu'est-ce que le panel de pharmacies en Grèce ? ALIRAHEALTH - [Qu'est-ce que le panel de pharmacies en Autriche ? INSIGHTHEALTH](https://success.openhealth.fr/fr/articles/6863949-qu-est-ce-que-le-panel-de-pharmacies-en-autriche-insighthealth.md): Qu'est-ce que le panel de pharmacies en Autriche ? INSIGHTHEALTH - [Qu'est-ce que le panel de pharmacies en Afrique ? PIEX - Afrique](https://success.openhealth.fr/fr/articles/6686633-qu-est-ce-que-le-panel-de-pharmacies-en-afrique-piex-afrique.md): Source de données PIEX - Afrique - [Qu'est-ce que le panel de pharmacies en ligne en Allemagne ? DATAMEDIQ](https://success.openhealth.fr/fr/articles/5689640-qu-est-ce-que-le-panel-de-pharmacies-en-ligne-en-allemagne-datamediq.md): Données PHARMA en ligne - Allemagne : DATAMEDIQ - [Qu'est-ce que le panel de pharmacies en Belgique ? IQVIA \(ex-REDPHARMA\)](https://success.openhealth.fr/fr/articles/4689894-qu-est-ce-que-le-panel-de-pharmacies-en-belgique-iqvia-ex-redpharma.md): Cet article a pour but de décrire le panel de pharmacies en Belgique. Visualisez les données BELGES dans votre plateforme - [Qu'est-ce que le panel de pharmacies en Espagne ? - HMR](https://success.openhealth.fr/fr/articles/5391363-qu-est-ce-que-le-panel-de-pharmacies-en-espagne-hmr.md): Cet article a pour but de décrire le panel de pharmacies en Espagne - HMR. Visualisez les données ESPAGNOLES dans votre Plateforme - [Qu'est-ce que le panel de pharmacies en Espagne ? - INFONIS](https://success.openhealth.fr/fr/articles/5428915-qu-est-ce-que-le-panel-de-pharmacies-en-espagne-infonis.md): Cet article a pour but de décrire le panel de pharmacies en Espagne - INFONIS. Visualisez les données ESPAGNOL dans la plateforme Openhealth - [Qu'est-ce que le panel de pharmacies au Portugal ? - HMR](https://success.openhealth.fr/fr/articles/5391477-qu-est-ce-que-le-panel-de-pharmacies-au-portugal-hmr.md): Cet article a pour but de décrire le panel de pharmacies au Portugal - [Qu'est-ce que le panel de pharmacies en Russie ? - ALPHARM](https://success.openhealth.fr/fr/articles/5701531-qu-est-ce-que-le-panel-de-pharmacies-en-russie-alpharm.md): Cet article a pour but de décrire le panel de pharmacies en Russie Visualisez les données Russe dans la plateforme Openhealth ALPHARM - [Qu'est-ce que le panel de pharmacies en Pologne ? Pex Pharma](https://success.openhealth.fr/fr/articles/5969485-qu-est-ce-que-le-panel-de-pharmacies-en-pologne-pex-pharma.md): Cet article a pour but de décrire le panel de pharmacies en Pologne. Visualisez les données Pologne dans votre plateforme - [Qu'est-ce que le panel de pharmacies au Bénin ? AS PHARM - ASPHARM BENIN](https://success.openhealth.fr/fr/articles/4238167-qu-est-ce-que-le-panel-de-pharmacies-au-benin-as-pharm-aspharm-benin.md): Source de données AS PHARM - ASPHARM BENIN - [CONVERT GROUP](https://success.openhealth.fr/fr/articles/6961966-convert-group.md): CONVERT GROUP - [Qu'est-ce que le panel de pharmacies en Jordanie ?](https://success.openhealth.fr/fr/articles/8176750-qu-est-ce-que-le-panel-de-pharmacies-en-jordanie.md): Cet article a pour but de décrire le panel de pharmacies en Jordanie. Visualisez les données Jordaniedans votre Plateforme - [Population - Cartography](https://success.openhealth.fr/fr/articles/3807695-population-cartography.md): Analyser la répartition géographique de la population - [AMELI - LPP](https://success.openhealth.fr/fr/articles/6962021-ameli-lpp.md): AMELI - LPP - [Population – Evolution by AGE & GENDER](https://success.openhealth.fr/fr/articles/3810789-population-evolution-by-age-gender.md): Analyser l’évolution de la structure de la population - [Population – Comparison by AGE & GENDER](https://success.openhealth.fr/fr/articles/3836795-population-comparison-by-age-gender.md): Comparer le profil démographique de deux populations - [EGYPT - Cartography](https://success.openhealth.fr/fr/articles/3714611-egypt-cartography.md): Analyser la population des gouvernorats de l’Égypte - [EGYPT – Analysis by AGE & GENDER](https://success.openhealth.fr/fr/articles/3714673-egypt-analysis-by-age-gender.md): Analyser la structure de la population - [UGANDA – Analysis by AGE & GENDER](https://success.openhealth.fr/fr/articles/3713884-uganda-analysis-by-age-gender.md): Analyser la structure de la population - [Population - Analysis by AGE & GENDER](https://success.openhealth.fr/fr/articles/3807673-population-analysis-by-age-gender.md): Analyser la structure de la population - [Medicabase - base de données médicamenteuses](https://success.openhealth.fr/fr/articles/6518920-medicabase-base-de-donnees-medicamenteuses.md): Medicabase - base de données médicamenteuses - [Naissance](https://success.openhealth.fr/fr/articles/6340025-naissance.md): Naissance - Données INSEE - [OpenEudra](https://success.openhealth.fr/fr/articles/6518977-openeudra.md): OpenEudra pharmacovigilance EudraVigilance - [Découpage IRIS](https://success.openhealth.fr/fr/articles/6383829-decoupage-iris.md): Découpage IRIS France - [ADICAP](https://success.openhealth.fr/fr/articles/6959465-adicap.md): ADICAP - [CND](https://success.openhealth.fr/fr/articles/6519012-cnd.md): Classification National des Dispositif Médicaux - [World population data](https://success.openhealth.fr/fr/articles/8217421-world-population-data.md): World population data - [INSEE : Fichiers des personnes décédées](https://success.openhealth.fr/fr/articles/4498126-insee-fichiers-des-personnes-decedees.md): INSEE \( Institut national de la statistique et des études économiques \) : Fichier des personnes décédées - [Données VAERS- VAERSDATA- Source CDC](https://success.openhealth.fr/fr/articles/6226665-donnees-vaers-vaersdata-source-cdc.md): Données VAERS - Données brutes VAERSDATA - [Données VAERS - VAERSVAX - Source CDC](https://success.openhealth.fr/fr/articles/6226440-donnees-vaers-vaersvax-source-cdc.md): Données VAERS - Données brutes VAERSVAX - [Données VAERS - VAERSSYMPTOMS - Source CDC](https://success.openhealth.fr/fr/articles/6219415-donnees-vaers-vaerssymptoms-source-cdc.md): Données VAERS - Données brutes VAERSSYMPTOMS - [Intégrer vos données dans votre Plateforme en moins de 2 semaines](https://success.openhealth.fr/fr/articles/5259828-integrer-vos-donnees-dans-votre-plateforme-en-moins-de-2-semaines.md) - [International Data Template](https://success.openhealth.fr/fr/articles/4684696-international-data-template.md): International Data Template - [Comment nous faire parvenir vos données par FTPS ou SFTP ?](https://success.openhealth.fr/fr/articles/4143451-comment-nous-faire-parvenir-vos-donnees-par-ftps-ou-sftp.md): Envoyer des données via FTPS - [Quelles sont les informations dont OpenHealth a besoin pour intégrer une nouvelle source de données ?](https://success.openhealth.fr/fr/articles/3459148-quelles-sont-les-informations-dont-openhealth-a-besoin-pour-integrer-une-nouvelle-source-de-donnees.md): Article relatif à l'intégration de nouvelles sources de données - [La Longue Vue](https://success.openhealth.fr/fr/articles/6959482-la-longue-vue.md): La Longue Vue - [Comment intégrer une nouvelle source de données dans votre plateforme ?](https://success.openhealth.fr/fr/articles/3467598-comment-integrer-une-nouvelle-source-de-donnees-dans-votre-plateforme.md): Article relatif au processus d'intégration de données dans la plateforme - [Intégrer vos données de sell-in dans votre Plateforme](https://success.openhealth.fr/fr/articles/3471145-integrer-vos-donnees-de-sell-in-dans-votre-plateforme.md): Article relatif à l'intégration des données de sell-in - [Réception et intégration de vos données de sell-in : spécifications format](https://success.openhealth.fr/fr/articles/3660043-reception-et-integration-de-vos-donnees-de-sell-in-specifications-format.md): Sell-in - [D’où proviennent les données d’analyse du marché des Prestataires de Santé A Domicile \(PSAD\) ?](https://success.openhealth.fr/fr/articles/3376155-d-ou-proviennent-les-donnees-d-analyse-du-marche-des-prestataires-de-sante-a-domicile-psad.md): PSAD - [Comment rejoindre l'observatoire SantéDom Stat ?](https://success.openhealth.fr/fr/articles/3798795-comment-rejoindre-l-observatoire-santedom-stat.md): Tutoriel d'adhésion à l'observatoire national de l'activité des Prestataires de Santé A Domicile \(PSAD\) - [Panel extrapolé à partir de l'observatoire SanteDomStat](https://success.openhealth.fr/fr/articles/6701602-panel-extrapole-a-partir-de-l-observatoire-santedomstat.md): PSAD - [Nombre de patients](https://success.openhealth.fr/fr/articles/3376499-nombre-de-patients.md): Définition du nombre de patients selon les fédérations de PSAD - [Nombre de traitements](https://success.openhealth.fr/fr/articles/3376682-nombre-de-traitements.md): Définition du nombre de traitements selon les fédérations de PSAD - [Nombre de nouveaux patients](https://success.openhealth.fr/fr/articles/3376672-nombre-de-nouveaux-patients.md): Définition du nombre de nouveaux patients selon les fédérations de PSAD - [Chiffre d’affaires TTC](https://success.openhealth.fr/fr/articles/3376725-chiffre-d-affaires-ttc.md): Définition du chiffre d’affaires TTC selon les fédérations de PSAD - [Nombre de patients en fin de traitement](https://success.openhealth.fr/fr/articles/3376675-nombre-de-patients-en-fin-de-traitement.md): Définition du nombre de patients en fin de traitement selon les fédérations de PSAD - [Montant assurance maladie obligatoire \(AMO\)](https://success.openhealth.fr/fr/articles/3376740-montant-assurance-maladie-obligatoire-amo.md): Définition du montant AMO selon les fédérations de PSAD - [Montant assurance maladie complémentaire \(AMC\)](https://success.openhealth.fr/fr/articles/3376749-montant-assurance-maladie-complementaire-amc.md): Définition du montant AMC selon les fédérations de PSAD - [Reste à charge \(RAC\)](https://success.openhealth.fr/fr/articles/3376751-reste-a-charge-rac.md): Définition du RAC selon les fédérations de PSAD - [Source : THESORIMED](https://success.openhealth.fr/fr/articles/3560018-source-thesorimed.md): Base de données sur les médicaments \(BdM\) - [International Nonproprietary Names \(INN\)](https://success.openhealth.fr/fr/articles/3954239-international-nonproprietary-names-inn.md): Dénominations Communes Internationales \(DCI\) - [Open Food Facts](https://success.openhealth.fr/fr/articles/6961970-open-food-facts.md): Open Food Facts - [LOINC - Logical Observation Identifiers Names & Codes](https://success.openhealth.fr/fr/articles/6959323-loinc-logical-observation-identifiers-names-codes.md): LOINC - Logical Observation Identifiers Names & Codes - [AMELI - CCAM](https://success.openhealth.fr/fr/articles/6959080-ameli-ccam.md): AMELI - CCAM - [OMS ATC VET](https://success.openhealth.fr/fr/articles/6959078-oms-atc-vet.md): OMS ATC VET - [CEPS](https://success.openhealth.fr/fr/articles/6959068-ceps.md): CEPS - [Institution](https://success.openhealth.fr/fr/articles/3935678-institution.md): Liste des établissements sanitaires, sociaux, médico-sociaux - [Offre de santé](https://success.openhealth.fr/fr/articles/7969680-offre-de-sante.md): Analyse l'offre de Santé \(établissements et professionnels de santé\) - [Extract FINESS](https://success.openhealth.fr/fr/articles/3946922-extract-finess.md): Réaliser une extraction selon vos attentes - [Evolution FINESS](https://success.openhealth.fr/fr/articles/3947009-evolution-finess.md): Suivre l’évolution du nombre de structures - [Authorization care activity](https://success.openhealth.fr/fr/articles/3947067-authorization-care-activity.md): Lister les structures selon leurs autorisations d’activité de soin - [Major medical equipment](https://success.openhealth.fr/fr/articles/3947269-major-medical-equipment.md): Lister les structures selon leurs équipements en matériel lourd - [Geographical](https://success.openhealth.fr/fr/articles/3947363-geographical.md): Visualisez la répartition des structures sur le territoire - [RPPS](https://success.openhealth.fr/fr/articles/3947568-rpps.md): Liste des professionnels de santé - [FINESS & RPPS](https://success.openhealth.fr/fr/articles/3947713-finess-rpps.md): Lister les lieux d’exercices des professionnels de santé - [Extract RPPS](https://success.openhealth.fr/fr/articles/3947829-extract-rpps.md): RPPS \( Répertoire partagé des professionnels de santé \) ### MODELES ET DATA QUALITY - [Données à l'UGA](https://success.openhealth.fr/fr/articles/4852310-donnees-a-l-uga.md): Ce qu'il faut savoir au sujet du calcul des données de ventes à l'UGA - [Calcul des ventes au Secteur / Customer Type : ce qu'il faut savoir](https://success.openhealth.fr/fr/articles/3545561-calcul-des-ventes-au-secteur-customer-type-ce-qu-il-faut-savoir.md): Quelles sont les différentes étapes pour calculer des ventes au secteur chez OpenHealth ? \(Pharma / Para GMS / Unassigned stores\) - [Réallocation sectorielle, méthodologie statique ou dynamique ?](https://success.openhealth.fr/fr/articles/3690615-reallocation-sectorielle-methodologie-statique-ou-dynamique.md): Réallocation sectorielle, méthodologie statique ou dynamique ? - [Strates de pharmacies](https://success.openhealth.fr/fr/articles/4291490-strates-de-pharmacies.md): Précisions sur les strates « théoriques » et les strates « réelles » ou « effectives ». - [La chaîne de production sous-jacente à votre Plateforme](https://success.openhealth.fr/fr/articles/4816146-la-chaine-de-production-sous-jacente-a-votre-plateforme.md): Vous trouverez l'ensemble des étapes de notre chaîne de production au sein de cet article. - [Comment mener une analyse comparative ?](https://success.openhealth.fr/fr/articles/3440093-comment-mener-une-analyse-comparative.md): Vous souhaitez comparer des données issues de deux fournisseurs différents. - [La Data Quality au service d'OpenHealth Company](https://success.openhealth.fr/fr/articles/3595822-la-data-quality-au-service-d-openhealth-company.md): Vous observez un phénomène que vous ne comprenez pas ? Nous pouvons vous fournir l'origine de cette observation et vous l'expliquer. - [Processus de Data quality chez OpenHealth](https://success.openhealth.fr/fr/articles/3415271-processus-de-data-quality-chez-openhealth.md): Cet article détaille les étapes des processus de data quality chez OpenHealth - [Intervalle et niveau de confiance](https://success.openhealth.fr/fr/articles/3633173-intervalle-et-niveau-de-confiance.md): Définitions, formules et limitations : ce qu'il faut savoir - [Data quality : Gestion des lots](https://success.openhealth.fr/fr/articles/3433509-data-quality-gestion-des-lots.md): Description du processus de gestion des lots - [Data Quality : Processus de décomposition des ventes](https://success.openhealth.fr/fr/articles/3415317-data-quality-processus-de-decomposition-des-ventes.md): Description du ​processus de décomposition des ventes - [Décalages Sell-in et Stock](https://success.openhealth.fr/fr/articles/4131084-decalages-sell-in-et-stock.md): Stock Sell-in - [Pourquoi analyser le sell-in en volume ?](https://success.openhealth.fr/fr/articles/3846167-pourquoi-analyser-le-sell-in-en-volume.md): Pourquoi analyser le sell-in en volume ? - [Il y a un écart de données entre le sell-in et le sell-out](https://success.openhealth.fr/fr/articles/3195358-il-y-a-un-ecart-de-donnees-entre-le-sell-in-et-le-sell-out.md): Dans quels cas peut-on avoir un écart de données entre le sell-in et le sell-out ? - [Qu’est-ce qu’une vente atypique ?](https://success.openhealth.fr/fr/articles/3195366-qu-est-ce-qu-une-vente-atypique.md): Les ventes atypiques et le processus de filtre atypique - [D’où viennent les informations des prix, volumes, chiffres d’affaires ?](https://success.openhealth.fr/fr/articles/3195348-d-ou-viennent-les-informations-des-prix-volumes-chiffres-d-affaires.md): Information de prix / volume / chiffres d'affaire - [Estimation des ventes volume par prescripteur](https://success.openhealth.fr/fr/articles/4171530-estimation-des-ventes-volume-par-prescripteur.md): Comment évaluer vos volumes de ventes en pharmacies par prescripteur et canaux de prescripteurs - [Comprendre l'écart entre 2 extractions](https://success.openhealth.fr/fr/articles/13399689-comprendre-l-ecart-entre-2-extractions.md) ### REFERENTIELS PRODUITS, MARCHÉS et CLASSIFICATIONS - [Le code GTIN](https://success.openhealth.fr/fr/articles/3608176-le-code-gtin.md): GTIN code \(Global Trade Item Number\) - [Attributs produits : spécifications](https://success.openhealth.fr/fr/articles/3704913-attributs-produits-specifications.md): Attribut produit / Champ produits - [Qu’est-ce qu’un code LPPR ?](https://success.openhealth.fr/fr/articles/3195365-qu-est-ce-qu-un-code-lppr.md): Le code LPPR \( Liste des Produits et Prestations Remboursables \) - [Suivi des locations de produits \(pharmacie\)](https://success.openhealth.fr/fr/articles/4206554-suivi-des-locations-de-produits-pharmacie.md): Location de produits "Cutoff Seuil" - [Je souhaite étendre mon marché](https://success.openhealth.fr/fr/articles/4420843-je-souhaite-etendre-mon-marche.md): Marché abonnement suivi - [OHC Classification](https://success.openhealth.fr/fr/articles/3194589-ohc-classification.md): Visualisez l’affectation de vos produits selon la classification propriétaire OpenHealth Company - [EphMRA AC Classes History](https://success.openhealth.fr/fr/articles/3557908-ephmra-ac-classes-history.md): Visualisez l’évolution des classes EphMRA AC depuis 2014 - [Veterinary Medicine Details](https://success.openhealth.fr/fr/articles/3194587-veterinary-medicine-details.md): Visualisez les caractéristiques des medicaments vétérinaires - [Veterinary Medicine Classification](https://success.openhealth.fr/fr/articles/3194579-veterinary-medicine-classification.md): Visualisez la classification des médicaments vétérinaires \(ANSES\) - [Human Medicine Details](https://success.openhealth.fr/fr/articles/3421225-human-medicine-details.md): Visualisez les caractéristiques d'un ou plusieurs produits au travers des champs de détails de THESORIMED - [Gestion des nouveautés produits](https://success.openhealth.fr/fr/articles/4470813-gestion-des-nouveautes-produits.md): Gestion des nouveaux produits - [Human Medicine Classification](https://success.openhealth.fr/fr/articles/3417281-human-medicine-classification.md): Visualisez les classifications EphMRA AC et OMS ATC de votre périmètre-produits - [Indications - Diagnosis](https://success.openhealth.fr/fr/articles/3568554-indications-diagnosis.md): Visualisez les médicaments indiqués pour une pathologie donnée et les pathologies associées à une sélection de médicaments - [Application "MP4U" : notre Référentiel produits à votre disposition](https://success.openhealth.fr/fr/articles/3574188-application-mp4u-notre-referentiel-produits-a-votre-disposition.md): Visualisez l’ensemble des produits et classifications mises à disposition par OpenHealth Company - [Qu'est ce que la TVASI \(Table des Ventes Achats et Stocks Inconnus\)](https://success.openhealth.fr/fr/articles/5992494-qu-est-ce-que-la-tvasi-table-des-ventes-achats-et-stocks-inconnus.md): TVASI - \(Table des Ventes Achats et Stocks Inconnus\) - [Je ne trouve pas mon produit](https://success.openhealth.fr/fr/articles/5686002-je-ne-trouve-pas-mon-produit.md) - [Gestion des codes produits](https://success.openhealth.fr/fr/articles/5652478-gestion-des-codes-produits.md) - [Qualification produits : Marques / Brands](https://success.openhealth.fr/fr/articles/5016985-qualification-produits-marques-brands.md) ### Les ABONNEMENTS et MODULES \(Consumer Health\) - [Les types d'applications](https://success.openhealth.fr/fr/articles/9489652-les-types-d-applications.md): Descriptif des 3 types d'applications Consumer Health - [Modules analytiques "avancés"](https://success.openhealth.fr/fr/articles/8374416-modules-analytiques-avances.md) - [Module "Subscription Traceability"](https://success.openhealth.fr/fr/articles/3344127-module-subscription-traceability.md): Toutes les dates de mises à jour et caractéristiques de votre application sont disponibles au sein de ce module - [Module "Markets and Selections"](https://success.openhealth.fr/fr/articles/8337016-module-markets-and-selections.md): Paramétrez vos sélections de produits - [Tableau de bord synthèse](https://success.openhealth.fr/fr/articles/9246867-tableau-de-bord-synthese.md) - [Analyse](https://success.openhealth.fr/fr/articles/9352287-analyse.md) - [Extracteur](https://success.openhealth.fr/fr/articles/9246875-extracteur.md) - [Growth Analysis](https://success.openhealth.fr/fr/articles/3158856-growth-analysis.md): Déterminez les facteurs clefs de l'évolution de vos marchés et ceux de vos concurrents - [Assortment Analysis](https://success.openhealth.fr/fr/articles/3473736-assortment-analysis.md): Etudiez le dynamisme d'un marché \(nouveaux produits, arrêt de commercialisation..\) - [Average Number of Products](https://success.openhealth.fr/fr/articles/3161474-average-number-of-products.md): Visualisez le nombre moyen de produit par point de vente, en pharmacie ou en parapharmacie de GMS - [Launch Tracking](https://success.openhealth.fr/fr/articles/3158488-launch-tracking.md): Monitorez les lancements de produit et leur contribution à la croissance - [Advanced Indicators Crossed](https://success.openhealth.fr/fr/articles/6007740-advanced-indicators-crossed.md): Module dédié à l’analyse du croisement de deux univers de sélection - [Sales Concentration](https://success.openhealth.fr/fr/articles/3095338-sales-concentration.md): Visualisez la concentration d’un marché à travers la courbe de concentration des ventes et l’indice de GINI - [Price Dispersion](https://success.openhealth.fr/fr/articles/3159289-price-dispersion.md): Visualisez la dispersion de prix d’un produit. Créez vos propres segments de pharmacie à partir du prix de vente - [Sell-Out Margin Analysis](https://success.openhealth.fr/fr/articles/3358322-sell-out-margin-analysis.md): Benchmarker l'attractivité de vos produits pour les pharmacies officinales - [Sell-Out Margin Evolution](https://success.openhealth.fr/fr/articles/3815561-sell-out-margin-evolution.md): SOME : Benchmarker l'attractivité de vos produits pour les pharmacies officinales - [Pharmacy Monitoring \(1/2\)](https://success.openhealth.fr/fr/articles/3358248-pharmacy-monitoring-1-2.md): Suivez l'évolution du trafic en officine - [Pharmacy Monitoring \(2/2\)](https://success.openhealth.fr/fr/articles/3810527-pharmacy-monitoring-2-2.md): Suivez l'évolution du trafic en officine - [Salesforce Performance](https://success.openhealth.fr/fr/articles/3159230-salesforce-performance.md): Comparez la performance commerciale des régions et secteurs d’une force de vente - [Customer Relationship Management \(CRM\) ASSISTANT](https://success.openhealth.fr/fr/articles/5953935-customer-relationship-management-crm-assistant.md): Suivez vos forces de ventes - [Point of Sales Tracking \(suivi nominatif\)](https://success.openhealth.fr/fr/articles/3778944-point-of-sales-tracking-suivi-nominatif.md): Point of Sales Tracking / suivi nominatif - [On Demand Evolution](https://success.openhealth.fr/fr/articles/6560184-on-demand-evolution.md): ODE / Tableau d'évolution - [On Demand Analysis](https://success.openhealth.fr/fr/articles/6127483-on-demand-analysis.md): Réalisez vos propres tableaux de bord - [On Demand Table](https://success.openhealth.fr/fr/articles/3158751-on-demand-table.md): ODT - Paramétrez vos tableaux de bord sur mesure à l'aide de toutes les informations dont vous disposez dans votre abonnement - [Time-Series Analysis](https://success.openhealth.fr/fr/articles/3635940-time-series-analysis.md): Décomposez votre marché en Saison, Tendance et Bruit - [National Data Forecast](https://success.openhealth.fr/fr/articles/3636015-national-data-forecast.md): Estimez le futur de votre marché - [Sectorial Forecast](https://success.openhealth.fr/fr/articles/3689811-sectorial-forecast.md): Estimez vos ventes sectorielles futures - [Sell-in Visualization](https://success.openhealth.fr/fr/articles/3559882-sell-in-visualization.md): Comparez l'évolution de vos ventes sell-in et sell-out - [Sell-in Analysis](https://success.openhealth.fr/fr/articles/6188132-sell-in-analysis.md): Analysez vos points de ventes officinal - [Sell-in Matching](https://success.openhealth.fr/fr/articles/6188090-sell-in-matching.md): Analysez vos données de Sell-in - [Sell-in Evolution](https://success.openhealth.fr/fr/articles/6191929-sell-in-evolution.md): Analysez l'évolution de votre sell-in - [Sell-in vs Sell-out Analysis](https://success.openhealth.fr/fr/articles/6191947-sell-in-vs-sell-out-analysis.md): Comparer votre Sell-In et votre Sell-Out - [Sell-in vs Sell-out Evolution](https://success.openhealth.fr/fr/articles/6191955-sell-in-vs-sell-out-evolution.md): Comparer les évolutions de vos Sell-in et Sell-out - [Price Evolution](https://success.openhealth.fr/fr/articles/5056489-price-evolution.md): Visualisez vos prix en évolution sur tout votre historique disponible - [Customize colors](https://success.openhealth.fr/fr/articles/8407897-customize-colors.md): Choisissez les couleurs de vos graphiques - [Product Export](https://success.openhealth.fr/fr/articles/3583206-product-export.md): Module d'export spécifique aux Apps de type Tous Produits et MP4U - [Market Analysis](https://success.openhealth.fr/fr/articles/3121933-market-analysis.md): Analysez la performance de votre marché : par segment, marque, produit et entreprise - [Price Analysis](https://success.openhealth.fr/fr/articles/3215190-price-analysis.md): Visualiser les prix pratiqués sur votre marché et analyser votre positionnement par rapport à vos concurrents - [Sales Evolution](https://success.openhealth.fr/fr/articles/3178323-sales-evolution.md): Visualisez vos ventes en évolution sur tout votre historique disponible - [Dashboard Summarize](https://success.openhealth.fr/fr/articles/4533213-dashboard-summarize.md): Tableaux de bord / dahboards - [Market Share Evolution](https://success.openhealth.fr/fr/articles/3193078-market-share-evolution.md): Visualisez l’évolution des ventes et des parts de marché sur des périodes longues - [My Data Archive](https://success.openhealth.fr/fr/articles/3193099-my-data-archive.md): Exportez une base de données à plat sur Excel - [Multiple Period Analysis](https://success.openhealth.fr/fr/articles/3192953-multiple-period-analysis.md): Créez un tableau personnalisé avec les indicateurs et périodes de votre choix - [Stock Evolution](https://success.openhealth.fr/fr/articles/3719256-stock-evolution.md): Visualisez et analysez l’évolution des stocks et leur distribution - [Advanced Indicators Evolution Para GMS](https://success.openhealth.fr/fr/articles/3193000-advanced-indicators-evolution-para-gms.md): Monitorez la performance de votre laboratoire au travers d'une analyse de l'évolution temporelle de vos indicateurs statistiques avancés. - [Advanced Indicators Analysis Para GMS](https://success.openhealth.fr/fr/articles/3192366-advanced-indicators-analysis-para-gms.md): Décomposer l’évolution d’un marché en parapharmacie de GMS en indicateurs avancés - [Advanced Indicators Evolution](https://success.openhealth.fr/fr/articles/3177853-advanced-indicators-evolution.md): Monitorez la performance de votre laboratoire au travers d'une analyse de l'évolution temporelle de vos indicateurs statistiques avancés. - [Advanced Indicators Evolution Bio](https://success.openhealth.fr/fr/articles/7051823-advanced-indicators-evolution-bio.md): Monitorez la performance de votre laboratoire au travers d'une analyse de l'évolution temporelle de vos indicateurs statistiques avancés. - [National Advanced Indicators](https://success.openhealth.fr/fr/articles/3364513-national-advanced-indicators.md): Décomposez l'évolution d'un marché en indicateurs avancés - [Stock Analysis](https://success.openhealth.fr/fr/articles/3178015-stock-analysis.md): Interprétez un niveau de stock et son évolution - [Advanced Indicators Analysis Bio](https://success.openhealth.fr/fr/articles/7051801-advanced-indicators-analysis-bio.md): Décomposez l’évolution d’un marché en indicateurs avancés - [Advanced Indicators Analysis](https://success.openhealth.fr/fr/articles/3124439-advanced-indicators-analysis.md): Décomposez l’évolution d’un marché en indicateurs avancés - [Cartography](https://success.openhealth.fr/fr/articles/3192450-cartography.md): Analyser la performance commerciale des régions et secteurs de votre force de vente - [Geographical Cross Table](https://success.openhealth.fr/fr/articles/3192466-geographical-cross-table.md): Créez un tableau croisé dynamique intégrant votre sectorisation - [Geographical Sales Evolution](https://success.openhealth.fr/fr/articles/3192482-geographical-sales-evolution.md): Visualisez les ventes par secteur sur 36 mois dans un tableau croisé dynamique - [Sales Force Effectiveness](https://success.openhealth.fr/fr/articles/5624011-sales-force-effectiveness.md): Suivre les performances des forces de vente - [Network Analysis](https://success.openhealth.fr/fr/articles/3894767-network-analysis.md): Network Analysis - [Geographical Advanced Indicators](https://success.openhealth.fr/fr/articles/3192508-geographical-advanced-indicators.md): Visualisez les indicateurs avancés par région ou par secteur - [Time-Series Sectorial Analysis](https://success.openhealth.fr/fr/articles/3814974-time-series-sectorial-analysis.md): Décomposez votre marché en tendance, saison, bruit - [Sales Analysis by Age & Gender](https://success.openhealth.fr/fr/articles/3192701-sales-analysis-by-age-gender.md): Analysez les ventes par âge & genre - [Sales Evolution by Pregnancy Status](https://success.openhealth.fr/fr/articles/3192910-sales-evolution-by-pregnancy-status.md): Suivez les ventes en officine sur la population des femmes enceintes - [Sales Evolution by Age & Gender](https://success.openhealth.fr/fr/articles/3192732-sales-evolution-by-age-gender.md): Visualisez l’évolution des ventes par âge & genre en utilisant la profondeur d’historique disponible - [Prescriptions Order Evolution](https://success.openhealth.fr/fr/articles/5790020-prescriptions-order-evolution.md): Visualisez l’évolution de répartition de vos ventes entre initiations & renouvellements - [Co-dispensations Evolution](https://success.openhealth.fr/fr/articles/3192529-co-dispensations-evolution.md): Visualisez et décomposez l’évolution des co-dispensations en officine - [Co-dispensations Analysis](https://success.openhealth.fr/fr/articles/3192633-co-dispensations-analysis.md): Visualisez les Co-Dispensations en officine associées à une sélection de produits de mon marché - [Source of business \(hospital/private office, prescriber specialty\)](https://success.openhealth.fr/fr/articles/3192751-source-of-business-hospital-private-office-prescriber-specialty.md): Visualisez les prescripteurs de votre marché - [AMO, AMC & RAC](https://success.openhealth.fr/fr/articles/3192929-amo-amc-rac.md): Visualiser les trois montants d’assurance maladie obligatoire, d’assurance maladie complémentaire santé et de reste à charge - [Co-dispensations Dispersion](https://success.openhealth.fr/fr/articles/3876946-co-dispensations-dispersion.md): Visualisez la distribution du nombre de produits vendus par dispensation - [Dispensation Dispersion Evolution](https://success.openhealth.fr/fr/articles/3920070-dispensation-dispersion-evolution.md): Visualisez la distribution du nombre de produits vendus par dispensation au cours du temps - [GP Prescriptions by AGE & GENDER](https://success.openhealth.fr/fr/articles/5789899-gp-prescriptions-by-age-gender.md): Visualisez les prescription medecin - [Prescriptions Order Analysis](https://success.openhealth.fr/fr/articles/5322866-prescriptions-order-analysis.md): UAN - Analysez les répartitions des ventes entre initiations et renouvellements - [GP Prescriptions Evolution](https://success.openhealth.fr/fr/articles/5790016-gp-prescriptions-evolution.md) - [Basket Analysis](https://success.openhealth.fr/fr/articles/3711049-basket-analysis.md): Description du module 'Basket Analysis' - [Co-dispensations](https://success.openhealth.fr/fr/articles/4738243-co-dispensations.md): Analyser les co-dispensations associés à une cohorte - [Module Cohort qualification](https://success.openhealth.fr/fr/articles/3928090-module-cohort-qualification.md): Qualification de la cohorte patient - [Module Treatment Status](https://success.openhealth.fr/fr/articles/3928067-module-treatment-status.md): Analyser les dynamiques des suivis de traitements - [Module Treatment Adherence](https://success.openhealth.fr/fr/articles/3928044-module-treatment-adherence.md): Analyser l’adhérence aux traitements - [Cohort definition](https://success.openhealth.fr/fr/articles/3894703-cohort-definition.md): Définissez le périmètre de votre analyse - [Co-treatments](https://success.openhealth.fr/fr/articles/4163623-co-treatments.md): Définissez un co-traitement à votre périmètre d'analyse - [Cohort vizualisation](https://success.openhealth.fr/fr/articles/3894721-cohort-vizualisation.md): Visualiser le profil des patients de la cohorte définie - [Definition of analysis criteria](https://success.openhealth.fr/fr/articles/3894728-definition-of-analysis-criteria.md): Définissez les paramètres pour l’analyse de votre cohorte - [Global cohort evolution](https://success.openhealth.fr/fr/articles/3894747-global-cohort-evolution.md): Visualisez l’évolution mensuelle de la cohorte - [Geographic distribution](https://success.openhealth.fr/fr/articles/3894751-geographic-distribution.md): Visualiser la répartition géographique des ID clients de la cohorte définie - [Cohort profile](https://success.openhealth.fr/fr/articles/3894755-cohort-profile.md): Analysez le profil démographique des patients inclus dans la cohorte - [Treatment status break down](https://success.openhealth.fr/fr/articles/3894764-treatment-status-break-down.md): Ayez une vue globale des différents types de suivi de traitement - [Treatment initiations](https://success.openhealth.fr/fr/articles/3894778-treatment-initiations.md): Analyser l’évolution du nombre d’initiations de traitement - [Treatment re-starts](https://success.openhealth.fr/fr/articles/3894788-treatment-re-starts.md): Analyser l’évolution du nombre de reprises de traitement - [New treatments](https://success.openhealth.fr/fr/articles/3894804-new-treatments.md): Analyser l’évolution du nombre d’initiations et de reprises de traitement - [Treatment recurrencies](https://success.openhealth.fr/fr/articles/3894812-treatment-recurrencies.md): Analyser les ID clients sous traitement - [Treatment switch balance](https://success.openhealth.fr/fr/articles/3894821-treatment-switch-balance.md): Analyser par traitement la balance des changements de traitements - [Treatment switch gains](https://success.openhealth.fr/fr/articles/3894830-treatment-switch-gains.md): Analyser les bénéficiaires des switch de traitement - [Treatment switch losses](https://success.openhealth.fr/fr/articles/3894843-treatment-switch-losses.md): Analyser par traitement les perdants des switch de traitement - [Switch gain origins](https://success.openhealth.fr/fr/articles/3894857-switch-gain-origins.md): Analyser l’origine du switch pour un traitement donné - [Switch loss destination](https://success.openhealth.fr/fr/articles/3894864-switch-loss-destination.md): Analyser la destination du switch pour un traitement donné - [Drop-outs](https://success.openhealth.fr/fr/articles/3894874-drop-outs.md): Analyser les arrêts de traitements - [KPI Summary](https://success.openhealth.fr/fr/articles/4229969-kpi-summary.md): Synthèse des différents types de suivi de traitement - [Treatment persistence](https://success.openhealth.fr/fr/articles/3894883-treatment-persistence.md): Analyser la durée des traitements - [Compliance](https://success.openhealth.fr/fr/articles/3894884-compliance.md): Analyser les quantités délivrées - [Qu'est-ce que le critère de régularité ?](https://success.openhealth.fr/fr/articles/3325816-qu-est-ce-que-le-critere-de-regularite.md): Définition du concept de critère de régularité - [Death - Cartography](https://success.openhealth.fr/fr/articles/3863677-death-cartography.md): Analyser la répartition géographique des décès - [Décalage du comptage de décès](https://success.openhealth.fr/fr/articles/3863573-decalage-du-comptage-de-deces.md): Évaluer la pertinence de vos données - [Death - Analysis by AGE & GENDER](https://success.openhealth.fr/fr/articles/3863808-death-analysis-by-age-gender.md): Analyser la structure des décès - [Death – Evolution by AGE & GENDER](https://success.openhealth.fr/fr/articles/3863939-death-evolution-by-age-gender.md): Analyser l’évolution de la structure des décès - [Death - Evolution](https://success.openhealth.fr/fr/articles/3864065-death-evolution.md): Visualisez l'évolution des décès - [Death - Evolution Comparison](https://success.openhealth.fr/fr/articles/3864073-death-evolution-comparison.md): Comparez l'évolution des décès par rapport aux années précédentes - [Pharmacy Monitoring CA](https://success.openhealth.fr/fr/articles/4634768-pharmacy-monitoring-ca.md): Décrivez le trafic en fonction de la taille des pharmacies - [Trafic Analysis \(Bêta-test\)](https://success.openhealth.fr/fr/articles/6848401-trafic-analysis-beta-test.md) - [Pharmacy Monitoring Details](https://success.openhealth.fr/fr/articles/4527868-pharmacy-monitoring-details.md): Analyser le trafic officinal par type de pharmacie - [Trafic Evolution \(Bêta-test\)](https://success.openhealth.fr/fr/articles/6848016-trafic-evolution-beta-test.md) - [Pharmacy Monitoring Cartography](https://success.openhealth.fr/fr/articles/4527811-pharmacy-monitoring-cartography.md): Analyser le trafic officinal en France métropolitaine - [Pharmacy Monitoring Details](https://success.openhealth.fr/fr/articles/4262306-pharmacy-monitoring-details.md): Discriminez le détail des ventes par type d'officine - [Pharmacy Monitoring Analysis](https://success.openhealth.fr/fr/articles/3839223-pharmacy-monitoring-analysis.md): Suivez l'évolution du trafic en officine - [Pharmacy Monitoring Evolution](https://success.openhealth.fr/fr/articles/3827973-pharmacy-monitoring-evolution.md): Étudier l'évolution du trafic officinal - [Décomposition Trafic](https://success.openhealth.fr/fr/articles/3826074-decomposition-trafic.md): Observez les composantes de saison, de tendance et de résidu - [Étude du trafic](https://success.openhealth.fr/fr/articles/3809042-etude-du-trafic.md): Analyser le trafic en officine - [Executive Summary - PIEX](https://success.openhealth.fr/fr/articles/5203335-executive-summary-piex.md) - [Purchasing](https://success.openhealth.fr/fr/articles/4605110-purchasing.md): Suivez vos achats et leurs réceptions - [My Query - PIEX](https://success.openhealth.fr/fr/articles/4210627-my-query-piex.md): Faites des sélections sur vos données - [Sales Evolution - PIEX](https://success.openhealth.fr/fr/articles/4210655-sales-evolution-piex.md): Visualisez l’évolution de votre activité sur l’historique disponible - [Sales Analysis - PIEX](https://success.openhealth.fr/fr/articles/4210650-sales-analysis-piex.md): Sales Analysis - PIEX - [Order details - PIEX](https://success.openhealth.fr/fr/articles/4210659-order-details-piex.md): Visualisez et suivez une commande client - [Stock overview - PIEX](https://success.openhealth.fr/fr/articles/4210672-stock-overview-piex.md): Suivez l'évolution de vos stocks - [My Data Archive - PIEX](https://success.openhealth.fr/fr/articles/4210694-my-data-archive-piex.md): Exportez une base de données à plat sur Excel - [EURAPHARMA - PIEX](https://success.openhealth.fr/fr/articles/4366306-eurapharma-piex.md): Visualisez l’évolution de l'activité d'EURAPHARMA - [Matching product](https://success.openhealth.fr/fr/articles/4366320-matching-product.md): Correspondance entre les désignations des produits PIEX et EURAPHARMA - [CLI My File \(1/5\)](https://success.openhealth.fr/fr/articles/4626422-cli-my-file-1-5.md): CLI My File \( 1/5 \) - [CLI\_File Counts \(2/5\)](https://success.openhealth.fr/fr/articles/4626421-cli_file-counts-2-5.md): CLI\_File Counts \( 2/5 \) - [CLI\_File Code Matching with OHC repository](https://success.openhealth.fr/fr/articles/4626419-cli_file-code-matching-with-ohc-repository.md): CLI\_FIL Code Matching with OHC Repository - [Sell-Out Export \(4/5\)](https://success.openhealth.fr/fr/articles/4626414-sell-out-export-4-5.md): Sell-out Export \( 4/5 \) ### Les OPTIONS PERSONNALISÉES - [Ajout d'attributs produit](https://success.openhealth.fr/fr/articles/4036045-ajout-d-attributs-produit.md): Ajouter des détails sur la qualification de vos produits - [Historique de données disponible : ajout d'années supplémentaires](https://success.openhealth.fr/fr/articles/3195251-historique-de-donnees-disponible-ajout-d-annees-supplementaires.md): Historique - [Analyse par typologie de point de vente \(customer type\)](https://success.openhealth.fr/fr/articles/4197147-analyse-par-typologie-de-point-de-vente-customer-type.md): typologie de point de vente / POS segmentation / customer type - [Section Access](https://success.openhealth.fr/fr/articles/4036458-section-access.md): Limiter la visualisation de vos collaborateurs - [Cycle personnalisé](https://success.openhealth.fr/fr/articles/4036444-cycle-personnalise.md): Analysez vos données sur des périodes temporelles personnalisées - [Année fiscale \(Fiscal Year\)](https://success.openhealth.fr/fr/articles/4036169-annee-fiscale-fiscal-year.md): Définissez votre année fiscale - [Option "Day" \(données quotidiennes\)](https://success.openhealth.fr/fr/articles/4036159-option-day-donnees-quotidiennes.md): Visualiser vos données avec une granularité plus fine - [Option "Week" \(données hebdomadaires\)](https://success.openhealth.fr/fr/articles/4036111-option-week-donnees-hebdomadaires.md): Visualiser vos données avec une granularité plus fine - [Conversion devise / Taux de change](https://success.openhealth.fr/fr/articles/8329594-conversion-devise-taux-de-change.md): Retrouvez comment est calculé le taux de change sur la plateforme - [Scoring / Ciblage](https://success.openhealth.fr/fr/articles/3777788-scoring-ciblage.md): Etude Scoring / Ciblage / typologie / segmentation points de vente ### Les INDICATEURS et PÉRIODES - [Glossaire des indicateurs](https://success.openhealth.fr/fr/articles/5194247-glossaire-des-indicateurs.md): Liste des abréviations des indicateurs de plateforme et leurs définitions - [Ventes Volume \(Vol\)](https://success.openhealth.fr/fr/articles/3194314-ventes-volume-vol.md): Spécification de l'indicateur Ventes Volume \(en Unité Consommateur ou Unité Convertie\) - [Ventes valeur \(CA - € TTC\)](https://success.openhealth.fr/fr/articles/3074854-ventes-valeur-ca-ttc.md): Chiffre d'affaires \(CA\) / Turnover \(To\) : sell-out / ventes valeurs / sales - [Part de marché / Market share](https://success.openhealth.fr/fr/articles/3194475-part-de-marche-market-share.md): Part de Marché \(PDM\) / Market share \(MS\) - [Part de Marché \(Evol\) / Market share \(Evol\)](https://success.openhealth.fr/fr/articles/5634266-part-de-marche-evol-market-share-evol.md): Part de Marché \(PDM\) / Market Share \(MS\) / Index Evol - [Part de Marché \(Delta\) / Market share \(Delta\)](https://success.openhealth.fr/fr/articles/3194469-part-de-marche-delta-market-share-delta.md): N MS - [Poids Vol \(CA\) par modalité / Custom Weight Vol \(To\)](https://success.openhealth.fr/fr/articles/9292839-poids-vol-ca-par-modalite-custom-weight-vol-to.md): Part de marché par modalité - [Ventes valeur basées sur le prix fabricant HT \(Turnover PF HT\) - \(Maroc\)](https://success.openhealth.fr/fr/articles/7508513-ventes-valeur-basees-sur-le-prix-fabricant-ht-turnover-pf-ht-maroc.md): Disponible pour les abonnements "Maroc" - Exprimé en dirham - [Contribution à la croissance](https://success.openhealth.fr/fr/articles/3194466-contribution-a-la-croissance.md): Définition et formule de calcul de la mesure 'N Growth CTR' - [In deal : suivi des ventes sous promo](https://success.openhealth.fr/fr/articles/6201859-in-deal-suivi-des-ventes-sous-promo.md): Suivez la performance des produits avec une offre préférentielle - [Crossed Weight Volume](https://success.openhealth.fr/fr/articles/6066324-crossed-weight-volume.md): Poids croisé en volume - [Crossed Weight Turnover](https://success.openhealth.fr/fr/articles/6066273-crossed-weight-turnover.md): Poids croisé en chiffre d'affaires - [Prix de Vente Moyen Constaté \(PVMC\)](https://success.openhealth.fr/fr/articles/3194302-prix-de-vente-moyen-constate-pvmc.md): Prix de Vente Moyen Constaté \(PVMC\) / Actual Average Sales Price \(AASP\) - [Prix de Vente Moyen Pondéré \(PVMP\)](https://success.openhealth.fr/fr/articles/3194292-prix-de-vente-moyen-pondere-pvmp.md): Prix de Vente Moyen Pondéré \(PVMP\) / Weighted Average Sales Price \(WASP\) - [Effet Prix](https://success.openhealth.fr/fr/articles/8426443-effet-prix.md): Evaluer l'effet de l'inflation sur la croissance - [\# PDV Pha : Nombre de pharmacies vendantes](https://success.openhealth.fr/fr/articles/3719566-pdv-pha-nombre-de-pharmacies-vendantes.md) - [ND / DNV \(PHARMA\)](https://success.openhealth.fr/fr/articles/3194321-nd-dnv-pharma.md): Distribution Numérique Vendante \( Numeric Distribution \) / DN / DNV / ND Pha - [Distribution Numérique Vendante Globale \(PHARMA\)](https://success.openhealth.fr/fr/articles/3194320-distribution-numerique-vendante-globale-pharma.md): Distribution Numérique Vendante Globale \( Global Numeric Distribution \) - [Distribution Numérique Vendante Rebasée \(PHARMA\)](https://success.openhealth.fr/fr/articles/4045636-distribution-numerique-vendante-rebasee-pharma.md): Distribution Numérique Vendante Rebasée \( Numeric Distribution Rebased \) - [Distribution Numérique Vendante Globale Rebasée \(PHARMA\)](https://success.openhealth.fr/fr/articles/4045725-distribution-numerique-vendante-globale-rebasee-pharma.md): DNV globale rebasée - [Distribution Numérique Vendante Rebasée personnalisée](https://success.openhealth.fr/fr/articles/6830813-distribution-numerique-vendante-rebasee-personnalisee.md): Rebaser votre distribution numérique selon des dimensions aux choix - [Distribution Valeur Vendante \(PHARMA\)](https://success.openhealth.fr/fr/articles/3194323-distribution-valeur-vendante-pharma.md): Distribution Valeur Vendante \( Weighted Distribution\) - [Distribution Valeur Vendante globale \(PHARMA\)](https://success.openhealth.fr/fr/articles/3194316-distribution-valeur-vendante-globale-pharma.md): DVV globale - [Distribution Valeur Vendante Rebasée \(PHARMA\)](https://success.openhealth.fr/fr/articles/3194501-distribution-valeur-vendante-rebasee-pharma.md): DVV rebasée - [Distribution Valeur Vendante Globale Rebasée \(PHARMA\)](https://success.openhealth.fr/fr/articles/4200619-distribution-valeur-vendante-globale-rebasee-pharma.md): DVV globale rebasée - [Distribution Valeur Vendante Rebasée personnalisée](https://success.openhealth.fr/fr/articles/6834423-distribution-valeur-vendante-rebasee-personnalisee.md): Rebaser votre distribution valeur selon des dimensions aux choix - [Distribution Numérique Vendante Para GMS](https://success.openhealth.fr/fr/articles/3365043-distribution-numerique-vendante-para-gms.md): Distribution Numérique Vendante Para GMS \(Para Mass Numeric Distribution \) - [Distribution Numérique Vendante Globale Para de GMS](https://success.openhealth.fr/fr/articles/4298341-distribution-numerique-vendante-globale-para-de-gms.md): Distribution Numérique Vendante Para GMS Globale \( Para Mass Global Numeric Distribution \) - [Distribution Numérique Vendante Rebasée Para de GMS](https://success.openhealth.fr/fr/articles/4298197-distribution-numerique-vendante-rebasee-para-de-gms.md): Distribution Numérique Vendante Para de GMS Rebasée \( Para Mass Numeric Distribution Rebased \) - [Distribution Numérique Vendante Globale Rebasée Para de GMS](https://success.openhealth.fr/fr/articles/4319783-distribution-numerique-vendante-globale-rebasee-para-de-gms.md): Distribution Numérique Vendante Para GMS Rebasée Globale \( Para Mass Global Numeric Distribution Rebased \) - [Distribution Valeur Vendante Para de GMS](https://success.openhealth.fr/fr/articles/3365478-distribution-valeur-vendante-para-de-gms.md): Distribution Valeur Vendante Para GMS \( Para Mass Weighted Distribution \) - [Distribution Numérique Vendante Rebasée recalculée Para GMS](https://success.openhealth.fr/fr/articles/4298303-distribution-numerique-vendante-rebasee-recalculee-para-gms.md): Distribution Numérique Vendante Rebasée Recalculée Para GMS - [Distribution Numérique Vendante Bio](https://success.openhealth.fr/fr/articles/7052424-distribution-numerique-vendante-bio.md): Distribution Numérique Vendante Bio \(Bio Numeric Distribution\) - [Turnover of Selling Pharmacies \(TSP\)](https://success.openhealth.fr/fr/articles/6096534-turnover-of-selling-pharmacies-tsp.md): Présentation de l'indicateur chiffre d'affaires des pharmacies vendantes - [Estimation de votre PDM détenteur](https://success.openhealth.fr/fr/articles/4214883-estimation-de-votre-pdm-detenteur.md): Estimer votre part de marché chez vos clients - [Gain de pharmacies](https://success.openhealth.fr/fr/articles/8426451-gain-de-pharmacies.md): Évaluer le gain des nouvelles pharmacies sur la croissance - [Perte de pharmacies](https://success.openhealth.fr/fr/articles/8426460-perte-de-pharmacies.md): Évaluer la perte d'anciennes pharmacies sur la croissance - [Distribution Numérique Vendante multicanal](https://success.openhealth.fr/fr/articles/9293487-distribution-numerique-vendante-multicanal.md) - [Distribution Numérique Vendante cumulée \(PHARMA\)](https://success.openhealth.fr/fr/articles/9330571-distribution-numerique-vendante-cumulee-pharma.md): DN cumulée / Cumulated Numeric Distribution - [AMS / VMM](https://success.openhealth.fr/fr/articles/3194303-ams-vmm.md): Average Monthly Sales / Ventes Moyennes Mensuelles - [AMS A / VMM A](https://success.openhealth.fr/fr/articles/3194290-ams-a-vmm-a.md): Adjusted Average Monthly Sales / Ventes Moyennes Mensuelles Ajustées - [AMS To / VMM CA](https://success.openhealth.fr/fr/articles/4535404-ams-to-vmm-ca.md): Ventes Moyennes Mensuelles Valeur - [AMS To A / VMM A](https://success.openhealth.fr/fr/articles/6028256-ams-to-a-vmm-a.md): Ventes Moyennes Mensuelles Valeur Ajustées - [AS Global / VM Globales](https://success.openhealth.fr/fr/articles/3563716-as-global-vm-globales.md): Averages sales / Ventes Moyennes - [AMS Para Mass Market / VMM Para GMS](https://success.openhealth.fr/fr/articles/3365496-ams-para-mass-market-vmm-para-gms.md): Ventes moyennes mensuelles - [AMS A Para Mass Market / VMM A Para GMS](https://success.openhealth.fr/fr/articles/3369340-ams-a-para-mass-market-vmm-a-para-gms.md): Ventes Moyennes Para GMS Ajustées - [AMS Bio / VMM Bio](https://success.openhealth.fr/fr/articles/7052551-ams-bio-vmm-bio.md): VMM Bio - [AMS To Bio / VMM CA Bio](https://success.openhealth.fr/fr/articles/7052573-ams-to-bio-vmm-ca-bio.md): VMM To Bio - [Stock](https://success.openhealth.fr/fr/articles/3194332-stock.md): Données de stocks en pharmacie dans la Plateforme, via les applications de suivi de données nationales et régionales. - [Stock Moyen](https://success.openhealth.fr/fr/articles/3194336-stock-moyen.md): Stock Moyen - [Part de Stock](https://success.openhealth.fr/fr/articles/3194334-part-de-stock.md): Part de Stock - [Indice de Pression Commerciale](https://success.openhealth.fr/fr/articles/3194335-indice-de-pression-commerciale.md): Indice de Pression Commerciale - [Taux de Transformation du Stock](https://success.openhealth.fr/fr/articles/3194344-taux-de-transformation-du-stock.md): Taux de transformation du Stock - [Durée d’Approvisionnement - N Stock Coverage](https://success.openhealth.fr/fr/articles/3194337-duree-d-approvisionnement-n-stock-coverage.md): Durée d'Approvisionnement - [Nombre de Pharmacies Stockistes](https://success.openhealth.fr/fr/articles/3194338-nombre-de-pharmacies-stockistes.md): Nombre de Pharmacies Stockistes - [Distribution Numérique Stockiste](https://success.openhealth.fr/fr/articles/3194339-distribution-numerique-stockiste.md): DNS \(ND Stock\) - [Distribution Numérique Stockiste Rebasée](https://success.openhealth.fr/fr/articles/4045743-distribution-numerique-stockiste-rebasee.md): DNS Rebasée \(Stock Numeric Distribution Rebased\) - [Distribution Numérique Stockiste Globale Rebasée](https://success.openhealth.fr/fr/articles/4045753-distribution-numerique-stockiste-globale-rebasee.md): Distribution Numérique Stockiste Rebasée Globale \( Global Stock Numeric Distribution Rebased \) - [Distribution Valeur Stockiste](https://success.openhealth.fr/fr/articles/3194342-distribution-valeur-stockiste.md): DVS \( Weighted Distribution Stock : WD Stock\) - [Distribution Valeur Stockiste Rebasée](https://success.openhealth.fr/fr/articles/3194505-distribution-valeur-stockiste-rebasee.md): DVS rebasée \(WD Stock rebased\) - [Distribution Numérique Stockiste lissée](https://success.openhealth.fr/fr/articles/5141830-distribution-numerique-stockiste-lissee.md): DNS lissée \(Smoothed ND Stock\) - [Distribution Numérique Stockiste lissée Rebasée](https://success.openhealth.fr/fr/articles/5142162-distribution-numerique-stockiste-lissee-rebasee.md): DNS Lissée Rebasée \(Smoothed Stock Numeric Distribution Rebased\) - [Distribution Valeur Stockiste lissée](https://success.openhealth.fr/fr/articles/5203640-distribution-valeur-stockiste-lissee.md): DVS lissée \(Smoothed WD Stock\) - [Distribution Valeur Stockiste lissée Rebasée](https://success.openhealth.fr/fr/articles/5203701-distribution-valeur-stockiste-lissee-rebasee.md): DVS lissée rebasée \(Smoothed Stock Weithted Distribution Rebased\) - [Marge](https://success.openhealth.fr/fr/articles/3507716-marge.md): Marge - [Taux de marge](https://success.openhealth.fr/fr/articles/3507767-taux-de-marge.md): Taux de marge - [Prix d'achat hors taxes](https://success.openhealth.fr/fr/articles/4557500-prix-d-achat-hors-taxes.md): Prix fabricant hors taxes \(PFHT\) - [Sell-in - Analyses de votre parc clients](https://success.openhealth.fr/fr/articles/3846225-sell-in-analyses-de-votre-parc-clients.md): Indicateurs de fidélisation : caractéristiques de votre parc clients et de son évolution - [Sell-in - Atypisme des pharmacies](https://success.openhealth.fr/fr/articles/3848791-sell-in-atypisme-des-pharmacies.md): Mesures de détection des atypismes - [Ratio d'évolution](https://success.openhealth.fr/fr/articles/3194287-ratio-d-evolution.md): Ratio d'évolution - [Ratio de pénétration](https://success.openhealth.fr/fr/articles/3194286-ratio-de-penetration.md): Ratio de pénétration - [Largeur de l'assortiment produits](https://success.openhealth.fr/fr/articles/3369425-largeur-de-l-assortiment-produits.md): Largeur de l'assortiment de produits - [Renouvellement de l'assortiment](https://success.openhealth.fr/fr/articles/3369545-renouvellement-de-l-assortiment.md): Renouvellement de l'assortiment - [Innovation dans l'assortiment](https://success.openhealth.fr/fr/articles/3369468-innovation-dans-l-assortiment.md): Innovation dans l'assortiment - [Attrition de l'assortiment](https://success.openhealth.fr/fr/articles/3369457-attrition-de-l-assortiment.md): Attrition de l'assortiment - [Taux d'attrition de l'assortiment](https://success.openhealth.fr/fr/articles/3369485-taux-d-attrition-de-l-assortiment.md): Taux d'attrition de l'assortiment - [Taux d'innovation de l'assortiment](https://success.openhealth.fr/fr/articles/3369541-taux-d-innovation-de-l-assortiment.md): Taux d'innovation de l'assortiment - [Part d'offre vendante](https://success.openhealth.fr/fr/articles/3369040-part-d-offre-vendante.md): Part d'offre vendante - [Nombre moyen de produits](https://success.openhealth.fr/fr/articles/3194284-nombre-moyen-de-produits.md): Nombre moyen de produits - [Taux de renouvellement de l'assortiment](https://success.openhealth.fr/fr/articles/3369561-taux-de-renouvellement-de-l-assortiment.md): Taux de renouvellement de l'assortiment - [Number of products](https://success.openhealth.fr/fr/articles/6312686-number-of-products.md) - [Sommes dépensées par acte](https://success.openhealth.fr/fr/articles/3447792-sommes-depensees-par-acte.md): Article relatif à l'indicateur 'Sommes dépensées par acte' - [Répartition des sommes dépensées par type d'acheteur](https://success.openhealth.fr/fr/articles/3447801-repartition-des-sommes-depensees-par-type-d-acheteur.md): Article relatif à l'indicateur 'Répartition des sommes dépensées par type d'acheteur' - [Indice de consommation](https://success.openhealth.fr/fr/articles/3432701-indice-de-consommation.md): Définition de l'indicateur 'Indice de consommation' - [Part de vente](https://success.openhealth.fr/fr/articles/3432664-part-de-vente.md): Définition de l'indicateur 'Part de vente' - [Taux de fidélité valeur](https://success.openhealth.fr/fr/articles/3432695-taux-de-fidelite-valeur.md): Définition de l'indicateur 'Taux de fidélité valeur' - [Pénétration absolue](https://success.openhealth.fr/fr/articles/3432556-penetration-absolue.md): Article relatif à l'indicateur 'Pénétration absolue' - [Part de chiffre d'affaires](https://success.openhealth.fr/fr/articles/3432655-part-de-chiffre-d-affaires.md): Définition de l'indicateur 'Part de chiffre d'affaires' - [Valeur p](https://success.openhealth.fr/fr/articles/5781702-valeur-p.md): Probabilité d'avoir un cas hors d'un périmètre donné - [Analyse en Composantes Principales](https://success.openhealth.fr/fr/articles/4231028-analyse-en-composantes-principales.md): ACP - [Valeur Prédictive Négative](https://success.openhealth.fr/fr/articles/4134220-valeur-predictive-negative.md): Valeur prédictive négative - [Valeur Prédictive positive](https://success.openhealth.fr/fr/articles/4134166-valeur-predictive-positive.md): Valeur Prédictive positive - [Test d'indépendance](https://success.openhealth.fr/fr/articles/4128369-test-d-independance.md): Vérifier si deux variables sont liées entre elles - [Étude des séries temporelles](https://success.openhealth.fr/fr/articles/3633991-etude-des-series-temporelles.md): Saisonnalité, tendance et prédiction : ce qu'il faut savoir - [Taux de variance saisonnier](https://success.openhealth.fr/fr/articles/3653790-taux-de-variance-saisonnier.md): Mesure la part de la variance dans une série temporelle - [Sensibilité et spécificité d'un test](https://success.openhealth.fr/fr/articles/3928135-sensibilite-et-specificite-d-un-test.md): Comprendre les notions pour analyser l'efficacité d'un test - [Taux de variance tendanciel](https://success.openhealth.fr/fr/articles/3653847-taux-de-variance-tendanciel.md): Mesure la part de la composante tendanciel dans une série temporelle - [Taux de variance résiduel](https://success.openhealth.fr/fr/articles/3653851-taux-de-variance-residuel.md): Mesure la part de la composante résiduelle d'une série temporelle - [Coefficient de détermination](https://success.openhealth.fr/fr/articles/3654093-coefficient-de-determination.md): Évaluer la qualité du modèle choisi - [Coefficient de variation](https://success.openhealth.fr/fr/articles/3653915-coefficient-de-variation.md): Indicateur pour choisir son modèle de décomposition - [Variance d'une série temporelle](https://success.openhealth.fr/fr/articles/3653855-variance-d-une-serie-temporelle.md): Mesure la dispersion d'une série - [Concentration des ventes](https://success.openhealth.fr/fr/articles/3395856-concentration-des-ventes.md): Concentration des ventes - [Indice de Gini](https://success.openhealth.fr/fr/articles/3395323-indice-de-gini.md): Indice de Gini - [Population](https://success.openhealth.fr/fr/articles/4396779-population.md): Population - [Evolution du nombre de décès](https://success.openhealth.fr/fr/articles/4396765-evolution-du-nombre-de-deces.md): Évolution du nombre de décès - [Sex-ratio](https://success.openhealth.fr/fr/articles/3812167-sex-ratio.md): Sex-ratio - [Population – Age moyen](https://success.openhealth.fr/fr/articles/3812180-population-age-moyen.md): Population - Age moyen - [Population – Age médian](https://success.openhealth.fr/fr/articles/3812198-population-age-median.md): Population - Age médian - [Population – Age 1er quartile](https://success.openhealth.fr/fr/articles/3812218-population-age-1er-quartile.md): Population - Age 1er quartile - [Population – Age 3ème quartile](https://success.openhealth.fr/fr/articles/3812227-population-age-3eme-quartile.md): Population - Age 3ème quartile - [Part de la sélection dans la population totale du territoire](https://success.openhealth.fr/fr/articles/3812233-part-de-la-selection-dans-la-population-totale-du-territoire.md): Part de la sélection dans la population totale du territoire - [Taux de mortalité](https://success.openhealth.fr/fr/articles/3947946-taux-de-mortalite.md): Taux de mortalité - [Taux de létalité](https://success.openhealth.fr/fr/articles/3948084-taux-de-letalite.md): Taux de létalité - [Femmes en age de procréer](https://success.openhealth.fr/fr/articles/4172859-femmes-en-age-de-procreer.md): Femmes en age de procréer - [Part de la sélection dans les décès totaux du territoire](https://success.openhealth.fr/fr/articles/3863734-part-de-la-selection-dans-les-deces-totaux-du-territoire.md): Part de la sélection dans les décès totaux du territoire - [Modélisation du nombre de décès manquant](https://success.openhealth.fr/fr/articles/3895572-modelisation-du-nombre-de-deces-manquant.md): Anticiper le nombre de décès à l'instant t - [Estimation des ventes en initiation d'ordonnance](https://success.openhealth.fr/fr/articles/5323282-estimation-des-ventes-en-initiation-d-ordonnance.md): UAN - Prescriptions Order Analysis - N Initiation - [Evolution par âge et statut de grossesse](https://success.openhealth.fr/fr/articles/6820051-evolution-par-age-et-statut-de-grossesse.md): UAN - Sales Evolution by Pregnancy Status - [Co-Dispensation Products Ratio](https://success.openhealth.fr/fr/articles/7892010-co-dispensation-products-ratio.md) - [Estimation des ventes en renouvellement d'ordonnance](https://success.openhealth.fr/fr/articles/5323209-estimation-des-ventes-en-renouvellement-d-ordonnance.md): UAN - Prescriptions Order Analysis - N Renewal - [Poids des ventes en renouvellement d'ordonnance](https://success.openhealth.fr/fr/articles/5323198-poids-des-ventes-en-renouvellement-d-ordonnance.md): UAN - Prescriptions Order Analysis - N Renewal Weight - [Poids des ventes en initiation d'ordonnance](https://success.openhealth.fr/fr/articles/5323086-poids-des-ventes-en-initiation-d-ordonnance.md): UAN - Prescriptions Order Analysis - N Initiation Weight - [Nombre de Co-dispensations](https://success.openhealth.fr/fr/articles/3194351-nombre-de-co-dispensations.md): Nombre de Co-dispensations - [Nombre de dispensations](https://success.openhealth.fr/fr/articles/3194348-nombre-de-dispensations.md): Nombre de dispensations - [Nombre moyen de dispensations par ID Client](https://success.openhealth.fr/fr/articles/3369626-nombre-moyen-de-dispensations-par-id-client.md): Nombre moyen de dispensations par ID Client - [Observance](https://success.openhealth.fr/fr/articles/3411996-observance.md): Medication Possession Rate \(MPR\) - [Taux de persistance](https://success.openhealth.fr/fr/articles/3369684-taux-de-persistance.md): Taux de persistance - [Adhésion thérapeutique](https://success.openhealth.fr/fr/articles/3412091-adhesion-therapeutique.md): Adhésion thérapeutique - [Posologie journalière moyenne par ID Client](https://success.openhealth.fr/fr/articles/4153587-posologie-journaliere-moyenne-par-id-client.md): Posologie journalière moyenne par ID Client - [Nombre de dispensations présentées au remboursement](https://success.openhealth.fr/fr/articles/3370942-nombre-de-dispensations-presentees-au-remboursement.md): Nombre de dispensations présentées au remboursement - [Nombre de dispensations non présentées au remboursement](https://success.openhealth.fr/fr/articles/3370920-nombre-de-dispensations-non-presentees-au-remboursement.md): Nombre de dispensations nos présentées au remboursement - [Ventes valeur portées au remboursement prises en charge par l'assurance maladie obligatoire](https://success.openhealth.fr/fr/articles/3371699-ventes-valeur-portees-au-remboursement-prises-en-charge-par-l-assurance-maladie-obligatoire.md): Ventes valeurs portées au remboursement - [Ventes valeurs portées au remboursement prises en charge par l'assurance maladie complémentaire](https://success.openhealth.fr/fr/articles/3371830-ventes-valeurs-portees-au-remboursement-prises-en-charge-par-l-assurance-maladie-complementaire.md): Ventes valeurs portées au remboursement - [Ventes valeurs en reste à charge](https://success.openhealth.fr/fr/articles/3371842-ventes-valeurs-en-reste-a-charge.md): Ventes valeurs en reste à charge - [Prévalence](https://success.openhealth.fr/fr/articles/3947955-prevalence.md): Taux de prévalence - [Nombre moyen de GTIN par dispensation](https://success.openhealth.fr/fr/articles/3396154-nombre-moyen-de-gtin-par-dispensation.md): Nombre de GTIN moyen par dispensation - [Volume moyen par dispensation](https://success.openhealth.fr/fr/articles/3396196-volume-moyen-par-dispensation.md): Volume moyen par dispensation - [CA moyen par dispensation](https://success.openhealth.fr/fr/articles/3396208-ca-moyen-par-dispensation.md): CA moyen par dispensation - [Dosage principe actif par boîte](https://success.openhealth.fr/fr/articles/3675409-dosage-principe-actif-par-boite.md): Dosage principe actif par boîte - [DDD par boîte](https://success.openhealth.fr/fr/articles/3675446-ddd-par-boite.md): Define Daily Dose par boîte - [Volume en unités de base](https://success.openhealth.fr/fr/articles/3675520-volume-en-unites-de-base.md): Volume en unités de base - [Volume en principe actif](https://success.openhealth.fr/fr/articles/3675539-volume-en-principe-actif.md): Volume en principe actif - [DDJ pour 1.000 habitants](https://success.openhealth.fr/fr/articles/3675667-ddj-pour-1-000-habitants.md): Dose Définie Journalière pour 1.000 habitants - [Volume en UC moyen ID Client](https://success.openhealth.fr/fr/articles/3675761-volume-en-uc-moyen-id-client.md): Volume en unités consommateurs moyen par ID Client - [Volume en UB moyen par ID Client](https://success.openhealth.fr/fr/articles/3675814-volume-en-ub-moyen-par-id-client.md): Volume en unités de base moyen par ID Client - [Volume en principe actif moyen par ID Client](https://success.openhealth.fr/fr/articles/3675824-volume-en-principe-actif-moyen-par-id-client.md): Volume en principe actif moyen par ID Client - [Durée moyenne observée de traitement](https://success.openhealth.fr/fr/articles/3675841-duree-moyenne-observee-de-traitement.md): Durée moyenne observée de traitement - [Couverture vaccinale](https://success.openhealth.fr/fr/articles/3822264-couverture-vaccinale.md): Couverture vaccinale - [ID clients inclus](https://success.openhealth.fr/fr/articles/3886665-id-clients-inclus.md): Nombre d'ID clients inclus dans la cohorte - [Différences entre MPR et PDC](https://success.openhealth.fr/fr/articles/3722666-differences-entre-mpr-et-pdc.md): MPR \(Medication Possession Rate\) vs. PDC \(Proportion of Days Covered\) - [Durée moyenne de traitement](https://success.openhealth.fr/fr/articles/3920967-duree-moyenne-de-traitement.md): Mesurer la durée de traitement moyenne à la fin de la période d’analyse - [Délai moyen de renouvellement](https://success.openhealth.fr/fr/articles/3921067-delai-moyen-de-renouvellement.md): Mesurer le délai moyen entre les renouvellements de traitement - [Initiations de traitement](https://success.openhealth.fr/fr/articles/3848844-initiations-de-traitement.md): Initiations de traitement - [Renouvellements de traitement](https://success.openhealth.fr/fr/articles/3885469-renouvellements-de-traitement.md): Renouvellement de traitement - [Reprises de traitement](https://success.openhealth.fr/fr/articles/3885608-reprises-de-traitement.md): Reprises de traitement - [Nouveaux traitements](https://success.openhealth.fr/fr/articles/3885297-nouveaux-traitements.md): Initiations et reprises de traitement - [Switch de traitement](https://success.openhealth.fr/fr/articles/3848886-switch-de-traitement.md): Switch de traitement - [Arrêts de traitement](https://success.openhealth.fr/fr/articles/3885426-arrets-de-traitement.md): Arrêts de traitement - [Drop-off](https://success.openhealth.fr/fr/articles/3885387-drop-off.md): Drop-off - [Traceability insert](https://success.openhealth.fr/fr/articles/4355163-traceability-insert.md): Traçabilité - [Arrêts puis reprise de traitement](https://success.openhealth.fr/fr/articles/8429189-arrets-puis-reprise-de-traitement.md): Arrêts puis reprise de traitement - [Part de dispensation](https://success.openhealth.fr/fr/articles/3624820-part-de-dispensation.md): Part de dispensation - [Suivi de dispensations pertinentes](https://success.openhealth.fr/fr/articles/3804193-suivi-de-dispensations-pertinentes.md): Suivez l'évolution du trafic en officines de dispensations pertinentes - [Taux de désintégration](https://success.openhealth.fr/fr/articles/4850138-taux-de-desintegration.md): Estimer la quantité restante d'un élément - [Cinétique d'une réaction](https://success.openhealth.fr/fr/articles/4850629-cinetique-d-une-reaction.md): Mesurer la vitesse d'une réaction chimique - [Temps de demi-vie](https://success.openhealth.fr/fr/articles/4849710-temps-de-demi-vie.md): Métrique de la durée de vie d'un élément - [PIEX - Taux de couverture des stocks](https://success.openhealth.fr/fr/articles/4210714-piex-taux-de-couverture-des-stocks.md): Taux de couverture des stocks - [Les périodes](https://success.openhealth.fr/fr/articles/3194479-les-periodes.md) - [Modifier la définition d'une année fiscale](https://success.openhealth.fr/fr/articles/3321750-modifier-la-definition-d-une-annee-fiscale.md): Paramétrer vos années fiscales - [Gestion des comparaisons hebdomadaires](https://success.openhealth.fr/fr/articles/3835180-gestion-des-comparaisons-hebdomadaires.md): Impacts analytiques des jours étudiés - [Les calendriers "GMS" : 4-4-5 et 4-4-4](https://success.openhealth.fr/fr/articles/3175583-les-calendriers-gms-4-4-5-et-4-4-4.md) - ["N" : Paramétrage période/indicateur](https://success.openhealth.fr/fr/articles/3194484-n-parametrage-periode-indicateur.md): N / N-1 / N\* - [Indicateurs : calculs d'évolutions \(Evol, Delta, Trend...\)](https://success.openhealth.fr/fr/articles/3194461-indicateurs-calculs-d-evolutions-evol-delta-trend.md): evol / evol abs / delta / trend ### IAS - Indicateurs Avancés Sanitaires - [IAS\(r\) Allergie](https://success.openhealth.fr/fr/articles/7339151-ias-r-allergie.md): IAS\(r\) Allergie - [IAS\(r\) Poux](https://success.openhealth.fr/fr/articles/7339168-ias-r-poux.md): IAS\(r\) Poux - [IAS\(r\) gastro-entérite](https://success.openhealth.fr/fr/articles/7339181-ias-r-gastro-enterite.md): IAS\(r\) gastro-entérite - [IAS\(r\) Syndromes Respiratoires](https://success.openhealth.fr/fr/articles/3815345-ias-r-syndromes-respiratoires.md): Introduction liée à l'IAS\(r\) Syndromes Respiratoires - [IAS\(r\) Syndrome grippal](https://success.openhealth.fr/fr/articles/7266711-ias-r-syndrome-grippal.md): Introduction liée à l'IAS\(r\) Syndromes grippal ### SOLUTION EMAILING - Professionnels de santé - [Solution Emailing OpenHealth](https://success.openhealth.fr/fr/articles/7055261-solution-emailing-openhealth.md) - [Prérequis à la production d'une campagne d'emailing](https://success.openhealth.fr/fr/articles/6282113-prerequis-a-la-production-d-une-campagne-d-emailing.md) - [Rapport de Tracking et Benchmarks](https://success.openhealth.fr/fr/articles/6302721-rapport-de-tracking-et-benchmarks.md) - [Glossaire pour les campagnes d'emailing](https://success.openhealth.fr/fr/articles/6282099-glossaire-pour-les-campagnes-d-emailing.md) ### PSAD - OBSERVATOIRE - [Analyse – NATIONAL](https://success.openhealth.fr/fr/articles/3376262-analyse-national.md): Analysez la performance du marché des Prestataires de Santé A Domicile \(PSAD\) : par domaine, activité, sous-activité, segment, acte LPP - [Volume / Chiffre d’affaires – NATIONAL](https://success.openhealth.fr/fr/articles/3376287-volume-chiffre-d-affaires-national.md): Visualisez simultanément l’activité en volume et en valeur : par domaine, activité, sous-activité, segment, acte... - [Evolution – NATIONAL](https://success.openhealth.fr/fr/articles/3376370-evolution-national.md): Visualisez l’évolution du marché sur l’historique disponible : par domaine, activité, sous-activité, segment, acte LPP - [Extraction – NATIONAL](https://success.openhealth.fr/fr/articles/3376420-extraction-national.md): Exportez ses données sur Excel - [Définition](https://success.openhealth.fr/fr/articles/3376439-definition.md): Retrouvez toutes les caractéristiques de l’application SantéDomStat Observatoire National - Essential ### AUTRES THEMATIQUES - [DocuSign, outil CRM dans notre processus commercial](https://success.openhealth.fr/fr/articles/4514472-docusign-outil-crm-dans-notre-processus-commercial.md): Docusign : Outil CRM dans notre processus commercial - [National vaccination tracking](https://success.openhealth.fr/fr/articles/4754333-national-vaccination-tracking.md): Suivre l'évolution de la vaccination - [Vaccination coverage](https://success.openhealth.fr/fr/articles/4754311-vaccination-coverage.md): Suivre la couverture vaccinale par région, sexe et âge - [KPI Monitoring](https://success.openhealth.fr/fr/articles/4091042-kpi-monitoring.md): POC ProPharma Systems : Tendances Marché Suisse - [Pharmacy Cockpit](https://success.openhealth.fr/fr/articles/4091025-pharmacy-cockpit.md): POC ProPharma Systems : Ma Pharmacie vs Suisse - [Equivalent Habitant \(EH\)](https://success.openhealth.fr/fr/articles/5431894-equivalent-habitant-eh.md) - [Demande en oxygène](https://success.openhealth.fr/fr/articles/5137158-demande-en-oxygene.md): Quantité de matière requise pour traiter les eaux usées - [IHU](https://success.openhealth.fr/fr/articles/4851687-ihu.md) - [Matière en suspensions](https://success.openhealth.fr/fr/articles/5137147-matiere-en-suspensions.md): Matières solides insolubles dans les eaux usées - [Chimie des eaux usées](https://success.openhealth.fr/fr/articles/5137101-chimie-des-eaux-usees.md): Substances chimiques suivies dans les eaux usées - [NRBCE](https://success.openhealth.fr/fr/articles/4851683-nrbce.md) - [Loi d'Arrhenius](https://success.openhealth.fr/fr/articles/4849672-loi-d-arrhenius.md): Décrire la cinétique d'une réaction chimique - [Rendement résultant](https://success.openhealth.fr/fr/articles/5137034-rendement-resultant.md): Calcul de la qualité du traitement des eaux usées - [Types d'eaux usées](https://success.openhealth.fr/fr/articles/5137183-types-d-eaux-usees.md): Classification des eaux usées - [Concentration en virus SARS-CoV-2](https://success.openhealth.fr/fr/articles/4867968-concentration-en-virus-sars-cov-2.md) - [MAPOM / BMPM](https://success.openhealth.fr/fr/articles/4851685-mapom-bmpm.md) - [La concentration contextualisée en virus SARS-CoV-2](https://success.openhealth.fr/fr/articles/4934604-la-concentration-contextualisee-en-virus-sars-cov-2.md) - [Type de réseau d'assainissement](https://success.openhealth.fr/fr/articles/4867954-type-de-reseau-d-assainissement.md) - [Dégradation du virus](https://success.openhealth.fr/fr/articles/4865742-degradation-du-virus.md) - [WBE](https://success.openhealth.fr/fr/articles/4865735-wbe.md): Wastewater Based Epidemiology - [ARN](https://success.openhealth.fr/fr/articles/4865733-arn.md) - [Coronavirus](https://success.openhealth.fr/fr/articles/4865728-coronavirus.md) - [COVID-19](https://success.openhealth.fr/fr/articles/4865726-covid-19.md) - [Séroprévalence : méthode d'échantillonnage](https://success.openhealth.fr/fr/articles/3924493-seroprevalence-methode-d-echantillonnage.md): Séroprévalence : Méthode d'échantillonnage - [Référentiel SANDRE](https://success.openhealth.fr/fr/articles/5415040-referentiel-sandre.md): Référentiel partagé dans le domaine de l'eau - [Base Nationale ROSEAU](https://success.openhealth.fr/fr/articles/5414523-base-nationale-roseau.md): Informations sur l'assainissement communal - [Concentration en virus SARS-CoV-2](https://success.openhealth.fr/fr/articles/4852404-concentration-en-virus-sars-cov-2.md): Suivez l'évolution de la concentration en virus SARS-CoV-2 par secteur - [Concentration en virus SARS-CoV-2 - Variants](https://success.openhealth.fr/fr/articles/4909854-concentration-en-virus-sars-cov-2-variants.md): Suivez l'évolution des variants du virus SARS-CoV-2 par secteur - [Marseille - Surveillance globale](https://success.openhealth.fr/fr/articles/4859311-marseille-surveillance-globale.md): Suivre l'évolution de la concentration en virus SARS-CoV-2 par réseau - [Concentration en virus SARS-CoV-2 - Nice](https://success.openhealth.fr/fr/articles/4879292-concentration-en-virus-sars-cov-2-nice.md): Suivez l'évolution de la concentration en virus SARS-CoV-2 par secteur - [Population - Structure](https://success.openhealth.fr/fr/articles/4842408-population-structure.md): Analyser la structure de la population - [Concentration en virus SARS-CoV-2 - Toulon \(FRANCE\)](https://success.openhealth.fr/fr/articles/4886417-concentration-en-virus-sars-cov-2-toulon-france.md): Suivez l'évolution de la concentration en virus SARS-CoV-2 par secteur - [Dubai - Airport wastewater monitoring](https://success.openhealth.fr/fr/articles/5276423-dubai-airport-wastewater-monitoring.md) - [Surveillance SARS-CoV-2 - OBEPINE](https://success.openhealth.fr/fr/articles/5210661-surveillance-sars-cov-2-obepine.md) - [Concentration contextualisée en virus SARS-CoV-2](https://success.openhealth.fr/fr/articles/4934608-concentration-contextualisee-en-virus-sars-cov-2.md): Suivez l'évolution de la concentration contextualisée en virus SARS-CoV-2 par secteur - [SUEZ - Bilan analytique](https://success.openhealth.fr/fr/articles/5140509-suez-bilan-analytique.md) - [Palais des festivals - Veille T0](https://success.openhealth.fr/fr/articles/5373515-palais-des-festivals-veille-t0.md): Sécurisation des lieux avant l'ouverture des évènements - [Palais des festivals - Veille quotidienne](https://success.openhealth.fr/fr/articles/5373231-palais-des-festivals-veille-quotidienne.md): Suivez l'évolution de la concentration en virus SARS-CoV-2 - [Palais des festivals - Dépistage](https://success.openhealth.fr/fr/articles/5404778-palais-des-festivals-depistage.md): Suivez l'évolution des dépistages - [Mustélidés - Veille](https://success.openhealth.fr/fr/articles/5169577-mustelides-veille.md) - [Population - IRIS](https://success.openhealth.fr/fr/articles/4842191-population-iris.md): Analyser la répartition géographique de la population à l'IRIS - [SARS-CoV-2](https://success.openhealth.fr/fr/articles/4865699-sars-cov-2.md): Severe Acute Respiratory Syndrome-related CoronaVirus-2 - [IAS - Analyse](https://success.openhealth.fr/fr/articles/4842430-ias-analyse.md): Suivre l'indicateur sanitaire des syndromes respiratoires - [Concentration en virus SARS-CoV-2 - SEM](https://success.openhealth.fr/fr/articles/5415600-concentration-en-virus-sars-cov-2-sem.md): Suivez la concentration en virus sur une sélection de STEU - [CARéDIAB - Profil patients](https://success.openhealth.fr/fr/articles/3789234-carediab-profil-patients.md): Analysez le profil des patients de la population CARéDIAB - [CARéDIAB - Complications](https://success.openhealth.fr/fr/articles/3789515-carediab-complications.md): Analyser la prévalence de complications dans notre population CARéDIAB - [CARéDIAB - Suivi global des patients](https://success.openhealth.fr/fr/articles/3792041-carediab-suivi-global-des-patients.md): Analyser la fréquence de suivis des patients de la population CARéDIAB - [CARéDIAB - Traitements](https://success.openhealth.fr/fr/articles/3792143-carediab-traitements.md): Analyser la prise de traitements dans le cadre du diabète ## Deutsch ### Votre PLATEFORME - présentation générale - [The HUB, eine Plattform für umfassende und kontinuierliche Begleitung](https://success.openhealth.fr/de/articles/4799621-the-hub-eine-plattform-fur-umfassende-und-kontinuierliche-begleitung.md) - [Ihr Erfahrungsniveau The HUB](https://success.openhealth.fr/de/articles/5712270-ihr-erfahrungsniveau-the-hub.md) - [Languages](https://success.openhealth.fr/de/articles/4649389-languages.md): Here is the description of all languages available on Success - [Fragen zu unseren Tarifen](https://success.openhealth.fr/de/articles/3292143-fragen-zu-unseren-tarifen.md): Unsere Preise ### Die ROADMAP - [Open-Innovation im Dienste unserer Kunden](https://success.openhealth.fr/de/articles/5200970-open-innovation-im-dienste-unserer-kunden.md) - [Apps + Administrationsbereich Version 240515](https://success.openhealth.fr/de/articles/9310541-apps-administrationsbereich-version-240515.md) - [Apps + Administrationsbereich Version 240415](https://success.openhealth.fr/de/articles/9310710-apps-administrationsbereich-version-240415.md) - [Apps + Administrationsbereich Version 240315](https://success.openhealth.fr/de/articles/9310790-apps-administrationsbereich-version-240315.md) - [Apps + Administrationsbereich Version 240215](https://success.openhealth.fr/de/articles/9311007-apps-administrationsbereich-version-240215.md) - [Plattform - Aktualisierung 231215](https://success.openhealth.fr/de/articles/8718485-plattform-aktualisierung-231215.md) - [Plattform - aktualisiert 231015](https://success.openhealth.fr/de/articles/8479932-plattform-aktualisiert-231015.md) - [Apps + Portal Version 230915](https://success.openhealth.fr/de/articles/8373640-apps-portal-version-230915.md) - [Apps + Portal Version 230815](https://success.openhealth.fr/de/articles/8267860-apps-portal-version-230815.md) - [Neuheiten 230715](https://success.openhealth.fr/de/articles/8115796-neuheiten-230715.md) - [Apps + Portal Version 230615](https://success.openhealth.fr/de/articles/8115791-apps-portal-version-230615.md) - [Apps + Portal Version 230515](https://success.openhealth.fr/de/articles/7895393-apps-portal-version-230515.md) - [Apps + Portal Version 230415](https://success.openhealth.fr/de/articles/7439447-apps-portal-version-230415.md) - [Apps + Portal Version 230315](https://success.openhealth.fr/de/articles/7439646-apps-portal-version-230315.md) - [Apps + Portal Version 230215](https://success.openhealth.fr/de/articles/7439744-apps-portal-version-230215.md) - [Neuheiten vom 15.01.2023](https://success.openhealth.fr/de/articles/6895740-neuheiten-vom-15-01-2023.md) - [HUB + TOR Version 221215](https://success.openhealth.fr/de/articles/6827027-hub-tor-version-221215.md) - [HUB + TOR Version 221115](https://success.openhealth.fr/de/articles/6742628-hub-tor-version-221115.md) - [HUB + PORTAL Version 220915](https://success.openhealth.fr/de/articles/6558070-hub-portal-version-220915.md) - [HUB + PORTAL Version 220815](https://success.openhealth.fr/de/articles/6475311-hub-portal-version-220815.md) - [HUB + PORTAL Version 220615](https://success.openhealth.fr/de/articles/6306090-hub-portal-version-220615.md) - [HUB + PORTAL Version 220515](https://success.openhealth.fr/de/articles/6201877-hub-portal-version-220515.md) - [HUB + PORTAL Version 220415](https://success.openhealth.fr/de/articles/6087747-hub-portal-version-220415.md) - [SMA HUB Version 220315](https://success.openhealth.fr/de/articles/6043772-sma-hub-version-220315.md) - [HUB TMA Version 220315](https://success.openhealth.fr/de/articles/6043802-hub-tma-version-220315.md) - [HUB UAN Version 220315](https://success.openhealth.fr/de/articles/6043852-hub-uan-version-220315.md) - [PORTAIL Version 220215](https://success.openhealth.fr/de/articles/5940805-portail-version-220215.md) - [SMA HUB Version 220215](https://success.openhealth.fr/de/articles/5940753-sma-hub-version-220215.md) - [HUB TMA Version 220215](https://success.openhealth.fr/de/articles/5947859-hub-tma-version-220215.md) - [PORTAIL Version 211215](https://success.openhealth.fr/de/articles/5819397-portail-version-211215.md) - [SMA HUB Version 211215](https://success.openhealth.fr/de/articles/5784709-sma-hub-version-211215.md) - [HUB TMA Version 211215](https://success.openhealth.fr/de/articles/5784888-hub-tma-version-211215.md) - [HUB UAN Version 211215](https://success.openhealth.fr/de/articles/5784904-hub-uan-version-211215.md) - [Anwendung The HUB: "Offizielle Konjunktur"](https://success.openhealth.fr/de/articles/5704485-anwendung-the-hub-offizielle-konjunktur.md) - [PORTAIL Version 211115](https://success.openhealth.fr/de/articles/5697844-portail-version-211115.md) - [SMA HUB Version 211115](https://success.openhealth.fr/de/articles/5671893-sma-hub-version-211115.md) - [HUB TMA Version 211115](https://success.openhealth.fr/de/articles/5671917-hub-tma-version-211115.md) - [HUB UAN Version 211115](https://success.openhealth.fr/de/articles/5671927-hub-uan-version-211115.md) - [PORTAIL Version 211015](https://success.openhealth.fr/de/articles/5652210-portail-version-211015.md) - [SMA HUB Version 211015](https://success.openhealth.fr/de/articles/5649822-sma-hub-version-211015.md) - [HUB TMA Version 211015](https://success.openhealth.fr/de/articles/5650073-hub-tma-version-211015.md) - [HUB UAN Version 211015](https://success.openhealth.fr/de/articles/5652242-hub-uan-version-211015.md) - [SMA HUB Version 210915](https://success.openhealth.fr/de/articles/5370516-sma-hub-version-210915.md) - [HUB TMA Version 210915](https://success.openhealth.fr/de/articles/5390983-hub-tma-version-210915.md) - [HUB UAN Version 210915](https://success.openhealth.fr/de/articles/5543213-hub-uan-version-210915.md) ### Votre ESPACE D'ADMINISTRATION - fonctionnalités - [Passwort zurücksetzen / ändern Der HUB](https://success.openhealth.fr/de/articles/4425325-passwort-zurucksetzen-andern-der-hub.md): So ändern Sie das HUB-Passwort - [Verbindungshilfe: Ich stoße auf eine Fehlermeldung](https://success.openhealth.fr/de/articles/5369783-verbindungshilfe-ich-stosse-auf-eine-fehlermeldung.md) - [Erstellen und verfolgen Sie ein Ticket](https://success.openhealth.fr/de/articles/3586214-erstellen-und-verfolgen-sie-ein-ticket.md): Tutorial zum Erstellen und Verfolgen der Entwicklung Ihrer Tickets in Ihrem persönlichen Bereich The HUB - [Einen SUCCESS-Artikel erstellen und bearbeiten](https://success.openhealth.fr/de/articles/6738705-einen-success-artikel-erstellen-und-bearbeiten.md) - [Meine Verträge](https://success.openhealth.fr/de/articles/5712273-meine-vertrage.md) - [Service Health](https://success.openhealth.fr/de/articles/4990600-service-health.md) - [Meine Zugänge](https://success.openhealth.fr/de/articles/5783418-meine-zugange.md) - [Einrichten meiner Startseite](https://success.openhealth.fr/de/articles/5712229-einrichten-meiner-startseite.md) - [Wie können Sie Ihren Markt von Ihrem persönlichen OpenHealth-Bereich aus ändern?](https://success.openhealth.fr/de/articles/3585971-wie-konnen-sie-ihren-markt-von-ihrem-personlichen-openhealth-bereich-aus-andern.md): Integrieren, ändern und deaktivieren Sie Produkte aus Ihrem persönlichen OpenHealth-Bereich - [Automatische Modalitätszuweisungsänderung \(Auto MAM\)](https://success.openhealth.fr/de/articles/4164818-automatische-modalitatszuweisungsanderung-auto-mam.md): Ändern Sie direkt die Zuordnungen Ihrer Produkte - [TEMPORAL MAM: Wie folgt man einer Marke, die Labor / Marke / Label ändert?](https://success.openhealth.fr/de/articles/4131072-temporal-mam-wie-folgt-man-einer-marke-die-labor-marke-label-andert.md): Vorteile und Risiken Ihrer Art der Verfolgung - [Automatische Produktintegration \(Auto IPR\)](https://success.openhealth.fr/de/articles/4164932-automatische-produktintegration-auto-ipr.md): Fordern Sie die Integration eines Produkts in Ihren Markt an - [Automatische Produktdeaktivierung \(Auto DPR\)](https://success.openhealth.fr/de/articles/4164866-automatische-produktdeaktivierung-auto-dpr.md): Deaktivieren Sie ein Produkt aus Ihrem Markt - [Automatische Produktaktivierung \(Auto RPR\)](https://success.openhealth.fr/de/articles/4818161-automatische-produktaktivierung-auto-rpr.md) - [Einrichten von Produktneuheiten](https://success.openhealth.fr/de/articles/5811248-einrichten-von-produktneuheiten.md) - [Einen Markt hinzufügen](https://success.openhealth.fr/de/articles/5712283-einen-markt-hinzufugen.md) - [Import / Export von Massenprodukten](https://success.openhealth.fr/de/articles/5712257-import-export-von-massenprodukten.md) - [Wechsel der typologischen Modalität \(CMT\)](https://success.openhealth.fr/de/articles/4670174-wechsel-der-typologischen-modalitat-cmt.md) - [Die verschiedenen Benutzerstatus](https://success.openhealth.fr/de/articles/3436418-die-verschiedenen-benutzerstatus.md): Was sind die Funktionen? - [Ein Konto für einen Nutzer einer Drittorganisation erstellen \(TPAA\)](https://success.openhealth.fr/de/articles/6466550-ein-konto-fur-einen-nutzer-einer-drittorganisation-erstellen-tpaa.md) - [Wie erstelle, ändere oder lösche ich ein Benutzerkonto in The HUB?](https://success.openhealth.fr/de/articles/3785138-wie-erstelle-andere-oder-losche-ich-ein-benutzerkonto-in-the-hub.md): Dies kann nur ein POWER USER - [Kann ich innerhalb meiner Teams differenzierte Anzeigerechte am HUB erstellen?](https://success.openhealth.fr/de/articles/3321731-kann-ich-innerhalb-meiner-teams-differenzierte-anzeigerechte-am-hub-erstellen.md): Rechte im Hub - [Aktivitätenprotokoll](https://success.openhealth.fr/de/articles/4687438-aktivitatenprotokoll.md) ### Vos APPLICATIONS - présentation - [Der Ausbildungsleitfaden The HUB](https://success.openhealth.fr/de/articles/5634967-der-ausbildungsleitfaden-the-hub.md) - [Dropdown-Selektor für die Sortierung](https://success.openhealth.fr/de/articles/5792113-dropdown-selektor-fur-die-sortierung.md) - [Aktualisierungsdatum der GSA-Drogerie-Daten \(SMKT\) im HuB](https://success.openhealth.fr/de/articles/3175557-aktualisierungsdatum-der-gsa-drogerie-daten-smkt-im-hub.md): Dieser Artikel beschreibt das Datum, an dem die Daten von GSA-Drogerien \(SMKT\) aktualisiert werden. - [Voraussetzungen Matching Pharmacies File](https://success.openhealth.fr/de/articles/3678146-voraussetzungen-matching-pharmacies-file.md): Voraussetzungen Matching Pharmacies File - [Wahlschalter "Ein und Aus Rezept"](https://success.openhealth.fr/de/articles/3729668-wahlschalter-ein-und-aus-rezept.md): Spezifikationen des Objekts 'Prescription Type Selector' - [Wie qualifiziere ich neue Produkte im HUB?](https://success.openhealth.fr/de/articles/3376100-wie-qualifiziere-ich-neue-produkte-im-hub.md): Qualifizierung Ihrer neuen Produkte im HUB - [Wie erstelle, ändere und teile ich einen Favoriten im HUB?](https://success.openhealth.fr/de/articles/3175689-wie-erstelle-andere-und-teile-ich-einen-favoriten-im-hub.md): Erstellen und Freigeben von Favoriten im Hub - [Wie wähle ich Produkte im HUB nach Startdatum aus?](https://success.openhealth.fr/de/articles/3158428-wie-wahle-ich-produkte-im-hub-nach-startdatum-aus.md): In diesem Artikel wird erläutert, wie Sie nur Produkte auswählen, die in einem bestimmten Zeitraum eingeführt wurden. - [Kann ich die Daten aus dem HUB im ".csv"-Format extrahieren?](https://success.openhealth.fr/de/articles/5671278-kann-ich-die-daten-aus-dem-hub-im-csv-format-extrahieren.md) - [Reaktionszeit ODT](https://success.openhealth.fr/de/articles/6632310-reaktionszeit-odt.md) - [Was sind die besten Anzeigeverfahren im HUB?](https://success.openhealth.fr/de/articles/3124454-was-sind-die-besten-anzeigeverfahren-im-hub.md): Dieser Artikel beschreibt die besten Praktiken zur Optimierung der Anzeige des HUBs - [Technische Voraussetzungen](https://success.openhealth.fr/de/articles/5369918-technische-voraussetzungen.md) - [Leeren Sie Ihren Browser-Cache](https://success.openhealth.fr/de/articles/4219722-leeren-sie-ihren-browser-cache.md): So löschen Sie Ihren Google Chrome-Browser-Cache - [Wie lege ich Google Chrome als Standardbrowser fest?](https://success.openhealth.fr/de/articles/3738717-wie-lege-ich-google-chrome-als-standardbrowser-fest.md): So legen Sie Google Chrome als Standard fest - [Der Navigationsaufzug ist in den Tabellen nicht sichtbar](https://success.openhealth.fr/de/articles/3195250-der-navigationsaufzug-ist-in-den-tabellen-nicht-sichtbar.md): Der Navigationslift - [Die Anzeige von Schaltflächen oder Objekten auf einem Blatt ist teilweise abgeschnitten oder nicht sichtbar](https://success.openhealth.fr/de/articles/3195245-die-anzeige-von-schaltflachen-oder-objekten-auf-einem-blatt-ist-teilweise-abgeschnitten-oder-nicht-sichtbar.md): Anzeigeproblem von Schaltflächen, Objekten - [Meine Gebietsverwaltungskarte wird nicht geladen und die Meldung "Laden" wird angezeigt](https://success.openhealth.fr/de/articles/3195239-meine-gebietsverwaltungskarte-wird-nicht-geladen-und-die-meldung-laden-wird-angezeigt.md): Problem bei der Anzeige von Territory Management / TMA-Karten - [Woher kommt die Fehlermeldung "Sie sind nicht berechtigt, auf diese Seite zuzugreifen"?](https://success.openhealth.fr/de/articles/3195338-woher-kommt-die-fehlermeldung-sie-sind-nicht-berechtigt-auf-diese-seite-zuzugreifen.md): Fehlermeldungen - [Ich habe die Fehlermeldung "Verbindung unterbrochen"](https://success.openhealth.fr/de/articles/4445141-ich-habe-die-fehlermeldung-verbindung-unterbrochen.md): Ein Fehler ist aufgetreten - [Schlechtes Tor](https://success.openhealth.fr/de/articles/4514555-schlechtes-tor.md): Fehlermeldung "Bad Gateway" - [Die Dimensions- und Kennzahlselektoren werden in den Abfragegeräten "Multiple Period Analysis" und "My Data Archive" nicht mehr angezeigt. Die Extraktion der Tabelle in "Market Analysis" ist teilweise](https://success.openhealth.fr/de/articles/3195377-die-dimensions-und-kennzahlselektoren-werden-in-den-abfragegeraten-multiple-period-analysis-und-my-data-archive-nicht-mehr-angezeigt-die-extraktion-der-tabelle-in-market-analysis-ist-teilweise.md): Abmessungen und Maße werden nicht mehr angezeigt - [Wie kann ich einen Begriff im HUB anzeigen?](https://success.openhealth.fr/de/articles/3194377-wie-kann-ich-einen-begriff-im-hub-anzeigen.md): Mit dem HUB können Sie Quadrimester einfach im Blatt "Sales Evolution" anzeigen - [Excel-Spezifikationen und Einschränkungen](https://success.openhealth.fr/de/articles/3753088-excel-spezifikationen-und-einschrankungen.md): Dieser Artikel erläutert die Spezifikationen und Einschränkungen für Excel. - [Wie erstellt, bearbeitet und teilt man einen Favoriten in seinen Anwendungen?](https://success.openhealth.fr/de/articles/10502803-wie-erstellt-bearbeitet-und-teilt-man-einen-favoriten-in-seinen-anwendungen.md) - [Consumer Panel Framework](https://success.openhealth.fr/de/articles/3455845-consumer-panel-framework.md): Artikel zum Rahmen des Verbraucherpanels - [Rahmen für die Marktanalyse von Apotheken](https://success.openhealth.fr/de/articles/3455857-rahmen-fur-die-marktanalyse-von-apotheken.md): Artikel zum OpenHealth-Framework zur Analyse der Marktleistung im Apothekenkanal ### Daten-QUELLEN - [Was ist das OpenHealth Pharmacy Panel?](https://success.openhealth.fr/de/articles/3304106-was-ist-das-openhealth-pharmacy-panel.md): Der Zweck dieses Artikels besteht darin, unser Apothekenpanel. - [Das Apothekennetzwerk ist ein entscheidender Faktor bei der Bewältigung aktueller und zukünftiger Gesundheitskrisen](https://success.openhealth.fr/de/articles/3825648-das-apothekennetzwerk-ist-ein-entscheidender-faktor-bei-der-bewaltigung-aktueller-und-zukunftiger-gesundheitskrisen.md): OpenHealth Company, das sich der Überwachung einer beispiellosen Gesundheitskrise verschrieben hat, mobilisiert seine Technologie und Daten - [Welche Gebiete der französischen überseeischen Departements und Gebiete können im HUB eingesehen werden?](https://success.openhealth.fr/de/articles/3194382-welche-gebiete-der-franzosischen-uberseeischen-departements-und-gebiete-konnen-im-hub-eingesehen-werden.md): DROM-COM-Gebiete im Hub verfügbar - [Vorausgesetzte Sektorisierungsdatei](https://success.openhealth.fr/de/articles/3702701-vorausgesetzte-sektorisierungsdatei.md): In diesem Artikel können Sie Ihre Sektorisierungsdatei herunterladen, vervollständigen und senden. - [SMKT-Datenquelle](https://success.openhealth.fr/de/articles/4485357-smkt-datenquelle.md): IRI, Anbieter von GSA-Drogerie-Daten - [Codierungsregeln für GSA-Parapharmazieprodukte \(SMKT\) bei IRI](https://success.openhealth.fr/de/articles/3524492-codierungsregeln-fur-gsa-parapharmazieprodukte-smkt-bei-iri.md): Erinnerung an die Kodifizierungsregeln für SMKT-Produkte bei IRI - [Daten zu BIO-MAGAZINEN - Quelle BIOANALYTICS](https://success.openhealth.fr/de/articles/5631260-daten-zu-bio-magazinen-quelle-bioanalytics.md) - [E-Parapharmazie: Überwachung der Plattformen](https://success.openhealth.fr/de/articles/9167006-e-parapharmazie-uberwachung-der-plattformen.md) - [E-Apotheken Produktgewinne und -verluste](https://success.openhealth.fr/de/articles/3568773-e-apotheken-produktgewinne-und-verluste.md): Artikel zum Modul „Produktgewinne und -verluste bei E-Apotheken“ - [Verbraucherprofil](https://success.openhealth.fr/de/articles/3711085-verbraucherprofil.md): Artikel zum Modul "Verbraucherprofil" - [AMAZON-Daten - Quelle SELLINGZ](https://success.openhealth.fr/de/articles/5669013-amazon-daten-quelle-sellingz.md) - [Ecommerce-Daten - Quelle WISER](https://success.openhealth.fr/de/articles/7983010-ecommerce-daten-quelle-wiser.md) - [Geografische Gebiete](https://success.openhealth.fr/de/articles/4661582-geografische-gebiete.md): Bei Open Health Company können Sie Ihre Märkte anhand der von uns angebotenen geografischen Gebiete analysieren. - [Was ist das Apothekenpanel in Deutschland? INSIGHTHEALTH](https://success.openhealth.fr/de/articles/5391412-was-ist-das-apothekenpanel-in-deutschland-insighthealth.md) - [Was ist das Apothekenpanel in Griechenland? ALIRAHEALTH](https://success.openhealth.fr/de/articles/6863963-was-ist-das-apothekenpanel-in-griechenland-alirahealth.md) - [Was ist das Apothekenpanel in Österreich? INSIGHTHEALTH](https://success.openhealth.fr/de/articles/6863949-was-ist-das-apothekenpanel-in-osterreich-insighthealth.md) - [Was ist das Apothekenpanel in Afrika? PIEX - Afrika](https://success.openhealth.fr/de/articles/6686633-was-ist-das-apothekenpanel-in-afrika-piex-afrika.md) - [Was ist das Online-Apothekenpanel in Deutschland? DATAMEDIQ](https://success.openhealth.fr/de/articles/5689640-was-ist-das-online-apothekenpanel-in-deutschland-datamediq.md) - [Was ist das Apothekenpanel in Belgien? REDPHARMA](https://success.openhealth.fr/de/articles/4689894-was-ist-das-apothekenpanel-in-belgien-redpharma.md) - [Was ist das Apothekenpanel in Spanien? - HMR](https://success.openhealth.fr/de/articles/5391363-was-ist-das-apothekenpanel-in-spanien-hmr.md) - [Wie sieht das Apothekenpanel in Spanien aus? - INFONIS](https://success.openhealth.fr/de/articles/5428915-wie-sieht-das-apothekenpanel-in-spanien-aus-infonis.md) - [Was ist das Apothekenpanel in Portugal? - HMR](https://success.openhealth.fr/de/articles/5391477-was-ist-das-apothekenpanel-in-portugal-hmr.md) - [Was ist das Apothekenpanel in Russland? - ALPHARM](https://success.openhealth.fr/de/articles/5701531-was-ist-das-apothekenpanel-in-russland-alpharm.md) - [Was ist das Apothekenpanel in Polen? Pex Pharma](https://success.openhealth.fr/de/articles/5969485-was-ist-das-apothekenpanel-in-polen-pex-pharma.md) - [CONVERT GROUP](https://success.openhealth.fr/de/articles/6961966-convert-group.md) - [Was ist das Apothekenpanel in Jordanien?](https://success.openhealth.fr/de/articles/8176750-was-ist-das-apothekenpanel-in-jordanien.md) - [Bevölkerung - Kartographie](https://success.openhealth.fr/de/articles/3807695-bevolkerung-kartographie.md): Analysieren Sie die geografische Verteilung der Bevölkerung - [AMELI - BVG](https://success.openhealth.fr/de/articles/6962021-ameli-bvg.md) - [Bevölkerung - Evolution von AGE & GENDER](https://success.openhealth.fr/de/articles/3810789-bevolkerung-evolution-von-age-gender.md): Analysieren Sie die Entwicklung der Bevölkerungsstruktur - [Bevölkerung - Vergleich von AGE & GENDER](https://success.openhealth.fr/de/articles/3836795-bevolkerung-vergleich-von-age-gender.md): Vergleichen Sie das demografische Profil zweier Bevölkerungsgruppen - [ÄGYPTEN - Kartographie](https://success.openhealth.fr/de/articles/3714611-agypten-kartographie.md): Analysieren Sie die Bevölkerung der ägyptischen Gouvernorate - [ÄGYPTEN - Analyse von AGE & GENDER](https://success.openhealth.fr/de/articles/3714673-agypten-analyse-von-age-gender.md): Analysieren Sie die Struktur der Bevölkerung - [UGANDA - Analyse von AGE & GENDER](https://success.openhealth.fr/de/articles/3713884-uganda-analyse-von-age-gender.md): Analysieren Sie die Struktur der Bevölkerung - [Bevölkerungsanalyse von AGE & GENDER](https://success.openhealth.fr/de/articles/3807673-bevolkerungsanalyse-von-age-gender.md): Analysieren Sie die Struktur der Bevölkerung - [Medicabase - Datenbank für Medikamente](https://success.openhealth.fr/de/articles/6518920-medicabase-datenbank-fur-medikamente.md) - [Geburt](https://success.openhealth.fr/de/articles/6340025-geburt.md) - [OpenEudra](https://success.openhealth.fr/de/articles/6518977-openeudra.md) - [IRIS-Ausschnitt](https://success.openhealth.fr/de/articles/6383829-iris-ausschnitt.md) - [ADICAP](https://success.openhealth.fr/de/articles/6959465-adicap.md) - [NDC](https://success.openhealth.fr/de/articles/6519012-ndc.md) - [Weltbevölkerungsdaten](https://success.openhealth.fr/de/articles/8217421-weltbevolkerungsdaten.md) - [INSEE: Akten von Verstorbenen](https://success.openhealth.fr/de/articles/4498126-insee-akten-von-verstorbenen.md): INSEE \(Nationales Institut für Statistik und Wirtschaftsstudien\): Akte der Verstorbenen - [VAERS- VAERSDATA- Quelle CDC](https://success.openhealth.fr/de/articles/6226665-vaers-vaersdata-quelle-cdc.md) - [VAERS-Daten - VAERSVAX - Quelle CDC](https://success.openhealth.fr/de/articles/6226440-vaers-daten-vaersvax-quelle-cdc.md) - [VAERS-Daten - VAERSSYMPTOMS - Quelle CDC](https://success.openhealth.fr/de/articles/6219415-vaers-daten-vaerssymptoms-quelle-cdc.md) - [Ihre Daten in weniger als 2 Wochen in den Hub integrieren](https://success.openhealth.fr/de/articles/5259828-ihre-daten-in-weniger-als-2-wochen-in-den-hub-integrieren.md) - [International Data Template](https://success.openhealth.fr/de/articles/4684696-international-data-template.md) - [Wie können Sie uns Ihre Daten per FTPS senden?](https://success.openhealth.fr/de/articles/4143451-wie-konnen-sie-uns-ihre-daten-per-ftps-senden.md): Daten über FTPS senden - [Welche Informationen benötigt OpenHealth, um eine neue Datenquelle zu integrieren?](https://success.openhealth.fr/de/articles/3459148-welche-informationen-benotigt-openhealth-um-eine-neue-datenquelle-zu-integrieren.md): Artikel zur Integration neuer Datenquellen - [Die Lange Sicht](https://success.openhealth.fr/de/articles/6959482-die-lange-sicht.md) - [Wie kann ich eine neue Datenquelle in den HUB integrieren?](https://success.openhealth.fr/de/articles/3467598-wie-kann-ich-eine-neue-datenquelle-in-den-hub-integrieren.md): Artikel zum Datenintegrationsprozess im HUB - [Integrieren Sie Ihre Verkaufsdaten in den HUB](https://success.openhealth.fr/de/articles/3471145-integrieren-sie-ihre-verkaufsdaten-in-den-hub.md): Artikel zur Integration von Verkaufsdaten - [Spezifikationen für den Empfang von Verkaufsdaten](https://success.openhealth.fr/de/articles/3660043-spezifikationen-fur-den-empfang-von-verkaufsdaten.md): So senden Sie uns Ihr Sell-In im Rahmen einer Sell-In / Sell-Out-Analyse oder eines Abonnements für das Modul Sell-In Vizualization - [Woher stammen die Analysedaten für den PSAD-Markt \(Home Health Providers\)?](https://success.openhealth.fr/de/articles/3376155-woher-stammen-die-analysedaten-fur-den-psad-markt-home-health-providers.md): PSAD - [Wie kann ich dem Observatorium von SantéDom Stat beitreten?](https://success.openhealth.fr/de/articles/3798795-wie-kann-ich-dem-observatorium-von-santedom-stat-beitreten.md): Tutorial für den Beitritt zum nationalen Observatorium für die Aktivitäten von Home Health Providers \(PSAD\) - [Hochgerechnetes Panel aus der Beobachtungsstelle SanteDomStat](https://success.openhealth.fr/de/articles/6701602-hochgerechnetes-panel-aus-der-beobachtungsstelle-santedomstat.md) - [Anzahl der Patienten](https://success.openhealth.fr/de/articles/3376499-anzahl-der-patienten.md): Definition der Anzahl der Patienten nach den PSAD-Verbänden - [Anzahl der Behandlungen](https://success.openhealth.fr/de/articles/3376682-anzahl-der-behandlungen.md): Definition der Anzahl der Behandlungen nach den PSAD-Verbänden - [Anzahl neuer Patienten](https://success.openhealth.fr/de/articles/3376672-anzahl-neuer-patienten.md): Definition der Anzahl neuer Patienten nach den PSAD-Verbänden - [Umsatz inklusive Steuern](https://success.openhealth.fr/de/articles/3376725-umsatz-inklusive-steuern.md): Definition des Umsatzes einschließlich Steuern nach Angaben der PSAD-Verbände - [Anzahl der Patienten am Ende der Behandlung](https://success.openhealth.fr/de/articles/3376675-anzahl-der-patienten-am-ende-der-behandlung.md): Definition der Anzahl der Patienten am Ende der Behandlung nach Angaben der PSAD-Verbände - [Obligatorische Krankenversicherungssumme \(AMO\)](https://success.openhealth.fr/de/articles/3376740-obligatorische-krankenversicherungssumme-amo.md): Definition des AMO-Betrags gemäß den PSAD-Verbänden - [Zusätzliche Krankenversicherungssumme \(AMC\)](https://success.openhealth.fr/de/articles/3376749-zusatzliche-krankenversicherungssumme-amc.md): Definition des AMC-Betrags gemäß den PSAD-Verbänden - [Ausstehende Gebühr \(RAC\)](https://success.openhealth.fr/de/articles/3376751-ausstehende-gebuhr-rac.md): Definition des RAC nach den PSAD-Verbänden - [Quelle: THESORIMED](https://success.openhealth.fr/de/articles/3560018-quelle-thesorimed.md): Medikamentendatenbank \(BdM\) - [Internationale nicht geschützte Namen \(INN\)](https://success.openhealth.fr/de/articles/3954239-internationale-nicht-geschutzte-namen-inn.md): Internationale gebräuchliche Namen \(INN\) - [Open Food Facts](https://success.openhealth.fr/de/articles/6961970-open-food-facts.md) - [LOINC - Logical Observation Identifiers Names & Codes \(Logische Beobachtungskennzeichen\)](https://success.openhealth.fr/de/articles/6959323-loinc-logical-observation-identifiers-names-codes-logische-beobachtungskennzeichen.md) - [AMELI - CCAM](https://success.openhealth.fr/de/articles/6959080-ameli-ccam.md) - [WHO ATC VET](https://success.openhealth.fr/de/articles/6959078-who-atc-vet.md) - [CEPS](https://success.openhealth.fr/de/articles/6959068-ceps.md) - [Institution](https://success.openhealth.fr/de/articles/3935678-institution.md): Liste der gesundheitlichen, sozialen und medizinisch-sozialen Einrichtungen - [Gesundheitsangebot](https://success.openhealth.fr/de/articles/7969680-gesundheitsangebot.md) - [FINESS extrahieren](https://success.openhealth.fr/de/articles/3946922-finess-extrahieren.md): Führen Sie eine Extraktion gemäß Ihren Erwartungen durch - [Evolution FINESS](https://success.openhealth.fr/de/articles/3947009-evolution-finess.md): Verfolgen Sie die Entwicklung der Anzahl der Strukturen - [Autorisierungspflege](https://success.openhealth.fr/de/articles/3947067-autorisierungspflege.md): Listen Sie die Strukturen gemäß ihren Berechtigungen für Aktivitäten im Gesundheitswesen auf - [Wichtige medizinische Geräte](https://success.openhealth.fr/de/articles/3947269-wichtige-medizinische-gerate.md): Listen Sie die Strukturen entsprechend ihrer Ausrüstung in schwerem Material auf - [Geografisch](https://success.openhealth.fr/de/articles/3947363-geografisch.md): Visualisieren Sie die Verteilung der Strukturen auf dem Territorium - [RPPS](https://success.openhealth.fr/de/articles/3947568-rpps.md): Liste der Angehörigen der Gesundheitsberufe - [Feinheit & RPPS](https://success.openhealth.fr/de/articles/3947713-feinheit-rpps.md): Listen Sie die Übungsorte der Angehörigen der Gesundheitsberufe auf - [RPPS extrahieren](https://success.openhealth.fr/de/articles/3947829-rpps-extrahieren.md): RPPS \(Shared Directory of Healthcare Professionals\) ### Die Modelle - [Daten auf UGA](https://success.openhealth.fr/de/articles/4852310-daten-auf-uga.md) - [Berechnung der Verkäufe an die Branche: Was Sie wissen müssen](https://success.openhealth.fr/de/articles/3545561-berechnung-der-verkaufe-an-die-branche-was-sie-wissen-mussen.md): Was sind die verschiedenen Schritte zur Berechnung des Branchenumsatzes bei OpenHealth? - [Sektorumverteilung, statische oder dynamische Methodik?](https://success.openhealth.fr/de/articles/3690615-sektorumverteilung-statische-oder-dynamische-methodik.md): Sektorumverteilung, statische oder dynamische Methodik? - [Apothekenschichten](https://success.openhealth.fr/de/articles/4291490-apothekenschichten.md): Details der "theoretischen" Schichten und der "realen" oder "effektiven" Schichten. - [Die Produktionskette The Hub](https://success.openhealth.fr/de/articles/4816146-die-produktionskette-the-hub.md) - [Wie führe ich eine vergleichende Analyse durch?](https://success.openhealth.fr/de/articles/3440093-wie-fuhre-ich-eine-vergleichende-analyse-durch.md): Sie möchten Daten von zwei verschiedenen Anbietern vergleichen. - [STUFE 1 UNTERSUCHUNG - Datenqualität im Dienste der OpenHealth Company](https://success.openhealth.fr/de/articles/3595822-stufe-1-untersuchung-datenqualitat-im-dienste-der-openhealth-company.md): Beobachten Sie ein Phänomen, das Sie nicht verstehen? Wir können Ihnen den Ursprung dieser Sichtung mitteilen und Ihnen erklären. - [Datenqualitätsprozess bei OpenHealth](https://success.openhealth.fr/de/articles/3415271-datenqualitatsprozess-bei-openhealth.md): Dieser Artikel beschreibt die Phasen der Datenqualitätsprozesse bei OpenHealth - [Intervall und Konfidenzniveau](https://success.openhealth.fr/de/articles/3633173-intervall-und-konfidenzniveau.md): Definitionen, Formeln und Einschränkungen: Was Sie wissen müssen - [Datenqualität: Chargenverwaltung](https://success.openhealth.fr/de/articles/3433509-datenqualitat-chargenverwaltung.md): Beschreibung des Batch-Management-Prozesses - [Datenqualität: Aufschlüsselungsprozess](https://success.openhealth.fr/de/articles/3415317-datenqualitat-aufschlusselungsprozess.md): Beschreibung des Verkaufsaufschlüsselungsprozesses - [Sell-In und Stock Offsets](https://success.openhealth.fr/de/articles/4131084-sell-in-und-stock-offsets.md): Lagerverkauf - [Warum das Verkaufsvolumen analysieren?](https://success.openhealth.fr/de/articles/3846167-warum-das-verkaufsvolumen-analysieren.md): Warum das Verkaufsvolumen analysieren? - [Es gibt eine Datenlücke zwischen Ausverkauf und Ausverkauf](https://success.openhealth.fr/de/articles/3195358-es-gibt-eine-datenlucke-zwischen-ausverkauf-und-ausverkauf.md): In welchen Fällen können wir eine Datenlücke zwischen Ausverkauf und Ausverkauf haben? - [Was ist ein atypischer Verkauf?](https://success.openhealth.fr/de/articles/3195366-was-ist-ein-atypischer-verkauf.md): Atypische Verkäufe und der ATYPICAL FILTER-Prozess. - [Woher kommen die Informationen zu Preisen, Mengen und Umsatz?](https://success.openhealth.fr/de/articles/3195348-woher-kommen-die-informationen-zu-preisen-mengen-und-umsatz.md): Preis- / Volumen- / Umsatzinformationen - [Geschätztes Verkaufsvolumen nach verschreibendem Arzt](https://success.openhealth.fr/de/articles/4171530-geschatztes-verkaufsvolumen-nach-verschreibendem-arzt.md): So bewerten Sie Ihr Verkaufsvolumen in Apotheken nach Verschreiber und Kategorie des Verschreibers - [Den Unterschied zwischen 2 Extraktionen verstehen](https://success.openhealth.fr/de/articles/13399689-den-unterschied-zwischen-2-extraktionen-verstehen.md) ### MÄRKTE - [GTIN](https://success.openhealth.fr/de/articles/3608176-gtin.md): GTIN-Code \(Global Trade Item Number\) - [Feldspezifikation für Kundenproduktqualifizierer \(CQCP\)](https://success.openhealth.fr/de/articles/3704913-feldspezifikation-fur-kundenproduktqualifizierer-cqcp.md): CQCP \(Product Customer Qualifier Field\) - [Was ist ein LPPR-Code?](https://success.openhealth.fr/de/articles/3195365-was-ist-ein-lppr-code.md): Der LPPR-Code \(Liste der erstattungsfähigen Produkte und Dienstleistungen\) - [Nachverfolgung der Produktmiete](https://success.openhealth.fr/de/articles/4206554-nachverfolgung-der-produktmiete.md): Produktvermietung - [Ich möchte meinen Markt erweitern](https://success.openhealth.fr/de/articles/4420843-ich-mochte-meinen-markt-erweitern.md): Der Abonnementmarkt folgte - [OHC-Klassifizierung](https://success.openhealth.fr/de/articles/3194589-ohc-klassifizierung.md): Zeigen Sie die Zuordnung Ihrer Produkte gemäß der proprietären OpenHealth Company-Klassifizierung an - [EphMRA AC Klassen Geschichte](https://success.openhealth.fr/de/articles/3557908-ephmra-ac-klassen-geschichte.md): Visualisieren Sie die Entwicklung der EphMRA AC-Klassen seit 2014 - [Veterinärmedizinische Details](https://success.openhealth.fr/de/articles/3194587-veterinarmedizinische-details.md): Visualisieren Sie die Eigenschaften von Tierarzneimitteln - [Veterinärmedizinische Klassifikation](https://success.openhealth.fr/de/articles/3194579-veterinarmedizinische-klassifikation.md): Anzeigen der Klassifizierung von Tierarzneimitteln \(ANSES\) - [Humanmedizin Details](https://success.openhealth.fr/de/articles/3421225-humanmedizin-details.md): Zeigen Sie die Eigenschaften eines oder mehrerer Produkte in den Detailfeldern von THESORIMED an - [Management neuer Produkte](https://success.openhealth.fr/de/articles/4470813-management-neuer-produkte.md): Neues Produktmanagement - [Humanmedizinische Klassifikation](https://success.openhealth.fr/de/articles/3417281-humanmedizinische-klassifikation.md): Zeigen Sie die EphMRA AC- und OMS ATC-Klassifizierungen für Ihren Produktumfang an - [Indikationen - Diagnose](https://success.openhealth.fr/de/articles/3568554-indikationen-diagnose.md): Zeigen Sie die für eine bestimmte Pathologie angegebenen Medikamente und die mit einer Auswahl von Medikamenten verbundenen Pathologien an - [MP4U](https://success.openhealth.fr/de/articles/3574188-mp4u.md): Alle von OpenHealth Company zur Verfügung gestellten Klassifikationen anzeigen - [Was ist TVASI \(Tabelle der Verkäufe, Einkäufe und unbekannten Lagerbestände\)?](https://success.openhealth.fr/de/articles/5992494-was-ist-tvasi-tabelle-der-verkaufe-einkaufe-und-unbekannten-lagerbestande.md) - [IRI-Produktklassifizierung](https://success.openhealth.fr/de/articles/3194597-iri-produktklassifizierung.md): Visualisieren Sie die Zuordnung Ihrer Produkte gemäß der Klassifizierung Besitzer IRI - [Löschen unverkaufter Produkte](https://success.openhealth.fr/de/articles/6135938-loschen-unverkaufter-produkte.md) - [STANDARDMARKT - Abonnement](https://success.openhealth.fr/de/articles/3798203-standardmarkt-abonnement.md): Dieser Artikel beschreibt das Interesse und die Grenzen eines sogenannten "Standard" -Marktes - [Ich kann mein Produkt nicht finden](https://success.openhealth.fr/de/articles/5686002-ich-kann-mein-produkt-nicht-finden.md) - [Verwaltung von Produktcodes](https://success.openhealth.fr/de/articles/5652478-verwaltung-von-produktcodes.md) - [Produktqualifikation: Marken / Brands](https://success.openhealth.fr/de/articles/5016985-produktqualifikation-marken-brands.md) ### ABSOLUTE und MODULE - [Die 3 Arten von Anwendungen](https://success.openhealth.fr/de/articles/9489652-die-3-arten-von-anwendungen.md) - [Ihre Plattform 2.0](https://success.openhealth.fr/de/articles/8374416-ihre-plattform-2-0.md) - [ZUSAMMENFASSUNG](https://success.openhealth.fr/de/articles/3344127-zusammenfassung.md): Alle Eigenschaften Ihrer Anwendung sind in diesem Modul verfügbar - [Markets & Selections](https://success.openhealth.fr/de/articles/8337016-markets-selections.md) - [Synthetisches Dashboard](https://success.openhealth.fr/de/articles/9246867-synthetisches-dashboard.md) - [Analyse](https://success.openhealth.fr/de/articles/9352287-analyse.md) - [Extraktor](https://success.openhealth.fr/de/articles/9246875-extraktor.md) - [Wachstumsanalyse](https://success.openhealth.fr/de/articles/3158856-wachstumsanalyse.md): Bestimmen Sie die Schlüsselfaktoren für die Entwicklung Ihrer Märkte und der Ihrer Wettbewerber - [Sortimentsanalyse](https://success.openhealth.fr/de/articles/3473736-sortimentsanalyse.md): Untersuchen Sie die Dynamik von Produkten in einem Markt - [Durchschnittliche Anzahl der Produkte](https://success.openhealth.fr/de/articles/3161474-durchschnittliche-anzahl-der-produkte.md): Zeigen Sie die durchschnittliche Anzahl der Produkte pro Verkaufsstelle, in Apotheken oder in GSA-Drogerien an - [Tracking starten](https://success.openhealth.fr/de/articles/3158488-tracking-starten.md): Überwachen Sie Produkteinführungen und ihren Beitrag zum Wachstum - [Advanced Indicators Crossed](https://success.openhealth.fr/de/articles/6007740-advanced-indicators-crossed.md) - [Vertriebskonzentration](https://success.openhealth.fr/de/articles/3095338-vertriebskonzentration.md): Visualisieren Sie die Konzentration eines Marktes anhand der Umsatzkonzentrationskurve und des GINI-Index - [Preisstreuung](https://success.openhealth.fr/de/articles/3159289-preisstreuung.md): Visualisieren Sie die Preisstreuung eines Produkts. Erstellen Sie aus dem Verkaufspreis Ihre eigenen Apothekensegmente - [Ausverkaufs-Margin-Analyse](https://success.openhealth.fr/de/articles/3358322-ausverkaufs-margin-analyse.md): Benchmarking der Attraktivität Ihrer Produkte für Apotheken - [Sell-Out Margin Evolution](https://success.openhealth.fr/de/articles/3815561-sell-out-margin-evolution.md) - [Apothekenüberwachung \(1/2\)](https://success.openhealth.fr/de/articles/3358248-apothekenuberwachung-1-2.md): Verfolgen Sie die Entwicklung des Apothekenverkehrs - [Apothekenüberwachung \(2/2\)](https://success.openhealth.fr/de/articles/3810527-apothekenuberwachung-2-2.md): Verfolgen Sie die Entwicklung des Apothekenverkehrs - [Salesforce-Leistung](https://success.openhealth.fr/de/articles/3159230-salesforce-leistung.md): Vergleichen Sie die Vertriebsleistung von Regionen und Sektoren eines Vertriebsteams - [Customer Relationship Management \(CRM\) ASSISTENTIN](https://success.openhealth.fr/de/articles/5953935-customer-relationship-management-crm-assistentin.md) - [Point-of-Sales-Tracking](https://success.openhealth.fr/de/articles/3778944-point-of-sales-tracking.md): Point-of-Sales-Tracking - [On Demand Evolution](https://success.openhealth.fr/de/articles/6560184-on-demand-evolution.md) - [On Demand Analysis](https://success.openhealth.fr/de/articles/6127483-on-demand-analysis.md) - [On-Demand-Tabelle](https://success.openhealth.fr/de/articles/3158751-on-demand-tabelle.md): Visualisieren Sie die wichtigsten HUB-Indikatoren und ihre Entwicklung über verschiedene Arten von Zeiträumen - [Zeitreihenanalyse](https://success.openhealth.fr/de/articles/3635940-zeitreihenanalyse.md): Teilen Sie Ihren Markt in Saison, Trend und Lärm auf - [Prognoseanalyse](https://success.openhealth.fr/de/articles/3636015-prognoseanalyse.md): Schätzen Sie die Zukunft Ihres Marktes - [Sektorale Prognose](https://success.openhealth.fr/de/articles/3689811-sektorale-prognose.md): Schätzen Sie Ihren zukünftigen Branchenumsatz - [Sell-In-Visualisierung](https://success.openhealth.fr/de/articles/3559882-sell-in-visualisierung.md): Vergleichen Sie die Entwicklung Ihrer Ausverkaufs- und Ausverkaufsverkäufe - [Sell-in Analysis](https://success.openhealth.fr/de/articles/6188132-sell-in-analysis.md) - [Sell-in Matching](https://success.openhealth.fr/de/articles/6188090-sell-in-matching.md) - [Sell-in Evolution](https://success.openhealth.fr/de/articles/6191929-sell-in-evolution.md) - [Sell-in vs. Sell-out Analysis](https://success.openhealth.fr/de/articles/6191947-sell-in-vs-sell-out-analysis.md) - [Sell-in vs. Sell-out Evolution](https://success.openhealth.fr/de/articles/6191955-sell-in-vs-sell-out-evolution.md) - [Price Evolution](https://success.openhealth.fr/de/articles/5056489-price-evolution.md) - [Customize colors](https://success.openhealth.fr/de/articles/8407897-customize-colors.md) - [Produktexport](https://success.openhealth.fr/de/articles/3583206-produktexport.md): Exportblatt für alle Produkte und Apps vom Typ MP4U - [Marktanalyse](https://success.openhealth.fr/de/articles/3121933-marktanalyse.md): Analysieren Sie die Leistung Ihres Marktes: nach Segment, Marke, Produkt und Unternehmen - [Preisanalyse](https://success.openhealth.fr/de/articles/3215190-preisanalyse.md): Zeigen Sie die Preise auf Ihrem Markt an und analysieren Sie Ihre Positionierung - [Umsatzentwicklung](https://success.openhealth.fr/de/articles/3178323-umsatzentwicklung.md): Zeigen Sie Ihre sich entwickelnden Verkäufe über den gesamten verfügbaren Verlauf an - [Dashboard Summarize](https://success.openhealth.fr/de/articles/4533213-dashboard-summarize.md) - [Marktanteilsentwicklung](https://success.openhealth.fr/de/articles/3193078-marktanteilsentwicklung.md): Visualisieren Sie die Entwicklung von Umsatz und Marktanteil über lange Zeiträume - [Sales Cross Table](https://success.openhealth.fr/de/articles/3193060-sales-cross-table.md): Erstellen Sie eine einfache Pivot-Tabelle - [UMSATZ / VOLUMEN \(CU\) -Synthese](https://success.openhealth.fr/de/articles/3193048-umsatz-volumen-cu-synthese.md): Visualisieren Sie gleichzeitig das Verkaufsvolumen und den Wert eines Marktes - [Ausverkauf der Wertesynthese \(PHARMACIES / SUPERMARKETS\)](https://success.openhealth.fr/de/articles/3193020-ausverkauf-der-wertesynthese-pharmacies-supermarkets.md): Vergleichen Sie die Verkäufe von GSA-Drogerien und Drogerien - [Marktanteilsanalyse](https://success.openhealth.fr/de/articles/3193069-marktanteilsanalyse.md): Analysieren Sie die Marktanteile der letzten 12 Monate - [Mein Datenarchiv](https://success.openhealth.fr/de/articles/3193099-mein-datenarchiv.md): Exportieren Sie eine flache Datenbank nach Excel - [Multiple Period Analysis](https://success.openhealth.fr/de/articles/3192953-multiple-period-analysis.md): Erstellen Sie eine vollständig angepasste Tabelle - [Meine Abfrage Alle Produkte](https://success.openhealth.fr/de/articles/4280353-meine-abfrage-alle-produkte.md): Zeigen Sie Ihre Segmente und qualifizierenden Felder \(z. B. Galenic, Solar Index, Promotions ...\) sowie Ihre Einschränkung an - [Stock Evolution \(NEU\)](https://success.openhealth.fr/de/articles/3719256-stock-evolution-neu.md): Visualisieren und analysieren Sie die Entwicklung der Bestände und ihre Verteilung - [Marktdefinition](https://success.openhealth.fr/de/articles/3158829-marktdefinition.md): Richten Sie Ihren Markt auf die 100 Basis Ihrer Wahl - [Erweiterte RAW DATA-Anzeigen](https://success.openhealth.fr/de/articles/3711095-erweiterte-raw-data-anzeigen.md): Stellen Sie Ihre Frühindikatordaten wieder her - [Erweiterte Indikatoren Evolution SMKT](https://success.openhealth.fr/de/articles/3193000-erweiterte-indikatoren-evolution-smkt.md): Überwachen Sie die Leistung Ihres Labors durch eine Analyse der zeitlichen Entwicklung Ihrer erweiterten statistischen Indikatoren. - [Erweiterte Indikatoranalyse SMKT](https://success.openhealth.fr/de/articles/3192366-erweiterte-indikatoranalyse-smkt.md): Teilen Sie die Entwicklung eines GSA-Marktes für Parapharmazie in Frühindikatoren auf - [Erweiterte Indikatoren Evolution](https://success.openhealth.fr/de/articles/3177853-erweiterte-indikatoren-evolution.md): Überwachen Sie die Leistung Ihres Labors durch eine Analyse der zeitlichen Entwicklung Ihrer erweiterten statistischen Indikatoren. - [Advanced Indicators Evolution Bio](https://success.openhealth.fr/de/articles/7051823-advanced-indicators-evolution-bio.md) - [Nationale fortgeschrittene Indikatoren](https://success.openhealth.fr/de/articles/3364513-nationale-fortgeschrittene-indikatoren.md): Zerlegen Sie die Entwicklung eines Marktes in Frühindikatoren - [Aktienanalyse](https://success.openhealth.fr/de/articles/3178015-aktienanalyse.md): Interpretieren Sie einen Lagerbestand und seine Entwicklung - [Advanced Indicators Analysis Bio](https://success.openhealth.fr/de/articles/7051801-advanced-indicators-analysis-bio.md) - [Erweiterte Indikatoren-Analyse](https://success.openhealth.fr/de/articles/3124439-erweiterte-indikatoren-analyse.md): Zerlegen Sie die Entwicklung eines Marktes in Frühindikatoren - [Kartographie](https://success.openhealth.fr/de/articles/3192450-kartographie.md): Analysieren Sie die kommerzielle Leistung der Regionen und Sektoren Ihrer Vertriebsmitarbeiter - [Geografische Kreuztabelle](https://success.openhealth.fr/de/articles/3192466-geografische-kreuztabelle.md): Erstellen Sie eine Pivot-Tabelle, die Ihre Sektorisierung integriert - [Geografische Umsatzentwicklung](https://success.openhealth.fr/de/articles/3192482-geografische-umsatzentwicklung.md): Zeigen Sie die 36-Monats-Verkäufe nach Sektoren in einer Pivot-Tabelle an - [Sales Force Effectiveness](https://success.openhealth.fr/de/articles/5624011-sales-force-effectiveness.md) - [Custom Weighting Method Analysis](https://success.openhealth.fr/de/articles/5169317-custom-weighting-method-analysis.md) - [Netzwerkanalyse](https://success.openhealth.fr/de/articles/3894767-netzwerkanalyse.md): Netzwerkanalyse - [Custom Weighting Method Evolution](https://success.openhealth.fr/de/articles/5169320-custom-weighting-method-evolution.md) - [ZUSAMMENFASSUNG KPIs](https://success.openhealth.fr/de/articles/3478199-zusammenfassung-kpis.md): Visualisieren Sie in einer dynamischen Tabelle Ihre Schlüsselindikatoren. Das Volumen ging auf Regionen und Sektoren zurück. - [Verkäufe in umgerechneten Einheiten](https://success.openhealth.fr/de/articles/3192412-verkaufe-in-umgerechneten-einheiten.md): Verwenden Sie konvertierte Einheiten, um Ihre Verkäufe zu visualisieren - [RAW DATA Aktienindikatoren](https://success.openhealth.fr/de/articles/3711142-raw-data-aktienindikatoren.md): Exportieren Sie Ihre Inventardaten - [RAW DATA SMKT AIA](https://success.openhealth.fr/de/articles/3720960-raw-data-smkt-aia.md): Finden Sie Ihre SMKT-Frühindikatordaten - [Aktienentwicklung](https://success.openhealth.fr/de/articles/3178277-aktienentwicklung.md): Visualisieren und analysieren Sie die Entwicklung der Bestände und ihre Verteilung - [Geografische erweiterte Indikatoren](https://success.openhealth.fr/de/articles/3192508-geografische-erweiterte-indikatoren.md): Frühindikatoren nach Region oder Branche anzeigen - [Produktleistung](https://success.openhealth.fr/de/articles/3850331-produktleistung.md): Vergleichen Sie die Geschäftsentwicklung von Regionen und Produktsektoren - [Territorial Advanced Indicators](https://success.openhealth.fr/de/articles/3370879-territorial-advanced-indicators.md): Zerlegen Sie die Entwicklung eines Marktes in Frühindikatoren - [Sektorale Zeitreihenanalyse](https://success.openhealth.fr/de/articles/3814974-sektorale-zeitreihenanalyse.md): Teilen Sie Ihren Markt in Trend, Jahreszeit und Lärm auf - [Verkaufsanalyse nach Alter und Geschlecht](https://success.openhealth.fr/de/articles/3192701-verkaufsanalyse-nach-alter-und-geschlecht.md): Analysieren Sie Verkäufe nach Alter und Geschlecht - [Umsatzentwicklung nach Schwangerschaftsstatus](https://success.openhealth.fr/de/articles/3192910-umsatzentwicklung-nach-schwangerschaftsstatus.md): Verfolgen Sie den Apothekenverkauf bei schwangeren Frauen - [Umsatzentwicklung nach Alter und Geschlecht](https://success.openhealth.fr/de/articles/3192732-umsatzentwicklung-nach-alter-und-geschlecht.md): Visualisieren Sie die Entwicklung des Umsatzes nach Alter und Geschlecht anhand der historischen Tiefe des HUB - [Vorschriften Order Evolution](https://success.openhealth.fr/de/articles/5790020-vorschriften-order-evolution.md) - [Evolution Co-Dispensationen](https://success.openhealth.fr/de/articles/3192529-evolution-co-dispensationen.md): Visualisieren und brechen Sie die Entwicklung von Co-Dispensationen in Apotheken auf - [Co-Dispensations-Analyse](https://success.openhealth.fr/de/articles/3192633-co-dispensations-analyse.md): Sehen Sie sich die Co-Dispensationen in Apotheken an, die mit einer Auswahl von Produkten aus meinem Markt verbunden sind - [Umsatz pro Channel & Prescriber](https://success.openhealth.fr/de/articles/3192751-umsatz-pro-channel-prescriber.md): Visualisieren Sie die Influencer in Ihrem Markt - [AMO, AMC & RAC](https://success.openhealth.fr/de/articles/3192929-amo-amc-rac.md): Zeigen Sie die drei Beträge der obligatorischen Krankenversicherung, der ergänzenden Krankenversicherung und der Auslagen an - [Co-Dispensation Dispersion](https://success.openhealth.fr/de/articles/3876946-co-dispensation-dispersion.md): Visualisieren Sie die Verteilung der Anzahl der durch Dispensation verkauften Produkte - [Dispensation Dispersion Evolution](https://success.openhealth.fr/de/articles/3920070-dispensation-dispersion-evolution.md): Visualisieren Sie die Verteilung der Anzahl der pro Dispensation verkauften Produkte über die Zeit - [GP Prescriptions by AGE & GENDER](https://success.openhealth.fr/de/articles/5789899-gp-prescriptions-by-age-gender.md) - [Vorschriften Order Analysis](https://success.openhealth.fr/de/articles/5322866-vorschriften-order-analysis.md) - [GP Vorschriften Evolution](https://success.openhealth.fr/de/articles/5790016-gp-vorschriften-evolution.md) - [Korbanalyse](https://success.openhealth.fr/de/articles/3711049-korbanalyse.md): Beschreibung des Moduls 'Basket Analysis' - [Co-Dispensationen](https://success.openhealth.fr/de/articles/4738243-co-dispensationen.md) - [Kohortenqualifizierungsmodul](https://success.openhealth.fr/de/articles/3928090-kohortenqualifizierungsmodul.md): Qualifikation der Patientenkohorte - [Behandlungsstatusmodul](https://success.openhealth.fr/de/articles/3928067-behandlungsstatusmodul.md): Analysieren Sie die Dynamik der Behandlungsüberwachung - [Modul zur Einhaltung der Behandlung](https://success.openhealth.fr/de/articles/3928044-modul-zur-einhaltung-der-behandlung.md): Analysieren Sie die Einhaltung von Behandlungen - [Kohortendefinition](https://success.openhealth.fr/de/articles/3894703-kohortendefinition.md): Definieren Sie den Umfang Ihrer Analyse - [Co-Behandlungen](https://success.openhealth.fr/de/articles/4163623-co-behandlungen.md): Definieren Sie die Co-Verarbeitung in Ihrem Analysebereich - [Visualisierungskohorte](https://success.openhealth.fr/de/articles/3894721-visualisierungskohorte.md): Zeigen Sie das Patientenprofil der definierten Kohorte an - [Definition von Analysekriterien](https://success.openhealth.fr/de/articles/3894728-definition-von-analysekriterien.md): Definieren Sie die Parameter für die Analyse Ihrer Kohorte - [Globale Kohortenentwicklung](https://success.openhealth.fr/de/articles/3894747-globale-kohortenentwicklung.md): Visualisieren Sie die monatliche Entwicklung der Kohorte - [Geografische Verteilung](https://success.openhealth.fr/de/articles/3894751-geografische-verteilung.md): Zeigen Sie die geografische Verteilung der Patienten in der definierten Kohorte an - [Kohortenprofil](https://success.openhealth.fr/de/articles/3894755-kohortenprofil.md): Analysieren Sie das demografische Profil der in die Kohorte einbezogenen Patienten - [Behandlungsstatus zusammenbrechen](https://success.openhealth.fr/de/articles/3894764-behandlungsstatus-zusammenbrechen.md): Verschaffen Sie sich einen Überblick über die verschiedenen Arten der Nachsorge - [Behandlungsbeginn](https://success.openhealth.fr/de/articles/3894778-behandlungsbeginn.md): Analysieren Sie die Entwicklung der Anzahl der Behandlungsbeginns - [Die Behandlung beginnt erneut](https://success.openhealth.fr/de/articles/3894788-die-behandlung-beginnt-erneut.md): Analysieren Sie die Entwicklung der Anzahl der Wiederholungen der Behandlung - [Neue Behandlungen](https://success.openhealth.fr/de/articles/3894804-neue-behandlungen.md): Analysieren Sie die Entwicklung der Anzahl der Einweihungen und der Wiederaufnahme der Behandlung - [Behandlungswiederholungen](https://success.openhealth.fr/de/articles/3894812-behandlungswiederholungen.md): Analysieren Sie die behandelten Patienten - [Balance des Behandlungsschalters](https://success.openhealth.fr/de/articles/3894821-balance-des-behandlungsschalters.md): Analysieren Sie das Gleichgewicht der Behandlungsänderungen nach Behandlung - [Behandlungsschalter gewinnt](https://success.openhealth.fr/de/articles/3894830-behandlungsschalter-gewinnt.md): Analysieren Sie die Begünstigten von Behandlungswechseln - [Behandlungsschalterverluste](https://success.openhealth.fr/de/articles/3894843-behandlungsschalterverluste.md): Analysieren Sie nach Behandlung die Verlierer der Behandlungsschalter - [Verstärkungsursprünge wechseln](https://success.openhealth.fr/de/articles/3894857-verstarkungsursprunge-wechseln.md): Analysieren Sie den Ursprung des Schalters für eine bestimmte Behandlung - [Verlustziel wechseln](https://success.openhealth.fr/de/articles/3894864-verlustziel-wechseln.md): Analysieren Sie das Ziel des Schalters für eine bestimmte Behandlung - [Aussteiger](https://success.openhealth.fr/de/articles/3894874-aussteiger.md): Behandlungsstopps analysieren - [KPI-Zusammenfassung](https://success.openhealth.fr/de/articles/4229969-kpi-zusammenfassung.md): Zusammenfassung der verschiedenen Arten der Behandlungsüberwachung - [Behandlungspersistenz](https://success.openhealth.fr/de/articles/3894883-behandlungspersistenz.md): Analysieren Sie die Dauer der Behandlungen - [Beachtung](https://success.openhealth.fr/de/articles/3894884-beachtung.md): Analysieren Sie die gelieferten Mengen - [Was ist das Regelmäßigkeitskriterium?](https://success.openhealth.fr/de/articles/3325816-was-ist-das-regelmassigkeitskriterium.md): Definition des Konzepts des Regelmäßigkeitskriteriums - [Tod - Kartographie](https://success.openhealth.fr/de/articles/3863677-tod-kartographie.md): Analysieren Sie die geografische Verteilung der Todesfälle - [Offset der Todeszahl](https://success.openhealth.fr/de/articles/3863573-offset-der-todeszahl.md): Bewerten Sie die Relevanz Ihrer Daten - [Todesanalyse von AGE & GENDER](https://success.openhealth.fr/de/articles/3863808-todesanalyse-von-age-gender.md): Analysieren Sie die Struktur der Todesfälle - [Tod - Evolution von AGE & GENDER](https://success.openhealth.fr/de/articles/3863939-tod-evolution-von-age-gender.md): Analysieren Sie die Entwicklung der Struktur von Todesfällen - [Tod - Evolution](https://success.openhealth.fr/de/articles/3864065-tod-evolution.md): Visualisieren Sie die Entwicklung der Todesfälle - [Vergleich Tod - Evolution](https://success.openhealth.fr/de/articles/3864073-vergleich-tod-evolution.md): Vergleichen Sie die Entwicklung der Todesfälle im Vergleich zu den Vorjahren - [Apothekenüberwachung CA.](https://success.openhealth.fr/de/articles/4634768-apothekenuberwachung-ca.md): Beschreiben Sie den Verkehr entsprechend der Größe der Apotheken - [Traffic Analysis \(Beta-Test\)](https://success.openhealth.fr/de/articles/6848401-traffic-analysis-beta-test.md) - [Details zur Apothekenüberwachung](https://success.openhealth.fr/de/articles/4527868-details-zur-apothekenuberwachung.md): Analysieren Sie den Apothekenverkehr nach Apothekentyp - [Traffic Evolution \(Beta-Test\)](https://success.openhealth.fr/de/articles/6848016-traffic-evolution-beta-test.md) - [Kartographie zur Überwachung der Apotheke](https://success.openhealth.fr/de/articles/4527811-kartographie-zur-uberwachung-der-apotheke.md): Analysieren Sie den Apothekenverkehr auf dem französischen Festland - [Details zur Apothekenüberwachung](https://success.openhealth.fr/de/articles/4262306-details-zur-apothekenuberwachung.md): Unterscheiden Sie die Verkaufsdetails nach Art der Apotheke - [Analyse der Apothekenüberwachung](https://success.openhealth.fr/de/articles/3839223-analyse-der-apothekenuberwachung.md): Verfolgen Sie die Entwicklung des Apothekenverkehrs - [Entwicklung der Apothekenüberwachung](https://success.openhealth.fr/de/articles/3827973-entwicklung-der-apothekenuberwachung.md): Untersuchen Sie die Entwicklung des Apothekenverkehrs - [Verkehrszerlegung](https://success.openhealth.fr/de/articles/3826074-verkehrszerlegung.md): Beobachten Sie die Komponenten Saison, Trend und Rückstände - [Verkehrsstudie](https://success.openhealth.fr/de/articles/3809042-verkehrsstudie.md): Analysieren Sie den Apothekenverkehr - [Executive Summary - PIEX](https://success.openhealth.fr/de/articles/5203335-executive-summary-piex.md) - [Einkauf](https://success.openhealth.fr/de/articles/4605110-einkauf.md): Verfolgen Sie Ihre Einkäufe und deren Belege - [Meine Frage - PIEX](https://success.openhealth.fr/de/articles/4210627-meine-frage-piex.md): Treffen Sie eine Auswahl für Ihre Daten - [Umsatzentwicklung - PIEX](https://success.openhealth.fr/de/articles/4210655-umsatzentwicklung-piex.md): Zeigen Sie die Entwicklung Ihrer Aktivität im verfügbaren Verlauf an - [Verkaufsanalyse - PIEX](https://success.openhealth.fr/de/articles/4210650-verkaufsanalyse-piex.md): Verkaufsanalyse - PIEX - [Bestelldetails - PIEX](https://success.openhealth.fr/de/articles/4210659-bestelldetails-piex.md): Anzeigen und Verfolgen eines Kundenauftrags - [Bestandsübersicht - PIEX](https://success.openhealth.fr/de/articles/4210672-bestandsubersicht-piex.md): Visualisieren Sie die Variationen Ihrer Aktien - [Mein Datenarchiv - PIEX](https://success.openhealth.fr/de/articles/4210694-mein-datenarchiv-piex.md): Exportieren Sie eine flache Datenbank nach Excel - [EURAPHARMA-PIEX](https://success.openhealth.fr/de/articles/4366306-eurapharma-piex.md): Visualisieren Sie die Entwicklung der Aktivitäten von EURAPHARMA - [Passendes Produkt](https://success.openhealth.fr/de/articles/4366320-passendes-produkt.md): Korrespondenz zwischen den Bezeichnungen der Produkte PIEX und EURAPHARMA - [CLI Meine Datei \(1/5\)](https://success.openhealth.fr/de/articles/4626422-cli-meine-datei-1-5.md): CLI Meine Datei \(1/5\) - [CLI\_File Counts \(2/5\)](https://success.openhealth.fr/de/articles/4626421-cli_file-counts-2-5.md): CLI\_File Counts \(2/5\) - [CLI\_File Code Matching mit OHC-Repository](https://success.openhealth.fr/de/articles/4626419-cli_file-code-matching-mit-ohc-repository.md): CLI\_FIL-Code-Matching mit OHC-Repository - [Ausverkaufter Export \(4/5\)](https://success.openhealth.fr/de/articles/4626414-ausverkaufter-export-4-5.md): Ausverkaufter Export \(4/5\) ### PERSONALISIERTE OPTIONEN - [Nicht hierarchische Felder für die Produktqualifizierung](https://success.openhealth.fr/de/articles/4036045-nicht-hierarchische-felder-fur-die-produktqualifizierung.md): Fügen Sie Details zur Qualifikation Ihrer Produkte hinzu - [Was ist das maximale Alter der HUB-Daten?](https://success.openhealth.fr/de/articles/3195251-was-ist-das-maximale-alter-der-hub-daten.md): Letzte verfügbare Daten - [Kundentyp](https://success.openhealth.fr/de/articles/4197147-kundentyp.md): Benutzerdefinierte Option Kundentyp - [Sitzungszugriff](https://success.openhealth.fr/de/articles/4036458-sitzungszugriff.md): Beschränken Sie die Anzeige Ihrer Mitarbeiter - [Benutzerdefinierter Zyklus](https://success.openhealth.fr/de/articles/4036444-benutzerdefinierter-zyklus.md): Analysieren Sie Ihre Daten über personalisierte Zeiträume - [Fiskaljahr](https://success.openhealth.fr/de/articles/4036169-fiskaljahr.md): Definieren Sie Ihr Geschäftsjahr - [Tagestaste](https://success.openhealth.fr/de/articles/4036159-tagestaste.md): Visualisieren Sie Ihre Daten mit feinerer Granularität - [Wochentaste](https://success.openhealth.fr/de/articles/4036111-wochentaste.md): Visualisieren Sie Ihre Daten mit feinerer Granularität - [Wechselkurs](https://success.openhealth.fr/de/articles/8329594-wechselkurs.md) - [SMKT-Periodenkalender](https://success.openhealth.fr/de/articles/4036549-smkt-periodenkalender.md): Verwenden Sie einen GSA-Kalender - [Umfang einschränken](https://success.openhealth.fr/de/articles/4560699-umfang-einschranken.md): Auswählen einer GTIN-Liste in Meine Abfrage aus einer XLSX-Datei - [Umfang einschränken \(Code 7\)](https://success.openhealth.fr/de/articles/4560791-umfang-einschranken-code-7.md): Auswahl einer Liste von \[TECHNISCHER CODE 2\] in Meine Abfrage aus einer XLSX-Datei - [Marktflagge](https://success.openhealth.fr/de/articles/4560797-marktflagge.md): Auswählen einer GTIN-Liste in "Meine Abfrage" aus einer Marktdefinition in einer XLSX-Datei - [Targeting / Definition eines Kundentyps](https://success.openhealth.fr/de/articles/3777788-targeting-definition-eines-kundentyps.md): Targeting \(Kundentyp\) ### NABENANZEIGER - [Glossar der HUB-Indikatoren](https://success.openhealth.fr/de/articles/5194247-glossar-der-hub-indikatoren.md) - [Verkaufsmengen](https://success.openhealth.fr/de/articles/3194314-verkaufsmengen.md): Verkaufsmengen - [Verkaufswerte](https://success.openhealth.fr/de/articles/3074854-verkaufswerte.md): Indikatorspezifikation Verkaufswerte - [N MS](https://success.openhealth.fr/de/articles/3194475-n-ms.md): Definition der Maßnahme 'N MS' - [N MS Evol.](https://success.openhealth.fr/de/articles/5634266-n-ms-evol.md) - [N MS Delta](https://success.openhealth.fr/de/articles/3194469-n-ms-delta.md): Definition der Maßnahme 'N MS Delta' - [Fluggewicht \(CA\) nach Modalität / Custom Weight Vol \(To\)](https://success.openhealth.fr/de/articles/9292839-fluggewicht-ca-nach-modalitat-custom-weight-vol-to.md) - [Wertvolle Verkäufe auf der Grundlage des Herstellerpreises ohne Steuern \(Turnover PF HT\) - Marokko](https://success.openhealth.fr/de/articles/7508513-wertvolle-verkaufe-auf-der-grundlage-des-herstellerpreises-ohne-steuern-turnover-pf-ht-marokko.md) - [N Wachstums-CTR](https://success.openhealth.fr/de/articles/3194466-n-wachstums-ctr.md): Definition und Berechnungsformel der Kennzahl 'N Growth CTR' - [In deal](https://success.openhealth.fr/de/articles/6201859-in-deal.md) - [Crossed Weight Volume](https://success.openhealth.fr/de/articles/6066324-crossed-weight-volume.md) - [Crossed Weight Turnover](https://success.openhealth.fr/de/articles/6066273-crossed-weight-turnover.md) - [N Wachstums-CTR angepasst](https://success.openhealth.fr/de/articles/3205376-n-wachstums-ctr-angepasst.md): Definition und Berechnungsformel der Kennzahl 'N Growth CTR A' - [Gewicht der Quelle](https://success.openhealth.fr/de/articles/5151525-gewicht-der-quelle.md) - [Durchschnittlicher Preis beobachtet](https://success.openhealth.fr/de/articles/3194302-durchschnittlicher-preis-beobachtet.md): AASP: Beobachteter Durchschnittspreis - [Gewichteter Durchschnittspreis](https://success.openhealth.fr/de/articles/3194292-gewichteter-durchschnittspreis.md): WASP: Gewichteter Durchschnittspreis - [Effekt Preis](https://success.openhealth.fr/de/articles/8426443-effekt-preis.md) - [Anzahl der Verkaufenden Apotheken](https://success.openhealth.fr/de/articles/3719566-anzahl-der-verkaufenden-apotheken.md) - [Verkauf digitaler Distribution](https://success.openhealth.fr/de/articles/3194321-verkauf-digitaler-distribution.md): Numerische Verteilung - [Global Selling Digital Distribution](https://success.openhealth.fr/de/articles/3194320-global-selling-digital-distribution.md): Globale numerische Verteilung - [Rebased Selling Digital Distribution](https://success.openhealth.fr/de/articles/4045636-rebased-selling-digital-distribution.md): Numerische Verteilung neu basiert - [Global Rebased Selling Digital Distribution](https://success.openhealth.fr/de/articles/4045725-global-rebased-selling-digital-distribution.md): Globale numerische Verteilung neu basiert - [Digitaler Vertrieb vending rebased personalized](https://success.openhealth.fr/de/articles/6830813-digitaler-vertrieb-vending-rebased-personalized.md) - [Verkaufswertverteilung](https://success.openhealth.fr/de/articles/3194323-verkaufswertverteilung.md): Gewichtete Verteilung - [Globale Verkaufswertverteilung](https://success.openhealth.fr/de/articles/3194316-globale-verkaufswertverteilung.md): Globale Verkaufswertverteilung - [Rebase Verkaufswertverteilung](https://success.openhealth.fr/de/articles/3194501-rebase-verkaufswertverteilung.md): DVV neu gestartet - [Globale Verteilung des Verkaufswerts](https://success.openhealth.fr/de/articles/4200619-globale-verteilung-des-verkaufswerts.md): Global neu basierter DVV - [Verteilung umbasierter Verkaufswert personalisiert](https://success.openhealth.fr/de/articles/6834423-verteilung-umbasierter-verkaufswert-personalisiert.md) - [Digital Selling Distribution SMKT](https://success.openhealth.fr/de/articles/3365043-digital-selling-distribution-smkt.md): Digital Selling Distribution SMKT \(SMK Numeric Distribution\) - [Global SMKT Selling Digital Distribution](https://success.openhealth.fr/de/articles/4298341-global-smkt-selling-digital-distribution.md): SMKT Global Numeric Distribution \(SMKT Global Numeric Distribution\) - [Neu basierter SMKT-Verkauf digitaler Distribution](https://success.openhealth.fr/de/articles/4298197-neu-basierter-smkt-verkauf-digitaler-distribution.md): SMKT Digital Distribution Rebased \(SMKT Numeric Distribution Rebased\) - [Global Rebased SMKT Selling Digital Distribution](https://success.openhealth.fr/de/articles/4319783-global-rebased-smkt-selling-digital-distribution.md): Verkauf der digitalen Distribution SMKT Rebasée Globale \(SMKT Global Numeric Distribution Rebased\) - [SMKT-Verkaufswertverteilung](https://success.openhealth.fr/de/articles/3365478-smkt-verkaufswertverteilung.md): SMKT-Verkaufswertverteilung \(SMKT Weighted Distribution\) - [Neu berechneter globaler SMKT-Verkauf digitaler Distribution](https://success.openhealth.fr/de/articles/4298373-neu-berechneter-globaler-smkt-verkauf-digitaler-distribution.md): Verkauf digitaler Distribution SMKT Global Numeric Recalculated \(SMKT Global Numeric Distribution neu berechnet\) - [Digital Distribution Selling SMKT Rebased Neu berechnet](https://success.openhealth.fr/de/articles/4298303-digital-distribution-selling-smkt-rebased-neu-berechnet.md): SMKT Numeric Distribution neu berechnet neu basiert - [Angepasste SMKT Selling Digital Distribution](https://success.openhealth.fr/de/articles/3369386-angepasste-smkt-selling-digital-distribution.md): Angepasste numerische Verteilung SMKT - [Digital Distribution Selling SMKT neu berechnet](https://success.openhealth.fr/de/articles/4298209-digital-distribution-selling-smkt-neu-berechnet.md): SMKT Numeric Distribution neu berechnet \(SMKT Numeric Distribution neu berechnet\) - [Angepasste SMKT-Verkaufswertverteilung](https://success.openhealth.fr/de/articles/3369397-angepasste-smkt-verkaufswertverteilung.md): Angepasste gewichtete Verteilung SMKT - [Digitaler Vertrieb Vendant Bio](https://success.openhealth.fr/de/articles/7052424-digitaler-vertrieb-vendant-bio.md) - [Turnover of Selling Pharmacies \(TSP\)](https://success.openhealth.fr/de/articles/6096534-turnover-of-selling-pharmacies-tsp.md) - [Schätzung Ihres Inhabers PDM](https://success.openhealth.fr/de/articles/4214883-schatzung-ihres-inhabers-pdm.md): Schätzen Sie Ihren Marktanteil bei Ihren Kunden - [Gewinn von Apotheken](https://success.openhealth.fr/de/articles/8426451-gewinn-von-apotheken.md) - [Verlust von Apotheken](https://success.openhealth.fr/de/articles/8426460-verlust-von-apotheken.md) - [Digitaler Vertrieb Vending Multichannel](https://success.openhealth.fr/de/articles/9293487-digitaler-vertrieb-vending-multichannel.md) - [Kumulierte verkaufende digitale Distribution \(PHARMA\)](https://success.openhealth.fr/de/articles/9330571-kumulierte-verkaufende-digitale-distribution-pharma.md) - [Monatlicher Durchschnittsumsatz](https://success.openhealth.fr/de/articles/3194303-monatlicher-durchschnittsumsatz.md): Durchschnittlicher monatlicher Umsatz - [Angepasster monatlicher Durchschnittsumsatz](https://success.openhealth.fr/de/articles/3194290-angepasster-monatlicher-durchschnittsumsatz.md): Angepasster durchschnittlicher Monatsumsatz - [Monatlicher durchschnittlicher Verkaufswert](https://success.openhealth.fr/de/articles/4535404-monatlicher-durchschnittlicher-verkaufswert.md): VMM CA. - [AMS To A: Durchschnittliche monatliche Verkäufe Wertberichtigt](https://success.openhealth.fr/de/articles/6028256-ams-to-a-durchschnittliche-monatliche-verkaufe-wertberichtigt.md) - [Durchschnittlicher Umsatz](https://success.openhealth.fr/de/articles/3563716-durchschnittlicher-umsatz.md): Durchschnittlicher Umsatz - [SMKT Durchschnittlicher Umsatz](https://success.openhealth.fr/de/articles/3365496-smkt-durchschnittlicher-umsatz.md): SMKT Durchschnittlicher Umsatz - [Bereinigter SMKT-Durchschnittsumsatz](https://success.openhealth.fr/de/articles/3369340-bereinigter-smkt-durchschnittsumsatz.md): Bereinigter SMKT-Durchschnittsumsatz - [Monatliche Durchschnittsverkäufe Bio](https://success.openhealth.fr/de/articles/7052551-monatliche-durchschnittsverkaufe-bio.md) - [Verkäufe Monatsdurchschnitt Bio-Wert](https://success.openhealth.fr/de/articles/7052573-verkaufe-monatsdurchschnitt-bio-wert.md) - [Lager](https://success.openhealth.fr/de/articles/3194332-lager.md): Definition und Verfügbarkeit von Inventardaten im HUB über SMAa-Anwendungen: Sales & Marketing Advanced-Abonnement - [Durchschnittlicher Bestand](https://success.openhealth.fr/de/articles/3194336-durchschnittlicher-bestand.md): Durchschnittlicher Bestand - [Aktie](https://success.openhealth.fr/de/articles/3194334-aktie.md): Aktie - [Kommerzieller Druckindex](https://success.openhealth.fr/de/articles/3194335-kommerzieller-druckindex.md): Kommerzieller Druckindex - [Aktienumwandlungsrate](https://success.openhealth.fr/de/articles/3194344-aktienumwandlungsrate.md): Aktienumwandlungsrate - [Lieferdauer](https://success.openhealth.fr/de/articles/3194337-lieferdauer.md): Lieferdauer - [Anzahl der Fachapotheken](https://success.openhealth.fr/de/articles/3194338-anzahl-der-fachapotheken.md): Anzahl der Fachapotheken - [Fachhändler Digital Distribution](https://success.openhealth.fr/de/articles/3194339-fachhandler-digital-distribution.md): Fachhändler Distribution \(ND Stock\) - [Digital Distribution Fachhändler neu gegründet](https://success.openhealth.fr/de/articles/4045743-digital-distribution-fachhandler-neu-gegrundet.md): Bestandsnumerische Verteilung neu basiert - [Weltweiter Vertrieb digitaler Fachhändler](https://success.openhealth.fr/de/articles/4045753-weltweiter-vertrieb-digitaler-fachhandler.md): Weltweiter Vertrieb digitaler Fachhändler - [Fachwertverteilung](https://success.openhealth.fr/de/articles/3194342-fachwertverteilung.md): Händlerwertverteilung \(gewichtete Aktienverteilung: WD Stock\) - [Bestandswertverteilung neu erstellen](https://success.openhealth.fr/de/articles/3194505-bestandswertverteilung-neu-erstellen.md): DVS neu starten - [Digitale Distribution Stockist geglättet](https://success.openhealth.fr/de/articles/5141830-digitale-distribution-stockist-geglattet.md) - [Digitale Verteilung Stockist geglättet unterfüttert](https://success.openhealth.fr/de/articles/5142162-digitale-verteilung-stockist-geglattet-unterfuttert.md) - [Verteilung Geglätteter Stockist Value](https://success.openhealth.fr/de/articles/5203640-verteilung-geglatteter-stockist-value.md) - [Verteilung Wert Stockist geglättet umbasiert](https://success.openhealth.fr/de/articles/5203701-verteilung-wert-stockist-geglattet-umbasiert.md) - [Spanne](https://success.openhealth.fr/de/articles/3507716-spanne.md): Spanne - [Margin Rate](https://success.openhealth.fr/de/articles/3507767-margin-rate.md): Margin Rate - [Herstellerpreis ohne Steuern \(PFHT\)](https://success.openhealth.fr/de/articles/4557500-herstellerpreis-ohne-steuern-pfht.md): PFHT - [Sell-in - Analysen Ihres Kundenstamms](https://success.openhealth.fr/de/articles/3846225-sell-in-analysen-ihres-kundenstamms.md): Loyalitätsindikatoren: Merkmale Ihres Kundenstamms und dessen Entwicklung - [Sell-in - Atypische Apotheken](https://success.openhealth.fr/de/articles/3848791-sell-in-atypische-apotheken.md): Maßnahmen zur Erkennung von Atypismen - [Entwicklungsverhältnis](https://success.openhealth.fr/de/articles/3194287-entwicklungsverhaltnis.md): Entwicklungsverhältnis - [Penetrationsverhältnis](https://success.openhealth.fr/de/articles/3194286-penetrationsverhaltnis.md): Penetrationsverhältnis - [Produktsortimentbreite](https://success.openhealth.fr/de/articles/3369425-produktsortimentbreite.md): Produktsortimentbreite - [Erneuerung des Sortiments](https://success.openhealth.fr/de/articles/3369545-erneuerung-des-sortiments.md): Erneuerung des Sortiments - [Innovation im Sortiment](https://success.openhealth.fr/de/articles/3369468-innovation-im-sortiment.md): Innovation im Sortiment - [Abrieb des Sortiments](https://success.openhealth.fr/de/articles/3369457-abrieb-des-sortiments.md): Abrieb des Sortiments - [Sortimentsabnutzungsrate](https://success.openhealth.fr/de/articles/3369485-sortimentsabnutzungsrate.md): Sortimentsabnutzungsrate - [Range Innovationsrate](https://success.openhealth.fr/de/articles/3369541-range-innovationsrate.md): Range Innovationsrate - [Anteil des Verkaufsangebots](https://success.openhealth.fr/de/articles/3369040-anteil-des-verkaufsangebots.md): Anteil des Verkaufsangebots - [Anzahl ausgewählter Produkte](https://success.openhealth.fr/de/articles/3511502-anzahl-ausgewahlter-produkte.md): Dies ist die Anzahl der Produkte, die anhand ihres GTIN-13-Zifferncodes ausgewählt wurden. - [Durchschnittliche Anzahl der Produkte](https://success.openhealth.fr/de/articles/3194284-durchschnittliche-anzahl-der-produkte.md): Durchschnittliche Anzahl der Produkte - [Bereichserneuerungsrate](https://success.openhealth.fr/de/articles/3369561-bereichserneuerungsrate.md): Bereichserneuerungsrate - [Anzahl der Produkte](https://success.openhealth.fr/de/articles/6312686-anzahl-der-produkte.md) - [Pro Akt ausgegebene Beträge](https://success.openhealth.fr/de/articles/3447792-pro-akt-ausgegebene-betrage.md): Artikel zum Indikator „Pro Akt ausgegebene Beträge“ - [Aufschlüsselung der ausgegebenen Beträge nach Käufertyp](https://success.openhealth.fr/de/articles/3447801-aufschlusselung-der-ausgegebenen-betrage-nach-kaufertyp.md): Artikel zum Indikator „Aufschlüsselung der ausgegebenen Beträge nach Käufertyp“ - [Verbrauchsindex](https://success.openhealth.fr/de/articles/3432701-verbrauchsindex.md): Definition des Indikators 'Verbrauchsindex' - [Verkaufsanteil](https://success.openhealth.fr/de/articles/3432664-verkaufsanteil.md): Definition des Indikators 'Umsatzbeteiligung' - [Wert Loyalitätsrate](https://success.openhealth.fr/de/articles/3432695-wert-loyalitatsrate.md): Definition des Indikators 'Werttreuequote' - [Absolute Penetration](https://success.openhealth.fr/de/articles/3432556-absolute-penetration.md): Artikel zum Indikator "Absolute Penetration" - [Umsatzanteil](https://success.openhealth.fr/de/articles/3432655-umsatzanteil.md): Definition des Indikators 'Umsatzanteil' - [p-Wert](https://success.openhealth.fr/de/articles/5781702-p-wert.md) - [Hauptkomponentenanalyse](https://success.openhealth.fr/de/articles/4231028-hauptkomponentenanalyse.md): ACP - [Negativer Vorhersagewert](https://success.openhealth.fr/de/articles/4134220-negativer-vorhersagewert.md): Negativer Vorhersagewert - [Positiv vorhergesagter Wert](https://success.openhealth.fr/de/articles/4134166-positiv-vorhergesagter-wert.md): Positiv vorhergesagter Wert - [Unabhängigkeitstest](https://success.openhealth.fr/de/articles/4128369-unabhangigkeitstest.md): Überprüfen Sie, ob zwei Variablen miteinander verknüpft sind - [Studium von Zeitreihen](https://success.openhealth.fr/de/articles/3633991-studium-von-zeitreihen.md): Saisonalität, Trend und Vorhersage: Was Sie wissen müssen - [Saisonale Varianzrate](https://success.openhealth.fr/de/articles/3653790-saisonale-varianzrate.md): Misst den Varianzanteil in einer Zeitreihe - [Empfindlichkeit und Spezifität eines Tests](https://success.openhealth.fr/de/articles/3928135-empfindlichkeit-und-spezifitat-eines-tests.md): Verstehen Sie die Konzepte zur Analyse der Wirksamkeit eines Tests - [Trendvarianzrate](https://success.openhealth.fr/de/articles/3653847-trendvarianzrate.md): Misst den Anteil der Trendkomponente in einer Zeitreihe - [Restvarianzrate](https://success.openhealth.fr/de/articles/3653851-restvarianzrate.md): Misst den Anteil der Restkomponente einer Zeitreihe - [Bestimmtheitsmaß](https://success.openhealth.fr/de/articles/3654093-bestimmtheitsmass.md): Bewerten Sie die Qualität des ausgewählten Modells - [Variationskoeffizient](https://success.openhealth.fr/de/articles/3653915-variationskoeffizient.md): Indikator zur Auswahl Ihres Zerlegungsmodells - [Varianz einer Zeitreihe](https://success.openhealth.fr/de/articles/3653855-varianz-einer-zeitreihe.md): Messen Sie die Streuung einer Reihe - [Umsatzkonzentration](https://success.openhealth.fr/de/articles/3395856-umsatzkonzentration.md): Umsatzkonzentration - [Gini-Index](https://success.openhealth.fr/de/articles/3395323-gini-index.md): Gini-Index - [Population](https://success.openhealth.fr/de/articles/4396779-population.md): Population - [Entwicklung der Zahl der Todesfälle](https://success.openhealth.fr/de/articles/4396765-entwicklung-der-zahl-der-todesfalle.md): Entwicklung der Zahl der Todesfälle - [Geschlechterverhältnis](https://success.openhealth.fr/de/articles/3812167-geschlechterverhaltnis.md): Geschlechterverhältnis - [Bevölkerung - Durchschnittsalter](https://success.openhealth.fr/de/articles/3812180-bevolkerung-durchschnittsalter.md): Bevölkerung - Durchschnittsalter - [Bevölkerung - Durchschnittsalter](https://success.openhealth.fr/de/articles/3812198-bevolkerung-durchschnittsalter.md): Bevölkerung - Durchschnittsalter - [Bevölkerung - Alter 1. Quartil](https://success.openhealth.fr/de/articles/3812218-bevolkerung-alter-1-quartil.md): Bevölkerung - Alter 1. Quartil - [Bevölkerung - Alter 3. Quartil](https://success.openhealth.fr/de/articles/3812227-bevolkerung-alter-3-quartil.md): Bevölkerung - Alter 3. Quartil - [Anteil der Auswahl an der Gesamtbevölkerung des Territoriums](https://success.openhealth.fr/de/articles/3812233-anteil-der-auswahl-an-der-gesamtbevolkerung-des-territoriums.md): Anteil der Auswahl an der Gesamtbevölkerung des Territoriums - [Sterblichkeitsrate](https://success.openhealth.fr/de/articles/3947946-sterblichkeitsrate.md): Sterblichkeitsrate - [Todesrate](https://success.openhealth.fr/de/articles/3948084-todesrate.md): Todesrate - [Frauen im gebärfähigen Alter](https://success.openhealth.fr/de/articles/4172859-frauen-im-gebarfahigen-alter.md): Frauen im gebärfähigen Alter - [Anteil der Selektion an den Gesamttoten im Gebiet](https://success.openhealth.fr/de/articles/3863734-anteil-der-selektion-an-den-gesamttoten-im-gebiet.md): Anteil der Selektion an den Gesamttoten im Gebiet - [Modellierung der Anzahl fehlender Todesfälle](https://success.openhealth.fr/de/articles/3895572-modellierung-der-anzahl-fehlender-todesfalle.md): Erwarten Sie die Anzahl der Todesfälle zum Zeitpunkt t - [Geschätzter Umsatz bei der Einführung von Rezepten](https://success.openhealth.fr/de/articles/5323282-geschatzter-umsatz-bei-der-einfuhrung-von-rezepten.md) - [Entwicklung nach Alter und Schwangerschaftsstatus](https://success.openhealth.fr/de/articles/6820051-entwicklung-nach-alter-und-schwangerschaftsstatus.md) - [Co-Dispensation Products Ratio](https://success.openhealth.fr/de/articles/7892010-co-dispensation-products-ratio.md) - [Geschätzte Umsätze bei Rezeptverlängerungen](https://success.openhealth.fr/de/articles/5323209-geschatzte-umsatze-bei-rezeptverlangerungen.md) - [Gewicht der Verkäufe bei Rezeptverlängerungen](https://success.openhealth.fr/de/articles/5323198-gewicht-der-verkaufe-bei-rezeptverlangerungen.md) - [Gewicht der Verkäufe in Rezeptinitiierung](https://success.openhealth.fr/de/articles/5323086-gewicht-der-verkaufe-in-rezeptinitiierung.md) - [Anzahl der Co-Dispensationen](https://success.openhealth.fr/de/articles/3194351-anzahl-der-co-dispensationen.md): Anzahl der Co-Dispensationen - [Anzahl der Abgaben](https://success.openhealth.fr/de/articles/3194348-anzahl-der-abgaben.md): Anzahl der Abgaben - [Durchschnittliche Anzahl der Abgaben pro versicherter Person](https://success.openhealth.fr/de/articles/3369626-durchschnittliche-anzahl-der-abgaben-pro-versicherter-person.md): Durchschnittliche Anzahl der Abgaben pro versicherter Person - [Beachtung](https://success.openhealth.fr/de/articles/3411996-beachtung.md): Medikamentenbesitzrate \(MPR\) - [Persistenzrate](https://success.openhealth.fr/de/articles/3369684-persistenzrate.md): Persistenzrate - [Therapeutische Einhaltung](https://success.openhealth.fr/de/articles/3412091-therapeutische-einhaltung.md): Therapeutische Einhaltung - [Durchschnittliche Tagesdosis pro versicherter Person](https://success.openhealth.fr/de/articles/4153587-durchschnittliche-tagesdosis-pro-versicherter-person.md): Durchschnittliche Tagesdosis pro versicherter Person - [Anzahl der zur Erstattung vorgelegten Abgaben](https://success.openhealth.fr/de/articles/3370942-anzahl-der-zur-erstattung-vorgelegten-abgaben.md): Anzahl der zur Erstattung vorgelegten Abgaben - [Anzahl der nicht zur Erstattung vorgelegten Abgaben](https://success.openhealth.fr/de/articles/3370920-anzahl-der-nicht-zur-erstattung-vorgelegten-abgaben.md): Anzahl der zur Erstattung vorgelegten Abgaben - [Wertverkäufe, die für die Erstattung durch die obligatorische Krankenversicherung berechnet werden](https://success.openhealth.fr/de/articles/3371699-wertverkaufe-die-fur-die-erstattung-durch-die-obligatorische-krankenversicherung-berechnet-werden.md): Verkauf von eingelösten Werten - [Verkauf von erstatteten Werten, die durch eine ergänzende Krankenversicherung gedeckt sind](https://success.openhealth.fr/de/articles/3371830-verkauf-von-erstatteten-werten-die-durch-eine-erganzende-krankenversicherung-gedeckt-sind.md): Verkauf von eingelösten Werten - [Verkauf von herausragenden Werten](https://success.openhealth.fr/de/articles/3371842-verkauf-von-herausragenden-werten.md): Verkauf von herausragenden Werten - [Häufigkeit](https://success.openhealth.fr/de/articles/3947955-haufigkeit.md): Prävalenzrate - [Durchschnittliche Anzahl von GTINs pro Abgabe](https://success.openhealth.fr/de/articles/3396154-durchschnittliche-anzahl-von-gtins-pro-abgabe.md): Durchschnittliche Anzahl von GTINs pro Abgabe - [Durchschnittliches Volumen pro Ausgabe](https://success.openhealth.fr/de/articles/3396196-durchschnittliches-volumen-pro-ausgabe.md): Durchschnittliches Volumen pro Ausgabe - [Durchschnittlicher Umsatz pro Abgabe](https://success.openhealth.fr/de/articles/3396208-durchschnittlicher-umsatz-pro-abgabe.md): Durchschnittlicher Umsatz pro Abgabe - [Wirkstoffdosierung pro Box](https://success.openhealth.fr/de/articles/3675409-wirkstoffdosierung-pro-box.md): Wirkstoffdosierung pro Box - [DDD pro Box](https://success.openhealth.fr/de/articles/3675446-ddd-pro-box.md): Definieren Sie die tägliche Dosis pro Box - [Volumen in Basiseinheiten](https://success.openhealth.fr/de/articles/3675520-volumen-in-basiseinheiten.md): Volumen in Basiseinheiten - [Lautstärke im aktiven Prinzip](https://success.openhealth.fr/de/articles/3675539-lautstarke-im-aktiven-prinzip.md): Lautstärke im aktiven Prinzip - [DDJ pro 1.000 Einwohner](https://success.openhealth.fr/de/articles/3675667-ddj-pro-1-000-einwohner.md): Täglich definierte Dosis pro 1.000 Einwohner - [Volumen in durchschnittlicher UA pro versicherter Person](https://success.openhealth.fr/de/articles/3675761-volumen-in-durchschnittlicher-ua-pro-versicherter-person.md): Volumen in durchschnittlichen Verbrauchereinheiten pro versicherter Person - [Durchschnittliches UB-Volumen pro versicherter Person](https://success.openhealth.fr/de/articles/3675814-durchschnittliches-ub-volumen-pro-versicherter-person.md): Volumen in durchschnittlichen Basiseinheiten pro versicherter Person - [Volumen im durchschnittlichen Wirkprinzip pro versicherter Person](https://success.openhealth.fr/de/articles/3675824-volumen-im-durchschnittlichen-wirkprinzip-pro-versicherter-person.md): Volumen im durchschnittlichen Wirkprinzip pro versicherter Person - [Beobachtete mittlere Behandlungsdauer](https://success.openhealth.fr/de/articles/3675841-beobachtete-mittlere-behandlungsdauer.md): Beobachtete mittlere Behandlungsdauer - [Impfschutz](https://success.openhealth.fr/de/articles/3822264-impfschutz.md): Impfschutz - [Patienten eingeschlossen](https://success.openhealth.fr/de/articles/3886665-patienten-eingeschlossen.md): Anzahl der in die Kohorte eingeschlossenen Patienten - [Unterschiede zwischen MPR und PDC](https://success.openhealth.fr/de/articles/3722666-unterschiede-zwischen-mpr-und-pdc.md): MPR \(Medication Possession Rate\) vs. PDC \(Anteil der abgedeckten Tage\) - [Durchschnittliche Behandlungsdauer](https://success.openhealth.fr/de/articles/3920967-durchschnittliche-behandlungsdauer.md): Messen Sie die durchschnittliche Behandlungszeit am Ende des Analysezeitraums - [Durchschnittliche Verlängerungszeit](https://success.openhealth.fr/de/articles/3921067-durchschnittliche-verlangerungszeit.md): Messen Sie die durchschnittliche Zeit zwischen den Erneuerungen der Behandlung - [Beginn der Behandlung](https://success.openhealth.fr/de/articles/3848844-beginn-der-behandlung.md): Beginn der Behandlung - [Erneuerung der Behandlung](https://success.openhealth.fr/de/articles/3885469-erneuerung-der-behandlung.md): Erneuerung der Behandlung - [Die Behandlung wird fortgesetzt](https://success.openhealth.fr/de/articles/3885608-die-behandlung-wird-fortgesetzt.md): Die Behandlung wird fortgesetzt - [Neue Behandlungen](https://success.openhealth.fr/de/articles/3885297-neue-behandlungen.md): Einleitung und Wiederaufnahme der Behandlung - [Behandlungsschalter](https://success.openhealth.fr/de/articles/3848886-behandlungsschalter.md): Behandlungsschalter - [Die Behandlung wird abgebrochen](https://success.openhealth.fr/de/articles/3885426-die-behandlung-wird-abgebrochen.md): Die Behandlung wird abgebrochen - [Rückgabe](https://success.openhealth.fr/de/articles/3885387-ruckgabe.md): Rückgabe - [Rückverfolgbarkeitseinsatz](https://success.openhealth.fr/de/articles/4355163-ruckverfolgbarkeitseinsatz.md): Rückverfolgbarkeit - [Stopps und anschließende Wiederaufnahme der Behandlung](https://success.openhealth.fr/de/articles/8429189-stopps-und-anschliessende-wiederaufnahme-der-behandlung.md) - [Anteil ausgeben](https://success.openhealth.fr/de/articles/3624820-anteil-ausgeben.md): Anteil ausgeben - [Überwachung relevanter Abgaben](https://success.openhealth.fr/de/articles/3804193-uberwachung-relevanter-abgaben.md): Verfolgen Sie die Entwicklung des Verkehrs in Apotheken mit relevanten Ausnahmeregelungen - [Auflösungsrate](https://success.openhealth.fr/de/articles/4850138-auflosungsrate.md): Abschätzen der Restmenge eines Elements - [Reaktionskinetik](https://success.openhealth.fr/de/articles/4850629-reaktionskinetik.md): Messung der Geschwindigkeit einer chemischen Reaktion - [Halbwertszeit](https://success.openhealth.fr/de/articles/4849710-halbwertszeit.md): Metrik der Lebensdauer eines Elements - [Bestandsdeckungsrate](https://success.openhealth.fr/de/articles/4210714-bestandsdeckungsrate.md): Bestandsdeckungsrate - [Zeit Abschnitte](https://success.openhealth.fr/de/articles/3194479-zeit-abschnitte.md): Zeit Abschnitte - [Ändern Sie die Definition eines Geschäftsjahres](https://success.openhealth.fr/de/articles/3321750-andern-sie-die-definition-eines-geschaftsjahres.md): Mit dem HUB können Sie Ihre Geschäftsjahre festlegen - [Verwaltung wöchentlicher Vergleiche](https://success.openhealth.fr/de/articles/3835180-verwaltung-wochentlicher-vergleiche.md): Analytische Auswirkungen der untersuchten Tage - [Parapharmaziekalender der GSA \(SMKT\)](https://success.openhealth.fr/de/articles/3175583-parapharmaziekalender-der-gsa-smkt.md): Der SMKT-Kalender \(IRI\) wird auch als GSA-Drogeriekalender bezeichnet - [NICHT](https://success.openhealth.fr/de/articles/3194484-nicht.md): Definition des Maßes 'N' - [N Evol](https://success.openhealth.fr/de/articles/3194461-n-evol.md): Definitions- und Berechnungsformel des Maßes 'N Evol' - [N Trend](https://success.openhealth.fr/de/articles/3194485-n-trend.md): Definition des Maßes 'N Trend' ### IAS - Indicateurs Avancés Sanitaires - [IAS\(r\) Allergie](https://success.openhealth.fr/de/articles/7339151-ias-r-allergie.md) - [IAS\(r\) Läuse](https://success.openhealth.fr/de/articles/7339168-ias-r-lause.md) - [IAS\(r\) Gastroenteritis](https://success.openhealth.fr/de/articles/7339181-ias-r-gastroenteritis.md) - [IAS \(r\) respiratorische Syndrome](https://success.openhealth.fr/de/articles/3815345-ias-r-respiratorische-syndrome.md): Einführung in Bezug auf IAS \(r\) Respiratory Syndrome - [IAS\(r\) Grippales Syndrom](https://success.openhealth.fr/de/articles/7266711-ias-r-grippales-syndrom.md) ### Marketing Direct - [Emailing-Lösung OpenHealth](https://success.openhealth.fr/de/articles/7055261-emailing-losung-openhealth.md) - [Voraussetzungen für die Erstellung einer E-Mail-Kampagne](https://success.openhealth.fr/de/articles/6282113-voraussetzungen-fur-die-erstellung-einer-e-mail-kampagne.md) - [Tracking-Bericht und Benchmarks](https://success.openhealth.fr/de/articles/6302721-tracking-bericht-und-benchmarks.md) - [Glossar für E-Mail-Kampagnen](https://success.openhealth.fr/de/articles/6282099-glossar-fur-e-mail-kampagnen.md) ### PSAD - [Analyse - NATIONAL](https://success.openhealth.fr/de/articles/3376262-analyse-national.md): Analysieren Sie die Leistung des PSAD-Marktes \(Home Health Providers\): nach Bereich, Aktivität, Unteraktivität, Segment, LPP-Gesetz - [Volumen / Umsatz - NATIONAL](https://success.openhealth.fr/de/articles/3376287-volumen-umsatz-national.md): Visualisieren Sie gleichzeitig die Aktivität in Volumen und Wert: nach Bereich, Aktivität, Unteraktivität, Segment, Handlung ... - [Evolution - NATIONAL](https://success.openhealth.fr/de/articles/3376370-evolution-national.md): Visualisieren Sie die Entwicklung des Marktes anhand der verfügbaren Historie: nach Gebiet, Aktivität, Unteraktivität, Segment, LPP-Akt - [Extraktion - NATIONAL](https://success.openhealth.fr/de/articles/3376420-extraktion-national.md): Daten nach Excel exportieren - [Definition](https://success.openhealth.fr/de/articles/3376439-definition.md): Hier finden Sie alle Funktionen der SantéDomStat Observatoire National - Essential-Anwendung ### AUTRES THEMATIQUES - [INTERCOM](https://success.openhealth.fr/de/articles/6959415-intercom.md) - [Salesforce](https://success.openhealth.fr/de/articles/6959337-salesforce.md) - [GIHSN: Excel-Datei senden](https://success.openhealth.fr/de/articles/3977478-gihsn-excel-datei-senden.md): GIHSN Excel-Datei - [Die Blockchain](https://success.openhealth.fr/de/articles/5385413-die-blockchain.md) - [DocuSign, CRM-Tool in unserem Geschäftsprozess](https://success.openhealth.fr/de/articles/4514472-docusign-crm-tool-in-unserem-geschaftsprozess.md): Docusign: CRM-Tool in unserem Geschäftsprozess - [National vaccination tracking](https://success.openhealth.fr/de/articles/4754333-national-vaccination-tracking.md) - [Impfschutz](https://success.openhealth.fr/de/articles/4754311-impfschutz.md) - [KPI-Überwachung](https://success.openhealth.fr/de/articles/4091042-kpi-uberwachung.md): POC ProPharma Systems: Schweizer Markttrends - [Apotheken-Cockpit](https://success.openhealth.fr/de/articles/4091025-apotheken-cockpit.md): POC ProPharma Systems: Meine Apotheke gegen die Schweiz - [Einwohnergleichwert \(EH\)](https://success.openhealth.fr/de/articles/5431894-einwohnergleichwert-eh.md) - [Sauerstoffbedarf](https://success.openhealth.fr/de/articles/5137158-sauerstoffbedarf.md) - [IHU](https://success.openhealth.fr/de/articles/4851687-ihu.md) - [Schwebende Materie](https://success.openhealth.fr/de/articles/5137147-schwebende-materie.md) - [Chemie des Abwassers](https://success.openhealth.fr/de/articles/5137101-chemie-des-abwassers.md) - [NRBCE](https://success.openhealth.fr/de/articles/4851683-nrbce.md) - [Arrhenius'sches Gesetz](https://success.openhealth.fr/de/articles/4849672-arrhenius-sches-gesetz.md) - [Resultierende Rendite](https://success.openhealth.fr/de/articles/5137034-resultierende-rendite.md) - [Arten von Abwasser](https://success.openhealth.fr/de/articles/5137183-arten-von-abwasser.md) - [SARS-CoV-2-Virus-Konzentration](https://success.openhealth.fr/de/articles/4867968-sars-cov-2-virus-konzentration.md) - [MAPOM / BMPM](https://success.openhealth.fr/de/articles/4851685-mapom-bmpm.md) - [Die kontextualisierte Konzentration des SARS-CoV-2-Virus](https://success.openhealth.fr/de/articles/4934604-die-kontextualisierte-konzentration-des-sars-cov-2-virus.md) - [Art des Abwassernetzes](https://success.openhealth.fr/de/articles/4867954-art-des-abwassernetzes.md) - [Abbau des Virus](https://success.openhealth.fr/de/articles/4865742-abbau-des-virus.md) - [WBE](https://success.openhealth.fr/de/articles/4865735-wbe.md) - [RNA](https://success.openhealth.fr/de/articles/4865733-rna.md) - [Coronavirus](https://success.openhealth.fr/de/articles/4865728-coronavirus.md) - [COVID-19](https://success.openhealth.fr/de/articles/4865726-covid-19.md) - [Seroprävalenz: Probenahmemethode](https://success.openhealth.fr/de/articles/3924493-seropravalenz-probenahmemethode.md): Seroprävalenz: Probenahmemethode - [SANDRE-Referenzsystem](https://success.openhealth.fr/de/articles/5415040-sandre-referenzsystem.md) - [National Base ROSEAU](https://success.openhealth.fr/de/articles/5414523-national-base-roseau.md) - [SARS-CoV2-Virus-Konzentration](https://success.openhealth.fr/de/articles/4852404-sars-cov2-virus-konzentration.md): Überwachen Sie die Entwicklung der SARS-CoV 2-Viruskonzentration nach Sektoren - [SARS-CoV-2-Viruskonzentration - Varianten](https://success.openhealth.fr/de/articles/4909854-sars-cov-2-viruskonzentration-varianten.md) - [Marseille - Umfassende Überwachung](https://success.openhealth.fr/de/articles/4859311-marseille-umfassende-uberwachung.md) - [SARS-CoV2-Viruskonzentration - Nizza \(FRANKREICH\)](https://success.openhealth.fr/de/articles/4879292-sars-cov2-viruskonzentration-nizza-frankreich.md): Verfolgen Sie die Entwicklung der SARS-CoV 2-Viruskonzentration nach Sektoren - [Bevölkerung - Struktur](https://success.openhealth.fr/de/articles/4842408-bevolkerung-struktur.md): Analysieren der Populationsstruktur - [SARS-CoV2-Viruskonzentration - Toulon \(FRANKREICH\)](https://success.openhealth.fr/de/articles/4886417-sars-cov2-viruskonzentration-toulon-frankreich.md): Verfolgen Sie die Entwicklung der SARS-CoV 2-Viruskonzentration nach Sektor - [Dubai - Überwachung des Flughafenabwassers](https://success.openhealth.fr/de/articles/5276423-dubai-uberwachung-des-flughafenabwassers.md): Dubai - Überwachung des Flughafenabwassers - [SARS-CoV-2-Überwachung - OBEPINE](https://success.openhealth.fr/de/articles/5210661-sars-cov-2-uberwachung-obepine.md) - [Kontextualisierte Konzentration von SARS-CoV-2-Viren](https://success.openhealth.fr/de/articles/4934608-kontextualisierte-konzentration-von-sars-cov-2-viren.md) - [SUEZ - Analytische Bilanz](https://success.openhealth.fr/de/articles/5140509-suez-analytische-bilanz.md) - [Palais des festivals - Nachtwache T0](https://success.openhealth.fr/de/articles/5373515-palais-des-festivals-nachtwache-t0.md) - [Palais des festivals - Täglicher Überblick](https://success.openhealth.fr/de/articles/5373231-palais-des-festivals-taglicher-uberblick.md) - [Palais des festivals - Screening](https://success.openhealth.fr/de/articles/5404778-palais-des-festivals-screening.md) - [Mustelidae - Wachsamkeit](https://success.openhealth.fr/de/articles/5169577-mustelidae-wachsamkeit.md) - [Bevölkerung - IRIS](https://success.openhealth.fr/de/articles/4842191-bevolkerung-iris.md): Analyse der geografischen Verteilung der Bevölkerung bei IRIS - [SARS-CoV-2](https://success.openhealth.fr/de/articles/4865699-sars-cov-2.md) - [IAS - Analyse](https://success.openhealth.fr/de/articles/4842430-ias-analyse.md): Überwachung des Gesundheitsindikators für Atemwegssyndrome - [SARS-CoV-2-Virus-Konzentration - SEM](https://success.openhealth.fr/de/articles/5415600-sars-cov-2-virus-konzentration-sem.md) - [Kartenvisualisierung](https://success.openhealth.fr/de/articles/3864657-kartenvisualisierung.md): Geografische Aufteilung der Patienten - [Beitragsseite](https://success.openhealth.fr/de/articles/3864668-beitragsseite.md): Beitrag nach Standort und Krankenhaus - [Kohortenprofil nach Standort](https://success.openhealth.fr/de/articles/3864672-kohortenprofil-nach-standort.md): Kohortenprofil nach Standort und Krankenhaus - [Kohortenprofil nach Saison](https://success.openhealth.fr/de/articles/3864673-kohortenprofil-nach-saison.md): Kohortenprofil nach Saison - [Alters- und Geschlechtsverteilung](https://success.openhealth.fr/de/articles/3864675-alters-und-geschlechtsverteilung.md): Demographie - [Virusverteilung nach Standort](https://success.openhealth.fr/de/articles/3864678-virusverteilung-nach-standort.md): Virusverteilung nach Standort - [Virusverteilung nach Alter](https://success.openhealth.fr/de/articles/3864677-virusverteilung-nach-alter.md): Virusverteilung nach Alter - [Entwicklung der Virusverteilung](https://success.openhealth.fr/de/articles/3864681-entwicklung-der-virusverteilung.md): Entwicklung der Virusverteilung - [Influenza-Impfung](https://success.openhealth.fr/de/articles/3864697-influenza-impfung.md): Influenza-Impfung - [Entwicklung der Influenza-Impfung](https://success.openhealth.fr/de/articles/3864701-entwicklung-der-influenza-impfung.md): Entwicklung der Influenza-Impfung - [Patientenverteilung nach chronischem Zustand](https://success.openhealth.fr/de/articles/3864676-patientenverteilung-nach-chronischem-zustand.md): Patientenverteilung nach chronischem Zustand - [Patientenverteilung nach Dauer des Krankenhausaufenthalts](https://success.openhealth.fr/de/articles/3864794-patientenverteilung-nach-dauer-des-krankenhausaufenthalts.md): Patientenverteilung nach Länge oh Krankenhausaufenthalt - [Gebrechlichkeit](https://success.openhealth.fr/de/articles/3864704-gebrechlichkeit.md): Fragilität von Patienten - [Schweregrad](https://success.openhealth.fr/de/articles/3864705-schweregrad.md): Schweregrad - [Mortalität](https://success.openhealth.fr/de/articles/3864710-mortalitat.md): Mortalität - [GIHSN](https://success.openhealth.fr/de/articles/3864712-gihsn.md): Globales Netzwerk zur Überwachung von Influenza-Krankenhäusern - [CARéDIAB - Patientenprofil](https://success.openhealth.fr/de/articles/3789234-carediab-patientenprofil.md): Analysieren Sie das Patientenprofil der CARéDIAB-Population - [CARéDIAB - Komplikationen](https://success.openhealth.fr/de/articles/3789515-carediab-komplikationen.md): Analysieren Sie die Prävalenz von Komplikationen in unserer Bevölkerung CAREDIAB - [CARéDIAB - Globale Patientenüberwachung](https://success.openhealth.fr/de/articles/3792041-carediab-globale-patientenuberwachung.md): Analysieren Sie die Häufigkeit der Nachuntersuchungen von Patienten in der CARéDIAB-Population - [CARéDIAB-Netzwerk](https://success.openhealth.fr/de/articles/3789106-carediab-netzwerk.md): Das CARéDIAB-Netzwerk - [CARéDIAB - Behandlungen](https://success.openhealth.fr/de/articles/3792143-carediab-behandlungen.md): Analysieren Sie die Einnahme von Behandlungen im Zusammenhang mit Diabetes ## Italiano ### Votre PLATEFORME - présentation générale - [L'HUB, una piattaforma di supporto completa e continua](https://success.openhealth.fr/it/articles/4799621-l-hub-una-piattaforma-di-supporto-completa-e-continua.md) - [Il vostro livello di esperienza The HUB](https://success.openhealth.fr/it/articles/5712270-il-vostro-livello-di-esperienza-the-hub.md) - [Languages](https://success.openhealth.fr/it/articles/4649389-languages.md): Here is the description of all languages available on Success - [Domande sulle nostre tariffe](https://success.openhealth.fr/it/articles/3292143-domande-sulle-nostre-tariffe.md): I nostri prezzi ### La ROADMAP - [L'innovazione aperta al servizio dei nostri clienti](https://success.openhealth.fr/it/articles/5200970-l-innovazione-aperta-al-servizio-dei-nostri-clienti.md) - [Applicazioni + Area di amministrazione versione 240515](https://success.openhealth.fr/it/articles/9310541-applicazioni-area-di-amministrazione-versione-240515.md) - [Applicazioni + Area di amministrazione versione 240415](https://success.openhealth.fr/it/articles/9310710-applicazioni-area-di-amministrazione-versione-240415.md) - [Applicazioni + Area di amministrazione versione 240315](https://success.openhealth.fr/it/articles/9310790-applicazioni-area-di-amministrazione-versione-240315.md) - [Applicazioni + Area di amministrazione versione 240215](https://success.openhealth.fr/it/articles/9311007-applicazioni-area-di-amministrazione-versione-240215.md) - [Piattaforma - aggiornamento 231215](https://success.openhealth.fr/it/articles/8718485-piattaforma-aggiornamento-231215.md) - [Piattaforma - aggiornamento 231015](https://success.openhealth.fr/it/articles/8479932-piattaforma-aggiornamento-231015.md) - [Applicazioni + Portale versione 230915](https://success.openhealth.fr/it/articles/8373640-applicazioni-portale-versione-230915.md) - [Applicazioni + Portale versione 230815](https://success.openhealth.fr/it/articles/8267860-applicazioni-portale-versione-230815.md) - [Nuovi prodotti 230715](https://success.openhealth.fr/it/articles/8115796-nuovi-prodotti-230715.md) - [Applicazioni + Portale versione 230615](https://success.openhealth.fr/it/articles/8115791-applicazioni-portale-versione-230615.md) - [Applicazioni + Portale versione 230515](https://success.openhealth.fr/it/articles/7895393-applicazioni-portale-versione-230515.md) - [Applicazioni + Portale versione 230415](https://success.openhealth.fr/it/articles/7439447-applicazioni-portale-versione-230415.md) - [Applicazioni + Portale versione 230315](https://success.openhealth.fr/it/articles/7439646-applicazioni-portale-versione-230315.md) - [Applicazioni + Portale versione 230215](https://success.openhealth.fr/it/articles/7439744-applicazioni-portale-versione-230215.md) - [Nuovo dal 15/01/2023](https://success.openhealth.fr/it/articles/6895740-nuovo-dal-15-01-2023.md) - [HUB + GATE versione 221215](https://success.openhealth.fr/it/articles/6827027-hub-gate-versione-221215.md) - [HUB + GATE versione 221115](https://success.openhealth.fr/it/articles/6742628-hub-gate-versione-221115.md) - [HUB + GATE versione 220915](https://success.openhealth.fr/it/articles/6558070-hub-gate-versione-220915.md) - [HUB + GATE versione 220815](https://success.openhealth.fr/it/articles/6475311-hub-gate-versione-220815.md) - [HUB + GATE versione 220615](https://success.openhealth.fr/it/articles/6306090-hub-gate-versione-220615.md) - [HUB + GATE versione 220515](https://success.openhealth.fr/it/articles/6201877-hub-gate-versione-220515.md) - [HUB + GATE versione 220415](https://success.openhealth.fr/it/articles/6087747-hub-gate-versione-220415.md) - [HUB SMA versione 220315](https://success.openhealth.fr/it/articles/6043772-hub-sma-versione-220315.md) - [HUB TMA versione 220315](https://success.openhealth.fr/it/articles/6043802-hub-tma-versione-220315.md) - [HUB UAN versione 220315](https://success.openhealth.fr/it/articles/6043852-hub-uan-versione-220315.md) - [GATE versione 220215](https://success.openhealth.fr/it/articles/5940805-gate-versione-220215.md) - [HUB SMA versione 220215](https://success.openhealth.fr/it/articles/5940753-hub-sma-versione-220215.md) - [HUB TMA versione 220215](https://success.openhealth.fr/it/articles/5947859-hub-tma-versione-220215.md) - [Versione GATE 211215](https://success.openhealth.fr/it/articles/5819397-versione-gate-211215.md) - [HUB SMA versione 211215](https://success.openhealth.fr/it/articles/5784709-hub-sma-versione-211215.md) - [HUB TMA versione 211215](https://success.openhealth.fr/it/articles/5784888-hub-tma-versione-211215.md) - [HUB UAN versione 211215](https://success.openhealth.fr/it/articles/5784904-hub-uan-versione-211215.md) - [Applicazione The HUB: "Lo stato della farmacia".](https://success.openhealth.fr/it/articles/5704485-applicazione-the-hub-lo-stato-della-farmacia.md) - [Versione GATE 211115](https://success.openhealth.fr/it/articles/5697844-versione-gate-211115.md) - [HUB SMA versione 211115](https://success.openhealth.fr/it/articles/5671893-hub-sma-versione-211115.md) - [HUB TMA versione 211115](https://success.openhealth.fr/it/articles/5671917-hub-tma-versione-211115.md) - [HUB UAN versione 211115](https://success.openhealth.fr/it/articles/5671927-hub-uan-versione-211115.md) - [Versione GATE 211015](https://success.openhealth.fr/it/articles/5652210-versione-gate-211015.md) - [HUB SMA versione 211015](https://success.openhealth.fr/it/articles/5649822-hub-sma-versione-211015.md) - [HUB TMA versione 211015](https://success.openhealth.fr/it/articles/5650073-hub-tma-versione-211015.md) - [HUB UAN versione 211015](https://success.openhealth.fr/it/articles/5652242-hub-uan-versione-211015.md) - [HUB SMA versione 210915](https://success.openhealth.fr/it/articles/5370516-hub-sma-versione-210915.md) - [HUB TMA versione 210915](https://success.openhealth.fr/it/articles/5390983-hub-tma-versione-210915.md) - [HUB UAN versione 210915](https://success.openhealth.fr/it/articles/5543213-hub-uan-versione-210915.md) ### Votre ESPACE D'ADMINISTRATION - fonctionnalités - [Reimposta / modifica la password L'HUB](https://success.openhealth.fr/it/articles/4425325-reimposta-modifica-la-password-l-hub.md): Come modificare la password dell'HUB - [Assistenza alla connessione: ricevo un messaggio di errore](https://success.openhealth.fr/it/articles/5369783-assistenza-alla-connessione-ricevo-un-messaggio-di-errore.md) - [Crea e monitora un ticket](https://success.openhealth.fr/it/articles/3586214-crea-e-monitora-un-ticket.md): Tutorial per creare e seguire l'evoluzione dei tuoi biglietti nel tuo spazio personale The HUB - [Creare e modificare un articolo di SUCCESSO](https://success.openhealth.fr/it/articles/6738705-creare-e-modificare-un-articolo-di-successo.md) - [I miei contratti](https://success.openhealth.fr/it/articles/5712273-i-miei-contratti.md) - [Servizio Salute](https://success.openhealth.fr/it/articles/4990600-servizio-salute.md) - [I miei accessi](https://success.openhealth.fr/it/articles/5783418-i-miei-accessi.md) - [Impostazione della mia homepage](https://success.openhealth.fr/it/articles/5712229-impostazione-della-mia-homepage.md) - [Come modificare il tuo mercato dal tuo spazio personale OpenHealth?](https://success.openhealth.fr/it/articles/3585971-come-modificare-il-tuo-mercato-dal-tuo-spazio-personale-openhealth.md): Integra, modifica e disattiva i prodotti dal tuo spazio personale OpenHealth - [Modifica dell'assegnazione automatica della modalità \(Auto MAM\)](https://success.openhealth.fr/it/articles/4164818-modifica-dell-assegnazione-automatica-della-modalita-auto-mam.md): Modifica direttamente le assegnazioni dei tuoi prodotti - [TEMPORAL MAM: Come seguire un marchio che cambia laboratorio / marca / etichetta?](https://success.openhealth.fr/it/articles/4131072-temporal-mam-come-seguire-un-marchio-che-cambia-laboratorio-marca-etichetta.md): Vantaggi e rischi del tuo tipo di monitoraggio - [Integrazione automatica del prodotto \(Auto IPR\)](https://success.openhealth.fr/it/articles/4164932-integrazione-automatica-del-prodotto-auto-ipr.md): Richiedi l'integrazione di un prodotto nel tuo mercato - [Disattivazione automatica del prodotto \(Auto DPR\)](https://success.openhealth.fr/it/articles/4164866-disattivazione-automatica-del-prodotto-auto-dpr.md): Disattiva un prodotto dal tuo mercato - [Riattivazione automatica del prodotto \(RPR auto\)](https://success.openhealth.fr/it/articles/4818161-riattivazione-automatica-del-prodotto-rpr-auto.md) - [Impostazione di nuovi prodotti](https://success.openhealth.fr/it/articles/5811248-impostazione-di-nuovi-prodotti.md) - [Aggiungere un mercato](https://success.openhealth.fr/it/articles/5712283-aggiungere-un-mercato.md) - [Importazione/esportazione di prodotti sfusi](https://success.openhealth.fr/it/articles/5712257-importazione-esportazione-di-prodotti-sfusi.md) - [Cambio di modalità tipologica \(CMT\)](https://success.openhealth.fr/it/articles/4670174-cambio-di-modalita-tipologica-cmt.md) - [I diversi stati dell'utente](https://success.openhealth.fr/it/articles/3436418-i-diversi-stati-dell-utente.md): Quali sono le caratteristiche? - [Creare un account per un utente di un'organizzazione terza \(TPAA\)](https://success.openhealth.fr/it/articles/6466550-creare-un-account-per-un-utente-di-un-organizzazione-terza-tpaa.md) - [Come creare, modificare o eliminare un account utente su The HUB?](https://success.openhealth.fr/it/articles/3785138-come-creare-modificare-o-eliminare-un-account-utente-su-the-hub.md): Solo un POWER USER può farlo - [Posso creare diritti di visualizzazione differenziati sull'HUB all'interno dei miei team?](https://success.openhealth.fr/it/articles/3321731-posso-creare-diritti-di-visualizzazione-differenziati-sull-hub-all-interno-dei-miei-team.md): Diritti nell'Hub - [Diario di attività](https://success.openhealth.fr/it/articles/4687438-diario-di-attivita.md) ### Vos APPLICATIONS - présentation - [La guida alla formazione HUB](https://success.openhealth.fr/it/articles/5634967-la-guida-alla-formazione-hub.md) - [Selettore a discesa di ordinamento](https://success.openhealth.fr/it/articles/5792113-selettore-a-discesa-di-ordinamento.md) - [Data di aggiornamento dei dati del drugstore GSA \(SMKT\) nell'Hub](https://success.openhealth.fr/it/articles/3175557-data-di-aggiornamento-dei-dati-del-drugstore-gsa-smkt-nell-hub.md): Questo articolo descrive la data in cui vengono aggiornati i dati delle farmacie GSA \(SMKT\). - [Prerequisiti File Farmacie corrispondenti](https://success.openhealth.fr/it/articles/3678146-prerequisiti-file-farmacie-corrispondenti.md): Prerequisiti File Farmacie corrispondenti - [Selettore "Prescrizione On e Off"](https://success.openhealth.fr/it/articles/3729668-selettore-prescrizione-on-e-off.md): Specifiche dell'oggetto "Selettore del tipo di prescrizione" - [Come qualificare i nuovi prodotti nell'HUB?](https://success.openhealth.fr/it/articles/3376100-come-qualificare-i-nuovi-prodotti-nell-hub.md): Qualificazione dei tuoi nuovi prodotti nell'HUB - [Come creare, modificare e condividere un preferito nell'HUB?](https://success.openhealth.fr/it/articles/3175689-come-creare-modificare-e-condividere-un-preferito-nell-hub.md): Creazione e condivisione di preferiti nell'Hub - [Come si selezionano i prodotti nell'HUB in base alla data di lancio?](https://success.openhealth.fr/it/articles/3158428-come-si-selezionano-i-prodotti-nell-hub-in-base-alla-data-di-lancio.md): Questo articolo spiega come selezionare solo i prodotti lanciati in un determinato periodo. - [È possibile estrarre i dati dall'HUB in formato ".csv"?](https://success.openhealth.fr/it/articles/5671278-e-possibile-estrarre-i-dati-dall-hub-in-formato-csv.md) - [Tempo di risposta ODT](https://success.openhealth.fr/it/articles/6632310-tempo-di-risposta-odt.md) - [Quali sono le migliori pratiche di visualizzazione nell'HUB](https://success.openhealth.fr/it/articles/3124454-quali-sono-le-migliori-pratiche-di-visualizzazione-nell-hub.md): Questo articolo descrive in dettaglio le migliori pratiche per ottimizzare la visualizzazione dell'HUB - [Requisiti tecnici](https://success.openhealth.fr/it/articles/5369918-requisiti-tecnici.md) - [Cancella la cache del browser](https://success.openhealth.fr/it/articles/4219722-cancella-la-cache-del-browser.md): Come svuotare la cache del browser Google Chrome - [Come imposto Google Chrome come browser predefinito?](https://success.openhealth.fr/it/articles/3738717-come-imposto-google-chrome-come-browser-predefinito.md): Come impostare Google Chrome come predefinito - [L'ascensore di navigazione non è visibile nelle tabelle](https://success.openhealth.fr/it/articles/3195250-l-ascensore-di-navigazione-non-e-visibile-nelle-tabelle.md): L'ascensore di navigazione - [La visualizzazione di pulsanti o oggetti su un foglio è parzialmente tagliata o non è visibile](https://success.openhealth.fr/it/articles/3195245-la-visualizzazione-di-pulsanti-o-oggetti-su-un-foglio-e-parzialmente-tagliata-o-non-e-visibile.md): Visualizza problema di pulsanti, oggetti - [La mia scheda di gestione del territorio non viene caricata e viene visualizzato il messaggio "caricamento"](https://success.openhealth.fr/it/articles/3195239-la-mia-scheda-di-gestione-del-territorio-non-viene-caricata-e-viene-visualizzato-il-messaggio-caricamento.md): Problema di visualizzazione della mappa di gestione del territorio / TMA - [Da dove viene il messaggio di errore "Non sei autorizzato ad accedere a questa pagina"?](https://success.openhealth.fr/it/articles/3195338-da-dove-viene-il-messaggio-di-errore-non-sei-autorizzato-ad-accedere-a-questa-pagina.md): Messaggio di errore - [Ho un messaggio di errore "Connessione persa"](https://success.openhealth.fr/it/articles/4445141-ho-un-messaggio-di-errore-connessione-persa.md): C'è stato un errore - [Bad gateway](https://success.openhealth.fr/it/articles/4514555-bad-gateway.md): Messaggio di errore "Bad Gateway" - [I selettori di dimensione e misura non sono più visualizzati nei query "Analisi di più periodi" e "Archivio dati personale", l'estrazione della tabella in "Analisi di mercato" è parziale](https://success.openhealth.fr/it/articles/3195377-i-selettori-di-dimensione-e-misura-non-sono-piu-visualizzati-nei-query-analisi-di-piu-periodi-e-archivio-dati-personale-l-estrazione-della-tabella-in-analisi-di-mercato-e-parziale.md): Dimensioni e misure non vengono più visualizzate - [Come visualizzare un termine nell'HUB?](https://success.openhealth.fr/it/articles/3194377-come-visualizzare-un-termine-nell-hub.md): L'HUB consente di visualizzare facilmente i quadrimestri nella scheda "Evoluzione delle vendite" - [Specifiche e limitazioni di Excel](https://success.openhealth.fr/it/articles/3753088-specifiche-e-limitazioni-di-excel.md): Questo articolo spiega le specifiche e le limitazioni per Excel. - [Come si crea, si modifica e si condivide un Preferito nelle applicazioni?](https://success.openhealth.fr/it/articles/10502803-come-si-crea-si-modifica-e-si-condivide-un-preferito-nelle-applicazioni.md) - [Quadro del pannello dei consumatori](https://success.openhealth.fr/it/articles/3455845-quadro-del-pannello-dei-consumatori.md): Articolo relativo al quadro del panel di consumatori - [Quadro di analisi del mercato farmaceutico](https://success.openhealth.fr/it/articles/3455857-quadro-di-analisi-del-mercato-farmaceutico.md): Articolo relativo al framework OpenHealth per l'analisi dell'andamento del mercato sul canale della farmacia ### FONTI DI DATI - [Che cos'è il Panel Farmacia OpenHealth?](https://success.openhealth.fr/it/articles/3304106-che-cos-e-il-panel-farmacia-openhealth.md): Lo scopo di questo articolo è di descrivere il nostro panel di farmacie. - [La rete delle farmacie, asset decisivo nella gestione delle crisi sanitarie attuali e future](https://success.openhealth.fr/it/articles/3825648-la-rete-delle-farmacie-asset-decisivo-nella-gestione-delle-crisi-sanitarie-attuali-e-future.md): OpenHealth Company, impegnata a monitorare una crisi sanitaria senza precedenti, mobilita la sua tecnologia e i suoi dati - [Quali sono i territori della DROM COM visualizzabili nell'HUB?](https://success.openhealth.fr/it/articles/3194382-quali-sono-i-territori-della-drom-com-visualizzabili-nell-hub.md): Territori DROM-COM disponibili nell'Hub - [File di settorizzazione dei prerequisiti](https://success.openhealth.fr/it/articles/3702701-file-di-settorizzazione-dei-prerequisiti.md): Questo articolo ti consente di scaricare, completare e inviare il tuo file di settorizzazione. - [Origine dati SMKT](https://success.openhealth.fr/it/articles/4485357-origine-dati-smkt.md): IRI, fornitore dei dati della farmacia GSA - [GSA Parapharmacy Products Coding Rules \(SMKT\) presso IRI](https://success.openhealth.fr/it/articles/3524492-gsa-parapharmacy-products-coding-rules-smkt-presso-iri.md): Promemoria delle regole di codifica per i prodotti SMKT presso IRI - [Dati di ORGANIC STORE - Fonte BIOANALYTICS](https://success.openhealth.fr/it/articles/5631260-dati-di-organic-store-fonte-bioanalytics.md) - [Parafarmacie elettroniche: piattaforme di monitoraggio](https://success.openhealth.fr/it/articles/9167006-parafarmacie-elettroniche-piattaforme-di-monitoraggio.md) - [Guadagni e perdite di prodotti delle farmacie elettroniche](https://success.openhealth.fr/it/articles/3568773-guadagni-e-perdite-di-prodotti-delle-farmacie-elettroniche.md): Articolo relativo al modulo "Guadagni e perdite sui prodotti delle farmacie elettroniche" - [Profilo del consumatore](https://success.openhealth.fr/it/articles/3711085-profilo-del-consumatore.md): Articolo relativo al modulo "Profilo del consumatore" - [Dati AMAZON - Fonte SELLINGZ](https://success.openhealth.fr/it/articles/5669013-dati-amazon-fonte-sellingz.md) - [Dati sul commercio elettronico - Fonte WISER](https://success.openhealth.fr/it/articles/7983010-dati-sul-commercio-elettronico-fonte-wiser.md) - [Territori geografici](https://success.openhealth.fr/it/articles/4661582-territori-geografici.md): In Open Health Company, puoi analizzare i tuoi mercati in base ai territori geografici che ti offriamo. - [Qual è il panel delle farmacie in Germania? INSIGHTHEALTH](https://success.openhealth.fr/it/articles/5391412-qual-e-il-panel-delle-farmacie-in-germania-insighthealth.md) - [Qual è il pannello delle farmacie in Grecia? ALIRA SALUTE](https://success.openhealth.fr/it/articles/6863963-qual-e-il-pannello-delle-farmacie-in-grecia-alira-salute.md) - [Qual è il panel delle farmacie in Austria? INSIGHTHEALTH](https://success.openhealth.fr/it/articles/6863949-qual-e-il-panel-delle-farmacie-in-austria-insighthealth.md) - [Che cos'è il Panel delle farmacie in Africa? PIEX - Africa](https://success.openhealth.fr/it/articles/6686633-che-cos-e-il-panel-delle-farmacie-in-africa-piex-africa.md) - [Qual è il pannello delle farmacie online in Germania? DATAMEDIQ](https://success.openhealth.fr/it/articles/5689640-qual-e-il-pannello-delle-farmacie-online-in-germania-datamediq.md) - [Qual è il panel delle farmacie in Belgio? REDPHARMA](https://success.openhealth.fr/it/articles/4689894-qual-e-il-panel-delle-farmacie-in-belgio-redpharma.md) - [Qual è il panel delle farmacie in Spagna? - HMR](https://success.openhealth.fr/it/articles/5391363-qual-e-il-panel-delle-farmacie-in-spagna-hmr.md) - [Che cos'è il panel di farmacie in Spagna? - INFONIS](https://success.openhealth.fr/it/articles/5428915-che-cos-e-il-panel-di-farmacie-in-spagna-infonis.md) - [Qual è il panel delle farmacie in Portogallo? - HMR](https://success.openhealth.fr/it/articles/5391477-qual-e-il-panel-delle-farmacie-in-portogallo-hmr.md) - [Qual è il pannello delle farmacie in Russia? - ALPHARM](https://success.openhealth.fr/it/articles/5701531-qual-e-il-pannello-delle-farmacie-in-russia-alpharm.md) - [Qual è il panel delle farmacie in Polonia? Pex Pharma](https://success.openhealth.fr/it/articles/5969485-qual-e-il-panel-delle-farmacie-in-polonia-pex-pharma.md) - [GRUPPO CONVERTITO](https://success.openhealth.fr/it/articles/6961966-gruppo-convertito.md) - [Qual è il pannello della farmacia in Giordania?](https://success.openhealth.fr/it/articles/8176750-qual-e-il-pannello-della-farmacia-in-giordania.md) - [Popolazione - Cartografia](https://success.openhealth.fr/it/articles/3807695-popolazione-cartografia.md): Analizza la distribuzione geografica della popolazione - [AMELI - LPP](https://success.openhealth.fr/it/articles/6962021-ameli-lpp.md) - [Popolazione - Evoluzione per ETÀ E GENERE](https://success.openhealth.fr/it/articles/3810789-popolazione-evoluzione-per-eta-e-genere.md): Analizza l'evoluzione della struttura della popolazione - [Popolazione - Confronto per ETÀ E GENERE](https://success.openhealth.fr/it/articles/3836795-popolazione-confronto-per-eta-e-genere.md): Confronta il profilo demografico di due popolazioni - [EGITTO - Cartografia](https://success.openhealth.fr/it/articles/3714611-egitto-cartografia.md): Analizza la popolazione dei governatorati dell'Egitto - [EGITTO - Analisi per ETÀ E GENERE](https://success.openhealth.fr/it/articles/3714673-egitto-analisi-per-eta-e-genere.md): Analizza la struttura della popolazione - [UGANDA - Analisi per ETÀ E GENERE](https://success.openhealth.fr/it/articles/3713884-uganda-analisi-per-eta-e-genere.md): Analizza la struttura della popolazione - [Popolazione - Analisi per ETÀ E GENERE](https://success.openhealth.fr/it/articles/3807673-popolazione-analisi-per-eta-e-genere.md): Analizza la struttura della popolazione - [Medicabase - database dei farmaci](https://success.openhealth.fr/it/articles/6518920-medicabase-database-dei-farmaci.md) - [Nascita](https://success.openhealth.fr/it/articles/6340025-nascita.md) - [AprireEudra](https://success.openhealth.fr/it/articles/6518977-aprireeudra.md) - [Ripartizione IRIS](https://success.openhealth.fr/it/articles/6383829-ripartizione-iris.md) - [ADICAP](https://success.openhealth.fr/it/articles/6959465-adicap.md) - [NEC](https://success.openhealth.fr/it/articles/6519012-nec.md) - [Dati sulla popolazione mondiale](https://success.openhealth.fr/it/articles/8217421-dati-sulla-popolazione-mondiale.md) - [INSEE: file di persone decedute](https://success.openhealth.fr/it/articles/4498126-insee-file-di-persone-decedute.md): INSEE \(Istituto Nazionale di Statistica e Studi Economici\): Fascicolo delle persone decedute - [Dati VAERS- VAERSDATA- Fonte CDC](https://success.openhealth.fr/it/articles/6226665-dati-vaers-vaersdata-fonte-cdc.md) - [Dati VAERS - VAERSVAX - Fonte CDC](https://success.openhealth.fr/it/articles/6226440-dati-vaers-vaersvax-fonte-cdc.md) - [Dati VAERS - VAERSSYMPTOMS - Fonte CDC](https://success.openhealth.fr/it/articles/6219415-dati-vaers-vaerssymptoms-fonte-cdc.md) - [Integrazione dei dati nell'Hub in meno di 2 settimane](https://success.openhealth.fr/it/articles/5259828-integrazione-dei-dati-nell-hub-in-meno-di-2-settimane.md) - [Modello di dati internazionali](https://success.openhealth.fr/it/articles/4684696-modello-di-dati-internazionali.md) - [Come inviarci i tuoi dati tramite FTPS?](https://success.openhealth.fr/it/articles/4143451-come-inviarci-i-tuoi-dati-tramite-ftps.md): Invia dati tramite FTPS - [Di quali informazioni ha bisogno OpenHealth per integrare una nuova origine dati?](https://success.openhealth.fr/it/articles/3459148-di-quali-informazioni-ha-bisogno-openhealth-per-integrare-una-nuova-origine-dati.md): Articolo sull'integrazione di nuove fonti di dati - [Lo sguardo lungo](https://success.openhealth.fr/it/articles/6959482-lo-sguardo-lungo.md) - [Come integrare una nuova origine dati nell'HUB?](https://success.openhealth.fr/it/articles/3467598-come-integrare-una-nuova-origine-dati-nell-hub.md): Articolo relativo al processo di integrazione dei dati nell'HUB - [Integra i tuoi dati di vendita nell'HUB](https://success.openhealth.fr/it/articles/3471145-integra-i-tuoi-dati-di-vendita-nell-hub.md): Articolo sull'integrazione dei dati di sell-in - [Specifiche per la ricezione dei dati di vendita](https://success.openhealth.fr/it/articles/3660043-specifiche-per-la-ricezione-dei-dati-di-vendita.md): Come inviarci il tuo sell-in come parte di un'analisi sell-in / sell-out o sottoscrizione al modulo Sell-in Vizualization - [Da dove provengono i dati di analisi per il mercato Home Health Providers \(PSAD\)?](https://success.openhealth.fr/it/articles/3376155-da-dove-provengono-i-dati-di-analisi-per-il-mercato-home-health-providers-psad.md): PSAD - [Come aderire all'osservatorio statale SantéDom?](https://success.openhealth.fr/it/articles/3798795-come-aderire-all-osservatorio-statale-santedom.md): Tutorial per l'adesione all'Osservatorio nazionale dell'attività degli Home Health Providers \(PSAD\) - [Pannello estrapolato dall'osservatorio SanteDomStat](https://success.openhealth.fr/it/articles/6701602-pannello-estrapolato-dall-osservatorio-santedomstat.md) - [Numero di pazienti](https://success.openhealth.fr/it/articles/3376499-numero-di-pazienti.md): Definizione del numero di pazienti secondo le federazioni PSAD - [Numero di trattamenti](https://success.openhealth.fr/it/articles/3376682-numero-di-trattamenti.md): Definizione del numero di cure secondo le federazioni PSAD - [Numero di nuovi pazienti](https://success.openhealth.fr/it/articles/3376672-numero-di-nuovi-pazienti.md): Definizione del numero di nuovi pazienti secondo le federazioni PSAD - [Fatturato comprensivo di tasse](https://success.openhealth.fr/it/articles/3376725-fatturato-comprensivo-di-tasse.md): Definizione di fatturato comprensivo di tasse secondo le federazioni PSAD - [Numero di pazienti alla fine del trattamento](https://success.openhealth.fr/it/articles/3376675-numero-di-pazienti-alla-fine-del-trattamento.md): Definizione del numero di pazienti alla fine del trattamento secondo le federazioni PSAD - [Importo dell'assicurazione sanitaria obbligatoria \(AMO\)](https://success.openhealth.fr/it/articles/3376740-importo-dell-assicurazione-sanitaria-obbligatoria-amo.md): Definizione dell'importo AMO secondo le federazioni PSAD - [Importo dell'assicurazione sanitaria complementare \(AMC\)](https://success.openhealth.fr/it/articles/3376749-importo-dell-assicurazione-sanitaria-complementare-amc.md): Definizione dell'importo AMC secondo le federazioni PSAD - [Carica eccezionale \(RAC\)](https://success.openhealth.fr/it/articles/3376751-carica-eccezionale-rac.md): Definizione del RAC secondo le federazioni PSAD - [Fonte: THESORIMED](https://success.openhealth.fr/it/articles/3560018-fonte-thesorimed.md): Database dei farmaci \(BdM\) - [Nomi internazionali non proprietari \(DCI\)](https://success.openhealth.fr/it/articles/3954239-nomi-internazionali-non-proprietari-dci.md): Nomi comuni internazionali \(INN\) - [Fatti di cibo aperti](https://success.openhealth.fr/it/articles/6961970-fatti-di-cibo-aperti.md) - [LOINC - Nomi e codici degli identificatori logici di osservazione](https://success.openhealth.fr/it/articles/6959323-loinc-nomi-e-codici-degli-identificatori-logici-di-osservazione.md) - [AMELI - CCAM](https://success.openhealth.fr/it/articles/6959080-ameli-ccam.md) - [WHO ATC VET](https://success.openhealth.fr/it/articles/6959078-who-atc-vet.md) - [CEPS](https://success.openhealth.fr/it/articles/6959068-ceps.md) - [Istituzione](https://success.openhealth.fr/it/articles/3935678-istituzione.md): Elenco delle strutture sanitarie, sociali, medico-sociali - [Servizi sanitari](https://success.openhealth.fr/it/articles/7969680-servizi-sanitari.md) - [Estrai FINESS](https://success.openhealth.fr/it/articles/3946922-estrai-finess.md): Esegui un'estrazione secondo le tue aspettative - [Evolution FINESS](https://success.openhealth.fr/it/articles/3947009-evolution-finess.md): Segui l'evoluzione del numero di strutture - [Attività di assistenza autorizzativa](https://success.openhealth.fr/it/articles/3947067-attivita-di-assistenza-autorizzativa.md): Elencare le strutture in base alle loro autorizzazioni all'attività sanitaria - [Principali apparecchiature mediche](https://success.openhealth.fr/it/articles/3947269-principali-apparecchiature-mediche.md): Elencare le strutture in base alla loro attrezzatura in materiale pesante - [Geografico](https://success.openhealth.fr/it/articles/3947363-geografico.md): Visualizza la distribuzione delle strutture sul territorio - [RPPS](https://success.openhealth.fr/it/articles/3947568-rpps.md): Elenco degli operatori sanitari - [FINESS E RPPS](https://success.openhealth.fr/it/articles/3947713-finess-e-rpps.md): Elencare i luoghi di esercizio degli operatori sanitari - [Estrai RPPS](https://success.openhealth.fr/it/articles/3947829-estrai-rpps.md): RPPS \(Directory condivisa degli operatori sanitari\) ### I MODELLI - [Dati presso l'UGA](https://success.openhealth.fr/it/articles/4852310-dati-presso-l-uga.md) - [Calcolo delle vendite al settore: cosa devi sapere](https://success.openhealth.fr/it/articles/3545561-calcolo-delle-vendite-al-settore-cosa-devi-sapere.md): Quali sono i diversi passaggi per calcolare le vendite del settore in OpenHealth? - [Riallocazione del settore, metodologia statica o dinamica?](https://success.openhealth.fr/it/articles/3690615-riallocazione-del-settore-metodologia-statica-o-dinamica.md): Riallocazione del settore, metodologia statica o dinamica? - [Strati di farmacie](https://success.openhealth.fr/it/articles/4291490-strati-di-farmacie.md): Dettagli degli strati "teorici" e degli strati "reali" o "effettivi". - [La linea di produzione Hub](https://success.openhealth.fr/it/articles/4816146-la-linea-di-produzione-hub.md) - [Come condurre un'analisi comparativa?](https://success.openhealth.fr/it/articles/3440093-come-condurre-un-analisi-comparativa.md): Vuoi confrontare i dati di due diversi provider. - [INDAGINE DI LIVELLO 1 - Data Quality al servizio di OpenHealth Company](https://success.openhealth.fr/it/articles/3595822-indagine-di-livello-1-data-quality-al-servizio-di-openhealth-company.md): Osservi un fenomeno che non capisci? Possiamo fornirti l'origine di questo avvistamento e spiegartelo. - [Processo di qualità dei dati in OpenHealth](https://success.openhealth.fr/it/articles/3415271-processo-di-qualita-dei-dati-in-openhealth.md): Questo articolo descrive in dettaglio le fasi dei processi di qualità dei dati in OpenHealth - [Intervallo e livello di confidenza](https://success.openhealth.fr/it/articles/3633173-intervallo-e-livello-di-confidenza.md): Definizioni, formule e limitazioni: cosa devi sapere - [Qualità dei dati: gestione batch](https://success.openhealth.fr/it/articles/3433509-qualita-dei-dati-gestione-batch.md): Descrizione del processo di gestione batch - [Qualità dei dati: processo di ripartizione delle vendite](https://success.openhealth.fr/it/articles/3415317-qualita-dei-dati-processo-di-ripartizione-delle-vendite.md): Descrizione del processo di ripartizione delle vendite - [Sell-in e stock offset](https://success.openhealth.fr/it/articles/4131084-sell-in-e-stock-offset.md): Vendita di azioni - [Perché analizzare il volume di sell-in?](https://success.openhealth.fr/it/articles/3846167-perche-analizzare-il-volume-di-sell-in.md): Perché analizzare il volume di sell-in? - [Esiste un divario di dati tra sell-in e sell-out](https://success.openhealth.fr/it/articles/3195358-esiste-un-divario-di-dati-tra-sell-in-e-sell-out.md): In quali casi possiamo avere un gap di dati tra sell-in e sell-out? - [Cos'è una vendita atipica?](https://success.openhealth.fr/it/articles/3195366-cos-e-una-vendita-atipica.md): Vendite atipiche e processo ATYPICAL FILTER. - [Da dove provengono le informazioni su prezzi, volumi, fatturato?](https://success.openhealth.fr/it/articles/3195348-da-dove-provengono-le-informazioni-su-prezzi-volumi-fatturato.md): Informazioni su prezzo / volume / fatturato - [Volume di vendita stimato per medico prescrittore](https://success.openhealth.fr/it/articles/4171530-volume-di-vendita-stimato-per-medico-prescrittore.md): Come valutare i volumi di vendita nelle farmacie per prescrittore e categoria di prescrittore - [Capire la differenza tra 2 estrazioni](https://success.openhealth.fr/it/articles/13399689-capire-la-differenza-tra-2-estrazioni.md) ### MERCATI - [GTIN](https://success.openhealth.fr/it/articles/3608176-gtin.md): Codice GTIN \(Global Trade Item Number\) - [Specifica del campo qualificatore prodotto del cliente \(CQCP\)](https://success.openhealth.fr/it/articles/3704913-specifica-del-campo-qualificatore-prodotto-del-cliente-cqcp.md): CQCP \(Product Customer Qualifier Field\) - [Cos'è un codice LPPR?](https://success.openhealth.fr/it/articles/3195365-cos-e-un-codice-lppr.md): Il codice LPPR \(Elenco di prodotti e servizi rimborsabili\) - [Monitoraggio del noleggio del prodotto](https://success.openhealth.fr/it/articles/4206554-monitoraggio-del-noleggio-del-prodotto.md): Noleggio di prodotti - [Voglio espandere il mio mercato](https://success.openhealth.fr/it/articles/4420843-voglio-espandere-il-mio-mercato.md): Seguì il mercato degli abbonamenti - [Classificazione OHC](https://success.openhealth.fr/it/articles/3194589-classificazione-ohc.md): Visualizza l'assegnazione dei tuoi prodotti secondo la classificazione proprietaria di OpenHealth Company - [EphMRA AC Classes History](https://success.openhealth.fr/it/articles/3557908-ephmra-ac-classes-history.md): Visualizza l'evoluzione delle classi EphMRA AC dal 2014 - [Dettagli di medicina veterinaria](https://success.openhealth.fr/it/articles/3194587-dettagli-di-medicina-veterinaria.md): Visualizza le caratteristiche dei farmaci veterinari - [Classificazione della medicina veterinaria](https://success.openhealth.fr/it/articles/3194579-classificazione-della-medicina-veterinaria.md): Visualizza la classificazione dei farmaci veterinari \(ANSES\) - [Dettagli della medicina umana](https://success.openhealth.fr/it/articles/3421225-dettagli-della-medicina-umana.md): Visualizza le caratteristiche di uno o più prodotti attraverso i campi di dettaglio di THESORIMED - [Gestione di nuovi prodotti](https://success.openhealth.fr/it/articles/4470813-gestione-di-nuovi-prodotti.md): Nuova gestione del prodotto - [Classificazione della medicina umana](https://success.openhealth.fr/it/articles/3417281-classificazione-della-medicina-umana.md): Visualizza le classificazioni EphMRA AC e OMS ATC per l'ambito del tuo prodotto - [Indicazioni - Diagnosi](https://success.openhealth.fr/it/articles/3568554-indicazioni-diagnosi.md): Visualizza i farmaci indicati per una determinata patologia e le patologie associate a una selezione di farmaci - [MP4U](https://success.openhealth.fr/it/articles/3574188-mp4u.md): Visualizza tutte le classificazioni messe a disposizione da OpenHealth Company - [Che cos'è il TVASI \(Tabella delle vendite, degli acquisti e delle scorte non note\)?](https://success.openhealth.fr/it/articles/5992494-che-cos-e-il-tvasi-tabella-delle-vendite-degli-acquisti-e-delle-scorte-non-note.md) - [Classificazione dei prodotti IRI](https://success.openhealth.fr/it/articles/3194597-classificazione-dei-prodotti-iri.md): Visualizza l'assegnazione dei tuoi prodotti in base alla classificazione proprietario IRI - [Rimozione dei prodotti invenduti](https://success.openhealth.fr/it/articles/6135938-rimozione-dei-prodotti-invenduti.md) - [MERCATO STANDARD - Abbonamento](https://success.openhealth.fr/it/articles/3798203-mercato-standard-abbonamento.md): Questo articolo descrive l'interesse e i limiti di un mercato cosiddetto "standard" - [Non riesco a trovare il mio prodotto](https://success.openhealth.fr/it/articles/5686002-non-riesco-a-trovare-il-mio-prodotto.md) - [Gestione del codice prodotto](https://success.openhealth.fr/it/articles/5652478-gestione-del-codice-prodotto.md) - [Qualificazione del prodotto: Marchi](https://success.openhealth.fr/it/articles/5016985-qualificazione-del-prodotto-marchi.md) ### ABBONAMENTI e MODULI - [I 3 tipi di applicazione](https://success.openhealth.fr/it/articles/9489652-i-3-tipi-di-applicazione.md) - [La vostra piattaforma 2.0](https://success.openhealth.fr/it/articles/8374416-la-vostra-piattaforma-2-0.md) - [SOMMARIO](https://success.openhealth.fr/it/articles/3344127-sommario.md): Tutte le caratteristiche della tua applicazione sono disponibili in questo modulo - [Mercati e selezioni](https://success.openhealth.fr/it/articles/8337016-mercati-e-selezioni.md) - [Cruscotto di sintesi](https://success.openhealth.fr/it/articles/9246867-cruscotto-di-sintesi.md) - [Analisi](https://success.openhealth.fr/it/articles/9352287-analisi.md) - [Estrattore](https://success.openhealth.fr/it/articles/9246875-estrattore.md) - [Analisi della crescita](https://success.openhealth.fr/it/articles/3158856-analisi-della-crescita.md): Determina i fattori chiave nell'evoluzione dei tuoi mercati e quelli dei tuoi concorrenti - [Analisi dell'assortimento](https://success.openhealth.fr/it/articles/3473736-analisi-dell-assortimento.md): Studia il dinamismo dei prodotti in un mercato - [Numero medio di prodotti](https://success.openhealth.fr/it/articles/3161474-numero-medio-di-prodotti.md): Visualizza il numero medio di prodotti per punto vendita, nelle farmacie o nelle farmacie GSA - [Avvia monitoraggio](https://success.openhealth.fr/it/articles/3158488-avvia-monitoraggio.md): Monitorare i lanci dei prodotti e il loro contributo alla crescita - [Indicatori avanzati incrociati](https://success.openhealth.fr/it/articles/6007740-indicatori-avanzati-incrociati.md) - [Concentrazione delle vendite](https://success.openhealth.fr/it/articles/3095338-concentrazione-delle-vendite.md): Visualizza la concentrazione di un mercato attraverso la curva di concentrazione delle vendite e l'indice GINI - [Dispersione dei prezzi](https://success.openhealth.fr/it/articles/3159289-dispersione-dei-prezzi.md): Visualizza la dispersione del prezzo di un prodotto. Crea i tuoi segmenti di farmacia dal prezzo di vendita - [Analisi del margine di sell-out](https://success.openhealth.fr/it/articles/3358322-analisi-del-margine-di-sell-out.md): Valuta l'attrattiva dei tuoi prodotti per le farmacie - [Evoluzione del margine di sell-out](https://success.openhealth.fr/it/articles/3815561-evoluzione-del-margine-di-sell-out.md) - [Monitoraggio della farmacia \(1/2\)](https://success.openhealth.fr/it/articles/3358248-monitoraggio-della-farmacia-1-2.md): Segui l'evoluzione del traffico in farmacia - [Monitoraggio della farmacia \(2/2\)](https://success.openhealth.fr/it/articles/3810527-monitoraggio-della-farmacia-2-2.md): Segui l'evoluzione del traffico in farmacia - [Performance di Salesforce](https://success.openhealth.fr/it/articles/3159230-performance-di-salesforce.md): Confronta l'andamento delle vendite di regioni e settori di una forza vendita - [Assistente alla gestione delle relazioni con i clienti \(CRM\)](https://success.openhealth.fr/it/articles/5953935-assistente-alla-gestione-delle-relazioni-con-i-clienti-crm.md) - [Monitoraggio del punto vendita](https://success.openhealth.fr/it/articles/3778944-monitoraggio-del-punto-vendita.md): Monitoraggio del punto vendita - [Evoluzione su richiesta](https://success.openhealth.fr/it/articles/6560184-evoluzione-su-richiesta.md) - [Analisi su richiesta](https://success.openhealth.fr/it/articles/6127483-analisi-su-richiesta.md) - [Tabella su richiesta](https://success.openhealth.fr/it/articles/3158751-tabella-su-richiesta.md): Visualizza i principali indicatori HUB e la loro evoluzione su diversi tipi di periodi - [Analisi delle serie temporali](https://success.openhealth.fr/it/articles/3635940-analisi-delle-serie-temporali.md): Suddividi il tuo mercato in stagione, tendenza e rumore - [Analisi previsionale](https://success.openhealth.fr/it/articles/3636015-analisi-previsionale.md): Stima il futuro del tuo mercato - [Previsioni settoriali](https://success.openhealth.fr/it/articles/3689811-previsioni-settoriali.md): Stima le vendite future del settore - [Visualizzazione sell-in](https://success.openhealth.fr/it/articles/3559882-visualizzazione-sell-in.md): Confronta l'evoluzione delle tue vendite sell-in e sell-out - [Analisi Sell-in](https://success.openhealth.fr/it/articles/6188132-analisi-sell-in.md) - [Corrispondenza Sell-in](https://success.openhealth.fr/it/articles/6188090-corrispondenza-sell-in.md) - [Evoluzione del sell-in](https://success.openhealth.fr/it/articles/6191929-evoluzione-del-sell-in.md) - [Analisi Sell-in vs Sell-out](https://success.openhealth.fr/it/articles/6191947-analisi-sell-in-vs-sell-out.md) - [Evoluzione di Sell-in e Sell-out](https://success.openhealth.fr/it/articles/6191955-evoluzione-di-sell-in-e-sell-out.md) - [Evoluzione del prezzo](https://success.openhealth.fr/it/articles/5056489-evoluzione-del-prezzo.md) - [Personalizzare i colori](https://success.openhealth.fr/it/articles/8407897-personalizzare-i-colori.md) - [Esportazione del prodotto](https://success.openhealth.fr/it/articles/3583206-esportazione-del-prodotto.md): Foglio di esportazione specifico per Tutti i prodotti e App di tipo MP4U - [Analisi di mercato](https://success.openhealth.fr/it/articles/3121933-analisi-di-mercato.md): Analizza l'andamento del tuo mercato: per segmento, brand, prodotto e azienda - [Analisi dei prezzi](https://success.openhealth.fr/it/articles/3215190-analisi-dei-prezzi.md): Visualizza i prezzi sul tuo mercato e analizza il tuo posizionamento - [Evoluzione delle vendite](https://success.openhealth.fr/it/articles/3178323-evoluzione-delle-vendite.md): Visualizza le tue vendite in evoluzione su tutta la cronologia disponibile - [Riassunto del cruscotto](https://success.openhealth.fr/it/articles/4533213-riassunto-del-cruscotto.md) - [Evoluzione della quota di mercato](https://success.openhealth.fr/it/articles/3193078-evoluzione-della-quota-di-mercato.md): Visualizza l'evoluzione delle vendite e della quota di mercato su lunghi periodi - [Tabella incrociata delle vendite](https://success.openhealth.fr/it/articles/3193060-tabella-incrociata-delle-vendite.md): Crea una semplice tabella pivot - [Sintesi FATTURATO / VOLUME \(CU\)](https://success.openhealth.fr/it/articles/3193048-sintesi-fatturato-volume-cu.md): Visualizza contemporaneamente i volumi di vendita e il valore di un mercato - [Sell Out Value Synthesis \(FARMACIE / SUPERMERCATI\)](https://success.openhealth.fr/it/articles/3193020-sell-out-value-synthesis-farmacie-supermercati.md): Confronta le vendite di farmacie e farmacie GSA - [Analisi della quota di mercato](https://success.openhealth.fr/it/articles/3193069-analisi-della-quota-di-mercato.md): Analizza le quote di mercato negli ultimi 12 mesi - [Archivio dati](https://success.openhealth.fr/it/articles/3193099-archivio-dati.md): Esporta un database semplice in Excel - [Analisi di più periodi](https://success.openhealth.fr/it/articles/3192953-analisi-di-piu-periodi.md): Crea un tavolo completamente personalizzato - [La mia query Tutti i prodotti](https://success.openhealth.fr/it/articles/4280353-la-mia-query-tutti-i-prodotti.md): Visualizza i tuoi segmenti e i campi qualificanti \(es: galenico, indice solare, promozioni ...\) così come la tua restrizione - [Stock Evolution \(NUOVO\)](https://success.openhealth.fr/it/articles/3719256-stock-evolution-nuovo.md): Visualizza e analizza l'evoluzione delle azioni e la loro distribuzione - [Definizione di mercato](https://success.openhealth.fr/it/articles/3158829-definizione-di-mercato.md): Riporta il tuo mercato sulla base 100 di tua scelta - [Indicatori avanzati DATI RAW](https://success.openhealth.fr/it/articles/3711095-indicatori-avanzati-dati-raw.md): Recupera i dati dell'indicatore principale - [Indicatori avanzati Evolution SMKT](https://success.openhealth.fr/it/articles/3193000-indicatori-avanzati-evolution-smkt.md): Monitora le prestazioni del tuo laboratorio attraverso un'analisi dell'evoluzione temporale dei tuoi indicatori statistici avanzati. - [Analisi degli indicatori avanzati SMKT](https://success.openhealth.fr/it/articles/3192366-analisi-degli-indicatori-avanzati-smkt.md): Suddividi l'evoluzione di un mercato della parafarmacia GSA in indicatori principali - [Evoluzione degli indicatori avanzati](https://success.openhealth.fr/it/articles/3177853-evoluzione-degli-indicatori-avanzati.md): Monitora le prestazioni del tuo laboratorio attraverso un'analisi dell'evoluzione temporale dei tuoi indicatori statistici avanzati. - [Indicatori avanzati Evoluzione Bio](https://success.openhealth.fr/it/articles/7051823-indicatori-avanzati-evoluzione-bio.md) - [Indicatori avanzati nazionali](https://success.openhealth.fr/it/articles/3364513-indicatori-avanzati-nazionali.md): Suddividi l'evoluzione di un mercato in indicatori anticipatori - [Analisi delle scorte](https://success.openhealth.fr/it/articles/3178015-analisi-delle-scorte.md): Interpretare un livello di stock e la sua evoluzione - [Analisi avanzata degli indicatori Bio](https://success.openhealth.fr/it/articles/7051801-analisi-avanzata-degli-indicatori-bio.md) - [Analisi avanzata degli indicatori](https://success.openhealth.fr/it/articles/3124439-analisi-avanzata-degli-indicatori.md): Scomporre l'evoluzione di un mercato in indicatori leader - [Cartografia](https://success.openhealth.fr/it/articles/3192450-cartografia.md): Analizza l'andamento commerciale delle regioni e dei settori della tua forza vendita - [Tavola a croce geografica](https://success.openhealth.fr/it/articles/3192466-tavola-a-croce-geografica.md): Crea una tabella pivot che integri la tua settorizzazione - [Evoluzione geografica delle vendite](https://success.openhealth.fr/it/articles/3192482-evoluzione-geografica-delle-vendite.md): Visualizza le vendite per settore nell'arco di 36 mesi in una tabella pivot - [Efficacia della forza vendita](https://success.openhealth.fr/it/articles/5624011-efficacia-della-forza-vendita.md) - [Analisi del metodo di ponderazione personalizzato](https://success.openhealth.fr/it/articles/5169317-analisi-del-metodo-di-ponderazione-personalizzato.md) - [Analisi di rete](https://success.openhealth.fr/it/articles/3894767-analisi-di-rete.md): Analisi di rete - [Evoluzione del metodo di ponderazione personalizzato](https://success.openhealth.fr/it/articles/5169320-evoluzione-del-metodo-di-ponderazione-personalizzato.md) - [KPI SINTESI](https://success.openhealth.fr/it/articles/3478199-kpi-sintesi.md): Visualizza in una tabella dinamica i tuoi indicatori chiave Volume declinato per regioni e settori. - [Vendite in unità convertite](https://success.openhealth.fr/it/articles/3192412-vendite-in-unita-convertite.md): Usa le unità convertite per visualizzare le tue vendite - [Indicatori delle scorte di DATI RAW](https://success.openhealth.fr/it/articles/3711142-indicatori-delle-scorte-di-dati-raw.md): Esporta i dati del tuo inventario - [DATI RAW SMKT AIA](https://success.openhealth.fr/it/articles/3720960-dati-raw-smkt-aia.md): Trova i dati dell'indicatore principale SMKT - [Stock Evolution](https://success.openhealth.fr/it/articles/3178277-stock-evolution.md): Visualizza e analizza l'evoluzione delle azioni e la loro distribuzione - [Indicatori geografici avanzati](https://success.openhealth.fr/it/articles/3192508-indicatori-geografici-avanzati.md): Visualizza gli indicatori principali per regione o settore - [Prestazioni dei prodotti](https://success.openhealth.fr/it/articles/3850331-prestazioni-dei-prodotti.md): Confronta le prestazioni aziendali delle regioni e dei settori di prodotto - [Indicatori avanzati territoriali](https://success.openhealth.fr/it/articles/3370879-indicatori-avanzati-territoriali.md): Suddividi l'evoluzione di un mercato in indicatori anticipatori - [Analisi settoriale delle serie storiche](https://success.openhealth.fr/it/articles/3814974-analisi-settoriale-delle-serie-storiche.md): Suddividi il tuo mercato in trend, stagione, rumore - [Analisi delle vendite per età e sesso](https://success.openhealth.fr/it/articles/3192701-analisi-delle-vendite-per-eta-e-sesso.md): Analizza le vendite per età e sesso - [Evoluzione delle vendite in base allo stato di gravidanza](https://success.openhealth.fr/it/articles/3192910-evoluzione-delle-vendite-in-base-allo-stato-di-gravidanza.md): Segui le vendite in farmacia sulla popolazione di donne in gravidanza - [Evoluzione delle vendite per età e sesso](https://success.openhealth.fr/it/articles/3192732-evoluzione-delle-vendite-per-eta-e-sesso.md): Visualizza l'evoluzione delle vendite per età e sesso utilizzando la profondità della storia dell'HUB - [Evoluzione dell'ordine dei requisiti](https://success.openhealth.fr/it/articles/5790020-evoluzione-dell-ordine-dei-requisiti.md) - [Evoluzione delle dispense](https://success.openhealth.fr/it/articles/3192529-evoluzione-delle-dispense.md): Visualizza e scomponi l'evoluzione delle co-dispensazioni nelle farmacie - [Analisi delle co-dispensazioni](https://success.openhealth.fr/it/articles/3192633-analisi-delle-co-dispensazioni.md): Visualizza le Co-Dispensazioni nelle farmacie associate a una selezione di prodotti del mio mercato - [Vendite per canale e prescrittore](https://success.openhealth.fr/it/articles/3192751-vendite-per-canale-e-prescrittore.md): Visualizza gli influencer nel tuo mercato - [AMO, AMC e RAC](https://success.openhealth.fr/it/articles/3192929-amo-amc-e-rac.md): Visualizza i tre importi di assicurazione sanitaria obbligatoria, assicurazione sanitaria complementare e spese vive - [Dispersione di co-dispensazioni](https://success.openhealth.fr/it/articles/3876946-dispersione-di-co-dispensazioni.md): Visualizza la distribuzione del numero di prodotti venduti per dispensa - [Evoluzione della dispersione della dispensazione](https://success.openhealth.fr/it/articles/3920070-evoluzione-della-dispersione-della-dispensazione.md): Visualizza la distribuzione del numero di prodotti venduti per dispensazione nel tempo - [Prescrizioni del medico di famiglia per età e sesso](https://success.openhealth.fr/it/articles/5789899-prescrizioni-del-medico-di-famiglia-per-eta-e-sesso.md) - [Analisi degli ordini di prescrizione](https://success.openhealth.fr/it/articles/5322866-analisi-degli-ordini-di-prescrizione.md) - [Evoluzione delle prescrizioni mediche](https://success.openhealth.fr/it/articles/5790016-evoluzione-delle-prescrizioni-mediche.md) - [Analisi del paniere](https://success.openhealth.fr/it/articles/3711049-analisi-del-paniere.md): Descrizione del modulo "Analisi del paniere" - [Co-distribuzione](https://success.openhealth.fr/it/articles/4738243-co-distribuzione.md) - [Modulo di qualificazione di coorte](https://success.openhealth.fr/it/articles/3928090-modulo-di-qualificazione-di-coorte.md): Qualificazione della coorte di pazienti - [Modulo di stato del trattamento](https://success.openhealth.fr/it/articles/3928067-modulo-di-stato-del-trattamento.md): Analizza le dinamiche del monitoraggio del trattamento - [Modulo di aderenza al trattamento](https://success.openhealth.fr/it/articles/3928044-modulo-di-aderenza-al-trattamento.md): Analizza l'aderenza ai trattamenti - [Definizione di coorte](https://success.openhealth.fr/it/articles/3894703-definizione-di-coorte.md): Definisci l'ambito della tua analisi - [Co-trattamenti](https://success.openhealth.fr/it/articles/4163623-co-trattamenti.md): Definisci la co-elaborazione nell'ambito del tuo ambito di analisi - [Coorte di visualizzazione](https://success.openhealth.fr/it/articles/3894721-coorte-di-visualizzazione.md): Visualizza il profilo del paziente della coorte definita - [Definizione dei criteri di analisi](https://success.openhealth.fr/it/articles/3894728-definizione-dei-criteri-di-analisi.md): Definisci i parametri per l'analisi della tua coorte - [Evoluzione della coorte globale](https://success.openhealth.fr/it/articles/3894747-evoluzione-della-coorte-globale.md): Visualizza l'evoluzione mensile della coorte - [Distribuzione geografica](https://success.openhealth.fr/it/articles/3894751-distribuzione-geografica.md): Visualizza la distribuzione geografica dei pazienti nella coorte definita - [Profilo di coorte](https://success.openhealth.fr/it/articles/3894755-profilo-di-coorte.md): Analizza il profilo demografico dei pazienti inclusi nella coorte - [Lo stato del trattamento si interrompe](https://success.openhealth.fr/it/articles/3894764-lo-stato-del-trattamento-si-interrompe.md): Ottieni una panoramica dei diversi tipi di follow-up del trattamento - [Inizio del trattamento](https://success.openhealth.fr/it/articles/3894778-inizio-del-trattamento.md): Analizza l'evoluzione del numero di iniziazioni del trattamento - [Il trattamento ricomincia](https://success.openhealth.fr/it/articles/3894788-il-trattamento-ricomincia.md): Analizza l'evoluzione del numero di ripetizioni del trattamento - [Nuovi trattamenti](https://success.openhealth.fr/it/articles/3894804-nuovi-trattamenti.md): Analizza l'evoluzione del numero di iniziazioni e riprende il trattamento - [Ricorrenze del trattamento](https://success.openhealth.fr/it/articles/3894812-ricorrenze-del-trattamento.md): Analizza i pazienti in trattamento - [Equilibrio dell'interruttore di trattamento](https://success.openhealth.fr/it/articles/3894821-equilibrio-dell-interruttore-di-trattamento.md): Analizza l'equilibrio dei cambiamenti di trattamento in base al trattamento - [Guadagni di cambio trattamento](https://success.openhealth.fr/it/articles/3894830-guadagni-di-cambio-trattamento.md): Analizza i beneficiari dei cambi di trattamento - [Perdite da interruzione del trattamento](https://success.openhealth.fr/it/articles/3894843-perdite-da-interruzione-del-trattamento.md): Analizza per trattamento i perdenti degli interruttori di trattamento - [Cambia le origini del guadagno](https://success.openhealth.fr/it/articles/3894857-cambia-le-origini-del-guadagno.md): Analizza l'origine dell'interruttore per un determinato trattamento - [Cambia la destinazione della perdita](https://success.openhealth.fr/it/articles/3894864-cambia-la-destinazione-della-perdita.md): Analizza la destinazione del passaggio per un determinato trattamento - [Abbandoni](https://success.openhealth.fr/it/articles/3894874-abbandoni.md): Analizza le interruzioni del trattamento - [Riepilogo KPI](https://success.openhealth.fr/it/articles/4229969-riepilogo-kpi.md): Riepilogo dei diversi tipi di monitoraggio del trattamento - [Persistenza del trattamento](https://success.openhealth.fr/it/articles/3894883-persistenza-del-trattamento.md): Analizza la durata dei trattamenti - [Conformità](https://success.openhealth.fr/it/articles/3894884-conformita.md): Analizza le quantità consegnate - [Qual è il criterio di regolarità?](https://success.openhealth.fr/it/articles/3325816-qual-e-il-criterio-di-regolarita.md): Definizione del concetto di criterio di regolarità - [Morte - Cartografia](https://success.openhealth.fr/it/articles/3863677-morte-cartografia.md): Analizza la distribuzione geografica dei decessi - [Compensazione del conteggio delle morti](https://success.openhealth.fr/it/articles/3863573-compensazione-del-conteggio-delle-morti.md): Valuta la pertinenza dei tuoi dati - [Morte - Analisi per ETÀ E GENERE](https://success.openhealth.fr/it/articles/3863808-morte-analisi-per-eta-e-genere.md): Analizza la struttura delle morti - [Morte - Evoluzione per ETÀ E GENERE](https://success.openhealth.fr/it/articles/3863939-morte-evoluzione-per-eta-e-genere.md): Analizza l'evoluzione della struttura delle morti - [Morte - Evoluzione](https://success.openhealth.fr/it/articles/3864065-morte-evoluzione.md): Visualizza l'evoluzione delle morti - [Morte - Confronto dell'evoluzione](https://success.openhealth.fr/it/articles/3864073-morte-confronto-dell-evoluzione.md): Confronta l'evoluzione dei decessi rispetto agli anni precedenti - [CA di monitoraggio della farmacia](https://success.openhealth.fr/it/articles/4634768-ca-di-monitoraggio-della-farmacia.md): Descrivi il traffico in base alle dimensioni delle farmacie - [Analisi del traffico \(Beta test\)](https://success.openhealth.fr/it/articles/6848401-analisi-del-traffico-beta-test.md) - [Dettagli sul monitoraggio della farmacia](https://success.openhealth.fr/it/articles/4527868-dettagli-sul-monitoraggio-della-farmacia.md): Analizza il traffico del dispensario per tipo di farmacia - [Evoluzione del traffico \(Beta test\)](https://success.openhealth.fr/it/articles/6848016-evoluzione-del-traffico-beta-test.md) - [Cartografia di monitoraggio della farmacia](https://success.openhealth.fr/it/articles/4527811-cartografia-di-monitoraggio-della-farmacia.md): Analizza il traffico dei dispensari nella Francia continentale - [Dettagli sul monitoraggio della farmacia](https://success.openhealth.fr/it/articles/4262306-dettagli-sul-monitoraggio-della-farmacia.md): Discriminare il dettaglio delle vendite in base al tipo di dispensario - [Analisi del monitoraggio della farmacia](https://success.openhealth.fr/it/articles/3839223-analisi-del-monitoraggio-della-farmacia.md): Segui l'evoluzione del traffico in farmacia - [Evoluzione del monitoraggio della farmacia](https://success.openhealth.fr/it/articles/3827973-evoluzione-del-monitoraggio-della-farmacia.md): Studia l'evoluzione del traffico dispensario - [Decomposizione del traffico](https://success.openhealth.fr/it/articles/3826074-decomposizione-del-traffico.md): Osserva le componenti di stagione, tendenza e residuo - [Studio del traffico](https://success.openhealth.fr/it/articles/3809042-studio-del-traffico.md): Analizza il traffico della farmacia - [Sintesi - PIEX](https://success.openhealth.fr/it/articles/5203335-sintesi-piex.md) - [Acquisto](https://success.openhealth.fr/it/articles/4605110-acquisto.md): Tieni traccia dei tuoi acquisti e delle loro ricevute - [La mia domanda - PIEX](https://success.openhealth.fr/it/articles/4210627-la-mia-domanda-piex.md): Effettua selezioni sui tuoi dati - [Evoluzione delle vendite - PIEX](https://success.openhealth.fr/it/articles/4210655-evoluzione-delle-vendite-piex.md): Visualizza l'evoluzione della tua attività sulla cronologia disponibile - [Analisi delle vendite - PIEX](https://success.openhealth.fr/it/articles/4210650-analisi-delle-vendite-piex.md): Analisi delle vendite - PIEX - [Dettagli ordine - PIEX](https://success.openhealth.fr/it/articles/4210659-dettagli-ordine-piex.md): Visualizza e traccia un ordine di vendita - [Panoramica delle scorte - PIEX](https://success.openhealth.fr/it/articles/4210672-panoramica-delle-scorte-piex.md): Visualizza le variazioni delle tue azioni - [Archivio dati personali - PIEX](https://success.openhealth.fr/it/articles/4210694-archivio-dati-personali-piex.md): Esporta un database semplice in Excel - [EURAPHARMA- PIEX](https://success.openhealth.fr/it/articles/4366306-eurapharma-piex.md): Visualizza l'evoluzione dell'attività di EURAPHARMA - [Prodotto abbinato](https://success.openhealth.fr/it/articles/4366320-prodotto-abbinato.md): Corrispondenza tra le denominazioni dei prodotti PIEX ed EURAPHARMA - [File CLI \(1/5\)](https://success.openhealth.fr/it/articles/4626422-file-cli-1-5.md): File CLI \(1/5\) - [CLI\_File Counts \(2/5\)](https://success.openhealth.fr/it/articles/4626421-cli_file-counts-2-5.md): CLI\_File Counts \(2/5\) - [CLI\_File Code Matching con il repository OHC](https://success.openhealth.fr/it/articles/4626419-cli_file-code-matching-con-il-repository-ohc.md): Codice CLI\_FIL che corrisponde al repository OHC - [Esportazione sell-out \(4/5\)](https://success.openhealth.fr/it/articles/4626414-esportazione-sell-out-4-5.md): Esportazione sell-out \(4/5\) ### OPZIONI PERSONALIZZATE - [Campi di qualificazione del prodotto non gerarchici](https://success.openhealth.fr/it/articles/4036045-campi-di-qualificazione-del-prodotto-non-gerarchici.md): Aggiungi dettagli sulla qualificazione dei tuoi prodotti - [Qual è l'età massima dei dati HUB?](https://success.openhealth.fr/it/articles/3195251-qual-e-l-eta-massima-dei-dati-hub.md): Ultimi dati disponibili - [tipo di cliente](https://success.openhealth.fr/it/articles/4197147-tipo-di-cliente.md): Opzione personalizzata Tipo di cliente - [Accesso alla sessione](https://success.openhealth.fr/it/articles/4036458-accesso-alla-sessione.md): Limita la visualizzazione dei tuoi dipendenti - [Ciclo personalizzato](https://success.openhealth.fr/it/articles/4036444-ciclo-personalizzato.md): Analizza i tuoi dati su periodi di tempo personalizzati - [Anno fiscale](https://success.openhealth.fr/it/articles/4036169-anno-fiscale.md): Definisci il tuo anno fiscale - [Pulsante Giorno](https://success.openhealth.fr/it/articles/4036159-pulsante-giorno.md): Visualizza i tuoi dati con una granularità più fine - [Pulsante settimana](https://success.openhealth.fr/it/articles/4036111-pulsante-settimana.md): Visualizza i tuoi dati con una granularità più fine - [Tassi di cambio](https://success.openhealth.fr/it/articles/8329594-tassi-di-cambio.md) - [Calendario del periodo SMKT](https://success.openhealth.fr/it/articles/4036549-calendario-del-periodo-smkt.md): Utilizza un calendario GSA - [Limita il perimetro](https://success.openhealth.fr/it/articles/4560699-limita-il-perimetro.md): Selezione di un elenco GTIN in La mia query da un file .xlsx - [Limita perimetro \(codice 7\)](https://success.openhealth.fr/it/articles/4560791-limita-perimetro-codice-7.md): Selezione di un elenco di \[CODICE TECNICO 2\] in La mia query da un file .xlsx - [Flagg di mercato](https://success.openhealth.fr/it/articles/4560797-flagg-di-mercato.md): Selezione di un elenco GTIN in My Query da una definizione di mercato contenuta in un file .xlsx - [Targeting / definizione di un tipo di cliente](https://success.openhealth.fr/it/articles/3777788-targeting-definizione-di-un-tipo-di-cliente.md): Targeting \(tipo di cliente\) ### INDICATORI HUB - [Glossario degli indicatori HUB](https://success.openhealth.fr/it/articles/5194247-glossario-degli-indicatori-hub.md) - [Quantità di vendita](https://success.openhealth.fr/it/articles/3194314-quantita-di-vendita.md): Quantità di vendita - [Valori di vendita](https://success.openhealth.fr/it/articles/3074854-valori-di-vendita.md): Specifiche dell'indicatore Valori di vendita - [N MS](https://success.openhealth.fr/it/articles/3194475-n-ms.md): Definizione della misura "N MS" - [N MS Evol](https://success.openhealth.fr/it/articles/5634266-n-ms-evol.md) - [N MS Delta](https://success.openhealth.fr/it/articles/3194469-n-ms-delta.md): Definizione della misura "N MS Delta" - [Poids Vol \(CA\) par modalité / Peso personalizzato Vol \(To\)](https://success.openhealth.fr/it/articles/9292839-poids-vol-ca-par-modalite-peso-personalizzato-vol-to.md) - [Valore delle vendite basato sul prezzo al produttore, IVA esclusa \(Fatturato PF IVA esclusa\) - Marocco](https://success.openhealth.fr/it/articles/7508513-valore-delle-vendite-basato-sul-prezzo-al-produttore-iva-esclusa-fatturato-pf-iva-esclusa-marocco.md) - [N crescita CTR](https://success.openhealth.fr/it/articles/3194466-n-crescita-ctr.md): Definizione e formula di calcolo della misura "N Growth CTR" - [In accordo](https://success.openhealth.fr/it/articles/6201859-in-accordo.md) - [Peso incrociato Volume](https://success.openhealth.fr/it/articles/6066324-peso-incrociato-volume.md) - [Turnover del peso incrociato](https://success.openhealth.fr/it/articles/6066273-turnover-del-peso-incrociato.md) - [N CTR crescita corretto](https://success.openhealth.fr/it/articles/3205376-n-ctr-crescita-corretto.md): Definizione e formula di calcolo della misura 'N Growth CTR A' - [Peso sorgente](https://success.openhealth.fr/it/articles/5151525-peso-sorgente.md) - [Prezzo medio osservato](https://success.openhealth.fr/it/articles/3194302-prezzo-medio-osservato.md): AASP: prezzo medio osservato - [Prezzo medio ponderato](https://success.openhealth.fr/it/articles/3194292-prezzo-medio-ponderato.md): WASP: prezzo medio ponderato - [Effetto prezzo](https://success.openhealth.fr/it/articles/8426443-effetto-prezzo.md) - [Numero di farmacie che vendono](https://success.openhealth.fr/it/articles/3719566-numero-di-farmacie-che-vendono.md) - [Vendere la distribuzione digitale](https://success.openhealth.fr/it/articles/3194321-vendere-la-distribuzione-digitale.md): Distribuzione numerica - [Vendita globale di distribuzione digitale](https://success.openhealth.fr/it/articles/3194320-vendita-globale-di-distribuzione-digitale.md): Distribuzione numerica globale - [Distribuzione digitale di vendita ribasata](https://success.openhealth.fr/it/articles/4045636-distribuzione-digitale-di-vendita-ribasata.md): Distribuzione numerica ribasata - [Distribuzione digitale di vendita globale ribasata](https://success.openhealth.fr/it/articles/4045725-distribuzione-digitale-di-vendita-globale-ribasata.md): Distribuzione numerica globale ribasata - [Distribuzione digitale rebased personalizzata](https://success.openhealth.fr/it/articles/6830813-distribuzione-digitale-rebased-personalizzata.md) - [Vendita di distribuzione del valore](https://success.openhealth.fr/it/articles/3194323-vendita-di-distribuzione-del-valore.md): Distribuzione ponderata - [Distribuzione del valore di vendita globale](https://success.openhealth.fr/it/articles/3194316-distribuzione-del-valore-di-vendita-globale.md): Distribuzione del valore di vendita globale - [Ridurre la distribuzione del valore di vendita](https://success.openhealth.fr/it/articles/3194501-ridurre-la-distribuzione-del-valore-di-vendita.md): DVV ribasato - [Distribuzione globale del valore di vendita ribasata](https://success.openhealth.fr/it/articles/4200619-distribuzione-globale-del-valore-di-vendita-ribasata.md): DVV ribasato globale - [Distribuzione personalizzata del valore delle vendite in base al metodo rebased](https://success.openhealth.fr/it/articles/6834423-distribuzione-personalizzata-del-valore-delle-vendite-in-base-al-metodo-rebased.md) - [Distribuzione di vendita digitale SMKT](https://success.openhealth.fr/it/articles/3365043-distribuzione-di-vendita-digitale-smkt.md): Distribuzione di vendita digitale SMKT \(distribuzione numerica SMK\) - [Global SMKT che vende distribuzione digitale](https://success.openhealth.fr/it/articles/4298341-global-smkt-che-vende-distribuzione-digitale.md): SMKT Global Numeric Distribution \(SMKT Global Numeric Distribution\) - [SMKT ribasato che vende distribuzione digitale](https://success.openhealth.fr/it/articles/4298197-smkt-ribasato-che-vende-distribuzione-digitale.md): Distribuzione digitale SMKT ribasata \(distribuzione numerica SMKT ribasata\) - [SMKT ribasato globale che vende distribuzione digitale](https://success.openhealth.fr/it/articles/4319783-smkt-ribasato-globale-che-vende-distribuzione-digitale.md): Vendita della distribuzione digitale SMKT Rebasée Globale \(SMKT Global Numeric Distribution Rebased\) - [Distribuzione del valore di vendita SMKT](https://success.openhealth.fr/it/articles/3365478-distribuzione-del-valore-di-vendita-smkt.md): Distribuzione del valore di vendita SMKT \(distribuzione ponderata SMKT\) - [Distribuzione digitale di vendita SMKT globale ricalcolata](https://success.openhealth.fr/it/articles/4298373-distribuzione-digitale-di-vendita-smkt-globale-ricalcolata.md): Vendita della distribuzione digitale SMKT Global Numeric Ricalcolata \(SMKT Global Numeric Distribution ricalcolata\) - [Vendita di distribuzione digitale SMKT ribasato ricalcolato](https://success.openhealth.fr/it/articles/4298303-vendita-di-distribuzione-digitale-smkt-ribasato-ricalcolato.md): Distribuzione numerica SMKT ribasata ricalcolata - [SMKT rettificato che vende distribuzione digitale](https://success.openhealth.fr/it/articles/3369386-smkt-rettificato-che-vende-distribuzione-digitale.md): Distribuzione numerica rettificata SMKT - [Vendita di distribuzione digitale SMKT ricalcolata](https://success.openhealth.fr/it/articles/4298209-vendita-di-distribuzione-digitale-smkt-ricalcolata.md): Distribuzione numerica SMKT ricalcolata \(distribuzione numerica SMKT ricalcolata\) - [Distribuzione del valore di vendita SMKT rettificata](https://success.openhealth.fr/it/articles/3369397-distribuzione-del-valore-di-vendita-smkt-rettificata.md): Distribuzione ponderata rettificata SMKT - [Distribuzione organica delle vendite digitali](https://success.openhealth.fr/it/articles/7052424-distribuzione-organica-delle-vendite-digitali.md) - [Fatturato delle farmacie venditrici \(TSP\)](https://success.openhealth.fr/it/articles/6096534-fatturato-delle-farmacie-venditrici-tsp.md) - [Stima del tuo titolare PDM](https://success.openhealth.fr/it/articles/4214883-stima-del-tuo-titolare-pdm.md): Stima la tua quota di mercato con i tuoi clienti - [Più farmacie](https://success.openhealth.fr/it/articles/8426451-piu-farmacie.md) - [Perdita di farmacie](https://success.openhealth.fr/it/articles/8426460-perdita-di-farmacie.md) - [Vendite e distribuzione digitale multicanale](https://success.openhealth.fr/it/articles/9293487-vendite-e-distribuzione-digitale-multicanale.md) - [Vendita cumulativa Distribuzione digitale \(PHARMA\)](https://success.openhealth.fr/it/articles/9330571-vendita-cumulativa-distribuzione-digitale-pharma.md) - [Vendite medie mensili](https://success.openhealth.fr/it/articles/3194303-vendite-medie-mensili.md): Vendite mensili medie - [Vendite medie mensili rettificate](https://success.openhealth.fr/it/articles/3194290-vendite-medie-mensili-rettificate.md): Vendite mensili medie rettificate - [Valore delle vendite medie mensili](https://success.openhealth.fr/it/articles/4535404-valore-delle-vendite-medie-mensili.md): VMM CA - [AMS A: Valore medio mensile delle vendite rettificato](https://success.openhealth.fr/it/articles/6028256-ams-a-valore-medio-mensile-delle-vendite-rettificato.md) - [Vendite medie](https://success.openhealth.fr/it/articles/3563716-vendite-medie.md): Vendite medie - [Vendite medie SMKT](https://success.openhealth.fr/it/articles/3365496-vendite-medie-smkt.md): Vendite medie SMKT - [Vendite medie SMKT rettificate](https://success.openhealth.fr/it/articles/3369340-vendite-medie-smkt-rettificate.md): Vendite medie SMKT rettificate - [Vendite organiche medie mensili](https://success.openhealth.fr/it/articles/7052551-vendite-organiche-medie-mensili.md) - [Vendite medie mensili Valore organico](https://success.openhealth.fr/it/articles/7052573-vendite-medie-mensili-valore-organico.md) - [Azione](https://success.openhealth.fr/it/articles/3194332-azione.md): Definizione e disponibilità dei dati di inventario nell'HUB, tramite applicazioni SMAa: abbonamento Sales & Marketing Advanced - [Stock medio](https://success.openhealth.fr/it/articles/3194336-stock-medio.md): Stock medio - [Quota di azioni](https://success.openhealth.fr/it/articles/3194334-quota-di-azioni.md): Quota di azioni - [Indice di pressione commerciale](https://success.openhealth.fr/it/articles/3194335-indice-di-pressione-commerciale.md): Indice di pressione commerciale - [Tasso di trasformazione dei titoli](https://success.openhealth.fr/it/articles/3194344-tasso-di-trasformazione-dei-titoli.md): Tasso di trasformazione delle scorte - [Durata della fornitura](https://success.openhealth.fr/it/articles/3194337-durata-della-fornitura.md): Durata della fornitura - [Numero di farmacie stockist](https://success.openhealth.fr/it/articles/3194338-numero-di-farmacie-stockist.md): Numero di farmacie al dettaglio - [Stockist Digital Distribution](https://success.openhealth.fr/it/articles/3194339-stockist-digital-distribution.md): Distribuzione presso grossisti \(Stock ND\) - [Rivenditore della distribuzione digitale ribasato](https://success.openhealth.fr/it/articles/4045743-rivenditore-della-distribuzione-digitale-ribasato.md): Distribuzione numerica delle scorte ribasata - [Distribuzione globale di grossisti digitali ribasati](https://success.openhealth.fr/it/articles/4045753-distribuzione-globale-di-grossisti-digitali-ribasati.md): Distribuzione globale di grossisti digitali ribasata - [Distribuzione del valore dei grossisti](https://success.openhealth.fr/it/articles/3194342-distribuzione-del-valore-dei-grossisti.md): Distribuzione del valore dei grossisti \(distribuzione ponderata delle azioni: azioni WD\) - [Ridurre la distribuzione del valore dell'inventario](https://success.openhealth.fr/it/articles/3194505-ridurre-la-distribuzione-del-valore-dell-inventario.md): Rebase DVS - [Distribuzione digitale Stockista liscio](https://success.openhealth.fr/it/articles/5141830-distribuzione-digitale-stockista-liscio.md) - [Distribuzione digitale Stockista lisciato ribasato](https://success.openhealth.fr/it/articles/5142162-distribuzione-digitale-stockista-lisciato-ribasato.md) - [Distribuzione Valore azionario lisciato](https://success.openhealth.fr/it/articles/5203640-distribuzione-valore-azionario-lisciato.md) - [Distribuzione Valore azionario rideterminato lisciato](https://success.openhealth.fr/it/articles/5203701-distribuzione-valore-azionario-rideterminato-lisciato.md) - [Margine](https://success.openhealth.fr/it/articles/3507716-margine.md): Margine - [Tasso di margine](https://success.openhealth.fr/it/articles/3507767-tasso-di-margine.md): Tasso di margine - [Prezzo del produttore IVA esclusa \(PFHT\)](https://success.openhealth.fr/it/articles/4557500-prezzo-del-produttore-iva-esclusa-pfht.md): PFHT - [Sell-in - Analisi della tua base di clienti](https://success.openhealth.fr/it/articles/3846225-sell-in-analisi-della-tua-base-di-clienti.md): Indicatori di fedeltà: caratteristiche della tua base clienti e sua evoluzione - [Sell-in - Farmacie atipiche](https://success.openhealth.fr/it/articles/3848791-sell-in-farmacie-atipiche.md): Misure per rilevare gli atipismi - [Rapporto di evoluzione](https://success.openhealth.fr/it/articles/3194287-rapporto-di-evoluzione.md): Rapporto di evoluzione - [Rapporto di penetrazione](https://success.openhealth.fr/it/articles/3194286-rapporto-di-penetrazione.md): Rapporto di penetrazione - [Larghezza dell'assortimento di prodotti](https://success.openhealth.fr/it/articles/3369425-larghezza-dell-assortimento-di-prodotti.md): Larghezza dell'assortimento di prodotti - [Rinnovo dell'assortimento](https://success.openhealth.fr/it/articles/3369545-rinnovo-dell-assortimento.md): Rinnovo dell'assortimento - [Innovazione nell'assortimento](https://success.openhealth.fr/it/articles/3369468-innovazione-nell-assortimento.md): Innovazione nell'assortimento - [Logoramento dell'assortimento](https://success.openhealth.fr/it/articles/3369457-logoramento-dell-assortimento.md): Logoramento dell'assortimento - [Tasso di abbandono dell'assortimento](https://success.openhealth.fr/it/articles/3369485-tasso-di-abbandono-dell-assortimento.md): Tasso di abbandono dell'assortimento - [Tasso di innovazione della gamma](https://success.openhealth.fr/it/articles/3369541-tasso-di-innovazione-della-gamma.md): Tasso di innovazione della gamma - [Quota dell'offerta di vendita](https://success.openhealth.fr/it/articles/3369040-quota-dell-offerta-di-vendita.md): Quota dell'offerta di vendita - [Numero di prodotti selezionati](https://success.openhealth.fr/it/articles/3511502-numero-di-prodotti-selezionati.md): Questo è il numero di prodotti selezionati dal loro codice GTIN-13 cifre. - [Numero medio di prodotti](https://success.openhealth.fr/it/articles/3194284-numero-medio-di-prodotti.md): Numero medio di prodotti - [Tasso di rinnovo della gamma](https://success.openhealth.fr/it/articles/3369561-tasso-di-rinnovo-della-gamma.md): Tasso di rinnovo della gamma - [Numero di prodotti](https://success.openhealth.fr/it/articles/6312686-numero-di-prodotti.md) - [Importi spesi per atto](https://success.openhealth.fr/it/articles/3447792-importi-spesi-per-atto.md): Articolo relativo all'indicatore "Importi spesi per atto" - [Ripartizione degli importi spesi per tipologia di acquirente](https://success.openhealth.fr/it/articles/3447801-ripartizione-degli-importi-spesi-per-tipologia-di-acquirente.md): Articolo relativo all'indicatore "Ripartizione delle somme spese per tipologia di acquirente" - [Indice di consumo](https://success.openhealth.fr/it/articles/3432701-indice-di-consumo.md): Definizione dell'indicatore "Indice di consumo" - [Quota di vendita](https://success.openhealth.fr/it/articles/3432664-quota-di-vendita.md): Definizione dell'indicatore "Quota di vendita" - [Valore tasso di fedeltà](https://success.openhealth.fr/it/articles/3432695-valore-tasso-di-fedelta.md): Definizione dell'indicatore 'Tasso di fedeltà al valore' - [Penetrazione assoluta](https://success.openhealth.fr/it/articles/3432556-penetrazione-assoluta.md): Articolo relativo all'indicatore "Penetrazione assoluta" - [Quota di fatturato](https://success.openhealth.fr/it/articles/3432655-quota-di-fatturato.md): Definizione dell'indicatore "Quota di fatturato" - [p-value](https://success.openhealth.fr/it/articles/5781702-p-value.md) - [Analisi del componente principale](https://success.openhealth.fr/it/articles/4231028-analisi-del-componente-principale.md): ACP - [Valore predittivo negativo](https://success.openhealth.fr/it/articles/4134220-valore-predittivo-negativo.md): Valore predittivo negativo - [Valore predittivo positivo](https://success.openhealth.fr/it/articles/4134166-valore-predittivo-positivo.md): Valore predittivo positivo - [Test di indipendenza](https://success.openhealth.fr/it/articles/4128369-test-di-indipendenza.md): Controlla se due variabili sono correlate l'una all'altra - [Studio delle serie storiche](https://success.openhealth.fr/it/articles/3633991-studio-delle-serie-storiche.md): Stagionalità, trend e previsione: cosa devi sapere - [Tasso di varianza stagionale](https://success.openhealth.fr/it/articles/3653790-tasso-di-varianza-stagionale.md): Misura la quota di varianza in una serie temporale - [Sensibilità e specificità di un test](https://success.openhealth.fr/it/articles/3928135-sensibilita-e-specificita-di-un-test.md): Comprendere i concetti per analizzare l'efficacia di un test - [Tasso di variazione del trend](https://success.openhealth.fr/it/articles/3653847-tasso-di-variazione-del-trend.md): Misura la quota della componente trend in una serie temporale - [Tasso di varianza residuo](https://success.openhealth.fr/it/articles/3653851-tasso-di-varianza-residuo.md): Misura la quota della componente residua di una serie storica - [Coefficiente di determinazione](https://success.openhealth.fr/it/articles/3654093-coefficiente-di-determinazione.md): Valuta la qualità del modello scelto - [Coefficiente di variazione](https://success.openhealth.fr/it/articles/3653915-coefficiente-di-variazione.md): Indicatore per scegliere il modello di decomposizione - [Varianza di una serie temporale](https://success.openhealth.fr/it/articles/3653855-varianza-di-una-serie-temporale.md): Misura la dispersione di una serie - [Concentrazione delle vendite](https://success.openhealth.fr/it/articles/3395856-concentrazione-delle-vendite.md): Concentrazione delle vendite - [Indice Gini](https://success.openhealth.fr/it/articles/3395323-indice-gini.md): Indice Gini - [Popolazione](https://success.openhealth.fr/it/articles/4396779-popolazione.md): Popolazione - [Evoluzione del numero di morti](https://success.openhealth.fr/it/articles/4396765-evoluzione-del-numero-di-morti.md): Evoluzione del numero di morti - [Rapporto tra i sessi](https://success.openhealth.fr/it/articles/3812167-rapporto-tra-i-sessi.md): Rapporto tra i sessi - [Popolazione - Età media](https://success.openhealth.fr/it/articles/3812180-popolazione-eta-media.md): Popolazione - Età media - [Popolazione - Età media](https://success.openhealth.fr/it/articles/3812198-popolazione-eta-media.md): Popolazione - Età media - [Popolazione - Età 1 ° quartile](https://success.openhealth.fr/it/articles/3812218-popolazione-eta-1-quartile.md): Popolazione - Età 1 ° quartile - [Popolazione - Età 3 ° quartile](https://success.openhealth.fr/it/articles/3812227-popolazione-eta-3-quartile.md): Popolazione - Età 3 ° quartile - [Quota di selezione sulla popolazione totale del territorio](https://success.openhealth.fr/it/articles/3812233-quota-di-selezione-sulla-popolazione-totale-del-territorio.md): Quota di selezione sulla popolazione totale del territorio - [Tasso di mortalità](https://success.openhealth.fr/it/articles/3947946-tasso-di-mortalita.md): Tasso di mortalità - [Tasso di mortalità del caso](https://success.openhealth.fr/it/articles/3948084-tasso-di-mortalita-del-caso.md): Tasso di mortalità del caso - [Donne in età fertile](https://success.openhealth.fr/it/articles/4172859-donne-in-eta-fertile.md): Donne in età fertile - [Quota di selezione sul totale dei decessi nel territorio](https://success.openhealth.fr/it/articles/3863734-quota-di-selezione-sul-totale-dei-decessi-nel-territorio.md): Quota di selezione sul totale dei decessi nel territorio - [Modellazione del numero di morti scomparse](https://success.openhealth.fr/it/articles/3895572-modellazione-del-numero-di-morti-scomparse.md): Anticipare il numero di morti al tempo t - [Vendite stimate per l'iniziazione alla prescrizione](https://success.openhealth.fr/it/articles/5323282-vendite-stimate-per-l-iniziazione-alla-prescrizione.md) - [Evoluzione per età e stato di gravidanza](https://success.openhealth.fr/it/articles/6820051-evoluzione-per-eta-e-stato-di-gravidanza.md) - [Rapporto prodotti di co-distribuzione](https://success.openhealth.fr/it/articles/7892010-rapporto-prodotti-di-co-distribuzione.md) - [Stima delle vendite di ricariche di ricette mediche](https://success.openhealth.fr/it/articles/5323209-stima-delle-vendite-di-ricariche-di-ricette-mediche.md) - [Peso delle vendite di ricariche di ricette mediche](https://success.openhealth.fr/it/articles/5323198-peso-delle-vendite-di-ricariche-di-ricette-mediche.md) - [Peso delle vendite nell'iniziazione alla prescrizione](https://success.openhealth.fr/it/articles/5323086-peso-delle-vendite-nell-iniziazione-alla-prescrizione.md) - [Numero di dispensazioni congiunte](https://success.openhealth.fr/it/articles/3194351-numero-di-dispensazioni-congiunte.md): Numero di dispensazioni congiunte - [Numero di dispensazioni](https://success.openhealth.fr/it/articles/3194348-numero-di-dispensazioni.md): Numero di dispensazioni - [Numero medio di dispense per assicurato](https://success.openhealth.fr/it/articles/3369626-numero-medio-di-dispense-per-assicurato.md): Numero medio di dispense per assicurato - [Osservanza](https://success.openhealth.fr/it/articles/3411996-osservanza.md): Tasso di possesso di farmaci \(MPR\) - [Tasso di persistenza](https://success.openhealth.fr/it/articles/3369684-tasso-di-persistenza.md): Tasso di persistenza - [Aderenza terapeutica](https://success.openhealth.fr/it/articles/3412091-aderenza-terapeutica.md): Aderenza terapeutica - [Dosaggio giornaliero medio per persona assicurata](https://success.openhealth.fr/it/articles/4153587-dosaggio-giornaliero-medio-per-persona-assicurata.md): Dosaggio giornaliero medio per persona assicurata - [Numero di dispense presentate per il rimborso](https://success.openhealth.fr/it/articles/3370942-numero-di-dispense-presentate-per-il-rimborso.md): Numero di dispense presentate per il rimborso - [Numero di dispense non presentate per il rimborso](https://success.openhealth.fr/it/articles/3370920-numero-di-dispense-non-presentate-per-il-rimborso.md): Numero di dispense presentate per il rimborso - [Valore di rimborso delle vendite coperte da assicurazione sanitaria obbligatoria](https://success.openhealth.fr/it/articles/3371699-valore-di-rimborso-delle-vendite-coperte-da-assicurazione-sanitaria-obbligatoria.md): Vendite di valori riscattati - [Vendita di valori rimborsati coperti da assicurazione sanitaria complementare](https://success.openhealth.fr/it/articles/3371830-vendita-di-valori-rimborsati-coperti-da-assicurazione-sanitaria-complementare.md): Vendite di valori riscattati - [Vendite di valori eccezionali](https://success.openhealth.fr/it/articles/3371842-vendite-di-valori-eccezionali.md): Vendite di valori eccezionali - [Prevalenza](https://success.openhealth.fr/it/articles/3947955-prevalenza.md): Tasso di prevalenza - [Numero medio di GTIN per dispensazione](https://success.openhealth.fr/it/articles/3396154-numero-medio-di-gtin-per-dispensazione.md): Numero medio di GTIN per dispensazione - [Volume medio per erogazione](https://success.openhealth.fr/it/articles/3396196-volume-medio-per-erogazione.md): Volume medio per erogazione - [Fatturato medio per dispensazione](https://success.openhealth.fr/it/articles/3396208-fatturato-medio-per-dispensazione.md): Fatturato medio per dispensazione - [Dosaggio di principio attivo per scatola](https://success.openhealth.fr/it/articles/3675409-dosaggio-di-principio-attivo-per-scatola.md): Dosaggio di principio attivo per scatola - [DDD per scatola](https://success.openhealth.fr/it/articles/3675446-ddd-per-scatola.md): Definisci la dose giornaliera per scatola - [Volume in unità base](https://success.openhealth.fr/it/articles/3675520-volume-in-unita-base.md): Volume in unità base - [Volume in principio attivo](https://success.openhealth.fr/it/articles/3675539-volume-in-principio-attivo.md): Volume in principio attivo - [DDJ per 1.000 abitanti](https://success.openhealth.fr/it/articles/3675667-ddj-per-1-000-abitanti.md): Dose definita giornaliera per 1.000 abitanti - [Volume in UA medio per persona assicurata](https://success.openhealth.fr/it/articles/3675761-volume-in-ua-medio-per-persona-assicurata.md): Volume in unità di consumo medio per persona assicurata - [Volume in UB medio per persona assicurata](https://success.openhealth.fr/it/articles/3675814-volume-in-ub-medio-per-persona-assicurata.md): Volume in unità di base medie per persona assicurata - [Volume in principio attivo medio per persona assicurata](https://success.openhealth.fr/it/articles/3675824-volume-in-principio-attivo-medio-per-persona-assicurata.md): Volume in principio attivo medio per persona assicurata - [Durata media osservata del trattamento](https://success.openhealth.fr/it/articles/3675841-durata-media-osservata-del-trattamento.md): Durata media osservata del trattamento - [Copertura vaccinale](https://success.openhealth.fr/it/articles/3822264-copertura-vaccinale.md): Copertura vaccinale - [Pazienti inclusi](https://success.openhealth.fr/it/articles/3886665-pazienti-inclusi.md): Numero di pazienti inclusi nella coorte - [Differenze tra MPR e PDC](https://success.openhealth.fr/it/articles/3722666-differenze-tra-mpr-e-pdc.md): MPR \(tasso di possesso di farmaci\) vs. PDC \(proporzione di giorni coperti\) - [Durata media del trattamento](https://success.openhealth.fr/it/articles/3920967-durata-media-del-trattamento.md): Misurare il tempo medio di trattamento alla fine del periodo di analisi - [Tempo medio di rinnovo](https://success.openhealth.fr/it/articles/3921067-tempo-medio-di-rinnovo.md): Misura il tempo medio tra i rinnovi del trattamento - [Inizio del trattamento](https://success.openhealth.fr/it/articles/3848844-inizio-del-trattamento.md): Inizio del trattamento - [Rinnovi del trattamento](https://success.openhealth.fr/it/articles/3885469-rinnovi-del-trattamento.md): Rinnovo del trattamento - [Il trattamento riprende](https://success.openhealth.fr/it/articles/3885608-il-trattamento-riprende.md): Il trattamento riprende - [Nuovi trattamenti](https://success.openhealth.fr/it/articles/3885297-nuovi-trattamenti.md): Inizio e ripresa del trattamento - [Interruttore di trattamento](https://success.openhealth.fr/it/articles/3848886-interruttore-di-trattamento.md): Interruttore di trattamento - [Il trattamento si interrompe](https://success.openhealth.fr/it/articles/3885426-il-trattamento-si-interrompe.md): Il trattamento si interrompe - [Drop-off](https://success.openhealth.fr/it/articles/3885387-drop-off.md): Drop-off - [Inserto di tracciabilità](https://success.openhealth.fr/it/articles/4355163-inserto-di-tracciabilita.md): Tracciabilità - [Arresto e riavvio](https://success.openhealth.fr/it/articles/8429189-arresto-e-riavvio.md) - [Quota erogazione](https://success.openhealth.fr/it/articles/3624820-quota-erogazione.md): Quota erogazione - [Monitoraggio delle dispense rilevanti](https://success.openhealth.fr/it/articles/3804193-monitoraggio-delle-dispense-rilevanti.md): Segui l'evoluzione del traffico nelle farmacie delle relative dispense - [Tasso di disintegrazione](https://success.openhealth.fr/it/articles/4850138-tasso-di-disintegrazione.md): Stimare la quantità rimanente di un elemento - [Cinetica della reazione](https://success.openhealth.fr/it/articles/4850629-cinetica-della-reazione.md): Misurare la velocità di una reazione chimica - [Tempo di emivita](https://success.openhealth.fr/it/articles/4849710-tempo-di-emivita.md): Metrica della durata di vita di un elemento - [Tasso di copertura delle scorte](https://success.openhealth.fr/it/articles/4210714-tasso-di-copertura-delle-scorte.md): Tasso di copertura delle scorte - [Periodi di tempo](https://success.openhealth.fr/it/articles/3194479-periodi-di-tempo.md): Periodi di tempo - [Modificare la definizione di anno fiscale](https://success.openhealth.fr/it/articles/3321750-modificare-la-definizione-di-anno-fiscale.md): L'HUB ti consente di impostare i tuoi anni fiscali - [Gestione dei confronti settimanali](https://success.openhealth.fr/it/articles/3835180-gestione-dei-confronti-settimanali.md): Impatti analitici delle giornate studiate - [Calendario della parafarmacia di GSA \(SMKT\)](https://success.openhealth.fr/it/articles/3175583-calendario-della-parafarmacia-di-gsa-smkt.md): Il calendario SMKT \(IRI\) è anche chiamato calendario delle farmacie GSA - [NON](https://success.openhealth.fr/it/articles/3194484-non.md): Definizione di misura 'N' - [N Evol](https://success.openhealth.fr/it/articles/3194461-n-evol.md): Definizione e formula di calcolo della misura "N Evol" - [N Trend](https://success.openhealth.fr/it/articles/3194485-n-trend.md): Definizione della misura "Trend N" ### IAS - Indicateurs Avancés Sanitaires - [IAS\(r\) Allergia](https://success.openhealth.fr/it/articles/7339151-ias-r-allergia.md) - [IAS\(r\) Poux](https://success.openhealth.fr/it/articles/7339168-ias-r-poux.md) - [Gastroenterite IAS\(r\)](https://success.openhealth.fr/it/articles/7339181-gastroenterite-ias-r.md) - [Sindromi respiratorie IAS \(r\)](https://success.openhealth.fr/it/articles/3815345-sindromi-respiratorie-ias-r.md): Introduzione relativa alle sindromi respiratorie IAS \(r\) - [IAS\(r\) Malattia simil-influenzale](https://success.openhealth.fr/it/articles/7266711-ias-r-malattia-simil-influenzale.md) ### Marketing Direct - [Soluzione di invio e-mail OpenHealth](https://success.openhealth.fr/it/articles/7055261-soluzione-di-invio-e-mail-openhealth.md) - [Requisiti per la produzione di una campagna e-mail](https://success.openhealth.fr/it/articles/6282113-requisiti-per-la-produzione-di-una-campagna-e-mail.md) - [Rapporto di monitoraggio e parametri di riferimento](https://success.openhealth.fr/it/articles/6302721-rapporto-di-monitoraggio-e-parametri-di-riferimento.md) - [Glossario per le campagne e-mail](https://success.openhealth.fr/it/articles/6282099-glossario-per-le-campagne-e-mail.md) ### PSAD - [Analisi - NAZIONALE](https://success.openhealth.fr/it/articles/3376262-analisi-nazionale.md): Analizza l'andamento del mercato Home Health Providers \(PSAD\): per area, attività, sottoattività, segmento, legge LPP - [Volume / Fatturato - NAZIONALE](https://success.openhealth.fr/it/articles/3376287-volume-fatturato-nazionale.md): Visualizza contemporaneamente l'attività in volume e valore: per area, attività, sottoattività, segmento, azione ... - [Evoluzione - NAZIONALE](https://success.openhealth.fr/it/articles/3376370-evoluzione-nazionale.md): Visualizza l'evoluzione del mercato sulla cronologia disponibile: per dominio, attività, sottoattività, segmento, atto LPP - [Estrazione - NAZIONALE](https://success.openhealth.fr/it/articles/3376420-estrazione-nazionale.md): Esporta i dati in Excel - [Definizione](https://success.openhealth.fr/it/articles/3376439-definizione.md): Trova tutte le caratteristiche dell'Osservatorio Nazionale SantéDomStat - Applicazione essenziale ### AUTRES THEMATIQUES - [INTERFONICO](https://success.openhealth.fr/it/articles/6959415-interfonico.md) - [Salesforce](https://success.openhealth.fr/it/articles/6959337-salesforce.md) - [GIHSN: invia file Excel](https://success.openhealth.fr/it/articles/3977478-gihsn-invia-file-excel.md): File Excel GIHSN - [Blockchain](https://success.openhealth.fr/it/articles/5385413-blockchain.md) - [DocuSign, strumento CRM nel nostro processo aziendale](https://success.openhealth.fr/it/articles/4514472-docusign-strumento-crm-nel-nostro-processo-aziendale.md): Docusign: strumento CRM nel nostro processo aziendale - [Monitoraggio nazionale delle vaccinazioni](https://success.openhealth.fr/it/articles/4754333-monitoraggio-nazionale-delle-vaccinazioni.md) - [Copertura vaccinale](https://success.openhealth.fr/it/articles/4754311-copertura-vaccinale.md) - [Monitoraggio KPI](https://success.openhealth.fr/it/articles/4091042-monitoraggio-kpi.md): Sistemi POC ProPharma: tendenze del mercato svizzero - [Cockpit della farmacia](https://success.openhealth.fr/it/articles/4091025-cockpit-della-farmacia.md): Sistemi POC ProPharma: My Pharmacy vs Svizzera - [Popolazione equivalente \(p.e.\)](https://success.openhealth.fr/it/articles/5431894-popolazione-equivalente-p-e.md) - [Domanda di ossigeno](https://success.openhealth.fr/it/articles/5137158-domanda-di-ossigeno.md) - [IHU](https://success.openhealth.fr/it/articles/4851687-ihu.md) - [Materia in sospensione](https://success.openhealth.fr/it/articles/5137147-materia-in-sospensione.md) - [Chimica delle acque reflue](https://success.openhealth.fr/it/articles/5137101-chimica-delle-acque-reflue.md) - [NRBCE](https://success.openhealth.fr/it/articles/4851683-nrbce.md) - [Legge di Arrhenius](https://success.openhealth.fr/it/articles/4849672-legge-di-arrhenius.md) - [Prestazioni risultanti](https://success.openhealth.fr/it/articles/5137034-prestazioni-risultanti.md) - [Tipi di acque reflue](https://success.openhealth.fr/it/articles/5137183-tipi-di-acque-reflue.md) - [Concentrazione del virus SARS-CoV-2](https://success.openhealth.fr/it/articles/4867968-concentrazione-del-virus-sars-cov-2.md) - [MAPOM / BMPM](https://success.openhealth.fr/it/articles/4851685-mapom-bmpm.md) - [Concentrazione contestualizzata di SARS-CoV-2](https://success.openhealth.fr/it/articles/4934604-concentrazione-contestualizzata-di-sars-cov-2.md) - [Tipo di rete fognaria](https://success.openhealth.fr/it/articles/4867954-tipo-di-rete-fognaria.md) - [Degradazione del virus](https://success.openhealth.fr/it/articles/4865742-degradazione-del-virus.md) - [WBE](https://success.openhealth.fr/it/articles/4865735-wbe.md) - [RNA](https://success.openhealth.fr/it/articles/4865733-rna.md) - [Coronavirus](https://success.openhealth.fr/it/articles/4865728-coronavirus.md) - [COVID-19](https://success.openhealth.fr/it/articles/4865726-covid-19.md) - [Sieroprevalenza: metodo di campionamento](https://success.openhealth.fr/it/articles/3924493-sieroprevalenza-metodo-di-campionamento.md): Sieroprevalenza: metodo di campionamento - [Deposito di SANDRE](https://success.openhealth.fr/it/articles/5415040-deposito-di-sandre.md) - [Base nazionale ROSEAU](https://success.openhealth.fr/it/articles/5414523-base-nazionale-roseau.md) - [Concentrazione del virus SARS-CoV2](https://success.openhealth.fr/it/articles/4852404-concentrazione-del-virus-sars-cov2.md): Seguire l'evoluzione della concentrazione del virus SARS-CoV 2 per settore - [Concentrazione del virus SARS-CoV-2 - Varianti](https://success.openhealth.fr/it/articles/4909854-concentrazione-del-virus-sars-cov-2-varianti.md) - [Marsiglia - Monitoraggio globale](https://success.openhealth.fr/it/articles/4859311-marsiglia-monitoraggio-globale.md) - [Concentrazione del virus SARS-CoV2 - Nizza \(FRANCIA\)](https://success.openhealth.fr/it/articles/4879292-concentrazione-del-virus-sars-cov2-nizza-francia.md): Seguire l'evoluzione della concentrazione del virus SARS-CoV 2 per settore - [Popolazione - Struttura](https://success.openhealth.fr/it/articles/4842408-popolazione-struttura.md): Analizzare la struttura della popolazione - [Concentrazione del virus SARS-CoV2 - Tolone \(FRANCIA\)](https://success.openhealth.fr/it/articles/4886417-concentrazione-del-virus-sars-cov2-tolone-francia.md): Seguite l'evoluzione della concentrazione del virus SARS-CoV 2 per settore - [Dubai - Monitoraggio delle acque reflue dell'aeroporto](https://success.openhealth.fr/it/articles/5276423-dubai-monitoraggio-delle-acque-reflue-dell-aeroporto.md): Dubai - Monitoraggio delle acque reflue dell'aeroporto - [Sorveglianza della SARS-CoV-2 - OBEPINA](https://success.openhealth.fr/it/articles/5210661-sorveglianza-della-sars-cov-2-obepina.md) - [Concentrazione contestualizzata di SARS-CoV-2](https://success.openhealth.fr/it/articles/4934608-concentrazione-contestualizzata-di-sars-cov-2.md) - [SUEZ - Bilancio analitico](https://success.openhealth.fr/it/articles/5140509-suez-bilancio-analitico.md) - [Palazzo dei festival - Guarda T0](https://success.openhealth.fr/it/articles/5373515-palazzo-dei-festival-guarda-t0.md) - [Palais des festivals - Veglia quotidiana](https://success.openhealth.fr/it/articles/5373231-palais-des-festivals-veglia-quotidiana.md) - [Palais des festivals - Proiezione](https://success.openhealth.fr/it/articles/5404778-palais-des-festivals-proiezione.md) - [Mustelidi - Guarda](https://success.openhealth.fr/it/articles/5169577-mustelidi-guarda.md) - [Popolazione - IRIS](https://success.openhealth.fr/it/articles/4842191-popolazione-iris.md): Analizzare la distribuzione geografica della popolazione di IRIS - [SARS-CoV-2](https://success.openhealth.fr/it/articles/4865699-sars-cov-2.md) - [IAS - Analisi](https://success.openhealth.fr/it/articles/4842430-ias-analisi.md): Monitoraggio dell'indicatore di salute per le sindromi respiratorie - [Concentrazione del virus SARS-CoV-2 - SEM](https://success.openhealth.fr/it/articles/5415600-concentrazione-del-virus-sars-cov-2-sem.md) - [Visualizzazione della mappa](https://success.openhealth.fr/it/articles/3864657-visualizzazione-della-mappa.md): Ripartizione geografica dei pazienti - [Sito di contributo](https://success.openhealth.fr/it/articles/3864668-sito-di-contributo.md): Contributo per sito e ospedale - [Profilo di coorte per sito](https://success.openhealth.fr/it/articles/3864672-profilo-di-coorte-per-sito.md): Profilo di coorte per sito e ospedale - [Profilo di coorte per stagione](https://success.openhealth.fr/it/articles/3864673-profilo-di-coorte-per-stagione.md): Profilo di coorte per stagione - [Distribuzione per età e sesso](https://success.openhealth.fr/it/articles/3864675-distribuzione-per-eta-e-sesso.md): Demografia - [Distribuzione dei virus per sito](https://success.openhealth.fr/it/articles/3864678-distribuzione-dei-virus-per-sito.md): Distribuzione dei virus per sito - [Distribuzione dei virus per età](https://success.openhealth.fr/it/articles/3864677-distribuzione-dei-virus-per-eta.md): Distribuzione dei virus per età - [Evoluzione della distribuzione dei virus](https://success.openhealth.fr/it/articles/3864681-evoluzione-della-distribuzione-dei-virus.md): Evoluzione della distribuzione dei virus - [Vaccinazione antinfluenzale](https://success.openhealth.fr/it/articles/3864697-vaccinazione-antinfluenzale.md): Vaccinazione antinfluenzale - [Evoluzione della vaccinazione antinfluenzale](https://success.openhealth.fr/it/articles/3864701-evoluzione-della-vaccinazione-antinfluenzale.md): Evoluzione della vaccinazione antinfluenzale - [Distribuzione dei pazienti in base alla condizione cronica](https://success.openhealth.fr/it/articles/3864676-distribuzione-dei-pazienti-in-base-alla-condizione-cronica.md): Distribuzione dei pazienti in base alla condizione cronica - [Distribuzione dei pazienti per durata della degenza ospedaliera](https://success.openhealth.fr/it/articles/3864794-distribuzione-dei-pazienti-per-durata-della-degenza-ospedaliera.md): Distribuzione dei pazienti per durata della degenza ospedaliera - [Fragilità](https://success.openhealth.fr/it/articles/3864704-fragilita.md): Fragilità dei pazienti - [Stato di gravità](https://success.openhealth.fr/it/articles/3864705-stato-di-gravita.md): Stato di gravità - [Mortalità](https://success.openhealth.fr/it/articles/3864710-mortalita.md): Mortalità - [GIHSN](https://success.openhealth.fr/it/articles/3864712-gihsn.md): Rete globale di sorveglianza degli ospedali per l'influenza - [CARéDIAB - Profilo del paziente](https://success.openhealth.fr/it/articles/3789234-carediab-profilo-del-paziente.md): Analizza il profilo del paziente della popolazione CARéDIAB - [CARéDIAB - Complicazioni](https://success.openhealth.fr/it/articles/3789515-carediab-complicazioni.md): Analizza la prevalenza delle complicanze nella nostra popolazione CAREDIAB - [CARéDIAB - Monitoraggio globale dei pazienti](https://success.openhealth.fr/it/articles/3792041-carediab-monitoraggio-globale-dei-pazienti.md): Analizza la frequenza dei follow-up per i pazienti nella popolazione CARéDIAB - [Rete CARéDIAB](https://success.openhealth.fr/it/articles/3789106-rete-carediab.md): La rete CARéDIAB - [CARéDIAB - Trattamenti](https://success.openhealth.fr/it/articles/3792143-carediab-trattamenti.md): Analizza l'assunzione di trattamenti nel contesto del diabete ## 日本語 ### Votre PLATEFORME - présentation générale - [包括的・継続的な支援プラットフォーム「HUB（ハブ）」。](https://success.openhealth.fr/ja/articles/4799621-包括的-継続的な支援プラットフォーム-hub-ハブ.md) - [あなたの経験レベル The HUB](https://success.openhealth.fr/ja/articles/5712270-あなたの経験レベル-the-hub.md) - [Languages](https://success.openhealth.fr/ja/articles/4649389-languages.md): Here is the description of all languages available on Success - [料金に関する質問](https://success.openhealth.fr/ja/articles/3292143-料金に関する質問.md): 私たちの価格 ### ROADMAPについて - [オープンイノベーションでお客様に貢献する](https://success.openhealth.fr/ja/articles/5200970-オープンイノベーションでお客様に貢献する.md) - [アプリ＋管理エリア バージョン240515](https://success.openhealth.fr/ja/articles/9310541-アプリ-管理エリア-バージョン240515.md) - [アプリ＋管理エリア バージョン240415](https://success.openhealth.fr/ja/articles/9310710-アプリ-管理エリア-バージョン240415.md) - [アプリ＋管理エリア バージョン240315](https://success.openhealth.fr/ja/articles/9310790-アプリ-管理エリア-バージョン240315.md) - [アプリ＋管理エリア バージョン240215](https://success.openhealth.fr/ja/articles/9311007-アプリ-管理エリア-バージョン240215.md) - [プラットフォーム - アップデート 231215](https://success.openhealth.fr/ja/articles/8718485-プラットフォーム-アップデート-231215.md) - [プラットフォーム - アップデート 231015](https://success.openhealth.fr/ja/articles/8479932-プラットフォーム-アップデート-231015.md) - [アプリ＋ポータル バージョン230915](https://success.openhealth.fr/ja/articles/8373640-アプリ-ポータル-バージョン230915.md) - [アプリ＋ポータル バージョン230815](https://success.openhealth.fr/ja/articles/8267860-アプリ-ポータル-バージョン230815.md) - [新製品 230715](https://success.openhealth.fr/ja/articles/8115796-新製品-230715.md) - [アプリ＋ポータル バージョン230615](https://success.openhealth.fr/ja/articles/8115791-アプリ-ポータル-バージョン230615.md) - [アプリ＋ポータル バージョン230515](https://success.openhealth.fr/ja/articles/7895393-アプリ-ポータル-バージョン230515.md) - [アプリ＋ポータル バージョン230415](https://success.openhealth.fr/ja/articles/7439447-アプリ-ポータル-バージョン230415.md) - [アプリ＋ポータル バージョン230315](https://success.openhealth.fr/ja/articles/7439646-アプリ-ポータル-バージョン230315.md) - [アプリ＋ポータル バージョン230215](https://success.openhealth.fr/ja/articles/7439744-アプリ-ポータル-バージョン230215.md) - [2023年1月15日より新発売](https://success.openhealth.fr/ja/articles/6895740-2023年1月15日より新発売.md) - [HUB + GATE バージョン221215](https://success.openhealth.fr/ja/articles/6827027-hub-gate-バージョン221215.md) - [HUB + GATE バージョン221115](https://success.openhealth.fr/ja/articles/6742628-hub-gate-バージョン221115.md) - [HUB + GATE バージョン220915](https://success.openhealth.fr/ja/articles/6558070-hub-gate-バージョン220915.md) - [HUB + GATE バージョン220815](https://success.openhealth.fr/ja/articles/6475311-hub-gate-バージョン220815.md) - [HUB + GATE バージョン220615](https://success.openhealth.fr/ja/articles/6306090-hub-gate-バージョン220615.md) - [HUB + GATE バージョン220515](https://success.openhealth.fr/ja/articles/6201877-hub-gate-バージョン220515.md) - [HUB + GATE バージョン220415](https://success.openhealth.fr/ja/articles/6087747-hub-gate-バージョン220415.md) - [HUB SMAバージョン220315](https://success.openhealth.fr/ja/articles/6043772-hub-smaバージョン220315.md) - [HUB TMA バージョン220315](https://success.openhealth.fr/ja/articles/6043802-hub-tma-バージョン220315.md) - [HUB UAN バージョン220315](https://success.openhealth.fr/ja/articles/6043852-hub-uan-バージョン220315.md) - [GATEバージョン220215](https://success.openhealth.fr/ja/articles/5940805-gateバージョン220215.md) - [HUB SMAバージョン220215](https://success.openhealth.fr/ja/articles/5940753-hub-smaバージョン220215.md) - [HUB TMA バージョン220215](https://success.openhealth.fr/ja/articles/5947859-hub-tma-バージョン220215.md) - [GATE バージョン211215](https://success.openhealth.fr/ja/articles/5819397-gate-バージョン211215.md) - [HUB SMAバージョン211215](https://success.openhealth.fr/ja/articles/5784709-hub-smaバージョン211215.md) - [HUB TMAバージョン211215](https://success.openhealth.fr/ja/articles/5784888-hub-tmaバージョン211215.md) - [HUB UAN バージョン211215](https://success.openhealth.fr/ja/articles/5784904-hub-uan-バージョン211215.md) - [アプリケーション The HUB：「薬局のあり方」。](https://success.openhealth.fr/ja/articles/5704485-アプリケーション-the-hub-薬局のあり方.md) - [GATE バージョン 211115](https://success.openhealth.fr/ja/articles/5697844-gate-バージョン-211115.md) - [HUB SMA バージョン 211115](https://success.openhealth.fr/ja/articles/5671893-hub-sma-バージョン-211115.md) - [HUB TMA バージョン 211115](https://success.openhealth.fr/ja/articles/5671917-hub-tma-バージョン-211115.md) - [HUB UAN バージョン 211115](https://success.openhealth.fr/ja/articles/5671927-hub-uan-バージョン-211115.md) - [GATEバージョン211015](https://success.openhealth.fr/ja/articles/5652210-gateバージョン211015.md) - [ハブ SMA バージョン 211015](https://success.openhealth.fr/ja/articles/5649822-ハブ-sma-バージョン-211015.md) - [HUB TMA バージョン 211015](https://success.openhealth.fr/ja/articles/5650073-hub-tma-バージョン-211015.md) - [HUB UAN バージョン 211015](https://success.openhealth.fr/ja/articles/5652242-hub-uan-バージョン-211015.md) - [HUB SMA バージョン 210915](https://success.openhealth.fr/ja/articles/5370516-hub-sma-バージョン-210915.md) - [HUB TMAバージョン210915](https://success.openhealth.fr/ja/articles/5390983-hub-tmaバージョン210915.md) - [HUB UAN バージョン 210915](https://success.openhealth.fr/ja/articles/5543213-hub-uan-バージョン-210915.md) ### Votre ESPACE D'ADMINISTRATION - fonctionnalités - [パスワードのリセット/変更ハブ](https://success.openhealth.fr/ja/articles/4425325-パスワードのリセット-変更ハブ.md): HUBパスワードを変更する方法 - [接続支援：エラーメッセージが表示されるのですが](https://success.openhealth.fr/ja/articles/5369783-接続支援-エラーメッセージが表示されるのですが.md) - [チケットを作成して追跡する](https://success.openhealth.fr/ja/articles/3586214-チケットを作成して追跡する.md): パーソナルスペースでチケットの進化を作成して追跡するためのチュートリアルTheHUB - [SUCCESSの記事を作成・修正する](https://success.openhealth.fr/ja/articles/6738705-successの記事を作成-修正する.md) - [私の契約](https://success.openhealth.fr/ja/articles/5712273-私の契約.md) - [サービスヘルス](https://success.openhealth.fr/ja/articles/4990600-サービスヘルス.md) - [私のアクセス数](https://success.openhealth.fr/ja/articles/5783418-私のアクセス数.md) - [ホームページの設定](https://success.openhealth.fr/ja/articles/5712229-ホームページの設定.md) - [個人のOpenHealthスペースから市場を変更するにはどうすればよいですか？](https://success.openhealth.fr/ja/articles/3585971-個人のopenhealthスペースから市場を変更するにはどうすればよいですか.md): 個人のOpenHealthスペースから製品を統合、変更、および非アクティブ化する - [自動モダリティ割り当て変更（自動MAM）](https://success.openhealth.fr/ja/articles/4164818-自動モダリティ割り当て変更-自動mam.md): 製品の割り当てを直接変更する - [TEMPORAL MAM：ラボ/ブランド/ラベルを変更するブランドをフォローする方法は？](https://success.openhealth.fr/ja/articles/4131072-temporal-mam-ラボ-ブランド-ラベルを変更するブランドをフォローする方法は.md): あなたのタイプの追跡の利点とリスク - [自動製品統合（自動IPR）](https://success.openhealth.fr/ja/articles/4164932-自動製品統合-自動ipr.md): 市場での製品の統合をリクエストする - [自動製品非アクティブ化（自動DPR）](https://success.openhealth.fr/ja/articles/4164866-自動製品非アクティブ化-自動dpr.md): 市場から製品を非アクティブ化する - [製品の自動再活性化（RPRオート）](https://success.openhealth.fr/ja/articles/4818161-製品の自動再活性化-rprオート.md) - [新製品のセットアップ](https://success.openhealth.fr/ja/articles/5811248-新製品のセットアップ.md) - [マーケットを追加する](https://success.openhealth.fr/ja/articles/5712283-マーケットを追加する.md) - [バルク品の輸入・輸出](https://success.openhealth.fr/ja/articles/5712257-バルク品の輸入-輸出.md) - [CMT（Change of Typological Modality）とは？](https://success.openhealth.fr/ja/articles/4670174-cmt-change-of-typological-modality-とは.md) - [さまざまなユーザーステータス](https://success.openhealth.fr/ja/articles/3436418-さまざまなユーザーステータス.md): 機能は何ですか？ - [第三者機関（TPAA）のユーザーのアカウント作成](https://success.openhealth.fr/ja/articles/6466550-第三者機関-tpaa-のユーザーのアカウント作成.md) - [HUBでユーザーアカウントを作成、変更、または削除するにはどうすればよいですか？](https://success.openhealth.fr/ja/articles/3785138-hubでユーザーアカウントを作成-変更-または削除するにはどうすればよいですか.md): これを実行できるのはパワーユーザーのみです - [チーム内のHUBで差別化された表示権を作成できますか？](https://success.openhealth.fr/ja/articles/3321731-チーム内のhubで差別化された表示権を作成できますか.md): ハブでの権利 - [活動記録](https://success.openhealth.fr/ja/articles/4687438-活動記録.md) ### Vos APPLICATIONS - présentation - [HUBトレーニングガイド](https://success.openhealth.fr/ja/articles/5634967-hubトレーニングガイド.md) - [ドロップダウンセレクタの並べ替え](https://success.openhealth.fr/ja/articles/5792113-ドロップダウンセレクタの並べ替え.md) - [HuBのGSAドラッグストアデータ（SMKT）の更新日](https://success.openhealth.fr/ja/articles/3175557-hubのgsaドラッグストアデータ-smkt-の更新日.md): この記事では、GSAドラッグストア（SMKT）のデータが更新される日付について説明します。 - [薬局ファイルに一致する前提条件](https://success.openhealth.fr/ja/articles/3678146-薬局ファイルに一致する前提条件.md): 薬局ファイルに一致する前提条件 - [「処方箋のオンとオフ」セレクター](https://success.openhealth.fr/ja/articles/3729668-処方箋のオンとオフ-セレクター.md): 「処方タイプセレクター」オブジェクトの仕様 - [HUBで新製品を認定するにはどうすればよいですか？](https://success.openhealth.fr/ja/articles/3376100-hubで新製品を認定するにはどうすればよいですか.md): HUBでの新製品の認定 - [HUBでお気に入りを作成、変更、共有するにはどうすればよいですか？](https://success.openhealth.fr/ja/articles/3175689-hubでお気に入りを作成-変更-共有するにはどうすればよいですか.md): ハブでのお気に入りの作成と共有 - [発売日までにHUB内の製品を選択するにはどうすればよいですか？](https://success.openhealth.fr/ja/articles/3158428-発売日までにhub内の製品を選択するにはどうすればよいですか.md): この記事では、特定の期間に発売された製品のみを選択する方法について説明します。 - [HUBから".csv "形式でデータを取り出すことはできますか？](https://success.openhealth.fr/ja/articles/5671278-hubから-csv-形式でデータを取り出すことはできますか.md) - [ODT応答時間](https://success.openhealth.fr/ja/articles/6632310-odt応答時間.md) - [HUBでのベストディスプレイプラクティスは何ですか](https://success.openhealth.fr/ja/articles/3124454-hubでのベストディスプレイプラクティスは何ですか.md): この記事では、HUBの表示を最適化するためのベストプラクティスについて詳しく説明します - [技術要件](https://success.openhealth.fr/ja/articles/5369918-技術要件.md) - [ブラウザのキャッシュをクリアする](https://success.openhealth.fr/ja/articles/4219722-ブラウザのキャッシュをクリアする.md): GoogleChromeブラウザのキャッシュをクリアする方法 - [Google Chromeをデフォルトのブラウザとして設定するにはどうすればよいですか？](https://success.openhealth.fr/ja/articles/3738717-google-chromeをデフォルトのブラウザとして設定するにはどうすればよいですか.md): GoogleChromeをデフォルトとして設定する方法 - [ナビゲーションエレベーターはテーブルに表示されていません](https://success.openhealth.fr/ja/articles/3195250-ナビゲーションエレベーターはテーブルに表示されていません.md): ナビゲーションリフト - [シート上のボタンやオブジェクトの表示が部分的に途切れているか、表示されていない](https://success.openhealth.fr/ja/articles/3195245-シート上のボタンやオブジェクトの表示が部分的に途切れているか-表示されていない.md): ボタン、オブジェクトの表示の問題 - [テリトリー管理カードが読み込まれず、「読み込み中」というメッセージが表示されます](https://success.openhealth.fr/ja/articles/3195239-テリトリー管理カードが読み込まれず-読み込み中-というメッセージが表示されます.md): テリトリー管理/ TMAマップ表示の問題 - [「このページへのアクセスが許可されていません」というエラーメッセージはどこから表示されますか？](https://success.openhealth.fr/ja/articles/3195338-このページへのアクセスが許可されていません-というエラーメッセージはどこから表示されますか.md): エラーメッセージ - [「接続が失われました」というエラーメッセージが表示されます](https://success.openhealth.fr/ja/articles/4445141-接続が失われました-というエラーメッセージが表示されます.md): エラーが発生しました - [悪いゲートウェイ](https://success.openhealth.fr/ja/articles/4514555-悪いゲートウェイ.md): 「BadGateway」エラーメッセージ - [ディメンションとメジャーのセレクターは、「複数期間分析」および「マイデータアーカイブ」クエリで表示されなくなりました。「市場分析」でのテーブルの抽出は部分的です。](https://success.openhealth.fr/ja/articles/3195377-ディメンションとメジャーのセレクターは-複数期間分析-および-マイデータアーカイブ-クエリで表示されなくなりました-市場分析-でのテーブルの抽出は部分的です.md): 寸法とメジャーは表示されなくなりました - [HUBで用語を表示するにはどうすればよいですか？](https://success.openhealth.fr/ja/articles/3194377-hubで用語を表示するにはどうすればよいですか.md): HUBを使用すると、「SalesEvolution」シートで四分円を簡単に表示できます。 - [Excelの仕様と制限](https://success.openhealth.fr/ja/articles/3753088-excelの仕様と制限.md): この記事では、Excelの仕様と制限について説明します。 - [アプリケーションで「お気に入り」を作成、編集、共有するには？](https://success.openhealth.fr/ja/articles/10502803-アプリケーションで-お気に入り-を作成-編集-共有するには.md) - [消費者パネルフレームワーク](https://success.openhealth.fr/ja/articles/3455845-消費者パネルフレームワーク.md): 消費者パネルの枠組みに関する記事 - [薬局市場分析フレームワーク](https://success.openhealth.fr/ja/articles/3455857-薬局市場分析フレームワーク.md): 薬局チャネルの市場パフォーマンスを分析するためのOpenHealthフレームワークに関連する記事 ### データソース - [OpenHealth薬局パネルとは何ですか？](https://success.openhealth.fr/ja/articles/3304106-openhealth薬局パネルとは何ですか.md): この記事は、薬局のパネル、その構成方法、その進化、および外挿方法について説明することを目的としています - [現在および将来の健康危機の管理における決定的な資産である薬局ネットワーク](https://success.openhealth.fr/ja/articles/3825648-現在および将来の健康危機の管理における決定的な資産である薬局ネットワーク.md): 前例のない健康危機の監視に取り組んでいるOpenHealthCompanyは、その技術とデータを動員します - [フランスの海外部門の領土とHUBで閲覧できる領土は何ですか？](https://success.openhealth.fr/ja/articles/3194382-フランスの海外部門の領土とhubで閲覧できる領土は何ですか.md): ハブで利用可能なDROM-COMテリトリー - [前提条件のセクター化ファイル](https://success.openhealth.fr/ja/articles/3702701-前提条件のセクター化ファイル.md): この記事では、セクター化ファイルをダウンロードして完成させ、送信することができます。 - [SMKTデータソース](https://success.openhealth.fr/ja/articles/4485357-smktデータソース.md): IRI、GSAドラッグストアデータのサプライヤー - [IRIでのGSAパラファーマシー製品コーディング規則（SMKT）](https://success.openhealth.fr/ja/articles/3524492-iriでのgsaパラファーマシー製品コーディング規則-smkt.md): IRIでのSMKT製品のコード化ルールのリマインダー - [ORGANIC STOREデータ - 出典：BIOANALYTICS](https://success.openhealth.fr/ja/articles/5631260-organic-storeデータ-出典-bioanalytics.md) - [電子薬局：監視プラットフォーム](https://success.openhealth.fr/ja/articles/9167006-電子薬局-監視プラットフォーム.md) - [E-薬局製品の利益と損失](https://success.openhealth.fr/ja/articles/3568773-e-薬局製品の利益と損失.md): 「E-pharmaciesProduct Gains＆Loss」モジュールに関連する記事 - [消費者プロファイル](https://success.openhealth.fr/ja/articles/3711085-消費者プロファイル.md): 「消費者プロファイル」モジュールに関連する記事 - [AMAZONデータ - 提供 SELLINGZ](https://success.openhealth.fr/ja/articles/5669013-amazonデータ-提供-sellingz.md) - [Eコマース・データ - WISER提供](https://success.openhealth.fr/ja/articles/7983010-eコマース-データ-wiser提供.md) - [地理的領域](https://success.openhealth.fr/ja/articles/4661582-地理的領域.md): Open Health Companyでは、提供する地理的領域に従って市場を分析できます。 - [ドイツのファーマシーパネルとは？INSIGHTHEALTH](https://success.openhealth.fr/ja/articles/5391412-ドイツのファーマシーパネルとは-insighthealth.md) - [ギリシャのファーマシーパネルとは？ALIRAHEALTH](https://success.openhealth.fr/ja/articles/6863963-ギリシャのファーマシーパネルとは-alirahealth.md) - [オーストリアのファーマシーパネルとは？INSIGHTHEALTH](https://success.openhealth.fr/ja/articles/6863949-オーストリアのファーマシーパネルとは-insighthealth.md) - [アフリカのファーマシーパネルとは？PIEX - アフリカ](https://success.openhealth.fr/ja/articles/6686633-アフリカのファーマシーパネルとは-piex-アフリカ.md) - [ドイツのオンラインファーマシーパネルとは？DATAMEDIQ](https://success.openhealth.fr/ja/articles/5689640-ドイツのオンラインファーマシーパネルとは-datamediq.md) - [ベルギーのファーマシーパネルとは？REDPHARMA](https://success.openhealth.fr/ja/articles/4689894-ベルギーのファーマシーパネルとは-redpharma.md) - [スペインのファーマシーパネルとは？- HMR](https://success.openhealth.fr/ja/articles/5391363-スペインのファーマシーパネルとは-hmr.md) - [スペインのファーマシーパネルとは？- INFONIS（インフォニス](https://success.openhealth.fr/ja/articles/5428915-スペインのファーマシーパネルとは-infonis-インフォニス.md) - [ポルトガルのファーマシーパネルとは？- HMR](https://success.openhealth.fr/ja/articles/5391477-ポルトガルのファーマシーパネルとは-hmr.md) - [ロシアのファーマシーパネルとは？- アルファーム](https://success.openhealth.fr/ja/articles/5701531-ロシアのファーマシーパネルとは-アルファーム.md) - [ポーランドのファーマシーパネルとは？ペックスファーマ](https://success.openhealth.fr/ja/articles/5969485-ポーランドのファーマシーパネルとは-ペックスファーマ.md) - [CONVERT GROUP](https://success.openhealth.fr/ja/articles/6961966-convert-group.md) - [ヨルダンの薬局パネルとは何ですか？](https://success.openhealth.fr/ja/articles/8176750-ヨルダンの薬局パネルとは何ですか.md) - [人口-カートグラフィー](https://success.openhealth.fr/ja/articles/3807695-人口-カートグラフィー.md): 人口の地理的分布を分析する - [AMELI - LPP](https://success.openhealth.fr/ja/articles/6962021-ameli-lpp.md) - [人口-年齢と性別による進化](https://success.openhealth.fr/ja/articles/3810789-人口-年齢と性別による進化.md): 人口構造の進化を分析する - [人口-年齢と性別による比較](https://success.openhealth.fr/ja/articles/3836795-人口-年齢と性別による比較.md): 2つの集団の人口統計プロファイルを比較する - [EGYPT-カートグラフィー](https://success.openhealth.fr/ja/articles/3714611-egypt-カートグラフィー.md): エジプトの県の人口を分析する - [EGYPT-年齢と性別による分析](https://success.openhealth.fr/ja/articles/3714673-egypt-年齢と性別による分析.md): 人口の構造を分析する - [UGANDA-AGE＆GENDERによる分析](https://success.openhealth.fr/ja/articles/3713884-uganda-age-genderによる分析.md): 人口の構造を分析する - [人口-年齢と性別による分析](https://success.openhealth.fr/ja/articles/3807673-人口-年齢と性別による分析.md): 人口の構造を分析する - [Medicabase - 医薬品データベース](https://success.openhealth.fr/ja/articles/6518920-medicabase-医薬品データベース.md) - [誕生](https://success.openhealth.fr/ja/articles/6340025-誕生.md) - [オープンエウドラ](https://success.openhealth.fr/ja/articles/6518977-オープンエウドラ.md) - [IRISの故障](https://success.openhealth.fr/ja/articles/6383829-irisの故障.md) - [アディカプ](https://success.openhealth.fr/ja/articles/6959465-アディカプ.md) - [エヌイーシー](https://success.openhealth.fr/ja/articles/6519012-エヌイーシー.md) - [世界人口データ](https://success.openhealth.fr/ja/articles/8217421-世界人口データ.md) - [INSEE：故人のファイル](https://success.openhealth.fr/ja/articles/4498126-insee-故人のファイル.md): INSEE（国立統計経済研究所）：故人のファイル - [データ VAERS- VAERSDATA- 出典 CDC](https://success.openhealth.fr/ja/articles/6226665-データ-vaers-vaersdata-出典-cdc.md) - [VAERSデータ - VAERSVAX - 出典CDC](https://success.openhealth.fr/ja/articles/6226440-vaersデータ-vaersvax-出典cdc.md) - [VAERSデータ - VAERSSYMPTOMS - 出典：CDC](https://success.openhealth.fr/ja/articles/6219415-vaersデータ-vaerssymptoms-出典-cdc.md) - [2週間以内にデータをハブに統合する](https://success.openhealth.fr/ja/articles/5259828-2週間以内にデータをハブに統合する.md) - [国際データテンプレート](https://success.openhealth.fr/ja/articles/4684696-国際データテンプレート.md) - [FTPSでデータを送信するにはどうすればよいですか？](https://success.openhealth.fr/ja/articles/4143451-ftpsでデータを送信するにはどうすればよいですか.md): FTPS経由でデータを送信する - [OpenHealthが新しいデータソースを統合するために必要な情報は何ですか？](https://success.openhealth.fr/ja/articles/3459148-openhealthが新しいデータソースを統合するために必要な情報は何ですか.md): 新しいデータソースの統合に関する記事 - [長い目で見る](https://success.openhealth.fr/ja/articles/6959482-長い目で見る.md) - [新しいデータソースをHUBに統合する方法は？](https://success.openhealth.fr/ja/articles/3467598-新しいデータソースをhubに統合する方法は.md): HUBでのデータ統合プロセスに関連する記事 - [セルインデータをHUBに統合する](https://success.openhealth.fr/ja/articles/3471145-セルインデータをhubに統合する.md): セルインデータの統合に関する記事 - [セルインデータを受信するための仕様](https://success.openhealth.fr/ja/articles/3660043-セルインデータを受信するための仕様.md): セルイン/セルアウト分析またはセルインVizualizationモジュールのサブスクリプションの一部としてセルインを送信する方法 - [ホームヘルスプロバイダー（PSAD）市場の分析データはどこから来ていますか？](https://success.openhealth.fr/ja/articles/3376155-ホームヘルスプロバイダー-psad-市場の分析データはどこから来ていますか.md): PSAD - [SantéDomStat天文台に参加するにはどうすればよいですか？](https://success.openhealth.fr/ja/articles/3798795-santedomstat天文台に参加するにはどうすればよいですか.md): ホームヘルスプロバイダー（PSAD）の活動の国立天文台に参加するためのチュートリアル - [SanteDomStat観測所から外挿されたパネル](https://success.openhealth.fr/ja/articles/6701602-santedomstat観測所から外挿されたパネル.md) - [患者数](https://success.openhealth.fr/ja/articles/3376499-患者数.md): PSAD連盟による患者数の定義 - [治療回数](https://success.openhealth.fr/ja/articles/3376682-治療回数.md): PSADフェデレーションに従った治療数の定義 - [新規患者数](https://success.openhealth.fr/ja/articles/3376672-新規患者数.md): PSAD連盟による新規患者数の定義 - [税込みの売上高](https://success.openhealth.fr/ja/articles/3376725-税込みの売上高.md): PSAD連盟による税を含む売上高の定義 - [治療終了時の患者数](https://success.openhealth.fr/ja/articles/3376675-治療終了時の患者数.md): PSAD連盟による治療終了時の患者数の定義 - [強制健康保険金額（AMO）](https://success.openhealth.fr/ja/articles/3376740-強制健康保険金額-amo.md): PSADフェデレーションに従ったAMO金額の定義 - [補足健康保険金額（AMC）](https://success.openhealth.fr/ja/articles/3376749-補足健康保険金額-amc.md): PSADフェデレーションに従ったAMC金額の定義 - [未払い料金（RAC）](https://success.openhealth.fr/ja/articles/3376751-未払い料金-rac.md): PSADフェデレーションに従ったRACの定義 - [出典：THESORIMED](https://success.openhealth.fr/ja/articles/3560018-出典-thesorimed.md): 薬物データベース（BdM） - [国際的な非独占的名称（INN）](https://success.openhealth.fr/ja/articles/3954239-国際的な非独占的名称-inn.md): 国際共通名（INN） - [オープンフードの基本情報](https://success.openhealth.fr/ja/articles/6961970-オープンフードの基本情報.md) - [LOINC - Logical Observation Identifiers 名称とコード。](https://success.openhealth.fr/ja/articles/6959323-loinc-logical-observation-identifiers-名称とコード.md) - [AMELI - CCAM](https://success.openhealth.fr/ja/articles/6959080-ameli-ccam.md) - [WHO ATC VET](https://success.openhealth.fr/ja/articles/6959078-who-atc-vet.md) - [シーピーエス](https://success.openhealth.fr/ja/articles/6959068-シーピーエス.md) - [機関](https://success.openhealth.fr/ja/articles/3935678-機関.md): 健康、社会、医療社会施設のリスト - [健康サービス](https://success.openhealth.fr/ja/articles/7969680-健康サービス.md) - [FINESSを抽出する](https://success.openhealth.fr/ja/articles/3946922-finessを抽出する.md): 期待どおりに抽出を実行します - [エボリューションフィネス](https://success.openhealth.fr/ja/articles/3947009-エボリューションフィネス.md): 構造の数の進化に従ってください - [認可ケア活動](https://success.openhealth.fr/ja/articles/3947067-認可ケア活動.md): ヘルスケア活動の承認に従って構造を一覧表示します - [主要な医療機器](https://success.openhealth.fr/ja/articles/3947269-主要な医療機器.md): 重い材料でそれらの機器に従って構造をリスト - [地理的](https://success.openhealth.fr/ja/articles/3947363-地理的.md): 領土上の構造物の分布を視覚化する - [RPPS](https://success.openhealth.fr/ja/articles/3947568-rpps.md): 医療専門家のリスト - [FINESS＆RPPS](https://success.openhealth.fr/ja/articles/3947713-finess-rpps.md): 医療専門家の運動場所を一覧表示する - [RPPS抽出](https://success.openhealth.fr/ja/articles/3947829-rpps抽出.md): RPPS（ヘルスケア専門家の共有ディレクトリ） ### モデル - [UGAでのデータ](https://success.openhealth.fr/ja/articles/4852310-ugaでのデータ.md) - [セクターへの売上高の計算：あなたが知る必要があること](https://success.openhealth.fr/ja/articles/3545561-セクターへの売上高の計算-あなたが知る必要があること.md): OpenHealthでセクター売上高を計算するためのさまざまなステップは何ですか？ - [セクターの再割り当て、静的または動的な方法論？](https://success.openhealth.fr/ja/articles/3690615-セクターの再割り当て-静的または動的な方法論.md): セクターの再割り当て、静的または動的な方法論？ - [薬局層](https://success.openhealth.fr/ja/articles/4291490-薬局層.md): 「理論的」層と「実際の」または「効果的」層の詳細。 - [ハブの生産ライン](https://success.openhealth.fr/ja/articles/4816146-ハブの生産ライン.md) - [比較分析を行う方法は？](https://success.openhealth.fr/ja/articles/3440093-比較分析を行う方法は.md): 2つの異なるプロバイダーからのデータを比較したいとします。 - [レベル1の調査-OpenHealthCompanyのサービスでのデータ品質](https://success.openhealth.fr/ja/articles/3595822-レベル1の調査-openhealthcompanyのサービスでのデータ品質.md): わからない現象が見られますか？私たちはあなたにこの目撃の起源を提供し、あなたにそれを説明することができます。 - [OpenHealthでのデータ品質プロセス](https://success.openhealth.fr/ja/articles/3415271-openhealthでのデータ品質プロセス.md): この記事では、OpenHealthでのデータ品質プロセスの段階について詳しく説明します - [間隔と信頼レベル](https://success.openhealth.fr/ja/articles/3633173-間隔と信頼レベル.md): 定義、式、制限：知っておくべきこと - [データ品質：バッチ管理](https://success.openhealth.fr/ja/articles/3433509-データ品質-バッチ管理.md): バッチ管理プロセスの説明 - [データ品質：販売分解プロセス](https://success.openhealth.fr/ja/articles/3415317-データ品質-販売分解プロセス.md): 販売内訳プロセスの説明 - [セルインとストックオフセット](https://success.openhealth.fr/ja/articles/4131084-セルインとストックオフセット.md): 株式売り込み - [なぜセルインを大量に分析するのですか？](https://success.openhealth.fr/ja/articles/3846167-なぜセルインを大量に分析するのですか.md): なぜセルインを大量に分析するのですか？ - [セルインとセルアウトの間にはデータギャップがあります](https://success.openhealth.fr/ja/articles/3195358-セルインとセルアウトの間にはデータギャップがあります.md): セルインとセルアウトの間にデータギャップがあるのはどの場合ですか？ - [非定型セールとは何ですか？](https://success.openhealth.fr/ja/articles/3195366-非定型セールとは何ですか.md): 非定型販売とATYPICALFILTERプロセス。 - [価格、数量、売上高に関する情報はどこから来ていますか？](https://success.openhealth.fr/ja/articles/3195348-価格-数量-売上高に関する情報はどこから来ていますか.md): 価格/数量/売上高情報 - [処方者による推定販売量](https://success.openhealth.fr/ja/articles/4171530-処方者による推定販売量.md): 処方者および処方者のカテゴリーごとに薬局での販売量を評価する方法 - [2つのエクストラクションの違いを理解する](https://success.openhealth.fr/ja/articles/13399689-2つのエクストラクションの違いを理解する.md) ### 手順 - [GTIN](https://success.openhealth.fr/ja/articles/3608176-gtin.md): GTINコード（グローバルトレードアイテム番号） - [顧客製品修飾子フィールド仕様（CQCP）](https://success.openhealth.fr/ja/articles/3704913-顧客製品修飾子フィールド仕様-cqcp.md): CQCP（製品顧客修飾子フィールド） - [LPPRコードとは何ですか？](https://success.openhealth.fr/ja/articles/3195365-lpprコードとは何ですか.md): LPPRコード（払い戻し可能な製品とサービスのリスト） - [製品レンタル追跡](https://success.openhealth.fr/ja/articles/4206554-製品レンタル追跡.md): 製品レンタル - [市場を拡大したい](https://success.openhealth.fr/ja/articles/4420843-市場を拡大したい.md): サブスクリプション市場が続きました - [OHC分類](https://success.openhealth.fr/ja/articles/3194589-ohc分類.md): 独自のOpenHealthCompany分類に従って、製品の割り当てを視覚化します - [EphMRAACクラスの履歴](https://success.openhealth.fr/ja/articles/3557908-ephmraacクラスの履歴.md): 2014年以降のEphMRAACクラスの進化を視覚化する - [獣医学の詳細](https://success.openhealth.fr/ja/articles/3194587-獣医学の詳細.md): 獣薬の特徴を視覚化する - [獣医学分類](https://success.openhealth.fr/ja/articles/3194579-獣医学分類.md): 獣薬（ANSES）の分類を表示する - [人間医学の詳細](https://success.openhealth.fr/ja/articles/3421225-人間医学の詳細.md): THESORIMEDの詳細フィールドから1つまたは複数の製品の特性を表示します - [新製品の管理](https://success.openhealth.fr/ja/articles/4470813-新製品の管理.md): 新製品管理 - [人間医学の分類](https://success.openhealth.fr/ja/articles/3417281-人間医学の分類.md): 製品範囲のEphMRAACおよびOMSATC分類を表示する - [適応症-診断](https://success.openhealth.fr/ja/articles/3568554-適応症-診断.md): 特定の病状に示されている薬と、薬の選択に関連する病状を表示する - [MP4U](https://success.openhealth.fr/ja/articles/3574188-mp4u.md): OpenHealthCompanyによって提供されたすべての分類を表示する - [TVASI（売上高・仕入高・不明在庫表）とは？](https://success.openhealth.fr/ja/articles/5992494-tvasi-売上高-仕入高-不明在庫表-とは.md) - [IRI製品の分類](https://success.openhealth.fr/ja/articles/3194597-iri製品の分類.md): 分類に従って製品の割り当てを視覚化します オーナーIRI - [売れ残り商品の撤去](https://success.openhealth.fr/ja/articles/6135938-売れ残り商品の撤去.md) - [標準市場-サブスクリプション](https://success.openhealth.fr/ja/articles/3798203-標準市場-サブスクリプション.md): この記事では、いわゆる「標準」市場の関心と限界について説明します。 - [製品が見つからない](https://success.openhealth.fr/ja/articles/5686002-製品が見つからない.md) - [プロダクトコード管理](https://success.openhealth.fr/ja/articles/5652478-プロダクトコード管理.md) - [商品資格：ブランド](https://success.openhealth.fr/ja/articles/5016985-商品資格-ブランド.md) ### サブスクリプションとモジュール - [3種類のアプリケーション](https://success.openhealth.fr/ja/articles/9489652-3種類のアプリケーション.md) - [あなたの2.0プラットフォーム](https://success.openhealth.fr/ja/articles/8374416-あなたの2-0プラットフォーム.md) - [概要](https://success.openhealth.fr/ja/articles/3344127-概要.md): このモジュールでは、アプリケーションのすべての特性を利用できます - [市場とセレクション](https://success.openhealth.fr/ja/articles/8337016-市場とセレクション.md) - [サマリー・ダッシュボード](https://success.openhealth.fr/ja/articles/9246867-サマリー-ダッシュボード.md) - [分析](https://success.openhealth.fr/ja/articles/9352287-分析.md) - [エクストラクター](https://success.openhealth.fr/ja/articles/9246875-エクストラクター.md) - [成長分析](https://success.openhealth.fr/ja/articles/3158856-成長分析.md): あなたの市場とあなたの競争相手の市場の進化における重要な要素を決定します - [品揃え分析](https://success.openhealth.fr/ja/articles/3473736-品揃え分析.md): 市場における製品のダイナミズムを研究する - [製品の平均数](https://success.openhealth.fr/ja/articles/3161474-製品の平均数.md): 薬局またはGSAドラッグストアでの販売ポイントごとの製品の平均数を表示する - [起動追跡](https://success.openhealth.fr/ja/articles/3158488-起動追跡.md): 製品の発売と成長への貢献を監視する - [先進的な指標をクロスさせる](https://success.openhealth.fr/ja/articles/6007740-先進的な指標をクロスさせる.md) - [売上集中](https://success.openhealth.fr/ja/articles/3095338-売上集中.md): 売上集中曲線とGINIインデックスを通じて市場の集中を視覚化する - [価格分散](https://success.openhealth.fr/ja/articles/3159289-価格分散.md): 製品の価格分散を視覚化します。セール価格から独自の薬局セグメントを作成する - [売り切れマージン分析](https://success.openhealth.fr/ja/articles/3358322-売り切れマージン分析.md): 薬局にとっての製品の魅力をベンチマークする - [売り切りマージン進化論](https://success.openhealth.fr/ja/articles/3815561-売り切りマージン進化論.md) - [薬局モニタリング（1/2）](https://success.openhealth.fr/ja/articles/3358248-薬局モニタリング-1-2.md): 薬局のトラフィックの進化を追う - [薬局モニタリング（2/2）](https://success.openhealth.fr/ja/articles/3810527-薬局モニタリング-2-2.md): 薬局のトラフィックの進化を追う - [Salesforceのパフォーマンス](https://success.openhealth.fr/ja/articles/3159230-salesforceのパフォーマンス.md): 営業部隊の地域とセクターの販売実績を比較する - [カスタマーリレーションシップマネジメント（CRM）ASSISTANT](https://success.openhealth.fr/ja/articles/5953935-カスタマーリレーションシップマネジメント-crm-assistant.md) - [ポイントオブセールストラッキング](https://success.openhealth.fr/ja/articles/3778944-ポイントオブセールストラッキング.md): ポイントオブセールストラッキング - [オンデマンド・エボリューション](https://success.openhealth.fr/ja/articles/6560184-オンデマンド-エボリューション.md) - [オンデマンド解析](https://success.openhealth.fr/ja/articles/6127483-オンデマンド解析.md) - [オンデマンドテーブル](https://success.openhealth.fr/ja/articles/3158751-オンデマンドテーブル.md): さまざまなタイプの期間にわたる主要なHUBインジケーターとその進化を視覚化します - [時系列分析](https://success.openhealth.fr/ja/articles/3635940-時系列分析.md): 市場をシーズン、トレンド、ノイズに分類します - [予測分析](https://success.openhealth.fr/ja/articles/3636015-予測分析.md): あなたの市場の未来を見積もる - [部門別予測](https://success.openhealth.fr/ja/articles/3689811-部門別予測.md): 将来のセクター売上高を見積もる - [セルインビジュアライゼーション](https://success.openhealth.fr/ja/articles/3559882-セルインビジュアライゼーション.md): 売り切れと売り切れの売り上げの推移を比較する - [セルインアナリシス](https://success.openhealth.fr/ja/articles/6188132-セルインアナリシス.md) - [セルインマッチング](https://success.openhealth.fr/ja/articles/6188090-セルインマッチング.md) - [セルインエボリューション](https://success.openhealth.fr/ja/articles/6191929-セルインエボリューション.md) - [セルインとセルアウトの分析](https://success.openhealth.fr/ja/articles/6191947-セルインとセルアウトの分析.md) - [セルインとセルアウトの進化](https://success.openhealth.fr/ja/articles/6191955-セルインとセルアウトの進化.md) - [プライスエボリューション](https://success.openhealth.fr/ja/articles/5056489-プライスエボリューション.md) - [色のカスタマイズ](https://success.openhealth.fr/ja/articles/8407897-色のカスタマイズ.md) - [製品の輸出](https://success.openhealth.fr/ja/articles/3583206-製品の輸出.md): すべての製品およびMP4Uタイプのアプリに固有のエクスポートシート - [市場分析](https://success.openhealth.fr/ja/articles/3121933-市場分析.md): 市場のパフォーマンスを分析する：セグメント、ブランド、製品、会社ごと - [価格分析](https://success.openhealth.fr/ja/articles/3215190-価格分析.md): 市場の価格を表示し、位置付けを分析します - [セールスエボリューション](https://success.openhealth.fr/ja/articles/3178323-セールスエボリューション.md): 利用可能なすべての履歴にわたって進化する売上を表示する - [ダッシュボードを要約する](https://success.openhealth.fr/ja/articles/4533213-ダッシュボードを要約する.md) - [市場シェアの進化](https://success.openhealth.fr/ja/articles/3193078-市場シェアの進化.md): 長期にわたる売上高と市場シェアの進化を視覚化する - [セールスクロステーブル](https://success.openhealth.fr/ja/articles/3193060-セールスクロステーブル.md): 簡単なピボットテーブルを作成する - [ターンオーバー/ボリューム（CU）合成](https://success.openhealth.fr/ja/articles/3193048-ターンオーバー-ボリューム-cu-合成.md): 市場の販売量と価値を同時に視覚化する - [売り切れバリューシンセシス（PHARMACIES / SUPERMARKETS）](https://success.openhealth.fr/ja/articles/3193020-売り切れバリューシンセシス-pharmacies-supermarkets.md): GSAドラッグストアとドラッグストアの売上を比較する - [市場シェア分析](https://success.openhealth.fr/ja/articles/3193069-市場シェア分析.md): 過去12か月間の市場シェアを分析する - [マイデータアーカイブ](https://success.openhealth.fr/ja/articles/3193099-マイデータアーカイブ.md): フラットデータベースをExcelにエクスポートする - [多周期解析](https://success.openhealth.fr/ja/articles/3192953-多周期解析.md): 完全にカスタマイズされたテーブルを作成する - [私のクエリすべての製品](https://success.openhealth.fr/ja/articles/4280353-私のクエリすべての製品.md): セグメントと対象フィールド（例：生薬、ソーラーインデックス、プロモーションなど）、および制限を表示します - [ストックエボリューション（NEW）](https://success.openhealth.fr/ja/articles/3719256-ストックエボリューション-new.md): 株式の進化とその分布を視覚化して分析する - [市場の定義](https://success.openhealth.fr/ja/articles/3158829-市場の定義.md): 選択した100ベースに基づいて市場をリベースします - [RAWDATAの高度なインジケーター](https://success.openhealth.fr/ja/articles/3711095-rawdataの高度なインジケーター.md): 主要な指標データを回復する - [高度なインジケーターの進化SMKT](https://success.openhealth.fr/ja/articles/3193000-高度なインジケーターの進化smkt.md): 高度な統計指標の時間的変化の分析を通じて、ラボのパフォーマンスを監視します。 - [高度な指標分析SMKT](https://success.openhealth.fr/ja/articles/3192366-高度な指標分析smkt.md): GSAパラファーマシー市場の進化を主要な指標に分解する - [高度な指標の進化](https://success.openhealth.fr/ja/articles/3177853-高度な指標の進化.md): 高度な統計指標の時間的変化の分析を通じて、ラボのパフォーマンスを監視します。 - [アドバンスト・インディケーター・エボリューション・バイオ](https://success.openhealth.fr/ja/articles/7051823-アドバンスト-インディケーター-エボリューション-バイオ.md) - [国家の高度な指標](https://success.openhealth.fr/ja/articles/3364513-国家の高度な指標.md): 市場の進化を主要な指標に分解する - [在庫分析](https://success.openhealth.fr/ja/articles/3178015-在庫分析.md): 在庫レベルとその進化を解釈する - [アドバンスト・インディケーター・アナライズ・バイオ](https://success.openhealth.fr/ja/articles/7051801-アドバンスト-インディケーター-アナライズ-バイオ.md) - [高度な指標分析](https://success.openhealth.fr/ja/articles/3124439-高度な指標分析.md): 市場の進化を主要な指標に分解する - [カートグラフィー](https://success.openhealth.fr/ja/articles/3192450-カートグラフィー.md): 営業部隊の地域およびセクターの商業的パフォーマンスを分析する - [地理的クロステーブル](https://success.openhealth.fr/ja/articles/3192466-地理的クロステーブル.md): セクター化を統合するピボットテーブルを作成する - [地理的な販売の進化](https://success.openhealth.fr/ja/articles/3192482-地理的な販売の進化.md): ピボットテーブルでセクター別の36か月の売上高を表示 - [セールスフォース・エフェクティブネス](https://success.openhealth.fr/ja/articles/5624011-セールスフォース-エフェクティブネス.md) - [カスタムウェイトメソッド解析](https://success.openhealth.fr/ja/articles/5169317-カスタムウェイトメソッド解析.md) - [ネットワーク分析](https://success.openhealth.fr/ja/articles/3894767-ネットワーク分析.md): ネットワーク分析 - [カスタムウェイトメソッドエボリューション](https://success.openhealth.fr/ja/articles/5169320-カスタムウェイトメソッドエボリューション.md) - [KPIの概要](https://success.openhealth.fr/ja/articles/3478199-kpiの概要.md): 動的な表で主要な指標を視覚化します。ボリュームは地域とセクターに減少しました。 - [換算単位での売上](https://success.openhealth.fr/ja/articles/3192412-換算単位での売上.md): 変換された単位を使用して売上を視覚化する - [RAWデータストックインジケーター](https://success.openhealth.fr/ja/articles/3711142-rawデータストックインジケーター.md): 在庫データをエクスポートする - [RAWデータSMKTAIA](https://success.openhealth.fr/ja/articles/3720960-rawデータsmktaia.md): SMKTの主要な指標データを見つける - [ストックエボリューション](https://success.openhealth.fr/ja/articles/3178277-ストックエボリューション.md): 株式の進化とその分布を視覚化して分析する - [地理的高度指標](https://success.openhealth.fr/ja/articles/3192508-地理的高度指標.md): 地域またはセクター別の主要な指標を表示する - [製品のパフォーマンス](https://success.openhealth.fr/ja/articles/3850331-製品のパフォーマンス.md): 地域と製品セクターの業績を比較する - [テリトリアルアドバンストインジケーター](https://success.openhealth.fr/ja/articles/3370879-テリトリアルアドバンストインジケーター.md): 市場の進化を主要な指標に分解する - [時系列の部門別分析](https://success.openhealth.fr/ja/articles/3814974-時系列の部門別分析.md): 市場をトレンド、シーズン、ノイズに分類します - [年齢と性別による売上分析](https://success.openhealth.fr/ja/articles/3192701-年齢と性別による売上分析.md): 年齢と性別で売上を分析する - [妊娠状況別の売上高の推移](https://success.openhealth.fr/ja/articles/3192910-妊娠状況別の売上高の推移.md): 妊婦の人口に関する薬局の売上高をフォローする - [年齢と性別による売上高の進化](https://success.openhealth.fr/ja/articles/3192732-年齢と性別による売上高の進化.md): HUBの歴史の深さを使用して、年齢と性別による売上の推移を視覚化します - [要件順序の進化](https://success.openhealth.fr/ja/articles/5790020-要件順序の進化.md) - [進化の共同調剤](https://success.openhealth.fr/ja/articles/3192529-進化の共同調剤.md): 薬局での共同調剤の進化を視覚化し、分解する - [共同調剤分析](https://success.openhealth.fr/ja/articles/3192633-共同調剤分析.md): 私の市場からの製品の選択に関連する薬局の共同調剤を見る - [チャネルおよび処方者ごとの売上](https://success.openhealth.fr/ja/articles/3192751-チャネルおよび処方者ごとの売上.md): 市場の影響力を視覚化する - [AMO、AMC、RAC](https://success.openhealth.fr/ja/articles/3192929-amo-amc-rac.md): 強制健康保険、補足健康保険、自己負担費用の3つの金額を表示します - [共同調剤分散](https://success.openhealth.fr/ja/articles/3876946-共同調剤分散.md): 調剤によって販売された製品数の分布を表示する - [調剤分散の進化](https://success.openhealth.fr/ja/articles/3920070-調剤分散の進化.md): ディスペンスごとに販売された製品数の経時的な分布を視覚化します - [GP処方箋（年齢・性別別](https://success.openhealth.fr/ja/articles/5789899-gp処方箋-年齢-性別別.md) - [処方箋オーダー解析](https://success.openhealth.fr/ja/articles/5322866-処方箋オーダー解析.md) - [GP Prescriptions Evolution（GP処方箋の進化](https://success.openhealth.fr/ja/articles/5790016-gp-prescriptions-evolution-gp処方箋の進化.md) - [バスケット分析](https://success.openhealth.fr/ja/articles/3711049-バスケット分析.md): 「バスケット分析」モジュールの説明 - [コ・ディスペンシング](https://success.openhealth.fr/ja/articles/4738243-コ-ディスペンシング.md) - [コホート認定モジュール](https://success.openhealth.fr/ja/articles/3928090-コホート認定モジュール.md): 患者コホートの資格 - [治療ステータスモジュール](https://success.openhealth.fr/ja/articles/3928067-治療ステータスモジュール.md): 治療モニタリングのダイナミクスを分析する - [治療アドヒアランスモジュール](https://success.openhealth.fr/ja/articles/3928044-治療アドヒアランスモジュール.md): 治療の遵守を分析する - [コホートの定義](https://success.openhealth.fr/ja/articles/3894703-コホートの定義.md): 分析の範囲を定義する - [共治療](https://success.openhealth.fr/ja/articles/4163623-共治療.md): 分析範囲内でコプロセッシングを定義する - [視覚化コホート](https://success.openhealth.fr/ja/articles/3894721-視覚化コホート.md): 定義されたコホートの患者プロファイルを表示する - [分析基準の定義](https://success.openhealth.fr/ja/articles/3894728-分析基準の定義.md): コホートの分析用のパラメーターを定義します - [グローバルコホートの進化](https://success.openhealth.fr/ja/articles/3894747-グローバルコホートの進化.md): コホートの毎月の進化を視覚化する - [地理的分布](https://success.openhealth.fr/ja/articles/3894751-地理的分布.md): 定義されたコホートの患者の地理的分布を表示する - [コホートプロファイル](https://success.openhealth.fr/ja/articles/3894755-コホートプロファイル.md): コホートに含まれる患者の人口統計プロファイルを分析する - [治療状況の内訳](https://success.openhealth.fr/ja/articles/3894764-治療状況の内訳.md): さまざまな種類の治療フォローアップの概要を把握する - [治療開始](https://success.openhealth.fr/ja/articles/3894778-治療開始.md): 治療開始数の変化を分析する - [治療再開](https://success.openhealth.fr/ja/articles/3894788-治療再開.md): 治療の再受験数の変化を分析する - [新しい治療法](https://success.openhealth.fr/ja/articles/3894804-新しい治療法.md): 治療の開始と再開の数の変化を分析する - [治療の再発](https://success.openhealth.fr/ja/articles/3894812-治療の再発.md): 治療中の患者を分析する - [治療スイッチバランス](https://success.openhealth.fr/ja/articles/3894821-治療スイッチバランス.md): 治療による治療の変化のバランスを分析する - [治療スイッチゲイン](https://success.openhealth.fr/ja/articles/3894830-治療スイッチゲイン.md): 治療スイッチの受益者を分析する - [治療スイッチの損失](https://success.openhealth.fr/ja/articles/3894843-治療スイッチの損失.md): 治療スイッチの敗者を治療によって分析する - [ゲイン原点の切り替え](https://success.openhealth.fr/ja/articles/3894857-ゲイン原点の切り替え.md): 特定の治療のスイッチの起源を分析します - [スイッチ損失先](https://success.openhealth.fr/ja/articles/3894864-スイッチ損失先.md): 特定の治療のスイッチの宛先を分析します - [ドロップアウト](https://success.openhealth.fr/ja/articles/3894874-ドロップアウト.md): 治療停止の分析 - [KPIの概要](https://success.openhealth.fr/ja/articles/4229969-kpiの概要.md): さまざまなタイプの治療モニタリングの要約 - [治療の持続性](https://success.openhealth.fr/ja/articles/3894883-治療の持続性.md): 治療期間を分析する - [コンプライアンス](https://success.openhealth.fr/ja/articles/3894884-コンプライアンス.md): 配信された数量を分析する - [規則性の基準は何ですか？](https://success.openhealth.fr/ja/articles/3325816-規則性の基準は何ですか.md): 規則性基準の概念の定義 - [死-カートグラフィー](https://success.openhealth.fr/ja/articles/3863677-死-カートグラフィー.md): 死亡の地理的分布を分析する - [死亡数のオフセット](https://success.openhealth.fr/ja/articles/3863573-死亡数のオフセット.md): データの関連性を評価する - [死-年齢と性別による分析](https://success.openhealth.fr/ja/articles/3863808-死-年齢と性別による分析.md): 死の構造を分析する - [死-年齢と性別による進化](https://success.openhealth.fr/ja/articles/3863939-死-年齢と性別による進化.md): 死の構造の進化を分析する - [死-進化](https://success.openhealth.fr/ja/articles/3864065-死-進化.md): 死の進化を視覚化する - [死-進化の比較](https://success.openhealth.fr/ja/articles/3864073-死-進化の比較.md): 死の進化を前の年と比較してください - [薬局モニタリングCA](https://success.openhealth.fr/ja/articles/4634768-薬局モニタリングca.md): 薬局の規模に応じて交通量を説明する - [トラフィック解析（ベータテスト）](https://success.openhealth.fr/ja/articles/6848401-トラフィック解析-ベータテスト.md) - [薬局モニタリングの詳細](https://success.openhealth.fr/ja/articles/4527868-薬局モニタリングの詳細.md): 薬局の種類ごとに調剤トラフィックを分析する - [トラフィックエボリューション（βテスト）](https://success.openhealth.fr/ja/articles/6848016-トラフィックエボリューション-βテスト.md) - [薬局モニタリングカートグラフィー](https://success.openhealth.fr/ja/articles/4527811-薬局モニタリングカートグラフィー.md): フランス本土の調剤トラフィックを分析する - [薬局モニタリングの詳細](https://success.openhealth.fr/ja/articles/4262306-薬局モニタリングの詳細.md): 薬局の種類ごとに販売の詳細を区別する - [薬局モニタリング分析](https://success.openhealth.fr/ja/articles/3839223-薬局モニタリング分析.md): 薬局のトラフィックの進化を追う - [薬局モニタリングの進化](https://success.openhealth.fr/ja/articles/3827973-薬局モニタリングの進化.md): 調剤トラフィックの進化を研究する - [トラフィックの分解](https://success.openhealth.fr/ja/articles/3826074-トラフィックの分解.md): 季節、傾向、残留物の要素を観察する - [交通調査](https://success.openhealth.fr/ja/articles/3809042-交通調査.md): 薬局のトラフィックを分析する - [エグゼクティブサマリー - PIEX](https://success.openhealth.fr/ja/articles/5203335-エグゼクティブサマリー-piex.md) - [購入](https://success.openhealth.fr/ja/articles/4605110-購入.md): あなたの購入とその領収書を追跡する - [私の質問-PIEX](https://success.openhealth.fr/ja/articles/4210627-私の質問-piex.md): データを選択します - [セールスエボリューション-PIEX](https://success.openhealth.fr/ja/articles/4210655-セールスエボリューション-piex.md): 利用可能な履歴でアクティビティの進化を表示します - [販売分析-PIEX](https://success.openhealth.fr/ja/articles/4210650-販売分析-piex.md): 販売分析-PIEX - [注文の詳細-PIEX](https://success.openhealth.fr/ja/articles/4210659-注文の詳細-piex.md): 受注の表示と追跡 - [在庫概要-PIEX](https://success.openhealth.fr/ja/articles/4210672-在庫概要-piex.md): あなたの株のバリエーションを視覚化する - [マイデータアーカイブ-PIEX](https://success.openhealth.fr/ja/articles/4210694-マイデータアーカイブ-piex.md): フラットデータベースをExcelにエクスポートする - [EURAPHARMA- PIEX](https://success.openhealth.fr/ja/articles/4366306-eurapharma-piex.md): EURAPHARMAの活動の進化を視覚化する - [マッチング製品](https://success.openhealth.fr/ja/articles/4366320-マッチング製品.md): PIEX製品とEURAPHARMA製品の指定の対応 - [CLIマイファイル（1/5）](https://success.openhealth.fr/ja/articles/4626422-cliマイファイル-1-5.md): CLIマイファイル（1/5） - [CLI\_Fileカウント（2/5）](https://success.openhealth.fr/ja/articles/4626421-cli_fileカウント-2-5.md): CLI\_Fileカウント（2/5） - [CLI\_FileコードとOHCリポジトリのマッチング](https://success.openhealth.fr/ja/articles/4626419-cli_fileコードとohcリポジトリのマッチング.md): OHCリポジトリとのCLI\_FILコードマッチング - [売り切れ輸出（4/5）](https://success.openhealth.fr/ja/articles/4626414-売り切れ輸出-4-5.md): 売り切れ輸出（4/5） ### パーソナライズされたオプション - [非階層的な製品認定フィールド](https://success.openhealth.fr/ja/articles/4036045-非階層的な製品認定フィールド.md): 製品の認定に関する詳細を追加します - [HUBデータの最大経過時間はどれくらいですか？](https://success.openhealth.fr/ja/articles/3195251-hubデータの最大経過時間はどれくらいですか.md): 利用可能な最後のデータ - [顧客タイプ](https://success.openhealth.fr/ja/articles/4197147-顧客タイプ.md): カスタムオプション顧客タイプ - [セッションアクセス](https://success.openhealth.fr/ja/articles/4036458-セッションアクセス.md): 従業員の表示を制限する - [カスタムサイクル](https://success.openhealth.fr/ja/articles/4036444-カスタムサイクル.md): パーソナライズされた期間にわたってデータを分析します - [会計年度](https://success.openhealth.fr/ja/articles/4036169-会計年度.md): 会計年度を定義する - [日ボタン](https://success.openhealth.fr/ja/articles/4036159-日ボタン.md): より細かい粒度でデータを視覚化する - [週ボタン](https://success.openhealth.fr/ja/articles/4036111-週ボタン.md): より細かい粒度でデータを視覚化する - [為替レート](https://success.openhealth.fr/ja/articles/8329594-為替レート.md) - [SMKT期間カレンダー](https://success.openhealth.fr/ja/articles/4036549-smkt期間カレンダー.md): GSAカレンダーを使用する - [境界を制限する](https://success.openhealth.fr/ja/articles/4560699-境界を制限する.md): .xlsxファイルからマイクエリでGTINリストを1つ選択する - [境界を制限する（コード7）](https://success.openhealth.fr/ja/articles/4560791-境界を制限する-コード7.md): .xlsxファイルからのマイクエリでの\[テクニカルコード2\]のリストの1つを選択 - [マーケットフラッグ](https://success.openhealth.fr/ja/articles/4560797-マーケットフラッグ.md): .xlsxファイルに含まれているマーケット定義からマイクエリで1つのGTINリストを選択する - [顧客タイプのターゲティング/定義](https://success.openhealth.fr/ja/articles/3777788-顧客タイプのターゲティング-定義.md): ターゲティング（顧客タイプ） ### ハブインジケーター - [HUB指標に関する用語集](https://success.openhealth.fr/ja/articles/5194247-hub指標に関する用語集.md) - [売上高](https://success.openhealth.fr/ja/articles/3194314-売上高.md): 売上高 - [販売価値](https://success.openhealth.fr/ja/articles/3074854-販売価値.md): 売上値インジケーターの指定 - [N MS](https://success.openhealth.fr/ja/articles/3194475-n-ms.md): 「NMS」メジャーの定義 - [N MSエボル](https://success.openhealth.fr/ja/articles/5634266-n-msエボル.md) - [NMSデルタ](https://success.openhealth.fr/ja/articles/3194469-nmsデルタ.md): 「NMSデルタ」メジャーの定義 - [モード別重量\(CA\) / カスタム重量\(To\)](https://success.openhealth.fr/ja/articles/9292839-モード別重量-ca-カスタム重量-to.md) - [付加価値税抜きメーカー価格に基づく販売額（付加価値税抜き売上高PF） - モロッコ](https://success.openhealth.fr/ja/articles/7508513-付加価値税抜きメーカー価格に基づく販売額-付加価値税抜き売上高pf-モロッコ.md) - [N成長CTR](https://success.openhealth.fr/ja/articles/3194466-n成長ctr.md): 「NGrowthCTR」メジャーの定義と計算式 - [ディールでは](https://success.openhealth.fr/ja/articles/6201859-ディールでは.md) - [クロスウェイトボリューム](https://success.openhealth.fr/ja/articles/6066324-クロスウェイトボリューム.md) - [クロスウェイトターンオーバー](https://success.openhealth.fr/ja/articles/6066273-クロスウェイトターンオーバー.md) - [N成長CTR調整済み](https://success.openhealth.fr/ja/articles/3205376-n成長ctr調整済み.md): 「NGrowthCTRA」メジャーの定義と計算式 - [ソース重量](https://success.openhealth.fr/ja/articles/5151525-ソース重量.md) - [観測された平均価格](https://success.openhealth.fr/ja/articles/3194302-観測された平均価格.md): AASP：観測された平均価格 - [加重平均価格](https://success.openhealth.fr/ja/articles/3194292-加重平均価格.md): WASP：加重平均価格 - [価格効果](https://success.openhealth.fr/ja/articles/8426443-価格効果.md) - [販売する薬局の数](https://success.openhealth.fr/ja/articles/3719566-販売する薬局の数.md) - [デジタル配信の販売](https://success.openhealth.fr/ja/articles/3194321-デジタル配信の販売.md): 数値分布 - [グローバルセリングデジタルディストリビューション](https://success.openhealth.fr/ja/articles/3194320-グローバルセリングデジタルディストリビューション.md): グローバル数値分布 - [リベース販売デジタル配信](https://success.openhealth.fr/ja/articles/4045636-リベース販売デジタル配信.md): リベースされた数値分布 - [グローバルリベース販売デジタル配信](https://success.openhealth.fr/ja/articles/4045725-グローバルリベース販売デジタル配信.md): グローバル数値分布リベース - [カスタマイズされたリベースのデジタル販売流通](https://success.openhealth.fr/ja/articles/6830813-カスタマイズされたリベースのデジタル販売流通.md) - [販売価値の分配](https://success.openhealth.fr/ja/articles/3194323-販売価値の分配.md): 加重分布 - [グローバルな販売価値の分布](https://success.openhealth.fr/ja/articles/3194316-グローバルな販売価値の分布.md): グローバルな販売価値の分布 - [販売価値の分配をリベース](https://success.openhealth.fr/ja/articles/3194501-販売価値の分配をリベース.md): リベースされたDVV - [グローバルなリベースされた販売価値の分配](https://success.openhealth.fr/ja/articles/4200619-グローバルなリベースされた販売価値の分配.md): グローバルリベースDVV - [カスタマイズされたリベースの販売価値配分](https://success.openhealth.fr/ja/articles/6834423-カスタマイズされたリベースの販売価値配分.md) - [デジタル販売流通SMKT](https://success.openhealth.fr/ja/articles/3365043-デジタル販売流通smkt.md): デジタル販売流通SMKT（SMK数値流通） - [デジタル配信を販売するグローバルSMKT](https://success.openhealth.fr/ja/articles/4298341-デジタル配信を販売するグローバルsmkt.md): SMKTグローバル数値分布（SMKTグローバル数値分布） - [リベースされたSMKT販売デジタル配信](https://success.openhealth.fr/ja/articles/4298197-リベースされたsmkt販売デジタル配信.md): SMKT Digital Distribution Rebased（SMKT Numeric Distribution Rebased） - [デジタル配信を販売するグローバルリベースSMKT](https://success.openhealth.fr/ja/articles/4319783-デジタル配信を販売するグローバルリベースsmkt.md): デジタル配信の販売SMKTRebaséeGlobale（SMKT Global Numeric Distribution Rebased） - [SMKT販売価値分布](https://success.openhealth.fr/ja/articles/3365478-smkt販売価値分布.md): SMKT販売価値分布（SMKT加重分布） - [再計算されたグローバルSMKT販売デジタル配信](https://success.openhealth.fr/ja/articles/4298373-再計算されたグローバルsmkt販売デジタル配信.md): 再計算されたSMKTグローバル数値分布 - [再計算されたSMKTリベースのデジタル配布販売](https://success.openhealth.fr/ja/articles/4298303-再計算されたsmktリベースのデジタル配布販売.md): SMKT数値分布再計算リベース - [調整されたSMKT販売デジタル配信](https://success.openhealth.fr/ja/articles/3369386-調整されたsmkt販売デジタル配信.md): 調整された数値分布SMKT - [再計算されたSMKTを販売するデジタル配布](https://success.openhealth.fr/ja/articles/4298209-再計算されたsmktを販売するデジタル配布.md): 再計算されたSMKT数値分布（再計算されたSMKT数値分布） - [調整されたSMKT販売価値分布](https://success.openhealth.fr/ja/articles/3369397-調整されたsmkt販売価値分布.md): 調整された加重分布SMKT - [オーガニックデジタル販売流通](https://success.openhealth.fr/ja/articles/7052424-オーガニックデジタル販売流通.md) - [販売薬局の売上高（TSP\)](https://success.openhealth.fr/ja/articles/6096534-販売薬局の売上高-tsp.md) - [所有者のPDMの見積もり](https://success.openhealth.fr/ja/articles/4214883-所有者のpdmの見積もり.md): 顧客との市場シェアを見積もる - [その他の薬局](https://success.openhealth.fr/ja/articles/8426451-その他の薬局.md) - [薬局の損失](https://success.openhealth.fr/ja/articles/8426460-薬局の損失.md) - [マルチチャネル・デジタル販売と流通](https://success.openhealth.fr/ja/articles/9293487-マルチチャネル-デジタル販売と流通.md) - [累積販売数デジタル配信（PHARMA）](https://success.openhealth.fr/ja/articles/9330571-累積販売数デジタル配信-pharma.md) - [月間平均売上高](https://success.openhealth.fr/ja/articles/3194303-月間平均売上高.md): 平均月間売上高 - [調整後の月間平均売上高](https://success.openhealth.fr/ja/articles/3194290-調整後の月間平均売上高.md): 調整後の平均月間売上高 - [月間平均売上高](https://success.openhealth.fr/ja/articles/4535404-月間平均売上高.md): VMM CA - [AMS To A：月次売上高平均値調整済み](https://success.openhealth.fr/ja/articles/6028256-ams-to-a-月次売上高平均値調整済み.md) - [平均売上高](https://success.openhealth.fr/ja/articles/3563716-平均売上高.md): 平均売上高 - [SMKT平均売上高](https://success.openhealth.fr/ja/articles/3365496-smkt平均売上高.md): SMKT平均売上高 - [調整済みSMKT平均売上高](https://success.openhealth.fr/ja/articles/3369340-調整済みsmkt平均売上高.md): 調整済みSMKT平均売上高 - [平均月次オーガニック売上高](https://success.openhealth.fr/ja/articles/7052551-平均月次オーガニック売上高.md) - [平均月商 オーガニックバリュー](https://success.openhealth.fr/ja/articles/7052573-平均月商-オーガニックバリュー.md) - [株式](https://success.openhealth.fr/ja/articles/3194332-株式.md): SMAaアプリケーションを介したHUB内の在庫データの定義と可用性：Sales＆MarketingAdvancedサブスクリプション - [平均在庫](https://success.openhealth.fr/ja/articles/3194336-平均在庫.md): 平均在庫 - [株式のシェア](https://success.openhealth.fr/ja/articles/3194334-株式のシェア.md): 株式のシェア - [商業圧力指数](https://success.openhealth.fr/ja/articles/3194335-商業圧力指数.md): 商業圧力指数 - [株式転換率](https://success.openhealth.fr/ja/articles/3194344-株式転換率.md): 株式転換率 - [供給期間](https://success.openhealth.fr/ja/articles/3194337-供給期間.md): 供給期間 - [仕入れ薬局の数](https://success.openhealth.fr/ja/articles/3194338-仕入れ薬局の数.md): 仕入れ薬局の数 - [ストッカーデジタル配信](https://success.openhealth.fr/ja/articles/3194339-ストッカーデジタル配信.md): Stockist Distribution（ND Stock） - [デジタル配信ストッカーがリベース](https://success.openhealth.fr/ja/articles/4045743-デジタル配信ストッカーがリベース.md): 在庫数値分布リベース - [グローバルにリベースされたデジタルストッカーの配布](https://success.openhealth.fr/ja/articles/4045753-グローバルにリベースされたデジタルストッカーの配布.md): グローバルにリベースされたデジタルストッカーの配布 - [仕入れ業者の価値分布](https://success.openhealth.fr/ja/articles/3194342-仕入れ業者の価値分布.md): ストッカーの価値分布（加重ストック分布：WDストック） - [在庫値の分布をリベース](https://success.openhealth.fr/ja/articles/3194505-在庫値の分布をリベース.md): DVSをリベース - [デジタル配信 スムーズストックリスト](https://success.openhealth.fr/ja/articles/5141830-デジタル配信-スムーズストックリスト.md) - [デジタル配信 ストックストア 平滑化 リベース](https://success.openhealth.fr/ja/articles/5142162-デジタル配信-ストックストア-平滑化-リベース.md) - [分布図 平滑化した株式価値](https://success.openhealth.fr/ja/articles/5203640-分布図-平滑化した株式価値.md) - [分配金 平滑化再算出株式価値](https://success.openhealth.fr/ja/articles/5203701-分配金-平滑化再算出株式価値.md) - [マージン](https://success.openhealth.fr/ja/articles/3507716-マージン.md): マージン - [マージン率](https://success.openhealth.fr/ja/articles/3507767-マージン率.md): マージン率 - [税抜きメーカー価格（PFHT）](https://success.openhealth.fr/ja/articles/4557500-税抜きメーカー価格-pfht.md): PFHT - [セルイン-顧客ベースの分析](https://success.openhealth.fr/ja/articles/3846225-セルイン-顧客ベースの分析.md): 忠誠心の指標：顧客基盤の特徴とその進化 - [セルイン-非定型薬局](https://success.openhealth.fr/ja/articles/3848791-セルイン-非定型薬局.md): 異型を検出するための措置 - [進化比](https://success.openhealth.fr/ja/articles/3194287-進化比.md): 進化比 - [浸透率](https://success.openhealth.fr/ja/articles/3194286-浸透率.md): 浸透率 - [製品の品揃え幅](https://success.openhealth.fr/ja/articles/3369425-製品の品揃え幅.md): 製品の品揃え幅 - [品揃えのリニューアル](https://success.openhealth.fr/ja/articles/3369545-品揃えのリニューアル.md): 品揃えのリニューアル - [品揃えの革新](https://success.openhealth.fr/ja/articles/3369468-品揃えの革新.md): 品揃えの革新 - [品揃えの損耗](https://success.openhealth.fr/ja/articles/3369457-品揃えの損耗.md): 品揃えの損耗 - [品揃えの減少率](https://success.openhealth.fr/ja/articles/3369485-品揃えの減少率.md): 品揃えの減少率 - [範囲革新率](https://success.openhealth.fr/ja/articles/3369541-範囲革新率.md): 範囲革新率 - [販売オファーのシェア](https://success.openhealth.fr/ja/articles/3369040-販売オファーのシェア.md): 販売オファーのシェア - [選択した製品の数](https://success.openhealth.fr/ja/articles/3511502-選択した製品の数.md): これは、GTIN-13桁のコードで選択された製品の数です。 - [製品の平均数](https://success.openhealth.fr/ja/articles/3194284-製品の平均数.md): 製品の平均数 - [範囲更新率](https://success.openhealth.fr/ja/articles/3369561-範囲更新率.md): 範囲更新率 - [製品数](https://success.openhealth.fr/ja/articles/6312686-製品数.md) - [行為ごとに費やされた金額](https://success.openhealth.fr/ja/articles/3447792-行為ごとに費やされた金額.md): 指標「行為あたりの支出額」に関する記事 - [購入者の種類ごとの支出額の内訳](https://success.openhealth.fr/ja/articles/3447801-購入者の種類ごとの支出額の内訳.md): 指標「購入者の種類別の支出額の内訳」に関する記事 - [消費指数](https://success.openhealth.fr/ja/articles/3432701-消費指数.md): 「消費指数」指標の定義 - [売上シェア](https://success.openhealth.fr/ja/articles/3432664-売上シェア.md): 「セールスシェア」インジケーターの定義 - [価値の忠誠率](https://success.openhealth.fr/ja/articles/3432695-価値の忠誠率.md): 指標の定義「価値の忠誠率」 - [絶対浸透](https://success.openhealth.fr/ja/articles/3432556-絶対浸透.md): 指標「絶対浸透」に関する記事 - [売上高のシェア](https://success.openhealth.fr/ja/articles/3432655-売上高のシェア.md): 指標「売上高のシェア」の定義 - [ピーバリュー](https://success.openhealth.fr/ja/articles/5781702-ピーバリュー.md) - [主成分分析](https://success.openhealth.fr/ja/articles/4231028-主成分分析.md): ACP - [負の予測値](https://success.openhealth.fr/ja/articles/4134220-負の予測値.md): 負の予測値 - [正の予測値](https://success.openhealth.fr/ja/articles/4134166-正の予測値.md): 正の予測値 - [独立性テスト](https://success.openhealth.fr/ja/articles/4128369-独立性テスト.md): 2つの変数が互いに関連しているかどうかを確認します - [時系列の研究](https://success.openhealth.fr/ja/articles/3633991-時系列の研究.md): 季節性、傾向、予測：知っておくべきこと - [季節変動率](https://success.openhealth.fr/ja/articles/3653790-季節変動率.md): 時系列の分散のシェアを測定します - [テストの感度と特異性](https://success.openhealth.fr/ja/articles/3928135-テストの感度と特異性.md): テストの有効性を分析するための概念を理解する - [トレンド変動率](https://success.openhealth.fr/ja/articles/3653847-トレンド変動率.md): 時系列のトレンドコンポーネントのシェアを測定します - [残差分散率](https://success.openhealth.fr/ja/articles/3653851-残差分散率.md): 時系列の残差成分のシェアを測定します - [決定係数](https://success.openhealth.fr/ja/articles/3654093-決定係数.md): 選択したモデルの品質を評価します - [変動係数](https://success.openhealth.fr/ja/articles/3653915-変動係数.md): 分解モデルを選択するためのインジケーター - [時系列の分散](https://success.openhealth.fr/ja/articles/3653855-時系列の分散.md): 系列の分散を測定する - [売上集中](https://success.openhealth.fr/ja/articles/3395856-売上集中.md): 売上集中 - [ジニインデックス](https://success.openhealth.fr/ja/articles/3395323-ジニインデックス.md): ジニインデックス - [人口](https://success.openhealth.fr/ja/articles/4396779-人口.md): 人口 - [死者数の進化](https://success.openhealth.fr/ja/articles/4396765-死者数の進化.md): 死者数の進化 - [性別比率](https://success.openhealth.fr/ja/articles/3812167-性別比率.md): 性別比率 - [人口-平均年齢](https://success.openhealth.fr/ja/articles/3812180-人口-平均年齢.md): 人口-平均年齢 - [人口-年齢の中央値](https://success.openhealth.fr/ja/articles/3812198-人口-年齢の中央値.md): 人口-年齢の中央値 - [人口-年齢第1四分位](https://success.openhealth.fr/ja/articles/3812218-人口-年齢第1四分位.md): 人口-年齢第1四分位 - [人口-年齢第3四分位](https://success.openhealth.fr/ja/articles/3812227-人口-年齢第3四分位.md): 人口-年齢第3四分位 - [領土の総人口における選択のシェア](https://success.openhealth.fr/ja/articles/3812233-領土の総人口における選択のシェア.md): 領土の総人口における選択のシェア - [死亡率](https://success.openhealth.fr/ja/articles/3947946-死亡率.md): 死亡率 - [症例死亡率](https://success.openhealth.fr/ja/articles/3948084-症例死亡率.md): 症例死亡率 - [出産可能年齢の女性](https://success.openhealth.fr/ja/articles/4172859-出産可能年齢の女性.md): 出産可能年齢の女性 - [領土内の総死亡者数に占める選択の割合](https://success.openhealth.fr/ja/articles/3863734-領土内の総死亡者数に占める選択の割合.md): 領土内の総死亡者数に占める選択の割合 - [行方不明の死者数のモデル化](https://success.openhealth.fr/ja/articles/3895572-行方不明の死者数のモデル化.md): 時間tでの死亡者数を予測する - [処方開始時の推定売上高](https://success.openhealth.fr/ja/articles/5323282-処方開始時の推定売上高.md) - [年齢・妊娠状態による進化](https://success.openhealth.fr/ja/articles/6820051-年齢-妊娠状態による進化.md) - [共同配送商品比率](https://success.openhealth.fr/ja/articles/7892010-共同配送商品比率.md) - [処方箋リフィル売上高推計](https://success.openhealth.fr/ja/articles/5323209-処方箋リフィル売上高推計.md) - [処方箋リフィル売上高の重み](https://success.openhealth.fr/ja/articles/5323198-処方箋リフィル売上高の重み.md) - [処方せん受付における売上高のウェイト](https://success.openhealth.fr/ja/articles/5323086-処方せん受付における売上高のウェイト.md) - [共同調剤の数](https://success.openhealth.fr/ja/articles/3194351-共同調剤の数.md): 共同調剤の数 - [調剤の数](https://success.openhealth.fr/ja/articles/3194348-調剤の数.md): 調剤の数 - [被保険者1人あたりの平均調剤数](https://success.openhealth.fr/ja/articles/3369626-被保険者1人あたりの平均調剤数.md): 被保険者1人あたりの平均調剤数 - [遵守](https://success.openhealth.fr/ja/articles/3411996-遵守.md): 薬所持率（MPR） - [持続率](https://success.openhealth.fr/ja/articles/3369684-持続率.md): 持続率 - [治療の遵守](https://success.openhealth.fr/ja/articles/3412091-治療の遵守.md): 治療の遵守 - [被保険者1人あたりの平均1日投与量](https://success.openhealth.fr/ja/articles/4153587-被保険者1人あたりの平均1日投与量.md): 被保険者1人あたりの平均1日投与量 - [償還のために提示された調剤の数](https://success.openhealth.fr/ja/articles/3370942-償還のために提示された調剤の数.md): 償還のために提示された調剤の数 - [償還のために提示されていない調剤の数](https://success.openhealth.fr/ja/articles/3370920-償還のために提示されていない調剤の数.md): 償還のために提示された調剤の数 - [強制健康保険の対象となる償還のために請求されるバリューセールス](https://success.openhealth.fr/ja/articles/3371699-強制健康保険の対象となる償還のために請求されるバリューセールス.md): 償還価値の販売 - [補完的な健康保険の対象となる返済額の販売](https://success.openhealth.fr/ja/articles/3371830-補完的な健康保険の対象となる返済額の販売.md): 償還価値の販売 - [優れた価値の販売](https://success.openhealth.fr/ja/articles/3371842-優れた価値の販売.md): 優れた価値の販売 - [有病率](https://success.openhealth.fr/ja/articles/3947955-有病率.md): 有病率 - [調剤ごとのGTINの平均数](https://success.openhealth.fr/ja/articles/3396154-調剤ごとのgtinの平均数.md): 調剤ごとのGTINの平均数 - [ディスペンスあたりの平均量](https://success.openhealth.fr/ja/articles/3396196-ディスペンスあたりの平均量.md): ディスペンスあたりの平均量 - [調剤あたりの平均売上高](https://success.openhealth.fr/ja/articles/3396208-調剤あたりの平均売上高.md): 調剤あたりの平均売上高 - [ボックスあたりの有効成分投与量](https://success.openhealth.fr/ja/articles/3675409-ボックスあたりの有効成分投与量.md): ボックスあたりの有効成分投与量 - [ボックスあたりのDDD](https://success.openhealth.fr/ja/articles/3675446-ボックスあたりのddd.md): ボックスごとの1日量を定義する - [基本単位のボリューム](https://success.openhealth.fr/ja/articles/3675520-基本単位のボリューム.md): 基本単位のボリューム - [アクティブな原則のボリューム](https://success.openhealth.fr/ja/articles/3675539-アクティブな原則のボリューム.md): アクティブな原則のボリューム - [住民1,000人あたりのDDJ](https://success.openhealth.fr/ja/articles/3675667-住民1-000人あたりのddj.md): 住民1,000人あたりの1日あたりの定義用量 - [被保険者1人あたりの平均UAの量](https://success.openhealth.fr/ja/articles/3675761-被保険者1人あたりの平均uaの量.md): 被保険者1人あたりの平均消費者単位のボリューム - [被保険者1人あたりの平均UBの量](https://success.openhealth.fr/ja/articles/3675814-被保険者1人あたりの平均ubの量.md): 被保険者1人あたりの平均基本単位のボリューム - [被保険者1人あたりの平均有効原理の量](https://success.openhealth.fr/ja/articles/3675824-被保険者1人あたりの平均有効原理の量.md): 被保険者1人あたりの平均有効原理の量 - [観察された平均治療期間](https://success.openhealth.fr/ja/articles/3675841-観察された平均治療期間.md): 観察された平均治療期間 - [免疫範囲](https://success.openhealth.fr/ja/articles/3822264-免疫範囲.md): 免疫範囲 - [含まれる患者](https://success.openhealth.fr/ja/articles/3886665-含まれる患者.md): コホートに含まれる患者の数 - [MPRとPDCの違い](https://success.openhealth.fr/ja/articles/3722666-mprとpdcの違い.md): MPR（薬所持率）vs。 PDC（対象日数の割合） - [平均治療期間](https://success.openhealth.fr/ja/articles/3920967-平均治療期間.md): 分析期間の終了時に平均治療時間を測定します - [平均更新時間](https://success.openhealth.fr/ja/articles/3921067-平均更新時間.md): 治療更新間の平均時間を測定する - [治療開始](https://success.openhealth.fr/ja/articles/3848844-治療開始.md): 治療開始 - [治療の更新](https://success.openhealth.fr/ja/articles/3885469-治療の更新.md): 治療の更新 - [治療の再開](https://success.openhealth.fr/ja/articles/3885608-治療の再開.md): 治療再開 - [新しい治療法](https://success.openhealth.fr/ja/articles/3885297-新しい治療法.md): 治療の開始と再開 - [治療スイッチ](https://success.openhealth.fr/ja/articles/3848886-治療スイッチ.md): 治療スイッチ - [治療が停止します](https://success.openhealth.fr/ja/articles/3885426-治療が停止します.md): 治療が停止します - [落ちる](https://success.openhealth.fr/ja/articles/3885387-落ちる.md): 落ちる - [トレーサビリティインサート](https://success.openhealth.fr/ja/articles/4355163-トレーサビリティインサート.md): トレーサビリティ - [一旦停止し、再スタート](https://success.openhealth.fr/ja/articles/8429189-一旦停止し-再スタート.md) - [ディスペンシングシェア](https://success.openhealth.fr/ja/articles/3624820-ディスペンシングシェア.md): ディスペンシングシェア - [関連する調剤のモニタリング](https://success.openhealth.fr/ja/articles/3804193-関連する調剤のモニタリング.md): 関連する薬局の薬局でのトラフィックの進化を追跡する - [崩壊率](https://success.openhealth.fr/ja/articles/4850138-崩壊率.md) - [反応のカイネティクス](https://success.openhealth.fr/ja/articles/4850629-反応のカイネティクス.md) - [半減期](https://success.openhealth.fr/ja/articles/4849710-半減期.md) - [在庫カバー率](https://success.openhealth.fr/ja/articles/4210714-在庫カバー率.md): 在庫カバー率 - [期間](https://success.openhealth.fr/ja/articles/3194479-期間.md): 期間 - [会計年度の定義を変更する](https://success.openhealth.fr/ja/articles/3321750-会計年度の定義を変更する.md): HUBを使用すると、会計年度を設定できます - [毎週の比較の管理](https://success.openhealth.fr/ja/articles/3835180-毎週の比較の管理.md): 調査した日の分析的影響 - [GSAのパラファーマシーカレンダー（SMKT）](https://success.openhealth.fr/ja/articles/3175583-gsaのパラファーマシーカレンダー-smkt.md): SMKTカレンダー（IRI）は、GSAドラッグストアカレンダーとも呼ばれます。 - [ない](https://success.openhealth.fr/ja/articles/3194484-ない.md): メジャー「N」の定義 - [NEvol](https://success.openhealth.fr/ja/articles/3194461-nevol.md): 「NEvol」メジャーの定義と計算式 - [Nトレンド](https://success.openhealth.fr/ja/articles/3194485-nトレンド.md): 「Nトレンド」メジャーの定義 ### IAS - Indicateurs Avancés Sanitaires - [IAS\(r\)アレルギー](https://success.openhealth.fr/ja/articles/7339151-ias-r-アレルギー.md) - [IAS\(r\) プー](https://success.openhealth.fr/ja/articles/7339168-ias-r-プー.md) - [IAS\(r\)胃腸炎](https://success.openhealth.fr/ja/articles/7339181-ias-r-胃腸炎.md) - [IAS\(r\) インフルエンザ様疾患](https://success.openhealth.fr/ja/articles/7266711-ias-r-インフルエンザ様疾患.md) ### Marketing Direct - [OpenHealthメール配信ソリューション](https://success.openhealth.fr/ja/articles/7055261-openhealthメール配信ソリューション.md) - [メールキャンペーン制作に必要な条件](https://success.openhealth.fr/ja/articles/6282113-メールキャンペーン制作に必要な条件.md) - [トラッキングレポートとベンチマーク](https://success.openhealth.fr/ja/articles/6302721-トラッキングレポートとベンチマーク.md) - [メールキャンペーンに関する用語集](https://success.openhealth.fr/ja/articles/6282099-メールキャンペーンに関する用語集.md) ### プサド - [分析-全国](https://success.openhealth.fr/ja/articles/3376262-分析-全国.md): ホームヘルスプロバイダー（PSAD）市場のパフォーマンスを分析します：エリア、アクティビティ、サブアクティビティ、セグメント、LPP行為 - [ボリューム/売上高-全国](https://success.openhealth.fr/ja/articles/3376287-ボリューム-売上高-全国.md): アクティビティをボリュームと値で同時に表示します：エリア、アクティビティ、サブアクティビティ、セグメント、LPP行為（製品とサービスのリスト） - [進化-全国](https://success.openhealth.fr/ja/articles/3376370-進化-全国.md): 利用可能な履歴に基づいて市場の進化を視覚化します：ドメイン、アクティビティ、サブアクティビティ、セグメント、LPP行為 - [抽出-NATIONAL](https://success.openhealth.fr/ja/articles/3376420-抽出-national.md): データをExcelにエクスポートする - [定義](https://success.openhealth.fr/ja/articles/3376439-定義.md): SantéDomStatObservatoireNationalのすべての機能を見つける-必須アプリケーション ### AUTRES THEMATIQUES - [インターコム](https://success.openhealth.fr/ja/articles/6959415-インターコム.md) - [セールスフォース](https://success.openhealth.fr/ja/articles/6959337-セールスフォース.md) - [GIHSN：Excelファイルを送信する](https://success.openhealth.fr/ja/articles/3977478-gihsn-excelファイルを送信する.md): GIHSNExcelファイル - [ブロックチェーン](https://success.openhealth.fr/ja/articles/5385413-ブロックチェーン.md) - [DocuSign、ビジネスプロセスのCRMツール](https://success.openhealth.fr/ja/articles/4514472-docusign-ビジネスプロセスのcrmツール.md): Docusign：ビジネスプロセスにおけるCRMツール - [全国予防接種の追跡調査](https://success.openhealth.fr/ja/articles/4754333-全国予防接種の追跡調査.md) - [ワクチン接種率](https://success.openhealth.fr/ja/articles/4754311-ワクチン接種率.md) - [KPIモニタリング](https://success.openhealth.fr/ja/articles/4091042-kpiモニタリング.md): POC ProPharma Systems：スイスの市場動向 - [薬局コックピット](https://success.openhealth.fr/ja/articles/4091025-薬局コックピット.md): POC ProPharma Systems：My Pharmacy vs Switzerland - [人口当量（p.e.）](https://success.openhealth.fr/ja/articles/5431894-人口当量-p-e.md) - [酸素要求量](https://success.openhealth.fr/ja/articles/5137158-酸素要求量.md): 廃水処理に必要な物質量 - [アイエイチユー](https://success.openhealth.fr/ja/articles/4851687-アイエイチユー.md) - [浮遊物質](https://success.openhealth.fr/ja/articles/5137147-浮遊物質.md): 排水中の不溶性固形物 - [廃水化学](https://success.openhealth.fr/ja/articles/5137101-廃水化学.md): 排水中の監視対象化学物質 - [エヌアールビーシーイー](https://success.openhealth.fr/ja/articles/4851683-エヌアールビーシーイー.md) - [アレニウスの法則](https://success.openhealth.fr/ja/articles/4849672-アレニウスの法則.md) - [結果パフォーマンス](https://success.openhealth.fr/ja/articles/5137034-結果パフォーマンス.md): 排水処理の質の算出 - [排水の種類](https://success.openhealth.fr/ja/articles/5137183-排水の種類.md): 排水の分類 - [SARS-CoV-2ウイルス濃度](https://success.openhealth.fr/ja/articles/4867968-sars-cov-2ウイルス濃度.md) - [MAPOM / BMPM](https://success.openhealth.fr/ja/articles/4851685-mapom-bmpm.md) - [SARS-CoV-2のコンテクスト濃度](https://success.openhealth.fr/ja/articles/4934604-sars-cov-2のコンテクスト濃度.md) - [下水道設備の種類](https://success.openhealth.fr/ja/articles/4867954-下水道設備の種類.md): 下水道設備の種類 - [ウイルスの分解](https://success.openhealth.fr/ja/articles/4865742-ウイルスの分解.md): ウイルスの分解 - [廃液を利用した疫学](https://success.openhealth.fr/ja/articles/4865735-廃液を利用した疫学.md): 廃液を利用した疫学 - [RNA](https://success.openhealth.fr/ja/articles/4865733-rna.md) - [コロナウイルス](https://success.openhealth.fr/ja/articles/4865728-コロナウイルス.md) - [COVID-19](https://success.openhealth.fr/ja/articles/4865726-covid-19.md): COVID-19 - [血清有病率：サンプリング方法](https://success.openhealth.fr/ja/articles/3924493-血清有病率-サンプリング方法.md): 血清有病率：サンプリング法 - [SANDREレポジトリ](https://success.openhealth.fr/ja/articles/5415040-sandreレポジトリ.md) - [ナショナルベース ROSEAU](https://success.openhealth.fr/ja/articles/5414523-ナショナルベース-roseau.md): 自治体の衛生に関する情報 - [SARS-CoV-2ウイルス濃度](https://success.openhealth.fr/ja/articles/4852404-sars-cov-2ウイルス濃度.md) - [SARS-CoV-2ウイルス濃度 - 変異例](https://success.openhealth.fr/ja/articles/4909854-sars-cov-2ウイルス濃度-変異例.md) - [マルセイユ - グローバルモニタリング](https://success.openhealth.fr/ja/articles/4859311-マルセイユ-グローバルモニタリング.md) - [SARS-CoV-2ウイルス濃度 - ニース](https://success.openhealth.fr/ja/articles/4879292-sars-cov-2ウイルス濃度-ニース.md) - [人口 - 構造](https://success.openhealth.fr/ja/articles/4842408-人口-構造.md) - [SARS-CoV-2ウイルスの濃縮 - トゥーロン \(フランス\)](https://success.openhealth.fr/ja/articles/4886417-sars-cov-2ウイルスの濃縮-トゥーロン-フランス.md) - [ドバイ - 空港排水のモニタリング](https://success.openhealth.fr/ja/articles/5276423-ドバイ-空港排水のモニタリング.md) - [SARS-CoV-2サーベイランス - OBEPINE](https://success.openhealth.fr/ja/articles/5210661-sars-cov-2サーベイランス-obepine.md) - [SARS-CoV-2のコンテクスト濃度](https://success.openhealth.fr/ja/articles/4934608-sars-cov-2のコンテクスト濃度.md): セクター別のSARS-CoV-2濃度の推移を確認する。 - [SUEZ - アナリティカル・バランスシート](https://success.openhealth.fr/ja/articles/5140509-suez-アナリティカル-バランスシート.md) - [パレ・デ・フェスティヴァル - T0を見る](https://success.openhealth.fr/ja/articles/5373515-パレ-デ-フェスティヴァル-t0を見る.md) - [パレ・デ・フェスティヴァル - 日々の祈り](https://success.openhealth.fr/ja/articles/5373231-パレ-デ-フェスティヴァル-日々の祈り.md) - [パレ・デ・フェスティヴァル - 上映](https://success.openhealth.fr/ja/articles/5404778-パレ-デ-フェスティヴァル-上映.md) - [ムステリッド - 見る](https://success.openhealth.fr/ja/articles/5169577-ムステリッド-見る.md) - [人口 - IRIS](https://success.openhealth.fr/ja/articles/4842191-人口-iris.md) - [SARS-CoV-2](https://success.openhealth.fr/ja/articles/4865699-sars-cov-2.md) - [IAS - 分析](https://success.openhealth.fr/ja/articles/4842430-ias-分析.md) - [SARS-CoV-2ウイルス濃度 - SEM](https://success.openhealth.fr/ja/articles/5415600-sars-cov-2ウイルス濃度-sem.md) - [マップの視覚化](https://success.openhealth.fr/ja/articles/3864657-マップの視覚化.md): 患者の地理的再分割 - [寄稿サイト](https://success.openhealth.fr/ja/articles/3864668-寄稿サイト.md): サイトおよび病院による貢献 - [サイト別のコホートプロファイル](https://success.openhealth.fr/ja/articles/3864672-サイト別のコホートプロファイル.md): サイトおよび病院別のコホートプロファイル - [季節別のコホートプロファイル](https://success.openhealth.fr/ja/articles/3864673-季節別のコホートプロファイル.md): 季節別のコホートプロファイル - [年齢と性別の分布](https://success.openhealth.fr/ja/articles/3864675-年齢と性別の分布.md): 人口統計 - [サイトごとのウイルス分布](https://success.openhealth.fr/ja/articles/3864678-サイトごとのウイルス分布.md): サイトごとのウイルス分布 - [年齢別のウイルス分布](https://success.openhealth.fr/ja/articles/3864677-年齢別のウイルス分布.md): 年齢別のウイルス分布 - [ウイルス分布の進化](https://success.openhealth.fr/ja/articles/3864681-ウイルス分布の進化.md): ウイルス分布の進化 - [インフルエンザワクチン接種](https://success.openhealth.fr/ja/articles/3864697-インフルエンザワクチン接種.md): インフルエンザワクチン接種 - [インフルエンザワクチン接種の進化](https://success.openhealth.fr/ja/articles/3864701-インフルエンザワクチン接種の進化.md): インフルエンザワクチン接種の進化 - [慢性状態による患者の分布](https://success.openhealth.fr/ja/articles/3864676-慢性状態による患者の分布.md): 慢性状態による患者の分布 - [入院期間別の患者分布](https://success.openhealth.fr/ja/articles/3864794-入院期間別の患者分布.md): 入院期間別の患者分布 - [虚弱](https://success.openhealth.fr/ja/articles/3864704-虚弱.md): 患者の脆弱性 - [重大度ステータス](https://success.openhealth.fr/ja/articles/3864705-重大度ステータス.md): 重大度ステータス - [死亡](https://success.openhealth.fr/ja/articles/3864710-死亡.md): 死亡 - [GIHSN](https://success.openhealth.fr/ja/articles/3864712-gihsn.md): グローバルインフルエンザ病院監視ネットワーク - [CARéDIAB-患者プロファイル](https://success.openhealth.fr/ja/articles/3789234-carediab-患者プロファイル.md): CARéDIAB集団の患者プロファイルを分析する - [CARéDIAB-合併症](https://success.openhealth.fr/ja/articles/3789515-carediab-合併症.md): 私たちの人口の合併症の有病率を分析します カレディアブ - [CARéDIAB-グローバルな患者モニタリング](https://success.openhealth.fr/ja/articles/3792041-carediab-グローバルな患者モニタリング.md): CARéDIAB集団における患者のフォローアップの頻度を分析する - [CARéDIABネットワーク](https://success.openhealth.fr/ja/articles/3789106-carediabネットワーク.md): CARéDIABネットワーク - [CARéDIAB-トリートメント](https://success.openhealth.fr/ja/articles/3792143-carediab-トリートメント.md): 糖尿病との関連で治療を受けることを分析する ## 한국어 ### Votre PLATEFORME - présentation générale - [종합적이고 지속적인 지원 플랫폼, HUB](https://success.openhealth.fr/ko/articles/4799621-종합적이고-지속적인-지원-플랫폼-hub.md) - [경험 수준 The HUB](https://success.openhealth.fr/ko/articles/5712270-경험-수준-the-hub.md) - [Languages](https://success.openhealth.fr/ko/articles/4649389-languages.md): Here is the description of all languages available on Success - [요금에 대한 질문](https://success.openhealth.fr/ko/articles/3292143-요금에-대한-질문.md): 가격 ### 로드맵 - [고객을 위한 개방형 혁신](https://success.openhealth.fr/ko/articles/5200970-고객을-위한-개방형-혁신.md) - [앱 + 관리 영역 버전 240515](https://success.openhealth.fr/ko/articles/9310541-앱-관리-영역-버전-240515.md) - [앱 + 관리 영역 버전 240415](https://success.openhealth.fr/ko/articles/9310710-앱-관리-영역-버전-240415.md) - [앱 + 관리 영역 버전 240315](https://success.openhealth.fr/ko/articles/9310790-앱-관리-영역-버전-240315.md) - [앱 + 관리 영역 버전 240215](https://success.openhealth.fr/ko/articles/9311007-앱-관리-영역-버전-240215.md) - [플랫폼 - 업데이트 231215](https://success.openhealth.fr/ko/articles/8718485-플랫폼-업데이트-231215.md) - [플랫폼 - 업데이트 231015](https://success.openhealth.fr/ko/articles/8479932-플랫폼-업데이트-231015.md) - [앱 + 포털 버전 230915](https://success.openhealth.fr/ko/articles/8373640-앱-포털-버전-230915.md) - [앱 + 포털 버전 230815](https://success.openhealth.fr/ko/articles/8267860-앱-포털-버전-230815.md) - [신제품 230715](https://success.openhealth.fr/ko/articles/8115796-신제품-230715.md) - [앱 + 포털 버전 230615](https://success.openhealth.fr/ko/articles/8115791-앱-포털-버전-230615.md) - [앱 + 포털 버전 230515](https://success.openhealth.fr/ko/articles/7895393-앱-포털-버전-230515.md) - [앱 + 포털 버전 230415](https://success.openhealth.fr/ko/articles/7439447-앱-포털-버전-230415.md) - [앱 + 포털 버전 230315](https://success.openhealth.fr/ko/articles/7439646-앱-포털-버전-230315.md) - [앱 + 포털 버전 230215](https://success.openhealth.fr/ko/articles/7439744-앱-포털-버전-230215.md) - [15/01/2023 뉴스](https://success.openhealth.fr/ko/articles/6895740-15-01-2023-뉴스.md) - [허브 + 게이트 버전 221215](https://success.openhealth.fr/ko/articles/6827027-허브-게이트-버전-221215.md) - [허브 + 게이트 버전 221115](https://success.openhealth.fr/ko/articles/6742628-허브-게이트-버전-221115.md) - [허브 + 게이트 버전 220915](https://success.openhealth.fr/ko/articles/6558070-허브-게이트-버전-220915.md) - [허브 + 게이트 버전 220815](https://success.openhealth.fr/ko/articles/6475311-허브-게이트-버전-220815.md) - [허브 + 게이트 버전 220615](https://success.openhealth.fr/ko/articles/6306090-허브-게이트-버전-220615.md) - [허브 + 게이트 버전 220515](https://success.openhealth.fr/ko/articles/6201877-허브-게이트-버전-220515.md) - [허브 + 게이트 버전 220415](https://success.openhealth.fr/ko/articles/6087747-허브-게이트-버전-220415.md) - [HUB SMA 버전 220315](https://success.openhealth.fr/ko/articles/6043772-hub-sma-버전-220315.md) - [HUB TMA 버전 220315](https://success.openhealth.fr/ko/articles/6043802-hub-tma-버전-220315.md) - [HUB UAN 버전 220315](https://success.openhealth.fr/ko/articles/6043852-hub-uan-버전-220315.md) - [GATE 버전 220215](https://success.openhealth.fr/ko/articles/5940805-gate-버전-220215.md) - [HUB SMA 버전 220215](https://success.openhealth.fr/ko/articles/5940753-hub-sma-버전-220215.md) - [HUB TMA 버전 220215](https://success.openhealth.fr/ko/articles/5947859-hub-tma-버전-220215.md) - [GATE 버전 211215](https://success.openhealth.fr/ko/articles/5819397-gate-버전-211215.md) - [HUB SMA 버전 211215](https://success.openhealth.fr/ko/articles/5784709-hub-sma-버전-211215.md) - [HUB TMA 버전 211215](https://success.openhealth.fr/ko/articles/5784888-hub-tma-버전-211215.md) - [HUB UAN 버전 211215](https://success.openhealth.fr/ko/articles/5784904-hub-uan-버전-211215.md) - [애플리케이션 허브: "약국 상태".](https://success.openhealth.fr/ko/articles/5704485-애플리케이션-허브-약국-상태.md) - [GATE 버전 211115](https://success.openhealth.fr/ko/articles/5697844-gate-버전-211115.md) - [HUB SMA 버전 211115](https://success.openhealth.fr/ko/articles/5671893-hub-sma-버전-211115.md) - [HUB TMA 버전 211115](https://success.openhealth.fr/ko/articles/5671917-hub-tma-버전-211115.md) - [HUB UAN 버전 211115](https://success.openhealth.fr/ko/articles/5671927-hub-uan-버전-211115.md) - [GATE 버전 211015](https://success.openhealth.fr/ko/articles/5652210-gate-버전-211015.md) - [HUB SMA 버전 211015](https://success.openhealth.fr/ko/articles/5649822-hub-sma-버전-211015.md) - [HUB TMA 버전 211015](https://success.openhealth.fr/ko/articles/5650073-hub-tma-버전-211015.md) - [HUB UAN 버전 211015](https://success.openhealth.fr/ko/articles/5652242-hub-uan-버전-211015.md) - [HUB SMA 버전 210915](https://success.openhealth.fr/ko/articles/5370516-hub-sma-버전-210915.md) - [HUB TMA 버전 210915](https://success.openhealth.fr/ko/articles/5390983-hub-tma-버전-210915.md) - [HUB UAN 버전 210915](https://success.openhealth.fr/ko/articles/5543213-hub-uan-버전-210915.md) ### Votre ESPACE D'ADMINISTRATION - fonctionnalités - [비밀번호 재설정 / 변경 The HUB](https://success.openhealth.fr/ko/articles/4425325-비밀번호-재설정-변경-the-hub.md): HUB 비밀번호 변경 방법 - [연결 지원: 오류 메시지가 표시됩니다.](https://success.openhealth.fr/ko/articles/5369783-연결-지원-오류-메시지가-표시됩니다.md) - [티켓 생성 및 추적](https://success.openhealth.fr/ko/articles/3586214-티켓-생성-및-추적.md): 개인 공간에서 티켓의 진화 과정을 만들고 따르기위한 튜토리얼 The HUB - [성공 문서 만들기 및 수정하기](https://success.openhealth.fr/ko/articles/6738705-성공-문서-만들기-및-수정하기.md) - [내 계약](https://success.openhealth.fr/ko/articles/5712273-내-계약.md) - [서비스 상태](https://success.openhealth.fr/ko/articles/4990600-서비스-상태.md) - [내 액세스 권한](https://success.openhealth.fr/ko/articles/5783418-내-액세스-권한.md) - [내 홈페이지 설정](https://success.openhealth.fr/ko/articles/5712229-내-홈페이지-설정.md) - [개인 OpenHealth 공간에서 시장을 수정하는 방법은 무엇입니까?](https://success.openhealth.fr/ko/articles/3585971-개인-openhealth-공간에서-시장을-수정하는-방법은-무엇입니까.md): 개인 OpenHealth 공간에서 제품 통합, 수정 및 비활성화 - [자동 양식 할당 수정 \(Auto MAM\)](https://success.openhealth.fr/ko/articles/4164818-자동-양식-할당-수정-auto-mam.md): 제품 할당을 직접 수정 - [TEMPORAL MAM : 실험실 / 브랜드 / 라벨을 바꾸는 브랜드를 어떻게 따르나요?](https://success.openhealth.fr/ko/articles/4131072-temporal-mam-실험실-브랜드-라벨을-바꾸는-브랜드를-어떻게-따르나요.md): 추적 유형의 이점 및 위험 - [자동 제품 통합 \(자동 IPR\)](https://success.openhealth.fr/ko/articles/4164932-자동-제품-통합-자동-ipr.md): 시장에서 제품 통합 요청 - [자동 제품 비활성화 \(자동 DPR\)](https://success.openhealth.fr/ko/articles/4164866-자동-제품-비활성화-자동-dpr.md): 시장에서 제품 비활성화 - [자동 제품 재활성화\(RPR 자동\)](https://success.openhealth.fr/ko/articles/4818161-자동-제품-재활성화-rpr-자동.md) - [새 제품 설정](https://success.openhealth.fr/ko/articles/5811248-새-제품-설정.md) - [마켓 추가](https://success.openhealth.fr/ko/articles/5712283-마켓-추가.md) - [벌크 제품 가져오기/내보내기](https://success.openhealth.fr/ko/articles/5712257-벌크-제품-가져오기-내보내기.md) - [유형학적 양식 변경\(CMT\)](https://success.openhealth.fr/ko/articles/4670174-유형학적-양식-변경-cmt.md) - [다른 사용자 상태](https://success.openhealth.fr/ko/articles/3436418-다른-사용자-상태.md): 기능은 무엇입니까? - [타사 조직\(TPAA\)에서 사용자 계정 만들기](https://success.openhealth.fr/ko/articles/6466550-타사-조직-tpaa-에서-사용자-계정-만들기.md) - [The HUB에서 사용자 계정을 생성, 수정 또는 삭제하는 방법은 무엇입니까?](https://success.openhealth.fr/ko/articles/3785138-the-hub에서-사용자-계정을-생성-수정-또는-삭제하는-방법은-무엇입니까.md): 파워 유저 만이이 작업을 수행 할 수 있습니다. - [팀 내 HUB에서 차별화 된 시청 권한을 만들 수 있습니까?](https://success.openhealth.fr/ko/articles/3321731-팀-내-hub에서-차별화-된-시청-권한을-만들-수-있습니까.md): 허브에서의 권리 - [활동 로그](https://success.openhealth.fr/ko/articles/4687438-활동-로그.md) ### Vos APPLICATIONS - présentation - [HUB 교육 가이드](https://success.openhealth.fr/ko/articles/5634967-hub-교육-가이드.md) - [정렬 드롭다운 선택기](https://success.openhealth.fr/ko/articles/5792113-정렬-드롭다운-선택기.md) - [HuB의 GSA 약국 데이터 \(SMKT\) 업데이트 날짜](https://success.openhealth.fr/ko/articles/3175557-hub의-gsa-약국-데이터-smkt-업데이트-날짜.md): 이 문서는 GSA 약국 \(SMKT\)의 데이터가 업데이트 된 날짜를 설명합니다. - [전제 조건 일치 약국 파일](https://success.openhealth.fr/ko/articles/3678146-전제-조건-일치-약국-파일.md): 전제 조건 일치 약국 파일 - ["On and Off Prescription"선택기](https://success.openhealth.fr/ko/articles/3729668-on-and-off-prescription-선택기.md): 'Prescription Type Selector'개체의 사양 - [HUB에서 신제품을 인증하는 방법은 무엇입니까?](https://success.openhealth.fr/ko/articles/3376100-hub에서-신제품을-인증하는-방법은-무엇입니까.md): HUB의 신제품 자격 - [HUB에서 즐겨 찾기를 생성, 편집 및 공유하는 방법은 무엇입니까?](https://success.openhealth.fr/ko/articles/3175689-hub에서-즐겨-찾기를-생성-편집-및-공유하는-방법은-무엇입니까.md): 허브에서 즐겨 찾기 생성 및 공유 - [출시일까지 HUB에서 제품을 선택하려면 어떻게하나요?](https://success.openhealth.fr/ko/articles/3158428-출시일까지-hub에서-제품을-선택하려면-어떻게하나요.md): 이 문서에서는 특정 기간에 출시 된 제품 만 선택하는 방법을 설명합니다. - [HUB에서 데이터를 ".csv" 형식으로 추출할 수 있나요?](https://success.openhealth.fr/ko/articles/5671278-hub에서-데이터를-csv-형식으로-추출할-수-있나요.md) - [ODT 응답 시간](https://success.openhealth.fr/ko/articles/6632310-odt-응답-시간.md) - [HUB의 모범 디스플레이 사례는 무엇입니까?](https://success.openhealth.fr/ko/articles/3124454-hub의-모범-디스플레이-사례는-무엇입니까.md): 이 문서에서는 HUB 표시를 최적화하는 모범 사례를 자세히 설명합니다. - [기술 요구 사항](https://success.openhealth.fr/ko/articles/5369918-기술-요구-사항.md) - [브라우저 캐시 지우기](https://success.openhealth.fr/ko/articles/4219722-브라우저-캐시-지우기.md): Google 크롬 브라우저 캐시를 지우는 방법 - [Google 크롬을 기본 브라우저로 설정하려면 어떻게합니까?](https://success.openhealth.fr/ko/articles/3738717-google-크롬을-기본-브라우저로-설정하려면-어떻게합니까.md): Google 크롬을 기본값으로 설정하는 방법 - [내비게이션 엘리베이터는 테이블에 보이지 않습니다.](https://success.openhealth.fr/ko/articles/3195250-내비게이션-엘리베이터는-테이블에-보이지-않습니다.md): 내비게이션 리프트 - [시트의 단추 또는 개체 표시가 부분적으로 잘 리거나 보이지 않습니다.](https://success.openhealth.fr/ko/articles/3195245-시트의-단추-또는-개체-표시가-부분적으로-잘-리거나-보이지-않습니다.md): 버튼, 개체의 표시 문제 - [내 영역 관리 카드가로드되지 않고 "로드 중"메시지가 나타납니다.](https://success.openhealth.fr/ko/articles/3195239-내-영역-관리-카드가로드되지-않고-로드-중-메시지가-나타납니다.md): 영토 관리 / TMA지도 표시 문제 - ["이 페이지에 액세스 할 수있는 권한이 없습니다."오류 메시지의 출처는 어디입니까?](https://success.openhealth.fr/ko/articles/3195338-이-페이지에-액세스-할-수있는-권한이-없습니다-오류-메시지의-출처는-어디입니까.md): 오류 메시지 - ["연결 끊김"오류 메시지가 나타납니다.](https://success.openhealth.fr/ko/articles/4445141-연결-끊김-오류-메시지가-나타납니다.md): 오류가 발생했습니다 - [잘못된 게이트웨이](https://success.openhealth.fr/ko/articles/4514555-잘못된-게이트웨이.md): "잘못된 게이트웨이"오류 메시지 - [차원 및 측정 값 선택기가 "Multiple Period Analysis"및 "My Data Archive"쿼리 러에 더 이상 표시되지 않으며 "Market Analysis"에서 테이블 추출이 부분적으로 수행됩니다.](https://success.openhealth.fr/ko/articles/3195377-차원-및-측정-값-선택기가-multiple-period-analysis-및-my-data-archive-쿼리-러에-더-이상-표시되지-않으며-market-analysis-에서-테이블-추출이-부분적으로-수행됩니다.md): 차원 및 측정 값이 더 이상 표시되지 않습니다. - [HUB에서 용어를 보는 방법?](https://success.openhealth.fr/ko/articles/3194377-hub에서-용어를-보는-방법.md): HUB를 사용하면 'Sales Evolution'시트에서 4 륜구동기를 쉽게 볼 수 있습니다. - [Excel 사양 및 제한 사항](https://success.openhealth.fr/ko/articles/3753088-excel-사양-및-제한-사항.md): 이 문서에서는 Excel의 사양 및 제한 사항에 대해 설명합니다. - [애플리케이션에서 즐겨찾기를 만들고, 편집하고, 공유하려면 어떻게 해야 하나요?](https://success.openhealth.fr/ko/articles/10502803-애플리케이션에서-즐겨찾기를-만들고-편집하고-공유하려면-어떻게-해야-하나요.md) - [소비자 패널 프레임 워크](https://success.openhealth.fr/ko/articles/3455845-소비자-패널-프레임-워크.md): 소비자 패널 프레임 워크 관련 기사 - [약국 시장 분석 프레임 워크](https://success.openhealth.fr/ko/articles/3455857-약국-시장-분석-프레임-워크.md): 약국 채널에서 시장 성과를 분석하기위한 OpenHealth 프레임 워크 관련 기사 ### 데이터 소스 - [OpenHealth 약국 패널이란 무엇입니까?](https://success.openhealth.fr/ko/articles/3304106-openhealth-약국-패널이란-무엇입니까.md): 이 기사는 약국 패널, 구성 방식, 진화 및 외삽 방법을 설명하는 것을 목표로합니다. - [현재 및 미래의 건강 위기 관리에 결정적인 자산 인 약국 네트워크](https://success.openhealth.fr/ko/articles/3825648-현재-및-미래의-건강-위기-관리에-결정적인-자산-인-약국-네트워크.md): 전례없는 건강 위기를 모니터링하기 위해 노력하는 OpenHealth Company는 자사의 기술과 데이터를 동원합니다. - [HUB에서 볼 수있는 프랑스 해외 부서의 영토 및 영토는 무엇입니까?](https://success.openhealth.fr/ko/articles/3194382-hub에서-볼-수있는-프랑스-해외-부서의-영토-및-영토는-무엇입니까.md): 허브에서 사용할 수있는 DROM-COM 영역 - [필수 섹터 화 파일](https://success.openhealth.fr/ko/articles/3702701-필수-섹터-화-파일.md): 이 문서에서는 섹터 화 파일을 다운로드, 완료 및 제출할 수 있습니다. - [SMKT 데이터 소스](https://success.openhealth.fr/ko/articles/4485357-smkt-데이터-소스.md): IRI, GSA 약국 데이터 공급 업체 - [IRI의 GSA Parapharmacy Products Coding Rules \(SMKT\)](https://success.openhealth.fr/ko/articles/3524492-iri의-gsa-parapharmacy-products-coding-rules-smkt.md): IRI에서 SMKT 제품에 대한 코드화 규칙 알림 - [유기농 스토어 데이터 - 출처 바이오애널리틱스](https://success.openhealth.fr/ko/articles/5631260-유기농-스토어-데이터-출처-바이오애널리틱스.md) - [전자 약국: 모니터링 플랫폼](https://success.openhealth.fr/ko/articles/9167006-전자-약국-모니터링-플랫폼.md) - [E-pharmacies 제품 손익](https://success.openhealth.fr/ko/articles/3568773-e-pharmacies-제품-손익.md): 'E-pharmacies Product Gains & Losses'모듈 관련 기사 - [소비자 프로필](https://success.openhealth.fr/ko/articles/3711085-소비자-프로필.md): '소비자 프로필'모듈 관련 기사 - [아마존 데이터 - 출처 SELLINGZ](https://success.openhealth.fr/ko/articles/5669013-아마존-데이터-출처-sellingz.md) - [이커머스 데이터 - 출처 WISER](https://success.openhealth.fr/ko/articles/7983010-이커머스-데이터-출처-wiser.md) - [지리적 영역](https://success.openhealth.fr/ko/articles/4661582-지리적-영역.md): Open Health Company에서는 우리가 제공하는 지리적 영역에 따라 시장을 분석 할 수 있습니다. - [독일의 약국 패널이란 무엇인가요? 인사이트](https://success.openhealth.fr/ko/articles/5391412-독일의-약국-패널이란-무엇인가요-인사이트.md) - [그리스의 약국 패널이란 무엇인가요? ALIRAHEALTH](https://success.openhealth.fr/ko/articles/6863963-그리스의-약국-패널이란-무엇인가요-alirahealth.md) - [오스트리아의 약국 패널이란 무엇인가요? 인사이트](https://success.openhealth.fr/ko/articles/6863949-오스트리아의-약국-패널이란-무엇인가요-인사이트.md) - [아프리카 약국 패널이란 무엇인가요? PIEX - 아프리카](https://success.openhealth.fr/ko/articles/6686633-아프리카-약국-패널이란-무엇인가요-piex-아프리카.md) - [독일의 온라인 약국 패널이란 무엇인가요? 데이터메디크](https://success.openhealth.fr/ko/articles/5689640-독일의-온라인-약국-패널이란-무엇인가요-데이터메디크.md) - [벨기에의 약국 패널이란 무엇인가요? REDPHARMA](https://success.openhealth.fr/ko/articles/4689894-벨기에의-약국-패널이란-무엇인가요-redpharma.md) - [스페인의 약국 패널이란 무엇인가요? - HMR](https://success.openhealth.fr/ko/articles/5391363-스페인의-약국-패널이란-무엇인가요-hmr.md) - [스페인의 약국 패널은 무엇입니까? - INFONIS](https://success.openhealth.fr/ko/articles/5428915-스페인의-약국-패널은-무엇입니까-infonis.md) - [포르투갈의 약국 패널이란 무엇인가요? - HMR](https://success.openhealth.fr/ko/articles/5391477-포르투갈의-약국-패널이란-무엇인가요-hmr.md) - [러시아의 약국 패널이란 무엇인가요? - ALPHARM](https://success.openhealth.fr/ko/articles/5701531-러시아의-약국-패널이란-무엇인가요-alpharm.md) - [폴란드의 약국 패널이란 무엇인가요? 펙스 파마](https://success.openhealth.fr/ko/articles/5969485-폴란드의-약국-패널이란-무엇인가요-펙스-파마.md) - [그룹 전환](https://success.openhealth.fr/ko/articles/6961966-그룹-전환.md) - [요르단의 약국 패널은 무엇인가요?](https://success.openhealth.fr/ko/articles/8176750-요르단의-약국-패널은-무엇인가요.md) - [인구-지도 제작](https://success.openhealth.fr/ko/articles/3807695-인구-지도-제작.md): 인구의 지리적 분포 분석 - [AMELI - LPP](https://success.openhealth.fr/ko/articles/6962021-ameli-lpp.md) - [인구-연령 및 성별에 따른 진화](https://success.openhealth.fr/ko/articles/3810789-인구-연령-및-성별에-따른-진화.md): 인구 구조의 진화 분석 - [인구-연령 및 성별 비교](https://success.openhealth.fr/ko/articles/3836795-인구-연령-및-성별-비교.md): 두 모집단의 인구 통계 학적 프로필 비교 - [이집트-지도 제작](https://success.openhealth.fr/ko/articles/3714611-이집트-지도-제작.md): 이집트 정부의 인구 분석 - [이집트-연령 및 성별 분석](https://success.openhealth.fr/ko/articles/3714673-이집트-연령-및-성별-분석.md): 인구 구조 분석 - [UGANDA-연령 및 성별 분석](https://success.openhealth.fr/ko/articles/3713884-uganda-연령-및-성별-분석.md): 인구 구조 분석 - [인구-연령 및 성별 분석](https://success.openhealth.fr/ko/articles/3807673-인구-연령-및-성별-분석.md): 인구 구조 분석 - [Medicabase - 의약품 데이터베이스](https://success.openhealth.fr/ko/articles/6518920-medicabase-의약품-데이터베이스.md) - [출생](https://success.openhealth.fr/ko/articles/6340025-출생.md) - [OpenEudra](https://success.openhealth.fr/ko/articles/6518977-openeudra.md) - [IRIS 분석](https://success.openhealth.fr/ko/articles/6383829-iris-분석.md) - [ADICAP](https://success.openhealth.fr/ko/articles/6959465-adicap.md) - [NEC](https://success.openhealth.fr/ko/articles/6519012-nec.md) - [세계 인구 데이터](https://success.openhealth.fr/ko/articles/8217421-세계-인구-데이터.md) - [INSEE : 고인의 파일](https://success.openhealth.fr/ko/articles/4498126-insee-고인의-파일.md): INSEE \(국립 통계 경제 연구소\) : 사망자 파일 - [데이터 VAERS- VAERSDATA- 출처 CDC](https://success.openhealth.fr/ko/articles/6226665-데이터-vaers-vaersdata-출처-cdc.md) - [VAERS 데이터 - VAERSVAX - 출처 CDC](https://success.openhealth.fr/ko/articles/6226440-vaers-데이터-vaersvax-출처-cdc.md) - [VAERS 데이터 - VAERSSYMPTOMS - 출처 CDC](https://success.openhealth.fr/ko/articles/6219415-vaers-데이터-vaerssymptoms-출처-cdc.md) - [2주 이내에 데이터를 Hub에 통합하세요.](https://success.openhealth.fr/ko/articles/5259828-2주-이내에-데이터를-hub에-통합하세요.md) - [국제 데이터 템플릿](https://success.openhealth.fr/ko/articles/4684696-국제-데이터-템플릿.md) - [FTPS로 데이터를 보내려면 어떻게해야합니까?](https://success.openhealth.fr/ko/articles/4143451-ftps로-데이터를-보내려면-어떻게해야합니까.md): FTPS를 통해 데이터 보내기 - [OpenHealth는 새로운 데이터 소스를 통합하기 위해 어떤 정보가 필요합니까?](https://success.openhealth.fr/ko/articles/3459148-openhealth는-새로운-데이터-소스를-통합하기-위해-어떤-정보가-필요합니까.md): 새로운 데이터 소스 통합에 관한 기사 - [긴 안목으로 보기](https://success.openhealth.fr/ko/articles/6959482-긴-안목으로-보기.md) - [HUB에서 새 데이터 소스를 통합하는 방법은 무엇입니까?](https://success.openhealth.fr/ko/articles/3467598-hub에서-새-데이터-소스를-통합하는-방법은-무엇입니까.md): HUB의 데이터 통합 프로세스 관련 기사 - [판매 데이터를 HUB에 통합](https://success.openhealth.fr/ko/articles/3471145-판매-데이터를-hub에-통합.md): 판매 데이터 통합에 관한 기사 - [판매 데이터 수신 사양](https://success.openhealth.fr/ko/articles/3660043-판매-데이터-수신-사양.md): 판매 / 판매 분석 또는 판매 시각화 모듈 구독의 일부로 판매 판매를 보내는 방법 - [가정 건강 서비스 제공 업체 \(PSAD\) 시장에 대한 분석 데이터는 어디에서 제공됩니까?](https://success.openhealth.fr/ko/articles/3376155-가정-건강-서비스-제공-업체-psad-시장에-대한-분석-데이터는-어디에서-제공됩니까.md): PSAD - [SantéDom Stat 천문대에 어떻게 가입하나요?](https://success.openhealth.fr/ko/articles/3798795-santedom-stat-천문대에-어떻게-가입하나요.md): 가정 건강 서비스 제공자 \(PSAD\) 활동에 대한 국립 천문대에 참여하기위한 튜토리얼 - [SanteDomStat 관측소에서 추정한 패널](https://success.openhealth.fr/ko/articles/6701602-santedomstat-관측소에서-추정한-패널.md) - [환자 수](https://success.openhealth.fr/ko/articles/3376499-환자-수.md): PSAD 연맹에 따른 환자 수 정의 - [치료 횟수](https://success.openhealth.fr/ko/articles/3376682-치료-횟수.md): PSAD 연맹에 따른 치료 횟수 정의 - [신규 환자 수](https://success.openhealth.fr/ko/articles/3376672-신규-환자-수.md): PSAD 연맹에 따른 신규 환자 수 정의 - [세금을 포함한 매출액](https://success.openhealth.fr/ko/articles/3376725-세금을-포함한-매출액.md): PSAD 연맹에 따른 세금을 포함한 매출의 정의 - [치료 종료시 환자 수](https://success.openhealth.fr/ko/articles/3376675-치료-종료시-환자-수.md): PSAD 연맹에 따른 치료 종료시 환자 수 정의 - [의무 건강 보험 금액 \(AMO\)](https://success.openhealth.fr/ko/articles/3376740-의무-건강-보험-금액-amo.md): PSAD 연합에 따른 AMO 금액 정의 - [추가 건강 보험 금액 \(AMC\)](https://success.openhealth.fr/ko/articles/3376749-추가-건강-보험-금액-amc.md): PSAD 연합에 따른 AMC 금액 정의 - [미결제 요금 \(RAC\)](https://success.openhealth.fr/ko/articles/3376751-미결제-요금-rac.md): PSAD 연합에 따른 RAC의 정의 - [출처 : THESORIMED](https://success.openhealth.fr/ko/articles/3560018-출처-thesorimed.md): 약물 데이터베이스 \(BdM\) - [국제 비 독점 이름 \(INN\)](https://success.openhealth.fr/ko/articles/3954239-국제-비-독점-이름-inn.md): 국제 공통 이름 \(INN\) - [식품 성분표 열기](https://success.openhealth.fr/ko/articles/6961970-식품-성분표-열기.md) - [LOINC - 논리적 관찰 식별자 이름 및 코드](https://success.openhealth.fr/ko/articles/6959323-loinc-논리적-관찰-식별자-이름-및-코드.md) - [AMELI - CCAM](https://success.openhealth.fr/ko/articles/6959080-ameli-ccam.md) - [WHO ATC 수의사](https://success.openhealth.fr/ko/articles/6959078-who-atc-수의사.md) - [CEPS](https://success.openhealth.fr/ko/articles/6959068-ceps.md) - [제도](https://success.openhealth.fr/ko/articles/3935678-제도.md): 건강, 사회, 의료 사회 시설 목록 - [건강 서비스](https://success.openhealth.fr/ko/articles/7969680-건강-서비스.md) - [FINESS 추출](https://success.openhealth.fr/ko/articles/3946922-finess-추출.md): 기대에 따라 추출을 수행하십시오. - [진화 FINESS](https://success.openhealth.fr/ko/articles/3947009-진화-finess.md): 구조 수의 진화를 따르십시오. - [인정 개호 활동](https://success.openhealth.fr/ko/articles/3947067-인정-개호-활동.md): 의료 활동 승인에 따라 구조 나열 - [주요 의료 기기](https://success.openhealth.fr/ko/articles/3947269-주요-의료-기기.md): 장비에 따라 무거운 물질에 구조를 나열하십시오. - [지리적](https://success.openhealth.fr/ko/articles/3947363-지리적.md): 영토의 구조 분포 시각화 - [RPPS](https://success.openhealth.fr/ko/articles/3947568-rpps.md): 건강 전문가 목록 - [FINESS 및 RPPS](https://success.openhealth.fr/ko/articles/3947713-finess-및-rpps.md): 건강 전문가의 운동 장소 나열 - [RPPS 추출](https://success.openhealth.fr/ko/articles/3947829-rpps-추출.md): RPPS \(의료 전문가의 공유 디렉토리\) ### 모델레스 - [UGA의 데이터](https://success.openhealth.fr/ko/articles/4852310-uga의-데이터.md) - [부문 판매 계산 : 알아야 할 사항](https://success.openhealth.fr/ko/articles/3545561-부문-판매-계산-알아야-할-사항.md): OpenHealth에서 부문 판매를 계산하는 다른 단계는 무엇입니까? - [섹터 재 할당, 정적 또는 동적 방법론?](https://success.openhealth.fr/ko/articles/3690615-섹터-재-할당-정적-또는-동적-방법론.md): 섹터 재 할당, 정적 또는 동적 방법론? - [약국 계층](https://success.openhealth.fr/ko/articles/4291490-약국-계층.md): "이론적"계층과 "실제"또는 "효과적인"계층의 세부 사항. - [허브 생산 라인](https://success.openhealth.fr/ko/articles/4816146-허브-생산-라인.md) - [비교 분석을 수행하는 방법은 무엇입니까?](https://success.openhealth.fr/ko/articles/3440093-비교-분석을-수행하는-방법은-무엇입니까.md): 서로 다른 두 공급자의 데이터를 비교하려고합니다. - [레벨 1 조사-OpenHealth Company 서비스의 데이터 품질](https://success.openhealth.fr/ko/articles/3595822-레벨-1-조사-openhealth-company-서비스의-데이터-품질.md): 당신이 이해하지 못하는 현상을 관찰합니까? 우리는이 목격의 기원을 제공하고 설명 할 수 있습니다. - [OpenHealth의 데이터 품질 프로세스](https://success.openhealth.fr/ko/articles/3415271-openhealth의-데이터-품질-프로세스.md): 이 기사는 OpenHealth의 데이터 품질 프로세스 단계를 자세히 설명합니다. - [간격 및 신뢰 수준](https://success.openhealth.fr/ko/articles/3633173-간격-및-신뢰-수준.md): 정의, 공식 및 제한 : 알아야 할 사항 - [데이터 품질 : 배치 관리](https://success.openhealth.fr/ko/articles/3433509-데이터-품질-배치-관리.md): 배치 관리 프로세스에 대한 설명 - [데이터 품질 : 판매 분석 프로세스](https://success.openhealth.fr/ko/articles/3415317-데이터-품질-판매-분석-프로세스.md): 판매 분석 프로세스에 대한 설명 - [판매 및 재고 상쇄](https://success.openhealth.fr/ko/articles/4131084-판매-및-재고-상쇄.md): 주식 매도 - [판매량을 분석하는 이유는 무엇입니까?](https://success.openhealth.fr/ko/articles/3846167-판매량을-분석하는-이유는-무엇입니까.md): 판매량을 분석하는 이유는 무엇입니까? - [매진과 매진 사이에 데이터 차이가 있습니다.](https://success.openhealth.fr/ko/articles/3195358-매진과-매진-사이에-데이터-차이가-있습니다.md): 어떤 경우에 매진과 매진 사이에 데이터 차이가있을 수 있습니까? - [비정형 판매 란 무엇입니까?](https://success.openhealth.fr/ko/articles/3195366-비정형-판매-란-무엇입니까.md): 비정형 판매 및 비정형 필터 프로세스. - [가격, 거래량, 매출액에 대한 정보는 어디에서 제공됩니까?](https://success.openhealth.fr/ko/articles/3195348-가격-거래량-매출액에-대한-정보는-어디에서-제공됩니까.md): 가격 / 거래량 / 회전율 정보 - [처방 자별 예상 판매량](https://success.openhealth.fr/ko/articles/4171530-처방-자별-예상-판매량.md): 처방 자 및 처방 자 범주별로 약국 판매량을 평가하는 방법 - [두 추출의 차이점 이해](https://success.openhealth.fr/ko/articles/13399689-두-추출의-차이점-이해.md) ### 단계들 - [GTIN](https://success.openhealth.fr/ko/articles/3608176-gtin.md): GTIN 코드 \(Global Trade Item Number\) - [고객 제품 한정자 필드 사양 \(CQCP\)](https://success.openhealth.fr/ko/articles/3704913-고객-제품-한정자-필드-사양-cqcp.md): CQCP \(제품 고객 한정자 필드\) - [LPPR 코드는 무엇입니까?](https://success.openhealth.fr/ko/articles/3195365-lppr-코드는-무엇입니까.md): LPPR 코드 \(환급 가능한 제품 및 서비스 목록\) - [제품 대여 추적](https://success.openhealth.fr/ko/articles/4206554-제품-대여-추적.md): 제품 대여 - [내 시장을 확장하고 싶습니다](https://success.openhealth.fr/ko/articles/4420843-내-시장을-확장하고-싶습니다.md): 구독 시장 followed - [OHC 분류](https://success.openhealth.fr/ko/articles/3194589-ohc-분류.md): 독점적 인 OpenHealth Company 분류에 따라 제품 할당을 시각화합니다. - [EphMRA AC 수업 내역](https://success.openhealth.fr/ko/articles/3557908-ephmra-ac-수업-내역.md): 2014 년 이후 EphMRA AC 클래스의 진화를 시각화 - [수의학 세부 정보](https://success.openhealth.fr/ko/articles/3194587-수의학-세부-정보.md): 동물 용 의약품의 특성 시각화 - [수의학 분류](https://success.openhealth.fr/ko/articles/3194579-수의학-분류.md): 동물 용 의약품 \(ANSES\) 분류보기 - [인간 의학 세부 사항](https://success.openhealth.fr/ko/articles/3421225-인간-의학-세부-사항.md): THESORIMED의 상세 필드를 통해 하나 이상의 제품의 특성보기 - [신제품 관리](https://success.openhealth.fr/ko/articles/4470813-신제품-관리.md): 신제품 관리 - [인간 의학 분류](https://success.openhealth.fr/ko/articles/3417281-인간-의학-분류.md): 제품 범위에 대한 EphMRA AC 및 OMS ATC 분류보기 - [표시-진단](https://success.openhealth.fr/ko/articles/3568554-표시-진단.md): 특정 병리에 표시된 약물 및 선택한 약물과 관련된 병리보기 - [MP4U](https://success.openhealth.fr/ko/articles/3574188-mp4u.md): OpenHealth Company에서 제공하는 모든 분류보기 - [TVASI\(판매, 구매 및 알 수 없는 재고 테이블\)란 무엇인가요?](https://success.openhealth.fr/ko/articles/5992494-tvasi-판매-구매-및-알-수-없는-재고-테이블-란-무엇인가요.md) - [IRI 제품 분류](https://success.openhealth.fr/ko/articles/3194597-iri-제품-분류.md): 분류에 따라 제품 할당 시각화 소유자 IRI - [판매되지 않은 제품 제거](https://success.openhealth.fr/ko/articles/6135938-판매되지-않은-제품-제거.md) - [표준 시장-구독](https://success.openhealth.fr/ko/articles/3798203-표준-시장-구독.md): 이 기사는 소위 "표준"시장의 관심과 한계를 설명합니다. - [제품을 찾을 수 없습니다.](https://success.openhealth.fr/ko/articles/5686002-제품을-찾을-수-없습니다.md) - [제품 코드 관리](https://success.openhealth.fr/ko/articles/5652478-제품-코드-관리.md) - [제품 자격: 브랜드](https://success.openhealth.fr/ko/articles/5016985-제품-자격-브랜드.md) ### 구독 및 모듈 - [3가지 유형의 애플리케이션](https://success.openhealth.fr/ko/articles/9489652-3가지-유형의-애플리케이션.md) - [2.0 플랫폼](https://success.openhealth.fr/ko/articles/8374416-2-0-플랫폼.md) - [요약](https://success.openhealth.fr/ko/articles/3344127-요약.md): 응용 프로그램의 모든 특성을이 모듈에서 사용할 수 있습니다. - [시장 및 선택](https://success.openhealth.fr/ko/articles/8337016-시장-및-선택.md) - [요약 대시보드](https://success.openhealth.fr/ko/articles/9246867-요약-대시보드.md) - [분석](https://success.openhealth.fr/ko/articles/9352287-분석.md) - [추출기](https://success.openhealth.fr/ko/articles/9246875-추출기.md) - [성장 분석](https://success.openhealth.fr/ko/articles/3158856-성장-분석.md): 시장과 경쟁사의 진화에 핵심 요소를 결정하십시오. - [구색 분석](https://success.openhealth.fr/ko/articles/3473736-구색-분석.md): 시장에서 제품의 역 동성 연구 - [평균 제품 수](https://success.openhealth.fr/ko/articles/3161474-평균-제품-수.md): 판매 시점, 약국 또는 GSA 약국에서 평균 제품 수보기 - [추적 시작](https://success.openhealth.fr/ko/articles/3158488-추적-시작.md): 제품 출시 및 성장 기여도 모니터링 - [교차된 고급 지표](https://success.openhealth.fr/ko/articles/6007740-교차된-고급-지표.md) - [판매 집중](https://success.openhealth.fr/ko/articles/3095338-판매-집중.md): 매출 집중 곡선과 GINI 지수를 통해 시장 집중도를 시각화 - [가격 분산](https://success.openhealth.fr/ko/articles/3159289-가격-분산.md): 제품의 가격 분산을 시각화합니다. 판매 가격에서 나만의 약국 세그먼트를 만듭니다. - [매진 마진 분석](https://success.openhealth.fr/ko/articles/3358322-매진-마진-분석.md): 약국에서 제품의 매력도를 벤치마킹하십시오. - [판매 마진 진화](https://success.openhealth.fr/ko/articles/3815561-판매-마진-진화.md) - [약국 모니터링 \(1/2\)](https://success.openhealth.fr/ko/articles/3358248-약국-모니터링-1-2.md): 약국 트래픽의 진화를 따르십시오 - [약국 모니터링 \(2/2\)](https://success.openhealth.fr/ko/articles/3810527-약국-모니터링-2-2.md): 약국 트래픽의 진화를 따르십시오 - [Salesforce 성능](https://success.openhealth.fr/ko/articles/3159230-salesforce-성능.md): 영업 인력의 지역 및 부문 별 판매 실적 비교 - [고객 관계 관리\(CRM\) 어시스턴트](https://success.openhealth.fr/ko/articles/5953935-고객-관계-관리-crm-어시스턴트.md) - [POS 추적](https://success.openhealth.fr/ko/articles/3778944-pos-추적.md): POS 추적 - [온디맨드 진화](https://success.openhealth.fr/ko/articles/6560184-온디맨드-진화.md) - [온디맨드 분석](https://success.openhealth.fr/ko/articles/6127483-온디맨드-분석.md) - [주문형 테이블](https://success.openhealth.fr/ko/articles/3158751-주문형-테이블.md): 주요 HUB 지표와 다양한 유형의 기간에 따른 진화를 시각화합니다. - [시계열 분석](https://success.openhealth.fr/ko/articles/3635940-시계열-분석.md): 시장을 시즌, 트렌드 및 노이즈로 분류 - [예측 분석](https://success.openhealth.fr/ko/articles/3636015-예측-분석.md): 시장의 미래 예측 - [분야별 예측](https://success.openhealth.fr/ko/articles/3689811-분야별-예측.md): 미래 부문 매출 추정 - [판매 시각화](https://success.openhealth.fr/ko/articles/3559882-판매-시각화.md): 판매 및 판매 판매의 진화를 비교 - [Sell-in 분석](https://success.openhealth.fr/ko/articles/6188132-sell-in-분석.md) - [셀인 매칭](https://success.openhealth.fr/ko/articles/6188090-셀인-매칭.md) - [셀인 진화](https://success.openhealth.fr/ko/articles/6191929-셀인-진화.md) - [판매 대 매진 분석](https://success.openhealth.fr/ko/articles/6191947-판매-대-매진-분석.md) - [셀인 대 셀아웃의 진화](https://success.openhealth.fr/ko/articles/6191955-셀인-대-셀아웃의-진화.md) - [가격 진화](https://success.openhealth.fr/ko/articles/5056489-가격-진화.md) - [색상 사용자 지정](https://success.openhealth.fr/ko/articles/8407897-색상-사용자-지정.md) - [제품 수출](https://success.openhealth.fr/ko/articles/3583206-제품-수출.md): 모든 제품 및 MP4U 유형 앱에 특정한 내보내기 시트 - [시장 분석](https://success.openhealth.fr/ko/articles/3121933-시장-분석.md): 시장 실적 분석 : 세그먼트, 브랜드, 제품 및 회사 별 - [가격 분석](https://success.openhealth.fr/ko/articles/3215190-가격-분석.md): 시장 가격을 확인하고 포지셔닝을 분석합니다. - [판매 발전](https://success.openhealth.fr/ko/articles/3178323-판매-발전.md): 사용 가능한 모든 내역에 대해 진화하는 판매보기 - [대시보드 요약](https://success.openhealth.fr/ko/articles/4533213-대시보드-요약.md) - [시장 점유율 진화](https://success.openhealth.fr/ko/articles/3193078-시장-점유율-진화.md): 장기간에 걸친 판매 및 시장 점유율의 변화를 시각화합니다. - [판매 크로스 테이블](https://success.openhealth.fr/ko/articles/3193060-판매-크로스-테이블.md): 간단한 피벗 테이블 만들기 - [회전율 / 볼륨 \(CU\) 합성](https://success.openhealth.fr/ko/articles/3193048-회전율-볼륨-cu-합성.md): 판매량과 시장 가치를 동시에 시각화 - [판매 가치 합성 \(약국 / 슈퍼마켓\)](https://success.openhealth.fr/ko/articles/3193020-판매-가치-합성-약국-슈퍼마켓.md): GSA 약국 및 약국 판매 비교 - [시장 점유율 분석](https://success.openhealth.fr/ko/articles/3193069-시장-점유율-분석.md): 지난 12 개월 동안 시장 점유율 분석 - [내 데이터 아카이브](https://success.openhealth.fr/ko/articles/3193099-내-데이터-아카이브.md): 플랫 데이터베이스를 Excel로 내보내기 - [여러 기간 분석](https://success.openhealth.fr/ko/articles/3192953-여러-기간-분석.md): 완전히 사용자 정의 된 표 만들기 - [내 쿼리 모든 제품](https://success.openhealth.fr/ko/articles/4280353-내-쿼리-모든-제품.md): 세그먼트 및 적격 필드 \(예 : galenic, 태양 지수, 프로모션 ...\)와 제한 사항을 봅니다. - [주식 진화 \(신규\)](https://success.openhealth.fr/ko/articles/3719256-주식-진화-신규.md): 주식의 진화와 분포를 시각화하고 분석합니다. - [시장 정의](https://success.openhealth.fr/ko/articles/3158829-시장-정의.md): 선택한 100 기반으로 시장을 다시 설정하십시오. - [RAW DATA 고급 표시기](https://success.openhealth.fr/ko/articles/3711095-raw-data-고급-표시기.md): 선행 지표 데이터 복구 - [고급 지표 진화 SMKT](https://success.openhealth.fr/ko/articles/3193000-고급-지표-진화-smkt.md): 고급 통계 지표의 시간적 진화 분석을 통해 실험실 성능을 모니터링합니다. - [고급 지표 분석 SMKT](https://success.openhealth.fr/ko/articles/3192366-고급-지표-분석-smkt.md): GSA parapharmacy 시장의 진화를 주요 지표로 분류 - [고급 지표 진화](https://success.openhealth.fr/ko/articles/3177853-고급-지표-진화.md): 고급 통계 지표의 시간적 진화 분석을 통해 실험실 성능을 모니터링합니다. - [고급 지표 진화 바이오](https://success.openhealth.fr/ko/articles/7051823-고급-지표-진화-바이오.md) - [국가 고급 지표](https://success.openhealth.fr/ko/articles/3364513-국가-고급-지표.md): 시장의 진화를 선행 지표로 분류 - [주식 분석](https://success.openhealth.fr/ko/articles/3178015-주식-분석.md): 재고 수준 및 그 진화 해석 - [고급 지표 분석 바이오](https://success.openhealth.fr/ko/articles/7051801-고급-지표-분석-바이오.md) - [고급 지표 분석](https://success.openhealth.fr/ko/articles/3124439-고급-지표-분석.md): 시장의 진화를 선행 지표로 분류 - [지도 작성](https://success.openhealth.fr/ko/articles/3192450-지도-작성.md): 영업 인력의 지역 및 부문에 대한 상업적 성과 분석 - [지리적 크로스 테이블](https://success.openhealth.fr/ko/articles/3192466-지리적-크로스-테이블.md): 섹터 화를 통합하는 피벗 테이블 만들기 - [지리적 판매 발전](https://success.openhealth.fr/ko/articles/3192482-지리적-판매-발전.md): 피벗 테이블에서 36 개월 동안의 부문 별 매출 시각화 - [영업 인력 효율성](https://success.openhealth.fr/ko/articles/5624011-영업-인력-효율성.md) - [사용자 지정 가중치 방법 분석](https://success.openhealth.fr/ko/articles/5169317-사용자-지정-가중치-방법-분석.md) - [네트워크 분석](https://success.openhealth.fr/ko/articles/3894767-네트워크-분석.md): 네트워크 분석 - [사용자 지정 가중치 방법 진화](https://success.openhealth.fr/ko/articles/5169320-사용자-지정-가중치-방법-진화.md) - [요약 KPI](https://success.openhealth.fr/ko/articles/3478199-요약-kpi.md): 동적 테이블에서 주요 지표 볼륨이 지역 및 부문으로 감소한 것을 시각화하십시오. - [변환 된 단위 판매](https://success.openhealth.fr/ko/articles/3192412-변환-된-단위-판매.md): 변환 된 단위를 사용하여 매출을 시각화하십시오. - [원시 데이터 재고 지표](https://success.openhealth.fr/ko/articles/3711142-원시-데이터-재고-지표.md): 재고 데이터 내보내기 - [원시 데이터 SMKT AIA](https://success.openhealth.fr/ko/articles/3720960-원시-데이터-smkt-aia.md): SMKT 선행 지표 데이터 찾기 - [주식 진화](https://success.openhealth.fr/ko/articles/3178277-주식-진화.md): 주식의 진화와 분포를 시각화하고 분석합니다. - [지리적 고급 지표](https://success.openhealth.fr/ko/articles/3192508-지리적-고급-지표.md): 지역 또는 부문 별 선행 지표보기 - [제품 성능](https://success.openhealth.fr/ko/articles/3850331-제품-성능.md): 지역 및 제품 부문의 비즈니스 성과 비교 - [영토 고급 지표](https://success.openhealth.fr/ko/articles/3370879-영토-고급-지표.md): 시장의 진화를 주요 지표로 분류 - [시계열 분야 분석](https://success.openhealth.fr/ko/articles/3814974-시계열-분야-분석.md): 시장을 추세, 계절, 소음으로 분류 - [연령 및 성별 별 매출 분석](https://success.openhealth.fr/ko/articles/3192701-연령-및-성별-별-매출-분석.md): 연령 및 성별에 따른 매출 분석 - [임신 상태 별 판매 진화](https://success.openhealth.fr/ko/articles/3192910-임신-상태-별-판매-진화.md): 임산부 인구에 대한 약국 판매를 따르십시오. - [연령 및 성별에 따른 판매 발전](https://success.openhealth.fr/ko/articles/3192732-연령-및-성별에-따른-판매-발전.md): HUB의 깊이있는 역사를 사용하여 연령 및 성별에 따른 매출 변화를 시각화합니다. - [요구 사항 순서 진화](https://success.openhealth.fr/ko/articles/5790020-요구-사항-순서-진화.md) - [진화 공동 분배](https://success.openhealth.fr/ko/articles/3192529-진화-공동-분배.md): 약국에서 공동 조제의 진화를 시각화하고 분석 - [공동 분배 분석](https://success.openhealth.fr/ko/articles/3192633-공동-분배-분석.md): 내 시장에서 선택한 제품과 관련된 약국의 공동 분배보기 - [채널 및 처방 자별 판매](https://success.openhealth.fr/ko/articles/3192751-채널-및-처방-자별-판매.md): 시장의 인플 루 언서 시각화 - [AMO, AMC 및 RAC](https://success.openhealth.fr/ko/articles/3192929-amo-amc-및-rac.md): 의무 건강 보험, 보완 건강 보험 및 본인 부담 비용의 세 가지 금액보기 - [공동 분배 분산](https://success.openhealth.fr/ko/articles/3876946-공동-분배-분산.md): 조제별로 판매 된 제품 수의 분포를 시각화합니다. - [분배 분산 진화](https://success.openhealth.fr/ko/articles/3920070-분배-분산-진화.md): 시간 경과에 따른 분 배당 판매 된 제품 수의 분포를 시각화합니다. - [연령 및 성별에 따른 GP 처방전](https://success.openhealth.fr/ko/articles/5789899-연령-및-성별에-따른-gp-처방전.md) - [처방전 주문 분석](https://success.openhealth.fr/ko/articles/5322866-처방전-주문-분석.md) - [GP 처방의 진화](https://success.openhealth.fr/ko/articles/5790016-gp-처방의-진화.md) - [바구니 분석](https://success.openhealth.fr/ko/articles/3711049-바구니-분석.md): '바스켓 분석'모듈에 대한 설명 - [공동 조제](https://success.openhealth.fr/ko/articles/4738243-공동-조제.md) - [코호트 자격 모듈](https://success.openhealth.fr/ko/articles/3928090-코호트-자격-모듈.md): 환자 코호트의 자격 - [치료 상태 모듈](https://success.openhealth.fr/ko/articles/3928067-치료-상태-모듈.md): 치료 모니터링의 역학 분석 - [치료 준수 모듈](https://success.openhealth.fr/ko/articles/3928044-치료-준수-모듈.md): 치료 순응도 분석 - [코호트 정의](https://success.openhealth.fr/ko/articles/3894703-코호트-정의.md): 분석 범위 정의 - [공동 치료](https://success.openhealth.fr/ko/articles/4163623-공동-치료.md): 분석 범위 내에서 공동 처리 정의 - [시각화 코호트](https://success.openhealth.fr/ko/articles/3894721-시각화-코호트.md): 정의 된 코호트의 환자 프로필보기 - [분석 기준의 정의](https://success.openhealth.fr/ko/articles/3894728-분석-기준의-정의.md): 코호트 분석을위한 매개 변수 정의 - [글로벌 코호트 진화](https://success.openhealth.fr/ko/articles/3894747-글로벌-코호트-진화.md): 코호트의 월별 진화 시각화 - [지리적 분포](https://success.openhealth.fr/ko/articles/3894751-지리적-분포.md): 정의 된 코호트에서 환자의 지리적 분포보기 - [코호트 프로필](https://success.openhealth.fr/ko/articles/3894755-코호트-프로필.md): 코호트에 포함 된 환자의 인구 통계 학적 프로파일 분석 - [치료 상태 분석](https://success.openhealth.fr/ko/articles/3894764-치료-상태-분석.md): 다양한 유형의 치료 후속 조치에 대한 개요보기 - [치료 개시](https://success.openhealth.fr/ko/articles/3894778-치료-개시.md): 치료 개시 횟수의 진화 분석 - [치료 재개](https://success.openhealth.fr/ko/articles/3894788-치료-재개.md): 치료 재 수행 횟수의 변화 분석 - [새로운 치료법](https://success.openhealth.fr/ko/articles/3894804-새로운-치료법.md): 치료 시작 및 재개 횟수의 진화 분석 - [치료 재발](https://success.openhealth.fr/ko/articles/3894812-치료-재발.md): 치료중인 환자 분석 - [치료 스위치 균형](https://success.openhealth.fr/ko/articles/3894821-치료-스위치-균형.md): 치료에 따른 치료 변화의 균형 분석 - [치료 스위치 이득](https://success.openhealth.fr/ko/articles/3894830-치료-스위치-이득.md): 치료 스위치의 수혜자 분석 - [치료 스위치 손실](https://success.openhealth.fr/ko/articles/3894843-치료-스위치-손실.md): 치료 스위치의 패자를 치료하여 분석 - [게인 원점 전환](https://success.openhealth.fr/ko/articles/3894857-게인-원점-전환.md): 주어진 치료에 대한 스위치의 출처 분석 - [손실 대상 전환](https://success.openhealth.fr/ko/articles/3894864-손실-대상-전환.md): 주어진 치료에 대한 스위치 목적지 분석 - [탈락](https://success.openhealth.fr/ko/articles/3894874-탈락.md): 치료 중단 분석 - [KPI 요약](https://success.openhealth.fr/ko/articles/4229969-kpi-요약.md): 다양한 유형의 치료 모니터링 요약 - [치료 지속성](https://success.openhealth.fr/ko/articles/3894883-치료-지속성.md): 치료 기간 분석 - [응낙](https://success.openhealth.fr/ko/articles/3894884-응낙.md): 배송 된 수량 분석 - [규칙 성 기준은 무엇입니까?](https://success.openhealth.fr/ko/articles/3325816-규칙-성-기준은-무엇입니까.md): 규칙 성 기준의 개념 정의 - [죽음-지도 제작](https://success.openhealth.fr/ko/articles/3863677-죽음-지도-제작.md): 사망자의 지리적 분포 분석 - [사망 횟수 오프셋](https://success.openhealth.fr/ko/articles/3863573-사망-횟수-오프셋.md): 데이터의 관련성 평가 - [사망-연령 및 성별 분석](https://success.openhealth.fr/ko/articles/3863808-사망-연령-및-성별-분석.md): 죽음의 구조 분석 - [죽음-연령과 성별에 따른 진화](https://success.openhealth.fr/ko/articles/3863939-죽음-연령과-성별에-따른-진화.md): 죽음 구조의 진화 분석 - [죽음-진화](https://success.openhealth.fr/ko/articles/3864065-죽음-진화.md): 죽음의 진화를 시각화 - [죽음-진화 비교](https://success.openhealth.fr/ko/articles/3864073-죽음-진화-비교.md): 과거와 비교하여 사망의 진화를 비교 - [약국 모니터링 CA](https://success.openhealth.fr/ko/articles/4634768-약국-모니터링-ca.md): 약국 규모에 따른 교통량 설명 - [트래픽 분석\(베타 테스트\)](https://success.openhealth.fr/ko/articles/6848401-트래픽-분석-베타-테스트.md) - [약국 모니터링 세부 정보](https://success.openhealth.fr/ko/articles/4527868-약국-모니터링-세부-정보.md): 약국 유형별 조제 트래픽 분석 - [트래픽 에볼루션\(베타 테스트\)](https://success.openhealth.fr/ko/articles/6848016-트래픽-에볼루션-베타-테스트.md) - [약국 모니터링지도 제작](https://success.openhealth.fr/ko/articles/4527811-약국-모니터링지도-제작.md): 프랑스 본토의 조제 교통 분석 - [약국 모니터링 세부 정보](https://success.openhealth.fr/ko/articles/4262306-약국-모니터링-세부-정보.md): 진료소 유형별로 판매 세부 사항을 구별 - [약국 모니터링 분석](https://success.openhealth.fr/ko/articles/3839223-약국-모니터링-분석.md): 약국 트래픽의 진화를 따르십시오 - [약국 모니터링 진화](https://success.openhealth.fr/ko/articles/3827973-약국-모니터링-진화.md): 약국 교통의 진화 연구 - [교통 분해](https://success.openhealth.fr/ko/articles/3826074-교통-분해.md): 계절, 추세 및 잔류 물의 구성 요소 관찰 - [교통 연구](https://success.openhealth.fr/ko/articles/3809042-교통-연구.md): 약국 트래픽 분석 - [요약 - PIEX](https://success.openhealth.fr/ko/articles/5203335-요약-piex.md) - [구매](https://success.openhealth.fr/ko/articles/4605110-구매.md): 구매 내역 및 영수증 추적 - [내 쿼리-PIEX](https://success.openhealth.fr/ko/articles/4210627-내-쿼리-piex.md): 데이터 선택 - [판매 발전-PIEX](https://success.openhealth.fr/ko/articles/4210655-판매-발전-piex.md): 사용 가능한 기록에서 활동의 진화를 봅니다. - [판매 분석-PIEX](https://success.openhealth.fr/ko/articles/4210650-판매-분석-piex.md): 판매 분석-PIEX - [주문 세부 정보-PIEX](https://success.openhealth.fr/ko/articles/4210659-주문-세부-정보-piex.md): 판매 주문보기 및 추적 - [주식 개요-PIEX](https://success.openhealth.fr/ko/articles/4210672-주식-개요-piex.md): 주식의 변형 시각화 - [내 데이터 아카이브-PIEX](https://success.openhealth.fr/ko/articles/4210694-내-데이터-아카이브-piex.md): 플랫 데이터베이스를 Excel로 내보내기 - [EURAPHARMA- PIEX](https://success.openhealth.fr/ko/articles/4366306-eurapharma-piex.md): EURAPHARMA 활동의 진화 시각화 - [일치하는 제품](https://success.openhealth.fr/ko/articles/4366320-일치하는-제품.md): PIEX 및 EURAPHARMA 제품 명칭 간의 대응 - [CLI 내 파일 \(1/5\)](https://success.openhealth.fr/ko/articles/4626422-cli-내-파일-1-5.md): CLI 내 파일 \(1/5\) - [CLI\_ 파일 수 \(2/5\)](https://success.openhealth.fr/ko/articles/4626421-cli_-파일-수-2-5.md): CLI\_ 파일 수 \(2/5\) - [CLI\_OHC 저장소와 일치하는 파일 코드](https://success.openhealth.fr/ko/articles/4626419-cli_ohc-저장소와-일치하는-파일-코드.md): OHC 저장소와 CLI\_FIL 코드 매칭 - [매진 수출 \(4/5\)](https://success.openhealth.fr/ko/articles/4626414-매진-수출-4-5.md): 매진 수출 \(4/5\) ### 맞춤형 옵션 - [비 계층 적 제품 자격 필드](https://success.openhealth.fr/ko/articles/4036045-비-계층-적-제품-자격-필드.md): 제품 자격에 대한 세부 정보 추가 - [HUB 데이터의 최대 연령은 얼마입니까?](https://success.openhealth.fr/ko/articles/3195251-hub-데이터의-최대-연령은-얼마입니까.md): 사용 가능한 마지막 데이터 - [고객 유형](https://success.openhealth.fr/ko/articles/4197147-고객-유형.md): 맞춤형 옵션 고객 유형 - [세션 액세스](https://success.openhealth.fr/ko/articles/4036458-세션-액세스.md): 직원의보기 제한 - [커스텀 사이클](https://success.openhealth.fr/ko/articles/4036444-커스텀-사이클.md): 개인화 된 기간 동안 데이터 분석 - [회계 연도](https://success.openhealth.fr/ko/articles/4036169-회계-연도.md): 회계 연도 정의 - [요일 버튼](https://success.openhealth.fr/ko/articles/4036159-요일-버튼.md): 더 세분화 된 데이터 시각화 - [주 버튼](https://success.openhealth.fr/ko/articles/4036111-주-버튼.md): 더 세분화 된 데이터 시각화 - [환율](https://success.openhealth.fr/ko/articles/8329594-환율.md) - [SMKT 기간 달력](https://success.openhealth.fr/ko/articles/4036549-smkt-기간-달력.md): GSA 캘린더 사용 - [경계 제한](https://success.openhealth.fr/ko/articles/4560699-경계-제한.md): .xlsx 파일에서 내 쿼리의 GTIN 목록 하나 선택 - [경계 제한 \(코드 7\)](https://success.openhealth.fr/ko/articles/4560791-경계-제한-코드-7.md): .xlsx 파일에서 내 쿼리의 \[TECHNICAL CODE 2\] 목록 1 개 선택 - [시장 신고](https://success.openhealth.fr/ko/articles/4560797-시장-신고.md): .xlsx 파일에 포함 된 시장 정의에서 내 쿼리에서 하나의 GTIN 목록 선택 - [고객 유형의 타겟팅 / 정의](https://success.openhealth.fr/ko/articles/3777788-고객-유형의-타겟팅-정의.md): 타겟팅 \(고객 유형\) ### 허브 표시기 - [HUB 지표 용어집](https://success.openhealth.fr/ko/articles/5194247-hub-지표-용어집.md) - [판매 수량](https://success.openhealth.fr/ko/articles/3194314-판매-수량.md): 판매 수량 - [판매 가치](https://success.openhealth.fr/ko/articles/3074854-판매-가치.md): 판매 가치 표시기 지정 - [N MS](https://success.openhealth.fr/ko/articles/3194475-n-ms.md): 'N MS'측정의 정의 - [N MS Evol](https://success.openhealth.fr/ko/articles/5634266-n-ms-evol.md) - [N MS 델타](https://success.openhealth.fr/ko/articles/3194469-n-ms-델타.md): 'N MS 델타'측정의 정의 - [방식별 중량\(CA\) / 사용자 지정 중량\(To\)](https://success.openhealth.fr/ko/articles/9292839-방식별-중량-ca-사용자-지정-중량-to.md) - [부가가치세를 제외한 제조업체 가격 기준 판매액\(부가가치세를 제외한 매출액 PF\) - 모로코](https://success.openhealth.fr/ko/articles/7508513-부가가치세를-제외한-제조업체-가격-기준-판매액-부가가치세를-제외한-매출액-pf-모로코.md) - [N 성장 CTR](https://success.openhealth.fr/ko/articles/3194466-n-성장-ctr.md): 'N 성장 CTR'측정의 정의 및 계산 공식 - [거래 중](https://success.openhealth.fr/ko/articles/6201859-거래-중.md) - [교차 중량 부피](https://success.openhealth.fr/ko/articles/6066324-교차-중량-부피.md) - [교차 중량 회전율](https://success.openhealth.fr/ko/articles/6066273-교차-중량-회전율.md) - [N 성장 CTR 조정](https://success.openhealth.fr/ko/articles/3205376-n-성장-ctr-조정.md): 'N Growth CTR A'척도의 정의 및 계산 공식 - [소스 무게](https://success.openhealth.fr/ko/articles/5151525-소스-무게.md) - [관찰 된 평균 가격](https://success.openhealth.fr/ko/articles/3194302-관찰-된-평균-가격.md): AASP : 관찰 된 평균 가격 - [가중 평균 가격](https://success.openhealth.fr/ko/articles/3194292-가중-평균-가격.md): WASP : 가중 평균 가격 - [가격 효과](https://success.openhealth.fr/ko/articles/8426443-가격-효과.md) - [판매 약국 수](https://success.openhealth.fr/ko/articles/3719566-판매-약국-수.md) - [디지털 배포 판매](https://success.openhealth.fr/ko/articles/3194321-디지털-배포-판매.md): 숫자 분포 - [글로벌 판매 디지털 유통](https://success.openhealth.fr/ko/articles/3194320-글로벌-판매-디지털-유통.md): 글로벌 숫자 분포 - [리베이스 판매 디지털 배포](https://success.openhealth.fr/ko/articles/4045636-리베이스-판매-디지털-배포.md): 숫자 분포 기반 - [글로벌 리 기반 판매 디지털 유통](https://success.openhealth.fr/ko/articles/4045725-글로벌-리-기반-판매-디지털-유통.md): 글로벌 숫자 분포 기반 - [맞춤형 리기반 디지털 판매 배포](https://success.openhealth.fr/ko/articles/6830813-맞춤형-리기반-디지털-판매-배포.md) - [판매 가치 분배](https://success.openhealth.fr/ko/articles/3194323-판매-가치-분배.md): 가중 분포 - [글로벌 판매 가치 분배](https://success.openhealth.fr/ko/articles/3194316-글로벌-판매-가치-분배.md): 글로벌 판매 가치 분배 - [판매 가치 분배를 재조정하십시오](https://success.openhealth.fr/ko/articles/3194501-판매-가치-분배를-재조정하십시오.md): 리베이스 DVV - [글로벌 기반 판매 가치 분배](https://success.openhealth.fr/ko/articles/4200619-글로벌-기반-판매-가치-분배.md): 글로벌 기반 DVV - [맞춤형 재기반 판매 가치 분배](https://success.openhealth.fr/ko/articles/6834423-맞춤형-재기반-판매-가치-분배.md) - [디지털 판매 유통 SMKT](https://success.openhealth.fr/ko/articles/3365043-디지털-판매-유통-smkt.md): 디지털 판매 유통 SMKT \(SMK 수치 분포\) - [글로벌 SMKT 판매 디지털 유통](https://success.openhealth.fr/ko/articles/4298341-글로벌-smkt-판매-디지털-유통.md): SMKT 글로벌 수치 분포 \(SMKT 글로벌 수치 분포\) - [Rebased SMKT Selling Digital Distribution](https://success.openhealth.fr/ko/articles/4298197-rebased-smkt-selling-digital-distribution.md): SMKT 디지털 배포 기반 \(SMKT 숫자 분포 기반\) - [글로벌 기반 SMKT 판매 디지털 유통](https://success.openhealth.fr/ko/articles/4319783-글로벌-기반-smkt-판매-디지털-유통.md): 디지털 유통 판매 SMKT Rebasée Globale \(SMKT Global Numeric Distribution Rebased\) - [SMKT 판매 가치 분배](https://success.openhealth.fr/ko/articles/3365478-smkt-판매-가치-분배.md): SMKT 판매 가치 분배 \(SMKT 가중치 분배\) - [재 계산 된 글로벌 SMKT 판매 디지털 유통](https://success.openhealth.fr/ko/articles/4298373-재-계산-된-글로벌-smkt-판매-디지털-유통.md): 판매 디지털 유통 SMKT 글로벌 수치 재 계산 \(SMKT 글로벌 수치 유통 재 계산\) - [디지털 유통 판매 SMKT 재 계산](https://success.openhealth.fr/ko/articles/4298303-디지털-유통-판매-smkt-재-계산.md): SMKT 숫자 분포 재 계산 기반 - [조정 된 SMKT 판매 디지털 배포](https://success.openhealth.fr/ko/articles/3369386-조정-된-smkt-판매-디지털-배포.md): 조정 된 숫자 분포 SMKT - [SMKT 판매 디지털 유통 재 계산](https://success.openhealth.fr/ko/articles/4298209-smkt-판매-디지털-유통-재-계산.md): 재 계산 된 SMKT 수치 분포 \(재 계산 된 SMKT 수치 분포\) - [SMKT 판매 가치 분배 조정](https://success.openhealth.fr/ko/articles/3369397-smkt-판매-가치-분배-조정.md): 조정 된 가중 분포 SMKT - [유기적 디지털 판매 배포](https://success.openhealth.fr/ko/articles/7052424-유기적-디지털-판매-배포.md) - [판매 약국 매출\(TSP\)](https://success.openhealth.fr/ko/articles/6096534-판매-약국-매출-tsp.md) - [보유자 PDM 견적](https://success.openhealth.fr/ko/articles/4214883-보유자-pdm-견적.md): 고객과의 시장 점유율 추정 - [더 많은 약국](https://success.openhealth.fr/ko/articles/8426451-더-많은-약국.md) - [약국 손실](https://success.openhealth.fr/ko/articles/8426460-약국-손실.md) - [멀티채널 디지털 판매 및 유통](https://success.openhealth.fr/ko/articles/9293487-멀티채널-디지털-판매-및-유통.md) - [누적 판매 디지털 유통\(제약\)](https://success.openhealth.fr/ko/articles/9330571-누적-판매-디지털-유통-제약.md) - [월 평균 매출](https://success.openhealth.fr/ko/articles/3194303-월-평균-매출.md): 월평균 매출 - [조정 된 월 평균 판매](https://success.openhealth.fr/ko/articles/3194290-조정-된-월-평균-판매.md): 조정 된 평균 월간 판매 - [월 평균 판매액](https://success.openhealth.fr/ko/articles/4535404-월-평균-판매액.md): VMM CA - [AMS To A: 조정된 월 평균 판매액](https://success.openhealth.fr/ko/articles/6028256-ams-to-a-조정된-월-평균-판매액.md) - [평균 판매](https://success.openhealth.fr/ko/articles/3563716-평균-판매.md): 평균 판매 - [SMKT 평균 매출](https://success.openhealth.fr/ko/articles/3365496-smkt-평균-매출.md): SMKT 평균 매출 - [조정 된 SMKT 평균 판매](https://success.openhealth.fr/ko/articles/3369340-조정-된-smkt-평균-판매.md): 조정 된 SMKT 평균 판매 - [월 평균 유기적 매출](https://success.openhealth.fr/ko/articles/7052551-월-평균-유기적-매출.md) - [월 평균 매출 유기적 가치](https://success.openhealth.fr/ko/articles/7052573-월-평균-매출-유기적-가치.md) - [스톡](https://success.openhealth.fr/ko/articles/3194332-스톡.md): SMAa 애플리케이션을 통한 HUB의 주식 데이터 정의 및 가용성 : Sales & Marketing Advanced 구독 - [평균 재고](https://success.openhealth.fr/ko/articles/3194336-평균-재고.md): 평균 재고 - [주식 점유율](https://success.openhealth.fr/ko/articles/3194334-주식-점유율.md): 주식 점유율 - [상업 압력 지수](https://success.openhealth.fr/ko/articles/3194335-상업-압력-지수.md): 상업 압력 지수 - [주식 변형률](https://success.openhealth.fr/ko/articles/3194344-주식-변형률.md): 주식 변형률 - [공급 기간](https://success.openhealth.fr/ko/articles/3194337-공급-기간.md): 공급 기간 - [Stockist 약국 수](https://success.openhealth.fr/ko/articles/3194338-stockist-약국-수.md): Stockist 약국 수 - [Stockist 디지털 배포](https://success.openhealth.fr/ko/articles/3194339-stockist-디지털-배포.md): Stockist Distribution \(ND Stock\) - [디지털 유통 Stockist rebased](https://success.openhealth.fr/ko/articles/4045743-디지털-유통-stockist-rebased.md): 주식 숫자 분포 기반 - [글로벌 기반 디지털 Stockist 배포](https://success.openhealth.fr/ko/articles/4045753-글로벌-기반-디지털-stockist-배포.md): 글로벌 기반 디지털 Stockist 배포 - [Stockist 가치 분배](https://success.openhealth.fr/ko/articles/3194342-stockist-가치-분배.md): Stockist Value Distribution \(가중 재고 분배 : WD Stock\) - [재고 가치 분배 리베이스](https://success.openhealth.fr/ko/articles/3194505-재고-가치-분배-리베이스.md): DVS 리베이스 - [디지털 유통 원활화 재고 관리](https://success.openhealth.fr/ko/articles/5141830-디지털-유통-원활화-재고-관리.md) - [디지털 배포 스톡리스트가 리베이스를 원활하게 개선했습니다.](https://success.openhealth.fr/ko/articles/5142162-디지털-배포-스톡리스트가-리베이스를-원활하게-개선했습니다.md) - [유통 평활화된 주식 가치](https://success.openhealth.fr/ko/articles/5203640-유통-평활화된-주식-가치.md) - [유통 평활화된 기준 주식 가치](https://success.openhealth.fr/ko/articles/5203701-유통-평활화된-기준-주식-가치.md) - [여유](https://success.openhealth.fr/ko/articles/3507716-여유.md): 여유 - [마진율](https://success.openhealth.fr/ko/articles/3507767-마진율.md): 마진율 - [세금 별도 제조업체 가격 \(PFHT\)](https://success.openhealth.fr/ko/articles/4557500-세금-별도-제조업체-가격-pfht.md): PFHT - [판매-고객 기반 분석](https://success.openhealth.fr/ko/articles/3846225-판매-고객-기반-분석.md): 충성도 지표 : 고객 기반의 특성과 진화 - [판매-비정형 약국](https://success.openhealth.fr/ko/articles/3848791-판매-비정형-약국.md): 이형성을 감지하기위한 조치 - [진화 비율](https://success.openhealth.fr/ko/articles/3194287-진화-비율.md): 진화 비율 - [침투율](https://success.openhealth.fr/ko/articles/3194286-침투율.md): 침투율 - [제품 구색 폭](https://success.openhealth.fr/ko/articles/3369425-제품-구색-폭.md): 제품 구색 폭 - [구색 갱신](https://success.openhealth.fr/ko/articles/3369545-구색-갱신.md): 구색 갱신 - [구색의 혁신](https://success.openhealth.fr/ko/articles/3369468-구색의-혁신.md): 구색의 혁신 - [구색의 소모](https://success.openhealth.fr/ko/articles/3369457-구색의-소모.md): 구색의 소모 - [분류 감소율](https://success.openhealth.fr/ko/articles/3369485-분류-감소율.md): 분류 감소율 - [범위 혁신 률](https://success.openhealth.fr/ko/articles/3369541-범위-혁신-률.md): 범위 혁신 률 - [판매 제안 점유율](https://success.openhealth.fr/ko/articles/3369040-판매-제안-점유율.md): 판매 제안 점유율 - [선택한 제품 수](https://success.openhealth.fr/ko/articles/3511502-선택한-제품-수.md): GTIN-13 숫자 코드로 선택한 제품 수입니다. - [평균 제품 수](https://success.openhealth.fr/ko/articles/3194284-평균-제품-수.md): 평균 제품 수 - [범위 갱신 율](https://success.openhealth.fr/ko/articles/3369561-범위-갱신-율.md): 범위 갱신 율 - [제품 수](https://success.openhealth.fr/ko/articles/6312686-제품-수.md) - [행위 당 지출 금액](https://success.openhealth.fr/ko/articles/3447792-행위-당-지출-금액.md): '행당 지출 금액'지표 관련 기사 - [구매자 유형별 지출 금액 내역](https://success.openhealth.fr/ko/articles/3447801-구매자-유형별-지출-금액-내역.md): '구매자 유형별 지출액 내역'지표 관련 기사 - [소비 지수](https://success.openhealth.fr/ko/articles/3432701-소비-지수.md): '소비 지수'지표의 정의 - [판매 점유율](https://success.openhealth.fr/ko/articles/3432664-판매-점유율.md): '판매 점유율'지표의 정의 - [가치 충성도](https://success.openhealth.fr/ko/articles/3432695-가치-충성도.md): '가치 충성도'지표의 정의 - [절대 침투](https://success.openhealth.fr/ko/articles/3432556-절대-침투.md): '절대 침투'지표 관련 기사 - [매출 비중](https://success.openhealth.fr/ko/articles/3432655-매출-비중.md): '매출 비중'지표의 정의 - [p-값](https://success.openhealth.fr/ko/articles/5781702-p-값.md) - [주요 구성 요소 분석](https://success.openhealth.fr/ko/articles/4231028-주요-구성-요소-분석.md): ACP - [부정적인 예측 값](https://success.openhealth.fr/ko/articles/4134220-부정적인-예측-값.md): 부정적인 예측 값 - [긍정적 인 예측 가치](https://success.openhealth.fr/ko/articles/4134166-긍정적-인-예측-가치.md): 긍정적 인 예측 가치 - [독립 테스트](https://success.openhealth.fr/ko/articles/4128369-독립-테스트.md): 두 변수가 서로 관련되어 있는지 확인 - [시계열 연구](https://success.openhealth.fr/ko/articles/3633991-시계열-연구.md): 계절성, 추세 및 예측 : 알아야 할 사항 - [계절 변동률](https://success.openhealth.fr/ko/articles/3653790-계절-변동률.md): 시계열에서 분산 비율을 측정합니다. - [검사의 민감도 및 특이성](https://success.openhealth.fr/ko/articles/3928135-검사의-민감도-및-특이성.md): 테스트의 효과를 분석하기위한 개념 이해 - [추세 변동률](https://success.openhealth.fr/ko/articles/3653847-추세-변동률.md): 시계열에서 추세 구성 요소의 점유율을 측정합니다. - [잔여 분산 비율](https://success.openhealth.fr/ko/articles/3653851-잔여-분산-비율.md): 시계열의 잔여 성분의 비율을 측정합니다. - [결정 계수](https://success.openhealth.fr/ko/articles/3654093-결정-계수.md): 선택한 모델의 품질 평가 - [변동 계수](https://success.openhealth.fr/ko/articles/3653915-변동-계수.md): 분해 모델을 선택하는 지표 - [시계열의 분산](https://success.openhealth.fr/ko/articles/3653855-시계열의-분산.md): 시리즈의 분산 측정 - [판매 집중](https://success.openhealth.fr/ko/articles/3395856-판매-집중.md): 판매 집중 - [지니 지수](https://success.openhealth.fr/ko/articles/3395323-지니-지수.md): 지니 지수 - [인구](https://success.openhealth.fr/ko/articles/4396779-인구.md): 인구 - [사망자 수의 진화](https://success.openhealth.fr/ko/articles/4396765-사망자-수의-진화.md): 사망자 수의 진화 - [성비](https://success.openhealth.fr/ko/articles/3812167-성비.md): 성비 - [인구-평균 연령](https://success.openhealth.fr/ko/articles/3812180-인구-평균-연령.md): 인구-평균 연령 - [인구-중간 연령](https://success.openhealth.fr/ko/articles/3812198-인구-중간-연령.md): 인구-중간 연령 - [인구-연령 1 분위](https://success.openhealth.fr/ko/articles/3812218-인구-연령-1-분위.md): 인구-연령 1 분위 - [인구-연령 3 분위](https://success.openhealth.fr/ko/articles/3812227-인구-연령-3-분위.md): 인구-연령 3 분위 - [영토의 총 인구에서 선택 비율](https://success.openhealth.fr/ko/articles/3812233-영토의-총-인구에서-선택-비율.md): 영토의 총 인구에서 선택 비율 - [사망률](https://success.openhealth.fr/ko/articles/3947946-사망률.md): 사망률 - [케이스 사망률](https://success.openhealth.fr/ko/articles/3948084-케이스-사망률.md): 케이스 사망률 - [가임기 여성](https://success.openhealth.fr/ko/articles/4172859-가임기-여성.md): 가임기 여성 - [영토 내 총 사망자 중 선택 비율](https://success.openhealth.fr/ko/articles/3863734-영토-내-총-사망자-중-선택-비율.md): 영토 내 총 사망자 중 선택 비율 - [실종 사망자 수 모델링](https://success.openhealth.fr/ko/articles/3895572-실종-사망자-수-모델링.md): 시간 t에서 사망자 수 예측 - [처방전 개시에 따른 예상 매출](https://success.openhealth.fr/ko/articles/5323282-처방전-개시에-따른-예상-매출.md) - [연령 및 임신 상태별 진화](https://success.openhealth.fr/ko/articles/6820051-연령-및-임신-상태별-진화.md) - [공동 보상 상품 비율](https://success.openhealth.fr/ko/articles/7892010-공동-보상-상품-비율.md) - [예상 처방전 리필 판매량](https://success.openhealth.fr/ko/articles/5323209-예상-처방전-리필-판매량.md) - [처방전 리필 판매 비중](https://success.openhealth.fr/ko/articles/5323198-처방전-리필-판매-비중.md) - [처방전 개시에서 매출 비중](https://success.openhealth.fr/ko/articles/5323086-처방전-개시에서-매출-비중.md) - [공동 분배 횟수](https://success.openhealth.fr/ko/articles/3194351-공동-분배-횟수.md): 공동 분배 횟수 - [경륜의 횟수](https://success.openhealth.fr/ko/articles/3194348-경륜의-횟수.md): 경륜의 횟수 - [피보험자 1 인당 평균 지급 횟수](https://success.openhealth.fr/ko/articles/3369626-피보험자-1-인당-평균-지급-횟수.md): 피보험자 1 인당 평균 지급 횟수 - [준수](https://success.openhealth.fr/ko/articles/3411996-준수.md): 약물 보유율 \(MPR\) - [지속 율](https://success.openhealth.fr/ko/articles/3369684-지속-율.md): 지속 율 - [치료 적 순응](https://success.openhealth.fr/ko/articles/3412091-치료-적-순응.md): 치료 적 순응 - [피보험자 1 인당 일일 평균 복용량](https://success.openhealth.fr/ko/articles/4153587-피보험자-1-인당-일일-평균-복용량.md): 피보험자 1 인당 일일 평균 복용량 - [환급을 위해 제시된 분배 횟수](https://success.openhealth.fr/ko/articles/3370942-환급을-위해-제시된-분배-횟수.md): 환급을 위해 제시된 분배 횟수 - [환급을 위해 제시되지 않은 지급 횟수](https://success.openhealth.fr/ko/articles/3370920-환급을-위해-제시되지-않은-지급-횟수.md): 환급을 위해 제시된 분배 횟수 - [의무적 인 건강 보험이 적용되는 환급을 위해 청구 된 가치 판매](https://success.openhealth.fr/ko/articles/3371699-의무적-인-건강-보험이-적용되는-환급을-위해-청구-된-가치-판매.md): 상환 된 가치의 판매 - [보완 건강 보험이 적용되는 환급 가치 판매](https://success.openhealth.fr/ko/articles/3371830-보완-건강-보험이-적용되는-환급-가치-판매.md): 상환 된 가치의 판매 - [뛰어난 가치의 판매](https://success.openhealth.fr/ko/articles/3371842-뛰어난-가치의-판매.md): 뛰어난 가치의 판매 - [널리 퍼짐](https://success.openhealth.fr/ko/articles/3947955-널리-퍼짐.md): 유병률 - [조제 당 평균 GTIN 수](https://success.openhealth.fr/ko/articles/3396154-조제-당-평균-gtin-수.md): 조제 당 평균 GTIN 수 - [분 배당 평균 부피](https://success.openhealth.fr/ko/articles/3396196-분-배당-평균-부피.md): 분 배당 평균 부피 - [분 배당 평균 매출액](https://success.openhealth.fr/ko/articles/3396208-분-배당-평균-매출액.md): 분 배당 평균 매출액 - [상자 당 활성 원칙 복용량](https://success.openhealth.fr/ko/articles/3675409-상자-당-활성-원칙-복용량.md): 상자 당 활성 원칙 복용량 - [상자 당 DDD](https://success.openhealth.fr/ko/articles/3675446-상자-당-ddd.md): 상자 당 일일 복용량 정의 - [기본 단위의 부피](https://success.openhealth.fr/ko/articles/3675520-기본-단위의-부피.md): 기본 단위의 부피 - [활성 원리의 볼륨](https://success.openhealth.fr/ko/articles/3675539-활성-원리의-볼륨.md): 활성 원리의 볼륨 - [주민 1,000 명당 DDJ](https://success.openhealth.fr/ko/articles/3675667-주민-1-000-명당-ddj.md): 인구 1,000 명당 일일 정의 선량 - [피보험자 당 평균 UA 볼륨](https://success.openhealth.fr/ko/articles/3675761-피보험자-당-평균-ua-볼륨.md): 피보험자 당 평균 소비자 단위의 양 - [피보험자 당 평균 UB 볼륨](https://success.openhealth.fr/ko/articles/3675814-피보험자-당-평균-ub-볼륨.md): 피보험자 당 평균 기본 단위 볼륨 - [피보험자 1 인당 평균 유효 원칙의 양](https://success.openhealth.fr/ko/articles/3675824-피보험자-1-인당-평균-유효-원칙의-양.md): 피보험자 1 인당 평균 유효 원칙의 양 - [관찰 된 평균 치료 기간](https://success.openhealth.fr/ko/articles/3675841-관찰-된-평균-치료-기간.md): 관찰 된 평균 치료 기간 - [예방 접종 보장](https://success.openhealth.fr/ko/articles/3822264-예방-접종-보장.md): 예방 접종 보장 - [포함 된 환자](https://success.openhealth.fr/ko/articles/3886665-포함-된-환자.md): 코호트에 포함 된 환자 수 - [MPR과 PDC의 차이점](https://success.openhealth.fr/ko/articles/3722666-mpr과-pdc의-차이점.md): MPR \(약물 보유율\) 대 PDC \(일수 비율\) - [평균 치료 기간](https://success.openhealth.fr/ko/articles/3920967-평균-치료-기간.md): 분석 기간 종료시 평균 치료 시간 측정 - [평균 갱신 시간](https://success.openhealth.fr/ko/articles/3921067-평균-갱신-시간.md): 치료 갱신 사이의 평균 시간 측정 - [치료 시작](https://success.openhealth.fr/ko/articles/3848844-치료-시작.md): 치료 시작 - [치료 갱신](https://success.openhealth.fr/ko/articles/3885469-치료-갱신.md): 치료의 갱신 - [치료 재개](https://success.openhealth.fr/ko/articles/3885608-치료-재개.md): 치료 재개 - [새로운 치료법](https://success.openhealth.fr/ko/articles/3885297-새로운-치료법.md): 치료 시작 및 재개 - [치료 스위치](https://success.openhealth.fr/ko/articles/3848886-치료-스위치.md): 치료 스위치 - [치료 중지](https://success.openhealth.fr/ko/articles/3885426-치료-중지.md): 치료 중지 - [내려](https://success.openhealth.fr/ko/articles/3885387-내려.md): 내려 - [추적 성 삽입](https://success.openhealth.fr/ko/articles/4355163-추적-성-삽입.md): 추적 성 - [중지했다가 다시 시작](https://success.openhealth.fr/ko/articles/8429189-중지했다가-다시-시작.md) - [분배 몫](https://success.openhealth.fr/ko/articles/3624820-분배-몫.md): 분배 몫 - [관련 섭리 모니터링](https://success.openhealth.fr/ko/articles/3804193-관련-섭리-모니터링.md): 관련 약국의 약국에서 트래픽의 진화를 따르십시오. - [분해 속도](https://success.openhealth.fr/ko/articles/4850138-분해-속도.md) - [반응의 동역학](https://success.openhealth.fr/ko/articles/4850629-반응의-동역학.md) - [반감기 시간](https://success.openhealth.fr/ko/articles/4849710-반감기-시간.md) - [주식 보상률](https://success.openhealth.fr/ko/articles/4210714-주식-보상률.md): 주식 보상률 - [기간](https://success.openhealth.fr/ko/articles/3194479-기간.md): 기간 - [회계 연도의 정의 변경](https://success.openhealth.fr/ko/articles/3321750-회계-연도의-정의-변경.md): HUB를 사용하면 회계 연도를 설정할 수 있습니다. - [주간 비교 관리](https://success.openhealth.fr/ko/articles/3835180-주간-비교-관리.md): 연구 당시의 분석적 영향 - [GSA의 Parapharmacy Calendar \(SMKT\)](https://success.openhealth.fr/ko/articles/3175583-gsa의-parapharmacy-calendar-smkt.md): SMKT 캘린더 \(IRI\)는 GSA 약국 캘린더라고도합니다. - [아니](https://success.openhealth.fr/ko/articles/3194484-아니.md): 측정 'N'의 정의 - [N 진화](https://success.openhealth.fr/ko/articles/3194461-n-진화.md): 'N Evol'측정의 정의 및 계산 공식 - [N 트렌드](https://success.openhealth.fr/ko/articles/3194485-n-트렌드.md): 'N 트렌드'척도의 정의 ### IAS - Indicateurs Avancés Sanitaires - [IAS\(r\) 알레르기](https://success.openhealth.fr/ko/articles/7339151-ias-r-알레르기.md) - [IAS\(r\) Poux](https://success.openhealth.fr/ko/articles/7339168-ias-r-poux.md) - [IAS\(r\) 위장관염](https://success.openhealth.fr/ko/articles/7339181-ias-r-위장관염.md) - [IAS\(r\) 인플루엔자 유사 질환](https://success.openhealth.fr/ko/articles/7266711-ias-r-인플루엔자-유사-질환.md) ### Marketing Direct - [오픈헬스 이메일 솔루션](https://success.openhealth.fr/ko/articles/7055261-오픈헬스-이메일-솔루션.md) - [이메일 캠페인 제작을 위한 요구 사항](https://success.openhealth.fr/ko/articles/6282113-이메일-캠페인-제작을-위한-요구-사항.md) - [추적 보고서 및 벤치마크](https://success.openhealth.fr/ko/articles/6302721-추적-보고서-및-벤치마크.md) - [이메일 캠페인 용어집](https://success.openhealth.fr/ko/articles/6282099-이메일-캠페인-용어집.md) ### 파드 \(주\) - [분석-NATIONAL](https://success.openhealth.fr/ko/articles/3376262-분석-national.md): 홈 헬스 제공자 \(PSAD\) 시장의 성과 분석 : 지역, 활동, 하위 활동, 세그먼트, LPP 법 - [거래량 / 회전율-전국](https://success.openhealth.fr/ko/articles/3376287-거래량-회전율-전국.md): 영역 별, 활동 별, 하위 활동 별, 세그먼트 별, LPP 행위 \(제품 및 서비스 목록\)별로 활동의 양과 가치를 동시에 확인합니다. - [진화-NATIONAL](https://success.openhealth.fr/ko/articles/3376370-진화-national.md): 지역, 활동, 하위 활동, 세그먼트, LPP 행위별로 사용 가능한 역사에 대한 시장의 진화를 시각화합니다. - [추출-NATIONAL](https://success.openhealth.fr/ko/articles/3376420-추출-national.md): Excel로 데이터 내보내기 - [정의](https://success.openhealth.fr/ko/articles/3376439-정의.md): SantéDomStat Observatoire National의 모든 기능 찾기-필수 애플리케이션 ### AUTRES THEMATIQUES - [인터콤](https://success.openhealth.fr/ko/articles/6959415-인터콤.md) - [Salesforce](https://success.openhealth.fr/ko/articles/6959337-salesforce.md) - [GIHSN : Excel 파일 제출](https://success.openhealth.fr/ko/articles/3977478-gihsn-excel-파일-제출.md): GIHSN Excel 파일 - [블록체인](https://success.openhealth.fr/ko/articles/5385413-블록체인.md) - [비즈니스 프로세스의 CRM 도구 인 DocuSign](https://success.openhealth.fr/ko/articles/4514472-비즈니스-프로세스의-crm-도구-인-docusign.md): Docusign : 비즈니스 프로세스의 CRM 도구 - [국가 예방 접종 추적](https://success.openhealth.fr/ko/articles/4754333-국가-예방-접종-추적.md) - [예방 접종 범위](https://success.openhealth.fr/ko/articles/4754311-예방-접종-범위.md) - [KPI 모니터링](https://success.openhealth.fr/ko/articles/4091042-kpi-모니터링.md): POC ProPharma 시스템 : 스위스 시장 동향 - [약국 조종석](https://success.openhealth.fr/ko/articles/4091025-약국-조종석.md): POC ProPharma 시스템 : 내 약국 vs 스위스 - [인구 환산\(p.e.\)](https://success.openhealth.fr/ko/articles/5431894-인구-환산-p-e.md) - [산소 요구량](https://success.openhealth.fr/ko/articles/5137158-산소-요구량.md) - [IHU](https://success.openhealth.fr/ko/articles/4851687-ihu.md) - [부유 물질](https://success.openhealth.fr/ko/articles/5137147-부유-물질.md) - [폐수 화학](https://success.openhealth.fr/ko/articles/5137101-폐수-화학.md) - [NRBCE](https://success.openhealth.fr/ko/articles/4851683-nrbce.md) - [아레니우스의 법칙](https://success.openhealth.fr/ko/articles/4849672-아레니우스의-법칙.md) - [결과 성능](https://success.openhealth.fr/ko/articles/5137034-결과-성능.md) - [폐수의 종류](https://success.openhealth.fr/ko/articles/5137183-폐수의-종류.md) - [SARS-CoV-2 바이러스 농도](https://success.openhealth.fr/ko/articles/4867968-sars-cov-2-바이러스-농도.md) - [MAPOM / BMPM](https://success.openhealth.fr/ko/articles/4851685-mapom-bmpm.md) - [상황에 맞게 조정된 SARS-CoV-2 농도](https://success.openhealth.fr/ko/articles/4934604-상황에-맞게-조정된-sars-cov-2-농도.md) - [하수도 시스템 유형](https://success.openhealth.fr/ko/articles/4867954-하수도-시스템-유형.md) - [바이러스 분해](https://success.openhealth.fr/ko/articles/4865742-바이러스-분해.md) - [WBE](https://success.openhealth.fr/ko/articles/4865735-wbe.md) - [RNA](https://success.openhealth.fr/ko/articles/4865733-rna.md) - [코로나바이러스](https://success.openhealth.fr/ko/articles/4865728-코로나바이러스.md) - [COVID-19](https://success.openhealth.fr/ko/articles/4865726-covid-19.md) - [혈청 유병률 : 샘플링 방법](https://success.openhealth.fr/ko/articles/3924493-혈청-유병률-샘플링-방법.md): 혈청 유병률 : 샘플링 방법 - [SANDRE 리포지토리](https://success.openhealth.fr/ko/articles/5415040-sandre-리포지토리.md) - [국가 거점 ROSEAU](https://success.openhealth.fr/ko/articles/5414523-국가-거점-roseau.md) - [SARS-CoV-2 바이러스 농도](https://success.openhealth.fr/ko/articles/4852404-sars-cov-2-바이러스-농도.md) - [SARS-CoV-2 바이러스 농도 - 변종](https://success.openhealth.fr/ko/articles/4909854-sars-cov-2-바이러스-농도-변종.md) - [마르세유 - 글로벌 모니터링](https://success.openhealth.fr/ko/articles/4859311-마르세유-글로벌-모니터링.md) - [SARS-CoV-2 바이러스 농도 - 니스](https://success.openhealth.fr/ko/articles/4879292-sars-cov-2-바이러스-농도-니스.md) - [인구 - 구조](https://success.openhealth.fr/ko/articles/4842408-인구-구조.md) - [SARS-CoV-2 바이러스 농도 - 툴롱\(프랑스\)](https://success.openhealth.fr/ko/articles/4886417-sars-cov-2-바이러스-농도-툴롱-프랑스.md) - [두바이 - 공항 폐수 모니터링](https://success.openhealth.fr/ko/articles/5276423-두바이-공항-폐수-모니터링.md) - [SARS-CoV-2 감시 - OBEPINE](https://success.openhealth.fr/ko/articles/5210661-sars-cov-2-감시-obepine.md) - [상황에 맞게 조정된 SARS-CoV-2 농도](https://success.openhealth.fr/ko/articles/4934608-상황에-맞게-조정된-sars-cov-2-농도.md) - [SUEZ - 분석 대차 대조표](https://success.openhealth.fr/ko/articles/5140509-suez-분석-대차-대조표.md) - [팔레 데 페스티벌 - T0 보기](https://success.openhealth.fr/ko/articles/5373515-팔레-데-페스티벌-t0-보기.md) - [팔레 데 페스티벌 - 매일 철야 기도회](https://success.openhealth.fr/ko/articles/5373231-팔레-데-페스티벌-매일-철야-기도회.md) - [팔레 데 페스티벌 - 상영관](https://success.openhealth.fr/ko/articles/5404778-팔레-데-페스티벌-상영관.md) - [겨드랑이 - 시계](https://success.openhealth.fr/ko/articles/5169577-겨드랑이-시계.md) - [인구 - IRIS](https://success.openhealth.fr/ko/articles/4842191-인구-iris.md) - [SARS-CoV-2](https://success.openhealth.fr/ko/articles/4865699-sars-cov-2.md) - [IAS - 분석](https://success.openhealth.fr/ko/articles/4842430-ias-분석.md) - [SARS-CoV-2 바이러스 농도 - SEM](https://success.openhealth.fr/ko/articles/5415600-sars-cov-2-바이러스-농도-sem.md) - [지도 시각화](https://success.openhealth.fr/ko/articles/3864657-지도-시각화.md): 환자의 지리적 재분할 - [기부 사이트](https://success.openhealth.fr/ko/articles/3864668-기부-사이트.md): 현장 및 병원 별 기여 - [사이트 별 코호트 프로필](https://success.openhealth.fr/ko/articles/3864672-사이트-별-코호트-프로필.md): 사이트 및 병원 별 코호트 프로필 - [시즌 별 코호트 프로필](https://success.openhealth.fr/ko/articles/3864673-시즌-별-코호트-프로필.md): 시즌 별 코호트 프로필 - [연령 및 성별 분포](https://success.openhealth.fr/ko/articles/3864675-연령-및-성별-분포.md): 인구 통계학 - [사이트 별 바이러스 분포](https://success.openhealth.fr/ko/articles/3864678-사이트-별-바이러스-분포.md): 사이트 별 바이러스 분포 - [연령별 바이러스 분포](https://success.openhealth.fr/ko/articles/3864677-연령별-바이러스-분포.md): 연령별 바이러스 분포 - [바이러스 분포 진화](https://success.openhealth.fr/ko/articles/3864681-바이러스-분포-진화.md): 바이러스 분포 진화 - [인플루엔자 예방 접종](https://success.openhealth.fr/ko/articles/3864697-인플루엔자-예방-접종.md): 인플루엔자 예방 접종 - [인플루엔자 예방 접종 진화](https://success.openhealth.fr/ko/articles/3864701-인플루엔자-예방-접종-진화.md): 인플루엔자 예방 접종의 진화 - [만성 질환 별 환자 분포](https://success.openhealth.fr/ko/articles/3864676-만성-질환-별-환자-분포.md): 만성 질환 별 환자 분포 - [입원 기간별 환자 분포](https://success.openhealth.fr/ko/articles/3864794-입원-기간별-환자-분포.md): 병원 입원 기간별 환자 분포 - [여림](https://success.openhealth.fr/ko/articles/3864704-여림.md): 환자의 취약성 - [심각도 상태](https://success.openhealth.fr/ko/articles/3864705-심각도-상태.md): 심각도 상태 - [인류](https://success.openhealth.fr/ko/articles/3864710-인류.md): 인류 - [GIHSN](https://success.openhealth.fr/ko/articles/3864712-gihsn.md): 글로벌 인플루엔자 병원 감시 네트워크 - [CARéDIAB-환자 프로필](https://success.openhealth.fr/ko/articles/3789234-carediab-환자-프로필.md): CARéDIAB 모집단의 환자 프로필 분석 - [CARéDIAB-합병증](https://success.openhealth.fr/ko/articles/3789515-carediab-합병증.md): 인구의 합병증 유병률 분석 케어 디아 브 - [CARéDIAB-글로벌 환자 모니터링](https://success.openhealth.fr/ko/articles/3792041-carediab-글로벌-환자-모니터링.md): CARéDIAB 모집단에서 환자의 후속 조치 빈도 분석 - [CARéDIAB 네트워크](https://success.openhealth.fr/ko/articles/3789106-carediab-네트워크.md): CARéDIAB 네트워크 - [CARéDIAB-트리트먼트](https://success.openhealth.fr/ko/articles/3792143-carediab-트리트먼트.md): 당뇨병의 맥락에서 치료를받는 것을 분석하십시오 ## Norsk ### Votre PLATEFORME - présentation générale - [HUB, en omfattende og kontinuerlig støtteplattform](https://success.openhealth.fr/nb/articles/4799621-hub-en-omfattende-og-kontinuerlig-stotteplattform.md) - [Ditt erfaringsnivå The HUB](https://success.openhealth.fr/nb/articles/5712270-ditt-erfaringsniva-the-hub.md) - [Languages](https://success.openhealth.fr/nb/articles/4649389-languages.md): Here is the description of all languages available on Success - [Spørsmål om våre priser](https://success.openhealth.fr/nb/articles/3292143-sporsmal-om-vare-priser.md): Våre priser ### VEIKARTET - [Open-Innovation til tjeneste for våre kunder](https://success.openhealth.fr/nb/articles/5200970-open-innovation-til-tjeneste-for-vare-kunder.md) - [Apper + Administrasjonsområde versjon 240515](https://success.openhealth.fr/nb/articles/9310541-apper-administrasjonsomrade-versjon-240515.md) - [Apper + Administrasjonsområde versjon 240415](https://success.openhealth.fr/nb/articles/9310710-apper-administrasjonsomrade-versjon-240415.md) - [Apper + Administrasjonsområde versjon 240315](https://success.openhealth.fr/nb/articles/9310790-apper-administrasjonsomrade-versjon-240315.md) - [Apper + Administrasjonsområde versjon 240215](https://success.openhealth.fr/nb/articles/9311007-apper-administrasjonsomrade-versjon-240215.md) - [Plattform - oppdatering 231215](https://success.openhealth.fr/nb/articles/8718485-plattform-oppdatering-231215.md) - [Plattform - oppdatering 231015](https://success.openhealth.fr/nb/articles/8479932-plattform-oppdatering-231015.md) - [Apper + Portal versjon 230915](https://success.openhealth.fr/nb/articles/8373640-apper-portal-versjon-230915.md) - [Apper + Portal versjon 230815](https://success.openhealth.fr/nb/articles/8267860-apper-portal-versjon-230815.md) - [Nye produkter 230715](https://success.openhealth.fr/nb/articles/8115796-nye-produkter-230715.md) - [Apper + Portal versjon 230615](https://success.openhealth.fr/nb/articles/8115791-apper-portal-versjon-230615.md) - [Apper + Portal versjon 230515](https://success.openhealth.fr/nb/articles/7895393-apper-portal-versjon-230515.md) - [Apper + Portal versjon 230415](https://success.openhealth.fr/nb/articles/7439447-apper-portal-versjon-230415.md) - [Apper + Portal versjon 230315](https://success.openhealth.fr/nb/articles/7439646-apper-portal-versjon-230315.md) - [Apper + Portal versjon 230215](https://success.openhealth.fr/nb/articles/7439744-apper-portal-versjon-230215.md) - [Nytt fra 15/01/2023](https://success.openhealth.fr/nb/articles/6895740-nytt-fra-15-01-2023.md) - [HUB + GATE versjon 221215](https://success.openhealth.fr/nb/articles/6827027-hub-gate-versjon-221215.md) - [HUB + GATE versjon 221115](https://success.openhealth.fr/nb/articles/6742628-hub-gate-versjon-221115.md) - [HUB + GATE versjon 220915](https://success.openhealth.fr/nb/articles/6558070-hub-gate-versjon-220915.md) - [HUB + GATE versjon 220815](https://success.openhealth.fr/nb/articles/6475311-hub-gate-versjon-220815.md) - [HUB + GATE versjon 220615](https://success.openhealth.fr/nb/articles/6306090-hub-gate-versjon-220615.md) - [HUB + GATE versjon 220515](https://success.openhealth.fr/nb/articles/6201877-hub-gate-versjon-220515.md) - [HUB + GATE versjon 220415](https://success.openhealth.fr/nb/articles/6087747-hub-gate-versjon-220415.md) - [HUB SMA versjon 220315](https://success.openhealth.fr/nb/articles/6043772-hub-sma-versjon-220315.md) - [HUB TMA versjon 220315](https://success.openhealth.fr/nb/articles/6043802-hub-tma-versjon-220315.md) - [HUB UAN versjon 220315](https://success.openhealth.fr/nb/articles/6043852-hub-uan-versjon-220315.md) - [GATE versjon 220215](https://success.openhealth.fr/nb/articles/5940805-gate-versjon-220215.md) - [HUB SMA versjon 220215](https://success.openhealth.fr/nb/articles/5940753-hub-sma-versjon-220215.md) - [HUB TMA versjon 220215](https://success.openhealth.fr/nb/articles/5947859-hub-tma-versjon-220215.md) - [GATE versjon 211215](https://success.openhealth.fr/nb/articles/5819397-gate-versjon-211215.md) - [HUB SMA versjon 211215](https://success.openhealth.fr/nb/articles/5784709-hub-sma-versjon-211215.md) - [HUB TMA versjon 211215](https://success.openhealth.fr/nb/articles/5784888-hub-tma-versjon-211215.md) - [HUB UAN versjon 211215](https://success.openhealth.fr/nb/articles/5784904-hub-uan-versjon-211215.md) - [Søknad HUB: "The state of the pharmacy".](https://success.openhealth.fr/nb/articles/5704485-soknad-hub-the-state-of-the-pharmacy.md) - [GATE versjon 211115](https://success.openhealth.fr/nb/articles/5697844-gate-versjon-211115.md) - [HUB SMA versjon 211115](https://success.openhealth.fr/nb/articles/5671893-hub-sma-versjon-211115.md) - [HUB TMA versjon 211115](https://success.openhealth.fr/nb/articles/5671917-hub-tma-versjon-211115.md) - [HUB UAN versjon 211115](https://success.openhealth.fr/nb/articles/5671927-hub-uan-versjon-211115.md) - [GATE versjon 211015](https://success.openhealth.fr/nb/articles/5652210-gate-versjon-211015.md) - [HUB SMA versjon 211015](https://success.openhealth.fr/nb/articles/5649822-hub-sma-versjon-211015.md) - [HUB TMA versjon 211015](https://success.openhealth.fr/nb/articles/5650073-hub-tma-versjon-211015.md) - [HUB UAN versjon 211015](https://success.openhealth.fr/nb/articles/5652242-hub-uan-versjon-211015.md) - [HUB SMA versjon 210915](https://success.openhealth.fr/nb/articles/5370516-hub-sma-versjon-210915.md) - [HUB TMA versjon 210915](https://success.openhealth.fr/nb/articles/5390983-hub-tma-versjon-210915.md) - [HUB UAN versjon 210915](https://success.openhealth.fr/nb/articles/5543213-hub-uan-versjon-210915.md) ### Votre ESPACE D'ADMINISTRATION - fonctionnalités - [Tilbakestill / endre passordet HUB](https://success.openhealth.fr/nb/articles/4425325-tilbakestill-endre-passordet-hub.md): Hvordan endre HUB-passordet - [Hjelp til tilkobling: Jeg får en feilmelding](https://success.openhealth.fr/nb/articles/5369783-hjelp-til-tilkobling-jeg-far-en-feilmelding.md) - [Opprett og spor en billett](https://success.openhealth.fr/nb/articles/3586214-opprett-og-spor-en-billett.md): Opplæring for å lage og følge utviklingen av billettene dine på din personlige plass The HUB - [Opprette og endre en SUCCESS-artikkel](https://success.openhealth.fr/nb/articles/6738705-opprette-og-endre-en-success-artikkel.md) - [Mine kontrakter](https://success.openhealth.fr/nb/articles/5712273-mine-kontrakter.md) - [Tjeneste Helse](https://success.openhealth.fr/nb/articles/4990600-tjeneste-helse.md) - [Mine tilganger](https://success.openhealth.fr/nb/articles/5783418-mine-tilganger.md) - [Sette opp hjemmesiden min](https://success.openhealth.fr/nb/articles/5712229-sette-opp-hjemmesiden-min.md) - [Hvordan endrer du markedet fra ditt personlige OpenHealth-område?](https://success.openhealth.fr/nb/articles/3585971-hvordan-endrer-du-markedet-fra-ditt-personlige-openhealth-omrade.md): Integrer, modifiser og deaktiver produkter fra ditt personlige OpenHealth-rom - [Automatisk modalitetsmodifisering \(Auto MAM\)](https://success.openhealth.fr/nb/articles/4164818-automatisk-modalitetsmodifisering-auto-mam.md): Endre oppdragene til produktene dine direkte - [TIDLIG MAM: Hvordan følge et merke som endrer laboratorium / merke / merke?](https://success.openhealth.fr/nb/articles/4131072-tidlig-mam-hvordan-folge-et-merke-som-endrer-laboratorium-merke-merke.md): Fordeler og risiko ved din type sporing - [Automatisk produktintegrasjon \(Auto IPR\)](https://success.openhealth.fr/nb/articles/4164932-automatisk-produktintegrasjon-auto-ipr.md): Be om integrering av et produkt i markedet - [Automatisk produktdeaktivering \(Auto DPR\)](https://success.openhealth.fr/nb/articles/4164866-automatisk-produktdeaktivering-auto-dpr.md): Deaktiver et produkt fra markedet - [Automatisk produktreaktivering \(RPR auto\)](https://success.openhealth.fr/nb/articles/4818161-automatisk-produktreaktivering-rpr-auto.md) - [Etablering av nye produkter](https://success.openhealth.fr/nb/articles/5811248-etablering-av-nye-produkter.md) - [Legg til et marked](https://success.openhealth.fr/nb/articles/5712283-legg-til-et-marked.md) - [Import/eksport av bulkprodukter](https://success.openhealth.fr/nb/articles/5712257-import-eksport-av-bulkprodukter.md) - [Endring av typologisk modalitet \(CMT\)](https://success.openhealth.fr/nb/articles/4670174-endring-av-typologisk-modalitet-cmt.md) - [De forskjellige brukerstatusene](https://success.openhealth.fr/nb/articles/3436418-de-forskjellige-brukerstatusene.md): Hva er funksjonene? - [Opprett en konto for en bruker fra en tredjepartsorganisasjon \(TPAA\)](https://success.openhealth.fr/nb/articles/6466550-opprett-en-konto-for-en-bruker-fra-en-tredjepartsorganisasjon-tpaa.md) - [Hvordan lage, endre eller slette en brukerkonto på The HUB?](https://success.openhealth.fr/nb/articles/3785138-hvordan-lage-endre-eller-slette-en-brukerkonto-pa-the-hub.md): Bare en POWER USER kan gjøre dette - [Kan jeg opprette differensierte visningsrettigheter på HUB i teamene mine?](https://success.openhealth.fr/nb/articles/3321731-kan-jeg-opprette-differensierte-visningsrettigheter-pa-hub-i-teamene-mine.md): Rettigheter i navet - [Aktivitetslogg](https://success.openhealth.fr/nb/articles/4687438-aktivitetslogg.md) ### Vos APPLICATIONS - présentation - [Opplæringsveiledningen for HUB](https://success.openhealth.fr/nb/articles/5634967-opplaeringsveiledningen-for-hub.md) - [Nedtrekksvelger for sortering](https://success.openhealth.fr/nb/articles/5792113-nedtrekksvelger-for-sortering.md) - [Oppdateringsdato for GSA apotekdata \(SMKT\) i HuB](https://success.openhealth.fr/nb/articles/3175557-oppdateringsdato-for-gsa-apotekdata-smkt-i-hub.md): Denne artikkelen beskriver datoen da dataene fra GSA-apoteker \(SMKT\) oppdateres. - [Forutsetninger Matching Pharmacies File](https://success.openhealth.fr/nb/articles/3678146-forutsetninger-matching-pharmacies-file.md): Forutsetninger Matching Pharmacies File - ["På og av resept" -velger](https://success.openhealth.fr/nb/articles/3729668-pa-og-av-resept-velger.md): Spesifikasjoner for objektet 'Prescription Type Selector' - [Hvordan kvalifisere nye produkter i HUB?](https://success.openhealth.fr/nb/articles/3376100-hvordan-kvalifisere-nye-produkter-i-hub.md): Kvalifisering av de nye produktene dine i HUB - [Hvordan lage, endre og dele en favoritt i HUB?](https://success.openhealth.fr/nb/articles/3175689-hvordan-lage-endre-og-dele-en-favoritt-i-hub.md): Opprette og dele favoritter i Hub - [Hvordan velger jeg produkter i HUB etter lanseringsdato?](https://success.openhealth.fr/nb/articles/3158428-hvordan-velger-jeg-produkter-i-hub-etter-lanseringsdato.md): Denne artikkelen forklarer hvordan du bare velger produkter lansert i en bestemt periode. - [Kan jeg trekke ut data fra HUB-en i ".csv"-format?](https://success.openhealth.fr/nb/articles/5671278-kan-jeg-trekke-ut-data-fra-hub-en-i-csv-format.md) - [ODT-responstid](https://success.openhealth.fr/nb/articles/6632310-odt-responstid.md) - [Hva er den beste skjermpraksis i HUB](https://success.openhealth.fr/nb/articles/3124454-hva-er-den-beste-skjermpraksis-i-hub.md): Denne artikkelen beskriver de beste metodene for å optimalisere visningen av HUB - [Tekniske krav](https://success.openhealth.fr/nb/articles/5369918-tekniske-krav.md) - [Tøm nettleserens hurtigbuffer](https://success.openhealth.fr/nb/articles/4219722-tom-nettleserens-hurtigbuffer.md): Slik tømmer du hurtigbufferen for Google Chrome - [Hvordan setter jeg Google Chrome som standard nettleser?](https://success.openhealth.fr/nb/articles/3738717-hvordan-setter-jeg-google-chrome-som-standard-nettleser.md): Hvordan sette Google Chrome som standard - [Navigasjonsheisen er ikke synlig i tabellene](https://success.openhealth.fr/nb/articles/3195250-navigasjonsheisen-er-ikke-synlig-i-tabellene.md): Navigasjonsheisen - [Visningen av knapper eller gjenstander på et ark er delvis avskåret eller ikke synlig](https://success.openhealth.fr/nb/articles/3195245-visningen-av-knapper-eller-gjenstander-pa-et-ark-er-delvis-avskaret-eller-ikke-synlig.md): Vis problem med knapper, gjenstander - [Mitt territoriumadministrasjonskort lastes ikke inn og meldingen "lasting" vises](https://success.openhealth.fr/nb/articles/3195239-mitt-territoriumadministrasjonskort-lastes-ikke-inn-og-meldingen-lasting-vises.md): Territory Management / TMA-kartvisningsproblem - [Hvor kommer feilmeldingen "Du har ikke rett til å få tilgang til på denne siden"?](https://success.openhealth.fr/nb/articles/3195338-hvor-kommer-feilmeldingen-du-har-ikke-rett-til-a-fa-tilgang-til-pa-denne-siden.md): Feilmeldinger - [Jeg har en feilmelding "Mistet forbindelse"](https://success.openhealth.fr/nb/articles/4445141-jeg-har-en-feilmelding-mistet-forbindelse.md): Det har oppstått en feil - [Dårlig inngangsport](https://success.openhealth.fr/nb/articles/4514555-darlig-inngangsport.md): Feilmelding "Bad Gateway" - [Dimensjons- og målvelgerne vises ikke lenger i spørringene "Multiple Period Analysis" og "My Data Archive", utvinningen av tabellen i "Market Analysis" er delvis](https://success.openhealth.fr/nb/articles/3195377-dimensjons-og-malvelgerne-vises-ikke-lenger-i-sporringene-multiple-period-analysis-og-my-data-archive-utvinningen-av-tabellen-i-market-analysis-er-delvis.md): Dimensjoner og mål vises ikke lenger - [Hvordan ser jeg på et begrep i HUB?](https://success.openhealth.fr/nb/articles/3194377-hvordan-ser-jeg-pa-et-begrep-i-hub.md): HUB lar deg enkelt se quadrimesters i 'Sales Evolution' -arket - [Excel spesifikasjoner og begrensninger](https://success.openhealth.fr/nb/articles/3753088-excel-spesifikasjoner-og-begrensninger.md): Denne artikkelen forklarer spesifikasjonene og begrensningene for Excel. - [Hvordan oppretter, redigerer og deler du en favoritt i applikasjonene dine?](https://success.openhealth.fr/nb/articles/10502803-hvordan-oppretter-redigerer-og-deler-du-en-favoritt-i-applikasjonene-dine.md) - [Forbrukerpanel rammeverk](https://success.openhealth.fr/nb/articles/3455845-forbrukerpanel-rammeverk.md): Artikkel om forbrukerpanelets rammeverk - [Rammeverk for markedsanalyse av apotek](https://success.openhealth.fr/nb/articles/3455857-rammeverk-for-markedsanalyse-av-apotek.md): Artikkel om OpenHealth-rammeverket for å analysere markedsytelsen på apotekkanalen ### Datakilder - [Untitled article](https://success.openhealth.fr/nb/articles/3304106-untitled-article.md): Denne artikkelen tar sikte på å beskrive vårt apotekpanel, hvordan det er sammensatt, dets utvikling og ekstrapolasjonsmetoden. - [Apoteknettverket, en avgjørende ressurs i styringen av nåværende og fremtidige helsekriser](https://success.openhealth.fr/nb/articles/3825648-apoteknettverket-en-avgjorende-ressurs-i-styringen-av-navaerende-og-fremtidige-helsekriser.md): OpenHealth Company, forpliktet til å overvåke en enestående helsekrise, mobiliserer sin teknologi og data - [Hva er territoriene til de franske utenlandske avdelingene og territoriene som er synlige i HUB?](https://success.openhealth.fr/nb/articles/3194382-hva-er-territoriene-til-de-franske-utenlandske-avdelingene-og-territoriene-som-er-synlige-i-hub.md): DROM-COM-territorier tilgjengelig i Hub - [Forutsette sektoriseringsfil](https://success.openhealth.fr/nb/articles/3702701-forutsette-sektoriseringsfil.md): Denne artikkelen lar deg laste ned, fullføre og sende inn sektoriseringsfilen din. - [SMKT datakilde](https://success.openhealth.fr/nb/articles/4485357-smkt-datakilde.md): IRI, leverandør av GSA apotekdata - [GSA Parapharmacy Products Coding Rules \(SMKT\) på IRI](https://success.openhealth.fr/nb/articles/3524492-gsa-parapharmacy-products-coding-rules-smkt-pa-iri.md): Påminnelse om kodifiseringsreglene for SMKT-produkter på IRI - [ORGANIC STORE-data - Kilde BIOANALYTICS](https://success.openhealth.fr/nb/articles/5631260-organic-store-data-kilde-bioanalytics.md) - [E-parafarmasi: overvåkingsplattformer](https://success.openhealth.fr/nb/articles/9167006-e-parafarmasi-overvakingsplattformer.md) - [E-apotek Produktgevinst og tap](https://success.openhealth.fr/nb/articles/3568773-e-apotek-produktgevinst-og-tap.md): Artikkel relatert til 'E-apotekets produktgevinst og tap' -modul - [Forbrukerprofil](https://success.openhealth.fr/nb/articles/3711085-forbrukerprofil.md): Artikkel om 'Forbrukerprofil'-modulen - [AMAZON-data - Kilde SELLINGZ](https://success.openhealth.fr/nb/articles/5669013-amazon-data-kilde-sellingz.md) - [Data om netthandel - Kilde WISER](https://success.openhealth.fr/nb/articles/7983010-data-om-netthandel-kilde-wiser.md) - [Geografiske territorier](https://success.openhealth.fr/nb/articles/4661582-geografiske-territorier.md): Hos Open Health Company kan du analysere markedene dine i henhold til de geografiske områdene vi tilbyr deg. - [Hva er apotekpanelet i Tyskland? INSIGHTHEALTH](https://success.openhealth.fr/nb/articles/5391412-hva-er-apotekpanelet-i-tyskland-insighthealth.md) - [Hva er apotekpanelet i Hellas? ALIRAHEALTH](https://success.openhealth.fr/nb/articles/6863963-hva-er-apotekpanelet-i-hellas-alirahealth.md) - [Hva er apotekpanelet i Østerrike? INSIGHTHEALTH](https://success.openhealth.fr/nb/articles/6863949-hva-er-apotekpanelet-i-osterrike-insighthealth.md) - [Hva er apotekpanelet i Afrika? PIEX - Afrika](https://success.openhealth.fr/nb/articles/6686633-hva-er-apotekpanelet-i-afrika-piex-afrika.md) - [Hva er nettapotekpanelet i Tyskland? DATAMEDIQ](https://success.openhealth.fr/nb/articles/5689640-hva-er-nettapotekpanelet-i-tyskland-datamediq.md) - [Hva er apotekpanelet i Belgia? REDPHARMA](https://success.openhealth.fr/nb/articles/4689894-hva-er-apotekpanelet-i-belgia-redpharma.md) - [Hva er apotekpanelet i Spania? - HMR](https://success.openhealth.fr/nb/articles/5391363-hva-er-apotekpanelet-i-spania-hmr.md) - [Hva er apotekpanelet i Spania? - INFONIS](https://success.openhealth.fr/nb/articles/5428915-hva-er-apotekpanelet-i-spania-infonis.md) - [Hva er apotekpanelet i Portugal? - HMR](https://success.openhealth.fr/nb/articles/5391477-hva-er-apotekpanelet-i-portugal-hmr.md) - [Hva er apotekpanelet i Russland? - ALPHARM](https://success.openhealth.fr/nb/articles/5701531-hva-er-apotekpanelet-i-russland-alpharm.md) - [Hva er apotekpanelet i Polen? Pex Pharma](https://success.openhealth.fr/nb/articles/5969485-hva-er-apotekpanelet-i-polen-pex-pharma.md) - [KONVERTERINGSGRUPPE](https://success.openhealth.fr/nb/articles/6961966-konverteringsgruppe.md) - [Hva er apotekpanelet i Jordan?](https://success.openhealth.fr/nb/articles/8176750-hva-er-apotekpanelet-i-jordan.md) - [Befolkning - kartografi](https://success.openhealth.fr/nb/articles/3807695-befolkning-kartografi.md): Analyser den geografiske fordelingen av befolkningen - [AMELI - LPP](https://success.openhealth.fr/nb/articles/6962021-ameli-lpp.md) - [Befolkning - Evolusjon etter AGE & GENDER](https://success.openhealth.fr/nb/articles/3810789-befolkning-evolusjon-etter-age-gender.md): Analyser utviklingen av befolkningsstrukturen - [Befolkning - sammenligning etter AGE & GENDER](https://success.openhealth.fr/nb/articles/3836795-befolkning-sammenligning-etter-age-gender.md): Sammenlign den demografiske profilen til to populasjoner - [EGYPT - Kartografi](https://success.openhealth.fr/nb/articles/3714611-egypt-kartografi.md): Analyser befolkningen i fylkene i Egypt - [EGYPT - Analyse av AGE & GENDER](https://success.openhealth.fr/nb/articles/3714673-egypt-analyse-av-age-gender.md): Analyser strukturen i befolkningen - [UGANDA - Analyse av AGE & GENDER](https://success.openhealth.fr/nb/articles/3713884-uganda-analyse-av-age-gender.md): Analyser strukturen i befolkningen - [Befolkning - analyse etter AGE & GENDER](https://success.openhealth.fr/nb/articles/3807673-befolkning-analyse-etter-age-gender.md): Analyser strukturen i befolkningen - [Medicabase - legemiddeldatabase](https://success.openhealth.fr/nb/articles/6518920-medicabase-legemiddeldatabase.md) - [Fødsel](https://success.openhealth.fr/nb/articles/6340025-fodsel.md) - [OpenEudra](https://success.openhealth.fr/nb/articles/6518977-openeudra.md) - [IRIS-fordeling](https://success.openhealth.fr/nb/articles/6383829-iris-fordeling.md) - [ADICAP](https://success.openhealth.fr/nb/articles/6959465-adicap.md) - [NEC](https://success.openhealth.fr/nb/articles/6519012-nec.md) - [Data om verdens befolkning](https://success.openhealth.fr/nb/articles/8217421-data-om-verdens-befolkning.md) - [INSEE: Filer av avdøde personer](https://success.openhealth.fr/nb/articles/4498126-insee-filer-av-avdode-personer.md): INSEE \(National Institute for Statistics and Economic Studies\): Fil av avdøde personer - [Data VAERS- VAERSDATA- Kilde CDC](https://success.openhealth.fr/nb/articles/6226665-data-vaers-vaersdata-kilde-cdc.md) - [VAERS-data - VAERSVAX - Kilde CDC](https://success.openhealth.fr/nb/articles/6226440-vaers-data-vaersvax-kilde-cdc.md) - [VAERS-data - VAERSSYMPTOMER - Kilde CDC](https://success.openhealth.fr/nb/articles/6219415-vaers-data-vaerssymptomer-kilde-cdc.md) - [Integrer dataene dine i knutepunktet på mindre enn to uker.](https://success.openhealth.fr/nb/articles/5259828-integrer-dataene-dine-i-knutepunktet-pa-mindre-enn-to-uker.md) - [Internasjonal datamal](https://success.openhealth.fr/nb/articles/4684696-internasjonal-datamal.md) - [Hvordan sender vi dataene dine med FTPS?](https://success.openhealth.fr/nb/articles/4143451-hvordan-sender-vi-dataene-dine-med-ftps.md): Send data via FTPS - [Hvilken informasjon trenger OpenHealth for å integrere en ny datakilde?](https://success.openhealth.fr/nb/articles/3459148-hvilken-informasjon-trenger-openhealth-for-a-integrere-en-ny-datakilde.md): Artikkel om integrering av nye datakilder - [Det lange perspektivet](https://success.openhealth.fr/nb/articles/6959482-det-lange-perspektivet.md) - [Hvordan integrere en ny datakilde i HUB?](https://success.openhealth.fr/nb/articles/3467598-hvordan-integrere-en-ny-datakilde-i-hub.md): Artikkel relatert til dataintegrasjonsprosessen i HUB - [Integrer dine salgsdata i HUB](https://success.openhealth.fr/nb/articles/3471145-integrer-dine-salgsdata-i-hub.md): Artikkel om integrering av salgsdata - [Spesifikasjoner for mottak av salgsdata](https://success.openhealth.fr/nb/articles/3660043-spesifikasjoner-for-mottak-av-salgsdata.md): Slik sender du oss ditt salg som en del av en salgs- / utsalgsanalyse eller abonnement på Selg inn visualiseringsmodulen - [Hvor kommer analysedataene fra hjemmet Health Providers \(PSAD\) markedet fra?](https://success.openhealth.fr/nb/articles/3376155-hvor-kommer-analysedataene-fra-hjemmet-health-providers-psad-markedet-fra.md): PSAD - [Hvordan bli med i SantéDom Stat-observatoriet?](https://success.openhealth.fr/nb/articles/3798795-hvordan-bli-med-i-santedom-stat-observatoriet.md): Veiledning for å bli med i det nasjonale observatoriet for aktiviteten til hjemmeleverandører \(PSAD\) - [Panel ekstrapolert fra SanteDomStat-observatoriet](https://success.openhealth.fr/nb/articles/6701602-panel-ekstrapolert-fra-santedomstat-observatoriet.md) - [Antall pasienter](https://success.openhealth.fr/nb/articles/3376499-antall-pasienter.md): Definisjon av antall pasienter i henhold til PSAD-føderasjonene - [Antall behandlinger](https://success.openhealth.fr/nb/articles/3376682-antall-behandlinger.md): Definisjon av antall behandlinger i henhold til PSAD-føderasjonene - [Antall nye pasienter](https://success.openhealth.fr/nb/articles/3376672-antall-nye-pasienter.md): Definisjon av antall nye pasienter i henhold til PSAD-føderasjonene - [Omsetning inkludert skatt](https://success.openhealth.fr/nb/articles/3376725-omsetning-inkludert-skatt.md): Definisjon av omsetning inkludert skatt i henhold til PSAD-føderasjonene - [Antall pasienter ved slutten av behandlingen](https://success.openhealth.fr/nb/articles/3376675-antall-pasienter-ved-slutten-av-behandlingen.md): Definisjon av antall pasienter ved slutten av behandlingen i henhold til PSAD-føderasjonene - [Obligatorisk helseforsikringsbeløp \(AMO\)](https://success.openhealth.fr/nb/articles/3376740-obligatorisk-helseforsikringsbelop-amo.md): Definisjon av AMO-beløpet i henhold til PSAD-føderasjonene - [Supplerende helseforsikringsbeløp \(AMC\)](https://success.openhealth.fr/nb/articles/3376749-supplerende-helseforsikringsbelop-amc.md): Definisjon av AMC-beløpet i henhold til PSAD-føderasjonene - [Utestående kostnad \(RAC\)](https://success.openhealth.fr/nb/articles/3376751-utestaende-kostnad-rac.md): Definisjon av RAC i henhold til PSAD-føderasjonene - [Kilde: THESORIMED](https://success.openhealth.fr/nb/articles/3560018-kilde-thesorimed.md): Legemiddeldatabase \(BdM\) - [Internasjonale ikke-proprietære navn \(INN\)](https://success.openhealth.fr/nb/articles/3954239-internasjonale-ikke-proprietaere-navn-inn.md): Internasjonale vanlige navn \(INN\) - [Åpne fakta om mat](https://success.openhealth.fr/nb/articles/6961970-apne-fakta-om-mat.md) - [LOINC - Logiske observasjonsidentifikatorer - navn og koder](https://success.openhealth.fr/nb/articles/6959323-loinc-logiske-observasjonsidentifikatorer-navn-og-koder.md) - [AMELI - CCAM](https://success.openhealth.fr/nb/articles/6959080-ameli-ccam.md) - [WHO ATC VET](https://success.openhealth.fr/nb/articles/6959078-who-atc-vet.md) - [CEPS](https://success.openhealth.fr/nb/articles/6959068-ceps.md) - [Institusjon](https://success.openhealth.fr/nb/articles/3935678-institusjon.md): Liste over helse-, sosiale, medisinsk-sosiale institusjoner - [Helsetjenester](https://success.openhealth.fr/nb/articles/7969680-helsetjenester.md) - [Pakk ut FINESS](https://success.openhealth.fr/nb/articles/3946922-pakk-ut-finess.md): Utfør et ekstraksjon i henhold til dine forventninger - [Evolusjon FINESS](https://success.openhealth.fr/nb/articles/3947009-evolusjon-finess.md): Følg utviklingen av antall strukturer - [Autorisasjonsomsorgsaktivitet](https://success.openhealth.fr/nb/articles/3947067-autorisasjonsomsorgsaktivitet.md): Liste strukturer i henhold til autorisasjoner for helsevirksomhet - [Stort medisinsk utstyr](https://success.openhealth.fr/nb/articles/3947269-stort-medisinsk-utstyr.md): Oppgi konstruksjonene i henhold til utstyret i tungt materiale - [Geografisk](https://success.openhealth.fr/nb/articles/3947363-geografisk.md): Visualiser fordelingen av strukturer på territoriet - [RPPS](https://success.openhealth.fr/nb/articles/3947568-rpps.md): Liste over helsepersonell - [FINESS & RPPS](https://success.openhealth.fr/nb/articles/3947713-finess-rpps.md): Oppgi treningsstedene til helsepersonell - [Pakk ut RPPS](https://success.openhealth.fr/nb/articles/3947829-pakk-ut-rpps.md): RPPS \(delt katalog over helsepersonell\) ### Modellene - [Data på UGA](https://success.openhealth.fr/nb/articles/4852310-data-pa-uga.md) - [Beregning av salg til sektoren: det du trenger å vite](https://success.openhealth.fr/nb/articles/3545561-beregning-av-salg-til-sektoren-det-du-trenger-a-vite.md): Hva er de forskjellige trinnene for å beregne sektoromsetningen på OpenHealth? - [Sektoromfordeling, statisk eller dynamisk metodikk?](https://success.openhealth.fr/nb/articles/3690615-sektoromfordeling-statisk-eller-dynamisk-metodikk.md): Sektoromfordeling, statisk eller dynamisk metodikk? - [Apotek lag](https://success.openhealth.fr/nb/articles/4291490-apotek-lag.md): Detaljer om de "teoretiske" lagene og de "virkelige" eller "effektive" lagene. - [Knutepunktets produksjonslinje](https://success.openhealth.fr/nb/articles/4816146-knutepunktets-produksjonslinje.md) - [Hvordan gjennomføre en komparativ analyse?](https://success.openhealth.fr/nb/articles/3440093-hvordan-gjennomfore-en-komparativ-analyse.md): Du vil sammenligne data fra to forskjellige leverandører. - [NIVÅ 1 UNDERSØKELSE - Datakvalitet til tjeneste for OpenHealth Company](https://success.openhealth.fr/nb/articles/3595822-niva-1-undersokelse-datakvalitet-til-tjeneste-for-openhealth-company.md): Ser du et fenomen som du ikke forstår? Vi kan gi deg opprinnelsen til denne observasjonen og forklare det for deg. - [Datakvalitetsprosess på OpenHealth](https://success.openhealth.fr/nb/articles/3415271-datakvalitetsprosess-pa-openhealth.md): Denne artikkelen beskriver trinnene i datakvalitetsprosesser på OpenHealth - [Intervall og selvtillit](https://success.openhealth.fr/nb/articles/3633173-intervall-og-selvtillit.md): Definisjoner, formler og begrensninger: hva du trenger å vite - [Datakvalitet: Partihåndtering](https://success.openhealth.fr/nb/articles/3433509-datakvalitet-partihandtering.md): Beskrivelse av batch management prosessen - [Datakvalitet: Nedbrytingsprosess for salg](https://success.openhealth.fr/nb/articles/3415317-datakvalitet-nedbrytingsprosess-for-salg.md): Beskrivelse av salgsprosessen - [Selger inn og lagerforskyvning](https://success.openhealth.fr/nb/articles/4131084-selger-inn-og-lagerforskyvning.md): Lager selger inn - [Hvorfor analysere salg i volum?](https://success.openhealth.fr/nb/articles/3846167-hvorfor-analysere-salg-i-volum.md): Hvorfor analysere salg i volum? - [Det er et datagap mellom inn- og utsalg](https://success.openhealth.fr/nb/articles/3195358-det-er-et-datagap-mellom-inn-og-utsalg.md): I hvilke tilfeller kan vi ha et datagap mellom inn- og utsalg? - [Hva er et atypisk salg?](https://success.openhealth.fr/nb/articles/3195366-hva-er-et-atypisk-salg.md): Atypisk salg og ATYPISK FILTER-prosess. - [Hvor kommer informasjonen om priser, volumer, omsetning fra?](https://success.openhealth.fr/nb/articles/3195348-hvor-kommer-informasjonen-om-priser-volumer-omsetning-fra.md): Pris / volum / omsetningsinformasjon - [Anslått salgsvolum etter reseptbelagte](https://success.openhealth.fr/nb/articles/4171530-anslatt-salgsvolum-etter-reseptbelagte.md): Hvordan evaluere salgsvolumet ditt på apotek etter reseptbelagt og kategori reseptbelagt - [Forstå forskjellen mellom to ekstraksjoner](https://success.openhealth.fr/nb/articles/13399689-forsta-forskjellen-mellom-to-ekstraksjoner.md) ### Stegene - [GTIN](https://success.openhealth.fr/nb/articles/3608176-gtin.md): GTIN-kode \(globalt varenummer\) - [Kundespesifikasjon feltspesifikasjon \(CQCP\)](https://success.openhealth.fr/nb/articles/3704913-kundespesifikasjon-feltspesifikasjon-cqcp.md): CQCP \(produktkundekvalifiseringsfelt\) - [Hva er en LPPR-kode?](https://success.openhealth.fr/nb/articles/3195365-hva-er-en-lppr-kode.md): LPPR-koden \(Liste over refunderbare produkter og tjenester\) - [Produktutleie sporing](https://success.openhealth.fr/nb/articles/4206554-produktutleie-sporing.md): Produktutleie - [Jeg vil utvide markedet](https://success.openhealth.fr/nb/articles/4420843-jeg-vil-utvide-markedet.md): Abonnementsmarkedet fulgte - [OHC-klassifisering](https://success.openhealth.fr/nb/articles/3194589-ohc-klassifisering.md): Se tildelingen av produktene dine i henhold til den proprietære OpenHealth Company-klassifiseringen - [EphMRA AC-kurshistorie](https://success.openhealth.fr/nb/articles/3557908-ephmra-ac-kurshistorie.md): Visualiser utviklingen av EphMRA AC-klasser siden 2014 - [Detaljer om veterinærmedisin](https://success.openhealth.fr/nb/articles/3194587-detaljer-om-veterinaermedisin.md): Visualiser egenskapene til veterinærmedisiner - [Veterinærmedisinsk klassifisering](https://success.openhealth.fr/nb/articles/3194579-veterinaermedisinsk-klassifisering.md): Se klassifiseringen av veterinærmedisiner \(ANSES\) - [Humanmedisinsk informasjon](https://success.openhealth.fr/nb/articles/3421225-humanmedisinsk-informasjon.md): Se egenskapene til ett eller flere produkter gjennom detaljfeltene til THESORIMED - [Styring av nye produkter](https://success.openhealth.fr/nb/articles/4470813-styring-av-nye-produkter.md): Ny produktadministrasjon - [Human Medicine Classification](https://success.openhealth.fr/nb/articles/3417281-human-medicine-classification.md): Se EphMRA AC og OMS ATC-klassifiseringene for produktomfanget ditt - [Indikasjoner - Diagnose](https://success.openhealth.fr/nb/articles/3568554-indikasjoner-diagnose.md): Se legemidlene som er angitt for en gitt patologi og patologiene knyttet til et utvalg medikamenter - [MP4U](https://success.openhealth.fr/nb/articles/3574188-mp4u.md): Vis alle klassifiseringene som er tilgjengelige av OpenHealth Company - [Hva er TVASI \(tabell over salg, kjøp og ukjente beholdninger\)?](https://success.openhealth.fr/nb/articles/5992494-hva-er-tvasi-tabell-over-salg-kjop-og-ukjente-beholdninger.md) - [IRI-produktklassifisering](https://success.openhealth.fr/nb/articles/3194597-iri-produktklassifisering.md): Visualiser tildelingen av produktene dine i henhold til klassifiseringen eier IRI - [Fjerning av usolgte produkter](https://success.openhealth.fr/nb/articles/6135938-fjerning-av-usolgte-produkter.md) - [STANDARDMARKED - Abonnement](https://success.openhealth.fr/nb/articles/3798203-standardmarked-abonnement.md): Denne artikkelen beskriver interessen og begrensningene til et såkalt "standard" marked - [Jeg finner ikke produktet mitt](https://success.openhealth.fr/nb/articles/5686002-jeg-finner-ikke-produktet-mitt.md) - [Forvaltning av produktkoder](https://success.openhealth.fr/nb/articles/5652478-forvaltning-av-produktkoder.md) - [Produktkvalifisering: Varemerker](https://success.openhealth.fr/nb/articles/5016985-produktkvalifisering-varemerker.md) ### Abonnementer og moduler - [De 3 søknadstypene](https://success.openhealth.fr/nb/articles/9489652-de-3-soknadstypene.md) - [Din 2.0-plattform](https://success.openhealth.fr/nb/articles/8374416-din-2-0-plattform.md) - [SAMMENDRAG](https://success.openhealth.fr/nb/articles/3344127-sammendrag.md): Alle egenskapene til søknaden din er tilgjengelig i denne modulen - [Markeder og utvalg](https://success.openhealth.fr/nb/articles/8337016-markeder-og-utvalg.md) - [Sammendrag dashbord](https://success.openhealth.fr/nb/articles/9246867-sammendrag-dashbord.md) - [Analyse](https://success.openhealth.fr/nb/articles/9352287-analyse.md) - [Avtrekker](https://success.openhealth.fr/nb/articles/9246875-avtrekker.md) - [Vekstanalyse](https://success.openhealth.fr/nb/articles/3158856-vekstanalyse.md): Bestem nøkkelfaktorene i utviklingen av markedene dine og konkurrentene dine - [Sortimentanalyse](https://success.openhealth.fr/nb/articles/3473736-sortimentanalyse.md): Studer dynamikken til produkter i et marked - [Gjennomsnittlig antall produkter](https://success.openhealth.fr/nb/articles/3161474-gjennomsnittlig-antall-produkter.md): Se gjennomsnittlig antall produkter per salgssted, på apotek eller i GSA-apoteker - [Start sporing](https://success.openhealth.fr/nb/articles/3158488-start-sporing.md): Overvåk produktlanseringer og deres bidrag til vekst - [Avanserte indikatorer krysset](https://success.openhealth.fr/nb/articles/6007740-avanserte-indikatorer-krysset.md) - [Salgskonsentrasjon](https://success.openhealth.fr/nb/articles/3095338-salgskonsentrasjon.md): Visualiser konsentrasjonen av et marked gjennom salgskonsentrasjonskurven og GINI-indeksen - [Prisdispersjon](https://success.openhealth.fr/nb/articles/3159289-prisdispersjon.md): Visualiser prisdispersjonen på et produkt. Lag dine egne apoteksegmenter fra salgsprisen - [Selg ut marginanalyse](https://success.openhealth.fr/nb/articles/3358322-selg-ut-marginanalyse.md): Benchmark produktets attraktivitet for apotek - [Utvikling av utsalgsmarginer](https://success.openhealth.fr/nb/articles/3815561-utvikling-av-utsalgsmarginer.md) - [Apotekovervåking \(1/2\)](https://success.openhealth.fr/nb/articles/3358248-apotekovervaking-1-2.md): Følg utviklingen i apotekstrafikk - [Apotekovervåking \(2/2\)](https://success.openhealth.fr/nb/articles/3810527-apotekovervaking-2-2.md): Følg utviklingen i apotekstrafikk - [Salesforce ytelse](https://success.openhealth.fr/nb/articles/3159230-salesforce-ytelse.md): Sammenlign salgsytelsen til regioner og sektorer i en salgsstyrke - [ASSISTENT FOR KUNDRELASTSJONSSTYRING \(CRM\)](https://success.openhealth.fr/nb/articles/5953935-assistent-for-kundrelastsjonsstyring-crm.md) - [Point of Sales Tracking](https://success.openhealth.fr/nb/articles/3778944-point-of-sales-tracking.md): Point of Sales Tracking - [Utvikling på forespørsel](https://success.openhealth.fr/nb/articles/6560184-utvikling-pa-foresporsel.md) - [Analyse på forespørsel](https://success.openhealth.fr/nb/articles/6127483-analyse-pa-foresporsel.md) - [On Demand Table](https://success.openhealth.fr/nb/articles/3158751-on-demand-table.md): Visualiser de viktigste HUB-indikatorene og deres utvikling over forskjellige typer perioder - [Tidsserie-analyse](https://success.openhealth.fr/nb/articles/3635940-tidsserie-analyse.md): Del opp markedet ditt i sesong, trend og støy - [Prognoseanalyse](https://success.openhealth.fr/nb/articles/3636015-prognoseanalyse.md): Beregn fremtiden for markedet ditt - [Sektoriell prognose](https://success.openhealth.fr/nb/articles/3689811-sektoriell-prognose.md): Anslå ditt fremtidige sektor salg - [Selge inn visualisering](https://success.openhealth.fr/nb/articles/3559882-selge-inn-visualisering.md): Sammenlign utviklingen av salg og utsalg - [Analyse av innsalg](https://success.openhealth.fr/nb/articles/6188132-analyse-av-innsalg.md) - [Matching ved salg](https://success.openhealth.fr/nb/articles/6188090-matching-ved-salg.md) - [Utvikling av salg](https://success.openhealth.fr/nb/articles/6191929-utvikling-av-salg.md) - [Analyse av sell-in vs. sell-out](https://success.openhealth.fr/nb/articles/6191947-analyse-av-sell-in-vs-sell-out.md) - [Sell-in vs. Sell-out Evolution](https://success.openhealth.fr/nb/articles/6191955-sell-in-vs-sell-out-evolution.md) - [Prisutvikling](https://success.openhealth.fr/nb/articles/5056489-prisutvikling.md) - [Tilpass farger](https://success.openhealth.fr/nb/articles/8407897-tilpass-farger.md) - [Produkteksport](https://success.openhealth.fr/nb/articles/3583206-produkteksport.md): Eksporter ark spesifikt til alle produkter og MP4U-apper - [Markedsanalyse](https://success.openhealth.fr/nb/articles/3121933-markedsanalyse.md): Analyser ytelsen til markedet ditt: etter segment, merke, produkt og selskap - [Prisanalyse](https://success.openhealth.fr/nb/articles/3215190-prisanalyse.md): Se prisene på markedet og analyser posisjoneringen din - [Salgsutvikling](https://success.openhealth.fr/nb/articles/3178323-salgsutvikling.md): Se ditt utviklende salg over hele din tilgjengelige historie - [Oppsummering av dashbordet](https://success.openhealth.fr/nb/articles/4533213-oppsummering-av-dashbordet.md) - [Markedsandelsutvikling](https://success.openhealth.fr/nb/articles/3193078-markedsandelsutvikling.md): Visualiser utviklingen i salg og markedsandel over lange perioder - [Salg kryssbord](https://success.openhealth.fr/nb/articles/3193060-salg-kryssbord.md): Lag et enkelt pivottabell - [OMSETTING / VOLUM \(CU\) Syntese](https://success.openhealth.fr/nb/articles/3193048-omsetting-volum-cu-syntese.md): Visualiser samtidig salgsvolumene og verdien til et marked - [Sell Out Value Synthesis \(FARMACIES / SUPERMARKETS\)](https://success.openhealth.fr/nb/articles/3193020-sell-out-value-synthesis-farmacies-supermarkets.md): Sammenlign GSA apotek og apotek salg - [Analyse av markedsandeler](https://success.openhealth.fr/nb/articles/3193069-analyse-av-markedsandeler.md): Analyser markedsandeler de siste 12 månedene - [Mitt dataarkiv](https://success.openhealth.fr/nb/articles/3193099-mitt-dataarkiv.md): Eksporter en flat database til Excel - [Analyse av flere perioder](https://success.openhealth.fr/nb/articles/3192953-analyse-av-flere-perioder.md): Lag et helt tilpasset bord - [Min forespørsel Alle produkter](https://success.openhealth.fr/nb/articles/4280353-min-foresporsel-alle-produkter.md): Se segmentene og kvalifiseringsfeltene dine \(Eks: galenisk, solindeks, kampanjer ...\) så vel som begrensningen din - [Lagerutvikling \(NYTT\)](https://success.openhealth.fr/nb/articles/3719256-lagerutvikling-nytt.md): Visualiser og analyser utviklingen av aksjer og distribusjon av dem - [Markedsdefinisjon](https://success.openhealth.fr/nb/articles/3158829-markedsdefinisjon.md): Baser markedet ditt på 100-basen du velger - [RAW DATA avanserte indikatorer](https://success.openhealth.fr/nb/articles/3711095-raw-data-avanserte-indikatorer.md): Gjenopprett dine ledende indikatordata - [Avanserte indikatorer Evolusjon SMKT](https://success.openhealth.fr/nb/articles/3193000-avanserte-indikatorer-evolusjon-smkt.md): Overvåk ytelsen til laboratoriet ditt gjennom en analyse av den tidsmessige utviklingen av dine avanserte statistiske indikatorer. - [Avansert indikatoranalyse SMKT](https://success.openhealth.fr/nb/articles/3192366-avansert-indikatoranalyse-smkt.md): Bryt utviklingen av et GSA-parafarmatmarked til ledende indikatorer - [Avanserte indikatorer Evolusjon](https://success.openhealth.fr/nb/articles/3177853-avanserte-indikatorer-evolusjon.md): Overvåk ytelsen til laboratoriet ditt gjennom en analyse av den tidsmessige utviklingen av dine avanserte statistiske indikatorer. - [Avanserte indikatorer Evolution Bio](https://success.openhealth.fr/nb/articles/7051823-avanserte-indikatorer-evolution-bio.md) - [Nasjonale avanserte indikatorer](https://success.openhealth.fr/nb/articles/3364513-nasjonale-avanserte-indikatorer.md): Bryt utviklingen av et marked til ledende indikatorer - [Akseanalyse](https://success.openhealth.fr/nb/articles/3178015-akseanalyse.md): Tolke et aksjenivå og dets utvikling - [Avanserte indikatorer Analyse Bio](https://success.openhealth.fr/nb/articles/7051801-avanserte-indikatorer-analyse-bio.md) - [Avansert indikatoranalyse](https://success.openhealth.fr/nb/articles/3124439-avansert-indikatoranalyse.md): Bryt utviklingen av et marked til ledende indikatorer - [Kartografi](https://success.openhealth.fr/nb/articles/3192450-kartografi.md): Analyser den kommersielle ytelsen til regionene og sektorene i salgsstyrken din - [Geografisk kryssbord](https://success.openhealth.fr/nb/articles/3192466-geografisk-kryssbord.md): Lag en pivottabell som integrerer sektoriseringen din - [Geografisk salgsutvikling](https://success.openhealth.fr/nb/articles/3192482-geografisk-salgsutvikling.md): Visualiser salg etter sektor over 36 måneder i en pivottabell - [Salgsstyrkenes effektivitet](https://success.openhealth.fr/nb/articles/5624011-salgsstyrkenes-effektivitet.md) - [Analyse av egendefinert vektingsmetode](https://success.openhealth.fr/nb/articles/5169317-analyse-av-egendefinert-vektingsmetode.md) - [Nettverksanalyse](https://success.openhealth.fr/nb/articles/3894767-nettverksanalyse.md): Nettverksanalyse - [Tilpasset utvikling av vektingsmetode](https://success.openhealth.fr/nb/articles/5169320-tilpasset-utvikling-av-vektingsmetode.md) - [SAMMENDRAG KPI](https://success.openhealth.fr/nb/articles/3478199-sammendrag-kpi.md): Visualiser i en dynamisk tabell nøkkelindikatorene Volumet avvist til regioner og sektorer. - [Salg i konverterte enheter](https://success.openhealth.fr/nb/articles/3192412-salg-i-konverterte-enheter.md): Bruk konverterte enheter for å visualisere salget ditt - [RAW DATA lagerindikatorer](https://success.openhealth.fr/nb/articles/3711142-raw-data-lagerindikatorer.md): Eksporter beholdningsdataene dine - [RÅ DATA SMKT AIA](https://success.openhealth.fr/nb/articles/3720960-ra-data-smkt-aia.md): Finn SMKT-ledende indikatordata - [Lagerutvikling](https://success.openhealth.fr/nb/articles/3178277-lagerutvikling.md): Visualiser og analyser utviklingen av aksjer og distribusjon av dem - [Geografiske avanserte indikatorer](https://success.openhealth.fr/nb/articles/3192508-geografiske-avanserte-indikatorer.md): Se ledende indikatorer etter region eller sektor - [Produktytelse](https://success.openhealth.fr/nb/articles/3850331-produktytelse.md): Sammenlign forretningsresultatene til regioner og produktsektorer - [Territoriale avanserte indikatorer](https://success.openhealth.fr/nb/articles/3370879-territoriale-avanserte-indikatorer.md): Bryt utviklingen av et marked til ledende indikatorer - [Tidsserie sektoriell analyse](https://success.openhealth.fr/nb/articles/3814974-tidsserie-sektoriell-analyse.md): Bryt markedet opp i trend, sesong, støy - [Salgsanalyse etter alder og kjønn](https://success.openhealth.fr/nb/articles/3192701-salgsanalyse-etter-alder-og-kjonn.md): Analyser salg etter alder og kjønn - [Salgsutvikling etter graviditetsstatus](https://success.openhealth.fr/nb/articles/3192910-salgsutvikling-etter-graviditetsstatus.md): Følg salg av apotek på befolkningen av gravide kvinner - [Salgsutvikling etter alder og kjønn](https://success.openhealth.fr/nb/articles/3192732-salgsutvikling-etter-alder-og-kjonn.md): Visualiser utviklingen av salg etter alder og kjønn ved hjelp av HUBs dybde i historien - [Krav til utvikling av rekkefølgen](https://success.openhealth.fr/nb/articles/5790020-krav-til-utvikling-av-rekkefolgen.md) - [Evolusjon co-dispensasjoner](https://success.openhealth.fr/nb/articles/3192529-evolusjon-co-dispensasjoner.md): Visualiser og nedbryt utviklingen av ko-dispensasjoner på apotek - [Co-dispensations analyse](https://success.openhealth.fr/nb/articles/3192633-co-dispensations-analyse.md): Se co-dispensasjoner på apotek knyttet til et utvalg av produkter fra markedet mitt - [Salg per kanal og forskriver](https://success.openhealth.fr/nb/articles/3192751-salg-per-kanal-og-forskriver.md): Visualiser påvirkerne i markedet ditt - [AMO, AMC & RAC](https://success.openhealth.fr/nb/articles/3192929-amo-amc-rac.md): Se de tre beløpene for obligatorisk helseforsikring, utfyllende helseforsikring og utgifter - [Co-dispensasjoner spredning](https://success.openhealth.fr/nb/articles/3876946-co-dispensasjoner-spredning.md): Se fordelingen av antall produkter solgt etter dispensasjon - [Dispensasjon Dispersjon Evolusjon](https://success.openhealth.fr/nb/articles/3920070-dispensasjon-dispersjon-evolusjon.md): Visualiser fordelingen av antall solgte produkter per dispensasjon over tid - [Fastlegeforskrivninger etter ALDER og KJØNN](https://success.openhealth.fr/nb/articles/5789899-fastlegeforskrivninger-etter-alder-og-kjonn.md) - [Analyse av reseptordrer](https://success.openhealth.fr/nb/articles/5322866-analyse-av-reseptordrer.md) - [Utvikling av allmennlegers resepter](https://success.openhealth.fr/nb/articles/5790016-utvikling-av-allmennlegers-resepter.md) - [Kurvanalyse](https://success.openhealth.fr/nb/articles/3711049-kurvanalyse.md): Beskrivelse av modulen 'Basket Analysis' - [Samdispensering](https://success.openhealth.fr/nb/articles/4738243-samdispensering.md) - [Kullkvalifiseringsmodul](https://success.openhealth.fr/nb/articles/3928090-kullkvalifiseringsmodul.md): Kvalifisering av pasientkullet - [Behandlingsstatusmodul](https://success.openhealth.fr/nb/articles/3928067-behandlingsstatusmodul.md): Analyser dynamikken i behandlingsovervåking - [Behandlingsoverholdelsesmodul](https://success.openhealth.fr/nb/articles/3928044-behandlingsoverholdelsesmodul.md): Analyser etterlevelse av behandlingen - [Kulldefinisjon](https://success.openhealth.fr/nb/articles/3894703-kulldefinisjon.md): Definer omfanget av analysen din - [Sambehandlinger](https://success.openhealth.fr/nb/articles/4163623-sambehandlinger.md): Definer samprosessering innenfor analysen - [Visualiseringskull](https://success.openhealth.fr/nb/articles/3894721-visualiseringskull.md): Se pasientprofilen til den definerte kohorten - [Definisjon av analysekriterier](https://success.openhealth.fr/nb/articles/3894728-definisjon-av-analysekriterier.md): Definer parametrene for analysen av kohorten - [Global kohortutvikling](https://success.openhealth.fr/nb/articles/3894747-global-kohortutvikling.md): Visualiser den månedlige utviklingen av kohorten - [Geografisk fordeling](https://success.openhealth.fr/nb/articles/3894751-geografisk-fordeling.md): Se den geografiske fordelingen av pasienter i den definerte kohorten - [Kullprofil](https://success.openhealth.fr/nb/articles/3894755-kullprofil.md): Analyser den demografiske profilen til pasienter som er inkludert i kohorten - [Behandlingsstatus brytes ned](https://success.openhealth.fr/nb/articles/3894764-behandlingsstatus-brytes-ned.md): Få oversikt over de forskjellige typene behandlingsovervåking - [Behandlingsinnledninger](https://success.openhealth.fr/nb/articles/3894778-behandlingsinnledninger.md): Analyser utviklingen av antall behandlingsinnledninger - [Behandlingen starter igjen](https://success.openhealth.fr/nb/articles/3894788-behandlingen-starter-igjen.md): Analyser utviklingen av antall behandlinger på nytt - [Nye behandlinger](https://success.openhealth.fr/nb/articles/3894804-nye-behandlinger.md): Analyser utviklingen av antall initieringer og gjenopptak av behandlingen - [Behandling gjentar seg](https://success.openhealth.fr/nb/articles/3894812-behandling-gjentar-seg.md): Analyser pasienter på behandling - [Behandling bryter balanse](https://success.openhealth.fr/nb/articles/3894821-behandling-bryter-balanse.md): Analyser balansen mellom behandlingsendringer etter behandling - [Behandlingsbryter gevinster](https://success.openhealth.fr/nb/articles/3894830-behandlingsbryter-gevinster.md): Analyser mottakerne av behandlingsbrytere - [Tap for behandlingsbryter](https://success.openhealth.fr/nb/articles/3894843-tap-for-behandlingsbryter.md): Analyser ved behandling tapere av behandlingsbrytere - [Bytt gevinstopprinnelse](https://success.openhealth.fr/nb/articles/3894857-bytt-gevinstopprinnelse.md): Analyser bryterens opprinnelse for en gitt behandling - [Bytt tap destinasjon](https://success.openhealth.fr/nb/articles/3894864-bytt-tap-destinasjon.md): Analyser destinasjonen til bryteren for en gitt behandling - [Frafall](https://success.openhealth.fr/nb/articles/3894874-frafall.md): Analyser behandlingsstopp - [Sammendrag av KPI](https://success.openhealth.fr/nb/articles/4229969-sammendrag-av-kpi.md): Sammendrag av de forskjellige typene behandlingsovervåking - [Behandlingsutholdenhet](https://success.openhealth.fr/nb/articles/3894883-behandlingsutholdenhet.md): Analyser varigheten av behandlingene - [Samsvar](https://success.openhealth.fr/nb/articles/3894884-samsvar.md): Analyser leverte mengder - [Hva er regelmessighetskriteriet?](https://success.openhealth.fr/nb/articles/3325816-hva-er-regelmessighetskriteriet.md): Definisjon av begrepet regelmessighetskriterium - [Død - Kartografi](https://success.openhealth.fr/nb/articles/3863677-dod-kartografi.md): Analyser den geografiske fordelingen av dødsfall - [Forskyvning av dødstall](https://success.openhealth.fr/nb/articles/3863573-forskyvning-av-dodstall.md): Evaluer relevansen av dataene dine - [Death - Analyse av AGE & GENDER](https://success.openhealth.fr/nb/articles/3863808-death-analyse-av-age-gender.md): Analyser strukturen til dødsfall - [Death - Evolution by AGE & GENDER](https://success.openhealth.fr/nb/articles/3863939-death-evolution-by-age-gender.md): Analyser utviklingen av strukturen til dødsfall - [Død - Evolusjon](https://success.openhealth.fr/nb/articles/3864065-dod-evolusjon.md): Visualiser utviklingen av dødsfall - [Death - Evolution Comparison](https://success.openhealth.fr/nb/articles/3864073-death-evolution-comparison.md): Sammenlign utviklingen av dødsfall sammenlignet med tidligere år - [Apotekovervåking CA](https://success.openhealth.fr/nb/articles/4634768-apotekovervaking-ca.md): Beskriv trafikken i henhold til størrelsen på apotekene - [Trafikkanalyse \(betatest\)](https://success.openhealth.fr/nb/articles/6848401-trafikkanalyse-betatest.md) - [Apotekovervåkingsdetaljer](https://success.openhealth.fr/nb/articles/4527868-apotekovervakingsdetaljer.md): Analyser apotekstrafikk etter apotekstype - [Trafikkutvikling \(betatest\)](https://success.openhealth.fr/nb/articles/6848016-trafikkutvikling-betatest.md) - [Apotekovervåkingskartografi](https://success.openhealth.fr/nb/articles/4527811-apotekovervakingskartografi.md): Analyser dispensertrafikken på det franske fastlandet - [Apotekovervåkingsdetaljer](https://success.openhealth.fr/nb/articles/4262306-apotekovervakingsdetaljer.md): Diskriminer detaljene i salg etter type apotek - [Apotekovervåkingsanalyse](https://success.openhealth.fr/nb/articles/3839223-apotekovervakingsanalyse.md): Følg utviklingen i apotekstrafikk - [Apotekovervåking av evolusjon](https://success.openhealth.fr/nb/articles/3827973-apotekovervaking-av-evolusjon.md): Studer utviklingen av apotekstrafikk - [Trafikknedbrytning](https://success.openhealth.fr/nb/articles/3826074-trafikknedbrytning.md): Observer komponentene i sesong, trend og rester - [Trafikkundersøkelse](https://success.openhealth.fr/nb/articles/3809042-trafikkundersokelse.md): Analyser apotekstrafikk - [Sammendrag - PIEX](https://success.openhealth.fr/nb/articles/5203335-sammendrag-piex.md) - [Innkjøp](https://success.openhealth.fr/nb/articles/4605110-innkjop.md): Spor kjøpene dine og kvitteringene deres - [Min forespørsel - PIEX](https://success.openhealth.fr/nb/articles/4210627-min-foresporsel-piex.md): Gjør valg på dataene dine - [Salgsutvikling - PIEX](https://success.openhealth.fr/nb/articles/4210655-salgsutvikling-piex.md): Se utviklingen av aktiviteten din i den tilgjengelige historikken - [Salgsanalyse - PIEX](https://success.openhealth.fr/nb/articles/4210650-salgsanalyse-piex.md): Salgsanalyse - PIEX - [Bestillingsdetaljer - PIEX](https://success.openhealth.fr/nb/articles/4210659-bestillingsdetaljer-piex.md): Se på og følg en salgsordre - [Lageroversikt - PIEX](https://success.openhealth.fr/nb/articles/4210672-lageroversikt-piex.md): Visualiser varianter av aksjene dine - [Mitt dataarkiv - PIEX](https://success.openhealth.fr/nb/articles/4210694-mitt-dataarkiv-piex.md): Eksporter en flat database til Excel - [EURAPHARMA- PIEX](https://success.openhealth.fr/nb/articles/4366306-eurapharma-piex.md): Visualiser utviklingen av EURAPHARMAs aktivitet - [Matchende produkt](https://success.openhealth.fr/nb/articles/4366320-matchende-produkt.md): Korrespondanse mellom betegnelsene på PIEX- og EURAPHARMA-produktene - [CLI My File \(1/5\)](https://success.openhealth.fr/nb/articles/4626422-cli-my-file-1-5.md): CLI My File \(1/5\) - [CLI\_File Counts \(2/5\)](https://success.openhealth.fr/nb/articles/4626421-cli_file-counts-2-5.md): CLI\_File Counts \(2/5\) - [CLI\_File Code Matching med OHC repository](https://success.openhealth.fr/nb/articles/4626419-cli_file-code-matching-med-ohc-repository.md): CLI\_FIL-kode samsvarende med OHC Repository - [Eksport av utsalg \(4/5\)](https://success.openhealth.fr/nb/articles/4626414-eksport-av-utsalg-4-5.md): Utsalg av eksport \(4/5\) ### PERSONLIGE ALTERNATIVER - [Ikke-hierarkiske produktkvalifiserende felt](https://success.openhealth.fr/nb/articles/4036045-ikke-hierarkiske-produktkvalifiserende-felt.md): Legg til detaljer om kvalifiseringen av produktene dine - [Hva er maksimal alder på HUB-dataene?](https://success.openhealth.fr/nb/articles/3195251-hva-er-maksimal-alder-pa-hub-dataene.md): Siste data tilgjengelig - [Kundetype](https://success.openhealth.fr/nb/articles/4197147-kundetype.md): Egendefinert alternativ Kundetype - [Tilgang til økt](https://success.openhealth.fr/nb/articles/4036458-tilgang-til-okt.md): Begrens visningen av dine ansatte - [Egendefinert syklus](https://success.openhealth.fr/nb/articles/4036444-egendefinert-syklus.md): Analyser dataene dine over personlige perioder - [Regnskapsår](https://success.openhealth.fr/nb/articles/4036169-regnskapsar.md): Definer regnskapsåret ditt - [Dagsknapp](https://success.openhealth.fr/nb/articles/4036159-dagsknapp.md): Visualiser dataene dine med finere detaljer - [Uke-knapp](https://success.openhealth.fr/nb/articles/4036111-uke-knapp.md): Visualiser dataene dine med finere detaljer - [Valutakurser](https://success.openhealth.fr/nb/articles/8329594-valutakurser.md) - [SMKT periodekalender](https://success.openhealth.fr/nb/articles/4036549-smkt-periodekalender.md): Bruk en GSA-kalender - [Begrens omkretsen](https://success.openhealth.fr/nb/articles/4560699-begrens-omkretsen.md): Velge en GTIN-liste i Min forespørsel fra en .xlsx-fil - [Begrens omkretsen \(kode 7\)](https://success.openhealth.fr/nb/articles/4560791-begrens-omkretsen-kode-7.md): Valg av en liste over \[TEKNISK KODE 2\] i Min forespørsel fra en .xlsx-fil - [Markedsflagg](https://success.openhealth.fr/nb/articles/4560797-markedsflagg.md): Velge en GTIN-liste i Min forespørsel fra en markedsdefinisjon i en .xlsx-fil - [Målretting / definisjon av kundetype](https://success.openhealth.fr/nb/articles/3777788-malretting-definisjon-av-kundetype.md): Målretting \(kundetype\) ### HUB-INDIKATORENE - [Ordliste over HUB-indikatorer](https://success.openhealth.fr/nb/articles/5194247-ordliste-over-hub-indikatorer.md) - [Salgsmengder](https://success.openhealth.fr/nb/articles/3194314-salgsmengder.md): Salgsmengder - [Salgsverdier](https://success.openhealth.fr/nb/articles/3074854-salgsverdier.md): Spesifisere salgsverdier-indikatoren - [N MS](https://success.openhealth.fr/nb/articles/3194475-n-ms.md): Definisjon av 'N MS' tiltaket - [N MS Evol](https://success.openhealth.fr/nb/articles/5634266-n-ms-evol.md) - [N MS Delta](https://success.openhealth.fr/nb/articles/3194469-n-ms-delta.md): Definisjon av 'N MS Delta' tiltaket - [Poids Vol \(CA\) par modalité / Custom Weight Vol \(To\)](https://success.openhealth.fr/nb/articles/9292839-poids-vol-ca-par-modalite-custom-weight-vol-to.md) - [Salgsverdi basert på produsentens pris ekskl. mva. \(omsetning PF ekskl. mva.\) - Marokko](https://success.openhealth.fr/nb/articles/7508513-salgsverdi-basert-pa-produsentens-pris-ekskl-mva-omsetning-pf-ekskl-mva-marokko.md) - [N CTR for vekst](https://success.openhealth.fr/nb/articles/3194466-n-ctr-for-vekst.md): Definisjon og beregningsformel for tiltaket 'N Growth CTR' - [I avtale](https://success.openhealth.fr/nb/articles/6201859-i-avtale.md) - [Krysset Vekt Volum](https://success.openhealth.fr/nb/articles/6066324-krysset-vekt-volum.md) - [Krysset vektomsetning](https://success.openhealth.fr/nb/articles/6066273-krysset-vektomsetning.md) - [N Vekst CTR justert](https://success.openhealth.fr/nb/articles/3205376-n-vekst-ctr-justert.md): Definisjons- og beregningsformel for tiltaket 'N Growth CTR A' - [Kildevekt](https://success.openhealth.fr/nb/articles/5151525-kildevekt.md) - [Gjennomsnittlig pris observert](https://success.openhealth.fr/nb/articles/3194302-gjennomsnittlig-pris-observert.md): AASP: Gjennomsnittlig pris observert - [Vektet gjennomsnittspris](https://success.openhealth.fr/nb/articles/3194292-vektet-gjennomsnittspris.md): WASP: Vektet gjennomsnittspris - [Priseffekt](https://success.openhealth.fr/nb/articles/8426443-priseffekt.md) - [Antall apotek som selger](https://success.openhealth.fr/nb/articles/3719566-antall-apotek-som-selger.md) - [Selger digital distribusjon](https://success.openhealth.fr/nb/articles/3194321-selger-digital-distribusjon.md): Numerisk distribusjon - [Global salg av digital distribusjon](https://success.openhealth.fr/nb/articles/3194320-global-salg-av-digital-distribusjon.md): Global numerisk distribusjon - [Rebased Selling Digital Distribution](https://success.openhealth.fr/nb/articles/4045636-rebased-selling-digital-distribution.md): Numerisk distribusjon rebased - [Global ombasert salg av digital distribusjon](https://success.openhealth.fr/nb/articles/4045725-global-ombasert-salg-av-digital-distribusjon.md): Global numerisk distribusjon rebased - [Tilpasset digital salgsdistribusjon på nytt grunnlag](https://success.openhealth.fr/nb/articles/6830813-tilpasset-digital-salgsdistribusjon-pa-nytt-grunnlag.md) - [Selger verdifordeling](https://success.openhealth.fr/nb/articles/3194323-selger-verdifordeling.md): Vektet fordeling - [Global salgsverdifordeling](https://success.openhealth.fr/nb/articles/3194316-global-salgsverdifordeling.md): Global salgsverdifordeling - [Fordel salgsverdien på nytt](https://success.openhealth.fr/nb/articles/3194501-fordel-salgsverdien-pa-nytt.md): Rebasert DVV - [Global rebased salgsverdifordeling](https://success.openhealth.fr/nb/articles/4200619-global-rebased-salgsverdifordeling.md): Global omstøttet DVV - [Skreddersydd fordeling av omregnet salgsverdi](https://success.openhealth.fr/nb/articles/6834423-skreddersydd-fordeling-av-omregnet-salgsverdi.md) - [Distribusjon av digital salg SMKT](https://success.openhealth.fr/nb/articles/3365043-distribusjon-av-digital-salg-smkt.md): Digital salgsdistribusjon SMKT \(SMK numerisk distribusjon\) - [Global SMKT selger digital distribusjon](https://success.openhealth.fr/nb/articles/4298341-global-smkt-selger-digital-distribusjon.md): SMKT Global Numeric Distribution \(SMKT Global Numeric Distribution\) - [Ombasert SMKT-salg av digital distribusjon](https://success.openhealth.fr/nb/articles/4298197-ombasert-smkt-salg-av-digital-distribusjon.md): SMKT Digital distribusjon rebased \(SMKT numerisk distribusjon rebased\) - [Global ombasert SMKT-salg av digital distribusjon](https://success.openhealth.fr/nb/articles/4319783-global-ombasert-smkt-salg-av-digital-distribusjon.md): Selger digital distribusjon SMKT Rebasée Globale \(SMKT Global Numeric Distribution Rebased\) - [Distribusjon av SMKT-salgsverdier](https://success.openhealth.fr/nb/articles/3365478-distribusjon-av-smkt-salgsverdier.md): Distribusjon av SMKT-salgsverdi \(SMKT-vektet fordeling\) - [Omberegnet global SMKT-salg av digital distribusjon](https://success.openhealth.fr/nb/articles/4298373-omberegnet-global-smkt-salg-av-digital-distribusjon.md): SMKT Global Numeric Distribution Beregnet på nytt - [Digital distribusjon selger SMKT ombasert på nytt](https://success.openhealth.fr/nb/articles/4298303-digital-distribusjon-selger-smkt-ombasert-pa-nytt.md): SMKT Numerisk distribusjon omberegnet på nytt - [Justert SMKT-salg av digital distribusjon](https://success.openhealth.fr/nb/articles/3369386-justert-smkt-salg-av-digital-distribusjon.md): Justert numerisk distribusjon SMKT - [Digital distribusjon selger SMKT beregnet på nytt](https://success.openhealth.fr/nb/articles/4298209-digital-distribusjon-selger-smkt-beregnet-pa-nytt.md): SMKT numerisk distribusjon beregnet på nytt \(SMKT numerisk distribusjon beregnet på nytt\) - [Justert SMKT salgsverdifordeling](https://success.openhealth.fr/nb/articles/3369397-justert-smkt-salgsverdifordeling.md): Justert vektet distribusjon SMKT - [Organisk digital salgsdistribusjon](https://success.openhealth.fr/nb/articles/7052424-organisk-digital-salgsdistribusjon.md) - [Omsetning av selgende apotek \(TSP\)](https://success.openhealth.fr/nb/articles/6096534-omsetning-av-selgende-apotek-tsp.md) - [Anslag for holderens PDM](https://success.openhealth.fr/nb/articles/4214883-anslag-for-holderens-pdm.md): Anslå markedsandelen med kundene dine - [Flere apotek](https://success.openhealth.fr/nb/articles/8426451-flere-apotek.md) - [Tap av apotek](https://success.openhealth.fr/nb/articles/8426460-tap-av-apotek.md) - [Flerkanals digitalt salg og distribusjon](https://success.openhealth.fr/nb/articles/9293487-flerkanals-digitalt-salg-og-distribusjon.md) - [Kumulativt salg av digital distribusjon \(PHARMA\)](https://success.openhealth.fr/nb/articles/9330571-kumulativt-salg-av-digital-distribusjon-pharma.md) - [Månedlig gjennomsnittlig salg](https://success.openhealth.fr/nb/articles/3194303-manedlig-gjennomsnittlig-salg.md): Gjennomsnittlig månedlig salg - [Justert månedlig gjennomsnittlig salg](https://success.openhealth.fr/nb/articles/3194290-justert-manedlig-gjennomsnittlig-salg.md): Justert gjennomsnittlig månedlig salg - [Månedlig gjennomsnittlig salgsverdi](https://success.openhealth.fr/nb/articles/4535404-manedlig-gjennomsnittlig-salgsverdi.md): VMM CA - [AMS til A: Gjennomsnittlig månedlig salgsverdi justert](https://success.openhealth.fr/nb/articles/6028256-ams-til-a-gjennomsnittlig-manedlig-salgsverdi-justert.md) - [Gjennomsnittlig salg](https://success.openhealth.fr/nb/articles/3563716-gjennomsnittlig-salg.md): Gjennomsnittlig salg - [SMKT Gjennomsnittlig salg](https://success.openhealth.fr/nb/articles/3365496-smkt-gjennomsnittlig-salg.md): SMKT Gjennomsnittlig salg - [Justert SMKT Gjennomsnittlig salg](https://success.openhealth.fr/nb/articles/3369340-justert-smkt-gjennomsnittlig-salg.md): Justert SMKT Gjennomsnittlig salg - [Gjennomsnittlig månedlig økologisk salg](https://success.openhealth.fr/nb/articles/7052551-gjennomsnittlig-manedlig-okologisk-salg.md) - [Gjennomsnittlig månedlig salg Økologisk verdi](https://success.openhealth.fr/nb/articles/7052573-gjennomsnittlig-manedlig-salg-okologisk-verdi.md) - [Lager](https://success.openhealth.fr/nb/articles/3194332-lager.md): Definisjon og tilgjengelighet av lagerdata i HUB, via SMAa-applikasjoner: Sales & Marketing Advanced abonnement - [Gjennomsnittlig aksje](https://success.openhealth.fr/nb/articles/3194336-gjennomsnittlig-aksje.md): Gjennomsnittlig aksje - [Andel av aksjen](https://success.openhealth.fr/nb/articles/3194334-andel-av-aksjen.md): Andel av aksjen - [Kommersielt trykkindeks](https://success.openhealth.fr/nb/articles/3194335-kommersielt-trykkindeks.md): Kommersielt trykkindeks - [Lageromdannelseshastighet](https://success.openhealth.fr/nb/articles/3194344-lageromdannelseshastighet.md): Lageromdannelseshastighet - [Leveringens varighet](https://success.openhealth.fr/nb/articles/3194337-leveringens-varighet.md): Forsyningsvarighet - [Antall forhandlerapoteker](https://success.openhealth.fr/nb/articles/3194338-antall-forhandlerapoteker.md): Antall forhandlerapoteker - [Stockist Digital Distribution](https://success.openhealth.fr/nb/articles/3194339-stockist-digital-distribution.md): Stockist Distribution \(ND Stock\) - [Digital distribusjonsforhandler ble rebasert](https://success.openhealth.fr/nb/articles/4045743-digital-distribusjonsforhandler-ble-rebasert.md): Lager numerisk distribusjon rebased - [Global rebasert distribusjon av digital forhandler](https://success.openhealth.fr/nb/articles/4045753-global-rebasert-distribusjon-av-digital-forhandler.md): Global rebasert distribusjon av digital forhandler - [Distribusjon av forhandlerverdien](https://success.openhealth.fr/nb/articles/3194342-distribusjon-av-forhandlerverdien.md): Distribusjon av lagerholdere \(vektet aksjefordeling: WD lager\) - [Fordel fordelingen av lagerverdien på nytt](https://success.openhealth.fr/nb/articles/3194505-fordel-fordelingen-av-lagerverdien-pa-nytt.md): Sett DVS på nytt - [Digital distribusjon Glatt forhandler](https://success.openhealth.fr/nb/articles/5141830-digital-distribusjon-glatt-forhandler.md) - [Digital distribusjon Lagerist utjevnet rebasering](https://success.openhealth.fr/nb/articles/5142162-digital-distribusjon-lagerist-utjevnet-rebasering.md) - [Fordeling Glattet beholdningsverdi](https://success.openhealth.fr/nb/articles/5203640-fordeling-glattet-beholdningsverdi.md) - [Fordeling Glattet omregnet beholdningsverdi](https://success.openhealth.fr/nb/articles/5203701-fordeling-glattet-omregnet-beholdningsverdi.md) - [Margin](https://success.openhealth.fr/nb/articles/3507716-margin.md): Margin - [Margin rate](https://success.openhealth.fr/nb/articles/3507767-margin-rate.md): Margin rate - [Produsentpris eksklusive skatt \(PFHT\)](https://success.openhealth.fr/nb/articles/4557500-produsentpris-eksklusive-skatt-pfht.md): PFHT - [Selg inn - Analyser av kundebasen din](https://success.openhealth.fr/nb/articles/3846225-selg-inn-analyser-av-kundebasen-din.md): Lojalitetsindikatorer: egenskapene til kundebasen din og dens utvikling - [Selg inn - Atypiske apotek](https://success.openhealth.fr/nb/articles/3848791-selg-inn-atypiske-apotek.md): Tiltak for å oppdage atypismer - [Utviklingsforhold](https://success.openhealth.fr/nb/articles/3194287-utviklingsforhold.md): Utviklingsforhold - [Gjennomtrengningsforhold](https://success.openhealth.fr/nb/articles/3194286-gjennomtrengningsforhold.md): Gjennomtrengningsforhold - [Produktsortimentbredde](https://success.openhealth.fr/nb/articles/3369425-produktsortimentbredde.md): Produktsortimentbredde - [Fornyelse av sortimentet](https://success.openhealth.fr/nb/articles/3369545-fornyelse-av-sortimentet.md): Fornyelse av sortimentet - [Innovasjon i sortimentet](https://success.openhealth.fr/nb/articles/3369468-innovasjon-i-sortimentet.md): Innovasjon i sortimentet - [Slitasje på sortimentet](https://success.openhealth.fr/nb/articles/3369457-slitasje-pa-sortimentet.md): Slitasje på sortimentet - [Utmattelsesgrad på sortiment](https://success.openhealth.fr/nb/articles/3369485-utmattelsesgrad-pa-sortiment.md): Utmattelsesgrad på sortiment - [Range innovasjonsrate](https://success.openhealth.fr/nb/articles/3369541-range-innovasjonsrate.md): Range innovasjonsrate - [Andel av salgstilbud](https://success.openhealth.fr/nb/articles/3369040-andel-av-salgstilbud.md): Andel av salgstilbud - [Antall valgte produkter](https://success.openhealth.fr/nb/articles/3511502-antall-valgte-produkter.md): Dette er antall produkter valgt av GTIN-13 sifret koden. - [Gjennomsnittlig antall produkter](https://success.openhealth.fr/nb/articles/3194284-gjennomsnittlig-antall-produkter.md): Gjennomsnittlig antall produkter - [Rekkefornyelsesrate](https://success.openhealth.fr/nb/articles/3369561-rekkefornyelsesrate.md): Rekkefornyelsesrate - [Antall produkter](https://success.openhealth.fr/nb/articles/6312686-antall-produkter.md) - [Beløp brukt per handling](https://success.openhealth.fr/nb/articles/3447792-belop-brukt-per-handling.md): Artikkel om indikatoren 'Beløp brukt per handling' - [Fordeling av beløp brukt etter type kjøper](https://success.openhealth.fr/nb/articles/3447801-fordeling-av-belop-brukt-etter-type-kjoper.md): Artikkel om indikatoren 'Fordeling av beløp brukt etter kjøpertype' - [Forbruksindeks](https://success.openhealth.fr/nb/articles/3432701-forbruksindeks.md): Definisjon av 'Forbruksindeks' indikator - [Salgsandel](https://success.openhealth.fr/nb/articles/3432664-salgsandel.md): Definisjon av indikatoren 'Salgsandel' - [Verdi lojalitetsrate](https://success.openhealth.fr/nb/articles/3432695-verdi-lojalitetsrate.md): Definisjon av indikatoren 'Verdi lojalitetsrate' - [Absolutt penetrasjon](https://success.openhealth.fr/nb/articles/3432556-absolutt-penetrasjon.md): Artikkel om indikatoren 'Absolutt penetrasjon' - [Andel av omsetningen](https://success.openhealth.fr/nb/articles/3432655-andel-av-omsetningen.md): Definisjon av indikatoren 'Omsetningsandel' - [p-verdi](https://success.openhealth.fr/nb/articles/5781702-p-verdi.md) - [Hovedkomponentanalyse](https://success.openhealth.fr/nb/articles/4231028-hovedkomponentanalyse.md): AVS - [Negativ prediktiv verdi](https://success.openhealth.fr/nb/articles/4134220-negativ-prediktiv-verdi.md): Negativ prediktiv verdi - [Positiv prediktiv verdi](https://success.openhealth.fr/nb/articles/4134166-positiv-prediktiv-verdi.md): Positiv prediktiv verdi - [Uavhengighetstest](https://success.openhealth.fr/nb/articles/4128369-uavhengighetstest.md): Sjekk om to variabler er relatert til hverandre - [Studie av tidsserier](https://success.openhealth.fr/nb/articles/3633991-studie-av-tidsserier.md): Sesongmessighet, trend og spådom: det du trenger å vite - [Sesongavvik](https://success.openhealth.fr/nb/articles/3653790-sesongavvik.md): Måler variansandelen i en tidsserie - [Sensitivitet og spesifisitet av en test](https://success.openhealth.fr/nb/articles/3928135-sensitivitet-og-spesifisitet-av-en-test.md): Forstå konseptene for å analysere effektiviteten av en test - [Trendvariansrate](https://success.openhealth.fr/nb/articles/3653847-trendvariansrate.md): Måler andelen av trendkomponenten i en tidsserie - [Restvarians](https://success.openhealth.fr/nb/articles/3653851-restvarians.md): Måler andelen av restkomponenten i en tidsserie - [Bestemmelseskoeffisient](https://success.openhealth.fr/nb/articles/3654093-bestemmelseskoeffisient.md): Evaluer kvaliteten på den valgte modellen - [Variasjonskoeffisient](https://success.openhealth.fr/nb/articles/3653915-variasjonskoeffisient.md): Indikator for å velge nedbrytingsmodell - [Variasjon av en tidsserie](https://success.openhealth.fr/nb/articles/3653855-variasjon-av-en-tidsserie.md): Mål spredningen av en serie - [Salgskonsentrasjon](https://success.openhealth.fr/nb/articles/3395856-salgskonsentrasjon.md): Salgskonsentrasjon - [Gini-indeks](https://success.openhealth.fr/nb/articles/3395323-gini-indeks.md): Gini-indeks - [Befolkning](https://success.openhealth.fr/nb/articles/4396779-befolkning.md): Befolkning - [Utvikling av antall dødsfall](https://success.openhealth.fr/nb/articles/4396765-utvikling-av-antall-dodsfall.md): Utvikling av antall dødsfall - [Kjønnsforhold](https://success.openhealth.fr/nb/articles/3812167-kjonnsforhold.md): Kjønnsforhold - [Befolkning - Gjennomsnittsalder](https://success.openhealth.fr/nb/articles/3812180-befolkning-gjennomsnittsalder.md): Befolkning - Gjennomsnittsalder - [Befolkning - Median alder](https://success.openhealth.fr/nb/articles/3812198-befolkning-median-alder.md): Befolkning - Median alder - [Befolkning - Alder 1. kvartil](https://success.openhealth.fr/nb/articles/3812218-befolkning-alder-1-kvartil.md): Befolkning - Alder 1. kvartil - [Befolkning - Alder 3. kvartil](https://success.openhealth.fr/nb/articles/3812227-befolkning-alder-3-kvartil.md): Befolkning - Alder 3. kvartil - [Andel av utvalg i den totale befolkningen i territoriet](https://success.openhealth.fr/nb/articles/3812233-andel-av-utvalg-i-den-totale-befolkningen-i-territoriet.md): Andel av utvalg i den totale befolkningen i territoriet - [Dødelighetsrate](https://success.openhealth.fr/nb/articles/3947946-dodelighetsrate.md): Dødelighetsrate - [Dødsfall i tilfelle](https://success.openhealth.fr/nb/articles/3948084-dodsfall-i-tilfelle.md): Dødsfall i tilfelle - [Kvinner i fertil alder](https://success.openhealth.fr/nb/articles/4172859-kvinner-i-fertil-alder.md): Kvinner i fertil alder - [Andel av utvalg i antall dødsfall i territoriet](https://success.openhealth.fr/nb/articles/3863734-andel-av-utvalg-i-antall-dodsfall-i-territoriet.md): Andel av utvalg i antall dødsfall i territoriet - [Modellering av antall savnede dødsfall](https://success.openhealth.fr/nb/articles/3895572-modellering-av-antall-savnede-dodsfall.md): Forvent antall dødsfall på tidspunktet t - [Estimert salg ved oppstart av resept](https://success.openhealth.fr/nb/articles/5323282-estimert-salg-ved-oppstart-av-resept.md) - [Utvikling etter alder og graviditetsstatus](https://success.openhealth.fr/nb/articles/6820051-utvikling-etter-alder-og-graviditetsstatus.md) - [Forholdstall for samkompensasjonsprodukter](https://success.openhealth.fr/nb/articles/7892010-forholdstall-for-samkompensasjonsprodukter.md) - [Estimert salg av reseptfornyelse](https://success.openhealth.fr/nb/articles/5323209-estimert-salg-av-reseptfornyelse.md) - [Vekt av salg av reseptfornyelse](https://success.openhealth.fr/nb/articles/5323198-vekt-av-salg-av-reseptfornyelse.md) - [Vekt av salg i reseptinitiering](https://success.openhealth.fr/nb/articles/5323086-vekt-av-salg-i-reseptinitiering.md) - [Antall meddispensasjoner](https://success.openhealth.fr/nb/articles/3194351-antall-meddispensasjoner.md): Antall meddispensasjoner - [Antall dispensasjoner](https://success.openhealth.fr/nb/articles/3194348-antall-dispensasjoner.md): Antall dispensasjoner - [Gjennomsnittlig antall dispensasjoner per forsikret person](https://success.openhealth.fr/nb/articles/3369626-gjennomsnittlig-antall-dispensasjoner-per-forsikret-person.md): Gjennomsnittlig antall dispensasjoner per forsikret person - [Overholdelse](https://success.openhealth.fr/nb/articles/3411996-overholdelse.md): Medisinsk besittelsesrate \(MPR\) - [Persistensrate](https://success.openhealth.fr/nb/articles/3369684-persistensrate.md): Persistensrate - [Terapeutisk overholdelse](https://success.openhealth.fr/nb/articles/3412091-terapeutisk-overholdelse.md): Terapeutisk overholdelse - [Gjennomsnittlig daglig dose per forsikret person](https://success.openhealth.fr/nb/articles/4153587-gjennomsnittlig-daglig-dose-per-forsikret-person.md): Gjennomsnittlig daglig dose per forsikret person - [Antall dispensasjoner presentert for refusjon](https://success.openhealth.fr/nb/articles/3370942-antall-dispensasjoner-presentert-for-refusjon.md): Antall dispensasjoner presentert for refusjon - [Antall dispensasjoner som ikke er presentert for refusjon](https://success.openhealth.fr/nb/articles/3370920-antall-dispensasjoner-som-ikke-er-presentert-for-refusjon.md): Antall dispensasjoner presentert for refusjon - [Salg av refusjonsverdi dekket av obligatorisk helseforsikring](https://success.openhealth.fr/nb/articles/3371699-salg-av-refusjonsverdi-dekket-av-obligatorisk-helseforsikring.md): Salg av innløste verdier - [Salg av refunderte verdier dekket av utfyllende helseforsikring](https://success.openhealth.fr/nb/articles/3371830-salg-av-refunderte-verdier-dekket-av-utfyllende-helseforsikring.md): Salg av innløste verdier - [Salg av fremragende verdier](https://success.openhealth.fr/nb/articles/3371842-salg-av-fremragende-verdier.md): Salg av fremragende verdier - [Utbredelse](https://success.openhealth.fr/nb/articles/3947955-utbredelse.md): Prevalensrate - [Gjennomsnittlig antall GTIN per dispensasjon](https://success.openhealth.fr/nb/articles/3396154-gjennomsnittlig-antall-gtin-per-dispensasjon.md): Gjennomsnittlig antall GTIN per dispensasjon - [Gjennomsnittlig volum per utlevering](https://success.openhealth.fr/nb/articles/3396196-gjennomsnittlig-volum-per-utlevering.md): Gjennomsnittlig volum per utlevering - [Gjennomsnittlig omsetning per dispensasjon](https://success.openhealth.fr/nb/articles/3396208-gjennomsnittlig-omsetning-per-dispensasjon.md): Gjennomsnittlig omsetning per dispensasjon - [Aktiv prinsippdosering per boks](https://success.openhealth.fr/nb/articles/3675409-aktiv-prinsippdosering-per-boks.md): Aktiv prinsippdosering per boks - [DDD per boks](https://success.openhealth.fr/nb/articles/3675446-ddd-per-boks.md): Definer daglig dose per boks - [Volum i baseenheter](https://success.openhealth.fr/nb/articles/3675520-volum-i-baseenheter.md): Volum i baseenheter - [Volum i aktivt prinsipp](https://success.openhealth.fr/nb/articles/3675539-volum-i-aktivt-prinsipp.md): Volum i aktivt prinsipp - [DDJ per 1000 innbyggere](https://success.openhealth.fr/nb/articles/3675667-ddj-per-1000-innbyggere.md): Daglig definert dose per 1000 innbyggere - [Volum i gjennomsnittlig UA per forsikret person](https://success.openhealth.fr/nb/articles/3675761-volum-i-gjennomsnittlig-ua-per-forsikret-person.md): Volum i gjennomsnittlige forbrukerenheter per forsikret person - [Volum i gjennomsnittlig UB per forsikret person](https://success.openhealth.fr/nb/articles/3675814-volum-i-gjennomsnittlig-ub-per-forsikret-person.md): Volum i gjennomsnittlige basisenheter per forsikret person - [Volum i gjennomsnittlig aktivt prinsipp per forsikret person](https://success.openhealth.fr/nb/articles/3675824-volum-i-gjennomsnittlig-aktivt-prinsipp-per-forsikret-person.md): Volum i gjennomsnittlig aktivt prinsipp per forsikret person - [Observert gjennomsnittlig behandlingsvarighet](https://success.openhealth.fr/nb/articles/3675841-observert-gjennomsnittlig-behandlingsvarighet.md): Observert gjennomsnittlig behandlingsvarighet - [Immuniseringsdekning](https://success.openhealth.fr/nb/articles/3822264-immuniseringsdekning.md): Immuniseringsdekning - [Pasienter inkludert](https://success.openhealth.fr/nb/articles/3886665-pasienter-inkludert.md): Antall pasienter inkludert i kohorten - [Forskjeller mellom MPR og PDC](https://success.openhealth.fr/nb/articles/3722666-forskjeller-mellom-mpr-og-pdc.md): MPR \(medikamentbesittelsesrate\) vs. PDC \(andel av dekket dager\) - [Gjennomsnittlig behandlingsvarighet](https://success.openhealth.fr/nb/articles/3920967-gjennomsnittlig-behandlingsvarighet.md): Mål den gjennomsnittlige behandlingstiden på slutten av analyseperioden - [Gjennomsnittlig fornyelsestid](https://success.openhealth.fr/nb/articles/3921067-gjennomsnittlig-fornyelsestid.md): Mål gjennomsnittlig tid mellom fornyelse av behandlingen - [Initiering av behandling](https://success.openhealth.fr/nb/articles/3848844-initiering-av-behandling.md): Initiering av behandlingen - [Behandlingsfornyelser](https://success.openhealth.fr/nb/articles/3885469-behandlingsfornyelser.md): Fornyelse av behandlingen - [Behandlingen gjenopptas](https://success.openhealth.fr/nb/articles/3885608-behandlingen-gjenopptas.md): Behandlingen gjenopptas - [Nye behandlinger](https://success.openhealth.fr/nb/articles/3885297-nye-behandlinger.md): Initiering og gjenopptakelse av behandlingen - [Behandlingsbryter](https://success.openhealth.fr/nb/articles/3848886-behandlingsbryter.md): Behandlingsbryter - [Behandlingen stopper](https://success.openhealth.fr/nb/articles/3885426-behandlingen-stopper.md): Behandlingen stopper - [Slippe av](https://success.openhealth.fr/nb/articles/3885387-slippe-av.md): Slippe av - [Sporbarhetsinnsats](https://success.openhealth.fr/nb/articles/4355163-sporbarhetsinnsats.md): Sporbarhet - [Stoppet og deretter startet på nytt](https://success.openhealth.fr/nb/articles/8429189-stoppet-og-deretter-startet-pa-nytt.md) - [Utleveringsandel](https://success.openhealth.fr/nb/articles/3624820-utleveringsandel.md): Utleveringsandel - [Overvåking av relevante dispensasjoner](https://success.openhealth.fr/nb/articles/3804193-overvaking-av-relevante-dispensasjoner.md): Følg utviklingen i trafikken på apotek i relevante dispensasjoner - [Oppløsningshastighet](https://success.openhealth.fr/nb/articles/4850138-opplosningshastighet.md) - [Kinetikken til en reaksjon](https://success.openhealth.fr/nb/articles/4850629-kinetikken-til-en-reaksjon.md) - [Halveringstid](https://success.openhealth.fr/nb/articles/4849710-halveringstid.md) - [Aksjedekning](https://success.openhealth.fr/nb/articles/4210714-aksjedekning.md): Aksjedekning - [Tidsperioder](https://success.openhealth.fr/nb/articles/3194479-tidsperioder.md): Tidsperioder - [Endre definisjonen av et regnskapsår](https://success.openhealth.fr/nb/articles/3321750-endre-definisjonen-av-et-regnskapsar.md): HUB lar deg angi regnskapsår - [Styring av ukentlige sammenligninger](https://success.openhealth.fr/nb/articles/3835180-styring-av-ukentlige-sammenligninger.md): Analytiske virkninger av studiene - [GSAs Parapharmacy Calendar \(SMKT\)](https://success.openhealth.fr/nb/articles/3175583-gsas-parapharmacy-calendar-smkt.md): SMKT-kalenderen \(IRI\) kalles også GSA apotekskalender - [IKKE](https://success.openhealth.fr/nb/articles/3194484-ikke.md): Definisjon av mål 'N' - [N Evol](https://success.openhealth.fr/nb/articles/3194461-n-evol.md): Definisjon og beregningsformel for 'N Evol' tiltaket - [N Trend](https://success.openhealth.fr/nb/articles/3194485-n-trend.md): Definisjon av 'N Trend' tiltaket ### IAS - Indicateurs Avancés Sanitaires - [IAS\(r\) Allergi](https://success.openhealth.fr/nb/articles/7339151-ias-r-allergi.md) - [IAS\(r\) Poux](https://success.openhealth.fr/nb/articles/7339168-ias-r-poux.md) - [IAS\(r\) gastroenteritt](https://success.openhealth.fr/nb/articles/7339181-ias-r-gastroenteritt.md) - [IAS\(r\) Influensalignende sykdom](https://success.openhealth.fr/nb/articles/7266711-ias-r-influensalignende-sykdom.md) ### Marketing Direct - [OpenHealth e-postløsning](https://success.openhealth.fr/nb/articles/7055261-openhealth-e-postlosning.md) - [Krav til produksjon av en e-postkampanje](https://success.openhealth.fr/nb/articles/6282113-krav-til-produksjon-av-en-e-postkampanje.md) - [Oppfølgingsrapport og referanseverdier](https://success.openhealth.fr/nb/articles/6302721-oppfolgingsrapport-og-referanseverdier.md) - [Ordliste for e-postkampanjer](https://success.openhealth.fr/nb/articles/6282099-ordliste-for-e-postkampanjer.md) ### PSAD - [Analyse - NATIONAL](https://success.openhealth.fr/nb/articles/3376262-analyse-national.md): Analyser ytelsen til markedet for helsepersonell \(PSAD\): etter område, aktivitet, underaktivitet, segment, LPP-handling - [Volum / omsetning - NATIONAL](https://success.openhealth.fr/nb/articles/3376287-volum-omsetning-national.md): Se samtidig aktiviteten i volum og verdi: etter område, aktivitet, underaktivitet, segment, LPP-handling \(Liste over produkter og tjenester\) - [Evolusjon - NATIONAL](https://success.openhealth.fr/nb/articles/3376370-evolusjon-national.md): Visualiser utviklingen av markedet i den tilgjengelige historikken: etter domene, aktivitet, underaktivitet, segment, LPP-handling - [Ekstraksjon - NATIONAL](https://success.openhealth.fr/nb/articles/3376420-ekstraksjon-national.md): Eksporter data til Excel - [Definisjon](https://success.openhealth.fr/nb/articles/3376439-definisjon.md): Finn alle funksjonene i SantéDomStat Observatoire National - Essential-applikasjonen ### AUTRES THEMATIQUES - [INTERCOM](https://success.openhealth.fr/nb/articles/6959415-intercom.md) - [Salgsstyrke](https://success.openhealth.fr/nb/articles/6959337-salgsstyrke.md) - [GIHSN: Send inn Excel-fil](https://success.openhealth.fr/nb/articles/3977478-gihsn-send-inn-excel-fil.md): GIHSN Excel-fil - [Blokkjede](https://success.openhealth.fr/nb/articles/5385413-blokkjede.md) - [DocuSign, CRM-verktøy i forretningsprosessen vår](https://success.openhealth.fr/nb/articles/4514472-docusign-crm-verktoy-i-forretningsprosessen-var.md): Docusign: CRM-verktøy i forretningsprosessen vår - [Nasjonal vaksinasjonssporing](https://success.openhealth.fr/nb/articles/4754333-nasjonal-vaksinasjonssporing.md) - [Vaksinasjonsdekning](https://success.openhealth.fr/nb/articles/4754311-vaksinasjonsdekning.md) - [KPI-overvåking](https://success.openhealth.fr/nb/articles/4091042-kpi-overvaking.md): POC ProPharma Systems: Sveitsiske markedstrender - [Apotek cockpit](https://success.openhealth.fr/nb/articles/4091025-apotek-cockpit.md): POC ProPharma Systems: My Pharmacy vs Switzerland - [Personekvivalenter \(p.e.\)](https://success.openhealth.fr/nb/articles/5431894-personekvivalenter-p-e.md) - [Oksygenbehov](https://success.openhealth.fr/nb/articles/5137158-oksygenbehov.md) - [IHU](https://success.openhealth.fr/nb/articles/4851687-ihu.md) - [Suspendert materiale](https://success.openhealth.fr/nb/articles/5137147-suspendert-materiale.md) - [Kjemi i avløpsvann](https://success.openhealth.fr/nb/articles/5137101-kjemi-i-avlopsvann.md) - [NRBCE](https://success.openhealth.fr/nb/articles/4851683-nrbce.md) - [Arrhenius' lov](https://success.openhealth.fr/nb/articles/4849672-arrhenius-lov.md) - [Resulterende ytelse](https://success.openhealth.fr/nb/articles/5137034-resulterende-ytelse.md) - [Typer avløpsvann](https://success.openhealth.fr/nb/articles/5137183-typer-avlopsvann.md) - [SARS-CoV-2-viruskonsentrasjon](https://success.openhealth.fr/nb/articles/4867968-sars-cov-2-viruskonsentrasjon.md) - [MAPOM / BMPM](https://success.openhealth.fr/nb/articles/4851685-mapom-bmpm.md) - [Kontekstualisert konsentrasjon av SARS-CoV-2](https://success.openhealth.fr/nb/articles/4934604-kontekstualisert-konsentrasjon-av-sars-cov-2.md) - [Type avløpssystem](https://success.openhealth.fr/nb/articles/4867954-type-avlopssystem.md) - [Nedbrytning av viruset](https://success.openhealth.fr/nb/articles/4865742-nedbrytning-av-viruset.md) - [WBE](https://success.openhealth.fr/nb/articles/4865735-wbe.md) - [RNA](https://success.openhealth.fr/nb/articles/4865733-rna.md) - [Koronavirus](https://success.openhealth.fr/nb/articles/4865728-koronavirus.md) - [COVID-19](https://success.openhealth.fr/nb/articles/4865726-covid-19.md) - [Seroprevalens: prøvetakingsmetode](https://success.openhealth.fr/nb/articles/3924493-seroprevalens-provetakingsmetode.md): Seroprevalens: Prøvetakingsmetode - [SANDRE-repositoriet](https://success.openhealth.fr/nb/articles/5415040-sandre-repositoriet.md) - [Nasjonal base ROSEAU](https://success.openhealth.fr/nb/articles/5414523-nasjonal-base-roseau.md) - [SARS-CoV-2-viruskonsentrasjon](https://success.openhealth.fr/nb/articles/4852404-sars-cov-2-viruskonsentrasjon.md) - [SARS-CoV-2-viruskonsentrasjon - Varianter](https://success.openhealth.fr/nb/articles/4909854-sars-cov-2-viruskonsentrasjon-varianter.md) - [Marseille - Global overvåking](https://success.openhealth.fr/nb/articles/4859311-marseille-global-overvaking.md) - [SARS-CoV-2-viruskonsentrasjon - Nice](https://success.openhealth.fr/nb/articles/4879292-sars-cov-2-viruskonsentrasjon-nice.md) - [Befolkning - Struktur](https://success.openhealth.fr/nb/articles/4842408-befolkning-struktur.md) - [SARS-CoV-2-viruskonsentrasjon - Toulon \(FRANKRIKE\)](https://success.openhealth.fr/nb/articles/4886417-sars-cov-2-viruskonsentrasjon-toulon-frankrike.md) - [Dubai - Overvåking av avløpsvann fra flyplasser](https://success.openhealth.fr/nb/articles/5276423-dubai-overvaking-av-avlopsvann-fra-flyplasser.md) - [Overvåking av SARS-CoV-2 - OBEPINE](https://success.openhealth.fr/nb/articles/5210661-overvaking-av-sars-cov-2-obepine.md) - [Kontekstualisert konsentrasjon av SARS-CoV-2](https://success.openhealth.fr/nb/articles/4934608-kontekstualisert-konsentrasjon-av-sars-cov-2.md) - [SUEZ - Analytisk balanse](https://success.openhealth.fr/nb/articles/5140509-suez-analytisk-balanse.md) - [Palais des festivals - Se T0](https://success.openhealth.fr/nb/articles/5373515-palais-des-festivals-se-t0.md) - [Palais des festivals - Daglig vakt](https://success.openhealth.fr/nb/articles/5373231-palais-des-festivals-daglig-vakt.md) - [Palais des festivals - Visning](https://success.openhealth.fr/nb/articles/5404778-palais-des-festivals-visning.md) - [Mustelider - Se](https://success.openhealth.fr/nb/articles/5169577-mustelider-se.md) - [Befolkning - IRIS](https://success.openhealth.fr/nb/articles/4842191-befolkning-iris.md) - [SARS-CoV-2](https://success.openhealth.fr/nb/articles/4865699-sars-cov-2.md) - [IAS - Analyse](https://success.openhealth.fr/nb/articles/4842430-ias-analyse.md) - [SARS-CoV-2-viruskonsentrasjon - SEM](https://success.openhealth.fr/nb/articles/5415600-sars-cov-2-viruskonsentrasjon-sem.md) - [Kartvisualisering](https://success.openhealth.fr/nb/articles/3864657-kartvisualisering.md): Geografisk fordeling av pasienter - [Bidragsside](https://success.openhealth.fr/nb/articles/3864668-bidragsside.md): Bidrag etter sted og sykehus - [Kullprofil etter nettsted](https://success.openhealth.fr/nb/articles/3864672-kullprofil-etter-nettsted.md): Kohortprofil etter sted og sykehus - [Kullprofil etter sesong](https://success.openhealth.fr/nb/articles/3864673-kullprofil-etter-sesong.md): Kullprofil etter sesong - [Alder og kjønnsfordeling](https://success.openhealth.fr/nb/articles/3864675-alder-og-kjonnsfordeling.md): Demografi - [Virusdistribusjon etter nettsted](https://success.openhealth.fr/nb/articles/3864678-virusdistribusjon-etter-nettsted.md): Virusdistribusjon etter nettsted - [Virusfordeling etter alder](https://success.openhealth.fr/nb/articles/3864677-virusfordeling-etter-alder.md): Virusfordeling etter alder - [Virusdistribusjon evolusjon](https://success.openhealth.fr/nb/articles/3864681-virusdistribusjon-evolusjon.md): Virusdistribusjon evolusjon - [Influensavaksinasjon](https://success.openhealth.fr/nb/articles/3864697-influensavaksinasjon.md): Influensavaksinasjon - [Influensavaksinasjon evolusjon](https://success.openhealth.fr/nb/articles/3864701-influensavaksinasjon-evolusjon.md): Utvikling av influensavaksinasjon - [Pasientfordeling etter kronisk tilstand](https://success.openhealth.fr/nb/articles/3864676-pasientfordeling-etter-kronisk-tilstand.md): Pasientfordeling etter kronisk tilstand - [Pasientfordeling etter sykehusopphold](https://success.openhealth.fr/nb/articles/3864794-pasientfordeling-etter-sykehusopphold.md): Pasientfordeling etter lengde oh sykehusopphold - [Svakhet](https://success.openhealth.fr/nb/articles/3864704-svakhet.md): Sårbarhet hos pasienter - [Alvorlighetsstatus](https://success.openhealth.fr/nb/articles/3864705-alvorlighetsstatus.md): Alvorlighetsstatus - [Dødelighet](https://success.openhealth.fr/nb/articles/3864710-dodelighet.md): Dødelighet - [GIHSN](https://success.openhealth.fr/nb/articles/3864712-gihsn.md): Global Influenza Hospital Surveillance Network - [CARéDIAB - Pasientprofil](https://success.openhealth.fr/nb/articles/3789234-carediab-pasientprofil.md): Analyser pasientprofilen til CARéDIAB-populasjonen - [CARéDIAB - Komplikasjoner](https://success.openhealth.fr/nb/articles/3789515-carediab-komplikasjoner.md): Analyser forekomsten av komplikasjoner i vår befolkning CAREDIAB - [CARéDIAB - Global pasientovervåking](https://success.openhealth.fr/nb/articles/3792041-carediab-global-pasientovervaking.md): Analyser hyppigheten av oppfølging av pasienter i CARéDIAB-populasjonen - [CARéDIAB-nettverk](https://success.openhealth.fr/nb/articles/3789106-carediab-nettverk.md): CARéDIAB-nettverket - [CARéDIAB - Behandlinger](https://success.openhealth.fr/nb/articles/3792143-carediab-behandlinger.md): Analyser behandling av behandlinger i sammenheng med diabetes ## Polski ### Votre PLATEFORME - présentation générale - [HUB - kompleksowa i stała platforma wsparcia](https://success.openhealth.fr/pl/articles/4799621-hub-kompleksowa-i-stala-platforma-wsparcia.md) - [Twój poziom doświadczenia The HUB](https://success.openhealth.fr/pl/articles/5712270-twoj-poziom-doswiadczenia-the-hub.md) - [Languages](https://success.openhealth.fr/pl/articles/4649389-languages.md): Here is the description of all languages available on Success - [Pytania dotyczące naszych stawek](https://success.openhealth.fr/pl/articles/3292143-pytania-dotyczace-naszych-stawek.md): Nasze ceny ### Mapa drogowa - ["Otwarte innowacje dla naszych klientów](https://success.openhealth.fr/pl/articles/5200970-otwarte-innowacje-dla-naszych-klientow.md) - [Aplikacje + obszar administracyjny w wersji 240515](https://success.openhealth.fr/pl/articles/9310541-aplikacje-obszar-administracyjny-w-wersji-240515.md) - [Aplikacje + obszar administracyjny w wersji 240415](https://success.openhealth.fr/pl/articles/9310710-aplikacje-obszar-administracyjny-w-wersji-240415.md) - [Aplikacje + Obszar administracyjny wersja 240315](https://success.openhealth.fr/pl/articles/9310790-aplikacje-obszar-administracyjny-wersja-240315.md) - [Aplikacje + Obszar administracyjny wersja 240215](https://success.openhealth.fr/pl/articles/9311007-aplikacje-obszar-administracyjny-wersja-240215.md) - [Platforma - aktualizacja 231215](https://success.openhealth.fr/pl/articles/8718485-platforma-aktualizacja-231215.md) - [Platforma - aktualizacja 231015](https://success.openhealth.fr/pl/articles/8479932-platforma-aktualizacja-231015.md) - [Aplikacje + Portal wersja 230915](https://success.openhealth.fr/pl/articles/8373640-aplikacje-portal-wersja-230915.md) - [Aplikacje + Portal wersja 230815](https://success.openhealth.fr/pl/articles/8267860-aplikacje-portal-wersja-230815.md) - [Nowe produkty 230715](https://success.openhealth.fr/pl/articles/8115796-nowe-produkty-230715.md) - [Aplikacje + Portal wersja 230615](https://success.openhealth.fr/pl/articles/8115791-aplikacje-portal-wersja-230615.md) - [Aplikacje + Portal wersja 230515](https://success.openhealth.fr/pl/articles/7895393-aplikacje-portal-wersja-230515.md) - [Aplikacje + Portal wersja 230415](https://success.openhealth.fr/pl/articles/7439447-aplikacje-portal-wersja-230415.md) - [Aplikacje + Portal wersja 230315](https://success.openhealth.fr/pl/articles/7439646-aplikacje-portal-wersja-230315.md) - [Aplikacje + Portal wersja 230215](https://success.openhealth.fr/pl/articles/7439744-aplikacje-portal-wersja-230215.md) - [Wiadomości z 15/01/2023 r.](https://success.openhealth.fr/pl/articles/6895740-wiadomosci-z-15-01-2023-r.md) - [HUB + GATE wersja 221215](https://success.openhealth.fr/pl/articles/6827027-hub-gate-wersja-221215.md) - [HUB + GATE wersja 221115](https://success.openhealth.fr/pl/articles/6742628-hub-gate-wersja-221115.md) - [HUB + GATE wersja 220915](https://success.openhealth.fr/pl/articles/6558070-hub-gate-wersja-220915.md) - [HUB + GATE wersja 220815](https://success.openhealth.fr/pl/articles/6475311-hub-gate-wersja-220815.md) - [HUB + GATE wersja 220615](https://success.openhealth.fr/pl/articles/6306090-hub-gate-wersja-220615.md) - [HUB + GATE wersja 220515](https://success.openhealth.fr/pl/articles/6201877-hub-gate-wersja-220515.md) - [HUB + GATE wersja 220415](https://success.openhealth.fr/pl/articles/6087747-hub-gate-wersja-220415.md) - [HUB SMA wersja 220315](https://success.openhealth.fr/pl/articles/6043772-hub-sma-wersja-220315.md) - [HUB TMA wersja 220315](https://success.openhealth.fr/pl/articles/6043802-hub-tma-wersja-220315.md) - [HUB UAN wersja 220315](https://success.openhealth.fr/pl/articles/6043852-hub-uan-wersja-220315.md) - [Wersja GATE 220215](https://success.openhealth.fr/pl/articles/5940805-wersja-gate-220215.md) - [HUB SMA wersja 220215](https://success.openhealth.fr/pl/articles/5940753-hub-sma-wersja-220215.md) - [HUB TMA wersja 220215](https://success.openhealth.fr/pl/articles/5947859-hub-tma-wersja-220215.md) - [Wersja GATE 211215](https://success.openhealth.fr/pl/articles/5819397-wersja-gate-211215.md) - [HUB SMA wersja 211215](https://success.openhealth.fr/pl/articles/5784709-hub-sma-wersja-211215.md) - [HUB TMA wersja 211215](https://success.openhealth.fr/pl/articles/5784888-hub-tma-wersja-211215.md) - [HUB UAN wersja 211215](https://success.openhealth.fr/pl/articles/5784904-hub-uan-wersja-211215.md) - [Aplikacja The HUB: "Stan apteki".](https://success.openhealth.fr/pl/articles/5704485-aplikacja-the-hub-stan-apteki.md) - [Wersja GATE 211115](https://success.openhealth.fr/pl/articles/5697844-wersja-gate-211115.md) - [HUB SMA wersja 211115](https://success.openhealth.fr/pl/articles/5671893-hub-sma-wersja-211115.md) - [HUB TMA wersja 211115](https://success.openhealth.fr/pl/articles/5671917-hub-tma-wersja-211115.md) - [HUB UAN wersja 211115](https://success.openhealth.fr/pl/articles/5671927-hub-uan-wersja-211115.md) - [Wersja GATE 211015](https://success.openhealth.fr/pl/articles/5652210-wersja-gate-211015.md) - [HUB SMA wersja 211015](https://success.openhealth.fr/pl/articles/5649822-hub-sma-wersja-211015.md) - [HUB TMA wersja 211015](https://success.openhealth.fr/pl/articles/5650073-hub-tma-wersja-211015.md) - [HUB UAN wersja 211015](https://success.openhealth.fr/pl/articles/5652242-hub-uan-wersja-211015.md) - [HUB SMA wersja 210915](https://success.openhealth.fr/pl/articles/5370516-hub-sma-wersja-210915.md) - [HUB TMA wersja 210915](https://success.openhealth.fr/pl/articles/5390983-hub-tma-wersja-210915.md) - [HUB UAN wersja 210915](https://success.openhealth.fr/pl/articles/5543213-hub-uan-wersja-210915.md) ### Votre ESPACE D'ADMINISTRATION - fonctionnalités - [Zresetuj / zmień hasło The HUB](https://success.openhealth.fr/pl/articles/4425325-zresetuj-zmien-haslo-the-hub.md): Jak zmienić hasło HUB - [Pomoc w nawiązaniu połączenia: Otrzymuję komunikat o błędzie](https://success.openhealth.fr/pl/articles/5369783-pomoc-w-nawiazaniu-polaczenia-otrzymuje-komunikat-o-bledzie.md) - [Utwórz i śledź bilet](https://success.openhealth.fr/pl/articles/3586214-utworz-i-sledz-bilet.md): Samouczek do tworzenia i śledzenia ewolucji biletów w Twojej osobistej przestrzeni The HUB - [Tworzenie i modyfikowanie artykułu SUCCESS](https://success.openhealth.fr/pl/articles/6738705-tworzenie-i-modyfikowanie-artykulu-success.md) - [Moje umowy](https://success.openhealth.fr/pl/articles/5712273-moje-umowy.md) - [Usługa Zdrowie](https://success.openhealth.fr/pl/articles/4990600-usluga-zdrowie.md) - [Moje dostępy](https://success.openhealth.fr/pl/articles/5783418-moje-dostepy.md) - [Konfiguracja mojej strony głównej](https://success.openhealth.fr/pl/articles/5712229-konfiguracja-mojej-strony-glownej.md) - [Jak zmodyfikować swój rynek z osobistej przestrzeni OpenHealth?](https://success.openhealth.fr/pl/articles/3585971-jak-zmodyfikowac-swoj-rynek-z-osobistej-przestrzeni-openhealth.md): Integruj, modyfikuj i dezaktywuj produkty z Twojej osobistej przestrzeni OpenHealth - [Automatyczna modyfikacja przypisania modalności \(Auto MAM\)](https://success.openhealth.fr/pl/articles/4164818-automatyczna-modyfikacja-przypisania-modalnosci-auto-mam.md): Bezpośrednio modyfikuj przypisania swoich produktów - [TEMPORAL MAM: Jak podążać za marką, która zmienia laboratorium / markę / etykietę?](https://success.openhealth.fr/pl/articles/4131072-temporal-mam-jak-podazac-za-marka-ktora-zmienia-laboratorium-marke-etykiete.md): Korzyści i zagrożenia związane z Twoim rodzajem śledzenia - [Automatyczna integracja produktów \(Auto IPR\)](https://success.openhealth.fr/pl/articles/4164932-automatyczna-integracja-produktow-auto-ipr.md): Poproś o integrację produktu na swoim rynku - [Automatyczna dezaktywacja produktu \(Auto DPR\)](https://success.openhealth.fr/pl/articles/4164866-automatyczna-dezaktywacja-produktu-auto-dpr.md): Dezaktywuj produkt ze swojego rynku - [Automatyczna reaktywacja produktu \(RPR auto\)](https://success.openhealth.fr/pl/articles/4818161-automatyczna-reaktywacja-produktu-rpr-auto.md) - [Tworzenie nowych produktów](https://success.openhealth.fr/pl/articles/5811248-tworzenie-nowych-produktow.md) - [Dodaj rynek](https://success.openhealth.fr/pl/articles/5712283-dodaj-rynek.md) - [Import / eksport produktów masowych](https://success.openhealth.fr/pl/articles/5712257-import-eksport-produktow-masowych.md) - [Zmiana modalności typologicznej \(CMT\)](https://success.openhealth.fr/pl/articles/4670174-zmiana-modalnosci-typologicznej-cmt.md) - [Różne statusy użytkowników](https://success.openhealth.fr/pl/articles/3436418-rozne-statusy-uzytkownikow.md): Jakie są funkcje? - [Utworzenie konta dla użytkownika z organizacji zewnętrznej \(TPAA\)](https://success.openhealth.fr/pl/articles/6466550-utworzenie-konta-dla-uzytkownika-z-organizacji-zewnetrznej-tpaa.md) - [Jak utworzyć, zmodyfikować lub usunąć konto użytkownika w The HUB?](https://success.openhealth.fr/pl/articles/3785138-jak-utworzyc-zmodyfikowac-lub-usunac-konto-uzytkownika-w-the-hub.md): Może to zrobić tylko UŻYTKOWNIK ZASILANIA - [Czy mogę utworzyć zróżnicowane prawa do oglądania w HUB w ramach moich zespołów?](https://success.openhealth.fr/pl/articles/3321731-czy-moge-utworzyc-zroznicowane-prawa-do-ogladania-w-hub-w-ramach-moich-zespolow.md): Prawa w centrum - [Dziennik działań](https://success.openhealth.fr/pl/articles/4687438-dziennik-dzialan.md) ### Vos APPLICATIONS - présentation - [Przewodnik szkoleniowy HUB](https://success.openhealth.fr/pl/articles/5634967-przewodnik-szkoleniowy-hub.md) - [Sortowanie selektora rozwijanego](https://success.openhealth.fr/pl/articles/5792113-sortowanie-selektora-rozwijanego.md) - [Data aktualizacji danych drogerii GSA \(SMKT\) w HuB](https://success.openhealth.fr/pl/articles/3175557-data-aktualizacji-danych-drogerii-gsa-smkt-w-hub.md): W tym artykule opisano datę aktualizacji danych z drogerii GSA \(SMKT\). - [Wymagania wstępne Plik dotyczący dopasowanych aptek](https://success.openhealth.fr/pl/articles/3678146-wymagania-wstepne-plik-dotyczacy-dopasowanych-aptek.md): Wymagania wstępne Plik dotyczący dopasowanych aptek - [Przełącznik „recepty włączania i wyłączania”](https://success.openhealth.fr/pl/articles/3729668-przelacznik-recepty-wlaczania-i-wylaczania.md): Specyfikacje obiektu „Prescription Type Selector” - [Jak zakwalifikować nowe produkty w HUB?](https://success.openhealth.fr/pl/articles/3376100-jak-zakwalifikowac-nowe-produkty-w-hub.md): Kwalifikacja nowych produktów w HUB - [Jak tworzyć, modyfikować i udostępniać ulubione w HUBIE?](https://success.openhealth.fr/pl/articles/3175689-jak-tworzyc-modyfikowac-i-udostepniac-ulubione-w-hubie.md): Tworzenie i udostępnianie ulubionych w centrum - [Jak wybrać produkty w HUB-ie według daty premiery?](https://success.openhealth.fr/pl/articles/3158428-jak-wybrac-produkty-w-hub-ie-wedlug-daty-premiery.md): W tym artykule wyjaśniono, jak wybrać tylko produkty wprowadzone na rynek w określonym okresie. - [Czy mogę wyciągnąć dane z HUBa w formacie ".csv"?](https://success.openhealth.fr/pl/articles/5671278-czy-moge-wyciagnac-dane-z-huba-w-formacie-csv.md) - [Czas reakcji ODT](https://success.openhealth.fr/pl/articles/6632310-czas-reakcji-odt.md) - [Jakie są najlepsze praktyki wyświetlania w HUB](https://success.openhealth.fr/pl/articles/3124454-jakie-sa-najlepsze-praktyki-wyswietlania-w-hub.md): Ten artykuł zawiera szczegółowe informacje na temat najlepszych praktyk w zakresie optymalizacji wyświetlania urządzenia HUB - [Wymagania techniczne](https://success.openhealth.fr/pl/articles/5369918-wymagania-techniczne.md) - [Wyczyść pamięć podręczną przeglądarki](https://success.openhealth.fr/pl/articles/4219722-wyczysc-pamiec-podreczna-przegladarki.md): Jak wyczyścić pamięć podręczną przeglądarki Google Chrome - [Jak ustawić Google Chrome jako domyślną przeglądarkę?](https://success.openhealth.fr/pl/articles/3738717-jak-ustawic-google-chrome-jako-domyslna-przegladarke.md): Jak ustawić Google Chrome jako domyślną - [Winda nawigacyjna nie jest widoczna w tabelach](https://success.openhealth.fr/pl/articles/3195250-winda-nawigacyjna-nie-jest-widoczna-w-tabelach.md): Winda nawigacyjna - [Wyświetlanie przycisków lub obiektów na arkuszu jest częściowo ucięte lub niewidoczne](https://success.openhealth.fr/pl/articles/3195245-wyswietlanie-przyciskow-lub-obiektow-na-arkuszu-jest-czesciowo-uciete-lub-niewidoczne.md): Problem z wyświetlaniem przycisków, obiektów - [Moja karta zarządzania terytorium nie ładuje się i pojawia się komunikat „ładowanie”](https://success.openhealth.fr/pl/articles/3195239-moja-karta-zarzadzania-terytorium-nie-laduje-sie-i-pojawia-sie-komunikat-ladowanie.md): Problem z wyświetlaniem mapy zarządzania obszarami / TMA - [Skąd pochodzi komunikat o błędzie „Nie masz uprawnień dostępu na tej stronie”?](https://success.openhealth.fr/pl/articles/3195338-skad-pochodzi-komunikat-o-bledzie-nie-masz-uprawnien-dostepu-na-tej-stronie.md): Komunikaty o błędach - [Wyświetlany jest komunikat o błędzie „Utracono połączenie”](https://success.openhealth.fr/pl/articles/4445141-wyswietlany-jest-komunikat-o-bledzie-utracono-polaczenie.md): Wystąpił błąd - [Zła Brama](https://success.openhealth.fr/pl/articles/4514555-zla-brama.md): Komunikat o błędzie „Zła brama” - [Selektory wymiarów i miar nie są już wyświetlane w zapytaniach „Analiza wielu okresów” i „Moje archiwum danych”, wyodrębnianie tabeli w „Analizie rynku” jest częściowe](https://success.openhealth.fr/pl/articles/3195377-selektory-wymiarow-i-miar-nie-sa-juz-wyswietlane-w-zapytaniach-analiza-wielu-okresow-i-moje-archiwum-danych-wyodrebnianie-tabeli-w-analizie-rynku-jest-czesciowe.md): Wymiary i miary nie są już wyświetlane - [Jak wyświetlić termin w HUB?](https://success.openhealth.fr/pl/articles/3194377-jak-wyswietlic-termin-w-hub.md): HUB umożliwia łatwe przeglądanie ćwierćestrów w arkuszu „Ewolucja sprzedaży” - [Specyfikacje i ograniczenia programu Excel](https://success.openhealth.fr/pl/articles/3753088-specyfikacje-i-ograniczenia-programu-excel.md): W tym artykule wyjaśniono specyfikacje i ograniczenia programu Excel. - [Jak tworzyć, edytować i udostępniać Ulubione w aplikacjach?](https://success.openhealth.fr/pl/articles/10502803-jak-tworzyc-edytowac-i-udostepniac-ulubione-w-aplikacjach.md) - [Ramy panelu konsumenckiego](https://success.openhealth.fr/pl/articles/3455845-ramy-panelu-konsumenckiego.md): Artykuł dotyczący ram panelu konsumentów - [Ramy analizy rynku aptecznego](https://success.openhealth.fr/pl/articles/3455857-ramy-analizy-rynku-aptecznego.md): Artykuł dotyczący platformy OpenHealth służącej do analizy wyników rynkowych w kanale aptecznym ### ŹRÓDŁA DANYCH - [Co to jest OpenHealth Pharmacy Panel?](https://success.openhealth.fr/pl/articles/3304106-co-to-jest-openhealth-pharmacy-panel.md): Celem tego artykułu jest opisanie naszego panelu aptek. - [Sieć aptek, decydujący atut w zarządzaniu obecnymi i przyszłymi kryzysami zdrowotnymi](https://success.openhealth.fr/pl/articles/3825648-siec-aptek-decydujacy-atut-w-zarzadzaniu-obecnymi-i-przyszlymi-kryzysami-zdrowotnymi.md): Firma OpenHealth, zaangażowana w monitorowanie bezprecedensowego kryzysu zdrowotnego, mobilizuje swoją technologię i dane - [Jakie terytoria francuskich departamentów zamorskich i terytoriów są widoczne w HUB?](https://success.openhealth.fr/pl/articles/3194382-jakie-terytoria-francuskich-departamentow-zamorskich-i-terytoriow-sa-widoczne-w-hub.md): Terytoria DROM-COM dostępne w centrum - [Plik sektorów wymagań wstępnych](https://success.openhealth.fr/pl/articles/3702701-plik-sektorow-wymagan-wstepnych.md): Ten artykuł umożliwia pobranie, uzupełnienie i przesłanie pliku sektorowego. - [Źródło danych SMKT](https://success.openhealth.fr/pl/articles/4485357-zrodlo-danych-smkt.md): IRI, dostawca danych drogeryjnych GSA - [GSA Parapharmacy Products Coding Rules \(SMKT\) w IRI](https://success.openhealth.fr/pl/articles/3524492-gsa-parapharmacy-products-coding-rules-smkt-w-iri.md): Przypomnienie o zasadach kodyfikacji produktów SMKT w IRI - [Dane ORGANIC STORE - źródło BIOANALITYKA](https://success.openhealth.fr/pl/articles/5631260-dane-organic-store-zrodlo-bioanalityka.md) - [E-parafarmaceutyki: platformy monitorujące](https://success.openhealth.fr/pl/articles/9167006-e-parafarmaceutyki-platformy-monitorujace.md) - [Zyski i straty produktów e-aptek](https://success.openhealth.fr/pl/articles/3568773-zyski-i-straty-produktow-e-aptek.md): Artykuł dotyczący modułu „Zyski i straty produktów aptek internetowych” - [Profil konsumenta](https://success.openhealth.fr/pl/articles/3711085-profil-konsumenta.md): Artykuł dotyczący modułu „Profil konsumenta” - [Dane AMAZON - źródło SPRZEDAŻ](https://success.openhealth.fr/pl/articles/5669013-dane-amazon-zrodlo-sprzedaz.md) - [Dane dotyczące handlu elektronicznego - źródło WISER](https://success.openhealth.fr/pl/articles/7983010-dane-dotyczace-handlu-elektronicznego-zrodlo-wiser.md) - [Terytoria geograficzne](https://success.openhealth.fr/pl/articles/4661582-terytoria-geograficzne.md): W Open Health Company możesz analizować swoje rynki według terytoriów geograficznych, które Ci oferujemy. - [Jak wygląda panel apteczny w Niemczech? INSIGHTHEALTH](https://success.openhealth.fr/pl/articles/5391412-jak-wyglada-panel-apteczny-w-niemczech-insighthealth.md) - [Jak wygląda panel apteczny w Grecji? ALIRAHEALTH](https://success.openhealth.fr/pl/articles/6863963-jak-wyglada-panel-apteczny-w-grecji-alirahealth.md) - [Jak wygląda panel apteczny w Austrii? INSIGHTHEALTH](https://success.openhealth.fr/pl/articles/6863949-jak-wyglada-panel-apteczny-w-austrii-insighthealth.md) - [Czym jest panel apteczny w Afryce? PIEX - Afryka](https://success.openhealth.fr/pl/articles/6686633-czym-jest-panel-apteczny-w-afryce-piex-afryka.md) - [Czym jest panel apteki internetowej w Niemczech? DATAMEDIQ](https://success.openhealth.fr/pl/articles/5689640-czym-jest-panel-apteki-internetowej-w-niemczech-datamediq.md) - [Jak wygląda panel apteczny w Belgii? REDPHARMA](https://success.openhealth.fr/pl/articles/4689894-jak-wyglada-panel-apteczny-w-belgii-redpharma.md) - [Jak wygląda panel apteczny w Hiszpanii? - HMR](https://success.openhealth.fr/pl/articles/5391363-jak-wyglada-panel-apteczny-w-hiszpanii-hmr.md) - [Qu'est-ce que le panel de pharmacies en Espagne ? - INFONIS](https://success.openhealth.fr/pl/articles/5428915-qu-est-ce-que-le-panel-de-pharmacies-en-espagne-infonis.md) - [Jak wygląda panel apteczny w Portugalii? - HMR](https://success.openhealth.fr/pl/articles/5391477-jak-wyglada-panel-apteczny-w-portugalii-hmr.md) - [Czym jest panel apteczny w Rosji? - ALPHARM](https://success.openhealth.fr/pl/articles/5701531-czym-jest-panel-apteczny-w-rosji-alpharm.md) - [Jak wygląda panel apteczny w Polsce? Pex Pharma](https://success.openhealth.fr/pl/articles/5969485-jak-wyglada-panel-apteczny-w-polsce-pex-pharma.md) - [GRUPA KONWERTOWA](https://success.openhealth.fr/pl/articles/6961966-grupa-konwertowa.md) - [Jak wygląda panel apteczny w Jordanii?](https://success.openhealth.fr/pl/articles/8176750-jak-wyglada-panel-apteczny-w-jordanii.md) - [Ludność - kartografia](https://success.openhealth.fr/pl/articles/3807695-ludnosc-kartografia.md): Przeanalizuj rozmieszczenie geograficzne populacji - [AMELI - LPP](https://success.openhealth.fr/pl/articles/6962021-ameli-lpp.md) - [Populacja - ewolucja według wieku i płci](https://success.openhealth.fr/pl/articles/3810789-populacja-ewolucja-wedlug-wieku-i-plci.md): Przeanalizuj ewolucję struktury populacji - [Ludność - porównanie według WIEKU I PŁCI](https://success.openhealth.fr/pl/articles/3836795-ludnosc-porownanie-wedlug-wieku-i-plci.md): Porównaj profil demograficzny dwóch populacji - [EGIPT - Kartografia](https://success.openhealth.fr/pl/articles/3714611-egipt-kartografia.md): Przeanalizuj populację gubernatorów Egiptu - [EGIPT - Analiza według WIEKU I PŁCI](https://success.openhealth.fr/pl/articles/3714673-egipt-analiza-wedlug-wieku-i-plci.md): Przeanalizuj strukturę populacji - [UGANDA - Analiza według WIEKU I PŁCI](https://success.openhealth.fr/pl/articles/3713884-uganda-analiza-wedlug-wieku-i-plci.md): Przeanalizuj strukturę populacji - [Ludność - analiza według wieku i płci](https://success.openhealth.fr/pl/articles/3807673-ludnosc-analiza-wedlug-wieku-i-plci.md): Przeanalizuj strukturę populacji - [Medicabase - baza danych leków](https://success.openhealth.fr/pl/articles/6518920-medicabase-baza-danych-lekow.md) - [Narodziny](https://success.openhealth.fr/pl/articles/6340025-narodziny.md) - [OpenEudra](https://success.openhealth.fr/pl/articles/6518977-openeudra.md) - [Podział IRIS](https://success.openhealth.fr/pl/articles/6383829-podzial-iris.md) - [ADICAP](https://success.openhealth.fr/pl/articles/6959465-adicap.md) - [NEC](https://success.openhealth.fr/pl/articles/6519012-nec.md) - [Dane dotyczące światowej populacji](https://success.openhealth.fr/pl/articles/8217421-dane-dotyczace-swiatowej-populacji.md) - [INSEE: Akta osób zmarłych](https://success.openhealth.fr/pl/articles/4498126-insee-akta-osob-zmarlych.md): INSEE \(Krajowy Instytut Statystyki i Studiów Ekonomicznych\): Akta osób zmarłych - [Dane VAERS- VAERSDATA- Źródło CDC](https://success.openhealth.fr/pl/articles/6226665-dane-vaers-vaersdata-zrodlo-cdc.md) - [Dane VAERS - VAERSVAX - źródło CDC](https://success.openhealth.fr/pl/articles/6226440-dane-vaers-vaersvax-zrodlo-cdc.md) - [Dane VAERS - VAERSSYMPTOMS - Źródło CDC](https://success.openhealth.fr/pl/articles/6219415-dane-vaers-vaerssymptoms-zrodlo-cdc.md) - [Zintegrowanie danych z Hubem w czasie krótszym niż 2 tygodnie](https://success.openhealth.fr/pl/articles/5259828-zintegrowanie-danych-z-hubem-w-czasie-krotszym-niz-2-tygodnie.md) - [Szablon danych międzynarodowych](https://success.openhealth.fr/pl/articles/4684696-szablon-danych-miedzynarodowych.md) - [Jak przesłać nam swoje dane przez FTPS?](https://success.openhealth.fr/pl/articles/4143451-jak-przeslac-nam-swoje-dane-przez-ftps.md): Wysyłaj dane przez FTPS - [Jakich informacji potrzebuje OpenHealth, aby zintegrować nowe źródło danych?](https://success.openhealth.fr/pl/articles/3459148-jakich-informacji-potrzebuje-openhealth-aby-zintegrowac-nowe-zrodlo-danych.md): Artykuł dotyczący integracji nowych źródeł danych - [Długie spojrzenie](https://success.openhealth.fr/pl/articles/6959482-dlugie-spojrzenie.md) - [Jak zintegrować nowe źródło danych w HUB?](https://success.openhealth.fr/pl/articles/3467598-jak-zintegrowac-nowe-zrodlo-danych-w-hub.md): Artykuł dotyczący procesu integracji danych w HUB - [Zintegruj swoje dane dotyczące sprzedaży z HUBem](https://success.openhealth.fr/pl/articles/3471145-zintegruj-swoje-dane-dotyczace-sprzedazy-z-hubem.md): Artykuł o integracji danych dotyczących sprzedaży - [Specyfikacje dotyczące otrzymywania danych dotyczących sprzedaży](https://success.openhealth.fr/pl/articles/3660043-specyfikacje-dotyczace-otrzymywania-danych-dotyczacych-sprzedazy.md): Jak przesłać nam swoją wypłatę w ramach analizy sprzedaży / wyprzedaży lub subskrypcji modułu Wizualizacja sprzedaży - [Skąd pochodzą dane analityczne dotyczące rynku domowych dostawców usług zdrowotnych \(PSAD\)?](https://success.openhealth.fr/pl/articles/3376155-skad-pochodza-dane-analityczne-dotyczace-rynku-domowych-dostawcow-uslug-zdrowotnych-psad.md): PSAD - [Jak dołączyć do obserwatorium SantéDom Stat?](https://success.openhealth.fr/pl/articles/3798795-jak-dolaczyc-do-obserwatorium-santedom-stat.md): Samouczek dotyczący przystąpienia do krajowego obserwatorium działalności świadczeniodawców opieki domowej \(PSAD\) - [Panel ekstrapolowany z obserwatorium SanteDomStat](https://success.openhealth.fr/pl/articles/6701602-panel-ekstrapolowany-z-obserwatorium-santedomstat.md) - [Liczba pacjentów](https://success.openhealth.fr/pl/articles/3376499-liczba-pacjentow.md): Definicja liczby pacjentów według federacji PSAD - [Liczba zabiegów](https://success.openhealth.fr/pl/articles/3376682-liczba-zabiegow.md): Określenie liczby zabiegów według federacji PSAD - [Liczba nowych pacjentów](https://success.openhealth.fr/pl/articles/3376672-liczba-nowych-pacjentow.md): Definicja liczby nowych pacjentów według federacji PSAD - [Obrót z podatkiem](https://success.openhealth.fr/pl/articles/3376725-obrot-z-podatkiem.md): Definicja obrotu wraz z podatkiem według federacji PSAD - [Liczba pacjentów na końcu leczenia](https://success.openhealth.fr/pl/articles/3376675-liczba-pacjentow-na-koncu-leczenia.md): Określenie liczby pacjentów na końcu leczenia według federacji PSAD - [Kwota obowiązkowego ubezpieczenia zdrowotnego \(AMO\)](https://success.openhealth.fr/pl/articles/3376740-kwota-obowiazkowego-ubezpieczenia-zdrowotnego-amo.md): Określenie kwoty AMO według federacji PSAD - [Kwota dodatkowego ubezpieczenia zdrowotnego \(AMC\)](https://success.openhealth.fr/pl/articles/3376749-kwota-dodatkowego-ubezpieczenia-zdrowotnego-amc.md): Określenie kwoty AMC według federacji PSAD - [Niespłacona opłata \(RAC\)](https://success.openhealth.fr/pl/articles/3376751-niesplacona-oplata-rac.md): Definicja RAC według federacji PSAD - [Źródło: THESORIMED](https://success.openhealth.fr/pl/articles/3560018-zrodlo-thesorimed.md): Baza danych leków \(BdM\) - [Międzynarodowe niezastrzeżone nazwy \(INN\)](https://success.openhealth.fr/pl/articles/3954239-miedzynarodowe-niezastrzezone-nazwy-inn.md): Międzynarodowe nazwy zwyczajowe \(INN\) - [Open Food Facts](https://success.openhealth.fr/pl/articles/6961970-open-food-facts.md) - [LOINC - Logiczne Identyfikatory Obserwacji Nazwy i Kody](https://success.openhealth.fr/pl/articles/6959323-loinc-logiczne-identyfikatory-obserwacji-nazwy-i-kody.md) - [AMELI - CCAM](https://success.openhealth.fr/pl/articles/6959080-ameli-ccam.md) - [WHO ATC VET](https://success.openhealth.fr/pl/articles/6959078-who-atc-vet.md) - [CEPS](https://success.openhealth.fr/pl/articles/6959068-ceps.md) - [Instytucja](https://success.openhealth.fr/pl/articles/3935678-instytucja.md): Lista placówek zdrowotnych, socjalnych, medyczno-społecznych - [Usługi zdrowotne](https://success.openhealth.fr/pl/articles/7969680-uslugi-zdrowotne.md) - [Wyodrębnij FINESS](https://success.openhealth.fr/pl/articles/3946922-wyodrebnij-finess.md): Wykonaj ekstrakcję zgodnie ze swoimi oczekiwaniami - [Ewolucja FINESS](https://success.openhealth.fr/pl/articles/3947009-ewolucja-finess.md): Śledź ewolucję liczby struktur - [Działalność opiekuńcza autoryzacyjna](https://success.openhealth.fr/pl/articles/3947067-dzialalnosc-opiekuncza-autoryzacyjna.md): Wymień struktury zgodnie z ich zezwoleniami na działalność zdrowotną - [Duży sprzęt medyczny](https://success.openhealth.fr/pl/articles/3947269-duzy-sprzet-medyczny.md): Wymień konstrukcje według ciężkiego wyposażenia - [Geograficzny](https://success.openhealth.fr/pl/articles/3947363-geograficzny.md): Wizualizuj rozmieszczenie struktur na terytorium - [RPPS](https://success.openhealth.fr/pl/articles/3947568-rpps.md): Lista pracowników służby zdrowia - [FINESS I RPPS](https://success.openhealth.fr/pl/articles/3947713-finess-i-rpps.md): Wymień miejsca ćwiczeń pracowników służby zdrowia - [Wyodrębnij RPPS](https://success.openhealth.fr/pl/articles/3947829-wyodrebnij-rpps.md): RPPS \(wspólny katalog pracowników służby zdrowia\) ### MODELE - [Dane w UGA](https://success.openhealth.fr/pl/articles/4852310-dane-w-uga.md) - [Obliczanie sprzedaży do sektora: co musisz wiedzieć](https://success.openhealth.fr/pl/articles/3545561-obliczanie-sprzedazy-do-sektora-co-musisz-wiedziec.md): Jakie są różne kroki, aby obliczyć sprzedaż sektorową w OpenHealth? - [Realokacja sektora, metodologia statyczna czy dynamiczna?](https://success.openhealth.fr/pl/articles/3690615-realokacja-sektora-metodologia-statyczna-czy-dynamiczna.md): Realokacja sektora, metodologia statyczna czy dynamiczna? - [Warstwy aptek](https://success.openhealth.fr/pl/articles/4291490-warstwy-aptek.md): Szczegóły dotyczące warstw „teoretycznych” i warstw „rzeczywistych” lub „skutecznych”. - [Linia produkcyjna hubów](https://success.openhealth.fr/pl/articles/4816146-linia-produkcyjna-hubow.md) - [Jak przeprowadzić analizę porównawczą?](https://success.openhealth.fr/pl/articles/3440093-jak-przeprowadzic-analize-porownawcza.md): Chcesz porównać dane od dwóch różnych dostawców. - [DOCHODZENIE POZIOMU 1 - Jakość danych w służbie firmy OpenHealth](https://success.openhealth.fr/pl/articles/3595822-dochodzenie-poziomu-1-jakosc-danych-w-sluzbie-firmy-openhealth.md): Czy obserwujesz zjawisko, którego nie rozumiesz? Możemy podać pochodzenie tej obserwacji i wyjaśnić ją. - [Proces jakości danych w OpenHealth](https://success.openhealth.fr/pl/articles/3415271-proces-jakosci-danych-w-openhealth.md): W tym artykule szczegółowo opisano etapy procesów jakości danych w OpenHealth - [Przedział czasu i poziom ufności](https://success.openhealth.fr/pl/articles/3633173-przedzial-czasu-i-poziom-ufnosci.md): Definicje, wzory i ograniczenia: co musisz wiedzieć - [Jakość danych: zarządzanie partiami](https://success.openhealth.fr/pl/articles/3433509-jakosc-danych-zarzadzanie-partiami.md): Opis procesu zarządzania partiami - [Jakość danych: proces podziału sprzedaży](https://success.openhealth.fr/pl/articles/3415317-jakosc-danych-proces-podzialu-sprzedazy.md): Opis procesu podziału sprzedaży - [Wyprzedaż i offset zapasów](https://success.openhealth.fr/pl/articles/4131084-wyprzedaz-i-offset-zapasow.md): Wyprzedaż towaru - [Po co analizować wielkość sprzedaży?](https://success.openhealth.fr/pl/articles/3846167-po-co-analizowac-wielkosc-sprzedazy.md): Po co analizować wielkość sprzedaży? - [Istnieje luka w danych między wyprzedażami i wyprzedażami](https://success.openhealth.fr/pl/articles/3195358-istnieje-luka-w-danych-miedzy-wyprzedazami-i-wyprzedazami.md): W jakich przypadkach może wystąpić luka w danych między wyprzedażą a wyprzedaniem? - [Co to jest nietypowa sprzedaż?](https://success.openhealth.fr/pl/articles/3195366-co-to-jest-nietypowa-sprzedaz.md): Nietypowa sprzedaż i proces ATYPICAL FILTER. - [Skąd pochodzą informacje o cenach, wolumenach, obrotach?](https://success.openhealth.fr/pl/articles/3195348-skad-pochodza-informacje-o-cenach-wolumenach-obrotach.md): Informacje o cenie / wolumenie / obrocie - [Szacunkowa wielkość sprzedaży według przepisującego lekarza](https://success.openhealth.fr/pl/articles/4171530-szacunkowa-wielkosc-sprzedazy-wedlug-przepisujacego-lekarza.md): Jak ocenić wielkość sprzedaży w aptekach według lekarza i kategorii lekarza - [Zrozumienie różnicy między 2 ekstrakcjami](https://success.openhealth.fr/pl/articles/13399689-zrozumienie-roznicy-miedzy-2-ekstrakcjami.md) ### RYNKI - [GTIN](https://success.openhealth.fr/pl/articles/3608176-gtin.md): Kod GTIN \(globalny numer jednostki handlowej\) - [Specyfikacja pola kwalifikatora produktu klienta \(CQCP\)](https://success.openhealth.fr/pl/articles/3704913-specyfikacja-pola-kwalifikatora-produktu-klienta-cqcp.md): CQCP \(pole kwalifikatora klienta produktu\) - [Co to jest kod LPPR?](https://success.openhealth.fr/pl/articles/3195365-co-to-jest-kod-lppr.md): Kod LPPR \(lista produktów i usług podlegających zwrotowi\) - [Śledzenie wynajmu produktów](https://success.openhealth.fr/pl/articles/4206554-sledzenie-wynajmu-produktow.md): Wynajem produktu - [Chcę poszerzyć swój rynek](https://success.openhealth.fr/pl/articles/4420843-chce-poszerzyc-swoj-rynek.md): Podążał za rynkiem subskrypcji - [Klasyfikacja OHC](https://success.openhealth.fr/pl/articles/3194589-klasyfikacja-ohc.md): Wizualizuj przypisanie swoich produktów zgodnie z zastrzeżoną klasyfikacją firmy OpenHealth - [Historia klas AC EphMRA](https://success.openhealth.fr/pl/articles/3557908-historia-klas-ac-ephmra.md): Wizualizuj ewolucję zajęć EphMRA AC od 2014 roku - [Szczegóły dotyczące medycyny weterynaryjnej](https://success.openhealth.fr/pl/articles/3194587-szczegoly-dotyczace-medycyny-weterynaryjnej.md): Wizualizuj cechy leków weterynaryjnych - [Klasyfikacja medycyny weterynaryjnej](https://success.openhealth.fr/pl/articles/3194579-klasyfikacja-medycyny-weterynaryjnej.md): Zobacz klasyfikację leków weterynaryjnych \(ANSES\) - [Szczegóły dotyczące medycyny ludzkiej](https://success.openhealth.fr/pl/articles/3421225-szczegoly-dotyczace-medycyny-ludzkiej.md): Wyświetl cechy jednego lub więcej produktów za pomocą pól szczegółowych THESORIMED - [Zarządzanie nowymi produktami](https://success.openhealth.fr/pl/articles/4470813-zarzadzanie-nowymi-produktami.md): Zarządzanie nowym produktem - [Klasyfikacja medycyny ludzkiej](https://success.openhealth.fr/pl/articles/3417281-klasyfikacja-medycyny-ludzkiej.md): Zobacz klasyfikacje EphMRA AC i OMS ATC dla swojego zakresu produktów - [Wskazania - Diagnoza](https://success.openhealth.fr/pl/articles/3568554-wskazania-diagnoza.md): Zobacz leki wskazane dla danej patologii i patologie związane z wyborem leków - [MP4U](https://success.openhealth.fr/pl/articles/3574188-mp4u.md): Wyświetl wszystkie klasyfikacje udostępnione przez firmę OpenHealth - [Co to jest TVASI \(tabela sprzedaży, zakupów i nieznanych zapasów\)](https://success.openhealth.fr/pl/articles/5992494-co-to-jest-tvasi-tabela-sprzedazy-zakupow-i-nieznanych-zapasow.md) - [Klasyfikacja produktów IRI](https://success.openhealth.fr/pl/articles/3194597-klasyfikacja-produktow-iri.md): Wizualizuj przypisanie swoich produktów zgodnie z klasyfikacją właściciel IRI - [Usuwanie niesprzedanych produktów](https://success.openhealth.fr/pl/articles/6135938-usuwanie-niesprzedanych-produktow.md) - [RYNEK STANDARDOWY - Subskrypcja](https://success.openhealth.fr/pl/articles/3798203-rynek-standardowy-subskrypcja.md): W artykule opisano zainteresowanie i ograniczenia tak zwanego „standardowego” Rynku - [Nie mogę znaleźć mojego produktu](https://success.openhealth.fr/pl/articles/5686002-nie-moge-znalezc-mojego-produktu.md) - [Zarządzanie kodami produktów](https://success.openhealth.fr/pl/articles/5652478-zarzadzanie-kodami-produktow.md) - [Kwalifikacja produktu: Marki](https://success.openhealth.fr/pl/articles/5016985-kwalifikacja-produktu-marki.md) ### SUBSKRYPCJE i MODUŁY - [3 rodzaje aplikacji](https://success.openhealth.fr/pl/articles/9489652-3-rodzaje-aplikacji.md) - [Twoja platforma 2.0](https://success.openhealth.fr/pl/articles/8374416-twoja-platforma-2-0.md) - [PODSUMOWANIE](https://success.openhealth.fr/pl/articles/3344127-podsumowanie.md): W tym module dostępne są wszystkie cechy Twojej aplikacji - [Rynki i wybór](https://success.openhealth.fr/pl/articles/8337016-rynki-i-wybor.md) - [Podsumowanie pulpitu nawigacyjnego](https://success.openhealth.fr/pl/articles/9246867-podsumowanie-pulpitu-nawigacyjnego.md) - [Analiza](https://success.openhealth.fr/pl/articles/9352287-analiza.md) - [Ekstraktor](https://success.openhealth.fr/pl/articles/9246875-ekstraktor.md) - [Analiza wzrostu](https://success.openhealth.fr/pl/articles/3158856-analiza-wzrostu.md): Określ kluczowe czynniki związane z ewolucją swoich rynków i konkurencji - [Analiza asortymentu](https://success.openhealth.fr/pl/articles/3473736-analiza-asortymentu.md): Zbadaj dynamikę produktów na rynku - [Średnia liczba produktów](https://success.openhealth.fr/pl/articles/3161474-srednia-liczba-produktow.md): Zobacz średnią liczbę produktów w punkcie sprzedaży, w aptekach lub w drogeriach GSA - [Uruchom śledzenie](https://success.openhealth.fr/pl/articles/3158488-uruchom-sledzenie.md): Monitoruj wprowadzanie produktów na rynek i ich wkład we wzrost - [Wskaźniki zaawansowane przekreślone](https://success.openhealth.fr/pl/articles/6007740-wskazniki-zaawansowane-przekreslone.md) - [Koncentracja sprzedaży](https://success.openhealth.fr/pl/articles/3095338-koncentracja-sprzedazy.md): Wizualizuj koncentrację rynku poprzez krzywą koncentracji sprzedaży i indeks GINI - [Rozrzut ceny](https://success.openhealth.fr/pl/articles/3159289-rozrzut-ceny.md): Wizualizuj rozrzut cen produktu. Utwórz własne segmenty aptek na podstawie ceny sprzedaży - [Analiza marży wyprzedaży](https://success.openhealth.fr/pl/articles/3358322-analiza-marzy-wyprzedazy.md): Sprawdź atrakcyjność swoich produktów dla aptek - [Ewolucja marży wyprzedaży](https://success.openhealth.fr/pl/articles/3815561-ewolucja-marzy-wyprzedazy.md) - [Monitorowanie apteki \(1/2\)](https://success.openhealth.fr/pl/articles/3358248-monitorowanie-apteki-1-2.md): Śledź ewolucję ruchu w aptekach - [Monitorowanie apteki \(2/2\)](https://success.openhealth.fr/pl/articles/3810527-monitorowanie-apteki-2-2.md): Śledź ewolucję ruchu w aptekach - [Wydajność Salesforce](https://success.openhealth.fr/pl/articles/3159230-wydajnosc-salesforce.md): Porównaj wyniki sprzedaży w regionach i sektorach sił sprzedaży - [Asystent ds. zarządzania relacjami z klientami \(CRM\)](https://success.openhealth.fr/pl/articles/5953935-asystent-ds-zarzadzania-relacjami-z-klientami-crm.md) - [Śledzenie punktu sprzedaży](https://success.openhealth.fr/pl/articles/3778944-sledzenie-punktu-sprzedazy.md): Śledzenie punktu sprzedaży - [Ewolucja na żądanie](https://success.openhealth.fr/pl/articles/6560184-ewolucja-na-zadanie.md) - [Analiza na żądanie](https://success.openhealth.fr/pl/articles/6127483-analiza-na-zadanie.md) - [Tabela na żądanie](https://success.openhealth.fr/pl/articles/3158751-tabela-na-zadanie.md): Wizualizuj główne wskaźniki HUB i ich ewolucję w różnych typach okresów - [Analiza szeregów czasowych](https://success.openhealth.fr/pl/articles/3635940-analiza-szeregow-czasowych.md): Podziel swój rynek na sezon, trendy i hałas - [Analiza prognoz](https://success.openhealth.fr/pl/articles/3636015-analiza-prognoz.md): Oszacuj przyszłość swojego rynku - [Prognoza sektorowa](https://success.openhealth.fr/pl/articles/3689811-prognoza-sektorowa.md): Oszacuj przyszłą sprzedaż w sektorze - [Wizualizacja sprzedaży](https://success.openhealth.fr/pl/articles/3559882-wizualizacja-sprzedazy.md): Porównaj ewolucję sprzedaży sprzedanej i sprzedanej - [Analiza Sell-in](https://success.openhealth.fr/pl/articles/6188132-analiza-sell-in.md) - [Sell-in Matching](https://success.openhealth.fr/pl/articles/6188090-sell-in-matching.md) - [Sell-in Ewolucja](https://success.openhealth.fr/pl/articles/6191929-sell-in-ewolucja.md) - [Analiza Sell-in vs Sell-out](https://success.openhealth.fr/pl/articles/6191947-analiza-sell-in-vs-sell-out.md) - [Sell-in vs Sell-out Ewolucja](https://success.openhealth.fr/pl/articles/6191955-sell-in-vs-sell-out-ewolucja.md) - [Ewolucja cenowa](https://success.openhealth.fr/pl/articles/5056489-ewolucja-cenowa.md) - [Dostosuj kolory](https://success.openhealth.fr/pl/articles/8407897-dostosuj-kolory.md) - [Eksport produktów](https://success.openhealth.fr/pl/articles/3583206-eksport-produktow.md): Eksportuj arkusz specyficzny dla wszystkich produktów i aplikacji typu MP4U - [Analiza rynku](https://success.openhealth.fr/pl/articles/3121933-analiza-rynku.md): Przeanalizuj wydajność swojego rynku: według segmentu, marki, produktu i firmy - [Analiza cen](https://success.openhealth.fr/pl/articles/3215190-analiza-cen.md): Przeglądaj ceny na swoim rynku i analizuj swoje pozycjonowanie - [Ewolucja sprzedaży](https://success.openhealth.fr/pl/articles/3178323-ewolucja-sprzedazy.md): Wyświetlaj ewoluującą sprzedaż w całej dostępnej historii - [Podsumuj tablicę rozdzielczą](https://success.openhealth.fr/pl/articles/4533213-podsumuj-tablice-rozdzielcza.md) - [Ewolucja udziału w rynku](https://success.openhealth.fr/pl/articles/3193078-ewolucja-udzialu-w-rynku.md): Wizualizuj ewolucję sprzedaży i udziału w rynku w długim okresie - [Tabela sprzedaży krzyżowej](https://success.openhealth.fr/pl/articles/3193060-tabela-sprzedazy-krzyzowej.md): Utwórz prostą tabelę przestawną - [Synteza OBROTÓW / OBJĘTOŚCI \(CU\)](https://success.openhealth.fr/pl/articles/3193048-synteza-obrotow-objetosci-cu.md): Jednocześnie wizualizuj wielkość sprzedaży i wartość rynku - [Synteza wartości sprzedaży \(apteki / supermarkety\)](https://success.openhealth.fr/pl/articles/3193020-synteza-wartosci-sprzedazy-apteki-supermarkety.md): Porównanie sprzedaży drogerii GSA i drogerii - [Analiza udziału w rynku](https://success.openhealth.fr/pl/articles/3193069-analiza-udzialu-w-rynku.md): Przeanalizuj udziały w rynku w ciągu ostatnich 12 miesięcy - [Moje archiwum danych](https://success.openhealth.fr/pl/articles/3193099-moje-archiwum-danych.md): Eksportuj płaską bazę danych do programu Excel - [Analiza wielu okresów](https://success.openhealth.fr/pl/articles/3192953-analiza-wielu-okresow.md): Stwórz całkowicie spersonalizowany stół - [Moje zapytanie Wszystkie produkty](https://success.openhealth.fr/pl/articles/4280353-moje-zapytanie-wszystkie-produkty.md): Wyświetlaj swoje segmenty i kwalifikujące się pola \(np .: galenowy, wskaźnik energii słonecznej, promocje ...\), a także ograniczenia - [Ewolucja zapasów \(NOWOŚĆ\)](https://success.openhealth.fr/pl/articles/3719256-ewolucja-zapasow-nowosc.md): Wizualizuj i analizuj ewolucję zasobów i ich rozmieszczenie - [Definicja rynku](https://success.openhealth.fr/pl/articles/3158829-definicja-rynku.md): Oprzyj swój rynek na bazie 100 wybranych przez siebie - [Zaawansowane wskaźniki RAW DATA](https://success.openhealth.fr/pl/articles/3711095-zaawansowane-wskazniki-raw-data.md): Odzyskaj dane wskaźnika wyprzedzającego - [Zaawansowane wskaźniki Evolution SMKT](https://success.openhealth.fr/pl/articles/3193000-zaawansowane-wskazniki-evolution-smkt.md): Monitoruj wydajność swojego laboratorium poprzez analizę czasowej ewolucji zaawansowanych wskaźników statystycznych. - [Zaawansowana analiza wskaźników SMKT](https://success.openhealth.fr/pl/articles/3192366-zaawansowana-analiza-wskaznikow-smkt.md): Podziel ewolucję rynku parafarmacji GSA na wskaźniki wyprzedzające - [Ewolucja wskaźników zaawansowanych](https://success.openhealth.fr/pl/articles/3177853-ewolucja-wskaznikow-zaawansowanych.md): Monitoruj wydajność swojego laboratorium poprzez analizę czasowej ewolucji zaawansowanych wskaźników statystycznych. - [Zaawansowane wskaźniki Evolution Bio](https://success.openhealth.fr/pl/articles/7051823-zaawansowane-wskazniki-evolution-bio.md) - [Krajowe wskaźniki zaawansowane](https://success.openhealth.fr/pl/articles/3364513-krajowe-wskazniki-zaawansowane.md): Podziel ewolucję rynku na wskaźniki wyprzedzające - [Analiza zapasów](https://success.openhealth.fr/pl/articles/3178015-analiza-zapasow.md): Zinterpretuj stan zapasów i jego ewolucję - [Zaawansowana analiza wskaźników Bio](https://success.openhealth.fr/pl/articles/7051801-zaawansowana-analiza-wskaznikow-bio.md) - [Zaawansowana analiza wskaźników](https://success.openhealth.fr/pl/articles/3124439-zaawansowana-analiza-wskaznikow.md): Rozłożyć ewolucję rynku na wiodące wskaźniki - [Kartografia](https://success.openhealth.fr/pl/articles/3192450-kartografia.md): Przeanalizuj wyniki handlowe regionów i sektorów swoich sił sprzedaży - [Geograficzna tabela krzyżowa](https://success.openhealth.fr/pl/articles/3192466-geograficzna-tabela-krzyzowa.md): Utwórz tabelę przestawną integrującą Twoją sektorację - [Ewolucja sprzedaży geograficznej](https://success.openhealth.fr/pl/articles/3192482-ewolucja-sprzedazy-geograficznej.md): Wizualizuj sprzedaż według sektorów w okresie 36 miesięcy w tabeli przestawnej - [Efektywność sił sprzedaży](https://success.openhealth.fr/pl/articles/5624011-efektywnosc-sil-sprzedazy.md) - [Analiza niestandardowej metody ważenia](https://success.openhealth.fr/pl/articles/5169317-analiza-niestandardowej-metody-wazenia.md) - [Analiza sieci](https://success.openhealth.fr/pl/articles/3894767-analiza-sieci.md): Analiza sieci - [Ewolucja niestandardowej metody ważenia](https://success.openhealth.fr/pl/articles/5169320-ewolucja-niestandardowej-metody-wazenia.md) - [PODSUMOWANIE KPI](https://success.openhealth.fr/pl/articles/3478199-podsumowanie-kpi.md): Wizualizuj w dynamicznej tabeli kluczowe wskaźniki Objętość spadła do regionów i sektorów. - [Sprzedaż w przeliczonych jednostkach](https://success.openhealth.fr/pl/articles/3192412-sprzedaz-w-przeliczonych-jednostkach.md): Użyj przeliczonych jednostek do wizualizacji sprzedaży - [Wskaźniki zapasów RAW DATA](https://success.openhealth.fr/pl/articles/3711142-wskazniki-zapasow-raw-data.md): Eksportuj dane inwentarza - [RAW DATA SMKT AIA](https://success.openhealth.fr/pl/articles/3720960-raw-data-smkt-aia.md): Znajdź dane dotyczące wskaźnika wyprzedzającego SMKT - [Ewolucja zapasów](https://success.openhealth.fr/pl/articles/3178277-ewolucja-zapasow.md): Wizualizuj i analizuj ewolucję zasobów i ich rozmieszczenie - [Zaawansowane wskaźniki geograficzne](https://success.openhealth.fr/pl/articles/3192508-zaawansowane-wskazniki-geograficzne.md): Zobacz wskaźniki wyprzedzające według regionu lub sektora - [Wydajność produktów](https://success.openhealth.fr/pl/articles/3850331-wydajnosc-produktow.md): Porównaj wyniki biznesowe regionów i sektorów produktów - [Zaawansowane wskaźniki terytorialne](https://success.openhealth.fr/pl/articles/3370879-zaawansowane-wskazniki-terytorialne.md): Podziel ewolucję rynku na wskaźniki wyprzedzające - [Analiza sektorowa szeregów czasowych](https://success.openhealth.fr/pl/articles/3814974-analiza-sektorowa-szeregow-czasowych.md): Podziel swój rynek na trendy, porę roku, hałas - [Analiza sprzedaży według wieku i płci](https://success.openhealth.fr/pl/articles/3192701-analiza-sprzedazy-wedlug-wieku-i-plci.md): Analizuj sprzedaż według wieku i płci - [Ewolucja sprzedaży według stanu ciąży](https://success.openhealth.fr/pl/articles/3192910-ewolucja-sprzedazy-wedlug-stanu-ciazy.md): Śledź sprzedaż aptek w populacji kobiet w ciąży - [Ewolucja sprzedaży według wieku i płci](https://success.openhealth.fr/pl/articles/3192732-ewolucja-sprzedazy-wedlug-wieku-i-plci.md): Wizualizuj ewolucję sprzedaży według wieku i płci, korzystając z głębokiej historii HUB - [Wymagania Ewolucja zamówienia](https://success.openhealth.fr/pl/articles/5790020-wymagania-ewolucja-zamowienia.md) - [Zwolnienia ewolucyjne](https://success.openhealth.fr/pl/articles/3192529-zwolnienia-ewolucyjne.md): Wizualizuj i opisuj ewolucję jednoczesnych wydań w aptekach - [Analiza ko-dyspensacji](https://success.openhealth.fr/pl/articles/3192633-analiza-ko-dyspensacji.md): Zobacz Co-Dispensations w aptekach związanych z wybranymi produktami z mojego rynku - [Sprzedaż na kanał i osobę przepisującą](https://success.openhealth.fr/pl/articles/3192751-sprzedaz-na-kanal-i-osobe-przepisujaca.md): Wizualizuj influencerów na swoim rynku - [AMO, AMC i RAC](https://success.openhealth.fr/pl/articles/3192929-amo-amc-i-rac.md): Zobacz trzy kwoty obowiązkowego ubezpieczenia zdrowotnego, dodatkowego ubezpieczenia zdrowotnego i wydatków bieżących - [Dyspersja dyspersji](https://success.openhealth.fr/pl/articles/3876946-dyspersja-dyspersji.md): Wyświetl rozkład liczby produktów sprzedanych w ramach zwolnienia - [Ewolucja dyspersji dyspensacji](https://success.openhealth.fr/pl/articles/3920070-ewolucja-dyspersji-dyspensacji.md): Wizualizuj dystrybucję liczby produktów sprzedawanych w ramach jednej dystrybucji w czasie - [Recepty lekarskie według wieku i płci](https://success.openhealth.fr/pl/articles/5789899-recepty-lekarskie-wedlug-wieku-i-plci.md) - [Analiza zamówień na recepty](https://success.openhealth.fr/pl/articles/5322866-analiza-zamowien-na-recepty.md) - [Ewolucja recept lekarskich](https://success.openhealth.fr/pl/articles/5790016-ewolucja-recept-lekarskich.md) - [Analiza koszyka](https://success.openhealth.fr/pl/articles/3711049-analiza-koszyka.md): Opis modułu „Analiza koszyka” - [Co-dispensing](https://success.openhealth.fr/pl/articles/4738243-co-dispensing.md) - [Moduł kwalifikacji kohorty](https://success.openhealth.fr/pl/articles/3928090-modul-kwalifikacji-kohorty.md): Kwalifikacja kohorty pacjentów - [Moduł statusu leczenia](https://success.openhealth.fr/pl/articles/3928067-modul-statusu-leczenia.md): Przeanalizuj dynamikę monitorowania leczenia - [Moduł przestrzegania zaleceń terapeutycznych](https://success.openhealth.fr/pl/articles/3928044-modul-przestrzegania-zalecen-terapeutycznych.md): Przeanalizuj przestrzeganie leczenia - [Definicja kohorty](https://success.openhealth.fr/pl/articles/3894703-definicja-kohorty.md): Określ zakres swojej analizy - [Zabiegi towarzyszące](https://success.openhealth.fr/pl/articles/4163623-zabiegi-towarzyszace.md): Zdefiniuj współprzetwarzanie w zakresie analizy - [Kohorta wizualizacji](https://success.openhealth.fr/pl/articles/3894721-kohorta-wizualizacji.md): Wyświetl profil pacjenta w zdefiniowanej kohorcie - [Definicja kryteriów analizy](https://success.openhealth.fr/pl/articles/3894728-definicja-kryteriow-analizy.md): Zdefiniuj parametry analizy Twojej kohorty - [Globalna ewolucja kohorty](https://success.openhealth.fr/pl/articles/3894747-globalna-ewolucja-kohorty.md): Wizualizuj miesięczną ewolucję kohorty - [Podział geograficzny](https://success.openhealth.fr/pl/articles/3894751-podzial-geograficzny.md): Wyświetl geograficzne rozmieszczenie pacjentów w określonej kohorcie - [Profil kohorty](https://success.openhealth.fr/pl/articles/3894755-profil-kohorty.md): Przeanalizuj profil demograficzny pacjentów włączonych do kohorty - [Brak statusu leczenia](https://success.openhealth.fr/pl/articles/3894764-brak-statusu-leczenia.md): Uzyskaj przegląd różnych rodzajów monitorowania leczenia - [Rozpoczęcie leczenia](https://success.openhealth.fr/pl/articles/3894778-rozpoczecie-leczenia.md): Przeanalizuj ewolucję liczby inicjacji leczenia - [Leczenie zostaje wznowione](https://success.openhealth.fr/pl/articles/3894788-leczenie-zostaje-wznowione.md): Przeanalizuj ewolucję liczby ponownych zabiegów - [Nowe zabiegi](https://success.openhealth.fr/pl/articles/3894804-nowe-zabiegi.md): Przeanalizuj ewolucję liczby inicjacji i wznowień leczenia - [Leczenie się nawraca](https://success.openhealth.fr/pl/articles/3894812-leczenie-sie-nawraca.md): Przeanalizuj pacjentów podczas leczenia - [Leczenie zmienia równowagę](https://success.openhealth.fr/pl/articles/3894821-leczenie-zmienia-rownowage.md): Przeanalizuj bilans zmian leczenia według leczenia - [Korzyści wynikające ze zmiany leczenia](https://success.openhealth.fr/pl/articles/3894830-korzysci-wynikajace-ze-zmiany-leczenia.md): Przeanalizuj beneficjentów zmiany leczenia - [Straty zmiany leczenia](https://success.openhealth.fr/pl/articles/3894843-straty-zmiany-leczenia.md): Przeanalizuj przez leczenie przegranych ze zmian leczenia - [Przełącz początki wzmocnienia](https://success.openhealth.fr/pl/articles/3894857-przelacz-poczatki-wzmocnienia.md): Przeanalizuj pochodzenie zmiany dla danego leczenia - [Zmień miejsce docelowe utraty](https://success.openhealth.fr/pl/articles/3894864-zmien-miejsce-docelowe-utraty.md): Przeanalizuj miejsce przełączenia na dany zabieg - [Porzucenia](https://success.openhealth.fr/pl/articles/3894874-porzucenia.md): Analiza zatrzymania leczenia - [Podsumowanie KPI](https://success.openhealth.fr/pl/articles/4229969-podsumowanie-kpi.md): Podsumowanie różnych rodzajów monitorowania leczenia - [Trwałość leczenia](https://success.openhealth.fr/pl/articles/3894883-trwalosc-leczenia.md): Analizuj czas trwania zabiegów - [Spełnienie](https://success.openhealth.fr/pl/articles/3894884-spelnienie.md): Przeanalizuj dostarczone ilości - [Jakie jest kryterium prawidłowości?](https://success.openhealth.fr/pl/articles/3325816-jakie-jest-kryterium-prawidlowosci.md): Definicja pojęcia kryterium regularności - [Śmierć - kartografia](https://success.openhealth.fr/pl/articles/3863677-smierc-kartografia.md): Przeanalizuj geograficzne rozmieszczenie zgonów - [Przesunięcie liczby zgonów](https://success.openhealth.fr/pl/articles/3863573-przesuniecie-liczby-zgonow.md): Oceń trafność swoich danych - [Śmierć - analiza według wieku i płci](https://success.openhealth.fr/pl/articles/3863808-smierc-analiza-wedlug-wieku-i-plci.md): Przeanalizuj strukturę zgonów - [Death - Evolution by AGE & GENDER](https://success.openhealth.fr/pl/articles/3863939-death-evolution-by-age-gender.md): Przeanalizuj ewolucję struktury zgonów - [Śmierć - ewolucja](https://success.openhealth.fr/pl/articles/3864065-smierc-ewolucja.md): Wizualizuj ewolucję zgonów - [Śmierć - porównanie ewolucji](https://success.openhealth.fr/pl/articles/3864073-smierc-porownanie-ewolucji.md): Porównaj ewolucję zgonów w porównaniu z poprzednimi latami - [Pharmacy Monitoring CA](https://success.openhealth.fr/pl/articles/4634768-pharmacy-monitoring-ca.md): Opisz ruch w zależności od wielkości aptek - [Analiza ruchu \(Beta test\)](https://success.openhealth.fr/pl/articles/6848401-analiza-ruchu-beta-test.md) - [Szczegóły monitorowania apteki](https://success.openhealth.fr/pl/articles/4527868-szczegoly-monitorowania-apteki.md): Przeanalizuj ruch w przychodniach według rodzaju apteki - [Traffic Evolution \(Beta test\)](https://success.openhealth.fr/pl/articles/6848016-traffic-evolution-beta-test.md) - [Kartografia monitorowania aptek](https://success.openhealth.fr/pl/articles/4527811-kartografia-monitorowania-aptek.md): Przeanalizuj ruch w przychodniach we Francji kontynentalnej - [Szczegóły monitorowania apteki](https://success.openhealth.fr/pl/articles/4262306-szczegoly-monitorowania-apteki.md): Rozróżnij szczegóły sprzedaży według rodzaju apteki - [Analiza monitorowania apteki](https://success.openhealth.fr/pl/articles/3839223-analiza-monitorowania-apteki.md): Śledź ewolucję ruchu w aptekach - [Ewolucja monitorowania aptek](https://success.openhealth.fr/pl/articles/3827973-ewolucja-monitorowania-aptek.md): Zbadaj ewolucję ruchu w przychodniach - [Rozkład ruchu](https://success.openhealth.fr/pl/articles/3826074-rozklad-ruchu.md): Obserwuj składowe sezonu, trendów i pozostałości - [Badanie ruchu](https://success.openhealth.fr/pl/articles/3809042-badanie-ruchu.md): Analizuj ruch w aptekach - [Streszczenie - PIEX](https://success.openhealth.fr/pl/articles/5203335-streszczenie-piex.md) - [Nabywczy](https://success.openhealth.fr/pl/articles/4605110-nabywczy.md): Śledź swoje zakupy i ich wpływy - [Moje zapytanie - PIEX](https://success.openhealth.fr/pl/articles/4210627-moje-zapytanie-piex.md): Dokonaj selekcji swoich danych - [Ewolucja sprzedaży - PIEX](https://success.openhealth.fr/pl/articles/4210655-ewolucja-sprzedazy-piex.md): Zobacz ewolucję swojej działalności w dostępnej historii - [Analiza sprzedaży - PIEX](https://success.openhealth.fr/pl/articles/4210650-analiza-sprzedazy-piex.md): Analiza sprzedaży - PIEX - [Szczegóły zamówienia - PIEX](https://success.openhealth.fr/pl/articles/4210659-szczegoly-zamowienia-piex.md): Wyświetl i śledź zamówienie sprzedaży - [Przegląd zapasów - PIEX](https://success.openhealth.fr/pl/articles/4210672-przeglad-zapasow-piex.md): Wizualizuj zmiany swoich zapasów - [Moje archiwum danych - PIEX](https://success.openhealth.fr/pl/articles/4210694-moje-archiwum-danych-piex.md): Eksportuj płaską bazę danych do programu Excel - [EURAPHARMA- PIEX](https://success.openhealth.fr/pl/articles/4366306-eurapharma-piex.md): Wizualizuj ewolucję działalności EURAPHARMA - [Pasujący produkt](https://success.openhealth.fr/pl/articles/4366320-pasujacy-produkt.md): Korespondencja między oznaczeniami produktów PIEX i EURAPHARMA - [CLI My File \(1/5\)](https://success.openhealth.fr/pl/articles/4626422-cli-my-file-1-5.md): CLI My File \(1/5\) - [CLI\_File Counts \(2/5\)](https://success.openhealth.fr/pl/articles/4626421-cli_file-counts-2-5.md): CLI\_File Counts \(2/5\) - [CLI\_File Code Matching with OHC repository](https://success.openhealth.fr/pl/articles/4626419-cli_file-code-matching-with-ohc-repository.md): CLI\_FIL Zgodność kodu z repozytorium OHC - [Wyprzedaż na eksport \(4/5\)](https://success.openhealth.fr/pl/articles/4626414-wyprzedaz-na-eksport-4-5.md): Wyprzedaż Eksport \(4/5\) ### SPERSONALIZOWANE OPCJE - [Niehierarchiczne pola kwalifikujące produkty](https://success.openhealth.fr/pl/articles/4036045-niehierarchiczne-pola-kwalifikujace-produkty.md): Dodaj szczegóły dotyczące kwalifikacji swoich produktów - [Jaki jest maksymalny wiek danych HUB?](https://success.openhealth.fr/pl/articles/3195251-jaki-jest-maksymalny-wiek-danych-hub.md): Ostatnie dostępne dane - [typ klienta](https://success.openhealth.fr/pl/articles/4197147-typ-klienta.md): Opcja niestandardowa Typ klienta - [Dostęp do sesji](https://success.openhealth.fr/pl/articles/4036458-dostep-do-sesji.md): Ogranicz oglądanie swoich pracowników - [Cykl niestandardowy](https://success.openhealth.fr/pl/articles/4036444-cykl-niestandardowy.md): Analizuj swoje dane w spersonalizowanych okresach - [Rok podatkowy](https://success.openhealth.fr/pl/articles/4036169-rok-podatkowy.md): Określ swój rok podatkowy - [Przycisk dnia](https://success.openhealth.fr/pl/articles/4036159-przycisk-dnia.md): Wizualizuj swoje dane z większą szczegółowością - [Przycisk tygodnia](https://success.openhealth.fr/pl/articles/4036111-przycisk-tygodnia.md): Wizualizuj swoje dane z większą szczegółowością - [Kursy wymiany](https://success.openhealth.fr/pl/articles/8329594-kursy-wymiany.md) - [Kalendarz okresowy SMKT](https://success.openhealth.fr/pl/articles/4036549-kalendarz-okresowy-smkt.md): Użyj kalendarza GSA - [Ogranicz obwód](https://success.openhealth.fr/pl/articles/4560699-ogranicz-obwod.md): Wybór jednej listy GTIN w Moje zapytanie z pliku .xlsx - [Ogranicz obwód \(kod 7\)](https://success.openhealth.fr/pl/articles/4560791-ogranicz-obwod-kod-7.md): Wybór jednej listy \[KOD TECHNICZNY 2\] w Moje zapytanie z pliku .xlsx - [Flaga rynkug](https://success.openhealth.fr/pl/articles/4560797-flaga-rynkug.md): Wybranie jednej listy GTIN w Moje zapytanie z definicji rynku zawartej w pliku .xlsx - [Kierowanie / definicja typu klienta](https://success.openhealth.fr/pl/articles/3777788-kierowanie-definicja-typu-klienta.md): Kierowanie \(typ klienta\) ### WSKAŹNIKI HUB - [Glosariusz wskaźników HUB](https://success.openhealth.fr/pl/articles/5194247-glosariusz-wskaznikow-hub.md) - [Ilości sprzedaży](https://success.openhealth.fr/pl/articles/3194314-ilosci-sprzedazy.md): Ilości sprzedaży - [Wartości sprzedaży](https://success.openhealth.fr/pl/articles/3074854-wartosci-sprzedazy.md): Specyfikacja wskaźnika Wartości sprzedaży - [N MS](https://success.openhealth.fr/pl/articles/3194475-n-ms.md): Definicja środka „N PC” - [N MS Evol](https://success.openhealth.fr/pl/articles/5634266-n-ms-evol.md) - [N MS Delta](https://success.openhealth.fr/pl/articles/3194469-n-ms-delta.md): Definicja środka „N MS Delta” - [Poids Vol \(CA\) par modalité / Custom Weight Vol \(To\)](https://success.openhealth.fr/pl/articles/9292839-poids-vol-ca-par-modalite-custom-weight-vol-to.md) - [Wartość sprzedaży na podstawie ceny producenta bez VAT \(Obrót PF bez VAT\) - Maroko](https://success.openhealth.fr/pl/articles/7508513-wartosc-sprzedazy-na-podstawie-ceny-producenta-bez-vat-obrot-pf-bez-vat-maroko.md) - [CTR wzrostu N](https://success.openhealth.fr/pl/articles/3194466-ctr-wzrostu-n.md): Definicja i wzór obliczeniowy dla miary „N Growth CTR” - [W umowie](https://success.openhealth.fr/pl/articles/6201859-w-umowie.md) - [Waga krzyżowa Objętość](https://success.openhealth.fr/pl/articles/6066324-waga-krzyzowa-objetosc.md) - [Skrzyżowany obrót wagowy](https://success.openhealth.fr/pl/articles/6066273-skrzyzowany-obrot-wagowy.md) - [Skorygowany CTR wzrostu N](https://success.openhealth.fr/pl/articles/3205376-skorygowany-ctr-wzrostu-n.md): Definicja i wzór obliczeniowy wskaźnika „N Growth CTR A” - [Waga źródłowa](https://success.openhealth.fr/pl/articles/5151525-waga-zrodlowa.md) - [Zaobserwowana średnia cena](https://success.openhealth.fr/pl/articles/3194302-zaobserwowana-srednia-cena.md): AASP: zaobserwowana średnia cena - [Średnia cena ważona](https://success.openhealth.fr/pl/articles/3194292-srednia-cena-wazona.md): WASP: Średnia cena ważona - [Efekt cenowy](https://success.openhealth.fr/pl/articles/8426443-efekt-cenowy.md) - [Liczba aptek sprzedających](https://success.openhealth.fr/pl/articles/3719566-liczba-aptek-sprzedajacych.md) - [Sprzedaż dystrybucji cyfrowej](https://success.openhealth.fr/pl/articles/3194321-sprzedaz-dystrybucji-cyfrowej.md): Rozkład liczbowy - [Globalna sprzedaż cyfrowej dystrybucji](https://success.openhealth.fr/pl/articles/3194320-globalna-sprzedaz-cyfrowej-dystrybucji.md): Globalny rozkład liczbowy - [Rebased Selling Digital Distribution](https://success.openhealth.fr/pl/articles/4045636-rebased-selling-digital-distribution.md): Ponowna dystrybucja liczbowa - [Globalna dystrybucja cyfrowa sprzedaży Rebased](https://success.openhealth.fr/pl/articles/4045725-globalna-dystrybucja-cyfrowa-sprzedazy-rebased.md): Globalna dystrybucja liczbowa Rebased - [Zindywidualizowana dystrybucja sprzedaży cyfrowej w systemie rebased](https://success.openhealth.fr/pl/articles/6830813-zindywidualizowana-dystrybucja-sprzedazy-cyfrowej-w-systemie-rebased.md) - [Dystrybucja wartości sprzedaży](https://success.openhealth.fr/pl/articles/3194323-dystrybucja-wartosci-sprzedazy.md): Dystrybucja ważona - [Globalna dystrybucja wartości sprzedaży](https://success.openhealth.fr/pl/articles/3194316-globalna-dystrybucja-wartosci-sprzedazy.md): Globalna dystrybucja wartości sprzedaży - [Dystrybucja wartości sprzedaży Rebase](https://success.openhealth.fr/pl/articles/3194501-dystrybucja-wartosci-sprzedazy-rebase.md): Rebased DVV - [Globalna dystrybucja wartości sprzedaży w oparciu o zmianę](https://success.openhealth.fr/pl/articles/4200619-globalna-dystrybucja-wartosci-sprzedazy-w-oparciu-o-zmiane.md): Globalna rebased DVV - [Indywidualny podział wartości sprzedaży rebased](https://success.openhealth.fr/pl/articles/6834423-indywidualny-podzial-wartosci-sprzedazy-rebased.md) - [Dystrybucja sprzedaży cyfrowej SMKT](https://success.openhealth.fr/pl/articles/3365043-dystrybucja-sprzedazy-cyfrowej-smkt.md): Dystrybucja sprzedaży cyfrowej SMKT \(dystrybucja numeryczna SMK\) - [Globalna sprzedaż dystrybucji cyfrowej SMKT](https://success.openhealth.fr/pl/articles/4298341-globalna-sprzedaz-dystrybucji-cyfrowej-smkt.md): Globalny rozkład liczbowy SMKT \(globalny rozkład liczbowy SMKT\) - [Rebased SMKT Selling Digital Distribution](https://success.openhealth.fr/pl/articles/4298197-rebased-smkt-selling-digital-distribution.md): Odebrano SMKT Digital Distribution \(Rebased Numeric Distribution SMKT\) - [Global Rebased SMKT Selling Digital Distribution](https://success.openhealth.fr/pl/articles/4319783-global-rebased-smkt-selling-digital-distribution.md): Sprzedaż dystrybucji cyfrowej SMKT Rebasée Globale \(przywrócenie SMKT Global Numeric Distribution\) - [Dystrybucja wartości sprzedaży SMKT](https://success.openhealth.fr/pl/articles/3365478-dystrybucja-wartosci-sprzedazy-smkt.md): Dystrybucja wartości sprzedaży SMKT \(dystrybucja ważona SMKT\) - [Przeliczona globalna sprzedaż dystrybucji cyfrowej SMKT](https://success.openhealth.fr/pl/articles/4298373-przeliczona-globalna-sprzedaz-dystrybucji-cyfrowej-smkt.md): Sprzedaż dystrybucji cyfrowej SMKT Global Recalculated \(SMKT Global Numeric Distribution Recalculated\) - [Dystrybucja cyfrowa Sprzedaży SMKT Rebased Przeliczone](https://success.openhealth.fr/pl/articles/4298303-dystrybucja-cyfrowa-sprzedazy-smkt-rebased-przeliczone.md): Ponownie obliczony rozkład liczbowy SMKT Rebased - [Dostosowana dystrybucja cyfrowa sprzedaży SMKT](https://success.openhealth.fr/pl/articles/3369386-dostosowana-dystrybucja-cyfrowa-sprzedazy-smkt.md): Skorygowany rozkład liczbowy SMKT - [Dystrybucja cyfrowa Sprzedaży SMKT Przeliczone](https://success.openhealth.fr/pl/articles/4298209-dystrybucja-cyfrowa-sprzedazy-smkt-przeliczone.md): Przeliczenie rozkładu liczbowego SMKT \(przeliczenie rozkładu liczbowego SMKT\) - [Skorygowany rozkład wartości sprzedaży SMKT](https://success.openhealth.fr/pl/articles/3369397-skorygowany-rozklad-wartosci-sprzedazy-smkt.md): Skorygowana dystrybucja ważona SMKT - [Organiczna dystrybucja sprzedaży cyfrowej](https://success.openhealth.fr/pl/articles/7052424-organiczna-dystrybucja-sprzedazy-cyfrowej.md) - [Obrót aptek sprzedających \(TSP\)](https://success.openhealth.fr/pl/articles/6096534-obrot-aptek-sprzedajacych-tsp.md) - [Kosztorys twojego posiadacza PDM](https://success.openhealth.fr/pl/articles/4214883-kosztorys-twojego-posiadacza-pdm.md): Oszacuj swój udział w rynku wśród klientów - [Więcej aptek](https://success.openhealth.fr/pl/articles/8426451-wiecej-aptek.md) - [Utrata aptek](https://success.openhealth.fr/pl/articles/8426460-utrata-aptek.md) - [Wielokanałowa sprzedaż i dystrybucja cyfrowa](https://success.openhealth.fr/pl/articles/9293487-wielokanalowa-sprzedaz-i-dystrybucja-cyfrowa.md) - [Łączna sprzedaż w dystrybucji cyfrowej \(PHARMA\)](https://success.openhealth.fr/pl/articles/9330571-laczna-sprzedaz-w-dystrybucji-cyfrowej-pharma.md) - [Miesięczna średnia sprzedaż](https://success.openhealth.fr/pl/articles/3194303-miesieczna-srednia-sprzedaz.md): Średnia miesięczna sprzedaż - [Skorygowana średnia miesięczna sprzedaż](https://success.openhealth.fr/pl/articles/3194290-skorygowana-srednia-miesieczna-sprzedaz.md): Skorygowana średnia miesięczna sprzedaż - [Miesięczna średnia wartość sprzedaży](https://success.openhealth.fr/pl/articles/4535404-miesieczna-srednia-wartosc-sprzedazy.md): VMM CA - [AMS to A: Średnia miesięczna wartość sprzedaży po korekcie](https://success.openhealth.fr/pl/articles/6028256-ams-to-a-srednia-miesieczna-wartosc-sprzedazy-po-korekcie.md) - [Średnia sprzedaż](https://success.openhealth.fr/pl/articles/3563716-srednia-sprzedaz.md): Średnia sprzedaż - [Średnia sprzedaż SMKT](https://success.openhealth.fr/pl/articles/3365496-srednia-sprzedaz-smkt.md): Średnia sprzedaż SMKT - [Skorygowana średnia sprzedaż SMKT](https://success.openhealth.fr/pl/articles/3369340-skorygowana-srednia-sprzedaz-smkt.md): Skorygowana średnia sprzedaż SMKT - [Średnia miesięczna sprzedaż organiczna](https://success.openhealth.fr/pl/articles/7052551-srednia-miesieczna-sprzedaz-organiczna.md) - [Średnia miesięczna sprzedaż Wartość organiczna](https://success.openhealth.fr/pl/articles/7052573-srednia-miesieczna-sprzedaz-wartosc-organiczna.md) - [Zbiory](https://success.openhealth.fr/pl/articles/3194332-zbiory.md): Definicja i dostępność danych magazynowych w HUB-ie za pośrednictwem aplikacji SMAa: subskrypcja Sales & Marketing Advanced - [Średni stan magazynowy](https://success.openhealth.fr/pl/articles/3194336-sredni-stan-magazynowy.md): Średni stan magazynowy - [Udział w magazynie](https://success.openhealth.fr/pl/articles/3194334-udzial-w-magazynie.md): Udział w magazynie - [Indeks ciśnienia komercyjnego](https://success.openhealth.fr/pl/articles/3194335-indeks-cisnienia-komercyjnego.md): Indeks ciśnienia komercyjnego - [Współczynnik przekształcenia zapasów](https://success.openhealth.fr/pl/articles/3194344-wspolczynnik-przeksztalcenia-zapasow.md): Wskaźnik transformacji zapasów - [Czas dostawy](https://success.openhealth.fr/pl/articles/3194337-czas-dostawy.md): Czas dostawy - [Liczba aptek branżowych](https://success.openhealth.fr/pl/articles/3194338-liczba-aptek-branzowych.md): Liczba aptek branżowych - [Dystrybucja cyfrowa dla dystrybutorów](https://success.openhealth.fr/pl/articles/3194339-dystrybucja-cyfrowa-dla-dystrybutorow.md): Dystrybucja cyfrowa dla dystrybutorów \(ND Stock\) - [Zmiana bazy dystrybutora dystrybucji cyfrowej](https://success.openhealth.fr/pl/articles/4045743-zmiana-bazy-dystrybutora-dystrybucji-cyfrowej.md): Ponowna dystrybucja liczby akcji - [Globalna dystrybucja cyfrowych dystrybutorów o rebased](https://success.openhealth.fr/pl/articles/4045753-globalna-dystrybucja-cyfrowych-dystrybutorow-o-rebased.md): Globalna dystrybucja cyfrowych dystrybutorów o rebased - [Dystrybucja wartości dla dystrybutorów](https://success.openhealth.fr/pl/articles/3194342-dystrybucja-wartosci-dla-dystrybutorow.md): Dystrybucja wartości dla dystrybutorów \(ważony rozkład zapasów: akcje WD\) - [Ponowna dystrybucja wartości zapasów](https://success.openhealth.fr/pl/articles/3194505-ponowna-dystrybucja-wartosci-zapasow.md): Rebase DVS - [Digital Distribution Smoothed stockist](https://success.openhealth.fr/pl/articles/5141830-digital-distribution-smoothed-stockist.md) - [Dystrybucja cyfrowa Stockista wygładzone, zredukowane](https://success.openhealth.fr/pl/articles/5142162-dystrybucja-cyfrowa-stockista-wygladzone-zredukowane.md) - [Dystrybucja Wygładzona wartość akcji](https://success.openhealth.fr/pl/articles/5203640-dystrybucja-wygladzona-wartosc-akcji.md) - [Podział Wygładzona wartość zaktualizowana akcji](https://success.openhealth.fr/pl/articles/5203701-podzial-wygladzona-wartosc-zaktualizowana-akcji.md) - [Margines](https://success.openhealth.fr/pl/articles/3507716-margines.md): Margines - [Stopa depozytu zabezpieczającego](https://success.openhealth.fr/pl/articles/3507767-stopa-depozytu-zabezpieczajacego.md): Stopa depozytu zabezpieczającego - [Cena producenta bez podatku \(PFHT\)](https://success.openhealth.fr/pl/articles/4557500-cena-producenta-bez-podatku-pfht.md): PFHT - [Sprzedaż - Analizy bazy klientów](https://success.openhealth.fr/pl/articles/3846225-sprzedaz-analizy-bazy-klientow.md): Wskaźniki lojalności: charakterystyka bazy klientów i jej ewolucja - [Wyprzedaż - Nietypowe apteki](https://success.openhealth.fr/pl/articles/3848791-wyprzedaz-nietypowe-apteki.md): Środki wykrywania atypizmu - [Współczynnik ewolucji](https://success.openhealth.fr/pl/articles/3194287-wspolczynnik-ewolucji.md): Współczynnik ewolucji - [Współczynnik penetracji](https://success.openhealth.fr/pl/articles/3194286-wspolczynnik-penetracji.md): Współczynnik penetracji - [Szerokość asortymentu produktów](https://success.openhealth.fr/pl/articles/3369425-szerokosc-asortymentu-produktow.md): Szerokość asortymentu produktów - [Odnowienie asortymentu](https://success.openhealth.fr/pl/articles/3369545-odnowienie-asortymentu.md): Odnowienie asortymentu - [Innowacja w asortymencie](https://success.openhealth.fr/pl/articles/3369468-innowacja-w-asortymencie.md): Innowacja w asortymencie - [Ścieranie asortymentu](https://success.openhealth.fr/pl/articles/3369457-scieranie-asortymentu.md): Ścieranie asortymentu - [Wskaźnik zużycia asortymentu](https://success.openhealth.fr/pl/articles/3369485-wskaznik-zuzycia-asortymentu.md): Wskaźnik zużycia asortymentu - [Zakres innowacyjności](https://success.openhealth.fr/pl/articles/3369541-zakres-innowacyjnosci.md): Zakres innowacyjności - [Udział w ofercie sprzedaży](https://success.openhealth.fr/pl/articles/3369040-udzial-w-ofercie-sprzedazy.md): Udział w ofercie sprzedaży - [Liczba wybranych produktów](https://success.openhealth.fr/pl/articles/3511502-liczba-wybranych-produktow.md): Jest to liczba produktów wybranych na podstawie kodu numeru GTIN-13. - [Średnia liczba produktów](https://success.openhealth.fr/pl/articles/3194284-srednia-liczba-produktow.md): Średnia liczba produktów - [Wskaźnik odnawiania zakresu](https://success.openhealth.fr/pl/articles/3369561-wskaznik-odnawiania-zakresu.md): Wskaźnik odnawiania zakresu - [Liczba produktów](https://success.openhealth.fr/pl/articles/6312686-liczba-produktow.md) - [Kwoty wydane na akt](https://success.openhealth.fr/pl/articles/3447792-kwoty-wydane-na-akt.md): Artykuł dotyczący wskaźnika „Kwoty wydane na czyn” - [Podział wydanych kwot według rodzaju kupującego](https://success.openhealth.fr/pl/articles/3447801-podzial-wydanych-kwot-wedlug-rodzaju-kupujacego.md): Artykuł dotyczący wskaźnika „Podział kwot wydanych według rodzaju nabywcy” - [Wskaźnik konsumpcji](https://success.openhealth.fr/pl/articles/3432701-wskaznik-konsumpcji.md): Definicja wskaźnika „Konsumpcja” - [Udział w sprzedaży](https://success.openhealth.fr/pl/articles/3432664-udzial-w-sprzedazy.md): Definicja wskaźnika „udział w sprzedaży” - [Wartość wskaźnika lojalności](https://success.openhealth.fr/pl/articles/3432695-wartosc-wskaznika-lojalnosci.md): Definicja wskaźnika „Wartość wskaźnika lojalności” - [Absolutna penetracja](https://success.openhealth.fr/pl/articles/3432556-absolutna-penetracja.md): Artykuł dotyczący wskaźnika „Bezwzględna penetracja” - [Udział w obrotach](https://success.openhealth.fr/pl/articles/3432655-udzial-w-obrotach.md): Definicja wskaźnika „Udział w obrotach” - [p-value](https://success.openhealth.fr/pl/articles/5781702-p-value.md) - [Analiza głównych składowych](https://success.openhealth.fr/pl/articles/4231028-analiza-glownych-skladowych.md): ACP - [Negatywna wartość predykcyjna](https://success.openhealth.fr/pl/articles/4134220-negatywna-wartosc-predykcyjna.md): Negatywna wartość predykcyjna - [Pozytywna wartość predykcyjna](https://success.openhealth.fr/pl/articles/4134166-pozytywna-wartosc-predykcyjna.md): Pozytywna wartość predykcyjna - [Test niezależności](https://success.openhealth.fr/pl/articles/4128369-test-niezaleznosci.md): Sprawdź, czy dwie zmienne są ze sobą powiązane - [Badanie szeregów czasowych](https://success.openhealth.fr/pl/articles/3633991-badanie-szeregow-czasowych.md): Sezonowość, trend i prognozy: co musisz wiedzieć - [Sezonowy współczynnik wariancji](https://success.openhealth.fr/pl/articles/3653790-sezonowy-wspolczynnik-wariancji.md): Mierzy udział wariancji w szeregach czasowych - [Czułość i swoistość testu](https://success.openhealth.fr/pl/articles/3928135-czulosc-i-swoistosc-testu.md): Zapoznaj się z koncepcjami analizy skuteczności testu - [Współczynnik wariancji trendu](https://success.openhealth.fr/pl/articles/3653847-wspolczynnik-wariancji-trendu.md): Mierzy udział składnika trendu w szeregu czasowym - [Wskaźnik wariancji rezydualnej](https://success.openhealth.fr/pl/articles/3653851-wskaznik-wariancji-rezydualnej.md): Mierzy udział rezydualnego składnika szeregu czasowego - [Współczynnik determinacji](https://success.openhealth.fr/pl/articles/3654093-wspolczynnik-determinacji.md): Oceń jakość wybranego modelu - [Współczynnik zmienności](https://success.openhealth.fr/pl/articles/3653915-wspolczynnik-zmiennosci.md): Wskaźnik do wyboru modelu dekompozycji - [Wariancja szeregu czasowego](https://success.openhealth.fr/pl/articles/3653855-wariancja-szeregu-czasowego.md): Zmierz rozproszenie serii - [Koncentracja sprzedaży](https://success.openhealth.fr/pl/articles/3395856-koncentracja-sprzedazy.md): Koncentracja sprzedaży - [Indeks Giniego](https://success.openhealth.fr/pl/articles/3395323-indeks-giniego.md): Indeks Giniego - [Populacja](https://success.openhealth.fr/pl/articles/4396779-populacja.md): Populacja - [Ewolucja liczby zgonów](https://success.openhealth.fr/pl/articles/4396765-ewolucja-liczby-zgonow.md): Ewolucja liczby zgonów - [Stosunek płci](https://success.openhealth.fr/pl/articles/3812167-stosunek-plci.md): Stosunek płci - [Ludność - średni wiek](https://success.openhealth.fr/pl/articles/3812180-ludnosc-sredni-wiek.md): Ludność - średni wiek - [Ludność - Mediana wieku](https://success.openhealth.fr/pl/articles/3812198-ludnosc-mediana-wieku.md): Ludność - mediana wieku - [Ludność - 1. kwartyl wieku](https://success.openhealth.fr/pl/articles/3812218-ludnosc-1-kwartyl-wieku.md): Ludność - 1. kwartyl wieku - [Ludność - trzeci kwartyl wieku](https://success.openhealth.fr/pl/articles/3812227-ludnosc-trzeci-kwartyl-wieku.md): Ludność - trzeci kwartyl wieku - [Udział selekcji w całkowitej populacji terytorium](https://success.openhealth.fr/pl/articles/3812233-udzial-selekcji-w-calkowitej-populacji-terytorium.md): Udział selekcji w całkowitej populacji terytorium - [Wskaźnik śmiertelności](https://success.openhealth.fr/pl/articles/3947946-wskaznik-smiertelnosci.md): Wskaźnik śmiertelności - [Wskaźnik śmiertelności przypadków](https://success.openhealth.fr/pl/articles/3948084-wskaznik-smiertelnosci-przypadkow.md): Wskaźnik śmiertelności przypadków - [Kobiety w wieku rozrodczym](https://success.openhealth.fr/pl/articles/4172859-kobiety-w-wieku-rozrodczym.md): Kobiety w wieku rozrodczym - [Udział selekcji w całkowitej liczbie zgonów na terytorium](https://success.openhealth.fr/pl/articles/3863734-udzial-selekcji-w-calkowitej-liczbie-zgonow-na-terytorium.md): Udział selekcji w całkowitej liczbie zgonów na terytorium - [Modelowanie liczby zaginionych zgonów](https://success.openhealth.fr/pl/articles/3895572-modelowanie-liczby-zaginionych-zgonow.md): Przewiduj liczbę zgonów w czasie t - [Szacunkowa sprzedaż w ramach inicjacji recepturowej](https://success.openhealth.fr/pl/articles/5323282-szacunkowa-sprzedaz-w-ramach-inicjacji-recepturowej.md) - [Ewolucja według wieku i stanu ciąży](https://success.openhealth.fr/pl/articles/6820051-ewolucja-wedlug-wieku-i-stanu-ciazy.md) - [Współczynnik produktów współdzielonych](https://success.openhealth.fr/pl/articles/7892010-wspolczynnik-produktow-wspoldzielonych.md) - [Szacunkowa sprzedaż uzupełniania recept](https://success.openhealth.fr/pl/articles/5323209-szacunkowa-sprzedaz-uzupelniania-recept.md) - [Waga sprzedaży uzupełnień do recept](https://success.openhealth.fr/pl/articles/5323198-waga-sprzedazy-uzupelnien-do-recept.md) - [Waga sprzedaży w inicjacji receptowej](https://success.openhealth.fr/pl/articles/5323086-waga-sprzedazy-w-inicjacji-receptowej.md) - [Liczba ko-dyspensacji](https://success.openhealth.fr/pl/articles/3194351-liczba-ko-dyspensacji.md): Liczba współdyspensacji - [Liczba zwolnień](https://success.openhealth.fr/pl/articles/3194348-liczba-zwolnien.md): Liczba zwolnień - [Średnia liczba zwolnień na osobę ubezpieczoną](https://success.openhealth.fr/pl/articles/3369626-srednia-liczba-zwolnien-na-osobe-ubezpieczona.md): Średnia liczba zwolnień na osobę ubezpieczoną - [Przestrzeganie](https://success.openhealth.fr/pl/articles/3411996-przestrzeganie.md): Wskaźnik posiadanych leków \(MPR\) - [Wskaźnik trwałości](https://success.openhealth.fr/pl/articles/3369684-wskaznik-trwalosci.md): Wskaźnik trwałości - [Przestrzeganie zaleceń terapeutycznych](https://success.openhealth.fr/pl/articles/3412091-przestrzeganie-zalecen-terapeutycznych.md): Przestrzeganie zaleceń terapeutycznych - [Średnia dzienna dawka na osobę ubezpieczoną](https://success.openhealth.fr/pl/articles/4153587-srednia-dzienna-dawka-na-osobe-ubezpieczona.md): Średnia dzienna dawka na osobę ubezpieczoną - [Liczba zwolnień zgłoszonych do zwrotu](https://success.openhealth.fr/pl/articles/3370942-liczba-zwolnien-zgloszonych-do-zwrotu.md): Liczba zwolnień zgłoszonych do zwrotu - [Liczba zwolnień nie przedstawionych do zwrotu](https://success.openhealth.fr/pl/articles/3370920-liczba-zwolnien-nie-przedstawionych-do-zwrotu.md): Liczba zwolnień zgłoszonych do zwrotu - [Wartość sprzedaży podlegającej refundacji objętej obowiązkowym ubezpieczeniem zdrowotnym](https://success.openhealth.fr/pl/articles/3371699-wartosc-sprzedazy-podlegajacej-refundacji-objetej-obowiazkowym-ubezpieczeniem-zdrowotnym.md): Sprzedaż odkupionych wartości - [Sprzedaż wartości refundowanych objętych dodatkowym ubezpieczeniem zdrowotnym](https://success.openhealth.fr/pl/articles/3371830-sprzedaz-wartosci-refundowanych-objetych-dodatkowym-ubezpieczeniem-zdrowotnym.md): Sprzedaż odkupionych wartości - [Sprzedaż wybitnych wartości](https://success.openhealth.fr/pl/articles/3371842-sprzedaz-wybitnych-wartosci.md): Sprzedaż wybitnych wartości - [Rozpowszechnienie](https://success.openhealth.fr/pl/articles/3947955-rozpowszechnienie.md): Wskaźnik rozpowszechnienia - [Średnia liczba numerów GTIN na zwolnienie](https://success.openhealth.fr/pl/articles/3396154-srednia-liczba-numerow-gtin-na-zwolnienie.md): Średnia liczba numerów GTIN na zwolnienie - [Średnia objętość na dozowanie](https://success.openhealth.fr/pl/articles/3396196-srednia-objetosc-na-dozowanie.md): Średnia objętość na dozowanie - [Średni obrót na zwolnienie](https://success.openhealth.fr/pl/articles/3396208-sredni-obrot-na-zwolnienie.md): Średni obrót na zwolnienie - [Dawka substancji czynnej w pudełku](https://success.openhealth.fr/pl/articles/3675409-dawka-substancji-czynnej-w-pudelku.md): Dawka substancji czynnej w pudełku - [DDD za pudełko](https://success.openhealth.fr/pl/articles/3675446-ddd-za-pudelko.md): Określ dawkę dzienną w pudełku - [Objętość w jednostkach podstawowych](https://success.openhealth.fr/pl/articles/3675520-objetosc-w-jednostkach-podstawowych.md): Objętość w jednostkach podstawowych - [Objętość w zasadzie aktywnej](https://success.openhealth.fr/pl/articles/3675539-objetosc-w-zasadzie-aktywnej.md): Objętość w zasadzie aktywnej - [DDJ na 1000 mieszkańców](https://success.openhealth.fr/pl/articles/3675667-ddj-na-1000-mieszkancow.md): Ustalona dzienna dawka na 1000 mieszkańców - [Wielkość w średniej jednostkowej jednostce chorobowej na osobę ubezpieczoną](https://success.openhealth.fr/pl/articles/3675761-wielkosc-w-sredniej-jednostkowej-jednostce-chorobowej-na-osobe-ubezpieczona.md): Wielkość w średnich jednostkach konsumenckich przypadających na ubezpieczonego - [Wielkość średniego UB na ubezpieczonego](https://success.openhealth.fr/pl/articles/3675814-wielkosc-sredniego-ub-na-ubezpieczonego.md): Wielkość w średnich jednostkach podstawowych na osobę ubezpieczoną - [Średnia wielkość aktywności na osobę ubezpieczoną](https://success.openhealth.fr/pl/articles/3675824-srednia-wielkosc-aktywnosci-na-osobe-ubezpieczona.md): Średnia wielkość aktywności na osobę ubezpieczoną - [Obserwowany średni czas trwania leczenia](https://success.openhealth.fr/pl/articles/3675841-obserwowany-sredni-czas-trwania-leczenia.md): Obserwowany średni czas trwania leczenia - [Zakres szczepień](https://success.openhealth.fr/pl/articles/3822264-zakres-szczepien.md): Zakres szczepień - [Włączono pacjentów](https://success.openhealth.fr/pl/articles/3886665-wlaczono-pacjentow.md): Liczba pacjentów włączonych do kohorty - [Różnice między MPR i PDC](https://success.openhealth.fr/pl/articles/3722666-roznice-miedzy-mpr-i-pdc.md): MPR \(wskaźnik posiadanych leków\) vs. PDC \(odsetek dni objętych programem\) - [Średni czas trwania leczenia](https://success.openhealth.fr/pl/articles/3920967-sredni-czas-trwania-leczenia.md): Zmierz średni czas leczenia pod koniec okresu analizy - [Średni czas odnowienia](https://success.openhealth.fr/pl/articles/3921067-sredni-czas-odnowienia.md): Zmierz średni czas między wznowieniami leczenia - [Rozpoczęcie leczenia](https://success.openhealth.fr/pl/articles/3848844-rozpoczecie-leczenia.md): Rozpoczęcie leczenia - [Wznowienie leczenia](https://success.openhealth.fr/pl/articles/3885469-wznowienie-leczenia.md): Odnowienie leczenia - [Leczenie zostaje wznowione](https://success.openhealth.fr/pl/articles/3885608-leczenie-zostaje-wznowione.md): Wznowienie leczenia - [Nowe zabiegi](https://success.openhealth.fr/pl/articles/3885297-nowe-zabiegi.md): Rozpoczęcie i wznowienie leczenia - [Zmiana leczenia](https://success.openhealth.fr/pl/articles/3848886-zmiana-leczenia.md): Zmiana leczenia - [Leczenie ustaje](https://success.openhealth.fr/pl/articles/3885426-leczenie-ustaje.md): Leczenie ustaje - [Oddać](https://success.openhealth.fr/pl/articles/3885387-oddac.md): Oddać - [Wstawka identyfikacyjna](https://success.openhealth.fr/pl/articles/4355163-wstawka-identyfikacyjna.md): Identyfikowalność - [Zatrzymany i ponownie uruchomiony](https://success.openhealth.fr/pl/articles/8429189-zatrzymany-i-ponownie-uruchomiony.md) - [Wydanie udziału](https://success.openhealth.fr/pl/articles/3624820-wydanie-udzialu.md): Wydanie udziału - [Monitorowanie odpowiednich zwolnień](https://success.openhealth.fr/pl/articles/3804193-monitorowanie-odpowiednich-zwolnien.md): Śledź ewolucję ruchu w aptekach odpowiednich aptek - [Szybkość rozpadu](https://success.openhealth.fr/pl/articles/4850138-szybkosc-rozpadu.md) - [Kinetyka reakcji](https://success.openhealth.fr/pl/articles/4850629-kinetyka-reakcji.md) - [Czas połowicznego rozpadu](https://success.openhealth.fr/pl/articles/4849710-czas-polowicznego-rozpadu.md) - [Wskaźnik pokrycia zapasów](https://success.openhealth.fr/pl/articles/4210714-wskaznik-pokrycia-zapasow.md): Wskaźnik pokrycia zapasów - [Okresy czasu](https://success.openhealth.fr/pl/articles/3194479-okresy-czasu.md): Okresy czasu - [Zmień definicję roku podatkowego](https://success.openhealth.fr/pl/articles/3321750-zmien-definicje-roku-podatkowego.md): HUB pozwala ustawić lata podatkowe - [Zarządzanie cotygodniowymi porównaniami](https://success.openhealth.fr/pl/articles/3835180-zarzadzanie-cotygodniowymi-porownaniami.md): Analityczne skutki badanych dni - [Kalendarz parafarmacji GSA \(SMKT\)](https://success.openhealth.fr/pl/articles/3175583-kalendarz-parafarmacji-gsa-smkt.md): Kalendarz SMKT \(IRI\) jest również nazywany kalendarzem drogeryjnym GSA - [NIE](https://success.openhealth.fr/pl/articles/3194484-nie.md): Definicja miary „N” - [N Evol](https://success.openhealth.fr/pl/articles/3194461-n-evol.md): Definicja i wzór obliczeniowy miary „N Evol” - [N Trend](https://success.openhealth.fr/pl/articles/3194485-n-trend.md): Definicja miary „N Trend” ### IAS - Indicateurs Avancés Sanitaires - [MSR\(r\) Alergia](https://success.openhealth.fr/pl/articles/7339151-msr-r-alergia.md) - [MSR\(r\) Poux](https://success.openhealth.fr/pl/articles/7339168-msr-r-poux.md) - [Zapalenie żołądka i jelit IAS\(r\)](https://success.openhealth.fr/pl/articles/7339181-zapalenie-zoladka-i-jelit-ias-r.md) - [IAS\(r\) Choroba grypopodobna](https://success.openhealth.fr/pl/articles/7266711-ias-r-choroba-grypopodobna.md) ### Marketing Direct - [OpenHealth Emailing Solution](https://success.openhealth.fr/pl/articles/7055261-openhealth-emailing-solution.md) - [Wymagania dotyczące produkcji kampanii e-mailowej](https://success.openhealth.fr/pl/articles/6282113-wymagania-dotyczace-produkcji-kampanii-e-mailowej.md) - [Sprawozdanie z monitorowania i punkty odniesienia](https://success.openhealth.fr/pl/articles/6302721-sprawozdanie-z-monitorowania-i-punkty-odniesienia.md) - [Słowniczek do kampanii e-mailowych](https://success.openhealth.fr/pl/articles/6282099-slowniczek-do-kampanii-e-mailowych.md) ### PSAD - [Analiza - KRAJOWA](https://success.openhealth.fr/pl/articles/3376262-analiza-krajowa.md): Analiza wyników rynku Świadczeń dla Domów Opieki Zdrowotnej \(PSAD\): według obszaru, działalności, podkategorii, segmentu, ustawy LPP - [Wolumen / Obrót - KRAJOWY](https://success.openhealth.fr/pl/articles/3376287-wolumen-obrot-krajowy.md): Jednocześnie wizualizuj aktywność pod względem wielkości i wartości: według obszaru, działania, poddziałania, segmentu ... - [Ewolucja - KRAJOWA](https://success.openhealth.fr/pl/articles/3376370-ewolucja-krajowa.md): Wizualizuj ewolucję rynku na dostępnej historii: według obszaru, działalności, poddziałalności, segmentu, ustawy LPP - [Wydobycie - KRAJOWE](https://success.openhealth.fr/pl/articles/3376420-wydobycie-krajowe.md): Eksportuj dane do programu Excel - [Definicja](https://success.openhealth.fr/pl/articles/3376439-definicja.md): Znajdź wszystkie cechy Obserwatorium Narodowego SantéDomStat - niezbędna aplikacja ### AUTRES THEMATIQUES - [INTERCOM](https://success.openhealth.fr/pl/articles/6959415-intercom.md) - [Salesforce](https://success.openhealth.fr/pl/articles/6959337-salesforce.md) - [GIHSN: prześlij plik Excel](https://success.openhealth.fr/pl/articles/3977478-gihsn-przeslij-plik-excel.md): Plik GIHSN Excel - [Blockchain](https://success.openhealth.fr/pl/articles/5385413-blockchain.md) - [DocuSign, narzędzie CRM w naszym procesie biznesowym](https://success.openhealth.fr/pl/articles/4514472-docusign-narzedzie-crm-w-naszym-procesie-biznesowym.md): Docusign: narzędzie CRM w naszym procesie biznesowym - [Krajowe śledzenie szczepień](https://success.openhealth.fr/pl/articles/4754333-krajowe-sledzenie-szczepien.md) - [Zakres szczepień](https://success.openhealth.fr/pl/articles/4754311-zakres-szczepien.md) - [Monitorowanie KPI](https://success.openhealth.fr/pl/articles/4091042-monitorowanie-kpi.md): POC ProPharma Systems: szwajcarskie trendy rynkowe - [Kokpit apteki](https://success.openhealth.fr/pl/articles/4091025-kokpit-apteki.md): Systemy POC ProPharma: Moja apteka a Szwajcaria - [Równoważna liczba ludności \(RLM\)](https://success.openhealth.fr/pl/articles/5431894-rownowazna-liczba-ludnosci-rlm.md) - [Zapotrzebowanie na tlen](https://success.openhealth.fr/pl/articles/5137158-zapotrzebowanie-na-tlen.md) - [IHU](https://success.openhealth.fr/pl/articles/4851687-ihu.md) - [Substancja zawieszona](https://success.openhealth.fr/pl/articles/5137147-substancja-zawieszona.md) - [Chemia ścieków](https://success.openhealth.fr/pl/articles/5137101-chemia-sciekow.md) - [NRBCE](https://success.openhealth.fr/pl/articles/4851683-nrbce.md) - [Prawo Arrheniusa](https://success.openhealth.fr/pl/articles/4849672-prawo-arrheniusa.md) - [Wynikająca z tego wydajność](https://success.openhealth.fr/pl/articles/5137034-wynikajaca-z-tego-wydajnosc.md) - [Rodzaje ścieków](https://success.openhealth.fr/pl/articles/5137183-rodzaje-sciekow.md) - [Stężenie wirusa SARS-CoV-2](https://success.openhealth.fr/pl/articles/4867968-stezenie-wirusa-sars-cov-2.md) - [MAPOM / BMPM](https://success.openhealth.fr/pl/articles/4851685-mapom-bmpm.md) - [Kontekstowe stężenie SARS-CoV-2](https://success.openhealth.fr/pl/articles/4934604-kontekstowe-stezenie-sars-cov-2.md) - [Rodzaj systemu kanalizacji](https://success.openhealth.fr/pl/articles/4867954-rodzaj-systemu-kanalizacji.md) - [Degradacja wirusa](https://success.openhealth.fr/pl/articles/4865742-degradacja-wirusa.md) - [WBE](https://success.openhealth.fr/pl/articles/4865735-wbe.md) - [RNA](https://success.openhealth.fr/pl/articles/4865733-rna.md) - [Koronawirus](https://success.openhealth.fr/pl/articles/4865728-koronawirus.md) - [COVID-19](https://success.openhealth.fr/pl/articles/4865726-covid-19.md) - [Seroprewalencja: metoda pobierania próbek](https://success.openhealth.fr/pl/articles/3924493-seroprewalencja-metoda-pobierania-probek.md): Seroprewalencja: metoda pobierania próbek - [Składowisko SANDRE](https://success.openhealth.fr/pl/articles/5415040-skladowisko-sandre.md) - [Baza krajowa ROSEAU](https://success.openhealth.fr/pl/articles/5414523-baza-krajowa-roseau.md) - [Stężenie wirusa SARS-CoV-2](https://success.openhealth.fr/pl/articles/4852404-stezenie-wirusa-sars-cov-2.md) - [Stężenie wirusa SARS-CoV-2 - warianty](https://success.openhealth.fr/pl/articles/4909854-stezenie-wirusa-sars-cov-2-warianty.md) - [Marsylia - Globalny monitoring](https://success.openhealth.fr/pl/articles/4859311-marsylia-globalny-monitoring.md) - [Stężenie wirusa SARS-CoV-2 - Nicea](https://success.openhealth.fr/pl/articles/4879292-stezenie-wirusa-sars-cov-2-nicea.md) - [Ludność - struktura](https://success.openhealth.fr/pl/articles/4842408-ludnosc-struktura.md) - [Stężenie wirusa SARS-CoV-2 - Tulon \(FRANCJA\)](https://success.openhealth.fr/pl/articles/4886417-stezenie-wirusa-sars-cov-2-tulon-francja.md) - [Dubaj - kontrola ścieków z lotniska](https://success.openhealth.fr/pl/articles/5276423-dubaj-kontrola-sciekow-z-lotniska.md) - [Nadzór nad SARS-CoV-2 - OBEPINA](https://success.openhealth.fr/pl/articles/5210661-nadzor-nad-sars-cov-2-obepina.md) - [Kontekstowe stężenie SARS-CoV-2](https://success.openhealth.fr/pl/articles/4934608-kontekstowe-stezenie-sars-cov-2.md) - [SUEZ - bilans analityczny](https://success.openhealth.fr/pl/articles/5140509-suez-bilans-analityczny.md) - [Palais des festivals - Watch T0](https://success.openhealth.fr/pl/articles/5373515-palais-des-festivals-watch-t0.md) - [Palais des festivals - Codzienne czuwanie](https://success.openhealth.fr/pl/articles/5373231-palais-des-festivals-codzienne-czuwanie.md) - [Palais des festivals - Pokaz](https://success.openhealth.fr/pl/articles/5404778-palais-des-festivals-pokaz.md) - [Mustelidy - Obserwuj](https://success.openhealth.fr/pl/articles/5169577-mustelidy-obserwuj.md) - [Ludność - IRIS](https://success.openhealth.fr/pl/articles/4842191-ludnosc-iris.md) - [SARS-CoV-2](https://success.openhealth.fr/pl/articles/4865699-sars-cov-2.md) - [MSR - analiza](https://success.openhealth.fr/pl/articles/4842430-msr-analiza.md) - [Stężenie wirusa SARS-CoV-2 - SEM](https://success.openhealth.fr/pl/articles/5415600-stezenie-wirusa-sars-cov-2-sem.md) - [Wizualizacja mapy](https://success.openhealth.fr/pl/articles/3864657-wizualizacja-mapy.md): Podział geograficzny pacjentów - [Witryna kontrybucji](https://success.openhealth.fr/pl/articles/3864668-witryna-kontrybucji.md): Wkład ze strony ośrodka i szpitala - [Profil kohorty według witryny](https://success.openhealth.fr/pl/articles/3864672-profil-kohorty-wedlug-witryny.md): Profil kohorty według ośrodka i szpitala - [Profil kohorty według sezonu](https://success.openhealth.fr/pl/articles/3864673-profil-kohorty-wedlug-sezonu.md): Profil kohorty według sezonu - [Rozkład wieku i płci](https://success.openhealth.fr/pl/articles/3864675-rozklad-wieku-i-plci.md): Demografia - [Dystrybucja wirusów według witryn](https://success.openhealth.fr/pl/articles/3864678-dystrybucja-wirusow-wedlug-witryn.md): Dystrybucja wirusów według witryn - [Dystrybucja wirusa według wieku](https://success.openhealth.fr/pl/articles/3864677-dystrybucja-wirusa-wedlug-wieku.md): Dystrybucja wirusa według wieku - [Ewolucja dystrybucji wirusów](https://success.openhealth.fr/pl/articles/3864681-ewolucja-dystrybucji-wirusow.md): Ewolucja dystrybucji wirusów - [Szczepienie przeciwko grypie](https://success.openhealth.fr/pl/articles/3864697-szczepienie-przeciwko-grypie.md): Szczepienie przeciwko grypie - [Ewolucja szczepień przeciwko grypie](https://success.openhealth.fr/pl/articles/3864701-ewolucja-szczepien-przeciwko-grypie.md): Rozwój szczepień przeciwko grypie - [Rozkład pacjentów według stanu przewlekłego](https://success.openhealth.fr/pl/articles/3864676-rozklad-pacjentow-wedlug-stanu-przewleklego.md): Rozkład pacjentów według stanu przewlekłego - [Rozkład pacjentów według długości pobytu w szpitalu](https://success.openhealth.fr/pl/articles/3864794-rozklad-pacjentow-wedlug-dlugosci-pobytu-w-szpitalu.md): Rozkład pacjentów według długości pobytu w szpitalu - [Słabość](https://success.openhealth.fr/pl/articles/3864704-slabosc.md): Kruchość pacjentów - [Stan ważności](https://success.openhealth.fr/pl/articles/3864705-stan-waznosci.md): Stan ważności - [Śmiertelność](https://success.openhealth.fr/pl/articles/3864710-smiertelnosc.md): Śmiertelność - [GIHSN](https://success.openhealth.fr/pl/articles/3864712-gihsn.md): Globalna Sieć Nadzoru Szpitala Grypy - [CARéDIAB - Profil pacjenta](https://success.openhealth.fr/pl/articles/3789234-carediab-profil-pacjenta.md): Przeanalizuj profil pacjentów w populacji CARéDIAB - [CARéDIAB - powikłania](https://success.openhealth.fr/pl/articles/3789515-carediab-powiklania.md): Przeanalizuj rozpowszechnienie powikłań w naszej populacji CAREDIAB - [CARéDIAB - Globalne monitorowanie pacjenta](https://success.openhealth.fr/pl/articles/3792041-carediab-globalne-monitorowanie-pacjenta.md): Przeanalizuj częstotliwość obserwacji pacjentów w populacji CARéDIAB - [Sieć CARéDIAB](https://success.openhealth.fr/pl/articles/3789106-siec-carediab.md): Sieć CARéDIAB - [CARéDIAB - Zabiegi](https://success.openhealth.fr/pl/articles/3792143-carediab-zabiegi.md): Przeanalizuj przyjmowanie leków w kontekście cukrzycy ## Português ### Votre PLATEFORME - présentation générale - [O HUB, uma plataforma de apoio abrangente e contínuo](https://success.openhealth.fr/pt/articles/4799621-o-hub-uma-plataforma-de-apoio-abrangente-e-continuo.md) - [O seu nível de experiência O HUB](https://success.openhealth.fr/pt/articles/5712270-o-seu-nivel-de-experiencia-o-hub.md) - [Línguas](https://success.openhealth.fr/pt/articles/4649389-linguas.md) - [Perguntas sobre as nossas tarifas](https://success.openhealth.fr/pt/articles/3292143-perguntas-sobre-as-nossas-tarifas.md) ### O ROADMAP - ["Inovação aberta para os nossos clientes](https://success.openhealth.fr/pt/articles/5200970-inovacao-aberta-para-os-nossos-clientes.md) - [Apps + Área de administração versão 240515](https://success.openhealth.fr/pt/articles/9310541-apps-area-de-administracao-versao-240515.md) - [Apps + Área de administração versão 240415](https://success.openhealth.fr/pt/articles/9310710-apps-area-de-administracao-versao-240415.md) - [Apps + Área de administração versão 240315](https://success.openhealth.fr/pt/articles/9310790-apps-area-de-administracao-versao-240315.md) - [Apps + Área de administração versão 240215](https://success.openhealth.fr/pt/articles/9311007-apps-area-de-administracao-versao-240215.md) - [Plataforma - atualização 231215](https://success.openhealth.fr/pt/articles/8718485-plataforma-atualizacao-231215.md) - [Plataforma - atualização 231015](https://success.openhealth.fr/pt/articles/8479932-plataforma-atualizacao-231015.md) - [Apps + Portal versão 230915](https://success.openhealth.fr/pt/articles/8373640-apps-portal-versao-230915.md) - [Apps + Portal versão 230815](https://success.openhealth.fr/pt/articles/8267860-apps-portal-versao-230815.md) - [Novos produtos 230715](https://success.openhealth.fr/pt/articles/8115796-novos-produtos-230715.md) - [Apps + Portal versão 230615](https://success.openhealth.fr/pt/articles/8115791-apps-portal-versao-230615.md) - [Apps + Portal versão 230515](https://success.openhealth.fr/pt/articles/7895393-apps-portal-versao-230515.md) - [Apps + Portal versão 230415](https://success.openhealth.fr/pt/articles/7439447-apps-portal-versao-230415.md) - [Apps + Portal versão 230315](https://success.openhealth.fr/pt/articles/7439646-apps-portal-versao-230315.md) - [Apps + Portal versão 230215](https://success.openhealth.fr/pt/articles/7439744-apps-portal-versao-230215.md) - [Notícias de 15/01/2023](https://success.openhealth.fr/pt/articles/6895740-noticias-de-15-01-2023.md) - [HUB + GATE versão 221215](https://success.openhealth.fr/pt/articles/6827027-hub-gate-versao-221215.md) - [HUB + GATE versão 221115](https://success.openhealth.fr/pt/articles/6742628-hub-gate-versao-221115.md) - [HUB + GATE versão 220915](https://success.openhealth.fr/pt/articles/6558070-hub-gate-versao-220915.md) - [HUB + GATE versão 220815](https://success.openhealth.fr/pt/articles/6475311-hub-gate-versao-220815.md) - [HUB + GATE versão 220615](https://success.openhealth.fr/pt/articles/6306090-hub-gate-versao-220615.md) - [HUB + GATE versão 220515](https://success.openhealth.fr/pt/articles/6201877-hub-gate-versao-220515.md) - [HUB + GATE versão 220415](https://success.openhealth.fr/pt/articles/6087747-hub-gate-versao-220415.md) - [HUB SMA versão 220315](https://success.openhealth.fr/pt/articles/6043772-hub-sma-versao-220315.md) - [HUB TMA versão 220315](https://success.openhealth.fr/pt/articles/6043802-hub-tma-versao-220315.md) - [HUB UAN versão 220315](https://success.openhealth.fr/pt/articles/6043852-hub-uan-versao-220315.md) - [GATE versão 220215](https://success.openhealth.fr/pt/articles/5940805-gate-versao-220215.md) - [HUB SMA versão 220215](https://success.openhealth.fr/pt/articles/5940753-hub-sma-versao-220215.md) - [HUB TMA versão 220215](https://success.openhealth.fr/pt/articles/5947859-hub-tma-versao-220215.md) - [GATE versão 211215](https://success.openhealth.fr/pt/articles/5819397-gate-versao-211215.md) - [HUB SMA versão 211215](https://success.openhealth.fr/pt/articles/5784709-hub-sma-versao-211215.md) - [HUB TMA versão 211215](https://success.openhealth.fr/pt/articles/5784888-hub-tma-versao-211215.md) - [HUB UAN versão 211215](https://success.openhealth.fr/pt/articles/5784904-hub-uan-versao-211215.md) - [Aplicação O HUB: "O estado da farmácia".](https://success.openhealth.fr/pt/articles/5704485-aplicacao-o-hub-o-estado-da-farmacia.md) - [GATE versão 211115](https://success.openhealth.fr/pt/articles/5697844-gate-versao-211115.md) - [HUB SMA versão 211115](https://success.openhealth.fr/pt/articles/5671893-hub-sma-versao-211115.md) - [HUB TMA versão 211115](https://success.openhealth.fr/pt/articles/5671917-hub-tma-versao-211115.md) - [HUB UAN versão 211115](https://success.openhealth.fr/pt/articles/5671927-hub-uan-versao-211115.md) - [GATE versão 211015](https://success.openhealth.fr/pt/articles/5652210-gate-versao-211015.md) - [HUB SMA versão 211015](https://success.openhealth.fr/pt/articles/5649822-hub-sma-versao-211015.md) - [HUB TMA versão 211015](https://success.openhealth.fr/pt/articles/5650073-hub-tma-versao-211015.md) - [HUB UAN versão 211015](https://success.openhealth.fr/pt/articles/5652242-hub-uan-versao-211015.md) - [HUB SMA versão 210915](https://success.openhealth.fr/pt/articles/5370516-hub-sma-versao-210915.md) - [HUB TMA versão 210915](https://success.openhealth.fr/pt/articles/5390983-hub-tma-versao-210915.md) - [HUB UAN versão 210915](https://success.openhealth.fr/pt/articles/5543213-hub-uan-versao-210915.md) ### Votre ESPACE D'ADMINISTRATION - fonctionnalités - [Repor/Modificar a sua palavra-passe O HUB](https://success.openhealth.fr/pt/articles/4425325-repor-modificar-a-sua-palavra-passe-o-hub.md) - [Assistência de ligação: estou a receber uma mensagem de erro](https://success.openhealth.fr/pt/articles/5369783-assistencia-de-ligacao-estou-a-receber-uma-mensagem-de-erro.md) - [Criar e localizar um bilhete](https://success.openhealth.fr/pt/articles/3586214-criar-e-localizar-um-bilhete.md) - [Criar e modificar um artigo de SUCESSO](https://success.openhealth.fr/pt/articles/6738705-criar-e-modificar-um-artigo-de-sucesso.md) - [Os meus contratos](https://success.openhealth.fr/pt/articles/5712273-os-meus-contratos.md) - [Serviço de Saúde](https://success.openhealth.fr/pt/articles/4990600-servico-de-saude.md) - [Os meus acessos](https://success.openhealth.fr/pt/articles/5783418-os-meus-acessos.md) - [Configurar a minha página inicial](https://success.openhealth.fr/pt/articles/5712229-configurar-a-minha-pagina-inicial.md) - [Como modificar o seu mercado a partir do seu espaço pessoal OpenHealth?](https://success.openhealth.fr/pt/articles/3585971-como-modificar-o-seu-mercado-a-partir-do-seu-espaco-pessoal-openhealth.md) - [Mudança Automática de Atribuição de Modalidade \(MAM auto\)](https://success.openhealth.fr/pt/articles/4164818-mudanca-automatica-de-atribuicao-de-modalidade-mam-auto.md) - [TEMPORÁRIO MAM: Como se segue uma marca que muda de nome de laboratório/marca/marca?](https://success.openhealth.fr/pt/articles/4131072-temporario-mam-como-se-segue-uma-marca-que-muda-de-nome-de-laboratorio-marca-marca.md) - [Integração de produtos \(RPI\)](https://success.openhealth.fr/pt/articles/4164932-integracao-de-produtos-rpi.md) - [Remoção de produtos \(SPR\)](https://success.openhealth.fr/pt/articles/4164866-remocao-de-produtos-spr.md) - [Reativação automática de produtos \(RPR auto\)](https://success.openhealth.fr/pt/articles/4818161-reativacao-automatica-de-produtos-rpr-auto.md) - [Criação de novos produtos](https://success.openhealth.fr/pt/articles/5811248-criacao-de-novos-produtos.md) - [Adicionar um mercado](https://success.openhealth.fr/pt/articles/5712283-adicionar-um-mercado.md) - [Importação / Exportação de produtos a granel](https://success.openhealth.fr/pt/articles/5712257-importacao-exportacao-de-produtos-a-granel.md) - [Mudança de Modalidade Tipológica \(CMT\)](https://success.openhealth.fr/pt/articles/4670174-mudanca-de-modalidade-tipologica-cmt.md) - [Os diferentes estados de utilizador](https://success.openhealth.fr/pt/articles/3436418-os-diferentes-estados-de-utilizador.md) - [Criar uma conta para um utilizador de uma organização terceira \(TPAA\)](https://success.openhealth.fr/pt/articles/6466550-criar-uma-conta-para-um-utilizador-de-uma-organizacao-terceira-tpaa.md) - [Como posso criar, modificar ou apagar uma conta de utilizador no HUB?](https://success.openhealth.fr/pt/articles/3785138-como-posso-criar-modificar-ou-apagar-uma-conta-de-utilizador-no-hub.md) - [Posso criar direitos de visualização diferenciados para o HUB dentro das minhas equipas?](https://success.openhealth.fr/pt/articles/3321731-posso-criar-direitos-de-visualizacao-diferenciados-para-o-hub-dentro-das-minhas-equipas.md) - [Diário de actividades](https://success.openhealth.fr/pt/articles/4687438-diario-de-actividades.md) ### Vos APPLICATIONS - présentation - [O guia de formação HUB](https://success.openhealth.fr/pt/articles/5634967-o-guia-de-formacao-hub.md) - [Seleccionador drop-down de ordenação](https://success.openhealth.fr/pt/articles/5792113-seleccionador-drop-down-de-ordenacao.md) - [Data de actualização para farmácias e parafarmácias GSA \(SMKT\)](https://success.openhealth.fr/pt/articles/3175557-data-de-actualizacao-para-farmacias-e-parafarmacias-gsa-smkt.md) - [Pré-requisitos Ficheiro de correspondência de farmácias](https://success.openhealth.fr/pt/articles/3678146-pre-requisitos-ficheiro-de-correspondencia-de-farmacias.md) - [Selector "On and Off Prescription" de "On and Off Prescription](https://success.openhealth.fr/pt/articles/3729668-selector-on-and-off-prescription-de-on-and-off-prescription.md) - [Questão de dados: como proceder](https://success.openhealth.fr/pt/articles/4374497-questao-de-dados-como-proceder.md) - [Como se qualificam os novos produtos no HUB?](https://success.openhealth.fr/pt/articles/3376100-como-se-qualificam-os-novos-produtos-no-hub.md) - [Como posso criar, editar e partilhar um favorito no HUB?](https://success.openhealth.fr/pt/articles/3175689-como-posso-criar-editar-e-partilhar-um-favorito-no-hub.md) - [Como selecciono os produtos no HUB por data de lançamento?](https://success.openhealth.fr/pt/articles/3158428-como-selecciono-os-produtos-no-hub-por-data-de-lancamento.md) - [Posso extrair os dados do HUB em formato ".csv"?](https://success.openhealth.fr/pt/articles/5671278-posso-extrair-os-dados-do-hub-em-formato-csv.md) - [Tempo de resposta ODT](https://success.openhealth.fr/pt/articles/6632310-tempo-de-resposta-odt.md) - [Boas práticas de lançamento no HUB](https://success.openhealth.fr/pt/articles/3124454-boas-praticas-de-lancamento-no-hub.md) - [Requisitos técnicos](https://success.openhealth.fr/pt/articles/5369918-requisitos-tecnicos.md) - [Esvazie a cache do seu navegador](https://success.openhealth.fr/pt/articles/4219722-esvazie-a-cache-do-seu-navegador.md) - [Como posso definir o Google Chrome como o meu navegador predefinido?](https://success.openhealth.fr/pt/articles/3738717-como-posso-definir-o-google-chrome-como-o-meu-navegador-predefinido.md) - [A barra de navegação não é visível nas tabelas](https://success.openhealth.fr/pt/articles/3195250-a-barra-de-navegacao-nao-e-visivel-nas-tabelas.md) - [A exibição de botões ou objectos numa folha é parcialmente cortada ou não visível](https://success.openhealth.fr/pt/articles/3195245-a-exibicao-de-botoes-ou-objectos-numa-folha-e-parcialmente-cortada-ou-nao-visivel.md) - [O meu cartão de Gestão do Território não carrega e a mensagem "loading" aparece](https://success.openhealth.fr/pt/articles/3195239-o-meu-cartao-de-gestao-do-territorio-nao-carrega-e-a-mensagem-loading-aparece.md) - [De onde vem a mensagem de erro "Não está autorizado a aceder a esta página"?](https://success.openhealth.fr/pt/articles/3195338-de-onde-vem-a-mensagem-de-erro-nao-esta-autorizado-a-aceder-a-esta-pagina.md) - [Estou a receber uma mensagem de erro "Ligação perdida"](https://success.openhealth.fr/pt/articles/4445141-estou-a-receber-uma-mensagem-de-erro-ligacao-perdida.md) - ["Bad Gateway](https://success.openhealth.fr/pt/articles/4514555-bad-gateway.md) - [Mensagem de erro: "Ocorreu um erro".](https://success.openhealth.fr/pt/articles/3195286-mensagem-de-erro-ocorreu-um-erro.md) - [Os selectores de dimensões e medidas já não são apresentados nas consultas "Multiple Period Analysis" e "My Data Archive", a extracção da tabela em "Market Analysis" é parcial](https://success.openhealth.fr/pt/articles/3195377-os-selectores-de-dimensoes-e-medidas-ja-nao-sao-apresentados-nas-consultas-multiple-period-analysis-e-my-data-archive-a-extraccao-da-tabela-em-market-analysis-e-parcial.md) - [Como ver um termo no HUB?](https://success.openhealth.fr/pt/articles/3194377-como-ver-um-termo-no-hub.md) - [Especificações e limitações do Excel](https://success.openhealth.fr/pt/articles/3753088-especificacoes-e-limitacoes-do-excel.md) - [Como criar, editar e partilhar um Favorito nas suas aplicações?](https://success.openhealth.fr/pt/articles/10502803-como-criar-editar-e-partilhar-um-favorito-nas-suas-aplicacoes.md) - [Painel de consumidores de enquadramento](https://success.openhealth.fr/pt/articles/3455845-painel-de-consumidores-de-enquadramento.md) - [Análise do mercado das farmácias de enquadramento](https://success.openhealth.fr/pt/articles/3455857-analise-do-mercado-das-farmacias-de-enquadramento.md) ### FONTES DE DADOS - [O que é o painel da farmácia OpenHealth?](https://success.openhealth.fr/pt/articles/3304106-o-que-e-o-painel-da-farmacia-openhealth.md) - [A rede de farmácias, um trunfo decisivo na gestão das crises sanitárias actuais e futuras](https://success.openhealth.fr/pt/articles/3825648-a-rede-de-farmacias-um-trunfo-decisivo-na-gestao-das-crises-sanitarias-actuais-e-futuras.md) - [Que territórios DROM COM podem ser visualizados no HUB?](https://success.openhealth.fr/pt/articles/3194382-que-territorios-drom-com-podem-ser-visualizados-no-hub.md) - [Ficheiro de sector de pré-requisitos](https://success.openhealth.fr/pt/articles/3702701-ficheiro-de-sector-de-pre-requisitos.md) - [Fonte de dados IRI França Parafarmácias \(SMKT\) / Retalhistas](https://success.openhealth.fr/pt/articles/4485357-fonte-de-dados-iri-franca-parafarmacias-smkt-retalhistas.md) - [Regras de codificação para produtos parafarmacêuticos da GSA \(SMKT\) no IRI](https://success.openhealth.fr/pt/articles/3524492-regras-de-codificacao-para-produtos-parafarmaceuticos-da-gsa-smkt-no-iri.md) - [Dados da ORGANIC STORE - Fonte BIOANALYTICS](https://success.openhealth.fr/pt/articles/5631260-dados-da-organic-store-fonte-bioanalytics.md) - [Parafarmácias electrónicas: plataformas de controlo](https://success.openhealth.fr/pt/articles/9167006-parafarmacias-electronicas-plataformas-de-controlo.md) - [E-pharmacies Ganhos e Perdas de Produtos](https://success.openhealth.fr/pt/articles/3568773-e-pharmacies-ganhos-e-perdas-de-produtos.md) - [Perfil do consumidor](https://success.openhealth.fr/pt/articles/3711085-perfil-do-consumidor.md) - [Dados AMAZON - Fonte SELLINGZ](https://success.openhealth.fr/pt/articles/5669013-dados-amazon-fonte-sellingz.md) - [Dados do comércio eletrónico - Fonte WISER](https://success.openhealth.fr/pt/articles/7983010-dados-do-comercio-eletronico-fonte-wiser.md) - [Territórios geográficos](https://success.openhealth.fr/pt/articles/4661582-territorios-geograficos.md) - [O que é o painel de farmácia na Alemanha? INSIGHTHEALTH](https://success.openhealth.fr/pt/articles/5391412-o-que-e-o-painel-de-farmacia-na-alemanha-insighthealth.md) - [O que é o painel de farmácia na Grécia? ALIRAHEALTH](https://success.openhealth.fr/pt/articles/6863963-o-que-e-o-painel-de-farmacia-na-grecia-alirahealth.md) - [O que é o painel de farmácia na Áustria? INSIGHTHEALTH](https://success.openhealth.fr/pt/articles/6863949-o-que-e-o-painel-de-farmacia-na-austria-insighthealth.md) - [O que é o Painel de Farmácia em África? PIEX - África](https://success.openhealth.fr/pt/articles/6686633-o-que-e-o-painel-de-farmacia-em-africa-piex-africa.md) - [O que é o painel de farmácias online na Alemanha? DATAMEDIQ](https://success.openhealth.fr/pt/articles/5689640-o-que-e-o-painel-de-farmacias-online-na-alemanha-datamediq.md) - [O que é o painel de farmácia na Bélgica? REDPHARMA](https://success.openhealth.fr/pt/articles/4689894-o-que-e-o-painel-de-farmacia-na-belgica-redpharma.md) - [O que é o painel da farmácia em Espanha? - HMR](https://success.openhealth.fr/pt/articles/5391363-o-que-e-o-painel-da-farmacia-em-espanha-hmr.md) - [O que é o painel da farmácia em Espanha? - INFONIS](https://success.openhealth.fr/pt/articles/5428915-o-que-e-o-painel-da-farmacia-em-espanha-infonis.md) - [O que é o painel da farmácia em Portugal? - HMR](https://success.openhealth.fr/pt/articles/5391477-o-que-e-o-painel-da-farmacia-em-portugal-hmr.md) - [O que é o painel de farmácia na Rússia? - ALPHARM](https://success.openhealth.fr/pt/articles/5701531-o-que-e-o-painel-de-farmacia-na-russia-alpharm.md) - [O que é o painel de farmácia na Polónia? Pex Pharma](https://success.openhealth.fr/pt/articles/5969485-o-que-e-o-painel-de-farmacia-na-polonia-pex-pharma.md) - [O que é o painel da farmácia no Benim? COMO PHARM - ASFALTO BENIM](https://success.openhealth.fr/pt/articles/4238167-o-que-e-o-painel-da-farmacia-no-benim-como-pharm-asfalto-benim.md) - [CONVERT GROUP](https://success.openhealth.fr/pt/articles/6961966-convert-group.md) - [Qual é o painel de farmácias na Jordânia?](https://success.openhealth.fr/pt/articles/8176750-qual-e-o-painel-de-farmacias-na-jordania.md) - [População - Cartografia](https://success.openhealth.fr/pt/articles/3807695-populacao-cartografia.md) - [AMELI - LPP](https://success.openhealth.fr/pt/articles/6962021-ameli-lpp.md) - [População - Evolução por IDADE & GÊNERO](https://success.openhealth.fr/pt/articles/3810789-populacao-evolucao-por-idade-genero.md) - [População - Comparação por IDADE & GÊNERO](https://success.openhealth.fr/pt/articles/3836795-populacao-comparacao-por-idade-genero.md) - [EGYPT - Cartografia](https://success.openhealth.fr/pt/articles/3714611-egypt-cartografia.md) - [EGYPT - Análise por IDADE & GÊNERO](https://success.openhealth.fr/pt/articles/3714673-egypt-analise-por-idade-genero.md) - [UGANDA - Análise por IDADE & GÊNERO](https://success.openhealth.fr/pt/articles/3713884-uganda-analise-por-idade-genero.md) - [População - Análise por IDADE & GÊNERO](https://success.openhealth.fr/pt/articles/3807673-populacao-analise-por-idade-genero.md) - [Medicabase - base de dados de medicamentos](https://success.openhealth.fr/pt/articles/6518920-medicabase-base-de-dados-de-medicamentos.md) - [Nascimento](https://success.openhealth.fr/pt/articles/6340025-nascimento.md) - [OpenEudra](https://success.openhealth.fr/pt/articles/6518977-openeudra.md) - [Avaria IRIS](https://success.openhealth.fr/pt/articles/6383829-avaria-iris.md) - [ADICAP](https://success.openhealth.fr/pt/articles/6959465-adicap.md) - [NEC](https://success.openhealth.fr/pt/articles/6519012-nec.md) - [Dados sobre a população mundial](https://success.openhealth.fr/pt/articles/8217421-dados-sobre-a-populacao-mundial.md) - [INSEE: Ficheiros de pessoas falecidas](https://success.openhealth.fr/pt/articles/4498126-insee-ficheiros-de-pessoas-falecidas.md) - [Dados VAERS- VAERSDATA- Fonte CDC](https://success.openhealth.fr/pt/articles/6226665-dados-vaers-vaersdata-fonte-cdc.md) - [Dados VAERS - VAERSVAX - Fonte CDC](https://success.openhealth.fr/pt/articles/6226440-dados-vaers-vaersvax-fonte-cdc.md) - [Dados VAERS - VAERSSYMPTOMS - Fonte CDC](https://success.openhealth.fr/pt/articles/6219415-dados-vaers-vaerssymptoms-fonte-cdc.md) - [Integre os seus dados no Hub em menos de 2 semanas](https://success.openhealth.fr/pt/articles/5259828-integre-os-seus-dados-no-hub-em-menos-de-2-semanas.md) - [Modelo Internacional de Dados](https://success.openhealth.fr/pt/articles/4684696-modelo-internacional-de-dados.md) - [Como é que nos envia os seus dados via FTPS ou SFTP?](https://success.openhealth.fr/pt/articles/4143451-como-e-que-nos-envia-os-seus-dados-via-ftps-ou-sftp.md) - [De que informações precisa o OpenHealth para integrar uma nova fonte de dados?](https://success.openhealth.fr/pt/articles/3459148-de-que-informacoes-precisa-o-openhealth-para-integrar-uma-nova-fonte-de-dados.md) - [A Longa Vista](https://success.openhealth.fr/pt/articles/6959482-a-longa-vista.md) - [Como integrar uma nova fonte de dados no HUB?](https://success.openhealth.fr/pt/articles/3467598-como-integrar-uma-nova-fonte-de-dados-no-hub.md) - [Integrar os seus dados de venda no HUB](https://success.openhealth.fr/pt/articles/3471145-integrar-os-seus-dados-de-venda-no-hub.md) - [Especificações para a recepção de dados de venda](https://success.openhealth.fr/pt/articles/3660043-especificacoes-para-a-recepcao-de-dados-de-venda.md) - [De onde vêm os dados para a análise do mercado dos prestadores de cuidados de saúde ao domicílio \(HHCP\)?](https://success.openhealth.fr/pt/articles/3376155-de-onde-vem-os-dados-para-a-analise-do-mercado-dos-prestadores-de-cuidados-de-saude-ao-domicilio-hhcp.md) - [Como aderir ao observatório do SantéDom Stat?](https://success.openhealth.fr/pt/articles/3798795-como-aderir-ao-observatorio-do-santedom-stat.md) - [Painel extrapolado a partir do observatório SanteDomStat](https://success.openhealth.fr/pt/articles/6701602-painel-extrapolado-a-partir-do-observatorio-santedomstat.md) - [Número de pacientes](https://success.openhealth.fr/pt/articles/3376499-numero-de-pacientes.md) - [Número de tratamentos](https://success.openhealth.fr/pt/articles/3376682-numero-de-tratamentos.md) - [Número de novos pacientes](https://success.openhealth.fr/pt/articles/3376672-numero-de-novos-pacientes.md) - [Volume de negócios incluindo IVA](https://success.openhealth.fr/pt/articles/3376725-volume-de-negocios-incluindo-iva.md) - [Número de pacientes no final do tratamento](https://success.openhealth.fr/pt/articles/3376675-numero-de-pacientes-no-final-do-tratamento.md) - [Montante do seguro de saúde obrigatório \(AMO\)](https://success.openhealth.fr/pt/articles/3376740-montante-do-seguro-de-saude-obrigatorio-amo.md) - [Montante do seguro complementar de saúde \(AMC\)](https://success.openhealth.fr/pt/articles/3376749-montante-do-seguro-complementar-de-saude-amc.md) - [Despesas de bolso \(RAC\)](https://success.openhealth.fr/pt/articles/3376751-despesas-de-bolso-rac.md) - [Fonte : THESORIMED](https://success.openhealth.fr/pt/articles/3560018-fonte-thesorimed.md) - [Nomes Não-Proprietários Internacionais \(DCI\)](https://success.openhealth.fr/pt/articles/3954239-nomes-nao-proprietarios-internacionais-dci.md) - [Factos alimentares abertos](https://success.openhealth.fr/pt/articles/6961970-factos-alimentares-abertos.md) - [LOINC - Nomes e Códigos de Identificação de Observação Lógica](https://success.openhealth.fr/pt/articles/6959323-loinc-nomes-e-codigos-de-identificacao-de-observacao-logica.md) - [AMELI - CCAM](https://success.openhealth.fr/pt/articles/6959080-ameli-ccam.md) - [OMS ATC VET](https://success.openhealth.fr/pt/articles/6959078-oms-atc-vet.md) - [CEPS](https://success.openhealth.fr/pt/articles/6959068-ceps.md) - [Instituição](https://success.openhealth.fr/pt/articles/3935678-instituicao.md) - [Serviços de saúde](https://success.openhealth.fr/pt/articles/7969680-servicos-de-saude.md) - [Extrair FINALIDADE](https://success.openhealth.fr/pt/articles/3946922-extrair-finalidade.md) - [Evolução FINAL](https://success.openhealth.fr/pt/articles/3947009-evolucao-final.md) - [Actividade de autorização de cuidados](https://success.openhealth.fr/pt/articles/3947067-actividade-de-autorizacao-de-cuidados.md) - [Equipamento médico principal](https://success.openhealth.fr/pt/articles/3947269-equipamento-medico-principal.md) - [Geográfico](https://success.openhealth.fr/pt/articles/3947363-geografico.md) - [RPPS](https://success.openhealth.fr/pt/articles/3947568-rpps.md) - [FINESS & RPPS](https://success.openhealth.fr/pt/articles/3947713-finess-rpps.md) - [Extracto de RPPS](https://success.openhealth.fr/pt/articles/3947829-extracto-de-rpps.md) ### Os MODELOS - [Dados na UGA](https://success.openhealth.fr/pt/articles/4852310-dados-na-uga.md) - [Cálculo das vendas por sector / Tipo de cliente: o que precisa de saber](https://success.openhealth.fr/pt/articles/3545561-calculo-das-vendas-por-sector-tipo-de-cliente-o-que-precisa-de-saber.md) - [Reatribuição sectorial, metodologia estática ou dinâmica?](https://success.openhealth.fr/pt/articles/3690615-reatribuicao-sectorial-metodologia-estatica-ou-dinamica.md) - [Estratos farmacêuticos](https://success.openhealth.fr/pt/articles/4291490-estratos-farmaceuticos.md) - [A linha de produção do Hub](https://success.openhealth.fr/pt/articles/4816146-a-linha-de-producao-do-hub.md) - [Como conduzir uma análise comparativa?](https://success.openhealth.fr/pt/articles/3440093-como-conduzir-uma-analise-comparativa.md) - [Qualidade dos dados para a empresa OpenHealth](https://success.openhealth.fr/pt/articles/3595822-qualidade-dos-dados-para-a-empresa-openhealth.md) - [Processo de qualidade de dados no OpenHealth](https://success.openhealth.fr/pt/articles/3415271-processo-de-qualidade-de-dados-no-openhealth.md) - [Intervalo e nível de confiança](https://success.openhealth.fr/pt/articles/3633173-intervalo-e-nivel-de-confianca.md) - [Qualidade dos dados: Gestão de lotes](https://success.openhealth.fr/pt/articles/3433509-qualidade-dos-dados-gestao-de-lotes.md) - [Qualidade dos dados: Processo de decomposição das vendas](https://success.openhealth.fr/pt/articles/3415317-qualidade-dos-dados-processo-de-decomposicao-das-vendas.md) - [Venda e turnos de stock](https://success.openhealth.fr/pt/articles/4131084-venda-e-turnos-de-stock.md) - [Porquê analisar a venda por volume?](https://success.openhealth.fr/pt/articles/3846167-porque-analisar-a-venda-por-volume.md) - [Existe uma lacuna de dados entre a entrada e a saída](https://success.openhealth.fr/pt/articles/3195358-existe-uma-lacuna-de-dados-entre-a-entrada-e-a-saida.md) - [O que é uma venda atípica?](https://success.openhealth.fr/pt/articles/3195366-o-que-e-uma-venda-atipica.md) - [De onde vem a informação sobre preços, volumes, volume de negócios?](https://success.openhealth.fr/pt/articles/3195348-de-onde-vem-a-informacao-sobre-precos-volumes-volume-de-negocios.md) - [Volume de vendas estimado por prescritor](https://success.openhealth.fr/pt/articles/4171530-volume-de-vendas-estimado-por-prescritor.md) - [Compreender a diferença entre 2 extracções](https://success.openhealth.fr/pt/articles/13399689-compreender-a-diferenca-entre-2-extraccoes.md) ### PRODUTOS, MERCADOS e CLASSIFICAÇÕES - [GTIN](https://success.openhealth.fr/pt/articles/3608176-gtin.md) - [Especificação de Campo de Qualificação de Cliente do Produto \(PCQFS\)](https://success.openhealth.fr/pt/articles/3704913-especificacao-de-campo-de-qualificacao-de-cliente-do-produto-pcqfs.md) - [O que é um código PBDA?](https://success.openhealth.fr/pt/articles/3195365-o-que-e-um-codigo-pbda.md) - [Acompanhamento do aluguer de produtos](https://success.openhealth.fr/pt/articles/4206554-acompanhamento-do-aluguer-de-produtos.md) - [Quero expandir o meu mercado](https://success.openhealth.fr/pt/articles/4420843-quero-expandir-o-meu-mercado.md) - [Classificação da CCE](https://success.openhealth.fr/pt/articles/3194589-classificacao-da-cce.md) - [História das Aulas EphMRA AC](https://success.openhealth.fr/pt/articles/3557908-historia-das-aulas-ephmra-ac.md) - [Detalhes da Medicina Veterinária](https://success.openhealth.fr/pt/articles/3194587-detalhes-da-medicina-veterinaria.md) - [Classificação da Medicina Veterinária](https://success.openhealth.fr/pt/articles/3194579-classificacao-da-medicina-veterinaria.md) - [Detalhes da Medicina Humana](https://success.openhealth.fr/pt/articles/3421225-detalhes-da-medicina-humana.md) - [Gestão de novos produtos](https://success.openhealth.fr/pt/articles/4470813-gestao-de-novos-produtos.md) - [Classificação da Medicina Humana](https://success.openhealth.fr/pt/articles/3417281-classificacao-da-medicina-humana.md) - [Indicações - Diagnóstico](https://success.openhealth.fr/pt/articles/3568554-indicacoes-diagnostico.md) - [MP4U: Referência do produto](https://success.openhealth.fr/pt/articles/3574188-mp4u-referencia-do-produto.md) - [O que é a TVASI \(Tabela de Vendas, Compras e Stocks Desconhecidos\)](https://success.openhealth.fr/pt/articles/5992494-o-que-e-a-tvasi-tabela-de-vendas-compras-e-stocks-desconhecidos.md) - [Classificação do IRI](https://success.openhealth.fr/pt/articles/3194597-classificacao-do-iri.md) - [Remoção de produtos não vendidos](https://success.openhealth.fr/pt/articles/6135938-remocao-de-produtos-nao-vendidos.md) - [STANDARD MARKET - Assinatura](https://success.openhealth.fr/pt/articles/3798203-standard-market-assinatura.md) - [Não consigo encontrar o meu produto](https://success.openhealth.fr/pt/articles/5686002-nao-consigo-encontrar-o-meu-produto.md) - [Gestão de códigos de produto](https://success.openhealth.fr/pt/articles/5652478-gestao-de-codigos-de-produto.md) - [Qualificação do produto: Marcas](https://success.openhealth.fr/pt/articles/5016985-qualificacao-do-produto-marcas.md) ### SUBSCRIÇÕES e MÓDULOS - [Os 3 tipos de aplicação](https://success.openhealth.fr/pt/articles/9489652-os-3-tipos-de-aplicacao.md) - [A sua plataforma 2.0](https://success.openhealth.fr/pt/articles/8374416-a-sua-plataforma-2-0.md) - [SÍNTESE](https://success.openhealth.fr/pt/articles/3344127-sintese.md) - [Mercados e selecções](https://success.openhealth.fr/pt/articles/8337016-mercados-e-seleccoes.md) - [Painel de controlo resumido](https://success.openhealth.fr/pt/articles/9246867-painel-de-controlo-resumido.md) - [Análise](https://success.openhealth.fr/pt/articles/9352287-analise.md) - [Extrator](https://success.openhealth.fr/pt/articles/9246875-extrator.md) - [Análise do crescimento](https://success.openhealth.fr/pt/articles/3158856-analise-do-crescimento.md) - [Análise do sortido](https://success.openhealth.fr/pt/articles/3473736-analise-do-sortido.md) - [Número médio de produtos](https://success.openhealth.fr/pt/articles/3161474-numero-medio-de-produtos.md) - [Rastreio de lançamento](https://success.openhealth.fr/pt/articles/3158488-rastreio-de-lancamento.md) - [Indicadores Avançados Cruzados](https://success.openhealth.fr/pt/articles/6007740-indicadores-avancados-cruzados.md) - [Concentração de vendas](https://success.openhealth.fr/pt/articles/3095338-concentracao-de-vendas.md) - [Dispersão de preços](https://success.openhealth.fr/pt/articles/3159289-dispersao-de-precos.md) - [Análise de Margens Sell-out](https://success.openhealth.fr/pt/articles/3358322-analise-de-margens-sell-out.md) - [Evolução da Margem de Venda](https://success.openhealth.fr/pt/articles/3815561-evolucao-da-margem-de-venda.md) - [Monitorização da Farmácia \(1/2\)](https://success.openhealth.fr/pt/articles/3358248-monitorizacao-da-farmacia-1-2.md) - [Monitorização da Farmácia \(2/2\)](https://success.openhealth.fr/pt/articles/3810527-monitorizacao-da-farmacia-2-2.md) - [Desempenho da força de vendas](https://success.openhealth.fr/pt/articles/3159230-desempenho-da-forca-de-vendas.md) - [Gestão das Relações com o Cliente \(CRM\) ASSISTENTE](https://success.openhealth.fr/pt/articles/5953935-gestao-das-relacoes-com-o-cliente-crm-assistente.md) - [Seguimento do ponto de venda](https://success.openhealth.fr/pt/articles/3778944-seguimento-do-ponto-de-venda.md) - [Evolução a pedido](https://success.openhealth.fr/pt/articles/6560184-evolucao-a-pedido.md) - [Análise a pedido](https://success.openhealth.fr/pt/articles/6127483-analise-a-pedido.md) - [Mesa a pedido](https://success.openhealth.fr/pt/articles/3158751-mesa-a-pedido.md) - [Análise da série temporal](https://success.openhealth.fr/pt/articles/3635940-analise-da-serie-temporal.md) - [Análise de Previsões](https://success.openhealth.fr/pt/articles/3636015-analise-de-previsoes.md) - [Previsão Sectorial](https://success.openhealth.fr/pt/articles/3689811-previsao-sectorial.md) - [Visualização de venda](https://success.openhealth.fr/pt/articles/3559882-visualizacao-de-venda.md) - [Análise de Vendizagem](https://success.openhealth.fr/pt/articles/6188132-analise-de-vendizagem.md) - [Correspondência da venda](https://success.openhealth.fr/pt/articles/6188090-correspondencia-da-venda.md) - [Evolução da venda](https://success.openhealth.fr/pt/articles/6191929-evolucao-da-venda.md) - [Análise Sell-in vs Sell-out](https://success.openhealth.fr/pt/articles/6191947-analise-sell-in-vs-sell-out.md) - [Evolução de Sell-in vs Sell-out](https://success.openhealth.fr/pt/articles/6191955-evolucao-de-sell-in-vs-sell-out.md) - [Evolução dos preços](https://success.openhealth.fr/pt/articles/5056489-evolucao-dos-precos.md) - [Personalizar cores](https://success.openhealth.fr/pt/articles/8407897-personalizar-cores.md) - [Exportação de produtos](https://success.openhealth.fr/pt/articles/3583206-exportacao-de-produtos.md) - [Análise de Mercado](https://success.openhealth.fr/pt/articles/3121933-analise-de-mercado.md) - [Análise de preços](https://success.openhealth.fr/pt/articles/3215190-analise-de-precos.md) - [Evolução das vendas](https://success.openhealth.fr/pt/articles/3178323-evolucao-das-vendas.md) - [Resumir Painel de instrumentos](https://success.openhealth.fr/pt/articles/4533213-resumir-painel-de-instrumentos.md) - [Evolução da quota de mercado](https://success.openhealth.fr/pt/articles/3193078-evolucao-da-quota-de-mercado.md) - [Tabela Cruzada de Vendas](https://success.openhealth.fr/pt/articles/3193060-tabela-cruzada-de-vendas.md) - [Síntese TURNOVER / VOLUME \(CU\)](https://success.openhealth.fr/pt/articles/3193048-sintese-turnover-volume-cu.md) - [Síntese do Valor de Venda \(PHARMACIES / SUPERMARKETS\)](https://success.openhealth.fr/pt/articles/3193020-sintese-do-valor-de-venda-pharmacies-supermarkets.md) - [Análise da quota de mercado](https://success.openhealth.fr/pt/articles/3193069-analise-da-quota-de-mercado.md) - [O meu arquivo de dados](https://success.openhealth.fr/pt/articles/3193099-o-meu-arquivo-de-dados.md) - [Análise de períodos múltiplos](https://success.openhealth.fr/pt/articles/3192953-analise-de-periodos-multiplos.md) - [A Minha Consulta Todos os Produtos](https://success.openhealth.fr/pt/articles/4280353-a-minha-consulta-todos-os-produtos.md) - [Evolução das existências \(NOVO\)](https://success.openhealth.fr/pt/articles/3719256-evolucao-das-existencias-novo.md) - [Definição do mercado](https://success.openhealth.fr/pt/articles/3158829-definicao-do-mercado.md) - [DADOS RAW Indicadores avançados](https://success.openhealth.fr/pt/articles/3711095-dados-raw-indicadores-avancados.md) - [Evolução de Indicadores Avançados SMKT](https://success.openhealth.fr/pt/articles/3193000-evolucao-de-indicadores-avancados-smkt.md) - [Análise de Indicadores Avançados SMKT](https://success.openhealth.fr/pt/articles/3192366-analise-de-indicadores-avancados-smkt.md) - [Evolução dos Indicadores Avançados](https://success.openhealth.fr/pt/articles/3177853-evolucao-dos-indicadores-avancados.md) - [Indicadores Avançados Evolução Bio](https://success.openhealth.fr/pt/articles/7051823-indicadores-avancados-evolucao-bio.md) - [Indicadores Nacionais Avançados](https://success.openhealth.fr/pt/articles/3364513-indicadores-nacionais-avancados.md) - [Análise de Estoque](https://success.openhealth.fr/pt/articles/3178015-analise-de-estoque.md) - [Análise de Indicadores Avançados Bio](https://success.openhealth.fr/pt/articles/7051801-analise-de-indicadores-avancados-bio.md) - [Análise de Indicadores Avançados](https://success.openhealth.fr/pt/articles/3124439-analise-de-indicadores-avancados.md) - [Cartografia](https://success.openhealth.fr/pt/articles/3192450-cartografia.md) - [Tabela de Cruzamentos Geográficos](https://success.openhealth.fr/pt/articles/3192466-tabela-de-cruzamentos-geograficos.md) - [Evolução Geográfica das Vendas](https://success.openhealth.fr/pt/articles/3192482-evolucao-geografica-das-vendas.md) - [Eficácia da Força de Vendas](https://success.openhealth.fr/pt/articles/5624011-eficacia-da-forca-de-vendas.md) - [Análise do Método de Ponderação Personalizada](https://success.openhealth.fr/pt/articles/5169317-analise-do-metodo-de-ponderacao-personalizada.md) - [Análise de rede](https://success.openhealth.fr/pt/articles/3894767-analise-de-rede.md) - [Evolução do método de ponderação personalizado](https://success.openhealth.fr/pt/articles/5169320-evolucao-do-metodo-de-ponderacao-personalizado.md) - [SUMÁRIO dos KPIs](https://success.openhealth.fr/pt/articles/3478199-sumario-dos-kpis.md) - [Vendas em unidades convertidas](https://success.openhealth.fr/pt/articles/3192412-vendas-em-unidades-convertidas.md) - [Indicadores de Estoque de DADOS RAW](https://success.openhealth.fr/pt/articles/3711142-indicadores-de-estoque-de-dados-raw.md) - [SMKT AIA DE DADOS BRUTOS](https://success.openhealth.fr/pt/articles/3720960-smkt-aia-de-dados-brutos.md) - [Evolução das existências](https://success.openhealth.fr/pt/articles/3178277-evolucao-das-existencias.md) - [Indicadores Geográficos Avançados](https://success.openhealth.fr/pt/articles/3192508-indicadores-geograficos-avancados.md) - [Análise Sectorial da Série Temporal](https://success.openhealth.fr/pt/articles/3814974-analise-sectorial-da-serie-temporal.md) - [Análise de vendas por idade e género](https://success.openhealth.fr/pt/articles/3192701-analise-de-vendas-por-idade-e-genero.md) - [Evolução das vendas por Gravidez](https://success.openhealth.fr/pt/articles/3192910-evolucao-das-vendas-por-gravidez.md) - [Evolução das vendas por idade e género](https://success.openhealth.fr/pt/articles/3192732-evolucao-das-vendas-por-idade-e-genero.md) - [Evolução das encomendas de requisitos](https://success.openhealth.fr/pt/articles/5790020-evolucao-das-encomendas-de-requisitos.md) - [Co-dispensing Evolution](https://success.openhealth.fr/pt/articles/3192529-co-dispensing-evolution.md) - [Análise de Co-dispensing](https://success.openhealth.fr/pt/articles/3192633-analise-de-co-dispensing.md) - [Vendas por Canal & Prescriber](https://success.openhealth.fr/pt/articles/3192751-vendas-por-canal-prescriber.md) - [AMO, AMC & RAC](https://success.openhealth.fr/pt/articles/3192929-amo-amc-rac.md) - [Dispersão de co-dispersão](https://success.openhealth.fr/pt/articles/3876946-dispersao-de-co-dispersao.md) - [Evolução da Dispersão da Dispersão da Compensação](https://success.openhealth.fr/pt/articles/3920070-evolucao-da-dispersao-da-dispersao-da-compensacao.md) - [Prescrições do GP por IDADE & GÊNERO](https://success.openhealth.fr/pt/articles/5789899-prescricoes-do-gp-por-idade-genero.md) - [Análise de Pedidos de Prescrição](https://success.openhealth.fr/pt/articles/5322866-analise-de-pedidos-de-prescricao.md) - [Evolução das Prescrições do GP](https://success.openhealth.fr/pt/articles/5790016-evolucao-das-prescricoes-do-gp.md) - [Análise de cestos](https://success.openhealth.fr/pt/articles/3711049-analise-de-cestos.md) - [Co-dispensing](https://success.openhealth.fr/pt/articles/4738243-co-dispensing.md) - [Módulo de qualificação de coorte](https://success.openhealth.fr/pt/articles/3928090-modulo-de-qualificacao-de-coorte.md) - [Módulo de estado de tratamento](https://success.openhealth.fr/pt/articles/3928067-modulo-de-estado-de-tratamento.md) - [Aderência ao Tratamento por Módulos](https://success.openhealth.fr/pt/articles/3928044-aderencia-ao-tratamento-por-modulos.md) - [Definição de coorte](https://success.openhealth.fr/pt/articles/3894703-definicao-de-coorte.md) - [Co-tratamentos](https://success.openhealth.fr/pt/articles/4163623-co-tratamentos.md) - [Vizualização de coorte](https://success.openhealth.fr/pt/articles/3894721-vizualizacao-de-coorte.md) - [Definição dos critérios de análise](https://success.openhealth.fr/pt/articles/3894728-definicao-dos-criterios-de-analise.md) - [Evolução global da coorte](https://success.openhealth.fr/pt/articles/3894747-evolucao-global-da-coorte.md) - [Distribuição geográfica](https://success.openhealth.fr/pt/articles/3894751-distribuicao-geografica.md) - [Perfil de coorte](https://success.openhealth.fr/pt/articles/3894755-perfil-de-coorte.md) - [Discriminação do estado de tratamento](https://success.openhealth.fr/pt/articles/3894764-discriminacao-do-estado-de-tratamento.md) - [Iniciativas de tratamento](https://success.openhealth.fr/pt/articles/3894778-iniciativas-de-tratamento.md) - [O tratamento recomeça](https://success.openhealth.fr/pt/articles/3894788-o-tratamento-recomeca.md) - [Novos tratamentos](https://success.openhealth.fr/pt/articles/3894804-novos-tratamentos.md) - [Recidivas de tratamento](https://success.openhealth.fr/pt/articles/3894812-recidivas-de-tratamento.md) - [Balanço do interruptor de tratamento](https://success.openhealth.fr/pt/articles/3894821-balanco-do-interruptor-de-tratamento.md) - [Ganhos de mudança de tratamento](https://success.openhealth.fr/pt/articles/3894830-ganhos-de-mudanca-de-tratamento.md) - [Perdas no interruptor de tratamento](https://success.openhealth.fr/pt/articles/3894843-perdas-no-interruptor-de-tratamento.md) - [Mudar as origens dos ganhos](https://success.openhealth.fr/pt/articles/3894857-mudar-as-origens-dos-ganhos.md) - [Mudar o destino de perda](https://success.openhealth.fr/pt/articles/3894864-mudar-o-destino-de-perda.md) - [Drop-outs](https://success.openhealth.fr/pt/articles/3894874-drop-outs.md) - [Resumo dos KPI](https://success.openhealth.fr/pt/articles/4229969-resumo-dos-kpi.md) - [Persistência do tratamento](https://success.openhealth.fr/pt/articles/3894883-persistencia-do-tratamento.md) - [Conformidade](https://success.openhealth.fr/pt/articles/3894884-conformidade.md) - [Qual é o critério de regularidade?](https://success.openhealth.fr/pt/articles/3325816-qual-e-o-criterio-de-regularidade.md) - [Morte - Cartografia](https://success.openhealth.fr/pt/articles/3863677-morte-cartografia.md) - [Turno de contagem de mortos](https://success.openhealth.fr/pt/articles/3863573-turno-de-contagem-de-mortos.md) - [Morte - Análise por IDADE & GÊNERO](https://success.openhealth.fr/pt/articles/3863808-morte-analise-por-idade-genero.md) - [Morte - Evolução por IDADE & GÊNERO](https://success.openhealth.fr/pt/articles/3863939-morte-evolucao-por-idade-genero.md) - [Morte - Evolução](https://success.openhealth.fr/pt/articles/3864065-morte-evolucao.md) - [Morte - Comparação da evolução](https://success.openhealth.fr/pt/articles/3864073-morte-comparacao-da-evolucao.md) - [Monitorização Farmacêutica CA](https://success.openhealth.fr/pt/articles/4634768-monitorizacao-farmaceutica-ca.md) - [Análise de tráfego \(Teste Beta\)](https://success.openhealth.fr/pt/articles/6848401-analise-de-trafego-teste-beta.md) - [Detalhes de monitorização da farmácia](https://success.openhealth.fr/pt/articles/4527868-detalhes-de-monitorizacao-da-farmacia.md) - [Evolução do tráfego \(Teste Beta\)](https://success.openhealth.fr/pt/articles/6848016-evolucao-do-trafego-teste-beta.md) - [Cartografia de Monitorização Farmacêutica](https://success.openhealth.fr/pt/articles/4527811-cartografia-de-monitorizacao-farmaceutica.md) - [Detalhes de monitorização da farmácia](https://success.openhealth.fr/pt/articles/4262306-detalhes-de-monitorizacao-da-farmacia.md) - [Análise de Monitorização da Farmácia](https://success.openhealth.fr/pt/articles/3839223-analise-de-monitorizacao-da-farmacia.md) - [Monitorização da Evolução da Farmácia](https://success.openhealth.fr/pt/articles/3827973-monitorizacao-da-evolucao-da-farmacia.md) - [Decomposição Tráfego](https://success.openhealth.fr/pt/articles/3826074-decomposicao-trafego.md) - [Estudo de tráfego](https://success.openhealth.fr/pt/articles/3809042-estudo-de-trafego.md) - [Sumário Executivo - PIEX](https://success.openhealth.fr/pt/articles/5203335-sumario-executivo-piex.md) - [Compras](https://success.openhealth.fr/pt/articles/4605110-compras.md) - [A Minha Consulta - PIEX](https://success.openhealth.fr/pt/articles/4210627-a-minha-consulta-piex.md) - [Evolução das vendas - PIEX](https://success.openhealth.fr/pt/articles/4210655-evolucao-das-vendas-piex.md) - [Análise de vendas - PIEX](https://success.openhealth.fr/pt/articles/4210650-analise-de-vendas-piex.md) - [Detalhes da encomenda - PIEX](https://success.openhealth.fr/pt/articles/4210659-detalhes-da-encomenda-piex.md) - [Visão geral do stock - PIEX](https://success.openhealth.fr/pt/articles/4210672-visao-geral-do-stock-piex.md) - [O meu arquivo de dados - PIEX](https://success.openhealth.fr/pt/articles/4210694-o-meu-arquivo-de-dados-piex.md) - [EURAPHARMA- PIEX](https://success.openhealth.fr/pt/articles/4366306-eurapharma-piex.md) - [Produto correspondente](https://success.openhealth.fr/pt/articles/4366320-produto-correspondente.md) - [CLI O Meu Ficheiro \(1/5\)](https://success.openhealth.fr/pt/articles/4626422-cli-o-meu-ficheiro-1-5.md) - [CLI\_File Counts \(2/5\)](https://success.openhealth.fr/pt/articles/4626421-cli_file-counts-2-5.md) - [CLI\_File Code Matching with OHC repository](https://success.openhealth.fr/pt/articles/4626419-cli_file-code-matching-with-ohc-repository.md) - [Exportação Sell-Out \(4/5\)](https://success.openhealth.fr/pt/articles/4626414-exportacao-sell-out-4-5.md) ### OPÇÕES PERSONALIZADAS - [Qualificadores de produtos não hierárquicos](https://success.openhealth.fr/pt/articles/4036045-qualificadores-de-produtos-nao-hierarquicos.md) - [Qual é a data-limite máxima para os dados HUB?](https://success.openhealth.fr/pt/articles/3195251-qual-e-a-data-limite-maxima-para-os-dados-hub.md) - [Tipo de cliente](https://success.openhealth.fr/pt/articles/4197147-tipo-de-cliente.md) - [Acesso à Sessão](https://success.openhealth.fr/pt/articles/4036458-acesso-a-sessao.md) - [Ciclo personalizado](https://success.openhealth.fr/pt/articles/4036444-ciclo-personalizado.md) - [Ano Fiscal](https://success.openhealth.fr/pt/articles/4036169-ano-fiscal.md) - [Botão de dia](https://success.openhealth.fr/pt/articles/4036159-botao-de-dia.md) - [Botão "Semana" \(dados semanais\)](https://success.openhealth.fr/pt/articles/4036111-botao-semana-dados-semanais.md) - [Taxas de câmbio](https://success.openhealth.fr/pt/articles/8329594-taxas-de-cambio.md) - [Calendário do período SMKT](https://success.openhealth.fr/pt/articles/4036549-calendario-do-periodo-smkt.md) - [Restringir o perímetro](https://success.openhealth.fr/pt/articles/4560699-restringir-o-perimetro.md) - [Restringir o perímetro \(código 7\)](https://success.openhealth.fr/pt/articles/4560791-restringir-o-perimetro-codigo-7.md) - [Bandeira do mercado](https://success.openhealth.fr/pt/articles/4560797-bandeira-do-mercado.md) - [Pontuação / Orientação \("Tipo de cliente"\)](https://success.openhealth.fr/pt/articles/3777788-pontuacao-orientacao-tipo-de-cliente.md) ### INDICADORES - [Glossário de indicadores HUB](https://success.openhealth.fr/pt/articles/5194247-glossario-de-indicadores-hub.md) - [Volume de vendas](https://success.openhealth.fr/pt/articles/3194314-volume-de-vendas.md) - [Valor de Venda](https://success.openhealth.fr/pt/articles/3074854-valor-de-venda.md) - [N EM, Quota de mercado](https://success.openhealth.fr/pt/articles/3194475-n-em-quota-de-mercado.md) - [N MS Evol](https://success.openhealth.fr/pt/articles/5634266-n-ms-evol.md) - [N MS Delta, evolução da quota de mercado](https://success.openhealth.fr/pt/articles/3194469-n-ms-delta-evolucao-da-quota-de-mercado.md) - [Poids Vol \(CA\) par modalité / Peso personalizado Vol \(To\)](https://success.openhealth.fr/pt/articles/9292839-poids-vol-ca-par-modalite-peso-personalizado-vol-to.md) - [Valor das vendas com base no preço do fabricante, excluindo o IVA \(Volume de negócios PF sem IVA\) - Marrocos](https://success.openhealth.fr/pt/articles/7508513-valor-das-vendas-com-base-no-preco-do-fabricante-excluindo-o-iva-volume-de-negocios-pf-sem-iva-marrocos.md) - [N Crescimento CTR](https://success.openhealth.fr/pt/articles/3194466-n-crescimento-ctr.md) - [No acordo](https://success.openhealth.fr/pt/articles/6201859-no-acordo.md) - [Volume de peso cruzado](https://success.openhealth.fr/pt/articles/6066324-volume-de-peso-cruzado.md) - [Volume de negócios com peso cruzado](https://success.openhealth.fr/pt/articles/6066273-volume-de-negocios-com-peso-cruzado.md) - [N Crescimento CTR ajustado](https://success.openhealth.fr/pt/articles/3205376-n-crescimento-ctr-ajustado.md) - [Peso da fonte](https://success.openhealth.fr/pt/articles/5151525-peso-da-fonte.md) - [Preço médio](https://success.openhealth.fr/pt/articles/3194302-preco-medio.md) - [Preço médio ponderado](https://success.openhealth.fr/pt/articles/3194292-preco-medio-ponderado.md) - [Efeito do preço](https://success.openhealth.fr/pt/articles/8426443-efeito-do-preco.md) - [Número de farmácias que vendem](https://success.openhealth.fr/pt/articles/3719566-numero-de-farmacias-que-vendem.md) - [Distribuição Digital de Vendas](https://success.openhealth.fr/pt/articles/3194321-distribuicao-digital-de-vendas.md) - [Distribuição Global de Vendas Digitais](https://success.openhealth.fr/pt/articles/3194320-distribuicao-global-de-vendas-digitais.md) - [Distribuição Digital de Vendas Rebaseada](https://success.openhealth.fr/pt/articles/4045636-distribuicao-digital-de-vendas-rebaseada.md) - [Distribuição Digital Vendor Global Rebased](https://success.openhealth.fr/pt/articles/4045725-distribuicao-digital-vendor-global-rebased.md) - [Distribuição digital de vendas rebaseada personalizada](https://success.openhealth.fr/pt/articles/6830813-distribuicao-digital-de-vendas-rebaseada-personalizada.md) - [Distribuição Valor de vendas](https://success.openhealth.fr/pt/articles/3194323-distribuicao-valor-de-vendas.md) - [Distribuição Valor global das vendas](https://success.openhealth.fr/pt/articles/3194316-distribuicao-valor-global-das-vendas.md) - [Distribuição de valor de vendas reconstruída](https://success.openhealth.fr/pt/articles/3194501-distribuicao-de-valor-de-vendas-reconstruida.md) - [Distribuição global do valor de vendas rebaseado](https://success.openhealth.fr/pt/articles/4200619-distribuicao-global-do-valor-de-vendas-rebaseado.md) - [Distribuição personalizada do valor de vendas rebaseado](https://success.openhealth.fr/pt/articles/6834423-distribuicao-personalizada-do-valor-de-vendas-rebaseado.md) - [SMKT Distribuição Digital Vendor](https://success.openhealth.fr/pt/articles/3365043-smkt-distribuicao-digital-vendor.md) - [SMKT Distribuição Global de Vendas Digitais](https://success.openhealth.fr/pt/articles/4298341-smkt-distribuicao-global-de-vendas-digitais.md) - [SMKT Vendas Distribuição Digital Rebaseada](https://success.openhealth.fr/pt/articles/4298197-smkt-vendas-distribuicao-digital-rebaseada.md) - [SMKT Vendas Distribuição Digital Global Rebaseada](https://success.openhealth.fr/pt/articles/4319783-smkt-vendas-distribuicao-digital-global-rebaseada.md) - [Distribuição Valor de Vendas SMKT](https://success.openhealth.fr/pt/articles/3365478-distribuicao-valor-de-vendas-smkt.md) - [SMKT Global Recalculated Digital Sales Distribution](https://success.openhealth.fr/pt/articles/4298373-smkt-global-recalculated-digital-sales-distribution.md) - [Vendas SMKT Distribuição Digital Recalculado](https://success.openhealth.fr/pt/articles/4298303-vendas-smkt-distribuicao-digital-recalculado.md) - [SMKT Distribuição Digital Ajustada de Vendas SMKT](https://success.openhealth.fr/pt/articles/3369386-smkt-distribuicao-digital-ajustada-de-vendas-smkt.md) - [Distribuição Digital de Vendas SMKT Recalculada](https://success.openhealth.fr/pt/articles/4298209-distribuicao-digital-de-vendas-smkt-recalculada.md) - [SMKT Distribuição de Valor de Vendas Ajustado](https://success.openhealth.fr/pt/articles/3369397-smkt-distribuicao-de-valor-de-vendas-ajustado.md) - [Distribuição Digital Orgânica de Vendas](https://success.openhealth.fr/pt/articles/7052424-distribuicao-digital-organica-de-vendas.md) - [Volume de negócios das farmácias de venda \(TSP\)](https://success.openhealth.fr/pt/articles/6096534-volume-de-negocios-das-farmacias-de-venda-tsp.md) - [Estimar o PDM do seu titular](https://success.openhealth.fr/pt/articles/4214883-estimar-o-pdm-do-seu-titular.md) - [Mais farmácias](https://success.openhealth.fr/pt/articles/8426451-mais-farmacias.md) - [Perda de farmácias](https://success.openhealth.fr/pt/articles/8426460-perda-de-farmacias.md) - [Vendas e distribuição digitais multicanais](https://success.openhealth.fr/pt/articles/9293487-vendas-e-distribuicao-digitais-multicanais.md) - [Distribuição digital de vendas acumuladas \(PHARMA\)](https://success.openhealth.fr/pt/articles/9330571-distribuicao-digital-de-vendas-acumuladas-pharma.md) - [AMS: Vendas Mensais Médias](https://success.openhealth.fr/pt/articles/3194303-ams-vendas-mensais-medias.md) - [AMS A: Média Ajustada de Vendas Mensais Mensais](https://success.openhealth.fr/pt/articles/3194290-ams-a-media-ajustada-de-vendas-mensais-mensais.md) - [AMS para: Valor médio mensal de vendas](https://success.openhealth.fr/pt/articles/4535404-ams-para-valor-medio-mensal-de-vendas.md) - [AMS para A: Valor Médio Mensal de Vendas Ajustado](https://success.openhealth.fr/pt/articles/6028256-ams-para-a-valor-medio-mensal-de-vendas-ajustado.md) - [Média de vendas](https://success.openhealth.fr/pt/articles/3563716-media-de-vendas.md) - [Vendas médias SMKT](https://success.openhealth.fr/pt/articles/3365496-vendas-medias-smkt.md) - [Média de vendas SMKT Ajustadas](https://success.openhealth.fr/pt/articles/3369340-media-de-vendas-smkt-ajustadas.md) - [Média mensal de vendas orgânicas](https://success.openhealth.fr/pt/articles/7052551-media-mensal-de-vendas-organicas.md) - [Vendas médias mensais Valor orgânico](https://success.openhealth.fr/pt/articles/7052573-vendas-medias-mensais-valor-organico.md) - [Stock](https://success.openhealth.fr/pt/articles/3194332-stock.md) - [Stock médio](https://success.openhealth.fr/pt/articles/3194336-stock-medio.md) - [Quota de stock](https://success.openhealth.fr/pt/articles/3194334-quota-de-stock.md) - [Índice de pressão comercial](https://success.openhealth.fr/pt/articles/3194335-indice-de-pressao-comercial.md) - [Taxa de transformação de stocks](https://success.openhealth.fr/pt/articles/3194344-taxa-de-transformacao-de-stocks.md) - [Duração do fornecimento - N Cobertura de stock](https://success.openhealth.fr/pt/articles/3194337-duracao-do-fornecimento-n-cobertura-de-stock.md) - [Número de farmácias em stock](https://success.openhealth.fr/pt/articles/3194338-numero-de-farmacias-em-stock.md) - [Armazenista de Distribuição Digital](https://success.openhealth.fr/pt/articles/3194339-armazenista-de-distribuicao-digital.md) - [Armazenista de Distribuição Digital rebaseado](https://success.openhealth.fr/pt/articles/4045743-armazenista-de-distribuicao-digital-rebaseado.md) - [Distribuição digital global rebased stockist](https://success.openhealth.fr/pt/articles/4045753-distribuicao-digital-global-rebased-stockist.md) - [Distribuição Valor do stock](https://success.openhealth.fr/pt/articles/3194342-distribuicao-valor-do-stock.md) - [Distribuição do valor de inventário rebaseado](https://success.openhealth.fr/pt/articles/3194505-distribuicao-do-valor-de-inventario-rebaseado.md) - [Distribuição Digital Armazenista alisado](https://success.openhealth.fr/pt/articles/5141830-distribuicao-digital-armazenista-alisado.md) - [Distribuição Digital Armazenista alisado rebaixado](https://success.openhealth.fr/pt/articles/5142162-distribuicao-digital-armazenista-alisado-rebaixado.md) - [Distribuição Valor do stock alisado](https://success.openhealth.fr/pt/articles/5203640-distribuicao-valor-do-stock-alisado.md) - [Distribuição Valor do stock alisado rebaseado](https://success.openhealth.fr/pt/articles/5203701-distribuicao-valor-do-stock-alisado-rebaseado.md) - [Margem](https://success.openhealth.fr/pt/articles/3507716-margem.md) - [Taxa de margem](https://success.openhealth.fr/pt/articles/3507767-taxa-de-margem.md) - [Preço de compra excluindo impostos](https://success.openhealth.fr/pt/articles/4557500-preco-de-compra-excluindo-impostos.md) - [Sell-in - Análise da sua base de clientes](https://success.openhealth.fr/pt/articles/3846225-sell-in-analise-da-sua-base-de-clientes.md) - [Sell-in - Atypismo nas farmácias](https://success.openhealth.fr/pt/articles/3848791-sell-in-atypismo-nas-farmacias.md) - [Taxa de evolução](https://success.openhealth.fr/pt/articles/3194287-taxa-de-evolucao.md) - [Taxa de penetração](https://success.openhealth.fr/pt/articles/3194286-taxa-de-penetracao.md) - [Amplitude da gama de produtos](https://success.openhealth.fr/pt/articles/3369425-amplitude-da-gama-de-produtos.md) - [Renovação do sortido](https://success.openhealth.fr/pt/articles/3369545-renovacao-do-sortido.md) - [Inovação na gama](https://success.openhealth.fr/pt/articles/3369468-inovacao-na-gama.md) - [Atracção a partir da gama](https://success.openhealth.fr/pt/articles/3369457-atraccao-a-partir-da-gama.md) - [Taxa de desgaste do sortido](https://success.openhealth.fr/pt/articles/3369485-taxa-de-desgaste-do-sortido.md) - [Taxa de inovação do sortido](https://success.openhealth.fr/pt/articles/3369541-taxa-de-inovacao-do-sortido.md) - [Quota de oferta de venda](https://success.openhealth.fr/pt/articles/3369040-quota-de-oferta-de-venda.md) - [Número de Produtos Selecionados](https://success.openhealth.fr/pt/articles/3511502-numero-de-produtos-selecionados.md) - [Número médio de produtos](https://success.openhealth.fr/pt/articles/3194284-numero-medio-de-produtos.md) - [Taxa de renovação do sortimento](https://success.openhealth.fr/pt/articles/3369561-taxa-de-renovacao-do-sortimento.md) - [Número de produtos](https://success.openhealth.fr/pt/articles/6312686-numero-de-produtos.md) - [Montantes gastos por acto](https://success.openhealth.fr/pt/articles/3447792-montantes-gastos-por-acto.md) - [Discriminação do dinheiro gasto por tipo de comprador](https://success.openhealth.fr/pt/articles/3447801-discriminacao-do-dinheiro-gasto-por-tipo-de-comprador.md) - [Índice de consumo](https://success.openhealth.fr/pt/articles/3432701-indice-de-consumo.md) - [Quota de vendas](https://success.openhealth.fr/pt/articles/3432664-quota-de-vendas.md) - [Taxa de fidelidade ao valor](https://success.openhealth.fr/pt/articles/3432695-taxa-de-fidelidade-ao-valor.md) - [Penetração absoluta](https://success.openhealth.fr/pt/articles/3432556-penetracao-absoluta.md) - [Percentagem do volume de negócios](https://success.openhealth.fr/pt/articles/3432655-percentagem-do-volume-de-negocios.md) - [p-valor](https://success.openhealth.fr/pt/articles/5781702-p-valor.md) - [Análise de componentes principais](https://success.openhealth.fr/pt/articles/4231028-analise-de-componentes-principais.md) - [Valor Predictivo Negativo](https://success.openhealth.fr/pt/articles/4134220-valor-predictivo-negativo.md) - [Valor Predictivo Positivo](https://success.openhealth.fr/pt/articles/4134166-valor-predictivo-positivo.md) - [Teste de independência](https://success.openhealth.fr/pt/articles/4128369-teste-de-independencia.md) - [Estudo das séries cronológicas](https://success.openhealth.fr/pt/articles/3633991-estudo-das-series-cronologicas.md) - [Taxa de variância sazonal](https://success.openhealth.fr/pt/articles/3653790-taxa-de-variancia-sazonal.md) - [Sensibilidade e especificidade de um teste](https://success.openhealth.fr/pt/articles/3928135-sensibilidade-e-especificidade-de-um-teste.md) - [Taxa de variação da tendência](https://success.openhealth.fr/pt/articles/3653847-taxa-de-variacao-da-tendencia.md) - [Taxa de variância residual](https://success.openhealth.fr/pt/articles/3653851-taxa-de-variancia-residual.md) - [Coeficiente de determinação](https://success.openhealth.fr/pt/articles/3654093-coeficiente-de-determinacao.md) - [Coeficiente de variação](https://success.openhealth.fr/pt/articles/3653915-coeficiente-de-variacao.md) - [Variância de uma série cronológica](https://success.openhealth.fr/pt/articles/3653855-variancia-de-uma-serie-cronologica.md) - [Concentração de vendas](https://success.openhealth.fr/pt/articles/3395856-concentracao-de-vendas.md) - [Índice de Gini](https://success.openhealth.fr/pt/articles/3395323-indice-de-gini.md) - [População](https://success.openhealth.fr/pt/articles/4396779-populacao.md) - [Evolução do número de mortes](https://success.openhealth.fr/pt/articles/4396765-evolucao-do-numero-de-mortes.md) - [Proporção de sexo](https://success.openhealth.fr/pt/articles/3812167-proporcao-de-sexo.md) - [População - Idade média](https://success.openhealth.fr/pt/articles/3812180-populacao-idade-media.md) - [População - Idade média](https://success.openhealth.fr/pt/articles/3812198-populacao-idade-media.md) - [População - Idade 1º quartil](https://success.openhealth.fr/pt/articles/3812218-populacao-idade-1º-quartil.md) - [População - Idade 3º quartil](https://success.openhealth.fr/pt/articles/3812227-populacao-idade-3º-quartil.md) - [Percentagem de pessoas seleccionadas no total da população do território](https://success.openhealth.fr/pt/articles/3812233-percentagem-de-pessoas-seleccionadas-no-total-da-populacao-do-territorio.md) - [Taxa de mortalidade](https://success.openhealth.fr/pt/articles/3947946-taxa-de-mortalidade.md) - [Taxa de mortalidade de casos](https://success.openhealth.fr/pt/articles/3948084-taxa-de-mortalidade-de-casos.md) - [Mulheres em idade de procriação](https://success.openhealth.fr/pt/articles/4172859-mulheres-em-idade-de-procriacao.md) - [Percentagem de selecção no total de mortes no território](https://success.openhealth.fr/pt/articles/3863734-percentagem-de-seleccao-no-total-de-mortes-no-territorio.md) - [Modelar o número de mortes em falta](https://success.openhealth.fr/pt/articles/3895572-modelar-o-numero-de-mortes-em-falta.md) - [Estimativa de vendas em iniciação de prescrição](https://success.openhealth.fr/pt/articles/5323282-estimativa-de-vendas-em-iniciacao-de-prescricao.md) - [Evolução por idade e estado de gravidez](https://success.openhealth.fr/pt/articles/6820051-evolucao-por-idade-e-estado-de-gravidez.md) - [Rácio de produtos de co-dispensa](https://success.openhealth.fr/pt/articles/7892010-racio-de-produtos-de-co-dispensa.md) - [Estimativa das vendas de recarga de prescrição](https://success.openhealth.fr/pt/articles/5323209-estimativa-das-vendas-de-recarga-de-prescricao.md) - [Peso das vendas de recarga de prescrição](https://success.openhealth.fr/pt/articles/5323198-peso-das-vendas-de-recarga-de-prescricao.md) - [Peso das vendas em iniciação de prescrição](https://success.openhealth.fr/pt/articles/5323086-peso-das-vendas-em-iniciacao-de-prescricao.md) - [Número de co-dispensadores](https://success.openhealth.fr/pt/articles/3194351-numero-de-co-dispensadores.md) - [Número de dispensas](https://success.openhealth.fr/pt/articles/3194348-numero-de-dispensas.md) - [Número médio de dispensas por identificação do cliente](https://success.openhealth.fr/pt/articles/3369626-numero-medio-de-dispensas-por-identificacao-do-cliente.md) - [Conformidade](https://success.openhealth.fr/pt/articles/3411996-conformidade.md) - [Taxa de persistência](https://success.openhealth.fr/pt/articles/3369684-taxa-de-persistencia.md) - [Aderência terapêutica](https://success.openhealth.fr/pt/articles/3412091-aderencia-terapeutica.md) - [Dosagem média diária por identificação do cliente](https://success.openhealth.fr/pt/articles/4153587-dosagem-media-diaria-por-identificacao-do-cliente.md) - [Número de dispensas submetidas para reembolso](https://success.openhealth.fr/pt/articles/3370942-numero-de-dispensas-submetidas-para-reembolso.md) - [Número de dispensas não submetidas para reembolso](https://success.openhealth.fr/pt/articles/3370920-numero-de-dispensas-nao-submetidas-para-reembolso.md) - [Vendas com valor reembolsado cobertas pelo seguro de saúde obrigatório](https://success.openhealth.fr/pt/articles/3371699-vendas-com-valor-reembolsado-cobertas-pelo-seguro-de-saude-obrigatorio.md) - [Valores de vendas reembolsados pelo seguro complementar de saúde](https://success.openhealth.fr/pt/articles/3371830-valores-de-vendas-reembolsados-pelo-seguro-complementar-de-saude.md) - [Valores de vendas no restante](https://success.openhealth.fr/pt/articles/3371842-valores-de-vendas-no-restante.md) - [Prevalência](https://success.openhealth.fr/pt/articles/3947955-prevalencia.md) - [Número médio de GTINs por dispensação](https://success.openhealth.fr/pt/articles/3396154-numero-medio-de-gtins-por-dispensacao.md) - [Volume médio por dispensação](https://success.openhealth.fr/pt/articles/3396196-volume-medio-por-dispensacao.md) - [Rotatividade média por dispensação](https://success.openhealth.fr/pt/articles/3396208-rotatividade-media-por-dispensacao.md) - [Dosagem de ingredientes activos por caixa](https://success.openhealth.fr/pt/articles/3675409-dosagem-de-ingredientes-activos-por-caixa.md) - [DDD por caixa](https://success.openhealth.fr/pt/articles/3675446-ddd-por-caixa.md) - [Volume em unidades básicas](https://success.openhealth.fr/pt/articles/3675520-volume-em-unidades-basicas.md) - [Volume do ingrediente activo](https://success.openhealth.fr/pt/articles/3675539-volume-do-ingrediente-activo.md) - [DDD por 1.000 habitantes](https://success.openhealth.fr/pt/articles/3675667-ddd-por-1-000-habitantes.md) - [Volume médio de CU Identificação do cliente](https://success.openhealth.fr/pt/articles/3675761-volume-medio-de-cu-identificacao-do-cliente.md) - [Volume médio de BU por identificação do cliente](https://success.openhealth.fr/pt/articles/3675814-volume-medio-de-bu-por-identificacao-do-cliente.md) - [Volume médio de ingrediente activo por identificação do cliente](https://success.openhealth.fr/pt/articles/3675824-volume-medio-de-ingrediente-activo-por-identificacao-do-cliente.md) - [Tempo médio de tratamento observado](https://success.openhealth.fr/pt/articles/3675841-tempo-medio-de-tratamento-observado.md) - [Cobertura vacinal](https://success.openhealth.fr/pt/articles/3822264-cobertura-vacinal.md) - [IDs de clientes incluídos](https://success.openhealth.fr/pt/articles/3886665-ids-de-clientes-incluidos.md) - [Diferenças entre PRM e DCP](https://success.openhealth.fr/pt/articles/3722666-diferencas-entre-prm-e-dcp.md) - [Tempo médio de tratamento](https://success.openhealth.fr/pt/articles/3920967-tempo-medio-de-tratamento.md) - [Tempo médio de renovação](https://success.openhealth.fr/pt/articles/3921067-tempo-medio-de-renovacao.md) - [Iniciativas de tratamento](https://success.openhealth.fr/pt/articles/3848844-iniciativas-de-tratamento.md) - [Renovações de tratamento](https://success.openhealth.fr/pt/articles/3885469-renovacoes-de-tratamento.md) - [Premissas de tratamento](https://success.openhealth.fr/pt/articles/3885608-premissas-de-tratamento.md) - [Novos tratamentos](https://success.openhealth.fr/pt/articles/3885297-novos-tratamentos.md) - [Interruptor de tratamento](https://success.openhealth.fr/pt/articles/3848886-interruptor-de-tratamento.md) - [Paragens no tratamento](https://success.openhealth.fr/pt/articles/3885426-paragens-no-tratamento.md) - [Drop-off](https://success.openhealth.fr/pt/articles/3885387-drop-off.md) - [Inserção de rastreabilidade](https://success.openhealth.fr/pt/articles/4355163-insercao-de-rastreabilidade.md) - [Parou e depois reiniciou](https://success.openhealth.fr/pt/articles/8429189-parou-e-depois-reiniciou.md) - [Distribuição de acções](https://success.openhealth.fr/pt/articles/3624820-distribuicao-de-accoes.md) - [Controlo das dispensas relevantes](https://success.openhealth.fr/pt/articles/3804193-controlo-das-dispensas-relevantes.md) - [Taxa de desintegração](https://success.openhealth.fr/pt/articles/4850138-taxa-de-desintegracao.md) - [Cinética de uma reacção](https://success.openhealth.fr/pt/articles/4850629-cinetica-de-uma-reaccao.md) - [Tempo de meia-vida](https://success.openhealth.fr/pt/articles/4849710-tempo-de-meia-vida.md) - [Taxa de cobertura de inventário - PIEX](https://success.openhealth.fr/pt/articles/4210714-taxa-de-cobertura-de-inventario-piex.md) - [Os períodos de tempo HUB](https://success.openhealth.fr/pt/articles/3194479-os-periodos-de-tempo-hub.md) - [Alterar a definição de um ano fiscal](https://success.openhealth.fr/pt/articles/3321750-alterar-a-definicao-de-um-ano-fiscal.md) - [Gestão de comparações semanais](https://success.openhealth.fr/pt/articles/3835180-gestao-de-comparacoes-semanais.md) - [O Calendário de Parafarmácias da GSA \(SMKT\)](https://success.openhealth.fr/pt/articles/3175583-o-calendario-de-parafarmacias-da-gsa-smkt.md) - [N](https://success.openhealth.fr/pt/articles/3194484-n.md) - [N Evolução](https://success.openhealth.fr/pt/articles/3194461-n-evolucao.md) - [Tendência N](https://success.openhealth.fr/pt/articles/3194485-tendencia-n.md) ### IAS - Indicateurs Avancés Sanitaires - [NIC\(r\) Alergia](https://success.openhealth.fr/pt/articles/7339151-nic-r-alergia.md) - [IAS\(r\) Poux](https://success.openhealth.fr/pt/articles/7339168-ias-r-poux.md) - [Gastroenterite NIC\(r\)](https://success.openhealth.fr/pt/articles/7339181-gastroenterite-nic-r.md) - [IAS\(r\) Síndromes Respiratórias](https://success.openhealth.fr/pt/articles/3815345-ias-r-sindromes-respiratorias.md) - [IAS\(r\) Doença semelhante à gripe](https://success.openhealth.fr/pt/articles/7266711-ias-r-doenca-semelhante-a-gripe.md) ### Marketing Direct - [Solução de correio electrónico OpenHealth](https://success.openhealth.fr/pt/articles/7055261-solucao-de-correio-electronico-openhealth.md) - [Requisitos para a produção de uma campanha de correio electrónico](https://success.openhealth.fr/pt/articles/6282113-requisitos-para-a-producao-de-uma-campanha-de-correio-electronico.md) - [Relatório de Rastreio e Benchmarks](https://success.openhealth.fr/pt/articles/6302721-relatorio-de-rastreio-e-benchmarks.md) - [Glossário para campanhas por correio electrónico](https://success.openhealth.fr/pt/articles/6282099-glossario-para-campanhas-por-correio-electronico.md) ### PSAD - OBSERVATOIRE - [Análise - NACIONAL](https://success.openhealth.fr/pt/articles/3376262-analise-nacional.md) - [Volume / Volume de negócios - NACIONAL](https://success.openhealth.fr/pt/articles/3376287-volume-volume-de-negocios-nacional.md) - [Evolução - NACIONAL](https://success.openhealth.fr/pt/articles/3376370-evolucao-nacional.md) - [Extracção - NACIONAL](https://success.openhealth.fr/pt/articles/3376420-extraccao-nacional.md) - [Definição](https://success.openhealth.fr/pt/articles/3376439-definicao.md) ### AUTRES THEMATIQUES - [INTERCOM](https://success.openhealth.fr/pt/articles/6959415-intercom.md) - [Força de vendas](https://success.openhealth.fr/pt/articles/6959337-forca-de-vendas.md) - [GIHSN: Submeter ficheiro Excel](https://success.openhealth.fr/pt/articles/3977478-gihsn-submeter-ficheiro-excel.md) - [Blockchain](https://success.openhealth.fr/pt/articles/5385413-blockchain.md) - [DocuSign, uma ferramenta de CRM no nosso processo empresarial](https://success.openhealth.fr/pt/articles/4514472-docusign-uma-ferramenta-de-crm-no-nosso-processo-empresarial.md) - [Rastreio nacional de vacinação](https://success.openhealth.fr/pt/articles/4754333-rastreio-nacional-de-vacinacao.md) - [Cobertura vacinal](https://success.openhealth.fr/pt/articles/4754311-cobertura-vacinal.md) - [Monitorização de KPI](https://success.openhealth.fr/pt/articles/4091042-monitorizacao-de-kpi.md) - [Cockpit da Farmácia](https://success.openhealth.fr/pt/articles/4091025-cockpit-da-farmacia.md) - [Equivalente populacional \(p.e.\)](https://success.openhealth.fr/pt/articles/5431894-equivalente-populacional-p-e.md) - [Demanda de oxigénio](https://success.openhealth.fr/pt/articles/5137158-demanda-de-oxigenio.md) - [IHU](https://success.openhealth.fr/pt/articles/4851687-ihu.md) - [Material em suspensão](https://success.openhealth.fr/pt/articles/5137147-material-em-suspensao.md) - [Química das águas residuais](https://success.openhealth.fr/pt/articles/5137101-quimica-das-aguas-residuais.md) - [NRBCE](https://success.openhealth.fr/pt/articles/4851683-nrbce.md) - [Lei "Arrhenius](https://success.openhealth.fr/pt/articles/4849672-lei-arrhenius.md) - [Desempenho resultante](https://success.openhealth.fr/pt/articles/5137034-desempenho-resultante.md) - [Tipos de águas residuais](https://success.openhealth.fr/pt/articles/5137183-tipos-de-aguas-residuais.md) - [Concentração do vírus SARS-CoV-2](https://success.openhealth.fr/pt/articles/4867968-concentracao-do-virus-sars-cov-2.md) - [MAPOM / BMPM](https://success.openhealth.fr/pt/articles/4851685-mapom-bmpm.md) - [Concentração contextualizada da SRA-CoV-2](https://success.openhealth.fr/pt/articles/4934604-concentracao-contextualizada-da-sra-cov-2.md) - [Tipo de sistema de esgotos](https://success.openhealth.fr/pt/articles/4867954-tipo-de-sistema-de-esgotos.md) - [Degradação do vírus](https://success.openhealth.fr/pt/articles/4865742-degradacao-do-virus.md) - [WBE](https://success.openhealth.fr/pt/articles/4865735-wbe.md) - [RNA](https://success.openhealth.fr/pt/articles/4865733-rna.md) - [Coronavírus](https://success.openhealth.fr/pt/articles/4865728-coronavirus.md) - [COVID-19](https://success.openhealth.fr/pt/articles/4865726-covid-19.md) - [Seroprevalência: método de amostragem](https://success.openhealth.fr/pt/articles/3924493-seroprevalencia-metodo-de-amostragem.md) - [Repositório SANDRE](https://success.openhealth.fr/pt/articles/5415040-repositorio-sandre.md) - [Base nacional ROSEAU](https://success.openhealth.fr/pt/articles/5414523-base-nacional-roseau.md) - [Concentração do vírus SARS-CoV-2](https://success.openhealth.fr/pt/articles/4852404-concentracao-do-virus-sars-cov-2.md) - [Concentração do vírus SARS-CoV-2 - Variantes](https://success.openhealth.fr/pt/articles/4909854-concentracao-do-virus-sars-cov-2-variantes.md) - [Marselha - Monitorização Global](https://success.openhealth.fr/pt/articles/4859311-marselha-monitorizacao-global.md) - [Concentração do vírus SARS-CoV-2 - Nice](https://success.openhealth.fr/pt/articles/4879292-concentracao-do-virus-sars-cov-2-nice.md) - [População - Estrutura](https://success.openhealth.fr/pt/articles/4842408-populacao-estrutura.md) - [Concentração do vírus SARS-CoV-2 - Toulon \(FRANÇA\)](https://success.openhealth.fr/pt/articles/4886417-concentracao-do-virus-sars-cov-2-toulon-franca.md) - [Dubai - Monitorização de águas residuais de aeroportos](https://success.openhealth.fr/pt/articles/5276423-dubai-monitorizacao-de-aguas-residuais-de-aeroportos.md) - [Vigilância da SRA-CoV-2 - OBEPINE](https://success.openhealth.fr/pt/articles/5210661-vigilancia-da-sra-cov-2-obepine.md) - [Concentração contextualizada da SRA-CoV-2](https://success.openhealth.fr/pt/articles/4934608-concentracao-contextualizada-da-sra-cov-2.md) - [SUEZ - Balanço analítico](https://success.openhealth.fr/pt/articles/5140509-suez-balanco-analitico.md) - [Palais des festivals - Ver T0](https://success.openhealth.fr/pt/articles/5373515-palais-des-festivals-ver-t0.md) - [Palais des festivals - Vigília diária](https://success.openhealth.fr/pt/articles/5373231-palais-des-festivals-vigilia-diaria.md) - [Palais des festivals - Rastreio](https://success.openhealth.fr/pt/articles/5404778-palais-des-festivals-rastreio.md) - [Mustelídeos - Relógio](https://success.openhealth.fr/pt/articles/5169577-mustelideos-relogio.md) - [População - IRIS](https://success.openhealth.fr/pt/articles/4842191-populacao-iris.md) - [SRA-CoV-2](https://success.openhealth.fr/pt/articles/4865699-sra-cov-2.md) - [IAS - Análise](https://success.openhealth.fr/pt/articles/4842430-ias-analise.md) - [Concentração do vírus SARS-CoV-2 - SEM](https://success.openhealth.fr/pt/articles/5415600-concentracao-do-virus-sars-cov-2-sem.md) - [Visualização do mapa](https://success.openhealth.fr/pt/articles/3864657-visualizacao-do-mapa.md) - [Contribuição do sítio](https://success.openhealth.fr/pt/articles/3864668-contribuicao-do-sitio.md) - [Perfil de coorte por site](https://success.openhealth.fr/pt/articles/3864672-perfil-de-coorte-por-site.md) - [Perfil de coorte por estação](https://success.openhealth.fr/pt/articles/3864673-perfil-de-coorte-por-estacao.md) - [Distribuição por idade e sexo](https://success.openhealth.fr/pt/articles/3864675-distribuicao-por-idade-e-sexo.md) - [Distribuição de vírus por local](https://success.openhealth.fr/pt/articles/3864678-distribuicao-de-virus-por-local.md) - [Distribuição de vírus por idade](https://success.openhealth.fr/pt/articles/3864677-distribuicao-de-virus-por-idade.md) - [Evolução da distribuição de vírus](https://success.openhealth.fr/pt/articles/3864681-evolucao-da-distribuicao-de-virus.md) - [Vacinação contra a gripe](https://success.openhealth.fr/pt/articles/3864697-vacinacao-contra-a-gripe.md) - [Evolução da vacinação contra a gripe](https://success.openhealth.fr/pt/articles/3864701-evolucao-da-vacinacao-contra-a-gripe.md) - [Distribuição de doentes por condição crónica](https://success.openhealth.fr/pt/articles/3864676-distribuicao-de-doentes-por-condicao-cronica.md) - [Distribuição dos pacientes por tempo de internamento hospitalar](https://success.openhealth.fr/pt/articles/3864794-distribuicao-dos-pacientes-por-tempo-de-internamento-hospitalar.md) - [Fragilidade](https://success.openhealth.fr/pt/articles/3864704-fragilidade.md) - [Estado de severidade](https://success.openhealth.fr/pt/articles/3864705-estado-de-severidade.md) - [Mortalidade](https://success.openhealth.fr/pt/articles/3864710-mortalidade.md) - [GIHSN](https://success.openhealth.fr/pt/articles/3864712-gihsn.md) - [CARéDIAB - Perfis dos pacientes](https://success.openhealth.fr/pt/articles/3789234-carediab-perfis-dos-pacientes.md) - [CARéDIAB - Complicações](https://success.openhealth.fr/pt/articles/3789515-carediab-complicacoes.md) - [CARéDIAB - Monitorização global de doentes](https://success.openhealth.fr/pt/articles/3792041-carediab-monitorizacao-global-de-doentes.md) - [Rede CARéDIAB](https://success.openhealth.fr/pt/articles/3789106-rede-carediab.md) - [CARéDIAB - Tratamentos](https://success.openhealth.fr/pt/articles/3792143-carediab-tratamentos.md) ## Pусский ### Votre PLATEFORME - présentation générale - [HUB, платформа комплексной и непрерывной поддержки](https://success.openhealth.fr/ru/articles/4799621-hub-платформа-комплексной-и-непрерывной-поддержки.md) - [Ваш уровень опыта The HUB](https://success.openhealth.fr/ru/articles/5712270-ваш-уровень-опыта-the-hub.md) - [Languages](https://success.openhealth.fr/ru/articles/4649389-languages.md): Here is the description of all languages available on Success - [Вопросы о наших тарифах](https://success.openhealth.fr/ru/articles/3292143-вопросы-о-наших-тарифах.md): Наши цены ### Дорожная карта - ["Открытые инновации для наших клиентов](https://success.openhealth.fr/ru/articles/5200970-открытые-инновации-для-наших-клиентов.md) - [Приложения + область администрирования версии 240515](https://success.openhealth.fr/ru/articles/9310541-приложения-область-администрирования-версии-240515.md) - [Приложения + область администрирования версии 240415](https://success.openhealth.fr/ru/articles/9310710-приложения-область-администрирования-версии-240415.md) - [Приложения + область администрирования версии 240315](https://success.openhealth.fr/ru/articles/9310790-приложения-область-администрирования-версии-240315.md) - [Приложения + область администрирования версии 240215](https://success.openhealth.fr/ru/articles/9311007-приложения-область-администрирования-версии-240215.md) - [Платформа - обновление 231215](https://success.openhealth.fr/ru/articles/8718485-платформа-обновление-231215.md) - [Платформа - обновление 231015](https://success.openhealth.fr/ru/articles/8479932-платформа-обновление-231015.md) - [Приложения + Портал версия 230915](https://success.openhealth.fr/ru/articles/8373640-приложения-портал-версия-230915.md) - [Приложения + Портал версия 230815](https://success.openhealth.fr/ru/articles/8267860-приложения-портал-версия-230815.md) - [Новые продукты 230715](https://success.openhealth.fr/ru/articles/8115796-новые-продукты-230715.md) - [Приложения + Портал версия 230615](https://success.openhealth.fr/ru/articles/8115791-приложения-портал-версия-230615.md) - [Приложения + Портал версия 230515](https://success.openhealth.fr/ru/articles/7895393-приложения-портал-версия-230515.md) - [Приложения + портал версия 230415](https://success.openhealth.fr/ru/articles/7439447-приложения-портал-версия-230415.md) - [Приложения + портал версия 230315](https://success.openhealth.fr/ru/articles/7439646-приложения-портал-версия-230315.md) - [Приложения + портал версия 230215](https://success.openhealth.fr/ru/articles/7439744-приложения-портал-версия-230215.md) - [Новинка с 15/01/2023](https://success.openhealth.fr/ru/articles/6895740-новинка-с-15-01-2023.md) - [HUB + GATE версия 221215](https://success.openhealth.fr/ru/articles/6827027-hub-gate-версия-221215.md) - [HUB + GATE версия 221115](https://success.openhealth.fr/ru/articles/6742628-hub-gate-версия-221115.md) - [HUB + GATE версия 220915](https://success.openhealth.fr/ru/articles/6558070-hub-gate-версия-220915.md) - [HUB + GATE версия 220815](https://success.openhealth.fr/ru/articles/6475311-hub-gate-версия-220815.md) - [HUB + GATE версия 220615](https://success.openhealth.fr/ru/articles/6306090-hub-gate-версия-220615.md) - [HUB + GATE версия 220515](https://success.openhealth.fr/ru/articles/6201877-hub-gate-версия-220515.md) - [HUB + GATE версия 220415](https://success.openhealth.fr/ru/articles/6087747-hub-gate-версия-220415.md) - [HUB SMA версия 220315](https://success.openhealth.fr/ru/articles/6043772-hub-sma-версия-220315.md) - [HUB TMA версия 220315](https://success.openhealth.fr/ru/articles/6043802-hub-tma-версия-220315.md) - [HUB UAN версия 220315](https://success.openhealth.fr/ru/articles/6043852-hub-uan-версия-220315.md) - [GATE версия 220215](https://success.openhealth.fr/ru/articles/5940805-gate-версия-220215.md) - [HUB SMA версия 220215](https://success.openhealth.fr/ru/articles/5940753-hub-sma-версия-220215.md) - [HUB TMA версия 220215](https://success.openhealth.fr/ru/articles/5947859-hub-tma-версия-220215.md) - [Версия GATE 211215](https://success.openhealth.fr/ru/articles/5819397-версия-gate-211215.md) - [HUB SMA версия 211215](https://success.openhealth.fr/ru/articles/5784709-hub-sma-версия-211215.md) - [HUB TMA версия 211215](https://success.openhealth.fr/ru/articles/5784888-hub-tma-версия-211215.md) - [HUB UAN версия 211215](https://success.openhealth.fr/ru/articles/5784904-hub-uan-версия-211215.md) - [Приложение The HUB: "Состояние аптеки".](https://success.openhealth.fr/ru/articles/5704485-приложение-the-hub-состояние-аптеки.md) - [Версия GATE 211115](https://success.openhealth.fr/ru/articles/5697844-версия-gate-211115.md) - [HUB SMA версия 211115](https://success.openhealth.fr/ru/articles/5671893-hub-sma-версия-211115.md) - [HUB TMA версия 211115](https://success.openhealth.fr/ru/articles/5671917-hub-tma-версия-211115.md) - [HUB UAN версия 211115](https://success.openhealth.fr/ru/articles/5671927-hub-uan-версия-211115.md) - [Версия GATE 211015](https://success.openhealth.fr/ru/articles/5652210-версия-gate-211015.md) - [HUB SMA версия 211015](https://success.openhealth.fr/ru/articles/5649822-hub-sma-версия-211015.md) - [HUB TMA версия 211015](https://success.openhealth.fr/ru/articles/5650073-hub-tma-версия-211015.md) - [HUB UAN версия 211015](https://success.openhealth.fr/ru/articles/5652242-hub-uan-версия-211015.md) - [HUB SMA версия 210915](https://success.openhealth.fr/ru/articles/5370516-hub-sma-версия-210915.md) - [HUB TMA версия 210915](https://success.openhealth.fr/ru/articles/5390983-hub-tma-версия-210915.md) - [HUB UAN версия 210915](https://success.openhealth.fr/ru/articles/5543213-hub-uan-версия-210915.md) ### Votre ESPACE D'ADMINISTRATION - fonctionnalités - [Сброс / изменение пароля The HUB](https://success.openhealth.fr/ru/articles/4425325-сброс-изменение-пароля-the-hub.md): Как изменить пароль HUB - [Помощь в подключении: я получаю сообщение об ошибке](https://success.openhealth.fr/ru/articles/5369783-помощь-в-подключении-я-получаю-сообщение-об-ошибке.md) - [Создать и отслеживать тикет](https://success.openhealth.fr/ru/articles/3586214-создать-и-отслеживать-тикет.md): Учебник по созданию и отслеживанию развития ваших билетов в вашем личном пространстве The HUB - [Создание и изменение статьи SUCCESS](https://success.openhealth.fr/ru/articles/6738705-создание-и-изменение-статьи-success.md) - [Мои контракты](https://success.openhealth.fr/ru/articles/5712273-мои-контракты.md) - [Служба здравоохранения](https://success.openhealth.fr/ru/articles/4990600-служба-здравоохранения.md) - [Мои доступы](https://success.openhealth.fr/ru/articles/5783418-мои-доступы.md) - [Настройка моей домашней страницы](https://success.openhealth.fr/ru/articles/5712229-настройка-моей-домашней-страницы.md) - [Как изменить свой рынок из личного пространства OpenHealth?](https://success.openhealth.fr/ru/articles/3585971-как-изменить-свой-рынок-из-личного-пространства-openhealth.md): Интегрируйте, изменяйте и деактивируйте продукты из вашего личного пространства OpenHealth - [Автоматическое изменение назначения модальности \(Auto MAM\)](https://success.openhealth.fr/ru/articles/4164818-автоматическое-изменение-назначения-модальности-auto-mam.md): Непосредственно изменять назначения ваших продуктов - [TEMPORAL MAM: Как следить за брендом, который меняет лабораторию / бренд / этикетку?](https://success.openhealth.fr/ru/articles/4131072-temporal-mam-как-следить-за-брендом-который-меняет-лабораторию-бренд-этикетку.md): Преимущества и риски вашего типа отслеживания - [Автоматическая интеграция продуктов \(Auto IPR\)](https://success.openhealth.fr/ru/articles/4164932-автоматическая-интеграция-продуктов-auto-ipr.md): Запросите интеграцию продукта на вашем рынке - [Автоматическая деактивация продукта \(Auto DPR\)](https://success.openhealth.fr/ru/articles/4164866-автоматическая-деактивация-продукта-auto-dpr.md): Деактивировать товар со своего рынка - [Автоматическая реактивация продукта \(RPR auto\)](https://success.openhealth.fr/ru/articles/4818161-автоматическая-реактивация-продукта-rpr-auto.md) - [Создание новых продуктов](https://success.openhealth.fr/ru/articles/5811248-создание-новых-продуктов.md) - [Добавить рынок](https://success.openhealth.fr/ru/articles/5712283-добавить-рынок.md) - [Импорт/экспорт сыпучих продуктов](https://success.openhealth.fr/ru/articles/5712257-импорт-экспорт-сыпучих-продуктов.md) - [Изменение типологической модальности \(CMT\)](https://success.openhealth.fr/ru/articles/4670174-изменение-типологической-модальности-cmt.md) - [Различные статусы пользователей](https://success.openhealth.fr/ru/articles/3436418-различные-статусы-пользователей.md): Какие особенности? - [Создание учетной записи для пользователя из сторонней организации \(TPAA\)](https://success.openhealth.fr/ru/articles/6466550-создание-учетной-записи-для-пользователя-из-сторонней-организации-tpaa.md) - [Как создать, изменить или удалить учетную запись пользователя в HUB?](https://success.openhealth.fr/ru/articles/3785138-как-создать-изменить-или-удалить-учетную-запись-пользователя-в-hub.md): Это может сделать только ПОЛЬЗОВАТЕЛЬ ПИТАНИЯ - [Могу ли я создать дифференцированные права на просмотр в HUB для моих команд?](https://success.openhealth.fr/ru/articles/3321731-могу-ли-я-создать-дифференцированные-права-на-просмотр-в-hub-для-моих-команд.md): Права в хабе - [Журнал активности](https://success.openhealth.fr/ru/articles/4687438-журнал-активности.md) ### Vos APPLICATIONS - présentation - [Руководство по обучению HUB](https://success.openhealth.fr/ru/articles/5634967-руководство-по-обучению-hub.md) - [Сортировка выпадающего селектора](https://success.openhealth.fr/ru/articles/5792113-сортировка-выпадающего-селектора.md) - [Дата обновления данных аптеки GSA \(SMKT\) в HuB](https://success.openhealth.fr/ru/articles/3175557-дата-обновления-данных-аптеки-gsa-smkt-в-hub.md): В этой статье описывается дата обновления данных из аптек GSA \(SMKT\). - [Предварительные требования Файл соответствия аптек](https://success.openhealth.fr/ru/articles/3678146-предварительные-требования-файл-соответствия-аптек.md): Предварительные требования Файл соответствия аптек - [Селектор включения и выключения рецепта](https://success.openhealth.fr/ru/articles/3729668-селектор-включения-и-выключения-рецепта.md): Характеристики объекта «Селектор типа рецепта» - [Как квалифицировать новые продукты в HUB?](https://success.openhealth.fr/ru/articles/3376100-как-квалифицировать-новые-продукты-в-hub.md): Квалификация ваших новинок в HUB - [Как создать, изменить и поделиться избранным в HUB?](https://success.openhealth.fr/ru/articles/3175689-как-создать-изменить-и-поделиться-избранным-в-hub.md): Создание и публикация избранного в Хабе - [Как выбрать продукты в HUB по дате запуска?](https://success.openhealth.fr/ru/articles/3158428-как-выбрать-продукты-в-hub-по-дате-запуска.md): В этой статье объясняется, как выбрать только продукты, выпущенные в определенный период. - [Могу ли я извлечь данные из HUB в формате ".csv"?](https://success.openhealth.fr/ru/articles/5671278-могу-ли-я-извлечь-данные-из-hub-в-формате-csv.md) - [Время реакции ODT](https://success.openhealth.fr/ru/articles/6632310-время-реакции-odt.md) - [Каковы лучшие практики отображения в HUB](https://success.openhealth.fr/ru/articles/3124454-каковы-лучшие-практики-отображения-в-hub.md): В этой статье подробно рассказывается о передовом опыте оптимизации отображения HUB - [Технические требования](https://success.openhealth.fr/ru/articles/5369918-технические-требования.md) - [Очистите кеш браузера](https://success.openhealth.fr/ru/articles/4219722-очистите-кеш-браузера.md): Как очистить кеш браузера Google Chrome - [Как установить Google Chrome в качестве браузера по умолчанию?](https://success.openhealth.fr/ru/articles/3738717-как-установить-google-chrome-в-качестве-браузера-по-умолчанию.md): Как установить Google Chrome по умолчанию - [Навигационный лифт не виден в таблицах](https://success.openhealth.fr/ru/articles/3195250-навигационный-лифт-не-виден-в-таблицах.md): Навигационный лифт - [Отображение кнопок или объектов на листе частично обрезано или не видно](https://success.openhealth.fr/ru/articles/3195245-отображение-кнопок-или-объектов-на-листе-частично-обрезано-или-не-видно.md): Проблема отображения кнопок, предметов - [Карточка управления моей территорией не загружается, и появляется сообщение "загружается"](https://success.openhealth.fr/ru/articles/3195239-карточка-управления-моей-территорией-не-загружается-и-появляется-сообщение-загружается.md): Проблема с отображением карты Territory Management / TMA - [Откуда появляется сообщение об ошибке «У вас нет прав доступа к этой странице»?](https://success.openhealth.fr/ru/articles/3195338-откуда-появляется-сообщение-об-ошибке-у-вас-нет-прав-доступа-к-этой-странице.md): Сообщения об ошибках - [У меня появляется сообщение об ошибке "Соединение потеряно"](https://success.openhealth.fr/ru/articles/4445141-у-меня-появляется-сообщение-об-ошибке-соединение-потеряно.md): произошла ошибка - [Плохой шлюз](https://success.openhealth.fr/ru/articles/4514555-плохой-шлюз.md): Сообщение об ошибке «Плохой шлюз» - [Селекторы измерения и меры больше не отображаются в запросах «Анализ за несколько периодов» и «Мой архив данных», извлечение таблицы в «Анализе рынка» является частичным.](https://success.openhealth.fr/ru/articles/3195377-селекторы-измерения-и-меры-больше-не-отображаются-в-запросах-анализ-за-несколько-периодов-и-мой-архив-данных-извлечение-таблицы-в-анализе-.md): Измерения и меры больше не отображаются - [Как просмотреть термин в ХАБЕ?](https://success.openhealth.fr/ru/articles/3194377-как-просмотреть-термин-в-хабе.md): HUB позволяет легко просматривать квадриместры на листе «Развитие продаж». - [Спецификации и ограничения Excel](https://success.openhealth.fr/ru/articles/3753088-спецификации-и-ограничения-excel.md): В этой статье объясняются характеристики и ограничения Excel. - [Как создавать, редактировать и делиться избранным в приложениях?](https://success.openhealth.fr/ru/articles/10502803-как-создавать-редактировать-и-делиться-избранным-в-приложениях.md) - [Каркас потребительской панели](https://success.openhealth.fr/ru/articles/3455845-каркас-потребительской-панели.md): Статья о структуре потребительской панели - [Система анализа аптечного рынка](https://success.openhealth.fr/ru/articles/3455857-система-анализа-аптечного-рынка.md): Статья, посвященная структуре OpenHealth для анализа рыночных показателей аптечного канала. ### ИСТОЧНИКИ ДАННЫХ - [Что такое аптечная панель OpenHealth?](https://success.openhealth.fr/ru/articles/3304106-что-такое-аптечная-панель-openhealth.md): Цель этой статьи - описать нашу аптечную панель. - [Сеть аптек - решающий актив в управлении текущими и будущими кризисами в области здравоохранения](https://success.openhealth.fr/ru/articles/3825648-сеть-аптек-решающий-актив-в-управлении-текущими-и-будущими-кризисами-в-области-здравоохранения.md): Компания OpenHealth, стремящаяся отслеживать беспрецедентный кризис в области здравоохранения, мобилизует свои технологии и данные - [Какие территории заморских департаментов и территорий Франции можно просмотреть в HUB?](https://success.openhealth.fr/ru/articles/3194382-какие-территории-заморских-департаментов-и-территорий-франции-можно-просмотреть-в-hub.md): Территории DROM-COM, доступные в Хабе - [Необходимый файл секторизации](https://success.openhealth.fr/ru/articles/3702701-необходимый-файл-секторизации.md): Эта статья позволяет вам загрузить, заполнить и отправить файл разбивки на разделы. - [Источник данных SMKT](https://success.openhealth.fr/ru/articles/4485357-источник-данных-smkt.md): IRI, поставщик данных аптек GSA - [Правила кодирования продуктов GSA Parapharmacy \(SMKT\) в IRI](https://success.openhealth.fr/ru/articles/3524492-правила-кодирования-продуктов-gsa-parapharmacy-smkt-в-iri.md): Напоминание о правилах кодификации продуктов SMKT в IRI - [Данные ORGANIC STORE - Источник BIOANALYTICS](https://success.openhealth.fr/ru/articles/5631260-данные-organic-store-источник-bioanalytics.md) - [Электронные парафармацевтики: платформы для мониторинга](https://success.openhealth.fr/ru/articles/9167006-электронные-парафармацевтики-платформы-для-мониторинга.md) - [Прибыли и убытки от продуктов электронных аптек](https://success.openhealth.fr/ru/articles/3568773-прибыли-и-убытки-от-продуктов-электронных-аптек.md): Статья, относящаяся к модулю "Прибыли и убытки от продаж электронных аптек" - [Потребительский профиль](https://success.openhealth.fr/ru/articles/3711085-потребительский-профиль.md): Статья о модуле "Профиль потребителя" - [Данные AMAZON - Источник SELLINGZ](https://success.openhealth.fr/ru/articles/5669013-данные-amazon-источник-sellingz.md) - [Данные по электронной коммерции - Источник WISER](https://success.openhealth.fr/ru/articles/7983010-данные-по-электронной-коммерции-источник-wiser.md) - [Географические территории](https://success.openhealth.fr/ru/articles/4661582-географические-территории.md): В Open Health Company вы можете анализировать свои рынки в соответствии с географическими территориями, которые мы вам предлагаем. - [Что представляет собой аптечная панель в Германии? INSIGHTHEALTH](https://success.openhealth.fr/ru/articles/5391412-что-представляет-собой-аптечная-панель-в-германии-insighthealth.md) - [Что представляет собой аптечная панель в Греции? ALIRAHEALTH](https://success.openhealth.fr/ru/articles/6863963-что-представляет-собой-аптечная-панель-в-греции-alirahealth.md) - [Что представляет собой аптечная панель в Австрии? INSIGHTHEALTH](https://success.openhealth.fr/ru/articles/6863949-что-представляет-собой-аптечная-панель-в-австрии-insighthealth.md) - [Что такое аптечная панель в Африке? PIEX - Африка](https://success.openhealth.fr/ru/articles/6686633-что-такое-аптечная-панель-в-африке-piex-африка.md) - [Что такое панель онлайн-аптеки в Германии? DATAMEDIQ](https://success.openhealth.fr/ru/articles/5689640-что-такое-панель-онлайн-аптеки-в-германии-datamediq.md) - [Что представляет собой аптечная панель в Бельгии? REDPHARMA](https://success.openhealth.fr/ru/articles/4689894-что-представляет-собой-аптечная-панель-в-бельгии-redpharma.md) - [Что представляет собой панель аптек в Испании? - HMR](https://success.openhealth.fr/ru/articles/5391363-что-представляет-собой-панель-аптек-в-испании-hmr.md) - [Что представляет собой панель аптек в Испании? - ИНФОНИС](https://success.openhealth.fr/ru/articles/5428915-что-представляет-собой-панель-аптек-в-испании-инфонис.md) - [Что представляет собой аптечная панель в Португалии? - HMR](https://success.openhealth.fr/ru/articles/5391477-что-представляет-собой-аптечная-панель-в-португалии-hmr.md) - [Что такое аптечная панель в России? - АЛЬФАРМ](https://success.openhealth.fr/ru/articles/5701531-что-такое-аптечная-панель-в-россии-альфарм.md) - [Что представляет собой аптечная панель в Польше? Pex Pharma](https://success.openhealth.fr/ru/articles/5969485-что-представляет-собой-аптечная-панель-в-польше-pex-pharma.md) - [КОНВЕРТ ГРУПП](https://success.openhealth.fr/ru/articles/6961966-конверт-групп.md) - [Что представляет собой аптечная панель в Иордании?](https://success.openhealth.fr/ru/articles/8176750-что-представляет-собой-аптечная-панель-в-иордании.md) - [Население - Картография](https://success.openhealth.fr/ru/articles/3807695-население-картография.md): Проанализировать географическое распределение населения - [AMELI - LPP](https://success.openhealth.fr/ru/articles/6962021-ameli-lpp.md) - [Население - Эволюция по ВОЗРАСТУ И ПОЛУ](https://success.openhealth.fr/ru/articles/3810789-население-эволюция-по-возрасту-и-полу.md): Проанализировать эволюцию структуры населения - [Население - Сравнение по возрасту и полу](https://success.openhealth.fr/ru/articles/3836795-население-сравнение-по-возрасту-и-полу.md): Сравните демографический профиль двух популяций - [ЕГИПЕТ - Картография](https://success.openhealth.fr/ru/articles/3714611-египет-картография.md): Проанализировать население провинций Египта - [ЕГИПЕТ - Анализ по ВОЗРАСТУ И ПОЛУ](https://success.openhealth.fr/ru/articles/3714673-египет-анализ-по-возрасту-и-полу.md): Проанализировать структуру населения - [УГАНДА - Анализ по возрасту и полу](https://success.openhealth.fr/ru/articles/3713884-уганда-анализ-по-возрасту-и-полу.md): Проанализировать структуру населения - [Население - Анализ по ВОЗРАСТУ И ПОЛУ](https://success.openhealth.fr/ru/articles/3807673-население-анализ-по-возрасту-и-полу.md): Проанализировать структуру населения - [Medicabase - база данных лекарств](https://success.openhealth.fr/ru/articles/6518920-medicabase-база-данных-лекарств.md) - [Рождение](https://success.openhealth.fr/ru/articles/6340025-рождение.md) - [OpenEudra](https://success.openhealth.fr/ru/articles/6518977-openeudra.md) - [Разбивка IRIS](https://success.openhealth.fr/ru/articles/6383829-разбивка-iris.md) - [ADICAP](https://success.openhealth.fr/ru/articles/6959465-adicap.md) - [NEC](https://success.openhealth.fr/ru/articles/6519012-nec.md) - [Данные о численности населения мира](https://success.openhealth.fr/ru/articles/8217421-данные-о-численности-населения-мира.md) - [INSEE: Досье умерших](https://success.openhealth.fr/ru/articles/4498126-insee-досье-умерших.md): INSEE \(Национальный институт статистики и экономических исследований\): Досье умерших - [Данные VAERS- VAERSDATA- Источник CDC](https://success.openhealth.fr/ru/articles/6226665-данные-vaers-vaersdata-источник-cdc.md) - [Данные VAERS - VAERSVAX - Источник CDC](https://success.openhealth.fr/ru/articles/6226440-данные-vaers-vaersvax-источник-cdc.md) - [Данные VAERS - VAERSSYMPTOMS - Источник CDC](https://success.openhealth.fr/ru/articles/6219415-данные-vaers-vaerssymptoms-источник-cdc.md) - [Интегрируйте свои данные в концентратор менее чем за 2 недели](https://success.openhealth.fr/ru/articles/5259828-интегрируйте-свои-данные-в-концентратор-менее-чем-за-2-недели.md) - [Шаблон международных данных](https://success.openhealth.fr/ru/articles/4684696-шаблон-международных-данных.md) - [Как отправить нам свои данные по FTPS?](https://success.openhealth.fr/ru/articles/4143451-как-отправить-нам-свои-данные-по-ftps.md): Отправлять данные по FTPS - [Какая информация нужна OpenHealth для интеграции нового источника данных?](https://success.openhealth.fr/ru/articles/3459148-какая-информация-нужна-openhealth-для-интеграции-нового-источника-данных.md): Статья об интеграции новых источников данных - [Долгий взгляд](https://success.openhealth.fr/ru/articles/6959482-долгий-взгляд.md) - [Как интегрировать новый источник данных в HUB?](https://success.openhealth.fr/ru/articles/3467598-как-интегрировать-новый-источник-данных-в-hub.md): Статья о процессе интеграции данных в HUB - [Интегрируйте свои данные о продажах в HUB](https://success.openhealth.fr/ru/articles/3471145-интегрируйте-свои-данные-о-продажах-в-hub.md): Статья об интеграции данных о продажах - [Характеристики для получения данных о продажах](https://success.openhealth.fr/ru/articles/3660043-характеристики-для-получения-данных-о-продажах.md): Как отправить нам информацию о продажах в рамках анализа продаж / продаж или подписки на модуль визуализации продаж - [Откуда берутся данные анализа рынка медицинских услуг на дому \(PSAD\)?](https://success.openhealth.fr/ru/articles/3376155-откуда-берутся-данные-анализа-рынка-медицинских-услуг-на-дому-psad.md): PSAD - [Как попасть в обсерваторию SantéDom Stat?](https://success.openhealth.fr/ru/articles/3798795-как-попасть-в-обсерваторию-santedom-stat.md): Учебное пособие для присоединения к национальной обсерватории деятельности поставщиков медицинских услуг на дому \(PSAD\) - [Панель экстраполирована из обсерватории SanteDomStat](https://success.openhealth.fr/ru/articles/6701602-панель-экстраполирована-из-обсерватории-santedomstat.md) - [Количество пациентов](https://success.openhealth.fr/ru/articles/3376499-количество-пациентов.md): Определение количества пациентов согласно федерациям PSAD - [Количество процедур](https://success.openhealth.fr/ru/articles/3376682-количество-процедур.md): Определение количества процедур согласно федерациям PSAD - [Количество новых пациентов](https://success.openhealth.fr/ru/articles/3376672-количество-новых-пациентов.md): Определение количества новых пациентов согласно федерациям PSAD - [Оборот с учетом налогов](https://success.openhealth.fr/ru/articles/3376725-оборот-с-учетом-налогов.md): Определение оборота с учетом налогов в соответствии с федерациями PSAD - [Количество пациентов в конце лечения](https://success.openhealth.fr/ru/articles/3376675-количество-пациентов-в-конце-лечения.md): Определение количества пациентов в конце лечения в соответствии с федерациями PSAD - [Сумма обязательного медицинского страхования \(AMO\)](https://success.openhealth.fr/ru/articles/3376740-сумма-обязательного-медицинского-страхования-amo.md): Определение суммы AMO согласно федерациям PSAD - [Сумма дополнительного медицинского страхования \(AMC\)](https://success.openhealth.fr/ru/articles/3376749-сумма-дополнительного-медицинского-страхования-amc.md): Определение суммы AMC согласно федерациям PSAD - [Непогашенный заряд \(RAC\)](https://success.openhealth.fr/ru/articles/3376751-непогашенный-заряд-rac.md): Определение RAC согласно федерациям PSAD - [Источник: THESORIMED](https://success.openhealth.fr/ru/articles/3560018-источник-thesorimed.md): База данных лекарств \(BdM\) - [Международные непатентованные наименования \(INN\)](https://success.openhealth.fr/ru/articles/3954239-международные-непатентованные-наименования-inn.md): Международные общеупотребительные названия \(INN\) - [Факты об открытой пище](https://success.openhealth.fr/ru/articles/6961970-факты-об-открытой-пище.md) - [LOINC - логические идентификаторы наблюдений Имена и коды](https://success.openhealth.fr/ru/articles/6959323-loinc-логические-идентификаторы-наблюдений-имена-и-коды.md) - [AMELI - CCAM](https://success.openhealth.fr/ru/articles/6959080-ameli-ccam.md) - [ВОЗ АТС ВЕТ](https://success.openhealth.fr/ru/articles/6959078-воз-атс-вет.md) - [CEPS](https://success.openhealth.fr/ru/articles/6959068-ceps.md) - [Учреждение](https://success.openhealth.fr/ru/articles/3935678-учреждение.md): Список медицинских, социальных, медико-социальных учреждений - [Медицинские услуги](https://success.openhealth.fr/ru/articles/7969680-медицинские-услуги.md) - [Извлечь FINESS](https://success.openhealth.fr/ru/articles/3946922-извлечь-finess.md): Выполните извлечение в соответствии с вашими ожиданиями - [Эволюция FINESS](https://success.openhealth.fr/ru/articles/3947009-эволюция-finess.md): Следите за эволюцией количества структур - [Авторизация ухода за деятельностью](https://success.openhealth.fr/ru/articles/3947067-авторизация-ухода-за-деятельностью.md): Составьте список структур в соответствии с их разрешениями на медицинскую деятельность - [Основное медицинское оборудование](https://success.openhealth.fr/ru/articles/3947269-основное-медицинское-оборудование.md): Перечислите конструкции в соответствии с их оборудованием из тяжелых материалов. - [Географический](https://success.openhealth.fr/ru/articles/3947363-географический.md): Визуализируйте распределение построек по территории - [RPPS](https://success.openhealth.fr/ru/articles/3947568-rpps.md): Список медицинских работников - [БЫСТРОСТЬ И RPPS](https://success.openhealth.fr/ru/articles/3947713-быстрость-и-rpps.md): Перечислите места тренировок медицинских работников. - [Извлечь RPPS](https://success.openhealth.fr/ru/articles/3947829-извлечь-rpps.md): RPPS \(общий справочник медицинских работников\) ### Модели - [Данные в УГА](https://success.openhealth.fr/ru/articles/4852310-данные-в-уга.md) - [Расчет продаж в сектор: что нужно знать](https://success.openhealth.fr/ru/articles/3545561-расчет-продаж-в-сектор-что-нужно-знать.md): Каковы различные шаги для расчета продаж сектора в OpenHealth? - [Перераспределение секторов, статическая или динамическая методология?](https://success.openhealth.fr/ru/articles/3690615-перераспределение-секторов-статическая-или-динамическая-методология.md): Перераспределение секторов, статическая или динамическая методология? - [Аптеки страты](https://success.openhealth.fr/ru/articles/4291490-аптеки-страты.md): Детали «теоретических» слоев и «реальных» или «эффективных» слоев. - [Производственная линия концентратора](https://success.openhealth.fr/ru/articles/4816146-производственная-линия-концентратора.md) - [Как провести сравнительный анализ?](https://success.openhealth.fr/ru/articles/3440093-как-провести-сравнительный-анализ.md): Вы хотите сравнить данные от двух разных поставщиков. - [ИССЛЕДОВАНИЕ УРОВНЯ 1 - Качество данных на службе компании OpenHealth](https://success.openhealth.fr/ru/articles/3595822-исследование-уровня-1-качество-данных-на-службе-компании-openhealth.md): Вы наблюдаете явление, которого не понимаете? Мы можем предоставить вам информацию о происхождении этого наблюдения и объяснить его вам. - [Процесс обеспечения качества данных в OpenHealth](https://success.openhealth.fr/ru/articles/3415271-процесс-обеспечения-качества-данных-в-openhealth.md): В этой статье подробно описаны этапы процессов обеспечения качества данных в OpenHealth. - [Интервал и уровень достоверности](https://success.openhealth.fr/ru/articles/3633173-интервал-и-уровень-достоверности.md): Определения, формулы и ограничения: что нужно знать - [Качество данных: управление партиями](https://success.openhealth.fr/ru/articles/3433509-качество-данных-управление-партиями.md): Описание процесса управления партиями - [Качество данных: процесс декомпозиции продаж](https://success.openhealth.fr/ru/articles/3415317-качество-данных-процесс-декомпозиции-продаж.md): Описание процесса распределения продаж - [Продажа и зачет запасов](https://success.openhealth.fr/ru/articles/4131084-продажа-и-зачет-запасов.md): Продажа акций - [Зачем анализировать объем продаж?](https://success.openhealth.fr/ru/articles/3846167-зачем-анализировать-объем-продаж.md): Зачем анализировать объем продаж? - [Существует разрыв в данных между продажами и продажами.](https://success.openhealth.fr/ru/articles/3195358-существует-разрыв-в-данных-между-продажами-и-продажами.md): В каких случаях у нас может быть разрыв в данных между продажами и продажами? - [Что такое нетипичная распродажа?](https://success.openhealth.fr/ru/articles/3195366-что-такое-нетипичная-распродажа.md): Нетипичные продажи и процесс АТИПИЧНЫЙ ФИЛЬТР. - [Откуда берется информация о ценах, объемах, оборотах?](https://success.openhealth.fr/ru/articles/3195348-откуда-берется-информация-о-ценах-объемах-оборотах.md): Информация о цене / объеме / обороте - [Предполагаемый объем продаж по рецепту](https://success.openhealth.fr/ru/articles/4171530-предполагаемый-объем-продаж-по-рецепту.md): Как оценить объемы продаж в аптеках по рецепту и категории врача - [Понимание разницы между двумя экстракциями](https://success.openhealth.fr/ru/articles/13399689-понимание-разницы-между-двумя-экстракциями.md) ### РЫНКИ - [GTIN](https://success.openhealth.fr/ru/articles/3608176-gtin.md): Код GTIN \(глобальный номер предмета торговли\) - [Спецификация поля спецификатора продукта клиента \(CQCP\)](https://success.openhealth.fr/ru/articles/3704913-спецификация-поля-спецификатора-продукта-клиента-cqcp.md): CQCP \(поле квалификатора клиента продукта\) - [Что такое код LPPR?](https://success.openhealth.fr/ru/articles/3195365-что-такое-код-lppr.md): Код LPPR \(Список продуктов и услуг, подлежащих возмещению\) - [Отслеживание аренды товара](https://success.openhealth.fr/ru/articles/4206554-отслеживание-аренды-товара.md): Аренда продукции - [Я хочу расширить свой рынок](https://success.openhealth.fr/ru/articles/4420843-я-хочу-расширить-свой-рынок.md): Рынок подписки followed - [Классификация OHC](https://success.openhealth.fr/ru/articles/3194589-классификация-ohc.md): Визуализируйте распределение ваших продуктов в соответствии с собственной классификацией компании OpenHealth. - [История классов EphMRA AC](https://success.openhealth.fr/ru/articles/3557908-история-классов-ephmra-ac.md): Визуализируйте эволюцию классов EphMRA AC с 2014 года - [Детали ветеринарной медицины](https://success.openhealth.fr/ru/articles/3194587-детали-ветеринарной-медицины.md): Визуализируйте характеристики ветеринарных препаратов - [Классификация ветеринарной медицины](https://success.openhealth.fr/ru/articles/3194579-классификация-ветеринарной-медицины.md): Посмотреть классификацию ветеринарных препаратов \(ANSES\) - [Детали медицины человека](https://success.openhealth.fr/ru/articles/3421225-детали-медицины-человека.md): Просмотрите характеристики одного или нескольких продуктов в полях сведений THESORIMED. - [Управление новыми продуктами](https://success.openhealth.fr/ru/articles/4470813-управление-новыми-продуктами.md): Управление новым продуктом - [Классификация медицины человека](https://success.openhealth.fr/ru/articles/3417281-классификация-медицины-человека.md): Ознакомьтесь с классификациями EphMRA AC и OMS ATC для вашей продукции - [Показания - Диагностика](https://success.openhealth.fr/ru/articles/3568554-показания-диагностика.md): Просмотрите препараты, указанные для данной патологии, и патологии, связанные с выбором препаратов. - [MP4U](https://success.openhealth.fr/ru/articles/3574188-mp4u.md): Просмотреть все классификации, предоставленные компанией OpenHealth - [Что такое TVASI \(таблица продаж, закупок и неизвестных запасов\)](https://success.openhealth.fr/ru/articles/5992494-что-такое-tvasi-таблица-продаж-закупок-и-неизвестных-запасов.md) - [Классификация продуктов IRI](https://success.openhealth.fr/ru/articles/3194597-классификация-продуктов-iri.md): Визуализируйте распределение ваших продуктов согласно классификации владелец IRI - [Удаление непроданных товаров](https://success.openhealth.fr/ru/articles/6135938-удаление-непроданных-товаров.md) - [СТАНДАРТНЫЙ РЫНОК - Подписка](https://success.openhealth.fr/ru/articles/3798203-стандартный-рынок-подписка.md): В этой статье описываются интересы и ограничения так называемого "стандартного" рынка. - [Я не могу найти свой продукт](https://success.openhealth.fr/ru/articles/5686002-я-не-могу-найти-свой-продукт.md) - [Управление кодом продукта](https://success.openhealth.fr/ru/articles/5652478-управление-кодом-продукта.md) - [Квалификация товара: Бренды](https://success.openhealth.fr/ru/articles/5016985-квалификация-товара-бренды.md) ### ОПИСАНИЯ и МОДУЛИ - [3 типа применения](https://success.openhealth.fr/ru/articles/9489652-3-типа-применения.md) - [Ваша платформа 2.0](https://success.openhealth.fr/ru/articles/8374416-ваша-платформа-2-0.md) - [РЕЗЮМЕ](https://success.openhealth.fr/ru/articles/3344127-резюме.md): В этом модуле доступны все характеристики вашего приложения. - [Рынки и выборки](https://success.openhealth.fr/ru/articles/8337016-рынки-и-выборки.md) - [Сводная приборная панель](https://success.openhealth.fr/ru/articles/9246867-сводная-приборная-панель.md) - [Анализ](https://success.openhealth.fr/ru/articles/9352287-анализ.md) - [Вытяжка](https://success.openhealth.fr/ru/articles/9246875-вытяжка.md) - [Анализ роста](https://success.openhealth.fr/ru/articles/3158856-анализ-роста.md): Определите ключевые факторы развития ваших рынков и рынков ваших конкурентов. - [Анализ ассортимента](https://success.openhealth.fr/ru/articles/3473736-анализ-ассортимента.md): Изучите динамизм продуктов на рынке - [Среднее количество товаров](https://success.openhealth.fr/ru/articles/3161474-среднее-количество-товаров.md): Просмотр среднего количества продуктов в торговой точке, в аптеке или в аптеке GSA - [Отслеживание запуска](https://success.openhealth.fr/ru/articles/3158488-отслеживание-запуска.md): Отслеживайте запуск новых продуктов и их вклад в рост - [Передовые показатели пересекаются](https://success.openhealth.fr/ru/articles/6007740-передовые-показатели-пересекаются.md) - [Концентрация продаж](https://success.openhealth.fr/ru/articles/3095338-концентрация-продаж.md): Визуализируйте концентрацию рынка с помощью кривой концентрации продаж и индекса GINI - [Разброс цен](https://success.openhealth.fr/ru/articles/3159289-разброс-цен.md): Визуализируйте разброс цен на продукт. Создавайте собственные сегменты аптек по продажной цене - [Анализ маржи продажи](https://success.openhealth.fr/ru/articles/3358322-анализ-маржи-продажи.md): Оцените привлекательность ваших продуктов для аптек - [Эволюция маржи распродаж](https://success.openhealth.fr/ru/articles/3815561-эволюция-маржи-распродаж.md) - [Аптечный мониторинг \(1/2\)](https://success.openhealth.fr/ru/articles/3358248-аптечный-мониторинг-1-2.md): Следите за развитием аптечного трафика - [Аптечный мониторинг \(2/2\)](https://success.openhealth.fr/ru/articles/3810527-аптечный-мониторинг-2-2.md): Следите за развитием аптечного трафика - [Эффективность Salesforce](https://success.openhealth.fr/ru/articles/3159230-эффективность-salesforce.md): Сравните показатели продаж по регионам и секторам продаж. - [АССИСТАНТ по управлению взаимоотношениями с клиентами \(CRM\)](https://success.openhealth.fr/ru/articles/5953935-ассистант-по-управлению-взаимоотношениями-с-клиентами-crm.md) - [Пункт отслеживания продаж](https://success.openhealth.fr/ru/articles/3778944-пункт-отслеживания-продаж.md): Пункт отслеживания продаж - [Эволюция по требованию](https://success.openhealth.fr/ru/articles/6560184-эволюция-по-требованию.md) - [Анализ по требованию](https://success.openhealth.fr/ru/articles/6127483-анализ-по-требованию.md) - [Таблица по запросу](https://success.openhealth.fr/ru/articles/3158751-таблица-по-запросу.md): Визуализируйте основные индикаторы HUB и их эволюцию за разные периоды - [Анализ временных рядов](https://success.openhealth.fr/ru/articles/3635940-анализ-временных-рядов.md): Разбейте свой рынок на сезон, тренд и шум - [Прогнозный анализ](https://success.openhealth.fr/ru/articles/3636015-прогнозный-анализ.md): Оцените будущее своего рынка - [Отраслевой прогноз](https://success.openhealth.fr/ru/articles/3689811-отраслевой-прогноз.md): Оцените свои будущие продажи в секторе - [Визуализация продаж](https://success.openhealth.fr/ru/articles/3559882-визуализация-продаж.md): Сравните динамику продаж и распродаж - [Анализ продаж](https://success.openhealth.fr/ru/articles/6188132-анализ-продаж.md) - [Сопоставление продаж](https://success.openhealth.fr/ru/articles/6188090-сопоставление-продаж.md) - [Эволюция продаж](https://success.openhealth.fr/ru/articles/6191929-эволюция-продаж.md) - [Анализ продаж в сравнении с продажами](https://success.openhealth.fr/ru/articles/6191947-анализ-продаж-в-сравнении-с-продажами.md) - [Эволюция Sell-in vs Sell-out](https://success.openhealth.fr/ru/articles/6191955-эволюция-sell-in-vs-sell-out.md) - [Эволюция цен](https://success.openhealth.fr/ru/articles/5056489-эволюция-цен.md) - [Настройка цветов](https://success.openhealth.fr/ru/articles/8407897-настройка-цветов.md) - [Экспорт продукции](https://success.openhealth.fr/ru/articles/3583206-экспорт-продукции.md): Лист экспорта для всех продуктов и приложений типа MP4U - [Анализ рынка](https://success.openhealth.fr/ru/articles/3121933-анализ-рынка.md): Проанализируйте эффективность вашего рынка: по сегментам, брендам, продуктам и компаниям - [Анализ цен](https://success.openhealth.fr/ru/articles/3215190-анализ-цен.md): Просмотрите цены на вашем рынке и проанализируйте свое позиционирование - [Развитие продаж](https://success.openhealth.fr/ru/articles/3178323-развитие-продаж.md): Просматривайте динамику продаж по всей доступной истории - [Резюме приборной панели](https://success.openhealth.fr/ru/articles/4533213-резюме-приборной-панели.md) - [Эволюция доли рынка](https://success.openhealth.fr/ru/articles/3193078-эволюция-доли-рынка.md): Визуализируйте эволюцию продаж и доли рынка в течение длительного периода - [Перекрестная таблица продаж](https://success.openhealth.fr/ru/articles/3193060-перекрестная-таблица-продаж.md): Создайте простую сводную таблицу - [ОБОРОТ / ОБЪЕМ \(CU\) Синтез](https://success.openhealth.fr/ru/articles/3193048-оборот-объем-cu-синтез.md): Одновременно визуализируйте объемы продаж и стоимость рынка - [Синтез стоимости продажи \(АПТЕКИ / СУПЕРМАРКЕТЫ\)](https://success.openhealth.fr/ru/articles/3193020-синтез-стоимости-продажи-аптеки-супермаркеты.md): Сравните продажи аптек и аптек GSA - [Анализ доли рынка](https://success.openhealth.fr/ru/articles/3193069-анализ-доли-рынка.md): Проанализировать доли рынка за последние 12 месяцев - [Мой архив данных](https://success.openhealth.fr/ru/articles/3193099-мой-архив-данных.md): Экспорт плоской базы данных в Excel - [Анализ нескольких периодов](https://success.openhealth.fr/ru/articles/3192953-анализ-нескольких-периодов.md): Создайте полностью индивидуальный стол - [Мой запрос Все товары](https://success.openhealth.fr/ru/articles/4280353-мой-запрос-все-товары.md): Просмотрите свои сегменты и соответствующие поля \(например, галеновый индекс, солнечный индекс, рекламные акции..\), а также ваше ограничение - [Stock Evolution \(НОВИНКА\)](https://success.openhealth.fr/ru/articles/3719256-stock-evolution-новинка.md): Визуализируйте и анализируйте эволюцию запасов и их распределение - [Определение рынка](https://success.openhealth.fr/ru/articles/3158829-определение-рынка.md): Заново основывайте свой рынок на базе 100 по вашему выбору - [Расширенные индикаторы RAW DATA](https://success.openhealth.fr/ru/articles/3711095-расширенные-индикаторы-raw-data.md): Восстановите данные опережающего индикатора - [Расширенные индикаторы Evolution SMKT](https://success.openhealth.fr/ru/articles/3193000-расширенные-индикаторы-evolution-smkt.md): Следите за производительностью вашей лаборатории с помощью анализа временной эволюции ваших передовых статистических показателей. - [Расширенный анализ индикаторов SMKT](https://success.openhealth.fr/ru/articles/3192366-расширенный-анализ-индикаторов-smkt.md): Разбейте эволюцию рынка парафармацевтики GSA на основные индикаторы - [Эволюция расширенных индикаторов](https://success.openhealth.fr/ru/articles/3177853-эволюция-расширенных-индикаторов.md): Контролируйте работу своей лаборатории с помощью анализа временной эволюции ваших расширенных статистических показателей. - [Передовые индикаторы Эволюция Био](https://success.openhealth.fr/ru/articles/7051823-передовые-индикаторы-эволюция-био.md) - [Национальные передовые индикаторы](https://success.openhealth.fr/ru/articles/3364513-национальные-передовые-индикаторы.md): Разбейте эволюцию рынка на опережающие индикаторы - [Анализ запасов](https://success.openhealth.fr/ru/articles/3178015-анализ-запасов.md): Интерпретируйте уровень запасов и его эволюцию - [Расширенный анализ индикаторов Био](https://success.openhealth.fr/ru/articles/7051801-расширенный-анализ-индикаторов-био.md) - [Расширенный анализ индикаторов](https://success.openhealth.fr/ru/articles/3124439-расширенный-анализ-индикаторов.md): Разложите эволюцию рынка на опережающие индикаторы - [Картография](https://success.openhealth.fr/ru/articles/3192450-картография.md): Анализируйте коммерческие показатели регионов и секторов вашего торгового персонала - [Географическая кросс-таблица](https://success.openhealth.fr/ru/articles/3192466-географическая-кросс-таблица.md): Создайте сводную таблицу, объединяющую вашу секторизацию - [Развитие географических продаж](https://success.openhealth.fr/ru/articles/3192482-развитие-географических-продаж.md): Просмотр продаж за 36 месяцев по секторам в сводной таблице - [Эффективность отдела продаж](https://success.openhealth.fr/ru/articles/5624011-эффективность-отдела-продаж.md) - [Анализ пользовательского метода взвешивания](https://success.openhealth.fr/ru/articles/5169317-анализ-пользовательского-метода-взвешивания.md) - [Сетевой анализ](https://success.openhealth.fr/ru/articles/3894767-сетевой-анализ.md): Сетевой анализ - [Эволюция метода пользовательских весов](https://success.openhealth.fr/ru/articles/5169320-эволюция-метода-пользовательских-весов.md) - [ИТОГОВЫЕ КПЭ](https://success.openhealth.fr/ru/articles/3478199-итоговые-кпэ.md): Визуализируйте в динамической таблице ваши ключевые показатели. Объем снизился по регионам и секторам. - [Продажи в конвертированных единицах](https://success.openhealth.fr/ru/articles/3192412-продажи-в-конвертированных-единицах.md): Используйте преобразованные единицы, чтобы визуализировать свои продажи - [Индикаторы запасов RAW DATA](https://success.openhealth.fr/ru/articles/3711142-индикаторы-запасов-raw-data.md): Экспортируйте данные инвентаризации - [RAW DATA SMKT AIA](https://success.openhealth.fr/ru/articles/3720960-raw-data-smkt-aia.md): Найдите данные опережающего индикатора SMKT - [Stock Evolution](https://success.openhealth.fr/ru/articles/3178277-stock-evolution.md): Визуализируйте и анализируйте эволюцию запасов и их распределение - [Расширенные географические индикаторы](https://success.openhealth.fr/ru/articles/3192508-расширенные-географические-индикаторы.md): Просмотр опережающих индикаторов по регионам или секторам - [Производительность продукции](https://success.openhealth.fr/ru/articles/3850331-производительность-продукции.md): Сравните бизнес-показатели регионов и товарных секторов - [Расширенные территориальные индикаторы](https://success.openhealth.fr/ru/articles/3370879-расширенные-территориальные-индикаторы.md): Разбейте эволюцию рынка на опережающие индикаторы - [Секториальный анализ временных рядов](https://success.openhealth.fr/ru/articles/3814974-секториальный-анализ-временных-рядов.md): Разбейте свой рынок на тренд, сезон, шум - [Анализ продаж по возрасту и полу](https://success.openhealth.fr/ru/articles/3192701-анализ-продаж-по-возрасту-и-полу.md): Анализируйте продажи по возрасту и полу - [Развитие продаж в зависимости от статуса беременности](https://success.openhealth.fr/ru/articles/3192910-развитие-продаж-в-зависимости-от-статуса-беременности.md): Следите за аптечными продажами по численности беременных - [Эволюция продаж по возрасту и полу](https://success.openhealth.fr/ru/articles/3192732-эволюция-продаж-по-возрасту-и-полу.md): Визуализируйте эволюцию продаж по возрасту и полу, используя глубину истории HUB - [Эволюция требований к порядку](https://success.openhealth.fr/ru/articles/5790020-эволюция-требований-к-порядку.md) - [Совместная эволюция](https://success.openhealth.fr/ru/articles/3192529-совместная-эволюция.md): Визуализируйте и проанализируйте эволюцию совместных отпусков в аптеках - [Анализ совместных диспенсаций](https://success.openhealth.fr/ru/articles/3192633-анализ-совместных-диспенсаций.md): Просмотр совместных отпусков в аптеках, связанных с выбором продуктов с моего рынка - [Продажи на канал и предписания](https://success.openhealth.fr/ru/articles/3192751-продажи-на-канал-и-предписания.md): Визуализируйте лидеров мнений на вашем рынке - [AMO, AMC и RAC](https://success.openhealth.fr/ru/articles/3192929-amo-amc-и-rac.md): Просмотр трех сумм обязательного медицинского страхования, дополнительного медицинского страхования и личных расходов - [Совместная диспенсация Дисперсия](https://success.openhealth.fr/ru/articles/3876946-совместная-диспенсация-дисперсия.md): Просмотр распределения количества продуктов, проданных по распределению - [Диспенсация Эволюция дисперсии](https://success.openhealth.fr/ru/articles/3920070-диспенсация-эволюция-дисперсии.md): Визуализируйте распределение количества продуктов, проданных за разлив, с течением времени - [Рецепты врача общей практики по возрасту и полу](https://success.openhealth.fr/ru/articles/5789899-рецепты-врача-общей-практики-по-возрасту-и-полу.md) - [Анализ рецептурных заказов](https://success.openhealth.fr/ru/articles/5322866-анализ-рецептурных-заказов.md) - [Эволюция рецептов врачей общей практики](https://success.openhealth.fr/ru/articles/5790016-эволюция-рецептов-врачей-общей-практики.md) - [Анализ корзины](https://success.openhealth.fr/ru/articles/3711049-анализ-корзины.md): Описание модуля «Анализ корзины» - [Совместное дозирование](https://success.openhealth.fr/ru/articles/4738243-совместное-дозирование.md) - [Квалификационный модуль когорты](https://success.openhealth.fr/ru/articles/3928090-квалификационный-модуль-когорты.md): Квалификация когорты пациентов - [Модуль статуса лечения](https://success.openhealth.fr/ru/articles/3928067-модуль-статуса-лечения.md): Анализировать динамику мониторинга лечения - [Модуль приверженности к лечению](https://success.openhealth.fr/ru/articles/3928044-модуль-приверженности-к-лечению.md): Анализировать приверженность к лечению - [Определение когорты](https://success.openhealth.fr/ru/articles/3894703-определение-когорты.md): Определите объем вашего анализа - [Совместное лечение](https://success.openhealth.fr/ru/articles/4163623-совместное-лечение.md): Определите совместную обработку в рамках вашего анализа - [Когорта визуализации](https://success.openhealth.fr/ru/articles/3894721-когорта-визуализации.md): Просмотр профиля пациента определенной когорты - [Определение критериев анализа](https://success.openhealth.fr/ru/articles/3894728-определение-критериев-анализа.md): Определите параметры для анализа вашей когорты - [Глобальная когортная эволюция](https://success.openhealth.fr/ru/articles/3894747-глобальная-когортная-эволюция.md): Визуализируйте ежемесячную эволюцию когорты - [Географическое распространение](https://success.openhealth.fr/ru/articles/3894751-географическое-распространение.md): Просмотр географического распределения пациентов в определенной когорте - [Профиль когорты](https://success.openhealth.fr/ru/articles/3894755-профиль-когорты.md): Проанализировать демографический профиль пациентов, включенных в когорту - [Нарушение статуса лечения](https://success.openhealth.fr/ru/articles/3894764-нарушение-статуса-лечения.md): Получите обзор различных типов мониторинга лечения - [Начало лечения](https://success.openhealth.fr/ru/articles/3894778-начало-лечения.md): Проанализировать динамику количества начатых лечебных мероприятий - [Лечение возобновлено](https://success.openhealth.fr/ru/articles/3894788-лечение-возобновлено.md): Проанализировать динамику количества повторных курсов лечения - [Новые методы лечения](https://success.openhealth.fr/ru/articles/3894804-новые-методы-лечения.md): Проанализировать динамику количества начатых и возобновлений лечения - [Рецидивы лечения](https://success.openhealth.fr/ru/articles/3894812-рецидивы-лечения.md): Проанализировать пациентов на лечении - [Баланс переключения режимов лечения](https://success.openhealth.fr/ru/articles/3894821-баланс-переключения-режимов-лечения.md): Анализируйте баланс изменений лечения по каждому лечению - [Преимущества переключения режима лечения](https://success.openhealth.fr/ru/articles/3894830-преимущества-переключения-режима-лечения.md): Проанализируйте тех, кому поменяли лечение - [Потери при переключении режимов лечения](https://success.openhealth.fr/ru/articles/3894843-потери-при-переключении-режимов-лечения.md): Анализируйте лечение проигравших переключателей лечения - [Переключить источники усиления](https://success.openhealth.fr/ru/articles/3894857-переключить-источники-усиления.md): Проанализировать происхождение переключения для данного лечения - [Пункт назначения потери переключения](https://success.openhealth.fr/ru/articles/3894864-пункт-назначения-потери-переключения.md): Проанализировать назначение переключателя для данного лечения - [Выпадение](https://success.openhealth.fr/ru/articles/3894874-выпадение.md): Проанализировать остановки лечения - [Сводка КПЭ](https://success.openhealth.fr/ru/articles/4229969-сводка-кпэ.md): Резюме различных видов мониторинга лечения - [Настойчивость лечения](https://success.openhealth.fr/ru/articles/3894883-настойчивость-лечения.md): Анализируйте продолжительность лечения - [Соблюдение](https://success.openhealth.fr/ru/articles/3894884-соблюдение.md): Проанализировать поставленное количество - [Каков критерий регулярности?](https://success.openhealth.fr/ru/articles/3325816-каков-критерий-регулярности.md): Определение понятия критерия регулярности - [Смерть - Картография](https://success.openhealth.fr/ru/articles/3863677-смерть-картография.md): Проанализировать географическое распределение смертей - [Смещение количества смертей](https://success.openhealth.fr/ru/articles/3863573-смещение-количества-смертей.md): Оцените актуальность ваших данных - [Смерть - анализ по возрасту и полу](https://success.openhealth.fr/ru/articles/3863808-смерть-анализ-по-возрасту-и-полу.md): Проанализировать структуру смертей - [Смерть - эволюция по возрасту и полу](https://success.openhealth.fr/ru/articles/3863939-смерть-эволюция-по-возрасту-и-полу.md): Анализировать эволюцию структуры смертей - [Смерть - Эволюция](https://success.openhealth.fr/ru/articles/3864065-смерть-эволюция.md): Визуализируйте эволюцию смертей - [Смерть - сравнение эволюции](https://success.openhealth.fr/ru/articles/3864073-смерть-сравнение-эволюции.md): Сравните динамику смертности по сравнению с предыдущими годами - [Центр контроля аптек](https://success.openhealth.fr/ru/articles/4634768-центр-контроля-аптек.md): Опишите трафик в соответствии с размером аптек. - [Анализ трафика \(бета-тест\)](https://success.openhealth.fr/ru/articles/6848401-анализ-трафика-бета-тест.md) - [Детали мониторинга аптек](https://success.openhealth.fr/ru/articles/4527868-детали-мониторинга-аптек.md): Анализировать оборот аптек по типам аптек - [Эволюция трафика \(бета-тест\)](https://success.openhealth.fr/ru/articles/6848016-эволюция-трафика-бета-тест.md) - [Картография аптечного мониторинга](https://success.openhealth.fr/ru/articles/4527811-картография-аптечного-мониторинга.md): Проанализируйте движение диспансеров на материковой части Франции - [Детали мониторинга аптек](https://success.openhealth.fr/ru/articles/4262306-детали-мониторинга-аптек.md): Различить детали продаж по типу диспансера - [Анализ мониторинга аптек](https://success.openhealth.fr/ru/articles/3839223-анализ-мониторинга-аптек.md): Следите за развитием аптечного трафика - [Эволюция мониторинга аптек](https://success.openhealth.fr/ru/articles/3827973-эволюция-мониторинга-аптек.md): Изучите эволюцию диспансерного трафика - [Разложение трафика](https://success.openhealth.fr/ru/articles/3826074-разложение-трафика.md): Обратите внимание на компоненты сезона, тренда и остатка - [Исследование трафика](https://success.openhealth.fr/ru/articles/3809042-исследование-трафика.md): Анализируйте посещаемость аптек - [Исполнительное резюме - PIEX](https://success.openhealth.fr/ru/articles/5203335-исполнительное-резюме-piex.md) - [Покупка](https://success.openhealth.fr/ru/articles/4605110-покупка.md): Отслеживайте свои покупки и их квитанции - [Мой запрос - PIEX](https://success.openhealth.fr/ru/articles/4210627-мой-запрос-piex.md): Сделайте выбор на своих данных - [Развитие продаж - PIEX](https://success.openhealth.fr/ru/articles/4210655-развитие-продаж-piex.md): Просматривайте эволюцию вашей активности в доступной истории - [Анализ продаж - PIEX](https://success.openhealth.fr/ru/articles/4210650-анализ-продаж-piex.md): Анализ продаж - PIEX - [Детали заказа - PIEX](https://success.openhealth.fr/ru/articles/4210659-детали-заказа-piex.md): Просмотр и отслеживание заказа на продажу - [Обзор акций - PIEX](https://success.openhealth.fr/ru/articles/4210672-обзор-акций-piex.md): Визуализируйте вариации ваших акций - [Мой архив данных - PIEX](https://success.openhealth.fr/ru/articles/4210694-мой-архив-данных-piex.md): Экспорт плоской базы данных в Excel - [EURAPHARMA- PIEX](https://success.openhealth.fr/ru/articles/4366306-eurapharma-piex.md): Визуализируйте эволюцию деятельности EURAPHARMA - [Соответствующий продукт](https://success.openhealth.fr/ru/articles/4366320-соответствующий-продукт.md): Соответствие обозначений продуктов PIEX и EURAPHARMA - [CLI Мой файл \(1/5\)](https://success.openhealth.fr/ru/articles/4626422-cli-мой-файл-1-5.md): CLI Мой файл \(1/5\) - [CLI\_File Counts \(2/5\)](https://success.openhealth.fr/ru/articles/4626421-cli_file-counts-2-5.md): CLI\_File Counts \(2/5\) - [CLI\_File Code Matching with OHC репозиторий](https://success.openhealth.fr/ru/articles/4626419-cli_file-code-matching-with-ohc-репозиторий.md): CLI\_FIL Соответствие кода с репозиторием OHC - [Распродажа на экспорт \(4/5\)](https://success.openhealth.fr/ru/articles/4626414-распродажа-на-экспорт-4-5.md): Распродажа Экспорт \(4/5\) ### ПЕРСОНАЛИЗИРОВАННЫЕ ОПЦИИ - [Неиерархические квалификационные поля продукта](https://success.openhealth.fr/ru/articles/4036045-неиерархические-квалификационные-поля-продукта.md): Добавьте подробности о квалификации ваших продуктов - [Каков максимальный возраст данных HUB?](https://success.openhealth.fr/ru/articles/3195251-каков-максимальный-возраст-данных-hub.md): Последние доступные данные - [Тип клиента](https://success.openhealth.fr/ru/articles/4197147-тип-клиента.md): Пользовательский вариант Тип клиента - [Сессионный доступ](https://success.openhealth.fr/ru/articles/4036458-сессионный-доступ.md): Ограничьте просмотр ваших сотрудников - [Пользовательский цикл](https://success.openhealth.fr/ru/articles/4036444-пользовательский-цикл.md): Анализируйте свои данные за индивидуальные периоды времени - [Отчетный год](https://success.openhealth.fr/ru/articles/4036169-отчетный-год.md): Определите свой финансовый год - [Кнопка дня](https://success.openhealth.fr/ru/articles/4036159-кнопка-дня.md): Визуализируйте данные с большей детализацией - [Кнопка недели](https://success.openhealth.fr/ru/articles/4036111-кнопка-недели.md): Визуализируйте данные с большей детализацией - [Курсы валют](https://success.openhealth.fr/ru/articles/8329594-курсы-валют.md) - [Календарь периодов СМКТ](https://success.openhealth.fr/ru/articles/4036549-календарь-периодов-смкт.md): Используйте календарь GSA - [Ограничить периметр](https://success.openhealth.fr/ru/articles/4560699-ограничить-периметр.md): Выбор одного списка GTIN в разделе "Мой запрос" из файла .xlsx - [Ограничить периметр \(код 7\)](https://success.openhealth.fr/ru/articles/4560791-ограничить-периметр-код-7.md): Выбор одного списка \[ТЕХНИЧЕСКИЙ КОД 2\] в My Query из файла .xlsx - [Флаг рынка](https://success.openhealth.fr/ru/articles/4560797-флаг-рынка.md): Выбор одного списка GTIN в My Query из определения рынка, содержащегося в файле .xlsx - [Таргетинг / определение типа клиента](https://success.openhealth.fr/ru/articles/3777788-таргетинг-определение-типа-клиента.md): Таргетинг \(тип клиента\) ### ИНДИКАТОРЫ ХУБА - [Глоссарий показателей HUB](https://success.openhealth.fr/ru/articles/5194247-глоссарий-показателей-hub.md) - [Количество продаж](https://success.openhealth.fr/ru/articles/3194314-количество-продаж.md): Количество продаж - [Продажная стоимость](https://success.openhealth.fr/ru/articles/3074854-продажная-стоимость.md): Спецификация индикатора Торговые значения - [N MS](https://success.openhealth.fr/ru/articles/3194475-n-ms.md): Определение меры N MS - [N MS Evol](https://success.openhealth.fr/ru/articles/5634266-n-ms-evol.md) - [N MS Delta](https://success.openhealth.fr/ru/articles/3194469-n-ms-delta.md): Определение меры N MS Delta - [Poids Vol \(CA\) par modalité / Пользовательский вес Vol \(To\)](https://success.openhealth.fr/ru/articles/9292839-poids-vol-ca-par-modalite-пользовательский-вес-vol-to.md) - [Стоимостной объем продаж на основе цены производителя без учета НДС \(Оборот ПФ без учета НДС\) - Марокко](https://success.openhealth.fr/ru/articles/7508513-стоимостной-объем-продаж-на-основе-цены-производителя-без-учета-ндс-оборот-пф-без-учета-ндс-марокко.md) - [N Рост CTR](https://success.openhealth.fr/ru/articles/3194466-n-рост-ctr.md): Определение и формула расчета показателя N Growth CTR - [В сделке](https://success.openhealth.fr/ru/articles/6201859-в-сделке.md) - [Поперечный вес Объем](https://success.openhealth.fr/ru/articles/6066324-поперечный-вес-объем.md) - [Оборот поперечного веса](https://success.openhealth.fr/ru/articles/6066273-оборот-поперечного-веса.md) - [N Рост CTR скорректирован](https://success.openhealth.fr/ru/articles/3205376-n-рост-ctr-скорректирован.md): Определение и формула расчета показателя 'N Growth CTR A' - [Исходный вес](https://success.openhealth.fr/ru/articles/5151525-исходный-вес.md) - [Средняя цена соблюдается](https://success.openhealth.fr/ru/articles/3194302-средняя-цена-соблюдается.md): AASP: наблюдаемая средняя цена - [Средневзвешенная цена](https://success.openhealth.fr/ru/articles/3194292-средневзвешенная-цена.md): WASP: средневзвешенная цена - [Эффект цены](https://success.openhealth.fr/ru/articles/8426443-эффект-цены.md) - [Количество аптек, осуществляющих продажу](https://success.openhealth.fr/ru/articles/3719566-количество-аптек-осуществляющих-продажу.md) - [Продажа цифрового распространения](https://success.openhealth.fr/ru/articles/3194321-продажа-цифрового-распространения.md): Числовое распределение - [Глобальное цифровое распространение](https://success.openhealth.fr/ru/articles/3194320-глобальное-цифровое-распространение.md): Глобальное числовое распространение - [Rebased продажа цифрового распространения](https://success.openhealth.fr/ru/articles/4045636-rebased-продажа-цифрового-распространения.md): Цифровое распространение переустановлено - [Глобальное цифровое распространение продаж](https://success.openhealth.fr/ru/articles/4045725-глобальное-цифровое-распространение-продаж.md): Глобальное числовое распространение - [Индивидуальное повторное распределение цифровых продаж](https://success.openhealth.fr/ru/articles/6830813-индивидуальное-повторное-распределение-цифровых-продаж.md) - [Распределение продажной стоимости](https://success.openhealth.fr/ru/articles/3194323-распределение-продажной-стоимости.md): Взвешенное распределение - [Глобальное распределение продажной стоимости](https://success.openhealth.fr/ru/articles/3194316-глобальное-распределение-продажной-стоимости.md): Распределение продажной стоимости по всему миру - [Rebase распределения стоимости продажи](https://success.openhealth.fr/ru/articles/3194501-rebase-распределения-стоимости-продажи.md): Rebased DVV - [Глобальное перераспределение продажной стоимости](https://success.openhealth.fr/ru/articles/4200619-глобальное-перераспределение-продажной-стоимости.md): Глобальный перебазированный DVV - [Индивидуальное распределение стоимости продаж на основе пересчета](https://success.openhealth.fr/ru/articles/6834423-индивидуальное-распределение-стоимости-продаж-на-основе-пересчета.md) - [Дистрибьюция цифровых продаж SMKT](https://success.openhealth.fr/ru/articles/3365043-дистрибьюция-цифровых-продаж-smkt.md): Цифровая сеть продаж SMKT \(Цифровая дистрибуция SMK\) - [Глобальный SMKT Selling Digital Distribution](https://success.openhealth.fr/ru/articles/4298341-глобальный-smkt-selling-digital-distribution.md): SMKT Global Numeric Distribution \(Глобальное числовое распределение SMKT\) - [Rebased SMKT Selling Digital Distribution](https://success.openhealth.fr/ru/articles/4298197-rebased-smkt-selling-digital-distribution.md): SMKT Digital Distribution Rebased \(SMKT Numeric Distribution Rebased\) - [Global Rebased SMKT Selling Digital Distribution](https://success.openhealth.fr/ru/articles/4319783-global-rebased-smkt-selling-digital-distribution.md): SMKT Global Numeric Distribution обновлен - [Распределение продажной стоимости SMKT](https://success.openhealth.fr/ru/articles/3365478-распределение-продажной-стоимости-smkt.md): Распределение продажной стоимости SMKT \(взвешенное распределение SMKT\) - [Пересчитанный глобальный SMKT Selling Digital Distribution](https://success.openhealth.fr/ru/articles/4298373-пересчитанный-глобальный-smkt-selling-digital-distribution.md): Продажа цифровой дистрибуции SMKT Global Numeric Recalculated \(SMKT Global Numeric Recalculated\) - [Продажа цифровой дистрибуции SMKT пересчитана](https://success.openhealth.fr/ru/articles/4298303-продажа-цифровой-дистрибуции-smkt-пересчитана.md): Пересчет числового распределения SMKT, пересчитанный, пересчитанный - [Скорректированный SMKT Selling Digital Distribution](https://success.openhealth.fr/ru/articles/3369386-скорректированный-smkt-selling-digital-distribution.md): Скорректированное числовое распределение SMKT - [Продажа цифровой дистрибуции СМКТ пересчитана](https://success.openhealth.fr/ru/articles/4298209-продажа-цифровой-дистрибуции-смкт-пересчитана.md): Пересчитано числовое распределение SMKT \(Пересчитано числовое распределение SMKT\) - [Скорректированное распределение продажной стоимости СМКТ](https://success.openhealth.fr/ru/articles/3369397-скорректированное-распределение-продажной-стоимости-смкт.md): Скорректированное взвешенное распределение SMKT - [Органическое распределение цифровых поставщиков](https://success.openhealth.fr/ru/articles/7052424-органическое-распределение-цифровых-поставщиков.md) - [Оборот продающих аптек \(TSP\)](https://success.openhealth.fr/ru/articles/6096534-оборот-продающих-аптек-tsp.md) - [Оценка вашего держателя PDM](https://success.openhealth.fr/ru/articles/4214883-оценка-вашего-держателя-pdm.md): Оцените свою долю рынка со своими клиентами - [Больше аптек](https://success.openhealth.fr/ru/articles/8426451-больше-аптек.md) - [Потеря аптек](https://success.openhealth.fr/ru/articles/8426460-потеря-аптек.md) - [Многоканальные цифровые продажи и дистрибуция](https://success.openhealth.fr/ru/articles/9293487-многоканальные-цифровые-продажи-и-дистрибуция.md) - [Кумулятивные продажи Цифровая дистрибуция \(PHARMA\)](https://success.openhealth.fr/ru/articles/9330571-кумулятивные-продажи-цифровая-дистрибуция-pharma.md) - [Среднемесячные продажи](https://success.openhealth.fr/ru/articles/3194303-среднемесячные-продажи.md): Среднемесячные продажи - [Скорректированные среднемесячные продажи](https://success.openhealth.fr/ru/articles/3194290-скорректированные-среднемесячные-продажи.md): Скорректированные среднемесячные продажи - [Среднемесячная стоимость продаж](https://success.openhealth.fr/ru/articles/4535404-среднемесячная-стоимость-продаж.md): ЦС VMM - [AMS к A: Скорректированная среднемесячная стоимость продаж](https://success.openhealth.fr/ru/articles/6028256-ams-к-a-скорректированная-среднемесячная-стоимость-продаж.md) - [Средние продажи](https://success.openhealth.fr/ru/articles/3563716-средние-продажи.md): Средние продажи - [СМКТ Средние продажи](https://success.openhealth.fr/ru/articles/3365496-смкт-средние-продажи.md): SMKT Средний объем продаж - [Скорректированные средние продажи SMKT](https://success.openhealth.fr/ru/articles/3369340-скорректированные-средние-продажи-smkt.md): Скорректированные средние продажи SMKT - [Среднемесячные органические продажи](https://success.openhealth.fr/ru/articles/7052551-среднемесячные-органические-продажи.md) - [Среднемесячные продажи Органическая стоимость](https://success.openhealth.fr/ru/articles/7052573-среднемесячные-продажи-органическая-стоимость.md) - [Склад](https://success.openhealth.fr/ru/articles/3194332-склад.md): Определение и доступность данных инвентаризации в HUB через приложения SMAa: подписка на продвинутый уровень продаж и маркетинга - [Средний запас](https://success.openhealth.fr/ru/articles/3194336-средний-запас.md): Средний запас - [Доля акций](https://success.openhealth.fr/ru/articles/3194334-доля-акций.md): Доля акций - [Индекс коммерческого давления](https://success.openhealth.fr/ru/articles/3194335-индекс-коммерческого-давления.md): Индекс коммерческого давления - [Скорость трансформации акций](https://success.openhealth.fr/ru/articles/3194344-скорость-трансформации-акций.md): Скорость трансформации запасов - [Продолжительность поставки](https://success.openhealth.fr/ru/articles/3194337-продолжительность-поставки.md): Срок поставки - [Количество аптек](https://success.openhealth.fr/ru/articles/3194338-количество-аптек.md): Количество аптек - [Stockist Digital Distribution](https://success.openhealth.fr/ru/articles/3194339-stockist-digital-distribution.md): Stockist Distribution \(ND Stock\) - [Перебазирование биржевого магазина цифровой дистрибуции](https://success.openhealth.fr/ru/articles/4045743-перебазирование-биржевого-магазина-цифровой-дистрибуции.md): Перебазирование численного распределения акций - [Глобальное перебазированное распространение цифровых продуктов](https://success.openhealth.fr/ru/articles/4045753-глобальное-перебазированное-распространение-цифровых-продуктов.md): Глобальное перебазированное распространение цифровых продуктов - [Распределение стоимости на складе](https://success.openhealth.fr/ru/articles/3194342-распределение-стоимости-на-складе.md): Распределение стоимости запасов \(взвешенное распределение запасов: акции WD\) - [Rebase распределения стоимости запасов](https://success.openhealth.fr/ru/articles/3194505-rebase-распределения-стоимости-запасов.md): Rebase DVS - [Цифровая дистрибуция Сглаженный склад](https://success.openhealth.fr/ru/articles/5141830-цифровая-дистрибуция-сглаженный-склад.md) - [Цифровая дистрибуция Стоклист сглаженный пересчитанный](https://success.openhealth.fr/ru/articles/5142162-цифровая-дистрибуция-стоклист-сглаженный-пересчитанный.md) - [Распределение Сглаженная стоимость акций](https://success.openhealth.fr/ru/articles/5203640-распределение-сглаженная-стоимость-акций.md) - [Распределение Сглаженная пересчитанная стоимость акций](https://success.openhealth.fr/ru/articles/5203701-распределение-сглаженная-пересчитанная-стоимость-акций.md) - [Прибыль](https://success.openhealth.fr/ru/articles/3507716-прибыль.md): Прибыль - [Маржа](https://success.openhealth.fr/ru/articles/3507767-маржа.md): Маржа - [Цена производителя без налога \(PFHT\)](https://success.openhealth.fr/ru/articles/4557500-цена-производителя-без-налога-pfht.md): PFHT - [Продажа - анализ вашей клиентской базы](https://success.openhealth.fr/ru/articles/3846225-продажа-анализ-вашей-клиентской-базы.md): Показатели лояльности: характеристики вашей клиентской базы и ее эволюция - [Продажа - нетипичные аптеки](https://success.openhealth.fr/ru/articles/3848791-продажа-нетипичные-аптеки.md): Меры по выявлению атипизмов - [Коэффициент эволюции](https://success.openhealth.fr/ru/articles/3194287-коэффициент-эволюции.md): Коэффициент эволюции - [Коэффициент проникновения](https://success.openhealth.fr/ru/articles/3194286-коэффициент-проникновения.md): Коэффициент проникновения - [Ширина товарного ассортимента](https://success.openhealth.fr/ru/articles/3369425-ширина-товарного-ассортимента.md): Ширина товарного ассортимента - [Обновление ассортимента](https://success.openhealth.fr/ru/articles/3369545-обновление-ассортимента.md): Обновление ассортимента - [Новинка в ассортименте](https://success.openhealth.fr/ru/articles/3369468-новинка-в-ассортименте.md): Новинка в ассортименте - [Истощение ассортимента](https://success.openhealth.fr/ru/articles/3369457-истощение-ассортимента.md): Истощение ассортимента - [Скорость истощения ассортимента](https://success.openhealth.fr/ru/articles/3369485-скорость-истощения-ассортимента.md): Скорость истощения ассортимента - [Скорость обновления ассортимента](https://success.openhealth.fr/ru/articles/3369541-скорость-обновления-ассортимента.md): Скорость обновления ассортимента - [Доля предложения продажи](https://success.openhealth.fr/ru/articles/3369040-доля-предложения-продажи.md): Доля предложения продажи - [Количество выбранных продуктов](https://success.openhealth.fr/ru/articles/3511502-количество-выбранных-продуктов.md): Это количество продуктов, выбранных по их 13-значному коду GTIN. - [Среднее количество товаров](https://success.openhealth.fr/ru/articles/3194284-среднее-количество-товаров.md): Среднее количество товаров - [Скорость обновления диапазона](https://success.openhealth.fr/ru/articles/3369561-скорость-обновления-диапазона.md): Скорость обновления диапазона - [Количество продуктов](https://success.openhealth.fr/ru/articles/6312686-количество-продуктов.md) - [Суммы, потраченные на акт](https://success.openhealth.fr/ru/articles/3447792-суммы-потраченные-на-акт.md): Статья, относящаяся к показателю «Суммы, потраченные на одно действие» - [Разбивка потраченных сумм по типу покупателя](https://success.openhealth.fr/ru/articles/3447801-разбивка-потраченных-сумм-по-типу-покупателя.md): Статья, относящаяся к показателю «Разбивка потраченных сумм по типам покупателей» - [Индекс потребления](https://success.openhealth.fr/ru/articles/3432701-индекс-потребления.md): Определение показателя «Индекс потребления» - [Доля продаж](https://success.openhealth.fr/ru/articles/3432664-доля-продаж.md): Определение показателя «Доля продаж» - [Ценность лояльности](https://success.openhealth.fr/ru/articles/3432695-ценность-лояльности.md): Определение показателя «Ценность лояльности» - [Абсолютное проникновение](https://success.openhealth.fr/ru/articles/3432556-абсолютное-проникновение.md): Статья по показателю «Абсолютное проникновение» - [Доля оборота](https://success.openhealth.fr/ru/articles/3432655-доля-оборота.md): Определение показателя «Доля оборота» - [p-value](https://success.openhealth.fr/ru/articles/5781702-p-value.md) - [Анализ главных компонентов](https://success.openhealth.fr/ru/articles/4231028-анализ-главных-компонентов.md): ACP - [Отрицательная прогностическая ценность](https://success.openhealth.fr/ru/articles/4134220-отрицательная-прогностическая-ценность.md): Отрицательная прогностическая ценность - [Положительная прогностическая ценность](https://success.openhealth.fr/ru/articles/4134166-положительная-прогностическая-ценность.md): Положительная прогностическая ценность - [Тест на независимость](https://success.openhealth.fr/ru/articles/4128369-тест-на-независимость.md): Проверьте, связаны ли две переменные друг с другом - [Изучение временных рядов](https://success.openhealth.fr/ru/articles/3633991-изучение-временных-рядов.md): Сезонность, тренд и прогноз: что нужно знать - [Уровень сезонной дисперсии](https://success.openhealth.fr/ru/articles/3653790-уровень-сезонной-дисперсии.md): Измеряет долю дисперсии во временном ряду - [Чувствительность и специфичность теста](https://success.openhealth.fr/ru/articles/3928135-чувствительность-и-специфичность-теста.md): Понять концепции для анализа эффективности теста - [Коэффициент отклонения тренда](https://success.openhealth.fr/ru/articles/3653847-коэффициент-отклонения-тренда.md): Измеряет долю компонента тренда во временном ряду. - [Остаточная дисперсия](https://success.openhealth.fr/ru/articles/3653851-остаточная-дисперсия.md): Измеряет долю остаточного компонента временного ряда. - [Коэффициент детерминации](https://success.openhealth.fr/ru/articles/3654093-коэффициент-детерминации.md): Оцените качество выбранной модели - [Коэффициент вариации](https://success.openhealth.fr/ru/articles/3653915-коэффициент-вариации.md): Индикатор для выбора модели разложения - [Дисперсия временного ряда](https://success.openhealth.fr/ru/articles/3653855-дисперсия-временного-ряда.md): Измерьте дисперсию серии - [Концентрация продаж](https://success.openhealth.fr/ru/articles/3395856-концентрация-продаж.md): Концентрация продаж - [Индекс Джини](https://success.openhealth.fr/ru/articles/3395323-индекс-джини.md): Индекс Джини - [численность населения](https://success.openhealth.fr/ru/articles/4396779-численность-населения.md): численность населения - [Эволюция количества смертей](https://success.openhealth.fr/ru/articles/4396765-эволюция-количества-смертей.md): Эволюция количества смертей - [Соотношение полов](https://success.openhealth.fr/ru/articles/3812167-соотношение-полов.md): Соотношение полов - [Население - Средний возраст](https://success.openhealth.fr/ru/articles/3812180-население-средний-возраст.md): Население - Средний возраст - [Население - средний возраст](https://success.openhealth.fr/ru/articles/3812198-население-средний-возраст.md): Население - средний возраст - [Население - возраст 1 квартиль](https://success.openhealth.fr/ru/articles/3812218-население-возраст-1-квартиль.md): Население - возраст 1 квартиль - [Население - возраст 3-го квартиля](https://success.openhealth.fr/ru/articles/3812227-население-возраст-3-го-квартиля.md): Население - возраст 3-го квартиля - [Доля отбора в общей численности населения территории](https://success.openhealth.fr/ru/articles/3812233-доля-отбора-в-общей-численности-населения-территории.md): Доля отбора в общей численности населения территории - [Уровень смертности](https://success.openhealth.fr/ru/articles/3947946-уровень-смертности.md): Уровень смертности - [Летальность](https://success.openhealth.fr/ru/articles/3948084-летальность.md): Летальность - [Женщины детородного возраста](https://success.openhealth.fr/ru/articles/4172859-женщины-детородного-возраста.md): Женщины детородного возраста - [Доля отбора в общем количестве смертей на территории](https://success.openhealth.fr/ru/articles/3863734-доля-отбора-в-общем-количестве-смертей-на-территории.md): Доля отбора в общем количестве смертей на территории - [Моделирование числа пропавших без вести](https://success.openhealth.fr/ru/articles/3895572-моделирование-числа-пропавших-без-вести.md): Прогнозируйте количество смертей в момент времени t - [Предполагаемые продажи по рецепту](https://success.openhealth.fr/ru/articles/5323282-предполагаемые-продажи-по-рецепту.md) - [Эволюция по возрасту и состоянию беременности](https://success.openhealth.fr/ru/articles/6820051-эволюция-по-возрасту-и-состоянию-беременности.md) - [Соотношение продуктов совместного использования](https://success.openhealth.fr/ru/articles/7892010-соотношение-продуктов-совместного-использования.md) - [Расчетные продажи рецептурных препаратов](https://success.openhealth.fr/ru/articles/5323209-расчетные-продажи-рецептурных-препаратов.md) - [Вес продаж пополнения рецептурных препаратов](https://success.openhealth.fr/ru/articles/5323198-вес-продаж-пополнения-рецептурных-препаратов.md) - [Вес продаж в инициации рецептов](https://success.openhealth.fr/ru/articles/5323086-вес-продаж-в-инициации-рецептов.md) - [Количество совместных диспенсаций](https://success.openhealth.fr/ru/articles/3194351-количество-совместных-диспенсаций.md): Количество совместных диспенсаций - [Количество диспенсаций](https://success.openhealth.fr/ru/articles/3194348-количество-диспенсаций.md): Количество диспенсаций - [Среднее количество выплат на одного застрахованного](https://success.openhealth.fr/ru/articles/3369626-среднее-количество-выплат-на-одного-застрахованного.md): Среднее количество выплат на одного застрахованного - [Соблюдение](https://success.openhealth.fr/ru/articles/3411996-соблюдение.md): Уровень владения лекарствами \(MPR\) - [Уровень стойкости](https://success.openhealth.fr/ru/articles/3369684-уровень-стойкости.md): Уровень стойкости - [Терапевтическая приверженность](https://success.openhealth.fr/ru/articles/3412091-терапевтическая-приверженность.md): Терапевтическая приверженность - [Средняя суточная доза на одного застрахованного](https://success.openhealth.fr/ru/articles/4153587-средняя-суточная-доза-на-одного-застрахованного.md): Средняя суточная доза на одного застрахованного - [Количество выплат, представленных для возмещения](https://success.openhealth.fr/ru/articles/3370942-количество-выплат-представленных-для-возмещения.md): Количество выплат, представленных для возмещения - [Количество выплат, не представленных для возмещения](https://success.openhealth.fr/ru/articles/3370920-количество-выплат-не-представленных-для-возмещения.md): Количество выплат, представленных для возмещения - [Стоимость продаж, взимаемая в качестве возмещения, покрытого обязательным медицинским страхованием](https://success.openhealth.fr/ru/articles/3371699-стоимость-продаж-взимаемая-в-качестве-возмещения-покрытого-обязательным-медицинским-страхованием.md): Продажа выкупленных ценностей - [Продажа возмещенных ценностей, покрытых дополнительным медицинским страхованием](https://success.openhealth.fr/ru/articles/3371830-продажа-возмещенных-ценностей-покрытых-дополнительным-медицинским-страхованием.md): Продажа выкупленных ценностей - [Продажа выдающихся ценностей](https://success.openhealth.fr/ru/articles/3371842-продажа-выдающихся-ценностей.md): Продажа выдающихся ценностей - [Распространенность](https://success.openhealth.fr/ru/articles/3947955-распространенность.md): Уровень распространенности - [Среднее количество номеров GTIN на выдачу](https://success.openhealth.fr/ru/articles/3396154-среднее-количество-номеров-gtin-на-выдачу.md): Среднее количество номеров GTIN на выдачу - [Средний объем за дозирование](https://success.openhealth.fr/ru/articles/3396196-средний-объем-за-дозирование.md): Средний объем на дозирование - [Средний оборот на выдачу](https://success.openhealth.fr/ru/articles/3396208-средний-оборот-на-выдачу.md): Средний оборот на выдачу - [Дозировка активного начала на коробку](https://success.openhealth.fr/ru/articles/3675409-дозировка-активного-начала-на-коробку.md): Дозировка активного начала на коробку - [DDD за коробку](https://success.openhealth.fr/ru/articles/3675446-ddd-за-коробку.md): Определите суточную дозу на коробку - [Объем в базовых единицах](https://success.openhealth.fr/ru/articles/3675520-объем-в-базовых-единицах.md): Объем в базовых единицах - [Объем в активном принципе](https://success.openhealth.fr/ru/articles/3675539-объем-в-активном-принципе.md): Объем в активном принципе - [DDJ на 1000 жителей](https://success.openhealth.fr/ru/articles/3675667-ddj-на-1000-жителей.md): Суточная доза на 1000 жителей - [Объем в среднем UA на одного застрахованного](https://success.openhealth.fr/ru/articles/3675761-объем-в-среднем-ua-на-одного-застрахованного.md): Объем в средних потребительских единицах на одного застрахованного - [Объем в среднем на одного застрахованного](https://success.openhealth.fr/ru/articles/3675814-объем-в-среднем-на-одного-застрахованного.md): Объем в среднем на одного застрахованного - [Объем в среднем активе на одного застрахованного](https://success.openhealth.fr/ru/articles/3675824-объем-в-среднем-активе-на-одного-застрахованного.md): Объем в среднем активном капитале на одного застрахованного - [Наблюдаемая средняя продолжительность лечения](https://success.openhealth.fr/ru/articles/3675841-наблюдаемая-средняя-продолжительность-лечения.md): Наблюдаемая средняя продолжительность лечения - [Охват иммунизацией](https://success.openhealth.fr/ru/articles/3822264-охват-иммунизацией.md): Охват иммунизацией - [Пациенты включены](https://success.openhealth.fr/ru/articles/3886665-пациенты-включены.md): Количество пациентов, включенных в когорту - [Различия между MPR и PDC](https://success.openhealth.fr/ru/articles/3722666-различия-между-mpr-и-pdc.md): MPR \(уровень владения лекарством\) vs. PDC \(доля охваченных дней\) - [Средняя продолжительность лечения](https://success.openhealth.fr/ru/articles/3920967-средняя-продолжительность-лечения.md): Измерьте среднее время лечения в конце периода анализа. - [Среднее время продления](https://success.openhealth.fr/ru/articles/3921067-среднее-время-продления.md): Измерьте среднее время между возобновлением лечения - [Начало лечения](https://success.openhealth.fr/ru/articles/3848844-начало-лечения.md): Начало лечения - [Возобновления лечения](https://success.openhealth.fr/ru/articles/3885469-возобновления-лечения.md): Возобновление лечения - [Лечение возобновляется](https://success.openhealth.fr/ru/articles/3885608-лечение-возобновляется.md): Лечение возобновляется - [Новые методы лечения](https://success.openhealth.fr/ru/articles/3885297-новые-методы-лечения.md): Начало и возобновление лечения - [Переключатель лечения](https://success.openhealth.fr/ru/articles/3848886-переключатель-лечения.md): Переключатель лечения - [Лечение прекращается](https://success.openhealth.fr/ru/articles/3885426-лечение-прекращается.md): Лечение прекращается - [Высадка](https://success.openhealth.fr/ru/articles/3885387-высадка.md): Высадка - [Вставка для отслеживания](https://success.openhealth.fr/ru/articles/4355163-вставка-для-отслеживания.md): Прослеживаемость - [Остановлен и затем перезапущен](https://success.openhealth.fr/ru/articles/8429189-остановлен-и-затем-перезапущен.md) - [Распределение доли](https://success.openhealth.fr/ru/articles/3624820-распределение-доли.md): Распределение доли - [Мониторинг соответствующих диспенсаций](https://success.openhealth.fr/ru/articles/3804193-мониторинг-соответствующих-диспенсаций.md): Следите за эволюцией трафика в аптеках соответствующих аптек - [Скорость дезинтеграции](https://success.openhealth.fr/ru/articles/4850138-скорость-дезинтеграции.md) - [Кинетика реакции](https://success.openhealth.fr/ru/articles/4850629-кинетика-реакции.md) - [Время полураспада](https://success.openhealth.fr/ru/articles/4849710-время-полураспада.md) - [Уровень покрытия запасов](https://success.openhealth.fr/ru/articles/4210714-уровень-покрытия-запасов.md): Уровень покрытия запасов - [Периоды времени](https://success.openhealth.fr/ru/articles/3194479-периоды-времени.md): Периоды времени - [Изменить определение финансового года](https://success.openhealth.fr/ru/articles/3321750-изменить-определение-финансового-года.md): HUB позволяет вам установить финансовые годы - [Управление еженедельными сравнениями](https://success.openhealth.fr/ru/articles/3835180-управление-еженедельными-сравнениями.md): Аналитическое влияние изученных дней - [Календарь парафармации GSA \(SMKT\)](https://success.openhealth.fr/ru/articles/3175583-календарь-парафармации-gsa-smkt.md): Календарь SMKT \(IRI\) также называют календарем аптек GSA. - [НЕ](https://success.openhealth.fr/ru/articles/3194484-не.md): Определение меры 'N' - [N Evol](https://success.openhealth.fr/ru/articles/3194461-n-evol.md): Определение и формула расчета меры N Evol - [N Тренд](https://success.openhealth.fr/ru/articles/3194485-n-тренд.md): Определение меры 'N Trend' ### IAS - Indicateurs Avancés Sanitaires - [IAS\(r\) Аллергия](https://success.openhealth.fr/ru/articles/7339151-ias-r-аллергия.md) - [IAS\(r\) Poux](https://success.openhealth.fr/ru/articles/7339168-ias-r-poux.md) - [IAS\(r\) гастроэнтерит](https://success.openhealth.fr/ru/articles/7339181-ias-r-гастроэнтерит.md) - [IAS\(r\) Гриппоподобное заболевание](https://success.openhealth.fr/ru/articles/7266711-ias-r-гриппоподобное-заболевание.md) ### Marketing Direct - [Решение для рассылки электронной почты OpenHealth](https://success.openhealth.fr/ru/articles/7055261-решение-для-рассылки-электронной-почты-openhealth.md) - [Требования к производству кампании по электронной почте](https://success.openhealth.fr/ru/articles/6282113-требования-к-производству-кампании-по-электронной-почте.md) - [Отчет об отслеживании и контрольные показатели](https://success.openhealth.fr/ru/articles/6302721-отчет-об-отслеживании-и-контрольные-показатели.md) - [Глоссарий для кампаний по электронной почте](https://success.openhealth.fr/ru/articles/6282099-глоссарий-для-кампаний-по-электронной-почте.md) ### PSAD - [Анализ - НАЦИОНАЛЬНЫЙ](https://success.openhealth.fr/ru/articles/3376262-анализ-национальный.md): Проанализируйте эффективность рынка поставщиков медицинских услуг на дому \(PSAD\): по областям, видам деятельности, подвидам деятельности... - [Объем / оборот - НАЦИОНАЛЬНЫЙ](https://success.openhealth.fr/ru/articles/3376287-объем-оборот-национальный.md): Одновременно визуализируйте активность по объему и стоимости: по площади, активности, подвиде деятельности, сегменту ... - [Эволюция - НАЦИОНАЛЬНЫЙ](https://success.openhealth.fr/ru/articles/3376370-эволюция-национальный.md): Визуализируйте эволюцию рынка на доступной истории: по областям, видам деятельности, поддеятельности, сегментам, действиям LPP - [Добыча - НАЦИОНАЛЬНЫЙ](https://success.openhealth.fr/ru/articles/3376420-добыча-национальный.md): Экспорт данных в Excel - [Определение](https://success.openhealth.fr/ru/articles/3376439-определение.md): Найдите все возможности приложения SantéDomStat Observatoire National - Essential ### AUTRES THEMATIQUES - [INTERCOM](https://success.openhealth.fr/ru/articles/6959415-intercom.md) - [Salesforce](https://success.openhealth.fr/ru/articles/6959337-salesforce.md) - [GIHSN: отправить файл Excel](https://success.openhealth.fr/ru/articles/3977478-gihsn-отправить-файл-excel.md): Файл Excel GIHSN - [Блокчейн](https://success.openhealth.fr/ru/articles/5385413-блокчейн.md) - [DocuSign, инструмент CRM в нашем бизнес-процессе](https://success.openhealth.fr/ru/articles/4514472-docusign-инструмент-crm-в-нашем-бизнес-процессе.md): Docusign: инструмент CRM в нашем бизнес-процессе - [Национальное отслеживание вакцинации](https://success.openhealth.fr/ru/articles/4754333-национальное-отслеживание-вакцинации.md) - [Охват вакцинацией](https://success.openhealth.fr/ru/articles/4754311-охват-вакцинацией.md) - [KPI Мониторинг](https://success.openhealth.fr/ru/articles/4091042-kpi-мониторинг.md): POC ProPharma Systems: тенденции швейцарского рынка - [Аптека Кабина](https://success.openhealth.fr/ru/articles/4091025-аптека-кабина.md): POC ProPharma Systems: Моя аптека против Швейцарии - [Эквивалент населения \(п.э.\)](https://success.openhealth.fr/ru/articles/5431894-эквивалент-населения-п-э.md) - [Потребность в кислороде](https://success.openhealth.fr/ru/articles/5137158-потребность-в-кислороде.md) - [IHU](https://success.openhealth.fr/ru/articles/4851687-ihu.md) - [Взвешенные вещества](https://success.openhealth.fr/ru/articles/5137147-взвешенные-вещества.md) - [Химия сточных вод](https://success.openhealth.fr/ru/articles/5137101-химия-сточных-вод.md) - [NRBCE](https://success.openhealth.fr/ru/articles/4851683-nrbce.md) - [Закон Аррениуса](https://success.openhealth.fr/ru/articles/4849672-закон-аррениуса.md) - [Результирующая производительность](https://success.openhealth.fr/ru/articles/5137034-результирующая-производительность.md) - [Типы сточных вод](https://success.openhealth.fr/ru/articles/5137183-типы-сточных-вод.md) - [Концентрация вируса SARS-CoV-2](https://success.openhealth.fr/ru/articles/4867968-концентрация-вируса-sars-cov-2.md) - [MAPOM / BMPM](https://success.openhealth.fr/ru/articles/4851685-mapom-bmpm.md) - [Контекстная концентрация SARS-CoV-2](https://success.openhealth.fr/ru/articles/4934604-контекстная-концентрация-sars-cov-2.md) - [Тип канализационной системы](https://success.openhealth.fr/ru/articles/4867954-тип-канализационной-системы.md) - [Деградация вируса](https://success.openhealth.fr/ru/articles/4865742-деградация-вируса.md) - [WBE](https://success.openhealth.fr/ru/articles/4865735-wbe.md) - [РНК](https://success.openhealth.fr/ru/articles/4865733-рнк.md) - [Коронавирус](https://success.openhealth.fr/ru/articles/4865728-коронавирус.md) - [КОВИД-19](https://success.openhealth.fr/ru/articles/4865726-ковид-19.md) - [Серопространственность: метод отбора проб](https://success.openhealth.fr/ru/articles/3924493-серопространственность-метод-отбора-проб.md): Серопространственность: метод отбора проб - [хранилище SANDRE](https://success.openhealth.fr/ru/articles/5415040-хранилище-sandre.md) - [Национальная база ROSEAU](https://success.openhealth.fr/ru/articles/5414523-национальная-база-roseau.md) - [Концентрация вируса SARS-CoV-2](https://success.openhealth.fr/ru/articles/4852404-концентрация-вируса-sars-cov-2.md) - [Концентрация вируса SARS-CoV-2 - Варианты](https://success.openhealth.fr/ru/articles/4909854-концентрация-вируса-sars-cov-2-варианты.md) - [Марсель - Глобальный мониторинг](https://success.openhealth.fr/ru/articles/4859311-марсель-глобальный-мониторинг.md) - [Концентрация вируса SARS-CoV-2 - Ницца](https://success.openhealth.fr/ru/articles/4879292-концентрация-вируса-sars-cov-2-ницца.md) - [Население - Структура](https://success.openhealth.fr/ru/articles/4842408-население-структура.md) - [Концентрация вируса SARS-CoV-2 - Тулон \(ФРАНЦИЯ\)](https://success.openhealth.fr/ru/articles/4886417-концентрация-вируса-sars-cov-2-тулон-франция.md) - [Дубай - Мониторинг сточных вод аэропорта](https://success.openhealth.fr/ru/articles/5276423-дубай-мониторинг-сточных-вод-аэропорта.md) - [Надзор за SARS-CoV-2 - ОБЕПИНА](https://success.openhealth.fr/ru/articles/5210661-надзор-за-sars-cov-2-обепина.md) - [Контекстная концентрация SARS-CoV-2](https://success.openhealth.fr/ru/articles/4934608-контекстная-концентрация-sars-cov-2.md) - [SUEZ - Аналитический баланс](https://success.openhealth.fr/ru/articles/5140509-suez-аналитический-баланс.md) - [Дворец фестивалей - Смотреть Т0](https://success.openhealth.fr/ru/articles/5373515-дворец-фестивалей-смотреть-т0.md) - [Дворец фестивалей - Ежедневное бдение](https://success.openhealth.fr/ru/articles/5373231-дворец-фестивалей-ежедневное-бдение.md) - [Дворец фестивалей - показ](https://success.openhealth.fr/ru/articles/5404778-дворец-фестивалей-показ.md) - [Мустелиды - смотреть](https://success.openhealth.fr/ru/articles/5169577-мустелиды-смотреть.md) - [Население - ИРИС](https://success.openhealth.fr/ru/articles/4842191-население-ирис.md) - [SARS-CoV-2](https://success.openhealth.fr/ru/articles/4865699-sars-cov-2.md) - [IAS - анализ](https://success.openhealth.fr/ru/articles/4842430-ias-анализ.md) - [Концентрация вируса SARS-CoV-2 - SEM](https://success.openhealth.fr/ru/articles/5415600-концентрация-вируса-sars-cov-2-sem.md) - [Визуализация карты](https://success.openhealth.fr/ru/articles/3864657-визуализация-карты.md): Географическое разделение пациентов - [Сайт для публикации](https://success.openhealth.fr/ru/articles/3864668-сайт-для-публикации.md): Вклад сайта и больницы - [Профиль когорты по сайту](https://success.openhealth.fr/ru/articles/3864672-профиль-когорты-по-сайту.md): Профиль когорты по сайту и больнице - [Профиль когорты по сезонам](https://success.openhealth.fr/ru/articles/3864673-профиль-когорты-по-сезонам.md): Профиль когорты по сезонам - [Распределение по возрасту и полу](https://success.openhealth.fr/ru/articles/3864675-распределение-по-возрасту-и-полу.md): Демография - [Распространение вирусов по сайтам](https://success.openhealth.fr/ru/articles/3864678-распространение-вирусов-по-сайтам.md): Распространение вирусов по сайтам - [Распределение вирусов по возрасту](https://success.openhealth.fr/ru/articles/3864677-распределение-вирусов-по-возрасту.md): Распределение вирусов по возрасту - [Эволюция распространения вирусов](https://success.openhealth.fr/ru/articles/3864681-эволюция-распространения-вирусов.md): Эволюция распространения вирусов - [Вакцинация против гриппа](https://success.openhealth.fr/ru/articles/3864697-вакцинация-против-гриппа.md): Вакцинация против гриппа - [Эволюция вакцинации против гриппа](https://success.openhealth.fr/ru/articles/3864701-эволюция-вакцинации-против-гриппа.md): Эволюция вакцинации против гриппа - [Распределение пациентов по хроническим заболеваниям](https://success.openhealth.fr/ru/articles/3864676-распределение-пациентов-по-хроническим-заболеваниям.md): Распределение пациентов по хроническим заболеваниям - [Распределение пациентов по продолжительности пребывания в больнице](https://success.openhealth.fr/ru/articles/3864794-распределение-пациентов-по-продолжительности-пребывания-в-больнице.md): Распределение пациентов по продолжительности пребывания в больнице - [Хрупкость](https://success.openhealth.fr/ru/articles/3864704-хрупкость.md): Хрупкость пациентов - [Статус серьезности](https://success.openhealth.fr/ru/articles/3864705-статус-серьезности.md): Статус серьезности - [Смертность](https://success.openhealth.fr/ru/articles/3864710-смертность.md): Смертность - [GIHSN](https://success.openhealth.fr/ru/articles/3864712-gihsn.md): Глобальная сеть эпиднадзора за больницей гриппа - [CARéDIAB - Профиль пациента](https://success.openhealth.fr/ru/articles/3789234-carediab-профиль-пациента.md): Проанализировать профиль пациента в популяции CARéDIAB - [CARéDIAB - Осложнения](https://success.openhealth.fr/ru/articles/3789515-carediab-осложнения.md): Проанализировать распространенность осложнений в нашей популяции CAREDIAB - [CARéDIAB - Глобальный мониторинг пациентов](https://success.openhealth.fr/ru/articles/3792041-carediab-глобальный-мониторинг-пациентов.md): Проанализировать частоту наблюдения за пациентами из популяции CARéDIAB - [Сеть CARéDIAB](https://success.openhealth.fr/ru/articles/3789106-сеть-carediab.md): Сеть CARéDIAB - [CARéDIAB - Лечение](https://success.openhealth.fr/ru/articles/3792143-carediab-лечение.md): Проанализировать лечение в контексте диабета ## 简体中文 ### Votre PLATEFORME - présentation générale - [HUB，一个全面和持续的支持平台](https://success.openhealth.fr/zh-CN/articles/4799621-hub-一个全面和持续的支持平台.md) - [你的经验水平 The HUB](https://success.openhealth.fr/zh-CN/articles/5712270-你的经验水平-the-hub.md) - [Languages](https://success.openhealth.fr/zh-CN/articles/4649389-languages.md): Here is the description of all languages available on Success - [有关我们费率的问题](https://success.openhealth.fr/zh-CN/articles/3292143-有关我们费率的问题.md): 我们的价格 ### 路线图 - ["为客户提供开放式创新](https://success.openhealth.fr/zh-CN/articles/5200970-为客户提供开放式创新.md) - [应用程序+管理区版本 240515](https://success.openhealth.fr/zh-CN/articles/9310541-应用程序-管理区版本-240515.md) - [应用程序+管理区版本 240415](https://success.openhealth.fr/zh-CN/articles/9310710-应用程序-管理区版本-240415.md) - [应用程序+管理区版本 240315](https://success.openhealth.fr/zh-CN/articles/9310790-应用程序-管理区版本-240315.md) - [应用程序 + 管理区 240215 版](https://success.openhealth.fr/zh-CN/articles/9311007-应用程序-管理区-240215-版.md) - [平台 - 更新 231215](https://success.openhealth.fr/zh-CN/articles/8718485-平台-更新-231215.md) - [平台 - 更新 231015](https://success.openhealth.fr/zh-CN/articles/8479932-平台-更新-231015.md) - [应用程序 + 门户 230915 版](https://success.openhealth.fr/zh-CN/articles/8373640-应用程序-门户-230915-版.md) - [应用程序 + 门户 230815 版](https://success.openhealth.fr/zh-CN/articles/8267860-应用程序-门户-230815-版.md) - [新产品 230715](https://success.openhealth.fr/zh-CN/articles/8115796-新产品-230715.md) - [应用程序 + 门户 230615 版](https://success.openhealth.fr/zh-CN/articles/8115791-应用程序-门户-230615-版.md) - [应用程序 + 门户 230515 版](https://success.openhealth.fr/zh-CN/articles/7895393-应用程序-门户-230515-版.md) - [应用程序 + 门户 230415 版](https://success.openhealth.fr/zh-CN/articles/7439447-应用程序-门户-230415-版.md) - [应用程序 + 门户 230315 版](https://success.openhealth.fr/zh-CN/articles/7439646-应用程序-门户-230315-版.md) - [应用程序 + 门户 230215 版](https://success.openhealth.fr/zh-CN/articles/7439744-应用程序-门户-230215-版.md) - [2023年1月15日的新闻](https://success.openhealth.fr/zh-CN/articles/6895740-2023年1月15日的新闻.md) - [HUB + GATE版本221215](https://success.openhealth.fr/zh-CN/articles/6827027-hub-gate版本221215.md) - [HUB + GATE版本221115](https://success.openhealth.fr/zh-CN/articles/6742628-hub-gate版本221115.md) - [HUB + GATE 版本 220915](https://success.openhealth.fr/zh-CN/articles/6558070-hub-gate-版本-220915.md) - [HUB + GATE 版本 220815](https://success.openhealth.fr/zh-CN/articles/6475311-hub-gate-版本-220815.md) - [HUB + GATE 版本 220615](https://success.openhealth.fr/zh-CN/articles/6306090-hub-gate-版本-220615.md) - [HUB + GATE 版本 220515](https://success.openhealth.fr/zh-CN/articles/6201877-hub-gate-版本-220515.md) - [HUB + GATE 版本 220415](https://success.openhealth.fr/zh-CN/articles/6087747-hub-gate-版本-220415.md) - [HUB SMA 版本 220315](https://success.openhealth.fr/zh-CN/articles/6043772-hub-sma-版本-220315.md) - [HUB TMA版本220315](https://success.openhealth.fr/zh-CN/articles/6043802-hub-tma版本220315.md) - [HUB UAN版本220315](https://success.openhealth.fr/zh-CN/articles/6043852-hub-uan版本220315.md) - [GATE版本220215](https://success.openhealth.fr/zh-CN/articles/5940805-gate版本220215.md) - [HUB SMA 版本 220215](https://success.openhealth.fr/zh-CN/articles/5940753-hub-sma-版本-220215.md) - [HUB TMA版本220215](https://success.openhealth.fr/zh-CN/articles/5947859-hub-tma版本220215.md) - [GATE版本211215](https://success.openhealth.fr/zh-CN/articles/5819397-gate版本211215.md) - [HUB SMA版本211215](https://success.openhealth.fr/zh-CN/articles/5784709-hub-sma版本211215.md) - [HUB TMA版本211215](https://success.openhealth.fr/zh-CN/articles/5784888-hub-tma版本211215.md) - [HUB UAN版本211215](https://success.openhealth.fr/zh-CN/articles/5784904-hub-uan版本211215.md) - [应用The HUB："药房的状况"。](https://success.openhealth.fr/zh-CN/articles/5704485-应用the-hub-药房的状况.md) - [GATE版本211115](https://success.openhealth.fr/zh-CN/articles/5697844-gate版本211115.md) - [HUB SMA版本211115](https://success.openhealth.fr/zh-CN/articles/5671893-hub-sma版本211115.md) - [HUB TMA版本211115](https://success.openhealth.fr/zh-CN/articles/5671917-hub-tma版本211115.md) - [HUB UAN版本211115](https://success.openhealth.fr/zh-CN/articles/5671927-hub-uan版本211115.md) - [GATE版本211015](https://success.openhealth.fr/zh-CN/articles/5652210-gate版本211015.md) - [HUB SMA 211015 版](https://success.openhealth.fr/zh-CN/articles/5649822-hub-sma-211015-版.md) - [HUB TMA版本211015](https://success.openhealth.fr/zh-CN/articles/5650073-hub-tma版本211015.md) - [HUB UAN版本211015](https://success.openhealth.fr/zh-CN/articles/5652242-hub-uan版本211015.md) - [HUB SMA版本210915](https://success.openhealth.fr/zh-CN/articles/5370516-hub-sma版本210915.md) - [HUB TMA 210915版](https://success.openhealth.fr/zh-CN/articles/5390983-hub-tma-210915版.md) - [HUB UAN 210915版本](https://success.openhealth.fr/zh-CN/articles/5543213-hub-uan-210915版本.md) ### Votre ESPACE D'ADMINISTRATION - fonctionnalités - [重设/更改密码HUB](https://success.openhealth.fr/zh-CN/articles/4425325-重设-更改密码hub.md): 如何更改HUB密码 - [连接协助：我收到一个错误信息](https://success.openhealth.fr/zh-CN/articles/5369783-连接协助-我收到一个错误信息.md) - [创建和跟踪票证](https://success.openhealth.fr/zh-CN/articles/3586214-创建和跟踪票证.md): 在您的个人空间上创建和跟踪票务演变的教程HUB - [创建和修改一篇SUCCESS文章](https://success.openhealth.fr/zh-CN/articles/6738705-创建和修改一篇success文章.md) - [我的合同](https://success.openhealth.fr/zh-CN/articles/5712273-我的合同.md) - [服务健康](https://success.openhealth.fr/zh-CN/articles/4990600-服务健康.md) - [我的访问](https://success.openhealth.fr/zh-CN/articles/5783418-我的访问.md) - [设置我的主页](https://success.openhealth.fr/zh-CN/articles/5712229-设置我的主页.md) - [如何从您的个人OpenHealth空间修改市场？](https://success.openhealth.fr/zh-CN/articles/3585971-如何从您的个人openhealth空间修改市场.md): 在您的个人OpenHealth空间中集成，修改和停用产品 - [自动模式分配修改（Auto MAM）](https://success.openhealth.fr/zh-CN/articles/4164818-自动模式分配修改-auto-mam.md): 直接修改您的产品分配 - [TEMPORAL MAM：如何跟随改变实验室/品牌/标签的品牌？](https://success.openhealth.fr/zh-CN/articles/4131072-temporal-mam-如何跟随改变实验室-品牌-标签的品牌.md): 跟踪类型的好处和风险 - [自动产品集成（自动IPR）](https://success.openhealth.fr/zh-CN/articles/4164932-自动产品集成-自动ipr.md): 要求将产品集成到您的市场中 - [自动停用产品（Auto DPR）](https://success.openhealth.fr/zh-CN/articles/4164866-自动停用产品-auto-dpr.md): 从市场上停用产品 - [自动产品重新激活（RPR自动）。](https://success.openhealth.fr/zh-CN/articles/4818161-自动产品重新激活-rpr自动.md) - [设置新产品](https://success.openhealth.fr/zh-CN/articles/5811248-设置新产品.md) - [增加一个市场](https://success.openhealth.fr/zh-CN/articles/5712283-增加一个市场.md) - [大宗产品的进口/出口](https://success.openhealth.fr/zh-CN/articles/5712257-大宗产品的进口-出口.md) - [类型化模式的改变（CMT）](https://success.openhealth.fr/zh-CN/articles/4670174-类型化模式的改变-cmt.md) - [不同的用户状态](https://success.openhealth.fr/zh-CN/articles/3436418-不同的用户状态.md): 有哪些功能？ - [为来自第三方组织的用户创建账户（TPAA）。](https://success.openhealth.fr/zh-CN/articles/6466550-为来自第三方组织的用户创建账户-tpaa.md) - [如何在HUB上创建，修改或删除用户帐户？](https://success.openhealth.fr/zh-CN/articles/3785138-如何在hub上创建-修改或删除用户帐户.md): 只有高级用户才能执行此操作 - [我可以在团队内部的HUB上创建差异化的观看权限吗？](https://success.openhealth.fr/zh-CN/articles/3321731-我可以在团队内部的hub上创建差异化的观看权限吗.md): 集线器中的权利 - [活动日志](https://success.openhealth.fr/zh-CN/articles/4687438-活动日志.md) ### Vos APPLICATIONS - présentation - [HUB培训指南](https://success.openhealth.fr/zh-CN/articles/5634967-hub培训指南.md) - [排序下拉选择器](https://success.openhealth.fr/zh-CN/articles/5792113-排序下拉选择器.md) - [HuB中GSA药房数据（SMKT）的更新日期](https://success.openhealth.fr/zh-CN/articles/3175557-hub中gsa药房数据-smkt-的更新日期.md): 本文介绍了GSA药店（SMKT）中的数据更新的日期。 - [前提条件匹配药房文件](https://success.openhealth.fr/zh-CN/articles/3678146-前提条件匹配药房文件.md): 前提条件匹配药房文件 - [“开和关处方”选择器](https://success.openhealth.fr/zh-CN/articles/3729668-开和关处方-选择器.md): “处方类型选择器”对象的规格 - [如何在HUB中限定新产品？](https://success.openhealth.fr/zh-CN/articles/3376100-如何在hub中限定新产品.md): 在HUB中对您的新产品进行资格鉴定 - [如何在HUB中创建，修改和共享收藏夹？](https://success.openhealth.fr/zh-CN/articles/3175689-如何在hub中创建-修改和共享收藏夹.md): 在中心中创建和共享收藏夹 - [如何按发布日期在HUB中选择产品？](https://success.openhealth.fr/zh-CN/articles/3158428-如何按发布日期在hub中选择产品.md): 本文介绍了如何仅选择在特定时期内推出的产品。 - [我可以从HUB提取".csv "格式的数据吗？](https://success.openhealth.fr/zh-CN/articles/5671278-我可以从hub提取-csv-格式的数据吗.md) - [ODT反应时间](https://success.openhealth.fr/zh-CN/articles/6632310-odt反应时间.md) - [集线器中的最佳显示做法是什么](https://success.openhealth.fr/zh-CN/articles/3124454-集线器中的最佳显示做法是什么.md): 本文详细介绍了优化HUB显示的最佳做法 - [技术要求](https://success.openhealth.fr/zh-CN/articles/5369918-技术要求.md) - [清除浏览器缓存](https://success.openhealth.fr/zh-CN/articles/4219722-清除浏览器缓存.md): 如何清除您的Google Chrome浏览器缓存 - [如何将Google Chrome浏览器设置为默认浏览器？](https://success.openhealth.fr/zh-CN/articles/3738717-如何将google-chrome浏览器设置为默认浏览器.md): 如何将谷歌浏览器设置为默认 - [表格中看不到导航电梯](https://success.openhealth.fr/zh-CN/articles/3195250-表格中看不到导航电梯.md): 导航升降机 - [纸张上的按钮或对象的显示被部分切除或不可见](https://success.openhealth.fr/zh-CN/articles/3195245-纸张上的按钮或对象的显示被部分切除或不可见.md): 按钮，对象的显示问题 - [我的领土管理卡未加载，并且出现“正在加载”消息](https://success.openhealth.fr/zh-CN/articles/3195239-我的领土管理卡未加载-并且出现-正在加载-消息.md): 区域管理/ TMA地图显示问题 - [“您无权访问此页面”错误消息从何而来？](https://success.openhealth.fr/zh-CN/articles/3195338-您无权访问此页面-错误消息从何而来.md): 错误讯息 - [我有一个“连接丢失”错误消息](https://success.openhealth.fr/zh-CN/articles/4445141-我有一个-连接丢失-错误消息.md): 发生了错误 - [错误的网关](https://success.openhealth.fr/zh-CN/articles/4514555-错误的网关.md): “错误的网关”错误消息 - [维度和度量选择器不再显示在“多周期分析”和“我的数据存档”查询器中，“市场分析”中表的提取是部分的](https://success.openhealth.fr/zh-CN/articles/3195377-维度和度量选择器不再显示在-多周期分析-和-我的数据存档-查询器中-市场分析-中表的提取是部分的.md): 尺寸和度量不再显示 - [如何在HUB中查看术语？](https://success.openhealth.fr/zh-CN/articles/3194377-如何在hub中查看术语.md): 通过HUB，您可以轻松地在“销售演变”表中查看前四个季度 - [Excel规格和限制](https://success.openhealth.fr/zh-CN/articles/3753088-excel规格和限制.md): 本文介绍了Excel的规格和限制。 - [如何在应用程序中创建、编辑和共享 "收藏夹"？](https://success.openhealth.fr/zh-CN/articles/10502803-如何在应用程序中创建-编辑和共享-收藏夹.md) - [消费者小组框架](https://success.openhealth.fr/zh-CN/articles/3455845-消费者小组框架.md): 有关消费者小组框架的文章 - [药房市场分析框架](https://success.openhealth.fr/zh-CN/articles/3455857-药房市场分析框架.md): 有关用于分析药房渠道市场表现的OpenHealth框架的文章 ### 数据源 - [什么是OpenHealth药房小组？](https://success.openhealth.fr/zh-CN/articles/3304106-什么是openhealth药房小组.md): 本文的目的是描述我们的药房面板，其组成，演变和外推方法。 - [药房网络是当前和未来健康危机管理中的决定性资产](https://success.openhealth.fr/zh-CN/articles/3825648-药房网络是当前和未来健康危机管理中的决定性资产.md): OpenHealth Company致力于监控前所未有的健康危机，动员其技术和数据 - [在HUB中可以查看法国海外部门和领地的哪些区域？](https://success.openhealth.fr/zh-CN/articles/3194382-在hub中可以查看法国海外部门和领地的哪些区域.md): 集线器中可用的DROM-COM区域 - [必备分区文件](https://success.openhealth.fr/zh-CN/articles/3702701-必备分区文件.md): 本文使您可以下载，完成和提交分区文件。 - [SMKT数据源](https://success.openhealth.fr/zh-CN/articles/4485357-smkt数据源.md): IRI，GSA药房数据供应商 - [IRI的GSA副药产品编码规则（SMKT）](https://success.openhealth.fr/zh-CN/articles/3524492-iri的gsa副药产品编码规则-smkt.md): 提醒IRI SMKT产品的编纂规则 - [ORGANIC STORE数据 - 来源于BIOANALYTICS](https://success.openhealth.fr/zh-CN/articles/5631260-organic-store数据-来源于bioanalytics.md) - [电子药房：监测平台](https://success.openhealth.fr/zh-CN/articles/9167006-电子药房-监测平台.md) - [电子药房产品损益](https://success.openhealth.fr/zh-CN/articles/3568773-电子药房产品损益.md): 有关“电子药房产品损益”模块的文章 - [消费者概况](https://success.openhealth.fr/zh-CN/articles/3711085-消费者概况.md): 与“消费者资料”模块有关的文章 - [AMAZON数据 - 来源于SELLINGZ](https://success.openhealth.fr/zh-CN/articles/5669013-amazon数据-来源于sellingz.md) - [电子商务数据 - 数据来源 WISER](https://success.openhealth.fr/zh-CN/articles/7983010-电子商务数据-数据来源-wiser.md) - [地理区域](https://success.openhealth.fr/zh-CN/articles/4661582-地理区域.md): 在Open Health Company，您可以根据我们提供给您的地理区域来分析您的市场。 - [德国的药学小组是什么？INSIGHTHEALTH](https://success.openhealth.fr/zh-CN/articles/5391412-德国的药学小组是什么-insighthealth.md) - [希腊的药学小组是什么？阿利拉健康](https://success.openhealth.fr/zh-CN/articles/6863963-希腊的药学小组是什么-阿利拉健康.md) - [奥地利的药学小组是什么？INSIGHTHEALTH](https://success.openhealth.fr/zh-CN/articles/6863949-奥地利的药学小组是什么-insighthealth.md) - [什么是非洲的药学小组？PIEX - 非洲](https://success.openhealth.fr/zh-CN/articles/6686633-什么是非洲的药学小组-piex-非洲.md) - [德国的网上药店面板是什么？DATAMEDIQ](https://success.openhealth.fr/zh-CN/articles/5689640-德国的网上药店面板是什么-datamediq.md) - [什么是比利时的药学小组？REDPHARMA](https://success.openhealth.fr/zh-CN/articles/4689894-什么是比利时的药学小组-redpharma.md) - [西班牙的药学小组是什么？- HMR](https://success.openhealth.fr/zh-CN/articles/5391363-西班牙的药学小组是什么-hmr.md) - [什么是西班牙的药学小组？- INFONIS](https://success.openhealth.fr/zh-CN/articles/5428915-什么是西班牙的药学小组-infonis.md) - [葡萄牙的药学小组是什么？- HMR](https://success.openhealth.fr/zh-CN/articles/5391477-葡萄牙的药学小组是什么-hmr.md) - [俄罗斯的药学小组是什么？- 阿尔法姆](https://success.openhealth.fr/zh-CN/articles/5701531-俄罗斯的药学小组是什么-阿尔法姆.md) - [波兰的药学小组是什么？Pex Pharma](https://success.openhealth.fr/zh-CN/articles/5969485-波兰的药学小组是什么-pex-pharma.md) - [皈依集团](https://success.openhealth.fr/zh-CN/articles/6961966-皈依集团.md) - [约旦有哪些药房？](https://success.openhealth.fr/zh-CN/articles/8176750-约旦有哪些药房.md) - [人口-制图](https://success.openhealth.fr/zh-CN/articles/3807695-人口-制图.md): 分析人口的地理分布 - [AMELI - LPP](https://success.openhealth.fr/zh-CN/articles/6962021-ameli-lpp.md) - [人口-年龄和性别的演变](https://success.openhealth.fr/zh-CN/articles/3810789-人口-年龄和性别的演变.md): 分析人口结构的演变 - [人口-按年龄和性别分类](https://success.openhealth.fr/zh-CN/articles/3836795-人口-按年龄和性别分类.md): 比较两个人口的人口统计资料 - [埃及-制图](https://success.openhealth.fr/zh-CN/articles/3714611-埃及-制图.md): 分析埃及各省的人口 - [埃及-按年龄和性别分析](https://success.openhealth.fr/zh-CN/articles/3714673-埃及-按年龄和性别分析.md): 分析人口结构 - [乌干达-AGE＆GENDER分析](https://success.openhealth.fr/zh-CN/articles/3713884-乌干达-age-gender分析.md): 分析人口结构 - [人口-按年龄和性别分类](https://success.openhealth.fr/zh-CN/articles/3807673-人口-按年龄和性别分类.md): 分析人口结构 - [Medicabase - 药物数据库](https://success.openhealth.fr/zh-CN/articles/6518920-medicabase-药物数据库.md) - [诞生](https://success.openhealth.fr/zh-CN/articles/6340025-诞生.md) - [敞开Eudra](https://success.openhealth.fr/zh-CN/articles/6518977-敞开eudra.md) - [IRIS分类](https://success.openhealth.fr/zh-CN/articles/6383829-iris分类.md) - [ADICAP](https://success.openhealth.fr/zh-CN/articles/6959465-adicap.md) - [NEC](https://success.openhealth.fr/zh-CN/articles/6519012-nec.md) - [世界人口数据](https://success.openhealth.fr/zh-CN/articles/8217421-世界人口数据.md) - [INSEE：死者档案](https://success.openhealth.fr/zh-CN/articles/4498126-insee-死者档案.md): INSEE（国家统计和经济研究所）：死者档案 - [数据VAERS- VAERSDATA- 来源CDC](https://success.openhealth.fr/zh-CN/articles/6226665-数据vaers-vaersdata-来源cdc.md) - [VAERS数据 - VAERSVAX - 来源CDC](https://success.openhealth.fr/zh-CN/articles/6226440-vaers数据-vaersvax-来源cdc.md) - [VAERS数据 - VAERSSYMPTOMS - 来源CDC](https://success.openhealth.fr/zh-CN/articles/6219415-vaers数据-vaerssymptoms-来源cdc.md) - [在不到2周的时间内将你的数据整合到Hub中](https://success.openhealth.fr/zh-CN/articles/5259828-在不到2周的时间内将你的数据整合到hub中.md) - [国际数据模板](https://success.openhealth.fr/zh-CN/articles/4684696-国际数据模板.md) - [如何通过FTPS向我们发送您的数据？](https://success.openhealth.fr/zh-CN/articles/4143451-如何通过ftps向我们发送您的数据.md): 通过FTPS发送数据 - [OpenHealth集成新数据源需要哪些信息？](https://success.openhealth.fr/zh-CN/articles/3459148-openhealth集成新数据源需要哪些信息.md): 关于整合新数据源的文章 - [长远来看](https://success.openhealth.fr/zh-CN/articles/6959482-长远来看.md) - [如何在HUB中集成新的数据源？](https://success.openhealth.fr/zh-CN/articles/3467598-如何在hub中集成新的数据源.md): 与HUB中的数据集成过程相关的文章 - [将您的销售数据集成到HUB中](https://success.openhealth.fr/zh-CN/articles/3471145-将您的销售数据集成到hub中.md): 关于出售数据集成的文章 - [接收卖出数据的规范](https://success.openhealth.fr/zh-CN/articles/3660043-接收卖出数据的规范.md): 如何在卖出/售罄分析或订阅卖出Vizualization模块的一部分中将您的卖出信息发送给我们 - [家庭健康提供者（PSAD）市场的分析数据从何而来？](https://success.openhealth.fr/zh-CN/articles/3376155-家庭健康提供者-psad-市场的分析数据从何而来.md): PSAD - [如何加入SantéDomStat天文台？](https://success.openhealth.fr/zh-CN/articles/3798795-如何加入santedomstat天文台.md): 加入国家家庭健康提供者活动观察站（PSAD）的教程 - [从SanteDomStat观察站推断出的面板](https://success.openhealth.fr/zh-CN/articles/6701602-从santedomstat观察站推断出的面板.md) - [患者人数](https://success.openhealth.fr/zh-CN/articles/3376499-患者人数.md): 根据PSAD联合会定义患者人数 - [治疗次数](https://success.openhealth.fr/zh-CN/articles/3376682-治疗次数.md): 根据PSAD联合会定义治疗数量 - [新病人数](https://success.openhealth.fr/zh-CN/articles/3376672-新病人数.md): 根据PSAD联合会确定新病人的数量 - [含税营业额](https://success.openhealth.fr/zh-CN/articles/3376725-含税营业额.md): 根据PSAD联盟定义营业额（含税） - [治疗结束时的患者人数](https://success.openhealth.fr/zh-CN/articles/3376675-治疗结束时的患者人数.md): 根据PSAD联合会定义治疗结束时的患者人数 - [强制健康保险金额（AMO）](https://success.openhealth.fr/zh-CN/articles/3376740-强制健康保险金额-amo.md): 根据PSAD联盟定义AMO量 - [补充健康保险金额（AMC）](https://success.openhealth.fr/zh-CN/articles/3376749-补充健康保险金额-amc.md): 根据PSAD联盟定义AMC数量 - [未付费用（RAC）](https://success.openhealth.fr/zh-CN/articles/3376751-未付费用-rac.md): 根据PSAD联盟对RAC的定义 - [资料来源：THESORIMED](https://success.openhealth.fr/zh-CN/articles/3560018-资料来源-thesorimed.md): 药品数据库（BdM） - [国际非专有名称（INN）](https://success.openhealth.fr/zh-CN/articles/3954239-国际非专有名称-inn.md): 国际通用名称（INN） - [开放的食品事实](https://success.openhealth.fr/zh-CN/articles/6961970-开放的食品事实.md) - [LOINC - 逻辑观测标识符名称和代码](https://success.openhealth.fr/zh-CN/articles/6959323-loinc-逻辑观测标识符名称和代码.md) - [AMELI - CCAM](https://success.openhealth.fr/zh-CN/articles/6959080-ameli-ccam.md) - [世界卫生组织ATC VET](https://success.openhealth.fr/zh-CN/articles/6959078-世界卫生组织atc-vet.md) - [CEPS](https://success.openhealth.fr/zh-CN/articles/6959068-ceps.md) - [机构](https://success.openhealth.fr/zh-CN/articles/3935678-机构.md): 卫生，社会，医疗社会机构清单 - [保健服务](https://success.openhealth.fr/zh-CN/articles/7969680-保健服务.md) - [提取精细度](https://success.openhealth.fr/zh-CN/articles/3946922-提取精细度.md): 根据您的期望进行提取 - [进化精](https://success.openhealth.fr/zh-CN/articles/3947009-进化精.md): 跟随结构数量的演变 - [授权关怀活动](https://success.openhealth.fr/zh-CN/articles/3947067-授权关怀活动.md): 根据其医疗保健活动授权列出结构 - [主要医疗设备](https://success.openhealth.fr/zh-CN/articles/3947269-主要医疗设备.md): 根据设备的重型材料列出结构 - [地域性](https://success.openhealth.fr/zh-CN/articles/3947363-地域性.md): 可视化领土上建筑物的分布 - [RPPS](https://success.openhealth.fr/zh-CN/articles/3947568-rpps.md): 卫生专业人员名单 - [细度和RPPS](https://success.openhealth.fr/zh-CN/articles/3947713-细度和rpps.md): 列出卫生专业人员的锻炼地点 - [提取RPPS](https://success.openhealth.fr/zh-CN/articles/3947829-提取rpps.md): RPPS（医疗保健专业人员共享目录） ### 型号 - [UGA的数据](https://success.openhealth.fr/zh-CN/articles/4852310-uga的数据.md) - [计算该部门的销售额：您需要知道的](https://success.openhealth.fr/zh-CN/articles/3545561-计算该部门的销售额-您需要知道的.md): 计算OpenHealth部门销售额的不同步骤是什么？ - [部门重新分配，静态还是动态方法？](https://success.openhealth.fr/zh-CN/articles/3690615-部门重新分配-静态还是动态方法.md): 部门重新分配，静态还是动态方法？ - [药房阶层](https://success.openhealth.fr/zh-CN/articles/4291490-药房阶层.md): “理论”层和“实际”或“有效”层的详细信息。 - [集线器生产线](https://success.openhealth.fr/zh-CN/articles/4816146-集线器生产线.md) - [如何进行比较分析？](https://success.openhealth.fr/zh-CN/articles/3440093-如何进行比较分析.md): 您要比较来自两个不同提供程序的数据。 - [第1级调查-OpenHealth Company服务的数据质量](https://success.openhealth.fr/zh-CN/articles/3595822-第1级调查-openhealth-company服务的数据质量.md): 您是否观察到您不了解的现象？我们可以为您提供这种瞄准的起源，并向您解释。 - [OpenHealth的数据质量流程](https://success.openhealth.fr/zh-CN/articles/3415271-openhealth的数据质量流程.md): 本文详细介绍了OpenHealth的数据质量流程的各个阶段 - [间隔和置信度](https://success.openhealth.fr/zh-CN/articles/3633173-间隔和置信度.md): 定义，公式和局限性：您需要了解的内容 - [数据质量：批次管理](https://success.openhealth.fr/zh-CN/articles/3433509-数据质量-批次管理.md): 批次管理过程说明 - [数据质量：销售分解过程](https://success.openhealth.fr/zh-CN/articles/3415317-数据质量-销售分解过程.md): 销售细分过程说明 - [卖出和库存抵消](https://success.openhealth.fr/zh-CN/articles/4131084-卖出和库存抵消.md): 股票卖出 - [为什么要分析销售量？](https://success.openhealth.fr/zh-CN/articles/3846167-为什么要分析销售量.md): 为什么要分析销售量？ - [买卖之间存在数据缺口](https://success.openhealth.fr/zh-CN/articles/3195358-买卖之间存在数据缺口.md): 在哪种情况下，我们在卖出与卖出之间会有数据缺口？ - [什么是非典型买卖？](https://success.openhealth.fr/zh-CN/articles/3195366-什么是非典型买卖.md): 非典型销售和非典型过滤器过程。 - [价格，数量，营业额的信息从何而来？](https://success.openhealth.fr/zh-CN/articles/3195348-价格-数量-营业额的信息从何而来.md): 价格/数量/营业额信息 - [按处方估计的销量](https://success.openhealth.fr/zh-CN/articles/4171530-按处方估计的销量.md): 如何按处方者和处方者类别评估药房的销售量 - [了解两种提取方法的区别](https://success.openhealth.fr/zh-CN/articles/13399689-了解两种提取方法的区别.md) ### 步骤 - [GTIN](https://success.openhealth.fr/zh-CN/articles/3608176-gtin.md): GTIN代码（全球贸易商品编号） - [客户产品合格者字段规范（CQCP）](https://success.openhealth.fr/zh-CN/articles/3704913-客户产品合格者字段规范-cqcp.md): CQCP（产品客户鉴定人字段） - [什么是LPPR代码？](https://success.openhealth.fr/zh-CN/articles/3195365-什么是lppr代码.md): LPPR代码（有偿产品和服务列表） - [产品租赁跟踪](https://success.openhealth.fr/zh-CN/articles/4206554-产品租赁跟踪.md): 产品租赁 - [我想扩大我的市场](https://success.openhealth.fr/zh-CN/articles/4420843-我想扩大我的市场.md): 订阅市场紧随其后 - [OHC分类](https://success.openhealth.fr/zh-CN/articles/3194589-ohc分类.md): 根据专有的OpenHealth Company分类可视化您的产品分配 - [EphMRA AC课程历史记录](https://success.openhealth.fr/zh-CN/articles/3557908-ephmra-ac课程历史记录.md): 自2014年以来可视化EphMRA AC类的演变 - [兽医详细资料](https://success.openhealth.fr/zh-CN/articles/3194587-兽医详细资料.md): 可视化兽药的特征 - [兽医分类](https://success.openhealth.fr/zh-CN/articles/3194579-兽医分类.md): 查看兽药（ANSES）的分类 - [人类医学细节](https://success.openhealth.fr/zh-CN/articles/3421225-人类医学细节.md): 通过THESORIMED的详细信息字段查看一种或多种产品的特征 - [新产品管理](https://success.openhealth.fr/zh-CN/articles/4470813-新产品管理.md): 新产品管理 - [人体医学分类](https://success.openhealth.fr/zh-CN/articles/3417281-人体医学分类.md): 查看适用于您产品范围的EphMRA AC和OMS ATC分类 - [适应症-诊断](https://success.openhealth.fr/zh-CN/articles/3568554-适应症-诊断.md): 查看给定病理学中指定的药物以及与选择药物相关的病理学 - [MP4U](https://success.openhealth.fr/zh-CN/articles/3574188-mp4u.md): 查看OpenHealth Company提供的所有分类 - [什么是TVASI（销售、采购和未知存货表）？](https://success.openhealth.fr/zh-CN/articles/5992494-什么是tvasi-销售-采购和未知存货表.md) - [IRI产品分类](https://success.openhealth.fr/zh-CN/articles/3194597-iri产品分类.md): 根据分类可视化您的产品分配 所有者IRI - [清除未售出的产品](https://success.openhealth.fr/zh-CN/articles/6135938-清除未售出的产品.md) - [标准市场-订阅](https://success.openhealth.fr/zh-CN/articles/3798203-标准市场-订阅.md): 本文介绍了所谓的“标准”市场的利益和局限性 - [我找不到我的产品](https://success.openhealth.fr/zh-CN/articles/5686002-我找不到我的产品.md) - [产品代码管理](https://success.openhealth.fr/zh-CN/articles/5652478-产品代码管理.md) - [产品资质: 品牌](https://success.openhealth.fr/zh-CN/articles/5016985-产品资质-品牌.md) ### 订阅和模块 - [3 种申请类型](https://success.openhealth.fr/zh-CN/articles/9489652-3-种申请类型.md) - [您的 2.0 平台](https://success.openhealth.fr/zh-CN/articles/8374416-您的-2-0-平台.md) - [概要](https://success.openhealth.fr/zh-CN/articles/3344127-概要.md): 该模块提供了应用程序的所有特征 - [市场与选择](https://success.openhealth.fr/zh-CN/articles/8337016-市场与选择.md) - [摘要仪表板](https://success.openhealth.fr/zh-CN/articles/9246867-摘要仪表板.md) - [分析](https://success.openhealth.fr/zh-CN/articles/9352287-分析.md) - [提取器](https://success.openhealth.fr/zh-CN/articles/9246875-提取器.md) - [成长分析](https://success.openhealth.fr/zh-CN/articles/3158856-成长分析.md): 确定您的市场以及竞争对手的市场发展中的关键因素 - [分类分析](https://success.openhealth.fr/zh-CN/articles/3473736-分类分析.md): 研究市场中产品的动力 - [平均产品数](https://success.openhealth.fr/zh-CN/articles/3161474-平均产品数.md): 查看每个销售点，药房或GSA药房的平均产品数量 - [发射跟踪](https://success.openhealth.fr/zh-CN/articles/3158488-发射跟踪.md): 监控产品发布及其对增长的贡献 - [交叉的先进指标](https://success.openhealth.fr/zh-CN/articles/6007740-交叉的先进指标.md) - [销售集中](https://success.openhealth.fr/zh-CN/articles/3095338-销售集中.md): 通过销售集中度曲线和GINI指数可视化市场集中度 - [价格分散](https://success.openhealth.fr/zh-CN/articles/3159289-价格分散.md): 可视化产品的价格分散。根据销售价格创建自己的药房细分 - [卖空保证金分析](https://success.openhealth.fr/zh-CN/articles/3358322-卖空保证金分析.md): 衡量产品对药房的吸引力 - [卖出保证金的演变](https://success.openhealth.fr/zh-CN/articles/3815561-卖出保证金的演变.md) - [药房监控（1/2）](https://success.openhealth.fr/zh-CN/articles/3358248-药房监控-1-2.md): 追踪药房流量的演变 - [药房监控（2/2）](https://success.openhealth.fr/zh-CN/articles/3810527-药房监控-2-2.md): 追踪药房流量的演变 - [Salesforce绩效](https://success.openhealth.fr/zh-CN/articles/3159230-salesforce绩效.md): 比较销售人员所在地区和部门的销售业绩 - [客户关系管理（CRM）助理](https://success.openhealth.fr/zh-CN/articles/5953935-客户关系管理-crm-助理.md) - [销售点追踪](https://success.openhealth.fr/zh-CN/articles/3778944-销售点追踪.md): 销售点追踪 - [随需应变](https://success.openhealth.fr/zh-CN/articles/6560184-随需应变.md) - [按需分析](https://success.openhealth.fr/zh-CN/articles/6127483-按需分析.md) - [按需表](https://success.openhealth.fr/zh-CN/articles/3158751-按需表.md): 直观显示主要HUB指标及其在不同类型时期内的演变 - [时间序列分析](https://success.openhealth.fr/zh-CN/articles/3635940-时间序列分析.md): 将您的市场细分为季节，趋势和噪音 - [预测分析](https://success.openhealth.fr/zh-CN/articles/3636015-预测分析.md): 估计市场的未来 - [部门预测](https://success.openhealth.fr/zh-CN/articles/3689811-部门预测.md): 估算您未来的部门销售额 - [买卖可视化](https://success.openhealth.fr/zh-CN/articles/3559882-买卖可视化.md): 比较卖出和卖出销售的演变 - [卖入分析](https://success.openhealth.fr/zh-CN/articles/6188132-卖入分析.md) - [卖入匹配](https://success.openhealth.fr/zh-CN/articles/6188090-卖入匹配.md) - [卖进的演变](https://success.openhealth.fr/zh-CN/articles/6191929-卖进的演变.md) - [卖入与卖出分析](https://success.openhealth.fr/zh-CN/articles/6191947-卖入与卖出分析.md) - [卖入与卖出的演变](https://success.openhealth.fr/zh-CN/articles/6191955-卖入与卖出的演变.md) - [价格演变](https://success.openhealth.fr/zh-CN/articles/5056489-价格演变.md) - [自定义颜色](https://success.openhealth.fr/zh-CN/articles/8407897-自定义颜色.md) - [产品出口](https://success.openhealth.fr/zh-CN/articles/3583206-产品出口.md): 导出特定于所有产品和MP4U类型应用程序的工作表 - [市场分析](https://success.openhealth.fr/zh-CN/articles/3121933-市场分析.md): 分析市场表现：按细分，品牌，产品和公司划分 - [价格分析](https://success.openhealth.fr/zh-CN/articles/3215190-价格分析.md): 查看您的市场价格并分析您的定位 - [销售演变](https://success.openhealth.fr/zh-CN/articles/3178323-销售演变.md): 查看所有可用历史记录中不断变化的销售额 - [总结仪表板](https://success.openhealth.fr/zh-CN/articles/4533213-总结仪表板.md) - [市场份额演变](https://success.openhealth.fr/zh-CN/articles/3193078-市场份额演变.md): 可视化长期的销售和市场份额变化 - [销售交叉表](https://success.openhealth.fr/zh-CN/articles/3193060-销售交叉表.md): 创建一个简单的数据透视表 - [营业额/销量（CU）综合](https://success.openhealth.fr/zh-CN/articles/3193048-营业额-销量-cu-综合.md): 同时可视化市场的销量和价值 - [卖出价值综合（药物/超级市场）](https://success.openhealth.fr/zh-CN/articles/3193020-卖出价值综合-药物-超级市场.md): 比较GSA药房和药房销售 - [市场份额分析](https://success.openhealth.fr/zh-CN/articles/3193069-市场份额分析.md): 分析过去12个月的市场份额 - [我的资料档案](https://success.openhealth.fr/zh-CN/articles/3193099-我的资料档案.md): 将平面数据库导出到Excel - [多周期分析](https://success.openhealth.fr/zh-CN/articles/3192953-多周期分析.md): 创建一个完全定制的表 - [我的查询所有产品](https://success.openhealth.fr/zh-CN/articles/4280353-我的查询所有产品.md): 查看您的细分受众群和合格字段（例如：盖伦尼克，太阳能指数，促销活动...）以及您的限制条件 - [库存演变（新）](https://success.openhealth.fr/zh-CN/articles/3719256-库存演变-新.md): 可视化并分析股票的演变及其分布 - [市场定义](https://success.openhealth.fr/zh-CN/articles/3158829-市场定义.md): 根据您选择的100个基准来重新建立您的市场 - [原始数据高级指示器](https://success.openhealth.fr/zh-CN/articles/3711095-原始数据高级指示器.md): 恢复您的领先指标数据 - [高级指标演进SMKT](https://success.openhealth.fr/zh-CN/articles/3193000-高级指标演进smkt.md): 通过分析高级统计指标的时间演变来监控实验室的性能。 - [高级指标分析SMKT](https://success.openhealth.fr/zh-CN/articles/3192366-高级指标分析smkt.md): 将GSA辅助药品市场的发展细分为领先指标 - [先进指标演变](https://success.openhealth.fr/zh-CN/articles/3177853-先进指标演变.md): 通过分析高级统计指标的时间演变来监控实验室的性能。 - [高级指标演化生物](https://success.openhealth.fr/zh-CN/articles/7051823-高级指标演化生物.md) - [国家先进指标](https://success.openhealth.fr/zh-CN/articles/3364513-国家先进指标.md): 将市场演变分解为领先指标 - [库存分析](https://success.openhealth.fr/zh-CN/articles/3178015-库存分析.md): 解释库存水平及其演变 - [高级指标分析生物](https://success.openhealth.fr/zh-CN/articles/7051801-高级指标分析生物.md) - [高级指标分析](https://success.openhealth.fr/zh-CN/articles/3124439-高级指标分析.md): 将市场演变分解为领先指标 - [制图](https://success.openhealth.fr/zh-CN/articles/3192450-制图.md): 分析销售人员所在地区和部门的商业表现 - [地理交叉表](https://success.openhealth.fr/zh-CN/articles/3192466-地理交叉表.md): 创建一个数据透视表，整合您的部门划分 - [地域销售演变](https://success.openhealth.fr/zh-CN/articles/3192482-地域销售演变.md): 在数据透视表中查看按行业划分的36个月的销售额 - [销售队伍的有效性](https://success.openhealth.fr/zh-CN/articles/5624011-销售队伍的有效性.md) - [自定义加权法分析](https://success.openhealth.fr/zh-CN/articles/5169317-自定义加权法分析.md) - [网络分析](https://success.openhealth.fr/zh-CN/articles/3894767-网络分析.md): 网络分析 - [自定义加权法演变](https://success.openhealth.fr/zh-CN/articles/5169320-自定义加权法演变.md) - [关键绩效指标](https://success.openhealth.fr/zh-CN/articles/3478199-关键绩效指标.md): 在动态表中可视化您的关键指标交易量下降到区域和部门。 - [换算单位销售](https://success.openhealth.fr/zh-CN/articles/3192412-换算单位销售.md): 使用转换后的单位可视化您的销售 - [原始数据库存指标](https://success.openhealth.fr/zh-CN/articles/3711142-原始数据库存指标.md): 导出库存数据 - [原始数据SMKT AIA](https://success.openhealth.fr/zh-CN/articles/3720960-原始数据smkt-aia.md): 查找您的SMKT领先指标数据 - [库存演变](https://success.openhealth.fr/zh-CN/articles/3178277-库存演变.md): 可视化并分析股票的演变及其分布 - [地理高级指标](https://success.openhealth.fr/zh-CN/articles/3192508-地理高级指标.md): 查看按地区或行业划分的领先指标 - [产品性能](https://success.openhealth.fr/zh-CN/articles/3850331-产品性能.md): 比较区域和产品部门的业务绩效 - [区域高级指标](https://success.openhealth.fr/zh-CN/articles/3370879-区域高级指标.md): 将市场演变分解为领先指标 - [时间序列部门分析](https://success.openhealth.fr/zh-CN/articles/3814974-时间序列部门分析.md): 将您的市场细分为趋势，季节，噪音 - [按年龄和性别划分的销售分析](https://success.openhealth.fr/zh-CN/articles/3192701-按年龄和性别划分的销售分析.md): 按年龄和性别分析销售 - [怀孕状况的销售变化](https://success.openhealth.fr/zh-CN/articles/3192910-怀孕状况的销售变化.md): 关注孕妇人口的药房销售情况 - [年龄和性别的销售变化](https://success.openhealth.fr/zh-CN/articles/3192732-年龄和性别的销售变化.md): 使用HUB的历史深度可视化按年龄和性别划分的销售变化 - [需求订单的演变](https://success.openhealth.fr/zh-CN/articles/5790020-需求订单的演变.md) - [进化共同分配](https://success.openhealth.fr/zh-CN/articles/3192529-进化共同分配.md): 可视化并分解药房中共同分配的演变 - [共存分析](https://success.openhealth.fr/zh-CN/articles/3192633-共存分析.md): 查看与我的市场中精选产品相关的药房联合配药 - [每个频道和处方者的销售额](https://success.openhealth.fr/zh-CN/articles/3192751-每个频道和处方者的销售额.md): 可视化您市场中的影响者 - [AMO，AMC和RAC](https://success.openhealth.fr/zh-CN/articles/3192929-amo-amc和rac.md): 查看强制性健康保险，补充性健康保险和自付费用的三种金额 - [共分散](https://success.openhealth.fr/zh-CN/articles/3876946-共分散.md): 可视化通过配给销售的产品数量的分布 - [点胶分散演变](https://success.openhealth.fr/zh-CN/articles/3920070-点胶分散演变.md): 可视化随时间推移每个配送的产品销售数量分布 - [按年龄和性别分类的全科医生处方](https://success.openhealth.fr/zh-CN/articles/5789899-按年龄和性别分类的全科医生处方.md) - [处方药订单分析](https://success.openhealth.fr/zh-CN/articles/5322866-处方药订单分析.md) - [全科医生处方的演变](https://success.openhealth.fr/zh-CN/articles/5790016-全科医生处方的演变.md) - [篮子分析](https://success.openhealth.fr/zh-CN/articles/3711049-篮子分析.md): “篮子分析”模块的说明 - [共同配药](https://success.openhealth.fr/zh-CN/articles/4738243-共同配药.md) - [同类群组资格模块](https://success.openhealth.fr/zh-CN/articles/3928090-同类群组资格模块.md): 患者队列的资格 - [治疗状态模块](https://success.openhealth.fr/zh-CN/articles/3928067-治疗状态模块.md): 分析治疗监测的动态 - [治疗依从性模块](https://success.openhealth.fr/zh-CN/articles/3928044-治疗依从性模块.md): 分析对治疗的依从性 - [同类群组定义](https://success.openhealth.fr/zh-CN/articles/3894703-同类群组定义.md): 定义分析范围 - [共同治疗](https://success.openhealth.fr/zh-CN/articles/4163623-共同治疗.md): 在您的分析范围内定义协同处理 - [可视化队列](https://success.openhealth.fr/zh-CN/articles/3894721-可视化队列.md): 查看已定义队列的患者资料 - [分析标准的定义](https://success.openhealth.fr/zh-CN/articles/3894728-分析标准的定义.md): 定义用于分析同类群组的参数 - [全球同类人群的演变](https://success.openhealth.fr/zh-CN/articles/3894747-全球同类人群的演变.md): 可视化队列的每月演变 - [地理分布](https://success.openhealth.fr/zh-CN/articles/3894751-地理分布.md): 查看已定义队列中患者的地理分布 - [同类群组](https://success.openhealth.fr/zh-CN/articles/3894755-同类群组.md): 分析队列中包括的患者的人口统计资料 - [治疗状态细分](https://success.openhealth.fr/zh-CN/articles/3894764-治疗状态细分.md): 概述不同类型的治疗随访 - [治疗开始](https://success.openhealth.fr/zh-CN/articles/3894778-治疗开始.md): 分析治疗开始次数的演变 - [重新开始治疗](https://success.openhealth.fr/zh-CN/articles/3894788-重新开始治疗.md): 分析再治疗次数的演变 - [新疗法](https://success.openhealth.fr/zh-CN/articles/3894804-新疗法.md): 分析治疗开始和恢复次数的演变 - [治疗复发](https://success.openhealth.fr/zh-CN/articles/3894812-治疗复发.md): 分析患者的治疗情况 - [治疗开关平衡](https://success.openhealth.fr/zh-CN/articles/3894821-治疗开关平衡.md): 按治疗分析治疗变化的平衡 - [治疗开关增益](https://success.openhealth.fr/zh-CN/articles/3894830-治疗开关增益.md): 分析治疗开关的受益者 - [治疗开关损耗](https://success.openhealth.fr/zh-CN/articles/3894843-治疗开关损耗.md): 通过治疗分析治疗开关的失败者 - [切换增益原点](https://success.openhealth.fr/zh-CN/articles/3894857-切换增益原点.md): 分析给定处理的开关的起源 - [开关损耗目的地](https://success.openhealth.fr/zh-CN/articles/3894864-开关损耗目的地.md): 分析给定处理方式的交换机的目的地 - [辍学](https://success.openhealth.fr/zh-CN/articles/3894874-辍学.md): 分析治疗停止 - [关键绩效指标摘要](https://success.openhealth.fr/zh-CN/articles/4229969-关键绩效指标摘要.md): 不同类型的治疗监测摘要 - [治疗持久性](https://success.openhealth.fr/zh-CN/articles/3894883-治疗持久性.md): 分析治疗时间 - [合规](https://success.openhealth.fr/zh-CN/articles/3894884-合规.md): 分析交货数量 - [规律性标准是什么？](https://success.openhealth.fr/zh-CN/articles/3325816-规律性标准是什么.md): 正则性准则概念的定义 - [死亡-制图](https://success.openhealth.fr/zh-CN/articles/3863677-死亡-制图.md): 分析死亡的地理分布 - [死亡计数偏移](https://success.openhealth.fr/zh-CN/articles/3863573-死亡计数偏移.md): 评估数据的相关性 - [死亡-AGE＆GENDER分析](https://success.openhealth.fr/zh-CN/articles/3863808-死亡-age-gender分析.md): 分析死亡的结构 - [死亡-AGE＆GENDER的进化](https://success.openhealth.fr/zh-CN/articles/3863939-死亡-age-gender的进化.md): 分析死亡结构的演变 - [死亡-进化](https://success.openhealth.fr/zh-CN/articles/3864065-死亡-进化.md): 可视化死亡的演变 - [死亡-进化比较](https://success.openhealth.fr/zh-CN/articles/3864073-死亡-进化比较.md): 比较过去几年的死亡人数变化 - [药房监控CA](https://success.openhealth.fr/zh-CN/articles/4634768-药房监控ca.md): 根据药房规模描述流量 - [流量分析（测试版）](https://success.openhealth.fr/zh-CN/articles/6848401-流量分析-测试版.md) - [药房监控详细信息](https://success.openhealth.fr/zh-CN/articles/4527868-药房监控详细信息.md): 按药房类型分析药房流量 - [交通演变（测试版）](https://success.openhealth.fr/zh-CN/articles/6848016-交通演变-测试版.md) - [药房监测制图](https://success.openhealth.fr/zh-CN/articles/4527811-药房监测制图.md): 分析法国大陆的药房流量 - [药房监控详细信息](https://success.openhealth.fr/zh-CN/articles/4262306-药房监控详细信息.md): 按药房类型区分销售细节 - [药房监测分析](https://success.openhealth.fr/zh-CN/articles/3839223-药房监测分析.md): 追踪药房流量的演变 - [药房监控演进](https://success.openhealth.fr/zh-CN/articles/3827973-药房监控演进.md): 研究药房流量的演变 - [交通分解](https://success.openhealth.fr/zh-CN/articles/3826074-交通分解.md): 观察季节，趋势和残留物的成分 - [交通研究](https://success.openhealth.fr/zh-CN/articles/3809042-交通研究.md): 分析药房流量 - [执行摘要 - PIEX](https://success.openhealth.fr/zh-CN/articles/5203335-执行摘要-piex.md) - [购买](https://success.openhealth.fr/zh-CN/articles/4605110-购买.md): 跟踪您的购买及其收据 - [我的查询-PIEX](https://success.openhealth.fr/zh-CN/articles/4210627-我的查询-piex.md): 对数据进行选择 - [销售演变-PIEX](https://success.openhealth.fr/zh-CN/articles/4210655-销售演变-piex.md): 在可用的历史记录上查看活动的演变 - [销售分析-PIEX](https://success.openhealth.fr/zh-CN/articles/4210650-销售分析-piex.md): 销售分析-PIEX - [订单明细-PIEX](https://success.openhealth.fr/zh-CN/articles/4210659-订单明细-piex.md): 查看和跟踪销售订单 - [库存概览-PIEX](https://success.openhealth.fr/zh-CN/articles/4210672-库存概览-piex.md): 可视化您的股票变化 - [我的数据存档-PIEX](https://success.openhealth.fr/zh-CN/articles/4210694-我的数据存档-piex.md): 将平面数据库导出到Excel - [EURAPHARMA- PIEX](https://success.openhealth.fr/zh-CN/articles/4366306-eurapharma-piex.md): 可视化EURAPHARMA活动的演变 - [配套产品](https://success.openhealth.fr/zh-CN/articles/4366320-配套产品.md): PIEX和EURAPHARMA产品名称之间的对应关系 - [CLI我的文件（1/5）](https://success.openhealth.fr/zh-CN/articles/4626422-cli我的文件-1-5.md): CLI我的文件（1/5） - [CLI\_文件计数（2/5）](https://success.openhealth.fr/zh-CN/articles/4626421-cli_文件计数-2-5.md): CLI\_文件计数（2/5） - [CLI\_文件代码与OHC存储库匹配](https://success.openhealth.fr/zh-CN/articles/4626419-cli_文件代码与ohc存储库匹配.md): CLI\_FIL代码与OHC存储库的匹配 - [售罄出口（4/5）](https://success.openhealth.fr/zh-CN/articles/4626414-售罄出口-4-5.md): 售罄出口（4/5） ### 个性化选项 - [非分级产品合格字段](https://success.openhealth.fr/zh-CN/articles/4036045-非分级产品合格字段.md): 添加有关您产品资格的详细信息 - [HUB数据的最大年龄是多少？](https://success.openhealth.fr/zh-CN/articles/3195251-hub数据的最大年龄是多少.md): 最新数据 - [客户类型](https://success.openhealth.fr/zh-CN/articles/4197147-客户类型.md): 自定义选项客户类型 - [会话访问](https://success.openhealth.fr/zh-CN/articles/4036458-会话访问.md): 限制对员工的观看 - [定制周期](https://success.openhealth.fr/zh-CN/articles/4036444-定制周期.md): 在个性化时间段内分析数据 - [财政年度](https://success.openhealth.fr/zh-CN/articles/4036169-财政年度.md): 定义您的会计年度 - [日按钮](https://success.openhealth.fr/zh-CN/articles/4036159-日按钮.md): 更加精细地可视化数据 - [周按钮](https://success.openhealth.fr/zh-CN/articles/4036111-周按钮.md): 更加精细地可视化数据 - [汇率](https://success.openhealth.fr/zh-CN/articles/8329594-汇率.md) - [SMKT期间日历](https://success.openhealth.fr/zh-CN/articles/4036549-smkt期间日历.md): 使用GSA日历 - [限制周长](https://success.openhealth.fr/zh-CN/articles/4560699-限制周长.md): 从.xlsx文件中选择“我的查询”中的一个GTIN列表 - [限制周长（代码7）](https://success.openhealth.fr/zh-CN/articles/4560791-限制周长-代码7.md): 从.xlsx文件中选择“我的查询”中的\[技术代码2\]的一个列表 - [市场标志](https://success.openhealth.fr/zh-CN/articles/4560797-市场标志.md): 从.xlsx文件中包含的市场定义中选择“我的查询”中的一个GTIN列表 - [定位/定义客户类型](https://success.openhealth.fr/zh-CN/articles/3777788-定位-定义客户类型.md): 定位（客户类型） ### 集线器指标 - [HUB指标词汇](https://success.openhealth.fr/zh-CN/articles/5194247-hub指标词汇.md) - [销售数量](https://success.openhealth.fr/zh-CN/articles/3194314-销售数量.md): 销售数量 - [销售价值](https://success.openhealth.fr/zh-CN/articles/3074854-销售价值.md): 指定销售价值指标 - [质谱](https://success.openhealth.fr/zh-CN/articles/3194475-质谱.md): “ N MS”度量的定义 - [N MS Evol](https://success.openhealth.fr/zh-CN/articles/5634266-n-ms-evol.md) - [N MS三角洲](https://success.openhealth.fr/zh-CN/articles/3194469-n-ms三角洲.md): “ N MS Delta”度量的定义 - [Poids Vol \(CA\) par modalité / Custom Weight Vol \(To\) \(按模式计\)](https://success.openhealth.fr/zh-CN/articles/9292839-poids-vol-ca-par-modalite-custom-weight-vol-to-按模式计.md) - [按不含增值税的制造商价格计算的销售额（不含增值税的营业额 PF） - 摩洛哥](https://success.openhealth.fr/zh-CN/articles/7508513-按不含增值税的制造商价格计算的销售额-不含增值税的营业额-pf-摩洛哥.md) - [氮增长点击率](https://success.openhealth.fr/zh-CN/articles/3194466-氮增长点击率.md): “ N增长点击率”测度的定义和计算公式 - [在交易中](https://success.openhealth.fr/zh-CN/articles/6201859-在交易中.md) - [交叉重量的体积](https://success.openhealth.fr/zh-CN/articles/6066324-交叉重量的体积.md) - [交叉配重翻转](https://success.openhealth.fr/zh-CN/articles/6066273-交叉配重翻转.md) - [调整了N增长的点击率](https://success.openhealth.fr/zh-CN/articles/3205376-调整了n增长的点击率.md): “ N增长CTR A”测度的定义和计算公式 - [源头重量](https://success.openhealth.fr/zh-CN/articles/5151525-源头重量.md) - [观察平均价格](https://success.openhealth.fr/zh-CN/articles/3194302-观察平均价格.md): AASP：观察到的平均价格 - [加权平均价](https://success.openhealth.fr/zh-CN/articles/3194292-加权平均价.md): WASP：加权平均价格 - [价格效应](https://success.openhealth.fr/zh-CN/articles/8426443-价格效应.md) - [销售的药店数量](https://success.openhealth.fr/zh-CN/articles/3719566-销售的药店数量.md) - [销售数字发行](https://success.openhealth.fr/zh-CN/articles/3194321-销售数字发行.md): 数值分布 - [全球销售数字分销](https://success.openhealth.fr/zh-CN/articles/3194320-全球销售数字分销.md): 全球数字分布 - [重新销售数字分销](https://success.openhealth.fr/zh-CN/articles/4045636-重新销售数字分销.md): 数值分布重新计算 - [全球基础销售数字分销](https://success.openhealth.fr/zh-CN/articles/4045725-全球基础销售数字分销.md): 全球数字分布重新计算 - [定制化的基于数字的销售分配](https://success.openhealth.fr/zh-CN/articles/6830813-定制化的基于数字的销售分配.md) - [销售价值分配](https://success.openhealth.fr/zh-CN/articles/3194323-销售价值分配.md): 加权分配 - [全球销售价值分配](https://success.openhealth.fr/zh-CN/articles/3194316-全球销售价值分配.md): 全球销售价值分配 - [重新设定销售价值分配](https://success.openhealth.fr/zh-CN/articles/3194501-重新设定销售价值分配.md): 重新设置DVV - [全球基础销售价值分配](https://success.openhealth.fr/zh-CN/articles/4200619-全球基础销售价值分配.md): 全球基础DVV - [定制化的重基销售价值分配](https://success.openhealth.fr/zh-CN/articles/6834423-定制化的重基销售价值分配.md) - [数字销售分销SMKT](https://success.openhealth.fr/zh-CN/articles/3365043-数字销售分销smkt.md): 数字销售分销SMKT（SMK数字分销） - [全球SMKT销售数字发行](https://success.openhealth.fr/zh-CN/articles/4298341-全球smkt销售数字发行.md): SMKT全球数字发行（SMKT全球数字发行） - [重新定位的SMKT销售数字发行](https://success.openhealth.fr/zh-CN/articles/4298197-重新定位的smkt销售数字发行.md): 基于SMKT数字发行版（基于SMKT数字发行版） - [全球重组的SMKT销售数字发行](https://success.openhealth.fr/zh-CN/articles/4319783-全球重组的smkt销售数字发行.md): 出售数字发行SMKTRebaséeGlobale（SMKT全球数字发行改组） - [SMKT销售价值分配](https://success.openhealth.fr/zh-CN/articles/3365478-smkt销售价值分配.md): SMKT销售价值分配（SMKT加权分配） - [重新计算了全球SMKT销售数字分销](https://success.openhealth.fr/zh-CN/articles/4298373-重新计算了全球smkt销售数字分销.md): 出售数字发行的SMKT全球数字发行重新计算（SMKT全球数字发行重新计算） - [重新计算销售SMKT的数字发行重新计算](https://success.openhealth.fr/zh-CN/articles/4298303-重新计算销售smkt的数字发行重新计算.md): 重新计算SMKT数值分布重新计算 - [调整后的SMKT销售数字发行](https://success.openhealth.fr/zh-CN/articles/3369386-调整后的smkt销售数字发行.md): 调整后的数字分布SMKT - [重新计算出售SMKT的数字发行](https://success.openhealth.fr/zh-CN/articles/4298209-重新计算出售smkt的数字发行.md): 重新计算SMKT数值分布（重新计算SMKT数值分布） - [调整后的SMKT销售价值分配](https://success.openhealth.fr/zh-CN/articles/3369397-调整后的smkt销售价值分配.md): 调整后的加权分布SMKT - [有机数字销售分布](https://success.openhealth.fr/zh-CN/articles/7052424-有机数字销售分布.md) - [销售药店的营业额\(TSP\)](https://success.openhealth.fr/zh-CN/articles/6096534-销售药店的营业额-tsp.md) - [您的持有人PDM的估算](https://success.openhealth.fr/zh-CN/articles/4214883-您的持有人pdm的估算.md): 估计您与客户的市场份额 - [更多药房](https://success.openhealth.fr/zh-CN/articles/8426451-更多药房.md) - [失去药房](https://success.openhealth.fr/zh-CN/articles/8426460-失去药房.md) - [多渠道数字销售与分销](https://success.openhealth.fr/zh-CN/articles/9293487-多渠道数字销售与分销.md) - [累计销售数字发行（医药）](https://success.openhealth.fr/zh-CN/articles/9330571-累计销售数字发行-医药.md) - [月平均销售额](https://success.openhealth.fr/zh-CN/articles/3194303-月平均销售额.md): 平均每月销售额 - [调整后的月平均销售额](https://success.openhealth.fr/zh-CN/articles/3194290-调整后的月平均销售额.md): 调整后的平均每月销售额 - [月平均销售额](https://success.openhealth.fr/zh-CN/articles/4535404-月平均销售额.md): VMM CA - [AMS To A: 调整后的月平均销售价值](https://success.openhealth.fr/zh-CN/articles/6028256-ams-to-a-调整后的月平均销售价值.md) - [平均销售](https://success.openhealth.fr/zh-CN/articles/3563716-平均销售.md): 平均销售 - [SMKT平均销售](https://success.openhealth.fr/zh-CN/articles/3365496-smkt平均销售.md): SMKT平均销售 - [调整后的SMKT平均销售额](https://success.openhealth.fr/zh-CN/articles/3369340-调整后的smkt平均销售额.md): 调整后的SMKT平均销售额 - [每月平均有机销售额](https://success.openhealth.fr/zh-CN/articles/7052551-每月平均有机销售额.md) - [月平均销售额 有机值](https://success.openhealth.fr/zh-CN/articles/7052573-月平均销售额-有机值.md) - [股票](https://success.openhealth.fr/zh-CN/articles/3194332-股票.md): 通过SMAa应用程序定义和提供HUB中的库存数据：销售和营销高级订阅 - [平均库存](https://success.openhealth.fr/zh-CN/articles/3194336-平均库存.md): 平均库存 - [股份比例](https://success.openhealth.fr/zh-CN/articles/3194334-股份比例.md): 股份比例 - [商业压力指数](https://success.openhealth.fr/zh-CN/articles/3194335-商业压力指数.md): 商业压力指数 - [库存转换率](https://success.openhealth.fr/zh-CN/articles/3194344-库存转换率.md): 库存转换率 - [供货期限](https://success.openhealth.fr/zh-CN/articles/3194337-供货期限.md): 供应持续时间 - [库存药房数量](https://success.openhealth.fr/zh-CN/articles/3194338-库存药房数量.md): 库存药房数量 - [库存商数字分销](https://success.openhealth.fr/zh-CN/articles/3194339-库存商数字分销.md): 库存商数字分销（ND库存） - [数字分销商重新定位](https://success.openhealth.fr/zh-CN/articles/4045743-数字分销商重新定位.md): 股票数字分布已重新计算 - [全球基础数字分销商分布](https://success.openhealth.fr/zh-CN/articles/4045753-全球基础数字分销商分布.md): 全球基础数字分销商分布 - [存货价值分配](https://success.openhealth.fr/zh-CN/articles/3194342-存货价值分配.md): 库存商价值分配（加权库存分配：WD库存） - [重新计算库存价值分配](https://success.openhealth.fr/zh-CN/articles/3194505-重新计算库存价值分配.md): 重新设置DVS - [数字分布平滑的存货商](https://success.openhealth.fr/zh-CN/articles/5141830-数字分布平滑的存货商.md) - [数字分销 储存商 平滑化的重新计算](https://success.openhealth.fr/zh-CN/articles/5142162-数字分销-储存商-平滑化的重新计算.md) - [分布情况 平滑的股票价值](https://success.openhealth.fr/zh-CN/articles/5203640-分布情况-平滑的股票价值.md) - [分布 平滑化的重新计算的股票价值](https://success.openhealth.fr/zh-CN/articles/5203701-分布-平滑化的重新计算的股票价值.md) - [保证金](https://success.openhealth.fr/zh-CN/articles/3507716-保证金.md): 保证金 - [保证金率](https://success.openhealth.fr/zh-CN/articles/3507767-保证金率.md): 保证金率 - [不含税的制造商价格（PFHT）](https://success.openhealth.fr/zh-CN/articles/4557500-不含税的制造商价格-pfht.md): 聚四氟乙烯 - [出售-分析您的客户群](https://success.openhealth.fr/zh-CN/articles/3846225-出售-分析您的客户群.md): 忠诚度指标：客户群的特征及其演变 - [出售-非典型药房](https://success.openhealth.fr/zh-CN/articles/3848791-出售-非典型药房.md): 检测非典型性的措施 - [进化率](https://success.openhealth.fr/zh-CN/articles/3194287-进化率.md): 进化率 - [穿透率](https://success.openhealth.fr/zh-CN/articles/3194286-穿透率.md): 穿透率 - [产品分类宽度](https://success.openhealth.fr/zh-CN/articles/3369425-产品分类宽度.md): 产品分类宽度 - [更新品种](https://success.openhealth.fr/zh-CN/articles/3369545-更新品种.md): 更新品种 - [品种创新](https://success.openhealth.fr/zh-CN/articles/3369468-品种创新.md): 品种创新 - [品种损耗](https://success.openhealth.fr/zh-CN/articles/3369457-品种损耗.md): 品种损耗 - [分类损耗率](https://success.openhealth.fr/zh-CN/articles/3369485-分类损耗率.md): 分类损耗率 - [范围创新率](https://success.openhealth.fr/zh-CN/articles/3369541-范围创新率.md): 范围创新率 - [出售要约份额](https://success.openhealth.fr/zh-CN/articles/3369040-出售要约份额.md): 出售要约份额 - [所选产品数量](https://success.openhealth.fr/zh-CN/articles/3511502-所选产品数量.md): 这是按其GTIN-13数字代码选择的产品数。 - [平均产品数](https://success.openhealth.fr/zh-CN/articles/3194284-平均产品数.md): 平均产品数 - [范围更新率](https://success.openhealth.fr/zh-CN/articles/3369561-范围更新率.md): 范围更新率 - [产品数量](https://success.openhealth.fr/zh-CN/articles/6312686-产品数量.md) - [每次行为花费的金额](https://success.openhealth.fr/zh-CN/articles/3447792-每次行为花费的金额.md): 关于“每项行为的支出额”指标的条款 - [按买方类型划分的支出金额明细](https://success.openhealth.fr/zh-CN/articles/3447801-按买方类型划分的支出金额明细.md): 有关指标的文章“按购买者类型划分支出总额” - [消费指数](https://success.openhealth.fr/zh-CN/articles/3432701-消费指数.md): “消费指数”指标的定义 - [销售份额](https://success.openhealth.fr/zh-CN/articles/3432664-销售份额.md): “销售份额”指标的定义 - [价值忠诚度](https://success.openhealth.fr/zh-CN/articles/3432695-价值忠诚度.md): 指标“价值忠诚度”的定义 - [绝对渗透](https://success.openhealth.fr/zh-CN/articles/3432556-绝对渗透.md): 关于“绝对渗透率”指标的文章 - [营业额份额](https://success.openhealth.fr/zh-CN/articles/3432655-营业额份额.md): 指标“营业额份额”的定义 - [P值](https://success.openhealth.fr/zh-CN/articles/5781702-p值.md) - [主成分分析](https://success.openhealth.fr/zh-CN/articles/4231028-主成分分析.md): ACP - [负预测值](https://success.openhealth.fr/zh-CN/articles/4134220-负预测值.md): 负预测值 - [阳性预测值](https://success.openhealth.fr/zh-CN/articles/4134166-阳性预测值.md): 阳性预测值 - [独立测试](https://success.openhealth.fr/zh-CN/articles/4128369-独立测试.md): 检查两个变量是否相互关联 - [时间序列研究](https://success.openhealth.fr/zh-CN/articles/3633991-时间序列研究.md): 季节性，趋势和预测：您需要知道的 - [季节变化率](https://success.openhealth.fr/zh-CN/articles/3653790-季节变化率.md): 测量时间序列中的方差份额 - [测试的敏感性和特异性](https://success.openhealth.fr/zh-CN/articles/3928135-测试的敏感性和特异性.md): 了解概念以分析测试的有效性 - [趋势变化率](https://success.openhealth.fr/zh-CN/articles/3653847-趋势变化率.md): 测量时间序列中趋势部分的份额 - [残差率](https://success.openhealth.fr/zh-CN/articles/3653851-残差率.md): 测量时间序列的剩余部分的份额 - [确定系数](https://success.openhealth.fr/zh-CN/articles/3654093-确定系数.md): 评估所选模型的质量 - [变异系数](https://success.openhealth.fr/zh-CN/articles/3653915-变异系数.md): 选择分解模型的指标 - [时间序列的方差](https://success.openhealth.fr/zh-CN/articles/3653855-时间序列的方差.md): 测量系列的离散度 - [销售集中](https://success.openhealth.fr/zh-CN/articles/3395856-销售集中.md): 销售集中 - [基尼系数](https://success.openhealth.fr/zh-CN/articles/3395323-基尼系数.md): 基尼系数 - [人口](https://success.openhealth.fr/zh-CN/articles/4396779-人口.md): 人口 - [死亡人数的演变](https://success.openhealth.fr/zh-CN/articles/4396765-死亡人数的演变.md): 死亡人数的演变 - [性别比例](https://success.openhealth.fr/zh-CN/articles/3812167-性别比例.md): 性别比例 - [人口-平均年龄](https://success.openhealth.fr/zh-CN/articles/3812180-人口-平均年龄.md): 人口-平均年龄 - [人口-中位年龄](https://success.openhealth.fr/zh-CN/articles/3812198-人口-中位年龄.md): 人口-中位年龄 - [人口-年龄第一四分位数](https://success.openhealth.fr/zh-CN/articles/3812218-人口-年龄第一四分位数.md): 人口-年龄第一四分位数 - [人口-年龄三分之四](https://success.openhealth.fr/zh-CN/articles/3812227-人口-年龄三分之四.md): 人口-年龄三分之四 - [甄选在全港总人口中所占的比例](https://success.openhealth.fr/zh-CN/articles/3812233-甄选在全港总人口中所占的比例.md): 甄选在全港总人口中所占的比例 - [死亡率](https://success.openhealth.fr/zh-CN/articles/3947946-死亡率.md): 死亡率 - [病死率](https://success.openhealth.fr/zh-CN/articles/3948084-病死率.md): 病死率 - [育龄妇女](https://success.openhealth.fr/zh-CN/articles/4172859-育龄妇女.md): 育龄妇女 - [选择人数占本地区总死亡人数的比例](https://success.openhealth.fr/zh-CN/articles/3863734-选择人数占本地区总死亡人数的比例.md): 选择人数占本地区总死亡人数的比例 - [模拟失踪死亡人数](https://success.openhealth.fr/zh-CN/articles/3895572-模拟失踪死亡人数.md): 预计在时间t的死亡人数 - [估算的处方开始的销售额](https://success.openhealth.fr/zh-CN/articles/5323282-估算的处方开始的销售额.md) - [按年龄和怀孕状况的演变](https://success.openhealth.fr/zh-CN/articles/6820051-按年龄和怀孕状况的演变.md) - [共同补偿产品比率](https://success.openhealth.fr/zh-CN/articles/7892010-共同补偿产品比率.md) - [估算的处方药补给销售额](https://success.openhealth.fr/zh-CN/articles/5323209-估算的处方药补给销售额.md) - [处方药补充销售的比重](https://success.openhealth.fr/zh-CN/articles/5323198-处方药补充销售的比重.md) - [销售额在处方启动中的比重](https://success.openhealth.fr/zh-CN/articles/5323086-销售额在处方启动中的比重.md) - [共批数](https://success.openhealth.fr/zh-CN/articles/3194351-共批数.md): 共同点数 - [配药数量](https://success.openhealth.fr/zh-CN/articles/3194348-配药数量.md): 配药数量 - [每个被保险人的平均配药次数](https://success.openhealth.fr/zh-CN/articles/3369626-每个被保险人的平均配药次数.md): 每个被保险人的平均配药次数 - [遵守](https://success.openhealth.fr/zh-CN/articles/3411996-遵守.md): 药物占有率（MPR） - [持续率](https://success.openhealth.fr/zh-CN/articles/3369684-持续率.md): 持续率 - [治疗依从性](https://success.openhealth.fr/zh-CN/articles/3412091-治疗依从性.md): 治疗依从性 - [每个被保险人的平均日剂量](https://success.openhealth.fr/zh-CN/articles/4153587-每个被保险人的平均日剂量.md): 每个被保险人的平均日剂量 - [提出要偿还的分配数](https://success.openhealth.fr/zh-CN/articles/3370942-提出要偿还的分配数.md): 提出要偿还的分配数 - [未列报的配药数量](https://success.openhealth.fr/zh-CN/articles/3370920-未列报的配药数量.md): 提出要偿还的分配数 - [强制性健康保险涵盖的报销价值销售](https://success.openhealth.fr/zh-CN/articles/3371699-强制性健康保险涵盖的报销价值销售.md): 赎回价值的销售 - [补充健康保险所覆盖的报销价值的销售](https://success.openhealth.fr/zh-CN/articles/3371830-补充健康保险所覆盖的报销价值的销售.md): 赎回价值的销售 - [突出价值的销售](https://success.openhealth.fr/zh-CN/articles/3371842-突出价值的销售.md): 突出价值的销售 - [患病率](https://success.openhealth.fr/zh-CN/articles/3947955-患病率.md): 患病率 - [每次分配的平均GTIN数](https://success.openhealth.fr/zh-CN/articles/3396154-每次分配的平均gtin数.md): 每次配药的平均GTIN数 - [每次分配的平均体积](https://success.openhealth.fr/zh-CN/articles/3396196-每次分配的平均体积.md): 每次分配的平均体积 - [每次配药的平均周转率](https://success.openhealth.fr/zh-CN/articles/3396208-每次配药的平均周转率.md): 每次配药的平均周转率 - [每盒有效成分剂量](https://success.openhealth.fr/zh-CN/articles/3675409-每盒有效成分剂量.md): 每盒有效成分剂量 - [每盒DDD](https://success.openhealth.fr/zh-CN/articles/3675446-每盒ddd.md): 定义每盒的每日剂量 - [基本单位数量](https://success.openhealth.fr/zh-CN/articles/3675520-基本单位数量.md): 基本单位数量 - [活动量](https://success.openhealth.fr/zh-CN/articles/3675539-活动量.md): 活动量 - [每千名居民DDJ](https://success.openhealth.fr/zh-CN/articles/3675667-每千名居民ddj.md): 每1000名居民的每日确定剂量 - [每个被保险人的平均UA量](https://success.openhealth.fr/zh-CN/articles/3675761-每个被保险人的平均ua量.md): 每个被保险人的平均消费单位数量 - [每个被保险人的平均UB量](https://success.openhealth.fr/zh-CN/articles/3675814-每个被保险人的平均ub量.md): 每个被保险人的平均基本单位数量 - [每个被保险人的平均有效原则数量](https://success.openhealth.fr/zh-CN/articles/3675824-每个被保险人的平均有效原则数量.md): 每个被保险人的平均有效原则数量 - [观察到的平均治疗时间](https://success.openhealth.fr/zh-CN/articles/3675841-观察到的平均治疗时间.md): 观察到的平均治疗时间 - [免疫覆盖](https://success.openhealth.fr/zh-CN/articles/3822264-免疫覆盖.md): 免疫覆盖 - [包括患者](https://success.openhealth.fr/zh-CN/articles/3886665-包括患者.md): 队列中包括的患者数 - [MPR和PDC之间的差异](https://success.openhealth.fr/zh-CN/articles/3722666-mpr和pdc之间的差异.md): MPR（药物拥有率）与PDC（涵盖天数） - [平均治疗时间](https://success.openhealth.fr/zh-CN/articles/3920967-平均治疗时间.md): 在分析期结束时测量平均治疗时间 - [平均续约时间](https://success.openhealth.fr/zh-CN/articles/3921067-平均续约时间.md): 测量两次治疗之间的平均时间 - [开始治疗](https://success.openhealth.fr/zh-CN/articles/3848844-开始治疗.md): 开始治疗 - [更新治疗](https://success.openhealth.fr/zh-CN/articles/3885469-更新治疗.md): 更新治疗 - [恢复治疗](https://success.openhealth.fr/zh-CN/articles/3885608-恢复治疗.md): 恢复治疗 - [新疗法](https://success.openhealth.fr/zh-CN/articles/3885297-新疗法.md): 开始和恢复治疗 - [治疗开关](https://success.openhealth.fr/zh-CN/articles/3848886-治疗开关.md): 治疗开关 - [治疗停止](https://success.openhealth.fr/zh-CN/articles/3885426-治疗停止.md): 治疗停止 - [放下](https://success.openhealth.fr/zh-CN/articles/3885387-放下.md): 放下 - [可追溯性插入](https://success.openhealth.fr/zh-CN/articles/4355163-可追溯性插入.md): 可追溯性 - [停止后又重新启动](https://success.openhealth.fr/zh-CN/articles/8429189-停止后又重新启动.md) - [分配份额](https://success.openhealth.fr/zh-CN/articles/3624820-分配份额.md): 分配份额 - [监控相关配药](https://success.openhealth.fr/zh-CN/articles/3804193-监控相关配药.md): 追踪相关配药店药房的流量变化 - [崩解率](https://success.openhealth.fr/zh-CN/articles/4850138-崩解率.md) - [反应的动力学](https://success.openhealth.fr/zh-CN/articles/4850629-反应的动力学.md) - [半衰期时间](https://success.openhealth.fr/zh-CN/articles/4849710-半衰期时间.md) - [库存覆盖率](https://success.openhealth.fr/zh-CN/articles/4210714-库存覆盖率.md): 库存覆盖率 - [时间段](https://success.openhealth.fr/zh-CN/articles/3194479-时间段.md): 时间段 - [更改会计年度的定义](https://success.openhealth.fr/zh-CN/articles/3321750-更改会计年度的定义.md): HUB允许您设置会计年度 - [每周比较的管理](https://success.openhealth.fr/zh-CN/articles/3835180-每周比较的管理.md): 研究天数的分析影响 - [GSA的Parapharmacy日历（SMKT）](https://success.openhealth.fr/zh-CN/articles/3175583-gsa的parapharmacy日历-smkt.md): SMKT日历（IRI）也称为GSA药房日历 - [不](https://success.openhealth.fr/zh-CN/articles/3194484-不.md): 量度“ N”的定义 - [进化](https://success.openhealth.fr/zh-CN/articles/3194461-进化.md): “ N Evol”度量的定义和计算公式 - [N趋势](https://success.openhealth.fr/zh-CN/articles/3194485-n趋势.md): “ N趋势”度量的定义 ### IAS - Indicateurs Avancés Sanitaires - [IAS\(r\) 过敏](https://success.openhealth.fr/zh-CN/articles/7339151-ias-r-过敏.md) - [Poux 国际会计准则](https://success.openhealth.fr/zh-CN/articles/7339168-poux-国际会计准则.md) - [IAS\(r\) 胃肠炎](https://success.openhealth.fr/zh-CN/articles/7339181-ias-r-胃肠炎.md) - [IAS\(r\) 流感样病例](https://success.openhealth.fr/zh-CN/articles/7266711-ias-r-流感样病例.md) ### Marketing Direct - [开放式医疗的电子邮件解决方案](https://success.openhealth.fr/zh-CN/articles/7055261-开放式医疗的电子邮件解决方案.md) - [制作电子邮件活动的要求](https://success.openhealth.fr/zh-CN/articles/6282113-制作电子邮件活动的要求.md) - [追踪报告和基准](https://success.openhealth.fr/zh-CN/articles/6302721-追踪报告和基准.md) - [电子邮件活动的词汇](https://success.openhealth.fr/zh-CN/articles/6282099-电子邮件活动的词汇.md) ### 普萨德 - [分析-国家](https://success.openhealth.fr/zh-CN/articles/3376262-分析-国家.md): 分析家庭健康提供者（PSAD）市场的表现：按区域，活动，子活动，细分，LPP行为 - [交易量/营业额-NATIONAL](https://success.openhealth.fr/zh-CN/articles/3376287-交易量-营业额-national.md): 同时查看活动的数量和价值：按面积，活动，子活动，细分，LPP行为（产品和服务列表） - [进化-民族](https://success.openhealth.fr/zh-CN/articles/3376370-进化-民族.md): 根据可用历史记录可视化市场的演变：按域，活动，子活动，细分，LPP行为 - [提取-国家](https://success.openhealth.fr/zh-CN/articles/3376420-提取-国家.md): 将数据导出到Excel - [定义](https://success.openhealth.fr/zh-CN/articles/3376439-定义.md): 查找SantéDomStat国家天文台的所有功能-基本应用程序 ### AUTRES THEMATIQUES - [INTERCOM](https://success.openhealth.fr/zh-CN/articles/6959415-intercom.md) - [销路](https://success.openhealth.fr/zh-CN/articles/6959337-销路.md) - [GIHSN：提交Excel文件](https://success.openhealth.fr/zh-CN/articles/3977478-gihsn-提交excel文件.md): GIHSN Excel文件 - [区块链](https://success.openhealth.fr/zh-CN/articles/5385413-区块链.md) - [DocuSign，我们业务流程中的CRM工具](https://success.openhealth.fr/zh-CN/articles/4514472-docusign-我们业务流程中的crm工具.md): Docusign：我们业务流程中的CRM工具 - [全国疫苗接种跟踪](https://success.openhealth.fr/zh-CN/articles/4754333-全国疫苗接种跟踪.md) - [疫苗接种范围](https://success.openhealth.fr/zh-CN/articles/4754311-疫苗接种范围.md) - [KPI监控](https://success.openhealth.fr/zh-CN/articles/4091042-kpi监控.md): POC ProPharma Systems：瑞士市场趋势 - [药房驾驶舱](https://success.openhealth.fr/zh-CN/articles/4091025-药房驾驶舱.md): POC ProPharma Systems：我的药房vs瑞士 - [人口当量\(p.e.\)](https://success.openhealth.fr/zh-CN/articles/5431894-人口当量-p-e.md) - [氧气需求](https://success.openhealth.fr/zh-CN/articles/5137158-氧气需求.md) - [IHU](https://success.openhealth.fr/zh-CN/articles/4851687-ihu.md) - [悬浮物](https://success.openhealth.fr/zh-CN/articles/5137147-悬浮物.md) - [废水化学](https://success.openhealth.fr/zh-CN/articles/5137101-废水化学.md) - [NRBCE](https://success.openhealth.fr/zh-CN/articles/4851683-nrbce.md) - [阿伦尼乌斯定律](https://success.openhealth.fr/zh-CN/articles/4849672-阿伦尼乌斯定律.md) - [结果表现](https://success.openhealth.fr/zh-CN/articles/5137034-结果表现.md) - [废水的类型](https://success.openhealth.fr/zh-CN/articles/5137183-废水的类型.md) - [SARS-CoV-2病毒浓度](https://success.openhealth.fr/zh-CN/articles/4867968-sars-cov-2病毒浓度.md) - [MAPOM / BMPM](https://success.openhealth.fr/zh-CN/articles/4851685-mapom-bmpm.md) - [SARS-CoV-2的内涵式浓度](https://success.openhealth.fr/zh-CN/articles/4934604-sars-cov-2的内涵式浓度.md) - [污水处理系统的类型](https://success.openhealth.fr/zh-CN/articles/4867954-污水处理系统的类型.md) - [病毒的降解](https://success.openhealth.fr/zh-CN/articles/4865742-病毒的降解.md) - [WBE](https://success.openhealth.fr/zh-CN/articles/4865735-wbe.md) - [RNA](https://success.openhealth.fr/zh-CN/articles/4865733-rna.md) - [冠状病毒](https://success.openhealth.fr/zh-CN/articles/4865728-冠状病毒.md) - [COVID-19](https://success.openhealth.fr/zh-CN/articles/4865726-covid-19.md) - [血清阳性率：抽样方法](https://success.openhealth.fr/zh-CN/articles/3924493-血清阳性率-抽样方法.md): 血清阳性率：抽样方法 - [SANDRE库房](https://success.openhealth.fr/zh-CN/articles/5415040-sandre库房.md) - [国家基地 ROSEAU](https://success.openhealth.fr/zh-CN/articles/5414523-国家基地-roseau.md) - [SARS-CoV-2病毒浓度](https://success.openhealth.fr/zh-CN/articles/4852404-sars-cov-2病毒浓度.md) - [SARS-CoV-2病毒浓度-变种](https://success.openhealth.fr/zh-CN/articles/4909854-sars-cov-2病毒浓度-变种.md) - [马赛--全球监测](https://success.openhealth.fr/zh-CN/articles/4859311-马赛-全球监测.md) - [SARS-CoV-2病毒浓度 - 尼斯](https://success.openhealth.fr/zh-CN/articles/4879292-sars-cov-2病毒浓度-尼斯.md) - [人口 - 结构](https://success.openhealth.fr/zh-CN/articles/4842408-人口-结构.md) - [SARS-CoV-2病毒浓度 - 土伦（法国）。](https://success.openhealth.fr/zh-CN/articles/4886417-sars-cov-2病毒浓度-土伦-法国.md) - [迪拜 - 机场废水监测](https://success.openhealth.fr/zh-CN/articles/5276423-迪拜-机场废水监测.md) - [SARS-CoV-2监测 - OBEPINE](https://success.openhealth.fr/zh-CN/articles/5210661-sars-cov-2监测-obepine.md) - [SARS-CoV-2的内涵式浓度](https://success.openhealth.fr/zh-CN/articles/4934608-sars-cov-2的内涵式浓度.md) - [苏伊士 - 分析性资产负债表](https://success.openhealth.fr/zh-CN/articles/5140509-苏伊士-分析性资产负债表.md) - [节日宫 - 观看T0](https://success.openhealth.fr/zh-CN/articles/5373515-节日宫-观看t0.md) - [庆典宫--每日守夜](https://success.openhealth.fr/zh-CN/articles/5373231-庆典宫-每日守夜.md) - [庆典宫--放映](https://success.openhealth.fr/zh-CN/articles/5404778-庆典宫-放映.md) - [鼬科动物 - 观察](https://success.openhealth.fr/zh-CN/articles/5169577-鼬科动物-观察.md) - [人口 - IRIS](https://success.openhealth.fr/zh-CN/articles/4842191-人口-iris.md) - [SARS-CoV-2](https://success.openhealth.fr/zh-CN/articles/4865699-sars-cov-2.md) - [国际会计准则--分析](https://success.openhealth.fr/zh-CN/articles/4842430-国际会计准则-分析.md) - [SARS-CoV-2病毒浓度 - SEM](https://success.openhealth.fr/zh-CN/articles/5415600-sars-cov-2病毒浓度-sem.md) - [地图可视化](https://success.openhealth.fr/zh-CN/articles/3864657-地图可视化.md): 患者的地域划分 - [贡献网站](https://success.openhealth.fr/zh-CN/articles/3864668-贡献网站.md): 现场和医院捐款 - [同类群组网站](https://success.openhealth.fr/zh-CN/articles/3864672-同类群组网站.md): 按地点和医院分组的队列 - [按季节分类的同类人群](https://success.openhealth.fr/zh-CN/articles/3864673-按季节分类的同类人群.md): 按季节分类的同类人群 - [年龄和性别分布](https://success.openhealth.fr/zh-CN/articles/3864675-年龄和性别分布.md): 人口统计学 - [病毒按站点分布](https://success.openhealth.fr/zh-CN/articles/3864678-病毒按站点分布.md): 病毒按站点分布 - [病毒按年龄分布](https://success.openhealth.fr/zh-CN/articles/3864677-病毒按年龄分布.md): 病毒按年龄分布 - [病毒分布演变](https://success.openhealth.fr/zh-CN/articles/3864681-病毒分布演变.md): 病毒分布演变 - [流感疫苗接种](https://success.openhealth.fr/zh-CN/articles/3864697-流感疫苗接种.md): 流感疫苗接种 - [流感疫苗的演变](https://success.openhealth.fr/zh-CN/articles/3864701-流感疫苗的演变.md): 流感疫苗接种的演变 - [慢性病患者分布](https://success.openhealth.fr/zh-CN/articles/3864676-慢性病患者分布.md): 慢性病患者分布 - [按住院时间划分的患者分布](https://success.openhealth.fr/zh-CN/articles/3864794-按住院时间划分的患者分布.md): 按住院时间长短分配患者 - [虚弱](https://success.openhealth.fr/zh-CN/articles/3864704-虚弱.md): 患者的脆弱性 - [严重等级](https://success.openhealth.fr/zh-CN/articles/3864705-严重等级.md): 严重等级 - [死亡](https://success.openhealth.fr/zh-CN/articles/3864710-死亡.md): 死亡 - [吉森](https://success.openhealth.fr/zh-CN/articles/3864712-吉森.md): 全球流感医院监控网络 - [CARéDIAB-患者档案](https://success.openhealth.fr/zh-CN/articles/3789234-carediab-患者档案.md): 分析CARéDIAB人群的患者资料 - [CARÉDIAB-并发症](https://success.openhealth.fr/zh-CN/articles/3789515-carediab-并发症.md): 分析我们人群中并发症的患病率 卡地亚 - [CARéDIAB-全球患者监测](https://success.openhealth.fr/zh-CN/articles/3792041-carediab-全球患者监测.md): 分析CARéDIAB人群中患者的随访频率 - [CARéDIAB网络](https://success.openhealth.fr/zh-CN/articles/3789106-carediab网络.md): CARéDIAB网络 - [CARÉDIAB-治疗](https://success.openhealth.fr/zh-CN/articles/3792143-carediab-治疗.md): 分析糖尿病情况下的治疗方法 ## Español ### Votre PLATEFORME - présentation générale - [El HUB, una plataforma de apoyo integral y continuo](https://success.openhealth.fr/es/articles/4799621-el-hub-una-plataforma-de-apoyo-integral-y-continuo.md) - [Su nivel de experiencia The HUB](https://success.openhealth.fr/es/articles/5712270-su-nivel-de-experiencia-the-hub.md) - [Languages](https://success.openhealth.fr/es/articles/4649389-languages.md): Here is the description of all languages available on Success - [Preguntas sobre nuestras tarifas](https://success.openhealth.fr/es/articles/3292143-preguntas-sobre-nuestras-tarifas.md): Nuestros precios ### La ROADMAP - ["Innovación abierta para nuestros clientes](https://success.openhealth.fr/es/articles/5200970-innovacion-abierta-para-nuestros-clientes.md) - [Apps + Área de administración versión 240515](https://success.openhealth.fr/es/articles/9310541-apps-area-de-administracion-version-240515.md) - [Apps + Área de administración versión 240415](https://success.openhealth.fr/es/articles/9310710-apps-area-de-administracion-version-240415.md) - [Apps + Área de Administración versión 240315](https://success.openhealth.fr/es/articles/9310790-apps-area-de-administracion-version-240315.md) - [Apps + Área de Administración versión 240215](https://success.openhealth.fr/es/articles/9311007-apps-area-de-administracion-version-240215.md) - [Plataforma - actualización 231215](https://success.openhealth.fr/es/articles/8718485-plataforma-actualizacion-231215.md) - [Plataforma - actualización 231015](https://success.openhealth.fr/es/articles/8479932-plataforma-actualizacion-231015.md) - [Apps + Portal versión 230915](https://success.openhealth.fr/es/articles/8373640-apps-portal-version-230915.md) - [Apps + Portal versión 230815](https://success.openhealth.fr/es/articles/8267860-apps-portal-version-230815.md) - [Nuevos productos 230715](https://success.openhealth.fr/es/articles/8115796-nuevos-productos-230715.md) - [Apps + Portal versión 230615](https://success.openhealth.fr/es/articles/8115791-apps-portal-version-230615.md) - [Apps + Portal versión 230515](https://success.openhealth.fr/es/articles/7895393-apps-portal-version-230515.md) - [Apps + Portal versión 230415](https://success.openhealth.fr/es/articles/7439447-apps-portal-version-230415.md) - [Apps + Portal versión 230315](https://success.openhealth.fr/es/articles/7439646-apps-portal-version-230315.md) - [Apps + Portal versión 230215](https://success.openhealth.fr/es/articles/7439744-apps-portal-version-230215.md) - [Nuevo a partir del 15/01/2023](https://success.openhealth.fr/es/articles/6895740-nuevo-a-partir-del-15-01-2023.md) - [HUB + GATE versión 221215](https://success.openhealth.fr/es/articles/6827027-hub-gate-version-221215.md) - [HUB + GATE versión 221115](https://success.openhealth.fr/es/articles/6742628-hub-gate-version-221115.md) - [HUB + GATE versión 220915](https://success.openhealth.fr/es/articles/6558070-hub-gate-version-220915.md) - [HUB + GATE versión 220815](https://success.openhealth.fr/es/articles/6475311-hub-gate-version-220815.md) - [HUB + GATE versión 220615](https://success.openhealth.fr/es/articles/6306090-hub-gate-version-220615.md) - [HUB + GATE versión 220515](https://success.openhealth.fr/es/articles/6201877-hub-gate-version-220515.md) - [HUB + GATE versión 220415](https://success.openhealth.fr/es/articles/6087747-hub-gate-version-220415.md) - [HUB SMA versión 220315](https://success.openhealth.fr/es/articles/6043772-hub-sma-version-220315.md) - [HUB TMA versión 220315](https://success.openhealth.fr/es/articles/6043802-hub-tma-version-220315.md) - [HUB UAN versión 220315](https://success.openhealth.fr/es/articles/6043852-hub-uan-version-220315.md) - [GATE versión 220215](https://success.openhealth.fr/es/articles/5940805-gate-version-220215.md) - [HUB SMA versión 220215](https://success.openhealth.fr/es/articles/5940753-hub-sma-version-220215.md) - [HUB TMA versión 220215](https://success.openhealth.fr/es/articles/5947859-hub-tma-version-220215.md) - [GATE versión 211215](https://success.openhealth.fr/es/articles/5819397-gate-version-211215.md) - [HUB SMA versión 211215](https://success.openhealth.fr/es/articles/5784709-hub-sma-version-211215.md) - [HUB TMA versión 211215](https://success.openhealth.fr/es/articles/5784888-hub-tma-version-211215.md) - [HUB UAN versión 211215](https://success.openhealth.fr/es/articles/5784904-hub-uan-version-211215.md) - [Aplicación The HUB: "El estado de la farmacia".](https://success.openhealth.fr/es/articles/5704485-aplicacion-the-hub-el-estado-de-la-farmacia.md) - [GATE versión 211115](https://success.openhealth.fr/es/articles/5697844-gate-version-211115.md) - [HUB SMA versión 211115](https://success.openhealth.fr/es/articles/5671893-hub-sma-version-211115.md) - [HUB TMA versión 211115](https://success.openhealth.fr/es/articles/5671917-hub-tma-version-211115.md) - [HUB UAN versión 211115](https://success.openhealth.fr/es/articles/5671927-hub-uan-version-211115.md) - [GATE versión 211015](https://success.openhealth.fr/es/articles/5652210-gate-version-211015.md) - [HUB SMA versión 211015](https://success.openhealth.fr/es/articles/5649822-hub-sma-version-211015.md) - [HUB TMA versión 211015](https://success.openhealth.fr/es/articles/5650073-hub-tma-version-211015.md) - [HUB UAN versión 211015](https://success.openhealth.fr/es/articles/5652242-hub-uan-version-211015.md) - [HUB SMA versión 210915](https://success.openhealth.fr/es/articles/5370516-hub-sma-version-210915.md) - [HUB TMA versión 210915](https://success.openhealth.fr/es/articles/5390983-hub-tma-version-210915.md) - [HUB UAN versión 210915](https://success.openhealth.fr/es/articles/5543213-hub-uan-version-210915.md) ### Votre ESPACE D'ADMINISTRATION - fonctionnalités - [Restablecer / cambiar su contraseña The HUB](https://success.openhealth.fr/es/articles/4425325-restablecer-cambiar-su-contrasena-the-hub.md): Cómo cambiar la contraseña del HUB - [Ayuda a la conexión: Recibo un mensaje de error](https://success.openhealth.fr/es/articles/5369783-ayuda-a-la-conexion-recibo-un-mensaje-de-error.md) - [Crea y rastrea un ticket](https://success.openhealth.fr/es/articles/3586214-crea-y-rastrea-un-ticket.md): Tutorial para crear y seguir la evolución de tus tickets en tu espacio personal The HUB - [Crear y modificar un artículo SUCCESS](https://success.openhealth.fr/es/articles/6738705-crear-y-modificar-un-articulo-success.md) - [Mis contratos](https://success.openhealth.fr/es/articles/5712273-mis-contratos.md) - [Servicio de Salud](https://success.openhealth.fr/es/articles/4990600-servicio-de-salud.md) - [Mis accesos](https://success.openhealth.fr/es/articles/5783418-mis-accesos.md) - [Configurar mi página de inicio](https://success.openhealth.fr/es/articles/5712229-configurar-mi-pagina-de-inicio.md) - [¿Cómo modificar su mercado desde su espacio personal de OpenHealth?](https://success.openhealth.fr/es/articles/3585971-como-modificar-su-mercado-desde-su-espacio-personal-de-openhealth.md): Integre, modifique y desactive productos desde su espacio personal de OpenHealth - [Modificación automática de la asignación de modalidad \(Auto MAM\)](https://success.openhealth.fr/es/articles/4164818-modificacion-automatica-de-la-asignacion-de-modalidad-auto-mam.md): Modifique directamente las asignaciones de sus productos - [TEMPORAL MAM: ¿Cómo seguir una marca que cambia de laboratorio / marca / etiqueta?](https://success.openhealth.fr/es/articles/4131072-temporal-mam-como-seguir-una-marca-que-cambia-de-laboratorio-marca-etiqueta.md): Beneficios y riesgos de su tipo de seguimiento - [Integración automática de productos \(IPR automático\)](https://success.openhealth.fr/es/articles/4164932-integracion-automatica-de-productos-ipr-automatico.md): Solicita la integración de un producto en tu mercado - [Desactivación automática de productos \(Auto DPR\)](https://success.openhealth.fr/es/articles/4164866-desactivacion-automatica-de-productos-auto-dpr.md): Desactive un producto de su mercado - [Reactivación automática de productos \(RPR auto\)](https://success.openhealth.fr/es/articles/4818161-reactivacion-automatica-de-productos-rpr-auto.md) - [Creación de nuevos productos](https://success.openhealth.fr/es/articles/5811248-creacion-de-nuevos-productos.md) - [Añadir un mercado](https://success.openhealth.fr/es/articles/5712283-anadir-un-mercado.md) - [Importación y exportación de productos a granel](https://success.openhealth.fr/es/articles/5712257-importacion-y-exportacion-de-productos-a-granel.md) - [Cambio de modalidad tipológica \(CMT\)](https://success.openhealth.fr/es/articles/4670174-cambio-de-modalidad-tipologica-cmt.md) - [Los diferentes estados de usuario](https://success.openhealth.fr/es/articles/3436418-los-diferentes-estados-de-usuario.md): Cuales son las caracteristicas? - [Crear una cuenta para un usuario de una organización tercera \(TPAA\)](https://success.openhealth.fr/es/articles/6466550-crear-una-cuenta-para-un-usuario-de-una-organizacion-tercera-tpaa.md) - [¿Cómo crear, modificar o eliminar una cuenta de usuario en The HUB?](https://success.openhealth.fr/es/articles/3785138-como-crear-modificar-o-eliminar-una-cuenta-de-usuario-en-the-hub.md): Solo un USUARIO PODER puede hacer esto - [¿Puedo crear derechos de visualización diferenciados en el HUB dentro de mis equipos?](https://success.openhealth.fr/es/articles/3321731-puedo-crear-derechos-de-visualizacion-diferenciados-en-el-hub-dentro-de-mis-equipos.md): Derechos en el Hub - [Registro de actividades](https://success.openhealth.fr/es/articles/4687438-registro-de-actividades.md) ### Vos APPLICATIONS - présentation - [La guía de formación HUB](https://success.openhealth.fr/es/articles/5634967-la-guia-de-formacion-hub.md) - [Selector desplegable de ordenación](https://success.openhealth.fr/es/articles/5792113-selector-desplegable-de-ordenacion.md) - [Actualizar la fecha de los datos de la farmacia de GSA \(SMKT\) en el HuB](https://success.openhealth.fr/es/articles/3175557-actualizar-la-fecha-de-los-datos-de-la-farmacia-de-gsa-smkt-en-el-hub.md): Este artículo describe la fecha en la que se actualizan los datos de las farmacias GSA \(SMKT\). - [Archivo de farmacias coincidentes de requisitos previos](https://success.openhealth.fr/es/articles/3678146-archivo-de-farmacias-coincidentes-de-requisitos-previos.md): Archivo de farmacias coincidentes de requisitos previos - [Selector "Encendido y apagado de prescripción"](https://success.openhealth.fr/es/articles/3729668-selector-encendido-y-apagado-de-prescripcion.md): Especificaciones del objeto 'Selector de tipo de prescripción' - [¿Cómo calificar nuevos productos en el HUB?](https://success.openhealth.fr/es/articles/3376100-como-calificar-nuevos-productos-en-el-hub.md): Calificación de sus nuevos productos en el HUB - [¿Cómo crear, modificar y compartir un favorito en el HUB?](https://success.openhealth.fr/es/articles/3175689-como-crear-modificar-y-compartir-un-favorito-en-el-hub.md): Crear y compartir favoritos en el Hub - [¿Cómo selecciono productos en el HUB por fecha de lanzamiento?](https://success.openhealth.fr/es/articles/3158428-como-selecciono-productos-en-el-hub-por-fecha-de-lanzamiento.md): Este artículo explica cómo seleccionar solo productos lanzados en un período determinado. - [¿Puedo extraer los datos del HUB en formato ".csv"?](https://success.openhealth.fr/es/articles/5671278-puedo-extraer-los-datos-del-hub-en-formato-csv.md) - [Tiempo de respuesta ODT](https://success.openhealth.fr/es/articles/6632310-tiempo-de-respuesta-odt.md) - [¿Cuáles son las mejores prácticas de visualización en el HUB?](https://success.openhealth.fr/es/articles/3124454-cuales-son-las-mejores-practicas-de-visualizacion-en-el-hub.md): Este artículo detalla las mejores prácticas para optimizar la visualización del HUB - [Requisitos técnicos](https://success.openhealth.fr/es/articles/5369918-requisitos-tecnicos.md) - [Limpia la caché de tu navegador](https://success.openhealth.fr/es/articles/4219722-limpia-la-cache-de-tu-navegador.md): Cómo borrar la memoria caché de su navegador Google Chrome - [¿Cómo configuro Google Chrome como mi navegador predeterminado?](https://success.openhealth.fr/es/articles/3738717-como-configuro-google-chrome-como-mi-navegador-predeterminado.md): Cómo configurar Google Chrome como predeterminado - [El ascensor de navegación no es visible en las tablas.](https://success.openhealth.fr/es/articles/3195250-el-ascensor-de-navegacion-no-es-visible-en-las-tablas.md): El ascensor de navegación - [La visualización de botones u objetos en una hoja está parcialmente cortada o no es visible](https://success.openhealth.fr/es/articles/3195245-la-visualizacion-de-botones-u-objetos-en-una-hoja-esta-parcialmente-cortada-o-no-es-visible.md): Problema de visualización de botones, objetos - [Mi tarjeta de administración de territorio no se carga y aparece el mensaje "cargando"](https://success.openhealth.fr/es/articles/3195239-mi-tarjeta-de-administracion-de-territorio-no-se-carga-y-aparece-el-mensaje-cargando.md): Problema de visualización del mapa de gestión de territorio / TMA - [¿De dónde proviene el mensaje de error "No tiene autorización para acceder a esta página"?](https://success.openhealth.fr/es/articles/3195338-de-donde-proviene-el-mensaje-de-error-no-tiene-autorizacion-para-acceder-a-esta-pagina.md): Error de mensajes - [Tengo un mensaje de error "Conexión perdida"](https://success.openhealth.fr/es/articles/4445141-tengo-un-mensaje-de-error-conexion-perdida.md): Se ha producido un error - [Puerta de enlace incorrecta](https://success.openhealth.fr/es/articles/4514555-puerta-de-enlace-incorrecta.md): Mensaje de error "Puerta de enlace incorrecta" - [Los selectores de dimensiones y medidas ya no se muestran en los consultadores "Análisis de períodos múltiples" y "Mi archivo de datos", la extracción de la tabla en "Análisis de mercado" es parcial.](https://success.openhealth.fr/es/articles/3195377-los-selectores-de-dimensiones-y-medidas-ya-no-se-muestran-en-los-consultadores-analisis-de-periodos-multiples-y-mi-archivo-de-datos-la-extraccion-de-la-tabla-en-analisis-de-mercado-es-parcial.md): Las dimensiones y las medidas ya no se muestran - [¿Cómo ver un término en el HUB?](https://success.openhealth.fr/es/articles/3194377-como-ver-un-termino-en-el-hub.md): El HUB le permite ver fácilmente los cuatrimestres en la hoja 'Evolución de las ventas' - [Especificaciones y limitaciones de Excel](https://success.openhealth.fr/es/articles/3753088-especificaciones-y-limitaciones-de-excel.md): Este artículo explica las especificaciones y limitaciones de Excel. - [¿Cómo crear, editar y compartir un Favorito en sus aplicaciones?](https://success.openhealth.fr/es/articles/10502803-como-crear-editar-y-compartir-un-favorito-en-sus-aplicaciones.md) - [Marco del panel de consumidores](https://success.openhealth.fr/es/articles/3455845-marco-del-panel-de-consumidores.md): Artículo relacionado con el marco del panel de consumidores - [Marco de análisis del mercado farmacéutico](https://success.openhealth.fr/es/articles/3455857-marco-de-analisis-del-mercado-farmaceutico.md): Artículo relacionado con el marco OpenHealth para analizar el desempeño del mercado en el canal de farmacia ### FUENTES de datos - [¿Qué es el Panel de Farmacia de OpenHealth?](https://success.openhealth.fr/es/articles/3304106-que-es-el-panel-de-farmacia-de-openhealth.md): El propósito de este artículo es describir nuestro panel de farmacias. - [La red de farmacias, un activo decisivo en la gestión de las crisis sanitarias actuales y futuras](https://success.openhealth.fr/es/articles/3825648-la-red-de-farmacias-un-activo-decisivo-en-la-gestion-de-las-crisis-sanitarias-actuales-y-futuras.md): OpenHealth Company, comprometida con el seguimiento de una crisis sanitaria sin precedentes, moviliza su tecnología y sus datos - [¿Cuáles son los territorios de los departamentos y territorios franceses de ultramar que se pueden ver en el HUB?](https://success.openhealth.fr/es/articles/3194382-cuales-son-los-territorios-de-los-departamentos-y-territorios-franceses-de-ultramar-que-se-pueden-ver-en-el-hub.md): Territorios DROM-COM disponibles en el Hub - [Archivo de sectorización de requisitos previos](https://success.openhealth.fr/es/articles/3702701-archivo-de-sectorizacion-de-requisitos-previos.md): Este artículo le permite descargar, completar y enviar su archivo de sectorización. - [Fuente de datos SMKT](https://success.openhealth.fr/es/articles/4485357-fuente-de-datos-smkt.md): IRI, proveedor de datos de farmacias de GSA - [Reglas de codificación de productos de parafarmacia de GSA \(SMKT\) en IRI](https://success.openhealth.fr/es/articles/3524492-reglas-de-codificacion-de-productos-de-parafarmacia-de-gsa-smkt-en-iri.md): Recordatorio de las reglas de codificación para productos SMKT en IRI - [Datos de ORGANIC STORE - Fuente BIOANALYTICS](https://success.openhealth.fr/es/articles/5631260-datos-de-organic-store-fuente-bioanalytics.md) - [Parafarmacias electrónicas: plataformas de seguimiento](https://success.openhealth.fr/es/articles/9167006-parafarmacias-electronicas-plataformas-de-seguimiento.md) - [Ganancias y pérdidas de productos de farmacias electrónicas](https://success.openhealth.fr/es/articles/3568773-ganancias-y-perdidas-de-productos-de-farmacias-electronicas.md): Artículo relacionado con el módulo 'Ganancias y pérdidas de productos de farmacias electrónicas' - [Perfil de consumidor](https://success.openhealth.fr/es/articles/3711085-perfil-de-consumidor.md): Artículo relacionado con el módulo 'Perfil del consumidor' - [Datos AMAZON - Fuente SELLINGZ](https://success.openhealth.fr/es/articles/5669013-datos-amazon-fuente-sellingz.md) - [Datos de comercio electrónico - Fuente WISER](https://success.openhealth.fr/es/articles/7983010-datos-de-comercio-electronico-fuente-wiser.md) - [Territorios geográficos](https://success.openhealth.fr/es/articles/4661582-territorios-geograficos.md): En Open Health Company, puede analizar sus mercados según los territorios geográficos que le ofrecemos. - [¿Qué es el panel de farmacias en Alemania? INSIGHTHEALTH](https://success.openhealth.fr/es/articles/5391412-que-es-el-panel-de-farmacias-en-alemania-insighthealth.md) - [¿Cuál es el panel de farmacias en Grecia? ALIRAHEALTH](https://success.openhealth.fr/es/articles/6863963-cual-es-el-panel-de-farmacias-en-grecia-alirahealth.md) - [¿Qué es el panel de farmacias en Austria? INSIGHTHEALTH](https://success.openhealth.fr/es/articles/6863949-que-es-el-panel-de-farmacias-en-austria-insighthealth.md) - [¿Qué es el Panel de Farmacias en África? PIEX - África](https://success.openhealth.fr/es/articles/6686633-que-es-el-panel-de-farmacias-en-africa-piex-africa.md) - [¿Qué es el panel de farmacias online en Alemania? DATAMEDIQ](https://success.openhealth.fr/es/articles/5689640-que-es-el-panel-de-farmacias-online-en-alemania-datamediq.md) - [¿Qué es el panel de farmacias en Bélgica? REDPHARMA](https://success.openhealth.fr/es/articles/4689894-que-es-el-panel-de-farmacias-en-belgica-redpharma.md) - [¿Qué es el panel de farmacias en España? - HMR](https://success.openhealth.fr/es/articles/5391363-que-es-el-panel-de-farmacias-en-espana-hmr.md): Este artículo pretende describir el Panel de Farmacias en España - HMR. Ver los datos en ESPAÑOL en su HUB - [¿Qué es el panel de farmacias en España? - INFONIS](https://success.openhealth.fr/es/articles/5428915-que-es-el-panel-de-farmacias-en-espana-infonis.md): Este artículo tiene como objetivo describir el panel de farmacias en España - INFONIS. Visualiza datos en ESPAÑOL en el Openhealth HUB - [¿Cuál es el panel de farmacias en Portugal? - HMR](https://success.openhealth.fr/es/articles/5391477-cual-es-el-panel-de-farmacias-en-portugal-hmr.md) - [¿Qué es el panel de farmacias en Rusia? - ALPHARM](https://success.openhealth.fr/es/articles/5701531-que-es-el-panel-de-farmacias-en-rusia-alpharm.md) - [¿Cuál es el panel de farmacias en Polonia? Pex Pharma](https://success.openhealth.fr/es/articles/5969485-cual-es-el-panel-de-farmacias-en-polonia-pex-pharma.md) - [CONVERTIR GRUPO](https://success.openhealth.fr/es/articles/6961966-convertir-grupo.md) - [¿Cuál es el panel de farmacias en Jordania?](https://success.openhealth.fr/es/articles/8176750-cual-es-el-panel-de-farmacias-en-jordania.md) - [Población - Cartografía](https://success.openhealth.fr/es/articles/3807695-poblacion-cartografia.md): Analizar la distribución geográfica de la población - [AMELI - LPP](https://success.openhealth.fr/es/articles/6962021-ameli-lpp.md) - [Población - Evolución por EDAD Y GÉNERO](https://success.openhealth.fr/es/articles/3810789-poblacion-evolucion-por-edad-y-genero.md): Analizar la evolución de la estructura poblacional - [Población - Comparación por EDAD Y GÉNERO](https://success.openhealth.fr/es/articles/3836795-poblacion-comparacion-por-edad-y-genero.md): Compare el perfil demográfico de dos poblaciones - [EGIPTO - Cartografía](https://success.openhealth.fr/es/articles/3714611-egipto-cartografia.md): Analizar la población de las gobernaciones de Egipto - [EGIPTO - Análisis por EDAD Y GÉNERO](https://success.openhealth.fr/es/articles/3714673-egipto-analisis-por-edad-y-genero.md): Analizar la estructura de la población - [UGANDA - Análisis por EDAD Y GÉNERO](https://success.openhealth.fr/es/articles/3713884-uganda-analisis-por-edad-y-genero.md): Analizar la estructura de la población - [Población - Análisis por EDAD Y GÉNERO](https://success.openhealth.fr/es/articles/3807673-poblacion-analisis-por-edad-y-genero.md): Analizar la estructura de la población - [Medicabase - base de datos de medicamentos](https://success.openhealth.fr/es/articles/6518920-medicabase-base-de-datos-de-medicamentos.md) - [Nacimiento](https://success.openhealth.fr/es/articles/6340025-nacimiento.md) - [OpenEudra](https://success.openhealth.fr/es/articles/6518977-openeudra.md) - [Desglose de IRIS](https://success.openhealth.fr/es/articles/6383829-desglose-de-iris.md) - [ADICAP](https://success.openhealth.fr/es/articles/6959465-adicap.md) - [NEC](https://success.openhealth.fr/es/articles/6519012-nec.md) - [Datos sobre la población mundial](https://success.openhealth.fr/es/articles/8217421-datos-sobre-la-poblacion-mundial.md) - [INSEE: Expedientes de personas fallecidas](https://success.openhealth.fr/es/articles/4498126-insee-expedientes-de-personas-fallecidas.md): INSEE \(Instituto Nacional de Estadística y Estudios Económicos\): Archivo de personas fallecidas - [Datos VAERS- VAERSDATA- Fuente CDC](https://success.openhealth.fr/es/articles/6226665-datos-vaers-vaersdata-fuente-cdc.md) - [Datos VAERS - VAERSVAX - Fuente CDC](https://success.openhealth.fr/es/articles/6226440-datos-vaers-vaersvax-fuente-cdc.md) - [Datos VAERS - VAERSSYMPTOMS - Fuente CDC](https://success.openhealth.fr/es/articles/6219415-datos-vaers-vaerssymptoms-fuente-cdc.md) - [Integre sus datos en Hub en menos de 2 semanas](https://success.openhealth.fr/es/articles/5259828-integre-sus-datos-en-hub-en-menos-de-2-semanas.md) - [Plantilla de datos internacionales](https://success.openhealth.fr/es/articles/4684696-plantilla-de-datos-internacionales.md) - [¿Cómo enviarnos sus datos por FTPS?](https://success.openhealth.fr/es/articles/4143451-como-enviarnos-sus-datos-por-ftps.md): Enviar datos a través de FTPS - [¿Qué información necesita OpenHealth para integrar una nueva fuente de datos?](https://success.openhealth.fr/es/articles/3459148-que-informacion-necesita-openhealth-para-integrar-una-nueva-fuente-de-datos.md): Artículo sobre la integración de nuevas fuentes de datos - [La visión a largo plazo](https://success.openhealth.fr/es/articles/6959482-la-vision-a-largo-plazo.md) - [¿Cómo integrar una nueva fuente de datos en el HUB?](https://success.openhealth.fr/es/articles/3467598-como-integrar-una-nueva-fuente-de-datos-en-el-hub.md): Artículo relacionado con el proceso de integración de datos en el HUB - [Integre sus datos de venta en el HUB](https://success.openhealth.fr/es/articles/3471145-integre-sus-datos-de-venta-en-el-hub.md): Artículo sobre la integración de datos de venta - [Especificaciones para recibir datos de venta](https://success.openhealth.fr/es/articles/3660043-especificaciones-para-recibir-datos-de-venta.md): Cómo enviarnos su sell-in como parte de un análisis de sell-in / sell-out o suscripción al módulo de visualización de Sell-in - [¿De dónde provienen los datos de análisis para el mercado de proveedores de atención médica a domicilio \(PSAD\)?](https://success.openhealth.fr/es/articles/3376155-de-donde-provienen-los-datos-de-analisis-para-el-mercado-de-proveedores-de-atencion-medica-a-domicilio-psad.md): PSAD - [¿Cómo unirse al observatorio SantéDom Stat?](https://success.openhealth.fr/es/articles/3798795-como-unirse-al-observatorio-santedom-stat.md): Tutorial para incorporarse al observatorio nacional de la actividad de Proveedores de Salud a Domicilio \(PSAD\) - [Panel extrapolado del observatorio SanteDomStat](https://success.openhealth.fr/es/articles/6701602-panel-extrapolado-del-observatorio-santedomstat.md) - [Numero de pacientes](https://success.openhealth.fr/es/articles/3376499-numero-de-pacientes.md): Definición del número de pacientes según las federaciones de PSAD - [Numero de tratamientos](https://success.openhealth.fr/es/articles/3376682-numero-de-tratamientos.md): Definición del número de tratamientos según las federaciones de PSAD - [Número de nuevos pacientes](https://success.openhealth.fr/es/articles/3376672-numero-de-nuevos-pacientes.md): Definición del número de nuevos pacientes según las federaciones de PSAD - [Volumen de negocios incluido impuestos](https://success.openhealth.fr/es/articles/3376725-volumen-de-negocios-incluido-impuestos.md): Definición de facturación con impuestos incluidos según las federaciones de la PSAD - [Número de pacientes al final del tratamiento](https://success.openhealth.fr/es/articles/3376675-numero-de-pacientes-al-final-del-tratamiento.md): Definición del número de pacientes al final del tratamiento según las federaciones de PSAD - [Monto del seguro médico obligatorio \(AMO\)](https://success.openhealth.fr/es/articles/3376740-monto-del-seguro-medico-obligatorio-amo.md): Definición del monto de la AMO según las federaciones PSAD - [Monto complementario del seguro médico \(AMC\)](https://success.openhealth.fr/es/articles/3376749-monto-complementario-del-seguro-medico-amc.md): Definición del monto de AMC según las federaciones de PSAD - [Carga excepcional \(RAC\)](https://success.openhealth.fr/es/articles/3376751-carga-excepcional-rac.md): Definición del RAC según las federaciones PSAD - [Fuente: THESORIMED](https://success.openhealth.fr/es/articles/3560018-fuente-thesorimed.md): Base de datos de medicamentos \(BdM\) - [Nombres comunes internacionales \(DCI\)](https://success.openhealth.fr/es/articles/3954239-nombres-comunes-internacionales-dci.md): Nombres comunes internacionales \(DCI\) - [Open Food Facts](https://success.openhealth.fr/es/articles/6961970-open-food-facts.md) - [LOINC - Identificadores lógicos de observaciones Nombres y códigos](https://success.openhealth.fr/es/articles/6959323-loinc-identificadores-logicos-de-observaciones-nombres-y-codigos.md) - [AMELI - CCAM](https://success.openhealth.fr/es/articles/6959080-ameli-ccam.md) - [OMS ATC VET](https://success.openhealth.fr/es/articles/6959078-oms-atc-vet.md) - [CEPS](https://success.openhealth.fr/es/articles/6959068-ceps.md) - [Institución](https://success.openhealth.fr/es/articles/3935678-institucion.md): Relación de establecimientos sanitarios, sociales, médico-sociales - [Servicios sanitarios](https://success.openhealth.fr/es/articles/7969680-servicios-sanitarios.md) - [Extraer FINESS](https://success.openhealth.fr/es/articles/3946922-extraer-finess.md): Realiza una extracción según tus expectativas - [Evolución FINESS](https://success.openhealth.fr/es/articles/3947009-evolucion-finess.md): Sigue la evolución del número de estructuras - [Actividad asistencial de autorización](https://success.openhealth.fr/es/articles/3947067-actividad-asistencial-de-autorizacion.md): Enumerar las estructuras según sus autorizaciones de actividad sanitaria - [Equipo médico importante](https://success.openhealth.fr/es/articles/3947269-equipo-medico-importante.md): Enumere las estructuras según su equipamiento en material pesado - [Geográfico](https://success.openhealth.fr/es/articles/3947363-geografico.md): Visualizar la distribución de estructuras en el territorio. - [RPPS](https://success.openhealth.fr/es/articles/3947568-rpps.md): Lista de profesionales sanitarios - [FINESS & RPPS](https://success.openhealth.fr/es/articles/3947713-finess-rpps.md): Enumere los lugares de ejercicio de los profesionales de la salud - [Extraer RPPS](https://success.openhealth.fr/es/articles/3947829-extraer-rpps.md): RPPS \(directorio compartido de profesionales sanitarios\) ### Los modelos - [Datos en la UGA](https://success.openhealth.fr/es/articles/4852310-datos-en-la-uga.md) - [Cálculo de ventas al sector: lo que necesita saber](https://success.openhealth.fr/es/articles/3545561-calculo-de-ventas-al-sector-lo-que-necesita-saber.md): ¿Cuáles son los diferentes pasos para calcular las ventas del sector en OpenHealth? - [Reasignación sectorial, ¿metodología estática o dinámica?](https://success.openhealth.fr/es/articles/3690615-reasignacion-sectorial-metodologia-estatica-o-dinamica.md): Reasignación sectorial, ¿metodología estática o dinámica? - [Estrato de farmacias](https://success.openhealth.fr/es/articles/4291490-estrato-de-farmacias.md): Detalles de los estratos “teóricos” y los estratos “reales” o “efectivos”. - [La línea de producción Hub](https://success.openhealth.fr/es/articles/4816146-la-linea-de-produccion-hub.md) - [¿Cómo realizar un análisis comparativo?](https://success.openhealth.fr/es/articles/3440093-como-realizar-un-analisis-comparativo.md): Quiere comparar datos de dos proveedores diferentes. - [INVESTIGACIÓN DE NIVEL 1 - Calidad de los datos al servicio de OpenHealth Company](https://success.openhealth.fr/es/articles/3595822-investigacion-de-nivel-1-calidad-de-los-datos-al-servicio-de-openhealth-company.md): ¿Observa un fenómeno que no comprende? Podemos proporcionarle el origen de este avistamiento y explicárselo. - [Proceso de calidad de datos en OpenHealth](https://success.openhealth.fr/es/articles/3415271-proceso-de-calidad-de-datos-en-openhealth.md): Este artículo detalla las etapas de los procesos de calidad de datos en OpenHealth - [Intervalo y nivel de confianza](https://success.openhealth.fr/es/articles/3633173-intervalo-y-nivel-de-confianza.md): Definiciones, fórmulas y limitaciones: lo que necesita saber - [Calidad de los datos: gestión de lotes](https://success.openhealth.fr/es/articles/3433509-calidad-de-los-datos-gestion-de-lotes.md): Descripción del proceso de gestión de lotes - [Calidad de los datos: proceso de desglose de ventas](https://success.openhealth.fr/es/articles/3415317-calidad-de-los-datos-proceso-de-desglose-de-ventas.md): Descripción del proceso de desglose de ventas - [Venta y compensaciones de stock](https://success.openhealth.fr/es/articles/4131084-venta-y-compensaciones-de-stock.md): Venta de acciones - [¿Por qué analizar el volumen de ventas?](https://success.openhealth.fr/es/articles/3846167-por-que-analizar-el-volumen-de-ventas.md): ¿Por qué analizar el volumen de ventas? - [Existe una brecha de datos entre la venta y la venta](https://success.openhealth.fr/es/articles/3195358-existe-una-brecha-de-datos-entre-la-venta-y-la-venta.md): ¿En qué casos podemos tener una brecha de datos entre la venta y la venta? - [¿Qué es una venta atípica?](https://success.openhealth.fr/es/articles/3195366-que-es-una-venta-atipica.md): Ventas atípicas y proceso de FILTRO ATÍPICO. - [¿De dónde proviene la información sobre precios, volúmenes, facturación?](https://success.openhealth.fr/es/articles/3195348-de-donde-proviene-la-informacion-sobre-precios-volumenes-facturacion.md): Información de precio / volumen / facturación - [Volumen de ventas estimado por prescriptor](https://success.openhealth.fr/es/articles/4171530-volumen-de-ventas-estimado-por-prescriptor.md): Cómo evaluar sus volúmenes de ventas en farmacias por prescriptor y categoría de prescriptor - [Comprender la diferencia entre 2 extracciones](https://success.openhealth.fr/es/articles/13399689-comprender-la-diferencia-entre-2-extracciones.md) ### MERCADOS - [GTIN](https://success.openhealth.fr/es/articles/3608176-gtin.md): Código GTIN \(número de artículo comercial global\) - [Especificación del campo del calificador de producto del cliente \(CQCP\)](https://success.openhealth.fr/es/articles/3704913-especificacion-del-campo-del-calificador-de-producto-del-cliente-cqcp.md): CQCP \(campo calificador del cliente del producto\) - [¿Qué es un código LPPR?](https://success.openhealth.fr/es/articles/3195365-que-es-un-codigo-lppr.md): El código LPPR \(Lista de productos y servicios reembolsables\) - [Seguimiento de alquiler de productos](https://success.openhealth.fr/es/articles/4206554-seguimiento-de-alquiler-de-productos.md): Alquiler de producto - [Quiero expandir mi mercado](https://success.openhealth.fr/es/articles/4420843-quiero-expandir-mi-mercado.md): Mercado de suscripciones siguió - [Clasificación OHC](https://success.openhealth.fr/es/articles/3194589-clasificacion-ohc.md): Visualice la asignación de sus productos según la clasificación patentada de OpenHealth Company - [Historia de las clases de EphMRA AC](https://success.openhealth.fr/es/articles/3557908-historia-de-las-clases-de-ephmra-ac.md): Visualice la evolución de las clases de EphMRA AC desde 2014 - [Detalles de medicina veterinaria](https://success.openhealth.fr/es/articles/3194587-detalles-de-medicina-veterinaria.md): Visualizar las características de los medicamentos veterinarios. - [Clasificación de medicina veterinaria](https://success.openhealth.fr/es/articles/3194579-clasificacion-de-medicina-veterinaria.md): Ver la clasificación de medicamentos veterinarios \(ANSES\) - [Detalles de la medicina humana](https://success.openhealth.fr/es/articles/3421225-detalles-de-la-medicina-humana.md): Ver las características de uno o más productos a través de los campos de detalle de THESORIMED - [Gestión de nuevos productos](https://success.openhealth.fr/es/articles/4470813-gestion-de-nuevos-productos.md): Gestión de nuevos productos - [Clasificación de medicina humana](https://success.openhealth.fr/es/articles/3417281-clasificacion-de-medicina-humana.md): Vea las clasificaciones EphMRA AC y OMS ATC para el alcance de su producto - [Indicaciones - Diagnóstico](https://success.openhealth.fr/es/articles/3568554-indicaciones-diagnostico.md): Ver los fármacos indicados para una patología determinada y las patologías asociadas a una selección de fármacos - [MP4U](https://success.openhealth.fr/es/articles/3574188-mp4u.md): Ver todas las clasificaciones disponibles por OpenHealth Company - [Qué es la TVASI \(Tabla de Ventas, Compras y Existencias Desconocidas\)](https://success.openhealth.fr/es/articles/5992494-que-es-la-tvasi-tabla-de-ventas-compras-y-existencias-desconocidas.md) - [Clasificación de productos IRI](https://success.openhealth.fr/es/articles/3194597-clasificacion-de-productos-iri.md): Visualice la asignación de sus productos según la clasificación propietario IRI - [Retirada de productos no vendidos](https://success.openhealth.fr/es/articles/6135938-retirada-de-productos-no-vendidos.md) - [MERCADO ESTÁNDAR - Suscripción](https://success.openhealth.fr/es/articles/3798203-mercado-estandar-suscripcion.md): Este artículo describe el interés y las limitaciones de un mercado llamado "estándar" - [No encuentro mi producto](https://success.openhealth.fr/es/articles/5686002-no-encuentro-mi-producto.md) - [Gestión de códigos de productos](https://success.openhealth.fr/es/articles/5652478-gestion-de-codigos-de-productos.md) - [Calificación de los productos: Marcas](https://success.openhealth.fr/es/articles/5016985-calificacion-de-los-productos-marcas.md) ### SUSCRIPCIONES y MÓDULOS - [Los 3 tipos de aplicación](https://success.openhealth.fr/es/articles/9489652-los-3-tipos-de-aplicacion.md) - [Su plataforma 2.0](https://success.openhealth.fr/es/articles/8374416-su-plataforma-2-0.md) - [RESUMEN](https://success.openhealth.fr/es/articles/3344127-resumen.md): Todas las características de su aplicación están disponibles en este módulo - [Mercados y selecciones](https://success.openhealth.fr/es/articles/8337016-mercados-y-selecciones.md) - [Cuadro de mando resumido](https://success.openhealth.fr/es/articles/9246867-cuadro-de-mando-resumido.md) - [Análisis](https://success.openhealth.fr/es/articles/9352287-analisis.md) - [Extractor](https://success.openhealth.fr/es/articles/9246875-extractor.md) - [Análisis de crecimiento](https://success.openhealth.fr/es/articles/3158856-analisis-de-crecimiento.md): Determinar los factores clave en la evolución de sus mercados y los de sus competidores - [Análisis de surtido](https://success.openhealth.fr/es/articles/3473736-analisis-de-surtido.md): Estudiar el dinamismo de los productos en un mercado - [Número medio de productos](https://success.openhealth.fr/es/articles/3161474-numero-medio-de-productos.md): Ver la cantidad promedio de productos por punto de venta, en farmacias o en droguerías GSA - [Seguimiento de lanzamiento](https://success.openhealth.fr/es/articles/3158488-seguimiento-de-lanzamiento.md): Monitorear los lanzamientos de productos y su contribución al crecimiento. - [Indicadores avanzados cruzados](https://success.openhealth.fr/es/articles/6007740-indicadores-avanzados-cruzados.md) - [Concentración de ventas](https://success.openhealth.fr/es/articles/3095338-concentracion-de-ventas.md): Visualice la concentración de un mercado a través de la curva de concentración de ventas y el índice GINI. - [Dispersión de precios](https://success.openhealth.fr/es/articles/3159289-dispersion-de-precios.md): Visualice la dispersión de precios de un producto. Cree sus propios segmentos de farmacia a partir del precio de oferta - [Análisis de margen de venta](https://success.openhealth.fr/es/articles/3358322-analisis-de-margen-de-venta.md): Compare el atractivo de sus productos para las farmacias - [Evolución del margen de venta](https://success.openhealth.fr/es/articles/3815561-evolucion-del-margen-de-venta.md) - [Monitoreo de farmacia \(1/2\)](https://success.openhealth.fr/es/articles/3358248-monitoreo-de-farmacia-1-2.md): Siga la evolución del tráfico de farmacias - [Monitoreo de farmacia \(2/2\)](https://success.openhealth.fr/es/articles/3810527-monitoreo-de-farmacia-2-2.md): Siga la evolución del tráfico de farmacias - [Rendimiento de Salesforce](https://success.openhealth.fr/es/articles/3159230-rendimiento-de-salesforce.md): Comparar el desempeño de ventas de regiones y sectores de una fuerza de ventas - [ASISTENTE DE GESTIÓN DE RELACIONES CON LOS CLIENTES \(CRM\)](https://success.openhealth.fr/es/articles/5953935-asistente-de-gestion-de-relaciones-con-los-clientes-crm.md) - [Seguimiento del punto de venta](https://success.openhealth.fr/es/articles/3778944-seguimiento-del-punto-de-venta.md): Seguimiento del punto de venta - [Evolución a la carta](https://success.openhealth.fr/es/articles/6560184-evolucion-a-la-carta.md) - [Análisis a la carta](https://success.openhealth.fr/es/articles/6127483-analisis-a-la-carta.md) - [Mesa bajo demanda](https://success.openhealth.fr/es/articles/3158751-mesa-bajo-demanda.md): Visualizar los principales indicadores HUB y su evolución en diferentes tipos de periodos - [Análisis de series temporales](https://success.openhealth.fr/es/articles/3635940-analisis-de-series-temporales.md): Divida su mercado en temporada, tendencia y ruido - [Análisis de pronóstico](https://success.openhealth.fr/es/articles/3636015-analisis-de-pronostico.md): Estime el futuro de su mercado - [Pronóstico sectorial](https://success.openhealth.fr/es/articles/3689811-pronostico-sectorial.md): Estime sus ventas futuras del sector - [Visualización de venta](https://success.openhealth.fr/es/articles/3559882-visualizacion-de-venta.md): Compare la evolución de sus ventas de sell-in y sell-out - [Análisis de ventas](https://success.openhealth.fr/es/articles/6188132-analisis-de-ventas.md) - [Coincidencia de venta](https://success.openhealth.fr/es/articles/6188090-coincidencia-de-venta.md) - [Evolución de la venta](https://success.openhealth.fr/es/articles/6191929-evolucion-de-la-venta.md) - [Análisis de entradas y salidas](https://success.openhealth.fr/es/articles/6191947-analisis-de-entradas-y-salidas.md) - [Evolución Sell-in vs Sell-out](https://success.openhealth.fr/es/articles/6191955-evolucion-sell-in-vs-sell-out.md) - [Evolución de los precios](https://success.openhealth.fr/es/articles/5056489-evolucion-de-los-precios.md) - [Personalizar colores](https://success.openhealth.fr/es/articles/8407897-personalizar-colores.md) - [Exportación de productos](https://success.openhealth.fr/es/articles/3583206-exportacion-de-productos.md): Exportar hoja específica para todos los productos y aplicaciones de tipo MP4U - [Análisis de mercado](https://success.openhealth.fr/es/articles/3121933-analisis-de-mercado.md): Analice el desempeño de su mercado: por segmento, marca, producto y empresa - [Análisis de precios](https://success.openhealth.fr/es/articles/3215190-analisis-de-precios.md): Consulta los precios de tu mercado y analiza tu posicionamiento - [Evolución de las ventas](https://success.openhealth.fr/es/articles/3178323-evolucion-de-las-ventas.md): Vea la evolución de sus ventas en todo su historial disponible - [Resumir el cuadro de mandos](https://success.openhealth.fr/es/articles/4533213-resumir-el-cuadro-de-mandos.md) - [Evolución de la cuota de mercado](https://success.openhealth.fr/es/articles/3193078-evolucion-de-la-cuota-de-mercado.md): Visualice la evolución de las ventas y la participación de mercado durante largos períodos - [Tabla cruzada de ventas](https://success.openhealth.fr/es/articles/3193060-tabla-cruzada-de-ventas.md): Crea una tabla dinámica simple - [Síntesis de ROTACIÓN / VOLUMEN \(CU\)](https://success.openhealth.fr/es/articles/3193048-sintesis-de-rotacion-volumen-cu.md): Visualizar simultáneamente los volúmenes de ventas y el valor de un mercado - [Síntesis de valor de venta \(FARMACIAS / SUPERMERCADOS\)](https://success.openhealth.fr/es/articles/3193020-sintesis-de-valor-de-venta-farmacias-supermercados.md): Compare las ventas de farmacias y farmacias de GSA - [Análisis de participación de mercado](https://success.openhealth.fr/es/articles/3193069-analisis-de-participacion-de-mercado.md): Analizar cuotas de mercado durante los últimos 12 meses - [Mi archivo de datos](https://success.openhealth.fr/es/articles/3193099-mi-archivo-de-datos.md): Exportar una base de datos plana a Excel - [Análisis de periodos múltiples](https://success.openhealth.fr/es/articles/3192953-analisis-de-periodos-multiples.md): Crea una mesa completamente personalizada - [Mi consulta Todos los productos](https://success.openhealth.fr/es/articles/4280353-mi-consulta-todos-los-productos.md): Ver sus segmentos y campos calificativos \(Ej .: galénico, índice solar, promociones ...\) así como su Restricción - [Evolución de existencias \(NUEVO\)](https://success.openhealth.fr/es/articles/3719256-evolucion-de-existencias-nuevo.md): Visualizar y analizar la evolución de las existencias y su distribución - [Definición de mercado](https://success.openhealth.fr/es/articles/3158829-definicion-de-mercado.md): Vuelva a basar su mercado en la base 100 de su elección - [Indicadores avanzados de RAW DATA](https://success.openhealth.fr/es/articles/3711095-indicadores-avanzados-de-raw-data.md): Recupere los datos de sus indicadores principales - [Indicadores avanzados Evolution SMKT](https://success.openhealth.fr/es/articles/3193000-indicadores-avanzados-evolution-smkt.md): Monitoriza el rendimiento de tu laboratorio mediante un análisis de la evolución temporal de tus indicadores estadísticos avanzados. - [Análisis de indicadores avanzados SMKT](https://success.openhealth.fr/es/articles/3192366-analisis-de-indicadores-avanzados-smkt.md): Desglose la evolución de un mercado de parafarmacia GSA en indicadores líderes - [Evolución de indicadores avanzados](https://success.openhealth.fr/es/articles/3177853-evolucion-de-indicadores-avanzados.md): Monitoriza el rendimiento de tu laboratorio mediante un análisis de la evolución temporal de tus indicadores estadísticos avanzados. - [Evolución de los indicadores avanzados Bio](https://success.openhealth.fr/es/articles/7051823-evolucion-de-los-indicadores-avanzados-bio.md) - [Indicadores nacionales avanzados](https://success.openhealth.fr/es/articles/3364513-indicadores-nacionales-avanzados.md): Desglose la evolución de un mercado en indicadores adelantados - [Análisis de stock](https://success.openhealth.fr/es/articles/3178015-analisis-de-stock.md): Interpretar un nivel de stock y su evolución - [Análisis avanzado de indicadores Bio](https://success.openhealth.fr/es/articles/7051801-analisis-avanzado-de-indicadores-bio.md) - [Análisis de indicadores avanzados](https://success.openhealth.fr/es/articles/3124439-analisis-de-indicadores-avanzados.md): Descomponer la evolución de un mercado en indicadores principales - [Cartografía](https://success.openhealth.fr/es/articles/3192450-cartografia.md): Analizar el desempeño comercial de las regiones y sectores de su fuerza de ventas - [Tabla de cruz geográfica](https://success.openhealth.fr/es/articles/3192466-tabla-de-cruz-geografica.md): Crea una tabla dinámica integrando tu sectorización - [Evolución geográfica de las ventas](https://success.openhealth.fr/es/articles/3192482-evolucion-geografica-de-las-ventas.md): Ver las ventas de 36 meses por sector en una tabla dinámica - [Eficacia de la fuerza de ventas](https://success.openhealth.fr/es/articles/5624011-eficacia-de-la-fuerza-de-ventas.md) - [Análisis personalizado del método de ponderación](https://success.openhealth.fr/es/articles/5169317-analisis-personalizado-del-metodo-de-ponderacion.md) - [Análisis de red](https://success.openhealth.fr/es/articles/3894767-analisis-de-red.md): Análisis de red - [Evolución del método de ponderación personalizado](https://success.openhealth.fr/es/articles/5169320-evolucion-del-metodo-de-ponderacion-personalizado.md) - [RESUMEN DE KPI](https://success.openhealth.fr/es/articles/3478199-resumen-de-kpi.md): Visualice en una tabla dinámica sus indicadores clave El volumen disminuyó por regiones y sectores. - [Ventas en unidades convertidas](https://success.openhealth.fr/es/articles/3192412-ventas-en-unidades-convertidas.md): Utilice unidades convertidas para visualizar sus ventas - [Indicadores de stock de RAW DATA](https://success.openhealth.fr/es/articles/3711142-indicadores-de-stock-de-raw-data.md): Exporta los datos de tu inventario - [DATOS SIN PROCESAR SMKT AIA](https://success.openhealth.fr/es/articles/3720960-datos-sin-procesar-smkt-aia.md): Encuentre los datos de su indicador adelantado SMKT - [Evolución de stock](https://success.openhealth.fr/es/articles/3178277-evolucion-de-stock.md): Visualizar y analizar la evolución de las existencias y su distribución - [Indicadores geográficos avanzados](https://success.openhealth.fr/es/articles/3192508-indicadores-geograficos-avanzados.md): Ver indicadores adelantados por región o sector - [Rendimiento de productos](https://success.openhealth.fr/es/articles/3850331-rendimiento-de-productos.md): Compare el desempeño comercial de regiones y sectores de productos - [Indicadores territoriales avanzados](https://success.openhealth.fr/es/articles/3370879-indicadores-territoriales-avanzados.md): Desglose la evolución de un mercado en indicadores adelantados - [Análisis sectorial de series temporales](https://success.openhealth.fr/es/articles/3814974-analisis-sectorial-de-series-temporales.md): Divida su mercado en tendencia, temporada, ruido - [Análisis de ventas por edad y género](https://success.openhealth.fr/es/articles/3192701-analisis-de-ventas-por-edad-y-genero.md): Analice las ventas por edad y sexo - [Evolución de las ventas por estado de embarazo](https://success.openhealth.fr/es/articles/3192910-evolucion-de-las-ventas-por-estado-de-embarazo.md): Siga las ventas de farmacia sobre la población de mujeres embarazadas. - [Evolución de las ventas por edad y sexo](https://success.openhealth.fr/es/articles/3192732-evolucion-de-las-ventas-por-edad-y-sexo.md): Visualice la evolución de las ventas por edad y género utilizando la profundidad de la historia del HUB - [Evolución de la orden de requisitos](https://success.openhealth.fr/es/articles/5790020-evolucion-de-la-orden-de-requisitos.md) - [Co-dispensaciones Evolution](https://success.openhealth.fr/es/articles/3192529-co-dispensaciones-evolution.md): Visualizar y desglosar la evolución de las co-dispensaciones en farmacias - [Análisis de co-dispensaciones](https://success.openhealth.fr/es/articles/3192633-analisis-de-co-dispensaciones.md): Ver las co-dispensaciones en farmacias asociadas con una selección de productos de mi mercado - [Ventas por canal y prescriptor](https://success.openhealth.fr/es/articles/3192751-ventas-por-canal-y-prescriptor.md): Visualiza a los influencers en tu mercado - [AMO, AMC y RAC](https://success.openhealth.fr/es/articles/3192929-amo-amc-y-rac.md): Ver las tres cantidades del seguro médico obligatorio, el seguro médico complementario y los gastos de bolsillo - [Dispersión de co-dispensaciones](https://success.openhealth.fr/es/articles/3876946-dispersion-de-co-dispensaciones.md): Visualizar la distribución del número de productos vendidos por dispensación - [Dispensación Dispersión Evolución](https://success.openhealth.fr/es/articles/3920070-dispensacion-dispersion-evolucion.md): Visualice la distribución del número de productos vendidos por dispensación a lo largo del tiempo - [Prescripciones médicas por edad y sexo](https://success.openhealth.fr/es/articles/5789899-prescripciones-medicas-por-edad-y-sexo.md) - [Análisis de pedidos de recetas](https://success.openhealth.fr/es/articles/5322866-analisis-de-pedidos-de-recetas.md) - [Evolución de las recetas médicas](https://success.openhealth.fr/es/articles/5790016-evolucion-de-las-recetas-medicas.md) - [Análisis de la cesta](https://success.openhealth.fr/es/articles/3711049-analisis-de-la-cesta.md): Descripción del módulo 'Análisis de la cesta' - [Co-dispensación](https://success.openhealth.fr/es/articles/4738243-co-dispensacion.md) - [Módulo de calificación de cohortes](https://success.openhealth.fr/es/articles/3928090-modulo-de-calificacion-de-cohortes.md): Calificación de la cohorte de pacientes - [Módulo de estado de tratamiento](https://success.openhealth.fr/es/articles/3928067-modulo-de-estado-de-tratamiento.md): Analizar la dinámica del seguimiento del tratamiento. - [Módulo de adherencia al tratamiento](https://success.openhealth.fr/es/articles/3928044-modulo-de-adherencia-al-tratamiento.md): Analizar la adherencia a los tratamientos - [Definición de cohorte](https://success.openhealth.fr/es/articles/3894703-definicion-de-cohorte.md): Defina el alcance de su análisis - [Co-tratamientos](https://success.openhealth.fr/es/articles/4163623-co-tratamientos.md): Defina el coprocesamiento dentro de su alcance de análisis - [Cohorte de visualización](https://success.openhealth.fr/es/articles/3894721-cohorte-de-visualizacion.md): Ver el perfil del paciente de la cohorte definida - [Definición de criterios de análisis](https://success.openhealth.fr/es/articles/3894728-definicion-de-criterios-de-analisis.md): Defina los parámetros para el análisis de su cohorte - [Evolución de la cohorte global](https://success.openhealth.fr/es/articles/3894747-evolucion-de-la-cohorte-global.md): Visualizar la evolución mensual de la cohorte - [Distribución geográfica](https://success.openhealth.fr/es/articles/3894751-distribucion-geografica.md): Ver la distribución geográfica de los pacientes en la cohorte definida - [Perfil de cohorte](https://success.openhealth.fr/es/articles/3894755-perfil-de-cohorte.md): Analizar el perfil demográfico de los pacientes incluidos en la cohorte - [Desglose del estado del tratamiento](https://success.openhealth.fr/es/articles/3894764-desglose-del-estado-del-tratamiento.md): Obtenga una descripción general de los diferentes tipos de seguimiento del tratamiento - [Iniciaciones de tratamiento](https://success.openhealth.fr/es/articles/3894778-iniciaciones-de-tratamiento.md): Analizar la evolución del número de inicios de tratamiento - [Reinicio del tratamiento](https://success.openhealth.fr/es/articles/3894788-reinicio-del-tratamiento.md): Analizar la evolución del número de repeticiones - [Nuevos tratamientos](https://success.openhealth.fr/es/articles/3894804-nuevos-tratamientos.md): Analizar la evolución del número de iniciaciones y reanudaciones de tratamiento - [Recurrencias de tratamiento](https://success.openhealth.fr/es/articles/3894812-recurrencias-de-tratamiento.md): Analizar pacientes en tratamiento - [Balance de cambio de tratamiento](https://success.openhealth.fr/es/articles/3894821-balance-de-cambio-de-tratamiento.md): Analizar el equilibrio de los cambios de tratamiento por tratamiento. - [Beneficios del cambio de tratamiento](https://success.openhealth.fr/es/articles/3894830-beneficios-del-cambio-de-tratamiento.md): Analizar los beneficiarios de los cambios de tratamiento - [Pérdidas por cambio de tratamiento](https://success.openhealth.fr/es/articles/3894843-perdidas-por-cambio-de-tratamiento.md): Analizar por tratamiento los perdedores de los cambios de tratamiento. - [Cambiar orígenes de ganancia](https://success.openhealth.fr/es/articles/3894857-cambiar-origenes-de-ganancia.md): Analizar el origen del cambio para un tratamiento dado - [Cambiar destino de pérdida](https://success.openhealth.fr/es/articles/3894864-cambiar-destino-de-perdida.md): Analizar el destino del cambio para un tratamiento determinado - [Abandonos](https://success.openhealth.fr/es/articles/3894874-abandonos.md): Analizar paradas de tratamiento - [Resumen de KPI](https://success.openhealth.fr/es/articles/4229969-resumen-de-kpi.md): Resumen de los diferentes tipos de seguimiento del tratamiento - [Persistencia del tratamiento](https://success.openhealth.fr/es/articles/3894883-persistencia-del-tratamiento.md): Analizar la duración de los tratamientos - [Conformidad](https://success.openhealth.fr/es/articles/3894884-conformidad.md): Analizar las cantidades entregadas - [¿Qué es el criterio de regularidad?](https://success.openhealth.fr/es/articles/3325816-que-es-el-criterio-de-regularidad.md): Definición del concepto de criterio de regularidad - [Muerte - Cartografía](https://success.openhealth.fr/es/articles/3863677-muerte-cartografia.md): Analizar la distribución geográfica de las muertes - [Compensación del recuento de muertes](https://success.openhealth.fr/es/articles/3863573-compensacion-del-recuento-de-muertes.md): Evalúe la relevancia de sus datos - [Muerte - Análisis por EDAD Y GÉNERO](https://success.openhealth.fr/es/articles/3863808-muerte-analisis-por-edad-y-genero.md): Analizar la estructura de las muertes - [Muerte - Evolución por EDAD Y GÉNERO](https://success.openhealth.fr/es/articles/3863939-muerte-evolucion-por-edad-y-genero.md): Analizar la evolución de la estructura de las muertes - [Muerte - Evolución](https://success.openhealth.fr/es/articles/3864065-muerte-evolucion.md): Visualiza la evolución de las muertes - [Comparación muerte - evolución](https://success.openhealth.fr/es/articles/3864073-comparacion-muerte-evolucion.md): Comparar la evolución de las defunciones respecto a años anteriores - [Monitoreo de farmacia CA](https://success.openhealth.fr/es/articles/4634768-monitoreo-de-farmacia-ca.md): Describe el tráfico según el tamaño de las farmacias. - [Análisis del tráfico \(prueba beta\)](https://success.openhealth.fr/es/articles/6848401-analisis-del-trafico-prueba-beta.md) - [Detalles de seguimiento de farmacia](https://success.openhealth.fr/es/articles/4527868-detalles-de-seguimiento-de-farmacia.md): Analizar el tráfico de dispensarios por tipo de farmacia - [Evolución del tráfico \(prueba beta\)](https://success.openhealth.fr/es/articles/6848016-evolucion-del-trafico-prueba-beta.md) - [Cartografía de monitorización de farmacia](https://success.openhealth.fr/es/articles/4527811-cartografia-de-monitorizacion-de-farmacia.md): Analizar el tráfico de dispensarios en Francia continental - [Detalles de seguimiento de farmacia](https://success.openhealth.fr/es/articles/4262306-detalles-de-seguimiento-de-farmacia.md): Discriminar el detalle de ventas por tipo de dispensario - [Análisis de seguimiento de farmacia](https://success.openhealth.fr/es/articles/3839223-analisis-de-seguimiento-de-farmacia.md): Siga la evolución del tráfico de farmacias - [Evolución del seguimiento farmacéutico](https://success.openhealth.fr/es/articles/3827973-evolucion-del-seguimiento-farmaceutico.md): Estudiar la evolución del tráfico de dispensarios - [Descomposición del tráfico](https://success.openhealth.fr/es/articles/3826074-descomposicion-del-trafico.md): Observe los componentes de temporada, tendencia y residuo. - [Estudio de tráfico](https://success.openhealth.fr/es/articles/3809042-estudio-de-trafico.md): Analizar el tráfico de farmacias - [Resumen ejecutivo - PIEX](https://success.openhealth.fr/es/articles/5203335-resumen-ejecutivo-piex.md) - [Adquisitivo](https://success.openhealth.fr/es/articles/4605110-adquisitivo.md): Seguimiento de sus compras y sus recibos - [Mi consulta - PIEX](https://success.openhealth.fr/es/articles/4210627-mi-consulta-piex.md): Realice selecciones en sus datos - [Evolución de las ventas - PIEX](https://success.openhealth.fr/es/articles/4210655-evolucion-de-las-ventas-piex.md): Ver la evolución de su actividad en el historial disponible - [Análisis de ventas - PIEX](https://success.openhealth.fr/es/articles/4210650-analisis-de-ventas-piex.md): Análisis de ventas - PIEX - [Detalles del pedido - PIEX](https://success.openhealth.fr/es/articles/4210659-detalles-del-pedido-piex.md): Ver y rastrear un pedido de ventas - [Resumen de existencias - PIEX](https://success.openhealth.fr/es/articles/4210672-resumen-de-existencias-piex.md): Visualice las variaciones de sus acciones - [Mi archivo de datos - PIEX](https://success.openhealth.fr/es/articles/4210694-mi-archivo-de-datos-piex.md): Exportar una base de datos plana a Excel - [EURAPHARMA- PIEX](https://success.openhealth.fr/es/articles/4366306-eurapharma-piex.md): Visualizar la evolución de la actividad de EURAPHARMA - [Producto a juego](https://success.openhealth.fr/es/articles/4366320-producto-a-juego.md): Correspondencia entre las denominaciones de los productos PIEX y EURAPHARMA - [CLI Mi archivo \(1/5\)](https://success.openhealth.fr/es/articles/4626422-cli-mi-archivo-1-5.md): CLI Mi archivo \(1/5\) - [CLI\_Recuentos de archivos \(2/5\)](https://success.openhealth.fr/es/articles/4626421-cli_recuentos-de-archivos-2-5.md): CLI\_Recuentos de archivos \(2/5\) - [Coincidencia de código CLI\_File con el repositorio OHC](https://success.openhealth.fr/es/articles/4626419-coincidencia-de-codigo-cli_file-con-el-repositorio-ohc.md): Coincidencia de código CLI\_FIL con el repositorio OHC - [Exportación con liquidación \(4/5\)](https://success.openhealth.fr/es/articles/4626414-exportacion-con-liquidacion-4-5.md): Exportación con liquidación \(4/5\) ### OPCIONES PERSONALIZADAS - [Campos de calificación de productos no jerárquicos](https://success.openhealth.fr/es/articles/4036045-campos-de-calificacion-de-productos-no-jerarquicos.md): Agregue detalles sobre la calificación de sus productos - [¿Cuál es la antigüedad máxima de los datos HUB?](https://success.openhealth.fr/es/articles/3195251-cual-es-la-antiguedad-maxima-de-los-datos-hub.md): Últimos datos disponibles - [tipo de cliente](https://success.openhealth.fr/es/articles/4197147-tipo-de-cliente.md): Opción personalizada Tipo de cliente - [Acceso a la sesión](https://success.openhealth.fr/es/articles/4036458-acceso-a-la-sesion.md): Limite la visualización de sus empleados - [Ciclo personalizado](https://success.openhealth.fr/es/articles/4036444-ciclo-personalizado.md): Analice sus datos durante períodos de tiempo personalizados - [Año fiscal](https://success.openhealth.fr/es/articles/4036169-ano-fiscal.md): Defina su año fiscal - [Botón de día](https://success.openhealth.fr/es/articles/4036159-boton-de-dia.md): Visualice sus datos con mayor granularidad - [Botón de semana](https://success.openhealth.fr/es/articles/4036111-boton-de-semana.md): Visualice sus datos con mayor granularidad - [Tipos de cambio](https://success.openhealth.fr/es/articles/8329594-tipos-de-cambio.md) - [Calendario del período SMKT](https://success.openhealth.fr/es/articles/4036549-calendario-del-periodo-smkt.md): Utilice un calendario de GSA - [Restringir el perímetro](https://success.openhealth.fr/es/articles/4560699-restringir-el-perimetro.md): Seleccionar una lista de GTIN en Mi consulta de un archivo .xlsx - [Restringir el perímetro \(código 7\)](https://success.openhealth.fr/es/articles/4560791-restringir-el-perimetro-codigo-7.md): Selección de una lista de \[CÓDIGO TÉCNICO 2\] en Mi consulta de un archivo .xlsx - [Bandera de mercado](https://success.openhealth.fr/es/articles/4560797-bandera-de-mercado.md): Seleccionar una lista de GTIN en Mi consulta de una definición de mercado contenida en un archivo .xlsx - [Segmentación / Definición de un tipo de cliente](https://success.openhealth.fr/es/articles/3777788-segmentacion-definicion-de-un-tipo-de-cliente.md): Segmentación \(tipo de cliente\) ### INDICADORES DEL HUB - [Glosario de indicadores HUB](https://success.openhealth.fr/es/articles/5194247-glosario-de-indicadores-hub.md) - [Cantidades de ventas](https://success.openhealth.fr/es/articles/3194314-cantidades-de-ventas.md): Cantidades de ventas - [Valores de ventas](https://success.openhealth.fr/es/articles/3074854-valores-de-ventas.md): Especificación del indicador Valores de venta - [N MS](https://success.openhealth.fr/es/articles/3194475-n-ms.md): Definición de la medida 'N MS' - [N MS Evol](https://success.openhealth.fr/es/articles/5634266-n-ms-evol.md) - [N MS Delta](https://success.openhealth.fr/es/articles/3194469-n-ms-delta.md): Definición de la medida 'N MS Delta' - [Poids Vol \(CA\) par modalité / Custom Weight Vol \(To\)](https://success.openhealth.fr/es/articles/9292839-poids-vol-ca-par-modalite-custom-weight-vol-to.md) - [Valor de las ventas basado en el precio del fabricante sin IVA \(Cifra de negocios sin IVA\) - Marruecos](https://success.openhealth.fr/es/articles/7508513-valor-de-las-ventas-basado-en-el-precio-del-fabricante-sin-iva-cifra-de-negocios-sin-iva-marruecos.md) - [N CTR de crecimiento](https://success.openhealth.fr/es/articles/3194466-n-ctr-de-crecimiento.md): Definición y fórmula de cálculo de la medida 'N Growth CTR' - [En trato](https://success.openhealth.fr/es/articles/6201859-en-trato.md) - [Peso cruzado Volumen](https://success.openhealth.fr/es/articles/6066324-peso-cruzado-volumen.md) - [Rotación cruzada de pesos](https://success.openhealth.fr/es/articles/6066273-rotacion-cruzada-de-pesos.md) - [N CTR de crecimiento ajustado](https://success.openhealth.fr/es/articles/3205376-n-ctr-de-crecimiento-ajustado.md): Definición y fórmula de cálculo de la medida 'N Growth CTR A' - [Peso fuente](https://success.openhealth.fr/es/articles/5151525-peso-fuente.md) - [Precio medio observado](https://success.openhealth.fr/es/articles/3194302-precio-medio-observado.md): AASP: Precio medio observado - [Precio medio ponderado](https://success.openhealth.fr/es/articles/3194292-precio-medio-ponderado.md): WASP: Precio medio ponderado - [Efecto precio](https://success.openhealth.fr/es/articles/8426443-efecto-precio.md) - [Número de farmacias que venden](https://success.openhealth.fr/es/articles/3719566-numero-de-farmacias-que-venden.md) - [Venta de distribución digital](https://success.openhealth.fr/es/articles/3194321-venta-de-distribucion-digital.md): Distribución numérica - [Distribución digital de venta global](https://success.openhealth.fr/es/articles/3194320-distribucion-digital-de-venta-global.md): Distribución numérica global - [Distribución digital basada en ventas](https://success.openhealth.fr/es/articles/4045636-distribucion-digital-basada-en-ventas.md): Rebasado de distribución numérica - [Distribución digital global de venta reconvertida](https://success.openhealth.fr/es/articles/4045725-distribucion-digital-global-de-venta-reconvertida.md): Distribución numérica global recalculada - [Distribución personalizada de ventas digitales](https://success.openhealth.fr/es/articles/6830813-distribucion-personalizada-de-ventas-digitales.md) - [Distribución de valor de venta](https://success.openhealth.fr/es/articles/3194323-distribucion-de-valor-de-venta.md): Distribución ponderada - [Distribución del valor de venta global](https://success.openhealth.fr/es/articles/3194316-distribucion-del-valor-de-venta-global.md): Distribución del valor de venta global - [Rebase de la distribución del valor de venta](https://success.openhealth.fr/es/articles/3194501-rebase-de-la-distribucion-del-valor-de-venta.md): DVV recalificado - [Distribución del valor de venta global reforzado](https://success.openhealth.fr/es/articles/4200619-distribucion-del-valor-de-venta-global-reforzado.md): DVV global rebasado - [Distribución personalizada del valor de las ventas](https://success.openhealth.fr/es/articles/6834423-distribucion-personalizada-del-valor-de-las-ventas.md) - [Distribución de venta digital SMKT](https://success.openhealth.fr/es/articles/3365043-distribucion-de-venta-digital-smkt.md): Distribución de venta digital SMKT \(distribución numérica SMK\) - [Distribución digital de ventas de SMKT global](https://success.openhealth.fr/es/articles/4298341-distribucion-digital-de-ventas-de-smkt-global.md): Distribución numérica global SMKT \(Distribución numérica global SMKT\) - [SMKT recalificado que vende distribución digital](https://success.openhealth.fr/es/articles/4298197-smkt-recalificado-que-vende-distribucion-digital.md): Rebasado de distribución digital SMKT \(Rebasado de distribución numérica SMKT\) - [Distribución digital global de SMKT con base en la venta](https://success.openhealth.fr/es/articles/4319783-distribucion-digital-global-de-smkt-con-base-en-la-venta.md): Rebasado de la distribución numérica global SMKT - [Distribución del valor de venta de SMKT](https://success.openhealth.fr/es/articles/3365478-distribucion-del-valor-de-venta-de-smkt.md): Distribución del valor de venta de SMKT \(distribución ponderada de SMKT\) - [Distribución digital de ventas de SMKT global recalculada](https://success.openhealth.fr/es/articles/4298373-distribucion-digital-de-ventas-de-smkt-global-recalculada.md): Venta de distribución digital SMKT Global Numeric Recalculated \(SMKT Global Numeric Distribution Recalculated\) - [Distribución digital Venta de SMKT recalculado recalculado](https://success.openhealth.fr/es/articles/4298303-distribucion-digital-venta-de-smkt-recalculado-recalculado.md): Distribución numérica SMKT recalculada recalculada - [Distribución digital de venta de SMKT ajustada](https://success.openhealth.fr/es/articles/3369386-distribucion-digital-de-venta-de-smkt-ajustada.md): Distribución numérica ajustada SMKT - [Ventas de distribución digital SMKT recalculadas](https://success.openhealth.fr/es/articles/4298209-ventas-de-distribucion-digital-smkt-recalculadas.md): Distribución numérica SMKT recalculada \(distribución numérica SMKT recalculada\) - [Distribución ajustada del valor de venta de SMKT](https://success.openhealth.fr/es/articles/3369397-distribucion-ajustada-del-valor-de-venta-de-smkt.md): Distribución ponderada ajustada SMKT - [Distribución orgánica de ventas digitales](https://success.openhealth.fr/es/articles/7052424-distribucion-organica-de-ventas-digitales.md) - [Facturación de las farmacias vendedoras \(TSP\)](https://success.openhealth.fr/es/articles/6096534-facturacion-de-las-farmacias-vendedoras-tsp.md) - [Estimación de su PDM titular](https://success.openhealth.fr/es/articles/4214883-estimacion-de-su-pdm-titular.md): Estime su participación de mercado con sus clientes - [Más farmacias](https://success.openhealth.fr/es/articles/8426451-mas-farmacias.md) - [Pérdida de farmacias](https://success.openhealth.fr/es/articles/8426460-perdida-de-farmacias.md) - [Distribución y ventas digitales multicanal](https://success.openhealth.fr/es/articles/9293487-distribucion-y-ventas-digitales-multicanal.md) - [Distribución digital de ventas acumuladas \(PHARMA\)](https://success.openhealth.fr/es/articles/9330571-distribucion-digital-de-ventas-acumuladas-pharma.md) - [Ventas promedio mensuales](https://success.openhealth.fr/es/articles/3194303-ventas-promedio-mensuales.md): Ventas mensuales promedio - [Ventas promedio mensuales ajustadas](https://success.openhealth.fr/es/articles/3194290-ventas-promedio-mensuales-ajustadas.md): Ventas mensuales promedio ajustadas - [Valor de ventas promedio mensual](https://success.openhealth.fr/es/articles/4535404-valor-de-ventas-promedio-mensual.md): VMM CA - [MGA a A: Valor medio mensual de las ventas ajustado](https://success.openhealth.fr/es/articles/6028256-mga-a-a-valor-medio-mensual-de-las-ventas-ajustado.md) - [Ventas promedio](https://success.openhealth.fr/es/articles/3563716-ventas-promedio.md): Ventas promedio - [Ventas promedio SMKT](https://success.openhealth.fr/es/articles/3365496-ventas-promedio-smkt.md): Ventas promedio SMKT - [Ventas promedio ajustadas de SMKT](https://success.openhealth.fr/es/articles/3369340-ventas-promedio-ajustadas-de-smkt.md): Ventas promedio ajustadas de SMKT - [Promedio mensual de ventas orgánicas](https://success.openhealth.fr/es/articles/7052551-promedio-mensual-de-ventas-organicas.md) - [Ventas medias mensuales Valor orgánico](https://success.openhealth.fr/es/articles/7052573-ventas-medias-mensuales-valor-organico.md) - [Valores](https://success.openhealth.fr/es/articles/3194332-valores.md): Definición y disponibilidad de datos de stock en el HUB, a través de aplicaciones SMAa: Suscripción avanzada de ventas y marketing - [Stock medio](https://success.openhealth.fr/es/articles/3194336-stock-medio.md): Stock medio - [Parte de la acción](https://success.openhealth.fr/es/articles/3194334-parte-de-la-accion.md): Parte de la acción - [Índice de presión comercial](https://success.openhealth.fr/es/articles/3194335-indice-de-presion-comercial.md): Índice de presión comercial - [Tasa de transformación de stock](https://success.openhealth.fr/es/articles/3194344-tasa-de-transformacion-de-stock.md): Tasa de transformación de stock - [Duración del suministro](https://success.openhealth.fr/es/articles/3194337-duracion-del-suministro.md): Duración de suministro - [Número de farmacias almacenistas](https://success.openhealth.fr/es/articles/3194338-numero-de-farmacias-almacenistas.md): Número de farmacias almacenistas - [Distribuidor Digital Distribuidor](https://success.openhealth.fr/es/articles/3194339-distribuidor-digital-distribuidor.md): Distribuciónde almacenistas \(ND Stock\) - [Distribuidor de distribución digital rebasado](https://success.openhealth.fr/es/articles/4045743-distribuidor-de-distribucion-digital-rebasado.md): Distribución numérica de stock basada en base - [Distribución global de almacenistas digitales mejorada](https://success.openhealth.fr/es/articles/4045753-distribucion-global-de-almacenistas-digitales-mejorada.md): Distribución global de almacenistas digitales mejorada - [Distribución del valor del almacenista](https://success.openhealth.fr/es/articles/3194342-distribucion-del-valor-del-almacenista.md): Distribución del valor del distribuidor \(distribución ponderada de acciones: acciones de WD\) - [Rebase de la distribución del valor del inventario](https://success.openhealth.fr/es/articles/3194505-rebase-de-la-distribucion-del-valor-del-inventario.md): Rebase DVS - [Distribución digital Suavizado almacenista](https://success.openhealth.fr/es/articles/5141830-distribucion-digital-suavizado-almacenista.md) - [Distribución digital Almacenista suavizada rebasada](https://success.openhealth.fr/es/articles/5142162-distribucion-digital-almacenista-suavizada-rebasada.md) - [Distribución Valor alisado de las acciones](https://success.openhealth.fr/es/articles/5203640-distribucion-valor-alisado-de-las-acciones.md) - [Distribución Valor alisado de las acciones](https://success.openhealth.fr/es/articles/5203701-distribucion-valor-alisado-de-las-acciones.md) - [Margen](https://success.openhealth.fr/es/articles/3507716-margen.md): Margen - [Tasa de margen](https://success.openhealth.fr/es/articles/3507767-tasa-de-margen.md): Tasa de margen - [Precio del fabricante sin impuestos \(PFHT\)](https://success.openhealth.fr/es/articles/4557500-precio-del-fabricante-sin-impuestos-pfht.md): PFHT - [Sell-in: análisis de su base de clientes](https://success.openhealth.fr/es/articles/3846225-sell-in-analisis-de-su-base-de-clientes.md): Indicadores de fidelización: características de su base de clientes y su evolución - [Sell-in - Farmacias atípicas](https://success.openhealth.fr/es/articles/3848791-sell-in-farmacias-atipicas.md): Medidas para detectar atipismos - [Razón de evolución](https://success.openhealth.fr/es/articles/3194287-razon-de-evolucion.md): Razón de evolución - [Relación de penetración](https://success.openhealth.fr/es/articles/3194286-relacion-de-penetracion.md): Relación de penetración - [Ancho de surtido de productos](https://success.openhealth.fr/es/articles/3369425-ancho-de-surtido-de-productos.md): Ancho de surtido de productos - [Renovación del surtido](https://success.openhealth.fr/es/articles/3369545-renovacion-del-surtido.md): Renovación del surtido - [Innovación en el surtido](https://success.openhealth.fr/es/articles/3369468-innovacion-en-el-surtido.md): Innovación en el surtido - [Desgaste del surtido](https://success.openhealth.fr/es/articles/3369457-desgaste-del-surtido.md): Desgaste del surtido - [Tasa de deserción de surtido](https://success.openhealth.fr/es/articles/3369485-tasa-de-desercion-de-surtido.md): Tasa de deserción de surtido - [Rango de tasa de innovación](https://success.openhealth.fr/es/articles/3369541-rango-de-tasa-de-innovacion.md): Rango de tasa de innovación - [Participación de la oferta de venta](https://success.openhealth.fr/es/articles/3369040-participacion-de-la-oferta-de-venta.md): Participación de la oferta de venta - [Número de productos seleccionados](https://success.openhealth.fr/es/articles/3511502-numero-de-productos-seleccionados.md): Este es el número de productos seleccionados por su código de dígitos GTIN-13. - [Número medio de productos](https://success.openhealth.fr/es/articles/3194284-numero-medio-de-productos.md): Número medio de productos - [Tasa de renovación de rango](https://success.openhealth.fr/es/articles/3369561-tasa-de-renovacion-de-rango.md): Tasa de renovación de rango - [Número de productos](https://success.openhealth.fr/es/articles/6312686-numero-de-productos.md) - [Cantidades gastadas por acto](https://success.openhealth.fr/es/articles/3447792-cantidades-gastadas-por-acto.md): Artículo relativo al indicador 'Cantidades gastadas por acto' - [Desglose de los importes gastados por tipo de comprador](https://success.openhealth.fr/es/articles/3447801-desglose-de-los-importes-gastados-por-tipo-de-comprador.md): Artículo relativo al indicador 'Desglose de los importes gastados por tipo de comprador' - [Índice de consumo](https://success.openhealth.fr/es/articles/3432701-indice-de-consumo.md): Definición del indicador 'índice de consumo' - [Cuota de ventas](https://success.openhealth.fr/es/articles/3432664-cuota-de-ventas.md): Definición del indicador 'Cuota de ventas' - [Tasa de fidelización de valor](https://success.openhealth.fr/es/articles/3432695-tasa-de-fidelizacion-de-valor.md): Definición del indicador 'Tasa de fidelización de valor' - [Penetración absoluta](https://success.openhealth.fr/es/articles/3432556-penetracion-absoluta.md): Artículo relativo al indicador 'Penetración absoluta' - [Participación en facturación](https://success.openhealth.fr/es/articles/3432655-participacion-en-facturacion.md): Definición del indicador 'Cuota de facturación' - [p-valor](https://success.openhealth.fr/es/articles/5781702-p-valor.md) - [Análisis de componentes principales](https://success.openhealth.fr/es/articles/4231028-analisis-de-componentes-principales.md): ACP - [Valor predictivo negativo](https://success.openhealth.fr/es/articles/4134220-valor-predictivo-negativo.md): Valor predictivo negativo - [Valor predictivo positivo](https://success.openhealth.fr/es/articles/4134166-valor-predictivo-positivo.md): Valor predictivo positivo - [Prueba de independencia](https://success.openhealth.fr/es/articles/4128369-prueba-de-independencia.md): Compruebe si dos variables están relacionadas entre sí - [Estudio de series de tiempo](https://success.openhealth.fr/es/articles/3633991-estudio-de-series-de-tiempo.md): Estacionalidad, tendencia y predicción: lo que necesita saber - [Tasa de variación estacional](https://success.openhealth.fr/es/articles/3653790-tasa-de-variacion-estacional.md): Mide la proporción de varianza en una serie de tiempo - [Sensibilidad y especificidad de una prueba](https://success.openhealth.fr/es/articles/3928135-sensibilidad-y-especificidad-de-una-prueba.md): Comprender los conceptos para analizar la efectividad de una prueba. - [Tasa de variación de tendencia](https://success.openhealth.fr/es/articles/3653847-tasa-de-variacion-de-tendencia.md): Mide la participación del componente de tendencia en una serie de tiempo - [Tasa de variación residual](https://success.openhealth.fr/es/articles/3653851-tasa-de-variacion-residual.md): Mide la participación del componente residual de una serie de tiempo - [Coeficiente de determinación](https://success.openhealth.fr/es/articles/3654093-coeficiente-de-determinacion.md): Evaluar la calidad del modelo elegido - [Coeficiente de variación](https://success.openhealth.fr/es/articles/3653915-coeficiente-de-variacion.md): Indicador para elegir su modelo de descomposición - [Varianza de una serie temporal](https://success.openhealth.fr/es/articles/3653855-varianza-de-una-serie-temporal.md): Medir la dispersión de una serie - [Concentración de ventas](https://success.openhealth.fr/es/articles/3395856-concentracion-de-ventas.md): Concentración de ventas - [Índice de Gini](https://success.openhealth.fr/es/articles/3395323-indice-de-gini.md): Índice de Gini - [Población](https://success.openhealth.fr/es/articles/4396779-poblacion.md): Población - [Evolución del número de muertes](https://success.openhealth.fr/es/articles/4396765-evolucion-del-numero-de-muertes.md): Evolución del número de muertes - [La proporción de sexos](https://success.openhealth.fr/es/articles/3812167-la-proporcion-de-sexos.md): La proporción de sexos - [Población - Edad media](https://success.openhealth.fr/es/articles/3812180-poblacion-edad-media.md): Población - Edad media - [Población - Edad mediana](https://success.openhealth.fr/es/articles/3812198-poblacion-edad-mediana.md): Población - Edad mediana - [Población: primer cuartil de edad](https://success.openhealth.fr/es/articles/3812218-poblacion-primer-cuartil-de-edad.md): Población: primer cuartil de edad - [Población - 3.er cuartil de edad](https://success.openhealth.fr/es/articles/3812227-poblacion-3-er-cuartil-de-edad.md): Población - 3.er cuartil de edad - [Participación de la selección en la población total del territorio](https://success.openhealth.fr/es/articles/3812233-participacion-de-la-seleccion-en-la-poblacion-total-del-territorio.md): Participación de la selección en la población total del territorio - [Tasa de mortalidad](https://success.openhealth.fr/es/articles/3947946-tasa-de-mortalidad.md): Tasa de mortalidad - [Tasa de letalidad](https://success.openhealth.fr/es/articles/3948084-tasa-de-letalidad.md): Tasa de letalidad - [Las mujeres en edad fértil](https://success.openhealth.fr/es/articles/4172859-las-mujeres-en-edad-fertil.md): Las mujeres en edad fértil - [Participación de la selección en el total de muertes en el territorio](https://success.openhealth.fr/es/articles/3863734-participacion-de-la-seleccion-en-el-total-de-muertes-en-el-territorio.md): Participación de la selección en el total de muertes en el territorio - [Modelando el número de muertes desaparecidas](https://success.openhealth.fr/es/articles/3895572-modelando-el-numero-de-muertes-desaparecidas.md): Anticipe el número de muertes en el momento t - [Ventas estimadas en iniciación a la prescripción](https://success.openhealth.fr/es/articles/5323282-ventas-estimadas-en-iniciacion-a-la-prescripcion.md) - [Evolución por edad y estado de gestación](https://success.openhealth.fr/es/articles/6820051-evolucion-por-edad-y-estado-de-gestacion.md) - [Ratio de productos de codistribución](https://success.openhealth.fr/es/articles/7892010-ratio-de-productos-de-codistribucion.md) - [Estimación de las ventas de recambios de recetas](https://success.openhealth.fr/es/articles/5323209-estimacion-de-las-ventas-de-recambios-de-recetas.md) - [Peso de las ventas de reposición de recetas](https://success.openhealth.fr/es/articles/5323198-peso-de-las-ventas-de-reposicion-de-recetas.md) - [Peso de las ventas en el inicio de la prescripción](https://success.openhealth.fr/es/articles/5323086-peso-de-las-ventas-en-el-inicio-de-la-prescripcion.md) - [Número de co-dispensaciones](https://success.openhealth.fr/es/articles/3194351-numero-de-co-dispensaciones.md): Número de co-dispensaciones - [Numero de dispensaciones](https://success.openhealth.fr/es/articles/3194348-numero-de-dispensaciones.md): Número de dispensaciones - [Número medio de dispensaciones por asegurado](https://success.openhealth.fr/es/articles/3369626-numero-medio-de-dispensaciones-por-asegurado.md): Número medio de dispensaciones por asegurado - [Observancia](https://success.openhealth.fr/es/articles/3411996-observancia.md): Tasa de posesión de medicamentos \(MPR\) - [Tasa de persistencia](https://success.openhealth.fr/es/articles/3369684-tasa-de-persistencia.md): Tasa de persistencia - [Adherencia terapéutica](https://success.openhealth.fr/es/articles/3412091-adherencia-terapeutica.md): Adherencia terapéutica - [Dosis diaria media por asegurado](https://success.openhealth.fr/es/articles/4153587-dosis-diaria-media-por-asegurado.md): Dosis diaria media por asegurado - [Número de dispensas presentadas para reembolso](https://success.openhealth.fr/es/articles/3370942-numero-de-dispensas-presentadas-para-reembolso.md): Número de dispensas presentadas para reembolso - [Número de dispensaciones no presentadas para reembolso](https://success.openhealth.fr/es/articles/3370920-numero-de-dispensaciones-no-presentadas-para-reembolso.md): Número de dispensas presentadas para reembolso - [Ventas de valor cobradas por reembolso cubiertas por el seguro médico obligatorio](https://success.openhealth.fr/es/articles/3371699-ventas-de-valor-cobradas-por-reembolso-cubiertas-por-el-seguro-medico-obligatorio.md): Ventas de valores canjeados - [Ventas de valores reembolsados cubiertos por un seguro médico complementario](https://success.openhealth.fr/es/articles/3371830-ventas-de-valores-reembolsados-cubiertos-por-un-seguro-medico-complementario.md): Ventas de valores canjeados - [Ventas de valores destacados](https://success.openhealth.fr/es/articles/3371842-ventas-de-valores-destacados.md): Ventas de valores destacados - [Predominio](https://success.openhealth.fr/es/articles/3947955-predominio.md): Tasa de prevalencia - [Número medio de GTIN por dispensación](https://success.openhealth.fr/es/articles/3396154-numero-medio-de-gtin-por-dispensacion.md): Número medio de GTIN por dispensación - [Volumen medio por dispensación](https://success.openhealth.fr/es/articles/3396196-volumen-medio-por-dispensacion.md): Volumen medio por dispensación - [Rotación promedio por dispensación](https://success.openhealth.fr/es/articles/3396208-rotacion-promedio-por-dispensacion.md): Rotación promedio por dispensación - [Dosis de principio activo por caja](https://success.openhealth.fr/es/articles/3675409-dosis-de-principio-activo-por-caja.md): Dosis de principio activo por caja - [DDD por caja](https://success.openhealth.fr/es/articles/3675446-ddd-por-caja.md): Definir dosis diaria por caja - [Volumen en unidades base](https://success.openhealth.fr/es/articles/3675520-volumen-en-unidades-base.md): Volumen en unidades base - [Volumen en principio activo](https://success.openhealth.fr/es/articles/3675539-volumen-en-principio-activo.md): Volumen en principio activo - [DDJ por 1.000 habitantes](https://success.openhealth.fr/es/articles/3675667-ddj-por-1-000-habitantes.md): Dosis diaria definida por 1.000 habitantes - [Volumen en UA media por asegurado](https://success.openhealth.fr/es/articles/3675761-volumen-en-ua-media-por-asegurado.md): Volumen en unidades de consumo medio por asegurado - [Volumen en UB promedio por asegurado](https://success.openhealth.fr/es/articles/3675814-volumen-en-ub-promedio-por-asegurado.md): Volumen en unidades base promedio por asegurado - [Volumen en principio activo medio por asegurado](https://success.openhealth.fr/es/articles/3675824-volumen-en-principio-activo-medio-por-asegurado.md): Volumen en principio activo medio por asegurado - [Duración media observada del tratamiento](https://success.openhealth.fr/es/articles/3675841-duracion-media-observada-del-tratamiento.md): Duración media observada del tratamiento - [Cobertura de vacunación](https://success.openhealth.fr/es/articles/3822264-cobertura-de-vacunacion.md): Cobertura de vacunación - [Pacientes incluidos](https://success.openhealth.fr/es/articles/3886665-pacientes-incluidos.md): Número de pacientes incluidos en la cohorte - [Diferencias entre MPR y PDC](https://success.openhealth.fr/es/articles/3722666-diferencias-entre-mpr-y-pdc.md): MPR \(tasa de posesión de medicamentos\) vs. PDC \(proporción de días cubiertos\) - [Duración media del tratamiento](https://success.openhealth.fr/es/articles/3920967-duracion-media-del-tratamiento.md): Mida el tiempo medio de tratamiento al final del período de análisis - [Tiempo medio de renovación](https://success.openhealth.fr/es/articles/3921067-tiempo-medio-de-renovacion.md): Medir el tiempo promedio entre renovaciones de tratamientos - [Inicio del tratamiento](https://success.openhealth.fr/es/articles/3848844-inicio-del-tratamiento.md): Inicio del tratamiento - [Renovaciones de tratamiento](https://success.openhealth.fr/es/articles/3885469-renovaciones-de-tratamiento.md): Renovación de tratamiento - [Se reanuda el tratamiento](https://success.openhealth.fr/es/articles/3885608-se-reanuda-el-tratamiento.md): Se reanuda el tratamiento - [Nuevos tratamientos](https://success.openhealth.fr/es/articles/3885297-nuevos-tratamientos.md): Inicio y reanudación del tratamiento - [Interruptor de tratamiento](https://success.openhealth.fr/es/articles/3848886-interruptor-de-tratamiento.md): Interruptor de tratamiento - [El tratamiento se detiene](https://success.openhealth.fr/es/articles/3885426-el-tratamiento-se-detiene.md): El tratamiento se detiene - [Bajar ó dejar algo](https://success.openhealth.fr/es/articles/3885387-bajar-o-dejar-algo.md): Bajar ó dejar algo - [Inserto de trazabilidad](https://success.openhealth.fr/es/articles/4355163-inserto-de-trazabilidad.md): Trazabilidad - [Detenido y reiniciado](https://success.openhealth.fr/es/articles/8429189-detenido-y-reiniciado.md) - [Parte de dispensación](https://success.openhealth.fr/es/articles/3624820-parte-de-dispensacion.md): Parte de dispensación - [Seguimiento de dispensas relevantes](https://success.openhealth.fr/es/articles/3804193-seguimiento-de-dispensas-relevantes.md): Seguir la evolución del tráfico en farmacias de dispensaciones relevantes - [Tasa de desintegración](https://success.openhealth.fr/es/articles/4850138-tasa-de-desintegracion.md): Estimación de la cantidad restante de un elemento - [Cinética de la reacción](https://success.openhealth.fr/es/articles/4850629-cinetica-de-la-reaccion.md): Medir la velocidad de una reacción química - [Tiempo de vida media](https://success.openhealth.fr/es/articles/4849710-tiempo-de-vida-media.md): Medida de la vida útil de un elemento - [Tasa de cobertura de stock](https://success.openhealth.fr/es/articles/4210714-tasa-de-cobertura-de-stock.md): Tasa de cobertura de stock - [Períodos de tiempo](https://success.openhealth.fr/es/articles/3194479-periodos-de-tiempo.md): Períodos de tiempo - [Cambiar la definición de año fiscal](https://success.openhealth.fr/es/articles/3321750-cambiar-la-definicion-de-ano-fiscal.md): El HUB le permite configurar sus años fiscales - [Gestión de comparaciones semanales](https://success.openhealth.fr/es/articles/3835180-gestion-de-comparaciones-semanales.md): Impactos analíticos de los días estudiados - [Calendario de parafarmacia de GSA \(SMKT\)](https://success.openhealth.fr/es/articles/3175583-calendario-de-parafarmacia-de-gsa-smkt.md): El calendario SMKT \(IRI\) también se denomina calendario de farmacia de GSA. - [NO](https://success.openhealth.fr/es/articles/3194484-no.md): Definición de la medida 'N' - [N Evol](https://success.openhealth.fr/es/articles/3194461-n-evol.md): Definición y fórmula de cálculo de la medida 'N Evol' - [N Tendencia](https://success.openhealth.fr/es/articles/3194485-n-tendencia.md): Definición de la medida 'N Trend' ### IAS - Indicateurs Avancés Sanitaires - [NIC\(r\) Alergia](https://success.openhealth.fr/es/articles/7339151-nic-r-alergia.md) - [NIC\(r\) Poux](https://success.openhealth.fr/es/articles/7339168-nic-r-poux.md) - [Gastroenteritis IAS\(r\)](https://success.openhealth.fr/es/articles/7339181-gastroenteritis-ias-r.md) - [Síndromes respiratorios IAS \(r\)](https://success.openhealth.fr/es/articles/3815345-sindromes-respiratorios-ias-r.md): Introducción relacionada con los síndromes respiratorios IAS \(r\) - [EEI\(r\) Enfermedad similar a la gripe](https://success.openhealth.fr/es/articles/7266711-eei-r-enfermedad-similar-a-la-gripe.md) ### Marketing Direct - [Solución OpenHealth Emailing](https://success.openhealth.fr/es/articles/7055261-solucion-openhealth-emailing.md) - [Requisitos para la producción de una campaña de correo electrónico](https://success.openhealth.fr/es/articles/6282113-requisitos-para-la-produccion-de-una-campana-de-correo-electronico.md) - [Informe de seguimiento y puntos de referencia](https://success.openhealth.fr/es/articles/6302721-informe-de-seguimiento-y-puntos-de-referencia.md) - [Glosario para campañas por correo electrónico](https://success.openhealth.fr/es/articles/6282099-glosario-para-campanas-por-correo-electronico.md) ### PSAD - [Análisis - NACIONAL](https://success.openhealth.fr/es/articles/3376262-analisis-nacional.md): Analizar el desempeño del mercado de Proveedores de Salud en el Hogar \(PSAD\): por área, actividad, subactividad, segmento, ley LPP - [Volumen / Rotación - NACIONAL](https://success.openhealth.fr/es/articles/3376287-volumen-rotacion-nacional.md): Visualizar simultáneamente la actividad en volumen y valor: por área, actividad, subactividad, segmento, acto ... - [Evolución - NACIONAL](https://success.openhealth.fr/es/articles/3376370-evolucion-nacional.md): Visualizar la evolución del mercado en el historial disponible: por área, actividad, subactividad, segmento, acto LPP - [Extracción - NACIONAL](https://success.openhealth.fr/es/articles/3376420-extraccion-nacional.md): Exportar datos a Excel - [Definición](https://success.openhealth.fr/es/articles/3376439-definicion.md): Encuentra todas las características del Observatorio Nacional SantéDomStat - Aplicación esencial ### AUTRES THEMATIQUES - [INTERCOM](https://success.openhealth.fr/es/articles/6959415-intercom.md) - [Salesforce](https://success.openhealth.fr/es/articles/6959337-salesforce.md) - [GIHSN: Enviar archivo Excel](https://success.openhealth.fr/es/articles/3977478-gihsn-enviar-archivo-excel.md): Archivo Excel de GIHSN - [Blockchain](https://success.openhealth.fr/es/articles/5385413-blockchain.md) - [DocuSign, herramienta CRM en nuestro proceso empresarial](https://success.openhealth.fr/es/articles/4514472-docusign-herramienta-crm-en-nuestro-proceso-empresarial.md): Docusign: herramienta CRM en nuestro proceso empresarial - [Seguimiento nacional de la vacunación](https://success.openhealth.fr/es/articles/4754333-seguimiento-nacional-de-la-vacunacion.md) - [Cobertura de vacunación](https://success.openhealth.fr/es/articles/4754311-cobertura-de-vacunacion.md) - [Monitoreo de KPI](https://success.openhealth.fr/es/articles/4091042-monitoreo-de-kpi.md): POC ProPharma Systems: Tendencias del mercado suizo - [Cabina de farmacia](https://success.openhealth.fr/es/articles/4091025-cabina-de-farmacia.md): POC ProPharma Systems: Mi farmacia frente a Suiza - [Equivalente habitante \(e-h\)](https://success.openhealth.fr/es/articles/5431894-equivalente-habitante-e-h.md) - [Demanda de oxígeno](https://success.openhealth.fr/es/articles/5137158-demanda-de-oxigeno.md) - [Untitled article](https://success.openhealth.fr/es/articles/4851687-untitled-article.md): IHU - [Materia en suspensión](https://success.openhealth.fr/es/articles/5137147-materia-en-suspension.md) - [Química de las aguas residuales](https://success.openhealth.fr/es/articles/5137101-quimica-de-las-aguas-residuales.md) - [NRBCE](https://success.openhealth.fr/es/articles/4851683-nrbce.md) - [Ley de Arrhenius](https://success.openhealth.fr/es/articles/4849672-ley-de-arrhenius.md) - [Resultados](https://success.openhealth.fr/es/articles/5137034-resultados.md) - [Tipos de aguas residuales](https://success.openhealth.fr/es/articles/5137183-tipos-de-aguas-residuales.md) - [Concentración del virus SARS-CoV-2](https://success.openhealth.fr/es/articles/4867968-concentracion-del-virus-sars-cov-2.md) - [MAPOM / BMPM](https://success.openhealth.fr/es/articles/4851685-mapom-bmpm.md) - [Concentración contextualizada de SARS-CoV-2](https://success.openhealth.fr/es/articles/4934604-concentracion-contextualizada-de-sars-cov-2.md) - [Tipo de alcantarillado](https://success.openhealth.fr/es/articles/4867954-tipo-de-alcantarillado.md) - [Degradación del virus](https://success.openhealth.fr/es/articles/4865742-degradacion-del-virus.md) - [WBE](https://success.openhealth.fr/es/articles/4865735-wbe.md) - [ARN](https://success.openhealth.fr/es/articles/4865733-arn.md) - [Coronavirus](https://success.openhealth.fr/es/articles/4865728-coronavirus.md) - [COVID-19](https://success.openhealth.fr/es/articles/4865726-covid-19.md) - [Seroprevalencia: método de muestreo](https://success.openhealth.fr/es/articles/3924493-seroprevalencia-metodo-de-muestreo.md): Seroprevalencia: método de muestreo - [depósito de SANDRE](https://success.openhealth.fr/es/articles/5415040-deposito-de-sandre.md) - [Base nacional ROSEAU](https://success.openhealth.fr/es/articles/5414523-base-nacional-roseau.md) - [Concentración del virus SARS-CoV2](https://success.openhealth.fr/es/articles/4852404-concentracion-del-virus-sars-cov2.md): Siga la evolución de la concentración del virus del SRAS-CoV 2 por sectores - [Concentración del virus SARS-CoV-2 - Variantes](https://success.openhealth.fr/es/articles/4909854-concentracion-del-virus-sars-cov-2-variantes.md) - [Marsella - Vigilancia mundial](https://success.openhealth.fr/es/articles/4859311-marsella-vigilancia-mundial.md) - [Concentración del virus del SRAS-CoV2 - Niza \(FRANCIA\)](https://success.openhealth.fr/es/articles/4879292-concentracion-del-virus-del-sras-cov2-niza-francia.md): Siga la evolución de la concentración del virus del SARS-CoV 2 por sectores - [Población - Estructura](https://success.openhealth.fr/es/articles/4842408-poblacion-estructura.md): Analizar la estructura de la población - [Concentración del virus del SARS-CoV2 - Toulon \(FRANCIA\)](https://success.openhealth.fr/es/articles/4886417-concentracion-del-virus-del-sars-cov2-toulon-francia.md): Siga la evolución de la concentración del virus SARS-CoV 2 por sector - [Dubai - Control de las aguas residuales del aeropuerto](https://success.openhealth.fr/es/articles/5276423-dubai-control-de-las-aguas-residuales-del-aeropuerto.md): Dubai - Control de las aguas residuales del aeropuerto - [Vigilancia del SARS-CoV-2 - OBEPINE](https://success.openhealth.fr/es/articles/5210661-vigilancia-del-sars-cov-2-obepine.md) - [Concentración contextualizada de SARS-CoV-2](https://success.openhealth.fr/es/articles/4934608-concentracion-contextualizada-de-sars-cov-2.md) - [SUEZ - Balance analítico](https://success.openhealth.fr/es/articles/5140509-suez-balance-analitico.md) - [Palacio de Festivales - Watch T0](https://success.openhealth.fr/es/articles/5373515-palacio-de-festivales-watch-t0.md) - [Palais des festivals - Vigilia diaria](https://success.openhealth.fr/es/articles/5373231-palais-des-festivals-vigilia-diaria.md) - [Palais des festivals - Proyección](https://success.openhealth.fr/es/articles/5404778-palais-des-festivals-proyeccion.md) - [Mustélidos - Reloj](https://success.openhealth.fr/es/articles/5169577-mustelidos-reloj.md) - [Población - IRIS](https://success.openhealth.fr/es/articles/4842191-poblacion-iris.md): Análisis de la distribución geográfica de la población en el IRIS - [SARS-CoV-2](https://success.openhealth.fr/es/articles/4865699-sars-cov-2.md) - [IAS - Análisis](https://success.openhealth.fr/es/articles/4842430-ias-analisis.md): Seguimiento del indicador de salud de los síndromes respiratorios - [Concentración del virus SARS-CoV-2 - SEM](https://success.openhealth.fr/es/articles/5415600-concentracion-del-virus-sars-cov-2-sem.md) - [Visualización de mapas](https://success.openhealth.fr/es/articles/3864657-visualizacion-de-mapas.md): Reparto geográfico de pacientes - [Sitio de contribución](https://success.openhealth.fr/es/articles/3864668-sitio-de-contribucion.md): Contribución por sitio y hospital - [Perfil de cohorte por sitio](https://success.openhealth.fr/es/articles/3864672-perfil-de-cohorte-por-sitio.md): Perfil de cohorte por sitio y hospital - [Perfil de cohorte por temporada](https://success.openhealth.fr/es/articles/3864673-perfil-de-cohorte-por-temporada.md): Perfil de cohorte por temporada - [Distribución por edad y género](https://success.openhealth.fr/es/articles/3864675-distribucion-por-edad-y-genero.md): Demografía - [Distribución de virus por sitio](https://success.openhealth.fr/es/articles/3864678-distribucion-de-virus-por-sitio.md): Distribución de virus por sitio - [Distribución de virus por edad](https://success.openhealth.fr/es/articles/3864677-distribucion-de-virus-por-edad.md): Distribución de virus por edad - [Evolución de la distribución de virus](https://success.openhealth.fr/es/articles/3864681-evolucion-de-la-distribucion-de-virus.md): Evolución de la distribución de virus - [Vacunación contra la influenza](https://success.openhealth.fr/es/articles/3864697-vacunacion-contra-la-influenza.md): Vacunación contra la influenza - [Evolución de la vacunación contra la influenza](https://success.openhealth.fr/es/articles/3864701-evolucion-de-la-vacunacion-contra-la-influenza.md): Evolución de la vacunación contra la influenza - [Distribución de pacientes por enfermedad crónica](https://success.openhealth.fr/es/articles/3864676-distribucion-de-pacientes-por-enfermedad-cronica.md): Distribución de pacientes por enfermedad crónica - [Distribución de pacientes por tiempo de estancia hospitalaria](https://success.openhealth.fr/es/articles/3864794-distribucion-de-pacientes-por-tiempo-de-estancia-hospitalaria.md): Distribución de pacientes por duración de la estancia hospitalaria - [Fragilidad](https://success.openhealth.fr/es/articles/3864704-fragilidad.md): Fragilidad del paciente - [Estado de gravedad](https://success.openhealth.fr/es/articles/3864705-estado-de-gravedad.md): Estado de gravedad - [Mortalidad](https://success.openhealth.fr/es/articles/3864710-mortalidad.md): Mortalidad - [GIHSN](https://success.openhealth.fr/es/articles/3864712-gihsn.md): Red mundial de vigilancia hospitalaria de influenza - [CARéDIAB - Perfil del paciente](https://success.openhealth.fr/es/articles/3789234-carediab-perfil-del-paciente.md): Analizar el perfil de pacientes de la población CARéDIAB - [CARéDIAB - Complicaciones](https://success.openhealth.fr/es/articles/3789515-carediab-complicaciones.md): Analizar la prevalencia de complicaciones en nuestra población CAREDIAB - [CARéDIAB - Monitorización global de pacientes](https://success.openhealth.fr/es/articles/3792041-carediab-monitorizacion-global-de-pacientes.md): Analizar la frecuencia de seguimiento de los pacientes de la población CARéDIAB - [Red CARéDIAB](https://success.openhealth.fr/es/articles/3789106-red-carediab.md): La red CARéDIAB - [CARéDIAB - Tratamientos](https://success.openhealth.fr/es/articles/3792143-carediab-tratamientos.md): Analizar la toma de tratamientos en el contexto de la diabetes. ## Svenska ### Votre PLATEFORME - présentation générale - [HUB, en omfattande och kontinuerlig stödplattform.](https://success.openhealth.fr/sv/articles/4799621-hub-en-omfattande-och-kontinuerlig-stodplattform.md) - [Din erfarenhetsnivå The HUB](https://success.openhealth.fr/sv/articles/5712270-din-erfarenhetsniva-the-hub.md) - [Languages](https://success.openhealth.fr/sv/articles/4649389-languages.md): Here is the description of all languages available on Success - [Frågor om våra priser](https://success.openhealth.fr/sv/articles/3292143-fragor-om-vara-priser.md): Våra priser ### La ROADMAP - ["Öppen innovation för våra kunder](https://success.openhealth.fr/sv/articles/5200970-oppen-innovation-for-vara-kunder.md) - [Appar + Administrationsområde version 240515](https://success.openhealth.fr/sv/articles/9310541-appar-administrationsomrade-version-240515.md) - [Apps + Administration område version 240415](https://success.openhealth.fr/sv/articles/9310710-apps-administration-omrade-version-240415.md) - [Appar + Administrationsområde version 240315](https://success.openhealth.fr/sv/articles/9310790-appar-administrationsomrade-version-240315.md) - [Appar + Administrationsområde version 240215](https://success.openhealth.fr/sv/articles/9311007-appar-administrationsomrade-version-240215.md) - [Plattform - uppdatering 231215](https://success.openhealth.fr/sv/articles/8718485-plattform-uppdatering-231215.md) - [Plattform - uppdatering 231015](https://success.openhealth.fr/sv/articles/8479932-plattform-uppdatering-231015.md) - [Appar + Portal version 230915](https://success.openhealth.fr/sv/articles/8373640-appar-portal-version-230915.md) - [Appar + Portal version 230815](https://success.openhealth.fr/sv/articles/8267860-appar-portal-version-230815.md) - [Nya produkter 230715](https://success.openhealth.fr/sv/articles/8115796-nya-produkter-230715.md) - [Appar + Portal version 230615](https://success.openhealth.fr/sv/articles/8115791-appar-portal-version-230615.md) - [Appar + Portal version 230515](https://success.openhealth.fr/sv/articles/7895393-appar-portal-version-230515.md) - [Appar + Portal version 230415](https://success.openhealth.fr/sv/articles/7439447-appar-portal-version-230415.md) - [Appar + Portal version 230315](https://success.openhealth.fr/sv/articles/7439646-appar-portal-version-230315.md) - [Appar + Portal version 230215](https://success.openhealth.fr/sv/articles/7439744-appar-portal-version-230215.md) - [Nytt från 15/01/2023](https://success.openhealth.fr/sv/articles/6895740-nytt-fran-15-01-2023.md) - [HUB + GATE version 221215](https://success.openhealth.fr/sv/articles/6827027-hub-gate-version-221215.md) - [HUB + GATE version 221115](https://success.openhealth.fr/sv/articles/6742628-hub-gate-version-221115.md) - [HUB + GATE version 220915](https://success.openhealth.fr/sv/articles/6558070-hub-gate-version-220915.md) - [HUB + GATE version 220815](https://success.openhealth.fr/sv/articles/6475311-hub-gate-version-220815.md) - [HUB + GATE version 220615](https://success.openhealth.fr/sv/articles/6306090-hub-gate-version-220615.md) - [HUB + GATE version 220515](https://success.openhealth.fr/sv/articles/6201877-hub-gate-version-220515.md) - [HUB + GATE version 220415](https://success.openhealth.fr/sv/articles/6087747-hub-gate-version-220415.md) - [HUB SMA version 220315](https://success.openhealth.fr/sv/articles/6043772-hub-sma-version-220315.md) - [HUB TMA version 220315](https://success.openhealth.fr/sv/articles/6043802-hub-tma-version-220315.md) - [HUB UAN version 220315](https://success.openhealth.fr/sv/articles/6043852-hub-uan-version-220315.md) - [GATE version 220215](https://success.openhealth.fr/sv/articles/5940805-gate-version-220215.md) - [HUB SMA version 220215](https://success.openhealth.fr/sv/articles/5940753-hub-sma-version-220215.md) - [HUB TMA version 220215](https://success.openhealth.fr/sv/articles/5947859-hub-tma-version-220215.md) - [GATE version 211215](https://success.openhealth.fr/sv/articles/5819397-gate-version-211215.md) - [HUB SMA version 211215](https://success.openhealth.fr/sv/articles/5784709-hub-sma-version-211215.md) - [HUB TMA version 211215](https://success.openhealth.fr/sv/articles/5784888-hub-tma-version-211215.md) - [HUB UAN version 211215](https://success.openhealth.fr/sv/articles/5784904-hub-uan-version-211215.md) - [Ansökan HUB: "Apotekets tillstånd".](https://success.openhealth.fr/sv/articles/5704485-ansokan-hub-apotekets-tillstand.md) - [GATE version 211115](https://success.openhealth.fr/sv/articles/5697844-gate-version-211115.md) - [HUB SMA version 211115](https://success.openhealth.fr/sv/articles/5671893-hub-sma-version-211115.md) - [HUB TMA version 211115](https://success.openhealth.fr/sv/articles/5671917-hub-tma-version-211115.md) - [HUB UAN version 211115](https://success.openhealth.fr/sv/articles/5671927-hub-uan-version-211115.md) - [GATE version 211015](https://success.openhealth.fr/sv/articles/5652210-gate-version-211015.md) - [HUB SMA version 211015](https://success.openhealth.fr/sv/articles/5649822-hub-sma-version-211015.md) - [HUB TMA version 211015](https://success.openhealth.fr/sv/articles/5650073-hub-tma-version-211015.md) - [HUB UAN version 211015](https://success.openhealth.fr/sv/articles/5652242-hub-uan-version-211015.md) - [HUB SMA version 210915](https://success.openhealth.fr/sv/articles/5370516-hub-sma-version-210915.md) - [HUB TMA version 210915](https://success.openhealth.fr/sv/articles/5390983-hub-tma-version-210915.md) - [HUB UAN version 210915](https://success.openhealth.fr/sv/articles/5543213-hub-uan-version-210915.md) ### Votre ESPACE D'ADMINISTRATION - fonctionnalités - [Återställ / ändra ditt lösenord HUB](https://success.openhealth.fr/sv/articles/4425325-aterstall-andra-ditt-losenord-hub.md): Hur man ändrar HUB-lösenordet - [Anslutningshjälp: Jag får ett felmeddelande](https://success.openhealth.fr/sv/articles/5369783-anslutningshjalp-jag-far-ett-felmeddelande.md) - [Skapa och spåra en biljett](https://success.openhealth.fr/sv/articles/3586214-skapa-och-spara-en-biljett.md): Handledning för att skapa och följa utvecklingen av dina biljetter på ditt personliga utrymme The HUB - [Skapa och ändra en SUCCESS-artikel](https://success.openhealth.fr/sv/articles/6738705-skapa-och-andra-en-success-artikel.md) - [Mina kontrakt](https://success.openhealth.fr/sv/articles/5712273-mina-kontrakt.md) - [Service Hälsa](https://success.openhealth.fr/sv/articles/4990600-service-halsa.md) - [Mina åtkomster](https://success.openhealth.fr/sv/articles/5783418-mina-atkomster.md) - [Inställning av min hemsida](https://success.openhealth.fr/sv/articles/5712229-installning-av-min-hemsida.md) - [Hur ändrar jag din marknad från ditt personliga OpenHealth-utrymme?](https://success.openhealth.fr/sv/articles/3585971-hur-andrar-jag-din-marknad-fran-ditt-personliga-openhealth-utrymme.md): Integrera, modifiera och inaktivera produkter från ditt personliga OpenHealth-utrymme - [Automatic Modality Assignment Modification \(Auto MAM\)](https://success.openhealth.fr/sv/articles/4164818-automatic-modality-assignment-modification-auto-mam.md): Ändra direkt dina produkters uppdrag - [TIDLIG MAM: Hur följer jag ett varumärke som byter laboratorium / varumärke / etikett?](https://success.openhealth.fr/sv/articles/4131072-tidlig-mam-hur-foljer-jag-ett-varumarke-som-byter-laboratorium-varumarke-etikett.md): Fördelar och risker med din typ av spårning - [Automatisk produktintegration \(Auto IPR\)](https://success.openhealth.fr/sv/articles/4164932-automatisk-produktintegration-auto-ipr.md): Begär att en produkt integreras på din marknad - [Automatisk produktavaktivering \(Auto DPR\)](https://success.openhealth.fr/sv/articles/4164866-automatisk-produktavaktivering-auto-dpr.md): Inaktivera en produkt från din marknad - [Automatisk återaktivering av produkter \(RPR auto\)](https://success.openhealth.fr/sv/articles/4818161-automatisk-ateraktivering-av-produkter-rpr-auto.md) - [Inrättande av nya produkter](https://success.openhealth.fr/sv/articles/5811248-inrattande-av-nya-produkter.md) - [Lägg till en marknad](https://success.openhealth.fr/sv/articles/5712283-lagg-till-en-marknad.md) - [Import/export av bulkprodukter](https://success.openhealth.fr/sv/articles/5712257-import-export-av-bulkprodukter.md) - [Ändring av typologisk modalitet \(CMT\)](https://success.openhealth.fr/sv/articles/4670174-andring-av-typologisk-modalitet-cmt.md) - [De olika användarstatuserna](https://success.openhealth.fr/sv/articles/3436418-de-olika-anvandarstatuserna.md): Vilka är funktionerna? - [Skapa ett konto för en användare från en tredjepartsorganisation \(TPAA\).](https://success.openhealth.fr/sv/articles/6466550-skapa-ett-konto-for-en-anvandare-fran-en-tredjepartsorganisation-tpaa.md) - [Hur skapar, ändrar eller tar jag bort ett användarkonto på The HUB?](https://success.openhealth.fr/sv/articles/3785138-hur-skapar-andrar-eller-tar-jag-bort-ett-anvandarkonto-pa-the-hub.md): Endast en POWER USER kan göra detta - [Kan jag skapa differentierade visningsrättigheter på HUB inom mina team?](https://success.openhealth.fr/sv/articles/3321731-kan-jag-skapa-differentierade-visningsrattigheter-pa-hub-inom-mina-team.md): Rättigheter i navet - [Aktivitetslogg](https://success.openhealth.fr/sv/articles/4687438-aktivitetslogg.md) ### Vos APPLICATIONS - présentation - [Utbildningsguiden för HUB](https://success.openhealth.fr/sv/articles/5634967-utbildningsguiden-for-hub.md) - [Sortering av rullgardinsväljare](https://success.openhealth.fr/sv/articles/5792113-sortering-av-rullgardinsvaljare.md) - [Uppdateringsdatum för GSA-apoteksdata \(SMKT\) i HuB](https://success.openhealth.fr/sv/articles/3175557-uppdateringsdatum-for-gsa-apoteksdata-smkt-i-hub.md): Den här artikeln beskriver datumet då uppgifterna från GSA-apotek \(SMKT\) uppdateras. - [Förutsättningar Matchande apoteksfil](https://success.openhealth.fr/sv/articles/3678146-forutsattningar-matchande-apoteksfil.md): Förutsättningar Matchande apoteksfil - ["På och av recept" -väljaren](https://success.openhealth.fr/sv/articles/3729668-pa-och-av-recept-valjaren.md): Specifikationer för objektet "Prescription Type Selector" - [Hur kvalificerar jag nya produkter i HUB?](https://success.openhealth.fr/sv/articles/3376100-hur-kvalificerar-jag-nya-produkter-i-hub.md): Kvalificering av dina nya produkter i HUB - [Hur skapar, modifierar och delar jag en favorit i HUB?](https://success.openhealth.fr/sv/articles/3175689-hur-skapar-modifierar-och-delar-jag-en-favorit-i-hub.md): Skapa och dela favoriter i navet - [Hur väljer jag produkter i HUB efter lanseringsdatum?](https://success.openhealth.fr/sv/articles/3158428-hur-valjer-jag-produkter-i-hub-efter-lanseringsdatum.md): Den här artikeln förklarar hur man endast väljer produkter som lanserats under en viss period. - [Kan jag extrahera data från HUB i ".csv"-format?](https://success.openhealth.fr/sv/articles/5671278-kan-jag-extrahera-data-fran-hub-i-csv-format.md) - [Svarstid för ODT](https://success.openhealth.fr/sv/articles/6632310-svarstid-for-odt.md) - [Vilka är de bästa visningsmetoderna i HUB](https://success.openhealth.fr/sv/articles/3124454-vilka-ar-de-basta-visningsmetoderna-i-hub.md): Den här artikeln beskriver de bästa metoderna för att optimera HUB-visningen - [Tekniska krav](https://success.openhealth.fr/sv/articles/5369918-tekniska-krav.md) - [Rensa webbläsarens cache](https://success.openhealth.fr/sv/articles/4219722-rensa-webblasarens-cache.md): Så här rensar du webbläsarens cache i Google Chrome - [Hur ställer jag in Google Chrome som min standardwebbläsare?](https://success.openhealth.fr/sv/articles/3738717-hur-staller-jag-in-google-chrome-som-min-standardwebblasare.md): Så här ställer du in Google Chrome som standard - [Navigationshissen syns inte i tabellerna](https://success.openhealth.fr/sv/articles/3195250-navigationshissen-syns-inte-i-tabellerna.md): Navigationslyften - [Visningen av knappar eller föremål på ett ark är delvis avskuret eller syns inte](https://success.openhealth.fr/sv/articles/3195245-visningen-av-knappar-eller-foremal-pa-ett-ark-ar-delvis-avskuret-eller-syns-inte.md): Visa problem med knappar, objekt - [Mitt Territory Management-kort laddas inte och meddelandet "loading" visas](https://success.openhealth.fr/sv/articles/3195239-mitt-territory-management-kort-laddas-inte-och-meddelandet-loading-visas.md): Territory Management / TMA-kartvisningsproblem - [Varifrån kommer felmeddelandet "Du har inte behörighet att komma åt på den här sidan"?](https://success.openhealth.fr/sv/articles/3195338-varifran-kommer-felmeddelandet-du-har-inte-behorighet-att-komma-at-pa-den-har-sidan.md): Felmeddelanden - [Jag har felmeddelandet "Anslutning förlorad"](https://success.openhealth.fr/sv/articles/4445141-jag-har-felmeddelandet-anslutning-forlorad.md): Ett fel har uppstått - [Dålig gateway](https://success.openhealth.fr/sv/articles/4514555-dalig-gateway.md): Felmeddelandet "Bad Gateway" - [Dimensions- och måttväljarna visas inte längre i frågorna "Flera periodanalyser" och "Mitt dataarkiv", utvinningen av tabellen i "Marknadsanalys" är partiell](https://success.openhealth.fr/sv/articles/3195377-dimensions-och-mattvaljarna-visas-inte-langre-i-fragorna-flera-periodanalyser-och-mitt-dataarkiv-utvinningen-av-tabellen-i-marknadsanalys-ar-partiell.md): Mått och mått visas inte längre - [Hur ser jag på en term i HUB?](https://success.openhealth.fr/sv/articles/3194377-hur-ser-jag-pa-en-term-i-hub.md): Med HUB kan du enkelt visa quadrimesters i "Sales Evolution" -arket - [Excel specifikationer och begränsningar](https://success.openhealth.fr/sv/articles/3753088-excel-specifikationer-och-begransningar.md): Den här artikeln förklarar specifikationerna och begränsningarna för Excel. - [Hur skapar, redigerar och delar du en favorit i dina applikationer?](https://success.openhealth.fr/sv/articles/10502803-hur-skapar-redigerar-och-delar-du-en-favorit-i-dina-applikationer.md) - [Konsumentpanelens ramverk](https://success.openhealth.fr/sv/articles/3455845-konsumentpanelens-ramverk.md): Artikel om konsumentpanelramen - [Ramverk för analys av apoteksmarknaden](https://success.openhealth.fr/sv/articles/3455857-ramverk-for-analys-av-apoteksmarknaden.md): Artikel om OpenHealth-ramverket för analys av marknadsprestanda på apotekskanalen ### Datakällor - [Vad är OpenHealth-apotekspanelen?](https://success.openhealth.fr/sv/articles/3304106-vad-ar-openhealth-apotekspanelen.md): Den här artikeln syftar till att beskriva vår apotekspanel. - [Apoteksnätverket, en avgörande tillgång för hanteringen av nuvarande och framtida hälsokriser](https://success.openhealth.fr/sv/articles/3825648-apoteksnatverket-en-avgorande-tillgang-for-hanteringen-av-nuvarande-och-framtida-halsokriser.md): OpenHealth Company, som åtagit sig att övervaka en aldrig tidigare skådad hälsokris, mobiliserar sin teknik och data - [Vilka är de franska utomeuropeiska departementens och territoriernas synliga områden i HUB?](https://success.openhealth.fr/sv/articles/3194382-vilka-ar-de-franska-utomeuropeiska-departementens-och-territoriernas-synliga-omraden-i-hub.md): DROM-COM-områden finns i navet - [Förutsedd sektoriseringsfil](https://success.openhealth.fr/sv/articles/3702701-forutsedd-sektoriseringsfil.md): Denna artikel låter dig ladda ner, fylla i och skicka in din sektoriseringsfil. - [SMKT-datakälla](https://success.openhealth.fr/sv/articles/4485357-smkt-datakalla.md): IRI, leverantör av GSA-apoteksdata - [GSA Parapharmacy Products Coding Rules \(SMKT\) vid IRI](https://success.openhealth.fr/sv/articles/3524492-gsa-parapharmacy-products-coding-rules-smkt-vid-iri.md): Påminnelse om kodifieringsreglerna för SMKT-produkter vid IRI - [Uppgifter från ORGANIC STORE - Källa BIOANALYTICS](https://success.openhealth.fr/sv/articles/5631260-uppgifter-fran-organic-store-kalla-bioanalytics.md) - [E-parafarmaci: övervakningsplattformar](https://success.openhealth.fr/sv/articles/9167006-e-parafarmaci-overvakningsplattformar.md) - [E-apotek Produktvinster och förluster](https://success.openhealth.fr/sv/articles/3568773-e-apotek-produktvinster-och-forluster.md): Artikel som hänför sig till modulen "E-apotekets produktvinster och förluster" - [Konsumentprofil](https://success.openhealth.fr/sv/articles/3711085-konsumentprofil.md): Artikel som rör modulen '' Konsumentprofil '' - [AMAZON-data - Källa SELLINGZ](https://success.openhealth.fr/sv/articles/5669013-amazon-data-kalla-sellingz.md) - [Uppgifter om e-handel - Källa WISER](https://success.openhealth.fr/sv/articles/7983010-uppgifter-om-e-handel-kalla-wiser.md) - [Geografiska territorier](https://success.openhealth.fr/sv/articles/4661582-geografiska-territorier.md): På Open Health Company kan du analysera dina marknader enligt de geografiska territorier som vi erbjuder dig. - [Hur ser apotekspanelen ut i Tyskland? INSIGHTHEALTH](https://success.openhealth.fr/sv/articles/5391412-hur-ser-apotekspanelen-ut-i-tyskland-insighthealth.md) - [Hur ser apoteksnämnden ut i Grekland? ALIRAHEALTH](https://success.openhealth.fr/sv/articles/6863963-hur-ser-apoteksnamnden-ut-i-grekland-alirahealth.md) - [Vad är apotekspanelen i Österrike? INSIGHTHEALTH](https://success.openhealth.fr/sv/articles/6863949-vad-ar-apotekspanelen-i-osterrike-insighthealth.md) - [Vad är apotekspanelen i Afrika? PIEX - Afrika](https://success.openhealth.fr/sv/articles/6686633-vad-ar-apotekspanelen-i-afrika-piex-afrika.md) - [Vad är apotekspanelen på nätet i Tyskland? DATAMEDIQ](https://success.openhealth.fr/sv/articles/5689640-vad-ar-apotekspanelen-pa-natet-i-tyskland-datamediq.md) - [Vad är apotekspanelen i Belgien? REDPHARMA](https://success.openhealth.fr/sv/articles/4689894-vad-ar-apotekspanelen-i-belgien-redpharma.md) - [Vad är apotekspanelen i Spanien? - HMR](https://success.openhealth.fr/sv/articles/5391363-vad-ar-apotekspanelen-i-spanien-hmr.md) - [Vad är apotekspanelen i Spanien? - INFONIS](https://success.openhealth.fr/sv/articles/5428915-vad-ar-apotekspanelen-i-spanien-infonis.md) - [Vad är apotekspanelen i Portugal? - HMR](https://success.openhealth.fr/sv/articles/5391477-vad-ar-apotekspanelen-i-portugal-hmr.md) - [Vad är apotekspanelen i Ryssland? - ALPHARM](https://success.openhealth.fr/sv/articles/5701531-vad-ar-apotekspanelen-i-ryssland-alpharm.md) - [Vad är apotekspanelen i Polen? Pex Pharma](https://success.openhealth.fr/sv/articles/5969485-vad-ar-apotekspanelen-i-polen-pex-pharma.md) - [CONVERT GROUP](https://success.openhealth.fr/sv/articles/6961966-convert-group.md) - [Hur ser apotekspanelen ut i Jordanien?](https://success.openhealth.fr/sv/articles/8176750-hur-ser-apotekspanelen-ut-i-jordanien.md) - [Befolkning - kartografi](https://success.openhealth.fr/sv/articles/3807695-befolkning-kartografi.md): Analysera den geografiska fördelningen av befolkningen - [AMELI - LPP](https://success.openhealth.fr/sv/articles/6962021-ameli-lpp.md) - [Befolkning - Evolution by AGE & GENDER](https://success.openhealth.fr/sv/articles/3810789-befolkning-evolution-by-age-gender.md): Analysera utvecklingen av befolkningsstrukturen - [Befolkning - Jämförelse efter AGE & KÖN](https://success.openhealth.fr/sv/articles/3836795-befolkning-jamforelse-efter-age-kon.md): Jämför den demografiska profilen för två populationer - [EGYPT - Kartografi](https://success.openhealth.fr/sv/articles/3714611-egypt-kartografi.md): Analysera befolkningen i landets Egypten - [EGYPT - Analys av AGE & GENDER](https://success.openhealth.fr/sv/articles/3714673-egypt-analys-av-age-gender.md): Analysera befolkningens struktur - [UGANDA - Analys av AGE & GENDER](https://success.openhealth.fr/sv/articles/3713884-uganda-analys-av-age-gender.md): Analysera befolkningens struktur - [Befolkning - Analys av AGE & KÖN](https://success.openhealth.fr/sv/articles/3807673-befolkning-analys-av-age-kon.md): Analysera befolkningens struktur - [Medicabase - läkemedelsdatabas](https://success.openhealth.fr/sv/articles/6518920-medicabase-lakemedelsdatabas.md) - [Födelse](https://success.openhealth.fr/sv/articles/6340025-fodelse.md) - [OpenEudra](https://success.openhealth.fr/sv/articles/6518977-openeudra.md) - [Uppdelning av IRIS](https://success.openhealth.fr/sv/articles/6383829-uppdelning-av-iris.md) - [ADICAP](https://success.openhealth.fr/sv/articles/6959465-adicap.md) - [NEC](https://success.openhealth.fr/sv/articles/6519012-nec.md) - [Uppgifter om världens befolkning](https://success.openhealth.fr/sv/articles/8217421-uppgifter-om-varldens-befolkning.md) - [INSEE: Filer av avlidna personer](https://success.openhealth.fr/sv/articles/4498126-insee-filer-av-avlidna-personer.md): INSEE \(National Institute for Statistics and Economic Studies\): Fil av avlidna personer - [Uppgifter VAERS- VAERSDATA- Källa CDC](https://success.openhealth.fr/sv/articles/6226665-uppgifter-vaers-vaersdata-kalla-cdc.md) - [VAERS-data - VAERSVAX - Källa CDC](https://success.openhealth.fr/sv/articles/6226440-vaers-data-vaersvax-kalla-cdc.md) - [VAERS-data - VAERSSYMPTOMS - Källa CDC](https://success.openhealth.fr/sv/articles/6219415-vaers-data-vaerssymptoms-kalla-cdc.md) - [Integrera dina data i hubben på mindre än 2 veckor](https://success.openhealth.fr/sv/articles/5259828-integrera-dina-data-i-hubben-pa-mindre-an-2-veckor.md) - [Mall för internationella uppgifter](https://success.openhealth.fr/sv/articles/4684696-mall-for-internationella-uppgifter.md) - [Hur skickar vi dina uppgifter via FTPS?](https://success.openhealth.fr/sv/articles/4143451-hur-skickar-vi-dina-uppgifter-via-ftps.md): Skicka data via FTPS - [Vilken information behöver OpenHealth för att integrera en ny datakälla?](https://success.openhealth.fr/sv/articles/3459148-vilken-information-behover-openhealth-for-att-integrera-en-ny-datakalla.md): Artikel om integrering av nya datakällor - [Det långa perspektivet](https://success.openhealth.fr/sv/articles/6959482-det-langa-perspektivet.md) - [Hur integrerar jag en ny datakälla i HUB?](https://success.openhealth.fr/sv/articles/3467598-hur-integrerar-jag-en-ny-datakalla-i-hub.md): Artikel relaterad till dataintegrationsprocessen i HUB - [Integrera dina försäljningsdata i HUB](https://success.openhealth.fr/sv/articles/3471145-integrera-dina-forsaljningsdata-i-hub.md): Artikel om integrering av försäljningsdata - [Specifikationer för mottagning av försäljningsdata](https://success.openhealth.fr/sv/articles/3660043-specifikationer-for-mottagning-av-forsaljningsdata.md): Så här skickar du in ditt införsäljning som en del av en in- och utförsäljningsanalys eller prenumeration på Sell-in Vizualization-modulen - [Varifrån kommer analysdata för marknaden för hemmafrågor \(PSAD\)?](https://success.openhealth.fr/sv/articles/3376155-varifran-kommer-analysdata-for-marknaden-for-hemmafragor-psad.md): PSAD - [Hur går man med i SantéDom Stat-observatoriet?](https://success.openhealth.fr/sv/articles/3798795-hur-gar-man-med-i-santedom-stat-observatoriet.md): Självstudier för att gå med i det nationella observatoriet för hemmafrågor \(PSAD\) - [Panel extrapolerad från observatoriet SanteDomStat.](https://success.openhealth.fr/sv/articles/6701602-panel-extrapolerad-fran-observatoriet-santedomstat.md) - [Antal patienter](https://success.openhealth.fr/sv/articles/3376499-antal-patienter.md): Definition av antalet patienter enligt PSAD-federationerna - [Antal behandlingar](https://success.openhealth.fr/sv/articles/3376682-antal-behandlingar.md): Definition av antalet behandlingar enligt PSAD-federationerna - [Antal nya patienter](https://success.openhealth.fr/sv/articles/3376672-antal-nya-patienter.md): Definition av antalet nya patienter enligt PSAD-federationerna - [Omsättning inklusive skatt](https://success.openhealth.fr/sv/articles/3376725-omsattning-inklusive-skatt.md): Definition av omsättning inklusive skatt enligt PSAD-federationerna - [Antal patienter vid slutet av behandlingen](https://success.openhealth.fr/sv/articles/3376675-antal-patienter-vid-slutet-av-behandlingen.md): Definition av antalet patienter i slutet av behandlingen enligt PSAD-federationerna - [Obligatoriskt sjukförsäkringsbelopp \(AMO\)](https://success.openhealth.fr/sv/articles/3376740-obligatoriskt-sjukforsakringsbelopp-amo.md): Definition av AMO-beloppet enligt PSAD-federationerna - [Kompletterande sjukförsäkringsbelopp \(AMC\)](https://success.openhealth.fr/sv/articles/3376749-kompletterande-sjukforsakringsbelopp-amc.md): Definition av AMC-beloppet enligt PSAD-federationerna - [Utestående avgift \(RAC\)](https://success.openhealth.fr/sv/articles/3376751-utestaende-avgift-rac.md): Definition av RAC enligt PSAD-federationer - [Källa: THESORIMED](https://success.openhealth.fr/sv/articles/3560018-kalla-thesorimed.md): Läkemedelsdatabas \(BdM\) - [Internationella icke-egentliga namn \(INN\)](https://success.openhealth.fr/sv/articles/3954239-internationella-icke-egentliga-namn-inn.md): Internationella vanliga namn \(INN\) - [Öppna fakta om mat](https://success.openhealth.fr/sv/articles/6961970-oppna-fakta-om-mat.md) - [LOINC - logiska observationsidentifierare Namn och koder](https://success.openhealth.fr/sv/articles/6959323-loinc-logiska-observationsidentifierare-namn-och-koder.md) - [AMELI - CCAM](https://success.openhealth.fr/sv/articles/6959080-ameli-ccam.md) - [WHO ATC VET](https://success.openhealth.fr/sv/articles/6959078-who-atc-vet.md) - [CEPS](https://success.openhealth.fr/sv/articles/6959068-ceps.md) - [Institution](https://success.openhealth.fr/sv/articles/3935678-institution.md): Lista över hälso-, social-, medicinsk-sociala anläggningar - [Hälso- och sjukvård](https://success.openhealth.fr/sv/articles/7969680-halso-och-sjukvard.md) - [Extrahera FINESS](https://success.openhealth.fr/sv/articles/3946922-extrahera-finess.md): Utför en extraktion enligt dina förväntningar - [Evolution FINESS](https://success.openhealth.fr/sv/articles/3947009-evolution-finess.md): Följ utvecklingen av antalet strukturer - [Auktorisation vårdaktivitet](https://success.openhealth.fr/sv/articles/3947067-auktorisation-vardaktivitet.md): Lista strukturerna enligt deras vårdaktivitetsbehörigheter - [Större medicinsk utrustning](https://success.openhealth.fr/sv/articles/3947269-storre-medicinsk-utrustning.md): Lista strukturerna efter deras utrustning för tung utrustning - [Geografisk](https://success.openhealth.fr/sv/articles/3947363-geografisk.md): Visualisera fördelningen av strukturer på territoriet - [RPPS](https://success.openhealth.fr/sv/articles/3947568-rpps.md): Lista över vårdpersonal - [FINESS & RPPS](https://success.openhealth.fr/sv/articles/3947713-finess-rpps.md): Lista träningsställen för vårdpersonal - [Extrahera RPPS](https://success.openhealth.fr/sv/articles/3947829-extrahera-rpps.md): RPPS \(Shared Directory of Healthcare Professionals\) ### Modellerna - [Uppgifter vid UGA](https://success.openhealth.fr/sv/articles/4852310-uppgifter-vid-uga.md) - [Beräkning av försäljning till sektorn: vad du behöver veta](https://success.openhealth.fr/sv/articles/3545561-berakning-av-forsaljning-till-sektorn-vad-du-behover-veta.md): Vilka är de olika stegen för att beräkna sektorsförsäljning på OpenHealth? - [Sektorfördelning, statisk eller dynamisk metod?](https://success.openhealth.fr/sv/articles/3690615-sektorfordelning-statisk-eller-dynamisk-metod.md): Sektorfördelning, statisk eller dynamisk metod? - [Apotek lager](https://success.openhealth.fr/sv/articles/4291490-apotek-lager.md): Detaljer om de "teoretiska" skikten och de "verkliga" eller "effektiva" skikten. - [Produktionslinjen för hubben](https://success.openhealth.fr/sv/articles/4816146-produktionslinjen-for-hubben.md) - [Hur gör man en jämförande analys?](https://success.openhealth.fr/sv/articles/3440093-hur-gor-man-en-jamforande-analys.md): Du vill jämföra data från två olika leverantörer. - [NIVÅ 1 UNDERSÖKNING - Datakvalitet till tjänst för OpenHealth Company](https://success.openhealth.fr/sv/articles/3595822-niva-1-undersokning-datakvalitet-till-tjanst-for-openhealth-company.md): Ser du ett fenomen som du inte förstår? Vi kan ge dig ursprunget till denna observation och förklara det för dig. - [Datakvalitetsprocess på OpenHealth](https://success.openhealth.fr/sv/articles/3415271-datakvalitetsprocess-pa-openhealth.md): Den här artikeln beskriver stegen i datakvalitetsprocesser på OpenHealth - [Intervall och konfidensnivå](https://success.openhealth.fr/sv/articles/3633173-intervall-och-konfidensniva.md): Definitioner, formler och begränsningar: vad du behöver veta - [Datakvalitet: Partihantering](https://success.openhealth.fr/sv/articles/3433509-datakvalitet-partihantering.md): Beskrivning av batchhanteringsprocessen - [Datakvalitet: Försäljningsnedbrytningsprocess](https://success.openhealth.fr/sv/articles/3415317-datakvalitet-forsaljningsnedbrytningsprocess.md): Beskrivning av försäljningsfördelningsprocessen - [Försäljnings- och lagerförskjutningar](https://success.openhealth.fr/sv/articles/4131084-forsaljnings-och-lagerforskjutningar.md): Lagerförsäljning - [Varför analysera försäljningsvolym?](https://success.openhealth.fr/sv/articles/3846167-varfor-analysera-forsaljningsvolym.md): Varför analysera försäljningsvolym? - [Det finns en dataklyfta mellan in- och utförsäljning](https://success.openhealth.fr/sv/articles/3195358-det-finns-en-dataklyfta-mellan-in-och-utforsaljning.md): I vilka fall kan vi ha en dataklyfta mellan in- och utförsäljning? - [Vad är en atypisk försäljning?](https://success.openhealth.fr/sv/articles/3195366-vad-ar-en-atypisk-forsaljning.md): Atypisk försäljning och ATYPISKT FILTER-process. - [Varifrån kommer informationen om priser, volymer, omsättning?](https://success.openhealth.fr/sv/articles/3195348-varifran-kommer-informationen-om-priser-volymer-omsattning.md): Information om pris / volym / omsättning - [Uppskattad försäljningsvolym per förskrivare](https://success.openhealth.fr/sv/articles/4171530-uppskattad-forsaljningsvolym-per-forskrivare.md): Hur man utvärderar dina försäljningsvolymer på apotek efter förskrivare och kategori för förskrivare - [Förstå skillnaden mellan 2 extraktioner](https://success.openhealth.fr/sv/articles/13399689-forsta-skillnaden-mellan-2-extraktioner.md) ### Stegen - [GTIN](https://success.openhealth.fr/sv/articles/3608176-gtin.md): GTIN-kod \(Global Trade Item Number\) - [Kundproduktspecifikation \(CQCP\)](https://success.openhealth.fr/sv/articles/3704913-kundproduktspecifikation-cqcp.md): CQCP \(fält för produktkundskvalificering\) - [Vad är en LPPR-kod?](https://success.openhealth.fr/sv/articles/3195365-vad-ar-en-lppr-kod.md): LPPR-koden \(Lista över återbetalningsbara produkter och tjänster\) - [Spårning av produktuthyrning](https://success.openhealth.fr/sv/articles/4206554-sparning-av-produktuthyrning.md): Produktuthyrning - [Jag vill utöka min marknad](https://success.openhealth.fr/sv/articles/4420843-jag-vill-utoka-min-marknad.md): Marknaden för prenumerationer följde - [OHC-klassificering](https://success.openhealth.fr/sv/articles/3194589-ohc-klassificering.md): Se tilldelningen av dina produkter enligt den egna OpenHealth Company-klassificeringen - [EphMRA AC-klasshistoria](https://success.openhealth.fr/sv/articles/3557908-ephmra-ac-klasshistoria.md): Visualisera utvecklingen av EphMRA AC-klasser sedan 2014 - [Detaljer om veterinärmedicin](https://success.openhealth.fr/sv/articles/3194587-detaljer-om-veterinarmedicin.md): Visualisera egenskaperna hos veterinärmedicinska läkemedel - [Klassificering av veterinärmedicin](https://success.openhealth.fr/sv/articles/3194579-klassificering-av-veterinarmedicin.md): Visa klassificeringen av veterinärmedicinska läkemedel \(ANSES\) - [Humanmedicinsk information](https://success.openhealth.fr/sv/articles/3421225-humanmedicinsk-information.md): Visa egenskaperna hos en eller flera produkter genom detaljfälten i THESORIMED - [Hantering av nya produkter](https://success.openhealth.fr/sv/articles/4470813-hantering-av-nya-produkter.md): Ny produkthantering - [Klassificering av humanmedicin](https://success.openhealth.fr/sv/articles/3417281-klassificering-av-humanmedicin.md): Visa EphMRA AC och OMS ATC-klassificeringar för ditt produktomfång - [Indikationer - Diagnos](https://success.openhealth.fr/sv/articles/3568554-indikationer-diagnos.md): Visa de läkemedel som anges för en viss patologi och de patologier som är associerade med ett urval av läkemedel - [MP4U](https://success.openhealth.fr/sv/articles/3574188-mp4u.md): Visa alla klassificeringar som görs tillgängliga av OpenHealth Company - [Vad är TVASI \(tabell över försäljning, inköp och okända lager\)?](https://success.openhealth.fr/sv/articles/5992494-vad-ar-tvasi-tabell-over-forsaljning-inkop-och-okanda-lager.md) - [IRI-produktklassificering](https://success.openhealth.fr/sv/articles/3194597-iri-produktklassificering.md): Visualisera tilldelningen av dina produkter enligt klassificeringen ägare IRI - [Borttagning av osålda produkter](https://success.openhealth.fr/sv/articles/6135938-borttagning-av-osalda-produkter.md) - [STANDARDMARKNAD - Prenumeration](https://success.openhealth.fr/sv/articles/3798203-standardmarknad-prenumeration.md): Denna artikel beskriver intresset och begränsningarna för en så kallad "standard" -marknad - [Jag kan inte hitta min produkt](https://success.openhealth.fr/sv/articles/5686002-jag-kan-inte-hitta-min-produkt.md) - [Hantering av produktkoder](https://success.openhealth.fr/sv/articles/5652478-hantering-av-produktkoder.md) - [Produktkvalifikation: Varumärken](https://success.openhealth.fr/sv/articles/5016985-produktkvalifikation-varumarken.md) ### TECKNINGAR OCH MODULER - [De 3 typerna av ansökningar](https://success.openhealth.fr/sv/articles/9489652-de-3-typerna-av-ansokningar.md) - [Din 2.0-plattform](https://success.openhealth.fr/sv/articles/8374416-din-2-0-plattform.md) - [SAMMANFATTNING](https://success.openhealth.fr/sv/articles/3344127-sammanfattning.md): Alla egenskaper hos din applikation finns i denna modul - [Marknader och urval](https://success.openhealth.fr/sv/articles/8337016-marknader-och-urval.md) - [Sammanfattande instrumentpanel](https://success.openhealth.fr/sv/articles/9246867-sammanfattande-instrumentpanel.md) - [Analys](https://success.openhealth.fr/sv/articles/9352287-analys.md) - [Extraktor](https://success.openhealth.fr/sv/articles/9246875-extraktor.md) - [Tillväxtanalys](https://success.openhealth.fr/sv/articles/3158856-tillvaxtanalys.md): Bestäm nyckelfaktorerna i utvecklingen av dina marknader och dina konkurrenters - [Sortimentanalys](https://success.openhealth.fr/sv/articles/3473736-sortimentanalys.md): Studera dynamiken i produkter på en marknad - [Genomsnittligt antal produkter](https://success.openhealth.fr/sv/articles/3161474-genomsnittligt-antal-produkter.md): Visa det genomsnittliga antalet produkter per försäljningsställe, på apotek eller i GSA-apotek - [Starta spårning](https://success.openhealth.fr/sv/articles/3158488-starta-sparning.md): Övervaka produktlanseringar och deras bidrag till tillväxt - [Avancerade indikatorer som korsats](https://success.openhealth.fr/sv/articles/6007740-avancerade-indikatorer-som-korsats.md) - [Försäljningskoncentration](https://success.openhealth.fr/sv/articles/3095338-forsaljningskoncentration.md): Visualisera koncentrationen av en marknad genom försäljningskoncentrationskurvan och GINI-indexet - [Prisspridning](https://success.openhealth.fr/sv/articles/3159289-prisspridning.md): Visualisera prisdispersionen för en produkt. Skapa dina egna apoteksegment från försäljningspriset - [Försäljningsmarginalanalys](https://success.openhealth.fr/sv/articles/3358322-forsaljningsmarginalanalys.md): Jämför dina produkters attraktivitet för apotek - [Sell-out Margin Evolution](https://success.openhealth.fr/sv/articles/3815561-sell-out-margin-evolution.md) - [Apotekskontroll \(1/2\)](https://success.openhealth.fr/sv/articles/3358248-apotekskontroll-1-2.md): Följ utvecklingen av apotekstrafik - [Apotekskontroll \(2/2\)](https://success.openhealth.fr/sv/articles/3810527-apotekskontroll-2-2.md): Följ utvecklingen av apotekstrafik - [Salesforce-prestanda](https://success.openhealth.fr/sv/articles/3159230-salesforce-prestanda.md): Jämför försäljningsprestanda för regioner och sektorer hos en säljkår - [ASSISTENT för hantering av kundrelationer \(CRM\)](https://success.openhealth.fr/sv/articles/5953935-assistent-for-hantering-av-kundrelationer-crm.md) - [Point of Sales Tracking](https://success.openhealth.fr/sv/articles/3778944-point-of-sales-tracking.md): Point of Sales Tracking - [Utveckling på begäran](https://success.openhealth.fr/sv/articles/6560184-utveckling-pa-begaran.md) - [Analys på begäran](https://success.openhealth.fr/sv/articles/6127483-analys-pa-begaran.md) - [On Demand Table](https://success.openhealth.fr/sv/articles/3158751-on-demand-table.md): Visualisera de viktigaste HUB-indikatorerna och deras utveckling över olika typer av perioder - [Tidsserie-analys](https://success.openhealth.fr/sv/articles/3635940-tidsserie-analys.md): Dela upp din marknad i säsong, trend och buller - [Prognosanalys](https://success.openhealth.fr/sv/articles/3636015-prognosanalys.md): Uppskatta framtiden för din marknad - [Sektoriell prognos](https://success.openhealth.fr/sv/articles/3689811-sektoriell-prognos.md): Uppskatta din framtida sektorförsäljning - [Försäljningsvisualisering](https://success.openhealth.fr/sv/articles/3559882-forsaljningsvisualisering.md): Jämför utvecklingen av din in- och utförsäljning - [Analys av försäljningen](https://success.openhealth.fr/sv/articles/6188132-analys-av-forsaljningen.md) - [Sälj in matchning](https://success.openhealth.fr/sv/articles/6188090-salj-in-matchning.md) - [Utveckling av försäljningen](https://success.openhealth.fr/sv/articles/6191929-utveckling-av-forsaljningen.md) - [Analys av försäljning och utförsäljning](https://success.openhealth.fr/sv/articles/6191947-analys-av-forsaljning-och-utforsaljning.md) - [Utveckling av försäljning och utförsäljning](https://success.openhealth.fr/sv/articles/6191955-utveckling-av-forsaljning-och-utforsaljning.md) - [Prisutveckling](https://success.openhealth.fr/sv/articles/5056489-prisutveckling.md) - [Anpassa färger](https://success.openhealth.fr/sv/articles/8407897-anpassa-farger.md) - [Produktexport](https://success.openhealth.fr/sv/articles/3583206-produktexport.md): Exportera ark som är specifikt för alla produkter och MP4U-appar - [Marknadsanalys](https://success.openhealth.fr/sv/articles/3121933-marknadsanalys.md): Analysera prestandan på din marknad: efter segment, varumärke, produkt och företag - [Prisanalys](https://success.openhealth.fr/sv/articles/3215190-prisanalys.md): Se priserna på din marknad och analysera din positionering - [Försäljningsutveckling](https://success.openhealth.fr/sv/articles/3178323-forsaljningsutveckling.md): Visa din försäljning under hela din tillgängliga historik - [Sammanfattning av instrumentpanelen](https://success.openhealth.fr/sv/articles/4533213-sammanfattning-av-instrumentpanelen.md) - [Marknadsandelsutveckling](https://success.openhealth.fr/sv/articles/3193078-marknadsandelsutveckling.md): Visualisera utvecklingen av försäljning och marknadsandelar under långa perioder - [Försäljningskorsbord](https://success.openhealth.fr/sv/articles/3193060-forsaljningskorsbord.md): Skapa en enkel pivottabell - [OMSÄTTNING / VOLYM \(CU\) Syntes](https://success.openhealth.fr/sv/articles/3193048-omsattning-volym-cu-syntes.md): Visualisera samtidigt försäljningsvolymer och värde på en marknad - [Sell Out Value Synthesis \(APOTEKER / SUPERMARKETS\)](https://success.openhealth.fr/sv/articles/3193020-sell-out-value-synthesis-apoteker-supermarkets.md): Jämför försäljning av GSA-apotek och apotek - [Analys av marknadsandelar](https://success.openhealth.fr/sv/articles/3193069-analys-av-marknadsandelar.md): Analysera marknadsandelar under de senaste 12 månaderna - [Mitt dataarkiv](https://success.openhealth.fr/sv/articles/3193099-mitt-dataarkiv.md): Exportera en platt databas till Excel - [Analys av flera perioder](https://success.openhealth.fr/sv/articles/3192953-analys-av-flera-perioder.md): Skapa en helt anpassad tabell - [Min fråga Alla produkter](https://success.openhealth.fr/sv/articles/4280353-min-fraga-alla-produkter.md): Visa dina segment och kvalificerande fält \(Ex: galenik, solindex, kampanjer ...\) samt din begränsning - [Lagerutveckling \(NY\)](https://success.openhealth.fr/sv/articles/3719256-lagerutveckling-ny.md): Visualisera och analysera lagerutvecklingen och deras distribution - [Marknadsdefinition](https://success.openhealth.fr/sv/articles/3158829-marknadsdefinition.md): Basera om din marknad på den 100-bas du väljer - [RAW DATA avancerade indikatorer](https://success.openhealth.fr/sv/articles/3711095-raw-data-avancerade-indikatorer.md): Återställ dina ledande indikatordata - [Avancerade indikatorer Evolution SMKT](https://success.openhealth.fr/sv/articles/3193000-avancerade-indikatorer-evolution-smkt.md): Övervaka laboratoriets prestanda genom en analys av den tidsmässiga utvecklingen av dina avancerade statistiska indikatorer. - [Avancerad indikatoranalys SMKT](https://success.openhealth.fr/sv/articles/3192366-avancerad-indikatoranalys-smkt.md): Bryt utvecklingen av en GSA-parafarmacimarknad till ledande indikatorer - [Avancerade indikatorers utveckling](https://success.openhealth.fr/sv/articles/3177853-avancerade-indikatorers-utveckling.md): Övervaka laboratoriets prestanda genom en analys av den tidsmässiga utvecklingen av dina avancerade statistiska indikatorer. - [Avancerade indikatorer Evolution Bio](https://success.openhealth.fr/sv/articles/7051823-avancerade-indikatorer-evolution-bio.md) - [Nationella avancerade indikatorer](https://success.openhealth.fr/sv/articles/3364513-nationella-avancerade-indikatorer.md): Bryt utvecklingen av en marknad till ledande indikatorer - [Lageranalys](https://success.openhealth.fr/sv/articles/3178015-lageranalys.md): Tolka en lagernivå och dess utveckling - [Avancerad analys av indikatorer Bio](https://success.openhealth.fr/sv/articles/7051801-avancerad-analys-av-indikatorer-bio.md) - [Avancerad indikatoranalys](https://success.openhealth.fr/sv/articles/3124439-avancerad-indikatoranalys.md): Bryt ned utvecklingen av en marknad till ledande indikatorer - [Kartografi](https://success.openhealth.fr/sv/articles/3192450-kartografi.md): Analysera den kommersiella utvecklingen i regionerna och sektorerna i din säljkår - [Geografiskt korsbord](https://success.openhealth.fr/sv/articles/3192466-geografiskt-korsbord.md): Skapa en pivottabell som integrerar din sektorisering - [Geografisk försäljningsutveckling](https://success.openhealth.fr/sv/articles/3192482-geografisk-forsaljningsutveckling.md): Visualisera försäljning efter sektor över 36 månader i en pivottabell - [Effektivitet för säljkåren](https://success.openhealth.fr/sv/articles/5624011-effektivitet-for-saljkaren.md) - [Analys av anpassad viktningsmetod](https://success.openhealth.fr/sv/articles/5169317-analys-av-anpassad-viktningsmetod.md) - [Nätverksanalys](https://success.openhealth.fr/sv/articles/3894767-natverksanalys.md): Nätverksanalys - [Anpassad viktningsmetod Evolution](https://success.openhealth.fr/sv/articles/5169320-anpassad-viktningsmetod-evolution.md) - [SAMMANFATTNING KPI](https://success.openhealth.fr/sv/articles/3478199-sammanfattning-kpi.md): Visualisera i en dynamisk tabell dina nyckelindikatorer Volymen minskade till regioner och sektorer. - [Försäljning i konverterade enheter](https://success.openhealth.fr/sv/articles/3192412-forsaljning-i-konverterade-enheter.md): Använd konverterade enheter för att visualisera din försäljning - [RAW DATA lagerindikatorer](https://success.openhealth.fr/sv/articles/3711142-raw-data-lagerindikatorer.md): Exportera dina lagerdata - [RAW DATA SMKT AIA](https://success.openhealth.fr/sv/articles/3720960-raw-data-smkt-aia.md): Hitta dina SMKT-ledande indikatordata - [Lagerutveckling](https://success.openhealth.fr/sv/articles/3178277-lagerutveckling.md): Visualisera och analysera lagerutvecklingen och deras distribution - [Geografiska avancerade indikatorer](https://success.openhealth.fr/sv/articles/3192508-geografiska-avancerade-indikatorer.md): Visa ledande indikatorer efter region eller sektor - [Produktens prestanda](https://success.openhealth.fr/sv/articles/3850331-produktens-prestanda.md): Jämför affärsresultat för regioner och produktsektorer - [Territoriella avancerade indikatorer](https://success.openhealth.fr/sv/articles/3370879-territoriella-avancerade-indikatorer.md): Bryt utvecklingen av en marknad till ledande indikatorer - [Tidsserie sektoriell analys](https://success.openhealth.fr/sv/articles/3814974-tidsserie-sektoriell-analys.md): Dela upp din marknad i trend, säsong, buller - [Försäljningsanalys efter ålder och kön](https://success.openhealth.fr/sv/articles/3192701-forsaljningsanalys-efter-alder-och-kon.md): Analysera försäljningen efter ålder och kön - [Försäljningsutveckling efter graviditetsstatus](https://success.openhealth.fr/sv/articles/3192910-forsaljningsutveckling-efter-graviditetsstatus.md): Följ apoteksförsäljningen på befolkningen av gravida kvinnor - [Försäljningsutveckling efter ålder och kön](https://success.openhealth.fr/sv/articles/3192732-forsaljningsutveckling-efter-alder-och-kon.md): Visualisera utvecklingen av försäljning efter ålder och kön med hjälp av HUB: s historia - [Utveckling av kravordning](https://success.openhealth.fr/sv/articles/5790020-utveckling-av-kravordning.md) - [Evolution co-dispensations](https://success.openhealth.fr/sv/articles/3192529-evolution-co-dispensations.md): Visualisera och bryt ned utvecklingen av ko-dispenser på apotek - [Co-dispensationsanalys](https://success.openhealth.fr/sv/articles/3192633-co-dispensationsanalys.md): Se samdispenseringar på apotek i samband med ett urval av produkter från min marknad - [Försäljning per kanal och förskrivare](https://success.openhealth.fr/sv/articles/3192751-forsaljning-per-kanal-och-forskrivare.md): Visualisera påverkarna på din marknad - [AMO, AMC & RAC](https://success.openhealth.fr/sv/articles/3192929-amo-amc-rac.md): Se de tre beloppen för obligatorisk sjukförsäkring, kompletterande sjukförsäkring och egna kostnader - [Co-dispensations Dispersion](https://success.openhealth.fr/sv/articles/3876946-co-dispensations-dispersion.md): Visualisera fördelningen av antalet produkter som säljs genom dispens - [Dispensation Dispersion Evolution](https://success.openhealth.fr/sv/articles/3920070-dispensation-dispersion-evolution.md): Visualisera fördelningen av antalet sålda produkter per dispens över tiden - [Husläkarrecept efter ålder och kön](https://success.openhealth.fr/sv/articles/5789899-huslakarrecept-efter-alder-och-kon.md) - [Analys av beställningar av recept](https://success.openhealth.fr/sv/articles/5322866-analys-av-bestallningar-av-recept.md) - [Utveckling av recept från allmänläkare](https://success.openhealth.fr/sv/articles/5790016-utveckling-av-recept-fran-allmanlakare.md) - [Korganalys](https://success.openhealth.fr/sv/articles/3711049-korganalys.md): Beskrivning av modulen 'Basketanalys' - [Samdistribution](https://success.openhealth.fr/sv/articles/4738243-samdistribution.md) - [Kohortkvalificeringsmodul](https://success.openhealth.fr/sv/articles/3928090-kohortkvalificeringsmodul.md): Kvalificering av patientkohorten - [Behandlingsstatusmodul](https://success.openhealth.fr/sv/articles/3928067-behandlingsstatusmodul.md): Analysera dynamiken i behandlingsövervakningen - [Behandlingsförebyggande modul](https://success.openhealth.fr/sv/articles/3928044-behandlingsforebyggande-modul.md): Analysera efterlevnad av behandlingar - [Kohortdefinition](https://success.openhealth.fr/sv/articles/3894703-kohortdefinition.md): Definiera omfattningen av din analys - [Samtidiga behandlingar](https://success.openhealth.fr/sv/articles/4163623-samtidiga-behandlingar.md): Definiera sambehandling inom ditt analysområde - [Visualiseringskohorte](https://success.openhealth.fr/sv/articles/3894721-visualiseringskohorte.md): Visa patientprofilen för den definierade kohorten - [Definition av analyskriterier](https://success.openhealth.fr/sv/articles/3894728-definition-av-analyskriterier.md): Definiera parametrarna för analysen av din kohort - [Global kohortutveckling](https://success.openhealth.fr/sv/articles/3894747-global-kohortutveckling.md): Visualisera kohortens månatliga utveckling - [Geografisk spridning](https://success.openhealth.fr/sv/articles/3894751-geografisk-spridning.md): Se den geografiska fördelningen av patienter i den definierade kohorten - [Kohortprofil](https://success.openhealth.fr/sv/articles/3894755-kohortprofil.md): Analysera den demografiska profilen för patienter som ingår i kohorten - [Behandlingsstatus bryts ner](https://success.openhealth.fr/sv/articles/3894764-behandlingsstatus-bryts-ner.md): Få en översikt över de olika typerna av uppföljning av behandlingen - [Behandlingsinitieringar](https://success.openhealth.fr/sv/articles/3894778-behandlingsinitieringar.md): Analysera utvecklingen av antalet behandlingsinitieringar - [Behandlingen startar igen](https://success.openhealth.fr/sv/articles/3894788-behandlingen-startar-igen.md): Analysera utvecklingen av antalet återupptagningar av behandlingen - [Nya behandlingar](https://success.openhealth.fr/sv/articles/3894804-nya-behandlingar.md): Analysera utvecklingen av antalet initieringar och återupptagningar av behandlingen - [Behandlingens återfall](https://success.openhealth.fr/sv/articles/3894812-behandlingens-aterfall.md): Analysera patienter vid behandling - [Balans mellan behandlingsomkopplare](https://success.openhealth.fr/sv/articles/3894821-balans-mellan-behandlingsomkopplare.md): Analysera balansen mellan behandlingsförändringar efter behandling - [Behandlingsomkopplingsvinster](https://success.openhealth.fr/sv/articles/3894830-behandlingsomkopplingsvinster.md): Analysera mottagarna av behandlingsomkopplare - [Förluster för behandlingsomkopplare](https://success.openhealth.fr/sv/articles/3894843-forluster-for-behandlingsomkopplare.md): Analysera genom behandling förlorarna av behandlingsomkopplarna - [Byt förstärkning](https://success.openhealth.fr/sv/articles/3894857-byt-forstarkning.md): Analysera brytarens ursprung för en given behandling - [Byt destination för förlust](https://success.openhealth.fr/sv/articles/3894864-byt-destination-for-forlust.md): Analysera destinationen för omkopplaren för en given behandling - [Avfall](https://success.openhealth.fr/sv/articles/3894874-avfall.md): Analysera behandlingsstopp - [Sammanfattning av KPI](https://success.openhealth.fr/sv/articles/4229969-sammanfattning-av-kpi.md): Sammanfattning av olika typer av behandlingsövervakning - [Behandlingens uthållighet](https://success.openhealth.fr/sv/articles/3894883-behandlingens-uthallighet.md): Analysera behandlingstiden - [Överensstämmelse](https://success.openhealth.fr/sv/articles/3894884-overensstammelse.md): Analysera levererade kvantiteter - [Vad är regelbundenhetskriteriet?](https://success.openhealth.fr/sv/articles/3325816-vad-ar-regelbundenhetskriteriet.md): Definition av begreppet regelbundenhetskriterium - [Död - kartografi](https://success.openhealth.fr/sv/articles/3863677-dod-kartografi.md): Analysera den geografiska fördelningen av dödsfall - [Offset of death count](https://success.openhealth.fr/sv/articles/3863573-offset-of-death-count.md): Utvärdera relevansen av dina data - [Death - Analys av AGE & KÖN](https://success.openhealth.fr/sv/articles/3863808-death-analys-av-age-kon.md): Analysera dödsstrukturen - [Death - Evolution by AGE & GENDER](https://success.openhealth.fr/sv/articles/3863939-death-evolution-by-age-gender.md): Analysera utvecklingen av dödsstrukturen - [Död - Evolution](https://success.openhealth.fr/sv/articles/3864065-dod-evolution.md): Visualisera utvecklingen av dödsfall - [Jämförelse mellan död och evolution](https://success.openhealth.fr/sv/articles/3864073-jamforelse-mellan-dod-och-evolution.md): Jämför utvecklingen av dödsfall jämfört med tidigare år - [Apotekskontroll CA](https://success.openhealth.fr/sv/articles/4634768-apotekskontroll-ca.md): Beskriv trafiken efter apotekens storlek - [Trafikanalys \(betatest\)](https://success.openhealth.fr/sv/articles/6848401-trafikanalys-betatest.md) - [Information om apoteksövervakning](https://success.openhealth.fr/sv/articles/4527868-information-om-apoteksovervakning.md): Analysera apotekstrafik efter typ av apotek - [Traffic Evolution \(Betatest\)](https://success.openhealth.fr/sv/articles/6848016-traffic-evolution-betatest.md) - [Apoteksövervakningskartografi](https://success.openhealth.fr/sv/articles/4527811-apoteksovervakningskartografi.md): Analysera apotekstrafiken i Frankrike - [Information om apoteksövervakning](https://success.openhealth.fr/sv/articles/4262306-information-om-apoteksovervakning.md): Diskriminera detaljhandeln efter försäljningstyp - [Analys av apoteksövervakning](https://success.openhealth.fr/sv/articles/3839223-analys-av-apoteksovervakning.md): Följ utvecklingen av apotekstrafik - [Apoteksövervakning Evolution](https://success.openhealth.fr/sv/articles/3827973-apoteksovervakning-evolution.md): Studera utvecklingen av apotekstrafik - [Trafiknedbrytning](https://success.openhealth.fr/sv/articles/3826074-trafiknedbrytning.md): Observera komponenterna i säsong, trend och rester - [Trafikstudie](https://success.openhealth.fr/sv/articles/3809042-trafikstudie.md): Analysera apotekstrafik - [Sammanfattning - PIEX](https://success.openhealth.fr/sv/articles/5203335-sammanfattning-piex.md) - [Köp av](https://success.openhealth.fr/sv/articles/4605110-kop-av.md): Spåra dina inköp och deras kvitton - [Min fråga - PIEX](https://success.openhealth.fr/sv/articles/4210627-min-fraga-piex.md): Gör val på dina data - [Försäljningsutveckling - PIEX](https://success.openhealth.fr/sv/articles/4210655-forsaljningsutveckling-piex.md): Se utvecklingen av din aktivitet i den tillgängliga historiken - [Försäljningsanalys - PIEX](https://success.openhealth.fr/sv/articles/4210650-forsaljningsanalys-piex.md): Försäljningsanalys - PIEX - [Beställningsinformation - PIEX](https://success.openhealth.fr/sv/articles/4210659-bestallningsinformation-piex.md): Visa och spåra en försäljningsorder - [Lageröversikt - PIEX](https://success.openhealth.fr/sv/articles/4210672-lageroversikt-piex.md): Visualisera variationerna i dina aktier - [Mitt dataarkiv - PIEX](https://success.openhealth.fr/sv/articles/4210694-mitt-dataarkiv-piex.md): Exportera en platt databas till Excel - [EURAPHARMA- PIEX](https://success.openhealth.fr/sv/articles/4366306-eurapharma-piex.md): Visualisera utvecklingen av EURAPHARMAs verksamhet - [Matchande produkt](https://success.openhealth.fr/sv/articles/4366320-matchande-produkt.md): Överensstämmelse mellan beteckningarna för PIEX- och EURAPHARMA-produkterna - [CLI My File \(1/5\)](https://success.openhealth.fr/sv/articles/4626422-cli-my-file-1-5.md): CLI My File \(1/5\) - [CLI\_File Count \(2/5\)](https://success.openhealth.fr/sv/articles/4626421-cli_file-count-2-5.md): CLI\_File Count \(2/5\) - [CLI\_File Code Matching with OHC repository](https://success.openhealth.fr/sv/articles/4626419-cli_file-code-matching-with-ohc-repository.md): CLI\_FIL-kodmatchning med OHC-förvar - [Försäljningsexport \(4/5\)](https://success.openhealth.fr/sv/articles/4626414-forsaljningsexport-4-5.md): Sälja export \(4/5\) ### PERSONLIGA ALTERNATIV - [Icke-hierarkiska produktkvalificerande fält](https://success.openhealth.fr/sv/articles/4036045-icke-hierarkiska-produktkvalificerande-falt.md): Lägg till information om kvalificeringen av dina produkter - [Vad är högsta ålder för HUB-data?](https://success.openhealth.fr/sv/articles/3195251-vad-ar-hogsta-alder-for-hub-data.md): Senast tillgängliga data - [kundtyp](https://success.openhealth.fr/sv/articles/4197147-kundtyp.md): Anpassat alternativ Kundtyp - [Tillgång till session](https://success.openhealth.fr/sv/articles/4036458-tillgang-till-session.md): Begränsa visningen av dina anställda - [Anpassad cykel](https://success.openhealth.fr/sv/articles/4036444-anpassad-cykel.md): Analysera dina data över anpassade tidsperioder - [Räkenskapsår](https://success.openhealth.fr/sv/articles/4036169-rakenskapsar.md): Definiera ditt räkenskapsår - [Dag-knapp](https://success.openhealth.fr/sv/articles/4036159-dag-knapp.md): Visualisera dina data med finare detaljer - [Veckoknapp](https://success.openhealth.fr/sv/articles/4036111-veckoknapp.md): Visualisera dina data med finare detaljer - [Valutakurser](https://success.openhealth.fr/sv/articles/8329594-valutakurser.md) - [SMKT-periodkalender](https://success.openhealth.fr/sv/articles/4036549-smkt-periodkalender.md): Använd en GSA-kalender - [Begränsa omkretsen](https://success.openhealth.fr/sv/articles/4560699-begransa-omkretsen.md): Välja en GTIN-lista i Min fråga från en .xlsx-fil - [Begränsa omkretsen \(kod 7\)](https://success.openhealth.fr/sv/articles/4560791-begransa-omkretsen-kod-7.md): Val av en lista med \[TEKNISK KOD 2\] i Min fråga från en .xlsx-fil - [Marknadsflagg](https://success.openhealth.fr/sv/articles/4560797-marknadsflagg.md): Välja en GTIN-lista i Min fråga från en marknadsdefinition som finns i en .xlsx-fil - [Inriktning / definition av en kundtyp](https://success.openhealth.fr/sv/articles/3777788-inriktning-definition-av-en-kundtyp.md): Inriktning \(kundtyp\) ### HUB-INDIKATORERNA - [Ordlista över HUB-indikatorer](https://success.openhealth.fr/sv/articles/5194247-ordlista-over-hub-indikatorer.md) - [Försäljningsmängder](https://success.openhealth.fr/sv/articles/3194314-forsaljningsmangder.md): Försäljningsmängder - [Försäljningsvärden](https://success.openhealth.fr/sv/articles/3074854-forsaljningsvarden.md): Specificera försäljningsvärden - [N MS](https://success.openhealth.fr/sv/articles/3194475-n-ms.md): Definition av "N MS" -åtgärden - [N MS Evol](https://success.openhealth.fr/sv/articles/5634266-n-ms-evol.md) - [N MS Delta](https://success.openhealth.fr/sv/articles/3194469-n-ms-delta.md): Definition av åtgärden 'N MS Delta' - [Poids Vol \(CA\) par modalité / Anpassad vikt Vol \(To\)](https://success.openhealth.fr/sv/articles/9292839-poids-vol-ca-par-modalite-anpassad-vikt-vol-to.md) - [Försäljningsvärde baserat på tillverkarens pris exklusive moms \(Omsättning PF exklusive moms\) - Marocko](https://success.openhealth.fr/sv/articles/7508513-forsaljningsvarde-baserat-pa-tillverkarens-pris-exklusive-moms-omsattning-pf-exklusive-moms-marocko.md) - [N CTR tillväxt](https://success.openhealth.fr/sv/articles/3194466-n-ctr-tillvaxt.md): Definition och beräkningsformel för måttet 'N Growth CTR' - [I affärer](https://success.openhealth.fr/sv/articles/6201859-i-affarer.md) - [Korsad vikt Volym](https://success.openhealth.fr/sv/articles/6066324-korsad-vikt-volym.md) - [Vändning av korsad vikt](https://success.openhealth.fr/sv/articles/6066273-vandning-av-korsad-vikt.md) - [N CTR justerad för tillväxt](https://success.openhealth.fr/sv/articles/3205376-n-ctr-justerad-for-tillvaxt.md): Definition och beräkningsformel för måttet 'N Growth CTR A' - [Källvikt](https://success.openhealth.fr/sv/articles/5151525-kallvikt.md) - [Genomsnittligt pris observerat](https://success.openhealth.fr/sv/articles/3194302-genomsnittligt-pris-observerat.md): AASP: Genomsnittspris observerat - [Vägt genomsnittspris](https://success.openhealth.fr/sv/articles/3194292-vagt-genomsnittspris.md): WASP: Vägt genomsnittspris - [Prispåverkan](https://success.openhealth.fr/sv/articles/8426443-prispaverkan.md) - [Antal apotek som säljer](https://success.openhealth.fr/sv/articles/3719566-antal-apotek-som-saljer.md) - [Säljer digital distribution](https://success.openhealth.fr/sv/articles/3194321-saljer-digital-distribution.md): Numerisk distribution - [Global säljande digital distribution](https://success.openhealth.fr/sv/articles/3194320-global-saljande-digital-distribution.md): Global numerisk distribution - [Omfördelad försäljning av digital distribution](https://success.openhealth.fr/sv/articles/4045636-omfordelad-forsaljning-av-digital-distribution.md): Numerisk fördelning baserad på nytt - [Global omfördelad försäljning av digital distribution](https://success.openhealth.fr/sv/articles/4045725-global-omfordelad-forsaljning-av-digital-distribution.md): Global Numerisk distribution omfördelad - [Skräddarsydd återbaserad digital försäljningsdistribution](https://success.openhealth.fr/sv/articles/6830813-skraddarsydd-aterbaserad-digital-forsaljningsdistribution.md) - [Försäljningsvärdefördelning](https://success.openhealth.fr/sv/articles/3194323-forsaljningsvardefordelning.md): Viktad fördelning - [Global försäljningsvärde distribution](https://success.openhealth.fr/sv/articles/3194316-global-forsaljningsvarde-distribution.md): Global försäljningsvärdefördelning - [Fördela försäljningsvärdet på nytt](https://success.openhealth.fr/sv/articles/3194501-fordela-forsaljningsvardet-pa-nytt.md): Omfördelad DVV - [Global omfördelad försäljningsvärdefördelning](https://success.openhealth.fr/sv/articles/4200619-global-omfordelad-forsaljningsvardefordelning.md): Global ombyggd DVV - [Skräddarsydd återbaserad fördelning av försäljningsvärdet](https://success.openhealth.fr/sv/articles/6834423-skraddarsydd-aterbaserad-fordelning-av-forsaljningsvardet.md) - [Digital försäljningsdistribution SMKT](https://success.openhealth.fr/sv/articles/3365043-digital-forsaljningsdistribution-smkt.md): Digital försäljningsdistribution SMKT \(SMK Numeric Distribution\) - [Global SMKT säljer digital distribution](https://success.openhealth.fr/sv/articles/4298341-global-smkt-saljer-digital-distribution.md): SMKT global numerisk distribution \(SMKT global numerisk distribution\) - [Omfördelad SMKT säljer digital distribution](https://success.openhealth.fr/sv/articles/4298197-omfordelad-smkt-saljer-digital-distribution.md): SMKT Digital Distribution rebased \(SMKT Numeric Distribution Rebased\) - [Global omfördelad SMKT-försäljning av digital distribution](https://success.openhealth.fr/sv/articles/4319783-global-omfordelad-smkt-forsaljning-av-digital-distribution.md): Säljer digital distribution SMKT Rebasée Globale \(SMKT Global Numeric Distribution Rebased\) - [SMKT-försäljningsfördelning](https://success.openhealth.fr/sv/articles/3365478-smkt-forsaljningsfordelning.md): SMKT-försäljningsvärdefördelning \(SMKT-viktad distribution\) - [Omberäknad global SMKT-försäljning av digital distribution](https://success.openhealth.fr/sv/articles/4298373-omberaknad-global-smkt-forsaljning-av-digital-distribution.md): Säljer digital distribution SMKT global numerisk omberäknad \(SMKT global numerisk distribution omberäknad\) - [Digital distribution Selling SMKT Rebased Recalculated](https://success.openhealth.fr/sv/articles/4298303-digital-distribution-selling-smkt-rebased-recalculated.md): SMKT Numerisk fördelning Omberäknas på nytt - [Justerad SMKT säljer digital distribution](https://success.openhealth.fr/sv/articles/3369386-justerad-smkt-saljer-digital-distribution.md): Justerad numerisk distribution SMKT - [Digital distribution säljer SMKT omberäknas](https://success.openhealth.fr/sv/articles/4298209-digital-distribution-saljer-smkt-omberaknas.md): SMKT Numerisk fördelning omberäknad \(SMKT Numerisk distribution omberäknad\) - [Justerad SMKT-försäljningsvärdefördelning](https://success.openhealth.fr/sv/articles/3369397-justerad-smkt-forsaljningsvardefordelning.md): Justerad viktad fördelning SMKT - [Organisk distribution av digitala leverantörer](https://success.openhealth.fr/sv/articles/7052424-organisk-distribution-av-digitala-leverantorer.md) - [Omsättning för säljande apotek \(TSP\)](https://success.openhealth.fr/sv/articles/6096534-omsattning-for-saljande-apotek-tsp.md) - [Uppskattning av din innehavares PDM](https://success.openhealth.fr/sv/articles/4214883-uppskattning-av-din-innehavares-pdm.md): Uppskatta din marknadsandel med dina kunder - [Fler apotek](https://success.openhealth.fr/sv/articles/8426451-fler-apotek.md) - [Förlust av apotek](https://success.openhealth.fr/sv/articles/8426460-forlust-av-apotek.md) - [Digital försäljning och distribution i flera kanaler](https://success.openhealth.fr/sv/articles/9293487-digital-forsaljning-och-distribution-i-flera-kanaler.md) - [Kumulativ försäljning av digital distribution \(PHARMA\)](https://success.openhealth.fr/sv/articles/9330571-kumulativ-forsaljning-av-digital-distribution-pharma.md) - [Månadsgenomsnittlig försäljning](https://success.openhealth.fr/sv/articles/3194303-manadsgenomsnittlig-forsaljning.md): Genomsnittlig månadsförsäljning - [Justerad månadsgenomsnittlig försäljning](https://success.openhealth.fr/sv/articles/3194290-justerad-manadsgenomsnittlig-forsaljning.md): Justerad genomsnittlig månadsförsäljning - [Månatligt genomsnittligt försäljningsvärde](https://success.openhealth.fr/sv/articles/4535404-manatligt-genomsnittligt-forsaljningsvarde.md): VMM CA - [AMS till A: Genomsnittligt månadsförsäljningsvärde justerat](https://success.openhealth.fr/sv/articles/6028256-ams-till-a-genomsnittligt-manadsforsaljningsvarde-justerat.md) - [Genomsnittlig försäljning](https://success.openhealth.fr/sv/articles/3563716-genomsnittlig-forsaljning.md): Genomsnittlig försäljning - [SMKT genomsnittlig försäljning](https://success.openhealth.fr/sv/articles/3365496-smkt-genomsnittlig-forsaljning.md): SMKT genomsnittlig försäljning - [Justerad SMKT-genomsnittlig försäljning](https://success.openhealth.fr/sv/articles/3369340-justerad-smkt-genomsnittlig-forsaljning.md): Justerad SMKT-genomsnittlig försäljning - [Genomsnittlig månatlig organisk försäljning](https://success.openhealth.fr/sv/articles/7052551-genomsnittlig-manatlig-organisk-forsaljning.md) - [Genomsnittlig månadsförsäljning Organiskt värde](https://success.openhealth.fr/sv/articles/7052573-genomsnittlig-manadsforsaljning-organiskt-varde.md) - [Stock](https://success.openhealth.fr/sv/articles/3194332-stock.md): Definition och tillgänglighet av lagerdata i HUB, via SMAa-applikationer: Försäljning och marknadsföring Avancerat abonnemang - [Genomsnittligt lager](https://success.openhealth.fr/sv/articles/3194336-genomsnittligt-lager.md): Genomsnittligt lager - [Andel av lager](https://success.openhealth.fr/sv/articles/3194334-andel-av-lager.md): Andel av lager - [Kommersiellt tryckindex](https://success.openhealth.fr/sv/articles/3194335-kommersiellt-tryckindex.md): Kommersiellt tryckindex - [Lageromvandlingshastighet](https://success.openhealth.fr/sv/articles/3194344-lageromvandlingshastighet.md): Lageromvandlingshastighet - [Leveransens varaktighet](https://success.openhealth.fr/sv/articles/3194337-leveransens-varaktighet.md): Leveransvaraktighet - [Antal lagerförsäljningsapotek](https://success.openhealth.fr/sv/articles/3194338-antal-lagerforsaljningsapotek.md): Antal lagerförsäljningsapotek - [Stockist Digital distribution](https://success.openhealth.fr/sv/articles/3194339-stockist-digital-distribution.md): Stockist Distribution \(ND Stock\) - [Digital distributör återförsäljare](https://success.openhealth.fr/sv/articles/4045743-digital-distributor-aterforsaljare.md): Lager Numerisk fördelning omfördelad - [Global omfördelad digital återförsäljardistribution](https://success.openhealth.fr/sv/articles/4045753-global-omfordelad-digital-aterforsaljardistribution.md): Global omfördelad digital återförsäljardistribution - [Försäljningsvärde distribution](https://success.openhealth.fr/sv/articles/3194342-forsaljningsvarde-distribution.md): Försäljningsvärde fördelning \(vägd lagerfördelning: WD lager\) - [Fördela lagervärdet på nytt](https://success.openhealth.fr/sv/articles/3194505-fordela-lagervardet-pa-nytt.md): Återställ DVS - [Digital distribution Jämnare lagerhållare](https://success.openhealth.fr/sv/articles/5141830-digital-distribution-jamnare-lagerhallare.md) - [Digital distribution Lagerhållare utjämnad omräknad](https://success.openhealth.fr/sv/articles/5142162-digital-distribution-lagerhallare-utjamnad-omraknad.md) - [Fördelning Utjämnat aktievärde](https://success.openhealth.fr/sv/articles/5203640-fordelning-utjamnat-aktievarde.md) - [Utdelning Utjämnat omräknat aktievärde](https://success.openhealth.fr/sv/articles/5203701-utdelning-utjamnat-omraknat-aktievarde.md) - [Marginal](https://success.openhealth.fr/sv/articles/3507716-marginal.md): Marginal - [Marginalränta](https://success.openhealth.fr/sv/articles/3507767-marginalranta.md): Marginalränta - [Tillverkarpris exklusive moms \(PFHT\)](https://success.openhealth.fr/sv/articles/4557500-tillverkarpris-exklusive-moms-pfht.md): PFHT - [Sell-in - Analyser av din kundbas](https://success.openhealth.fr/sv/articles/3846225-sell-in-analyser-av-din-kundbas.md): Lojalitetsindikatorer: egenskaper hos din kundbas och dess utveckling - [Försäljning - Atypiska apotek](https://success.openhealth.fr/sv/articles/3848791-forsaljning-atypiska-apotek.md): Åtgärder för att upptäcka atypismer - [Utvecklingsförhållande](https://success.openhealth.fr/sv/articles/3194287-utvecklingsforhallande.md): Utvecklingsförhållande - [Penetrationsförhållande](https://success.openhealth.fr/sv/articles/3194286-penetrationsforhallande.md): Penetrationsförhållande - [Produktsortimentbredd](https://success.openhealth.fr/sv/articles/3369425-produktsortimentbredd.md): Produktsortimentbredd - [Förnyelse av sortimentet](https://success.openhealth.fr/sv/articles/3369545-fornyelse-av-sortimentet.md): Förnyelse av sortimentet - [Innovation i sortimentet](https://success.openhealth.fr/sv/articles/3369468-innovation-i-sortimentet.md): Innovation i sortimentet - [Förslitning av sortimentet](https://success.openhealth.fr/sv/articles/3369457-forslitning-av-sortimentet.md): Förslitning av sortimentet - [Sortimentets nedgångshastighet](https://success.openhealth.fr/sv/articles/3369485-sortimentets-nedgangshastighet.md): Sortimentets nedgångshastighet - [Områdesinnovationsgrad](https://success.openhealth.fr/sv/articles/3369541-omradesinnovationsgrad.md): Områdesinnovationsgrad - [Andel av försäljningserbjudandet](https://success.openhealth.fr/sv/articles/3369040-andel-av-forsaljningserbjudandet.md): Andel av försäljningserbjudandet - [Antal utvalda produkter](https://success.openhealth.fr/sv/articles/3511502-antal-utvalda-produkter.md): Detta är antalet produkter som har valts med deras GTIN-13 siffrakod. - [Genomsnittligt antal produkter](https://success.openhealth.fr/sv/articles/3194284-genomsnittligt-antal-produkter.md): Genomsnittligt antal produkter - [Områdesförnyelseshastighet](https://success.openhealth.fr/sv/articles/3369561-omradesfornyelseshastighet.md): Områdesförnyelseshastighet - [Antal produkter](https://success.openhealth.fr/sv/articles/6312686-antal-produkter.md) - [Belopp spenderade per handling](https://success.openhealth.fr/sv/articles/3447792-belopp-spenderade-per-handling.md): Artikel som hänför sig till indikatorn '' Spenderade belopp per handling '' - [Fördelning av belopp spenderade efter köpartyp](https://success.openhealth.fr/sv/articles/3447801-fordelning-av-belopp-spenderade-efter-kopartyp.md): Artikel som rör indikatorn '' Uppdelning av belopp per köparstyp '' - [Förbrukningsindex](https://success.openhealth.fr/sv/articles/3432701-forbrukningsindex.md): Definition av indikatorn "konsumtionsindex" - [Försäljningsandel](https://success.openhealth.fr/sv/articles/3432664-forsaljningsandel.md): Definition av indikatorn 'Försäljningsandel' - [Värde lojalitetsgrad](https://success.openhealth.fr/sv/articles/3432695-varde-lojalitetsgrad.md): Definition av indikatorn "Lojalitetsvärde för värde" - [Absolut penetration](https://success.openhealth.fr/sv/articles/3432556-absolut-penetration.md): Artikel som rör indikatorn "Absolut penetration" - [Andel av omsättningen](https://success.openhealth.fr/sv/articles/3432655-andel-av-omsattningen.md): Definition av indikatorn "Andel av omsättningen" - [p-värde](https://success.openhealth.fr/sv/articles/5781702-p-varde.md) - [Huvudsaklig komponentanalys](https://success.openhealth.fr/sv/articles/4231028-huvudsaklig-komponentanalys.md): ACP - [Negativt förutsägbart värde](https://success.openhealth.fr/sv/articles/4134220-negativt-forutsagbart-varde.md): Negativt prediktivt värde - [Positivt prediktivt värde](https://success.openhealth.fr/sv/articles/4134166-positivt-prediktivt-varde.md): Positivt prediktivt värde - [Självständighetstest](https://success.openhealth.fr/sv/articles/4128369-sjalvstandighetstest.md): Kontrollera om två variabler är relaterade till varandra - [Studie av tidsserier](https://success.openhealth.fr/sv/articles/3633991-studie-av-tidsserier.md): Säsong, trend och förutsägelse: vad du behöver veta - [Säsongsvariation](https://success.openhealth.fr/sv/articles/3653790-sasongsvariation.md): Mäter variansandelen i en tidsserie - [Testets känslighet och specificitet](https://success.openhealth.fr/sv/articles/3928135-testets-kanslighet-och-specificitet.md): Förstå begreppen för att analysera testets effektivitet - [Trendvarians](https://success.openhealth.fr/sv/articles/3653847-trendvarians.md): Mäter andelen trendkomponent i en tidsserie - [Restvarians](https://success.openhealth.fr/sv/articles/3653851-restvarians.md): Mäter andelen återstående komponent i en tidsserie - [Determinationskoefficient](https://success.openhealth.fr/sv/articles/3654093-determinationskoefficient.md): Utvärdera kvaliteten på den valda modellen - [Variationskoefficient](https://success.openhealth.fr/sv/articles/3653915-variationskoefficient.md): Indikator för att välja din sönderdelningsmodell - [Variation av en tidsserie](https://success.openhealth.fr/sv/articles/3653855-variation-av-en-tidsserie.md): Mät spridningen av en serie - [Försäljningskoncentration](https://success.openhealth.fr/sv/articles/3395856-forsaljningskoncentration.md): Försäljningskoncentration - [Gini-index](https://success.openhealth.fr/sv/articles/3395323-gini-index.md): Gini-index - [Befolkning](https://success.openhealth.fr/sv/articles/4396779-befolkning.md): Befolkning - [Utvecklingen av antalet dödsfall](https://success.openhealth.fr/sv/articles/4396765-utvecklingen-av-antalet-dodsfall.md): Utvecklingen av antalet dödsfall - [Könsförhållande](https://success.openhealth.fr/sv/articles/3812167-konsforhallande.md): Sexförhållande - [Befolkning - medelålder](https://success.openhealth.fr/sv/articles/3812180-befolkning-medelalder.md): Befolkning - Genomsnittsålder - [Befolkning - Medianålder](https://success.openhealth.fr/sv/articles/3812198-befolkning-medianalder.md): Befolkning - Medianålder - [Befolkning - Ålder 1: e kvartilen](https://success.openhealth.fr/sv/articles/3812218-befolkning-alder-1-e-kvartilen.md): Befolkning - Ålder 1: e kvartilen - [Befolkning - Ålder 3: e kvartilen](https://success.openhealth.fr/sv/articles/3812227-befolkning-alder-3-e-kvartilen.md): Befolkning - Ålder 3: e kvartilen - [Andel av urvalet i den totala befolkningen i territoriet](https://success.openhealth.fr/sv/articles/3812233-andel-av-urvalet-i-den-totala-befolkningen-i-territoriet.md): Andel av urvalet i den totala befolkningen i territoriet - [Dödlighet](https://success.openhealth.fr/sv/articles/3947946-dodlighet.md): Dödlighet - [Fall dödsfall](https://success.openhealth.fr/sv/articles/3948084-fall-dodsfall.md): Fall dödsfall - [Kvinnor i fertil ålder](https://success.openhealth.fr/sv/articles/4172859-kvinnor-i-fertil-alder.md): Kvinnor i fertil ålder - [Andel urval av totala dödsfall i territoriet](https://success.openhealth.fr/sv/articles/3863734-andel-urval-av-totala-dodsfall-i-territoriet.md): Andel urval av totala dödsfall i territoriet - [Modellerar antalet saknade dödsfall](https://success.openhealth.fr/sv/articles/3895572-modellerar-antalet-saknade-dodsfall.md): Förutse antalet dödsfall vid tiden t - [Beräknad försäljning i receptbelagda läkemedel](https://success.openhealth.fr/sv/articles/5323282-beraknad-forsaljning-i-receptbelagda-lakemedel.md) - [Utveckling efter ålder och graviditetsstatus](https://success.openhealth.fr/sv/articles/6820051-utveckling-efter-alder-och-graviditetsstatus.md) - [Förhållande mellan samdistributionsprodukter](https://success.openhealth.fr/sv/articles/7892010-forhallande-mellan-samdistributionsprodukter.md) - [Uppskattad försäljning av receptförnyelse](https://success.openhealth.fr/sv/articles/5323209-uppskattad-forsaljning-av-receptfornyelse.md) - [Vikt av försäljningen av receptförnyade recept](https://success.openhealth.fr/sv/articles/5323198-vikt-av-forsaljningen-av-receptfornyade-recept.md) - [Vikt av försäljningen i receptförskrivning](https://success.openhealth.fr/sv/articles/5323086-vikt-av-forsaljningen-i-receptforskrivning.md) - [Antal samdispenser](https://success.openhealth.fr/sv/articles/3194351-antal-samdispenser.md): Antal meddispenser - [Antal dispenseringar](https://success.openhealth.fr/sv/articles/3194348-antal-dispenseringar.md): Antal dispenseringar - [Genomsnittligt antal dispenser per försäkrad person](https://success.openhealth.fr/sv/articles/3369626-genomsnittligt-antal-dispenser-per-forsakrad-person.md): Genomsnittligt antal dispenser per försäkrad person - [Efterlevnad](https://success.openhealth.fr/sv/articles/3411996-efterlevnad.md): Läkemedelsbesittningsgrad \(MPR\) - [Persistens](https://success.openhealth.fr/sv/articles/3369684-persistens.md): Persistens - [Terapeutisk vidhäftning](https://success.openhealth.fr/sv/articles/3412091-terapeutisk-vidhaftning.md): Terapeutisk vidhäftning - [Genomsnittlig daglig dos per försäkrad person](https://success.openhealth.fr/sv/articles/4153587-genomsnittlig-daglig-dos-per-forsakrad-person.md): Genomsnittlig daglig dos per försäkrad person - [Antal dispenseringar som presenteras för ersättning](https://success.openhealth.fr/sv/articles/3370942-antal-dispenseringar-som-presenteras-for-ersattning.md): Antal dispenseringar för ersättning - [Antal dispenseringar som inte presenteras för ersättning](https://success.openhealth.fr/sv/articles/3370920-antal-dispenseringar-som-inte-presenteras-for-ersattning.md): Antal dispenseringar för ersättning - [Ersättningsvärdesförsäljning som täcks av obligatorisk sjukförsäkring](https://success.openhealth.fr/sv/articles/3371699-ersattningsvardesforsaljning-som-tacks-av-obligatorisk-sjukforsakring.md): Försäljning av inlösta värden - [Försäljning av ersatta värden som omfattas av kompletterande sjukförsäkring](https://success.openhealth.fr/sv/articles/3371830-forsaljning-av-ersatta-varden-som-omfattas-av-kompletterande-sjukforsakring.md): Försäljning av inlösta värden - [Försäljning av utestående värden](https://success.openhealth.fr/sv/articles/3371842-forsaljning-av-utestaende-varden.md): Försäljning av utestående värden - [Utbredning](https://success.openhealth.fr/sv/articles/3947955-utbredning.md): Prevalens - [Genomsnittligt antal GTIN per dispens](https://success.openhealth.fr/sv/articles/3396154-genomsnittligt-antal-gtin-per-dispens.md): Genomsnittligt antal GTIN per dispens - [Genomsnittlig volym per dosering](https://success.openhealth.fr/sv/articles/3396196-genomsnittlig-volym-per-dosering.md): Genomsnittlig volym per dosering - [Genomsnittlig omsättning per dispens](https://success.openhealth.fr/sv/articles/3396208-genomsnittlig-omsattning-per-dispens.md): Genomsnittlig omsättning per dispens - [Aktiv principdosering per låda](https://success.openhealth.fr/sv/articles/3675409-aktiv-principdosering-per-lada.md): Aktiv principdosering per låda - [DDD per låda](https://success.openhealth.fr/sv/articles/3675446-ddd-per-lada.md): Definiera daglig dos per ruta - [Volym i basenheter](https://success.openhealth.fr/sv/articles/3675520-volym-i-basenheter.md): Volym i basenheter - [Volym i aktiv princip](https://success.openhealth.fr/sv/articles/3675539-volym-i-aktiv-princip.md): Volym i aktiv princip - [DDJ per 1000 invånare](https://success.openhealth.fr/sv/articles/3675667-ddj-per-1000-invanare.md): Dagligen definierad dos per 1000 invånare - [Volym i genomsnittlig UA per försäkrad person](https://success.openhealth.fr/sv/articles/3675761-volym-i-genomsnittlig-ua-per-forsakrad-person.md): Volym i genomsnittliga konsumentenheter per försäkrad person - [Volym i genomsnittlig UB per försäkrad person](https://success.openhealth.fr/sv/articles/3675814-volym-i-genomsnittlig-ub-per-forsakrad-person.md): Volym i genomsnittliga basenheter per försäkrad person - [Volym i genomsnittlig aktiv princip per försäkrad person](https://success.openhealth.fr/sv/articles/3675824-volym-i-genomsnittlig-aktiv-princip-per-forsakrad-person.md): Volym i genomsnittlig aktiv princip per försäkrad person - [Observerad genomsnittlig behandlingstid](https://success.openhealth.fr/sv/articles/3675841-observerad-genomsnittlig-behandlingstid.md): Observerad genomsnittlig behandlingstid - [Immuniseringstäckning](https://success.openhealth.fr/sv/articles/3822264-immuniseringstackning.md): Immuniseringstäckning - [Patienter inkluderade](https://success.openhealth.fr/sv/articles/3886665-patienter-inkluderade.md): Antal patienter som ingår i kohorten - [Skillnader mellan MPR och PDC](https://success.openhealth.fr/sv/articles/3722666-skillnader-mellan-mpr-och-pdc.md): MPR \(Läkemedelsbesittningsgrad\) vs. PDC \(Andel dagar som täcks\) - [Genomsnittlig behandlingstid](https://success.openhealth.fr/sv/articles/3920967-genomsnittlig-behandlingstid.md): Mät den genomsnittliga behandlingstiden i slutet av analysperioden - [Genomsnittlig förnyelsestid](https://success.openhealth.fr/sv/articles/3921067-genomsnittlig-fornyelsestid.md): Mät den genomsnittliga tiden mellan förnyelser av behandlingen - [Behandlingsinitiering](https://success.openhealth.fr/sv/articles/3848844-behandlingsinitiering.md): Behandlingsinitiering - [Behandlingsförnyelser](https://success.openhealth.fr/sv/articles/3885469-behandlingsfornyelser.md): Förnyelse av behandlingen - [Behandlingen återupptas](https://success.openhealth.fr/sv/articles/3885608-behandlingen-aterupptas.md): Återupptagande av behandlingen - [Nya behandlingar](https://success.openhealth.fr/sv/articles/3885297-nya-behandlingar.md): Initiering och återupptagande av behandlingen - [Behandlingsomkopplare](https://success.openhealth.fr/sv/articles/3848886-behandlingsomkopplare.md): Behandlingsomkopplare - [Behandlingen slutar](https://success.openhealth.fr/sv/articles/3885426-behandlingen-slutar.md): Behandlingen slutar - [Avlämning](https://success.openhealth.fr/sv/articles/3885387-avlamning.md): Avlämning - [Spårbarhetsinsats](https://success.openhealth.fr/sv/articles/4355163-sparbarhetsinsats.md): Spårbarhet - [Stoppad och sedan omstartad](https://success.openhealth.fr/sv/articles/8429189-stoppad-och-sedan-omstartad.md) - [Utdelningsandel](https://success.openhealth.fr/sv/articles/3624820-utdelningsandel.md): Utdelningsandel - [Övervakning av relevanta dispenser](https://success.openhealth.fr/sv/articles/3804193-overvakning-av-relevanta-dispenser.md): Följ utvecklingen av trafiken på apotek i relevanta dispens - [Upplösningshastighet](https://success.openhealth.fr/sv/articles/4850138-upplosningshastighet.md) - [Kinetik för en reaktion](https://success.openhealth.fr/sv/articles/4850629-kinetik-for-en-reaktion.md) - [Halveringstid](https://success.openhealth.fr/sv/articles/4849710-halveringstid.md) - [Lagertäckningsgrad](https://success.openhealth.fr/sv/articles/4210714-lagertackningsgrad.md): Lagertäckningsgrad - [Tidsperioder](https://success.openhealth.fr/sv/articles/3194479-tidsperioder.md): Tidsperioder - [Ändra definitionen av ett räkenskapsår](https://success.openhealth.fr/sv/articles/3321750-andra-definitionen-av-ett-rakenskapsar.md): Med HUB kan du ställa in dina räkenskapsår - [Hantering av veckovisa jämförelser](https://success.openhealth.fr/sv/articles/3835180-hantering-av-veckovisa-jamforelser.md): Analytiska effekter från de studerade dagarna - [GSA: s parafarmaskalender \(SMKT\)](https://success.openhealth.fr/sv/articles/3175583-gsa-s-parafarmaskalender-smkt.md): SMKT-kalendern \(IRI\) kallas också GSA-apotekskalendern - [INTE](https://success.openhealth.fr/sv/articles/3194484-inte.md): Definition av mått 'N' - [N Evol](https://success.openhealth.fr/sv/articles/3194461-n-evol.md): Definition och beräkningsformel för "N Evol" -måttet - [N Trend](https://success.openhealth.fr/sv/articles/3194485-n-trend.md): Definition av "N Trend" -måttet ### IAS - Indicateurs Avancés Sanitaires - [IAS\(r\) Allergier](https://success.openhealth.fr/sv/articles/7339151-ias-r-allergier.md) - [IAS\(r\) Poux](https://success.openhealth.fr/sv/articles/7339168-ias-r-poux.md) - [IAS\(r\) gastroenterit](https://success.openhealth.fr/sv/articles/7339181-ias-r-gastroenterit.md) - [IAS\(r\) Influensaliknande sjukdom](https://success.openhealth.fr/sv/articles/7266711-ias-r-influensaliknande-sjukdom.md) ### Marketing Direct - [OpenHealth e-postlösning](https://success.openhealth.fr/sv/articles/7055261-openhealth-e-postlosning.md) - [Krav för produktion av en e-postkampanj](https://success.openhealth.fr/sv/articles/6282113-krav-for-produktion-av-en-e-postkampanj.md) - [Uppföljningsrapport och riktmärken](https://success.openhealth.fr/sv/articles/6302721-uppfoljningsrapport-och-riktmarken.md) - [Ordlista för e-postkampanjer](https://success.openhealth.fr/sv/articles/6282099-ordlista-for-e-postkampanjer.md) ### PSAD - [Analys - NATIONAL](https://success.openhealth.fr/sv/articles/3376262-analys-national.md): Analysera prestandan på marknaden för hushållsleverantörer \(PSAD\): efter område, aktivitet, delaktivitet, segment, LPP-handling - [Volym / omsättning - NATIONAL](https://success.openhealth.fr/sv/articles/3376287-volym-omsattning-national.md): Visualisera samtidigt aktivitet i volym och värde: efter område, aktivitet, delaktivitet, segment, handling ... - [Evolution - NATIONAL](https://success.openhealth.fr/sv/articles/3376370-evolution-national.md): Visualisera utvecklingen av marknaden på den tillgängliga historien: efter område, aktivitet, delaktivitet, segment, LPP-handling - [Extraktion - NATIONAL](https://success.openhealth.fr/sv/articles/3376420-extraktion-national.md): Exportera data till Excel - [Definition](https://success.openhealth.fr/sv/articles/3376439-definition.md): Hitta alla funktioner i SantéDomStat National Observatory - Essential-applikation ### AUTRES THEMATIQUES - [INTERCOM](https://success.openhealth.fr/sv/articles/6959415-intercom.md) - [Salesforce](https://success.openhealth.fr/sv/articles/6959337-salesforce.md) - [GIHSN: Skicka Excel-fil](https://success.openhealth.fr/sv/articles/3977478-gihsn-skicka-excel-fil.md): GIHSN Excel-fil - [Blockkedja](https://success.openhealth.fr/sv/articles/5385413-blockkedja.md) - [DocuSign, CRM-verktyg i vår affärsprocess](https://success.openhealth.fr/sv/articles/4514472-docusign-crm-verktyg-i-var-affarsprocess.md): Docusign: CRM-verktyg i vår affärsprocess - [Nationell uppföljning av vaccinationer](https://success.openhealth.fr/sv/articles/4754333-nationell-uppfoljning-av-vaccinationer.md) - [Vaccinationstäckning](https://success.openhealth.fr/sv/articles/4754311-vaccinationstackning.md) - [KPI-övervakning](https://success.openhealth.fr/sv/articles/4091042-kpi-overvakning.md): POC ProPharma Systems: Schweiziska marknadstrender - [Apotekets cockpit](https://success.openhealth.fr/sv/articles/4091025-apotekets-cockpit.md): POC ProPharma Systems: My Pharmacy vs Switzerland - [Befolkningsekvivalenter \(pe\)](https://success.openhealth.fr/sv/articles/5431894-befolkningsekvivalenter-pe.md) - [Syrebehov](https://success.openhealth.fr/sv/articles/5137158-syrebehov.md) - [IHU](https://success.openhealth.fr/sv/articles/4851687-ihu.md) - [Suspenderad materia](https://success.openhealth.fr/sv/articles/5137147-suspenderad-materia.md) - [Kemi av avloppsvatten](https://success.openhealth.fr/sv/articles/5137101-kemi-av-avloppsvatten.md) - [NRBCE](https://success.openhealth.fr/sv/articles/4851683-nrbce.md) - [Arrhenius lag](https://success.openhealth.fr/sv/articles/4849672-arrhenius-lag.md) - [Resultat](https://success.openhealth.fr/sv/articles/5137034-resultat.md) - [Typer av avloppsvatten](https://success.openhealth.fr/sv/articles/5137183-typer-av-avloppsvatten.md) - [Koncentration av SARS-CoV-2-virus](https://success.openhealth.fr/sv/articles/4867968-koncentration-av-sars-cov-2-virus.md) - [MAPOM / BMPM](https://success.openhealth.fr/sv/articles/4851685-mapom-bmpm.md) - [Kontextualiserad koncentration av SARS-CoV-2](https://success.openhealth.fr/sv/articles/4934604-kontextualiserad-koncentration-av-sars-cov-2.md) - [Typ av avloppssystem](https://success.openhealth.fr/sv/articles/4867954-typ-av-avloppssystem.md) - [Nedbrytning av viruset](https://success.openhealth.fr/sv/articles/4865742-nedbrytning-av-viruset.md) - [WBE](https://success.openhealth.fr/sv/articles/4865735-wbe.md) - [RNA](https://success.openhealth.fr/sv/articles/4865733-rna.md) - [Coronavirus](https://success.openhealth.fr/sv/articles/4865728-coronavirus.md) - [COVID-19](https://success.openhealth.fr/sv/articles/4865726-covid-19.md) - [Seroprevalens: provtagningsmetod](https://success.openhealth.fr/sv/articles/3924493-seroprevalens-provtagningsmetod.md): Seroprevalens: Provtagningsmetod - [SANDRE förvaringsutrymme](https://success.openhealth.fr/sv/articles/5415040-sandre-forvaringsutrymme.md) - [Nationell bas ROSEAU](https://success.openhealth.fr/sv/articles/5414523-nationell-bas-roseau.md) - [Koncentration av SARS-CoV-2-virus](https://success.openhealth.fr/sv/articles/4852404-koncentration-av-sars-cov-2-virus.md) - [Koncentration av SARS-CoV-2-virus - Varianter](https://success.openhealth.fr/sv/articles/4909854-koncentration-av-sars-cov-2-virus-varianter.md) - [Marseille - Global övervakning](https://success.openhealth.fr/sv/articles/4859311-marseille-global-overvakning.md) - [Koncentration av SARS-CoV-2-virus - Nice](https://success.openhealth.fr/sv/articles/4879292-koncentration-av-sars-cov-2-virus-nice.md) - [Befolkning - struktur](https://success.openhealth.fr/sv/articles/4842408-befolkning-struktur.md) - [Koncentration av SARS-CoV-2-virus - Toulon \(FRANKRIKE\)](https://success.openhealth.fr/sv/articles/4886417-koncentration-av-sars-cov-2-virus-toulon-frankrike.md) - [Dubai - Övervakning av avloppsvatten från flygplatser](https://success.openhealth.fr/sv/articles/5276423-dubai-overvakning-av-avloppsvatten-fran-flygplatser.md) - [Övervakning av SARS-CoV-2 - OBEPINE](https://success.openhealth.fr/sv/articles/5210661-overvakning-av-sars-cov-2-obepine.md) - [Kontextualiserad koncentration av SARS-CoV-2](https://success.openhealth.fr/sv/articles/4934608-kontextualiserad-koncentration-av-sars-cov-2.md) - [SUEZ - Analytisk balansräkning](https://success.openhealth.fr/sv/articles/5140509-suez-analytisk-balansrakning.md) - [Palais des festivals - Titta på T0](https://success.openhealth.fr/sv/articles/5373515-palais-des-festivals-titta-pa-t0.md) - [Palais des festivals - Daglig vakan](https://success.openhealth.fr/sv/articles/5373231-palais-des-festivals-daglig-vakan.md) - [Palais des festivals - Visning](https://success.openhealth.fr/sv/articles/5404778-palais-des-festivals-visning.md) - [Mustelider - Titta](https://success.openhealth.fr/sv/articles/5169577-mustelider-titta.md) - [Befolkning - IRIS](https://success.openhealth.fr/sv/articles/4842191-befolkning-iris.md) - [SARS-CoV-2](https://success.openhealth.fr/sv/articles/4865699-sars-cov-2.md) - [IAS - Analys](https://success.openhealth.fr/sv/articles/4842430-ias-analys.md) - [Koncentration av SARS-CoV-2-virus - SEM](https://success.openhealth.fr/sv/articles/5415600-koncentration-av-sars-cov-2-virus-sem.md) - [Kartvisualisering](https://success.openhealth.fr/sv/articles/3864657-kartvisualisering.md): Geografisk fördelning av patienter - [Bidrag webbplats](https://success.openhealth.fr/sv/articles/3864668-bidrag-webbplats.md): Bidrag per webbplats och sjukhus - [Kohortprofil efter webbplats](https://success.openhealth.fr/sv/articles/3864672-kohortprofil-efter-webbplats.md): Kohortprofil efter plats och sjukhus - [Kohortprofil efter säsong](https://success.openhealth.fr/sv/articles/3864673-kohortprofil-efter-sasong.md): Kohortprofil efter säsong - [Ålder och könsfördelning](https://success.openhealth.fr/sv/articles/3864675-alder-och-konsfordelning.md): Demografi - [Virusdistribution per webbplats](https://success.openhealth.fr/sv/articles/3864678-virusdistribution-per-webbplats.md): Virusdistribution per webbplats - [Virusfördelning efter ålder](https://success.openhealth.fr/sv/articles/3864677-virusfordelning-efter-alder.md): Virusfördelning efter ålder - [Virusdistributionsutveckling](https://success.openhealth.fr/sv/articles/3864681-virusdistributionsutveckling.md): Virusdistributionsutveckling - [Influensavaccination](https://success.openhealth.fr/sv/articles/3864697-influensavaccination.md): Influensavaccination - [Influensavaccination evolution](https://success.openhealth.fr/sv/articles/3864701-influensavaccination-evolution.md): Utveckling av influensavaccination - [Patientfördelning efter kroniskt tillstånd](https://success.openhealth.fr/sv/articles/3864676-patientfordelning-efter-kroniskt-tillstand.md): Patientfördelning efter kroniskt tillstånd - [Patientfördelning efter sjukhusvistelse](https://success.openhealth.fr/sv/articles/3864794-patientfordelning-efter-sjukhusvistelse.md): Patientfördelning efter längd oh sjukhusvistelse - [Svaghet](https://success.openhealth.fr/sv/articles/3864704-svaghet.md): Bräcklighet hos patienter - [Allvarlighetsstatus](https://success.openhealth.fr/sv/articles/3864705-allvarlighetsstatus.md): Allvarlighetsstatus - [Dödlighet](https://success.openhealth.fr/sv/articles/3864710-dodlighet.md): Dödlighet - [GIHSN](https://success.openhealth.fr/sv/articles/3864712-gihsn.md): Global Influenza Hospital Surveillance Network - [CARéDIAB - Patientprofil](https://success.openhealth.fr/sv/articles/3789234-carediab-patientprofil.md): Analysera patientprofilen för CARéDIAB-populationen - [CARéDIAB - Komplikationer](https://success.openhealth.fr/sv/articles/3789515-carediab-komplikationer.md): Analysera förekomsten av komplikationer i vår befolkning CAREDIAB - [CARéDIAB - Global patientövervakning](https://success.openhealth.fr/sv/articles/3792041-carediab-global-patientovervakning.md): Analysera uppföljningsfrekvensen för patienter i CARéDIAB-populationen - [CARéDIAB-nätverk](https://success.openhealth.fr/sv/articles/3789106-carediab-natverk.md): CARéDIAB-nätverket - [CARéDIAB - Behandlingar](https://success.openhealth.fr/sv/articles/3792143-carediab-behandlingar.md): Analysera behandlingarna i samband med diabetes ## Türkçe ### Votre PLATEFORME - présentation générale - [HUB, kapsamlı ve sürekli bir destek platformu](https://success.openhealth.fr/tr/articles/4799621-hub-kapsamli-ve-surekli-bir-destek-platformu.md) - [Deneyim düzeyiniz The HUB](https://success.openhealth.fr/tr/articles/5712270-deneyim-duzeyiniz-the-hub.md) - [Diller](https://success.openhealth.fr/tr/articles/4649389-diller.md) - [Tarifelerimiz hakkında sorular](https://success.openhealth.fr/tr/articles/3292143-tarifelerimiz-hakkinda-sorular.md) ### Yol Haritası - ["Müşterilerimiz için açık inovasyon](https://success.openhealth.fr/tr/articles/5200970-musterilerimiz-icin-acik-inovasyon.md) - [Uygulamalar + Yönetim alanı sürüm 240515](https://success.openhealth.fr/tr/articles/9310541-uygulamalar-yonetim-alani-surum-240515.md) - [Uygulamalar + Yönetim alanı sürüm 240415](https://success.openhealth.fr/tr/articles/9310710-uygulamalar-yonetim-alani-surum-240415.md) - [Uygulamalar + Yönetim Alanı sürüm 240315](https://success.openhealth.fr/tr/articles/9310790-uygulamalar-yonetim-alani-surum-240315.md) - [Uygulamalar + Yönetim Alanı sürüm 240215](https://success.openhealth.fr/tr/articles/9311007-uygulamalar-yonetim-alani-surum-240215.md) - [Platform - güncelleme 231215](https://success.openhealth.fr/tr/articles/8718485-platform-guncelleme-231215.md) - [Platform - güncelleme 231015](https://success.openhealth.fr/tr/articles/8479932-platform-guncelleme-231015.md) - [Uygulamalar + Portal sürüm 230915](https://success.openhealth.fr/tr/articles/8373640-uygulamalar-portal-surum-230915.md) - [Uygulamalar + Portal sürüm 230815](https://success.openhealth.fr/tr/articles/8267860-uygulamalar-portal-surum-230815.md) - [Yeni ürünler 230715](https://success.openhealth.fr/tr/articles/8115796-yeni-urunler-230715.md) - [Uygulamalar + Portal sürüm 230615](https://success.openhealth.fr/tr/articles/8115791-uygulamalar-portal-surum-230615.md) - [Uygulamalar + Portal sürüm 230515](https://success.openhealth.fr/tr/articles/7895393-uygulamalar-portal-surum-230515.md) - [Uygulamalar + Portal sürüm 230415](https://success.openhealth.fr/tr/articles/7439447-uygulamalar-portal-surum-230415.md) - [Uygulamalar + Portal sürüm 230315](https://success.openhealth.fr/tr/articles/7439646-uygulamalar-portal-surum-230315.md) - [Uygulamalar + Portal sürümü 230215](https://success.openhealth.fr/tr/articles/7439744-uygulamalar-portal-surumu-230215.md) - [15/01/2023 tarihinden itibaren yeni](https://success.openhealth.fr/tr/articles/6895740-15-01-2023-tarihinden-itibaren-yeni.md) - [HUB + GATE sürüm 221215](https://success.openhealth.fr/tr/articles/6827027-hub-gate-surum-221215.md) - [HUB + GATE sürüm 221115](https://success.openhealth.fr/tr/articles/6742628-hub-gate-surum-221115.md) - [HUB + GATE sürüm 220915](https://success.openhealth.fr/tr/articles/6558070-hub-gate-surum-220915.md) - [HUB + GATE sürüm 220815](https://success.openhealth.fr/tr/articles/6475311-hub-gate-surum-220815.md) - [HUB + GATE sürüm 220615](https://success.openhealth.fr/tr/articles/6306090-hub-gate-surum-220615.md) - [HUB + GATE sürüm 220515](https://success.openhealth.fr/tr/articles/6201877-hub-gate-surum-220515.md) - [HUB + GATE sürüm 220415](https://success.openhealth.fr/tr/articles/6087747-hub-gate-surum-220415.md) - [HUB SMA versiyon 220315](https://success.openhealth.fr/tr/articles/6043772-hub-sma-versiyon-220315.md) - [HUB TMA sürüm 220315](https://success.openhealth.fr/tr/articles/6043802-hub-tma-surum-220315.md) - [HUB UAN sürüm 220315](https://success.openhealth.fr/tr/articles/6043852-hub-uan-surum-220315.md) - [GATE sürüm 220215](https://success.openhealth.fr/tr/articles/5940805-gate-surum-220215.md) - [HUB SMA versiyon 220215](https://success.openhealth.fr/tr/articles/5940753-hub-sma-versiyon-220215.md) - [HUB TMA sürüm 220215](https://success.openhealth.fr/tr/articles/5947859-hub-tma-surum-220215.md) - [GATE sürüm 211215](https://success.openhealth.fr/tr/articles/5819397-gate-surum-211215.md) - [HUB SMA sürüm 211215](https://success.openhealth.fr/tr/articles/5784709-hub-sma-surum-211215.md) - [HUB TMA sürüm 211215](https://success.openhealth.fr/tr/articles/5784888-hub-tma-surum-211215.md) - [HUB UAN sürüm 211215](https://success.openhealth.fr/tr/articles/5784904-hub-uan-surum-211215.md) - [Uygulama The HUB: "Eczanenin durumu".](https://success.openhealth.fr/tr/articles/5704485-uygulama-the-hub-eczanenin-durumu.md) - [GATE sürüm 211115](https://success.openhealth.fr/tr/articles/5697844-gate-surum-211115.md) - [HUB SMA sürüm 211115](https://success.openhealth.fr/tr/articles/5671893-hub-sma-surum-211115.md) - [HUB TMA sürüm 211115](https://success.openhealth.fr/tr/articles/5671917-hub-tma-surum-211115.md) - [HUB UAN sürüm 211115](https://success.openhealth.fr/tr/articles/5671927-hub-uan-surum-211115.md) - [GATE sürüm 211015](https://success.openhealth.fr/tr/articles/5652210-gate-surum-211015.md) - [HUB SMA sürüm 211015](https://success.openhealth.fr/tr/articles/5649822-hub-sma-surum-211015.md) - [HUB TMA sürüm 211015](https://success.openhealth.fr/tr/articles/5650073-hub-tma-surum-211015.md) - [HUB UAN sürüm 211015](https://success.openhealth.fr/tr/articles/5652242-hub-uan-surum-211015.md) - [HUB SMA sürüm 210915](https://success.openhealth.fr/tr/articles/5370516-hub-sma-surum-210915.md) - [HUB TMA sürüm 210915](https://success.openhealth.fr/tr/articles/5390983-hub-tma-surum-210915.md) - [HUB UAN sürüm 210915](https://success.openhealth.fr/tr/articles/5543213-hub-uan-surum-210915.md) ### Votre ESPACE D'ADMINISTRATION - fonctionnalités - [Şifrenizi Sıfırlayın/Değiştirin The HUB](https://success.openhealth.fr/tr/articles/4425325-sifrenizi-sifirlayin-degistirin-the-hub.md) - [Bağlantı yardımı: Bir hata mesajı alıyorum](https://success.openhealth.fr/tr/articles/5369783-baglanti-yardimi-bir-hata-mesaji-aliyorum.md) - [Bilet oluşturma ve takip etme](https://success.openhealth.fr/tr/articles/3586214-bilet-olusturma-ve-takip-etme.md) - [Bir SUCCESS makalesi oluşturma ve değiştirme](https://success.openhealth.fr/tr/articles/6738705-bir-success-makalesi-olusturma-ve-degistirme.md) - [Sözleşmelerim](https://success.openhealth.fr/tr/articles/5712273-sozlesmelerim.md) - [Hizmet Sağlığı](https://success.openhealth.fr/tr/articles/4990600-hizmet-sagligi.md) - [Erişimlerim](https://success.openhealth.fr/tr/articles/5783418-erisimlerim.md) - [Ana sayfamı ayarlama](https://success.openhealth.fr/tr/articles/5712229-ana-sayfami-ayarlama.md) - [Pazarınızı kişisel OpenHealth alanınızdan nasıl değiştirebilirsiniz?](https://success.openhealth.fr/tr/articles/3585971-pazarinizi-kisisel-openhealth-alaninizdan-nasil-degistirebilirsiniz.md) - [Otomatik Modalite Atama Değişikliği \(MAM auto\)](https://success.openhealth.fr/tr/articles/4164818-otomatik-modalite-atama-degisikligi-mam-auto.md) - [GEÇİCİ MAM: Laboratuvarını/markasını/marka adını değiştiren bir markayı nasıl takip ediyorsunuz?](https://success.openhealth.fr/tr/articles/4131072-gecici-mam-laboratuvarini-markasini-marka-adini-degistiren-bir-markayi-nasil-takip-ediyorsunuz.md) - [Ürün Entegrasyonu \(RPI\)](https://success.openhealth.fr/tr/articles/4164932-urun-entegrasyonu-rpi.md) - [Ürün Kaldırma \(SPR\)](https://success.openhealth.fr/tr/articles/4164866-urun-kaldirma-spr.md) - [Otomatik Ürün Yeniden Etkinleştirme \(RPR auto\)](https://success.openhealth.fr/tr/articles/4818161-otomatik-urun-yeniden-etkinlestirme-rpr-auto.md) - [Yeni ürünlerin kurulması](https://success.openhealth.fr/tr/articles/5811248-yeni-urunlerin-kurulmasi.md) - [Bir pazar ekleyin](https://success.openhealth.fr/tr/articles/5712283-bir-pazar-ekleyin.md) - [Dökme ürünlerin ithalatı / ihracatı](https://success.openhealth.fr/tr/articles/5712257-dokme-urunlerin-ithalati-ihracati.md) - [Tipolojik Modalite Değişikliği \(CMT\)](https://success.openhealth.fr/tr/articles/4670174-tipolojik-modalite-degisikligi-cmt.md) - [Farklı kullanıcı durumları](https://success.openhealth.fr/tr/articles/3436418-farkli-kullanici-durumlari.md) - [Üçüncü taraf bir kuruluştan bir kullanıcı için hesap oluşturma \(TPAA\)](https://success.openhealth.fr/tr/articles/6466550-ucuncu-taraf-bir-kurulustan-bir-kullanici-icin-hesap-olusturma-tpaa.md) - [The HUB'da bir kullanıcı hesabını nasıl oluşturabilir, değiştirebilir veya silebilirim?](https://success.openhealth.fr/tr/articles/3785138-the-hub-da-bir-kullanici-hesabini-nasil-olusturabilir-degistirebilir-veya-silebilirim.md) - [Ekiplerim içinde HUB için farklılaştırılmış görüntüleme hakları oluşturabilir miyim?](https://success.openhealth.fr/tr/articles/3321731-ekiplerim-icinde-hub-icin-farklilastirilmis-goruntuleme-haklari-olusturabilir-miyim.md) - [Faaliyet günlüğü](https://success.openhealth.fr/tr/articles/4687438-faaliyet-gunlugu.md) ### Vos APPLICATIONS - présentation - [HUB eğitim kılavuzu](https://success.openhealth.fr/tr/articles/5634967-hub-egitim-kilavuzu.md) - [Sıralama açılır seçicisi](https://success.openhealth.fr/tr/articles/5792113-siralama-acilir-secicisi.md) - [GSA eczaneleri ve parafarmasiler için güncelleme tarihi \(SMKT\)](https://success.openhealth.fr/tr/articles/3175557-gsa-eczaneleri-ve-parafarmasiler-icin-guncelleme-tarihi-smkt.md) - [Ön Koşullar Eşleşen Eczaneler Dosyası](https://success.openhealth.fr/tr/articles/3678146-on-kosullar-eslesen-eczaneler-dosyasi.md) - [Açık ve Kapalı Reçete" seçici](https://success.openhealth.fr/tr/articles/3729668-acik-ve-kapali-recete-secici.md) - [Veri sorunu: nasıl devam edilir](https://success.openhealth.fr/tr/articles/4374497-veri-sorunu-nasil-devam-edilir.md) - [HUB'da yeni ürünleri nasıl nitelendiriyorsunuz?](https://success.openhealth.fr/tr/articles/3376100-hub-da-yeni-urunleri-nasil-nitelendiriyorsunuz.md) - [HUB'da bir favoriyi nasıl oluşturabilir, düzenleyebilir ve paylaşabilirim?](https://success.openhealth.fr/tr/articles/3175689-hub-da-bir-favoriyi-nasil-olusturabilir-duzenleyebilir-ve-paylasabilirim.md) - [HUB'daki ürünleri lansman tarihine göre nasıl seçerim?](https://success.openhealth.fr/tr/articles/3158428-hub-daki-urunleri-lansman-tarihine-gore-nasil-secerim.md) - [Verileri HUB'dan ".csv" formatında çıkarabilir miyim?](https://success.openhealth.fr/tr/articles/5671278-verileri-hub-dan-csv-formatinda-cikarabilir-miyim.md) - [ODT yanıt süresi](https://success.openhealth.fr/tr/articles/6632310-odt-yanit-suresi.md) - [HUB'da iyi ilan verme uygulamaları](https://success.openhealth.fr/tr/articles/3124454-hub-da-iyi-ilan-verme-uygulamalari.md) - [Teknik gereksinimler](https://success.openhealth.fr/tr/articles/5369918-teknik-gereksinimler.md) - [Tarayıcınızın önbelleğini boşaltın](https://success.openhealth.fr/tr/articles/4219722-tarayicinizin-onbellegini-bosaltin.md) - [Google Chrome'u varsayılan tarayıcım olarak nasıl ayarlarım?](https://success.openhealth.fr/tr/articles/3738717-google-chrome-u-varsayilan-tarayicim-olarak-nasil-ayarlarim.md) - [Gezinme kaydırma çubuğu tablolarda görünmüyor](https://success.openhealth.fr/tr/articles/3195250-gezinme-kaydirma-cubugu-tablolarda-gorunmuyor.md) - [Sayfadaki düğmelerin veya nesnelerin görüntüsü kısmen kesilmiş veya görünmüyor](https://success.openhealth.fr/tr/articles/3195245-sayfadaki-dugmelerin-veya-nesnelerin-goruntusu-kismen-kesilmis-veya-gorunmuyor.md) - [Bölge Yönetimi kartım yüklenmiyor ve "yükleniyor" mesajı görünüyor](https://success.openhealth.fr/tr/articles/3195239-bolge-yonetimi-kartim-yuklenmiyor-ve-yukleniyor-mesaji-gorunuyor.md) - ["Bu sayfaya erişim yetkiniz yok" hata mesajı nereden geliyor?](https://success.openhealth.fr/tr/articles/3195338-bu-sayfaya-erisim-yetkiniz-yok-hata-mesaji-nereden-geliyor.md) - ["Bağlantı kesildi" hata mesajı alıyorum](https://success.openhealth.fr/tr/articles/4445141-baglanti-kesildi-hata-mesaji-aliyorum.md) - ["Kötü Geçit](https://success.openhealth.fr/tr/articles/4514555-kotu-gecit.md) - [Hata mesajı: "Bir hata oluştu".](https://success.openhealth.fr/tr/articles/3195286-hata-mesaji-bir-hata-olustu.md) - [Boyut ve hesaplama seçicileri artık "Çoklu Dönem Analizi" ve "Veri Arşivim" sorgularında görüntülenmiyor, "Piyasa Analizi "ndeki tablo çıkarma işlemi kısmi](https://success.openhealth.fr/tr/articles/3195377-boyut-ve-hesaplama-secicileri-artik-coklu-donem-analizi-ve-veri-arsivim-sorgularinda-goruntulenmiyor-piyasa-analizi-ndeki-tablo-cikarma-islemi-kismi.md) - [HUB'da bir terim nasıl görüntülenir?](https://success.openhealth.fr/tr/articles/3194377-hub-da-bir-terim-nasil-goruntulenir.md) - [Excel özellikleri ve sınırlamaları](https://success.openhealth.fr/tr/articles/3753088-excel-ozellikleri-ve-sinirlamalari.md) - [Uygulamalarınızda bir Sık Kullanılan'ı nasıl oluşturur, düzenler ve paylaşırsınız?](https://success.openhealth.fr/tr/articles/10502803-uygulamalarinizda-bir-sik-kullanilan-i-nasil-olusturur-duzenler-ve-paylasirsiniz.md) - [Çerçeve tüketici paneli](https://success.openhealth.fr/tr/articles/3455845-cerceve-tuketici-paneli.md) - [Çerçeve eczane pazar analizi](https://success.openhealth.fr/tr/articles/3455857-cerceve-eczane-pazar-analizi.md) ### Veri Kaynakları - [OpenHealth eczane paneli nedir?](https://success.openhealth.fr/tr/articles/3304106-openhealth-eczane-paneli-nedir.md) - [Eczane ağı, mevcut ve gelecekteki sağlık krizlerinin yönetiminde belirleyici bir varlık](https://success.openhealth.fr/tr/articles/3825648-eczane-agi-mevcut-ve-gelecekteki-saglik-krizlerinin-yonetiminde-belirleyici-bir-varlik.md) - [HUB'da hangi DROM COM bölgeleri görüntülenebilir?](https://success.openhealth.fr/tr/articles/3194382-hub-da-hangi-drom-com-bolgeleri-goruntulenebilir.md) - [Ön koşullar sektör dosyası](https://success.openhealth.fr/tr/articles/3702701-on-kosullar-sektor-dosyasi.md) - [Veri kaynağı IRI Fransa Parapharmacies \(SMKT\) / Perakendeciler](https://success.openhealth.fr/tr/articles/4485357-veri-kaynagi-iri-fransa-parapharmacies-smkt-perakendeciler.md) - [IRI'da GSA parafarmasi ürünleri \(SMKT\) için kodlama kuralları](https://success.openhealth.fr/tr/articles/3524492-iri-da-gsa-parafarmasi-urunleri-smkt-icin-kodlama-kurallari.md) - [ORGANİK MAĞAZA verileri - Kaynak BIOANALYTICS](https://success.openhealth.fr/tr/articles/5631260-organik-magaza-verileri-kaynak-bioanalytics.md) - [E-parapharmacies: izleme platformları](https://success.openhealth.fr/tr/articles/9167006-e-parapharmacies-izleme-platformlari.md) - [E-eczaneler Ürün Kazançları ve Kayıpları](https://success.openhealth.fr/tr/articles/3568773-e-eczaneler-urun-kazanclari-ve-kayiplari.md) - [Tüketici profili](https://success.openhealth.fr/tr/articles/3711085-tuketici-profili.md) - [AMAZON verileri - Kaynak SELLINGZ](https://success.openhealth.fr/tr/articles/5669013-amazon-verileri-kaynak-sellingz.md) - [E-ticaret verileri - Kaynak WISER](https://success.openhealth.fr/tr/articles/7983010-e-ticaret-verileri-kaynak-wiser.md) - [Coğrafi Bölgeler](https://success.openhealth.fr/tr/articles/4661582-cografi-bolgeler.md) - [Almanya'da eczane paneli nedir? INSIGHTHEALTH](https://success.openhealth.fr/tr/articles/5391412-almanya-da-eczane-paneli-nedir-insighthealth.md) - [Yunanistan'da eczane paneli nedir? ALIRAHEALTH](https://success.openhealth.fr/tr/articles/6863963-yunanistan-da-eczane-paneli-nedir-alirahealth.md) - [Avusturya'da eczane paneli nedir? INSIGHTHEALTH](https://success.openhealth.fr/tr/articles/6863949-avusturya-da-eczane-paneli-nedir-insighthealth.md) - [Afrika'da Eczacılık Paneli nedir? PIEX - Afrika](https://success.openhealth.fr/tr/articles/6686633-afrika-da-eczacilik-paneli-nedir-piex-afrika.md) - [Almanya'daki online eczane paneli nedir? DATAMEDIQ](https://success.openhealth.fr/tr/articles/5689640-almanya-daki-online-eczane-paneli-nedir-datamediq.md) - [Belçika'daki eczane paneli nedir? REDPHARMA](https://success.openhealth.fr/tr/articles/4689894-belcika-daki-eczane-paneli-nedir-redpharma.md) - [İspanya'da eczane paneli nedir? - HMR](https://success.openhealth.fr/tr/articles/5391363-ispanya-da-eczane-paneli-nedir-hmr.md) - [İspanya'da eczane paneli nedir? - INFONIS](https://success.openhealth.fr/tr/articles/5428915-ispanya-da-eczane-paneli-nedir-infonis.md) - [Portekiz'de eczane paneli nedir? - HMR](https://success.openhealth.fr/tr/articles/5391477-portekiz-de-eczane-paneli-nedir-hmr.md) - [Rusya'da eczane paneli nedir? - ALPHARM](https://success.openhealth.fr/tr/articles/5701531-rusya-da-eczane-paneli-nedir-alpharm.md) - [Polonya'da eczane paneli nedir? Pex Pharma](https://success.openhealth.fr/tr/articles/5969485-polonya-da-eczane-paneli-nedir-pex-pharma.md) - [Benin'de eczane paneli nedir? AS PHARM - ASPHARM BENIN](https://success.openhealth.fr/tr/articles/4238167-benin-de-eczane-paneli-nedir-as-pharm-aspharm-benin.md) - [CONVERT GRUBU](https://success.openhealth.fr/tr/articles/6961966-convert-grubu.md) - [Ürdün'deki eczane paneli nedir?](https://success.openhealth.fr/tr/articles/8176750-urdun-deki-eczane-paneli-nedir.md) - [Nüfus - Kartografya](https://success.openhealth.fr/tr/articles/3807695-nufus-kartografya.md) - [AMELI - LPP](https://success.openhealth.fr/tr/articles/6962021-ameli-lpp.md) - [Nüfus - YAŞ ve CİNSİYETE Göre Evrim](https://success.openhealth.fr/tr/articles/3810789-nufus-yas-ve-cinsiyete-gore-evrim.md) - [Nüfus - YAŞ ve CİNSİYETE Göre Karşılaştırma](https://success.openhealth.fr/tr/articles/3836795-nufus-yas-ve-cinsiyete-gore-karsilastirma.md) - [MISIR - Kartografya](https://success.openhealth.fr/tr/articles/3714611-misir-kartografya.md) - [MISIR - YAŞ VE CİNSİYETE GÖRE ANALİZ](https://success.openhealth.fr/tr/articles/3714673-misir-yas-ve-cinsiyete-gore-analiz.md) - [UGANDA - YAŞ VE CİNSİYETE GÖRE ANALİZ](https://success.openhealth.fr/tr/articles/3713884-uganda-yas-ve-cinsiyete-gore-analiz.md) - [Nüfus - YAŞ ve CİNSİYETE Göre Analiz](https://success.openhealth.fr/tr/articles/3807673-nufus-yas-ve-cinsiyete-gore-analiz.md) - [Medicabase - ilaç veritabanı](https://success.openhealth.fr/tr/articles/6518920-medicabase-ilac-veritabani.md) - [Doğum](https://success.openhealth.fr/tr/articles/6340025-dogum.md) - [OpenEudra](https://success.openhealth.fr/tr/articles/6518977-openeudra.md) - [IRIS dökümü](https://success.openhealth.fr/tr/articles/6383829-iris-dokumu.md) - [ADICAP](https://success.openhealth.fr/tr/articles/6959465-adicap.md) - [NEC](https://success.openhealth.fr/tr/articles/6519012-nec.md) - [Dünya nüfus verileri](https://success.openhealth.fr/tr/articles/8217421-dunya-nufus-verileri.md) - [INSEE: Vefat eden kişilerin dosyaları](https://success.openhealth.fr/tr/articles/4498126-insee-vefat-eden-kisilerin-dosyalari.md) - [Veriler VAERS- VAERSDATA- Kaynak CDC](https://success.openhealth.fr/tr/articles/6226665-veriler-vaers-vaersdata-kaynak-cdc.md) - [VAERS verileri - VAERSVAX - Kaynak CDC](https://success.openhealth.fr/tr/articles/6226440-vaers-verileri-vaersvax-kaynak-cdc.md) - [VAERS verileri - VAERSSYMPTOMS - Kaynak CDC](https://success.openhealth.fr/tr/articles/6219415-vaers-verileri-vaerssymptoms-kaynak-cdc.md) - [Verilerinizi 2 haftadan kısa sürede Hub'a entegre edin](https://success.openhealth.fr/tr/articles/5259828-verilerinizi-2-haftadan-kisa-surede-hub-a-entegre-edin.md) - [Uluslararası Veri Şablonu](https://success.openhealth.fr/tr/articles/4684696-uluslararasi-veri-sablonu.md) - [Verilerinizi FTPS veya SFTP aracılığıyla bize nasıl gönderirsiniz?](https://success.openhealth.fr/tr/articles/4143451-verilerinizi-ftps-veya-sftp-araciligiyla-bize-nasil-gonderirsiniz.md) - [OpenHealth yeni bir veri kaynağını entegre etmek için hangi bilgilere ihtiyaç duyar?](https://success.openhealth.fr/tr/articles/3459148-openhealth-yeni-bir-veri-kaynagini-entegre-etmek-icin-hangi-bilgilere-ihtiyac-duyar.md) - [Uzun Görüş](https://success.openhealth.fr/tr/articles/6959482-uzun-gorus.md) - [Yeni bir veri kaynağı HUB'a nasıl entegre edilir?](https://success.openhealth.fr/tr/articles/3467598-yeni-bir-veri-kaynagi-hub-a-nasil-entegre-edilir.md) - [Satış verilerinizi HUB'a entegre edin](https://success.openhealth.fr/tr/articles/3471145-satis-verilerinizi-hub-a-entegre-edin.md): Satış verilerinin entegrasyonuna ilişkin makale - [Satış verilerini almak için özellikler](https://success.openhealth.fr/tr/articles/3660043-satis-verilerini-almak-icin-ozellikler.md) - [Evde Sağlık Hizmeti Sağlayıcıları \(HHCP\) pazarının analizi için veriler nereden geliyor?](https://success.openhealth.fr/tr/articles/3376155-evde-saglik-hizmeti-saglayicilari-hhcp-pazarinin-analizi-icin-veriler-nereden-geliyor.md) - [SantéDom Stat gözlemevine nasıl katılabilirsiniz?](https://success.openhealth.fr/tr/articles/3798795-santedom-stat-gozlemevine-nasil-katilabilirsiniz.md) - [SanteDomStat gözlemevinden tahmin edilen panel](https://success.openhealth.fr/tr/articles/6701602-santedomstat-gozlemevinden-tahmin-edilen-panel.md) - [Hasta sayısı](https://success.openhealth.fr/tr/articles/3376499-hasta-sayisi.md) - [Tedavi sayısı](https://success.openhealth.fr/tr/articles/3376682-tedavi-sayisi.md) - [Yeni hasta sayısı](https://success.openhealth.fr/tr/articles/3376672-yeni-hasta-sayisi.md) - [KDV dahil ciro](https://success.openhealth.fr/tr/articles/3376725-kdv-dahil-ciro.md) - [Tedavi sonundaki hasta sayısı](https://success.openhealth.fr/tr/articles/3376675-tedavi-sonundaki-hasta-sayisi.md) - [Zorunlu sağlık sigortası miktarı \(AMO\)](https://success.openhealth.fr/tr/articles/3376740-zorunlu-saglik-sigortasi-miktari-amo.md) - [Tamamlayıcı sağlık sigortası tutarı \(AMC\)](https://success.openhealth.fr/tr/articles/3376749-tamamlayici-saglik-sigortasi-tutari-amc.md) - [Cepten yapılan harcamalar \(RAC\)](https://success.openhealth.fr/tr/articles/3376751-cepten-yapilan-harcamalar-rac.md) - [Kaynak : THESORIMED](https://success.openhealth.fr/tr/articles/3560018-kaynak-thesorimed.md) - [Uluslararası Tescilli Olmayan İsimler \(INN\)](https://success.openhealth.fr/tr/articles/3954239-uluslararasi-tescilli-olmayan-isimler-inn.md) - [Açık Gıda Gerçekleri](https://success.openhealth.fr/tr/articles/6961970-acik-gida-gercekleri.md) - [LOINC - Mantıksal Gözlem Tanımlayıcıları İsimler ve Kodlar](https://success.openhealth.fr/tr/articles/6959323-loinc-mantiksal-gozlem-tanimlayicilari-isimler-ve-kodlar.md) - [AMELI - CCAM](https://success.openhealth.fr/tr/articles/6959080-ameli-ccam.md) - [WHO ATC VET](https://success.openhealth.fr/tr/articles/6959078-who-atc-vet.md) - [CEPS](https://success.openhealth.fr/tr/articles/6959068-ceps.md) - [Kurum](https://success.openhealth.fr/tr/articles/3935678-kurum.md) - [Sağlık hizmetleri](https://success.openhealth.fr/tr/articles/7969680-saglik-hizmetleri.md) - [Ayıklama FINESS](https://success.openhealth.fr/tr/articles/3946922-ayiklama-finess.md) - [Evrim FINESS](https://success.openhealth.fr/tr/articles/3947009-evrim-finess.md) - [Yetkilendirme bakım faaliyeti](https://success.openhealth.fr/tr/articles/3947067-yetkilendirme-bakim-faaliyeti.md) - [Büyük tıbbi ekipman](https://success.openhealth.fr/tr/articles/3947269-buyuk-tibbi-ekipman.md) - [Coğrafi](https://success.openhealth.fr/tr/articles/3947363-cografi.md) - [RPPS](https://success.openhealth.fr/tr/articles/3947568-rpps.md) - [FINESS & RPPS](https://success.openhealth.fr/tr/articles/3947713-finess-rpps.md) - [RPPS'yi Çıkarın](https://success.openhealth.fr/tr/articles/3947829-rpps-yi-cikarin.md) ### MODELLER - [UGA'daki Veriler](https://success.openhealth.fr/tr/articles/4852310-uga-daki-veriler.md) - [Satışları sektöre / Müşteri Türüne göre hesaplama: bilmeniz gerekenler](https://success.openhealth.fr/tr/articles/3545561-satislari-sektore-musteri-turune-gore-hesaplama-bilmeniz-gerekenler.md) - [Sektörün yeniden tahsisi, statik mi dinamik metodoloji mi?](https://success.openhealth.fr/tr/articles/3690615-sektorun-yeniden-tahsisi-statik-mi-dinamik-metodoloji-mi.md) - [Eczane katmanları](https://success.openhealth.fr/tr/articles/4291490-eczane-katmanlari.md) - [Hub üretim hattı](https://success.openhealth.fr/tr/articles/4816146-hub-uretim-hatti.md) - [Karşılaştırmalı analiz nasıl yapılır?](https://success.openhealth.fr/tr/articles/3440093-karsilastirmali-analiz-nasil-yapilir.md) - [OpenHealth Şirketi için Veri Kalitesi](https://success.openhealth.fr/tr/articles/3595822-openhealth-sirketi-icin-veri-kalitesi.md) - [OpenHealth'te veri kalitesi süreci](https://success.openhealth.fr/tr/articles/3415271-openhealth-te-veri-kalitesi-sureci.md) - [Aralık ve güven düzeyi](https://success.openhealth.fr/tr/articles/3633173-aralik-ve-guven-duzeyi.md) - [Veri kalitesi: Toplu iş yönetimi](https://success.openhealth.fr/tr/articles/3433509-veri-kalitesi-toplu-is-yonetimi.md) - [Veri kalitesi: Satışları parçalara ayırma süreci](https://success.openhealth.fr/tr/articles/3415317-veri-kalitesi-satislari-parcalara-ayirma-sureci.md) - [Satış ve stok değişimleri](https://success.openhealth.fr/tr/articles/4131084-satis-ve-stok-degisimleri.md) - [Neden satışları hacme göre analiz ediyorsunuz?](https://success.openhealth.fr/tr/articles/3846167-neden-satislari-hacme-gore-analiz-ediyorsunuz.md) - [Satış ve satış dışı arasında bir veri boşluğu var](https://success.openhealth.fr/tr/articles/3195358-satis-ve-satis-disi-arasinda-bir-veri-boslugu-var.md) - [Atipik satış nedir?](https://success.openhealth.fr/tr/articles/3195366-atipik-satis-nedir.md) - [Fiyatlar, hacimler, ciro ile ilgili bilgiler nereden geliyor?](https://success.openhealth.fr/tr/articles/3195348-fiyatlar-hacimler-ciro-ile-ilgili-bilgiler-nereden-geliyor.md) - [Reçete sahibine göre tahmini satış hacmi](https://success.openhealth.fr/tr/articles/4171530-recete-sahibine-gore-tahmini-satis-hacmi.md) - [İki ekstraksiyon arasındaki farkın anlaşılması](https://success.openhealth.fr/tr/articles/13399689-iki-ekstraksiyon-arasindaki-farkin-anlasilmasi.md) ### ÜRÜNLER, PAZARLAR ve SINIFLANDIRMALAR - [GTIN](https://success.openhealth.fr/tr/articles/3608176-gtin.md) - [Ürün Müşteri Yeterlilik Alanı Şartnamesi \(PCQFS\)](https://success.openhealth.fr/tr/articles/3704913-urun-musteri-yeterlilik-alani-sartnamesi-pcqfs.md) - [PBDA kodu nedir?](https://success.openhealth.fr/tr/articles/3195365-pbda-kodu-nedir.md) - [Ürün kiralama takibi](https://success.openhealth.fr/tr/articles/4206554-urun-kiralama-takibi.md) - [Pazarımı genişletmek istiyorum](https://success.openhealth.fr/tr/articles/4420843-pazarimi-genisletmek-istiyorum.md) - [OHC Sınıflandırması](https://success.openhealth.fr/tr/articles/3194589-ohc-siniflandirmasi.md) - [EphMRA AC Sınıfları Tarihçesi](https://success.openhealth.fr/tr/articles/3557908-ephmra-ac-siniflari-tarihcesi.md) - [Veteriner Hekimliği Detayları](https://success.openhealth.fr/tr/articles/3194587-veteriner-hekimligi-detaylari.md) - [Veteriner Hekimliği Sınıflandırması](https://success.openhealth.fr/tr/articles/3194579-veteriner-hekimligi-siniflandirmasi.md) - [İnsan Tıbbı Detayları](https://success.openhealth.fr/tr/articles/3421225-insan-tibbi-detaylari.md) - [Yeni ürünlerin yönetimi](https://success.openhealth.fr/tr/articles/4470813-yeni-urunlerin-yonetimi.md) - [İnsan Tıbbı Sınıflandırması](https://success.openhealth.fr/tr/articles/3417281-insan-tibbi-siniflandirmasi.md) - [Endikasyonlar - Teşhis](https://success.openhealth.fr/tr/articles/3568554-endikasyonlar-teshis.md) - [MP4U: Ürün kıyaslaması](https://success.openhealth.fr/tr/articles/3574188-mp4u-urun-kiyaslamasi.md) - [TVASI \(Satışlar, Satın Alımlar ve Bilinmeyen Stoklar Tablosu\) nedir](https://success.openhealth.fr/tr/articles/5992494-tvasi-satislar-satin-alimlar-ve-bilinmeyen-stoklar-tablosu-nedir.md) - [IRI Sınıflandırması](https://success.openhealth.fr/tr/articles/3194597-iri-siniflandirmasi.md) - [Satılmayan ürünlerin kaldırılması](https://success.openhealth.fr/tr/articles/6135938-satilmayan-urunlerin-kaldirilmasi.md) - [STANDART MARKET - Abonelik](https://success.openhealth.fr/tr/articles/3798203-standart-market-abonelik.md) - [Ürünümü bulamıyorum](https://success.openhealth.fr/tr/articles/5686002-urunumu-bulamiyorum.md) - [Ürün kodu yönetimi](https://success.openhealth.fr/tr/articles/5652478-urun-kodu-yonetimi.md) - [Ürün niteliği: Markalar](https://success.openhealth.fr/tr/articles/5016985-urun-niteligi-markalar.md) ### ABONELİKLER ve MODÜLLER - [3 uygulama türü](https://success.openhealth.fr/tr/articles/9489652-3-uygulama-turu.md) - [2.0 Platformunuz](https://success.openhealth.fr/tr/articles/8374416-2-0-platformunuz.md) - [ÖZET](https://success.openhealth.fr/tr/articles/3344127-ozet.md) - [Piyasalar & Seçimler](https://success.openhealth.fr/tr/articles/8337016-piyasalar-secimler.md) - [Özet gösterge tablosu](https://success.openhealth.fr/tr/articles/9246867-ozet-gosterge-tablosu.md) - [Analiz](https://success.openhealth.fr/tr/articles/9352287-analiz.md) - [Çıkarıcı](https://success.openhealth.fr/tr/articles/9246875-cikarici.md) - [Büyüme Analizi](https://success.openhealth.fr/tr/articles/3158856-buyume-analizi.md) - [Ürün Çeşitliliği Analizi](https://success.openhealth.fr/tr/articles/3473736-urun-cesitliligi-analizi.md) - [Ortalama Ürün Sayısı](https://success.openhealth.fr/tr/articles/3161474-ortalama-urun-sayisi.md) - [Lansman Takibi](https://success.openhealth.fr/tr/articles/3158488-lansman-takibi.md) - [Gelişmiş Göstergeler Çaprazlandı](https://success.openhealth.fr/tr/articles/6007740-gelismis-gostergeler-caprazlandi.md) - [Satış Yoğunlaşması](https://success.openhealth.fr/tr/articles/3095338-satis-yogunlasmasi.md) - [Fiyat Dağılımı](https://success.openhealth.fr/tr/articles/3159289-fiyat-dagilimi.md) - [Satış Marjı Analizi](https://success.openhealth.fr/tr/articles/3358322-satis-marji-analizi.md) - [Satış Marjı Gelişimi](https://success.openhealth.fr/tr/articles/3815561-satis-marji-gelisimi.md) - [Eczane İzleme \(1/2\)](https://success.openhealth.fr/tr/articles/3358248-eczane-izleme-1-2.md) - [Eczane İzleme \(2/2\)](https://success.openhealth.fr/tr/articles/3810527-eczane-izleme-2-2.md) - [Salesforce Performansı](https://success.openhealth.fr/tr/articles/3159230-salesforce-performansi.md) - [Müşteri İlişkileri Yönetimi \(CRM\) Asistanı](https://success.openhealth.fr/tr/articles/5953935-musteri-iliskileri-yonetimi-crm-asistani.md) - [Satış Noktası Takibi](https://success.openhealth.fr/tr/articles/3778944-satis-noktasi-takibi.md) - [Talep Üzerine Evrim](https://success.openhealth.fr/tr/articles/6560184-talep-uzerine-evrim.md) - [Talep Üzerine Analiz](https://success.openhealth.fr/tr/articles/6127483-talep-uzerine-analiz.md) - [Talep Üzerine Masa](https://success.openhealth.fr/tr/articles/3158751-talep-uzerine-masa.md) - [Zaman Serisi Analizi](https://success.openhealth.fr/tr/articles/3635940-zaman-serisi-analizi.md) - [Tahmin Analizi](https://success.openhealth.fr/tr/articles/3636015-tahmin-analizi.md) - [Sektörel Tahmin](https://success.openhealth.fr/tr/articles/3689811-sektorel-tahmin.md) - [Satış Görselleştirme](https://success.openhealth.fr/tr/articles/3559882-satis-gorsellestirme.md) - [Satış Analizi](https://success.openhealth.fr/tr/articles/6188132-satis-analizi.md) - [Satış Eşleştirme](https://success.openhealth.fr/tr/articles/6188090-satis-eslestirme.md) - [Satış Evrimi](https://success.openhealth.fr/tr/articles/6191929-satis-evrimi.md) - [Satışa Karşı Satış Analizi](https://success.openhealth.fr/tr/articles/6191947-satisa-karsi-satis-analizi.md) - [Sell-in vs Sell-out Evrimi](https://success.openhealth.fr/tr/articles/6191955-sell-in-vs-sell-out-evrimi.md) - [Fiyat Evrimi](https://success.openhealth.fr/tr/articles/5056489-fiyat-evrimi.md) - [Renkleri özelleştirin](https://success.openhealth.fr/tr/articles/8407897-renkleri-ozellestirin.md) - [Ürün İhracatı](https://success.openhealth.fr/tr/articles/3583206-urun-ihracati.md) - [Pazar Analizi](https://success.openhealth.fr/tr/articles/3121933-pazar-analizi.md) - [Fiyat Analizi](https://success.openhealth.fr/tr/articles/3215190-fiyat-analizi.md) - [Satış Evrimi](https://success.openhealth.fr/tr/articles/3178323-satis-evrimi.md) - [Gösterge Tablosunu Özetleyin](https://success.openhealth.fr/tr/articles/4533213-gosterge-tablosunu-ozetleyin.md) - [Pazar Payı Gelişimi](https://success.openhealth.fr/tr/articles/3193078-pazar-payi-gelisimi.md) - [Satış Çapraz Tablosu](https://success.openhealth.fr/tr/articles/3193060-satis-capraz-tablosu.md) - [CİRO / HACİM \(CU\) Sentezi](https://success.openhealth.fr/tr/articles/3193048-ciro-hacim-cu-sentezi.md) - [Değer Sentezini Sat \(ECZANELER / SÜPERMARKETLER\)](https://success.openhealth.fr/tr/articles/3193020-deger-sentezini-sat-eczaneler-supermarketler.md) - [Pazar Payı Analizi](https://success.openhealth.fr/tr/articles/3193069-pazar-payi-analizi.md) - [Veri Arşivim](https://success.openhealth.fr/tr/articles/3193099-veri-arsivim.md) - [Çoklu Dönem Analizi](https://success.openhealth.fr/tr/articles/3192953-coklu-donem-analizi.md) - [Sorgum Tüm Ürünler](https://success.openhealth.fr/tr/articles/4280353-sorgum-tum-urunler.md) - [Stok Evrimi \(YENİ\)](https://success.openhealth.fr/tr/articles/3719256-stok-evrimi-yeni.md) - [Pazar Tanımı](https://success.openhealth.fr/tr/articles/3158829-pazar-tanimi.md) - [RAW DATA Gelişmiş Göstergeler](https://success.openhealth.fr/tr/articles/3711095-raw-data-gelismis-gostergeler.md) - [Gelişmiş Göstergeler Evrim SMKT](https://success.openhealth.fr/tr/articles/3193000-gelismis-gostergeler-evrim-smkt.md) - [Gelişmiş Göstergeler Analizi SMKT](https://success.openhealth.fr/tr/articles/3192366-gelismis-gostergeler-analizi-smkt.md) - [Gelişmiş Göstergeler Evrimi](https://success.openhealth.fr/tr/articles/3177853-gelismis-gostergeler-evrimi.md) - [Gelişmiş Göstergeler Evrim Biyografisi](https://success.openhealth.fr/tr/articles/7051823-gelismis-gostergeler-evrim-biyografisi.md) - [Ulusal Gelişmiş Göstergeler](https://success.openhealth.fr/tr/articles/3364513-ulusal-gelismis-gostergeler.md) - [Hisse Senedi Analizi](https://success.openhealth.fr/tr/articles/3178015-hisse-senedi-analizi.md) - [Gelişmiş Göstergeler Analizi Bio](https://success.openhealth.fr/tr/articles/7051801-gelismis-gostergeler-analizi-bio.md) - [Gelişmiş Göstergeler Analizi](https://success.openhealth.fr/tr/articles/3124439-gelismis-gostergeler-analizi.md) - [Kartografya](https://success.openhealth.fr/tr/articles/3192450-kartografya.md) - [Coğrafi Çapraz Tablo](https://success.openhealth.fr/tr/articles/3192466-cografi-capraz-tablo.md) - [Coğrafi Satış Gelişimi](https://success.openhealth.fr/tr/articles/3192482-cografi-satis-gelisimi.md) - [Satış Gücü Etkinliği](https://success.openhealth.fr/tr/articles/5624011-satis-gucu-etkinligi.md) - [Özel Ağırlıklandırma Yöntemi Analizi](https://success.openhealth.fr/tr/articles/5169317-ozel-agirliklandirma-yontemi-analizi.md) - [Ağ Analizi](https://success.openhealth.fr/tr/articles/3894767-ag-analizi.md) - [Özel Ağırlıklandırma Yöntemi Evrimi](https://success.openhealth.fr/tr/articles/5169320-ozel-agirliklandirma-yontemi-evrimi.md) - [KPI'lar ÖZET](https://success.openhealth.fr/tr/articles/3478199-kpi-lar-ozet.md) - [Dönüştürülmüş Birimlerde Satış](https://success.openhealth.fr/tr/articles/3192412-donusturulmus-birimlerde-satis.md) - [HAM VERİ Stok Göstergeleri](https://success.openhealth.fr/tr/articles/3711142-ham-veri-stok-gostergeleri.md) - [HAM VERI SMKT AIA](https://success.openhealth.fr/tr/articles/3720960-ham-veri-smkt-aia.md) - [Stok Evrimi](https://success.openhealth.fr/tr/articles/3178277-stok-evrimi.md) - [Coğrafi Gelişmiş Göstergeler](https://success.openhealth.fr/tr/articles/3192508-cografi-gelismis-gostergeler.md) - [Zaman Serisi Sektörel Analiz](https://success.openhealth.fr/tr/articles/3814974-zaman-serisi-sektorel-analiz.md) - [Yaş ve Cinsiyete Göre Satış Analizi](https://success.openhealth.fr/tr/articles/3192701-yas-ve-cinsiyete-gore-satis-analizi.md) - [Hamilelik Durumuna Göre Satış Gelişimi](https://success.openhealth.fr/tr/articles/3192910-hamilelik-durumuna-gore-satis-gelisimi.md) - [Yaş ve Cinsiyete Göre Satış Evrimi](https://success.openhealth.fr/tr/articles/3192732-yas-ve-cinsiyete-gore-satis-evrimi.md) - [Gereksinimler Sipariş Evrimi](https://success.openhealth.fr/tr/articles/5790020-gereksinimler-siparis-evrimi.md) - [Birlikte Dağıtım Evrimi](https://success.openhealth.fr/tr/articles/3192529-birlikte-dagitim-evrimi.md) - [Birlikte Dağıtım Analizi](https://success.openhealth.fr/tr/articles/3192633-birlikte-dagitim-analizi.md) - [Kanal ve Reçete Yazan Başına Satış](https://success.openhealth.fr/tr/articles/3192751-kanal-ve-recete-yazan-basina-satis.md) - [AMO, AMC & RAC](https://success.openhealth.fr/tr/articles/3192929-amo-amc-rac.md) - [Birlikte Dağıtım Dağılımı](https://success.openhealth.fr/tr/articles/3876946-birlikte-dagitim-dagilimi.md) - [Dağılım Dağılım Evrimi](https://success.openhealth.fr/tr/articles/3920070-dagilim-dagilim-evrimi.md) - [YAŞ ve CİNSİYETE Göre Aile Hekimi Reçeteleri](https://success.openhealth.fr/tr/articles/5789899-yas-ve-cinsiyete-gore-aile-hekimi-receteleri.md) - [Reçete Sipariş Analizi](https://success.openhealth.fr/tr/articles/5322866-recete-siparis-analizi.md) - [Aile Hekimi Reçetelerinin Gelişimi](https://success.openhealth.fr/tr/articles/5790016-aile-hekimi-recetelerinin-gelisimi.md) - [Sepet Analizi](https://success.openhealth.fr/tr/articles/3711049-sepet-analizi.md) - [Birlikte dağıtım](https://success.openhealth.fr/tr/articles/4738243-birlikte-dagitim.md) - [Kohort yeterlilik modülü](https://success.openhealth.fr/tr/articles/3928090-kohort-yeterlilik-modulu.md) - [Tedavi Durumu Modülü](https://success.openhealth.fr/tr/articles/3928067-tedavi-durumu-modulu.md) - [Modül Tedavi Bağlılığı](https://success.openhealth.fr/tr/articles/3928044-modul-tedavi-bagliligi.md) - [Kohort tanımı](https://success.openhealth.fr/tr/articles/3894703-kohort-tanimi.md) - [Ortak Tedaviler](https://success.openhealth.fr/tr/articles/4163623-ortak-tedaviler.md) - [Kohort görselleştirme](https://success.openhealth.fr/tr/articles/3894721-kohort-gorsellestirme.md) - [Analiz kriterlerinin tanımı](https://success.openhealth.fr/tr/articles/3894728-analiz-kriterlerinin-tanimi.md) - [Küresel kohort evrimi](https://success.openhealth.fr/tr/articles/3894747-kuresel-kohort-evrimi.md) - [Coğrafi dağılım](https://success.openhealth.fr/tr/articles/3894751-cografi-dagilim.md) - [Kohort profili](https://success.openhealth.fr/tr/articles/3894755-kohort-profili.md) - [Tedavi durumu dökümü](https://success.openhealth.fr/tr/articles/3894764-tedavi-durumu-dokumu.md) - [Tedavi başlangıçları](https://success.openhealth.fr/tr/articles/3894778-tedavi-baslangiclari.md) - [Tedavi yeniden başlar](https://success.openhealth.fr/tr/articles/3894788-tedavi-yeniden-baslar.md) - [Yeni tedaviler](https://success.openhealth.fr/tr/articles/3894804-yeni-tedaviler.md) - [Tedavi nüksleri](https://success.openhealth.fr/tr/articles/3894812-tedavi-nuksleri.md) - [Tedavi anahtarı dengesi](https://success.openhealth.fr/tr/articles/3894821-tedavi-anahtari-dengesi.md) - [Tedavi geçiş kazançları](https://success.openhealth.fr/tr/articles/3894830-tedavi-gecis-kazanclari.md) - [Arıtma anahtarı kayıpları](https://success.openhealth.fr/tr/articles/3894843-aritma-anahtari-kayiplari.md) - [Kazanç kökenlerini değiştir](https://success.openhealth.fr/tr/articles/3894857-kazanc-kokenlerini-degistir.md) - [Anahtar kaybı hedefi](https://success.openhealth.fr/tr/articles/3894864-anahtar-kaybi-hedefi.md) - [Okulu bırakanlar](https://success.openhealth.fr/tr/articles/3894874-okulu-birakanlar.md) - [KPI Özeti](https://success.openhealth.fr/tr/articles/4229969-kpi-ozeti.md) - [Tedavi kalıcılığı](https://success.openhealth.fr/tr/articles/3894883-tedavi-kaliciligi.md) - [Uyumluluk](https://success.openhealth.fr/tr/articles/3894884-uyumluluk.md) - [Düzenlilik kriteri nedir?](https://success.openhealth.fr/tr/articles/3325816-duzenlilik-kriteri-nedir.md) - [Ölüm - Kartografi](https://success.openhealth.fr/tr/articles/3863677-olum-kartografi.md) - [Ölüm sayısı kayması](https://success.openhealth.fr/tr/articles/3863573-olum-sayisi-kaymasi.md) - [Ölüm - YAŞ ve CİNSİYETE Göre Analiz](https://success.openhealth.fr/tr/articles/3863808-olum-yas-ve-cinsiyete-gore-analiz.md) - [Ölüm - YAŞ ve CİNSİYETE Göre Evrim](https://success.openhealth.fr/tr/articles/3863939-olum-yas-ve-cinsiyete-gore-evrim.md) - [Ölüm - Evrim](https://success.openhealth.fr/tr/articles/3864065-olum-evrim.md) - [Ölüm - Evrim Karşılaştırması](https://success.openhealth.fr/tr/articles/3864073-olum-evrim-karsilastirmasi.md) - [Eczane İzleme CA](https://success.openhealth.fr/tr/articles/4634768-eczane-izleme-ca.md) - [Trafik Analizi \(Beta testi\)](https://success.openhealth.fr/tr/articles/6848401-trafik-analizi-beta-testi.md) - [Eczane İzleme Detayları](https://success.openhealth.fr/tr/articles/4527868-eczane-izleme-detaylari.md) - [Trafik Evrimi \(Beta testi\)](https://success.openhealth.fr/tr/articles/6848016-trafik-evrimi-beta-testi.md) - [Eczane İzleme Kartografyası](https://success.openhealth.fr/tr/articles/4527811-eczane-izleme-kartografyasi.md) - [Eczane İzleme Detayları](https://success.openhealth.fr/tr/articles/4262306-eczane-izleme-detaylari.md) - [Eczane İzleme Analizi](https://success.openhealth.fr/tr/articles/3839223-eczane-izleme-analizi.md) - [Eczane İzleme Evrimi](https://success.openhealth.fr/tr/articles/3827973-eczane-izleme-evrimi.md) - [Ayrıştırma Trafiği](https://success.openhealth.fr/tr/articles/3826074-ayristirma-trafigi.md) - [Trafik çalışması](https://success.openhealth.fr/tr/articles/3809042-trafik-calismasi.md) - [Yönetici Özeti - PIEX](https://success.openhealth.fr/tr/articles/5203335-yonetici-ozeti-piex.md) - [Satın Alma](https://success.openhealth.fr/tr/articles/4605110-satin-alma.md) - [Sorgum - PIEX](https://success.openhealth.fr/tr/articles/4210627-sorgum-piex.md) - [Satış Evrimi - PIEX](https://success.openhealth.fr/tr/articles/4210655-satis-evrimi-piex.md) - [Satış Analizi - PIEX](https://success.openhealth.fr/tr/articles/4210650-satis-analizi-piex.md) - [Sipariş detayları - PIEX](https://success.openhealth.fr/tr/articles/4210659-siparis-detaylari-piex.md) - [Hisselere genel bakış - PIEX](https://success.openhealth.fr/tr/articles/4210672-hisselere-genel-bakis-piex.md) - [Veri Arşivim - PIEX](https://success.openhealth.fr/tr/articles/4210694-veri-arsivim-piex.md) - [EURAPHARMA- PIEX](https://success.openhealth.fr/tr/articles/4366306-eurapharma-piex.md) - [Eşleşen ürün](https://success.openhealth.fr/tr/articles/4366320-eslesen-urun.md) - [CLI Dosyam \(1/5\)](https://success.openhealth.fr/tr/articles/4626422-cli-dosyam-1-5.md) - [CLI\_Dosya Sayıları \(2/5\)](https://success.openhealth.fr/tr/articles/4626421-cli_dosya-sayilari-2-5.md) - [OHC deposu ile CLI\_Dosya Kodu Eşleştirme](https://success.openhealth.fr/tr/articles/4626419-ohc-deposu-ile-cli_dosya-kodu-eslestirme.md) - [Sell-Out İhracat \(4/5\)](https://success.openhealth.fr/tr/articles/4626414-sell-out-ihracat-4-5.md) ### ÖZELLEŞTIRILMIŞ SEÇENEKLER - [Hiyerarşik olmayan ürün niteleyicileri](https://success.openhealth.fr/tr/articles/4036045-hiyerarsik-olmayan-urun-niteleyicileri.md) - [HUB verileri için maksimum geriye dönük tarih nedir?](https://success.openhealth.fr/tr/articles/3195251-hub-verileri-icin-maksimum-geriye-donuk-tarih-nedir.md) - [Müşteri Tipi](https://success.openhealth.fr/tr/articles/4197147-musteri-tipi.md) - [Oturum Erişimi](https://success.openhealth.fr/tr/articles/4036458-oturum-erisimi.md) - [Özelleştirilmiş döngü](https://success.openhealth.fr/tr/articles/4036444-ozellestirilmis-dongu.md) - [Mali Yıl](https://success.openhealth.fr/tr/articles/4036169-mali-yil.md) - [Gün düğmesi](https://success.openhealth.fr/tr/articles/4036159-gun-dugmesi.md) - [Hafta" düğmesi \(haftalık veriler\)](https://success.openhealth.fr/tr/articles/4036111-hafta-dugmesi-haftalik-veriler.md) - [Döviz kurları](https://success.openhealth.fr/tr/articles/8329594-doviz-kurlari.md) - [SMKT dönem takvimi](https://success.openhealth.fr/tr/articles/4036549-smkt-donem-takvimi.md) - [Çevreyi kısıtlayın](https://success.openhealth.fr/tr/articles/4560699-cevreyi-kisitlayin.md) - [Çevreyi kısıtla \(kod 7\)](https://success.openhealth.fr/tr/articles/4560791-cevreyi-kisitla-kod-7.md) - [Pazar bayrağı](https://success.openhealth.fr/tr/articles/4560797-pazar-bayragi.md) - [Puanlama / Hedefleme \("Müşteri Tipi"\)](https://success.openhealth.fr/tr/articles/3777788-puanlama-hedefleme-musteri-tipi.md) ### GÖSTERGELER - [HUB göstergeleri sözlüğü](https://success.openhealth.fr/tr/articles/5194247-hub-gostergeleri-sozlugu.md) - [Satış Hacmi](https://success.openhealth.fr/tr/articles/3194314-satis-hacmi.md) - [Satış Değeri](https://success.openhealth.fr/tr/articles/3074854-satis-degeri.md) - [N MS, Pazar Payı](https://success.openhealth.fr/tr/articles/3194475-n-ms-pazar-payi.md) - [N MS Evol](https://success.openhealth.fr/tr/articles/5634266-n-ms-evol.md) - [N MS Delta, Pazar Payının Gelişimi](https://success.openhealth.fr/tr/articles/3194469-n-ms-delta-pazar-payinin-gelisimi.md) - [Poids Vol \(CA\) par modalité / Özel Ağırlık Hacmi \(To\)](https://success.openhealth.fr/tr/articles/9292839-poids-vol-ca-par-modalite-ozel-agirlik-hacmi-to.md) - [KDV hariç üretici fiyatına dayalı satış değeri \(KDV hariç PF cirosu\) - Fas](https://success.openhealth.fr/tr/articles/7508513-kdv-haric-uretici-fiyatina-dayali-satis-degeri-kdv-haric-pf-cirosu-fas.md) - [N Büyüme TO](https://success.openhealth.fr/tr/articles/3194466-n-buyume-to.md) - [Anlaştık.](https://success.openhealth.fr/tr/articles/6201859-anlastik.md) - [Çapraz Ağırlık Hacmi](https://success.openhealth.fr/tr/articles/6066324-capraz-agirlik-hacmi.md) - [Çapraz Ağırlık Devri](https://success.openhealth.fr/tr/articles/6066273-capraz-agirlik-devri.md) - [N Büyüme TO düzeltilmiş](https://success.openhealth.fr/tr/articles/3205376-n-buyume-to-duzeltilmis.md) - [Kaynak ağırlığı](https://success.openhealth.fr/tr/articles/5151525-kaynak-agirligi.md) - [Ortalama fiyat](https://success.openhealth.fr/tr/articles/3194302-ortalama-fiyat.md) - [Ağırlıklı ortalama fiyat](https://success.openhealth.fr/tr/articles/3194292-agirlikli-ortalama-fiyat.md) - [Fiyat etkisi](https://success.openhealth.fr/tr/articles/8426443-fiyat-etkisi.md) - [Satış Yapan Eczane Sayısı](https://success.openhealth.fr/tr/articles/3719566-satis-yapan-eczane-sayisi.md) - [Dijital Satış Dağıtımı](https://success.openhealth.fr/tr/articles/3194321-dijital-satis-dagitimi.md) - [Küresel Dijital Satış Dağıtımı](https://success.openhealth.fr/tr/articles/3194320-kuresel-dijital-satis-dagitimi.md) - [Dijital Satış Dağıtımı Yeniden Düzenlendi](https://success.openhealth.fr/tr/articles/4045636-dijital-satis-dagitimi-yeniden-duzenlendi.md) - [Dijital Dağıtım Satıcısı Global Rebased](https://success.openhealth.fr/tr/articles/4045725-dijital-dagitim-saticisi-global-rebased.md) - [Özelleştirilmiş yeniden tabanlı dijital satış dağıtımı](https://success.openhealth.fr/tr/articles/6830813-ozellestirilmis-yeniden-tabanli-dijital-satis-dagitimi.md) - [Dağıtım Satış Değeri](https://success.openhealth.fr/tr/articles/3194323-dagitim-satis-degeri.md) - [Dağıtım Toplam Satış Değeri](https://success.openhealth.fr/tr/articles/3194316-dagitim-toplam-satis-degeri.md) - [Yeniden oluşturulmuş satış değeri dağılımı](https://success.openhealth.fr/tr/articles/3194501-yeniden-olusturulmus-satis-degeri-dagilimi.md) - [Küresel yeniden bazlı satış değeri dağılımı](https://success.openhealth.fr/tr/articles/4200619-kuresel-yeniden-bazli-satis-degeri-dagilimi.md) - [Özelleştirilmiş yeniden düzenlenmiş satış değeri dağılımı](https://success.openhealth.fr/tr/articles/6834423-ozellestirilmis-yeniden-duzenlenmis-satis-degeri-dagilimi.md) - [SMKT Dijital Bayi Dağıtımı](https://success.openhealth.fr/tr/articles/3365043-smkt-dijital-bayi-dagitimi.md) - [SMKT Global Dijital Satış Dağıtımı](https://success.openhealth.fr/tr/articles/4298341-smkt-global-dijital-satis-dagitimi.md) - [SMKT Satışları Dijital Dağıtım Yeniden Düzenlendi](https://success.openhealth.fr/tr/articles/4298197-smkt-satislari-dijital-dagitim-yeniden-duzenlendi.md) - [SMKT Satış Dijital Dağıtım Global Yeniden Düzenlendi](https://success.openhealth.fr/tr/articles/4319783-smkt-satis-dijital-dagitim-global-yeniden-duzenlendi.md) - [Dağıtım Satış Değeri SMKT](https://success.openhealth.fr/tr/articles/3365478-dagitim-satis-degeri-smkt.md) - [SMKT Global Yeniden Hesaplanan Dijital Satış Dağılımı](https://success.openhealth.fr/tr/articles/4298373-smkt-global-yeniden-hesaplanan-dijital-satis-dagilimi.md) - [SMKT Satışları Dijital Dağıtım Yeniden Hesaplandı](https://success.openhealth.fr/tr/articles/4298303-smkt-satislari-dijital-dagitim-yeniden-hesaplandi.md) - [SMKT Düzeltilmiş Dijital Satış Dağılımı](https://success.openhealth.fr/tr/articles/3369386-smkt-duzeltilmis-dijital-satis-dagilimi.md) - [Yeniden Hesaplanan SMKT Dijital Satış Dağılımı](https://success.openhealth.fr/tr/articles/4298209-yeniden-hesaplanan-smkt-dijital-satis-dagilimi.md) - [SMKT Düzeltilmiş Satış Değeri Dağılımı](https://success.openhealth.fr/tr/articles/3369397-smkt-duzeltilmis-satis-degeri-dagilimi.md) - [Organik Dijital Satış Dağıtımı](https://success.openhealth.fr/tr/articles/7052424-organik-dijital-satis-dagitimi.md) - [Satış Yapan Eczanelerin Ciroları \(TSP\)](https://success.openhealth.fr/tr/articles/6096534-satis-yapan-eczanelerin-cirolari-tsp.md) - [Sahibinizin PDM'sini tahmin etme](https://success.openhealth.fr/tr/articles/4214883-sahibinizin-pdm-sini-tahmin-etme.md) - [Daha fazla eczane](https://success.openhealth.fr/tr/articles/8426451-daha-fazla-eczane.md) - [Eczane kaybı](https://success.openhealth.fr/tr/articles/8426460-eczane-kaybi.md) - [Çok Kanallı Dijital Satış ve Dağıtım](https://success.openhealth.fr/tr/articles/9293487-cok-kanalli-dijital-satis-ve-dagitim.md) - [Kümülatif Satış Dijital Dağıtım \(PHARMA\)](https://success.openhealth.fr/tr/articles/9330571-kumulatif-satis-dijital-dagitim-pharma.md) - [AMS: Ortalama Aylık Satışlar](https://success.openhealth.fr/tr/articles/3194303-ams-ortalama-aylik-satislar.md) - [AMS A: Düzeltilmiş Ortalama Aylık Satışlar](https://success.openhealth.fr/tr/articles/3194290-ams-a-duzeltilmis-ortalama-aylik-satislar.md) - [AMS To: Ortalama Aylık Satış Değeri](https://success.openhealth.fr/tr/articles/4535404-ams-to-ortalama-aylik-satis-degeri.md) - [AMS'den A'ya: Düzeltilmiş Ortalama Aylık Satış Değeri](https://success.openhealth.fr/tr/articles/6028256-ams-den-a-ya-duzeltilmis-ortalama-aylik-satis-degeri.md) - [Ortalama satışlar](https://success.openhealth.fr/tr/articles/3563716-ortalama-satislar.md) - [Ortalama satışlar SMKT](https://success.openhealth.fr/tr/articles/3365496-ortalama-satislar-smkt.md) - [Ortalama SMKT Düzeltilmiş Satışlar](https://success.openhealth.fr/tr/articles/3369340-ortalama-smkt-duzeltilmis-satislar.md) - [Ortalama aylık organik satışlar](https://success.openhealth.fr/tr/articles/7052551-ortalama-aylik-organik-satislar.md) - [Ortalama aylık satış Organik değer](https://success.openhealth.fr/tr/articles/7052573-ortalama-aylik-satis-organik-deger.md) - [Stok](https://success.openhealth.fr/tr/articles/3194332-stok.md) - [Ortalama stok](https://success.openhealth.fr/tr/articles/3194336-ortalama-stok.md) - [Hisse Senedi](https://success.openhealth.fr/tr/articles/3194334-hisse-senedi.md) - [Ticari Basınç Endeksi](https://success.openhealth.fr/tr/articles/3194335-ticari-basinc-endeksi.md) - [Stok Dönüşüm Oranı](https://success.openhealth.fr/tr/articles/3194344-stok-donusum-orani.md) - [Tedarik Süresi - N Stok Kapsamı](https://success.openhealth.fr/tr/articles/3194337-tedarik-suresi-n-stok-kapsami.md) - [Stoktaki eczane sayısı](https://success.openhealth.fr/tr/articles/3194338-stoktaki-eczane-sayisi.md) - [Dijital Dağıtım Stokçusu](https://success.openhealth.fr/tr/articles/3194339-dijital-dagitim-stokcusu.md) - [Dijital Dağıtım Stokçusu yeniden yapılandırıldı](https://success.openhealth.fr/tr/articles/4045743-dijital-dagitim-stokcusu-yeniden-yapilandirildi.md) - [Küresel yeniden stoklanmış dijital dağıtım](https://success.openhealth.fr/tr/articles/4045753-kuresel-yeniden-stoklanmis-dijital-dagitim.md) - [Dağıtım Stok değeri](https://success.openhealth.fr/tr/articles/3194342-dagitim-stok-degeri.md) - [Yeniden hesaplanan stok değerinin dağılımı](https://success.openhealth.fr/tr/articles/3194505-yeniden-hesaplanan-stok-degerinin-dagilimi.md) - [Dijital Dağıtım Düzgünleştirilmiş stokçu](https://success.openhealth.fr/tr/articles/5141830-dijital-dagitim-duzgunlestirilmis-stokcu.md) - [Dijital Dağıtım Stokçusu düzeltilmiş yeniden düzenlenmiş](https://success.openhealth.fr/tr/articles/5142162-dijital-dagitim-stokcusu-duzeltilmis-yeniden-duzenlenmis.md) - [Dağıtım Düzeltilmiş hisse senedi değeri](https://success.openhealth.fr/tr/articles/5203640-dagitim-duzeltilmis-hisse-senedi-degeri.md) - [Dağıtım Düzeltilmiş yeniden düzenlenmiş hisse senedi değeri](https://success.openhealth.fr/tr/articles/5203701-dagitim-duzeltilmis-yeniden-duzenlenmis-hisse-senedi-degeri.md) - [Marj](https://success.openhealth.fr/tr/articles/3507716-marj.md) - [Marj oranı](https://success.openhealth.fr/tr/articles/3507767-marj-orani.md) - [Vergiler hariç satın alma fiyatı](https://success.openhealth.fr/tr/articles/4557500-vergiler-haric-satin-alma-fiyati.md) - [Satış - Müşteri tabanınızın analizi](https://success.openhealth.fr/tr/articles/3846225-satis-musteri-tabaninizin-analizi.md) - [Satış - Eczanelerde atipizm](https://success.openhealth.fr/tr/articles/3848791-satis-eczanelerde-atipizm.md) - [Evrim oranı](https://success.openhealth.fr/tr/articles/3194287-evrim-orani.md) - [Penetrasyon oranı](https://success.openhealth.fr/tr/articles/3194286-penetrasyon-orani.md) - [Ürün yelpazesinin genişliği](https://success.openhealth.fr/tr/articles/3369425-urun-yelpazesinin-genisligi.md) - [Ürün yelpazesinin yenilenmesi](https://success.openhealth.fr/tr/articles/3369545-urun-yelpazesinin-yenilenmesi.md) - [Ürün yelpazesinde yenilik](https://success.openhealth.fr/tr/articles/3369468-urun-yelpazesinde-yenilik.md) - [Menzilden çekilme](https://success.openhealth.fr/tr/articles/3369457-menzilden-cekilme.md) - [Ürün çeşitliliği yıpranma oranı](https://success.openhealth.fr/tr/articles/3369485-urun-cesitliligi-yipranma-orani.md) - [Ürün yelpazesindeki yenilik oranı](https://success.openhealth.fr/tr/articles/3369541-urun-yelpazesindeki-yenilik-orani.md) - [Satış teklifinin payı](https://success.openhealth.fr/tr/articles/3369040-satis-teklifinin-payi.md) - [Seçilen Ürün Sayısı](https://success.openhealth.fr/tr/articles/3511502-secilen-urun-sayisi.md) - [Ortalama ürün sayısı](https://success.openhealth.fr/tr/articles/3194284-ortalama-urun-sayisi.md) - [Ürün yelpazesinin yenilenme oranı](https://success.openhealth.fr/tr/articles/3369561-urun-yelpazesinin-yenilenme-orani.md) - [Ürün sayısı](https://success.openhealth.fr/tr/articles/6312686-urun-sayisi.md) - [Eylem başına harcanan miktarlar](https://success.openhealth.fr/tr/articles/3447792-eylem-basina-harcanan-miktarlar.md) - [Harcanan paranın alıcı türüne göre dağılımı](https://success.openhealth.fr/tr/articles/3447801-harcanan-paranin-alici-turune-gore-dagilimi.md) - [Tüketim endeksi](https://success.openhealth.fr/tr/articles/3432701-tuketim-endeksi.md) - [Satış payı](https://success.openhealth.fr/tr/articles/3432664-satis-payi.md) - [Değer bağlılık oranı](https://success.openhealth.fr/tr/articles/3432695-deger-baglilik-orani.md) - [Mutlak penetrasyon](https://success.openhealth.fr/tr/articles/3432556-mutlak-penetrasyon.md) - [Ciro payı](https://success.openhealth.fr/tr/articles/3432655-ciro-payi.md) - [p-değeri](https://success.openhealth.fr/tr/articles/5781702-p-degeri.md) - [Temel Bileşen Analizi](https://success.openhealth.fr/tr/articles/4231028-temel-bilesen-analizi.md) - [Negatif Tahmin Değeri](https://success.openhealth.fr/tr/articles/4134220-negatif-tahmin-degeri.md) - [Pozitif Tahmin Değeri](https://success.openhealth.fr/tr/articles/4134166-pozitif-tahmin-degeri.md) - [Bağımsızlık testi](https://success.openhealth.fr/tr/articles/4128369-bagimsizlik-testi.md) - [Zaman serisi çalışması](https://success.openhealth.fr/tr/articles/3633991-zaman-serisi-calismasi.md) - [Mevsimsel varyans oranı](https://success.openhealth.fr/tr/articles/3653790-mevsimsel-varyans-orani.md) - [Bir testin duyarlılığı ve özgüllüğü](https://success.openhealth.fr/tr/articles/3928135-bir-testin-duyarliligi-ve-ozgullugu.md) - [Trend varyans oranı](https://success.openhealth.fr/tr/articles/3653847-trend-varyans-orani.md) - [Artık varyans oranı](https://success.openhealth.fr/tr/articles/3653851-artik-varyans-orani.md) - [Belirleme katsayısı](https://success.openhealth.fr/tr/articles/3654093-belirleme-katsayisi.md) - [Varyasyon katsayısı](https://success.openhealth.fr/tr/articles/3653915-varyasyon-katsayisi.md) - [Bir zaman serisinin varyansı](https://success.openhealth.fr/tr/articles/3653855-bir-zaman-serisinin-varyansi.md) - [Satış yoğunluğu](https://success.openhealth.fr/tr/articles/3395856-satis-yogunlugu.md) - [Gini endeksi](https://success.openhealth.fr/tr/articles/3395323-gini-endeksi.md) - [Nüfus](https://success.openhealth.fr/tr/articles/4396779-nufus.md) - [Ölüm sayısının evrimi](https://success.openhealth.fr/tr/articles/4396765-olum-sayisinin-evrimi.md) - [Cinsiyet oranı](https://success.openhealth.fr/tr/articles/3812167-cinsiyet-orani.md) - [Nüfus - Ortalama yaş](https://success.openhealth.fr/tr/articles/3812180-nufus-ortalama-yas.md) - [Nüfus - Ortanca yaş](https://success.openhealth.fr/tr/articles/3812198-nufus-ortanca-yas.md) - [Nüfus - Yaş 1. çeyrek dilimi](https://success.openhealth.fr/tr/articles/3812218-nufus-yas-1-ceyrek-dilimi.md) - [Nüfus - Yaş 3. çeyrek dilimi](https://success.openhealth.fr/tr/articles/3812227-nufus-yas-3-ceyrek-dilimi.md) - [Seçilen kişilerin bölgenin toplam nüfusu içindeki payı](https://success.openhealth.fr/tr/articles/3812233-secilen-kisilerin-bolgenin-toplam-nufusu-icindeki-payi.md) - [Ölüm oranı](https://success.openhealth.fr/tr/articles/3947946-olum-orani.md) - [Vaka ölüm oranı](https://success.openhealth.fr/tr/articles/3948084-vaka-olum-orani.md) - [Doğurganlık çağındaki kadınlar](https://success.openhealth.fr/tr/articles/4172859-dogurganlik-cagindaki-kadinlar.md) - [Bölgedeki toplam ölümler içinde seçimin payı](https://success.openhealth.fr/tr/articles/3863734-bolgedeki-toplam-olumler-icinde-secimin-payi.md) - [Kayıp ölümlerin sayısının modellenmesi](https://success.openhealth.fr/tr/articles/3895572-kayip-olumlerin-sayisinin-modellenmesi.md) - [Reçete başlangıcında tahmini satışlar](https://success.openhealth.fr/tr/articles/5323282-recete-baslangicinda-tahmini-satislar.md) - [Yaş ve gebelik durumuna göre evrim](https://success.openhealth.fr/tr/articles/6820051-yas-ve-gebelik-durumuna-gore-evrim.md) - [Ortak Dağıtım Ürünleri Oranı](https://success.openhealth.fr/tr/articles/7892010-ortak-dagitim-urunleri-orani.md) - [Tahmini reçete dolum satışları](https://success.openhealth.fr/tr/articles/5323209-tahmini-recete-dolum-satislari.md) - [Reçete dolum satışlarının ağırlığı](https://success.openhealth.fr/tr/articles/5323198-recete-dolum-satislarinin-agirligi.md) - [Reçete başlangıcında satışların ağırlığı](https://success.openhealth.fr/tr/articles/5323086-recete-baslangicinda-satislarin-agirligi.md) - [Ortak dağıtıcı sayısı](https://success.openhealth.fr/tr/articles/3194351-ortak-dagitici-sayisi.md) - [İzin sayısı](https://success.openhealth.fr/tr/articles/3194348-izin-sayisi.md) - [Müşteri Kimliği başına ortalama dağıtım sayısı](https://success.openhealth.fr/tr/articles/3369626-musteri-kimligi-basina-ortalama-dagitim-sayisi.md) - [Uyumluluk](https://success.openhealth.fr/tr/articles/3411996-uyumluluk.md) - [Kalıcılık oranı](https://success.openhealth.fr/tr/articles/3369684-kalicilik-orani.md) - [Terapötik bağlılık](https://success.openhealth.fr/tr/articles/3412091-terapotik-baglilik.md) - [Müşteri Kimliği başına ortalama günlük dozaj](https://success.openhealth.fr/tr/articles/4153587-musteri-kimligi-basina-ortalama-gunluk-dozaj.md) - [Geri ödeme için gönderilen dispanser sayısı](https://success.openhealth.fr/tr/articles/3370942-geri-odeme-icin-gonderilen-dispanser-sayisi.md) - [Geri ödeme için gönderilmeyen dispanser sayısı](https://success.openhealth.fr/tr/articles/3370920-geri-odeme-icin-gonderilmeyen-dispanser-sayisi.md) - [Zorunlu sağlık sigortası kapsamında geri ödenen değer satışları](https://success.openhealth.fr/tr/articles/3371699-zorunlu-saglik-sigortasi-kapsaminda-geri-odenen-deger-satislari.md) - [Tamamlayıcı sağlık sigortası tarafından geri ödenen satış değerleri](https://success.openhealth.fr/tr/articles/3371830-tamamlayici-saglik-sigortasi-tarafindan-geri-odenen-satis-degerleri.md) - [Kalan satış değerleri](https://success.openhealth.fr/tr/articles/3371842-kalan-satis-degerleri.md) - [Yaygınlık](https://success.openhealth.fr/tr/articles/3947955-yayginlik.md) - [Dispanser başına ortalama GTIN sayısı](https://success.openhealth.fr/tr/articles/3396154-dispanser-basina-ortalama-gtin-sayisi.md) - [Dağıtım başına ortalama hacim](https://success.openhealth.fr/tr/articles/3396196-dagitim-basina-ortalama-hacim.md) - [Dispanser başına ortalama ciro](https://success.openhealth.fr/tr/articles/3396208-dispanser-basina-ortalama-ciro.md) - [Kutu başına aktif bileşen dozajı](https://success.openhealth.fr/tr/articles/3675409-kutu-basina-aktif-bilesen-dozaji.md) - [Kutu başına DDD](https://success.openhealth.fr/tr/articles/3675446-kutu-basina-ddd.md) - [Temel birimlerde hacim](https://success.openhealth.fr/tr/articles/3675520-temel-birimlerde-hacim.md) - [Aktif bileşen hacmi](https://success.openhealth.fr/tr/articles/3675539-aktif-bilesen-hacmi.md) - [1.000 kişi başına DDD](https://success.openhealth.fr/tr/articles/3675667-1-000-kisi-basina-ddd.md) - [Ortalama CU hacmi Müşteri Kimliği](https://success.openhealth.fr/tr/articles/3675761-ortalama-cu-hacmi-musteri-kimligi.md) - [Müşteri kimliği başına ortalama BU hacmi](https://success.openhealth.fr/tr/articles/3675814-musteri-kimligi-basina-ortalama-bu-hacmi.md) - [Müşteri Kimliği başına ortalama aktif bileşen hacmi](https://success.openhealth.fr/tr/articles/3675824-musteri-kimligi-basina-ortalama-aktif-bilesen-hacmi.md) - [Gözlemlenen ortalama tedavi süresi](https://success.openhealth.fr/tr/articles/3675841-gozlemlenen-ortalama-tedavi-suresi.md) - [Aşılama kapsamı](https://success.openhealth.fr/tr/articles/3822264-asilama-kapsami.md) - [Müşteri kimlikleri dahil](https://success.openhealth.fr/tr/articles/3886665-musteri-kimlikleri-dahil.md) - [PRM ve DCP arasındaki farklar](https://success.openhealth.fr/tr/articles/3722666-prm-ve-dcp-arasindaki-farklar.md) - [Ortalama tedavi süresi](https://success.openhealth.fr/tr/articles/3920967-ortalama-tedavi-suresi.md) - [Ortalama yenileme süresi](https://success.openhealth.fr/tr/articles/3921067-ortalama-yenileme-suresi.md) - [Tedavi başlangıçları](https://success.openhealth.fr/tr/articles/3848844-tedavi-baslangiclari.md) - [Tedavi yenilemeleri](https://success.openhealth.fr/tr/articles/3885469-tedavi-yenilemeleri.md) - [Tedavi varsayımları](https://success.openhealth.fr/tr/articles/3885608-tedavi-varsayimlari.md) - [Yeni tedaviler](https://success.openhealth.fr/tr/articles/3885297-yeni-tedaviler.md) - [Tedavi anahtarı](https://success.openhealth.fr/tr/articles/3848886-tedavi-anahtari.md) - [Tedavinin durması](https://success.openhealth.fr/tr/articles/3885426-tedavinin-durmasi.md) - [Bırakma](https://success.openhealth.fr/tr/articles/3885387-birakma.md) - [İzlenebilirlik eki](https://success.openhealth.fr/tr/articles/4355163-izlenebilirlik-eki.md) - [Durduruldu ve sonra yeniden başlatıldı](https://success.openhealth.fr/tr/articles/8429189-durduruldu-ve-sonra-yeniden-baslatildi.md) - [Dağıtım payı](https://success.openhealth.fr/tr/articles/3624820-dagitim-payi.md) - [İlgili izinlerin izlenmesi](https://success.openhealth.fr/tr/articles/3804193-ilgili-izinlerin-izlenmesi.md) - [Parçalanma oranı](https://success.openhealth.fr/tr/articles/4850138-parcalanma-orani.md) - [Bir reaksiyonun kinetiği](https://success.openhealth.fr/tr/articles/4850629-bir-reaksiyonun-kinetigi.md) - [Yarı ömür süresi](https://success.openhealth.fr/tr/articles/4849710-yari-omur-suresi.md) - [Envanter karşılama oranı - PIEX](https://success.openhealth.fr/tr/articles/4210714-envanter-karsilama-orani-piex.md) - [HUB zaman dilimleri](https://success.openhealth.fr/tr/articles/3194479-hub-zaman-dilimleri.md) - [Mali yıl tanımının değiştirilmesi](https://success.openhealth.fr/tr/articles/3321750-mali-yil-taniminin-degistirilmesi.md) - [Haftalık karşılaştırmaların yönetimi](https://success.openhealth.fr/tr/articles/3835180-haftalik-karsilastirmalarin-yonetimi.md) - [GSA Parapharmacies Takvimi \(SMKT\)](https://success.openhealth.fr/tr/articles/3175583-gsa-parapharmacies-takvimi-smkt.md) - [N](https://success.openhealth.fr/tr/articles/3194484-n.md) - [N Evol](https://success.openhealth.fr/tr/articles/3194461-n-evol.md) - [N Trend](https://success.openhealth.fr/tr/articles/3194485-n-trend.md) ### IAS - Indicateurs Avancés Sanitaires - [IAS\(r\) Alerji](https://success.openhealth.fr/tr/articles/7339151-ias-r-alerji.md) - [IAS\(r\) Poux](https://success.openhealth.fr/tr/articles/7339168-ias-r-poux.md) - [IAS\(r\) gastroenterit](https://success.openhealth.fr/tr/articles/7339181-ias-r-gastroenterit.md) - [IAS\(r\) Solunum Sendromları](https://success.openhealth.fr/tr/articles/3815345-ias-r-solunum-sendromlari.md) - [IAS\(r\) Grip benzeri hastalık](https://success.openhealth.fr/tr/articles/7266711-ias-r-grip-benzeri-hastalik.md) ### Marketing Direct - [OpenHealth E-posta Gönderme Çözümü](https://success.openhealth.fr/tr/articles/7055261-openhealth-e-posta-gonderme-cozumu.md) - [Bir e-posta kampanyası oluşturmak için gerekenler](https://success.openhealth.fr/tr/articles/6282113-bir-e-posta-kampanyasi-olusturmak-icin-gerekenler.md) - [İzleme Raporu ve Karşılaştırma Ölçütleri](https://success.openhealth.fr/tr/articles/6302721-izleme-raporu-ve-karsilastirma-olcutleri.md) - [E-posta kampanyaları için sözlük](https://success.openhealth.fr/tr/articles/6282099-e-posta-kampanyalari-icin-sozluk.md) ### PSAD - OBSERVATOIRE - [Analiz - ULUSAL](https://success.openhealth.fr/tr/articles/3376262-analiz-ulusal.md) - [Hacim / Ciro - ULUSAL](https://success.openhealth.fr/tr/articles/3376287-hacim-ciro-ulusal.md) - [Evrim - ULUSAL](https://success.openhealth.fr/tr/articles/3376370-evrim-ulusal.md) - [Ekstraksiyon - ULUSAL](https://success.openhealth.fr/tr/articles/3376420-ekstraksiyon-ulusal.md) - [Tanım](https://success.openhealth.fr/tr/articles/3376439-tanim.md) ### AUTRES THEMATIQUES - [İNTERKOM](https://success.openhealth.fr/tr/articles/6959415-interkom.md) - [Satış Gücü](https://success.openhealth.fr/tr/articles/6959337-satis-gucu.md) - [GIHSN: Excel dosyasını gönderin](https://success.openhealth.fr/tr/articles/3977478-gihsn-excel-dosyasini-gonderin.md) - [Blok Zinciri](https://success.openhealth.fr/tr/articles/5385413-blok-zinciri.md) - [DocuSign, iş sürecimizde bir CRM aracı](https://success.openhealth.fr/tr/articles/4514472-docusign-is-surecimizde-bir-crm-araci.md) - [Ulusal aşılama takibi](https://success.openhealth.fr/tr/articles/4754333-ulusal-asilama-takibi.md) - [Aşılama kapsamı](https://success.openhealth.fr/tr/articles/4754311-asilama-kapsami.md) - [KPI İzleme](https://success.openhealth.fr/tr/articles/4091042-kpi-izleme.md) - [Eczane Kokpiti](https://success.openhealth.fr/tr/articles/4091025-eczane-kokpiti.md) - [Nüfus eşdeğeri \(p.e.\)](https://success.openhealth.fr/tr/articles/5431894-nufus-esdegeri-p-e.md) - [Oksijen ihtiyacı](https://success.openhealth.fr/tr/articles/5137158-oksijen-ihtiyaci.md) - [IHU](https://success.openhealth.fr/tr/articles/4851687-ihu.md) - [Askıya alınmış madde](https://success.openhealth.fr/tr/articles/5137147-askiya-alinmis-madde.md) - [Atık su kimyası](https://success.openhealth.fr/tr/articles/5137101-atik-su-kimyasi.md) - [NRBCE](https://success.openhealth.fr/tr/articles/4851683-nrbce.md) - [Arrhenius yasası](https://success.openhealth.fr/tr/articles/4849672-arrhenius-yasasi.md) - [Ortaya çıkan performans](https://success.openhealth.fr/tr/articles/5137034-ortaya-cikan-performans.md) - [Atık su türleri](https://success.openhealth.fr/tr/articles/5137183-atik-su-turleri.md) - [SARS-CoV-2 virüs konsantrasyonu](https://success.openhealth.fr/tr/articles/4867968-sars-cov-2-virus-konsantrasyonu.md) - [MAPOM / BMPM](https://success.openhealth.fr/tr/articles/4851685-mapom-bmpm.md) - [SARS-CoV-2'nin bağlamsallaştırılmış konsantrasyonu](https://success.openhealth.fr/tr/articles/4934604-sars-cov-2-nin-baglamsallastirilmis-konsantrasyonu.md) - [Kanalizasyon sistemi tipi](https://success.openhealth.fr/tr/articles/4867954-kanalizasyon-sistemi-tipi.md) - [Virüsün bozunması](https://success.openhealth.fr/tr/articles/4865742-virusun-bozunmasi.md) - [WBE](https://success.openhealth.fr/tr/articles/4865735-wbe.md) - [RNA](https://success.openhealth.fr/tr/articles/4865733-rna.md) - [Koronavirüs](https://success.openhealth.fr/tr/articles/4865728-koronavirus.md) - [COVID-19](https://success.openhealth.fr/tr/articles/4865726-covid-19.md) - [Seroprevalans: örnekleme yöntemi](https://success.openhealth.fr/tr/articles/3924493-seroprevalans-ornekleme-yontemi.md) - [SANDRE deposu](https://success.openhealth.fr/tr/articles/5415040-sandre-deposu.md) - [Ulusal Üs ROSEAU](https://success.openhealth.fr/tr/articles/5414523-ulusal-us-roseau.md) - [SARS-CoV-2 virüs konsantrasyonu](https://success.openhealth.fr/tr/articles/4852404-sars-cov-2-virus-konsantrasyonu.md) - [SARS-CoV-2 virüs konsantrasyonu - Varyantlar](https://success.openhealth.fr/tr/articles/4909854-sars-cov-2-virus-konsantrasyonu-varyantlar.md) - [Marsilya - Küresel İzleme](https://success.openhealth.fr/tr/articles/4859311-marsilya-kuresel-izleme.md) - [SARS-CoV-2 virüs konsantrasyonu - Nice](https://success.openhealth.fr/tr/articles/4879292-sars-cov-2-virus-konsantrasyonu-nice.md) - [Nüfus - Yapı](https://success.openhealth.fr/tr/articles/4842408-nufus-yapi.md) - [SARS-CoV-2 virüs konsantrasyonu - Toulon \(FRANSA\)](https://success.openhealth.fr/tr/articles/4886417-sars-cov-2-virus-konsantrasyonu-toulon-fransa.md) - [Dubai - Havalimanı atık su izleme](https://success.openhealth.fr/tr/articles/5276423-dubai-havalimani-atik-su-izleme.md) - [SARS-CoV-2 sürveyansı - OBEPINE](https://success.openhealth.fr/tr/articles/5210661-sars-cov-2-surveyansi-obepine.md) - [SARS-CoV-2'nin bağlamsallaştırılmış konsantrasyonu](https://success.openhealth.fr/tr/articles/4934608-sars-cov-2-nin-baglamsallastirilmis-konsantrasyonu.md) - [SUEZ - Analitik bilanço](https://success.openhealth.fr/tr/articles/5140509-suez-analitik-bilanco.md) - [Palais des festivals - Watch T0](https://success.openhealth.fr/tr/articles/5373515-palais-des-festivals-watch-t0.md) - [Palais des festivals - Günlük nöbet](https://success.openhealth.fr/tr/articles/5373231-palais-des-festivals-gunluk-nobet.md) - [Palais des festivals - Gösterim](https://success.openhealth.fr/tr/articles/5404778-palais-des-festivals-gosterim.md) - [Mustelidler - İzle](https://success.openhealth.fr/tr/articles/5169577-mustelidler-izle.md) - [Nüfus - IRIS](https://success.openhealth.fr/tr/articles/4842191-nufus-iris.md) - [SARS-CoV-2](https://success.openhealth.fr/tr/articles/4865699-sars-cov-2.md) - [IAS - Analiz](https://success.openhealth.fr/tr/articles/4842430-ias-analiz.md) - [SARS-CoV-2 virüs konsantrasyonu - SEM](https://success.openhealth.fr/tr/articles/5415600-sars-cov-2-virus-konsantrasyonu-sem.md) - [Harita görselleştirme](https://success.openhealth.fr/tr/articles/3864657-harita-gorsellestirme.md) - [Site katkısı](https://success.openhealth.fr/tr/articles/3864668-site-katkisi.md) - [Sahaya göre kohort profili](https://success.openhealth.fr/tr/articles/3864672-sahaya-gore-kohort-profili.md) - [Mevsime göre kohort profili](https://success.openhealth.fr/tr/articles/3864673-mevsime-gore-kohort-profili.md) - [Yaş ve cinsiyet dağılımı](https://success.openhealth.fr/tr/articles/3864675-yas-ve-cinsiyet-dagilimi.md) - [Siteye göre virüs dağılımı](https://success.openhealth.fr/tr/articles/3864678-siteye-gore-virus-dagilimi.md) - [Yaşa göre virüs dağılımı](https://success.openhealth.fr/tr/articles/3864677-yasa-gore-virus-dagilimi.md) - [Virüs dağılımının evrimi](https://success.openhealth.fr/tr/articles/3864681-virus-dagiliminin-evrimi.md) - [Grip aşısı](https://success.openhealth.fr/tr/articles/3864697-grip-asisi.md) - [Grip aşısının evrimi](https://success.openhealth.fr/tr/articles/3864701-grip-asisinin-evrimi.md) - [Kronik duruma göre hasta dağılımı](https://success.openhealth.fr/tr/articles/3864676-kronik-duruma-gore-hasta-dagilimi.md) - [Hastanede kalış süresine göre hasta dağılımı](https://success.openhealth.fr/tr/articles/3864794-hastanede-kalis-suresine-gore-hasta-dagilimi.md) - [Kırılganlık](https://success.openhealth.fr/tr/articles/3864704-kirilganlik.md) - [Önemlilik durumu](https://success.openhealth.fr/tr/articles/3864705-onemlilik-durumu.md) - [Ölüm oranı](https://success.openhealth.fr/tr/articles/3864710-olum-orani.md) - [GIHSN](https://success.openhealth.fr/tr/articles/3864712-gihsn.md) - [CARéDIAB - Hasta profilleri](https://success.openhealth.fr/tr/articles/3789234-carediab-hasta-profilleri.md) - [CARéDIAB - Komplikasyonlar](https://success.openhealth.fr/tr/articles/3789515-carediab-komplikasyonlar.md) - [CARéDIAB - Küresel hasta izleme](https://success.openhealth.fr/tr/articles/3792041-carediab-kuresel-hasta-izleme.md) - [CARéDIAB Ağı](https://success.openhealth.fr/tr/articles/3789106-carediab-agi.md) - [CARéDIAB - Tedaviler](https://success.openhealth.fr/tr/articles/3792143-carediab-tedaviler.md)